PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hua, XT; Li, BB; Song, L; Hu, CM; Li, XY; Wang, DD; Xiong, Y; Zhao, P; He, HW; Xia, QY; Wang, F				Hua, Xiaoting; Li, Binbin; Song, Liang; Hu, Cuimei; Li, Xianyang; Wang, Dandan; Xiong, Ying; Zhao, Ping; He, Huawei; Xia, Qingyou; Wang, Fei			Stimulator of interferon genes (STING) provides insect antiviral immunity by promoting Dredd caspase-mediated NF-kappa B activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC GMP-AMP; CYTOSOLIC-DNA; BOMBYX-MORI; INTRACELLULAR DNA; TRANSCRIPTION FACTOR; PATHWAY; DROSOPHILA; PROTEIN; ADAPTER; SENSOR	The antiviral cGMP-AMP (cGAMP)-stimulator of interferon genes (STING) pathway is well characterized in mammalian cells. However, whether this pathway also plays a role in insect antiviral immunity is unknown. In this study, we found that cGAMP is produced in silkworm (Bombyx mori) cells infected with nucleopolyhedrovirus (NPV). In searches for STING-related sequences, we identified BmSTING, a potential cGAMP sensor in B. mori. We observed that BmSTING overexpression effectively inhibits NPV replication in silkworm larvae, whereas dsRNA-mediated BmSTING knockdown resulted in higher viral load. Cleavage and nuclear translocation of BmRelish, a NF-B-related transcription factor, was also observed when BmSTING was overexpressed and was enhanced by cGAMP stimulation or viral infection of B. mori larvae. Moreover, we identified a caspase-8-like protein (BmCasp8L) as a BmSTING-interacting molecule and as a suppressor of BmSTING-mediated BmRelish activation. Interestingly, cGAMP stimulation decreased BmCasp8L binding to BmSTING and increased BmRelish activity. Of note, an interaction between death-related ced-3/Nedd2-like caspase (BmDredd) and BmSTING promoted BmRelish cleavage for efficient antiviral signaling and protection of insect cells from viral infection. Our findings have uncovered BmSTING as a critical mediator of antiviral immunity in the model insect B. mori and have identified several BmSTING-interacting proteins that control antiviral defenses.	[Hua, Xiaoting; Li, Binbin; Song, Liang; Hu, Cuimei; Li, Xianyang; Wang, Dandan; Xiong, Ying; Zhao, Ping; He, Huawei; Xia, Qingyou; Wang, Fei] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China; [Zhao, Ping; He, Huawei; Xia, Qingyou] Southwest Univ, Chongqing Engn & Technol Res Ctr Novel Silk Mat, Chongqing 400715, Peoples R China	Southwest University - China; Southwest University - China	He, HW; Xia, QY; Wang, F (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.	hehuawei@swu.edu.cn; xiaqy@swu.edu.cn; fwangswu@gmail.com			State Key Program of National Natural Science of China [31530071]; Natural Science Foundation of China [31672495, 31572465]; Chongqing Research Program of Basic Research and Frontier Technology [CSTC2014JCYJA80010, CSTC2015JCYJBX0035]	State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Research Program of Basic Research and Frontier Technology	This work was supported by State Key Program of National Natural Science of China Grant 31530071, Natural Science Foundation of China Grants 31672495 and 31572465, and Chongqing Research Program of Basic Research and Frontier Technology CSTC2014JCYJA80010 and CSTC2015JCYJBX0035. The authors declare that they have no conflicts of interest with the contents of this article.	Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Bao YY, 2009, GENOMICS, V94, P138, DOI 10.1016/j.ygeno.2009.04.003; Barber GN, 2014, TRENDS IMMUNOL, V35, P88, DOI 10.1016/j.it.2013.10.010; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Broderick NA, 2014, MBIO, V5, DOI 10.1128/mBio.01117-14; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Dong ZM, 2016, J PROTEOME RES, V15, P1435, DOI 10.1021/acs.jproteome.5b00943; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Guo R, 2015, APPL MICROBIOL BIOT, V99, P5175, DOI 10.1007/s00253-015-6634-x; Hua XT, 2016, INSECT SCI, V23, P297, DOI 10.1111/1744-7917.12210; Huang LL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.4001; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jiang Y, 2017, PROTEIN CELL, V8, P83, DOI 10.1007/s13238-016-0303-4; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Jin SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099200; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Ma XJ, 2015, INSECT BIOCHEM MOLEC, V63, P144, DOI 10.1016/j.ibmb.2015.06.009; Massie JP, 2012, P NATL ACAD SCI USA, V109, P12746, DOI 10.1073/pnas.1115663109; Meinander A, 2012, EMBO J, V31, P2770, DOI 10.1038/emboj.2012.121; Mon H, 2012, RNA BIOL, V9, P40, DOI 10.4161/rna.9.1.18084; Moreno-Habel DA, 2012, J INVERTEBR PATHOL, V110, P92, DOI 10.1016/j.jip.2012.02.007; O'Reilly D., 1992, BACULOVIRUS EXPRESSI, P69; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Pan MH, 2007, IN VITRO CELL DEV-AN, V43, P101, DOI 10.1007/s11626-006-9009-x; Paradkar PN, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002823; Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109; Qian WL, 2017, J BIOL CHEM, V292, P12460, DOI [10.1074/jbc.M117.775130, 10.1074/jbc.m117.775130]; Roers A, 2016, IMMUNITY, V44, P739, DOI 10.1016/j.immuni.2016.04.002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tatsuke T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092313; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	46	40	43	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11878	11890		10.1074/jbc.RA117.000194	http://dx.doi.org/10.1074/jbc.RA117.000194			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29875158	Green Published, hybrid			2022-12-26	WOS:000440134500020
J	Yuan, L; Singh, D; Buescher, JL; Arikkath, J				Yuan, Li; Singh, Dipika; Buescher, James L.; Arikkath, Jyothi			A role for proteolytic regulation of -catenin in remodeling a subpopulation of dendritic spines in the rodent brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						catenin; proteolysis; calpain; neuron; dendritic spine; -catenin; neural development	REPEAT PROTEIN/DELTA-CATENIN; DELTA-CATENIN; HIPPOCAMPAL-NEURONS; SYNAPSE MORPHOGENESIS; CALPAIN; PLASTICITY; CELLS; FAMILY; ACIDIFICATION; LOCALIZATION	Neural wiring and activity are essential for proper brain function and behavioral outputs and rely on mechanisms that guide the formation, elimination, and remodeling of synapses. During development, it is therefore vital that synaptic densities and architecture are tightly regulated to allow for appropriate neural circuit formation and function. -Catenin, a component of the cadherin-catenin cell adhesion complex, has been demonstrated to be a critical regulator of synaptic density and function in the developing central neurons. In this study, we identified forms of -catenin that include only the N-terminal (DcatNT) or the C-terminal (DcatCT) regions. We found that these -catenin forms are differentially expressed in different regions of the male mouse brain. Our results also indicated that in rat primary cortical culture, these forms are generated in an activity-dependent manner by Ca2+-dependent and calpain-mediated cleavage of -catenin or in an activity-independent but lysosome-dependent manner. Functionally, loss of the domain containing the calpain-cleavage sites allowing for generation of DcatCT and DcatNT perturbed the density of a subpopulation of dendritic protrusions in rat hippocampal neurons. This subpopulation likely included protrusions that are either in transition toward becoming mature mushroom spines or in the process of being eliminated. By influencing this subpopulation of spines, proteolytic processing of -catenin can likely regulate the balance between mature and immature dendritic protrusions in coordination with neural activity. We conclude that by undergoing cleavage, -catenin differentially regulates the densities of subpopulations of dendritic spines and contributes to proper neural circuit wiring in the developing brain.	[Yuan, Li; Arikkath, Jyothi] Univ Nebraska Med Ctr, Munroe Meyer Inst, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Yuan, Li; Singh, Dipika; Buescher, James L.; Arikkath, Jyothi] Univ Nebraska Med Ctr, Munroe Meyer Inst, Dev Neurosci, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Arikkath, J (corresponding author), Univ Nebraska Med Ctr, Munroe Meyer Inst, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.; Arikkath, J (corresponding author), Univ Nebraska Med Ctr, Munroe Meyer Inst, Dev Neurosci, Omaha, NE 68198 USA.	jyothi.arikkath@unmc.edu			Munroe-Meyer Institute; Alzheimer's Association; Nebraska Research Initiative; National Institutes of Health Institutional Development Award (IDeA) from NIGMS [5P20GM103471-10]; Nebraska EPSCoR [EPS-1004094]; National Institutes of Health [1R03MH110726-01]; University of Nebraska Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH110726] Funding Source: NIH RePORTER	Munroe-Meyer Institute; Alzheimer's Association(Alzheimer's Association); Nebraska Research Initiative; National Institutes of Health Institutional Development Award (IDeA) from NIGMS; Nebraska EPSCoR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nebraska Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by Startup Funds from the Munroe-Meyer Institute, grants from the Alzheimer's Association, The Nebraska Research Initiative, National Institutes of Health Institutional Development Award (IDeA) 5P20GM103471-10 from NIGMS, Nebraska EPSCoR Grant EPS-1004094, and National Institutes of Health Grant 1R03MH110726-01. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a graduate student fellowship from the University of Nebraska Medical Center.	Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Amini M, 2013, J NEUROSCI, V33, P5773, DOI 10.1523/JNEUROSCI.4247-12.2013; Arikkath J, 2008, J NEUROSCI, V28, P7047, DOI 10.1523/JNEUROSCI.0451-08.2008; Arikkath J, 2009, J NEUROSCI, V29, P5435, DOI 10.1523/JNEUROSCI.0835-09.2009; Bai G, 2011, NEURON, V72, P9, DOI 10.1016/j.neuron.2011.09.012; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Belcaro C, 2015, GENE, V565, P146, DOI 10.1016/j.gene.2015.03.054; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Bourgeron T, 2015, NAT REV NEUROSCI, V16, P551, DOI 10.1038/nrn3992; Brigidi GS, 2014, NAT NEUROSCI, V17, P522, DOI 10.1038/nn.3657; Gu DM, 2011, J BIOL CHEM, V286, P23178, DOI 10.1074/jbc.M110.167544; Gu DM, 2009, J CELL SCI, V122, P4049, DOI 10.1242/jcs.031948; Haggie PM, 2009, J BIOL CHEM, V284, P7681, DOI 10.1074/jbc.M809161200; Harris D. C., 2010, QUANTITATIVE CHEM AN; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Ide N, 1999, BIOCHEM BIOPH RES CO, V256, P456, DOI 10.1006/bbrc.1999.0364; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Jones SB, 2002, NEUROSCIENCE, V115, P1009, DOI 10.1016/S0306-4522(02)00532-8; Kawamura Y, 1999, NEUROSCI LETT, V277, P185, DOI 10.1016/S0304-3940(99)00875-7; Kim H, 2008, J BIOL CHEM, V283, P977, DOI 10.1074/jbc.M707158200; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Markham NO, 2014, MOL BIOL CELL, V25, P2592, DOI 10.1091/mbc.E13-08-0492; Martinez JA, 2010, APOPTOSIS, V15, P1480, DOI 10.1007/s10495-010-0526-4; Matter C, 2009, NEURON, V64, P320, DOI 10.1016/j.neuron.2009.09.026; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Ochiishi T, 2008, MOL CELL NEUROSCI, V39, P499, DOI 10.1016/j.mcn.2008.06.002; Ono Y, 2016, NAT REV DRUG DISCOV, V15, P854, DOI 10.1038/nrd.2016.212; Paffenholz R, 1997, DIFFERENTIATION, V61, P293, DOI 10.1046/j.1432-0436.1997.6150293.x; PAPA M, 1995, J NEUROSCI, V15, P1; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Seong E, 2015, CELL ADHES MIGR, V9, P202, DOI 10.4161/19336918.2014.994919; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Suresh A, 2017, CEREB CORTEX, V27, P4244, DOI 10.1093/cercor/bhx128; Turner TN, 2015, NATURE, V520, P51, DOI 10.1038/nature14186; Valcu M, 2011, NAT METHODS, V8, P104, DOI 10.1038/nmeth0211-104; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yuan L, 2017, SEMIN CELL DEV BIOL, V69, P70, DOI 10.1016/j.semcdb.2017.05.027; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	43	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11625	11638		10.1074/jbc.RA118.001966	http://dx.doi.org/10.1074/jbc.RA118.001966			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29875160	Green Published, hybrid			2022-12-26	WOS:000439449700030
J	Lynch, JH; Sa, N; Saeheng, S; Raffaelli, N; Roje, S				Lynch, Joseph H.; Sa, Na; Saeheng, Sompop; Raffaelli, Nadia; Roje, Sanja			Characterization of a non-nudix pyrophosphatase points to interplay between flavin and NAD(H) homeostasis in Saccharomyces cerevisiae	PLOS ONE			English	Article							HALOACID DEHALOGENASE SUPERFAMILY; HUMAN FAD SYNTHETASE; ADENINE-DINUCLEOTIDE; RAT-LIVER; HYDROLASE SUPERFAMILY; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; FMN PHOSPHOHYDROLASE; PARTIAL-PURIFICATION; YEAST MITOCHONDRIA	The flavin cofactors FMN and FAD are required for a wide variety of biological processes, however, little is known about their metabolism. Here, we report the cloning and biochemical characterization of the Saccharomyces cerevisiae pyrophosphatase Fpy1p. Genetic and functional studies suggest that Fpy1p may play a key role in flavin metabolism and is the first-reported non-Nudix superfamily enzyme to display FAD pyrophosphatase activity. Characterization of mutant yeast strains found that deletion of fpy1 counteracts the adverse effects that are caused by deletion of flx1, a known mitochondrial FAD transporter. We show that Fpy1p is capable of hydrolyzing FAD, NAD(H), and ADP-ribose. The enzymatic activity of Fpy1p is dependent upon the presence of K+ and divalent metal cations, with similar kinetic parameters to those that have been reported for Nudix FAD pyrophosphatases. In addition, we report that the deletion of fpy1 intensifies the FMN-dependence of null mutants of the riboflavin kinase Fmn1p, demonstrate that fpy1 mutation abolishes the decreased fitness resulting from the deletion of the flx1 ORF, and offer a possible mechanism for the genetic interplay between fpy1, flx1 and fmn1.	[Lynch, Joseph H.; Sa, Na; Saeheng, Sompop; Roje, Sanja] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Raffaelli, Nadia] Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, Ancona, Italy	Washington State University; Marche Polytechnic University	Roje, S (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	sanja@wsu.edu	; Hubbard, Mark/T-5856-2018	Lynch, Joseph/0000-0003-0685-1562; Hubbard, Mark/0000-0002-3337-8558	United States National Institute of Food and Agriculture under National Research Initiative Competitive Grant [2007-35318-18438]; National Science Foundation [MCB-1052492]; Italian Ministry of Foreign Affairs "Direzione Generale per la Promozione del Sistema Paese"	United States National Institute of Food and Agriculture under National Research Initiative Competitive Grant; National Science Foundation(National Science Foundation (NSF)); Italian Ministry of Foreign Affairs "Direzione Generale per la Promozione del Sistema Paese"(Ministry of Foreign Affairs and International Cooperation (Italy))	This work was supported by the United States National Institute of Food and Agriculture (https://nifa.usda.gov/) under National Research Initiative Competitive Grant 2007-35318-18438, the National Science Foundation (https.//www.nsf.gov/) Grant MCB-1052492, and the Italian Ministry of Foreign Affairs (http://www.esteri.it/mae/en) "Direzione Generale per la Promozione del Sistema Paese". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas CA, 2011, MICROBIOL MOL BIOL R, V75, P321, DOI 10.1128/MMBR.00030-10; Abdelraheim SR, 2003, BIOCHEM J, V374, P329, DOI 10.1042/BJ20030441; Aliverti A, 1999, IDENTIFYING QUANTITA, P9; Bacher A, 2001, VITAM HORM, V61, P1; Bacher A, 2000, ANNU REV NUTR, V20, P153, DOI 10.1146/annurev.nutr.20.1.153; Bafunno V, 2004, J BIOL CHEM, V279, P95, DOI 10.1074/jbc.M308230200; Bakker BM, 2000, J BACTERIOL, V182, P4730, DOI 10.1128/JB.182.17.4730-4737.2000; Barile M, 1997, EUR J BIOCHEM, V249, P777, DOI 10.1111/j.1432-1033.1997.00777.x; Barile M, 2000, EUR J BIOCHEM, V267, P4888, DOI 10.1046/j.1432-1327.2000.01552.x; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Briggs WR, 2001, PLANT PHYSIOL, V125, P85, DOI 10.1104/pp.125.1.85; Brizio C, 2006, BIOCHEM BIOPH RES CO, V344, P1008, DOI 10.1016/j.bbrc.2006.04.003; BYRD JC, 1985, J BIOL CHEM, V260, P7474; Cialabrini L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065595; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; De Colibus L, 2006, CURR OPIN STRUC BIOL, V16, P722, DOI 10.1016/j.sbi.2006.10.003; Fischer M, 2005, NAT PROD REP, V22, P324, DOI 10.1039/b210142b; Fischer M, 2006, PHYSIOL PLANTARUM, V126, P304, DOI 10.1111/j.1399-3054.2006.00607.x; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Galluccio M, 2007, PROTEIN EXPRES PURIF, V52, P175, DOI 10.1016/j.pep.2006.09.002; Gardner JM, 2014, METHODS MOL BIOL, V1205, P45, DOI 10.1007/978-1-4939-1363-3_5; Giancaspero TA, 2009, FEBS J, V276, P219, DOI 10.1111/j.1742-4658.2008.06775.x; Gliszczynska-Swiglo A, 2000, J CHROMATOGR A, V881, P285, DOI 10.1016/S0021-9673(00)00200-4; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Goncalves AMD, 2009, ACTA CRYSTALLOGR F, V65, P1083, DOI [10.1107/S174430910903791, 10.1107/S1744309109037191]; Granjeiro JM, 1997, BIOCHEM MOL BIOL INT, V41, P1201; Grossman E, 2012, ANNU REV BIOPHYS, V41, P557, DOI [10.1146/annurev-biophys-050511-102328, 10.1146/annurev-biophys-850511-102328]; Harju S, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-8; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; KEARNEY EB, 1956, J BIOL CHEM, V219, P963; King T.E., 1967, METHOD ENZYMOL, V10, P322, DOI DOI 10.1016/0076-6879(67)10061-X; KORNBERG A, 1950, J BIOL CHEM, V182, P763; KUMAR SA, 1965, ARCH BIOCHEM BIOPHYS, V111, P646, DOI 10.1016/0003-9861(65)90246-8; Larsson C, 1998, YEAST, V14, P347, DOI 10.1002/(SICI)1097-0061(19980315)14:4<347::AID-YEA226>3.0.CO;2-9; LEE RSF, 1988, J BIOL CHEM, V263, P14878; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARRES CAM, 1991, EUR J BIOCHEM, V195, P857, DOI 10.1111/j.1432-1033.1991.tb15775.x; Maruta T, 2012, PLANT CELL PHYSIOL, V53, P1106, DOI 10.1093/pcp/pcs054; Massey V, 1995, FLAVOPROTEIN STRUCTU; MCCORMICK DB, 1962, J BIOL CHEM, V237, P959; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Nakane S, 2011, J BIOL CHEM; Navarrete C, 2010, FEMS YEAST RES, V10, P508, DOI 10.1111/j.1567-1364.2010.00630.x; Ogawa T, 2008, PLANT PHYSIOL, V148, P1412, DOI 10.1104/pp.108.128413; Pallotta ML, 2011, YEAST, V28, P693, DOI 10.1002/yea.1897; Pallotta ML, 1998, FEBS LETT, V428, P245, DOI 10.1016/S0014-5793(98)00544-4; Pinto RM, 1999, ANAL BIOCHEM, V268, P409, DOI 10.1006/abio.1998.3063; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; Pourbaix M., 1966, ATLAS ELECTROCHEMICA, Vfirst English; Rawat R, 2011, J BIOL CHEM, V286, P42091, DOI 10.1074/jbc.M111.260885; Reed L.J., 1966, METHOD ENZYMOL, V9, P247; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Roje S, 2007, PHYTOCHEMISTRY, V68, P1904, DOI 10.1016/j.phytochem.2007.03.038; RUIZ A, 1989, J BACTERIOL, V171, P6703, DOI 10.1128/jb.171.12.6703-6709.1989; Rzewuski G, 2007, J EXP BOT, V58, P1505, DOI 10.1093/jxb/erm014; Sandoval FJ, 2005, J BIOL CHEM, V280, P38337, DOI 10.1074/jbc.M500350200; Sandoval FJ, 2008, J BIOL CHEM, V283, P30890, DOI 10.1074/jbc.M803416200; Santos MA, 2000, J BIOL CHEM, V275, P28618, DOI 10.1074/jbc.M004621200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHIN H, 1988, ARCH BIOCHEM BIOPHYS, V267, P95, DOI 10.1016/0003-9861(88)90012-4; Singh J, 2009, GENE DEV, V23, P1944, DOI 10.1101/gad.1804409; Sporty JL, 2008, J SEP SCI, V31, P3202, DOI 10.1002/jssc.200800238; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Tirrell IM, 2006, BIOCHEM J, V394, P665, DOI 10.1042/BJ20051172; Torchetti EM, 2011, FEBS J, V278, P4435, DOI 10.1111/j.1742-4658.2011.08368.x; Tzagoloff A, 1996, J BIOL CHEM, V271, P7392, DOI 10.1074/jbc.271.13.7392; Walker GM, 2004, ADV APPL MICROBIOL, V54, P197, DOI 10.1016/S0065-2164(04)54008-X; WU M, 1995, MOL CELL BIOL, V15, P264, DOI 10.1128/MCB.15.1.264; Xu WL, 2002, J BIOL CHEM, V277, P23181, DOI 10.1074/jbc.M203325200; Yatsyshyn VY, 2009, APPL BIOCHEM MICRO+, V45, P115, DOI 10.1134/S000368380902001X	73	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198787	10.1371/journal.pone.0198787	http://dx.doi.org/10.1371/journal.pone.0198787			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902190	gold, Green Submitted, Green Published			2022-12-26	WOS:000435424900042
J	Fantle-Lepczyk, J; Taylor, A; Duffy, DC; Crampton, LH; Conant, S				Fantle-Lepczyk, Jean; Taylor, Andrew; Duffy, David C.; Crampton, Lisa H.; Conant, Sheila			Using population viability analysis to evaluate management activities for an endangered Hawaiian endemic, the Puaiohi (Myadestes palmeri)	PLOS ONE			English	Article							CONSERVATION BIOLOGY; AVIAN MALARIA; KAUAI; ISLANDS; BIRDS; NEST; CLIMATE; PRECIPITATION; INCREASE; ECOLOGY	Evolution in the Hawaiian Islands has produced a unique avian assemblage. Unfortunately, many of these bird species are highly endangered or extinct. Despite numerous and increasing threats and great effort aimed at saving endemic birds, we lack basic science necessary for understanding many species of concern. One such species is the critically endangered Puaiohi (Myadestes palmen), a rare songbird endemic to the island of Kaua'i and the only remaining native thrush on the island. At present, the Puaiohi's breeding population is estimated to be similar to 500 birds restricted to the Alaka'i Wilderness Preserve. We collected demographic data from 2007-2012 and supplemented it with published sources. Using Vortex, we developed stochastic population models to represent Puaiohi population dynamics under current and potential management scenarios to determine management's potential efficacy in aiding species recovery. Management scenarios modeled included rat control, habitat improvement, general survival facilitation, and provision of nest boxes. The model indicated a decline in abundance with a growth rate (r) of -0.267 under baseline conditions. Female and juvenile survival appeared to be the most influential parameters related to population growth and persistence, so management should focus on increasing female and juvenile Puaiohi survival. Rat control, even at more conservative levels, appeared to be the most effective method of increasing Puaiohi abundance. Our results indicate that practical, attainable management activities can increase Puaiohi and bring the species back from the brink of extinction. Such findings provide an example for other endangered species conservation efforts.	[Fantle-Lepczyk, Jean; Taylor, Andrew; Conant, Sheila] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Duffy, David C.] Univ Hawaii Manoa, Dept Bot, Pacific Cooperat Studies Unit, Honolulu, HI 96822 USA; [Crampton, Lisa H.] Hawaii Div Forestry & Wildlife, Kauai Forest Birds Recovery Project, Hanapepe, HI USA; [Crampton, Lisa H.] Univ Hawaii Manoa, Hanapepe, HI USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Fantle-Lepczyk, J (corresponding author), Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA.	fantle@hawaii.edu		Fantle-Lepczyk, Jean/0000-0001-5388-0871	Watson T. Yoshimoto Fellowship of the Ecology, Evolution, and Conservation Biology program of the University of Hawaii at Manoa	Watson T. Yoshimoto Fellowship of the Ecology, Evolution, and Conservation Biology program of the University of Hawaii at Manoa	Project support was provided by the Watson T. Yoshimoto Fellowship of the Ecology, Evolution, and Conservation Biology program of the University of Hawaii at Manoa for the purchase of RAMAS software and travel funds to the field site.	Akcakaya H.R., 2005, RAMAS METAPOP VIABIL; Akcakaya H. Resit, 2000, Ecological Bulletins, V48, P9; Akû║akaya H.R., 1999, APPL POPULATION ECOL; American Bird Conservancy, 2016, PAR SOM ONG EXT CRIS; Atkinson CT, 2014, GLOBAL CHANGE BIOL, V20, P2426, DOI 10.1111/gcb.12535; Atkinson CT, 2001, CONDOR, V103, P209, DOI 10.1650/0010-5422(2001)103[0209:PSRADO]2.0.CO;2; Banko Winston E., 2009, P25; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Benning TL, 2002, P NATL ACAD SCI USA, V99, P14246, DOI 10.1073/pnas.162372399; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; Burney DA, 2001, ECOL MONOGR, V71, P615, DOI 10.1890/0012-9615(2001)071[0615:FEFADB]2.0.CO;2; Chu PS, 2010, J CLIMATE, V23, P4881, DOI 10.1175/2010JCLI3484.1; Chu PS, 2005, J CLIMATE, V18, P4796, DOI 10.1175/JCLI3578.1; Cobb KM, 2013, SCIENCE, V339, P67, DOI 10.1126/science.1228246; Conant S, 1998, WILSON BULL, V110, P1; Crampton LH, 2017, BIODIVERS CONSERV, V26, P1525, DOI 10.1007/s10531-017-1313-0; Cross PC, 2001, CONSERV BIOL, V15, P1335, DOI 10.1046/j.1523-1739.2001.00031.x; DiNezio PN, 2013, J CLIMATE, V26, P4038, DOI 10.1175/JCLI-D-12-00531.1; Duca C, 2009, BIOL CONSERV, V142, P563, DOI 10.1016/j.biocon.2008.11.010; Duffy David Cameron, 2008, Pacific Conservation Biology, V14, P80; Ellner SP, 2003, ECOLOGY, V84, P1359, DOI 10.1890/0012-9658(2003)084[1359:UPFMDU]2.0.CO;2; Ergon T, 2014, METHODS ECOL EVOL, V5, P1327, DOI 10.1111/2041-210X.12133; Fantle-Lepczyk J, 2016, WILSON J ORNITHOL, V128, P43, DOI 10.1676/wils-128-01-43-55.1; Garcia-Ripolles C, 2011, J ORNITHOL, V152, P879, DOI 10.1007/s10336-011-0671-8; Hammond RL, 2015, CONDOR, V117, P31, DOI 10.1650/CONDOR-14-75.1; Herrmann Christina M., 1997, Elepaio, V57, P73; Houston D, 2007, BIOL CONSERV, V138, P248, DOI 10.1016/j.biocon.2007.04.023; IUCN, 2012, IUCN RED LIST THREAT; James HF, 1991, ORNITHOLOGICAL MONOG, V45, P1, DOI DOI 10.2307/40166713; KEPLER CB, 1983, CONDOR, V85, P497, DOI 10.2307/1367996; Kolivras KN, 2007, PHYS GEOGR, V28, P76, DOI 10.2747/0272-3646.28.1.76; Lacy R.C., 2014, VORTEX STOCHASTIC SI; LaPointe DA, 2012, ANN NY ACAD SCI, V1249, P211, DOI 10.1111/j.1749-6632.2011.06431.x; Lindenmayer DB, 1996, CONSERV BIOL, V10, P235, DOI 10.1046/j.1523-1739.1996.10010235.x; Gonzalez L, 2006, BIOL CONSERV, V129, P477, DOI 10.1016/j.biocon.2005.11.014; Medeiros A. C., 2004, THESIS; Meng QJ, 2012, CLIM DYNAM, V38, P1757, DOI 10.1007/s00382-011-1047-8; Minden V, 2010, APPL VEG SCI, V13, P5, DOI 10.1111/j.1654-109X.2009.01056.x; Morris W. F., 2002, QUANTITATIVE CONSERV; Mounce HL, 2013, J FIELD ORNITHOL, V84, P32, DOI 10.1111/jofo.12003; Murakami H, 2013, NAT CLIM CHANGE, V3, P749, DOI [10.1038/nclimate1890, 10.1038/NCLIMATE1890]; National Climatic Data Center, 2013, NCDC GLOB HIST CLIM; Newton I., 1998, POPULATION LIMITATIO; Owen-Smith N., 2007, INTRO MODELING WILDL; Paxton EH, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600029; Perkins R.C.L., 1903, FAUNA HAWAIIENSIS, V1, Part. 4, P365; Pitt William C., 2011, Human-Wildlife Interactions, V5, P100; Pratt Thane K., 2009, P3; Proctor MF, 2004, URSUS, V15, P145, DOI 10.2192/1537-6176(2004)015<0145:ACAOMO>2.0.CO;2; Reed JM, 2002, CONSERV BIOL, V16, P7, DOI 10.1046/j.1523-1739.2002.99419.x; Robinson OJ, 2015, CONSERV LETT, V8, P190, DOI 10.1111/conl.12146; Schoech SJ, 2008, BIOL CONSERV, V141, P162, DOI 10.1016/j.biocon.2007.09.009; Scott J. M., 1986, STUD AVIAN BIOL SER, V9, P431; Snetsinger T. S., 1999, BIRDS N AM; Snetsinger TJ, 2005, WILSON BULL, V117, P72, DOI 10.1676/04-049; U. S. Fish and Wildlife Service, 2006, REV REC PLAN HAW FOR; VANDERWERF E.A., 2013, HAWAIIAN BIRD CONSER; VanderWerf E. A., 2011, P ISL INV ER MAN C; VanderWerf EA, 2014, CONDOR, V116, P609, DOI 10.1650/CONDOR-14-18.1; VanderWerf Eric A., 2002, Pacific Conservation Biology, V8, P73; Vanderwerf EA, 2009, J WILDLIFE MANAGE, V73, P737, DOI 10.2193/2008-284; Walther M, 2016, EXTINCT BIRDS HAWAII; White JW, 2014, OIKOS, V123, P385, DOI 10.1111/j.1600-0706.2013.01073.x; Woodworth Benthany L., 2009, P499; Woodworth Bethany L., 2009, P194	65	7	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198952	10.1371/journal.pone.0198952	http://dx.doi.org/10.1371/journal.pone.0198952			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897991	Green Published, gold, Green Submitted			2022-12-26	WOS:000435090700082
J	Sorensen, JR; Fuqua, JD; Deyhle, MR; Parmley, J; Skousen, C; Hancock, C; Parcell, AC; Hyldahl, RD				Sorensen, Jacob R.; Fuqua, Jordan D.; Deyhle, Michael R.; Parmley, Jacob; Skousen, Caitlin; Hancock, Chad; Parcell, Allen C.; Hyldahl, Robert D.			Preclinical characterization of the JAK/STAT inhibitor SGI-1252 on skeletal muscle function, morphology, and satellite cell content	PLOS ONE			English	Article							SELF-RENEWAL; STEM-CELLS; IN-VITRO; PATHWAY; HYPERTROPHY; ACTIVATION; MYOSTATIN; PROLIFERATION; QUIESCENCE; CAPACITY	Background Recent studies have highlighted the JAK/STAT signaling pathway in the regulation of muscle satellite cell behavior. Herein we report preclinical studies designed to characterize the effects of a novel JAK/STAT inhibitor on plantar flexor skeletal muscle function, morphology, and satellite cell content. Methods The compound, SGI-1252, was administered orally (400mg/kg) in a 10% dextrose solution to wild type mice (n = 6) 3 times per week for 8 weeks. A control group (n = 6) received only the dextrose solution. Results SGI-1252 was well tolerated, as animals displayed similar weight gain over the 8-week treatment period. Following treatment, fatigue in the gastrocnemius-soleus-plantaris complex was greater in the SGI-1252 mice during a 300 second tetanic contraction bout (p = 0.035), though both the rate of fatigue and maximal force production were similar. SGI-1252 treated mice had increased type II myofiber cross-sectional area (1434.8 +/- 225.4 vs 1754.7 +/- 138.5 mu m(2)), along with an increase in wet muscle mass (125.45 +/- 5.46 vs 139.6 +/- 12.34 mg, p = 0.032) of the gastrocnemius relative to vehicle treated mice. SGI-1252 treatment reduced gastrocnemius STAT3 phosphorylation 53% (94.79 +/- 45.9 vs 44.5 +/- 6.1 MFI) and significantly increased the concentration of Pax7+ satellite cells (2589.2 +/- 105.5 vs 2859.4 177.5 SC/mm(3)) in the gastrocnemius. SGI-1252 treatment suppressed MyoD (p = 0.013) and Myogenin (p<0.0001) expression in human primary myoblasts, resulting in reduced myogenic differentiation (p = 0.039). Conclusions Orally delivered SG1-1252 was well tolerated, attenuates skeletal muscle STAT3 activity, and increases satellite cell content in mouse gastrocnemius muscle, likely by inhibiting myogenic progression.	[Sorensen, Jacob R.; Fuqua, Jordan D.; Deyhle, Michael R.; Parmley, Jacob; Skousen, Caitlin; Parcell, Allen C.; Hyldahl, Robert D.] Brigham Young Univ, Dept Exercise Sci, Provo, UT 84602 USA; [Hancock, Chad] Brigham Young Univ, Dept Nutr Dietet & Food Sci, Provo, UT 84602 USA	Brigham Young University; Brigham Young University	Sorensen, JR (corresponding author), Brigham Young Univ, Dept Exercise Sci, Provo, UT 84602 USA.	jross.sorensen@gmail.com	Hancock, Chad R./X-4803-2018; Hyldahl, Robert/AAZ-3960-2020	Hancock, Chad R./0000-0002-1578-5301; Davis, Gavin/0000-0002-0654-7918; Deyhle, Michael/0000-0001-8526-4758; Sorensen, Jacob/0000-0001-5945-542X				Agley CC, 2015, JOVE-J VIS EXP, DOI 10.3791/52049; Ahmed KBR, 2011, EXP HEMATOL, V39, P14, DOI 10.1016/j.exphem.2010.09.013; Augusto V, 2004, BRAZ J MORPHOL SCIS, V21, P89; Bellamy LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109739; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Bonetto A, 2012, AM J PHYSIOL-ENDOC M, V303, pE410, DOI 10.1152/ajpendo.00039.2012; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Brack AS, 2007, STEM CELL REV, V3, P226, DOI 10.1007/s12015-007-9000-2; Bruusgaard JC, 2012, J APPL PHYSIOL, V113, P290, DOI 10.1152/japplphysiol.00436.2012; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Day K, 2010, DEV BIOL, V340, P330, DOI 10.1016/j.ydbio.2010.01.006; Gurzov EN, 2016, FEBS J, V283, P3002, DOI 10.1111/febs.13709; Hancock CR, 2005, AM J PHYSIOL-CELL PH, V288, pC1287, DOI 10.1152/ajpcell.00567.2004; Jang You-Na, 2013, JAKSTAT, V2, pe23282, DOI 10.4161/jkst.23282; Keefe AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8087; Kosek DJ, 2006, J APPL PHYSIOL, V101, P531, DOI 10.1152/japplphysiol.01474.2005; Kremer JM, 2009, ARTHRITIS RHEUM-US, V60, P1895, DOI 10.1002/art.24567; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Mendias CL, 2011, J APPL PHYSIOL, V111, P185, DOI 10.1152/japplphysiol.00126.2011; Merritt EK, 2013, J APPL PHYSIOL, V115, P937, DOI 10.1152/japplphysiol.00019.2013; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Silva KAS, 2015, J BIOL CHEM, V290, P11177, DOI 10.1074/jbc.M115.641514; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Smith IJ, 2014, FASEB J, V28, P2790, DOI 10.1096/fj.13-244210; Snijders T., 2014, AGE, V36, P1; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Sun LR, 2007, BEILSTEIN J ORG CHEM, V3, DOI 10.1186/1860-5397-3-3; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Thomson DM, 2010, J APPL PHYSIOL, V108, P1775, DOI 10.1152/japplphysiol.01293.2009; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Trenerry MK, 2007, J APPL PHYSIOL, V102, P1483, DOI 10.1152/japplphysiol.01147.2006; Troy A, 2012, CELL STEM CELL, V11, P541, DOI 10.1016/j.stem.2012.05.025; Verdijk LB, 2009, J GERONTOL A-BIOL, V64, P332, DOI 10.1093/gerona/gln050; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; Yamada M, 2010, AM J PHYSIOL-CELL PH, V298, pC465, DOI 10.1152/ajpcell.00449.2009; Yang YP, 2009, CYTOKINE, V46, P137, DOI 10.1016/j.cyto.2008.12.015; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zhang CC, 2013, J BIOL CHEM, V288, P1489, DOI 10.1074/jbc.M112.419788; Zhang LP, 2013, CELL METAB, V18, P368, DOI 10.1016/j.cmet.2013.07.012	46	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198611	10.1371/journal.pone.0198611	http://dx.doi.org/10.1371/journal.pone.0198611			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897957	Green Submitted, Green Published, gold			2022-12-26	WOS:000435090700059
J	Hanschmidt, F; Nagl, M; Klingner, J; Stepan, H; Kersting, A				Hanschmidt, Franz; Nagl, Michaela; Klingner, Johanna; Stepan, Holger; Kersting, Anette			Abortion after diagnosis of fetal anomaly: Psychometric properties of a German version of the individual level abortion stigma scale	PLOS ONE			English	Article							PREGNANCY TERMINATION; INTERNALIZED STIGMA; PRENATAL-DIAGNOSIS; MENTAL-ILLNESS; SPINA-BIFIDA; MISSING DATA; WOMEN; CONSEQUENCES; EXPERIENCES; HEALTH	Background Diagnosis of fetal anomaly is a significant life event and social stigma can negatively impact on the well-being of women opting for an abortion. This study investigated the psychometric properties of a measure of stigma among women who had had an abortion after diagnosis of fetal anomaly in a German setting. Methods The Individual Level Abortion Stigma (ILAS) scale was translated into German. Psychometric properties of the ILAS scale were examined among 130 women with a history of an abortion after diagnosis of fetal anomaly. Individual and situational factors associated with stigma in the context of an abortion after diagnosis of fetal anomaly were explored. Results Factor analysis suggested a four-dimensional structure of the German version of the Individual Level Abortion Stigma scale (Cronbach's alpha, .83-.91), corresponding to the subscales of the original scale. Test-retest reliability was acceptable for the worries about judgment sub scale, the self -judgment subscale, and the community condemnation subscale, but less convincing for the isolation subscale. Associations between the subscales and measures of depression, self-esteem and secrecy were found in directions consistent with theory. Women who did not perceive their fetus to have a low survival chance and women whose fetus was at higher gestational age reported higher levels of stigma, whereas higher perceived partner support was associated with lower levels of stigma. Limitation Generalizability of study results was limited, as participants were recruited from one clinic in Germany and the study had a response rate of 46.5%. Conclusions The ILAS subscales are largely reliable and valid measures to assess stigma among women who have had an abortion after diagnosis of fetal anomaly. Suggestions for improving the assessment of stigma experienced in this population are outlined. The scales can be useful in research aiming at investigating psychological outcomes of abortion after diagnosis of fetal anomaly and improving care structures.	[Hanschmidt, Franz; Nagl, Michaela; Klingner, Johanna; Kersting, Anette] Univ Leipzig, Dept Psychosomat Med, Leipzig, Germany; [Stepan, Holger] Univ Leipzig, Dept Obstet, Leipzig, Germany	Leipzig University; Leipzig University	Hanschmidt, F (corresponding author), Univ Leipzig, Dept Psychosomat Med, Leipzig, Germany.	franz.hanschmidt@medizin.uni-leipzig.de			German Research Foundation (DFG); University of Leipzig within the program of Open Access Publishing	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Leipzig within the program of Open Access Publishing	The authors acknowledge support from the German Research Foundation (DFG) and University of Leipzig within the program of Open Access Publishing. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, HERAUSFORDERUNGEN AU, P68; APA Task Force on Mental Health and Abortion, 2008, REP APA TASK FORC ME; Athanasiadis AP, 2009, FETAL DIAGN THER, V25, P255, DOI 10.1159/000223682; Bardos J, 2015, OBSTET GYNECOL, V125, P1313, DOI 10.1097/AOG.0000000000000859; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; Buhner M., 2011, EINF HRUNG TESTUND F; Busch U., 2012, FAM MAG, p4 ; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cockrill K, 2013, DEVIANT BEHAV, V34, P973, DOI 10.1080/01639625.2013.800423; Cockrill K, 2013, PERSPECT SEX REPRO H, V45, P79, DOI 10.1363/4507913; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Collani G., 2003, Z DIFFERENTIELLE DIA, V24, P3, DOI [DOI 10.1024//0170-1789.24.1.3, 10.1024//0170-1789.24.1.3]; Davies V, 2005, ULTRASOUND OBST GYN, V25, P389, DOI 10.1002/uog.1854; Davis AR, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.10.031; De Zordo S, 2018, GLOB PUBLIC HEALTH, V13, P711, DOI 10.1080/17441692.2017.1293707; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; EUROCAT, 2017, EUROCAT WEBS DAT; Ferring D, 1996, DIAGNOSTICA, V42, P284; Field A.P., 2020, DISCOVERING STAT USI, V4th; Fisher J, 2015, J REPROD INFANT PSYC, V33, P69, DOI 10.1080/02646838.2014.970149; GESIS D Leibniz- Institut fu E r Sozialwissenschaften, 2013, ZA4614 GESIS; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Hanschmidt F, 2018, ARCH WOMEN MENT HLTH, V21, P391, DOI 10.1007/s00737-017-0807-9; Hanschmidt F, 2018, GEBURTSH FRAUENHEILK, V78, P160, DOI 10.1055/s-0044-100380; Hanschmidt F, 2016, PERSPECT SEX REPRO H, V48, P169, DOI 10.1363/48e8516; Hautzinger M., 2009, BDI 2 BECK DEPRESSIO; Hume H, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.06.008; Janiak E, 2016, CONTRACEPTION, V93, P89, DOI 10.1016/j.contraception.2015.10.008; Johnson CY, 2012, BIRTH DEFECTS RES A, V94, P857, DOI 10.1002/bdra.23086; Kersting A, 2005, J PSYCHOSOM OBST GYN, V26, P9, DOI 10.1080/01443610400022967; Kersting A, 2007, EUR ARCH PSY CLIN N, V257, P437, DOI 10.1007/s00406-007-0743-1; Kersting Anette, 2012, Dialogues Clin Neurosci, V14, P187; Kersting A, 2009, ARCH WOMEN MENT HLTH, V12, P193, DOI 10.1007/s00737-009-0063-8; Korenromp MJ, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.007; Korenromp MJ, 2005, PRENATAL DIAG, V25, P253, DOI 10.1002/pd.1127; Lafarge C, 2014, REPROD HEALTH MATTER, V22, P191, DOI 10.1016/S0968-8080(14)44799-2; Lafarge C, 2013, QUAL HEALTH RES, V23, P924, DOI 10.1177/1049732313484198; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; LINK BG, 1991, J HEALTH SOC BEHAV, V32, P302, DOI 10.2307/2136810; Livingston JD, 2010, SOC SCI MED, V71, P2150, DOI 10.1016/j.socscimed.2010.09.030; Maguire M, 2015, CONTRACEPTION, V91, P234, DOI 10.1016/j.contraception.2014.11.015; Major B, 1999, J PERS SOC PSYCHOL, V77, P735, DOI 10.1037/0022-3514.77.4.735; Mansfield C, 1999, PRENATAL DIAG, V19, P808, DOI 10.1002/(SICI)1097-0223(199909)19:9<808::AID-PD637>3.0.CO;2-B; McCoyd JLM, 2010, BRIT J SOC WORK, V40, P133, DOI 10.1093/bjsw/bcn080; Norris A, 2011, WOMEN HEALTH ISS, V21, pS49, DOI 10.1016/j.whi.2011.02.010; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; O'Donnell AT, 2018, PSYCHOL WOMEN QUART, V42, P220, DOI 10.1177/0361684317748937; Peugh JL, 2004, REV EDUC RES, V74, P525, DOI 10.3102/00346543074004525; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Rice WS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174210; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Shellenberg KM, 2012, INT J GYNECOL OBSTET, V118, pS152, DOI 10.1016/S0020-7292(12)60015-0; Shellenberg KM, 2011, GLOB PUBLIC HEALTH, V6, pS111, DOI 10.1080/17441692.2011.594072; Statham H., 2002, FETAL MATERN MED REV, V13, P213, DOI [10.1017/S0965539502000414, DOI 10.1017/S0965539502000414]; Steinberg JR, 2016, SOC SCI MED, V150, P67, DOI 10.1016/j.socscimed.2015.12.007; Steinberg JR, 2011, WOMEN HEALTH ISS, V21, pS44, DOI 10.1016/j.whi.2011.02.002; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P945, DOI 10.1016/S0895-4356(98)00085-7; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wright D.B., 2011, J EXPER PSYCHOPATHOL, V2, P252, DOI [10.5127/jep.013611, DOI 10.5127/JEP.013611]	59	4	4	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0197986	10.1371/journal.pone.0197986	http://dx.doi.org/10.1371/journal.pone.0197986			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ1PQ	29894474	Green Published, gold, Green Submitted			2022-12-26	WOS:000435030900006
J	Marton, K; Flajsman, M; Radisek, S; Kosmelj, K; Jakse, J; Javornik, B; Berne, S				Marton, Kristina; Flajsman, Marko; Radisek, Sebastjan; Kosmelj, Katarina; Jakse, Jernej; Javornik, Branka; Berne, Sabina			Comprehensive analysis of Verticillium nonalfalfae in silico secretome uncovers putative effector proteins expressed during hop invasion	PLOS ONE			English	Article							CHITIN-TRIGGERED IMMUNITY; RICE BLAST FUNGUS; REAL-TIME PCR; ALBO-ATRUM; PHYTOPATHOGENIC FUNGI; NUCLEAR-LOCALIZATION; COMPARATIVE GENOMICS; DISEASE RESISTANCE; MAGNAPORTHE-ORYZAE; ANALYSIS REVEALS	The vascular plant pathogen Verticillium nonalfalfae causes Verticillium wilt in several important crops. VnaSSP4.2 was recently discovered as a V. nonalfalfae virulence effector protein in the xylem sap of infected hop. Here, we expanded our search for candidate secreted effector proteins (CSEPs) in the V. nonalfalfae predicted secretome using a bioinformatic pipeline built on V. nonalfalfae genome data, RNA-Seq and proteomic studies of the interaction with hop. The secretome, rich in carbohydrate active enzymes, proteases, redox proteins and proteins involved in secondary metabolism, cellular processing and signaling, includes 263 CSEPs. Several homologs of known fungal effectors (LysM, NLPs, Hce2, Cerato-platanins, Cyanovirin-N lectins, hydrophobins and CFEM domain containing proteins) and avirulence determinants in the PHI database (Avr-Pita1 and MgSM1) were found. The majority of CSEPs were non-annotated and were narrowed down to 44 top priority candidates based on their likelihood of being effectors. These were examined by spatiotemporal gene expression profiling of infected hop. Among the highest in planta expressed CSEPs, five deletion mutants were tested in pathogenicity assays. A deletion mutant of VnaUn.279, a lethal pathotype specific gene with sequence similarity to SAM-dependent methyltransferase (LaeA), had lower infectivity and showed highly reduced virulence, but no changes in morphology, fungal growth or conidiation were observed. Several putative secreted effector proteins that probably contribute to V. nonalfalfae colonization of hop were identified in this study. Among them, LaeA gene homolog was found to act as a potential novel virulence effector of V. nonalfalfae. The combined results will serve for future characterization of V. nonalfalfae effectors, which will advance our understanding of Verticillium wilt disease.	[Marton, Kristina; Flajsman, Marko; Kosmelj, Katarina; Jakse, Jernej; Javornik, Branka; Berne, Sabina] Univ Ljubljana, Biotech Fac, Dept Agron, Ljubljana, Slovenia; [Radisek, Sebastjan] Slovenian Inst Hop Res & Brewing, Zhalec, Slovenia	University of Ljubljana	Berne, S (corresponding author), Univ Ljubljana, Biotech Fac, Dept Agron, Ljubljana, Slovenia.	sabina.berne@bf.uni-lj.si	Berne, Sabina/A-2206-2016	Berne, Sabina/0000-0002-0441-4142	Slovenian Research Agency [P4-0077, J4-8220, 342250]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency (http://www.arrs.gov.si/en/index.asp) grants P4-0077 (BJ), J4-8220 (BJ) and 342250 (KM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn N, 2004, MOL CELLS, V17, P166; Akcapinar GB, 2015, CURR GENET, V61, P103, DOI 10.1007/s00294-014-0471-9; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Baccelli I, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00769; Baker R, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3721; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bayry J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002700; Blumke A, 2014, PLANT PHYSIOL, V165, P346, DOI 10.1104/pp.114.236737; Bok JW, 2005, EUKARYOT CELL, V4, P1574, DOI 10.1128/EC.4.9.1574-1582.2005; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Bu BW, 2014, PLANT CELL REP, V33, P461, DOI 10.1007/s00299-013-1546-7; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chandrasekaran M, 2016, J GEN PLANT PATHOL, V82, P233, DOI 10.1007/s10327-016-0672-9; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cregeen S, 2015, PLANT MOL BIOL REP, V33, P689, DOI 10.1007/s11105-014-0767-4; Cui HT, 2015, ANNU REV PLANT BIOL, V66, P487, DOI 10.1146/annurev-arplant-050213-040012; Daayf F, 2015, CAN J PLANT PATHOL, V37, P8, DOI 10.1080/07060661.2014.989908; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de Jonge R., 2012, METHODS MOL BIOL; de Jonge R, 2013, GENOME RES, V23, P1271, DOI 10.1101/gr.152660.112; de Jonge R, 2012, P NATL ACAD SCI USA, V109, P5110, DOI 10.1073/pnas.1119623109; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; Depotter JRL, 2017, ENVIRON MICROBIOL, V19, P3997, DOI 10.1111/1462-2920.13801; Di Pietro A, 2009, PLANT RELATIONSHIPS, P181; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Faino L, 2015, MBIO, V6, DOI 10.1128/mBio.00936-15; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Flajsman M, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2171; Flajsman M, 2016, MOL PLANT MICROBE IN, V29, P362, DOI 10.1094/MPMI-01-16-0016-R; Fradin EF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088208; Fradin EF, 2011, PLANT PHYSIOL, V156, P2255, DOI 10.1104/pp.111.180067; Frandsen RJN, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-70; Frandsen RJN, 2012, METHODS MOL BIOL, V835, P17, DOI 10.1007/978-1-61779-501-5_2; Gan P, 2013, NEW PHYTOL, V197, P1236, DOI 10.1111/nph.12085; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gayoso C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-232; Gibriel HAY, 2016, PHYTOPATHOLOGY, V106, P1206, DOI 10.1094/PHYTO-02-16-0110-FI; Gijzen M, 2006, PHYTOCHEMISTRY, V67, P1800, DOI 10.1016/j.phytochem.2005.12.008; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Gui YJ, 2017, ENVIRON MICROBIOL, V19, P1914, DOI 10.1111/1462-2920.13695; Guyon K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-336; Heard S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130534; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Inderbitzin P, 2014, PHYTOPATHOLOGY, V104, P564, DOI 10.1094/PHYTO-11-13-0315-IA; Inderbitzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028341; Jakse J, 2018, GENOME ANNOUNCEMENTS, V6, DOI 10.1128/genomeA.01458-17; Jashni MK, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00584; Jia YL, 2016, PHYTOPATHOLOGY, V106, P676, DOI 10.1094/PHYTO-02-16-0057-RVW; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kamoun S., 2009, MYCOTA; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Keyworth WG, 1942, ANN APPL BIOL, V29, P346, DOI 10.1111/j.1744-7348.1942.tb06138.x; Kim KT, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpfs.2016.00186, 10.3389/fpls.2016.00186]; Klimes A, 2006, FUNGAL GENET BIOL, V43, P283, DOI 10.1016/j.fgb.2005.12.006; Klimes A, 2015, ANNU REV PHYTOPATHOL, V53, P181, DOI 10.1146/annurev-phyto-080614-120224; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Knight CJ, 2009, J PLANT PATHOL, V91, P745; Koharudin LMI, 2011, STRUCTURE, V19, P662, DOI 10.1016/j.str.2011.03.004; Kombrink A, 2017, MOL PLANT PATHOL, V18, P596, DOI 10.1111/mpp.12520; Krijger JJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-722; Kubicek CP, 2014, ANNU REV PHYTOPATHOL, V52, P427, DOI 10.1146/annurev-phyto-102313-045831; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Lauge R, 1997, MOL PLANT MICROBE IN, V10, P725, DOI 10.1094/MPMI.1997.10.6.725; Liu WX, 2014, MICROBIOL RES, V169, P476, DOI 10.1016/j.micres.2013.08.001; Lo Presti L, 2015, ANNU REV PLANT BIOL, V66, P513, DOI 10.1146/annurev-arplant-043014-114623; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Ma ZC, 2015, PLANT CELL, V27, P2057, DOI 10.1105/tpc.15.00390; Macdonald SS, 2015, J BIOL CHEM, V290, P4887, DOI 10.1074/jbc.M114.621110; Mandelc S, 2015, PROTEOMICS, V15, P787, DOI 10.1002/pmic.201400181; Mandelc S, 2013, PLANT PHYSIOL BIOCH, V68, P23, DOI 10.1016/j.plaphy.2013.03.017; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; Mewis K, 2016, APPL ENVIRON MICROB, V82, P1686, DOI 10.1128/AEM.03453-15; Min XJ, 2010, J PROTEOM BIOINFORM, V3, P143, DOI DOI 10.4172/JPB.1000133; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Navarathna DHMLP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048475; Neumann MJ, 2003, FUNGAL GENET BIOL, V38, P54, DOI 10.1016/S1087-1845(02)00507-8; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pegg GF, 2002, VERTICILLIUM WILTS, DOI [10.1094/PHYTO-11-13-0315-IA, DOI 10.1094/PHYTO-11-13-0315-IA]; Perez-Nadales E, 2011, PLANT CELL, V23, P1171, DOI 10.1105/tpc.110.075093; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pinheiro J, 2000, MIXED EFFECTS MODELS; Progar V, 2017, PLANT CELL REP, V36, P1599, DOI 10.1007/s00299-017-2177-1; Qin YQ, 2014, MICROBIOL-SGM, V160, P2526, DOI 10.1099/mic.0.078469-0; R Core Team, 2021, R LANGUAGE ENV STAT; Radisek S, 2004, PLANT DIS, V88, P1115, DOI 10.1094/PDIS.2004.88.10.1115; Radisek S, 2003, PLANT DIS, V87, P633, DOI 10.1094/PDIS.2003.87.6.633; Radisek S, 2006, EUR J PLANT PATHOL, V116, P301, DOI 10.1007/s10658-006-9061-0; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rohm M, 2013, MOL MICROBIOL, V87, P132, DOI 10.1111/mmi.12087; Sanchez-Vallet A, 2013, ELIFE, V2, DOI 10.7554/eLife.00790; Santhanam P, 2013, MOL PLANT MICROBE IN, V26, P278, DOI 10.1094/MPMI-09-12-0222-R; Sarikaya-Bayram O, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00001; Saunders DGO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029847; Schlotter YM, 2009, VET IMMUNOL IMMUNOP, V129, P115, DOI 10.1016/j.vetimm.2008.12.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seidl MF, 2015, MOL PLANT MICROBE IN, V28, P362, DOI 10.1094/MPMI-06-14-0173-R; Serrano M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00274; SEWELL GWF, 1984, PLANT PATHOL, V33, P39, DOI 10.1111/j.1365-3059.1984.tb00585.x; Simko I, 2012, PHYTOPATHOLOGY, V102, P381, DOI 10.1094/PHYTO-07-11-0216; Sonah H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00126; Sperschneider J, 2017, APOPLASTP PREDICTION, V4, P1764, DOI [10.1038/srep44598, DOI 10.1038/SREP44598]; Sperschneider J, 2017, SCI REP-UK, V7, DOI 10.1038/srep44598; Sperschneider J, 2016, NEW PHYTOL, V210, P743, DOI 10.1111/nph.13794; Sperschneider J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01168; Stergiopoulos I, 2012, MOL BIOL EVOL, V29, P3371, DOI 10.1093/molbev/mss143; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Takahara H, 2016, NEW PHYTOL, V211, P1323, DOI 10.1111/nph.13994; TALBOYS PW, 1972, PROC R SOC SER B-BIO, V181, P319, DOI 10.1098/rspb.1972.0053; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Urban M, 2015, NUCLEIC ACIDS RES, V43, pD645, DOI 10.1093/nar/gku1165; Vleeshouwers VGAA, 2014, MOL PLANT MICROBE IN, V27, P196, DOI 10.1094/MPMI-10-13-0313-IA; Wang BN, 2012, APPL MICROBIOL BIOT, V93, P191, DOI 10.1007/s00253-011-3405-1; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Xie CJ, 2013, J GEN PLANT PATHOL, V79, P335, DOI 10.1007/s10327-013-0467-1; Yang YY, 2009, PLANT BIOTECHNOL J, V7, P763, DOI 10.1111/j.1467-7652.2009.00442.x; Zeilinger S, 2016, FEMS MICROBIOL REV, V40, P182, DOI 10.1093/femsre/fuv045; Zhang LS, 2017, NEW PHYTOL, V215, P368, DOI 10.1111/nph.14537; Zhang LS, 2014, PLANT PHYSIOL, V164, P352, DOI 10.1104/pp.113.230698; Zhao YL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005793; Zhou BJ, 2012, MOL PLANT MICROBE IN, V25, P964, DOI 10.1094/MPMI-12-11-0319; Zhou TT, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006275	128	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198971	10.1371/journal.pone.0198971	http://dx.doi.org/10.1371/journal.pone.0198971			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894496	Green Submitted, Green Published, gold			2022-12-26	WOS:000435030900038
J	Huang, JR; He, XY; Ma, XJ; Ren, YA; Zhao, TT; Zeng, X; Li, H; Chen, YH				Huang, Jianrui; He, Xianyou; Ma, Xiaojin; Ren, Yian; Zhao, Tingting; Zeng, Xin; Li, Han; Chen, Yiheng			Sequential biases on subjective judgments: Evidence from face attractiveness and ringtone agreeableness judgment	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; ABSOLUTE IDENTIFICATION; FACIAL ATTRACTIVENESS; DEPENDENCIES; CONTRAST; LOUDNESS; BEAUTY; MEMORY; ADAPTATION; PERCEPTION	When people make decisions about sequentially presented items in psychophysical experiments, their decisions are always biased by their preceding decisions and the preceding items, either by assimilation (shift towards the decision or item) or contrast (shift away from the decision or item). Such sequential biases also occur in naturalistic and real-world judgments such as facial attractiveness judgments. In this article, we aimed to cast light on the causes of these sequential biases. We first found significant assimilative and contrastive effects in a visual face attractiveness judgment task and an auditory ringtone agreeableness judgment task, indicating that sequential effects are not limited to the visual modality. We then found that the provision of trial-by-trial feedback of the preceding stimulus value eliminated the contrastive effect, but only weakened the assimilative effect. When participants orally reported their judgments rather than indicated them via a keyboard button press, we found a significant diminished assimilative effect, suggesting that motor response repetition strengthened the assimilation bias. Finally, we found that when visual and auditory stimuli were alternated, there was no longer a contrastive effect from the immediately previous trial, but there was an assimilative effect both from the previous trial (cross-modal) and the 2-back trial (same stimulus modality). These findings suggested that the contrastive effect results from perceptual processing, while the assimilative effect results from anchoring of the previous judgment and is strengthened by response repetition and numerical priming.	[Huang, Jianrui; He, Xianyou; Ma, Xiaojin; Ren, Yian; Zhao, Tingting; Zeng, Xin; Li, Han; Chen, Yiheng] South China Normal Univ, Ctr Studies Psychol Applicat, Sch Psychol, Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China	South China Normal University	He, XY (corresponding author), South China Normal Univ, Ctr Studies Psychol Applicat, Sch Psychol, Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China.	xianyouhe@163.com		Huang, Jianrui/0000-0001-9617-984X; Ma, Xiaojin/0000-0003-4592-6408	National Natural Science Foundation of China [31671132, J1210024, J1310031]; Innovation Fund for College Students [20160110]; MOE Project of Key Research Institute of Humanities and Social Sciences in Universities [15JJD190005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Fund for College Students; MOE Project of Key Research Institute of Humanities and Social Sciences in Universities	This research was supported by the National Natural Science Foundation of China (31671132, J1210024, J1310031), Innovation Fund for College Students (20160110) and MOE Project of Key Research Institute of Humanities and Social Sciences in Universities (15JJD190005).	[Anonymous], 2011, J SOCIO-ECON, DOI DOI 10.1016/J.SOCEC.2010.10.008; Beckstead JW, 2008, JUDGM DECIS MAK, V3, P570; Brewer NT, 2002, J BEHAV DECIS MAKING, V15, P65, DOI 10.1002/bdm.403; Burleson Mary H, 2016, EVOLUTIONARY BEHAV S, V10, P179; Cogan E, 2013, J EXP PSYCHOL HUMAN, V39, P16, DOI 10.1037/a0031020; CRUTCHER RJ, 1994, PSYCHOL SCI, V5, P241, DOI 10.1111/j.1467-9280.1994.tb00619.x; CUNNINGHAM MR, 1995, J PERS SOC PSYCHOL, V68, P261, DOI 10.1037/0022-3514.68.2.261; Defever E, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00004; EAGLY AH, 1991, PSYCHOL BULL, V110, P109, DOI 10.1037/0033-2909.110.1.109; Edition S, 2016, TECHNOMETRICS; Epley N, 2006, PSYCHOL SCI, V17, P311, DOI 10.1111/j.1467-9280.2006.01704.x; Ericsson KA, 1986, J MARKETING RES; FEINGOLD A, 1992, PSYCHOL BULL, V112, P125, DOI 10.1037/0033-2909.112.1.125; Fu GY, 2014, NEUROIMAGE, V85, P363, DOI 10.1016/j.neuroimage.2013.04.092; GARNER WR, 1953, J EXP PSYCHOL, V46, P373, DOI 10.1037/h0063212; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; Helson H, 1964, ADAPTATION LEVEL THE; HOLLAND MK, 1968, PERCEPT PSYCHOPHYS, V3, P409, DOI 10.3758/BF03205747; Hung SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep37117; JESTEADT W, 1977, J EXP PSYCHOL HUMAN, V3, P92, DOI 10.1037/0096-1523.3.1.92; Koechlin E, 1999, J EXP PSYCHOL HUMAN, V25, P1882, DOI 10.1037/0096-1523.25.6.1882; Kond A, 2011, TECHNICAL REPORT IEI, V111, P63; Kondo A, 2012, PERCEPTION, V41, P43, DOI 10.1068/p7116; Kondo A, 2013, ATTEN PERCEPT PSYCHO, V75, P1347, DOI 10.3758/s13414-013-0533-y; Kramer RSS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082226; Lammertyn J, 2005, Q J EXP PSYCHOL-A, V58, P1153, DOI 10.1080/02724980443000520; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; LORCH RF, 1990, J EXP PSYCHOL LEARN, V16, P149, DOI 10.1037/0278-7393.16.1.149; Matthews WJ, 2009, JUDGM DECIS MAK, V4, P64; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; MORI S, 1995, PERCEPT PSYCHOPHYS, V57, P1065, DOI 10.3758/BF03205465; Mussweiler T, 2005, ORGAN BEHAV HUM DEC, V98, P133, DOI 10.1016/j.obhdp.2004.12.002; Parker, 2008, DECLARED POSITIVE NE; Parker S., 2008, PSYCHOL AESTHET CREA, V2, P171, DOI DOI 10.1037/1931-3896.2.3.171; Pegors TK, 2015, J EXP PSYCHOL GEN, V144, P664, DOI 10.1037/xge0000069; Petzold P, 1982, DISTANCE EFFECTS SEQ, V7, P1371; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2007, VISION RES, V47, P2291, DOI 10.1016/j.visres.2007.05.012; Roggeman C, 2007, COGNITION, V105, P380, DOI 10.1016/j.cognition.2006.10.004; RUSSO JE, 1989, MEM COGNITION, V17, P759, DOI 10.3758/BF03202637; SCHIFFERSTEIN HNJ, 1992, PERCEPT PSYCHOPHYS, V52, P243, DOI 10.3758/BF03209142; SHANTEAU JC, 1970, J EXP PSYCHOL, V85, P181, DOI 10.1037/h0029552; Stewart N, 2005, PSYCHOL REV, V112, P881, DOI 10.1037/0033-295X.112.4.881; Surhone LM, 2015, VARIANCE INFLATION F; Taubert J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22740; TREISMAN M, 1984, PSYCHOL REV, V91, P68, DOI 10.1037/0033-295X.91.1.68; Tversky 82Amos, 1974, JUDGMENT UNCERTAINTY; WARD LM, 1970, J EXP PSYCHOL, V84, P27, DOI 10.1037/h0028949; WARD LM, 1971, PERCEPT PSYCHOPHYS, V9, P73, DOI 10.3758/BF03213031; WARD LM, 1985, PERCEPT PSYCHOPHYS, V38, P512, DOI 10.3758/BF03207060; WARD LM, 1979, J EXP PSYCHOL HUMAN, V5, P444, DOI 10.1037/0096-1523.5.3.444; WARD LM, 1987, J EXP PSYCHOL HUMAN, V13, P216, DOI 10.1037/0096-1523.13.2.216; WARD LM, 1982, PERCEPT PSYCHOPHYS, V31, P53, DOI 10.3758/BF03206200; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; WEDELL DH, 1987, J EXP SOC PSYCHOL, V23, P230, DOI 10.1016/0022-1031(87)90034-5; Wilson TD, 1996, J EXP PSYCHOL GEN, V125, P387, DOI 10.1037/0096-3445.125.4.387	56	5	5	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198723	10.1371/journal.pone.0198723	http://dx.doi.org/10.1371/journal.pone.0198723			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI8PJ	29889850	gold, Green Published, Green Submitted			2022-12-26	WOS:000434786600037
J	Costa, MB; Hungria, EM; Freitas, AA; Sousa, ALOM; Jampietro, J; Soares, FA; Stefani, MMA				Costa, Mauricio Barcelos; Hungria, Emerith Mayra; Freitas, Aline Araujo; Sousa, Ana Lucia O. M.; Jampietro, Juliano; Soares, Fernando A.; Stefani, Mariane M. A.			In situ T regulatory cells and Th17 cytokines in paired samples of leprosy type 1 and type 2 reactions	PLOS ONE			English	Article							DIFFERENT CLINICAL FORMS; LEPROMATOUS LEPROSY; EXPRESSION; CHALLENGES; LESIONS; REGS; TH2	Leprosy is a complex chronic, infectious dermato-neurological disease that affects the skin and peripheral nerves especially during immuno-inflammatory episodes known as type 1/T1R and type 2/T2R reactions. This study investigated the in situ expression of CD25(+)Foxp3(+)T(reg) cells and TGF-beta 1, IFN-gamma, IL-17 in leprosy T1R and T2R. T-regs were evaluated in 114 skin biopsies from 74 leprosy patients: 56 T1R (28-paired reaction-free/reactional biopsies, 28 unpaired T1R), 18 T2R (12 paired reaction-free/reactional biopsies, 6 unpaired T2R). Double CD25(+)Foxp3(+)immunostained T-reg cells obtained by automated platform (Ventana BenchMark XT, Roche, Mannheim, Germany) were counted (Nikon Eclipse E400 2mm(2)). Cytokine expression was evaluated by immunostaining in 96 biopsies (48 paired reaction-free/reactional lesions, 24 T1R, 24 T2R) using rabbit polyclonal anti human TGF-beta 1, IFN-gamma, IL-17 antibodies (Santa Cruz Biotechnology CA, USA). T-reg cell counts in leprosy reactional lesions were higher compared to reaction-free (p = 0.002). T-reg numbers were higher in T1R compared to paired unreactional T1R lesions (p = 0.001). Similar frequency of T-reg was seen in paired reactional versus unreactional T2R lesions. Higher expression of TGF-beta, IFN-gamma and IL-17 was seen in T2R lesions compared to T1R and reaction- free lesions. The increase in T-reg cells during T1R suggests a suppressive role to control the exacerbated cellular immune response during T1R that can cause tissue and nerve damage. Evidences of upregulated T-reg cells in TR1, which usually occurs in patients with Th1-Th17 immunity and the indications of the expression of Th17/IL-17 in T2R, which develops in patients with Th2-T-reg profile, suggest plasticity of T-reg-Th17 cells populations and a potential role for these cell populations in the immunopathogenesis of leprosy reactions.	[Costa, Mauricio Barcelos; Hungria, Emerith Mayra; Freitas, Aline Araujo; Sousa, Ana Lucia O. M.; Stefani, Mariane M. A.] Univ Fed Goias, Trop Pathol & Publ Hlth Inst, Goiania, Go, Brazil; [Jampietro, Juliano] Hosp AC Camargo Fund Antonio Prudente, Ctr Int Pesquisa, Sao Paulo, SP, Brazil; [Soares, Fernando A.] Rede DOr Hosp Network, Anat Pathol Dept, Sao Paulo, Brazil; [Soares, Fernando A.] Univ Sao Paulo, Fac Dent, Gen Pathol, Sao Paulo, Brazil	Universidade Federal de Goias; A.C.Camargo Cancer Center; Universidade de Sao Paulo	Stefani, MMA (corresponding author), Univ Fed Goias, Trop Pathol & Publ Hlth Inst, Goiania, Go, Brazil.	mmastefani@gmail.com			Programa de Apoio a Nucleos de Excelencia (PRONEX); Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) (PRONEX/FAPEG/CNPQ) [007/2009]	Programa de Apoio a Nucleos de Excelencia (PRONEX); Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) (PRONEX/FAPEG/CNPQ)	This work was supported by the Programa de Apoio a Nucleos de Excelencia (PRONEX), Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) (PRONEX/FAPEG/CNPQ Grant number 007/2009) (MMAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia EAS, 2014, ARCH DERMATOL RES, V306, P793, DOI 10.1007/s00403-014-1486-2; Attia EAS, 2010, INT J DERMATOL, V49, P1152, DOI 10.1111/j.1365-4632.2010.04535.x; Bobosha K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002773; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kumar S, 2013, MOL IMMUNOL, V56, P513, DOI 10.1016/j.molimm.2013.04.015; Massone C, 2010, AM J DERMATOPATH, V32, P251, DOI 10.1097/DAD.0b013e3181b7fc56; MODLIN RL, 1988, P NATL ACAD SCI USA, V85, P1213, DOI 10.1073/pnas.85.4.1213; Negera E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006001; Palermo ML, 2012, AM J TROP MED HYG, V86, P878, DOI 10.4269/ajtmh.2012.12-0088; Quaresma JAS, 2015, BRIT J DERMATOL, V173, P565, DOI 10.1111/bjd.13608; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Rodrigues LC, 2011, LANCET INFECT DIS, V11, P464, DOI 10.1016/S1473-3099(11)70006-8; Saini C, 2017, IMMUNOL LETT, V184, P61, DOI 10.1016/j.imlet.2017.02.013; Saini C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004592; Saini C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002639; Saini C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002338; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; Smith CS, 2017, LANCET INFECT DIS, V17, pE293, DOI 10.1016/S1473-3099(17)30418-8; Azevedo MDS, 2017, MED MICROBIOL IMMUN, V206, P429, DOI 10.1007/s00430-017-0519-9; Tarique M, 2017, MOL IMMUNOL, V83, P72, DOI 10.1016/j.molimm.2017.01.008; Parente JNT, 2015, AN BRAS DERMATOL, V90, P41, DOI 10.1590/abd1806-4841.20153311; Vieira AP, 2016, AM J TROP MED HYG, V94, P721, DOI 10.4269/ajtmh.15-0673; Fachin LRV, 2017, HISTOL HISTOPATHOL, V32, P385, DOI 10.14670/HH-11-804; World Health Organization, 2017, GLOB LEPR UPD 2016 A	24	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0196853	10.1371/journal.pone.0196853	http://dx.doi.org/10.1371/journal.pone.0196853			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883464	Green Published, Green Submitted, gold			2022-12-26	WOS:000434728100002
J	Ostrowskra, D; Salari, A; Zars, M; Zars, T				Ostrowskra, Daniela; Salari, Autoosa; Zars, Melissa; Zars, Troy			A biphasic locomotor response to acute unsignaled high temperature exposure in Drosophila	PLOS ONE			English	Article							SHORT-TERM-MEMORY; ORIENTATION; SEROTONIN; STRESS	Unsignaled stress can have profound effects on animal behavior. While most investigation of stress-effects on behavior follows chronic exposures, less is understood about acute exposures and potential after-effects. We examined walking activity in Drosophila following acute exposure to high temperature or electric shock. Compared to initial walking activity, flies first increase walking with exposure to high temperatures then have a strong reduction in activity. These effects are related to the intensity of the high temperature and number of exposures. The reduction in walking activity following high temperature and electric shock exposures survives context changes and lasts at least five hours. Reduction in the function of the biogenic amines octopamine/tyramine and serotonin both strongly blunt the increase in locomotor activity with high temperature exposure. However, neither set of biogenic amines alter the long lasting depression in walking activity after exposure.	[Ostrowskra, Daniela; Salari, Autoosa; Zars, Melissa; Zars, Troy] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Ostrowskra, Daniela] Truman State Univ, Biol Dept, Kirksville, MO USA; [Salari, Autoosa] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	University of Missouri System; University of Missouri Columbia; University of California System; University of California Berkeley	Zars, T (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	zarst@missouri.edu		Zars, Troy/0000-0003-4114-9322	National Sciences Foundation: Directorate for Biological Sciences [1535790, 1654866]; Alexander von Humboldt foundation	National Sciences Foundation: Directorate for Biological Sciences; Alexander von Humboldt foundation(Alexander von Humboldt Foundation)	Research in the laboratory of TZ is funded by the National Sciences Foundation: Directorate for Biological Sciences [Grants 1535790 and 1654866]. D.O. was supported by the Alexander von Humboldt foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelaira HM, 2013, REV BRAS PSIQUIATR, V35, pS112, DOI 10.1590/1516-4446-2013-1098; Batson S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161864; BULTHOFF H, 1982, J COMP PHYSIOL, V148, P471; Certel SJ, 2007, P NATL ACAD SCI USA, V104, P4706, DOI 10.1073/pnas.0700328104; Clinchy M, 2004, P ROY SOC B-BIOL SCI, V271, P2473, DOI 10.1098/rspb.2004.2913; Colomb J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042247; Guo A, 1996, LEARN MEMORY, V3, P49, DOI 10.1101/lm.3.1.49; Guo F, 2016, NATURE, V536, P292, DOI 10.1038/nature19097; Hampel S, 2017, ELIFE, V6, DOI 10.7554/eLife.28804; Hampel S, 2015, ELIFE, V4, DOI 10.7554/eLife.08758; Huser A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047518; Ishimoto H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003843; Jerbi-Elayed M, 2015, J INSECT BEHAV, V28, P157, DOI 10.1007/s10905-015-9490-8; Loeschcke V, 2007, AM NAT, V169, P175, DOI 10.1086/510632; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Parisky KM, 2016, CURR BIOL, V26, P882, DOI 10.1016/j.cub.2016.02.011; Putz G, 2002, LEARN MEMORY, V9, P349, DOI 10.1101/lm.50402; Ries AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15738; Scholz H, 2000, NEURON, V28, P261, DOI 10.1016/S0896-6273(00)00101-X; Sitaraman D, 2007, J COMP PHYSIOL A, V193, P903, DOI 10.1007/s00359-007-0243-9; Sitaraman D, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00092; Sitaraman D, 2012, J NEUROGENET, V26, P238, DOI 10.3109/01677063.2012.666298; Sitaraman D, 2010, J EXP BIOL, V213, P4018, DOI 10.1242/jeb.050344; Sitaraman D, 2010, J COMP PHYSIOL A, V196, P299, DOI 10.1007/s00359-010-0517-5; Soto-Padilla A, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.174151; Suverkropp BP, 2001, J APPL ENTOMOL, V125, P303, DOI 10.1046/j.1439-0418.2001.00546.x; Yang ZH, 2013, CURR BIOL, V23, P799, DOI 10.1016/j.cub.2013.03.054; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194	30	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198702	10.1371/journal.pone.0198702	http://dx.doi.org/10.1371/journal.pone.0198702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883493	Green Submitted, Green Published, gold			2022-12-26	WOS:000434728100037
J	Sim, MA; Liu, WL; Chew, STH; Ti, LK				Sim, Ming Ann; Liu, Weiling; Chew, Sophia T. H.; Ti, Lian Kah			Wider perioperative glycemic fluctuations increase risk of postoperative atrial fibrillation and ICU length of stay	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; OXIDATIVE STRESS; CARDIAC-SURGERY; GLUCOSE FLUCTUATIONS; VARIABILITY; MORTALITY; INFLAMMATION; PREDICTOR; COHORT	Introduction Postoperative atrial fibrillation (POAF) is a common complication following cardiac surgery associated with increased morbidity and mortality. Although sustained hyperglycemia is a known risk factor of AF and poor ICU outcomes, emerging in-vitro studies reveal acute glycemic fluctuations to be an additional independent predictor of AF. The effect of acute glycemic fluctuations on the incidence of POAF in the clinical setting remains unclear. We aim to investigate the effect of the magnitude of acute perioperative glycemic fluctuations on the incidence of POAF in a multi-ethnic Southeast-Asian population. Methods We obtained data from1743 patients who underwent elective CABG in a tertiary heart centre from 2009 +/- 2011. Patients were kept to a tight baseline glycemic control in accordance with hospital protocol. The magnitude of the difference between the highest and lowest perioperative glucose levels up till the first 48 postoperative hours was employed as a measure of glycemic fluctuation. Patients were divided into 4 groups for analysis based on the magnitude of glycemic fluctuation: A) 0-2mmol/L(N = 147); B)>2-4mmol/L(N = 426); C)>4-6mmol/L (N = 513); D)>6mmol/L(N = 657). Our primary outcome was the incidence of POAF. Secondary outcomes included ICU and 30-day mortality and length of stay. Results The overall incidence of POAF was 14.7%. This increased as the magnitude of glycemic fluctuation increased, and was statistically highest in Group D(16.4%) as compared with the other 3 sub-groups. Multivariate logistic regression revealed the magnitude of perioperative glycemic fluctuation to be an independent risk factor of POAF(O.R. 1.06, 95% C. I. 1.01 - 1.11, p = 0.014). ICU length of stay was statistically highest in Group D(63.1 hours, p = <.001). However, ICU and 30 day mortality rates were similar among the 4 groups. Conclusion Increased magnitudes of acute perioperative glycemic fluctuations are associated with a significantly increased risk of POAF and length of ICU stay; and should therefore be minimised but balanced against the risks of hypoglycemia so as to avoid POAF and optimise patient outcomes.	[Sim, Ming Ann; Ti, Lian Kah] Natl Univ Hlth Syst, Dept Anaesthesia, Singapore, Singapore; [Liu, Weiling] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Chew, Sophia T. H.] Singapore Gen Hosp, Dept Anaesthesia, Singapore, Singapore	National University of Singapore; National University of Singapore; Singapore General Hospital	Sim, MA (corresponding author), Natl Univ Hlth Syst, Dept Anaesthesia, Singapore, Singapore.	ming_ann_sim@nuhs.edu.sg			Khoo Research Grant from the Duke-NUS Graduate Medical School (Singapore)	Khoo Research Grant from the Duke-NUS Graduate Medical School (Singapore)	This study was supported by the Khoo Research Grant from the Duke-NUS Graduate Medical School (Singapore). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali NA, 2008, CRIT CARE MED, V36, P2316, DOI 10.1097/CCM.0b013e3181810378; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Dallak MM, 2008, OPEN CARDIOVASC MED, V2, P70, DOI 10.2174/1874192400802010070; Duncan AE, 2010, ANESTHESIOLOGY, V112, P860, DOI 10.1097/ALN.0b013e3181d3d4b4; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Gunjan Y, 2005, MAYO CLIN P, V80; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Krinsley JS, 2003, MAYO CLIN P, V78; Lapar DJ, 2014, ANN THORAC SURG, V98, P527, DOI 10.1016/j.athoracsur.2014.03.039; Lazar HL, 2009, ANN THORAC SURG, V87, P663, DOI 10.1016/j.athoracsur.2008.11.011; Maesen B, 2012, EUROPACE, V14, P159, DOI 10.1093/europace/eur208; Mathew JP, 2004, JAMA-J AM MED ASSOC, V291, P1720, DOI 10.1001/jama.291.14.1720; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Meynaar IA, 2012, J CRIT CARE, V27, P119, DOI 10.1016/j.jcrc.2011.11.004; Monnier Louis, 2008, J Diabetes Sci Technol, V2, P1094; Piconi L, 2006, DIABETES-METAB RES, V22, P198, DOI 10.1002/dmrr.613; Ramlawi B, 2007, ANN THORAC SURG, V84, P1166, DOI 10.1016/j.athoracsur.2007.04.126; Rizzo MR, 2012, DIABETES CARE, V35, P2076, DOI 10.2337/dc12-0199; Saito S, 2014, CARDIOVASC RES, V104, P5, DOI 10.1093/cvr/cvu176; Siegelaar SE, 2010, ENDOCR REV, V31, P171, DOI 10.1210/er.2009-0021; Sim MA, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001953; Subramaniam B, 2014, ANESTH ANALG, V118, P277, DOI 10.1213/ANE.0000000000000100; Tatsuishi W, 2015, CIRC J, V79, P112, DOI 10.1253/circj.CJ-14-0989; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; VILLAREAL RP, 2004, ACC CURR J REV, V13, P58; Zakkar M, 2015, PHARMACOL THERAPEUT, V154, P13, DOI 10.1016/j.pharmthera.2015.06.009; Zhang W, 2016, ANESTH ANALG, V123, P283, DOI 10.1213/ANE.0000000000001384	27	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198533	10.1371/journal.pone.0198533	http://dx.doi.org/10.1371/journal.pone.0198533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883468	Green Submitted, Green Published, gold			2022-12-26	WOS:000434728100028
J	Li, YK; Wang, HM				Li, Yongkun; Wang, Huimei			Almost periodic synchronization of quaternion-valued shunting inhibitory cellular neural networks with mixed delays via state-feedback control	PLOS ONE			English	Article							TIME-VARYING DELAYS; REACTION-DIFFUSION TERMS; LATERAL INHIBITION; ANTIPERIODIC SOLUTIONS; SECURE COMMUNICATION; DISTRIBUTED DELAYS; CHAOTIC SYSTEMS; STABILITY; FIELD; PERTURBATIONS	This paper studies the drive-response synchronization for quaternion-valued shunting inhibitory cellular neural networks (QVSICNNs) with mixed delays. First, QVSICNN is decomposed into an equivalent real-valued system in order to avoid the non-commutativity of the multiplicity. Then, the existence of almost periodic solutions is obtained based on the Banach fixed point theorem. An novel state-feedback controller is designed to ensure the global exponential almost periodic synchronization. At the end of the paper, an example is given to illustrate the effectiveness of the obtained results.	[Li, Yongkun; Wang, Huimei] Yunnan Univ, Dept Math, Kunming 650091, Yunnan, Peoples R China; [Wang, Huimei] Kunming Univ, Dept Math, Kunming 650214, Yunnan, Peoples R China	Yunnan University; Kunming University	Li, YK (corresponding author), Yunnan Univ, Dept Math, Kunming 650091, Yunnan, Peoples R China.	yklie@ynu.edu.cn			National Natural Sciences Foundation of People's Republic of China [11361072]	National Natural Sciences Foundation of People's Republic of China(National Natural Science Foundation of China (NSFC))	The funding institution for this work is the National Natural Sciences Foundation of People's Republic of China. The Grant number is 11361072 and the funder's website is http://www.nsfc.gov.on/; This work is supported by the National Natural Sciences Foundation of People's Republic of China under Grant 11361072.	ADLER S. L., 1995, QUATERNIONIC QUANTUM; Ali MS, 2018, NEUROCOMPUTING, V273, P209, DOI 10.1016/j.neucom.2017.07.053; Aouiti C, 2016, COGN NEURODYNAMICS, V10, P573, DOI 10.1007/s11571-016-9405-1; Bouzerdoum A., 1990, IJCNN International Joint Conference on Neural Networks (Cat. No.90CH2879-5), P149, DOI 10.1109/IJCNN.1990.137560; BOUZERDOUM A, 1993, IEEE T CIRCUITS-I, V40, P215, DOI 10.1109/81.222804; Bouzerdoum A., 1992, NONLINEAR VIS, P423; Cai ZW, 2015, J FRANKLIN I, V352, P4638, DOI 10.1016/j.jfranklin.2015.07.014; CARPENTER GA, 1988, COMPUTER, V21, P77, DOI 10.1109/2.33; Chen BJ, 2015, J MATH IMAGING VIS, V51, P124, DOI 10.1007/s10851-014-0511-6; Cheung H. N., 1999, ICONIP'99. ANZIIS'99 & ANNES'99 & ACNN'99. 6th International Conference on Neural Information Processing. Proceedings (Cat. No.99EX378), P1219, DOI 10.1109/ICONIP.1999.844715; CHOU JCK, 1992, IEEE T ROBOTIC AUTOM, V8, P53, DOI 10.1109/70.127239; Ding XS, 2017, NEURAL NETWORKS, V90, P42, DOI 10.1016/j.neunet.2017.03.006; Fink A.M., 1974, LECT NOTES MATH; GAUDIANO P, 1991, NEURAL NETWORKS, V4, P147, DOI 10.1016/0893-6080(91)90002-M; Grossberg S., 1992, NEURAL NETWORKNATU; Hu C, 2010, NONLINEARITY, V23, P2369, DOI 10.1088/0951-7715/23/10/002; Huang X, 2003, PHYS LETT A, V314, P222, DOI 10.1016/S0375-9601(03)00918-6; Jiang A, 2015, NEUROCOMPUTING, V165, P159, DOI 10.1016/j.neucom.2015.03.005; Kusamichi H, 2004, P 2 INT C AUT ROB AG, V1315; Li RX, 2017, APPL MATH COMPUT, V313, P37, DOI 10.1016/j.amc.2017.05.073; Li Y., 2017, COMPLEXITY, V2017, P1, DOI DOI 10.1155/2017/1409865; Li YK, 2005, PHYS LETT A, V337, P46, DOI 10.1016/j.physleta.2005.01.008; Li YK, 2018, NEUROCOMPUTING, V292, P91, DOI 10.1016/j.neucom.2018.02.077; Li YK, 2012, COMMUN NONLINEAR SCI, V17, P3258, DOI 10.1016/j.cnsns.2011.11.034; Li YK, 2011, COMMUN NONLINEAR SCI, V16, P3326, DOI 10.1016/j.cnsns.2010.11.004; Liu Y, 2017, NONLINEAR DYNAM, V87, P553, DOI 10.1007/s11071-016-3060-2; Liu Y, 2016, INFORM SCIENCES, V360, P273, DOI 10.1016/j.ins.2016.04.033; Liu Y, 2016, NONLINEAR DYNAM, V84, P767, DOI 10.1007/s11071-015-2526-y; Liu YG, 2007, PHYS LETT A, V364, P17, DOI 10.1016/j.physleta.2006.11.075; Lu J, 2002, PHYS LETT A, V305, P365, DOI 10.1016/S0375-9601(02)01497-4; Lu L, 2014, COMMUN NONLINEAR SCI, V19, P2843, DOI 10.1016/j.cnsns.2013.12.027; Luo YP, 2017, COMPLEXITY, DOI 10.1155/2017/7850958; M'Hamdi MS, 2016, ACTA MATH SCI, V36, P1662, DOI 10.1016/S0252-9602(16)30098-4; Ma Q, 2011, NEUROCOMPUTING, V74, P3404, DOI 10.1016/j.neucom.2011.05.018; Michalak A, 2017, J FRANKLIN I, V354, P8513, DOI 10.1016/j.jfranklin.2017.08.054; Mukundan, 2002, P 7 AS TECHN C MATH; Ozcan N, 2018, J FRANKLIN I, V355, P1192, DOI 10.1016/j.jfranklin.2017.12.016; PECORA LM, 1990, PHYS REV LETT, V64, P821, DOI 10.1103/PhysRevLett.64.821; PINTER RB, 1983, J THEOR BIOL, V100, P525, DOI 10.1016/0022-5193(83)90444-7; PINTER RB, 1983, J THEOR BIOL, V105, P233, DOI 10.1016/S0022-5193(83)80005-8; PINTER RB, 1984, J THEOR BIOL, V110, P435, DOI 10.1016/S0022-5193(84)80185-X; Popa CA, 2018, NEURAL NETWORKS, V99, P1, DOI 10.1016/j.neunet.2017.12.006; Su BC, 2004, SAE T; SUDBERY A, 1979, MATH PROC CAMBRIDGE, V85, P199, DOI 10.1017/S0305004100055638; VAIDYANATHAN S., 2015, INT J CHEMTECH RES, V8, P209; VAIDYANATHAN S., 2015, INT J CHEMTECH RES, V8, P684; van de Walle A, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.184101; Wang P, 2015, NEUROCOMPUTING, V167, P76, DOI 10.1016/j.neucom.2015.04.089; Wei Wang, 2014, Advances in Materials Science and Engineering, DOI 10.1155/2014/494851; Wu W, 2008, IEEE T NEURAL NETWOR, V19, P319, DOI 10.1109/TNN.2007.908639; Xu CJ, 2018, NEUROCOMPUTING, V275, P377, DOI 10.1016/j.neucom.2017.08.030; Yang T, 1997, IEEE T CIRCUITS-I, V44, P976, DOI 10.1109/81.633887; Yang XJ, 2018, CHAOS SOLITON FRACT, V110, P105, DOI 10.1016/j.chaos.2018.03.016; Zhang AP, 2017, NEURAL PROCESS LETT, V45, P183, DOI 10.1007/s11063-016-9518-x; Zhang DD, 2017, NEURAL NETWORKS, V94, P55, DOI 10.1016/j.neunet.2017.06.014; Zhang J, 2017, NEUROCOMPUTING, V219, P154, DOI 10.1016/j.neucom.2016.09.004; Zhang L, 2017, APPL MATH COMPUT, V306, P22, DOI 10.1016/j.amc.2017.02.004; Zhou C, 2017, NEURAL PROCESS LETT, V46, P271, DOI 10.1007/s11063-017-9590-x; Zou CM, 2016, IEEE T IMAGE PROCESS, V25, P3287, DOI 10.1109/TIP.2016.2567077	59	6	6	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198297	10.1371/journal.pone.0198297	http://dx.doi.org/10.1371/journal.pone.0198297			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879145	Green Submitted, gold, Green Published			2022-12-26	WOS:000434384900029
J	Marques, AP; Macedo, AF; Hernandez-Moreno, L; Ramos, PL; Butt, T; Rubin, G; Santana, R				Marques, Ana Patricia; Macedo, Antonio Filipe; Hernandez-Moreno, Laura; Ramos, Pedro Lima; Butt, Thomas; Rubin, Gary; Santana, Rui		Portuguese Visual Impairment Study	The use of informal care by people with vision impairment	PLOS ONE			English	Article							VISUAL DISABILITY VARIABLES; BLUE-MOUNTAINS-EYE; MACULAR DEGENERATION; ACTIVITY INVENTORY; UNITED-STATES; COSTS; SERVICES; HEALTH; QUESTIONNAIRE; INDIVIDUALS	Purpose To estimate and characterize the use of informal care by people with vision impairment in Portugal. Methods A total of 546 visually impaired individuals were recruited from Portuguese hospitals. Clinical information was obtained from medical records, socio-demographic details and informal care use were collected during face-to-face interviews. In addition, participants responded to a functional vision questionnaire (activity inventory) to assess their visual ability. Logistic regression was used to determine independent factors associated with informal care use and linear regression was used to determine independent predictors of intensity of informal care use. Results Informal care was reported by 39.6% of the participants. The probability of reporting informal care was higher in non-married, those with comorbidities, with lower visual ability and worse visual acuity. The median number of caregivers' hours per year was 390 (mean = 470; 95% CI = 488-407), which represent a median opportunity cost of 2,586. Visual ability was the only independent predictor of number of hours of informal care received. Conclusions Informal care was frequently used by individuals with impaired vision. Improving visual ability of people with impaired vision when performing valued activities may reduce the burden of visual loss at personal and societal level. This could be achieved with person-centred visual rehabilitation.	[Marques, Ana Patricia; Santana, Rui] NOVA Univ Lisbon, Natl Sch Publ Hlth, Lisbon, Portugal; [Marques, Ana Patricia; Santana, Rui] NOVA Univ Lisbon, Natl Sch Publ Hlth, Publ Hlth Res Ctr, Lisbon, Portugal; [Macedo, Antonio Filipe; Ramos, Pedro Lima] Linnaeus Univ Kalmar, Dept Med & Optometry, Kalmar, Sweden; [Macedo, Antonio Filipe; Hernandez-Moreno, Laura] Univ Minho Braga, Low Vis & Visual Rehabil Lab, Dept & Ctr Phys Optometry & Vis Sci, Braga, Portugal; [Butt, Thomas; Rubin, Gary] UCL, Inst Ophthalmol, London, England; [Butt, Thomas] Peking Univ, Natl Sch Dev, Beijing, Peoples R China	Universidade Nova de Lisboa; Universidade Nova de Lisboa; Linnaeus University; University of London; University College London; Peking University	Marques, AP (corresponding author), NOVA Univ Lisbon, Natl Sch Publ Hlth, Lisbon, Portugal.; Marques, AP (corresponding author), NOVA Univ Lisbon, Natl Sch Publ Hlth, Publ Hlth Res Ctr, Lisbon, Portugal.	ap.marques@ensp.unl.pt	Marques, Ana Patricia R S S/V-9571-2017; Macedo, Antonio/I-8108-2013; Butt, Thomas/AAH-7882-2019; Marques, Ana Patricia/AAY-3342-2020; Santana, Rui/I-3294-2017	Marques, Ana Patricia R S S/0000-0001-8242-7021; Macedo, Antonio/0000-0003-3436-2010; Butt, Thomas/0000-0002-0387-4550; Marques, Ana Patricia/0000-0001-8242-7021; Lima Ramos, Pedro/0000-0003-1280-9854; Santana, Rui/0000-0003-1370-3242	Fundacao para a Ciencia e a Tecnologia (COMPETE/QREN) [PTDC/DPT-EPI/0412/2012]; Fundação para a Ciência e a Tecnologia [PTDC/DTP-EPI/0412/2012] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia (COMPETE/QREN); Fundação para a Ciência e a Tecnologia	This study was supported by Fundacao para a Ciencia e a Tecnologia (COMPETE/QREN) grant reference PTDC/DPT-EPI/0412/2012 in the context of the Prevalence and Costs of Visual Impairment in Portugal: PCVIP-study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandello F, 2008, DRUG AGING, V25, P255, DOI 10.2165/00002512-200825030-00007; Bhandari A, 2006, MED CARE RES REV, V63, P217, DOI 10.1177/1077558705285298; Bonastre J, 2003, PHARMACOECONOMICS, V21, P181, DOI 10.2165/00019053-200321030-00003; Brown JC, 2014, OPHTHALMOLOGY, V121, P1655, DOI 10.1016/j.ophtha.2014.02.030; Chisholm D, 2000, EPSILON STUDY, V177, ps28, DOI [10.1192/bjp.177.39.s28, DOI 10.1192/BJP.177.39.S28]; Chou SL, 2003, CLIN EXP OPHTHALMOL, V31, P336, DOI 10.1046/j.1442-9071.2003.00667.x; Costa N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/852368; Courtin E, 2014, HEALTH POLICY, V118, P84, DOI 10.1016/j.healthpol.2014.07.013; Dhital A, 2010, EYE, V24, P1437, DOI 10.1038/eye.2010.60; Frick KD, 2010, INVEST OPHTH VIS SCI, V51, P1801, DOI 10.1167/iovs.09-4469; Goldstein JE, 2014, JAMA OPHTHALMOL, V132, P1169, DOI 10.1001/jamaophthalmol.2014.1747; Goodrich K, 2012, VALUE HEALTH, V15, P975, DOI 10.1016/j.jval.2012.05.009; Hernandez-Moreno L, 2015, INVEST OPHTH VIS SCI, V56; Hong T, 2013, AM J OPHTHALMOL, V156, P393, DOI 10.1016/j.ajo.2013.04.002; Ke KM, 2007, BRIT J OPHTHALMOL, V91, P1279, DOI 10.1136/bjo.2006.113142; Ke KM, 2010, EUR J HEALTH ECON, V11, P525, DOI 10.1007/s10198-009-0207-9; Keeffe JE, 2009, ARCH OPHTHALMOL-CHIC, V127, P1377, DOI 10.1001/archophthalmol.2009.242; Koberlein J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003471; Macedo AF, 2017, ACTA OPHTHALMOL, V95, pe783, DOI 10.1111/aos.13430; Massof RW, 2007, OPTOMETRY VISION SCI, V84, P763, DOI 10.1097/OPX.0b013e3181339efd; Massof RW, 2005, ARCH PHYS MED REHAB, V86, P946, DOI 10.1016/j.apmr.2004.09.016; Massof RW, 2005, ARCH PHYS MED REHAB, V86, P954, DOI 10.1016/j.apmr.2004.09.017; Oliva-Moreno J, 2017, PHARMACOECONOMICS, V35, P331, DOI 10.1007/s40273-016-0468-y; Pinto D, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-45; Schmier JK, 2006, RETINA-J RET VIT DIS, V26, P1056, DOI 10.1097/01.iae.0000254890.48272.5a; Schmier JK, 2009, DISABIL REHABIL, V31, P659, DOI 10.1080/09638280802239391; Severens JL, 2000, SOC SCI MED, V51, P243, DOI 10.1016/S0277-9536(99)00452-9; Thompson S, 2001, ANNOTATED COST QUEST; Triantafillou J., 2010, INFORMAL CARE LONG T; van Exel Job, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P557, DOI 10.1586/14737167.8.6.557; van Leeuwen LM, 2015, ACTA OPHTHALMOL, V93, P642, DOI 10.1111/aos.12782; Wang J.Y., 1999, J NW FOR COLL, V15, P9; Wang JJ, 2003, OPHTHALMIC EPIDEMIOL, V10, P3, DOI 10.1076/opep.10.1.3.13773; Wood JM, 2011, INVEST OPHTH VIS SCI, V52, P5088, DOI 10.1167/iovs.10-6644	34	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198631	10.1371/journal.pone.0198631	http://dx.doi.org/10.1371/journal.pone.0198631			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879193	Green Published, Green Submitted, gold			2022-12-26	WOS:000434384900063
J	Marra, R; Vinale, F; Cesarano, G; Lombardi, N; d'Errico, G; Crasto, A; Mazzei, P; Piccolo, A; Incerti, G; Woo, SL; Scala, F; Bonanomi, G				Marra, Roberta; Vinale, Francesco; Cesarano, Gaspare; Lombardi, Nadia; d'Errico, Giada; Crasto, Antonio; Mazzei, Pierluigi; Piccolo, Alessandro; Incerti, Guido; Woo, Sheridan L.; Scala, Felice; Bonanomi, Giuliano			Biochars from olive mill waste have contrasting effects on plants, fungi and phytoparasitic nematodes	PLOS ONE			English	Article							SOLID-STATE C-13; ACTIVATED CARBON; SOIL AMENDMENT; MELOIDOGYNE-INCOGNITA; CONTAMINATED SOILS; NMR-SPECTROSCOPY; POTTING MIXTURES; ORGANIC-MATTER; WATER EXTRACTS; OIL PRODUCTION	Olive mill waste (OMW), a byproduct from the extraction of olive oil, causes serious environmental problems for its disposal, and extensive efforts have been made to find cost-effective solutions for its management. Biochars produced from OMW were applied as soil amendment and found in many cases to successfully increase plant productivity and suppress diseases. This work aims to characterize biochars obtained by pyrolysis of OMW at 300 degrees C to 1000 degrees C using C-13 NMR spectroscopy, LC-ESI-Q-TOF-MS and SEM (Scanning Electron Microscopy). Chemical characterization revealed that biochar composition varied according to the increase of pyrolysis temperature (PT). Thermal treated materials showed a progressive reduction of alkyl C fractions coupled to the enrichment in aromatic C products. In addition, numerous compounds present in the organic feedstock (fatty acids, phenolic compounds, triterpene acids) reduced (PT = 300 degrees C) or completely disappeared (PT > 500 degrees C) in biochars as compared to untreated OMW. PT also affected surface morphology of biochars by increasing porosity and heterogeneity of pore size. The effects of biochars extracts on the growth of different organisms (two plants, one nematode and four fungal species) were also evaluated. When tested on different living organisms, biochars and OMW showed opposite effects. The root growth of Lepidium sativum and Brassica rapa, as well as the survival of the nematode Meloidogyne incognita, were inhibited by the untreated material or biochar produced at 300 degrees C, but toxicity decreased at higher PTs. Conversely, growth of Aspergillus, Fusarium, Rhizoctonia and Trichoderma fungi was stimulated by organic feedstock, while being inhibited by thermally treated biochars. Our findings showed a pattern of association between specific biochar chemical traits and its biological effects that, once mechanistically explained and tested in field conditions, may lead to effective applications in agriculture.	[Marra, Roberta; Vinale, Francesco; Cesarano, Gaspare; d'Errico, Giada; Crasto, Antonio; Piccolo, Alessandro; Scala, Felice; Bonanomi, Giuliano] Univ Naples Federico II, Dept Agr Sci, Naples, Italy; [Marra, Roberta; Woo, Sheridan L.; Bonanomi, Giuliano] Univ Naples Federico II, Task Force Microbiome Studies, Naples, Italy; [Vinale, Francesco; Lombardi, Nadia; d'Errico, Giada; Woo, Sheridan L.; Scala, Felice] CNR, Inst Sustainable Plant Protect, Naples, Italy; [Mazzei, Pierluigi; Piccolo, Alessandro] Univ Naples Federico II, Interdept Res Ctr Nucl Magnet Resonance Environm, Naples, Italy; [Incerti, Guido] Univ Udine, Dept Agrifood Environm & Anim Sci, Udine, Italy; [Woo, Sheridan L.] Univ Naples Federico II, Dept Pharm, Naples, Italy	University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR); University of Naples Federico II; University of Udine; University of Naples Federico II	Marra, R (corresponding author), Univ Naples Federico II, Dept Agr Sci, Naples, Italy.; Marra, R (corresponding author), Univ Naples Federico II, Task Force Microbiome Studies, Naples, Italy.	robmarra@unina.it	Incerti, Guido/O-5870-2019; Woo, Sheridan L/B-9165-2019; d'Errico, Giada/G-2419-2018; Vinale, Francesco/AAG-9323-2020; Marra, Roberta/AAL-7622-2020	Incerti, Guido/0000-0003-1288-8708; Woo, Sheridan L/0000-0001-8611-6140; Marra, Roberta/0000-0003-2110-7539; Mazzei, Pierluigi/0000-0002-5312-4969; BONANOMI, Giuliano/0000-0002-1831-4361	MIUR - PON [Linfa 03PE_00026_1, Marea 03PE_00106]; MIUR - GPS [Sicura DM29156]; P.O.R. Campania FESR [BIP Rete delle biotecnologie in Campania]; Regione Puglia [SIX 1410-12/06/2015];  [KENYA-AID: 10306/CEFA/KEN]	MIUR - PON(Ministry of Education, Universities and Research (MIUR)); MIUR - GPS(Ministry of Education, Universities and Research (MIUR)); P.O.R. Campania FESR [BIP Rete delle biotecnologie in Campania]; Regione Puglia(Regione Puglia); 	This work was supported by the following projects: MIUR - PON [grant number Linfa 03PE_00026_1], [grant number Marea 03PE_00106]; MIUR - GPS [grant number Sicura DM29156]; P.O.R. Campania FESR 2007-2013 [BIP Rete delle biotecnologie in Campania]; Regione Puglia [grant number SIX 1410-12/06/2015]; Grant contract no KENYA-AID: 10306/CEFA/KEN "Strengthening livelihoods of rural agro-pastoralists in Kitui East sub county, Kitui County, Kenya." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhadi SO, 2017, BIORESOURCE TECHNOL, V244, P759, DOI 10.1016/j.biortech.2017.08.013; Ahmad M, 2014, CHEMOSPHERE, V99, P19, DOI 10.1016/j.chemosphere.2013.10.071; Alcaide EM, 1996, INT BIODETER BIODEGR, V38, P227, DOI 10.1016/S0964-8305(96)00055-8; Almendros G, 2003, ORG GEOCHEM, V34, P1559, DOI 10.1016/S0146-6380(03)00152-9; Ameloot N, 2013, EUR J SOIL SCI, V64, P379, DOI 10.1111/ejss.12064; Antal MJ, 2003, IND ENG CHEM RES, V42, P1619, DOI 10.1021/ie0207919; Ariona R, 2005, J FOOD ENG, V68, P239, DOI 10.1016/j.jfoodeng.2004.05.049; Arjona R, 1999, J FOOD ENG, V41, P229, DOI 10.1016/S0260-8774(99)00104-1; Azbar N, 2004, CRIT REV ENV SCI TEC, V34, P209, DOI 10.1080/10643380490279932; Baccar R, 2009, J HAZARD MATER, V162, P1522, DOI 10.1016/j.jhazmat.2008.06.041; Beesley L, 2011, ENVIRON POLLUT, V159, P3269, DOI 10.1016/j.envpol.2011.07.023; Beesley L, 2010, ENVIRON POLLUT, V158, P2282, DOI 10.1016/j.envpol.2010.02.003; Bescher E., 2012, 12 INT C REC ADV CON; Blazquez G, 2010, CHEM ENG J, V160, P615, DOI 10.1016/j.cej.2010.03.085; Blum U, 1999, CRIT REV PLANT SCI, V18, P673, DOI 10.1016/S0735-2689(99)00396-2; Bonanomi G, 2015, J PLANT PATHOL, V97, P223; Bonanomi G, 2018, APPL SOIL ECOL, V124, P351, DOI 10.1016/j.apsoil.2017.11.027; Bonanomi G, 2018, ECOLOGY, V99, P158, DOI 10.1002/ecy.2053; Bonanomi G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09145-w; Bonanomi G, 2016, SOIL BIOL BIOCHEM, V92, P133, DOI 10.1016/j.soilbio.2015.10.003; Bonanomi G, 2011, NEW PHYTOL, V191, P1018, DOI 10.1111/j.1469-8137.2011.03765.x; Bonanomi G, 2011, APPL SOIL ECOL, V47, P184, DOI 10.1016/j.apsoil.2010.12.007; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; Cantrell KB, 2012, BIORESOURCE TECHNOL, V107, P419, DOI 10.1016/j.biortech.2011.11.084; Cayuela ML, 2004, COMPOST SCI UTIL, V12, P130; Celano G, 2008, ENVIRON SCI TECHNOL, V42, P4896, DOI 10.1021/es8000745; Chakraborty M, 2012, FUEL, V95, P63, DOI 10.1016/j.fuel.2011.10.055; Chitwood DJ, 2002, ANNU REV PHYTOPATHOL, V40, P221, DOI 10.1146/annurev.phyto.40.032602.130045; Cole DP, 2012, ENERG FUEL, V26, P3803, DOI 10.1021/ef300356u; Conte P, 2004, PROG NUCL MAG RES SP, V44, P215, DOI 10.1016/j.pnmrs.2004.02.002; d'Errico G, 2017, REDIA, V100, P95, DOI 10.19263/REDIA-100.17.12; Demirbas A, 2004, J ANAL APPL PYROL, V72, P243, DOI 10.1016/j.jaap.2004.07.003; Denyes MJ, 2012, SCI TOTAL ENVIRON, V437, P76, DOI 10.1016/j.scitotenv.2012.07.081; Domingues RR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176884; Emwas Abdul-Hamid M, 2015, Methods Mol Biol, V1277, P161, DOI 10.1007/978-1-4939-2377-9_13; Freitas JCC, 1999, ENERG FUEL, V13, P53, DOI 10.1021/ef980075c; Gaskin JW, 2008, T ASABE, V51, P2061, DOI 10.13031/2013.25409; Giacometti R, 2010, NEMATROPICA, V40, P263; Goebel M, 2011, ECOL MONOGR, V81, P89, DOI 10.1890/09-2390.1; Gonzalez-Perez JA, 2004, ENVIRON INT, V30, P855, DOI 10.1016/j.envint.2004.02.003; Graber ER, 2014, EUR J SOIL SCI, V65, P162, DOI 10.1111/ejss.12071; Graber ER, 2010, PLANT SOIL, V337, P481, DOI 10.1007/s11104-010-0544-6; Haddadin MS, 1999, J CHEM TECHNOL BIOT, V74, P613, DOI 10.1002/(SICI)1097-4660(199907)74:7<613::AID-JCTB80>3.3.CO;2-#; Hattenschwiler S, 2011, NEW PHYTOL, V189, P950, DOI 10.1111/j.1469-8137.2010.03483.x; Hille M, 2005, OIKOS, V108, P202, DOI 10.1111/j.0030-1299.2005.13482.x; Hmid A, 2015, ENVIRON SCI POLLUT R, V22, P1444, DOI 10.1007/s11356-014-3467-6; Hmid A, 2014, BIOMASS BIOENERG, V71, P330, DOI 10.1016/j.biombioe.2014.09.024; Hodge A, 2000, TRENDS PLANT SCI, V5, P304, DOI 10.1016/S1360-1385(00)01656-3; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; Incerti G, 2013, MYCOSCIENCE, V54, P449, DOI 10.1016/j.myc.2013.02.006; Jeffery S, 2011, AGR ECOSYST ENVIRON, V144, P175, DOI 10.1016/j.agee.2011.08.015; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; Knicker H, 2005, SOIL BIOL BIOCHEM, V37, P701, DOI 10.1016/j.soilbio.2004.09.008; Knicker H, 2007, BIOGEOCHEMISTRY, V85, P91, DOI 10.1007/s10533-007-9104-4; Knox OGG, 2015, J PLANT PATHOL, V97, P149; Krull E.S., 2009, BIOCHAR ENV MANAGEME, P53, DOI DOI 10.4324/9781849770552; Kuhlbusch T.A., 1996, BIOMASS BURNING GLOB, P160; Lehmann J., 2009, SCI TECHNOL HUM VAL, DOI 10.4324/9781849770552; LINDEN DR, 1994, SSSA SPEC PUBL, P91; Lopez-Iglesias B, 2014, PLANT SOIL, V381, P177, DOI 10.1007/s11104-014-2109-6; Lou YM, 2016, BIORESOURCES, V11, P249; Martin J, 2002, SOIL BIOL BIOCHEM, V34, P1769, DOI 10.1016/S0038-0717(02)00164-5; Mazzoleni S, 2015, NEW PHYTOL, V206, P127, DOI 10.1111/nph.13306; Meiners SJ, 2014, PLANT ECOL, V215, P661, DOI 10.1007/s11258-014-0331-1; Mocali S, 2015, IND CROP PROD, V75, P79, DOI 10.1016/j.indcrop.2015.04.031; Nguyen BT, 2010, ENVIRON SCI TECHNOL, V44, P3324, DOI 10.1021/es903016y; Niaounakis M, 2006, WASTE MANAG SER, V5, P1; Nico AI, 2004, CROP PROT, V23, P581, DOI 10.1016/j.cropro.2003.11.005; Novak J. M., 2009, Annals of Environmental Science, V3, P195; Obied HK, 2005, J AGR FOOD CHEM, V53, P823, DOI 10.1021/jf048569x; Oh TK, 2012, J FAC AGR KYUSHU U, V57, P55; Oleszczuk P, 2012, ECOTOX ENVIRON SAFE, V80, P321, DOI 10.1016/j.ecoenv.2012.03.015; Ro KS, 2009, BIORESOURCE TECHNOL, V100, P5466, DOI 10.1016/j.biortech.2009.03.005; Roig A, 2006, WASTE MANAGE, V26, P960, DOI 10.1016/j.wasman.2005.07.024; Singh B, 2010, AUST J SOIL RES, V48, P516, DOI 10.1071/SR10058; Soria J.A., 2012, BIOMASS CONVERSION I, P421; Sun JL, 2017, SCI TOTAL ENVIRON, V576, P858, DOI 10.1016/j.scitotenv.2016.10.095; Talhaoui N, 2015, J AGR FOOD CHEM, V63, P1722, DOI 10.1021/jf5058205; Tuitert G, 1998, PHYTOPATHOLOGY, V88, P764, DOI 10.1094/PHYTO.1998.88.8.764; Wallenstein MD, 2013, SOIL BIOL BIOCHEM, V57, P311, DOI 10.1016/j.soilbio.2012.09.027; Wickings K, 2012, ECOL LETT, V15, P1180, DOI 10.1111/j.1461-0248.2012.01837.x; Zabaniotou A, 2008, BIORESOURCE TECHNOL, V99, P320, DOI 10.1016/j.biortech.2006.12.020; Zackrisson O, 1996, OIKOS, V77, P10, DOI 10.2307/3545580	83	25	25	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198728	10.1371/journal.pone.0198728	http://dx.doi.org/10.1371/journal.pone.0198728			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879199	Green Published, gold, Green Submitted			2022-12-26	WOS:000434384900076
J	Vouraki, S; Gelasakis, AI; Alexandri, P; Boukouvala, E; Ekateriniadou, LV; Banos, G; Arsenos, G				Vouraki, Sotiria; Gelasakis, Athanasios I.; Alexandri, Panoraia; Boukouvala, Evridiki; Ekateriniadou, Loukia V.; Banos, Georgios; Arsenos, Georgios			Genetic profile of scrapie codons 146, 211 and 222 in the PRNP gene locus in three breeds of dairy goats	PLOS ONE			English	Article							PRION PROTEIN GENE; CAPRINE PRP GENE; CLASSICAL SCRAPIE; PRODUCTION TRAITS; CYPRUS GOATS; POLYMORPHISMS; ASSOCIATION; RESISTANCE; SHEEP; GENOTYPES	Polymorphisms at PRNP gene locus have been associated with resistance against classical scrapie in goats. Genetic selection on this gene within appropriate breeding programs may contribute to the control of the disease. The present study characterized the genetic profile of codons 146, 211 and 222 in three dairy goat breeds in Greece. A total of 766 dairy goats from seven farms were used. Animals belonged to two indigenous Greek, Eghoria (n = 264) and Skopelos (n = 287) and a foreign breed, Damascus (n = 215). Genomic DNA was extracted from blood samples from individual animals. Polymorphisms were detected in these codons using Real-Time PCR analysis and four different Custom TaqMan (R) SNP Gen-otyping Assays. Genotypic, allelic and haplotypic frequencies were calculated based on individual animal genotypes. Chi-square tests were used to examine Hardy-Weinberg equilibrium state and compare genotypic distribution across breeds. Genetic distances among the three breeds, and between these and 30 breeds reared in other countries were estimated based on haplotypic frequencies using fixation index F-ST with Arlequin v3.1 software; a Neighbor-Joining tree was created using PHYLIP package v3.695. Level of statistical significance was set at P = 0.01. All scrapie resistance-associated alleles (146S, 146D, 211Q and 222K) were detected in the studied population. Significant frequency differences were observed between the indigenous Greek and Damascus breeds. Alleles 222K and 146S had the highest frequency in the two indigenous and the Damascus breed, respectively (ca. 6.0%). The studied breeds shared similar haplotypic frequencies with most South Italian and Turkish breeds but differed significantly from North-Western European, Far East and some USA goat breeds. Results suggest there is adequate variation in the PRNP gene locus to support breeding programs for enhanced scrapie resistance in goats reared in Greece. Genetic comparisons among goat breeds indicate that separate breeding programs should apply to the two indigenous and the imported Damascus breeds.	[Vouraki, Sotiria; Alexandri, Panoraia; Banos, Georgios; Arsenos, Georgios] Aristotle Univ Thessaloniki, Fac Hlth Sci, Sch Vet Med, Lab Anim Husb, Thessaloniki, Greece; [Gelasakis, Athanasios I.; Boukouvala, Evridiki; Ekateriniadou, Loukia V.] Hellen Agr Org Demeter, Vet Res Inst Thessaloniki, Thessaloniki, Greece; [Banos, Georgios] Univ Edinburgh, Scotlands Rural Coll, Edinburgh, Midlothian, Scotland; [Banos, Georgios] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Gelasakis, Athanasios I.] Agr Univ Athens, Dept Anim Sci & Aquaculture, Athens, Greece	Aristotle University of Thessaloniki; Scotland's Rural College; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Agricultural University of Athens	Vouraki, S (corresponding author), Aristotle Univ Thessaloniki, Fac Hlth Sci, Sch Vet Med, Lab Anim Husb, Thessaloniki, Greece.	svouraki@vet.auth.gr	Gelasakis, Athanasios/AAY-1163-2020; Arsenos, Georgios/AAO-7147-2021	Arsenos, Georgios/0000-0003-3224-5128; Banos, Georgios/0000-0002-7674-858X; Gelasakis, Athanasios/0000-0003-1144-3918; Vouraki, Sotiria/0000-0003-4339-2051	European Union SOLID project [FP7-KBBE-266367]; Alexander S. Onassis Public Benefit Foundation [GZM 010-1/2016-2017]; BBSRC [BBS/E/D/20002173] Funding Source: UKRI	European Union SOLID project; Alexander S. Onassis Public Benefit Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by European Union SOLID project (FP7-KBBE-266367, http://www.solldairy.eu/, grant awarded to GA) and by a PhD scholarship to the first author (SV) granted by Alexander S. Onassis Public Benefit Foundation (GZM 010-1/2016-2017, http://www.onassis.org/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acutis PL, 2008, J APPL MICROBIOL, V104, P1782, DOI 10.1111/j.1365-2672.2007.03703.x; Acutis PL, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-8; Acutis PL, 2006, J GEN VIROL, V87, P1029, DOI 10.1099/vir.0.81440-0; Aguilar-Calvo P, 2014, J VIROL, V88, P2670, DOI 10.1128/JVI.02074-13; Alvarez L, 2006, J DAIRY SCI, V89, P1784, DOI 10.3168/jds.S0022-0302(06)72247-0; Amills M, 2009, ANIM GENET, V40, P315, DOI 10.1111/j.1365-2052.2008.01837.x; Barillet F, 2009, J GEN VIROL, V90, P769, DOI 10.1099/vir.0.006114-0; Baylis M, 2004, CURR MOL MED, V4, P385, DOI 10.2174/1566524043360672; Billinis C, 2002, J GEN VIROL, V83, P713, DOI 10.1099/0022-1317-83-3-713; Bossers A, 1996, J GEN VIROL, V77, P2669, DOI 10.1099/0022-1317-77-10-2669; Boukouvala E, 2018, SMALL RUMINANT RES, V161, P51, DOI 10.1016/j.smallrumres.2018.01.016; Boukouvala E, 2014, PRION, V8, P65; Bouzalas IG, 2010, J GEN VIROL, V91, P1629, DOI 10.1099/vir.0.017350-0; Canon J, 2006, ANIM GENET, V37, P327, DOI 10.1111/j.1365-2052.2006.01461.x; Casellas J, 2007, J ANIM SCI, V85, P592, DOI 10.2527/jas.2006-308; Dawson M, 2008, VET RES, V39, DOI 10.1051/vetres:2007064; De Vries F, 2005, J DAIRY SCI, V88, P392, DOI 10.3168/jds.S0022-0302(05)72699-0; DEFRA. National Scrapie Plan for Great Britain, 2001, NAT SCRAP PLAN GREAT; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fast C, 2017, VET RES, V48, DOI 10.1186/s13567-017-0455-0; Felsenstein J., 2013, PHYLIP PHYLOGENY INF; Fragkiadaki EG, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-104; Gelasakis AI, 2017, LIVEST SCI, V197, P22, DOI 10.1016/j.livsci.2017.01.003; Goldmann W, 1996, J GEN VIROL, V77, P2885, DOI 10.1099/0022-1317-77-11-2885; Goldmann W, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-110; Goldmann W, 2008, VET RES, V39, DOI 10.1051/vetres:2008010; Hunter N, 1997, NATURE, V386, P137, DOI 10.1038/386137a0; Hunter N, 1996, ARCH VIROL, V141, P809, DOI 10.1007/BF01718157; Kanata E, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-43; Kurosaki Y, 2005, J VET MED SCI, V67, P321, DOI 10.1292/jvms.67.321; Lacroux C, 2014, J VIROL, V88, P2406, DOI 10.1128/JVI.02872-13; Lipsky S, 2008, ANIM REPROD SCI, V103, P69, DOI 10.1016/j.anireprosci.2006.12.005; Man WYN, 2007, GENET SEL EVOL, V39, P711, DOI 10.1051/gse:2007027; Mazza M, 2017, J GEN VIROL, V98, P1963, DOI 10.1099/jgv.0.000843; Meydan H, 2017, J GENET, V96, P299, DOI 10.1007/s12041-017-0763-1; Migliore S, 2017, J GENET, V96, P319, DOI 10.1007/s12041-017-0776-9; Migliore S, 2015, SMALL RUMINANT RES, V125, P137, DOI 10.1016/j.smallrumres.2015.01.029; Papasavva-Stylianou P, 2007, VET J, V173, P459, DOI 10.1016/j.tvjl.2005.09.013; Papasavva-Stylianou P, 2011, VET J, V187, P245, DOI 10.1016/j.tvjl.2009.10.015; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Psifidi A, 2011, ANIM GENET, V42, P406, DOI 10.1111/j.1365-2052.2010.02159.x; Ricci A, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4962; Sweeney T, 2008, VET RES, V39, DOI 10.1051/vetres:2008004; Vaccari G, 2009, VET RES, V40, DOI 10.1051/vetres/2009031; White S, 2008, GENET SEL EVOL, V40, P553, DOI 10.1051/gse:2008021; White SN, 2012, GENE, V501, P49, DOI 10.1016/j.gene.2012.03.068; Zhang L, 2004, ANIM GENET, V35, P457, DOI 10.1111/j.1365-2052.2004.01204.x	47	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198819	10.1371/journal.pone.0198819	http://dx.doi.org/10.1371/journal.pone.0198819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879210	Green Published, Green Submitted, gold			2022-12-26	WOS:000434384900084
J	Matuszewska, A; Jaszek, M; Stefaniuk, D; Ciszewski, T; Matuszewski, L				Matuszewska, Anna; Jaszek, Magdalena; Stefaniuk, Dawid; Ciszewski, Tomasz; Matuszewski, Lukasz			Anticancer, antioxidant, and antibacterial activities of low molecular weight bioactive subfractions isolated from cultures of wood degrading fungus Cerrena unicolor	PLOS ONE			English	Article							EDIBLE MUSHROOM; ANTIPROLIFERATIVE ACTIVITY; ANTIMICROBIAL ACTIVITY; MEDICINAL MUSHROOMS; IN-VITRO; LACCASE; POLYSACCHARIDES; CAPACITY; EXTRACTS; PROTEIN	The aim of this study is to investigate in vitro the anticancer, antioxidant, and antibacterial activities of three low molecular weight subfractions I, II and III isolated from secondary metabolites produced by the wood degrading fungus Cerrena unicolor. The present study demonstrated that the low molecular weight subfractions III exhibited the strongest inhibitory activity towards breast carcinoma cells MDA-MB-231, prostatic carcinoma cells PC3, and breast cancer cells MCF7 with the half-maximal inhibitory concentration (IC50) value of 52,25 mu g/mL, 60,66 mu g/mL, and 54,92 mu g/mL, respectively. The highest percentage of inhibition was noted at a concentration of 300 mu g/mL in all the examined tumor lines. A significant percentage (59.08%) of ex-LMSIII inhibition of the MDA-MB-231 tumor line was reached at a concentration of 15 mu g/mI, while the concentration applied did not affect normal human fibroblast cells. The low molecular weight subfraction III was the most effective and additionally showed the highest free radical 1,1-dipheny1-2-picryl-hydrazyl scavenging activity (IC50 20.39 mu g/mL) followed by the low molecular weight subfraction I (IC50 64.14 mu g/mL) and II (IC50 49.22 mu g/mL). The antibacterial activity of the tested preparations was evaluated against three microorganisms: Bacillus subtilis, Staphylococcus aureus, and Escherichia coli. The MIG. minimal inhibitory concentration (MIC) values for the low molecular weight subfraction I, II, and III showed a stronger inhibition effect on S. aureus than on B. subtilis and E. coli cells. The MIC values for the low molecular weight subfractionllagainst S. aureus, B. subtilis, and E. co/iwere 6.25, 12.5, and 100 mg/mL, respectively.	[Matuszewska, Anna; Jaszek, Magdalena; Stefaniuk, Dawid] Maria Curie Skfodowska Univ, Dept Biochem, Lublin, Poland; [Ciszewski, Tomasz] St Johns Canc Ctr, Clin Oncol Ward, Lublin, Poland; [Matuszewski, Lukasz] Med Univ Lublin, Dept Paediat Orthopaed & Rehabil, Lublin, Poland	Medical University of Lublin	Matuszewska, A (corresponding author), Maria Curie Skfodowska Univ, Dept Biochem, Lublin, Poland.	anna.matuszewska@poczta.umcs.lublin.pl	Stefaniuk, Dawid/N-3223-2018; Stefaniuk, Dawid/AAM-5524-2020; Jaszek, Magdalena/N-3258-2018	Stefaniuk, Dawid/0000-0002-0183-6059; Jaszek, Magdalena/0000-0003-2609-1820; Matuszewska, Anna/0000-0002-5586-5568; Matuszewski, Lukasz/0000-0002-7733-0329	statutory research BS/UMCS from Ministry of Science and Higher Education in Poland [BS-P-11-010-16-1-09, BS-P-11-010-17-1-11]	statutory research BS/UMCS from Ministry of Science and Higher Education in Poland	This study was funded by statutory research BS/UMCS from the Ministry of Science and Higher Education in Poland, numbers BS-P-11-010-16-1-09 and BS-P-11-010-17-1-11.	Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen YJ, 2012, MOL NUTR FOOD RES, V56, P1729, DOI 10.1002/mnfr.201200316; Chen YY, 2012, PHYTOMEDICINE, V19, P768, DOI 10.1016/j.phymed.2012.02.016; Cote J, 2010, CRIT REV FOOD SCI, V50, P666, DOI 10.1080/10408390903044107; D'Archivio M, 2010, INT J MOL SCI, V11, P1321, DOI 10.3390/ijms11041321; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Duo-Chuan L, 2006, MYCOPATHOLOGIA, V161, P345, DOI 10.1007/s11046-006-0024-y; DZIEZAK JD, 1986, FOOD TECHNOL-CHICAGO, V40, P94; Elsayed EA, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/805841; Fan LF, 2006, FOOD TECHNOL BIOTECH, V44, P303; Gezer K, 2006, AFR J BIOTECHNOL, V5, P1924; Grymonpre DR, 2001, CHEM ENG J, V82, P189, DOI 10.1016/S1385-8947(00)00345-4; Hatakka A., 2010, FUNGAL BIODEGRADATIO; Hu DD, 2011, PHYTOMEDICINE, V18, P374, DOI 10.1016/j.phymed.2010.07.004; Janusz G, 2007, WORLD J MICROB BIOT, V23, P1459, DOI 10.1007/s11274-007-9390-y; Janusz G, 2012, J FAC AGR KYUSHU U, V57, P41; Jaszek M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/497492; Jennings D. H., 1999, FUNGAL BIOL UNDERSTA; Jung JY, 2008, J APPL MICROBIOL, V104, P1824, DOI 10.1111/j.1365-2672.2008.03737.x; Khan N, 2007, CARCINOGENESIS, V28, P163, DOI 10.1093/carcin/bgl145; Kosanic M, 2012, J FOOD SCI, V77, pT20, DOI 10.1111/j.1750-3841.2011.02459.x; Kozarski M, 2011, FOOD CHEM, V129, P1667, DOI 10.1016/j.foodchem.2011.06.029; Lin CH, 2010, PROCESS BIOCHEM, V45, P1537, DOI 10.1016/j.procbio.2010.06.006; Lindequist U, 2005, EVID-BASED COMPL ALT, V2, P285, DOI 10.1093/ecam/neh107; Liu K, 2012, J FOOD BIOCHEM, DOI [10.1111/j.1745-4514.2012, DOI 10.1111/J.1745-4514.2012]; Liu K, 2013, FOOD CHEM TOXICOL, V58, P375, DOI 10.1016/j.fct.2013.05.001; Liu QH, 2006, BBA-GEN SUBJECTS, V1760, P1914, DOI 10.1016/j.bbagen.2006.07.010; Mahajna J, 2009, NUTR CANCER, V61, P16, DOI 10.1080/01635580802379323; MALARCZYK E, 1989, ACTA MICROBIOL POL, V38, P45; Manrique GD, 2002, POSTHARVEST BIOL TEC, V25, P99, DOI 10.1016/S0925-5214(01)00160-0; Matuszewska A, 2016, ONCOL LETT, V11, P2009, DOI 10.3892/ol.2016.4220; Mizerska-Dudka M, 2015, INT J BIOL MACROMOL, V79, P459, DOI 10.1016/j.ijbiomac.2015.05.015; Paduch R, 2008, POL J ENVIRON STUD, V17, P569; Pan Y, 2010, CARBOHYD POLYM, V81, P93, DOI 10.1016/j.carbpol.2010.01.060; Rajewska Justyna, 2004, Postepy Hig Med Dosw (Online), V58, P352; Rashid S, 2011, FOOD CHEM TOXICOL, V49, P1477, DOI 10.1016/j.fct.2011.02.008; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Ren L, 2012, FOOD FUNCT, V3, P1118, DOI 10.1039/c2fo10279j; Rogalski J, 1999, J MOL CATAL B-ENZYM, V6, P29, DOI 10.1016/S1381-1177(98)00117-9; Sanchez C, 2017, SYN SYST BIOTECHNO, V2, P13, DOI 10.1016/j.synbio.2016.12.001; Siddiqi R, 2011, INT J FOOD SCI TECH, V46, P250, DOI 10.1111/j.1365-2621.2010.02480.x; Smolskaite L, 2015, LWT-FOOD SCI TECHNOL, V60, P462, DOI 10.1016/j.lwt.2014.08.007; Statkiewicz M, 2017, INT J MED MUSHROOMS, V19, P619, DOI 10.1615/IntJMedMushrooms.2017021241; UNYAYAR A, 2006, DRUG CHEM TOXICOL, V1, P1; van den Berg R, 1999, FOOD CHEM, V66, P511, DOI 10.1016/S0308-8146(99)00089-8; van Heijenoort J, 2001, GLYCOBIOLOGY, V11, p25R; Wang JL, 2012, FOOD SCI BIOTECHNOL, V21, P551, DOI 10.1007/s10068-012-0070-9; WORTHINGTON J, 2009, NATURAL PRODUCTS FUT; Wu HT, 2014, MOLECULES, V19, P2546, DOI 10.3390/molecules19022546; Wu XJ, 2008, J FOOD SCI, V73, pM1, DOI 10.1111/j.1750-3841.2007.00595.x; Xu T, 2015, ADV FOOD TECHNOL NUT, V1, P62, DOI [10.17140/AFTNSOJ-1-110, DOI 10.17140/AFTNSOJ-1-110]; Xu XF, 2011, BIOTECHNOL ADV, V29, P667, DOI 10.1016/j.biotechadv.2011.05.003; Yuswan M. H. M. Y., 2015, Advances in Bioscience and Biotechnology, V6, P320, DOI 10.4236/abb.2015.64031; Zhang BZ, 2012, CARBOHYD POLYM, V87, P2569, DOI 10.1016/j.carbpol.2011.11.042; Zhang GQ, 2009, ACTA BIOCHIM POL, V56, P415	56	40	41	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197044	10.1371/journal.pone.0197044	http://dx.doi.org/10.1371/journal.pone.0197044			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874240	gold, Green Published, Green Submitted			2022-12-26	WOS:000434369400010
J	Song, J; Zhao, YY; Nie, SM; Chen, X; Wu, XS; Mi, J				Song, Jian; Zhao, Yingying; Nie, Sumei; Chen, Xue; Wu, Xuesen; Mi, Jing			The effect of lipid accumulation product and its interaction with other factors on hypertension risk in Chinese Han population: A cross-sectional study	PLOS ONE			English	Article							BODY-MASS INDEX; TO-HEIGHT RATIO; HYPERTRIGLYCERIDEMIC WAIST PHENOTYPE; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; ADIPOSE-TISSUE; FAMILY-HISTORY; VISCERAL ADIPOSITY; INSULIN-RESISTANCE; GENE-EXPRESSION	Objectives Lipid accumulation product (LAP) is a simple and effective indicator that reflects visceral obesity. This study aimed to compare the significance of LAP in predicting hypertension risk with other obesity indices, and to evaluate the interactive effects of LAP and smoking, family history of hypertension on hypertension risk in Chinese Han adults. Methods A community based cross-sectional study was performed in Bengbu, China. Participants received face-to-face questionnaire survey, anthropometric tests and laboratory examinations. Relevant indicators that reflect obesity including BMI (body mass index), waist-toheight ratio (WHtR) and LAP were calculated. Multivariate logistic regression analysis was applied to explore the association between LAP and hypertension risk. The area under the receiver-operating characteristics curves (AUC) of LAP, BMI, and WHtR were calculated and then compared. Interactive effect was evaluated by relative excess risk due to interaction (RERI), attributable proportion due to interaction (AP) and synergy index (SI). Results A total of 1777 participants were enrolled, and the prevalence of hypertension was 24.4% (n = 433). There was a significant increase in hypertension risk with LAP levels in the fourth quartile as compared with the bottom quartile (OR: 3.31, 95%Cl: 1.76-6.25). The AUC of LAP was significantly different than that of BMI in males (Z= 2.158, p= 0.0309) and females (Z= 3.570, p= 0.0004), while only performed better in females as compared with that of WHtR (Z= 2.166, p = 0.0303). LAP was significantly interacted with family history of hypertension on hypertension risk both in males (RERI: 1.07, 95%Cl: 0.09-2.05; AP: 0.33, 95% CI: 0.23-0.44; SI: 1.92, 95%Cl: 1.53-2.41) and females (RERI: 0.80, 95%Cl: 0.07-1.53; AP: 0.25, 95%Cl: 0.11-0.39; SI: 1.59, 95%Cl: 1.16-2.19). However, a significant interaction between LAP and smoking was only observed in males (RERI: 1.32, 95%Cl: 0.15-2.75; AP: 0.40, 95% CI: 0.14-0.73). Conclusion Increased LAP was significantly associated with a higher risk of hypertension in Chinese Han adults. Moreover, the effect of LAP on predicting hypertension risk was better than that of other obesity indices. Our results also demonstrated interactive effects of LAP with smoking, family history of hypertension on hypertension risk.	[Song, Jian; Chen, Xue; Wu, Xuesen; Mi, Jing] Bengbu Med Coll, Sch Publ Hlth, Bengbu, Anhui, Peoples R China; [Zhao, Yingying; Nie, Sumei] Bengbu Hlth Board, Bengbu, Anhui, Peoples R China	Bengbu Medical College	Wu, XS (corresponding author), Bengbu Med Coll, Sch Publ Hlth, Bengbu, Anhui, Peoples R China.	xuesenwu@163.com		wu, xue-sen/0000-0001-8438-9380; song, jian/0000-0002-8073-1836	National Natural Science Foundation of China [81373100]; Key Projects of Humanities and Social Sciences Research Bases of Universities in Anhui Province [SK2014A055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects of Humanities and Social Sciences Research Bases of Universities in Anhui Province	This study is supported by the National Natural Science Foundation of China (number: 81373100) and the Key Projects of Humanities and Social Sciences Research Bases of Universities in Anhui Province (SK2014A055). We are grateful to all professionals and participants of the study. This work is supported by Bengbu health board, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alvarez GE, 2002, CIRCULATION, V106, P2533, DOI 10.1161/01.CIR.0000041244.79165.25; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Atzmon G, 2002, HORM METAB RES, V34, P622, DOI 10.1055/s-2002-38250; Bailey DP, 2013, J PEDIATR-US, V162, P746, DOI 10.1016/j.jpeds.2012.09.051; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Bundy JD, 2016, ANN GLOB HEALTH, V82, P227, DOI 10.1016/j.aogh.2016.02.002; Caminha Taina C S, 2017, Medicine (Baltimore), V96, pe5874, DOI 10.1097/MD.0000000000005874; Campbell NRC, 2014, J CLIN HYPERTENS, V16, P551, DOI 10.1111/jch.12372; Carmienke S, 2013, EUR J CLIN NUTR, V67, P573, DOI 10.1038/ejcn.2013.61; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Chiang JK, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-78; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560; Cullen MW, 2009, PREV MED, V48, P74, DOI 10.1016/j.ypmed.2008.10.008; Dai DX, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121231; David CN, 2017, J NUTR HEALTH AGING, V21, P597, DOI 10.1007/s12603-016-0812-0; de Oliveira CC, 2014, NUTR HOSP, V30, P25, DOI 10.3305/nh.2014.30.1.7411; Du T, 2014, INT J OBESITY, V38, P840, DOI 10.1038/ijo.2013.181; Frayn KN, 2003, INT J OBESITY, V27, P875, DOI 10.1038/sj.ijo.0802326; Gao X, 2013, OBES RES CLIN PRACT, V7, pE308, DOI 10.1016/j.orcp.2012.02.002; Giacchetti G, 2002, AM J HYPERTENS, V15, P381, DOI 10.1016/S0895-7061(02)02257-4; Hoffstedt J, 2010, DIABETOLOGIA, V53, P2496, DOI 10.1007/s00125-010-1889-3; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Hosseinpanah F, 2016, EUR J PREV CARDIOL, V23, P187, DOI 10.1177/2047487314558771; Igarashi R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004564; Ioachimescu AG, 2010, OBESITY, V18, P1836, DOI 10.1038/oby.2009.453; Kahn HS, 2008, INT J OBESITY, V32, P136, DOI 10.1038/sj.ijo.0803697; Kahn Henry S, 2005, BMC Cardiovasc Disord, V5, P26, DOI 10.1186/1471-2261-5-26; Kahn HS, 2006, DIABETES CARE, V29, P151, DOI 10.2337/diacare.29.1.151; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Kim EH, 2015, CARDIOLOGY, V131, P228, DOI 10.1159/000380941; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P433, DOI 10.1007/s10654-011-9554-9; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; Lewington S, 2016, JAMA INTERN MED, V176, P524, DOI 10.1001/jamainternmed.2016.0190; Li N, 2015, J HYPERTENS, V33, P2210, DOI 10.1097/HJH.0000000000000694; Li Y, 2003, EXP BIOL MED, V228, P1118, DOI 10.1177/153537020322801004; Li YC, 2017, INT J CARDIOL, V227, P516, DOI 10.1016/j.ijcard.2016.10.110; Lima-Martinez MM, 2013, ENDOCRINOL NUTR, V60, P320, DOI 10.1016/j.endonu.2012.08.001; Liu JF, 2014, J EPIDEMIOL, V24, P304, DOI 10.2188/jea.JE20130149; Liu Li-Sheng, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P579; Luo WS, 2015, PHYSIOL BEHAV, V139, P240, DOI 10.1016/j.physbeh.2014.11.038; Mi SQ, 2013, BIOMED ENVIRON SCI, V26, P485, DOI 10.3967/0895-3988.2013.06.009; Motamed N, 2016, J ENDOCRINOL INVEST, V39, P375, DOI 10.1007/s40618-015-0369-5; Nazare JA, 2012, AM J CLIN NUTR, V96, P714, DOI 10.3945/ajcn.112.035758; Nurdiantami Y, 2017, CLIN NUTR; Ranasinghe P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1927-7; Ren Q, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13030257; Ren YC, 2016, DIABETES-METAB RES, V32, P405, DOI 10.1002/dmrr.2725; Rotter I, 2017, EXP CLIN ENDOCR DIAB, V125, P176, DOI 10.1055/s-0042-116071; Sandeep S, 2010, INDIAN J MED RES, V131, P629; Schlecht I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175133; Seravalle G, 2017, PHARMACOL RES, V122, P1, DOI 10.1016/j.phrs.2017.05.013; Seravalle G, 2016, HIGH BLOOD PRESS CAR, V23, P175, DOI 10.1007/s40292-016-0137-4; Sun H, 2016, HERZ; Talukder MAH, 2011, AM J PHYSIOL-HEART C, V300, pH388, DOI 10.1152/ajpheart.00868.2010; Virdis A, 2010, CURR PHARM DESIGN, V16, P2518, DOI 10.2174/138161210792062920; Wakabayashi I, 2015, METAB SYNDR RELAT D, V13, P22, DOI 10.1089/met.2014.0093; Wakabayashi I, 2014, CLIN CHIM ACTA, V431, P221, DOI 10.1016/j.cca.2014.02.002; Wang AX, 2014, INT J CARDIOL, V174, P106, DOI 10.1016/j.ijcard.2014.03.177; Wehr E, 2011, OBESITY, V19, P1873, DOI 10.1038/oby.2011.42; Wehr E, 2011, J CLIN ENDOCR METAB, V96, pE986, DOI 10.1210/jc.2011-0031; Wolfgram PM, 2015, HORM RES PAEDIAT, V84, P258, DOI 10.1159/000439130; Wu J, 2017, SCI REP-UK, V7, DOI 10.1038/srep41518; Wu L, 2017, HYPERTENS RES, V40, P399, DOI 10.1038/hr.2016.162; Xia C, 2012, EUR J CLIN NUTR, V66, P1035, DOI 10.1038/ejcn.2012.83; Yang GH, 2010, BIOMED ENVIRON SCI, V23, P422, DOI 10.1016/S0895-3988(11)60002-0; Yang YR, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005811; Yatsuya H, 2014, CIRC J, V78, P2807, DOI 10.1253/circj.CJ-14-0850; Zeng J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009847; Zhou L, 2016, HYPERTENS RES, V39, P913, DOI 10.1038/hr.2016.80	71	10	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198105	10.1371/journal.pone.0198105	http://dx.doi.org/10.1371/journal.pone.0198105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874254	gold, Green Published, Green Submitted			2022-12-26	WOS:000434369400040
J	Teck, SJ; Lorda, J; Shears, NT; Ben-Horin, T; Toseland, RE; Rathbone, ST; Rudie, D; Gaines, SD				Teck, Sarah J.; Lorda, Julio; Shears, Nick T.; Ben-Horin, Tal; Toseland, Rebecca E.; Rathbone, Sarah T.; Rudie, Dave; Gaines, Steven D.			Quality of a fished resource: Assessing spatial and temporal dynamics	PLOS ONE			English	Article							URCHIN STRONGYLOCENTROTUS-PURPURATUS; GREEN SEA-URCHIN; SANTA-BARBARA CHANNEL; CLIMATE-CHANGE; REPRODUCTIVE-CYCLE; FOOD AVAILABILITY; BIOCHEMICAL-COMPOSITION; MANAGEMENT; PATTERNS; GROWTH	Understanding spatio-temporal variability in the demography of harvested species is essential to improve sustainability, especially if there is large geographic variation in demography. Reproductive patterns commonly vary spatially, which is particularly important for management of "roe"-based fisheries, since profits depend on both the number and reproductive condition of individuals. The red sea urchin, Mesocentrotus franciscanus, is harvested in California for its roe (gonad), which is sold to domestic and international sushi markets. The primary driver of price within this multi-million-dollar industry is gonad quality. A relatively simple measure of the fraction of the body mass that is gonad, the gonadosomatic index (GSI), provides important insight into the ecological and environmental factors associated with variability in reproductive quality, and hence value within the industry. We identified the seasonality of the reproductive cycle and determined whether it varied within a heavily fished region. We found that fishermen were predictable both temporally and spatially in collecting urchins according to the reproductive dynamics of urchins. We demonstrated the use of red sea urchin GSI as a simple, quantitative tool to predict quality, effort, landings, price, and value of the fishery. We found that current management is not effectively realizing some objectives for the southern California fishery, since the reproductive cycle does not match the cycle in northern California, where these management guidelines were originally shaped. Although regulations may not be meeting initial management goals, the scheme may in fact provide conservation benefits by curtailing effort during part of the high-quality fishing season right before spawning.	[Teck, Sarah J.; Gaines, Steven D.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Lorda, Julio] Tijuana River Natl Estuarine Res Reserve, Imperial Beach, CA USA; [Lorda, Julio] Univ Autonoma Baja California, Fac Ciencias, Ensenada, Baja California, Mexico; [Shears, Nick T.] Univ Auckland, Inst Marine Sci, Leigh Marine Lab, Auckland, New Zealand; [Ben-Horin, Tal] Univ Rhode Isl, Coll Environm & Life Sci, Kingston, RI 02881 USA; [Toseland, Rebecca E.] Stanford Univ, Stanford Inst Econ Policy Res, Stanford, CA 94305 USA; [Rathbone, Sarah T.] Community Seafood, Goleta, CA USA; [Rathbone, Sarah T.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Rudie, Dave] Catalina Offshore Prod, San Diego, CA USA; [Teck, Sarah J.] Univ Autonoma Baja California, Fac Ciencias Marinas, Ensenada, Baja California, Mexico	University of California System; University of California Santa Barbara; Universidad Autonoma de Baja California; University of Auckland; University of Rhode Island; Stanford University; University of California System; University of California Santa Barbara; Universidad Autonoma de Baja California	Teck, SJ (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.; Teck, SJ (corresponding author), Univ Autonoma Baja California, Fac Ciencias Marinas, Ensenada, Baja California, Mexico.	sarahjteck@gmail.com	Gaines, Steven/Y-3234-2019; Lorda, Julio/J-1464-2019; Lorda, Julio/A-3951-2009	Lorda, Julio/0000-0002-4293-7518; Lorda, Julio/0000-0002-4293-7518; Ben-Horin, Tal/0000-0001-5123-2643	Henry Luce Foundation; Nejat B. Ezal Memorial Fellowship Award; University of California, Santa Barbara (UCSB); UCSB	Henry Luce Foundation; Nejat B. Ezal Memorial Fellowship Award; University of California, Santa Barbara (UCSB)(University of California System); UCSB	This work was supported in part by the Henry Luce Foundation's Luce Environmental Science to Solutions Fellowship and the Nejat B. Ezal Memorial Fellowship Award. Sarah Teck (SJT)'s funding source was from fellowships, teaching assistantships, and supply grants through the University of California, Santa Barbara (UCSB). UCSB provided support in the form of salary and supplies for SJT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Andrew NL, 2002, OCEANOGR MAR BIOL, V40, P343; [Anonymous], 2000, MAR RESOUR EC; Arafa S, 2012, SCI WORLD J, DOI 10.1100/2012/815935; Babcock BA, 2004, WORKING PAPER; Bartram P, 1996, QUALITY PRODUCT DIFF; Basch LV, 2007, B MAR SCI, V81, P255; Bell TW, 2015, J BIOGEOGR, V42, P2010, DOI 10.1111/jbi.12550; Bell TW, 2015, REMOTE SENS ENVIRON, V167, P218, DOI 10.1016/j.rse.2015.05.003; BENNETT J, 1955, BIOL BULL, V109, P226, DOI 10.2307/1538723; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; BERNARD FR, 1977, J FISH RES BOARD CAN, V34, P604, DOI 10.1139/f77-095; Birkeland C, 2005, TRENDS ECOL EVOL, V20, P356, DOI 10.1016/j.tree.2005.03.015; Bronstein O, 2015, CORAL REEFS, V34, P275, DOI 10.1007/s00338-014-1209-3; Byrnes JE, 2011, GLOBAL CHANGE BIOL, V17, P2513, DOI 10.1111/j.1365-2486.2011.02409.x; Catton C, 2016, CALIFORNIA DEP FISH; Cavanaugh KC, 2011, MAR ECOL PROG SER, V429, P1, DOI 10.3354/meps09141; Chollett I, 2014, ECOL ECON, V102, P118, DOI 10.1016/j.ecolecon.2014.03.010; Claisse JT, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00408.1; Collins MR, 2000, B MAR SCI, V66, P917; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Cumming GS, 2013, LANDSCAPE ECOL, V28, P1139, DOI 10.1007/s10980-012-9725-4; Dewees C. M., 2003, SEA URCHINS FISHERIE, P37; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Ebert TA, 2012, MAR ECOL PROG SER, V467, P147, DOI 10.3354/meps09960; Ebert TA, 2011, MAR BIOL, V158, P47, DOI 10.1007/s00227-010-1541-2; Ebert T.A., 2013, ECOLOGY, V94, P2109, DOI [10.1890/13-0127.1, DOI 10.1890/13-0127.1]; EBERT TA, 1968, ECOLOGY, V49, P1075, DOI 10.2307/1934491; EBERT TA, 1994, MAR ECOL PROG SER, V111, P41, DOI 10.3354/meps111041; Eckert G.L., 2000, P 5 CAL ISL S US DEP, P390; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Fiedler PC, 2002, MAR ECOL PROG SER, V244, P265, DOI 10.3354/meps244265; Freitas FH, 2017, J GEOPHYS RES-OCEANS, V122, P355, DOI 10.1002/2016JC012152; GIESE AC, 1959, ANNU REV PHYSIOL, V21, P547, DOI 10.1146/annurev.ph.21.030159.002555; GONOR J J, 1972, Journal of Experimental Marine Biology and Ecology, V10, P89; Green AL, 2014, COAST MANAGE, V42, P143, DOI 10.1080/08920753.2014.877763; Hamilton SL, 2011, MAR ECOL PROG SER, V429, P227, DOI 10.3354/meps09086; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harley CDG, 2004, CAL COOP OCEAN FISH, V45, P98; Harms S, 1998, J GEOPHYS RES-OCEANS, V103, P3041, DOI 10.1029/97JC02393; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; HIMMELMAN JH, 1978, CAN J ZOOL, V56, P1828, DOI 10.1139/z78-249; HINEGARDNER RT, 1969, BIOL BULL-US, V137, P465, DOI 10.2307/1540168; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Iwata Y, 2010, FISH RES, V102, P286, DOI 10.1016/j.fishres.2009.12.010; Jacox MG, 2016, GEOPHYS RES LETT, V43, P7072, DOI 10.1002/2016GL069716; Johnson TR, 2013, FISH RES, V141, P107, DOI 10.1016/j.fishres.2012.05.008; Kalvass P., 1997, Marine Fisheries Review, V59, P1; KATO S, 1985, MAR FISH REV, V47, P1; KEATS DW, 1984, J EXP MAR BIOL ECOL, V80, P77, DOI 10.1016/0022-0981(84)90095-9; Kober KM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-88; Kreiner A, 2001, S AFR J MARINE SCI, V23, P123; LASKER R, 1954, BIOL BULL, V106, P328, DOI 10.2307/1538767; Leising AW, 2015, CAL COOP OCEAN FISH, V56, P31; Lester SE, 2007, ECOLOGY, V88, P2229, DOI 10.1890/06-1784.1; Lester SE, 2007, CAN J FISH AQUAT SCI, V64, P314, DOI 10.1139/F07-010; Martinez, 2012, DIARIO OFICIAL FEDER, P53; McConnell KE, 1998, ANAL AUCTION PRICES; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; MONTGOMERY WL, 1993, MAR BIOL, V115, P529, DOI 10.1007/BF00349359; Montort MC, 2002, FISH ROE EUROPE SUPP, V72, P47; Mos B, 2016, MAR ENVIRON RES, V113, P39, DOI 10.1016/j.marenvres.2015.11.001; Murphy Michael D., 1995, North American Journal of Fisheries Management, V15, P748, DOI 10.1577/1548-8675(1995)015<0748:MOSSRF>2.3.CO;2; Nenadovic M, 2012, ECOL SOC, V17, DOI 10.5751/ES-04431-170120; Nilo P, 1997, CAN J FISH AQUAT SCI, V54, P774, DOI 10.1139/cjfas-54-4-774; Otero MP, 2004, DEEP-SEA RES PT II, V51, P1129, DOI 10.1016/j.dsr2.2004.04.004; Ourens R, 2015, MAR POLICY, V51, P13, DOI 10.1016/j.marpol.2014.07.015; PEARSE JS, 1986, J EXP ZOOL, V237, P107, DOI 10.1002/jez.1402370115; PEARSE JS, 1980, ADV INVERTEBRATE REP, P53; Racotta IS, 1998, AQUACULTURE, V163, P111, DOI 10.1016/S0044-8486(98)00226-9; Reed D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13757; Reed DC, 2008, ECOLOGY, V89, P2493, DOI 10.1890/07-1106.1; Rodriguez GE, 2013, ECOLOGY, V94, P1848, DOI 10.1890/12-1340.1; Rogers-Bennett L, 2007, DEV AQUAC FISH SCI, V37, P393, DOI 10.1016/S0167-9309(07)80083-4; ROGERSBENNETT L, 1995, ECOL APPL, V5, P1171, DOI 10.2307/2269364; Ruttenberg BI, 2005, OECOLOGIA, V145, P394, DOI 10.1007/s00442-005-0150-0; Shears NT, 2012, ENVIRON CONSERV, V39, P225, DOI 10.1017/S0376892912000082; SMITH TIJ, 1985, ENVIRON BIOL FISH, V14, P61, DOI 10.1007/BF00001577; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; STARR M, 1990, SCIENCE, V247, P1071, DOI 10.1126/science.247.4946.1071; State of California Fish and Game Commission, 2017, IN STAT REAS REG ACT; Stephenson RL, 1999, ICES J MAR SCI, V56, P1005, DOI 10.1006/jmsc.1999.0555; TAYLOR AC, 1979, J MAR BIOL ASSOC UK, V59, P605, DOI 10.1017/S0025315400045628; Teck SJ, 2017, BIOL CONSERV, V209, P488, DOI 10.1016/j.biocon.2017.03.014; Tegner M.J., 1989, US NMFS MAR FISH REV, V51, P1; TEGNER MJ, 1977, SCIENCE, V196, P324, DOI 10.1126/science.847476; TEGNER MJ, 1991, MAR ECOL PROG SER, V77, P49, DOI 10.3354/meps077049; Trenberth KE, 2012, CLIMATIC CHANGE, V115, P283, DOI 10.1007/s10584-012-0441-5; Unuma T., 2002, P115; Vadas RL, 2015, J SHELLFISH RES, V34, P1097, DOI 10.2983/035.034.0337; Vadas Sr RL, 2000, AQUACULTURE, V182, P115, DOI [10.1016/S0044-8486(99)00254-9, DOI 10.1016/S0044-8486(99)00254-9]; Walker CW, 2007, DEV AQUAC FISH SCI, V37, P11; Walker CW, 2005, BIOL BULL-US, V209, P31, DOI 10.2307/3593140; Wilson JA, 2006, ECOL SOC, V11; Wright PJ, 2009, FISH FISH, V10, P283, DOI 10.1111/j.1467-2979.2008.00322.x	96	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0196864	10.1371/journal.pone.0196864	http://dx.doi.org/10.1371/journal.pone.0196864			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874229	Green Submitted, Green Published, gold			2022-12-26	WOS:000434369400007
J	Fiorentino, M; Tohme, FA; Wang, S; Murugan, R; Angus, DC; Kellum, JA				Fiorentino, Marco; Tohme, Fadi A.; Wang, Shu; Murugan, Raghavan; Angus, Derek C.; Kellum, John A.			Long-term survival in patients with septic acute kidney injury is strongly influenced by renal recovery	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; CLINICAL CHARACTERISTICS; EPIDEMIOLOGY; OUTCOMES; RISK; ASSOCIATION; PREDICTION; PNEUMONIA; MORTALITY; FAILURE	Background Several studies have shown that long-term survival after acute kidney injury (AKI) is reduced even if there is clinical recovery. However, we recently reported that in septic shock patients those that recover from AKI have survival similar to patients without AKI. Here, we studied a cohort with less severe sepsis to examine the effects of AKI on longer-term survival as a function of recovery by discharge. Methods We analyzed patients with community-acquired pneumonia from the Genetic and Inflammatory Markers of Sepsis (GenIMS) cohort. We included patients who developed AKI (KDIGO stages 2-3) and defined renal recovery as alive at hospital discharge with return of SCr to within 150% of baseline without dialysis. Our primary outcome was survival up to 3 years analyzed using Gray's model. Results Of the 1742 patients who survived to hospital discharge, stage 2-3 AKI occurred in 262 (15%), of which 111 (42.4%) recovered. Compared to recovered patients, patients without recovery were older (75 +/- 14 vs 69 +/- 15 years, p<0.001) and were more likely to have at least stage 1 AKI on day 1 (83% vs 52%, p<0.001). Overall, 445 patients (25.5%) died during follow-up, 23.4% (347/1480) for no AKI, 28% (31/111) for AKI with recovery and 44.3% (67/151) for AKI without recovery. Patients who did not recover had worse survival compared to no AKI (HR range 1.05-2.46, p = 0.01), while recovering patients had similar survival compared to no AKI (HR 1.01, 95%CI 10.69-1.47, p = 0.96). Absence of AKI on day 1, no in-hospital renal replacement therapy (RRT), higher Apache III score and higher baseline SCr were associated with recovery after AKI. Conclusions In patients with sepsis, recovery by hospital discharge is associated with long-term survival similar to patients without AKI.	[Fiorentino, Marco; Tohme, Fadi A.; Wang, Shu; Murugan, Raghavan; Kellum, John A.] Univ Pittsburgh, Dept Crit Care Med, Ctr Crit Care Nephrol, Pittsburgh, PA 15260 USA; [Fiorentino, Marco] Univ Bad, Nephrol Dialysis & Transplantat Unit, Dept Emergency & Organ Transplantat, Bari, Italy; [Tohme, Fadi A.; Murugan, Raghavan; Angus, Derek C.; Kellum, John A.] Univ Pittsburgh, Dept Crit Care Med, CRISMA Ctr, Pittsburgh, PA 15260 USA; [Tohme, Fadi A.; Kellum, John A.] Univ Pittsburgh, Renal & Electrolyte Div, Dept Med, Pittsburgh, PA 15260 USA; [Wang, Shu] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kellum, JA (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Ctr Crit Care Nephrol, Pittsburgh, PA 15260 USA.; Kellum, JA (corresponding author), Univ Pittsburgh, Dept Crit Care Med, CRISMA Ctr, Pittsburgh, PA 15260 USA.; Kellum, JA (corresponding author), Univ Pittsburgh, Renal & Electrolyte Div, Dept Med, Pittsburgh, PA 15260 USA.	kellum@pitt.edu	Angus, Derek C/E-9671-2012; Fiorentino, Marco/K-3771-2018; Fiorentino, Marco/AAC-1479-2020; Kellum, John/AAP-3072-2020; Kellum, John A/HCH-2944-2022	Fiorentino, Marco/0000-0001-7334-8372; Fiorentino, Marco/0000-0001-8867-3098; Kellum, John/0000-0003-1995-2653; Kellum, John A/0000-0003-1995-2653; Murugan, Raghavan/0000-0002-6823-6365; Wang, Shu/0000-0001-9813-6069	National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) [R01 GM61992]; GlaxoSmithKline; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01 DK083961]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083961] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); GlaxoSmithKline(GlaxoSmithKline); National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	GenIMS was funded by the National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) R01 GM61992 (https://www.nigms.nih.gov/Pages/default.aspx), with additional support from GlaxoSmithKline (https://www.gsk.com/). JAK and DCA were also supported by a grant from the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01 DK083961 (https://www.niddk.nih.gov/). The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official view of NIH, NIGMS or NIDDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Bucaloiu ID, 2012, KIDNEY INT, V81, P477, DOI 10.1038/ki.2011.405; Chawla LS, 2017, NAT REV NEPHROL, V13, P241, DOI 10.1038/nrneph.2017.2; Choi AI, 2010, KIDNEY INT, V78, P478, DOI 10.1038/ki.2010.171; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Jones J, 2012, AM J KIDNEY DIS, V60, P402, DOI 10.1053/j.ajkd.2012.03.014; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kellum JA, 2017, AM J RESP CRIT CARE, V195, P784, DOI 10.1164/rccm.201604-0799OC; Kellum JA, 2016, AM J RESP CRIT CARE, V193, P281, DOI 10.1164/rccm.201505-0995OC; Kellum JA, 2014, NEPHRON CLIN PRACT, V127, P81, DOI 10.1159/000363681; Linder A, 2014, AM J RESP CRIT CARE, V189, P1075, DOI 10.1164/rccm.201311-2097OC; Murugan R, 2010, KIDNEY INT, V77, P527, DOI 10.1038/ki.2009.502; Pannu N, 2013, CLIN J AM SOC NEPHRO, V8, P194, DOI 10.2215/CJN.06480612; Pike F, 2015, CLIN J AM SOC NEPHRO, V10, P1332, DOI 10.2215/CJN.09911014; Shum HP, 2016, RENAL FAILURE, V38, P706, DOI 10.3109/0886022X.2016.1157749; Srisawat N, 2011, KIDNEY INT, V80, P545, DOI 10.1038/ki.2011.160; Srisawat N, 2010, CONTRIB NEPHROL, V165, P284, DOI 10.1159/000313768; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; van Buuren S, 2011, J STAT SOFTW, V45, P1; Waikar SS, 2008, CLIN J AM SOC NEPHRO, V3, P844, DOI 10.2215/CJN.05191107; Wonnacott A, 2014, CLIN J AM SOC NEPHRO, V9, P1007, DOI 10.2215/CJN.07920713	27	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0198269	10.1371/journal.pone.0198269	http://dx.doi.org/10.1371/journal.pone.0198269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870535	gold, Green Published, Green Submitted			2022-12-26	WOS:000434128400019
J	Staniland, LJ; Ratcliffe, N; Trathan, PN; Forcada, J				Staniland, Iain J.; Ratcliffe, Norman; Trathan, Philip N.; Forcada, Jaume			Long term movements and activity patterns of an Antarctic marine apex predator: The leopard seal	PLOS ONE			English	Article							HYDRURGA-LEPTONYX; WINTER DISPERSAL; PRYDZ BAY; FUR SEALS; BEHAVIOR; ABUNDANCE; RATES	Leopard seals are an important Antarctic apex predator that can affect marine ecosystems through local predation. Here we report on the successful use of micro geolocation logging sensor tags to track the movements, and activity, of four leopard seals for trips of between 142-446 days including one individual in two separate years. Whilst the sample size is small the results represent an advance in our limited knowledge of leopard seals. We show the longest periods of tracking of leopard seals' migratory behaviour between the pack ice, close to the Antarctic continent, and the sub-Antarctic island of South Georgia. It appears that these tracked animals migrate in a directed manner towards Bird Island and, during their residency, use this as a central place for foraging trips as well as exploiting the local penguin and seal populations. Movements to the South Orkney Islands were also recorded, similar to those observed in other predators in the region including the krill fishery. Analysis of habitat associations, taking into account location errors, indicated the tracked seals had an affinity for shallow shelf water and regions of sea ice. Wet and dry sensors revealed that seals hauled out for between 22 and 31% of the time with maximum of 74 hours and a median of between 9 and 11 hours. The longest period a seal remained in the water was between 13 and 25 days. Fitting GAMMs showed that haul out rates changed throughout the year with the highest values occurring during the summer which has implications for visual surveys. Peak haul out occurred around midday for the months between October and April but was more evenly spread across the day between May and September. The seals' movements between, and behaviour within, areas important to breeding populations of birds and other seals, coupled with the dynamics of the region's fisheries, shows an understanding of leopard seal ecology is vital in the management of the Southern Ocean resources.	[Staniland, Iain J.; Ratcliffe, Norman; Trathan, Philip N.; Forcada, Jaume] Nat Environm Reach Council, British Antarct Survey, Cambridge, Cambs, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Staniland, LJ (corresponding author), Nat Environm Reach Council, British Antarct Survey, Cambridge, Cambs, England.	ijst@bas.ac.uk	Forcada, Jaume/GYU-0677-2022	Staniland, Iain/0000-0003-2736-9134	BAS (The British Antarctic Survey); Natural Environmental Research Council; NERC [bas0100035] Funding Source: UKRI	BAS (The British Antarctic Survey); Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by BAS (The British Antarctic Survey) core funding and the Natural Environmental Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasyev V, 2004, MEMOIRS NATL I POLAR, P227; Aguayo-Lobo A, 2011, PRESENCE LEOPARD SEA; Ainley DG, 2005, ANTARCT SCI, V17, P335, DOI 10.1017/S0954102005002750; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; BERRY J. ALLAN, 1960, ANN AND MAG NAT HIST, V3, P591; BESTER M N, 1986, South African Journal of Antarctic Research, V16, P29; Bester MN, 2002, ANTARCT SCI, V14, P123, DOI 10.1017/S0954102002000676; Boveng PL, 1998, ECOLOGY, V79, P2863, DOI 10.2307/176522; Boyd IL, 2002, MAR ECOL PROG SER, V242, P285, DOI 10.3354/meps242285; Brown K, 1957, LEOPARD SEAL HEARD I; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Dunn MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164025; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Fetterer F, 2016, UPDATED DAILY SEA IC; Forcada J, 2006, POLAR BIOL, V29, P1052, DOI 10.1007/s00300-006-0149-y; Forcada J, 2009, ECOL MODEL, V220, P1513, DOI 10.1016/j.ecolmodel.2009.03.020; Gwynn AM, 1953, STATUS LEOPARD SEAL; Jessopp MJ, 2004, J ZOOL, V263, P251, DOI 10.1017/S0952836904005102; Kawaguchi S, 2006, CCAMLR SCI, V13, P117; Krause D.J., 2015, ANIM BIOTELEM, V3, P1, DOI [10.1186/s40317-015-0059-2, DOI 10.1186/S40317-015-0059-2]; Kuhn CE, 2006, POLAR BIOL, V29, P303, DOI 10.1007/s00300-005-0053-x; Laws R, 1957, GROWTH RATES LEOPARD; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; Mate BR, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0071; Mawson P. R., 1999, Journal of the Royal Society of Western Australia, V82, P121; Murphy E. J., 1997, CCAMLR SCI, V4, P1; Nordoy ES, 2009, POLAR BIOL, V32, P263, DOI 10.1007/s00300-008-0527-8; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; R Core Team, 2020, R LANG ENV STAT COMP; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Rodriguez D, 2003, LATIN AM J AQUATIC M, V4; Rogers TL, 2005, POLAR BIOL, V28, P456, DOI 10.1007/s00300-004-0703-4; Rogers TL, 1997, MAR MAMMAL SCI, V13, P293, DOI 10.1111/j.1748-7692.1997.tb00632.x; Rounsevell D., 1994, Australian Mammalogy, V17, P97; Schwarz LK, 2013, J ANIM ECOL, V82, P903, DOI 10.1111/1365-2656.12059; SINIFF DB, 1981, J ROY SOC NEW ZEAL, V11, P317, DOI 10.1080/03036758.1981.10423323; Southwell C, 2008, DEEP-SEA RES PT I, V55, P519, DOI 10.1016/j.dsr.2008.01.005; Spreen G, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2005JC003384; Staniland IJ, 2012, MAR BIOL, V159, P291, DOI 10.1007/s00227-011-1807-3; Stevick PT, 2002, MARINE MAMMAL BIOLOGY: AN EVOLUTIONARY APPROACH, P185; Tancell C, 2016, BIOL CONSERV, V198, P165, DOI 10.1016/j.biocon.2016.03.020; THOMAS JA, 1982, CAN J ZOOL, V60, P2028, DOI 10.1139/z82-260; Trathan P., 1998, CCAMLR SCI, V5, P9; Wakefield ED, 2011, ECOL MONOGR, V81, P141, DOI 10.1890/09-0763.1; Waluda CM, 2010, POLAR BIOL, V33, P305, DOI 10.1007/s00300-009-0706-2; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; WOTHERSPOON S., 2013, BASTAG BASIC DATA PR; Wotherspoon S. J., 2013, PACKAGE SGAT SOLAR S	48	10	10	14	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0197767	10.1371/journal.pone.0197767	http://dx.doi.org/10.1371/journal.pone.0197767			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870541	Green Published, gold			2022-12-26	WOS:000434128400007
J	Tintori, C; Iovenitti, G; Ceresola, ER; Ferrarese, R; Zamperini, C; Brai, A; Poli, G; Dreassi, E; Cagno, V; Lembo, D; Canducci, F; Botta, M				Tintori, Cristina; Iovenitti, Giulia; Ceresola, Elisa Rita; Ferrarese, Roberto; Zamperini, Claudio; Brai, Annalaura; Poli, Giulio; Dreassi, Elena; Cagno, Valeria; Lembo, David; Canducci, Filippo; Botta, Maurizio			Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; MULTIPURPOSE PREVENTION TECHNOLOGIES; PATIENTS FAILING RALTEGRAVIR; CAPRISA 004 TRIAL; TYPE-2 INFECTION; TENOFOVIR GEL; BIOLOGICAL EVALUATION; KUWANON-L; RISK; ADHERENCE	Although highly active antiretroviral therapies (HAART) remarkably increased life expectancy of HIV positive people, the rate of novel HIV-1 infections worldwide still represent a major concern. In this context, pre-exposure prophylaxis (PrEP) approaches such as vaginal microbicide gels topically releasing antiretroviral drugs, showed to have a striking impact in limiting HIV-1 spread. Nevertheless, the co-presence of other genital infections, particularly those due to HSV-1 or 2, constitute a serious drawback that strongly limits the efficacy of PrEP approaches. For this reason, combinations of different compounds with mixed antiviral and antiretroviral activity are thoroughly investigated Here we report the synthesis and the biological evaluation of a novel series of rhodanine derivatives, which showed to inhibit both HIV-1 and HSV-1/2 replication at nanomolar concentration, and were found to be active also on acyclovir resistant HSV-2 strains. The compounds showed a considerable reduction of activity in presence of serum due to a high binding to serum albumin, as determined through in vitro ADME evaluations. However, the most promising compound of the series maintained a considerable activity in gel formulation, with an EC50 comparable to that obtained for the reference drug tenofovir. Moreover, the series of compounds showed pharmacokinetic properties suitable for topical formulation, thus suggesting that the novel rhodanine derivatives could represent effective agents to be used as dual anti HIV/HSV microbicides in PrEP approaches.	[Tintori, Cristina; Iovenitti, Giulia; Zamperini, Claudio; Brai, Annalaura; Poli, Giulio; Dreassi, Elena; Botta, Maurizio] Univ Siena, Dept Biotechnol Chem & Pharm, Siena, Italy; [Ceresola, Elisa Rita; Ferrarese, Roberto; Canducci, Filippo] Osped San Raffaele, Lab Microbiol & Virol, Milan, Italy; [Zamperini, Claudio; Brai, Annalaura; Botta, Maurizio] Lead Discovery Siena Srl, Siena, Italy; [Cagno, Valeria; Lembo, David] Univ Torino, Lab Mol Virol & Antiviral Res, Dept Clin & Biol Sci, Turin, Italy; [Cagno, Valeria] Univ Geneva, Dept Mol Microbiol, Geneva, Switzerland; [Botta, Maurizio] Temple Univ, Coll Sci & Technol, Ctr Biotechnol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA	University of Siena; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Turin; University of Geneva; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Botta, M (corresponding author), Univ Siena, Dept Biotechnol Chem & Pharm, Siena, Italy.; Canducci, F (corresponding author), Osped San Raffaele, Lab Microbiol & Virol, Milan, Italy.; Botta, M (corresponding author), Lead Discovery Siena Srl, Siena, Italy.; Botta, M (corresponding author), Temple Univ, Coll Sci & Technol, Ctr Biotechnol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA.	canducci.filippo@hsr.it; botta.maurizio@gmail.com	Cagno, Valeria/AAE-7612-2020; Dreassi, Elena/B-5728-2012; Ferrarese, Roberto/AAC-2671-2022; BRAI, Annalaura/AAV-3656-2020	Dreassi, Elena/0000-0001-8987-940X; Ferrarese, Roberto/0000-0002-8232-5786; BRAI, Annalaura/0000-0001-6395-9348; Cagno, Valeria/0000-0002-5597-334X; POLI, GIULIO/0000-0002-8061-5632	European Union [HEALTH-F3-2009-242135]	European Union(European Commission)	This work was supported by the European Union collaborative project "CHAARM" (grant no. HEALTH-F3-2009-242135). https://cordis.europa.eu/project/rcn/93644_en.html. Lead Discovery Siena srl provided support in the form of research materials but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botta L, 2017, BIOORG MED CHEM LETT, V27, P2502, DOI 10.1016/j.bmcl.2017.03.097; Canducci F, 2013, J ANTIMICROB CHEMOTH, V68, P2525, DOI 10.1093/jac/dkt220; Canducci F, 2011, J INFECT DIS, V204, P1811, DOI 10.1093/infdis/jir636; Cates Willard Jr, 2010, N C Med J, V71, P490; Cates W, 2010, LANCET, V376, P495, DOI 10.1016/S0140-6736(10)61200-7; Donalisio M, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-266; Esposito F, 2015, CHEMBIOCHEM, V16, P2507, DOI 10.1002/cbic.201500385; Fernandez-Romero JA, 2015, TRENDS MICROBIOL, V23, P429, DOI 10.1016/j.tim.2015.02.006; Friend DR, 2016, EXPERT OPIN DRUG DEL, V13, P533, DOI 10.1517/17425247.2016.1134485; Friend DR, 2012, EXPERT OPIN DRUG DEL, V9, P417, DOI 10.1517/17425247.2012.668183; Gengiah TN, 2014, AIDS BEHAV, V18, P820, DOI 10.1007/s10461-014-0749-4; Grobler A, 2012, AIDS, V26, P2261, DOI 10.1097/QAD.0b013e328355ce08; Hynes JS, 2018, CONTRACEPTION, V97, P277, DOI 10.1016/j.contraception.2017.10.006; Karim QA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-67; Kashuba ADM, 2015, JAIDS-J ACQ IMM DEF, V69, P264, DOI 10.1097/QAI.0000000000000607; Lehman DA, 2015, J INFECT DIS, V211, P1211, DOI 10.1093/infdis/jiu677; Mansoor LE, 2014, AIDS BEHAV, V18, P811, DOI 10.1007/s10461-014-0751-x; Martini R, 2017, CHEMBIOCHEM, V18, P374, DOI 10.1002/cbic.201600592; Mugo N, 2011, SEX TRANSM DIS, V38, P1059, DOI 10.1097/OLQ.0b013e31822e60b6; Parikh HH, 2000, PHARMACEUT RES, V17, P632, DOI 10.1023/A:1007537520620; Quaife M, 2017, LANCET INFECT DIS, V17, P21, DOI 10.1016/S1473-3099(16)30550-3; Redd AD, 2014, J CLIN MICROBIOL, V52, P844, DOI 10.1128/JCM.03143-13; Renzi C, 2003, J INFECT DIS, V187, P19, DOI 10.1086/345867; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Rinaldi M, 2011, CHEMMEDCHEM, V6, P343, DOI 10.1002/cmdc.201000510; Smith JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185946; Sugano K, 2001, J BIOMOL SCREEN, V6, P189, DOI 10.1177/108705710100600309; Tan DHS, 2012, INT J WOMENS HEALTH, V4, P341, DOI 10.2147/IJWH.S27601; Temesgen Zelalem, 2008, Ther Clin Risk Manag, V4, P493; Tiberi M, 2014, ANTIMICROB AGENTS CH, V58, P3043, DOI 10.1128/AAC.02739-13; Tintori C, 2016, CHEMBIOCHEM, V17, P683, DOI 10.1002/cbic.201500668; Tintori C, 2008, J CHEM INF MODEL, V48, P2166, DOI 10.1021/ci800105p; Valley-Omar Z, 2012, J INFECT DIS, V206, P35, DOI 10.1093/infdis/jis305; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wohnsland F, 2001, J MED CHEM, V44, P923, DOI 10.1021/jm001020e; Woollard SM, 2015, DRUG DES DEV THER, V9, DOI 10.2147/DDDT.S90580; World Health Organization, 2016, GLOB HLTH SECT STRAT	37	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0198478	10.1371/journal.pone.0198478	http://dx.doi.org/10.1371/journal.pone.0198478			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870553	Green Published, Green Submitted, gold			2022-12-26	WOS:000434128400025
J	Graeber, E; Korkhov, VM				Graeber, Elisabeth; Korkhov, Volodymyr M.			Expression and purification of the mammalian translocator protein for structural studies	PLOS ONE			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; 18 KDA TSPO; CHOLESTEROL TRANSPORT; MEMBRANE-PROTEINS; BREAST-CANCER; STABILIZATION; OUTER; PBR; STEROIDOGENESIS; CRYSTALLIZATION	The translocator protein (TSPO) is an 18 kDa polytopic membrane protein of the outer mitochondrial membrane, abundantly present in the steroid-synthesising cells. TSPO has been linked to a number of disorders, and it is recognised as a promising drug target with a range of potential medical applications. Structural and biochemical characterisation of a mammalian TSPO requires expression and purification of the protein of high quality in sufficiently large quantities. Here we describe detailed procedures for heterologous expression and purification of mammalian TSPO in HEK293 cells. We demonstrate that the established procedures can be used for untagged TSPO as well as for C-terminally fused TSPO constructs. Our protocol can be routinely used to generate high-quality TSPO preparations for biochemical and structural studies.	[Graeber, Elisabeth; Korkhov, Volodymyr M.] Paul Scherrer Inst, Div Biol & Chem, Lab Biomol Res, Villigen, Switzerland; [Korkhov, Volodymyr M.] Swiss Fed Inst Technol, Inst Biochem, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Korkhov, VM (corresponding author), Paul Scherrer Inst, Div Biol & Chem, Lab Biomol Res, Villigen, Switzerland.; Korkhov, VM (corresponding author), Swiss Fed Inst Technol, Inst Biochem, Zurich, Switzerland.	volodymyr.korkhov@psi.ch		Korkhov, Volodymyr/0000-0002-0962-9433	Swiss National Science Foundation, SNF [150665]	Swiss National Science Foundation, SNF(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science Foundation, SNF Professorship, 150665. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrell J, 2013, MOL MEMBR BIOL, V30, P52, DOI 10.3109/09687688.2012.703703; ANHOLT RRH, 1986, J BIOL CHEM, V261, P576; Barichello T, 2017, NEUROSCI BIOBEHAV R, V83, P183, DOI 10.1016/j.neubiorev.2017.10.010; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Bode J, 2012, PHARMACOGENET GENOM, V22, P538, DOI 10.1097/FPC.0b013e3283539cdc; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; BRAESTRUP C, 1977, NATURE, V269, P702, DOI 10.1038/269702a0; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Chaudhary S, 2012, NAT PROTOC, V7, P453, DOI 10.1038/nprot.2011.453; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Dupont AC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040785; Galiegue S, 2004, CLIN CANCER RES, V10, P2058, DOI 10.1158/1078-0432.CCR-03-0988; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; GARNIER M, 1994, MOL PHARMACOL, V45, P201; Gavish M, 1999, PHARMACOL REV, V51, P629; Gavish M, 1996, NEUROPSYCHOPHARMACOL, V14, P181, DOI 10.1016/0893-133X(95)00078-R; Guo YZ, 2015, SCIENCE, V347, P551, DOI 10.1126/science.aaa1534; Harberts E, 2013, J NEUROIMMUNE PHARM, V8, P51, DOI 10.1007/s11481-012-9397-5; Hardwick M, 1999, CANCER RES, V59, P831; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Jaremko L, 2014, SCIENCE, V343, P1363, DOI 10.1126/science.1248725; Johnson MR, 1998, BIOL PSYCHIAT, V43, P306, DOI 10.1016/S0006-3223(97)00390-9; Junge F, 2008, CELL MOL LIFE SCI, V65, P1729, DOI 10.1007/s00018-008-8067-5; Korkhov VM, 2010, STRUCTURE, V18, P677, DOI 10.1016/j.str.2010.03.001; KRUEGER KE, 1990, J BIOL CHEM, V265, P15015; Lacapere JJ, 2001, BIOCHEM BIOPH RES CO, V284, P536, DOI 10.1006/bbrc.2001.4975; Lacor P, 1999, BRAIN RES, V815, P70, DOI 10.1016/S0006-8993(98)01105-6; Li F, 2016, BIOCHEMISTRY-US, V55, P2821, DOI 10.1021/acs.biochem.6b00142; Lyons JA, 2016, CURR OPIN STRUC BIOL, V38, P137, DOI 10.1016/j.sbi.2016.06.011; Mancusso R, 2011, METHODS, V55, P324, DOI 10.1016/j.ymeth.2011.07.008; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Midzak A, 2011, MOL CELL ENDOCRINOL, V336, P70, DOI 10.1016/j.mce.2010.12.007; Mills CD, 2005, MOL CELL NEUROSCI, V30, P228, DOI 10.1016/j.mcn.2005.07.010; Murail S, 2008, BBA-BIOMEMBRANES, V1778, P1375, DOI 10.1016/j.bbamem.2008.03.012; Nakamura K, 2006, AM J MED GENET B, V141B, P222, DOI 10.1002/ajmg.b.30211; Papadopoulos V, 1997, STEROIDS, V62, P21, DOI 10.1016/S0039-128X(96)00154-7; Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Repalli Jayanthi, 2014, Curr Aging Sci, V7, P168; Rocca P, 1998, BIOL PSYCHIAT, V43, P767, DOI 10.1016/S0006-3223(97)00279-5; Rone MB, 2009, BIOCHEMISTRY-US, V48, P6909, DOI 10.1021/bi900854z; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Selvaraj V, 2015, MOL ENDOCRINOL, V29, P490, DOI 10.1210/me.2015-1033; Tate CG, 1996, TRENDS BIOTECHNOL, V14, P426, DOI 10.1016/0167-7799(96)10059-7; Tu LN, 2015, ENDOCRINOLOGY, V156, P1033, DOI 10.1210/en.2014-1707; Tu LN, 2014, J BIOL CHEM, V289, P27444, DOI 10.1074/jbc.M114.578286; Wodarz N, 1998, PSYCHIAT RES, V81, P363, DOI 10.1016/S0165-1781(98)00098-5; Yeliseev AA, 2005, PROTEIN SCI, V14, P2638, DOI 10.1110/ps.051550305; Zhang MR, 2004, J MED CHEM, V47, P2228, DOI 10.1021/jm0304919; Zhulyn O, 2015, DEV BIOL, V397, P191, DOI 10.1016/j.ydbio.2014.10.023; Zou YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046039	53	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198832	10.1371/journal.pone.0198832	http://dx.doi.org/10.1371/journal.pone.0198832			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897975	Green Submitted, Green Published, gold			2022-12-26	WOS:000435090700074
J	Dutra, WF; Guerra, YL; Ramos, JPC; Fernandes, PD; Silva, CRC; Bertioli, DJ; Leal-Bertioli, SCM; Santos, RC				Dutra, Wellison F.; Guerra, Yrlania L.; Ramos, Jean P. C.; Fernandes, Pedro D.; Silva, Carliane R. C.; Bertioli, David J.; Leal-Bertioli, Soraya C. M.; Santos, Roseane C.			Introgression of wild alleles into the tetraploid peanut crop to improve water use efficiency, earliness and yield	PLOS ONE			English	Article							ARACHIS-HYPOGAEA L.; CULTIVATED PEANUT; FLUORESCENCE PARAMETERS; DROUGHT TOLERANCE; REGISTRATION; TRAITS; GENES; RELATIVES; GENOTYPES; DEFICIT	The introduction of genes from wild species is a practice little adopted by breeders for the improvement of commercial crops, although it represents an excellent opportunity to enrich the genetic basis and create new cultivars. In peanut, this practice is being increasingly adopted. In this study we present results of introgression of wild alleles from the wild species Arachis duranensis and A. batizocoi improving photosynthetic traits and yield in a set of lines derived from the cross of an induced allotetraploid and cultivated peanut with selection under water stress. The assays were carried out in greenhouse and field focusing on physiological and agronomic traits. A multivariate model (UPGMA) was adopted in order to classify drought tolerant lines. Several lines showed improved levels of tolerance, with values similar to or greater than the tolerant control. Two BC1F6 lines (53 P4 and 96 P9) were highlighted for good drought-related traits, earliness and pod yield, having better phenotypic profile to the drought tolerant elite commercial cultivar BR1. These lines are good candidates for the creation of peanut cultivars suitable for production in semiarid environments.	[Dutra, Wellison F.; Ramos, Jean P. C.] Univ Fed Paraiba, Rodovia PB 079,Km 12, Areia, PB, Brazil; [Guerra, Yrlania L.; Fernandes, Pedro D.; Santos, Roseane C.] State Univ Paraiba, Posgrad & Pesquisa, Rua Baraonas 351, Campina Grande, PB, Brazil; [Silva, Carliane R. C.] Embrapa Cotton, Lab Biotechnol, Rua Osvaldo Cruz 1143, Campina Grande, PB, Brazil; [Bertioli, David J.] Univ Georgia, Ctr Appl Genet Technol, Crop & Soil Sci Dept, Athens, GA 30602 USA; [Leal-Bertioli, Soraya C. M.] Univ Georgia, Dept Plant Pathol, Ctr Appl Genet Technol, Athens, GA 30602 USA	Universidade Federal da Paraiba; Universidade Estadual da Paraiba; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Leal-Bertioli, SCM (corresponding author), Univ Georgia, Dept Plant Pathol, Ctr Appl Genet Technol, Athens, GA 30602 USA.	sorayab@uga.edu	Santos, Roseane RCS/B-7679-2016; Silva, Carliane R C/E-5758-2016; Fernandes, Pedro/X-3609-2019; Fernandes, Pedro/HGF-1507-2022; Dutra, Wellison/F-4980-2017	Silva, Carliane R C/0000-0002-9462-5823; Dutra, Wellison/0000-0002-0378-8046; BERTIOLI, SORAYA/0000-0002-9683-5357	CAPES (Coordination for the Improvement of Higher Level Personnel), Brazil	CAPES (Coordination for the Improvement of Higher Level Personnel), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CAPES (Coordination for the Improvement of Higher Level Personnel), Brazil.; The authors would like to acknowledge Embrapa Genetic Resources and Biotechnology for concession of induced allotetraploid germplasm, and to CAPES (Coordination for the Improvement of Higher Level Personnel) for grants.	Assuncao HF, 2009, IRRIGA, V14, P325; Neto ADA, 2010, J PLANT INTERACT, V5, P1, DOI 10.1080/17429140902999243; Bertioli DJ, 2011, PLANT GENET RESOUR-C, V9, P134, DOI 10.1017/S1479262110000444; Brasileiro ACM, 2015, PLANT MOL BIOL REP, V33, P1876, DOI 10.1007/s11105-015-0882-x; Clavel D, 2006, FIELD CROP RES, V96, P296, DOI 10.1016/j.fcr.2005.07.012; Cruz CD, 2013, ACTA SCI-AGRON, V35, P271, DOI 10.4025/actasciagron.v35i3.21251; da Silva FG, 2015, REV BRAS ENG AGR AMB, V19, P946, DOI 10.1590/1807-1929/agriambi.v19n10p946-952; Pereira JWD, 2016, AGR WATER MANAGE, V166, P70, DOI 10.1016/j.agwat.2015.12.010; Doorenbos J., 1979, YIELD RESPONSE WATER; Dwivedi SL, 2008, PL BRED RE, V30, P179; Favero AP, 2006, CROP SCI, V46, P1546, DOI 10.2135/cropsci2005.09-0331; Faye I, 2016, DOSSIER TECHNIQUE HO; Fonceka D, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-103; Gomes LR, 2007, PESQUISA AGROPECUARI, V72, P985; GOODMAN MM, 1972, SYST ZOOL, V21, P174, DOI 10.2307/2412287; Holbrook CC, 2008, J PLANT REGIST, V2, P92, DOI 10.3198/jpr2007.12.0662crc; Isleib TG, 2011, J PLANT REGIST, V5, P27, DOI 10.3198/jpr2009.12.0742crc; Kalariya KA, 2015, PHYSIOL MOL BIOL PLA, V21, P317, DOI 10.1007/s12298-015-0300-8; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Krapovickas A., 2007, BONPLANDIA, V16, P1, DOI 10.30972/bon.160158; Leal-Bertioli SCM, 2017, AM J BOT, V104, P379, DOI [10.3732/ajb.1600402, 10.3732/ajb.1600402_err]; Leal-Bertioli SCM, 2015, ANN BOT-LONDON, V115, P237, DOI 10.1093/aob/mcu237; Leal-Bertioli SCM, 2012, ENVIRON EXP BOT, V84, P17, DOI 10.1016/j.envexpbot.2012.04.005; Lisar SYS, 2011, WATER STRESS, P1; Mallikarjuna N, 2011, GENET RESOUR CROP EV, V58, P889, DOI 10.1007/s10722-010-9627-8; Nautiyal PC, 2008, EUPHYTICA, V159, P43, DOI 10.1007/s10681-007-9455-x; Nautiyal PC, 2002, FIELD CROP RES, V74, P67, DOI 10.1016/S0378-4290(01)00199-X; Painawadee M., 2009, Asian Journal of Plant Sciences, V8, P120, DOI 10.3923/ajps.2009.120.128; Pereira J. W. de L., 2015, Australian Journal of Crop Science, V9, P1095; Santos RC, 2006, RECOMENDACOES TECNIC; Santos RC, 2010, REV BRAS ENG AGR AMB, V14, P589, DOI 10.1590/S1415-43662010000600004; SIMPSON CE, 1993, CROP SCI, V33, P1418, DOI 10.2135/cropsci1993.0011183X003300060079x; Simpson CE, 2003, CROP SCI, V43, P1561, DOI 10.2135/cropsci2003.1561; SIMPSON CE, 1975, CROP SCI, V15, P603, DOI 10.2135/cropsci1975.0011183X001500040050x; Simpson CE, 2001, CROP SCI, V41, P918, DOI 10.2135/cropsci2001.413918x; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Valls JFM, 2013, GRONEGO CIO AMENDOIM, P45	37	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198776	10.1371/journal.pone.0198776	http://dx.doi.org/10.1371/journal.pone.0198776			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889864	Green Submitted, Green Published, gold			2022-12-26	WOS:000434786600048
J	Keravnou, A; Ioannides, M; Loizides, C; Tsangaras, K; Achilleos, A; Mina, P; Kypri, E; Hadjidaniel, MD; Neofytou, M; Kyriacou, S; Sismani, C; Koumbaris, G; Patsalis, PC				Keravnou, Anna; Ioannides, Marios; Loizides, Charalambos; Tsangaras, Kyriakos; Achilleos, Achilleas; Mina, Petros; Kypri, Elena; Hadjidaniel, Michael D.; Neofytou, Maria; Kyriacou, Skevi; Sismani, Carolina; Koumbaris, George; Patsalis, Philippos C.			MeDIP combined with in-solution targeted enrichment followed by NGS: Inter-individual methylation variability of fetal-specific biomarkers and their implementation in a proof of concept study for NIPT	PLOS ONE			English	Article							NONINVASIVE-PRENATAL-DIAGNOSIS; CELL-FREE DNA; MATERNAL PLASMA; PERIPHERAL-BLOOD; MARKERS; ANEUPLOIDY	DNA methylation is the most characterized epigenetic process exhibiting stochastic variation across different tissues and individuals. In non-invasive prenatal testing (NIPT) fetal specific methylated regions can potentially be used as biomarkers for the accurate detection of fetal aneuploidies. The aim of this study was the investigation of inter-individual methylation variability of previously reported fetal-specific markers and their implementation towards the development of a novel NIPT assay for the detection of trisomies 13, 18, and 21. Methylated DNA Immunoprecipitation (MeDIP) combined with in-solution targeted enrichment followed by NGS was performed in 29 CVS and 27 female plasma samples to assess inter-individual methylation variability of 331 fetal-specific differentially methylated regions (DMRs). The same approach was implemented for the NIPT of trisomies 13, 18 and 21 using spiked-in (n = 6) and pregnancy samples (n = 44), including one trisomy 13, one trisomy 18 and four trisomy 21. Despite the variability of DMRs, CVS samples showed statistically significant hypermethylation (p<2e-16) compared to plasma samples. Importantly, our assay correctly classified all euploid and aneuploid cases without any false positive results (n = 44). This work provides the starting point for the development of a NIPT assay based on a robust set of fetal specific biomarkers for the detection of fetal aneuploidies. Furthermore, the assay's targeted nature significantly reduces the analysis cost per sample while providing high read depth at regions of interest increasing significantly its accuracy.	[Keravnou, Anna; Hadjidaniel, Michael D.; Neofytou, Maria; Patsalis, Philippos C.] Cyprus Inst Neurol & Genet, Translat Genet Team, Nicosia, Cyprus; [Ioannides, Marios; Loizides, Charalambos; Tsangaras, Kyriakos; Achilleos, Achilleas; Mina, Petros; Kypri, Elena; Kyriacou, Skevi; Koumbaris, George; Patsalis, Philippos C.] NIPD Genet Ltd, Nicosia, Cyprus; [Sismani, Carolina] Cyprus Inst Neurol & Genet, Dept Cytogenet & Genom, Nicosia, Cyprus		Patsalis, PC (corresponding author), Cyprus Inst Neurol & Genet, Translat Genet Team, Nicosia, Cyprus.; Patsalis, PC (corresponding author), NIPD Genet Ltd, Nicosia, Cyprus.	p.patsalis@nipd.com			European Research Council (ERC) under 7th Framework Programme [322953];  [NEA YPiODeltaOMH/SigmaTPATH/0308/31]	European Research Council (ERC) under 7th Framework Programme; 	This work has received funding from the European Research Council (ERC) under 7th Framework Programme under grant agreement No 322953 for the project: A Novel Non-Invasive Prenatal Diagnosis of Genetic Disorders. Furthermore, the authors, Marios loannides, Charalambos Loizides, Kyriakos Tsangaras, Achilleas Achilleos, Petros Mina, Elena Kypri, Skevi Kyriacou, George Koumbaris and Philippos C Patsalis are employed by NIPD Genetics Ltd. NIPD Genetics Ltd., provided support in the form of salaries for authors MI, CL, KT, AA, PM, EK, SK, GK and PCP. Its role was mainly in the design of the study, data analysis, troubleshooting, editing of the manuscript and project supervision. The specific roles of these authors are articulated in the 'author contributions' section.; This project's computational processes were performed on the Cy-Tera High Performance computing facility for Cyprus (NEA Y Pi O Delta OMH/Sigma TPATH/0308/31).	Akolekar R, 2015, ULTRASOUND OBST GYN, V45, P16, DOI 10.1002/uog.14636; Avent ND, 2008, SEMIN FETAL NEONAT M, V13, P91, DOI 10.1016/j.siny.2007.12.011; Bock C, 2008, NUCLEIC ACIDS RES, V36, P2; Borgel Julie, 2012, Methods Mol Biol, V925, P149, DOI 10.1007/978-1-62703-011-3_9; Butcher LM, 2010, METHODS, V52, P223, DOI 10.1016/j.ymeth.2010.04.003; Chim SSC, 2008, CLIN CHEM, V54, P500, DOI 10.1373/clinchem.2007.098731; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chu TJ, 2009, PRENATAL DIAG, V29, P1020, DOI 10.1002/pd.2335; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Gerundino F, 2016, J MATERN-FETAL NEO M, V30, P1; Hatt L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128918; Huang Dorothy J., 2008, V444, P203, DOI 10.1007/978-1-59745-066-9_15; Ioannides M, 2014, MOL CYTOGENET, V7, DOI 10.1186/s13039-014-0073-8; Keravnou A, 2016, GENET RES CAMB, V98, P1; Koumbaris G, 2016, CLIN CHEM, V62, P848, DOI 10.1373/clinchem.2015.252502; Lam LL, 2012, P NATL ACAD SCI USA, V109, P17253, DOI 10.1073/pnas.1121249109; Lee DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078136; Lefkowitz RB, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.02.030; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao GJW, 2011, CLIN CHEM, V57, P92, DOI 10.1373/clinchem.2010.154336; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Motavaf M, 2014, NONINVASIVE PRENATAL, V5, P3; Neofytou MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171319; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Old RW, 2007, REPROD BIOMED ONLINE, V15, P227, DOI 10.1016/S1472-6483(10)60713-4; Papageorgiou EA, 2011, NAT MED, V17, P510, DOI 10.1038/nm.2312; Papageorgiou EA, 2009, AM J PATHOL, V174, P1609, DOI 10.2353/ajpath.2009.081038; Schneider E, 2010, NUCLEIC ACIDS RES, V38, P3880, DOI 10.1093/nar/gkq126; Slieker RC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005583; Sparks AB, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.030; Sparks AB, 2012, PRENATAL DIAG, V32, P3, DOI 10.1002/pd.2922; Tsaliki E, 2012, PRENATAL DIAG, V32, P996, DOI 10.1002/pd.3947; Tsangaras K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109101; Wong CCY, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12226; Xiang YQ, 2014, MOL HUM REPROD, V20, P875, DOI 10.1093/molehr/gau048; Xie HH, 2011, NUCLEIC ACIDS RES, V39, P4099, DOI 10.1093/nar/gkr017; Zimmermann B, 2005, CLIN CHEM, V51, P1598, DOI 10.1373/clinchem.2005.051235	42	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0199010	10.1371/journal.pone.0199010	http://dx.doi.org/10.1371/journal.pone.0199010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889893	Green Published, gold			2022-12-26	WOS:000434786600071
J	Gabay, Y; Holt, LL				Gabay, Yafit; Holt, Lori L.			Short-term adaptation to sound statistics is unimpaired in developmental dyslexia	PLOS ONE			English	Article							SPEECH-PERCEPTION; NONLINGUISTIC SOUNDS; NONSPEECH SOUNDS; PRECEDING LIQUID; CONTEXT; CATEGORIZATION; DEFICIT; DISCRIMINATION; INFORMATION; LANGUAGE	Developmental dyslexia is presumed to arise from phonological impairments. Accordingly, people with dyslexia show speech perception deficits taken as indication of impoverished phonological representations. However, the nature of speech perception deficits in those with dyslexia remains elusive. Specifically, there is no agreement as to whether speech perception deficits arise from speech-specific processing impairments, or from general auditory impairments that might be either specific to temporal processing or more general. Recent studies show that general auditory referents such as Long Term Average Spectrum (LTAS, the distribution of acoustic energy across the duration of a sound sequence) affect speech perception. Here we examine the impact of preceding target sounds' LTAS on phoneme categorization to assess the nature of putative general auditory impairments associated with dyslexia. Dyslexic and typical listeners categorized speech targets varying perceptually from /ga/-/da/preceded by speech and nonspeech tone contexts varying. Results revealed a spectrally contrastive influence of the preceding context LTAS on speech categorization, with a larger magnitude effect for nonspeech compared to speech precursors. Importantly, there was no difference in the presence or magnitude of the effects across dyslexia and control groups. These results demonstrate an aspect of general auditory processing that is spared in dyslexia, available to support phonemic processing when speech is presented in context.	[Gabay, Yafit] Univ Haifa, Dept Special Educ, Haifa, Israel; [Gabay, Yafit] Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, Haifa, Israel; [Holt, Lori L.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	University of Haifa; University of Haifa; Carnegie Mellon University	Gabay, Y (corresponding author), Univ Haifa, Dept Special Educ, Haifa, Israel.; Gabay, Y (corresponding author), Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, Haifa, Israel.; Holt, LL (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	ygabay@eciu.haifa.ac.il; loriholt@cmu.edu	Gabay, Yafit/P-8315-2019	Gabay, Yafit/0000-0002-7899-3044	National Institutes of Health [R01DC004674]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The research was supported by a grant from the National Institutes of Health (R01DC004674) to LLH.; The authors thank Christi Gomez for her assistance. The research was supported by a grant from the National Institutes of Health (R01DC004674) to LLH. Correspondence may be addressed to LLH, loriholt@cmu.edu or YG, ygabay@eclu.haifa.acil.	Agus TR, 2014, J SPEECH LANG HEAR R, V57, P1069, DOI 10.1044/1092-4388(2013/13-0020); Ahissar M, 2007, TRENDS COGN SCI, V11, P458, DOI 10.1016/j.tics.2007.08.015; Ahissar M, 2006, NAT NEUROSCI, V9, P1558, DOI 10.1038/nn1800; Aravamudhan R, 2008, J ACOUST SOC AM, V124, P1695, DOI 10.1121/1.2956482; Association AP Association AP, 2000, DSM 4 TR DIAGN STAT, V75, P78; Banai K, 2018, LANG COGN NEUROSCI, V33, P321, DOI 10.1080/23273798.2017.1408851; Beattie RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027893; Blomert L, 2004, J SPEECH LANG HEAR R, V47, P1030, DOI 10.1044/1092-4388(2004/077); Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; Demonet JF, 2004, LANCET, V363, P1451, DOI 10.1016/S0140-6736(04)16106-0; Di Filippo G, 2008, DEV SCI, V11; Farmer ME, 1995, PSYCHON B REV, V2, P460, DOI 10.3758/BF03210983; Gabay Y, 2015, CORTEX, V73, P131, DOI 10.1016/j.cortex.2015.08.008; Gabay Y, 2015, NEUROPSYCHOLOGY, V29, P844, DOI 10.1037/neu0000194; Gabay Y, 2015, J SPEECH LANG HEAR R, V58, P934, DOI 10.1044/2015_JSLHR-L-14-0324; Gabay Y, 2012, NEUROPSYCHOLOGIA, V50, P2435, DOI 10.1016/j.neuropsychologia.2012.06.014; Georgiou GK, 2018, ANN DYSLEXIA, P1, DOI [10.1007/s11881-018-0158-x, DOI 10.1007/S11881-018-0158-X]; GODFREY JJ, 1981, J EXP CHILD PSYCHOL, V32, P401, DOI 10.1016/0022-0965(81)90105-3; Hamalainen JA, 2013, J LEARN DISABIL-US, V46, P413, DOI 10.1177/0022219411436213; Holt LL, 2006, J ACOUST SOC AM, V119, P4016, DOI 10.1121/1.2195119; Holt LL, 2005, PSYCHOL SCI, V16, P305, DOI 10.1111/j.0956-7976.2005.01532.x; Holt LL, 2006, J ACOUST SOC AM, V120, P2801, DOI 10.1121/1.2354071; Huang J, 2012, FRONTIERS PSYCHOL, V3; Huang JY, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00010; Huang JY, 2011, J ACOUST SOC AM, V129, P1145, DOI 10.1121/1.3543994; Huang JY, 2009, J ACOUST SOC AM, V125, P3983, DOI 10.1121/1.3125342; Hufnagle DG, 2013, J EXP CHILD PSYCHOL, V116, P728, DOI 10.1016/j.jecp.2013.05.008; Jaffe-Dax S, 2018, ELIFE, V7, DOI 10.7554/eLife.30018; Jaffe-Dax S, 2016, J VISION, V16, DOI 10.1167/16.9.10; Jaffe-Dax S, 2015, J NEUROSCI, V35, P12116, DOI 10.1523/JNEUROSCI.1302-15.2015; KLATT DH, 1990, J ACOUST SOC AM, V87, P820, DOI 10.1121/1.398894; LADEFOGED P, 1957, J ACOUST SOC AM, V29, P98, DOI 10.1121/1.1908694; Laing EJC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00203; Lotto AJ, 1998, PERCEPT PSYCHOPHYS, V60, P602, DOI 10.3758/BF03206049; Lotto AJ, 2003, J ACOUST SOC AM, V113, P53, DOI 10.1121/1.1527959; MANN VA, 1980, PERCEPT PSYCHOPHYS, V28, P407, DOI 10.3758/BF03204884; McDermott JH, 2013, NAT NEUROSCI, V16, P493, DOI 10.1038/nn.3347; Mody M, 1997, J EXP CHILD PSYCHOL, V64, P199, DOI 10.1006/jecp.1996.2343; Nicolson RI, 2007, TRENDS NEUROSCI, V30, P135, DOI 10.1016/j.tins.2007.02.003; Nicolson RI, 2011, CORTEX, V47, P117, DOI 10.1016/j.cortex.2009.08.016; Noordenbos MW, 2015, SCI STUD READ, V19, P340, DOI 10.1080/10888438.2015.1052455; Perrachione TK, 2016, NEURON, V92, P1383, DOI 10.1016/j.neuron.2016.11.020; Ramus F, 2008, Q J EXP PSYCHOL, V61, P129, DOI 10.1080/17470210701508822; Rashotte, 1999, TOWRE 2 TEST WORD RE; Raven J-C, 1992, STANDARD PROGR MATRI, V1992, DOI [10.2466/pms.1992.74.3c.1193, DOI 10.2466/PMS.1992.74.3C.1193]; REED MA, 1989, J EXP CHILD PSYCHOL, V48, P270, DOI 10.1016/0022-0965(89)90006-4; Rosen S, 2003, J PHONETICS, V31, P509, DOI 10.1016/S0095-4470(03)00046-9; Rosenholtz R, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00013; Schneider W, 2002, GUIDE E PUS; Serniclaes WI, 2004, J EXP CHILD PSYCHOL, V87, P336, DOI 10.1016/j.jecp.2004.02.001; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; Torgesen J.K., 1999, TOWRE TEST WORD READ; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Vandermosten M, 2011, RES DEV DISABIL, V32, P593, DOI 10.1016/j.ridd.2010.12.015; Vandermosten M, 2010, P NATL ACAD SCI USA, V107, P10389, DOI 10.1073/pnas.0912858107; Vellutino FR, 2004, J CHILD PSYCHOL PSYC, V45, P2, DOI 10.1046/j.0021-9630.2003.00305.x; Vitela AD, 2015, J ACOUST SOC AM, V137, pEL65, DOI 10.1121/1.4903917; Vitela AD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00399; Vitela AD, 2010, J ACOUST SOC AM, V128, P2349; Wade T, 2005, PERCEPT PSYCHOPHYS, V67, P939, DOI 10.3758/BF03193621; Wade T, 2005, J ACOUST SOC AM, V118, P1701, DOI 10.1121/1.1984839; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wijnen F, 2012, J SPEECH LANG HEAR R, V55, P1387, DOI 10.1044/1092-4388(2012/10-0302); Wilson AM, 2001, J LEARN DISABIL-US, V34, P394, DOI 10.1177/002221940103400501; Wolf M., 2005, RAN RAS RAPID AUTOMA; Woodcock R.W., 2011, WOODCOCK READING MAS	66	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198146	10.1371/journal.pone.0198146	http://dx.doi.org/10.1371/journal.pone.0198146			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI5BF	29879142	gold, Green Published, Green Submitted			2022-12-26	WOS:000434384900023
J	Islam, S; Perkins, J; Siddique, MA; Mazumder, T; Haider, MR; Rahman, MM; Capello, C; Hoque, DME; Santarelli, C; El Arlfeen, S; Rahman, AE				Islam, Sajia; Perkins, Janet; Siddique, Md. Abu Bakkar; Mazumder, Tapas; Haider, Mohammad Rifat; Rahman, Mohammad Masudur; Capello, Cecilia; Hoque, Dewan Md. Emdadul; Santarelli, Carlo; El Arlfeen, Shams; Rahman, Ahmed Ehsanur			Birth preparedness and complication readiness among women and couples and its association with skilled birth attendance in rural Bangladesh	PLOS ONE			English	Article							MORTALITY; CARE; TRIAL	Introduction Despite remarkable progress in maternal and neonatal health over past two decades, maternal and neonatal mortality in Bangladesh remain high, which is partially attributable to low use of skilled maternal and newborn health (MNH) services. Birth preparedness and complications readiness (BCPR) is recommended by the World Health Organization and by the Government of Bangladesh as a key intervention to increasing appropriate MNH services. This study aims to explore the status of BPCR in a hard-to-reach area of rural Bangladesh and to demonstrate how BPCR practices is associated with birth in the presence of a skilled birth attendant. Methods Data was collected using multistage cluster sampling-based household survey in two sub districts of Netrokona, Bangladesh in 2014. Interviews were conducted among women with a recent birth history in 12-months and their husbands. Univariate, bivariate, and multivariable analysis using Stata 14.0 were performed from 317 couples. Results Mean age of respondents was 26.1 (SD +/- 5.3) years. There was a significant difference in BPCR practice between women and couples for identification of the place of birth (84% vs. 75%), identification of a birth attendant (89% vs.72%), arranging transport for birth or emergencies (20% vs. 13%), and identification of a blood donor (15% vs. 8%). In multivariable analysis, odds of giving birth in presence of a skilled birth attendant consistently increased with higher completeness of preparedness (OR 3.3 for 3-5 BPCR components, OR 5.5 for 4-5 BPCR components, OR 10.4 for all 5 BPCR components). For different levels of completeness of BPCR practice, the adjusted odds ratios were higher for couple preparedness comparatively. Conclusions BPCR is associated with birth in the presence of a skilled attendant and this effect is magnified when planning is carried out by the couple. Interventions aiming to increase BPCR practices should not focus on women only, as involving the couple is most likely lead to positive care -seeking practices.	[Islam, Sajia; Siddique, Md. Abu Bakkar; Mazumder, Tapas; Hoque, Dewan Md. Emdadul; El Arlfeen, Shams; Rahman, Ahmed Ehsanur] Int Ctr Diarrhoeal Dis Res, Maternal & Child Hlth Div, Dhaka, Bangladesh; [Perkins, Janet; Capello, Cecilia; Santarelli, Carlo] Enfants Monde, Hlth Dept, Geneva, Switzerland; [Haider, Mohammad Rifat; Rahman, Mohammad Masudur] Univ South Carolina, Dept Hlth Promot Educ & Behav, Norman J Arnold Sch Publ Hlth, Columbia, SC USA	International Centre for Diarrhoeal Disease Research (ICDDR); University of South Carolina System; University of South Carolina Columbia	Rahman, AE (corresponding author), Int Ctr Diarrhoeal Dis Res, Maternal & Child Hlth Div, Dhaka, Bangladesh.	ehsanur@icddrb.org	Haider, Mohammad Rifat/N-9987-2016; Hoque, Dewan Md. Emdadul/J-1999-2019; Rahman, Ahmed Ehsanur/ABC-5318-2021; Perkins, Janet/GVS-1117-2022	Haider, Mohammad Rifat/0000-0002-0690-8242; Hoque, Dewan Md. Emdadul/0000-0001-8219-9196; Rahman, Mohammad Masudur/0000-0001-8995-748X; Arifeen, Shams/0000-0002-5372-5932	Swiss Agency for Development and Cooperation; Geneva Federation for Cooperation through Enfant du Monde [GR-01173]	Swiss Agency for Development and Cooperation; Geneva Federation for Cooperation through Enfant du Monde	The study was funded by Swiss Agency for Development and Cooperation, Geneva Federation for Cooperation through Enfant du Monde (GR-01173). The funders had no role in study design, data collection and analysis, and preparation of the manuscript.	Bankole A, 2010, J CLIN MED RES, V2, P55; Baqui AH, 2008, B WORLD HEALTH ORGAN, V86, P796, DOI 10.2471/BLT.07.042226; Belda SS, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0837-8; Bhatta DN, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-14; Bintabara D, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0041-8; Darmstadt GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009696; Debelew GT, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.272.4244; Gebre M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137570; Haider MR, 2017, SEX REPROD HEALTHC, V14, P40, DOI 10.1016/j.srhc.2017.09.002; Hailu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021432; Hounton S, 2008, TROP MED INT HEALTH, V13, P53, DOI 10.1111/j.1365-3156.2008.02087.x; Ibrahim M. S., 2014, Annals of Nigerian Medicine, V8, P20, DOI 10.4103/0331-3131.141025; Kabakyenga JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035747; Kakaire O, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-12; Kuganab-Lem RB, 2014, PUBLIC HLTH RES, V4, P225; Magoma M, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-13; Midhet F, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-30; Miltenburg AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143382; Moinuddin M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189365; Mukhopadhyay Dipta Kanti, 2013, Indian J Public Health, V57, P147, DOI 10.4103/0019-557X.119827; National Institute of Population Research and Training, 2012, BANGL MAT MORT HLTH; National Institute of Population Research and Training, 2011, BANGL DISTR LEV SOC; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; Sarker BK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146161; Shefner-Rogers CL, 2004, J HEALTH COMMUN, V9, P233, DOI 10.1080/10810730490447075; Sood S, 2004, MEASURING EFFECTS SI; Soubeiga D, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-129; Story WT, 2012, SOC SCI MED, V75, P2403, DOI 10.1016/j.socscimed.2012.09.017; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Tura G, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-60; Turan JM, 2011, J MIDWIFERY WOM HEAL, V56, P8, DOI 10.1111/j.1542-2011.2010.00001.x; Turkmani S, 2015, J ASIAN MIDWIVES JAM, V1, P17; UN, 2015, MILLENNIUM DEV GOALS; UNICEF WHO and the World Bank Group, 2020, LEVELS TRENDS CHILD; United Nations, 2015, SUST DEV GOALS 2015; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wai KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144135; Welfare MoHa F, 2017, MAT HLTH STRAT BANGL; WHO, 2015, WHO REC HLTH PROM IN; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Yargawa J, 2015, J EPIDEMIOL COMMUN H, V69, P604, DOI 10.1136/jech-2014-204784; You D, 2015, LEVELS TRENDS CHILD; Zepre K, 2017, INT J WOMENS HEALTH, V9, P11, DOI 10.2147/IJWH.S111769	44	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0197693	10.1371/journal.pone.0197693	http://dx.doi.org/10.1371/journal.pone.0197693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI5BF	29879138	Green Submitted, Green Published, gold			2022-12-26	WOS:000434384900008
J	Jarzabek, MA; Proctor, WR; Vogt, J; Desai, R; Dicker, P; Cain, G; Raja, R; Brodbeck, J; Stevens, D; van der Stok, EP; Martens, JWM; Verhoef, C; Hegde, PS; Byrne, AT; Tarrant, JM				Jarzabek, Monika A.; Proctor, William R.; Vogt, Jennifer; Desai, Rupal; Dicker, Patrick; Cain, Gary; Raja, Rajiv; Brodbeck, Jens; Stevens, Dale; van der Stok, Eric P.; Martens, John W. M.; Verhoef, Cornelis; Hegde, Priti S.; Byrne, Annette T.; Tarrant, Jacqueline M.			Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer	PLOS ONE			English	Article							NODULAR REGENERATIVE HYPERPLASIA; ENDOTHELIAL-CELL FUNCTION; OBSTRUCTION SYNDROME; LIVER METASTASES; SOLID TUMORS; ANGIOGENESIS; OXALIPLATIN; ANTI-DLL4; ANTIBODY; MICE	Drug-related sinusoidal dilatation (SD) is a common form of hepatotoxicity associated with oxaliplatin-based chemotherapy used prior to resection of colorectal liver metastases (CRLM). Recently, hepatic SD has also been associated with anti-delta like 4 (DLL4) cancer therapies targeting the NOTCH pathway. To investigate the hypothesis that NOTCH signaling plays an important role in drug-induced SD, gene expression changes were examined in livers from anti-DLL4 and oxaliplatin-induced SD in non-human primate (NHP) and patients, respectively. Putative mechanistic biomarkers of bevacizumab (bev)-mediated protection against oxaliplatin-induced SD were also investigated. RNA was extracted from whole liver sections or centrilobular regions by laser-capture microdissection (LCM) obtained from NHP administered anti-DLL4 fragment antigen-binding (F(ab')(2) or patients with CRLM receiving oxaliplatin-based chemotherapy with or without bev. mRNA expression was quantified using high-throughput real-time quantitative PCR. Significance analysis was used to identify genes with differential expression patterns (false discovery rate (FDR) < 0.05). Eleven (CCL2, CCND1, EFNB2, ERG, ICAM1,116, LFNG, NOTCH1, NOTCH4, PRDX1, and TGFB1) and six (CDH5, EFNB2, HES1, IL16, MIK67, HES1 and VWF) candidate genes were differentially expressed in the liver of anti-DLL4- and oxaliplatin-induced SD, respectively. Addition of bev to oxaliplatin-based chemotherapy resulted in differential changes in hepatic CDH5, HEY1, IL16, JAG1, MMP9, NOTCH4 and TIMP1 expression. This work implicates NOTCH and IL16 pathways in the pathogenesis of drug-induced SD and further explains the hepato-protective effect of bev in oxaliplatin-induced SD observed in CRLM patients.	[Jarzabek, Monika A.; Byrne, Annette T.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin, Ireland; [Proctor, William R.; Vogt, Jennifer; Cain, Gary; Brodbeck, Jens; Stevens, Dale; Tarrant, Jacqueline M.] Genentech Inc, Dept Safety Assessment, San Francisco, CA 94080 USA; [Desai, Rupal; Raja, Rajiv; Hegde, Priti S.] Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Dicker, Patrick] Royal Coll Surgeons Ireland, Dept Epidemiol & Publ Hlth Med, Dublin, Ireland; [van der Stok, Eric P.; Verhoef, Cornelis] Erasmus MC, Dept Surg Oncol, Rotterdam, Netherlands; [Martens, John W. M.] Erasmus MC, Dept Med Oncol, Rotterdam, Netherlands	Royal College of Surgeons - Ireland; Roche Holding; Genentech; Roche Holding; Genentech; Royal College of Surgeons - Ireland; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Tarrant, JM (corresponding author), Genentech Inc, Dept Safety Assessment, San Francisco, CA 94080 USA.	jacqueline.tarrant@gilead.com	Brodbeck, Jens/AAB-9275-2020; Dicker, Patrick/ABA-9881-2021; van der Stok, Eric/GYD-6548-2022; Verhoef, Cornelis/ABD-3648-2020	Verhoef, Cornelis/0000-0001-9980-8613; Jarzabek, Monika/0000-0001-7008-4797; Byrne, Annette/0000-0003-0287-8899	AngioTox; European Commission [251528]; Genentech, Inc.; Science Foundation Ireland (SFI) Career Development Award 'Coloforetell' [13/CDA/2183]; European Union's Horizon 2020 Health Research and Innovation award 'Colossus' [754923]	AngioTox; European Commission(European CommissionEuropean Commission Joint Research Centre); Genentech, Inc.(Roche HoldingGenentech); Science Foundation Ireland (SFI) Career Development Award 'Coloforetell'(Science Foundation Ireland); European Union's Horizon 2020 Health Research and Innovation award 'Colossus'	This project was funded by AngioTox [www.angiotox.com], a European Commission funded FP7 Industry Academia Pathways and Partnerships Marie Curie Award (grant agreement number: 251528) to ATB and by Genentech, Inc. The funder provided support in the form of salaries for authors [MAJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. ATB is further funded by Science Foundation Ireland (SFI) Career Development Award 'Coloforetell' (grant agreement number: 13/CDA/2183) and the European Union's Horizon 2020 Health Research and Innovation award 'Colossus' (grant agreement number: 754923). Genentech, Inc. provided support in the form of salaries for authors WRP, JV, RD, GC, RR, JB, DS, PSH, and JMT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agostini J, 2012, J HEPATOL, V56, P869, DOI 10.1016/j.jhep.2011.10.023; Andersson ER, 2014, NAT REV DRUG DISCOV, V13, P359, DOI 10.1038/nrd4252; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birdsey GM, 2015, DEV CELL, V32, P82, DOI 10.1016/j.devcel.2014.11.016; Bray SJ, 2016, NAT REV MOL CELL BIO, V17, P722, DOI 10.1038/nrm.2016.94; Chiorean EG, 2015, CLIN CANCER RES, V21, P2695, DOI 10.1158/1078-0432.CCR-14-2797; Couch JA, 2016, CLIN CANCER RES, V22, P1469, DOI 10.1158/1078-0432.CCR-15-1380; Cruikshank WW, 2000, J LEUKOCYTE BIOL, V67, P757, DOI 10.1002/jlb.67.6.757; Cuervo H, 2016, HEPATOLOGY, V64, P1302, DOI 10.1002/hep.28713; DeLeve LD, 2003, GASTROENTEROLOGY, V125, P882, DOI 10.1016/S0016-5085(03)01056-4; Dill MT, 2012, GASTROENTEROLOGY, V142, P967, DOI 10.1053/j.gastro.2011.12.052; Fischer M, 2011, CANCER RES, V71, P1520, DOI 10.1158/0008-5472.CAN-10-2817; Jenkins DW, 2012, MOL CANCER THER, V11, P1650, DOI 10.1158/1535-7163.MCT-11-1027; Liu XX, 2016, REPRODUCTION, V152, P47, DOI 10.1530/REP-16-0132; Magwood-Golston JS, 2016, LEUKEMIA RES, V44, P61, DOI 10.1016/j.leukres.2016.03.004; Marzano C, 2015, HEPATOLOGY, V62, P956, DOI 10.1002/hep.27747; Mimche PN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20926-9; Mohty M, 2015, BONE MARROW TRANSPL, V50, P781, DOI 10.1038/bmt.2015.52; Murphy PA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002670; Neuman MG, 2015, J PHARM PHARM SCI, V18, P825, DOI 10.18433/J3BG7J; Park S, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0455-5; Plessier A, 2012, J HEPATOL, V56, pS25, DOI 10.1016/S0168-8278(12)60004-X; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Rothweiler S, 2014, LIVER INT, V34, P594, DOI 10.1111/liv.12261; Rubbia-Brandt L, 2011, MOL CANCER THER, V10, P687, DOI 10.1158/1535-7163.MCT-10-1072; Rubbia-Brandt L, 2010, HISTOPATHOLOGY, V56, P430, DOI 10.1111/j.1365-2559.2010.03511.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salvucci O, 2012, ADV CANCER RES, V114, P21, DOI 10.1016/B978-0-12-386503-8.00002-8; Santamaria S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01509; Shen Z, 2016, AM J PATHOL, V186, P1874, DOI 10.1016/j.ajpath.2016.03.010; Smith DC, 2014, CLIN CANCER RES, V20, P6295, DOI 10.1158/1078-0432.CCR-14-1373; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068893; Tarrant JM, 2014, BIOMARKERS, V19, P391, DOI 10.3109/1354750X.2014.919026; Van der Pool AEM, 2012, J SURG ONCOL, V106, P892, DOI 10.1002/jso.23142; Vreuls CPH, 2012, HISTOPATHOLOGY, V61, P314, DOI 10.1111/j.1365-2559.2012.04208.x; Yamanda S, 2009, BLOOD, V113, P3631, DOI 10.1182/blood-2008-07-170381; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751	38	8	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198099	10.1371/journal.pone.0198099	http://dx.doi.org/10.1371/journal.pone.0198099			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879147	Green Published, Green Submitted, gold			2022-12-26	WOS:000434384900020
J	Asslander, L; Smith, CP; Reynolds, RF				Asslaender, Lorenz; Smith, Craig P.; Reynolds, Raymond F.			Sensory integration of a light touch reference in human standing balance	PLOS ONE			English	Article							HUMAN POSTURAL CONTROL; MULTISENSORY FUSION; SWAY; VISION; INFORMATION; FEEDBACK; CONTACT; SUPPORT; FINGER; STANCE	In upright stance, light touch of a space-stationary touch reference reduces spontaneous sway. Moving the reference evokes sway responses which exhibit non-linear behavior that has been attributed to sensory reweighting. Reweighting refers to a change in the relative contribution of sensory cues signaling body sway in space and light touch cues signaling finger position with respect to the body. Here we test the hypothesis that the sensory fusion process involves a transformation of light touch signals into the same reference frame as other sensory inputs encoding body sway in space, or vice versa. Eight subjects lightly gripped a robotic manipulandum which moved in a circular arc around the ankle joint. A pseudo-randomized motion sequence with broad spectral characteristics was applied at three amplitudes. The stimulus was presented at two different heights and therefore different radial distances, which were matched in terms of angular motion. However, the higher stimulus evoked a significantly larger sway response, indicating that the response was not matched to stimulus angular motion. Instead, the body sway response was strongly related to the horizontal translation of the manipulandum. The results suggest that light touch is integrated as the horizontal distance between body COM and the finger. The data were well explained by a model with one feedback loop minimizing changes in horizontal COM-finger distance. The model further includes a second feedback loop estimating the horizontal finger motion and correcting the first loop when the touch reference is moving. The second loop includes the predicted transformation of sensory signals into the same reference frame and a non-linear threshold element that reproduces the non-linear sway responses, thus providing a mechanism that can explain reweighting.	[Asslaender, Lorenz] Univ Konstanz, Sensorimotor Performance Lab, Constance, Germany; [Smith, Craig P.; Reynolds, Raymond F.] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England	University of Konstanz; University of Birmingham	Asslander, L (corresponding author), Univ Konstanz, Sensorimotor Performance Lab, Constance, Germany.	lorenz.asslaender@uni-konstanz.de	Assländer, Lorenz/ABG-4916-2021	Assländer, Lorenz/0000-0003-1394-9883; Reynolds, Raymond/0000-0002-5031-3473	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M027880/1]; BBSRC [BB/M027880/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	CPS is supported by the UK Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/M027880/1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asslander L, 2015, HUM MOVEMENT SCI, V41, P147, DOI 10.1016/j.humov.2015.02.010; Bosco G, 1997, J NEUROPHYSIOL, V78, P1421, DOI 10.1152/jn.1997.78.3.1421; Breniere Y, 1996, J MOTOR BEHAV, V28, P291, DOI 10.1080/00222895.1996.10544598; Casabona A, 2010, CEREBELLUM, V9, P103, DOI 10.1007/s12311-009-0149-x; Cenciarini M, 2006, J NEUROPHYSIOL, V95, P2733, DOI 10.1152/jn.00856.2004; Davies W.D.T., 1970, SYSTEM IDENTIFICATIO, Vfirst; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Hettich G, 2014, HUM MOVEMENT SCI, V37, P123, DOI 10.1016/j.humov.2014.07.004; Holden M, 1994, J Vestib Res, V4, P285; Horak F, 1996, HDB PHYSIOL 12, V12, P255; Jeka J, 1998, J NEUROPHYSIOL, V79, P1661, DOI 10.1152/jn.1998.79.4.1661; Jeka J, 2000, EXP BRAIN RES, V134, P107, DOI 10.1007/s002210000412; JEKA JJ, 1994, EXP BRAIN RES, V100, P495, DOI 10.1007/BF02738408; JEKA JJ, 1995, EXP BRAIN RES, V103, P267; Jeka JJ, 1997, EXP BRAIN RES, V113, P475, DOI 10.1007/PL00005600; Kouzaki M, 2008, EXP BRAIN RES, V188, P153, DOI 10.1007/s00221-008-1426-5; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Mergner T, 2004, ARCH ITAL BIOL, V142, P175; Mergner T, 2003, PROG BRAIN RES, V142, P189; Mergner T, 2010, ANNU REV CONTROL, V34, P177, DOI 10.1016/j.arcontrol.2010.08.001; Mergner T., 2012, ROUTLEDGE HDB MOTOR; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Oie KS, 2001, NEUROSCI LETT, V315, P113, DOI 10.1016/S0304-3940(01)02348-5; Peterka RJ, 2003, IEEE ENG MED BIOL, V22, P63, DOI 10.1109/MEMB.2003.1195698; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pintelon R., 2004, SYSTEM IDENTIFICATIO; Reynolds RF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0751; Rogers MW, 2001, EXP BRAIN RES, V136, P514, DOI 10.1007/s002210000615; Thurrell AEI, 2002, EXP BRAIN RES, V147, P558, DOI 10.1007/s00221-002-1296-1; van der Kooij H, 2005, J NEUROSCI METH, V145, P175, DOI 10.1016/j.jneumeth.2005.01.003; van der Kooij H, 2011, J COMPUT NEUROSCI, V30, P759, DOI 10.1007/s10827-010-0291-y; Winter D. A., 2009, BIOMECHANICS MOTOR C, DOI DOI 10.1002/9780470549148	33	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197316	10.1371/journal.pone.0197316	http://dx.doi.org/10.1371/journal.pone.0197316			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874252	Green Published, Green Submitted, gold			2022-12-26	WOS:000434369400019
J	Zheng, XH; Lian, Y; Wang, QG				Zheng, Xiaohui; Lian, Yi; Wang, Qiguang			The long-range correlation and evolution law of centennial-scale temperatures in Northeast China	PLOS ONE			English	Article							DETRENDED FLUCTUATION ANALYSIS; TIME-SERIES; DEPENDENCE; MONSOON; TRENDS	This paper applies the detrended fluctuation analysis (DFA) method to investigate the longrange correlation of monthly mean temperatures from three typical measurement stations at Harbin, Changchun, and Shenyang in Northeast China from 1909 to 2014. The results reveal the memory characteristics of the climate system in this region. By comparing the temperatures from different time periods and investigating the variations of its scaling exponents at the three stations during these different time periods, we found that the monthly mean temperature has long-range correlation, which indicates that the temperature in Northeast China has long-term memory and good predictability. The monthly time series of temperatures over the past 106 years also shows good long-range correlation characteristics. These characteristics are also obviously observed in the annual mean temperature time series. Finally, we separated the centennial-length temperature time series into two time periods. These results reveal that the long-range correlations at the Harbin station over these two time periods have large variations, whereas no obvious variations are observed at the other two stations. This indicates that warming affects the regional climate system's predictability differently at different time periods. The research results can provide a quantitative reference point for regional climate predictability assessment and future climate model evaluation.	[Zheng, Xiaohui] Beijing Normal Univ, Coll Climate Change & Earth Syst Sci, Beijing, Peoples R China; [Lian, Yi] Inst Jilin Meteorol Sci, Changchun, Jilin, Peoples R China; [Wang, Qiguang] CMA, China Meteorol Adm Training Ctr, Beijing, Peoples R China	Beijing Normal University; China Meteorological Administration	Wang, QG (corresponding author), CMA, China Meteorol Adm Training Ctr, Beijing, Peoples R China.	wangqg@cma.gov.cn			National Natural Science Foundation of China [41675107, 41775081, 41530531]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (41675107, 41775081, 41530531).; This research was supported by National Natural Science Foundation of China (41675107, 41775081, 41530531).	[白虎志 Bai Huzhi], 2005, [应用气象学报, Journal of Applied Meteorolgical Science], V16, P484; Bunde A, 2014, NAT GEOSCI, V7, P246, DOI 10.1038/ngeo2126; Cao LJ, 2013, J GEOPHYS RES-ATMOS, V118, P8197, DOI 10.1002/jgrd.50615; Castellanos MT, 2018, BIOSYST ENG, V168, P14, DOI 10.1016/j.biosystemseng.2017.09.016; Feng GL, 2003, CHINESE PHYS, V12, P1076, DOI 10.1088/1009-1963/12/10/307; Feng GL, 1998, MODELQUARTERLY J APP, V9, P219; Feng Y, 2016, J VIBROENG, V18, P5153, DOI 10.21595/jve.2016.17030; Franzke C, 2012, J CLIMATE, V25, P4172, DOI 10.1175/JCLI-D-11-00293.1; Franzke C, 2010, J CLIMATE, V23, P6074, DOI 10.1175/2010JCLI3654.1; Gao M, 2017, J CLIMATE, V30, P9897, DOI [10.1175/JCLI-D-17-0356.1, 10.1175/jcli-d-17-0356.1]; Gu GF, 2006, PHYS REV E, V74, P3293, DOI [10.1103/PhysRevLett.74.3293, DOI 10.1103/PHYSREVLETT.74.3293]; Habib A, 2017, J HYDROL, V549, P715, DOI 10.1016/j.jhydrol.2017.04.034; Hou W, 2006, ACTA PHYS SIN-CH ED, V55, P2663, DOI 10.7498/aps.55.2663; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; Kun Hu, 2001, Physical Review E (Statistical, Nonlinear, and Soft Matter Physics), V64, p011114/1, DOI 10.1103/PhysRevE.64.011114; Lee JM, 2002, COMPUT BIOL MED, V32, P37, DOI 10.1016/S0010-4825(01)00031-2; Lian Y, 1998, ACTA METEOROL SIN, V56, P724; Lim YK, 2002, J CLIMATE, V15, P3630, DOI 10.1175/1520-0442(2002)015&lt;3630:TASEOT&gt;2.0.CO;2; Liu D, 2016, WATER RESOUR MANAG, V30, P505, DOI 10.1007/s11269-015-1174-9; Ludescher J, 2016, CLIM DYNAM, V46, P263, DOI 10.1007/s00382-015-2582-5; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Shen Baizhu, 2011, Acta Meteorologica Sinica, V69, P320; Shukla J, 1998, SCIENCE, V282, P728, DOI 10.1126/science.282.5389.728; Sun L, 2000, ACTA METEOROLOGICA S, V58, P70, DOI DOI 10.11676/QXXB2000.007; Wang QG, 2008, ACTA PHYS SIN-CH ED, V57, P5343, DOI 10.7498/aps.57.5343; Wang QG, 2014, SCI CHINA EARTH SCI, V57, P1525, DOI 10.1007/s11430-014-4832-5; Wu GX, 1998, MON WEATHER REV, V126, P913, DOI 10.1175/1520-0493(1998)126<0913:TPFATT>2.0.CO;2; Xiong H, 2017, COMMUN NONLINEAR SCI, V42, P12, DOI 10.1016/j.cnsns.2016.04.035; Yang MX, 1999, EXPLORATION NATURE, V18, P30; Yang PC, 2003, CHINESE SCI BULL, V48, P2148, DOI 10.1360/03wd0175; Zhi R, 2006, ACTA PHYS SIN-CH ED, V55, P6185, DOI 10.7498/aps.55.6185	31	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198238	10.1371/journal.pone.0198238	http://dx.doi.org/10.1371/journal.pone.0198238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874281	Green Published, Green Submitted, gold			2022-12-26	WOS:000434369400044
J	Lee, GW; Park, JB; Park, SY; Seo, J; Shin, SH; Park, JW; Kim, SJ; Watanabe, M; Chun, YS				Lee, Gun-Woo; Park, Jun Bum; Park, Sung Yeon; Seo, Jieun; Shin, Seung-Hyun; Park, Jong-Wan; Kim, Sang Jung; Watanabe, Masatoshi; Chun, Yang-Sook			The E3 ligase C-CBL inhibits cancer cell migration by neddylating the proto-oncogene c-Src	ONCOGENE			English	Article							NEDD8-ACTIVATING ENZYME-INHIBITOR; PROTEIN NEDDYLATION; NEDD8 CONJUGATION; IN-VITRO; MLN4924; EXPRESSION; PATHWAY; TARGET; ACTIVATION; APOPTOSIS	Neddylation is a cellular process that covalently conjugates substrate proteins with the small ubiquitin-like molecule NEDD8. As neddylation is required for fast turnover of proteins in proliferating cancer cells, the neddylation process is currently regarded as a potential target for cancer therapy. However, little is known about the role of neddylation in cancer invasion and metastasis. Unexpectedly, we here found that the neddylation blockade stimulates migration of lung cancer and glioblastoma cells. Mechanistically, C-CBL acts as the E3 ligase for neddylation of the proto-oncogene c-Src. After neddylation, c-Src is poly-ubiquitinated and degraded through the proteasome, which inhibits the PI3K-AKT pathway responsible for cell migration. In human lung cancer tissues, the downregulation of C-CBL was associated with c-Src/AKT, cancer metastasis, and poor survival in patients. Therefore, C-CBL is likely to play a tumor suppressive role by antagonizing a robust oncogenic signaling driven by c-Src. This study provides new insight about the role of neddylation in cancer metastasis. It also implies that the metastasis risk should be carefully evaluated before the clinical application of neddylation inhibitors as anticancer regimens.	[Lee, Gun-Woo; Park, Jun Bum; Park, Sung Yeon; Seo, Jieun; Shin, Seung-Hyun; Park, Jong-Wan; Kim, Sang Jung; Chun, Yang-Sook] Dept Biomed Sci, Seoul 110799, South Korea; [Park, Sung Yeon; Park, Jong-Wan; Kim, Sang Jung; Chun, Yang-Sook] Ischem Hypox Dis Inst, Seoul 110799, South Korea; [Kim, Sang Jung; Chun, Yang-Sook] Seoul Natl Univ, Dept Physiol, Coll Med, Seoul 110799, South Korea; [Watanabe, Masatoshi] Yokohama Natl Univ, Grad Sch Engn, Lab Med Engn, Yokohama, Kanagawa 2408501, Japan	Seoul National University (SNU)	Chun, YS (corresponding author), Dept Biomed Sci, Seoul 110799, South Korea.; Chun, YS (corresponding author), Ischem Hypox Dis Inst, Seoul 110799, South Korea.; Chun, YS (corresponding author), Seoul Natl Univ, Dept Physiol, Coll Med, Seoul 110799, South Korea.	chunys@snu.ac.kr		Seo, Jieun/0000-0003-1319-832X; Park, Jong-Wan/0000-0003-4676-5191; Kim, Sang Jeong/0000-0001-8931-3713	Korean Health Technology RD grant [HI15C2695]; National Research Foundation grants from the Korean government [2016R1AB4013377, 2012R1A5A2A44671346]	Korean Health Technology RD grant; National Research Foundation grants from the Korean government(National Research Foundation of Korea)	This work was supported by a Korean Health Technology R&D grant (HI15C2695), and National Research Foundation grants from the Korean government (2016R1AB4013377, 2012R1A5A2A44671346).	Abidi N, 2015, ENDOCR-RELAT CANCER, V22, pT55, DOI 10.1530/ERC-14-0315; Aoki I, 2013, ONCOGENE, V32, P3954, DOI 10.1038/onc.2012.428; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Cheng CY, 2010, BRIT J PHARMACOL, V160, P1595, DOI 10.1111/j.1476-5381.2010.00858.x; Duncan K, 2012, FUTURE ONCOL, V8, P1461, DOI [10.2217/FON.12.131, 10.2217/fon.12.131]; Embade N, 2012, HEPATOLOGY, V55, P1237, DOI 10.1002/hep.24795; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Katzav S, 2015, ONCOTARGET, V6, P10689, DOI 10.18632/oncotarget.3986; Korrodi-Gregorio L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165973; Kuo KL, 2015, CANCER LETT, V363, P127, DOI 10.1016/j.canlet.2015.01.015; Kuo LY, 2006, J CELL PHYSIOL, V207, P729, DOI 10.1002/jcp.20616; Lo FY, 2011, CANCER-AM CANCER SOC, V117, P5344, DOI 10.1002/cncr.26153; Luo ZG, 2012, CANCER RES, V72, P3360, DOI 10.1158/0008-5472.CAN-12-0388; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Nawrocki ST, 2013, CLIN CANCER RES, V19, P3577, DOI 10.1158/1078-0432.CCR-12-3212; Noguchi K, 2011, CARCINOGENESIS, V32, P995, DOI 10.1093/carcin/bgr068; Ohh Michael, 2003, Methods Mol Biol, V222, P167; Oved S, 2006, J BIOL CHEM, V281, P21640, DOI 10.1074/jbc.M513034200; Park HS, 2016, CELL DEATH DIFFER, V23, P1296, DOI 10.1038/cdd.2016.6; Ryu JH, 2011, J BIOL CHEM, V286, P6963, DOI 10.1074/jbc.M110.188706; Salon C, 2007, J PATHOL, V213, P303, DOI 10.1002/path.2223; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Sandilands E, 2012, NAT CELL BIOL, V14, P51, DOI 10.1038/ncb2386; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Seong MW, 2014, BIOCHEM BIOPH RES CO, V455, P153, DOI 10.1016/j.bbrc.2014.10.129; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stickle NH, 2004, MOL CELL BIOL, V24, P3251, DOI 10.1128/MCB.24.8.3251-3261.2004; Tan YHC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008972; Truitt L, 2010, CANCER RES, V70, P1141, DOI 10.1158/0008-5472.CAN-09-1710; Wang XF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/974309; Wu X, 2016, INT J MOL MED, V37, P639, DOI 10.3892/ijmm.2016.2472; Xie P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4733; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Zhang LY, 2012, ONCOL LETT, V3, P395, DOI 10.3892/ol.2011.487; Zhou XC, 2016, P NATL ACAD SCI USA, V113, pE2935, DOI 10.1073/pnas.1522367113	37	20	20	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 11	2018	37	41					5552	5568		10.1038/s41388-018-0354-5	http://dx.doi.org/10.1038/s41388-018-0354-5			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GW5QO	29899407				2022-12-26	WOS:000446991200006
J	Pollock, LM; Xie, J; Bell, BA; Anand-Apte, B				Pollock, Lana M.; Xie, Jing; Bell, Brent A.; Anand-Apte, Bela			Retinoic acid signaling is essential for maintenance of the blood-retinal barrier	FASEB JOURNAL			English	Article						zebrafish; tight junctions; vasculature	IN-VIVO; BRAIN-BARRIER; DIABETIC-RETINOPATHY; VASCULAR DEVELOPMENT; VITAMIN-A; ZEBRAFISH; DIFFERENTIATION; RECEPTORS; BREAKDOWN; PHOTORECEPTORS	The predominant function of the blood-retinal barrier (BRB) is to maintain retinal homeostasis by regulating the influx and efflux between the blood and retina. Breakdown of the BRB occurs in a number of ocular diseases that result in vision loss. Understanding the molecular and cellular pathways involved in the development and maintenance of the BRB is critical to developing therapeutics for these conditions. To visualize the BRB in vivo, we used the transgenic Tg(l-fabp:DBP-EGFP:flk1:mCherry) zebrafish model that expresses vitamin D binding protein (a member of the albumin gene family) tagged to green fluorescent protein. Retinoic acid (RA) plays a number of important roles in vertebrate development and has been shown to play a protective role during inflammation-induced blood-brain barrier disruption. The role of RA in BRB development and maintenance remains unknown. To disrupt RA signaling, Tg(l-fabp:DBP-EGFP:flk1:mCherry) zebrafish were treated with N,N-diethylaminobenzaldehyde and 4-[(1E)-2-[5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoic acid, which are antagonists of retinal dehydrogenase and the RA receptor, respectively. Treatment with either compound resulted in BRB disruption and reduced visual acuity, whereas cotreatment with all-trans RA effectively rescued BRB integrity. Additionally, transgenic overexpression of Cyp26a1, which catalyzes RA degradation, resulted in breakdown of the BRB. Our results demonstrate that RA signaling is critical for maintenance of the BRB and could play a role in diseases such as diabetic macular edema.Pollock, L. M., Xie, J., Bell, B. A., Anand-Apte, B. Retinoic acid signaling is essential for maintenance of the blood-retinal barrier.	[Pollock, Lana M.; Xie, Jing; Bell, Brent A.; Anand-Apte, Bela] Cleveland Clin, Cole Eye Inst, Dept Ophthalm Res, Cleveland, OH 44106 USA; [Anand-Apte, Bela] Case Western Reserve Univ, Dept Ophthalmol, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Anand-Apte, B (corresponding author), Cleveland Clin, Cole Eye Inst, 9500 Euclid Ave,I31, Cleveland, OH 44195 USA.	anandab@ccf.org			U.S. National Institutes of Health, National Eye Institute [EY016490, EY015638, EY026181, T32EY024236, P30EY025585]; Research to Prevent Blindness Unrestricted/Challenge Grant; Foundation Fighting Blindness Center Grant; NATIONAL EYE INSTITUTE [R01EY027083, R01EY020861, P30EY025585, T32EY024236, R01EY026181] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Unrestricted/Challenge Grant; Foundation Fighting Blindness Center Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Mariya Ali (Cleveland Clinic) and Alecia Cutler (Cleveland Clinic) for technical assistance; Dr. Johannes von Lintig (Case Western Reserve University) and Dr. Brian Perkins (Cleveland Clinic) for helpful discussions; Dr. Didier Stainier (Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany), Dr. Suk-Won Jin (Yale Cardiovascular Research Center, New Haven, CT, USA), and Dr. Neil Chi (University of California, San Diego, La Jolla, CA, USA) for providing the Tg(flk1:mCherry) fish; Dr. Brant Weinstein (National Institutes of Health, Bethesda, MD, USA) for providing the Tg(fli1a:EGFP-cldn5b) fish; and Dr. Nicola Blum and Dr. Gerrit Begemann (both from the University of Bayreuth, Bayreuth, Germany) for providing the Tg(hsp70I: cyp26a1) fish. The authors also thank Amanda Mendelsohn (Center for Medical Art and Photography, Cleveland Clinic) for illustrations. This work was supported by U.S. National Institutes of Health, National Eye Institute Grants EY016490, EY015638, EY026181, T32EY024236, and P30EY025585; a Research to Prevent Blindness Unrestricted/Challenge Grant; and a Foundation Fighting Blindness Center Grant. The authors declare no conflicts of interest.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bell BA, 2014, EXP EYE RES, V129, P107, DOI 10.1016/j.exer.2014.10.018; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Blum N, 2012, DEVELOPMENT, V139, P107, DOI 10.1242/dev.065391; Bonney S, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0378-16.2017; Campbell M, 2013, ADV EXP MED BIOL, V763, P70; CUNHAVAZ J, 1975, BRIT J OPHTHALMOL, V59, P649, DOI 10.1136/bjo.59.11.649; Daniele LL, 2016, INVEST OPHTH VIS SCI, V57, P2942, DOI 10.1167/iovs.15-18996; Diaz-Coranguez M, 2017, VISION RES, V139, P123, DOI 10.1016/j.visres.2017.05.009; Dobbs-McAuliffe B, 2004, MECH DEVELOP, V121, P339, DOI 10.1016/j.mod.2004.02.008; Drager UC, 1997, PROG RETIN EYE RES, V16, P323, DOI 10.1016/S1350-9462(96)00029-8; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Hartsock A, 2014, DEV BIOL, V394, P327, DOI 10.1016/j.ydbio.2014.07.024; Hyatt GA, 1996, P NATL ACAD SCI USA, V93, P13298, DOI 10.1073/pnas.93.23.13298; Jeong JY, 2008, BRAIN RES BULL, V75, P619, DOI 10.1016/j.brainresbull.2007.10.043; Jung SH, 2016, BRIT J PHARMACOL, V173, P15, DOI 10.1111/bph.13279; KELLEY MW, 1994, DEVELOPMENT, V120, P2091; Kelley MW, 1999, NEUROREPORT, V10, P2389, DOI 10.1097/00001756-199908020-00031; Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001; KREMPF M, 1991, INT J VITAM NUTR RES, V61, P38; Le HGT, 2012, VISUAL NEUROSCI, V29, P219, DOI 10.1017/S0952523812000296; LOHNES D, 1994, DEVELOPMENT, V120, P2723; MARSHARMSTRONG N, 1994, P NATL ACAD SCI USA, V91, P7286, DOI 10.1073/pnas.91.15.7286; McCaffery P, 1996, P NATL ACAD SCI USA, V93, P12570, DOI 10.1073/pnas.93.22.12570; McDowell RE, 2016, INVEST OPHTH VIS SCI, V57, P4762, DOI 10.1167/iovs.16-19424; Mizee MR, 2013, J NEUROSCI, V33, P1660, DOI 10.1523/JNEUROSCI.1338-12.2013; Mori M, 2001, INVEST OPHTH VIS SCI, V42, P1312; Mueller K. P., 2011, JOVE-J VIS EXP, V56, P3556; Nishikiori N, 2007, DIABETES, V56, P1333, DOI 10.2337/db06-1431; Raverdeau M, 2012, P NATL ACAD SCI USA, V109, P16582, DOI 10.1073/pnas.1214936109; Rinner O, 2005, INVEST OPHTH VIS SCI, V46, P137, DOI 10.1167/iovs.04-0682; RUSSO JE, 1988, BIOCHEM PHARMACOL, V37, P1639, DOI 10.1016/0006-2952(88)90030-5; STENKAMP DL, 1993, INVEST OPHTH VIS SCI, V34, P2425; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Trasino SE, 2016, DIABETES OBES METAB, V18, P142, DOI 10.1111/dom.12590; Trasino SE, 2015, SCI REP-UK, V5, DOI 10.1038/srep15893; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Wendling O, 2000, DEVELOPMENT, V127, P1553; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76; Yu JXA, 2015, DEVELOPMENT, V142, P2951, DOI 10.1242/dev.123174; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431; Zhou YL, 2016, NEUROCHEM RES, V41, P813, DOI 10.1007/s11064-015-1756-1	45	14	14	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5674	5684		10.1096/fj.201701469R	http://dx.doi.org/10.1096/fj.201701469R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29874129	Bronze, Green Published			2022-12-26	WOS:000447972500039
J	Cruz, JM; Hupper, N; Wilson, LS; Concannon, JB; Wang, Y; Oberhauser, B; Patora-Komisarska, K; Zhang, YY; Glass, DJ; Trendelenburg, AU; Clarke, BA				Cruz, Joseph M.; Hupper, Nicole; Wilson, Liz S.; Concannon, John B.; Wang, Yuan; Oberhauser, Berndt; Patora-Komisarska, Krystyna; Zhang, Yunyu; Glass, David J.; Trendelenburg, Anne-Ulrike; Clarke, Brian A.			Protein kinase A activation inhibits DUX4 gene expression in myotubes from patients with facioscapulohumeral muscular dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; DNA REARRANGEMENTS; UBIQUITIN LIGASES; CONTROLLED-TRIAL; CLENBUTEROL; POPULATION; ATROPHY; PATHOPHYSIOLOGY; DIFFERENTIATION; PREVALENCE	Facioscapulohumeral muscular dystrophy (FSHD) is among the most prevalent of the adult-onset muscular dystrophies. FSHD causes a loss of muscle mass and function, resulting in severe debilitation and reduction in quality of life. Currently, only the symptoms of FSHD can be treated, and such treatments have minimal benefit. The available options are not curative, and none of the treatments address the underlying cause of FSHD. The genetic, epigenetic, and molecular mechanisms triggering FSHD are now quite well-understood, and it has been shown that expression of the transcriptional regulator double homeobox 4 (DUX4) is necessary for disease onset and is largely thought to be the causative factor in FSHD. Therefore, we sought to identify compounds suppressing DUX4 expression in a phenotypic screen using FSHD patient-derived muscle cells, a zinc finger and SCAN domain-containing 4 (ZSCAN4)-based reporter gene assay for measuring DUX4 activity, and similar to 3,000 small molecules. This effort identified molecules that reduce DUX4 gene expression and hence DUX4 activity. Among those, beta(2)-adrenergic receptor agonists and phosphodiesterase inhibitors, both leading to increased cellular cAMP, effectively decreased DUX4 expression by >75% in cells from individuals with FSHD. Of note, we found that cAMP production reduces DUX4 expression through a protein kinase A-dependent mode of action in FSHD patient myotubes. These findings increase our understanding of how DUX4 expression is regulated in FSHD and point to potential areas of therapeutic intervention.	[Cruz, Joseph M.; Hupper, Nicole; Wilson, Liz S.; Zhang, Yunyu; Trendelenburg, Anne-Ulrike; Clarke, Brian A.] Novartis Inst Biomed Res, Musculoskeletal Dis, 181 Massachusetts Ave, Cambridge, MA 02139 USA; [Concannon, John B.; Wang, Yuan; Glass, David J.] Novartis Inst Biomed Res, Chem Biol & Therapeut, Cambridge, MA 02139 USA; [Oberhauser, Berndt; Patora-Komisarska, Krystyna] Novartis Inst Biomed Res, Global Discovery Chem, CH-4056 Basel, Switzerland	Novartis; Novartis; Novartis	Clarke, BA (corresponding author), Novartis Inst Biomed Res, Musculoskeletal Dis, 181 Massachusetts Ave, Cambridge, MA 02139 USA.	Brian.Clarke@novartis.com	Glass, David/AAI-3910-2021; Glass, David/C-4782-2012	Glass, David/0000-0001-6187-4164				Badrinarayan P, 2013, CURR PHARM DESIGN, V19, P4714, DOI 10.2174/1381612811319260005; Block GJ, 2013, HUM MOL GENET, V22, P4661, DOI 10.1093/hmg/ddt314; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brand T, 2017, CELL SIGNAL, V40, P156, DOI 10.1016/j.cellsig.2017.09.015; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Campbell AE, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0134-x; Ceci R, 2011, HORM METAB RES, V43, P702, DOI 10.1055/s-0031-1285867; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cox ME, 2000, J BIOL CHEM, V275, P13812, DOI 10.1074/jbc.275.18.13812; Deenen JCW, 2014, NEUROLOGY, V83, P1056, DOI 10.1212/WNL.0000000000000797; Flanigan KM, 2001, NEUROMUSCULAR DISORD, V11, P525, DOI 10.1016/S0960-8966(01)00201-2; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Hagg A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23042; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Himeda CL, 2014, MOL CELL BIOL, V34, P1942, DOI 10.1128/MCB.00149-14; Hinkle RT, 2002, MUSCLE NERVE, V25, P729, DOI 10.1002/mus.10092; Huichalaf C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115278; Jones TI, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-23; Kissel JT, 2001, NEUROLOGY, V57, P1434, DOI 10.1212/WNL.57.8.1434; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; MALTIN CA, 1989, BIOCHEM J, V261, P965, DOI 10.1042/bj2610965; MALTIN CA, 1993, AM J PHYSIOL, V265, pE176, DOI 10.1152/ajpendo.1993.265.1.E176; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Mostacciuolo ML, 2009, CLIN GENET, V75, P550, DOI 10.1111/j.1399-0004.2009.01158.x; MUMMERY CJ, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003278; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Norwood FLM, 2009, BRAIN, V132, P3175, DOI 10.1093/brain/awp236; PADBERG GW, 1995, MUSCLE NERVE, pS81, DOI 10.1002/mus.880181315; Pannerec A, 2016, AGING-US, V8, P712, DOI 10.18632/aging.100926; Payan CA, 2009, ARCH PHYS MED REHAB, V90, P1094, DOI 10.1016/j.apmr.2008.12.027; Sharma Chandramohan, 2014, BMJ Case Rep, V2014, DOI 10.1136/bcr-2013-203411; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Statland Jeffrey M, 2015, J Neuromuscul Dis, V2, P291; Tan HN, 2017, BMC SURG, V17, DOI 10.1186/s12893-017-0276-0; Tawil R, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-12; Tupler R, 1996, J MED GENET, V33, P366, DOI 10.1136/jmg.33.5.366; TYLER FH, 1950, ANN INTERN MED, V32, P640, DOI 10.7326/0003-4819-32-4-640; van der Kooi EL, 2004, NEUROLOGY, V63, P702, DOI 10.1212/01.WNL.0000134660.30793.1F; van der Maarel SM, 2007, BBA-MOL BASIS DIS, V1772, P186, DOI 10.1016/j.bbadis.2006.05.009; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Wang Y, 2016, CELL CHEM BIOL, V23, P862, DOI 10.1016/j.chembiol.2016.05.016; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26	44	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11837	11849		10.1074/jbc.RA118.002633	http://dx.doi.org/10.1074/jbc.RA118.002633			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29899111	Green Published, hybrid			2022-12-26	WOS:000440134500017
J	Ong, SC; Belgi, A; van Lierop, B; Delaine, C; Andrikopoulos, S; MacRaild, CA; Norton, RS; Haworth, NL; Robinson, AJ; Forbes, BE				Ong, Shee Chee; Belgi, Alessia; van Lierop, Bianca; Delaine, Carlie; Andrikopoulos, Sofianos; MacRaild, Christopher A.; Norton, Raymond S.; Haworth, Naomi L.; Robinson, Andrea J.; Forbes, Briony E.			Probing the correlation between insulin activity and structural stability through introduction of the rigid A6-A11 bond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; POTENTIAL-ENERGY SURFACE; BIOLOGICAL-ACTIVITY; POLYMERIZATION PATTERN; MOLECULAR-DYNAMICS; DIABETES-MELLITUS; DISULFIDE BONDS; KINETIC TRAP; B-CHAIN; PH 7.0	The development of fast-acting and highly stable insulin analogues is challenging. Insulin undergoes structural transitions essential for binding and activation of the insulin receptor (IR), but these conformational changes can also affect insulin stability. Previously, we substituted the insulin A6-A11 cystine with a rigid, non-reducible C=C linkage ("dicarba" linkage). A cis-alkene permitted the conformational flexibility of the A-chain N-terminal helix necessary for high-affinity IR binding, resulting in surprisingly rapid activity in vivo. Here, we show that, unlike the rapidly acting Lys(B28)Pro(B29) insulin analogue (KP insulin), cis-dicarba insulin is not inherently monomeric. We also show that cis-dicarba KP insulin lowers blood glucose levels even more rapidly than KP insulin, suggesting that an inability to oligomerize is not responsible for the observed rapid activity onset of cis-dicarba analogues. Although rapid-acting, neither dicarba species is stable, as assessed by fibrillation and thermodynamics assays. MALDI analyses and molecular dynamics simulations of cis-dicarba insulin revealed a previously unidentified role of the A6-A11 linkage in insulin conformational dynamics. By controlling the conformational flexibility of the insulin B-chain helix, this linkage affects overall insulin structural stability. This effect is independent of its regulation of the A-chain N-terminal helix flexibility necessary for IR engagement. We conclude that high-affinity IR binding, rapid in vivo activity, and insulin stability can be regulated by the specific conformational arrangement of the A6-A11 linkage. This detailed understanding of insulin's structural dynamics may aid in the future design of rapid-acting insulin analogues with improved stability.	[Ong, Shee Chee; Delaine, Carlie; Forbes, Briony E.] Flinders Univ South Australia, Coll Med & Publ Hlth, Bedford Pk, SA 5042, Australia; [Belgi, Alessia; van Lierop, Bianca; Haworth, Naomi L.; Robinson, Andrea J.] Monash Univ, Sch Chem, Clayton, Vic 3800, Australia; [Andrikopoulos, Sofianos] Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia; [MacRaild, Christopher A.; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia; [Haworth, Naomi L.] Australian Natl Univ, Res Sch Chem, Acton, ACT 2601, Australia; [Haworth, Naomi L.] Deakin Univ, Sch Life & Environm Sci, Waurn Ponds, Vic 3216, Australia	Flinders University South Australia; Monash University; University of Melbourne; Monash University; Australian National University; Deakin University	Forbes, BE (corresponding author), Flinders Univ South Australia, Coll Med & Publ Hlth, Bedford Pk, SA 5042, Australia.	briony.forbes@flinders.edu.au	Forbes, Briony/R-1838-2019; Haworth, Naomi L/G-5254-2011	Haworth, Naomi L/0000-0002-3299-3137; Forbes, Briony/0000-0003-4360-9927; Norton, Raymond/0000-0001-8893-0584; Robinson, Andrea/0000-0003-3859-1312	Australian postgraduate scholarship; Australian National Health and Medical Research Council; National Health and Medical Research Council Project [APP1069328]; Australian Research Council [LP12020200792]	Australian postgraduate scholarship(Australian Government); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Project(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	Supported by an Australian postgraduate scholarship.; Recipient of fellowship support from the Australian National Health and Medical Research Council.; Supported by National Health and Medical Research Council Project Grant APP1069328 and Australian Research Council Grant LP12020200792.	ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Banting FG, 2007, INDIAN J MED RES, V125, pA251; Bonnesen C, 2010, CELL BIOL TOXICOL, V26, P293, DOI 10.1007/s10565-009-9142-x; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1993, Pharm Biotechnol, V5, P315; Campbell RK, 1996, ANN PHARMACOTHER, V30, P1263, DOI 10.1177/106002809603001111; Case DA, 2014, AMBER 14; Chang SG, 2003, MOL CELLS, V16, P323; Chen Y, 2004, BIOCHEMISTRY-US, V43, P9225, DOI 10.1021/bi049710y; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; Dai Y, 1996, BBA-PROTEIN STRUCT M, V1296, P63, DOI 10.1016/0167-4838(96)00054-4; De Meyts P, 2015, BIOESSAYS, V37, P389, DOI 10.1002/bies.201400190; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; GANDERTON RH, 1992, BIOCHEM J, V288, P195, DOI 10.1042/bj2880195; Gauguin L, 2008, J BIOL CHEM, V283, P20821, DOI 10.1074/jbc.M802620200; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Groenning M, 2007, J STRUCT BIOL, V159, P483, DOI 10.1016/j.jsb.2007.06.004; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haworth NL, 2007, MOL SIMULAT, V33, P475, DOI 10.1080/08927020701361876; Haworth NL, 2010, AUST J CHEM, V63, P379, DOI 10.1071/CH09456; Hossain MA, 2015, ORG BIOMOL CHEM, V13, P10895, DOI 10.1039/c5ob01539a; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Hua Qing-Xin, 2011, Front Endocrinol (Lausanne), V2, P48, DOI 10.3389/fendo.2011.00048; Hua QX, 2004, J BIOL CHEM, V279, P21449, DOI 10.1074/jbc.M314141200; HUA QX, 1995, NAT STRUCT BIOL, V2, P129, DOI 10.1038/nsb0295-129; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JEFFREY PD, 1976, BIOCHEMISTRY-US, V15, P4660, DOI 10.1021/bi00666a018; Jensen M., 2000, THESIS; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lawrence M. C., 2015, RECEPTOR TYROSINE KI, P163; Liu Y, 2004, J BIOCHEM, V135, P1, DOI 10.1093/jb/mvg134; Ludwig DB, 2011, BIOTECHNOL BIOENG, V108, P2359, DOI 10.1002/bit.23188; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mathieu C, 2017, NAT REV ENDOCRINOL, V13, P385, DOI 10.1038/nrendo.2017.39; Mauro M, 2007, J MOL BIOL, V366, P258, DOI 10.1016/j.jmb.2006.11.008; Menting JG, 2016, NAT STRUCT MOL BIOL, V23, P916, DOI 10.1038/nsmb.3292; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MILTHORPE BK, 1977, BIOCHIM BIOPHYS ACTA, V495, P195, DOI 10.1016/0005-2795(77)90376-2; Pandyarajan V, 2012, CURR DIABETES REP, V12, P697, DOI 10.1007/s11892-012-0318-z; Papaioannou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144058; Phillips Nelson B, 2012, J Diabetes Sci Technol, V6, P277; PIETRZKOWSKI Z, 1992, CELL GROWTH DIFFER, V3, P199; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; SCHILLING RJ, 1991, PHARMACEUT RES, V8, P721, DOI 10.1023/A:1015893832222; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; SIEBER P, 1978, H-S Z PHYSIOL CHEM, V359, P113; SOOS MA, 1989, BIOCHEM J, V263, P553, DOI 10.1042/bj2630553; SOOS MA, 1989, P NATL ACAD SCI USA, V86, P5217, DOI 10.1073/pnas.86.14.5217; van Dam EM, 2005, MOL ENDOCRINOL, V19, P1067, DOI 10.1210/me.2004-0413; van Lierop B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16876-3; van Lierop BJ, 2011, AUST J CHEM, V64, P806, DOI 10.1071/CH11090; Weiss MA, 2009, VITAM HORM, V80, P33, DOI 10.1016/S0083-6729(08)00602-X; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h; Wong N, 2011, ENDOCRINOLOGY, V152, P3690, DOI 10.1210/en.2011-0288; Woods R Jeremy, 2012, J Diabetes Sci Technol, V6, P265; Yang YW, 2010, J BIOL CHEM, V285, P10806, DOI 10.1074/jbc.M109.067850; Zakova L, 2004, BIOCHEMISTRY-US, V43, P2323, DOI 10.1021/bi036001w; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w; Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033	64	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11928	11943		10.1074/jbc.RA118.002486	http://dx.doi.org/10.1074/jbc.RA118.002486			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29899115	Green Published, hybrid			2022-12-26	WOS:000440134500024
J	Pedrosa, AG; Francisco, T; Bicho, D; Dias, AF; Barros-Barbosa, A; Hagmann, V; Dodt, G; Rodrigues, TA; Azevedo, JE				Pedrosa, Ana G.; Francisco, Tania; Bicho, Diana; Dias, Ana F.; Barros-Barbosa, Aurora; Hagmann, Vera; Dodt, Gabriele; Rodrigues, Tony A.; Azevedo, Jorge E.			Peroxisomal monoubiquitinated PEX5 interacts with the AAA ATPases PEX1 and PEX6 and is unfolded during its dislocation into the cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases associated with diverse cellular activities (AAA); peroxisome; ubiquitin; protein sorting; protein translocation; PEX1; PEX5; PEX6	PROTEIN IMPORT PATHWAY; TARGETING SIGNAL; PTS1 RECEPTOR; SACCHAROMYCES-CEREVISIAE; CYCLING RECEPTOR; DIHYDROFOLATE-REDUCTASE; BIOGENESIS DISORDERS; CONSERVED CYSTEINE; AMINO-ACID; MACHINERY	PEX1 and PEX6 are two members of the ATPases associated with diverse cellular activities (AAA) family and the core components of the receptor export module of the peroxisomal matrix protein import machinery. Their role is to extract monoubiquitinated PEX5, the peroxisomal protein-shuttling receptor, from the peroxisomal membrane docking/translocation module (DTM), so that a new cycle of protein transportation can start. Recent data have shown that PEX1 and PEX6 form a heterohexameric complex that unfolds substrates by processive threading. However, whether the natural substrate of the PEX1-PEX6 complex is monoubiquitinated PEX5 (Ub-PEX5) itself or some Ub-PEX5-interacting component(s) of the DTM remains unknown. In this work, we used an established cell-free in vitro system coupled with photoaffinity cross-linking and protein PEGylation assays to address this problem. We provide evidence suggesting that DTM-embedded Ub-PEX5 interacts directly with both PEX1 and PEX6 through its ubiquitin moiety and that the PEX5 polypeptide chain is globally unfolded during the ATP-dependent extraction event. These findings strongly suggest that DTM-embedded Ub-PEX5 is a bona fide substrate of the PEX1-PEX6 complex.	[Pedrosa, Ana G.; Francisco, Tania; Bicho, Diana; Dias, Ana F.; Barros-Barbosa, Aurora; Rodrigues, Tony A.; Azevedo, Jorge E.] Univ Porto, i3S, Rua Alfredo Allen 208, P-4200135 Porto, Portugal; [Pedrosa, Ana G.; Francisco, Tania; Bicho, Diana; Dias, Ana F.; Barros-Barbosa, Aurora; Rodrigues, Tony A.; Azevedo, Jorge E.] Univ Porto, IBMC, Rua Alfredo Allen 208, P-4200135 Porto, Portugal; [Pedrosa, Ana G.; Dias, Ana F.; Rodrigues, Tony A.; Azevedo, Jorge E.] Univ Porto, ICBAS, P-4200135 Porto, Portugal; [Hagmann, Vera; Dodt, Gabriele] Univ Tubingen, Interfak Inst Biochem, Hoppe Seyler Str 4, D-72076 Tubingen, Germany	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Eberhard Karls University of Tubingen	Azevedo, JE (corresponding author), Univ Porto, IBMC, Rua Alfredo Allen 208, P-4200135 Porto, Portugal.	jazevedo@ibmc.up.pt	Francisco, Tânia/AAK-9920-2020; Bicho, Diana/M-2454-2017; Azevedo, Jorge E/A-4113-2008; Barros-Barbosa, AR/L-1321-2014; Rodrigues, Tony/K-1141-2014	Francisco, Tânia/0000-0003-3571-5164; Bicho, Diana/0000-0002-9095-7134; Azevedo, Jorge E/0000-0001-7714-5302; Barros-Barbosa, AR/0000-0003-4484-4427; Pedrosa, Ana G/0000-0001-8887-2046; Rodrigues, Tony/0000-0003-2311-8258; Dias, Ana Filipa/0000-0002-6667-1961	FEDER (Fundo Europeu de Desenvolvimento Regional), through COMPETE 2020-Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020; Portuguese funds through Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia, Tecnologia e Ensino Superior [POCI-01-0145-FEDER-007274, PTDC/BEX-BCM/2311/2014]; Portuguese funds through Norte 2020-Programa Operacional Regional do Norte under the application of the "Porto Neurosciences and Neurologic Disease Research Initiative at i3S" [NORTE-01-0145-FEDER-000008]; Fundacao para a Ciencia e Tecnologia; Programa Operacional Potencial Humano do QREN; Fundo Social Europeu	FEDER (Fundo Europeu de Desenvolvimento Regional), through COMPETE 2020-Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020; Portuguese funds through Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia, Tecnologia e Ensino Superior; Portuguese funds through Norte 2020-Programa Operacional Regional do Norte under the application of the "Porto Neurosciences and Neurologic Disease Research Initiative at i3S"; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Potencial Humano do QREN; Fundo Social Europeu	This work was funded by FEDER (Fundo Europeu de Desenvolvimento Regional), through COMPETE 2020-Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020, and by Portuguese funds through Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia, Tecnologia e Ensino Superior in the framework of the projects "Institute for Research and Innovation in Health Sciences" (POCI-01-0145-FEDER-007274) and "The molecular mechanisms of peroxisome biogenesis" (PTDC/BEX-BCM/2311/2014), and through Norte 2020-Programa Operacional Regional do Norte, under the application of the "Porto Neurosciences and Neurologic Disease Research Initiative at i3S" (NORTE-01-0145-FEDER-000008). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Fundacao para a Ciencia e Tecnologia, Programa Operacional Potencial Humano do QREN, and Fundo Social Europeu.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Alencastre IS, 2009, J BIOL CHEM, V284, P27243, DOI 10.1074/jbc.M109.032565; Bailey ME, 2015, BIOPHYS J, V109, P2546, DOI 10.1016/j.bpj.2015.11.011; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Bhogal MS, 2016, J BIOL CHEM, V291, P2460, DOI 10.1074/jbc.M115.686501; Birschmann I, 2003, MOL BIOL CELL, V14, P2226, DOI 10.1091/mbc.E02-11-0752; Blok NB, 2015, P NATL ACAD SCI USA, V112, pE4017, DOI 10.1073/pnas.1500257112; Bodnar NO, 2017, CELL, V169, P722, DOI 10.1016/j.cell.2017.04.020; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Ciniawsky S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8331; Costa-Rodrigues J, 2004, J BIOL CHEM, V279, P46573, DOI 10.1074/jbc.M406399200; Debelyy MO, 2011, J BIOL CHEM, V286, P28223, DOI 10.1074/jbc.M111.238600; Dias AF, 2017, J BIOL CHEM, V292, P15287, DOI 10.1074/jbc.M117.805044; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; Dodt G, 2001, J BIOL CHEM, V276, P41769, DOI 10.1074/jbc.M106932200; Dorman G, 2016, CHEM REV, V116, P15284, DOI 10.1021/acs.chemrev.6b00342; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; Francisco T, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700047; Francisco T, 2013, J BIOL CHEM, V288, P29151, DOI 10.1074/jbc.M113.487140; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Galland N, 2007, BBA-MOL CELL RES, V1773, P521, DOI 10.1016/j.bbamcr.2007.01.006; Gardner BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02474-4; Gardner BM, 2015, J MOL BIOL, V427, P1375, DOI 10.1016/j.jmb.2015.01.019; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Goto S, 2011, PLANT CELL, V23, P1573, DOI 10.1105/tpc.110.080770; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Grou CP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12836; Grou CP, 2012, J BIOL CHEM, V287, P12815, DOI 10.1074/jbc.M112.340158; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; HAAS AL, 1983, BIOCHEMISTRY-US, V22, P4388, DOI 10.1021/bi00288a007; Islinger M, 2010, BBA-MOL CELL RES, V1803, P881, DOI 10.1016/j.bbamcr.2010.03.013; Islinger M, 2012, HISTOCHEM CELL BIOL, V137, P547, DOI 10.1007/s00418-012-0941-4; Jardim A, 2000, J BIOL CHEM, V275, P13637, DOI 10.1074/jbc.275.18.13637; Johjima A, 2015, J BIOL CHEM, V290, P11762, DOI 10.1074/jbc.M114.614768; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Junker JP, 2005, BIOPHYS J, V89, pL46, DOI 10.1529/biophysj.105.072066; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; KOSTER A, 1986, BIOCHEM BIOPH RES CO, V137, P626, DOI 10.1016/0006-291X(86)91124-1; Kragler F, 1998, P NATL ACAD SCI USA, V95, P13336, DOI 10.1073/pnas.95.22.13336; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Miyata N, 2012, TRAFFIC, V13, P168, DOI 10.1111/j.1600-0854.2011.01298.x; Monroe N, 2016, J MOL BIOL, V428, P1897, DOI 10.1016/j.jmb.2015.11.004; Neuhaus A, 2014, J BIOL CHEM, V289, P437, DOI 10.1074/jbc.M113.499707; Nordgren M, 2015, AUTOPHAGY, V11, P1326, DOI 10.1080/15548627.2015.1061846; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Popov-Celeketic D, 2011, EMBO REP, V12, P542, DOI 10.1038/embor.2011.72; Portsteffen H, 1997, NAT GENET, V17, P449, DOI 10.1038/ng1297-449; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Reuber BE, 1997, NAT GENET, V17, P445, DOI 10.1038/ng1297-445; Rodrigues TA, 2016, NAT PROTOC, V11, P2454, DOI 10.1038/nprot.2016.147; Rodrigues TA, 2014, MOL CELL BIOL, V34, P2917, DOI 10.1128/MCB.01727-13; Tamura S, 2006, J BIOL CHEM, V281, P27693, DOI 10.1074/jbc.M605159200; Tamura S, 2014, J BIOL CHEM, V289, P24336, DOI 10.1074/jbc.M114.588038; Tan DY, 2016, FEBS J, V283, P986, DOI 10.1111/febs.13569; TSUKAMOTO T, 1995, NAT GENET, V11, P395, DOI 10.1038/ng1295-395; Van Veldhoven PP, 2010, J LIPID RES, V51, P2863, DOI 10.1194/jlr.R005959; VANDERKLEI IJ, 1995, J BIOL CHEM, V270, P17229, DOI 10.1074/jbc.270.29.17229; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Walter C, 2001, AM J HUM GENET, V69, P35, DOI 10.1086/321265; Wanders RJA, 2014, BIOCHIMIE, V98, P36, DOI 10.1016/j.biochi.2013.08.022; Waterham HR, 2016, BBA-MOL CELL RES, V1863, P922, DOI 10.1016/j.bbamcr.2015.11.015; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	78	21	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11553	11563		10.1074/jbc.RA118.003669	http://dx.doi.org/10.1074/jbc.RA118.003669			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29884772	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000439449700024
J	Ulaganathan, T; Banin, E; Helbert, W; Cygler, M				Ulaganathan, ThirumalaiSelvi; Banin, Ehud; Helbert, William; Cygler, Miroslaw			Structural and functional characterization of PL28 family ulvan lyase NLR48 from Nonlabens ulvanivorans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate processing; catalysis; crystal structure; substrate specificity; bacteria; algae; substrate binding; ulvan lyase; -jelly roll fold; PL28 family	SUBSTRATE RECOGNITION; ALGINATE LYASE; POLYSACCHARIDE; ENZYMES; ENVIRONMENT; FEATURES	Ulvan is a complex sulfated polysaccharide present in the cell wall of green algae of the genus Ulva (Chlorophyta). The first ulvan-degrading polysaccharide lyases were identified several years ago, and more were discovered through genome sequencing of marine bacteria. Ulvan lyases are now grouped in three polysaccharide lyase (PL) families in the CAZy database, PL24, PL25, and PL28. The recently determined structures of the representative lyases from families PL24 and PL25 show that they adopt a seven-bladed -propeller fold and utilize the His/Tyr catalytic mechanism. No structural information is yet available for PL28 ulvan lyases. NLR48 from Nonlabens ulvanivorans belongs to PL28 together with its close paralog, NLR42. Biochemical studies of NLR42 have revealed that it can cleave ulvan next to both uronic acid epimers. We report the crystal structure of ulvan lyase NLR48 at 1.9- resolution. It has a -jelly roll fold with an extended, deep, and positively charged substrate-binding cleft. Putative active-site residues were identified from the sequence conservation pattern, and their role was confirmed by site-directed mutagenesis. The structure of an inactive K162M mutant with a tetrasaccharide substrate showed the substrate occupying the - subsites. Comparison with lyases from other PL families with -jelly roll folds supported assignment of the active site and explained its ability to degrade ulvan next to either epimer of uronic acid. NLR48 contains the His/Tyr catalytic machinery with Lys(162) and Tyr(281) playing the catalytic base/acid roles.	[Ulaganathan, ThirumalaiSelvi; Cygler, Miroslaw] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Banin, Ehud] Bar Ilan Univ, Fac Life Sci, IL-5290002 Ramat Gan, Israel; [Helbert, William] CNRS, Ctr Rech Macromol Vegetales CERMAV, BP53, F-38000 Grenoble 9, France; [Helbert, William] Grenoble Alpes Univ, BP53, F-38000 Grenoble 9, France; [Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada	University of Saskatchewan; Bar Ilan University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); McGill University	Cygler, M (corresponding author), Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada.	miroslaw.cygler@usask.ca		Cygler, Miroslaw/0000-0003-4579-1881	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank Kevin Voth for comments. We acknowledge the Protein Characterization and Crystallization Facility, College of Medicine, University of Saskatchewan for access to the crystallization robot. Research described in this paper was performed using beamline 08ID-1 at the Canadian Light Source synchrotron, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collen PN, 2011, J BIOL CHEM, V286, P42063, DOI 10.1074/jbc.M111.271825; Cunha L, 2016, MAR DRUGS, V14, DOI 10.3390/md14030042; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dong S, 2014, J BIOL CHEM, V289, P29558, DOI 10.1074/jbc.M114.584573; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foran E, 2017, ALGAL RES, V25, P39, DOI 10.1016/j.algal.2017.04.036; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Garron ML, 2014, CURR OPIN STRUC BIOL, V28, P87, DOI 10.1016/j.sbi.2014.07.012; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Han YH, 2009, J BIOL CHEM, V284, P34019, DOI 10.1074/jbc.M109.025338; Hehemann JH, 2014, CURR OPIN STRUC BIOL, V28, P77, DOI 10.1016/j.sbi.2014.07.009; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konno N, 2009, FEBS LETT, V583, P1323, DOI 10.1016/j.febslet.2009.03.034; Kopel M, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00793-14; Kopel M, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01257-14; Kopel M, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01081-14; Kopel M, 2016, J BIOL CHEM, V291, P5871, DOI 10.1074/jbc.M115.673947; Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Melcher RLJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep44115; Michel G, 2013, WOODH PUB SER BIOMED, P429, DOI 10.1533/9781908818355.3.429; Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008; Ogura K, 2009, J BIOL CHEM, V284, P35572, DOI 10.1074/jbc.M109.068056; Popa EG, 2015, CRIT REV BIOTECHNOL, V35, P410, DOI 10.3109/07388551.2014.889079; Shalaby EA, 2011, PLANT SIGNAL BEHAV, V6, P1338, DOI 10.4161/psb.6.9.16779; Sudha PN, 2014, ADV FOOD NUTR RES, V73, P145, DOI 10.1016/B978-0-12-800268-1.00008-1; Ulaganathan T, 2018, J BIOL CHEM, V293, P4026, DOI 10.1074/jbc.RA117.001642; Ulaganathan T, 2017, ACS CHEM BIOL, V12, P1269, DOI 10.1021/acschembio.7b00126	34	19	21	4	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11564	11573		10.1074/jbc.RA118.003659	http://dx.doi.org/10.1074/jbc.RA118.003659			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29875159	Green Published, hybrid			2022-12-26	WOS:000439449700025
J	Katte, R; Yu, C				Katte, Revansiddha; Yu, Chin			Blocking the interaction between S100A9 protein and RAGE V domain using S100A12 protein	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; CALCIUM-BINDING PROTEINS; THERAPEUTIC TARGET; RECEPTOR; DOCKING; DISEASE; INFLAMMATION; EXPRESSION; ARTHRITIS; BIOLOGY	The proteins S100A9 and S100A12 are associated with the human S100 calcium-binding protein family. These proteins promote interaction with target proteins and alter their conformation when they bind to calcium ions in EF-hand motifs. The V domain of RAGE (Receptor for Advanced Glycation End products) is crucial for S100A9 binding. The binding of RAGE with S100 family proteins aids in cell proliferation. In this report, we demonstrate that S100A12 protein hinders the binding of S100A9 with the RAGE V-domain. We used fluorescence and NMR spectroscopy to analyze the interaction of S100A9 with S100A12. The binary complex models of S100A9-S100A12 were developed using data obtained from H-1-N-15 HSQC NMR titrations and the HADDOCK program. We overlaid the complex models of S100A9-S100A12 with the same orientation of S100A9 and the RAGE V-domain. This complex showed that S100A12 protein blocks the interaction between S100A9 and the RAGE V-domain. It means S100A12 may be used as an antagonist for S100A9. The results could be favorable for developing anti-cancer drugs based on S100 family proteins.	[Katte, Revansiddha; Yu, Chin] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan	National Tsing Hua University	Yu, C (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan.	cyu.nthu@gmail.com		katte, revansiddha/0000-0002-3844-8797	Ministry of Science and Technology (MOST) of Taiwan [MOST 103-2113-M-007 -017 -MY3]	Ministry of Science and Technology (MOST) of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Ministry of Science and Technology (MOST) of Taiwan (Grant number MOST 103-2113-M-007 -017 -MY3 to CY.) The funders had no role in study design, data collection and analysis, or decision to publish.	Averill MM, 2012, ARTERIOSCL THROM VAS, V32, P223, DOI 10.1161/ATVBAHA.111.236927; Averill MM, 2011, CIRCULATION; Baillet A, 2010, REV MED INTERNE, V31, P458, DOI 10.1016/j.revmed.2009.10.435; BAUDIER J, 1986, J BIOL CHEM, V261, P8204; Chang CC, 2016, BBA-PROTEINS PROTEOM, V1864, P1558, DOI 10.1016/j.bbapap.2016.08.008; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deloulme JC, 2000, J BIOL CHEM, V275, P35302, DOI 10.1074/jbc.M003943200; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Fernandez-Recio J, 2004, J MOL BIOL, V335, P843, DOI 10.1016/j.jmb.2003.10.069; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Goddard TD., 2000, SPARKY 3; Hatakeyama T, 2004, EUR J BIOCHEM, V271, P3765, DOI 10.1111/j.1432-1033.2004.04318.x; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Henke MO, 2006, EXP LUNG RES, V32, P331, DOI 10.1080/01902140600959580; Hubbard SJ, 1993, NACCESS COMPUTER PRO, V2; Hung KW, 2013, J BIOMOL NMR, V57, P313, DOI 10.1007/s10858-013-9781-3; LAGASSE E, 1988, MOL CELL BIOL, V8, P2402, DOI 10.1128/MCB.8.6.2402; Lakowicz J. R., PRINCIPLES FLUORESCE, P533; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leanderson T, 2012, ONCOIMMUNOLOGY, V1, P1404, DOI 10.4161/onci.21027; Lim SY, 2011, ANTIOXID REDOX SIGN, V15, P2235, DOI 10.1089/ars.2010.3641; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu X, 2014, J BIOL CHEM, V289, P27571, DOI 10.1074/jbc.M114.562561; LUGERING N, 1995, DIGESTION, V56, P406, DOI 10.1159/000201267; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Markowitz J, 2013, BBA-REV CANCER, V1835, P100, DOI 10.1016/j.bbcan.2012.10.003; Mohan SK, 2013, BIOCHEM BIOPH RES CO, V434, P328, DOI 10.1016/j.bbrc.2013.03.049; Narumi K, 2015, J IMMUNOL, V194, P5539, DOI 10.4049/jimmunol.1402301; NEEPER M, 1992, J BIOL CHEM, V267, P14998; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Penumutchu SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103947; Permyakov EA, 1993, LUMINESCENT SPECTROS; Propper C, 1999, J BIOL CHEM, V274, P183, DOI 10.1074/jbc.274.1.183; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Sakaguchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023132; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; Takeuchi K, 2006, CURR OPIN STRUC BIOL, V16, P109, DOI 10.1016/j.sbi.2006.01.006; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yamagishi SI, 2008, CURR PHARM DESIGN, V14, P487, DOI 10.2174/138161208783597416	45	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198767	10.1371/journal.pone.0198767	http://dx.doi.org/10.1371/journal.pone.0198767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902210	Green Published, Green Submitted, gold			2022-12-26	WOS:000435424900038
J	Amarilla, AA; Fumagalli, MJ; Figueiredo, ML; Lima, DS; Santos, NN; Alfonso, HL; Lippi, V; Trabuco, AC; Lauretti, F; Muller, VD; Colon, DF; Luiz, JPM; Suhrbier, A; Setoh, YX; Khromykh, AA; Figueiredo, LTM; Aquino, VH				Amarilla, Alberto Anastacio; Fumagalli, Marcilio Jorge; Figueiredo, Mario Luis; Lima-Junior, Djalma S.; Santos-Junior, Nilton Nascimento; Alfonso, Helda Liz; Lippi, Veronica; Trabuco, Amanda Cristina; Lauretti, Flavio; Muller, Vanessa Danielle; Colon, David F.; Luiz, Joao P. M.; Suhrbier, Andreas; Setoh, Yin Xiang; Khromykh, Alexander A.; Moraes Figueiredo, Luiz Tadeu; Aquino, Victor Hugo			Ilheus and Saint Louis encephalitis viruses elicit cross-protection against a lethal Rocio virus challenge in mice	PLOS ONE			English	Article							WEST NILE VIRUS; GROUP-B ARBOVIRUSES; ANTIGENIC RELATIONSHIPS; SEROLOGICAL EVIDENCE; FLAVIVIRUSES; INFECTION; ANTIBODIES; SEROSURVEY; EMERGENCE; DISEASE	Rocio virus (ROCV) was the causative agent of an unprecedented outbreak of encephalitis during the 1970s in the Vale do Ribeira, Sao Paulo State, in the Southeast region of Brazil. Surprisingly, no further cases of ROCV infection were identified after this outbreak; however, serological surveys have suggested the circulation of ROCV among humans and animals in different regions of Brazil. Cross-protective immunity among flaviviruses is well documented; consequently, immunity induced by infections with other flaviviruses endemic to Brazil could potentially be responsible for the lack of ROCV infections. Herein, we evaluated the cross-protection mediated by other flaviviruses against ROCV infection using an experimental C57BU6 mouse model. Cross-protection against ROCV infection was observed when animals had prior exposure to Ilheus virus or Saint Louis encephalitis virus, suggesting that cross-reactive anti-flavivirus antibodies may limit ROCV disease outbreaks.	[Amarilla, Alberto Anastacio; Figueiredo, Mario Luis; Alfonso, Helda Liz; Lippi, Veronica; Trabuco, Amanda Cristina; Muller, Vanessa Danielle; Aquino, Victor Hugo] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Clin Anal Toxicol & Food Sci, Lab Virol, Ribeirao Preto, SP, Brazil; [Fumagalli, Marcilio Jorge; Lauretti, Flavio; Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Ribeirao Preto Med Sch, Virol Res Ctr, Ribeirao Preto, SP, Brazil; [Lima-Junior, Djalma S.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, Ribeirao Preto, SP, Brazil; [Santos-Junior, Nilton Nascimento] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Neurosci & Behav Sci, Ribeirao Preto, SP, Brazil; [Colon, David F.; Luiz, Joao P. M.] Univ Sao Paulo, Ribeirao Preto Med Sch, Lab Inflammat & Pain, Dept Immunol, Ribeirao Preto, SP, Brazil; [Amarilla, Alberto Anastacio; Suhrbier, Andreas; Setoh, Yin Xiang; Khromykh, Alexander A.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Queensland; QIMR Berghofer Medical Research Institute	Aquino, VH (corresponding author), Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Clin Anal Toxicol & Food Sci, Lab Virol, Ribeirao Preto, SP, Brazil.	vhugo@fcfrp.usp.br	Khromykh, Alexander/X-7200-2018; Setoh, Yin Xiang/K-4503-2012; Amarilla, Alberto Anastacio/AFO-4805-2022; Fumagalli, Marcilio/ABE-1183-2020; Colon, David/M-2509-2018; Silva, Veronica LO Lippi Oliveira/G-3080-2017; SANTOS-JUNIOR, NILTON NASCIMENTO/C-6439-2015; Aquino, Victor Hugo/C-1922-2012	Khromykh, Alexander/0000-0001-6206-6935; Setoh, Yin Xiang/0000-0002-1683-3555; Amarilla, Alberto Anastacio/0000-0002-6640-3377; Fumagalli, Marcilio/0000-0002-0207-5423; Colon, David/0000-0002-6911-4765; Silva, Veronica LO Lippi Oliveira/0000-0003-2309-2406; SANTOS-JUNIOR, NILTON NASCIMENTO/0000-0003-2155-032X; Aquino, Victor Hugo/0000-0003-1910-0776; Trabuco, Amanda Cristina/0000-0003-1512-1561; Suhrbier, Andreas/0000-0001-8986-9025	Sao Paulo Research Foundation (FAPESP), Brazil [2014/15548-4, 2014/02438-6]; FAPESP Scholarships [2012/08778-8]; Fundacao de Apoio ao Ensino, Pesquisa e Assistencia (FAEPA) from the Hospital of the Medical School of Ribeirao Preto, University of Sao Paulo [97/16]; CNPq-PQ scholarship [310735/2013-0]	Sao Paulo Research Foundation (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP Scholarships(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia (FAEPA) from the Hospital of the Medical School of Ribeirao Preto, University of Sao Paulo; CNPq-PQ scholarship	This work was supported by the Sao Paulo Research Foundation (FAPESP), Brazil, Grant No. 2014/15548-4 and 2014/02438-6. MO was supported by an FAPESP Scholarships No. 2012/08778-8 and Fundacao de Apoio ao Ensino, Pesquisa e Assistencia (FAEPA) from the Hospital of the Medical School of Ribeirao Preto, University of Sao Paulo (Scholarships No 97/16). VHA holds a CNPq-PQ scholarship (Grant no. 310735/2013-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarilla AA, 2017, SCI REP-UK, V7, DOI 10.1038/srep44642; Batista WC, 2011, REV SOC BRAS MED TRO, V44, P528, DOI 10.1590/S0037-86822011000400028; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Casseb AR, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-9; Chiu CY, 2017, EMERG INFECT DIS, V23, P1694, DOI 10.3201/eid2310.161986; DEMADRID AT, 1974, J GEN VIROL, V23, P91, DOI 10.1099/0022-1317-23-1-91; DESOUZALOPES O, 1978, AM J EPIDEMIOL, V108, P394, DOI 10.1093/oxfordjournals.aje.a112637; Ferreira Ivani B., 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P265, DOI 10.1590/S0036-46651994000300011; Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4; GOVERDHAN MK, 1992, ACTA VIROL, V36, P277, DOI 10.1016/0166-0934(92)90058-L; Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/1v1IvER.00055-16, DOI 10.1128/1V1IVER.00055-16]; Johnson BW, 2007, EMERG INFECT DIS, V13, P956, DOI 10.3201/eid1306.070118; KARABATSOS N, 1978, AM J TROP MED HYG, V27, P372; Khan MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005017; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Li J., 2016, STEM CELLS INT, V2016, P6, DOI DOI 10.1016/J.ENGGE0.2016.03.006; LOPES OD, 1981, AM J EPIDEMIOL, V113, P122; LOPES ODS, 1978, AM J EPIDEMIOL, V107, P444; Medeiros DBA, 2007, J GEN VIROL, V88, P2237, DOI 10.1099/vir.0.82883-0; Medlin S, 2016, J WILDLIFE DIS, V52, P883, DOI 10.7589/2015-02-040; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s77, 10.1002/0471142735.im1501s88]; Morales MA, 2017, PLOS NEGLECT TROP D, V11, DOI [10.1371/journal.pntd.0005351, 10.1371/journal.pntd, DOI 10.1371/journal.pntd.0005351]; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Pauvolid-Correa A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002706; Pauvolid-Correa A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002318; Petrovsky N, 2013, J VIROL, V87, P10324, DOI 10.1128/JVI.00480-13; PRIASLANDINEZ E, 1968, AM J TROP MED HYG, V17, P112, DOI 10.4269/ajtmh.1968.17.112; PRICE WH, 1971, AM J EPIDEMIOL, V94, P596, DOI 10.1093/oxfordjournals.aje.a121358; Quinones-Mateu ME, 2014, J CLIN VIROL, V61, P9, DOI 10.1016/j.jcv.2014.06.013; Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007; Romano-Lieber NS, 2000, REV SAUDE PUBL, V34, P236, DOI 10.1590/S0034-89102000000300005; SATHER GE, 1970, P SOC EXP BIOL MED, V135, P573, DOI 10.3181/00379727-135-35098a; Setoh YX, 2018, ARCH VIROL, V163, P255, DOI 10.1007/s00705-017-3561-4; Silva JR, 2014, REV SOC BRAS MED TRO, V47, P414, DOI 10.1590/0037-8682-0117-2014; SRIHONGSE S, 1967, AM J TROP MED HYG, V16, P516, DOI 10.4269/ajtmh.1967.16.516; Straatmann A, 1997, Rev Soc Bras Med Trop, V30, P511, DOI 10.1590/S0037-86821997000600012; TARR GC, 1974, INFECT IMMUN, V9, P909, DOI 10.1128/IAI.9.5.909-915.1974; Tesh RB, 2002, EMERG INFECT DIS, V8, P245, DOI 10.3201/eid0803.010238; Thompson NN, 2012, VECTOR-BORNE ZOONOT, V12, P969, DOI 10.1089/vbz.2012.0959; Tiriba A C, 1976, AMB Rev Assoc Med Bras, V22, P415; VARELASWESLEY I, 1982, AM J TROP MED HYG, V31, P1273, DOI 10.4269/ajtmh.1982.31.1273; Vazquez-Calvo A, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.68; Venegas EA, 2012, EMERG INFECT DIS, V18, P516, DOI 10.3201/eid1803.111486; Wilson MR, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14058	45	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0199071	10.1371/journal.pone.0199071	http://dx.doi.org/10.1371/journal.pone.0199071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897990	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700092
J	Budak, F; Bal, SH; Tezcan, G; Akalin, EH; Yilmaz, A; Hiz, P; Oral, HB				Budak, Ferah; Bal, Salih Haldun; Tezcan, Gulcin; Akalin, Emin Halis; Yilmaz, Abdullah; Hiz, Pinar; Oral, Haluk Barbaros			The microRNA expression signature of CD4+T cells in the transition of brucellosis into chronicity	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; INHIBITS PROLIFERATION; MIRNA EXPRESSION; OVARIAN-CANCER; T-CELLS; TARGETS; GROWTH; CARCINOMA; RECEPTOR; PROMOTES	Brucellosis is a serious infectious disease that continues to be a significant cause of morbidity worldwide and across all ages. Despite early diagnosis and treatment, 10-30% of patients develop chronic brucellosis. Although there have been recent advances in our knowledge of Brucella virulence factors and hosts' immune response to the infection, there is a lack of clear data regarding how the infection bypasses the immune system and becomes chronic. The present study investigated immunological factors and their roles in the transition of brucellosis from an acute to a chronic infection in CD4+T cells. CD4+T cells sorted from peripheral blood samples of patients with acute or chronic brucellosis and healthy controls using flow cytometry as well as more than 2000 miRNAs were screened using the GeneSpring GX (Agilent) 13.0 miRNA microarray software and were validated using reverse transcription polymerase chain reaction (RT-qPCR). Compared to acute cases, the expression levels of 28 miRNAs were significantly altered in chronic cases. Apart from one miRNA (miR-4649-3p), 27 miRNAs were not expressed in the acute cases (p <0.05, fold change> 2). According to KEGG pathway analysis, these miRNAs are involved in the regulation of target genes that were previously involved in the MAPK signalling pathway, regulation of the actin cytoskeleton, endocytosis, and protein processing in the endoplasmic reticulum. This indicates the potential role of these miRNAs in the development of chronic brucellosis. We suggest that these miRNAs can be used as markers to determine the transition of the disease into chronicity. This is the first study of miRNA expression that analyses human CD4+T cells to clarify the mechanism of chronicity in brucellosis.	[Budak, Ferah; Bal, Salih Haldun; Hiz, Pinar; Oral, Haluk Barbaros] Uludag Univ, Fac Med, Dept Immunol, Bursa, Turkey; [Tezcan, Gulcin] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [Akalin, Emin Halis] Uludag Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Bursa, Turkey; [Yilmaz, Abdullah] Istanbul Univ, Aziz Sancar Inst Expt Med, Dept Immunol, Istanbul, Turkey	Uludag University; Kazan Federal University; Uludag University; Istanbul University	Budak, F (corresponding author), Uludag Univ, Fac Med, Dept Immunol, Bursa, Turkey.	fbudak@uludag.edu.tr	Akalin, Halis/AAU-8952-2020; Ertan, Asli/AAE-6201-2021; Budak, Ferah/F-4657-2014; ORAL, HALUK BARBAROS Haluk/K-7285-2012; Tezcan, Gulcin/AAH-3843-2020	ORAL, HALUK BARBAROS Haluk/0000-0003-0463-6818; Tezcan, Gulcin/0000-0002-5956-8755	Turkiye Bilimsel ve Teknolojik Arastirma Kurumu [SBAG-111S183]	Turkiye Bilimsel ve Teknolojik Arastirma Kurumu(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	Ferah Budak, Haluk Barbaros Oral, Emin Halis Akalin were the authors who were supported by a funder. They were supported by the the same grand. The name of the funder is: Turkiye Bilimsel ve Teknolojik Arastirma Kurumu. The link of the funder: (https://www.tubitak.gov.tr). The grand number: SBAG-111S183. This funder (Turkiye Bilimsel ve Teknolojik Arastirma Kurumu) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The rest of the authors (Salih Haldun Bal, Gulcin Tezcan, Abdullah Yilmaz, Pinar Hiz) were not supported by any funder.	Afanasyeva EA, 2011, CELL DEATH DIFFER, V18, P974, DOI 10.1038/cdd.2010.164; Ahmed W, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00030; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Araj GF, 2010, INT J ANTIMICROB AG, V36, pS12, DOI 10.1016/j.ijantimicag.2010.06.014; ARIZA J, 1992, CLIN INFECT DIS, V14, P131, DOI 10.1093/clinids/14.1.131; BADOLATO R, 1994, J CLIN ENDOCR METAB, V79, P984, DOI 10.1210/jc.79.4.984; Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Boo L, 2016, INT J BIOL SCI, V12, P427, DOI 10.7150/ijbs.12777; Borrelli N, 2017, MODERN PATHOL, V30, P39, DOI [10.1038/nnodpathol.2016.157, 10.1038/modpathol.2016.157]; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Budak F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165138; Budak F, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4591468; Cassataro J, 2005, INFECT IMMUN, V73, P8079, DOI 10.1128/IAI.73.12.8079-8088.2005; Chen JY, 2013, INT J MOL MED, V32, P557, DOI 10.3892/ijmm.2013.1424; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cheng J, 2017, ONCOL LETT, V13, P3859, DOI 10.3892/ol.2017.5882; Cui Z, 2014, P 13 S VET MED CHIN, V7, P1, DOI DOI 10.1186/1756-3305-7-1; de Figueiredo P, 2015, AM J PATHOL, V185, P1505, DOI 10.1016/j.ajpath.2015.03.003; Doganay Mehmet, 2003, International Journal of Infectious Diseases, V7, P173, DOI 10.1016/S1201-9712(03)90049-X; Dornand J, 2004, INFECT IMMUN, V72, P2303, DOI 10.1128/IAI.72.4.2303-2311.2004; El-Awady RA, 2015, CANCER BIOL THER, V16, P1056, DOI 10.1080/15384047.2015.1046023; Fawzy IO, 2015, FEBS LETT, V589, P2257, DOI 10.1016/j.febslet.2015.06.038; Ferooz Jonathan, 2010, BMC Res Notes, V3, P333, DOI 10.1186/1756-0500-3-333; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Galinska EM, 2013, ANN AGR ENV MED, V20, P233; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hori S, 2003, ADV IMMUNOL, V81, P331, DOI 10.1016/S0065-2776(03)81008-8; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KOOIJMAN R, 1992, ENDOCRINOLOGY, V131, P2244, DOI 10.1210/en.131.5.2244; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Li H, 2015, CANCER BIOMARK, V15, P807, DOI 10.3233/CBM-150524; Li J, 2015, BIO-MED MATER ENG, V26, pS1985, DOI 10.3233/BME-151502; Liu CH, 2015, MOL MED REP, V12, P7389, DOI 10.3892/mmr.2015.4390; Liu N, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0788-2; Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135; Martirosyan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082508; Miao XL, 2016, IUBMB LIFE, V68, P136, DOI 10.1002/iub.1467; Mutlu S, 2015, EUR REV MED PHARMACO, V19, P2384; Ni F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2484; Norman FF, 2016, TRAVEL MED INFECT DI, V14, P182, DOI 10.1016/j.tmaid.2016.05.005; Oliveira SC, 1996, CELL IMMUNOL, V172, P262, DOI 10.1006/cimm.1996.0241; Padgett KA, 2009, J AUTOIMMUN, V32, P246, DOI 10.1016/j.jaut.2009.02.022; Quan Y, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317697565; Rong H, 2017, INNATE IMMUN-LONDON, V23, P424, DOI 10.1177/1753425917707025; Saber A, 2016, IRAN RED CRESCENT ME, V18, DOI 10.5812/ircmj.42360; Sand M, 2012, BRIT J DERMATOL, V167, P847, DOI 10.1111/j.1365-2133.2012.11022.x; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Sripada L, 2017, J MOL MED, V95, P641, DOI 10.1007/s00109-017-1517-5; Stegeman S, 2015, CANCER DISCOV, V5, P368, DOI 10.1158/2159-8290.CD-14-1057; STUART CA, 1991, J CLIN ENDOCR METAB, V72, P1117, DOI 10.1210/jcem-72-5-1117; Takahashi K, 2014, DRUG METAB PHARMACOK, V29, P333, DOI 10.2133/dmpk.DMPK-13-RG-114; Tay HL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004549; Turan H, 2011, INTERNAL MED, V50, P421, DOI 10.2169/internalmedicine.50.4700; Ulu-Kilic Aysegul, 2013, Recent Pat Antiinfect Drug Discov, V8, P34; Vitry MA, 2012, INFECT IMMUN, V80, P4271, DOI 10.1128/IAI.00761-12; Wahlquist C, 2014, NATURE, V508, P531, DOI 10.1038/nature13073; Wang B, 2014, IUBMB LIFE, V66, P371, DOI 10.1002/iub.1273; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang Y, 2016, IMMUNOBIOLOGY, V221, P1378, DOI 10.1016/j.imbio.2016.07.008; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu AH, 2016, BIOMED PHARMACOTHER, V77, P92, DOI 10.1016/j.biopha.2015.12.005; Wu GY, 2015, ONCOTARGET, V6, P28882, DOI 10.18632/oncotarget.4921; Xie ZJ, 2015, CANCER PREV RES, V8, P165, DOI 10.1158/1940-6207.CAPR-14-0192; Yan SS, 2017, ONCOTARGET, V8, P60149, DOI 10.18632/oncotarget.18557; Yan W, 2011, BRAIN RES, V1411, P108, DOI 10.1016/j.brainres.2011.07.002; Young EJ., 2005, PRINCIPLES PRACTICE, V6; Yuce A, 2006, KLIMIK J, V19, P87; Zhao LY, 2014, DIGEST DIS SCI, V59, P1743, DOI 10.1007/s10620-014-3087-5; Zheng HY, 2016, ONCOTARGET, V7, P4647, DOI 10.18632/oncotarget.6615; Zheng K, 2012, INT J BIOL SCI, V8, P1013, DOI 10.7150/ijbs.3836; Zhou R, 2016, SCI REP-UK, V6, DOI 10.1038/srep35714	74	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198659	10.1371/journal.pone.0198659	http://dx.doi.org/10.1371/journal.pone.0198659			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897958	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700064
J	Centini, R; Tsang, M; Iwata, T; Park, H; Delrow, J; Margineantu, D; Iritani, BM; Gu, HW; Liggitt, HD; Kang, J; Kang, L; Hockenbery, DM; Raftery, D; Iritani, BM				Centini, Ryan; Tsang, Mark; Iwata, Terri; Park, Heon; Delrow, Jeffrey; Margineantu, Daciana; Iritani, Brandon M.; Gu, Haiwei; Liggitt, H. Denny; Kang, Janella; Kang, Lim; Hockenbery, David M.; Raftery, Daniel; Iritani, Brian M.			Loss of Fnip1 alters kidney developmental transcriptional program and synergizes with TSC1 loss to promote mTORC1 activation and renal cyst formation	PLOS ONE			English	Article							HOGG-DUBE-SYNDROME; TRANSMEMBRANE CONDUCTANCE REGULATOR; B-CELL DEVELOPMENT; PROTEIN-KINASE; TUMOR-SUPPRESSOR; POLYCYSTIC KIDNEYS; GENE-EXPRESSION; MOUSE MODEL; IN-VITRO; LYMPHOCYTE DEVELOPMENT	Birt-Hogg-Dube' Syndrome (BHDS) is a rare genetic disorder in humans characterized by skin hamartomas, lung cysts, pneumothorax, and increased risk of renal tumors. BHDS is caused by mutations in the BHD gene, which encodes for Folliculin, a cytoplasmic adapter protein that binds to Folliculin interacting proteins-1 and-2 (Fnip1, Fnip2) as well as the master energy sensor AMP kinase (AMPK). Whereas kidney-specific deletion of the Bhd gene in mice is known to result in polycystic kidney disease (PKD) and renal cell carcinoma, the roles of Fnip1 in renal cell development and function are unclear. In this study, we utilized mice with constitutive deletion of the Fnip1 gene to show that the loss of Fnip1 is sufficient to result in renal cyst formation, which was characterized by decreased AMPK activation, increased mTOR activation, and metabolic hyperactivation. Using RNAseq, we found that Fnip1 disruption resulted in many cellular and molecular changes previously implicated in the development of PKD in humans, including alterations in the expression of ion and amino acid transporters, increased cell adhesion, and increased inflammation. Loss of Fnip1 synergized with Tsc1 loss to hyperactivate mTOR, increase Erk activation, and greatly accelerate the development of PKD. Our results collectively define roles for Fnip1 in regulating kidney development and function, and provide a model for how loss of Fnip1 contributes to PKD and perhaps renal cell carcinoma.	[Centini, Ryan; Tsang, Mark; Iwata, Terri; Park, Heon; Iritani, Brandon M.; Liggitt, H. Denny; Kang, Janella; Kang, Lim; Iritani, Brian M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Delrow, Jeffrey] Fred Hutchinson Canc Res Ctr, Genom & Bioinformat Shared Resources, 1124 Columbia St, Seattle, WA 98104 USA; [Margineantu, Daciana; Hockenbery, David M.] Fred Hutchinson Canc Res Ctr, Clin Div, 1124 Columbia St, Seattle, WA 98104 USA; [Gu, Haiwei; Raftery, Daniel] Univ Washington, Dept Anesthesiol & Pain Med, Mitochondria & Metab Ctr, Northwest Metabol Res Ctr, Seattle, WA 98195 USA; [Hockenbery, David M.; Raftery, Daniel] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Gu, Haiwei] Arizona State Univ, Sch Nutr & Hlth Promot, Coll Hlth Solut, Ctr Metab & Vasc Biol, Phoenix, AZ USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Arizona State University; Arizona State University-Downtown Phoenix	Iritani, BM (corresponding author), Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA.	biritani@uw.edu		Iwata, Terri/0000-0002-6262-1422; Iritani, Brian/0000-0003-1903-7850; Kang, Janella/0000-0002-6960-7922	National Institutes of Health [R01A1114556, R21A110920, R250D010450, R56A1092093]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI092093, R01AI114556] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD021421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health, R01A1114556 (BI), R21A110920 (BI, HP), R250D010450 (BI), R56A1092093 (BI, HP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altobelli E, 2016, J CANCER, V7, P1984, DOI 10.7150/jca.16244; Anders HJ, 2011, KIDNEY INT, V80, P915, DOI 10.1038/ki.2011.217; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Baba M, 2012, BLOOD, V120, P1254, DOI 10.1182/blood-2012-02-410407; Bastola P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070030; Betschinger J, 2013, CELL, V153, P335, DOI 10.1016/j.cell.2013.03.012; Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Buchholz B, 2011, NEPHROL DIAL TRANSPL, V26, P3458, DOI 10.1093/ndt/gfr432; Calvet J P, 1994, Curr Opin Nephrol Hypertens, V3, P340, DOI 10.1097/00041552-199405000-00017; Chapin HC, 2010, J CELL BIOL, V191, P701, DOI 10.1083/jcb.201006173; Chen JD, 2015, KIDNEY INT, V88, P1057, DOI 10.1038/ki.2015.177; Chen JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003581; Cowley BD, 2001, KIDNEY INT, V60, P2087, DOI 10.1046/j.1523-1755.2001.00065.x; Davidow CJ, 1996, KIDNEY INT, V50, P208, DOI 10.1038/ki.1996.304; Distefano G, 2009, MOL CELL BIOL, V29, P2359, DOI 10.1128/MCB.01259-08; Dominissini D, 2016, NATURE, V530, P441, DOI 10.1038/nature16998; Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372; Fragiadaki M, 2017, KIDNEY INT, V91, P575, DOI 10.1016/j.kint.2016.10.039; GARDNER KD, 1991, KIDNEY INT, V39, P718, DOI 10.1038/ki.1991.87; Goncharova EA, 2014, CELL REP, V7, P412, DOI 10.1016/j.celrep.2014.03.025; Grantham JJ, 1996, AM J KIDNEY DIS, V28, P788, DOI 10.1016/S0272-6386(96)90378-9; Gu HW, 2016, ANGEW CHEM INT EDIT, V55, P15646, DOI 10.1002/anie.201609236; Gu HW, 2015, ANAL CHEM, V87, P12355, DOI 10.1021/acs.analchem.5b03812; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hallows KR, 2003, J BIOL CHEM, V278, P998, DOI 10.1074/jbc.M210621200; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Han SH, 2016, J AM SOC NEPHROL, V27, P439, DOI 10.1681/ASN.2014121181; Happe H, 2009, HUM MOL GENET, V18, P2532, DOI 10.1093/hmg/ddp190; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Harris PC, 2014, J CLIN INVEST, V124, P2315, DOI 10.1172/JCI72272; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hartman TR, 2009, HUM MOL GENET, V18, P151, DOI 10.1093/hmg/ddn325; Hasumi H, 2008, GENE, V415, P60, DOI 10.1016/j.gene.2008.02.022; Hasumi H, 2015, P NATL ACAD SCI USA, V112, pE1624, DOI 10.1073/pnas.1419502112; Hasumi H, 2012, JNCI-J NATL CANCER I, V104, P1750, DOI 10.1093/jnci/djs418; Hasumi Y, 2014, HUM MOL GENET, V23, P5706, DOI 10.1093/hmg/ddu286; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hsu WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081701; Hudon V, 2010, J MED GENET, V47, P182, DOI 10.1136/jmg.2009.072009; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Iwata TN, 2016, J IMMUNOL, V197, P2250, DOI 10.4049/jimmunol.1600492; Karihaloo A, 2015, POLYCYSTIC KIDNEY DISEASE, P335; Karihaloo A, 2011, J AM SOC NEPHROL, V22, P1809, DOI 10.1681/ASN.2011010084; Khabibullin D, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12107; King JD, 2009, AM J PHYSIOL-CELL PH, V297, pC94, DOI 10.1152/ajpcell.00677.2008; Klomp JA, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-59; Kongsuphol P, 2009, PFLUG ARCH EUR J PHY, V457, P1071, DOI 10.1007/s00424-008-0577-3; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lal M, 2008, HUM MOL GENET, V17, P3105, DOI 10.1093/hmg/ddn208; Magenheimer BS, 2006, J AM SOC NEPHROL, V17, P3424, DOI 10.1681/ASN.2006030295; Merta M, 1997, BIOCHEM MOL BIOL INT, V41, P619; Montesano R, 2009, AM J PHYSIOL-RENAL, V296, pF446, DOI 10.1152/ajprenal.90415.2008; Mostov KE, 2006, P NATL ACAD SCI USA, V103, P5247, DOI 10.1073/pnas.0601352103; Mrug M, 2008, KIDNEY INT, V73, P63, DOI 10.1038/sj.ki.5002627; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Park H, 2014, P NATL ACAD SCI USA, V111, P7066, DOI 10.1073/pnas.1406473111; Park H, 2012, IMMUNITY, V36, P769, DOI 10.1016/j.immuni.2012.02.019; Park H, 2008, J EXP MED, V205, P2899, DOI 10.1084/jem.20080340; Pavlovich CP, 2002, AM J SURG PATHOL, V26, P1542, DOI 10.1097/00000478-200212000-00002; Pema M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10786; Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Possik E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004273; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Reyes NL, 2015, P NATL ACAD SCI USA, V112, P424, DOI 10.1073/pnas.1413021112; Riwanto M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146654; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schmidt LS, 2015, NAT REV UROL, V12, P558, DOI 10.1038/nrurol.2015.206; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seeger-Nukpezah T, 2015, NAT REV NEPHROL, V11, P515, DOI 10.1038/nrneph.2015.46; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Siggs OM, 2016, P NATL ACAD SCI USA, V113, pE3706, DOI 10.1073/pnas.1607592113; Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165; Sperber H, 2015, NAT CELL BIOL, V17, P1523, DOI 10.1038/ncb3264; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Swenson-Fields KI, 2013, KIDNEY INT, V83, P855, DOI 10.1038/ki.2012.446; Takagi Y, 2008, ONCOGENE, V27, P5339, DOI 10.1038/onc.2008.261; Takiar V, 2011, P NATL ACAD SCI USA, V108, P2462, DOI 10.1073/pnas.1011498108; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TRUDEL M, 1991, KIDNEY INT, V39, P665, DOI 10.1038/ki.1991.80; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; WERDER AA, 1984, J LAB CLIN MED, V103, P399; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x; Yamaguchi T, 2010, AM J PHYSIOL-RENAL, V299, pF944, DOI 10.1152/ajprenal.00387.2010; Yan M, 2016, GENE DEV, V30, P1034, DOI 10.1101/gad.281410.116; Yan M, 2014, J CLIN INVEST, V124, P2640, DOI 10.1172/JCI71749; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014; Zhou J, 2009, HUM MOL GENET, V18, P4428, DOI 10.1093/hmg/ddp398; Zhu JJ, 2014, J PROTEOME RES, V13, P4120, DOI 10.1021/pr500494u	98	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197973	10.1371/journal.pone.0197973	http://dx.doi.org/10.1371/journal.pone.0197973			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897930	Green Published, gold, Green Submitted			2022-12-26	WOS:000435090700036
J	Araya, JF; Newman, WA				Francisco Araya, Juan; Newman, William Anderson			A new deep-sea balanomorph barnacle (Cirripedia: Thoracica: Bathylasmatidae) from Chile	PLOS ONE			English	Article							SALA Y GOMEZ; SOUTHEASTERN PACIFIC; ACORN BARNACLE; 1ST RECORD; SOUTHERN-HEMISPHERE; MOLECULAR PHYLOGENY; NORTHERN; OCEAN; FAMILIES; EASTER	Deep waters of the South Pacific off northern Chile remain poorly studied, particularly in regard to invertebrate faunas. Some recent works include new records on deep-water species, mostly from the bycatch of benthic fisheries concentrated along the continental margin of the country. Among these, a few specimens of an unidentified bathylasmatine balanomorph were collected off Caldera, northern Chile, and they are described here as Bathylasma chilense sp. nov. While this is the second report of a bathylasmatid in the Eastern Pacific Ocean, the first being Tetrachaelasma southwardi Newman & Ross, 1971, it is not only the first but the deepest known (1800-2000 m) species of Bathylasma. Its discovery increases the number of described Bathylasma species to eight, four of which are extant. This is the third deep-water balanomorph cirriped recorded for the region where it may represent an isolate from a West Wind Drift fauna, an immigrant from the western Pacific, or a relict of a once cosmopolitan Paleocene-Eocene fauna now having an amphitropical component.	[Francisco Araya, Juan] Univ Concepcion, Fac Ciencias Zool & Oceanog, Dept Zool, Programa Doctorado Sistemat & Biodiversidad, Concepcion, Chile; [Francisco Araya, Juan] Univ Atacama, Ctr Invest Costeras Univ Atacama CIC UDA, Copiapo, Region De Ataca, Chile; [Newman, William Anderson] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Universidad de Concepcion; Universidad de Atacama; University of California System; University of California San Diego; Scripps Institution of Oceanography	Araya, JF (corresponding author), Univ Concepcion, Fac Ciencias Zool & Oceanog, Dept Zool, Programa Doctorado Sistemat & Biodiversidad, Concepcion, Chile.; Araya, JF (corresponding author), Univ Atacama, Ctr Invest Costeras Univ Atacama CIC UDA, Copiapo, Region De Ataca, Chile.	juan.araya@uda.cl	Araya, Juan Francisco/N-4942-2017; Araya, Juan Francisco/HGV-1247-2022	Araya, Juan Francisco/0000-0002-4087-9641; 				Abbott, 1980, CIRRIPEDIA BARNACLES; Araya Juan Francisco, 2013, Zookeys, P89, DOI 10.3897/zookeys.257.4446; Bage F., 1938, SCI REPORTS C, V2, P5; BUCKERIDGE J S, 1985, Proceedings of the Royal Society of Victoria, V97, P139; Buckeridge J. S., 1983, NZ GEOLOGICAL SURVEY, V50, P1; Buckeridge J.S., 1975, TANE, V21, P121; Buckeridge JS, 2010, ZOOTAXA, P39; Buckeridge JS, 1999, NEW ZEAL J MAR FRESH, V33, P521, DOI 10.1080/00288330.1999.9516897; Chan BKK, 2017, ZOOL J LINN SOC-LOND, V180, P542, DOI 10.1093/zoolinnean/zlw005; DAYTON PK, 1982, J BIOGEOGR, V9, P95, DOI 10.2307/2844695; Manso CLD, 2018, THALASSAS, V34, P93, DOI 10.1007/s41208-017-0042-1; Foster BA, 1978, MARINE FAUNA NZ BARN; Foster BA, 1983, AUSTR MUS MEM, V8, P349; Foster Brain A., 1995, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V17, P163; Araya JF, 2018, MAR BIODIVERS, V48, P1637, DOI 10.1007/s12526-016-0616-9; Araya JF, 2018, MAR BIODIVERS, V48, P1601, DOI 10.1007/s12526-016-0591-1; Araya JF, 2018, ZOOTAXA, V4407, P443, DOI 10.11646/zootaxa.4407.3.11; Araya JF, 2017, ZOOTAXA, V4312, P189, DOI 10.11646/zootaxa.4312.1.11; Araya JF, 2016, GAYANA, V80, P204; Araya JF, 2016, MAR BIODIVERS, V46, P725, DOI 10.1007/s12526-015-0416-7; Araya JF, 2016, ZOOTAXA, V4139, P140, DOI 10.11646/zootaxa.4139.1.11; Hoek PPC, 1913, SIBOGA EXPED, V31b, P129, DOI DOI 10.5962/BHL.TI-TLE.12959; Hoek PPC, 1883, ZOOLOGY, V25, P1; Jones Diana S., 2000, Memoires du Museum National d'Histoire Naturelle, V184, P141; Koci T, 2017, ZOOTAXA, V4294, P181, DOI 10.11646/zootaxa.4294.2.3; NEWMAN W A, 1977, Crustaceana (Leiden), V32, P102, DOI 10.1163/156854077X00953; NEWMAN W.A., 1996, TRAITE ZOOLOGIE, V7, P453; NEWMAN WA, 1987, B MAR SCI, V41, P361; NEWMAN WA, 1983, B MAR SCI, V33, P633; NEWMAN WA, 1993, CRUSTACEAN ISS, V8, P349; Newman WA, 1976, MEM SAN DIEGO SOC NA, V9, P102; Newman WA, 1971, ANTARCTIC RES SERIES, V14; Parin NV, 1997, ADV MAR BIOL, V32, P145; Pilsbry HA., 1916, B US NATN MUS, V93, P1, DOI DOI 10.5479/SI.03629236.93.1; Reiswig HM, 2014, ZOOTAXA, V3889, P414, DOI 10.11646/zootaxa.3889.3.4; ROBERTSON R, 1976, Veliger, V19, P13; ROBERTSON R, 1979, VELIGER, V22, P191; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Tsang LM, 2015, MOL PHYLOGENET EVOL, V82, P324, DOI 10.1016/j.ympev.2014.09.015; Utinomi H., 1965, SCI REPS JAP ANTARCT, P1; Yamaguchi T, 1997, J CRUSTACEAN BIOL, V17, P488, DOI 10.2307/1549443; ZULLO V A, 1979, Southeastern Geology, V20, P229; ZULLO VICTOR A., 1964, PACIFIC SCI, V18, P355	43	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197821	10.1371/journal.pone.0197821	http://dx.doi.org/10.1371/journal.pone.0197821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897932	Green Published, gold, Green Submitted			2022-12-26	WOS:000435090700030
J	Weis, CA; Aban, IB; Cutter, G; Kaminski, HJ; Scharff, C; Griessmann, BW; Deligianni, M; Kayser, K; Wolfe, GI; Strobel, P; Marx, A				Weis, Cleo-Aron; Aban, Inmaculada B.; Cutter, Garry; Kaminski, Henry J.; Scharff, Christoph; Griessmann, Benedict W.; Deligianni, Maria; Kayser, Klaus; Wolfe, Gil, I; Stroebel, Philipp; Marx, Alexander			Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distribution	PLOS ONE			English	Article							INTRATUMOR HETEROGENEITY; TEXTURE ANALYSIS; RELIABILITY; FEATURES; THYMUS	The thymectomy specimens from the "thymectomy trial in non-thymomatous myasthenia gravis patients receiving prednisone therapy" (MGTX) underwent rigid and comprehensive work-up, which permits analysis of the spatial distribution of histological and immunohistological features. This analysis revealed strong intra- and inter-case variability. While many histological features (e.g. median percent fat content among different specimens) can easily be correlated with clinical parameters, intra-case spatial variability of histological features has yet defied quantification and statistical evaluation. To overcome this gap in digital pathology, we here propose intra-case entropy of measured histological features in all available slides of a given thymectomy specimen as a quantitative marker of spatial histological heterogeneity. Calculation of entropy led to one value per specimen and histological feature. Through these 'entropy values' the so far neglected degree of spatial histological heterogeneity could be fed into statistical analyses, extending the scope of clinico-pathological correlations.	[Weis, Cleo-Aron; Scharff, Christoph; Griessmann, Benedict W.; Deligianni, Maria; Marx, Alexander] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, Mannheim, Germany; [Aban, Inmaculada B.; Cutter, Garry] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Kaminski, Henry J.] George Washington Univ, Med Ctr, Dept Neurol, Washington, DC 20037 USA; [Kayser, Klaus] Charite, Inst Pathol, Berlin, Germany; [Wolfe, Gil, I] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurol, Buffalo, NY USA; [Stroebel, Philipp] Univ Gottingen, Univ Med Ctr Gottingen, Inst Pathol, Gottingen, Germany	Ruprecht Karls University Heidelberg; University of Alabama System; University of Alabama Birmingham; George Washington University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Gottingen	Weis, CA (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, Mannheim, Germany.	cleo-aron.weis@medma.uni-heidelberg.de	Cutter, Gary/AAY-5392-2021; Weis, Cleo-Aron/GVT-8400-2022	Cutter, Gary/0000-0002-8455-980X; Kaminski, Henry/0000-0002-8195-0141	National Institute of Neurological Disorders and Stroke (NINDDS), National Institutes of Health; Myasthenia Gravis Foundation of America [U01 NS042685]; MGTX study group; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS042685] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDDS), National Institutes of Health; Myasthenia Gravis Foundation of America; MGTX study group; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke (NINDDS), National Institutes of Health and the Myasthenia Gravis Foundation of America, grant U01 NS042685, the MGTX study group. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, R DOCUMENTATION SHAP; Barohn RJ, 1998, ANN NY ACAD SCI, V841, P769, DOI 10.1111/j.1749-6632.1998.tb11015.x; Besusparis J, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0525-z; Domingos P., 2010, FEW USEFUL THINGS KN; Gonzalez RC, 2013, DIGITAL IMAGE PROCES; Haralick RM, 1973, IEEE T SYSTEMS MAN C; Harte J, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199593415.001.0001; Hastie T, 2013, ELEMENTS STAT LEARNI; Horton N.J., 2015, USING R RSTUDIO DATA; Kayser K., 1987, ACTA STEREOL, V6, P373; Kayser K, 2016, DIAGNOSTIC PATHOLOGY, V2; Kayser K., 1996, ANAL QUANT CYTOL HIS, P18; Kim JH, 2017, RADIOLOGY, V282, P665, DOI 10.1148/radiol.2016160261; Liu LH, 2017, J MAGN RESON IMAGING, V45, P1798, DOI 10.1002/jmri.25460; Mahajan S., 2010, STREET FIGHTING MATH; Marx A, 2012, ANN NY ACAD SCI, V1275, P92, DOI 10.1111/j.1749-6632.2012.06799.x; Morris LGT, 2016, ONCOTARGET, V7, P10051, DOI 10.18632/oncotarget.7067; Nielsen B, 2015, CYTOM PART A, V87A, P315, DOI 10.1002/cyto.a.22601; Park Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37767; Petrolis R, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0389-7; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sharshar T, 2000, J NEUROL, V247, P286, DOI 10.1007/s004150050585; Silva DA, 2013, J BIOMED MATER RES A, V101, P326, DOI 10.1002/jbm.a.34334; STEINMANN GG, 1985, SCAND J IMMUNOL, V22, P563, DOI 10.1111/j.1365-3083.1985.tb01916.x; Strobel P, 2008, J NEUROIMMUNOL, V201, P64, DOI 10.1016/j.jneuroim.2008.06.017; Taylor C.R., 2013, IMMUNOHISTOCHEMICAL, V6th, P36; Thomas MC, 2006, ELEMENTS INFORM THEO; Welsch U, 2010, ROMEIS MIKROSKOPISCH; Wolfe GI, 2016, NEW ENGL J MED, V375, P511, DOI 10.1056/NEJMoa1602489	30	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197435	10.1371/journal.pone.0197435	http://dx.doi.org/10.1371/journal.pone.0197435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897907	Green Published, gold, Green Submitted			2022-12-26	WOS:000435090700014
J	Nanfuka, EK; Kyaddondo, D; Ssali, SN; Asingwire, N				Nanfuka, Esther Kalule; Kyaddondo, David; Ssali, Sarah N.; Asingwire, Narathius			Social capital and resilience among people living on antiretroviral therapy in resource-poor Uganda	PLOS ONE			English	Article							HEALTH-CARE; ADHERENCE; AFRICA	Background Despite the national roll-out of free HIV medicines in Uganda and other sub-Saharan African countries, many HIV positive patients on antiretroviral therapy (ART) are at risk of nonadherence due to poverty and other structural and health system related constraints. However, several patients exhibit resilience by attaining and sustaining high levels of adherence amid adversity. Social capital, defined as resources embedded within social networks, is key in facilitating resilience but the mechanism through which it operates remains understudied. This article provides insights into mechanisms through which social capital enables patients on ART in a resource-poor setting to overcome risk and sustain adherence to treatment. Methodology The article draws from an ethnographic study of 50 adult male and female HIV patients enrolled at two treatment sites in Uganda, 15 of whom were followed-up for an extended period of six months for narrative interviews and observation. The patients were selected purposively on the basis of socio-demographic and treatment related criteria. Findings Social capital protects patients on ART against the risk of non-adherence in three ways. 1) It facilitates access to scarce resources; 2) encourages HIV patients to continue on treatment; and 3) averts risk for non-adherence. Conclusions Social capital is a key resource that can be harnessed to promote resilience among HIV patients in a resource-limited setting amid individual, structural and health system related barriers to ART adherence. Invigoration and maintenance of collectivist norms may however be necessary if its protective benefits are to be fully realized.	[Nanfuka, Esther Kalule; Kyaddondo, David; Asingwire, Narathius] Makerere Univ, Dept Social Work & Social Adm, Kampala, Uganda; [Ssali, Sarah N.] Makerere Univ, Sch Gender & Women Studies, Kampala, Uganda	Makerere University; Makerere University	Nanfuka, EK (corresponding author), Makerere Univ, Dept Social Work & Social Adm, Kampala, Uganda.	esthernanfuka@yahoo.com	SSALI, SARAH/AAT-6884-2021; Nanfuka, Esther/R-8148-2019	SSALI, SARAH/0000-0002-5678-1868; Nanfuka, Esther/0000-0003-1917-0432	Volkswagenstiftung [I/86615]	Volkswagenstiftung(Volkswagen)	The study was funded by Volkswagenstiftung (https://www.volkswagenstiftung.de), Grant number: I/86615 to DK. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKRAH EM, 1993, AIDS CARE, V5, P5, DOI 10.1080/09540129308258580; Basu-Zharku IO., 2011, INQ J, V3, P1; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Bernard RH, 2002, QUALITATIVE QUANTITA; Binagwaho A, 2009, PLOS MED, V6, P10, DOI 10.1371/journal.pmed.1000018; Bourdieu P, 1986, HDB THEORY RES SOCIO, V241, P258; Brown K, 2011, ANNU REV ENV RESOUR, V36, P321, DOI 10.1146/annurev-environ-052610-092905; Bukuluki Paul, 2013, INT LETT SOCIAL HUMA, V5, P27, DOI [DOI 10.18052/www.scipress.com/ILSHS.5.27, DOI 10.18052/WWW.SCIPRESS.COM/ILSHS.5.27]; Carr RL, 2004, J ASSOC NURSE AIDS C, V15, P30, DOI 10.1177/1055329003261981; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Fraser MW, 1999, SOC WORK RES, V23, P131, DOI 10.1093/swr/23.3.131; Gilbert L, 2010, HEALTH SOC CARE COMM, V18, P139, DOI 10.1111/j.1365-2524.2009.00881.x; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Harper R., 2001, SOCIAL CAPITAL REV L; Hawe P, 2000, SOC SCI MED, V51, P871, DOI 10.1016/S0277-9536(00)00067-8; HUI CH, 1988, J RES PERS, V22, P17, DOI 10.1016/0092-6566(88)90022-0; Kunutsor S, 2011, AIDS BEHAV, V15, P1795, DOI 10.1007/s10461-011-9927-9; Liamputtong P, QUALITATIVE RES METH; Lin N, 1999, ANNU REV SOCIOL, V25, P467, DOI 10.1146/annurev.soc.25.1.467; Lin N, 2005, NETWORK THEORY SOCIA; Lin N., 2008, SOCIAL CAPITAL INT R, P1; Mason J., 2002, QUALITATIVE RES; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Muyinda H, 2015, SOC SCI MED, V146, P316, DOI 10.1016/j.socscimed.2015.10.022; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, pS127, DOI 10.1097/01.qai.0000248349.25630.3d; Nachega JB, 2010, CURR OPIN HIV AIDS, V5, P70, DOI 10.1097/COH.0b013e328333ad61; NAFOPHANU, 2013, PEOPL LIV HIV STIGM; O'Laughlin KN, 2012, AIDS BEHAV, V16, P1308, DOI 10.1007/s10461-011-0038-4; Ogden J, 2014, HEALTH POLICY PLANN, V29, P1075, DOI 10.1093/heapol/czt087; Olsson CA, 2003, J ADOLESCENCE, V26, P1, DOI 10.1016/S0140-1971(02)00118-5; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Saleebey D., 2002, STRENGTHS PERSPECTIV, P1; Titeca K, 2008, WORLD DEV, V36, P2205, DOI 10.1016/j.worlddev.2007.10.021; Toomey A, 2008, RESILIENCE THEORY FR; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; Uganda AIDS Commission, 2015, HIV AIDS UG COUNTR P; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; Wong YT., 2001, ASIAN PROFILE, V30, P279; Woolcock M., 2002, SOCIAL CAPITAL POVER, P20	42	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0197979	10.1371/journal.pone.0197979	http://dx.doi.org/10.1371/journal.pone.0197979			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI8PJ	29889849	Green Published, gold, Green Submitted			2022-12-26	WOS:000434786600012
J	Fang, J; Demic, S; Cheng, S				Fang, Jing; Demic, Selver; Cheng, Sen			The reduction of adult neurogenesis in depression impairs the retrieval of new as well as remote episodic memory	PLOS ONE			English	Article							NATIONAL COMORBIDITY SURVEY; SLOW FEATURE ANALYSIS; RAT DENTATE GYRUS; HIPPOCAMPAL NEUROGENESIS; PATTERN SEPARATION; MAJOR DEPRESSION; ANTIDEPRESSANT TREATMENT; AUTOBIOGRAPHICAL MEMORY; RECURRENT DEPRESSION; LATE-LIFE	Major depressive disorder (MDD) is associated with an impairment of episodic memory, but the mechanisms underlying this deficit remain unclear. Animal models of MDD find impaired adult neurogenesis (AN) in the dentate gyrus (DG), and AN in DG has been suggested to play a critical role in reducing the interference between overlapping memories through pattern separation. Here, we study the effect of reduced AN in MDD on the accuracy of episodic memory using computational modeling. We focus on how memory is affected when periods with a normal rate of AN (asymptomatic states) alternate with periods with a low rate (depressive episodes), which has never been studied before. Also, unlike previous models of adult neurogenesis, which consider memories as static patterns, we model episodic memory as sequences of neural activity patterns. In our model, AN adds additional random components to the memory patterns, which results in the decorrelation of similar patterns. Consistent with previous studies, higher rates of AN lead to higher memory accuracy in our model, which implies that memories stored in the depressive state are impaired. Intriguingly, our model makes the novel prediction that memories stored in an earlier asymptomatic state are also impaired by a later depressive episode. This retrograde effect exacerbates with increased duration of the depressive episode. Finally, pattern separation at the sensory processing stage does not improve, but rather worsens, the accuracy of episodic memory retrieval, suggesting an explanation for why AN is found in brain areas serving memory rather than sensory function. In conclusion, while cognitive retrieval biases might contribute to episodic memory deficits in MDD, our model suggests a mechanistic explanation that affects all episodic memories, regardless of emotional relevance.	[Fang, Jing; Cheng, Sen] Ruhr Univ Bochum, Inst Neural Computat, Bochum, Germany; [Fang, Jing; Cheng, Sen] Ruhr Univ Bochum, Mercator Res Grp Struct Memory, Bochum, Germany; [Fang, Jing] Ruhr Univ Bochum, Fac Psychol, Bochum, Germany; [Demic, Selver] St Elizabeth Hosp, Gutersloh, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Cheng, S (corresponding author), Ruhr Univ Bochum, Inst Neural Computat, Bochum, Germany.; Cheng, S (corresponding author), Ruhr Univ Bochum, Mercator Res Grp Struct Memory, Bochum, Germany.	sen.cheng@rub.de	Cheng, Sen/A-5722-2009	Cheng, Sen/0000-0002-6719-8029	German Research Foundation (DFG) [SFB 874, 01GQ1506]; Stiftung Mercator; German Federal Ministry of Education and Research (BMBF) [01GQ1506]	German Research Foundation (DFG)(German Research Foundation (DFG)); Stiftung Mercator; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Research Foundation (DFG) through the SFB 874 project B2, grant 01GQ1506 and a grant from the Stiftung Mercator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sonakchhi Shrestha for support in performing the computer simulations. This work was supported by grants from the Stiftung Mercator, from the German Research Foundation (DFG) through the SFB 874, project B2, and from the German Federal Ministry of Education and Research (BMBF), grant 01GQ1506.	Aimone JB, 2011, EUR J NEUROSCI, V33, P1160, DOI 10.1111/j.1460-9568.2011.07615.x; Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Amaral D., 2006, HIPPOCAMPUS BOOK, VVolume 1, P37, DOI DOI 10.1093/ACPROF:OSO/9780195100273.001.0001; Azizi AH, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00161; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; Becker S, 2007, TRENDS COGN SCI, V11, P70, DOI 10.1016/j.tics.2006.10.013; Bierman EJM, 2005, AM J GERIAT PSYCHIAT, V13, P686, DOI 10.1176/appi.ajgp.13.8.686; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Boldrini M, 2013, NEUROPSYCHOPHARMACOL, V38, P1068, DOI 10.1038/npp.2013.5; Brunet J, 2011, J INT NEUROPSYCH SOC, V17, P865, DOI 10.1017/S1355617711000877; Burt DB, 1995, PSYCHOL B; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Chambers RA, 2007, J COGNITIVE NEUROSCI, V19, P1, DOI 10.1162/jocn.2007.19.1.1; Cheng S, 2017, STUD NEUROSCI, P57, DOI 10.1007/978-3-319-45066-7_4; Cheng S, 2016, NEUROSCI BIOBEHAV R, V60, P82, DOI 10.1016/j.neubiorev.2015.11.011; Cheng S, 2016, SYNTHESE, V193, P1345, DOI 10.1007/s11229-014-0628-6; Cheng S, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00088; Clark L, 2009, ANNU REV NEUROSCI, V32, P57, DOI 10.1146/annurev.neuro.31.060407.125618; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Conway M.A., 2008, LEARNING MEMORY COMP, P893, DOI 10.1016/B978-012370509-9.00135-2; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Crick C, 2006, BIOL CYBERN, V94, P9, DOI 10.1007/s00422-005-0026-8; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Demic S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110358; Dere E, 2010, BEHAV BRAIN RES, V215, P162, DOI 10.1016/j.bbr.2010.03.017; Dery N, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00066; Dranovsky A, 2011, NEURON, V70, P908, DOI 10.1016/j.neuron.2011.05.022; Fang J, 2018, NEURAL COMPUT, V30, P293, DOI 10.1162/neco_a_01044; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Fossati P, 2004, J PSYCHIATR RES, V38, P137, DOI 10.1016/j.jpsychires.2003.08.002; Franzius M, 2011, NEURAL COMPUT, V23, P2289, DOI 10.1162/NECO_a_00171; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Grant MM, 2001, BIOL PSYCHIAT, V50, P35, DOI 10.1016/S0006-3223(00)01072-6; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Huang YS, 2013, BIOL PSYCHIAT, V74, P62, DOI 10.1016/j.biopsych.2013.01.005; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Kesner RP, 2004, REV NEUROSCIENCE, V15, P333; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Luu P, 2012, BEHAV NEUROSCI, V126, P381, DOI 10.1037/a0028252; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Meltzer LA, 2005, TRENDS NEUROSCI, V28, P653, DOI 10.1016/j.tins.2005.09.007; Neher T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004250; Pantel J, 1997, J AFFECT DISORDERS, V42, P69, DOI 10.1016/S0165-0327(96)00105-X; Perera TD, 2007, J NEUROSCI, V27, P4894, DOI 10.1523/JNEUROSCI.0237-07.2007; Perera TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017600; Petrik D, 2012, NEUROPHARMACOLOGY, V62, P21, DOI 10.1016/j.neuropharm.2011.09.003; Pham K, 2003, EUR J NEUROSCI, V17, P879, DOI 10.1046/j.1460-9568.2003.02513.x; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Shelton DJ, 2013, BEHAV BRAIN RES, V256, P20, DOI 10.1016/j.bbr.2013.08.016; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Soderlund H, 2014, J ABNORM PSYCHOL, V123, P51, DOI 10.1037/a0035610; Spinhoven P, 2006, J ABNORM PSYCHOL, V115, P590, DOI 10.1037/0021-843X.115.3.590; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Van Bokhoven P, 2011, EUR J NEUROSCI, V33, P1833, DOI 10.1111/j.1460-9568.2011.07668.x; van der Werf SY, 2006, ARCH GEN PSYCHIAT, V63, P509, DOI 10.1001/archpsyc.63.5.509; van Eijndhoven P, 2013, HUM BRAIN MAPP, V34, P283, DOI 10.1002/hbm.21439; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; Weisz VI, 2012, COGNITION, V125, P13, DOI 10.1016/j.cognition.2012.07.002; Weisz VI, 2009, COGNITION, V112, P229, DOI 10.1016/j.cognition.2009.05.001; Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Wiskott L, 2002, NEURAL COMPUT, V14, P715, DOI 10.1162/089976602317318938; Zakzanis KK, 1998, NEUROPSY NEUROPSY BE, V11, P111; Zito Tiziano, 2008, Front Neuroinform, V2, P8, DOI 10.3389/neuro.11.008.2008; ZUBENKO GS, 1990, ARCH NEUROL-CHICAGO, V47, P1107, DOI 10.1001/archneur.1990.00530100075016	79	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198406	10.1371/journal.pone.0198406	http://dx.doi.org/10.1371/journal.pone.0198406			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI5BF	29879169	Green Published, Green Submitted, gold			2022-12-26	WOS:000434384900040
J	Lee, K; Choi, JH; Lee, S; Park, HJ; Oh, YJ; Kim, GB; Lee, WS; Son, BS				Lee, Kyoungho; Choi, Jae-Hyun; Lee, Seokwon; Park, Hee-Jin; Oh, Yu-Jin; Kim, Geun-Bae; Lee, Woo-Seok; Son, Bu-Soon			Indoor levels of volatile organic compounds and formaldehyde from emission sources at elderly care centers in Korea	PLOS ONE			English	Article							AIR-QUALITY; RESPIRATORY HEALTH; HOMES; POLLUTION; URBAN; VOC; IDENTIFICATION; DETERMINANTS; BUILDINGS; MICROCOSM	The objective of this study is to characterize indoor and outdoor levels of volatile organic compounds (VOCs) and formaldehyde (HCHO) and identify indoor emission sources in thirty elderly care centers (ECCs) located in the Seoul metropolitan city and Gyeonggi province in Korea. Air monitoring samples from indoor and outdoor environments were collected from January to December in 2007. Statistical analyses of indoor and outdoor VOCs and HCHO levels in three rooms (a bedroom, living, and dining rooms) of each ECC were performed, and these were compared to identify environmental factors associated with an increase of indoor pollution levels. Total volatile organic compounds (TVOC) levels were significantly (p<0.05) different between indoor (230.7 +/- 1.7 mu g/m(3)) and outdoor (137.8 +/- 1.9 mu g/m(3)) environments, with an I/O ratio of 1.67. The indoor HCHO level (20.1 +/- 1.6 mu g/m(3)) was significantly (p<0.05) higher than the outdoor level (8.1 +/- 1.9 mu g/m(3)), with an I/O ratio of 2.48. Indoor VOCs and HCHO levels in the bedrooms were significantly (p<0.05) higher than those in the living and dining rooms. Furthermore, indoor levels of VOCs and HCHO at ECCs were significantly (p<0.05) different depending on environmental factors such as the use of carpet, paint, and wooden furniture. In multiple regression analysis, indoor VOCs and HCHO levels at ECCs were significantly (p<0.05) correlated with two micro-environmental factors: the use of carpet and paint. This study confirmed that indoor VOCs and HCHO levels were significantly higher than those in outdoor environments. These air pollutants were mainly emitted from indoor sources, such as carpet, paint, and construction materials at the ECCs in Korea.	[Lee, Kyoungho; Lee, Seokwon] Samsung Elect Co Ltd, Samsung Hlth Res Inst, Hwaseong, South Korea; [Choi, Jae-Hyun; Park, Hee-Jin; Oh, Yu-Jin; Son, Bu-Soon] Soonchunhyang Univ, Dept Environm Hlth Sci, Asan, South Korea; [Kim, Geun-Bae; Lee, Woo-Seok] Natl Inst Environm Res, Environm Hlth Res Div, Incheon, South Korea	Samsung; Soonchunhyang University; National Institute of Environmental Research (NIER), Republic of Korea	Son, BS (corresponding author), Soonchunhyang Univ, Dept Environm Hlth Sci, Asan, South Korea.	sonbss@sch.ac.kr		Lee, Seokwon/0000-0001-6405-3150; Lee, Kyoungho/0000-0003-2353-2547	Soonchunhyang University Research Fund	Soonchunhyang University Research Fund	The study was primarily supported by the Soonchunhyang University Research Fund, and JHC, HJP, YJO recevied a salary from Soonchunhyang University. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to pulish, or preparation of the manuscript.; This work was supported by the Soonchunhyang University Research Fund.	Bentayeb M, 2015, EUR RESPIR J, V45, P1228, DOI 10.1183/09031936.00082414; Brunekreef Bert, 2005, Res Rep Health Eff Inst, P1; Campagnolo D, 2017, BUILD ENVIRON, V115, P18, DOI 10.1016/j.buildenv.2017.01.009; Cattaneo A, 2016, ENVIRON POLLUT, V218, P16, DOI 10.1016/j.envpol.2016.08.033; Cho E, 2011, ANN REPORT BUSAN MET, V20, P122; Clarisse B, 2003, ENVIRON RES, V92, P245, DOI 10.1016/S0013-9351(03)00039-2; Guo H, 2009, INDOOR AIR, V19, P206, DOI 10.1111/j.1600-0668.2008.00580.x; Habre R, 2014, J EXPO SCI ENV EPID, V24, P269, DOI 10.1038/jes.2013.74; Hodgson M, 2002, ENVIRON HEALTH PERSP, V110, P663, DOI 10.1289/ehp.02110s4663; Hoskins JA, 2003, INDOOR BUILT ENVIRON, V12, P427, DOI 10.1177/1420326X03037109; Jia C, 2008, ATMOS ENVIRON, V42, P2101, DOI 10.1016/j.atmosenv.2007.11.047; Jones AP, 1999, ATMOS ENVIRON, V33, P4535, DOI 10.1016/S1352-2310(99)00272-1; Kabir E, 2012, ENVIRON MONIT ASSESS, V184, P6395, DOI 10.1007/s10661-011-2428-5; Katsoyiannis A, 2008, J HAZARD MATER, V152, P669, DOI 10.1016/j.jhazmat.2007.07.058; Kim SD, 2002, STUDY INDOOR AIR POL; Kim SS, 2008, BUILD ENVIRON, V43, P320, DOI 10.1016/j.buildenv.2006.03.026; Larsen RK, 2003, ENVIRON SCI TECHNOL, V37, P1873, DOI 10.1021/es0206184; Lee SY, 2013, ASIA PAC ALLERGY, V3, P145, DOI [10.5415/apallergy.2013.3.3.145, 10.5415/apallergy.2013.3.1.15]; Lim Y-W, 2008, J KOREAN SOC INDOOR, V35, P37; Liu YJ, 2007, ATMOS ENVIRON, V41, P650, DOI 10.1016/j.atmosenv.2006.08.001; Mendes A, 2013, J TOXICOL ENV HEAL A, V76, P333, DOI 10.1080/15287394.2013.757213; Orwell RL, 2004, WATER AIR SOIL POLL, V157, P193, DOI 10.1023/B:WATE.0000038896.55713.5b; Park H, 2010, J KOREAN SOC ENV ADM, V16, P53; Park JS, 2006, INDOOR AIR, V16, P129, DOI 10.1111/j.1600-0668.2005.00408.x; Sim Sanghyo, 2010, Toxicology and Environmental Health Sciences, V2, P263; Simoni M, 2003, EUR RESPIR J, V21, p15S, DOI 10.1183/09031936.03.00403603; Son B, 2003, ENVIRON INT, V29, P79, DOI 10.1016/S0160-4120(02)00148-4; Tunsaringkarn T, 2015, AIR QUAL ATMOS HLTH, V8, P603, DOI 10.1007/s11869-014-0302-7; Walgraeve C, 2011, ATMOS ENVIRON, V45, P5828, DOI 10.1016/j.atmosenv.2011.07.007; Wood RA, 2006, WATER AIR SOIL POLL, V175, P163, DOI 10.1007/s11270-006-9124-z; Yang J, 2015, ATMOS POLLUT RES, V6, P1113, DOI 10.1016/j.apr.2015.06.009; Yoon HI, 2010, EUR RESPIR J, V36, P1270, DOI 10.1183/09031936.00153509; Zhang JF, 2003, BRIT MED BULL, V68, P209, DOI 10.1093/bmb/ldg029; 서병량, 2006, [JOURNAL OF ENVIRONMENTAL HEALTH SCIENCES, 한국환경보건학회지], V32, P387	34	14	14	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0197495	10.1371/journal.pone.0197495	http://dx.doi.org/10.1371/journal.pone.0197495			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879122	gold, Green Submitted, Green Published			2022-12-26	WOS:000434384900006
J	Yu, DL; Wen, ZG; Li, XM; Song, XJ; Wu, HJ; Yang, PL				Yu, Dali; Wen, Zhiguo; Li, Xiumei; Song, Xiaojun; Wu, Huijun; Yang, Peilong			Effects of straw return on bacterial communities in a wheat-maize rotation system in the North China Plain	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITY; ORGANIC-CARBON FRACTIONS; RICE ROTATION; BLACK SOIL; MANAGEMENT; DIVERSITY; FERTILIZATION; DYNAMICS; TILLAGE; IMPACTS	Straw return plays an important role in reducing the use of chemical fertilizer, promoting soil carbon sequestration, thus maintaining soil fertility and alleviating environmental pollution. To examine the effects of straw return on soil bacterial communities, quantitative PCR and high-throughput sequencing approaches were used to analyze the bacterial abundance and community structures at the depths of 5-25 cm and 25-45 cm in the soils under six-year continuous straw return and removal treatments in Langfang, Hebei, the North China Plain. As a result, straw return had no effects on soil chemical properties, bacterial abundance, richness or diversity at both soil depths. In contrast, vertical distributions of available nitrogen and available potassium were affected. Similarly, straw return also changed the vertical distributions of Proteobacteria and Chloroflexi. Principal coordinate analysis based on weighted UniFrac distance matrix indicated a moderate separation of the bacterial community in the soil treated with straw return from that with straw removal at 5-25 cm depth, but they were not distinctly distinguished at 25-45 cm depth. T-test identified increased abundance of Candidatus Latescibacteria in the soil under straw return treatment at 5-25 cm depth but no differentially abundant phyla at 25-45 cm depth was found. These results suggested a selection effect from the six-year continuous straw return treatment and the soil bacterial communities were moderately changed.	[Yu, Dali; Wen, Zhiguo; Li, Xiumei; Yang, Peilong] Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing, Peoples R China; [Yu, Dali] Qilu Normal Univ, Sch Life Sci, Jinan, Shandong, Peoples R China; [Song, Xiaojun; Wu, Huijun] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Qilu Normal University; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS	Yang, PL (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing, Peoples R China.; Wu, HJ (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing, Peoples R China.	hjwu@caas.ac.cn; yangpeilong@caas.cn	li, xiu/GXV-1745-2022	Song, Xiaojun/0000-0002-7971-9696	Chinese Agricultural Science and Technology Innovation Program [ASTIPERI07, CMS-XTCX2016011-04-3]	Chinese Agricultural Science and Technology Innovation Program	This work was supported by the Chinese Agricultural Science and Technology Innovation Program (ASTIPERI07 and CMS-XTCX2016011-04-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, METHODS SOIL ANAL 3; [Anonymous], 1954, 34 USDA; Bach EM, 2010, SOIL BIOL BIOCHEM, V42, P2182, DOI 10.1016/j.soilbio.2010.08.014; Buyer JS, 2010, SOIL BIOL BIOCHEM, V42, P831, DOI 10.1016/j.soilbio.2010.01.020; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carbonetto B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099949; Chen ZM, 2017, SOIL TILL RES, V165, P121, DOI 10.1016/j.still.2016.07.018; CORNFIELD AH, 1960, NATURE, V187, P260, DOI 10.1038/187260a0; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Farag IF, 2017, APPL ENVIRON MICROB, P83; Figuerola ELM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051075; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Guo LJ, 2015, BIOL FERT SOILS, V51, P65, DOI 10.1007/s00374-014-0951-6; Guo LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33155; Guo ZB, 2017, J SCI FOOD AGR, V97, P3333, DOI 10.1002/jsfa.8183; He J, 2011, SOIL TILL RES, V113, P48, DOI 10.1016/j.still.2011.01.005; Hernandez-Raquet G, 2006, FEMS MICROBIOL ECOL, V58, P550, DOI 10.1111/j.1574-6941.2006.00187.x; Ikenaga M, 2010, MICROB ECOL, V59, P284, DOI 10.1007/s00248-009-9572-2; Kennedy AC, 1999, AGR ECOSYST ENVIRON, V74, P65, DOI 10.1016/S0167-8809(99)00030-4; Kormas KA, 2008, GEOBIOLOGY, V6, P450, DOI 10.1111/j.1472-4669.2008.00172.x; Lehtinen T, 2014, SOIL USE MANAGE, V30, P524, DOI 10.1111/sum.12151; Lei YP, 2017, J MICROBIOL, V55, P349, DOI 10.1007/s12275-017-6242-9; Li F, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00187; Liu C, 2014, GLOBAL CHANGE BIOL, V20, P1366, DOI 10.1111/gcb.12517; Luo XS, 2017, J BASIC MICROB, V57, P309, DOI 10.1002/jobm.201600400; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marschner P, 2011, SOIL BIOL BIOCHEM, V43, P445, DOI 10.1016/j.soilbio.2010.11.015; Navarro-Noya YE, 2013, SOIL BIOL BIOCHEM, V65, P86, DOI 10.1016/j.soilbio.2013.05.009; Pereira AD, 2014, BIORESOURCE TECHNOL, V166, P103, DOI 10.1016/j.biortech.2014.05.043; Poll C, 2008, SOIL BIOL BIOCHEM, V40, P1306, DOI 10.1016/j.soilbio.2007.04.002; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shen JP, 2010, APPL SOIL ECOL, V46, P119, DOI 10.1016/j.apsoil.2010.06.015; Sun JF, 2016, J CLEAN PROD, V112, P2625, DOI 10.1016/j.jclepro.2015.09.112; Tardy V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130672; Wang JH, 2015, NUTR CYCL AGROECOSYS, V102, P371, DOI 10.1007/s10705-015-9710-9; Yakimov MM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03554; Yin C, 2015, APPL MICROBIOL BIOT, V99, P5719, DOI 10.1007/s00253-015-6461-0; Zhang FS, 2011, J ENVIRON QUAL, V40, P1051, DOI 10.2134/jeq2010.0292; Zhang Y, 2014, AM J INFECT CONTROL, V42, P815, DOI 10.1016/j.ajic.2014.03.015; Zhao SC, 2016, AGR ECOSYST ENVIRON, V216, P82, DOI 10.1016/j.agee.2015.09.028; Zhou J, 2015, SOIL BIOL BIOCHEM, V90, P42, DOI 10.1016/j.soilbio.2015.07.005; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	44	18	27	17	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198087	10.1371/journal.pone.0198087	http://dx.doi.org/10.1371/journal.pone.0198087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879153	Green Submitted, Green Published, gold			2022-12-26	WOS:000434384900019
J	Silva, MA; Ryall, KA; Wilm, C; Caldara, J; Grote, HJ; Patterson-Kane, JC				Silva, Manuel A.; Ryall, Karen A.; Wilm, Claudia; Caldara, Jenifer; Grote, Hans Juergen; Patterson-Kane, Janet C.			PD-L1 immunostaining scoring for non-small cell lung cancer based on immunosurveillance parameters	PLOS ONE			English	Article							T-CELLS; EXPRESSION; MICROENVIRONMENT; ACTIVATION	Non-Small Cell Lung Cancer (NSCLC) is the leading cause of cancer death globally, and new immunotherapies developed and under development targeting PD-1/PD-L1 checkpoint inhibition require accurate patient selection to assure good clinical outcome. PD-L1 immunohistochemistry is the current biomarker assay used for patient selection, but still imprecise in predicting therapy response. Exploring this issue, we performed computational tissue analysis of PD-L1 immunostaining in procured NSCLC tissues (n = 50) using the Merck KGaA anti-PD-L1 clone MKP1A07310. Staining patterns and PD-L1 cut-off points were interrogated using relevant cancer immune-surveillance biomarkers. Groups with high PD-L1 expression levels (above 25/50% staining cut-off points) were enriched for a biomarker profile in the tumor-nest and microenvironment indicating escape from host-immunity, as represented by increased numbers of cells positive for CD8 and Granzyme B (immuneeffectors), FOXP3 (immune-suppressive), and CD68 (P< 0.05). Manual analysis of PD-L1 staining patterns identified tumors with an immune-induced reactive pattern relevant for immunotherapy that would ordinarily be excluded by the arbitrary 25% staining threshold (P < 0.05). Conversely, some cases with completely or predominantly immune-independent constitutive PD-L1 staining patterns that indicate insensitivity to immunotherapy may have been incorrectly selected using this staining cut-off point criterion. Therefore, we propose differentiation of reactive vs constitutive PD-L1 staining patterns to improve the accuracy of this biomarker assay in selecting NSCLC patients for PD-1/PD-L1 immunotherapy.	[Silva, Manuel A.; Wilm, Claudia; Grote, Hans Juergen] Merck KGaA, Dept Clin Biomarkers & Compan Diagnost, Darmstadt, Germany; [Ryall, Karen A.; Caldara, Jenifer; Patterson-Kane, Janet C.] Flagship Biosci Inc, Dept Pathol, Westminster, CO USA	Merck KGaA	Silva, MA (corresponding author), Merck KGaA, Dept Clin Biomarkers & Compan Diagnost, Darmstadt, Germany.	manuel.silva@merckgroup.com		Patterson-Kane, Janet/0000-0002-9094-1263	Merck KGaA; Flagship Biosciences Inc.	Merck KGaA(Merck & Company); Flagship Biosciences Inc.	This work was funded by Merck KGaA. The funder provided support in the form of salaries for authors MAS, CW, and HJG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Flagship Biosciences Inc. provided support in the form of salaries for authors KAR, JC and JCPK but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; Droeser RA, 2013, EUR J CANCER, V49, P2233, DOI 10.1016/j.ejca.2013.02.015; Dustin ML, 2014, CANCER IMMUNOL RES, V2, P1023, DOI 10.1158/2326-6066.CIR-14-0161; Feng Z, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.e20581; Ferenbach D, 2008, KIDNEY INT, V74, P5, DOI 10.1038/ki.2008.189; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; Grigg C, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0153-x; Gulley JL, 2017, LANCET ONCOL, V18, P599, DOI 10.1016/S1470-2045(17)30240-1; He Haiyang, 2017, Zhongguo Fei Ai Za Zhi, V20, P293, DOI 10.3779/j.issn.1009-3419.2017.05.01; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Ilie M, 2016, VIRCHOWS ARCH, V468, P511, DOI 10.1007/s00428-016-1910-4; Jiang Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.162; Lee Y., 2013, ADV BIOSCI BIOTECHNO, V4, P19, DOI [10.4236/abb.2013.48A3003, DOI 10.4236/ABB.2013.48A3003]; Lipson EJ, 2013, CANCER IMMUNOL RES, V1, P54, DOI 10.1158/2326-6066.CIR-13-0034; Mu CY, 2011, MED ONCOL, V28, P682, DOI 10.1007/s12032-010-9515-2; Nazareth MR, 2007, J IMMUNOL, V178, P5552, DOI 10.4049/jimmunol.178.9.5552; Nowacki TM, 2007, CELL IMMUNOL, V247, P36, DOI 10.1016/j.cellimm.2007.07.004; Parra ER, 2016, CLIN CANCER RES, V22, P6278, DOI 10.1158/1078-0432.CCR-15-2443; Prado-Garcia H, 2017, CANCER IMMUNOL IMMUN, V66, P765, DOI 10.1007/s00262-017-1979-x; Ribas A, 2016, J EXP MED, V213, P2835, DOI 10.1084/jem.20161462; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Schalper KA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju435; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Spranger S, 2016, INT IMMUNOL, V28, P383, DOI 10.1093/intimm/dxw014; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Teng FF, 2016, ONCOTARGET, V7, P64318, DOI 10.18632/oncotarget.11793; Teng MWL, 2015, CANCER RES, V75, P2139, DOI 10.1158/0008-5472.CAN-15-0255; Velcheti V, 2014, LAB INVEST, V94, P107, DOI 10.1038/labinvest.2013.130; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284	32	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0196464	10.1371/journal.pone.0196464	http://dx.doi.org/10.1371/journal.pone.0196464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874226	Green Submitted, Green Published, gold			2022-12-26	WOS:000434369400003
J	Deshpande, NR; Uhrlaub, JL; Way, SS; Nikolich-Zugich, J; Kuhns, MS				Deshpande, Neha R.; Uhrlaub, Jennifer L.; Way, Sing Sing; Nikolich-Zugich, Janko; Kuhns, Michael S.			A disconnect between precursor frequency, expansion potential, and site-specific CD4(+) T cell responses in aged mice	PLOS ONE			English	Article							WEST-NILE-VIRUS; REPERTOIRE DIVERSITY; ANTIGEN PRESENTATION; POSITIVE SELECTION; IMMUNE-SYSTEM; INFECTION; ENCEPHALITIS; GENERATION; PROTECTION; FOREIGN	T cell recognition of peptides presented within self-major histocompatibility complex (pMHC) molecules is essential for long-lived protective immunity. As mice age the number of naive CD4(+) and CD8(+) T cells declines. However, unlike for CD8(+) T cells, there are more naive and memory phenotype CD4(+) T cells that bind foreign pMHCII in old mice (18-22 months) than adults (12-15 weeks), suggesting increased promiscuity of pMHCII recognition with aging. Here we asked if CD4(+) T cell responses to immunization or infection increase with aging since the magnitude of a CD4(+) T cell response to a foreign pMHCII is proportional to the size of the precursor population in adult mice. We observed no difference in the number of pMHCII-specific CD4(+) T cells in adult versus old mice for pooled secondary lymphoid organs after immunization, bacterial infection, or viral infection, but we did observe diminished numbers of pMHCII-specific CD4(+) T cells in both the draining lymph node and brain of old mice after West Nile virus infection. These data indicate that an increased precursor frequency does not translate into more robust responses upon immunization or infection in old mice.	[Deshpande, Neha R.; Uhrlaub, Jennifer L.; Nikolich-Zugich, Janko; Kuhns, Michael S.] Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85721 USA; [Deshpande, Neha R.; Uhrlaub, Jennifer L.; Nikolich-Zugich, Janko; Kuhns, Michael S.] Univ Arizona, Coll Med, BIO Inst 5, Tucson, AZ 85721 USA; [Deshpande, Neha R.; Uhrlaub, Jennifer L.; Nikolich-Zugich, Janko; Kuhns, Michael S.] Univ Arizona, Coll Med, Arizona Ctr Aging, Tucson, AZ 85721 USA; [Way, Sing Sing] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA	University of Arizona; University of Arizona; University of Arizona; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Nikolich-Zugich, J; Kuhns, MS (corresponding author), Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85721 USA.; Nikolich-Zugich, J; Kuhns, MS (corresponding author), Univ Arizona, Coll Med, BIO Inst 5, Tucson, AZ 85721 USA.; Nikolich-Zugich, J; Kuhns, MS (corresponding author), Univ Arizona, Coll Med, Arizona Ctr Aging, Tucson, AZ 85721 USA.	nikolich@email.arizona.edu; mkuhns@email.arizona.edu		Kuhns, Michael/0000-0002-0403-6313; Uhrlaub, Jennifer/0000-0002-7745-0179	NIH/NIAID [HHSN272201100017C]; Pew Charitable Trusts; UACC/ALR Cytometry Core Facility; Cancer Center Support Grant [CCSG-CA 023074]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP1AI131080, R01AI101053] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pew Charitable Trusts; UACC/ALR Cytometry Core Facility; Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the following: NIH/NIAID HHSN272201100017C to MSK and JNZ; Pew Charitable Trusts to MSK; and UACC/ALR Cytometry Core Facility and the Cancer Center Support Grant (CCSG-CA 023074).	Blair DA, 2007, P NATL ACAD SCI USA, V104, P15045, DOI 10.1073/pnas.0703767104; Brien JD, 2009, J EXP MED, V206, P2735, DOI 10.1084/jem.20090222; Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568; Chambers TJ, 2003, J VIROL, V77, P3655, DOI 10.1128/JVI.77.6.3655-3668.2003; Decman V, 2012, J IMMUNOL, V188, P1933, DOI 10.4049/jimmunol.1101098; Deshpande NR, 2015, ELIFE, V4, DOI 10.7554/eLife.05949; Ertelt JM, 2009, J IMMUNOL, V182, P3032, DOI 10.4049/jimmunol.0803402; Hayes CG, 2001, ANN NY ACAD SCI, V951, P25; Haynes L, 1999, J EXP MED, V190, P1013, DOI 10.1084/jem.190.7.1013; Haynes L, 2003, P NATL ACAD SCI USA, V100, P15053, DOI 10.1073/pnas.2433717100; Haynes L, 2009, CURR OPIN IMMUNOL, V21, P414, DOI 10.1016/j.coi.2009.05.009; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387; Li G, 2012, AGING CELL, V11, P968, DOI 10.1111/j.1474-9726.2012.00867.x; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Martinet KZ, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-8; Maue AC, 2009, TRENDS IMMUNOL, V30, P301, DOI 10.1016/j.it.2009.04.007; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Murray K, 2006, EPIDEMIOL INFECT, V134, P1325, DOI 10.1017/S0950268806006339; Nelson RW, 2015, IMMUNITY, V42, P95, DOI 10.1016/j.immuni.2014.12.022; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x; Nishioka T, 2006, J IMMUNOL, V176, P6586, DOI 10.4049/jimmunol.176.11.6586; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Richner JM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005027; Rudd BD, 2011, P NATL ACAD SCI USA, V108, P13694, DOI 10.1073/pnas.1107594108; Rudd BD, 2010, J IMMUNOL, V184, P2958, DOI 10.4049/jimmunol.0903493; Smithey MJ, 2012, J IMMUNOL, V189, P5356, DOI 10.4049/jimmunol.1201867; Smithey MJ, 2011, EUR J IMMUNOL, V41, P1352, DOI 10.1002/eji.201041141; Uhrlaub JL, 2017, J IMMUNOL, V199, P403, DOI 10.4049/jimmunol.1700625; Uhrlaub JL, 2011, J IMMUNOL, V186, P3882, DOI 10.4049/jimmunol.1002799; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Vrisekoop N, 2014, IMMUNITY, V41, P181, DOI 10.1016/j.immuni.2014.07.007; Wong C, 2013, CURR OPIN IMMUNOL, V25, P535, DOI 10.1016/j.coi.2013.05.016; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198354	10.1371/journal.pone.0198354	http://dx.doi.org/10.1371/journal.pone.0198354			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864157	Green Published, Green Submitted, gold			2022-12-26	WOS:000434097100029
J	Serandour, AA; Mohammed, H; Miremadi, A; Mulder, KW; Carroll, JS				Serandour, A. A.; Mohammed, H.; Miremadi, A.; Mulder, K. W.; Carroll, J. S.			TRPS1 regulates oestrogen receptor binding and histone acetylation at enhancers	ONCOGENE			English	Article							BREAST-CANCER; THERAPY; FOXA1; TRANSCRIPTION; INTEGRATION; INHIBITORS; COMPLEXES; PROTEINS; REVEALS; TARGET	The chromatin state is finely tuned to regulate function and specificity for transcription factors such as oestrogen receptor alpha (ER), which contributes to cell growth in breast cancer. ER transcriptional potential is mediated, in large part, by the specific associated proteins and co-factors that interact with it. Despite the identification and characterisation of several ER coregulators, a complete and systematic view of ER-regulating chromatin modifiers is lacking. By exploiting a focused siRNA screen that investigated the requirement for a library of 330 chromatin regulators in ER-mediated cell growth, we find that the NuRD and coREST histone deacetylation complexes are critical for breast cancer cell proliferation. Further, by proteomic and genomics approaches, we discover the transcription factor TRPS1 to be a key interactor of the NuRD and coREST complexes. Interestingly, TRPS1 gene amplification occurs in 28% of human breast tumours and is associated with poor prognosis. We propose that TRPS1 is required to repress spurious binding of ER, where it contributes to the removal of histone acetylation. Our data suggest that TRPS1 is an important ER-associated transcriptional repressor that regulates cell proliferation, chromatin acetylation and ER binding at the chromatin of cis-regulatory elements.	[Serandour, A. A.; Mohammed, H.; Miremadi, A.; Mulder, K. W.; Carroll, J. S.] Univ Cambridge, Cambridge Inst, Canc Res UK, Robinson Way, Cambridge CB2 0RE, England; [Serandour, A. A.] Univ Nantes, CRCINA, INSERM, CNRS,Univ Angers, Nantes, France; [Serandour, A. A.] Ecole Cent Nantes, Nantes, France; [Mohammed, H.] Oregon Hlth & Sci Univ, Knight Canc Early Detect Adv Res Ctr, Portland, OR 97201 USA; [Mulder, K. W.] Radboud Univ Nijmegen, Fac Sci, Radboud Inst Mol Life Sci, Dept Mol Dev Biol, Nijmegen, Netherlands	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Universite d'Angers; Nantes Universite; Ecole Centrale de Nantes; Oregon Health & Science University; Radboud University Nijmegen	Mulder, KW; Carroll, JS (corresponding author), Univ Cambridge, Cambridge Inst, Canc Res UK, Robinson Way, Cambridge CB2 0RE, England.; Mulder, KW (corresponding author), Radboud Univ Nijmegen, Fac Sci, Radboud Inst Mol Life Sci, Dept Mol Dev Biol, Nijmegen, Netherlands.	k.mulder@science.ru.nl; jason.carroll@cruk.cam.ac.uk	Serandour, Aurelien/AAG-7036-2019	Serandour, Aurelien/0000-0001-5253-9567; Carroll, Jason/0000-0003-3643-0080	ERC; Komen Scholar Award; University of Cambridge; Cancer Research UK; Hutchison Whampoa Limited	ERC(European Research Council (ERC)European Commission); Komen Scholar Award; University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); Hutchison Whampoa Limited	We would like to thank Clive D'Santos and Chris Taylor from the CRUK CI Proteomics core, James Hadfield and the other members of the Genomics core, and Suraj Menon from the Bioinformatics core. Jason Carroll is supported by an ERC Consolidator grant and a Komen Scholar Award. We would like to acknowledge the support of the University of Cambridge, Cancer Research UK and Hutchison Whampoa Limited.	Alluri PG, 2014, CELL RES, V24, P899, DOI 10.1038/cr.2014.90; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Cerase A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0733-y; Chen Jie Qing, 2011, Hormones & Cancer, V2, P132, DOI 10.1007/s12672-011-0067-5; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; DiRenzo J, 2000, MOL CELL BIOL, V20, P7541, DOI 10.1128/MCB.20.20.7541-7549.2000; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Fortunati N, 2010, MOL CELL ENDOCRINOL, V314, P17, DOI 10.1016/j.mce.2009.09.011; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Hohmann AF, 2014, TRENDS GENET, V30, P356, DOI 10.1016/j.tig.2014.05.001; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Johnston SRD, 2003, NAT REV CANCER, V3, P821, DOI 10.1038/nrc1211; Jozwik KM, 2016, CELL REP, V17, P2715, DOI 10.1016/j.celrep.2016.11.028; Jozwik KM, 2012, NAT REV CANCER, V12, P381, DOI 10.1038/nrc3263; Kawai H, 2002, ONCOGENE, V21, P7730, DOI 10.1038/sj.onc.1205971; Kurihara I, 2007, PLOS GENET, V3, P1053, DOI 10.1371/journal.pgen.0030102; Ladd B, 2016, ONCOTARGET, V7, P54120, DOI 10.18632/oncotarget.10852; Mohammed H, 2016, NAT PROTOC, V11, P316, DOI 10.1038/nprot.2016.020; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Mulder KW, 2012, NAT CELL BIOL, V14, P753, DOI 10.1038/ncb2520; Nagarajan S, 2014, CELL REP, V8, P459, DOI 10.1016/j.celrep.2014.06.016; Perdomo J, 2002, EUR J BIOCHEM, V269, P5885, DOI 10.1046/j.1432-1033.2002.03313.x; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Sanchez-Garcia F, 2014, CELL, V159, P1461, DOI 10.1016/j.cell.2014.10.048; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; Shu SK, 2016, NATURE, V529, P413, DOI 10.1038/nature16508; Theodorou V, 2013, GENOME RES, V23, P12, DOI 10.1101/gr.139469.112; Thomas C, 2015, TRENDS ENDOCRIN MET, V26, P453, DOI 10.1016/j.tem.2015.08.002; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Toska E, 2017, SCIENCE, V355, P1324, DOI 10.1126/science.aah6893; Wang S, 2013, NAT PROTOC, V8, P2502, DOI 10.1038/nprot.2013.150; Wu LL, 2014, ONCOTARGET, V5, P7677, DOI 10.18632/oncotarget.2291; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	39	11	11	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 27	2018	37	39					5281	5291		10.1038/s41388-018-0312-2	http://dx.doi.org/10.1038/s41388-018-0312-2			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GV0NW	29895970	Green Submitted, Green Accepted			2022-12-26	WOS:000445759700003
J	Kritsiligkou, P; Rand, JD; Weids, AJ; Wang, XM; Kershaw, CJ; Grant, CM				Kritsiligkou, Paraskevi; Rand, Jonathan D.; Weids, Alan J.; Wang, Ximeng; Kershaw, Chris J.; Grant, Chris M.			Endoplasmic reticulum (ER) stress-induced reactive oxygen species (ROS) are detrimental for the fitness of a thioredoxin reductase mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); thioredoxin; peroxiredoxin; reactive oxygen species (ROS); redox regulation	UNFOLDED PROTEIN RESPONSE; YEAST SACCHAROMYCES-CEREVISIAE; YAP-1 TRANSCRIPTIONAL REGULATION; CHRONOLOGICAL LIFE-SPAN; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; GLUTATHIONE-REDUCTASE; SIGNAL-TRANSDUCTION; TSA1 PEROXIREDOXIN; REDOX REGULATION	The unfolded protein response (UPR) is constitutively active in yeast thioredoxin reductase mutants, suggesting a link between cytoplasmic thiol redox control and endoplasmic reticulum (ER) oxidative protein folding. The unique oxidative environment of the ER lumen requires tight regulatory control, and we show that the active UPR depends on the presence of oxidized thioredoxins rather than arising because of a loss of thioredoxin function. Preventing activation of the UPR by deletion of HAC1, encoding the UPR transcription factor, rescues a number of thioredoxin reductase mutant phenotypes, including slow growth, shortened longevity, and oxidation of the cytoplasmic GSH pool. This is because the constitutive UPR in a thioredoxin reductase mutant results in the generation of hydrogen peroxide. The oxidation of thioredoxins in a thioredoxin reductase mutant requires aerobic metabolism and the presence of the Tsa1 and Tsa2 peroxiredoxins, indicating that a complete cytoplasmic thioredoxin system is crucial for maintaining ER redox homeostasis.	[Kritsiligkou, Paraskevi; Rand, Jonathan D.; Weids, Alan J.; Wang, Ximeng; Kershaw, Chris J.; Grant, Chris M.] Univ Manchester, Fac Biol Med & Hlth, Manchester M13 9PT, Lancs, England; [Kritsiligkou, Paraskevi] German Canc Res Ctr, Div Redox Regulat, Neuenheimer Feld 280, D-69120 Heidelberg, Germany	University of Manchester; Helmholtz Association; German Cancer Research Center (DKFZ)	Grant, CM (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Div Mol & Cellular Funct, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	chris.grant@manchester.ac.uk	Kritsiligkou, Paraskevi/W-9399-2019	Kritsiligkou, Paraskevi/0000-0003-2452-141X; Kershaw, Christopher/0000-0001-6625-7894; Grant, Chris/0000-0002-0616-6576	Biotechnology and Biological Sciences Research (BBSRC) Council [BB/M020770/1, BB/P005594/1]; BBSRC; BBSRC [BB/P005594/1, BB/M020770/1] Funding Source: UKRI; MRC [MR/L011840/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research (BBSRC) Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Biotechnology and Biological Sciences Research (BBSRC) Council Project Grants BB/M020770/1 and BB/P005594/1 (to C. M. G.) and a BBSRC funded studentship (to A. J. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Ayer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044278; Ayer A, 2010, FREE RADICAL BIO MED, V49, P1956, DOI 10.1016/j.freeradbiomed.2010.09.023; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Brandes N, 2013, ELIFE, V2, DOI 10.7554/eLife.00306; Brown JD, 2013, CELL REP, V5, P1425, DOI 10.1016/j.celrep.2013.10.036; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Carmel-Harel O, 2001, MOL MICROBIOL, V39, P595, DOI 10.1046/j.1365-2958.2001.02255.x; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Costello J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0559-z; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cuozzo JW, 1999, NAT CELL BIOL, V1, P130, DOI 10.1038/11047; Day AM, 2012, MOL CELL, V45, P398, DOI 10.1016/j.molcel.2011.11.027; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Deponte M, 2015, BIOL CHEM, V396, P401, DOI 10.1515/hsz-2014-0280; Draculic T, 2000, MOL MICROBIOL, V36, P1167, DOI 10.1046/j.1365-2958.2000.01948.x; Eletto D, 2014, J CELL SCI, V127, P3649, DOI 10.1242/jcs.153643; Ellgaard L, 2018, TRENDS BIOCHEM SCI, V43, P32, DOI 10.1016/j.tibs.2017.10.006; GAN ZR, 1991, J BIOL CHEM, V266, P1692; Garrido EO, 2002, MOL MICROBIOL, V43, P993, DOI 10.1046/j.1365-2958.2002.02795.x; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hauptmann P, 2006, MOL MICROBIOL, V59, P765, DOI 10.1111/j.1365-2958.2005.04981.x; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Honda F, 2012, NAT IMMUNOL, V13, P369, DOI 10.1038/ni.2234; Izawa S, 1999, J BIOL CHEM, V274, P28459, DOI 10.1074/jbc.274.40.28459; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Kimata Y, 2006, GENES CELLS, V11, P59, DOI 10.1111/j.1365-2443.2005.00921.x; KOHNO K, 1993, MOL CELL BIOL, V13, P877, DOI 10.1128/MCB.13.2.877; Kojer K, 2012, EMBO J, V31, P3169, DOI 10.1038/emboj.2012.165; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Leichert LI, 2015, BIOL CHEM, V396, P389, DOI 10.1515/hsz-2014-0314; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Machado AK, 1997, J BIOL CHEM, V272, P17045, DOI 10.1074/jbc.272.27.17045; Margittai E, 2011, TRAFFIC, V12, P1, DOI 10.1111/j.1600-0854.2010.01108.x; Mason JT, 2006, BIOCHEMISTRY-US, V45, P13409, DOI 10.1021/bi061136y; Morgan B, 2016, NAT CHEM BIOL, V12, P437, DOI [10.1038/NCHEMBIO.2067, 10.1038/nchembio.2067]; Morgan B, 2011, FREE RADICAL BIO MED, V51, P1943, DOI 10.1016/j.freeradbiomed.2011.08.035; MULLER EGD, 1991, J BIOL CHEM, V266, P9194; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Netto LES, 2016, MOL CELLS, V39, P65, DOI 10.14348/molcells.2016.2349; Ocampo A, 2011, MECH AGEING DEV, V132, P315, DOI 10.1016/j.mad.2011.06.007; Okazaki S, 2005, ANTIOXID REDOX SIGN, V7, P327, DOI 10.1089/ars.2005.7.327; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Pearson GD, 1998, J BIOL CHEM, V273, P5431, DOI 10.1074/jbc.273.10.5431; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Pincus D, 2014, P NATL ACAD SCI USA, V111, P14800, DOI 10.1073/pnas.1409588111; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Poet GJ, 2017, EMBO J, V36, P693, DOI 10.15252/embj.201695336; Ragu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108123; Rand JD, 2006, MOL BIOL CELL, V17, P387, DOI 10.1091/mbc.E05-06-0520; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; ROSE M, 1983, METHOD ENZYMOL, V101, P167; Sideri TC, 2010, P NATL ACAD SCI USA, V107, P6394, DOI 10.1073/pnas.1000347107; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Stocker S, 2018, ANTIOXID REDOX SIGN, V28, P558, DOI 10.1089/ars.2017.7162; Swalwell H, 2012, FREE RADICAL BIO MED, V52, P626, DOI 10.1016/j.freeradbiomed.2011.11.019; Toledano MB, 2004, TRENDS BIOCHEM SCI, V29, P351, DOI 10.1016/j.tibs.2004.05.005; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Trotter EW, 2008, BIOCHEM J, V412, P73, DOI 10.1042/BJ20071634; Trotter EW, 2003, EMBO REP, V4, P184, DOI 10.1038/sj.embor.embor729; Trotter EW, 2005, EUKARYOT CELL, V4, P392, DOI 10.1128/EC.4.2.392-400.2005; Trotter EW, 2002, MOL MICROBIOL, V46, P869, DOI 10.1046/j.1365-2958.2002.03216.x; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Weids AJ, 2014, J CELL SCI, V127, P1327, DOI 10.1242/jcs.144022; Williams CH, 2000, EUR J BIOCHEM, V267, P6110, DOI 10.1046/j.1432-1327.2000.01702.x; Wong CM, 2004, J BIOL CHEM, V279, P23207, DOI 10.1074/jbc.M402095200; WU AL, 1994, MOL CELL BIOL, V14, P5832, DOI 10.1128/MCB.14.9.5832; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200	76	20	20	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					11984	11995		10.1074/jbc.RA118.001824	http://dx.doi.org/10.1074/jbc.RA118.001824			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29871930	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000440803200002
J	Hsu, AT; Lupancu, TJ; Lee, MC; Fleetwood, AJ; Cook, AD; Hamilton, JA; Achuthan, A				Hsu, Amy T.; Lupancu, Tanya J.; Lee, Ming-Chin; Fleetwood, Andrew J.; Cook, Andrew D.; Hamilton, John A.; Achuthan, Adrian			Epigenetic and transcriptional regulation of IL4-induced CCL17 production in human monocytes and murine macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon regulatory factor (IRF); STAT transcription factor; signal transduction; epigenetics; monocyte; macrophage; chemokine; cytokine; dendritic cell; interleukin	COLONY-STIMULATING FACTOR; NECROSIS-FACTOR-ALPHA; DENDRITIC CELLS; ALTERNATIVE ACTIVATION; GM-CSF; GENE-EXPRESSION; IN-VIVO; INFLAMMATION; POLARIZATION; DIFFERENTIATION	Interleukin 4 (IL4) is generally viewed as a Th2 cytokine capable of polarizing macrophages into an anti-inflammatory phenotype, whereas granulocyte macrophage-colony-stimulating factor (GM-CSF) is often viewed as a proinflammatory cytokine with part of this function due to its action on monocytes/macrophages. Paradoxically, these two cytokines act additively to enhance the in vitro differentiation of dendritic cells from precursors such as monocytes. One up-regulated marker of an IL4-polarized M2 macrophage is the chemokine (C-C motif) ligand 17 (CCL17), which we have recently reported to be induced by GM-CSF in monocytes/macrophages in an interferon regulatory factor 4 (IRF4)-dependent manner. In this study, we report that IL4 also induces CCL17 production by acting through IRF4 in human monocytes and murine macrophages. Furthermore, evidence is presented that IL4 up-regulates IRF4 expression at the epigenetic level by enhancing the expression and activity of jumonji domain-containing protein 3 (JMJD3) demethylase. Intriguingly, silencing the signal transducer and activator of transcription 6 (STAT6) gene led to a decrease in not only CCL17 formation, but also in that of its upstream regulators, JMJD3 and IRF4. Moreover, IL4 treatment of human monocytes resulted in an increased association of STAT6 to the promoter regions of the CCL17, IRF4, and JMJD3 genes. Thus, despite their vastly different functions, IL4 and GM-CSF appear to share elements of a common signaling pathway in regulating CCL17 production in human monocytes and murine macrophages.	[Hsu, Amy T.; Lupancu, Tanya J.; Lee, Ming-Chin; Fleetwood, Andrew J.; Cook, Andrew D.; Hamilton, John A.; Achuthan, Adrian] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia; [Hamilton, John A.] Univ Melbourne, Australian Inst Musculoskeletal Sci AIMSS, St Albans, Vic 3021, Australia; [Hamilton, John A.] Western Hlth, St Albans, Vic 3021, Australia	Royal Melbourne Hospital; University of Melbourne; University of Melbourne	Achuthan, A (corresponding author), Royal Melbourne Hosp, 4th Fl,Clin Sci Bldg, Parkville, Vic 3050, Australia.	aaa@unimelb.edu.au	Achuthan, Adrian/K-7281-2015; Fleetwood, Andrew/AAB-4743-2019; Achuthan, Adrian/S-3931-2019	Achuthan, Adrian/0000-0003-3640-2338; Fleetwood, Andrew/0000-0002-6803-3533; Achuthan, Adrian/0000-0003-3640-2338; Lee, Kevin Ming-Chin/0000-0002-6609-3524; Hsu, Amy/0000-0002-9873-0719	National Health and Medical Research Council of Australia; Research Grant Support Scheme from the University of Melbourne	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Research Grant Support Scheme from the University of Melbourne	This work was supported by grants from the National Health and Medical Research Council of Australia (to J. A. H. and A. D. C), and a Research Grant Support Scheme from the University of Melbourne (to A. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Achuthan A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0332-4; Achuthan A, 2016, J CLIN INVEST, V126, P3453, DOI 10.1172/JCI87828; Alferink J, 2003, J EXP MED, V197, P585, DOI 10.1084/jem.20021859; Borriello F, 2015, EUR J IMMUNOL, V45, P2042, DOI 10.1002/eji.201445303; Bowdridge S, 2010, NAT IMMUNOL, V11, P879, DOI 10.1038/ni1010-879; CHEUNG DL, 1992, BLOOD, V79, P1972; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; El Chartouni C, 2010, IMMUNOBIOLOGY, V215, P821, DOI 10.1016/j.imbio.2010.05.031; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; HAMILTON JA, 1992, IMMUNOLOGY, V76, P566; HAMILTON JA, 1994, J LEUKOCYTE BIOL, V55, P355; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hamilton JA, 2017, NAT REV DRUG DISCOV, V16, P53, DOI 10.1038/nrd.2016.231; Hamilton JA, 2015, EXPERT REV CLIN IMMU, V11, P457, DOI 10.1586/1744666X.2015.1024110; HART PH, 1989, P NATL ACAD SCI USA, V86, P3803, DOI 10.1073/pnas.86.10.3803; Hayashida S, 2011, J DERMATOL SCI, V61, P180, DOI 10.1016/j.jdermsci.2010.10.013; Hemmerle T, 2014, P NATL ACAD SCI USA, V111, P12008, DOI 10.1073/pnas.1402783111; Honma K, 2005, P NATL ACAD SCI USA, V102, P16001, DOI 10.1073/pnas.0504226102; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Lehtonen A, 2002, J LEUKOCYTE BIOL, V71, P511; Lehtonen A, 2005, J IMMUNOL, V175, P6570, DOI 10.4049/jimmunol.175.10.6570; Liddiard K, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-45; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; MUI ALF, 1995, J LEUKOCYTE BIOL, V57, P799, DOI 10.1002/jlb.57.5.799; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Semnani RT, 2011, INFECT IMMUN, V79, P3957, DOI 10.1128/IAI.05191-11; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Vento-Tormo R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-015-0863-2; Weigel BJ, 2002, BLOOD, V100, P4169, DOI 10.1182/blood-2002-04-1063; Weiss M, 2015, P NATL ACAD SCI USA, V112, P11001, DOI 10.1073/pnas.1506254112; Wirnsberger G, 2006, EUR J IMMUNOL, V36, P1882, DOI 10.1002/eji.200635972	43	26	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11415	11423		10.1074/jbc.RA118.002416	http://dx.doi.org/10.1074/jbc.RA118.002416			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29871928	Green Published, hybrid			2022-12-26	WOS:000439449700012
J	Martin, P; Cortina-Borja, M; Newburn, M; Harper, G; Gibson, R; Dodwell, M; Dattani, N; Macfarlane, A				Martin, Peter; Cortina-Borja, Mario; Newburn, Mary; Harper, Gill; Gibson, Rod; Dodwell, Miranda; Dattani, Nirupa; Macfarlane, Alison			Timing of singleton births by onset of labour and mode of birth in NHS maternity units in England, 2005-2014: A study of linked birth registration, birth notification, and hospital episode data	PLOS ONE			English	Article							PERINATAL-MORTALITY; DELIVERY; HOUR; TIME; NUMBER; CONVENIENCE; PATTERN; RATES; WOMEN; BORN	Background Maternity care has to be available 24 hours a day, seven days a week. It is known that obstetric intervention can influence the time of birth, but no previous analysis at a national level in England has yet investigated in detail the ways in which the day and time of birth varies by onset of labour and mode of giving birth. Method We linked data from birth registration, birth notification, and Maternity Hospital Episode Statistics and analysed 5,093,615 singleton births in NHS maternity units in England from 2005 to 2014. We used descriptive statistics and negative binomial regression models with harmonic terms to establish how patterns of timing of birth vary by onset of labour, mode of giving birth and gestational age. Results The timing of birth by time of day and day of the week varies considerably by onset of labour and mode of birth. Spontaneous births after spontaneous onset are more likely to occur between midnight and 6am than at other times of day, and are also slightly more likely on weekdays than at weekends and on public holidays. Elective caesarean births are concentrated onto weekday mornings. Births after induced labours are more likely to occur at hours around midnight on Tuesdays to Saturdays and on days before a public holiday period, than on Sundays, Mondays and during or just after a public holiday. Conclusion The timing of births varies by onset of labour and mode of birth and these patterns have implications for midwifery and medical staffing. Further research is needed to understand the processes behind these findings.	[Martin, Peter; Newburn, Mary; Harper, Gill; Dodwell, Miranda; Dattani, Nirupa; Macfarlane, Alison] City Univ London, Ctr Maternal & Child Hlth Res, Sch Hlth Sci, London, England; [Cortina-Borja, Mario] UCL, Great Ormond St Inst Child Hlth, Populat Policy & Practice Programme, London, England; [Gibson, Rod] Rod Gibson Associates Ltd, Wotton Under Edge, England; [Martin, Peter] UCL, Dept Appl Hlth Res, London, England	City University London; University of London; University College London; University of London; University College London	Macfarlane, A (corresponding author), City Univ London, Ctr Maternal & Child Hlth Res, Sch Hlth Sci, London, England.	A.J.Macfarlane@city.ac.uk	Dangal, Ganesh/O-1989-2017; Borja, Mario Cortina/A-3847-2009	Dangal, Ganesh/0000-0002-5834-5525; Borja, Mario Cortina/0000-0003-0627-2624; Martin, Peter/0000-0003-4638-0638; Harper, Gillian/0000-0002-3492-2076	National Institute for Health Research, HSDR Programme [HSDR 12/136/93]	National Institute for Health Research, HSDR Programme	'Births and their outcome: analysing the daily, weekly and yearly cycle and their implications for the NHS' was funded by the National Institute for Health Research, HS&DR Programme, project number HS&DR 12/136/93 and will be published in full in the Health Services & Delivery Research Journal. The funder provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 1984, LANCET, V323, P1448; Barnett, 2010, ANAL SEASONAL HLTH D; Bernis C, 2013, MATERN CHILD HLTH J, V17, P918, DOI 10.1007/s10995-012-1079-7; Bernis C, 2012, AM J HUM BIOL, V24, P14, DOI 10.1002/ajhb.21228; CALOT G, 1981, POPULATION, V36, P9, DOI 10.2307/1532429; Charles E, 1953, BRIT J PREV SOC MED, V7, P43; COHEN A, 1983, J R STAT SOC C-APPL, V32, P228; COLE S, 1984, LANCET, V2, P222; Cox NJ, 2006, STATA J, V6, P561, DOI 10.1177/1536867X0600600408; Dattani N, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017897; Dattani Nirupa, 2011, Health Stat Q, P53, DOI 10.1057/hsq.2011.3; de Graaf JP, 2010, BJOG-INT J OBSTET GY, V117, P1098, DOI 10.1111/j.1471-0528.2010.02611.x; Department of Health, 1997, STAT B, V1997/28, P1; FRASER W, 1987, AM J OBSTET GYNECOL, V156, P300, DOI 10.1016/0002-9378(87)90272-9; Ghosh RE, 2016, ARCH DIS CHILD-FETAL, V101, pF451, DOI 10.1136/archdischild-2015-309540; Harper G, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017898; Hawe E, 2015, HLTH STAT Q, V9, P5; Heres MHG, 2000, MIDWIFERY, V16, P173, DOI 10.1054/midw.1999.0210; Hilder L, 2007, HEAL STAT Q, V25-33; JOLLY A, 1972, FOLIA PRIMATOL, V18, P108, DOI 10.1159/000155472; Knight HE, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002000; Knight HE, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-200; Macfarlane A, 1998, BRIT MED J, V316, P566, DOI 10.1136/bmj.316.7131.566; MACFARLANE A, 1979, BRIT MED J, V1, P750, DOI 10.1136/bmj.1.6165.750-b; MACFARLANE A, 1978, BRIT MED J, V2, P1670, DOI 10.1136/bmj.2.6153.1670; Macfarlane A., 1986, TRENDS MATERNITY CAR, V19; Macfarlane A, 1978, POPULATION TRENDS, V13, P23; Macfarlane A, 2000, BIRTH COUNTS STAT PR, V2; Macfarlane A, 1984, LANCET, V324, P1984; Macfarlane A, 2018, BIRTHS THEIR OUTCOME; Martins J M, 1972, Med J Aust, V1, P487; MATHERS CD, 1983, J EPIDEMIOL COMMUN H, V37, P57, DOI 10.1136/jech.37.1.57; Melbye M, 1997, BRIT MED J, V315, P1654, DOI 10.1136/bmj.315.7123.1654; Merry L, 2016, WOMEN BIRTH, V29, pE89, DOI 10.1016/j.wombi.2016.04.001; Merry L, 2016, BEST PRACT RES CL OB, V32, P88, DOI 10.1016/j.bpobgyn.2015.09.002; Murray J, 2013, J PUBLIC HEALTH-UK, V35, P298, DOI 10.1093/pubmed/fds077; NEWTON RW, 1984, LANCET, V2, P470; NHS England, 2014, 5 YEAR FORW VIEW; PACCAUD F, 1984, LANCET, V2, P470; Palmer WL, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5774; Pasupathy D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3498; Quetelet Adolphe, 1835, ESSAI PHYS SOCIALE; R Core Team, 2021, R LANGUAGE ENV STAT; RINDFUSS RR, 1976, MED CARE, V14, P685, DOI 10.1097/00005650-197608000-00005; RINDFUSS RR, 1979, INT J HEALTH SERV, V9, P439, DOI 10.2190/C8CF-GLPC-6LBW-9KWA; Secondary Care Analysis Team NHS Digital, 2016, HOSP MAT ACT 2015 16; SIMPSON AS, 1952, BRIT MED J, V2, P831, DOI 10.1136/bmj.2.4788.831; SMOLENSKY M, 1972, ADV CLIMATIC PHYSL, P281, DOI DOI 10.1007/978-3-642-93010-2_18; The Information Centre for Health and Social Care, 2007, NHS MAT STAT ENGL 20; Varea C, 2014, AM J HUM BIOL, V26, P707, DOI 10.1002/ajhb.22557; Webb DA, 2002, J EPIDEMIOL COMMUN H, V56, P577, DOI 10.1136/jech.56.8.577; WELLS R, 1980, MED J AUSTRALIA, V2, P160; Yerushalmy J, 1938, CHILD DEV, V9, P373; Young D, 2011, BIRTH-ISS PERINAT C, V38, P1, DOI 10.1111/j.1523-536X.2010.00448.x	54	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198183	10.1371/journal.pone.0198183	http://dx.doi.org/10.1371/journal.pone.0198183			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ5MF	29902220	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000435424900013
J	Fernandes, FM; Silva, EP; Martins, RR; Oliveira, AG				Fernandes, Flavia Medeiros; Silva, Eliane Pereira; Martins, Rand Randall; Oliveira, Antonio Gouveia			QTc interval prolongation in critically ill patients: Prevalence, risk factors and associated medications	PLOS ONE			English	Article							TORSADES-DE-POINTES; INTENSIVE-CARE PATIENTS; PROLONGING MEDICATIONS; FREQUENCY; SYSTEM; DRUGS; PHARMACIST; PREVENTION; MORTALITY; UNITS	Purpose To investigate the prevalence and risk factors of acquired long QT syndrome (LOTS) on admission to a general Intensive Care Unit (ICU), and to assess the risk of LOTS associated with prescribed medications. Methods Prospective observational, cross-sectional study approved by the Institutional Review Board. Between May 2014 and July 2016, 412 patients >18 years-old consecutively admitted to the ICU of a university hospital were included. LOTS was defined as a OT interval on the admission electrocardiogram corrected using Bazett's formula (QTc) >460 ms for men and >470 ms for women. All medications administered within 24 hours before admission were recorded. Logistic regression was used. Results LOTS prevalence was 27.9%. In LOTS patients, 70.4% had >= 1 LOTS-inducing drug prescribed in the 24 hours prior to ICU admission versus 70.4% in non-LOTS patients (p = 0.99). Bradycardia and Charlson morbidity index score are independent risk factors for LOTS. Haloperidol (OR 4.416), amiodarone (OR 2.509) and furosemide (OR 1.895) were associated with LOTS, as well as another drug not yet described, namely clopidogrel (OR 2.241). Conclusions The LQTS is highly prevalent in critically ill patients, ICU patients are often admitted with LQTS-inducing medications, and patients with slow heart rate or with high Charlson comorbidity index should be evaluated for LQTS.	[Fernandes, Flavia Medeiros] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Pharm Dept, Adult Intens Care Unit,Integrated Multiprofess Hl, Natal, RN, Brazil; [Silva, Eliane Pereira] Univ Fed Rio Grande do Norte, Univ Hosp Onofre Lopes, Hlth Sci Ctr, Natal, RN, Brazil; [Martins, Rand Randall; Oliveira, Antonio Gouveia] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Pharm Dept, Natal, RN, Brazil; [Fernandes, Flavia Medeiros] Univ Fed Rio Grande do Norte, Fac Farm, Ctr Ciencias Saude, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Fernandes, FM (corresponding author), Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Pharm Dept, Adult Intens Care Unit,Integrated Multiprofess Hl, Natal, RN, Brazil.; Fernandes, FM (corresponding author), Univ Fed Rio Grande do Norte, Fac Farm, Ctr Ciencias Saude, Natal, RN, Brazil.	flaviaemf@gmail.com	Martins, Rand Randall/X-8188-2019	Martins, Rand Randall/0000-0001-9668-0482; Pereira da Silva, Eliane/0000-0002-3364-5046				Allyn J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164828; Antzelevitch C, 2004, J ELECTROCARDIOL, V37, P15, DOI 10.1016/j.jelectrocard.2004.08.004; Chiladakis J, 2010, J CARDIOVASC ELECTR, V21, P905, DOI 10.1111/j.1540-8167.2010.01738.x; Drew BJ, 2010, J AM COLL CARDIOL, V55, P934, DOI [10.1016/j.jacc.2010.01.001, 10.1161/CIRCULATIONAHA.109.192704]; Fraccaro P, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004973; Gowda RM, 2004, INT J CARDIOL, V96, P1, DOI 10.1016/j.ijcard.2003.04.055; Green SM, 2011, ANN EMERG MED, V58, P427, DOI 10.1016/j.annemergmed.2011.06.009; Hoogstraaten E, 2014, J CRIT CARE, V29, P835, DOI 10.1016/j.jcrc.2014.05.005; Isbister GK, 2013, BRIT J CLIN PHARMACO, V76, P48, DOI 10.1111/bcp.12040; Kallergis EM, 2012, SCI WORLD J, DOI 10.1100/2012/212178; Katoh T, 2009, J ARRYTHM, V25, P56; Keller GA, 2016, CURR DRUG SAF, V11, P86, DOI 10.2174/1574886311207040262; Kozik TM, 2012, CRIT CARE NURSE, V32, P32, DOI 10.4037/ccn2012900; LaPointe NMA, 2006, PHARMACOEPIDEM DR S, V15, P361, DOI 10.1002/pds.1155; Li GL, 2013, ADV THER, V30, P793, DOI 10.1007/s12325-013-0056-x; Mason PK, 2007, DRUG DISCOV TODAY, V4, P159; Michels G, 2016, MED KLIN-INTENSIVMED, V111, P302, DOI 10.1007/s00063-015-0071-6; Nelson S, 2011, AACN ADV CRIT CARE, V22, P289, DOI 10.1097/NCI.0b013e31822db49d; Ng Tien M H, 2010, J Pharm Pract, V23, P19, DOI 10.1177/0897190009356549; Ng TM, 2008, ANN PHARMACOTHER, V42, P475, DOI 10.1345/aph.1K458; Ng TM, 2004, CRIT CARE MED, V32, pA40; Park E, 2013, INT J CARDIOL, V168, P4975, DOI 10.1016/j.ijcard.2013.07.136; Pham JC, 2016, J CLIN MONIT COMPUT, V30, P437, DOI 10.1007/s10877-015-9736-1; Pickham D, 2012, CRIT CARE MED, V40, P394, DOI 10.1097/CCM.0b013e318232db4a; Pickham D, 2010, J ELECTROCARDIOL, V43, P572, DOI 10.1016/j.jelectrocard.2010.05.016; Poluzzi E, 2009, PHARMACOEPIDEM DR S, V18, P512, DOI 10.1002/pds.1746; Riad FS, 2017, AM J CARDIOL, V119, P280, DOI 10.1016/j.amjcard.2016.09.041; Ridruejo R, 2005, MED INTENSIVA, V29, P379; Safari S, 2016, TURK J EMERG MED, V16, P146, DOI 10.1016/j.tjem.2016.09.005; Sarganas G, 2014, EUROPACE, V16, P101, DOI 10.1093/europace/eut214; Schwartz PJ, 2016, J AM COLL CARDIOL, V67, P1639, DOI 10.1016/j.jacc.2015.12.063; Seftchick MW, 2009, ANN EMERG MED, V54, P763, DOI 10.1016/j.annemergmed.2009.03.021; Tisdale JE, 2016, CAN PHARM J, V149, P139, DOI 10.1177/1715163516641136; Tisdale JE, 2014, CIRC-CARDIOVASC QUAL, V7, P381, DOI 10.1161/CIRCOUTCOMES.113.000651; Tisdale JE, 2012, DRUG SAFETY, V35, P459, DOI 10.2165/11598160-000000000-00000; Vandenberk B, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003264; Vlachos K, 2016, EXPERT REV CLIN PHAR, V9, P117, DOI 10.1586/17512433.2016.1100073	37	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0199028	10.1371/journal.pone.0199028	http://dx.doi.org/10.1371/journal.pone.0199028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29898002	Green Published, gold, Green Submitted			2022-12-26	WOS:000435090700087
J	Haddad, F; Bourke, J; Wong, K; Leonard, H				Haddad, Fatma; Bourke, Jenny; Wong, Kingsley; Leonard, Helen			An investigation of the determinants of quality of life in adolescents and young adults with Down syndrome	PLOS ONE			English	Article							DEVELOPMENTAL BEHAVIOR CHECKLIST; ANXIETY STRESS SCALES; INTELLECTUAL DISABILITY; MENTAL-RETARDATION; WESTERN-AUSTRALIA; CHILDREN; PEOPLE; HEALTH; MOTHERS; PSYCHOPATHOLOGY	Background Young people with Down syndrome experience varying abilities in activities of daily living, cognitive functioning, behaviour and social skills. The aim of this research was to investigate, from a carer's perspective, the factors that influenced the quality of life of these young people. Methods Families of young people with Down syndrome (n = 197), aged 16-31 years, living in Western Australia, took part in a questionnaire study regarding young person daily functioning, family characteristics, medical background and quality of life measured by the Kidscreen 27-item scale. Kidscreen-10 total score was used as an outcome in the investigation of determinants with higher scores indicating better quality of life. Results After adjustment for confounders including carer's mental health measured by the Depression and Anxiety Scale (DASS), global impact of illness as well as impact of mental health and bowel conditions were all negatively associated with the young person's quality of life. Young people who had three or more friends had better quality of life than those with no friends. Scores were lower (reflecting poor quality of life) in individuals who had more behavioural problems but these relationships were attenuated after adjustment for confounders and DASS. Conclusions Overall, our findings revealed that quality of life of young people with Down syndrome was most negatively associated with burden of medical conditions, but also with lack of friendships. We were somewhat surprised to find the effect of medical problems on quality of life persisting into adolescence and adulthood where in general the burden of medical comorbidities is much less than in childhood.	[Haddad, Fatma; Leonard, Helen] Univ Western Australia, Perth, WA, Australia; [Bourke, Jenny; Wong, Kingsley; Leonard, Helen] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia	University of Western Australia; Telethon Kids Institute; University of Western Australia	Leonard, H (corresponding author), Univ Western Australia, Perth, WA, Australia.; Leonard, H (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia.	helen.leonard@telethonkids.org.au	Wong, Kingsley/I-6935-2013; Leonard, Helen/A-1010-2013	Wong, Kingsley/0000-0001-5178-6080; Leonard, Helen/0000-0001-6405-5834	Australian Research Alliance for Children and Youth; Australian Research Council [LP0989847]; NHMRC [1117105]	Australian Research Alliance for Children and Youth; Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We acknowledge the initial seed funding from Australian Research Alliance for Children and Youth and the ongoing funding provided by the Australian Research Council #LP0989847 for the project 'Leaving School: Maximising participation and life outcomes in youth with an intellectual disability transitioning from secondary school to adult life'. We acknowledge NHMRC Fellowship funding for Helen Leonard (#1117105).	Rodriguez VB, 2016, PSICOTHEMA, V28, P311, DOI 10.7334/psicothema2016.10; Bittles AH, 2007, EUR J PUBLIC HEALTH, V17, P221, DOI 10.1093/eurpub/ckl103; Bourke J, 2008, J PEDIATR-US, V153, P320, DOI 10.1016/j.jpeds.2008.02.047; Bower C, 2000, J PAEDIATR CHILD H, V36, P213, DOI 10.1046/j.1440-1754.2000.00480.x; Brown I, 2009, J POLICY PRACTICE IN, V6; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Clarke AR, 2003, J INTELL DISABIL RES, V47, P210, DOI 10.1046/j.1365-2788.2003.00470.x; Cuskelly M, 2003, AM J MENT RETARD, V108, P234, DOI 10.1352/0895-8017(2003)108<234:SROCWD>2.0.CO;2; Davis E, 2007, QUAL LIFE RES, V16, P863, DOI 10.1007/s11136-007-9187-3; de Winter CF, 2011, J INTELL DISABIL RES, V55, P675, DOI 10.1111/j.1365-2788.2011.01390.x; Dykens EM, 2007, MENT RETARD DEV D R, V13, P272, DOI 10.1002/mrdd.20159; EINFELD SL, 1995, J AUTISM DEV DISORD, V25, P81, DOI 10.1007/BF02178498; Einfeld SL, 1996, J INTELL DISABIL RES, V40, P99, DOI 10.1111/j.1365-2788.1996.tb00611.x; Einfeld SL, 2006, JAMA-J AM MED ASSOC, V296, P1981, DOI 10.1001/jama.296.16.1981; FELCE D, 1995, RES DEV DISABIL, V16, P51, DOI 10.1016/0891-4222(94)00028-8; Fidler Deborah J, 2006, Downs Syndr Res Pract, V10, P23, DOI 10.3104/reports.302; Finlay WML, 2002, MENT RETARD, V40, P14, DOI 10.1352/0047-6765(2002)040<0014:AIIWPW>2.0.CO;2; Fitzgerald P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070401; Foley KR, 2013, CHILD CARE HLTH DEV, V39, P789, DOI 10.1111/cch.12019; Foley KR, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000710; Foley KR, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0266-z; Foley KR, 2014, SOC PSYCH PSYCH EPID, V49, P1455, DOI 10.1007/s00127-013-0812-x; Graves RJ, 2016, AJIDD-AM J INTELLECT, V121, P312, DOI 10.1352/1944-7558-121.4.312; HEAL LW, 1995, J INTELL DISABIL RES, V39, P331, DOI 10.1111/j.1365-2788.1995.tb00525.x; Hodapp RM, 2001, PARENT-SCI PRACT, V1, P317, DOI 10.1207/S15327922PAR0104_3; Leonard S, 2002, J PAEDIATR CHILD H, V38, P160, DOI 10.1046/j.1440-1754.2002.00736.x; Mantry D, 2008, J INTELL DISABIL RES, V52, P141, DOI 10.1111/j.1365-2788.2007.00985.x; McCarthy J, 2008, J INTELL DISABIL RES, V52, P877, DOI 10.1111/j.1365-2788.2008.01104.x; McClintock K, 2003, J INTELL DISABIL RES, V47, P405, DOI 10.1046/j.1365-2788.2003.00517.x; MCCONKEY R, 1982, J MENT DEFIC RES, V26, P47; Mulroy S, 2008, J INTELL DISABIL RES, V52, P216, DOI 10.1111/j.1365-2788.2007.01005.x; Ng F, 2007, ACTA NEUROPSYCHIATR, V19, P304, DOI 10.1111/j.1601-5215.2007.00217.x; Oates A, 2011, DISABIL REHABIL, V33, P1880, DOI 10.3109/09638288.2011.553701; Olsson MB, 2001, J INTELL DISABIL RES, V45, P535, DOI 10.1046/j.1365-2788.2001.00372.x; Petterson B, 2005, ANN HUM BIOL, V32, P237, DOI 10.1080/03014460500075035; Phillips A, 2009, AUST J RURAL HEALTH, V17, P2, DOI 10.1111/j.1440-1584.2008.01029.x; Pikora TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096868; Pillay D, 2012, DISABIL REHABIL, V34, P1501, DOI 10.3109/09638288.2011.650313; RASCH G, 1966, BRIT J MATH STAT PSY, V19, P49, DOI 10.1111/j.2044-8317.1966.tb00354.x; Rofail D, 2017, ADV THERAPY; Roizen NJ, 2010, INT REV RES MENTAL R, V39; Thomas K, 2010, INT REV RES MENTAL R, V39; van Gameren-Oosterom HBM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021879; White-Koning M, 2005, DEV MED CHILD NEUROL, V47, P281, DOI 10.1017/S0012162205000526; WHO, 2021, WHO GUID HLTH WORKF; Xanthopoulos MS, 2017, J PEDIAT SC, V189	46	18	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197394	10.1371/journal.pone.0197394	http://dx.doi.org/10.1371/journal.pone.0197394			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ2HI	29897903	gold, Green Published, Green Submitted			2022-12-26	WOS:000435090700013
J	Krashin, JW; Haddad, LB; Tweya, H; Chiwoko, J; Ng'ambi, W; Samala, B; Chaweza, T; Tang, JH; Hosseinipour, MC; Phiri, S				Krashin, Jamie W.; Haddad, Lisa B.; Tweya, Hannock; Chiwoko, Jane; Ng'ambi, Wingston; Samala, Bernadette; Chaweza, Thomas; Tang, Jennifer H.; Hosseinipour, Mina C.; Phiri, Sam			Factors associated with desired fertility among HIV-positive women and men attending two urban clinics in Lilongwe, Malawi	PLOS ONE			English	Article							PREGNANCY INTENTIONS; SAFER CONCEPTION; ANTIRETROVIRAL THERAPY; ETHIOPIA IMPLICATIONS; INFECTED WOMEN; RISK BEHAVIOR; SOUTH-AFRICA; CHILDBEARING; DETERMINANTS; PREVENTION	As access to antiretroviral therapy increases, more HIV-infected patients in sub-Saharan Africa may desire fertility. We conducted a cross-sectional study of reproductive health knowledge, attitudes and practices to identify factors associated with desired fertility among women and men receiving care at two large public HIV clinics in Lilongwe, Malawi. Research assistants administered questionnaires to participants. We performed descriptive, bivariable and multivariable analysis of factors related to desired fertility and of factors related to contraceptive non-use among participants who did not desire fertility. One-third of participants desired future children. Having a partner who desired fertility and having lower parity were associated with desiring children among both genders. For women, believing that pregnancy was unhealthy was associated with decreased fertility desire. Fifty-five percent of women and 69% of men who did not want children in the future reported using contraception at last intercourse. Increasing age, lower parity, and making the decision to use contraception herself were associated with contraceptive non-use among women who did not desire fertility. Having discussed family planning with his partner was associated with contraceptive use among men who did not desire fertility. Knowledge of these factors can guide reproductive health counseling and service provision.	[Krashin, Jamie W.; Haddad, Lisa B.] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30322 USA; [Krashin, Jamie W.; Tang, Jennifer H.] Univ N Carolina, Dept Obstet & Gynecol, Sch Med, Chapel Hill, NC 27599 USA; [Tweya, Hannock; Chiwoko, Jane; Ng'ambi, Wingston; Samala, Bernadette; Chaweza, Thomas; Phiri, Sam] Kamuzu Cent Hosp, Lighthouse Trust, Lilongwe, Malawi; [Tang, Jennifer H.; Hosseinipour, Mina C.] Kamuzu Cent Hosp, UNC Project Malawi, Lilongwe, Malawi; [Hosseinipour, Mina C.; Phiri, Sam] Univ N Carolina, Dept Med, Sch Med, Chapel Hill, NC USA; [Tweya, Hannock] Int Union TB & Lung Dis, Paris, France	Emory University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Krashin, JW (corresponding author), Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30322 USA.; Krashin, JW (corresponding author), Univ N Carolina, Dept Obstet & Gynecol, Sch Med, Chapel Hill, NC 27599 USA.	krashin@med.unc.edu		Haddad, Lisa/0000-0002-7631-6760	Society of Family Planning (SPFR) [11-14]	Society of Family Planning (SPFR)	This study was conducted with funding from the Society of Family Planning (SPFR #11-14, PI: LBH), https://www.societyfp.org/Research-and-aspx. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asfaw HM, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-36; Beyeza-Kashesya J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-247; Cooper D, 2009, AIDS BEHAV, V13, pS38, DOI 10.1007/s10461-009-9550-1; Coutinho Leticia M S, 2008, Rev. Saúde Pública, V42, P992, DOI 10.1590/S0034-89102008000600003; Davies NECG, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.2.21271; Evens E, 2015, CULT HEALTH SEX, V17, P374, DOI 10.1080/13691058.2014.968806; Government of Malawi, 2015, MAL AIDS RESP PROGR; Gutin SA, 2014, AFR J REPROD HEALTH, V18, P67; Haddad LB, 2017, J FAM PLAN REPROD H, V43, P210, DOI 10.1136/jfprhc-2015-101395; Haddad LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121039; Harrington Elizabeth K, 2012, Infect Dis Obstet Gynecol, V2012, P809682, DOI 10.1155/2012/809682; Hoffman IF, 2008, JAIDS-J ACQ IMM DEF, V47, P477, DOI 10.1097/QAI.0b013e318165dc52; Iliyasu Zubairu, 2009, Afr J Reprod Health, V13, P71; Kaida Angela, 2006, Curr HIV/AIDS Rep, V3, P187, DOI 10.1007/s11904-006-0015-0; Kaida A, 2011, AM J PUBLIC HEALTH, V101, P350, DOI 10.2105/AJPH.2009.177469; Kaida A, 2009, AIDS BEHAV, V13, pS72, DOI 10.1007/s10461-009-9553-y; Kawale P, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0004-0; Kawale P, 2014, AIDS CARE, V26, P769, DOI 10.1080/09540121.2013.855294; Litwin LE, 2015, JAIDS-J ACQ IMM DEF, V69, P377, DOI 10.1097/QAI.0000000000000612; Maier M, 2009, AIDS BEHAV, V13, pS28, DOI 10.1007/s10461-008-9371-7; Mantell JE, 2014, JAIDS-J ACQ IMM DEF, V67, pS202, DOI 10.1097/QAI.0000000000000369; Matthews LT, 2015, AIDS BEHAV, V19, P2291, DOI 10.1007/s10461-015-1050-x; Matthews LT, 2018, AIDS BEHAV, V22, P1713, DOI 10.1007/s10461-017-1777-7; Melaku YA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/s12905-014-0137-2; Melka AS, 2014, AFR J REPROD HEALTH, V18, P54; Mmbaga EJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-86; Morroni C, 2015, LANCET HIV, V2, pE454, DOI 10.1016/S2352-3018(15)00204-0; Myer L, 2007, AIDS PATIENT CARE ST, V21, P278, DOI 10.1089/apc.2006.0108; Nakayiwa S, 2006, AIDS BEHAV, V10, pS95, DOI 10.1007/s10461-006-9126-2; National Statistical Office (NSO) and ICF Macro, 2011, MAL DEM HLTH SURV 20; Peltzer K, 2009, AIDS BEHAV, V13, P973, DOI 10.1007/s10461-008-9365-5; Scarsi KK, 2016, CLIN INFECT DIS, V62, P675, DOI 10.1093/cid/civ1001; Schwartz SR, 2012, AIDS BEHAV, V16, P69, DOI 10.1007/s10461-011-9981-3; Wagner G, 2012, MATERN CHILD HLTH J, V16, P510, DOI 10.1007/s10995-011-0761-5; World Health Organization, 2016, HORM CONTR EL WOM HI; Ya Melaku, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0094682, DOI 10.1371/JOURNAL.PONE.0094682]	36	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198798	10.1371/journal.pone.0198798	http://dx.doi.org/10.1371/journal.pone.0198798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ2HI	29897961	Green Submitted, Green Published, gold			2022-12-26	WOS:000435090700070
J	Takasu, S; Parida, IS; Onose, S; Ito, J; Ikeda, R; Yamagishi, K; Higuchi, O; Tanaka, F; Kimura, T; Miyazawa, T; Nakagawa, K				Takasu, Soo; Parida, Isabella Supardi; Onose, Shinji; Ito, Junya; Ikeda, Ryoichi; Yamagishi, Kenji; Higuchi, Oki; Tanaka, Fukuyo; Kimura, Toshiyuki; Miyazawa, Teruo; Nakagawa, Kiyotaka			Evaluation of the anti-hyperglycemic effect and safety of microorganism 1-deoxynojirimycin	PLOS ONE			English	Article							ALPHA-GLUCOSIDASE INHIBITOR; POSTPRANDIAL BLOOD-GLUCOSE; TYPE-2 DIABETES-MELLITUS; MULBERRY LEAF EXTRACT; DIET-INDUCED OBESITY; N-CONTAINING SUGARS; BACILLUS-AMYLOLIQUEFACIENS; MORUS-ALBA; RATS; MICE	1-Deoxpojinmycin (DNJ) is a potent a-glucosidase inhibitor and thus beneficial for prevention of diabetes. While we have succeeded in obtaining the culture supernatant extract (CSE) rich in DNJ from microorganism source, information regarding its anti-hyperglycemic effect and safety were still limited. Therefore, this study was aimed to evaluate the anti hyperglycemic effect and safety of microorganism DNJ. Oral sucrose tolerance test was performed, and the result showed that CSE was able to significantly suppress the blood glucose elevation and suggested DNJ as the main active compound. To determine its safety, the absorption and excretion of microorganism DNJ were evaluated using N-15 labeling method. Our findings investigated the recovery rate of N-15 from DNJ reached 80% up to 48 hours after oral administration, suggesting its rapid excretion, suggesting the safety of DNJ. This study verified the functional properties and safety of DNJ from microorganisms, suggesting its potential use for functional purpose.	[Takasu, Soo; Parida, Isabella Supardi; Onose, Shinji; Ito, Junya; Miyazawa, Teruo; Nakagawa, Kiyotaka] Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi, Japan; [Ikeda, Ryoichi] Asahimatsu Foods Co Ltd, Food Res Lab, Iida, Nagano, Japan; [Yamagishi, Kenji; Kimura, Toshiyuki] Natl Agr & Food Res Org NARO, Food Res Inst NFRI, Tsukuba, Ibaraki, Japan; [Higuchi, Oki] Biodynam Plant Inst Co Ltd, Sapporo, Hokkaido, Japan; [Tanaka, Fukuyo] Natl Agr & Food Res Org NARO, Cent Reg Agr Res Ctr, Tsukuba, Ibaraki, Japan; [Miyazawa, Teruo] Tohoku Univ, New Ind Creat Hatchery Ctr NICHe, Sendai, Miyagi, Japan	Tohoku University; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; Tohoku University	Nakagawa, K (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi, Japan.	nkgw@m.tohoku.ac.jp	TANAKA, Fukuyo/L-3978-2019	TANAKA, Fukuyo/0000-0002-0904-3248; Takasu, Soo/0000-0001-6053-2269	KAKENHI of Japan Society for the Promotion of Science, Japan [16K07750]; Asahimatsu Foods Co., Ltd.; Biodynamic Plant Institute Co., Ltd.	KAKENHI of Japan Society for the Promotion of Science, Japan; Asahimatsu Foods Co., Ltd.; Biodynamic Plant Institute Co., Ltd.	This work was supported in part by KAKENHI (Grant Number 16K07750 to TK) of Japan Society for the Promotion of Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Asahimatsu Foods Co., Ltd. provided support in the form of salaries for author RI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biodynamic Plant Institute Co., Ltd. provided support in the form of remuneration for author OH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahr HJ, 1997, ARZNEIMITTEL-FORSCH, V47, P734; Amezqueta S, 2017, J AGR FOOD CHEM, V65, P4414, DOI 10.1021/acs.jafc.7b01026; [Anonymous], 1996, HANDB EXP PHARM; ASANO N, 1994, CARBOHYD RES, V259, P243, DOI 10.1016/0008-6215(94)84060-1; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Clark LF, 2011, CHEMBIOCHEM, V12, P2147, DOI 10.1002/cbic.201100347; de Oliveira AM, 2016, J ETHNOPHARMACOL, V194, P162, DOI 10.1016/j.jep.2016.09.004; EZURE Y, 1985, AGR BIOL CHEM TOKYO, V49, P1119, DOI 10.1080/00021369.1985.10866866; Gomez L, 2012, BRIT J NUTR, V107, P1739, DOI 10.1017/S0007114511005009; ICH Harmonised Tripartite Guideline, 2000, SAF PHARM STUD HUM P; Kim J, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/3607089; KIMURA M, 1995, J TRAD MED, V12, P214; Kimura T, 2004, BIOFACTORS, V22, P341, DOI 10.1002/biof.5520220167; Kimura T, 2007, J AGR FOOD CHEM, V55, P5869, DOI 10.1021/jf062680g; Kuriyama C, 2008, BIOORGAN MED CHEM, V16, P7330, DOI 10.1016/j.bmc.2008.06.026; Lim HH, 2013, EXP BIOL MED, V238, P1160, DOI 10.1177/1535370213498982; Miura T, 1998, J NUTR SCI VITAMINOL, V44, P371, DOI 10.3177/jnsv.44.371; Miyahara C, 2004, J NUTR SCI VITAMINOL, V50, P161, DOI 10.3177/jnsv.50.161; Nakagawa K, 2008, BIOSCI BIOTECH BIOCH, V72, P2210, DOI 10.1271/bbb.80200; Naowaboot J, 2009, PLANT FOOD HUM NUTR, V64, P116, DOI 10.1007/s11130-009-0112-5; Nojima H, 1998, J NAT PROD, V61, P397, DOI 10.1021/np970277l; Onose S, 2013, FOOD CHEM, V138, P516, DOI 10.1016/j.foodchem.2012.11.012; Papandreou MJ, 2002, MOL PHARMACOL, V61, P186, DOI 10.1124/mol.61.1.186; Park JM, 2009, NUTR RES PRACT, V3, P272, DOI 10.4162/nrp.2009.3.4.272; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Scott LJ, 2000, DRUGS, V59, P521, DOI 10.2165/00003495-200059030-00012; Shuang E, 2017, J CLIN BIOCHEM NUTR, V61, P47, DOI 10.3164/jcbn.16-94; STEIN DC, 1984, APPL ENVIRON MICROB, V48, P280, DOI 10.1128/AEM.48.2.280-284.1984; Tsuduki T, 2013, FOOD CHEM, V139, P16, DOI 10.1016/j.foodchem.2013.02.025; Tsuduki T, 2009, J AGR FOOD CHEM, V57, P11024, DOI 10.1021/jf903132r; Yamagishi K, 2017, FOOD SCI TECHNOL RES, V23, P349, DOI 10.3136/fstr.23.349; Yang S, 2017, MOLECULES, V22, DOI 10.3390/molecules22101616	32	10	10	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0199057	10.1371/journal.pone.0199057	http://dx.doi.org/10.1371/journal.pone.0199057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897983	Green Published, gold, Green Submitted			2022-12-26	WOS:000435090700091
J	Verburg, IWM; de Jonge, E; Peek, N; de Keizer, NF				Verburg, Ilona W. M.; de Jonge, Evert; Peek, Niels; de Keizer, Nicolette F.			The association between outcome-based quality indicators for intensive care units	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; LENGTH-OF-STAY; CRITICALLY-ILL PATIENTS; RELIABILITY ADJUSTMENT; DISCHARGE PRACTICES; PREDICTION MODELS; READMISSION RATE; ACUTE PHYSIOLOGY; PERFORMANCE; ICU	Purpose To assess and improve the effectiveness of ICU care, in-hospital mortality rates are often used as principal quality indicator for benchmarking purposes. Two other often used, easily quantifiable, quality indicators to assess the efficiency of ICU care are based on readmission to the ICU and ICU length of stay. Our aim was to examine whether there is an association between case-mix adjusted outcome-based quality indicators in the general ICU population as well as within specific subgroups. Materials and methods We included patients admitted in 2015 of all Dutch ICUs. We derived the standardized in hospital mortality ratio (SMR); the standardized readmission ratio (SRR); and the standardized length of stay ratio (SLOSR). We expressed association through Pearson's correlation coefficients. Results The SMR ranged from 0.6 to 1.5; the SRR ranged from 0.7 to 2.1; and the SLOSR ranged from 0.7 to 1.3. For the total ICU population we found no significant associations. We found a positive, non-significant, association between SMR and SLOSR for admissions with low mortality risk, (r = 0.25; p = 0.024), and a negative association between these indicators for admissions with high-mortality risk (r =-0.49; p<0.001). Conclusion Overall, we found no association at ICU population level. Differential associations were found between performance on mortality and length of stay within different risk strata. We recommend users of quality information to take these three outcome indicators into account when benchmarking ICUs as they capture different aspects of ICU performance. Furthermore, we suggest to report quality indicators for patient subgroups.	[Verburg, Ilona W. M.; de Keizer, Nicolette F.] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, Amsterdam Publ Hlth res inst, Amsterdam, Netherlands; [de Jonge, Evert] Leiden Univ, Med Ctr, Dept Intens Care, Leiden, Netherlands; [Peek, Niels] Univ Manchester, Div Informat Imaging & Data Sci, Manchester, Lancs, England	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Manchester	Verburg, IWM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Informat, Amsterdam Publ Hlth res inst, Amsterdam, Netherlands.	i.w.verburg@amc.uva.nl	Peek, Niels/AAD-9334-2019	Peek, Niels/0000-0002-6393-9969	National Intensive Care Evaluation (NICE) Foundation	National Intensive Care Evaluation (NICE) Foundation	Drs. Verburg and De Keizer's institutions received grant support and support for participation in review activities from the National Intensive Care Evaluation (NICE) Foundation (The NICE Foundation pays the department of Medical Informatics for maintaining the national database, providing feedback reports, and doing analyses; Drs. Verburg and De Keizer are employees of the Department of Medical Informatics). Drs. de Keizer and De Jonge are members of the board of the NICE Foundation.	Bates D, PACKAGE IME4 1; Beck DH, 2002, INTENS CARE MED, V28, P1287, DOI 10.1007/s00134-002-1412-5; Benbassat J, 2000, ARCH INTERN MED, V160, P1074, DOI 10.1001/archinte.160.8.1074; Berenholtz SM, 2002, J CRIT CARE, V17, P1, DOI 10.1053/jcrc.2002.33035; Brinkman S, 2013, INTENS CARE MED, V39, P1925, DOI 10.1007/s00134-013-3042-5; Brinkman S, 2012, CRIT CARE MED, V40, P373, DOI 10.1097/CCM.0b013e318232d7b0; Brown SES, 2012, AM J RESP CRIT CARE, V185, P955, DOI 10.1164/rccm.201109-1720OC; Cooper GS, 1999, MED CARE, V37, P399, DOI 10.1097/00005650-199904000-00009; Dara SI, 2005, CHEST, V128, P567, DOI 10.1378/chest.128.2.567; Davies S., FITTING GEN LINEAR M; Development Core Team R, 2005, LANG ENV STAT COMP; Dimick JB, 2010, HEALTH SERV RES, V45, P1614, DOI 10.1111/j.1475-6773.2010.01158.x; Dutch National Intensive Care Evaluation (NICE) foundation, 2014, DAT IN BEELD; Engerstrom L, 2016, CRIT CARE MED, V44, pE1038, DOI 10.1097/CCM.0000000000001877; Flaatten H, 2012, ACTA ANAESTH SCAND, V56, P1078, DOI 10.1111/j.1399-6576.2012.02656.x; Goldfrad C, 2000, LANCET, V355, P1138, DOI 10.1016/S0140-6736(00)02062-6; Goldstein H, 1996, J ROY STAT SOC A STA, V159, P385, DOI 10.2307/2983325; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Harell FE, 2017, PACKAGE RMS 2017; Hashmi ZG, 2013, J TRAUMA ACUTE CARE, V75, P166, DOI 10.1097/TA.0b013e318298494f; Hofstede SN, 2018, BMJ QUAL SAF, V27, P474, DOI 10.1136/bmjqs-2017-006776; Kaboli PJ, 2012, ANN INTERN MED, V157, P837, DOI 10.7326/0003-4819-157-12-201212180-00003; Kahn JM, 2008, MED CARE, V46, P1226, DOI 10.1097/MLR.0b013e31817d9342; Koetsier A, 2013, METHOD INFORM MED, V52, P432, DOI 10.3414/ME12-02-0070; Kolfschoten NE, 2013, EJSO-EUR J SURG ONC, V39, P156, DOI 10.1016/j.ejso.2012.10.007; Kramer AA, 2013, CRIT CARE MED, V41, P24, DOI 10.1097/CCM.0b013e3182657b8a; Mainz J, 2003, INT J QUAL HEALTH C, V15, P523, DOI 10.1093/intqhc/mzg081; Metnitz PGH, 2003, INTENS CARE MED, V29, P241, DOI 10.1007/s00134-002-1584-z; Moran JL, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-68; Mulvey GK, 2009, CIRC-CARDIOVASC QUAL, V2, P558, DOI 10.1161/CIRCOUTCOMES.108.826784; Pouw ME, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5913; Roos-Blom MJ, 2015, STUD HEALTH TECHNOL, V210, P429, DOI 10.3233/978-1-61499-512-8-429; Rosenberg AL, 2000, CHEST, V118, P492, DOI 10.1378/chest.118.2.492; Rosenberg AL, 2001, CRIT CARE MED, V29, P511, DOI 10.1097/00003246-200103000-00008; Russell S, 1999, HEART LUNG, V28, P365, DOI 10.1053/hl.1999.v28.a101055; Rydenfelt K, 2015, ACTA ANAESTH SCAND, V59, P846, DOI 10.1111/aas.12554; Savicky P., 2017, TEST ASS CORRELATION; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Strand K, 2010, CRIT CARE, V14, DOI 10.1186/cc9279; van de Klundert N, 2015, INT J EPIDEMIOL, V44, P1850, DOI 10.1093/ije/dyv291; van Sluisveld N, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2234-z; Vasilevskis EE, 2009, MED CARE, V47, P803, DOI 10.1097/MLR.0b013e3181a39454; Verburg IWM, 2018, STAT METHODS MED RES, V27, P3350, DOI 10.1177/0962280217700169; Verburg IWM, 2018, J CRIT CARE, V43, P114, DOI 10.1016/j.jcrc.2017.08.014; Verburg IWM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109684; Williams Teresa, 2004, Aust Health Rev, V28, P87; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	47	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198522	10.1371/journal.pone.0198522	http://dx.doi.org/10.1371/journal.pone.0198522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897994	Green Published, gold, Green Submitted			2022-12-26	WOS:000435090700057
J	Kisner, A; Slocomb, JE; Sarsfield, S; Zuccoli, ML; Siemian, J; Gupta, JF; Kumar, A; Aponte, Y				Kisner, Alexandre; Slocomb, Julia E.; Sarsfield, Sarah; Zuccoli, Maria Laura; Siemian, Justin; Gupta, Jay F.; Kumar, Arvind; Aponte, Yeka			Electrophysiological properties and projections of lateral hypothalamic parvalbumin positive neurons	PLOS ONE			English	Article							IMMUNOREACTIVE PV1 NUCLEUS; GABAERGIC INTERNEURONS; SYSTEM; OBESITY; REWARD; GABA; FEAR	Cracking the cytoarchitectural organization, activity patterns, and neurotransmitter nature of genetically-distinct cell types in the lateral hypothalamus (LH) is fundamental to develop a mechanistic understanding of how activity dynamics within this brain region are generated and operate together through synaptic connections to regulate circuit function. However, the precise mechanisms through which LH circuits orchestrate such dynamics have remained elusive due to the heterogeneity of the intermingled and functionally distinct cell types in this brain region. Here we reveal that a cell type in the mouse LH identified by the expression of the calcium-binding protein parvalbumin (PVALB; LHPV) is fast-spiking, releases the excitatory neurotransmitter glutamate, and sends long range projections throughout the brain. Thus, our findings challenge long-standing concepts that define neurons with a fast-spiking phenotype as exclusively GABAergic. Furthermore, we provide for the first time a detailed characterization of the electrophysiological properties of these neurons. Our work identifies LHPV neurons as a novel functional component within the LH glutamatergic circuitry.	[Kisner, Alexandre; Slocomb, Julia E.; Sarsfield, Sarah; Zuccoli, Maria Laura; Siemian, Justin; Gupta, Jay F.; Aponte, Yeka] NIDA, Neuronal Circuits & Behav Unit, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Zuccoli, Maria Laura] Univ Genoa, Dept Internal Med, Pharmacol & Toxicol Unit, Genoa, Italy; [Kumar, Arvind] KTH Royal Inst Technol, Sch Elect Engn & Comp Sci, Dept Computat Sci & Technol, Stockholm, Sweden; [Aponte, Yeka] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); University of Genoa; Royal Institute of Technology; Johns Hopkins University	Aponte, Y (corresponding author), NIDA, Neuronal Circuits & Behav Unit, Intramural Res Program, NIH, Baltimore, MD 21224 USA.; Aponte, Y (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	yeka.aponte@nih.gov	Aponte, Yeka/AAL-4643-2020; Sarsfield, Sarah/Y-5113-2019	Aponte, Yeka/0000-0002-5967-2579; Kisner, Alexandre/0000-0002-1462-2228; Kumar, Arvind/0000-0002-8044-9195; Gupta, Jay/0000-0002-1779-042X	National Institute on Drug Abuse Intramural Research Program, U.S. National Institutes of Health; Swedish Research Foundation (Strategic Research Area Neuroscience - StratNeuro Program); NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000595] Funding Source: NIH RePORTER	National Institute on Drug Abuse Intramural Research Program, U.S. National Institutes of Health; Swedish Research Foundation (Strategic Research Area Neuroscience - StratNeuro Program); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Y. Aponte is supported by the National Institute on Drug Abuse Intramural Research Program, U.S. National Institutes of Health. A. Kumar is supported by the Swedish Research Foundation (Strategic Research Area Neuroscience - StratNeuro Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis A, 2008, CELL MOL LIFE SCI, V65, P1475, DOI 10.1007/s00018-008-7521-8; Alcaraz F, 2015, J NEUROSCI, V35, P13183, DOI 10.1523/JNEUROSCI.1237-15.2015; Aponte Y, 2006, J PHYSIOL-LONDON, V574, P229, DOI 10.1113/jphysiol.2005.104042; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Cason AM, 2010, PHYSIOL BEHAV, V100, P419, DOI 10.1016/j.physbeh.2010.03.009; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Franklin K. B. J., 2013, PAXINOS FRANKLINS MO, V1; Girard F, 2011, EUR J NEUROSCI, V34, P1934, DOI 10.1111/j.1460-9568.2011.07918.x; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Jennings JH, 2013, SCIENCE, V341, P1517, DOI 10.1126/science.1241812; Keshavarzi S, 2014, J NEUROSCI, V34, P8699, DOI 10.1523/JNEUROSCI.1176-14.2014; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Lintas A, 2014, NEUROSCI LETT, V571, P29, DOI 10.1016/j.neulet.2014.04.023; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandelblat-Cerf Y, 2015, ELIFE, V4, DOI 10.7554/eLife.07122; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Meszar Z, 2012, J COMP NEUROL, V520, P798, DOI 10.1002/cne.22789; Opland D, 2013, MOL METAB, V2, P423, DOI 10.1016/j.molmet.2013.07.008; Peng HC, 2014, NAT PROTOC, V9, P193, DOI 10.1038/nprot.2014.011; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Povysheva NV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070553; Qi J, 2016, NAT NEUROSCI, V19, P725, DOI 10.1038/nn.4281; Root DH, 2014, NAT NEUROSCI, V17, P1543, DOI 10.1038/nn.3823; Shang CP, 2015, SCIENCE, V348, P1472, DOI 10.1126/science.aaa8694; Stamatakis AM, 2016, J NEUROSCI, V36, P302, DOI 10.1523/JNEUROSCI.1202-15.2016; Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14; van den Pol AN, 2003, NEURON, V40, P1059, DOI 10.1016/S0896-6273(03)00809-2; Wallace ML, 2017, NEURON, V94, P138, DOI 10.1016/j.neuron.2017.03.017; Watson TC, 2016, J NEUROSCI, V36, P12707, DOI 10.1523/JNEUROSCI.1100-16.2016; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217	33	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198991	10.1371/journal.pone.0198991	http://dx.doi.org/10.1371/journal.pone.0198991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894514	Green Published, gold, Green Submitted			2022-12-26	WOS:000435030900039
J	McCudden, C; Akbari, A; White, CA; Biyani, M; Hiremath, S; Brown, PA; Tangri, N; Brimble, S; Knoll, G; Blake, PG; Sood, MM				McCudden, Christopher; Akbari, Ayub; White, Christine A.; Biyani, Mohan; Hiremath, Swapnil; Brown, Pierre Antoine; Tangri, Navdeep; Brimble, Scott; Knoll, Greg; Blake, Peter G.; Sood, Manish M.			Individual patient variability with the application of the kidney failure risk equation in advanced chronic kidney disease	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; COOKED-MEAT MEAL; PREDICTION; CREATININE; MODEL	The Kidney Failure Risk Equation (KFRE) predicts the need for dialysis or transplantation using age, sex, estimated glomerular filtration rate (eGFR), and urine albumin to creatinine ratio (ACR). The eGFR and ACR have known biological and analytical variability. We examined the effect of biological and analytical variability of eGFR and ACR on the 2-year KFRE predicted kidney failure probabilities using single measure and the average of repeat measures of simulated eGFR and ACR. Previously reported values for coefficient of variation (CV) for ACR and eGFR were used to calculate day to day variability. Variation was also examined with outpatient laboratory data from patients with an eGFR between 15 and 50 mL/min/1.72 m(2). A web application was developed to calculate and model day to day variation in risk. The biological and analytical variability related to ACR and eGFR lead to variation in the predicted probability of kidney failure. A male patient age 50, ACR 30 mg/mmol and eGFR 25, had a day to day variation in risk of 7% (KFRE point estimate: 17%, variability range 14% to 21%). The addition of inter laboratory variation due to different instrumentation increased the variability to 9% (KFRE point estimate 17%, variability range 13% to 22%). Averaging of repeated measures of eGFR and ACR significantly decreased the variability (KFRE point estimate 17%, variability range 15% to 19%). These findings were consistent when using outpatient laboratory data which showed that most patients had a KFRE 2-year risk variability of <= 5% (79% of patients). Approximately 13% of patients had variability from 5-10% and 8% had variability > 10%. The mean age (SD) of this cohort was 64 (15) years, 36% were females, the mean (SD) eGFR was 32 (10) ml/min/1.73m(2) and median (IQR) ACR was 22.7 (110). Biological and analytical variation intrinsic to the eGFR and ACR may lead to a substantial degree of variability that decreases with repeat measures. Use of a web application may help physicians and patients understand individual patient's risk variability and communicate risk (https://mccudden.shinyapps.io/kfre_app/). The web application allows the user to alter age, gender, eGFR, ACR, CV (for both eGFR and ACR) as well as units of measurements for ACR (g/mol versus mg/g).	[McCudden, Christopher] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Akbari, Ayub; Biyani, Mohan; Hiremath, Swapnil; Brown, Pierre Antoine; Knoll, Greg; Sood, Manish M.] Univ Ottawa, Div Nephrol, Dept Med, Ottawa, ON, Canada; [Akbari, Ayub; Biyani, Mohan; Hiremath, Swapnil; Brown, Pierre Antoine; Knoll, Greg; Sood, Manish M.] Ottawa Hosp, Res Inst, Kidney Res Ctr, Ottawa, ON, Canada; [White, Christine A.] Queens Univ, Div Nephrol, Dept Med, Kingston, ON, Canada; [Tangri, Navdeep] Univ Manitoba, Oaks Gen Hosp 7, Winnipeg, MB, Canada; [Brimble, Scott] McMaster Univ, Div Nephrol, Dept Med, Hamilton, ON, Canada; [Blake, Peter G.] Western Univ, London, ON, Canada; [Blake, Peter G.] London Hlth Sci Ctr, London, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Queens University - Canada; University of Manitoba; McMaster University; Western University (University of Western Ontario); London Health Sciences Centre	Akbari, A (corresponding author), Univ Ottawa, Div Nephrol, Dept Med, Ottawa, ON, Canada.; Akbari, A (corresponding author), Ottawa Hosp, Res Inst, Kidney Res Ctr, Ottawa, ON, Canada.	aakbari@ottawahospital.on.ca	Sood, Manish M/H-3134-2019; Brown, Pierre Antoine/L-2175-2019; Blake, Peter/G-3279-2011; Hiremath, Swapnil/H-3492-2019	Sood, Manish M/0000-0002-9146-2344; Brown, Pierre Antoine/0000-0002-0283-4530; Hiremath, Swapnil/0000-0003-0010-3416; Knoll, Greg/0000-0001-5442-9310; McCudden, Christopher/0000-0002-4172-4641; White, Christine/0000-0001-7546-393X	Department of medicine at the Ottawa Hospital/University of Ottawa; Kidney Research Centre	Department of medicine at the Ottawa Hospital/University of Ottawa; Kidney Research Centre	Ayub Akbari, Greg Knoll, Swapnil Hiremath and Manish Sood received salary support from the Department of medicine at the Ottawa Hospital/University of Ottawa and clinical research support from the Kidney Research Centre.	Delanaye P, 2011, NEPHRON CLIN PRACT, V119, pC187, DOI 10.1159/000328911; Fraser CG, 2001, BIOL VARIATION PRINC; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hansen HP, 2002, KIDNEY INT, V61, P163, DOI 10.1046/j.1523-1755.2002.00092.x; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Lee E, 2017, CLIN J AM SOC NEPHRO, V12, P29, DOI 10.2215/CJN.05400516; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Nair S, 2014, DIABETES CARE, V37, P483, DOI 10.2337/dc13-1770; Naresh CN, 2013, AM J KIDNEY DIS, V62, P1095, DOI 10.1053/j.ajkd.2013.06.016; Ontario Renal Network, 2016, ONT 2016 CKD SYST AT; Preiss DJ, 2007, ANN CLIN BIOCHEM, V44, P35, DOI 10.1258/000456307779595995; RICOS C, 1994, CLIN CHEM, V40, P472; Selvin E, 2013, AM J KIDNEY DIS, V61, P716, DOI 10.1053/j.ajkd.2012.11.048; Sontrop Jessica M, 2016, Can J Kidney Health Dis, V3, P3, DOI 10.1186/s40697-016-0095-8; Stemp J., REV PROFICIENCY TEST; Tangri N, 2016, JAMA-J AM MED ASSOC, V315, P164, DOI 10.1001/jama.2015.18202; Tangri N, 2013, J CLIN EPIDEMIOL, V66, P697, DOI 10.1016/j.jclinepi.2012.11.012; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Team RC, 2016, R LANG ENV STAT COMP; Wavamunno MD, 2005, KIDNEY INT, V67, pS128, DOI 10.1111/j.1523-1755.2005.09429.x; White CA., 2017, CANADIAN J KIDNEY HL, V4, P1; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wojciechowski P, 2016, ADV CHRONIC KIDNEY D, V23, P227, DOI 10.1053/j.ackd.2016.04.002	24	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198456	10.1371/journal.pone.0198456	http://dx.doi.org/10.1371/journal.pone.0198456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894480	Green Submitted, Green Published, gold			2022-12-26	WOS:000435030900013
J	Tao, YH; Niu, YA; Wang, Y; Chen, TX; Naveed, SA; Zhang, J; Xu, JL; Li, ZK				Tao, Yonghong; Niu, Yanan; Wang, Yun; Chen, Tianxiao; Naveed, Shahzad Amir; Zhang, Jian; Xu, Jianlong; Li, Zhikang			Genome-wide association mapping of aluminum toxicity tolerance and fine mapping of a candidate gene for Nratl in rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ORYZA-SATIVA L.; AL-TOLERANCE; ABIOTIC STRESS; QTL; IDENTIFICATION; EXPRESSION; TRANSPORTER; POPULATIONS; CULTIVARS	Aluminum (Al) stress is becoming the major limiting factor in crop production in acidic soils. Rice has been reported as the most Al-tolerant crop and the capacity of Al toxicity tolerance is generally evaluated by comparing root growth under Al stress. Here, we performed an association mapping of Al toxicity tolerance using a core collection of 211 indica rice accessions with 700 K high quality SNP data. A total of 21 putative QTL affecting shoot height (SH), root length (RL), shoot fresh weight (SFW), shoot dry weight (SDW), root dry weight (RDW) and shoot water content (SWC) were identified at seedling stage, including three QTL detected only under control condition, eight detected only under Al stress condition, ten simultaneously detected in both control and Al stress conditions, and seven were identified by stress tolerance index of their corresponding traits. Total of 21 candidate genes for 7 important QTL regions associated with Al toxicity tolerance were identified based on combined haplotype analysis and functional annotation, and the most likely candidate gene(s) for each important QTL were also discussed. Also a candidate gene Nratl on chromosome 2 was further fine-mapped using BSA-seq and linkage analysis in the F2 population derived from the cross of Al tolerant accession CC105 and super susceptible accession CC180. A new non-synonymous SNP variation was observed at Nratl between CC105 and CC180, which resulted in an amino-acid substitution from Ala (A) in CC105 to Asp (D) in CC180. Haplotype analysis of Nratl using 327 3K RGP accessions indicated that minor allele variations in aus and indica subpopulations decreased Al toxicity tolerance in rice. The candidate genes identified in this study provide valuable information for improvement of Al toxicity tolerance in rice. Our research indicated that minor alleles are important for QTL mapping and its application in rice breeding when natural gene resources are used.	[Tao, Yonghong; Niu, Yanan; Wang, Yun; Chen, Tianxiao; Naveed, Shahzad Amir; Xu, Jianlong; Li, Zhikang] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing, Peoples R China; [Zhang, Jian] Beijing Acad Agr & Forestry Sci, Beijing Vegetable Res Ctr, Beijing, Peoples R China; [Xu, Jianlong; Li, Zhikang] Chinese Acad Agr Sci, Shenzhen Inst Breeding & Innovat, Shenzhen, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Beijing Academy of Agriculture & Forestry; Chinese Academy of Agricultural Sciences	Xu, JL (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing, Peoples R China.; Zhang, J (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Vegetable Res Ctr, Beijing, Peoples R China.; Xu, JL (corresponding author), Chinese Acad Agr Sci, Shenzhen Inst Breeding & Innovat, Shenzhen, Peoples R China.	zhangjian@nercv.org; xujlcaas@126.com	Xu, Jianlong/AAI-8310-2020	Niu, Yanan/0000-0002-6874-7069	863 Key Project from the Chinese Ministry of Science Technology; Agricultural Science and Technology Innovation Program Cooperation and Innovation Mission [CMS-ZDXT201800]; Bill & Melinda Gates Foundation [0PP1130530]; Shenzhen Peacock Plan [20130415095710361]; 948 Project from the Chinese Ministry of Agriculture [2016-X16]	863 Key Project from the Chinese Ministry of Science Technology; Agricultural Science and Technology Innovation Program Cooperation and Innovation Mission; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Shenzhen Peacock Plan; 948 Project from the Chinese Ministry of Agriculture	This research was financially supported by the 863 Key Project to JX (2014AA10A601) from the Chinese Ministry of Science & Technology (http://www863.gov.cn/), the Agricultural Science and Technology Innovation Program Cooperation and Innovation Mission (CMS-ZDXT201800), the Bill & Melinda Gates Foundation to ZK Li (0PP1130530), and the Shenzhen Peacock Plan (20130415095710361) to ZL (http://www.szsti.gov.cn), the 948 Project to JX (2016-X16) from the Chinese Ministry of Agriculture (http://www.moa.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Alexandrov N, 2015, NUCLEIC ACIDS RES, V43, pD1023, DOI 10.1093/nar/gku1039; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bojorquez-Quintal E, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01767; Caniato FF, 2007, THEOR APPL GENET, V114, P863, DOI 10.1007/s00122-006-0485-x; Chen FF, 2017, THEOR APPL GENET, V130, P1549, DOI 10.1007/s00122-017-2909-1; Chen LJ, 2013, PLANT PHYSIOL, V163, P1752, DOI 10.1104/pp.113.224881; Chen ZC, 2012, PLANT PHYSIOL, V159, P1624, DOI 10.1104/pp.112.199778; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Famoso AN, 2010, PLANT PHYSIOL, V153, P1678, DOI 10.1104/pp.110.156794; Feng B, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00306; GIOVANNONI JJ, 1991, NUCLEIC ACIDS RES, V19, P6553, DOI 10.1093/nar/19.23.6553; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Krill AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009958; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JY, 2014, P NATL ACAD SCI USA, V111, P6503, DOI 10.1073/pnas.1318975111; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HF, 2014, THEOR APPL GENET, V127, P1491, DOI 10.1007/s00122-014-2313-z; Ma JF, 2002, PLANT CELL PHYSIOL, V43, P652, DOI 10.1093/pcp/pcf081; Magalhaes JV, 2004, GENETICS, V167, P1905, DOI 10.1534/genetics.103.023580; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; Meng L, 2015, CROP J, V3, P269, DOI 10.1016/j.cj.2015.01.001; Meng LJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01822; Munde N. A., 2016, Indian Journal of Plant Physiology, V21, P161, DOI 10.1007/s40502-016-0217-4; Nakajima H, 2009, J BIOL CHEM, V284, P34331, DOI 10.1074/jbc.M109.027698; Navakode S, 2014, EUPHYTICA, V198, P401, DOI 10.1007/s10681-014-1114-4; Navakode S, 2009, CEREAL RES COMMUN, V37, P531, DOI 10.1556/CRC.37.2009.4.6; Nguyen BD, 2003, THEOR APPL GENET, V106, P583, DOI 10.1007/s00122-002-1072-4; Nguyen VT, 2002, MOL GENET GENOMICS, V267, P772, DOI 10.1007/s00438-002-0686-1; Nguyen VT, 2001, THEOR APPL GENET, V102, P1002, DOI 10.1007/s001220000472; Ninamango-Cardenas FE, 2003, EUPHYTICA, V130, P223, DOI 10.1023/A:1022867416513; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Rodriguez-Uribe L, 2011, PLANT SCI, V180, P461, DOI 10.1016/j.plantsci.2010.10.009; RYAN PR, 1992, PLANT PHYSIOL, V99, P1193, DOI 10.1104/pp.99.3.1193; Singh UM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00286; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Wang CY, 2013, J PROTEOMICS, V78, P281, DOI 10.1016/j.jprot.2012.09.035; Wang H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00266; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu P, 1997, EUPHYTICA, V97, P289, DOI 10.1023/A:1003084409038; Xia JX, 2014, J EXP BOT, V65, P4297, DOI 10.1093/jxb/eru201; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Xue Y, 2006, EUPHYTICA, V150, P37, DOI 10.1007/s10681-006-9089-4; Yamaji N, 2009, PLANT CELL, V21, P3339, DOI 10.1105/tpc.109.070771; Yang ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068433; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; Zhang CB, 2010, BIOTECHNOL LETT, V32, P861, DOI 10.1007/s10529-010-0220-1; Zhang J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4221-5; Zhang P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01415; Zhou LL, 2007, MOL BREEDING, V19, P153, DOI 10.1007/s11032-006-9054-x; Zou C, 2016, PLANT BIOTECHNOL J, V14, P1941, DOI 10.1111/pbi.12559	53	19	19	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198589	10.1371/journal.pone.0198589	http://dx.doi.org/10.1371/journal.pone.0198589			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894520	Green Published, Green Submitted, gold			2022-12-26	WOS:000435030900021
J	Tatebayashi, D; Himori, K; Yamada, R; Ashida, Y; Miyazaki, M; Yamada, T				Tatebayashi, Daisuke; Himori, Koichi; Yamada, Ryotaro; Ashida, Yuki; Miyazaki, Mitsunori; Yamada, Takashi			High-intensity eccentric training ameliorates muscle wasting in colon 26 tumor-bearing mice	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; MYOSIN HEAVY-CHAIN; PARENTERAL-NUTRITION; CANCER; ATROPHY; CACHEXIA; ACTIVATION; EXPRESSION; AUTOPHAGY; EXERCISE	Eccentric (ECC) contractions are used to maintain skeletal muscle mass and strength in healthy subjects and patients. Here we investigated the effects of ECC training induced by electrical stimulation (ES) on muscle wasting in colon 26 (C-26) tumor-bearing mice. Mice were divided into four groups: control (CNT), CNT + ECC, C-26, and C-26 + ECC. Cancer cachexia was induced by a subcutaneous injection of C-26 cells and developed for four weeks. In experiment 1, muscle protein synthesis rate and mammalian target of rapamycin complex (mTORC) 1 signaling were investigated six hours after one bout of ECC-ES (2 s contraction given every 6 s, 20 degrees/s, 4 sets of 5 contractions). In experiment 2, ECC-ES training, a total of 14 sessions, was performed every other day starting one day after C-26 injection. Compared to the CNT mice, the gastrocnemius muscle weight was significantly decreased in the tumor-bearing mice. This change was accompanied by a reduction in protein synthesis rate and a marked increase in the expression levels of genes including regulated in development and DNA damage responses (REDD) 1, forkhead box protein 01 (FoxO1), muscle-specific E3 ubiquitin ligases atrogin-1, and muscle ring finger 1 (MuRF-1) mRNA. ECC-ES increased the protein synthesis rate and the phosphorylation levels of p70S6K (Thr389) and rpS6 (Ser240/244), markers for mTORC1 signaling, and reversed an upregulation of MuRF-1 mRNA in muscles from C-26 mice. Our findings suggest that ECC-ES training reduces skeletal muscle atrophy in C-26 tumor-bearing mice through activation of mTORC1 signaling and the inhibition of ubiquitin-proteasome pathway. Thus, ECC-ES training might be used to effectively ameliorate muscle wasting in patients with cancer cachexia.	[Tatebayashi, Daisuke; Himori, Koichi; Yamada, Ryotaro; Ashida, Yuki; Yamada, Takashi] Sapporo Med Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Miyazaki, Mitsunori] Hlth Sci Univ Hokkaido, Sch Rehabil Sci, Tobetsu, Japan	Sapporo Medical University; Health Sciences University of Hokkaido	Yamada, T (corresponding author), Sapporo Med Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan.	takashi.yamada1976@sapmed.ac.jp	Miyazaki, Mitsunori/AAM-8598-2021; Yamada, Takashi/AAZ-6212-2021; Yamada, Takashi/U-8443-2019	Miyazaki, Mitsunori/0000-0001-7824-2091; Yamada, Takashi/0000-0003-1797-3880; Yamada, Takashi/0000-0003-1797-3880	Japan Society for the Promotion of Science [50583176]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by grants from the Japan Society for the Promotion of Science (No. 50583176).	Adams GR, 2004, J APPL PHYSIOL, V96, P1613, DOI 10.1152/japplphysiol.01162.2003; al-Majid S, 2001, Biol Res Nurs, V2, P155, DOI 10.1177/109980040100200301; Ashida Y, 2018, J APPL PHYSIOL, V124, P341, DOI 10.1152/japplphysiol.00708.2017; Ato S, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12976; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun TP, 2013, FASEB J, V27, P3572, DOI 10.1096/fj.13-230375; Britto FA, 2014, AM J PHYSIOL-ENDOC M, V307, pE983, DOI 10.1152/ajpendo.00234.2014; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Cosper PF, 2012, INT J CANCER, V130, P2722, DOI 10.1002/ijc.26298; EVANS WK, 1985, CANCER RES, V45, P3347; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Gordon BS, 2014, AM J PHYSIOL-ENDOC M, V307, pE703, DOI 10.1152/ajpendo.00250.2014; Grande AJ, 2015, J CACHEXIA SARCOPENI, V6, P208, DOI 10.1002/jcsm.12055; Gregory CM, 2005, PHYS THER, V85, P358, DOI 10.1093/ptj/85.4.358; Hardee JP, 2018, J CACHEXIA SARCOPENI, V9, P369, DOI 10.1002/jcsm.12271; Hardee JP, 2016, J APPL PHYSIOL, V120, P29, DOI 10.1152/japplphysiol.00416.2015; Hoffman EP, 2004, NAT MED, V10, P584, DOI 10.1038/nm0604-584; Hurley BF, 2011, SPORTS MED, V41, P289, DOI 10.2165/11585920-000000000-00000; Maddocks M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009419.pub2; Maddocks Matthew, 2012, Critical Reviews in Oncogenesis, V17, P285; Maffiuletti NA, 2010, EUR J APPL PHYSIOL, V110, P223, DOI 10.1007/s00421-010-1502-y; Martinet W, 2006, J HISTOCHEM CYTOCHEM, V54, P85, DOI 10.1369/jhc.5A6743.2005; McCall GE, 1998, J APPL PHYSIOL, V84, P1407, DOI 10.1152/jappl.1998.84.4.1407; MCGEER AJ, 1990, NUTRITION, V6, P233; Ochala J, 2008, EXP PHYSIOL, V93, P486, DOI 10.1113/expphysiol.2007.041798; Phillips SM, 2009, J APPL PHYSIOL, V107, P645, DOI 10.1152/japplphysiol.00452.2009; Pigna E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26991; Place N, 2010, EUR J APPL PHYSIOL, V110, P1, DOI 10.1007/s00421-010-1480-0; Puppa MJ, 2014, J APPL PHYSIOL, V116, P1078, DOI 10.1152/japplphysiol.01270.2013; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Schwalm C, 2015, FASEB J, V29, P3515, DOI 10.1096/fj.14-267187; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; TANAKA Y, 1990, CANCER RES, V50, P2290; Tatebayashi D., 2016, JPN J ELECTROAGENTS JPN J ELECTROAGENTS, V23, P35; Thompson LV, 2006, J APPL PHYSIOL, V101, P1581, DOI 10.1152/japplphysiol.00426.2006; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Troncoso R, 2014, CELL CYCLE, V13, P2281, DOI 10.4161/cc.29272	43	8	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0199050	10.1371/journal.pone.0199050	http://dx.doi.org/10.1371/journal.pone.0199050			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894511	Green Submitted, Green Published, gold			2022-12-26	WOS:000435030900047
J	Kilmarx, PH; Gonese, E; Lewis, DA; Chirenje, ZM; Barr, BAT; Latif, AS; Gwanzura, L; Handsfield, HH; Machiha, A; Mugurungi, O; Rietmeijer, CA				Kilmarx, Peter H.; Gonese, Elizabeth; Lewis, David A.; Chirenje, Z. Mike; Barr, Beth A. Tippett; Latif, Ahmed S.; Gwanzura, Lovemore; Handsfield, H. Hunter; Machiha, Anna; Mugurungi, Owen; Rietmeijer, Cornelius A.			HIV infection in patients with sexually transmitted infections in Zimbabwe - Results from the Zimbabwe STI etiology study	PLOS ONE			English	Article							DISEASES	Background HIV and other sexually transmitted infections (STI) frequently co-occur. We conducted HIV diagnostic testing in an assessment of the etiologies of major STI syndromes in Zimbabwe. Methods A total of 600 patients were enrolled at six geographically diverse, high-volume STI clinics in Zimbabwe in 2014-15: 200 men with urethral discharge, 200 women with vaginal discharge, and 100 men and 100 women each with genital ulcer disease (GUD). Patients completed a questionnaire, underwent a genital examination, and had specimens taken for etiologic testing. Patients were offered, but not required to accept, HIV testing using a standard HIV algorithm in which two rapid tests defined a positive result. Results A total of 489 participants (81.5%) accepted HIV testing; 201 (41.1%) tested HIV-1-positive, including 16 (11.9%) of 134 participants who reported an HIV-negative status at study enrollment, and 58 (28.2%) of 206 participants who reported their HIV status as unknown. Of 147 who self-reported being HIV-positive at study enrollment, 21 (14.3%) tested HIV negative. HIV infection prevalence was higher in women (47.3%) than in men (34.8%, p<0.01), and was 28.5% in men with urethral discharge, 40.5% in women with vaginal discharge, 45.2% in men with GUD, and 59.8% in women with GUD (p<0.001). Conclusions The high prevalence of HIV infection in STI clinic patients in Zimbabwe underscores the importance of providing HIV testing and referral for indicated prevention and treatment services for this population. The discrepancy between positive self-reported and negative study HIV test results highlights the need for operator training, strict attention to laboratory quality assurance, and clear communication with patients about their HIV infection status.	[Kilmarx, Peter H.; Barr, Beth A. Tippett] Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA 30333 USA; [Kilmarx, Peter H.; Gonese, Elizabeth; Barr, Beth A. Tippett] US Ctr Dis Control & Prevent, Div Global HIV & TB, Harare, Zimbabwe; [Lewis, David A.] Univ Sydney, Sydney Med Sch Westmead, Marie Bashir Inst Infect Dis & Biosecur, Western Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [Chirenje, Z. Mike] Univ Zimbabwe, Coll Hlth Sci, Dept Obstet Gynecol & Reprod Sci, Harare, Zimbabwe; [Latif, Ahmed S.] Publ Hlth Consultant, Brisbane, Qld, Australia; [Gwanzura, Lovemore] Univ Zimbabwe, Coll Hlth Sci, Dept Med Lab Sci, Harare, Zimbabwe; [Handsfield, H. Hunter] Univ Washington, Dept Med, Seattle, WA USA; [Machiha, Anna; Mugurungi, Owen] Zimbabwe Minist Hlth & Child Care, Harare, Zimbabwe; [Rietmeijer, Cornelius A.] Univ Zimbabwe, Coll Med, Dept Community Med, Surveillance Evaluat Assessment & Monitoring SEAM, Harare, Zimbabwe; [Rietmeijer, Cornelius A.] Univ Colorado, Colorado Sch Publ Hlth, Denver, CO 80202 USA; [Rietmeijer, Cornelius A.] Rietmeijer Consulting, Denver, CO USA; [Kilmarx, Peter H.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; University of Sydney; University of Zimbabwe; University of Zimbabwe; University of Washington; University of Washington Seattle; University of Zimbabwe; Colorado School of Public Health; University of Colorado System; University of Colorado Denver; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Kilmarx, PH (corresponding author), Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA 30333 USA.; Kilmarx, PH (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV & TB, Harare, Zimbabwe.; Kilmarx, PH (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.	peter.kilmarx@nih.gov	Tippett Barr, Beth A./GLU-1101-2022; Barr, Beth Tippett/L-5008-2019; Unemo, Magnus/ABD-6653-2021	Barr, Beth Tippett/0000-0001-5877-2968; Lewis, David/0000-0002-5534-8392; Kilmarx, Peter/0000-0001-6464-3345	U.S. Centers for Disease Control and Prevention (CDC); University of Zimbabwe Department of Community Medicine SEAM Project [1U2GGH000315-01]; Rietmeijer Consulting, Denver, Colorado, USA	U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); University of Zimbabwe Department of Community Medicine SEAM Project; Rietmeijer Consulting, Denver, Colorado, USA	The Zimbabwe STI Etiology Study was supported by funds from the President's Emergency Plan for AIDS Relief (PEPFAR) through a cooperative agreement between the U.S. Centers for Disease Control and Prevention (CDC) and the University of Zimbabwe Department of Community Medicine SEAM Project under the terms of Cooperative Agreement Number: 1U2GGH000315-01 and a sub-grant to Rietmeijer Consulting, Denver, Colorado, USA. Under the terms of the cooperative agreement, CDC scientists collaborated in the research and the research protocol and manuscripts were reviewed and cleared by the CDC. Dr. Rietmeijer is the sole proprietor of Rietmeijer Consulting. Rietmeijer Consulting provided support in the form of salary for author CAR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Batteiger BE, 2010, J INFECT DIS, V201, pS178, DOI 10.1086/652400; Centers for Disease Control and Prevention Health Resources and Services Administration National Institutes of Health American Academy of HIV Medicine Association of Nurses in AIDS Care International Association of Providers of AIDS Care the National Minority AIDS Council Urban Coalition for HIV/AIDS Prevention Services, 2014, REC HIV PREV AD AD H, V2014; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Gaydos C, 2014, EXPERT REV ANTI-INFE, V12, P657, DOI 10.1586/14787210.2014.880651; Mhlongo S, 2010, SEX TRANSM DIS, V37, P566, DOI 10.1097/OLQ.0b013e3181d877b7; Parekh BS, 2010, AM J CLIN PATHOL, V134, P573, DOI 10.1309/AJCPTDIMFR00IKYX; Paz-Bailey G, 2005, CLIN INFECT DIS, V41, P1304, DOI 10.1086/496979; Pickering JM, 2005, SEX TRANSM INFECT, V81, P488, DOI 10.1136/sti.2004.013276; Rietmeijer C, 2017, ZIMBABWE STI ETIOLOG; The Zimbabwe STI Aetiology Study Group, 2014, AET SEX TRANSM INF Z; UNAIDS, 2015, COUNTR PROF ZIMB; WHO, 2015, CONSOLIDATED GUIDELI; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; World Health Organization, 2015, GUID START ANT THER; Zimba TF, 2011, J INFECT DEV COUNTR, V5, P41	15	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198683	10.1371/journal.pone.0198683	http://dx.doi.org/10.1371/journal.pone.0198683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889865	Green Published, Green Submitted, gold			2022-12-26	WOS:000434786600035
J	Dong, KR; Tang, AM; Stopka, TJ; Becicwith, CG; Must, A				Dong, Kimberly R.; Tang, Alice M.; Stopka, Thomas J.; Becicwith, Curt G.; Must, Aviva			Food acquisition methods and correlates of food insecurity in adults on probation in Rhode Island	PLOS ONE			English	Article							LOW-INCOME FAMILIES; DEPRESSIVE SYMPTOMS; REGRESSION-MODELS; SEXUAL-BEHAVIOR; SUBSTANCE USE; 12 STATES; RISK; OBESITY; HEALTH; HIV	Background Individuals under community corrections supervision may be at increased risk for food insecurity because they face challenges similar to other marginalized populations, such as people experiencing housing instability or substance users. The prevalence of food insecurity and its correlates have not been studied in the community corrections population. Methods We conducted a cross-sectional study in 2016, surveying 304 probationers in Rhode Island to estimate the prevalence of food insecurity, identify food acquisition methods, and determine characteristics of groups most at-risk for food insecurity. We used chi-square and Fisher's exact tests to assess differences in sociodemographics and eating and food acquisition patterns, GIS to examine geospatial differences, and ordinal logistic regression to identify independent correlates across the four levels of food security. Results Nearly three-quarters (70.4%) of the participants experienced food insecurity, with almost half (48.0%) having very low food security. This is substantially higher than the general population within the state of Rhode Island, which reported a prevalence of 12.8% food insecurity with 6.1% very low food security in 2016. Participants with very low food security most often acquired lunch foods from convenience stores (and less likely from grocery stores) compared to the other three levels of food security. Participants did not differ significantly with regards to places for food acquisition related to breakfast or dinner meals based upon food security status. In adjusted models, being homeless (AOR 2.34, 95% CI: 1.31, 4.18) and depressed (AOR 3.12, 95% CI: 1.98, 4.91) were independently associated with a greater odds of being in a food insecure group. Compared to having help with meals none of the time, participants who reported having meal help all of the time (AOR 0.28, 95% CI: 0.12, 0.64), most of the time (AOR 0.31, 95% CI: 0.15, 0.61), and some of the time (AOR 0.54, 95% CI: 0.29, 0.98) had a lower odds of being in a food insecure group. Food insecure participants resided in different neighborhoods than food secure participants. The highest density of food insecure participants resided in census tracts with the lowest median incomes for the general population. The areas of highest density for each level of food security for our participants were in the census tracts with the lowest levels of full-time employment for the general population. Conclusions The prevalence of food insecurity and very low food security were markedly higher in our probation population compared to the general RI population. These findings suggest that access to food on a regular basis is a challenge for adults on probation. Depression and being homeless were independently associated with a greater odds of being in a food insecure group. In addition to intervening directly on food insecurity, developing interventions and policies that address the contributing factors of food insecurity, such as safe housing and treatment for depression, are critical.	[Dong, Kimberly R.; Tang, Alice M.; Stopka, Thomas J.; Must, Aviva] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Becicwith, Curt G.] Brown Univ, Miriam Hosp, Providence, RI USA; [Becicwith, Curt G.] Brown Univ, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA	Massachusetts Department of Public Health; Tufts University; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Brown University	Dong, KR (corresponding author), Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA.	Kimberly.dong@tufts.edu	Stopka, Thomas/GSN-6831-2022	Dong, Kimberly/0000-0001-9941-2942	National Institute on Drug Abuse (NIDA), The Lifespan/Brown Criminal Justice Research Program on Substance Use, HIV, and Comorbidities [R25DA037190]; Providence/Boston Center for AIDS Research [P30AI042853]; Boston Obesity Research Center [P30DK046200]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA037190] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA), The Lifespan/Brown Criminal Justice Research Program on Substance Use, HIV, and Comorbidities; Providence/Boston Center for AIDS Research; Boston Obesity Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by National Institute on Drug Abuse (NIDA) Grant #R25DA037190, The Lifespan/Brown Criminal Justice Research Program on Substance Use, HIV, and Comorbidities; The Providence/Boston Center for AIDS Research Grant #P30AI042853; and The Boston Obesity Research Center Grant #P30DK046200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth CV, 1997, INT J EPIDEMIOL, V26, P1323, DOI 10.1093/ije/26.6.1323; Anema A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061277; ARMSTRONG BG, 1989, AM J EPIDEMIOL, V129, P191, DOI 10.1093/oxfordjournals.aje.a115109; Babor TF., 2001, AUDIT ALCOHOL USE DI; Bowen EA, 2016, PUBLIC HEALTH NUTR, V19, P1122, DOI 10.1017/S1368980015002384; Bureau USC, 2017, AM FACT FIND; Caudy MS, 2014, J SUBST ABUSE TREAT, V46, P202, DOI 10.1016/j.jsat.2013.07.006; Clark CB, 2013, J ADDICT MED, V7, P45, DOI 10.1097/ADM.0b013e3182781806; Coleman-Jensen A., 2016, ERR215 USDA EC RES S; Coleman-Jensen A., 2017, ERR 237; Davey-Rothwell MA, 2014, J COMMUNITY PSYCHOL, V42, P469, DOI 10.1002/jcop.21622; Dong KR, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5201-7; Garg A, 2015, ACAD PEDIATR, V15, P305, DOI 10.1016/j.acap.2014.10.002; Goldberg SL, 2015, PUBLIC HEALTH NURS, V32, P397, DOI 10.1111/phn.12173; Green TC, 2012, SEX TRANSM DIS, V39, P424, DOI 10.1097/OLQ.0b013e318254c81a; Hanson KL, 2012, J HEALTH CARE POOR U, V23, P1174, DOI 10.1353/hpu.2012.0116; Hewett PC, 2004, SEX TRANSM INFECT, V80, P43, DOI 10.1136/sti.2004.013250; Irving SM, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140190; Kaeble D., 2016, PROBATION PAROLE US, P1; Kaeble Danielle, 2016, CORRECTIONAL POPULAT; Kollannoor-Samuel G, 2011, J IMMIGR MINOR HEALT, V13, P982, DOI 10.1007/s10903-011-9499-9; Laraia BA, 2009, J AM DIET ASSOC, V109, P1042, DOI 10.1016/j.jada.2009.03.005; Leung CW, 2015, J NUTR, V145, P622, DOI 10.3945/jn.114.199414; Leung CW, 2012, PUBLIC HEALTH NUTR, V15, P2228, DOI 10.1017/S1368980012000857; Lipari RN, 2013, TRENDS SUBSTANCE USE; Lurigio AJ, 2003, INT J OFFENDER THER, V47, P630, DOI 10.1177/0306624X03257710; Martin KS, 2007, J NUTR EDUC BEHAV, V39, P31, DOI 10.1016/j.jneb.2006.08.021; Martins DC, 2015, PUBLIC HEALTH NURS, V32, P453, DOI 10.1111/phn.12180; National Commission on Hunger, 2015, FREED HUNG ACH GOAL; O'Toole TP, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160375; Pager D, 2003, AM J SOCIOL, V108, P937, DOI 10.1086/374403; Palar K, 2015, AIDS BEHAV, V19, P1527, DOI 10.1007/s10461-014-0922-9; Pan LP, 2012, J ACAD NUTR DIET, V112, P1403, DOI 10.1016/j.jand.2012.06.011; Parpouchi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159334; Perez-Escamilla R, 2014, SALUD PUBLICA MEXICO, V56, pS62; Plugge E, 2014, INT J PRISON HEALTH, V10, P38, DOI 10.1108/IJPH-01-2013-0001; Radloff LS, 1977, APPL PSYCH MEAS, V1, P401; Rhode Island Department of Corrections, 2016, FISC YEAR 2015 ANN P; Rugel EJ, 2015, APPETITE, V92, P102, DOI 10.1016/j.appet.2015.05.011; Schmitt J, 2016, EXOFFENDERS LABOR MA; Schmitz J, 2016, PUBLIC HEALTH NUTR, V19, P2204, DOI 10.1017/S1368980016000306; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Silverman J, 2015, J GEN INTERN MED, V30, P1476, DOI 10.1007/s11606-015-3351-1; Simoes AA, 2006, DRUG ALCOHOL DEPEN, V82, pS103, DOI 10.1016/S0376-8716(06)80016-5; Strike C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1058; Substance Abuse and Mental Health Services Administration, 2014, NSDUH REP TRENDS SUB; Townsend MS, 2001, J NUTR, V131, P1738, DOI 10.1093/jn/131.6.1738; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; United States Department of Agriculture Economic Research Service, 2016, USDA AD FOOD SEC SUR; Vogenthaler NS, 2010, PUBLIC HEALTH NUTR, V13, P1478, DOI 10.1017/S1368980009993181; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; Whittle HJ, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20293; Wilde PE, 2010, J HUNGER ENVIRON NUT, V5, P380, DOI 10.1080/19320248.2010.504115	53	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198598	10.1371/journal.pone.0198598	http://dx.doi.org/10.1371/journal.pone.0198598			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI7ZT	29883491	Green Published, Green Submitted, gold			2022-12-26	WOS:000434728100033
J	Vaiglova, P; Halstead, P; Pappa, M; Triantaphyllou, S; Valamoti, SM; Evans, J; Fraser, R; Karkanas, P; Kale, A; Lee-Thorp, J; Bogaard, A				Vaiglova, Petra; Halstead, Paul; Pappa, Maria; Triantaphyllou, Sevi; Valamoti, Soultana M.; Evans, Jane; Fraser, Rebecca; Karkanas, Panagiotis; Kale, Andrea; Lee-Thorp, Julia; Bogaard, Amy			Of cattle and feasts: Multi-isotope investigation of animal husbandry and communal feasting at Neolithic Makriyalos, northern Greece	PLOS ONE			English	Article							THESSALONIKI PLAIN GREECE; STRONTIUM ISOTOPES; NITROGEN ISOTOPES; TOOTH DEVELOPMENT; STABLE CARBON; DIET; FRACTIONATION; SR-87/SR-86; RATIOS; RECONSTRUCTION	The aim of this study is to investigate livestock husbandry and its relationship to the mobilization of domestic animals for slaughter at large communal feasting events, in Late Neolithic Makriyalos, northern Greece. A multi-isotope approach is built that integrates analysis of: 1. delta C-13 and delta N-15 values of human and animal bone collagen for understanding long-term dietary behavior, 2. Incremental delta C-13 and delta O-18 values of domestic animal tooth enamel carbonate for assessing seasonal patterns in grazing habits and mobility, and 3. Sr-87/Sr-86 ratios of cattle tooth enamel for examining the possibility that some of the animals consumed at the site were born outside the local environment. The findings indicate that cattle had isotopically more variable diets than sheep, which may reflect grazing over a wider catchment area in the local landscape. Cattle products did not make a significant contribution to the long-term dietary protein intake of the humans, which may indicate that they were primarily consumed during episodic feasting events. There is no indication that pasturing of livestock was pre-determined by their eventual context of slaughter (i.e. large-scale feasting vs. more routine consumption events). Two non local cattle identified among those deposited in a feasting context may have been brought to the site as contributions to these feasts. The evidence presented provides a more detailed insight into local land use and into the role of livestock and feasting in forging social relationships within the regional human population.	[Vaiglova, Petra; Lee-Thorp, Julia] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England; [Vaiglova, Petra; Karkanas, Panagiotis] Amer Sch Class Studies, Wiener Lab Archaeol Sci, Athens, Greece; [Halstead, Paul] Univ Sheffield, Dept Archaeol, Sheffield, S Yorkshire, England; [Pappa, Maria] Hellen Minist Educ & Religious Affairs Culture &, Ephorea Pieria, Thessaloniki, Greece; [Triantaphyllou, Sevi; Valamoti, Soultana M.] Aristotle Univ Thessaloniki, Sch Hist & Archaeol, Thessaloniki, Greece; [Evans, Jane] British Geol Survey, Nat Environm Res Council, Isotope Geosci Lab, Keyworth, Notts, England; [Fraser, Rebecca; Bogaard, Amy] Univ Oxford, Inst Archaeol, Oxford, England; [Kale, Andrea] Univ Lausanne, Inst Earth Surface Dynam, Lausanne, Switzerland	University of Oxford; University of Sheffield; Aristotle University of Thessaloniki; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Oxford; University of Lausanne	Vaiglova, P (corresponding author), Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England.; Vaiglova, P (corresponding author), Amer Sch Class Studies, Wiener Lab Archaeol Sci, Athens, Greece.	vaiglova.petra@gmail.com	Kay, Andrea/X-4373-2019; Vaiglova, Petra/ABD-1636-2021; Vaiglova, Petra/GMW-4994-2022; Vaiglova, Petra/AAC-6418-2020; Karkanas, Panagiotis/AAD-1227-2020; Karkanas, Panagiotis/N-3168-2019; Evans, Jane A/G-3673-2010	Kay, Andrea/0000-0001-8285-1893; Vaiglova, Petra/0000-0002-9468-8138; Karkanas, Panagiotis/0000-0002-7156-671X; Bogaard, Amy/0000-0002-6716-8890	Clarendon doctoral studentship from the University of Oxford; Malcolm H. Wiener Pre-Doctoral Fellowship at the Wiener Laboratory for Archaeological Science, American School of Classical Studies at Athens; Natural Environment Research Council [NE/003761/1]; Natural Environment Research Council Geoscience Facility steering grant [IP-1447-0514]; European Research Council starting grant [312785]; NERC [NE/E003761/1] Funding Source: UKRI	Clarendon doctoral studentship from the University of Oxford; Malcolm H. Wiener Pre-Doctoral Fellowship at the Wiener Laboratory for Archaeological Science, American School of Classical Studies at Athens; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council Geoscience Facility steering grant; European Research Council starting grant(European Research Council (ERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was financially supported by a Clarendon doctoral studentship from the University of Oxford (PV; http://www.ox.ac.uk/clarendon/about), a Malcolm H. Wiener Pre-Doctoral Fellowship at the Wiener Laboratory for Archaeological Science, American School of Classical Studies at Athens (PV; http://www.ascsa.edu.gr/index.php/wiener-laboratoryipre-doctoral-fellowship), Natural Environment Research Council (AB, award number NE/003761/1; http://www.nerc.ac.uk/funding/available/fellowships/), Natural Environment Research Council Geoscience Facility steering grant (AB, JLT, PV, award number IP-1447-0514; https://wm.bgs.ac.uk/sciencefacilities/igfs/steeringCommittee.html), European Research Council starting grant (AB, award number 312785; https://erc.europa.eu/%23). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, GREEK I GEOLOGY MINE; [Anonymous], 1989, COLLAGEN DENT MATRIC; [Anonymous], 1986, GREEK I GEOLOGY MINE; [Anonymous], 1985, GREEK I GEOLOGY MINE; [Anonymous], 2002, GREEK I GEOLOGY MINE; Balasse M, 2012, ARCHAEOMETRY, V54, P349, DOI 10.1111/j.1475-4754.2011.00624.x; Balasse M, 2002, J ARCHAEOL SCI, V29, P917, DOI 10.1006/jasc.2001.0787; Balasse M, 2002, INT J OSTEOARCHAEOL, V12, P155, DOI 10.1002/oa.601; Balasse M, 2013, EUR J ARCHAEOL, V16, P221, DOI 10.1179/1461957112Y.0000000028; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bentley RA, 2005, ARCHAEOMETRY, V47, P629, DOI 10.1111/j.1475-4754.2005.00223.x; Bocherens H, 2001, CR ACAD SCI II A, V332, P67, DOI 10.1016/S1251-8050(00)01488-9; Boessneck J, 1964, KUHN ARCH, V78, P1; Bogaard A, 2007, J ARCHAEOL SCI, V34, P335, DOI 10.1016/j.jas.2006.04.009; Bogaard A., 2015, OXFORD HDB NEOLITHIC, P385; Bowen GJ, 2010, ANNU REV EARTH PL SC, V38, P161, DOI 10.1146/annurev-earth-040809-152429; Bowen GJ, 2002, GEOLOGY, V30, P315, DOI 10.1130/0091-7613(2002)030<0315:SDOOIM>2.0.CO;2; BROWN WAB, 1960, AM J VET RES, V21, P7; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; DANSGAARD W, 1964, TELLUS, V16, P436; DELWICHE CC, 1979, BOT GAZ, V140, pS65, DOI 10.1086/337037; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Dietrich O, 2012, ANTIQUITY, V86, P674, DOI 10.1017/S0003598X00047840; EHLERINGER JR, 1991, TRENDS ECOL EVOL, V6, P95, DOI 10.1016/0169-5347(91)90183-X; ELDERFIELD H, 1986, PALAEOGEOGR PALAEOCL, V57, P71, DOI 10.1016/0031-0182(86)90007-6; Evans JA, 2010, J GEOL SOC LONDON, V167, P1, DOI 10.1144/0016-76492009-090; Evans JA, 2009, J GEOL SOC LONDON, V166, P617, DOI 10.1144/0016-76492008-043; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Faure G., 1972, STRONTIUM ISOTOPE GE; Friedman I., 1977, DATA GEOCHEMISTRY CO; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Ghilardi M, 2008, GEOMORPHOLOGY, V97, P617, DOI 10.1016/j.geomorph.2007.09.007; Ghilardi M, 2008, J ARCHAEOL SCI, V35, P111, DOI 10.1016/j.jas.2007.02.017; Halstead P., 1992, ANTHROPOZOOLOGICA, V16, P19; Halstead P., 2007, COOKING FOOD CULINAR, P25; Halstead P, 2011, DYNAMICS NEOLITHISAT, P131, DOI DOI 10.2307/J.CTVH1DHQM.13; Hartman G, 2010, OECOLOGIA, V162, P837, DOI 10.1007/s00442-009-1514-7; HAYDEN B, 1990, J ANTHROPOL ARCHAEOL, V9, P31, DOI 10.1016/0278-4165(90)90005-X; Hayden B, 2003, WORLD ARCHAEOL, V34, P458, DOI 10.1080/0043824021000026459a; Hedges REM, 2007, J ARCHAEOL SCI, V34, P1240, DOI 10.1016/j.jas.2006.10.015; Heier A, 2009, ARCHAEOMETRY, V51, P277, DOI 10.1111/j.1475-4754.2008.00409.x; Hillson S., 2005, TEETH; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; Jones GG, 2012, ENVIRON ARCHAEOL, V17, P11, DOI 10.1179/1461410312Z.0000000002; Kendall C, 2001, HYDROL PROCESS, V15, P1363, DOI 10.1002/hyp.217; Kotsakis K., 1999, NEOLITHIC SOC GREECE, P66; Krahtopoulou A., 2010, GEOARCHAEOLOGY NO PI; Krahtopoulou A, 2017, J ARCHAEOL SCI-REP, V15, P423, DOI 10.1016/j.jasrep.2016.02.003; KRUEGER HW, 1984, ACS SYM SER, V258, P205; Laffoon JE, 2012, J ARCHAEOL SCI, V39, P2371, DOI 10.1016/j.jas.2012.02.002; Lambeck K, 1996, ANTIQUITY, V70, P588, DOI 10.1017/S0003598X00083733; LAND LS, 1980, PALAEOGEOGR PALAEOCL, V32, P143, DOI 10.1016/0031-0182(80)90037-1; Lee-Thorp JA, 2008, ARCHAEOMETRY, V50, P925, DOI 10.1111/j.1475-4754.2008.00441.x; LEETHORP JA, 1989, J ARCHAEOL SCI, V16, P585, DOI 10.1016/0305-4403(89)90024-1; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; Mainland I, 2005, Diet and Health in Past Animal Populations: Current Research and Future Directions, P104; Makarewicz CA, 2017, PALAEOGEOGR PALAEOCL, V485, P16, DOI 10.1016/j.palaeo.2017.01.028; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; Nafplioti A, 2008, J ARCHAEOL SCI, V35, P2307, DOI 10.1016/j.jas.2008.03.006; Nafplioti A, 2011, J ARCHAEOL SCI, V38, P1560, DOI 10.1016/j.jas.2011.02.021; Nitsch E.K., 2015, SCI TECHNOL ARCHAEOL, V1, P1, DOI [10.1179/2054892315Y.0000000001, DOI 10.1179/2054892315Y.0000000001]; O'Connell TC, 2012, AM J PHYS ANTHROPOL, V149, P426, DOI 10.1002/ajpa.22140; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Pappa M, 1999, J FIELD ARCHAEOL, V26, P177, DOI 10.1179/jfa.1999.26.2.177; Pappa M, EC SOC ANCIENT GREEK; Pappa M, 1999, NEOLITHIC SOC GREECE, P108; Pappa Maria, 2004, FOOD CUISINE SOC PRE, P16; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Payne S., 1973, ANATOL STUD, V23, P281, DOI [10.2307/3642547, DOI 10.2307/3642547]; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Pyankov VI, 2010, BOT J LINN SOC, P163; Richards M, 2008, J ARCHAEOL SCI, V35, P1251, DOI 10.1016/j.jas.2007.08.018; Richards MP, 1999, J ARCHAEOL SCI, V26, P717, DOI 10.1006/jasc.1998.0387; Robinson D, 2001, TRENDS ECOL EVOL, V16, P153, DOI 10.1016/S0169-5347(00)02098-X; ROZANSKI K, 1992, SCIENCE, V258, P981, DOI 10.1126/science.258.5084.981; Sage RF, 1999, C4 PLANT BIOL; Scheeres M, 2013, J ARCHAEOL SCI, V40, P3614, DOI 10.1016/j.jas.2013.05.003; Sharp Z., 2007, PRINCIPLES STABLE IS; Sillen A, 1998, GEOCHIM COSMOCHIM AC, V62, P2463, DOI 10.1016/S0016-7037(98)00182-3; Simpson G., 1985, 27 FENL PROJ COMM CA, V1, P219; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Snoeck C, 2015, CHEM GEOL, V417, P394, DOI 10.1016/j.chemgeo.2015.10.004; Spiteria CD, 2016, P NATL ACAD SCI USA, V113, P13594, DOI 10.1073/pnas.1607810113; Styring AK, 2015, J ARCHAEOL SCI, V53, P504, DOI 10.1016/j.jas.2014.11.009; Szpak P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00288; Triantaphyllou S., 2001, BIOARCHAEOLOGICAL AP; Tsoraki C., 2007, DOCUMENTA PRAEHISTOR, V34, P289; Vaiglova P, 2014, RAPID COMMUN MASS SP, V28, P2497, DOI 10.1002/rcm.7044; Valamoti S.M., 2004, PLANTS PEOPLE LATE N, VVolume 1258; Valamoti SM, 2007, ANTIQUITY, V81, P1053, DOI 10.1017/S0003598X00096113; VANDERMERWE NJ, 1978, NATURE, V276, P815, DOI 10.1038/276815a0; Weiner S, 2010, MICROARCHAEOLOGY; WEINREB MM, 1964, AM J VET RES, V25, P891; Yamazaki D, 2017, GEOPHYS RES LETT, V44, P5844, DOI 10.1002/2017GL072874	100	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0194474	10.1371/journal.pone.0194474	http://dx.doi.org/10.1371/journal.pone.0194474			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI5BF	29879125	Green Published, gold, Green Accepted			2022-12-26	WOS:000434384900002
J	Aljarbou, F; Almousa, N; Bazzi, M; Aldaihan, S; Alanazi, M; Alharbi, O; Almadi, M; Aljebreen, AM; Azzam, NA; Arafa, M; Aldbassl, A; Sheik, J; Alasirril, S; Warsy, A; Alamri, A; Parine, NR; Alamro, G				Aljarbou, Ftoon; Almousa, Nourah; Bazzi, Mohammad; Aldaihan, Sooad; Alanazi, Mohammed; Alharbi, Othman; Almadi, Majid; Aljebreen, Abdulrahman M.; Azzam, Nahla Ali; Arafa, Maha; Aldbassl, Abeer; Sheik, Jilani; Alasirril, Shaheerah; Warsy, Arjumand; Alamri, Abdullah; Parine, Narasimha Reddy; Alamro, Ghadah			The expression of telomere-related proteins and DNA damage response and their association with telomere length in colorectal cancer in Saudi patients	PLOS ONE			English	Article							TERT PROMOTER MUTATIONS; REVERSE-TRANSCRIPTASE; DOWN-REGULATION; RISK-FACTORS; CARCINOMA; COLON; GENE; CHROMOSOMES; MAINTENANCE; INSTABILITY	Background Colorectal cancer is the leading cause of cancer-related deaths in Saudi Arabia. Cancer has a multifactorial nature and can be described as a disease of altered gene expression. The profiling of gene expression has been used to identify cancer subtypes and to predict patients' responsiveness. Telomere-associated proteins that regulate telomere biology are essential molecules in cancer development. Thus, the present study examined their contributions to colorectal cancer progression in Saudi patients. Methods The expression of hTERT, TRF1, TRF2, POT1, ATR, ATM, Chk1 and Chk2 were measured via real-time PCR in matched cancerous and adjacent tissues of CRC patients. The protein level of hTERT, TRF1, TRF2, ATR, ATM, Chk1 and Chk2 were measured using immunohistochemistry. A region of hTERT core promoter was sequenced via Sanger sequencing. Methylation of CTCF binding site was examined via methylation-specific PCR. Finally, the length of telomere was estimated using q-PCR. Results Our results showed that POT1, ATR, Chk1 and Chk2 show increased expression in CRC relative to the adjacent mucosa. The expression levels of each gene were associated with clinicopathological characteristics of patients with CRC. There was a positive correlation between the age of the patients and hTERT expression. Regarding tumor site, telomere length, ATR, ATM and Chk1 were shown to be altered. No somatic mutation was detected in hTERTcore promoter, and no differences in methylation patterns at CTCF binding site in the promoter between normal and cancer tissues. Conclusion Analysis of targeted genes expression in colorectal cancer based on the clinical variables revealed that tumor location and age could have a role in gene expression and telomere length variations and this could be taken under consideration during CRC diagnosis and therapy. Other epigenetic mechanisms could influence hTERT expression in cancers. Our findings warrant further validation through experiments involving a larger number of patients.	[Aljarbou, Ftoon; Almousa, Nourah; Bazzi, Mohammad; Aldaihan, Sooad; Alanazi, Mohammed; Aldbassl, Abeer; Sheik, Jilani; Alasirril, Shaheerah; Warsy, Arjumand; Alamri, Abdullah; Parine, Narasimha Reddy; Alamro, Ghadah] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh, Saudi Arabia; [Alharbi, Othman; Almadi, Majid; Aljebreen, Abdulrahman M.; Azzam, Nahla Ali] King Saud Univ, King Khalid Univ Hosp, Div Gastroenterol, Riyadh, Saudi Arabia; [Arafa, Maha] King Saud Univ, King Khalid Univ Hosp, Dept Histopathol, Riyadh, Saudi Arabia	King Saud University; King Saud University; King Khalid University Hospital; King Saud University; King Khalid University Hospital	Aljarbou, F (corresponding author), King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh, Saudi Arabia.	ftaljarbou@ksu.edu.sa	Almadi, Majid A/K-7819-2017; Warsy, Arjumand/D-5274-2015; Parine, Narasimha Reddy/B-7975-2011; Arafah, Maha/GZM-4328-2022; Alamri, Abdullah M/C-3108-2012	Almadi, Majid A/0000-0001-9917-2758; Warsy, Arjumand/0000-0001-6957-203X; Parine, Narasimha Reddy/0000-0002-0765-9022; Arafah, Maha/0000-0003-4966-2358; Alamri, Abdullah M/0000-0002-3045-1350	King Abdulaziz City for Science and Technology (KACST) [A-T-35-291]	King Abdulaziz City for Science and Technology (KACST)	This project was funded by King Abdulaziz City for Science and Technology (KACST), grant number (A-T-35-291). URL: https://www.kacst.edu.sa/eng/Pages/default.aspx. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Fatah TMA, 2014, BBA CLIN, V2, P10, DOI 10.1016/j.bbacli.2014.08.001; Altekruse S. F., 2007, SEER CANC STAT REV 1; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Bertorelle R, 2014, WORLD J GASTROENTERO, V20, P1940, DOI 10.3748/wjg.v20.i8.1940; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Braakhuis BJM, 2004, J PATHOL, V203, P620, DOI 10.1002/path.1549; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; BROWN WRA, 1989, NATURE, V338, P774, DOI 10.1038/338774a0; Cancer Incidence and Mortality Worldwide, 2013, IARC CANCERBASENO; Castellsague E, 2008, CLIN CHEM, V54, P1132, DOI 10.1373/clinchem.2007.101006; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Derwinger K, 2010, ANTICANCER RES, V30, P5227; Fazeli Mohammad Sadegh, 2015, Med J Islam Repub Iran, V29, P171; Frattini M, 2004, CLIN CANCER RES, V10, P4015, DOI 10.1158/1078-0432.CCR-04-0031; Glass D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r75; Grabowski P, 2005, BLOOD, V105, P4807, DOI 10.1182/blood-2004-11-4394; Grandjenette C, 2014, NEOPLASIA, V16, P511, DOI 10.1016/j.neo.2014.05.009; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hawthorn L, 2014, GENOMICS, V103, P211, DOI 10.1016/j.ygeno.2013.11.003; Hines WC, 2005, MOL CANCER RES, V3, P503, DOI 10.1158/1541-7786.MCR-05-0031; Ibrahim Ezzeldin M, 2008, Saudi J Gastroenterol, V14, P178, DOI 10.4103/1319-3767.43275; Jackson-Thompson J, 2006, CANCER, V107, P1103, DOI 10.1002/cncr.22007; Johnson CM, 2013, CANCER CAUSE CONTROL, V24, P1207, DOI 10.1007/s10552-013-0201-5; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Li FY, 2009, J ZHEJIANG UNIV-SC B, V10, P219, DOI 10.1631/jzus.B0820273; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu XL, 2013, CELL CYCLE, V12, P1637, DOI 10.4161/cc.24662; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; McMichael AJ, 2008, PUBLIC HEALTH NUTR, V11, P762, DOI 10.1017/S1368980008002358; Mitomo S, 2008, CANCER SCI, V99, P280, DOI 10.1111/j.1349-7006.2007.00666.x; Mosli MH, 2012, ASIAN PAC J CANCER P, V13, P3809, DOI 10.7314/APJCP.2012.13.8.3809; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Nikitina T, 2004, J CELL BIOL, V166, P161, DOI 10.1083/jcb.200403118; Nilbert M, 1999, EUR J CANCER, V35, P942, DOI 10.1016/S0959-8049(99)00045-3; Nowak J, 2003, EUR J GASTROEN HEPAT, V15, P75, DOI 10.1097/00042737-200301000-00013; Omori Y, 2009, CANCER SCI, V100, P413, DOI 10.1111/j.1349-7006.2008.01063.x; Preston RJ, 1997, RADIAT RES, V147, P529, DOI 10.2307/3579618; Rampazzo E, 2010, BRIT J CANCER, V102, P1300, DOI 10.1038/sj.bjc.6605644; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Tarsounas M, 2004, CELL, V117, P337, DOI 10.1016/S0092-8674(04)00337-X; Terrin L, 2008, CLIN CANCER RES, V14, P7444, DOI 10.1158/1078-0432.CCR-08-0478; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zou L, 2003, SCIENCE, V6, P7	49	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0197154	10.1371/journal.pone.0197154	http://dx.doi.org/10.1371/journal.pone.0197154			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870526	Green Published, gold, Green Submitted			2022-12-26	WOS:000434128400003
J	Lu, M; He, XW				Lu, Min; He, Xiangwei			Ccp1 modulates epigenetic stability at centromeres and affects heterochromatin distribution in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; histone chaperone; centromere; heterochromatin; yeast; epigenetic stability; fission yeast	FISSION YEAST CENTROMERES; CENP-A; HISTONE H3; CHROMATIN INTEGRITY; NUCLEOSOME DYNAMICS; MESSENGER-RNAS; BUDDING YEAST; PROTEIN; KINETOCHORE; COMPLEX	Distinct chromatin organization features, such as centromeres and heterochromatin domains, are inherited epigenetically. However, the mechanisms that modulate the accuracy of epigenetic inheritance, especially at the individual nucleosome level, are not well-understood. Here, using ChIP and next-generation sequencing (ChIP-Seq), we characterized Ccp1, a homolog of the histone chaperone Vps75 in budding yeast that functions in centromere chromatin duplication and heterochromatin maintenance in fission yeast (Schizosaccharomyces pombe). We show that Ccp1 is enriched at the central core regions of the centromeres. Of note, among all histone chaperones characterized, deletion of the ccp1 gene uniquely reduced the rate of epigenetic switching, manifested as position effect variegation within the centromeric core region (CEN-PEV). In contrast, gene deletion of other histone chaperones either elevated the PEV switching rates or did not affect centromeric PEV. Ccp1 and the kinetochore components Mis6 and Sim4 were mutually dependent for centromere or kinetochore association at the proper levels. Moreover, Ccp1 influenced heterochromatin distribution at multiple loci in the genome, including the subtelomeric and the pericentromeric regions. We also found that Gar2, a protein predominantly enriched in the nucleolus, functions similarly to Ccp1 in modulating the epigenetic stability of centromeric regions, although its mechanism remained unclear. Together, our results identify Ccp1 as an important player in modulating epigenetic stability and maintaining proper organization of multiple chromatin domains throughout the fission yeast genome.	[He, Xiangwei] Zhejiang Univ, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China; Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	He, XW (corresponding author), Zhejiang Univ, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China.	xhe@zju.edu.cn			National 973 Plan for Basic Research Grant [2015CB910602]; National Natural Science Foundation of China (NSFC) [31628012]	National 973 Plan for Basic Research Grant; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National 973 Plan for Basic Research Grant 2015CB910602 (to X. H.) and National Natural Science Foundation of China (NSFC) Grant 31628012 (to X. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Allshire RC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018770; Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Bassett EA, 2012, DEV CELL, V22, P749, DOI 10.1016/j.devcel.2012.02.001; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Buttrick GJ, 2011, CHROMOSOME RES, V19, P393, DOI 10.1007/s10577-011-9185-8; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Castillo AG, 2007, PLOS GENET, V3, P1264, DOI 10.1371/journal.pgen.0030121; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; Clement C, 2015, NAT STRUCT MOL BIOL, V22, P587, DOI 10.1038/nsmb.3067; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Dong QH, 2016, MOL CELL, V64, P79, DOI 10.1016/j.molcel.2016.08.022; Dunleavy EM, 2007, MOL CELL, V28, P1029, DOI 10.1016/j.molcel.2007.10.010; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Gao Q, 2010, P NATL ACAD SCI USA, V107, P13330, DOI 10.1073/pnas.1004887107; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; GULLI MP, 1995, NUCLEIC ACIDS RES, V23, P1912, DOI 10.1093/nar/23.11.1912; Gurard-Levin ZA, 2014, ANNU REV BIOCHEM, V83, P487, DOI 10.1146/annurev-biochem-060713-035536; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Hatziapostolou M, 2011, CELL MOL LIFE SCI, V68, P1681, DOI 10.1007/s00018-010-0624-z; Hayashi A, 2006, MOL BIOL CELL, V17, P5173, DOI 10.1091/mbc.E06-05-0388; Henikoff S, 2012, GENETICS, V190, P1575, DOI 10.1534/genetics.111.137711; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Jin QW, 2007, MOL BIOL CELL, V18, P2924, DOI 10.1091/mbc.E06-09-0853; Infante JJ, 2012, METHODS MOL BIOL, V833, P63, DOI 10.1007/978-1-61779-477-3_5; Keck KM, 2011, TRAFFIC, V12, P826, DOI 10.1111/j.1600-0854.2011.01202.x; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kim S, 2015, J CELL BIOL, V208, P181, DOI 10.1083/jcb.201407074; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Li WZ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006900; Link Andrew J, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5606; Link Andrew J, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5607; Liu TY, 2016, P NATL ACAD SCI USA, V113, pE2822, DOI 10.1073/pnas.1523295113; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Muller HJ, 1930, J GENET, V22, P299, DOI 10.1007/BF02984195; Nakazawa N, 2008, J CELL BIOL, V180, P1115, DOI 10.1083/jcb.200708170; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Radman-Livaja M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001075; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Sadeghi L, 2014, NAT STRUCT MOL BIOL, V21, P236, DOI 10.1038/nsmb.2776; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Selth L, 2007, J BIOL CHEM, V282, P12358, DOI 10.1074/jbc.C700012200; Selth LA, 2009, MOL CELL BIOL, V29, P4220, DOI 10.1128/MCB.01882-08; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Sicard H, 1998, MOL BIOL CELL, V9, P2011, DOI 10.1091/mbc.9.8.2011; Sugiyama T, 2013, NUCLEIC ACIDS RES, V41, P6674, DOI 10.1093/nar/gkt363; Tang Y, 2008, P NATL ACAD SCI USA, V105, P12206, DOI 10.1073/pnas.0802393105; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trewick SC, 2007, EMBO J, V26, P4670, DOI 10.1038/sj.emboj.7601892; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2011, METHODS MOL BIOL, V725, P15, DOI 10.1007/978-1-61779-046-1_2; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Xue YM, 2013, MOL CELL BIOL, V33, P1645, DOI 10.1128/MCB.01121-12; Yao JH, 2013, J BIOL CHEM, V288, P19184, DOI 10.1074/jbc.M113.471276; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu B, 2011, CELL RES, V21, P435, DOI 10.1038/cr.2011.26; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651	74	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12068	12080		10.1074/jbc.RA118.003873	http://dx.doi.org/10.1074/jbc.RA118.003873			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29899117	hybrid, Green Published			2022-12-26	WOS:000440803200008
J	Ewart, KM; Frankham, GJ; McEwing, R; The, DT; Hogg, CJ; Wade, C; Lo, N; Johnson, RN				Ewart, Kyle M.; Frankham, Greta J.; McEwing, Ross; Dang Tat The; Hogg, Carolyn J.; Wade, Claire; Lo, Nathan; Johnson, Rebecca N.			A rapid multiplex PCR assay for presumptive species identification of rhinoceros horns and its implementation in Vietnam	PLOS ONE			English	Article								Rhinoceros (rhinos) have suffered a dramatic increase in poaching over the past decade due to the growing demand for rhino horn products in Asia. One way to reverse this trend is to enhance enforcement and intelligence gathering tools used for species identification of horns, in particular making them fast, inexpensive and accurate. Traditionally, species identification tests are based on DNA sequence data, which, depending on laboratory resources, can be either time or cost prohibitive. This study presents a rapid rhino species identification test, utilizing species-specific primers within the cytochrome b gene multiplexed in a single reaction, with a presumptive species identification based on the length of the resultant amplicon. This multiplex PCR assay can provide a presumptive species identification result in less than 24 hours. Sequence-based definitive testing can be conducted if/when required (e.g. court purposes). This work also presents an actual casework scenario in which the presumptive test was successfully utlitised, in concert with sequence-based definitive testing. The test was carried out on seized suspected rhino horns tested at the Institute of Ecology and Biological Resources, the CITES mandated laboratory in Vietnam, a country that is known to be a major source of demand for rhino horns. This test represents the basis for which future 'rapid species identification tests' can be trialed.	[Ewart, Kyle M.; Frankham, Greta J.; Johnson, Rebecca N.] Australian Museum Res Inst, Australian Ctr Wildlife Genom, Sydney, NSW, Australia; [Ewart, Kyle M.; Hogg, Carolyn J.; Wade, Claire; Lo, Nathan] Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney, NSW, Australia; [McEwing, Ross] TRACE Wildlife Forens Network, Edinburgh, Midlothian, Scotland; [Dang Tat The] Inst Ecol & Biol Resources, Hanoi, Vietnam; [Hogg, Carolyn J.] Zoo & Aquarium Assoc Australasia, Mosman, NSW, Australia	Australian Museum; University of Sydney; Vietnam Academy of Science & Technology (VAST)	Ewart, KM; Johnson, RN (corresponding author), Australian Museum Res Inst, Australian Ctr Wildlife Genom, Sydney, NSW, Australia.; Ewart, KM (corresponding author), Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney, NSW, Australia.	Kyle.Ewart@austmus.gov.au; rebecca.johnson@austmus.gov.au	Lo, Nathan/E-6115-2010; Ewart, Kyle/AAZ-2578-2021; Johnson, Rebecca N/U-6514-2017	Lo, Nathan/0000-0003-2176-2840; Johnson, Rebecca/0000-0003-3035-2827; Hogg, Carolyn/0000-0002-6328-398X; Wade, Claire/0000-0003-3413-4771	Australian Museum Foundation; University of Sydney; TRACE Wildlife Forensic Network; U.S. Agency for International Development, under the Wildlife Trafficking, Response, Assessment, and Priority Setting (Wildlife TRAPS) Project [AID-AID-EGEE-IO-13-00002]	Australian Museum Foundation; University of Sydney(University of Sydney); TRACE Wildlife Forensic Network; U.S. Agency for International Development, under the Wildlife Trafficking, Response, Assessment, and Priority Setting (Wildlife TRAPS) Project(United States Agency for International Development (USAID))	The authors would like to thank the Australian Museum Foundation (https://australianmuseum.net.au/foundation) (RNJ), particularly Chris Grubb and Peter Warne, the University of Sydney (https://sydney.edu.au), TRACE Wildlife Forensic Network (https://www.tracenetwork.org) (RM), and the U.S. Agency for International Development, under the Wildlife Trafficking, Response, Assessment, and Priority Setting (Wildlife TRAPS) Project, award number AID-AID-EGEE-IO-13-00002 (see Acknowledgements section) for funding.; The authors would like to thank the Zoo and Aquarium Association Australasia, and in particular Werribee Zoo, Perth Zoo, Taronga Western Plains Zoo, Australian Zoo, Hamilton Zoo, Orana Wildlife Park, Auckland Zoo and the Auckland Museum for samples. We would like to thank Andrew King, Scott Ginn and Sandy Ingleby from the Australian Museum, and the IEBR Staff for assistance in the lab, and in organizing samples. We are grateful to Nick Ahlers and for the financial support provided by the U.S. Agency for International Development, under the Wildlife Trafficking, Response, Assessment, and Priority Setting (Wildlife TRAPS) Project, award number AID-AID-EGEE-IO-13-00002. The opinions expressed in this publication are those of the authors and do not necessarily reflect the view of the U.S. Agency for International Development. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Department of Agriculture Forestry and Fisheries South Africa, 2017, ANIMAL HLTH; Ewart KM, 2018, FORENSIC SCI INT-GEN, V32, P33, DOI 10.1016/j.fsigen.2017.10.003; Harper C, 2018, CURR BIOL, V28, pR13, DOI 10.1016/j.cub.2017.11.005; Harper CK, 2013, FORENSIC SCI INT-GEN, V7, P428, DOI 10.1016/j.fsigen.2013.04.003; Hsieh HM, 2001, FORENSIC SCI INT, V122, P7, DOI 10.1016/S0379-0738(01)00403-0; McEwing R, 2017, COLL ACT PLANN WORKS, P30; Milliken T., 2012, S AFRICA VIET NAM RH; Mrema, 2014, ENV CRIME CRISIS THR; Ogden R, 2011, MOL ECOL RESOUR, V11, P109, DOI 10.1111/j.1755-0998.2010.02954.x; Ogden Rob, 2010, Endangered Species Research, V9, P179, DOI 10.3354/esr00144; Rychlik Wojciech, 2007, V402, P35; Setiawan R, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12366; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tobe SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014156; United Nations Office on Drugs and Crime, 2016, WORLD WILDL CRIM REP; Zafir AWA, 2011, ORYX, V45, P225, DOI 10.1017/S0030605310000864	16	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198565	10.1371/journal.pone.0198565	http://dx.doi.org/10.1371/journal.pone.0198565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902212	Green Published, Green Submitted, gold			2022-12-26	WOS:000435424900031
J	Badejo, OA; Menson, WNA; Sam-Agudu, NA; Pharr, J; Erekaha, S; Bruno, T; Nwanne, G; Ogunsola, O; Llozumba, J; Busari, O; Ezeanolue, EE				Badejo, Okikiolu A.; Menson, William N. A.; Sam-Agudu, Nadia A.; Pharr, Jennifer; Erekaha, Salome; Bruno, Tamara; Nwanne, Gift; Ogunsola, Olabanjo; Llozumba, Jude; Busari, Olusegun; Ezeanolue, Echezona E.			Pediatric to adult healthcare transitioning for adolescents living with HIV in Nigeria: A national survey	PLOS ONE			English	Article							YOUNG-ADULTS; ANTIRETROVIRAL THERAPY; INFECTED ADOLESCENTS; OUTCOMES; STRATEGIES; PEOPLE	Introduction The period of transition from pediatric to adult care has been associated with poor health outcomes among 10-19 year old adolescents living with HIV (ALHIV). This has prompted a focus on the quality of transition services, especially in high ALHIV-burden countries. Due to lack of guidelines, there are no healthcare transition standards for Nigeria's estimated 240,000 ALHIV. We conducted a nationwide survey to characterize routine transition procedures for Nigerian ALHIV. Materials and methods This cross-sectional survey was conducted at public healthcare facilities supported by five local HIV service implementing partners. Comprehensive HIV treatment facilities with >1 year of HIV service provision and >20 ALHIVs enrolled were selected. A structured questionnaire assessed availability of treatment, care and transition services for ALHIV. Transition was defined as a preparatory process catering to the medical, psychosocial, and educational needs of adolescents moving from pediatric to adult care. Comprehensive transition services were defined by 6 core elements: policy, tracking and monitoring, readiness evaluation, planning, transfer of care, and follow-up. Results All 152 eligible facilities were surveyed and comprised 106 (69.7%) secondary and 46 (30.3%) tertiary centers at which 17,662 ALHIV were enrolled. The majority (73, 48.3%) of the 151 facilities responding to the "clinic type" question were family-centered and saw all clients together regardless of age. Only 42 (27.8%) facilities had an adolescent-specific HIV clinic; 53 (35.1%) had separate pediatric/adolescent and adult HIV clinics, of which 39 (73.6%) reported having a transfer/transition policy. Only 6 (15.4%) of these 39 facilities reported having a written protocol. There was a bimodal peak at 15 and 18 years for age of ALHIV transfer to adult care. No surveyed facility met the study definition for comprehensive transition services. Conclusions Facilities surveyed were more likely to have non-specialized HIV treatment services and had loosely-defined, abrupt transfer versus transition practices, which lacked the core transition elements. Evidence-based standards of transitional care tailored to non-specialized HIV treatment programs need to be established to optimize transition outcomes among ALHIV in Nigeria and in similar settings.	[Badejo, Okikiolu A.] FHI360, Abuja, Nigeria; [Menson, William N. A.; Pharr, Jennifer; Bruno, Tamara] Univ Nevada, Global Hlth Initiat, Sch Community Hlth Sci, Las Vegas, NV 89154 USA; [Sam-Agudu, Nadia A.; Erekaha, Salome; Nwanne, Gift] Inst Human Virol Nigeria, Int Res Ctr Excellence, Abuja, Nigeria; [Sam-Agudu, Nadia A.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Ogunsola, Olabanjo] APIN Publ Hlth Initiat, Abuja, Nigeria; [Llozumba, Jude] Ctr Clin Care & Clin Res Nigeria, Abuja, Nigeria; [Busari, Olusegun] Ctr Integrated Hlth Programs, Abuja, Nigeria; [Ezeanolue, Echezona E.] HealthySunrise Fdn, Las Vegas, NV USA; [Ezeanolue, Echezona E.] Univ Nigeria Nsukka, Dept Paediat & Child Hlth, Enugu, Nigeria	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University System of Maryland; University of Maryland Baltimore; University of Nigeria	Sam-Agudu, NA (corresponding author), Inst Human Virol Nigeria, Int Res Ctr Excellence, Abuja, Nigeria.; Sam-Agudu, NA (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	nsamagudu@ihvnigeria.org	Pharr, Jennifer/AAZ-1368-2020	Pharr, Jennifer/0000-0002-0383-2641; Badejo, Okikiolu/0000-0002-8124-7018; Busari, Olusegun/0000-0003-3468-2364; Erekaha, Salome/0000-0002-6304-4209	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [R01HD089871]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD089871] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (https://grants.nih.gov/grants/oer.htm) under award number R01HD089871, awarded to EEE and NASA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agwu AL, 2015, J ADOLESCENT HEALTH, V56, P345, DOI 10.1016/j.jadohealth.2014.11.009; [Anonymous], 2014, 6 CORE ELEMENTS HLTH; [Anonymous], 2017, UNAIDS DAT 2017; Auld AF, 2014, MMWR-MORBID MORTAL W, V63, P1097; Boudreau ME, 2012, J ASSOC NURSE AIDS C, V23, P318, DOI 10.1016/j.jana.2011.06.003; Callahan T, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21858; Chu PY, 2015, J PEDIATR NURS, V30, pE19, DOI 10.1016/j.pedn.2015.05.022; Crowley R, 2011, ARCH DIS CHILD, V96, P548, DOI 10.1136/adc.2010.202473; Dahourou DL, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.4.21528; Davies MA, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.4.21668; Davis AM, 2014, PEDIATRICS, V134, P900, DOI 10.1542/peds.2014-1909; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; Ezeanolue EE, 2016, JAIDS-J ACQ IMM DEF, V72, pS161, DOI 10.1097/QAI.0000000000001066; Federal Government of Nigeria National AIDS Spending Assessment (NASA), 2013, 2014 LEV FLOW RES EX; Federal Ministry of Health Nigeria, 2010, NAT GUID HIV AIDS TR; Federal Ministry of Health Nigeria, 2011, CLIN PROT HLTH DEV A; Federal Ministry of Health Nigeria/ UNFPA, 2010, ACT PLAN ADV YOUNG P; Fish R, 2014, HIV MED, V15, P239, DOI 10.1111/hiv.12091; Folayan MO, 2017, AIDS BEHAV, V21, P2736, DOI 10.1007/s10461-016-1534-3; Hussen SA, 2014, FUTURE VIROL, V9, P921, DOI 10.2217/FVL.14.73; IBM Corp, 2012, SOFTW WIND REL 21 0; Kasedde S, 2013, CURR HIV-AIDS REP, V10, P159, DOI 10.1007/s11904-013-0159-7; Katusiime C, 2013, S AFR J HIV MED, V14, P20, DOI 10.7196/SAJHIVMED.885; Kennedy A, 2008, CURR OPIN PEDIATR, V20, P403, DOI 10.1097/MOP.0b013e328305e128; Kung T H, 2016, SAMJ, S. Afr. med. j., V106, P804, DOI [10.7196/SAMJ.2016.v106i8.10496, 10.7196/samj.2016.v106i8.10496]; Lam PK, 2017, JIAS S3, V20, P91; Mark D, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.4.21591; Maturo D, 2007, J PEDIATR HEALTH CAR, V25, p16 ; Okoboi S, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.5.20841; Olakunde BO, 2015, ANN GLOB HEALTH, V81, P684, DOI 10.1016/j.aogh.2015.10.005; Peter NG, 2009, PEDIATRICS, V123, P417, DOI 10.1542/peds.2008-0740; Pettitt ED, 2013, AFR J REPROD HLTH, V17; Ridgeway K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189770; Ryscavage PA, 2011, JAIDS-J ACQ IMM DEF, V58, P193, DOI [10.1097/QAI.0B013E31822D7564, 10.1097/QAI.0b013e31822d7564]; Sainz T, 2015, C RETR OPP INF CROI, P918; Sam-Agudu NA, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2347-z; Slogrove AL, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.4.21520; Sohn AH, 2017, J INT AIDS SOC, V20, p19 ; UNAIDS, 2013, GLOBAL REPORT UNAIDS; UNAIDS, 2017, AIDSINFO 2016 DAT; UNICEF, 2016, GLOB REG TRENDS UNIC; UNICEF, 2014, AD AND AIDS; United States President's Emergency Plan for AIDS Relief, NIG COUNTR OP PLAN C; Vreeman RC, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18466; Weijsenfeld AM, 2016, CLIN INFECT DIS, V63, P1105, DOI 10.1093/cid/ciw487; WHO, 2014, HLTH WORLDS AD 2 CHA; World Health Organization, HIV AD GUID ACT	47	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198802	10.1371/journal.pone.0198802	http://dx.doi.org/10.1371/journal.pone.0198802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894519	Green Published, gold			2022-12-26	WOS:000435030900028
J	Zhang, X; Dash, RK; Jacobs, ER; Camara, AKS; Clough, AV; Audi, SH				Zhang, Xiao; Dash, Ranjan K.; Jacobs, Elizabeth R.; Camara, Amadou K. S.; Clough, Anne, V; Audi, Said H.			Integrated computational model of the bioenergetics of isolated lung mitochondria	PLOS ONE			English	Article							RAT-HEART MITOCHONDRIA; SKELETAL-MUSCLE; OXIDATIVE-PHOSPHORYLATION; ENDOTHELIAL-CELLS; METABOLIC DYNAMICS; COENZYME Q(1); ACID CYCLE; IN-SILICO; OXYGEN; TRANSPORT	Integrated computational modeling provides a mechanistic and quantitative framework for describing lung mitochondrial bioenergetics. Thus, the objective of this study was to develop and validate a thermodynamically-constrained integrated computational model of the bioenergetics of isolated lung mitochondria. The model incorporates the major biochemical reactions and transport processes in lung mitochondria. A general framework was developed to model those biochemical reactions and transport processes. Intrinsic model parameters such as binding constants were estimated using previously published isolated enzymes and transporters kinetic data. Extrinsic model parameters such as maximal reaction and transport velocities were estimated by fitting the integrated bioenergetics model to published and new tricarboxylic acid cycle and respirometry data measured in isolated rat lung mitochondria. The integrated model was then validated by assessing its ability to predict experimental data not used for the estimation of the extrinsic model parameters. For example, the model was able to predict reasonably well the substrate and temperature dependency of mitochondrial oxygen consumption, kinetics of NADH redox status, and the kinetics of mitochondrial accumulation of the cationic dye rhodamine 123, driven by mitochondrial membrane potential, under different respiratory states. The latter required the coupling of the integrated bioenergetics model to a pharmacokinetic model for the mitochondrial uptake of rhodamine 123 from buffer. The integrated bioenergetics model provides a mechanistic and quantitative framework for 1) integrating experimental data from isolated lung mitochondria under diverse experimental conditions, and 2) assessing the impact of a change in one or more mitochondrial processes on overall lung mitochondrial bioenergetics. In addition, the model provides important insights into the bioenergetics and respiration of lung mitochondria and how they differ from those of mitochondria from other organs. To the best of our knowledge, this model is the first for the bioenergetics of isolated lung mitochondria.	[Zhang, Xiao; Dash, Ranjan K.; Audi, Said H.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA; [Dash, Ranjan K.; Audi, Said H.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Dash, Ranjan K.; Camara, Amadou K. S.] Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Jacobs, Elizabeth R.; Clough, Anne, V; Audi, Said H.] Zablocki VA Med Ctr, Milwaukee, WI 53295 USA; [Jacobs, Elizabeth R.; Audi, Said H.] Med Coll Wisconsin, Div Pulm & Crit Care Med, Milwaukee, WI 53226 USA; [Camara, Amadou K. S.] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA; [Clough, Anne, V] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA	Marquette University; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Marquette University	Audi, SH (corresponding author), Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA.; Audi, SH (corresponding author), Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA.; Audi, SH (corresponding author), Zablocki VA Med Ctr, Milwaukee, WI 53295 USA.; Audi, SH (corresponding author), Med Coll Wisconsin, Div Pulm & Crit Care Med, Milwaukee, WI 53226 USA.	said.audi@marquette.edu	Zhang, Xiao/GZH-1960-2022	Zhang, Xiao/0000-0002-7584-0712	National Institute of Health [1R15HL129209, 1R01HL116530, U01-HL122199, P01-GM066730]; VA Merit Review Award [BX001681]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116530, R15HL129209, U01HL122199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM066730] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review Award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health grants 1R15HL129209 (SHA, AVC, ERJ), 1R01HL116530 (ERJ, SHA, AVC), U01-HL122199 (RKD), and P01-GM066730 (RKD), and VA Merit Review Award BX001681 (ERJ, SHA, AVC). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberty RA, 1998, ARCH BIOCHEM BIOPHYS, V353, P116, DOI 10.1006/abbi.1998.0638; Audi SH, 2017, SHOCK, V48, P467, DOI 10.1097/SHK.0000000000000872; Audi SH, 2012, J APPL PHYSIOL, V113, P658, DOI 10.1152/japplphysiol.00441.2012; Audi SH, 2001, AM J PHYSIOL-LUNG C, V281, pL969, DOI 10.1152/ajplung.2001.281.4.L969; Bazil JN, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000632; Bongard RD, 2015, FREE RADICAL BIO MED, V79, P69, DOI 10.1016/j.freeradbiomed.2014.09.030; Bongard RD, 2013, FREE RADICAL BIO MED, V65, P1455, DOI 10.1016/j.freeradbiomed.2013.07.040; BRAND MD, 1974, BIOCHEM J, V140, P205, DOI 10.1042/bj1400205; Camara AKS, 2010, ANTIOXID REDOX SIGN, V13, P279, DOI 10.1089/ars.2009.2788; Cortassa S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005588; Das KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073358; Dash RK, 2008, J PHYSIOL-LONDON, V586, P3267, DOI 10.1113/jphysiol.2008.151977; Dash RK, 2008, IEEE T BIO-MED ENG, V55, P1298, DOI 10.1109/TBME.2007.913422; Dash RK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003168; EVANS RM, 1975, BIOCHIM BIOPHYS ACTA, V381, P278, DOI 10.1016/0304-4165(75)90234-2; EVANS RM, 1977, INT J BIOCHEM, V8, P107, DOI 10.1016/0020-711X(77)90086-6; Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475; FISHER AB, 1973, BIOCHEMISTRY-US, V12, P1438, DOI 10.1021/bi00731a026; FISHER AB, 1984, ENVIRON HEALTH PERSP, V55, P149, DOI 10.2307/3429699; Gan ZH, 2011, J APPL PHYSIOL, V111, P95, DOI 10.1152/japplphysiol.01451.2010; Gan Z, 2011, AM J PHYSIOL-LUNG C, V300, pL762, DOI 10.1152/ajplung.00334.2010; Gnaiger E, 2012, MITOCHONDRIAL PATHWA; Huang M, 2007, ANN BIOMED ENG, V35, P1276, DOI 10.1007/s10439-007-9265-2; KERR JS, 1979, AM J PHYSIOL, V236, pE229, DOI 10.1152/ajpendo.1979.236.3.E229; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; LANOUE K, 1970, J BIOL CHEM, V245, P102; Li YJ, 2012, CELL MOL BIOENG, V5, P92, DOI 10.1007/s12195-011-0210-y; Li YJ, 2009, AM J PHYSIOL-CELL PH, V296, pC25, DOI 10.1152/ajpcell.00094.2008; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Ma C, 2018, ARTERIOSCL THROM VAS, V38, P622, DOI 10.1161/ATVBAHA.117.310605; Man KF, 1996, IEEE T IND ELECTRON, V43, P519, DOI 10.1109/41.538609; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nedergaard J, 1979, Methods Enzymol, V55, P3; NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Piantadosi CA, 2017, ANNU REV PHYSIOL, V79, P495, DOI 10.1146/annurev-physiol-022516-034322; Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045; SCHLAME M, 1986, BIOCHEM J, V240, P247, DOI 10.1042/bj2400247; Schumacker PT, 2014, AM J PHYSIOL-LUNG C, V306, pL962, DOI 10.1152/ajplung.00073.2014; Sepehr R, 2013, IEEE J TRANSL ENG HE, V1, DOI 10.1109/JTEHM.2013.2285916; SPEAR RK, 1978, ANAL BIOCHEM, V90, P211, DOI 10.1016/0003-2697(78)90025-8; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI [10.1089/ars.2008.2331, 10.1089/ARS.2008.2331]; Tkaczyk J, 2007, Prague Med Rep, V108, P105; Vinnakota KC, 2011, J BIOL CHEM, V286, P30816, DOI 10.1074/jbc.M111.242529; Wagner M., 1976, J CHEM EDUC, V53, pA472, DOI DOI 10.1021/ED053PA472; Wu F, 2007, J BIOL CHEM, V282, P24525, DOI 10.1074/jbc.M701024200	48	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0197921	10.1371/journal.pone.0197921	http://dx.doi.org/10.1371/journal.pone.0197921			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889855	Green Published, Green Submitted, gold			2022-12-26	WOS:000434786600009
J	Gilbert, N; Bernier, RA; Calhoun, VD; Brenner, E; Grossner, E; Rajtmajer, SM; Hillary, FG				Gilbert, Nicholas; Bernier, Rachel A.; Calhoun, Vincent D.; Brenner, Einat; Grossner, Emily; Rajtmajer, Sarah M.; Hillary, Frank G.			Diminished neural network dynamics after moderate and severe traumatic brain injury	PLOS ONE			English	Article							PROCESSING SPEED DEFICITS; WORKING-MEMORY; FUNCTIONAL CONNECTIVITY; ATTENTION DEFICITS; COGNITIVE-CONTROL; FMRI; SEGMENTATION; REGIONS; MRI	Over the past decade there has been increasing enthusiasm in the cognitive neurosciences around using network science to understand the system-level changes associated with brain disorders. A growing literature has used whole-brain fMRI analysis to examine changes in the brain's subnetworks following traumatic brain injury (TBI). Much of network modeling in this literature has focused on static network mapping, which provides a window into gross inter-nodal relationships, but is insensitive to more subtle fluctuations in network dynamics, which may be an important predictor of neural network plasticity. In this study, we examine the dynamic connectivity with focus on state-level connectivity (state) and evaluate the reliability of dynamic network states over the course of two runs of intermittent task and resting data. The goal was to examine the dynamic properties of neural networks engaged periodically with task stimulation in order to determine: 1) the reliability of inter-nodal and network-level characteristics over time and 2) the transitions between distinct network states after traumatic brain injury. To do so, we enrolled 23 individuals with moderate and severe TBI at least 1-year post injury and 19 age-and education-matched healthy adults using functional MRI methods, dynamic connectivity modeling, and graph theory. The results reveal several distinct network "states" that were reliably evident when comparing runs; the overall frequency of dynamic network states are highly reproducible (r-values>0.8) for both samples. Analysis of movement between states resulted in fewer state transitions in the TBI sample and, in a few cases, brain injury resulted in the appearance of states not exhibited by the healthy control (HC) sample. Overall, the findings presented here demonstrate the reliability of observable dynamic mental states during periods of on-task performance and support emerging evidence that brain injury may result in diminished network dynamics.	[Gilbert, Nicholas; Bernier, Rachel A.; Brenner, Einat; Grossner, Emily; Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Gilbert, Nicholas; Bernier, Rachel A.; Brenner, Einat; Grossner, Emily; Hillary, Frank G.] Social & Life & Engn Sci Imaging Ctr, University Pk, PA 16802 USA; [Calhoun, Vincent D.] Mind Res Network, Albuquerque, NM USA; [Calhoun, Vincent D.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Rajtmajer, Sarah M.] Penn State Univ, Coll Informat Sci & Technol, University Pk, PA 16802 USA; [Hillary, Frank G.] Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Lovelace Respiratory Research Institute; University of New Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, University Pk, PA 16802 USA.; Hillary, FG (corresponding author), Social & Life & Engn Sci Imaging Ctr, University Pk, PA 16802 USA.; Hillary, FG (corresponding author), Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA.	fhillary@psu.edu	Hillary, Frank/AAN-8622-2021; Calhoun, Vince/H-7146-2013	Calhoun, Vince/0000-0001-9058-0747; Bernier, Rachel/0000-0002-2759-9186	National Center for Advancing Translational Sciences, NIHUL [Tr000127]; Social Life and Engineering Sciences imaging Center; Social Sciences Research Institute at the Pennsylvania state; University, University Park, PA, USA; Quantitative Science Solutions (QS2); National Center for Advancing Translational Sciences, NIHUL through the Clinical Translational Science Institute [Tr000127]	National Center for Advancing Translational Sciences, NIHUL; Social Life and Engineering Sciences imaging Center; Social Sciences Research Institute at the Pennsylvania state; University, University Park, PA, USA; Quantitative Science Solutions (QS2); National Center for Advancing Translational Sciences, NIHUL through the Clinical Translational Science Institute	This research was supported by the National Center for Advancing Translational Sciences, NIHUL Tr000127, the Social Life and Engineering Sciences imaging Center and the Social Sciences Research Institute at the Pennsylvania state and the University, University Park, PA, 16801, USA to FGH. Quantitative Science Solutions (QS2) provided support in the form of salary for one author (SMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We want to thank Dr. Arnab Roy for his support of this work and for his mentorship of the first author during analysis and manuscript preparation. This research was supported by the National Center for Advancing Translational Sciences, NIHUL Tr000127 through the Clinical Translational Science Institute, the Social Life and Engineering Sciences imaging Center and the Social Sciences Research Institute at the Pennsylvania state and the University, University Park, PA, 16801, USA.	Allen E. A., 2012, CEREB CORTEX; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; [Anonymous], 2009, HUM BRAIN MAPP; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; BERNIER RA, 2017, FRONT NEUROL, V8; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Caeyenberghs K., 2016, NEUROIMAGE; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Calhoun VD, 2014, NEURON, V84, P262, DOI 10.1016/j.neuron.2014.10.015; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Genova HM, 2009, J INT NEUROPSYCH SOC, V15, P383, DOI 10.1017/S1355617709090535; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; Goni J, 2014, P NATL ACAD SCI USA, V111, P833, DOI 10.1073/pnas.1315529111; Gu S, 2017, NEUROIMAGE; Hallquist MN, 2018, NETW NEUROSCI, V3, P1, DOI 10.1162/netn_a_00054; Hillary FG, 2014, BRAIN IMAGING BEHAV, V8, P435, DOI 10.1007/s11682-012-9205-0; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2017, TRENDS COGN SCI; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Hutchison RM, 2013, HUM BRAIN MAPP, V34, P2154, DOI 10.1002/hbm.22058; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jones DT, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039731, 10.1371/journal.pone.0044294]; Lindquist MA, 2008, HUM BRAIN MAPP, V29, P1276, DOI 10.1002/hbm.20475; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; Manktelow AE, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00058; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Medaglia JD, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00407; Medaglia JD, 2011, NETWORK-COMP NEURAL, V22, P148, DOI 10.3109/09638237.2011.639604; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Nenadovic V, 2008, J NEUROTRAUM, V25, P615, DOI 10.1089/neu.2007.0474; Nugent AC, 2015, J CEREBR BLOOD F MET, V35, P583, DOI 10.1038/jcbfm.2014.228; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Poldrack RA, 2016, ANNU REV PSYCHOL, V67, P587, DOI 10.1146/annurev-psych-122414-033729; Rabinowitz AR, 2013, NEUROPSYCHOLOGY, V27, P481, DOI 10.1037/a0033023; Raja Beharelle A, 2012, NEUROIMAGE, V60, P1528, DOI 10.1016/j.neuroimage.2012.01.037; Rajtmajer SM, 2015, FRONT NEUROANAT, V9, DOI [10.3389/fnana.7015.00097, 10.3389/fnana.2015.00097]; Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170541; Roy A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00146; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; SCHMAHMANN JD, 1991, ARCH NEUROL-CHICAGO, V48, P1178, DOI 10.1001/archneur.1991.00530230086029; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2017, EXP BRAIN RES, V235, P799, DOI 10.1007/s00221-016-4841-z; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; TEASDALE G, 1974, LANCET, V2, P81; Telesford QK, 2016, NEUROIMAGE, V142, P188, DOI 10.1016/j.neuroimage.2016.05.078; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Vergara VM, 2017, NEUROIMAGE, V145, P365, DOI 10.1016/j.neuroimage.2016.03.038; Zamora-Lopez G, 2010, FRONT NEUROINFORM, V4	68	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0197419	10.1371/journal.pone.0197419	http://dx.doi.org/10.1371/journal.pone.0197419			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI7ZT	29883447	Green Published, Green Submitted, gold			2022-12-26	WOS:000434728100005
J	Hamasuna, R; Le, PT; Kutsuna, S; Furubayashi, K; Matsumoto, M; Ohmagari, N; Fujimoto, N; Matsumoto, T; Jensen, JS				Hamasuna, Ryoichi; Phuong Thi Le; Kutsuna, Satoshi; Furubayashi, Keiichi; Matsumoto, Masahiro; Ohmagari, Norio; Fujimoto, Naohiro; Matsumoto, Tetsuro; Jensen, Jorgen Skov			Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains	PLOS ONE			English	Article							REAL-TIME PCR; NONGONOCOCCAL URETHRITIS; MACROLIDE RESISTANCE; FLUOROQUINOLONE RESISTANCE; URINE SPECIMENS; CLINICAL-TRIAL; JAPAN; AZITHROMYCIN; FAILURE; INFECTIONS	Macrolide or fluoroquinolone-resistant Mycoplasma genitalium is spreading worldwide. We aimed to determine the influence of single nucleotide polymorphisms (SNPs) in the quinolone resistance determining regions (QRDR) of parC and gyrA in cultured M. genitalium strains. In addition, we examined the prevalence of macrolide-and fluoroquinolone resistance mediating mutations in specimens collected from Japanese male patients with urethritis in two time-periods between 2005-2009 and 2010-2017, respectively, by sequencing the QRDR of parC and gyrA and domain V of the 23S rRNA gene. The minimum inhibitory concentrations (MIC) of moxifloxacin, sitafloxacin, ciprofloxacin, levofloxacin, doxycycline, minocycline, azithromycin and clarithromycin were determined in 23 M. genitalium strains. Three cultured strains had elevated MICs for moxifloxacin at 16, 4 and 2 mg/L and had SNPs with the amino-acid change Ser83 -> Ile in ParC (p<0.001) and 3 kinds of SNPs with amino-acid changes Asp99 -> Asn, Gly93 -> Cys and Met95 -> Ile in GyrA, respectively. Among a total of 148 M. genitalium positive urine specimens, the prevalence of A2058G and A2059G SNPs in the 23S rRNA gene and any SNPs in ParC increased from 4.8% and 22.6% in 2005-2009 to 42.2% and 53.1% in 2010-2017, respectively. If M. genitalium is considered multi-drug resistant in clinical specimens carrying SNPs in the 23S rRNA gene and Ser83 -> Ile in ParC, the prevalence of multi-drug resistance is 12.5% in 2010-2017 in Japan. In conclusion, the SNP resulting in Ser83 -> Ile in ParC is closely related to moxifloxacin resistance even though other factors may also affect treatment outcomes by moxifloxacin. The prevalence of circulating multi-drug resistant M. genitalium strains with macrolide-and fluoroquinolone-resistance is dramatically increasing in Japan.	[Hamasuna, Ryoichi; Phuong Thi Le; Matsumoto, Masahiro; Fujimoto, Naohiro; Matsumoto, Tetsuro] Univ Occupat & Environm Hlth, Dept Urol, Kitakyushu, Fukuoka, Japan; [Kutsuna, Satoshi; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Int Hlth Care Ctr, Dis Control & Prevent Ctr, Tokyo, Japan; [Furubayashi, Keiichi] Sonezaki Furubayashi Clin, Osaka, Japan; [Jensen, Jorgen Skov] Statens Serum Inst, Res Unit Reprod Tract Microbiol, Copenhagen, Denmark	University of Occupational & Environmental Health - Japan; National Center for Global Health & Medicine - Japan; Statens Serum Institut	Hamasuna, R (corresponding author), Univ Occupat & Environm Hlth, Dept Urol, Kitakyushu, Fukuoka, Japan.	hamaryo@med.uoeh-u.ac.jp	Ohmagari, Norio/GLN-5290-2022	Ohmagari, Norio/0000-0002-4622-8970; Matsumoto, Masahiro/0000-0001-8374-3595	Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [26462456, 17K11193]	Japan Society for the Promotion of Science (JSPS) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by grants from the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 26462456 and 17K11193. Dr. Hamasuma R obtained fund and designed the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradshaw CS, 2006, EMERG INFECT DIS, V12, P1149, DOI 10.3201/eid1207.051558; Couldwell DL, 2013, INT J STD AIDS, V24, P822, DOI 10.1177/0956462413502008; Deguchi T, 2017, J INFECT CHEMOTHER, V23, P648, DOI 10.1016/j.jiac.2017.03.008; Falk L, 2003, SEX TRANSM INFECT, V79, P318, DOI 10.1136/sti.79.4.318; Hamasuna R, 2005, ANTIMICROB AGENTS CH, V49, P4993, DOI 10.1128/AAC.49.12.4993-4998.2005; Hamasuna R, 2007, J CLIN MICROBIOL, V45, P847, DOI 10.1128/JCM.02056-06; Hamasuna R, 2018, MICROB DRUG RESIST, V24, P30, DOI 10.1089/mdr.2017.0054; Hamasuna R, 2013, INT J UROL, V20, P676, DOI 10.1111/iju.12152; Hamasuna R, 2013, J INFECT CHEMOTHER, V19, P1, DOI 10.1007/s10156-012-0487-3; Hamasuna R, 2011, SEX TRANSM INFECT, V87, P389, DOI 10.1136/sti.2010.048553; Hamasuna R, 2009, ANTIMICROB AGENTS CH, V53, P4938, DOI 10.1128/AAC.00724-09; Hannan PCT, 2000, VET RES, V31, P373, DOI 10.1051/vetres:2000100; Jensen JS, 2016, J EUR ACAD DERMATOL, V30, P1686, DOI 10.1111/jdv.13850; Jensen JS, 2008, CLIN INFECT DIS, V47, P1546, DOI 10.1086/593188; Jensen JS, 2014, ANTIMICROB AGENTS CH, V58, P3151, DOI 10.1128/AAC.02411-14; Jensen JS, 1996, J CLIN MICROBIOL, V34, P286, DOI 10.1128/JCM.34.2.286-291.1996; Jensen JS, 2004, J CLIN MICROBIOL, V42, P683, DOI 10.1128/JCM.42.2.683-692.2004; Kikuchi M, 2014, J ANTIMICROB CHEMOTH, V69, P2376, DOI 10.1093/jac/dku164; Le PT, 2017, J INFECT CHEMOTHER; Maeda S, 2001, SEX TRANSM DIS, V28, P472, DOI 10.1097/00007435-200108000-00010; Matsumoto T, 2010, JPN J CHEMOTHER, V58, P466; McGowin CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001324; Mena LA, 2009, CLIN INFECT DIS, V48, P1649, DOI 10.1086/599033; Morozumi M, 2005, ANTIMICROB AGENTS CH, V49, P2302, DOI 10.1128/AAC.49.6.2302-2306.2005; Murray GL, 2017, EMERG INFECT DIS, V23, P809, DOI 10.3201/eid2305.161745; Salado-Rasmussen K, 2014, CLIN INFECT DIS, V59, P24, DOI 10.1093/cid/ciu217; Schwebke JR, 2011, CLIN INFECT DIS, V52, P163, DOI 10.1093/cid/ciq074; Shimada Y, 2011, EMERG INFECT DIS, V17, P1148, DOI [10.3201/eid1706.101055, 10.3201/eid/1706.101055]; Shimada Y, 2010, INT J ANTIMICROB AG, V36, P255, DOI 10.1016/j.ijantimicag.2010.05.011; Tagg KA, 2013, J CLIN MICROBIOL, V51, P2245, DOI 10.1128/JCM.00495-13; Takahashi S, 2013, J INFECT CHEMOTHER, V19, P941, DOI 10.1007/s10156-013-0620-y; Taylor-Robinson D, 2011, CLIN MICROBIOL REV, V24, P498, DOI 10.1128/CMR.00006-11; Yamagishi Y, 2017, JPN J INFECT DIS, V70, P616, DOI 10.7883/yoken.JJID.2017.068; You CL, 2016, MICROB PATHOGENESIS, V95, P95, DOI 10.1016/j.micpath.2016.02.022	34	59	62	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198355	10.1371/journal.pone.0198355	http://dx.doi.org/10.1371/journal.pone.0198355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883482	gold, Green Published, Green Submitted			2022-12-26	WOS:000434728100017
J	Nanni, M; Martinez-Soto, J; Gonzalez-Santos, L; Barrios, FA				Nanni, Melanni; Martinez-Soto, Joel; Gonzalez-Santos, Leopoldo; Barrios, Fernando A.			Neural correlates of the natural observation of an emotionally loaded video	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; RESTING-STATE; DEFAULT-MODE; MODULAR ORGANIZATION; PSYCHOSOCIAL STRESS; CORTISOL RESPONSES; VIEWING CONDITIONS; EYE-MOVEMENTS	Studies based on a paradigm of free or natural viewing have revealed characteristics that allow us to know how the brain processes stimuli within a natural environment. This method has been little used to study brain function. With a connectivity approach, we examine the processing of emotions using an exploratory method to analyze functional magnetic resonance imaging (fMRI) data. This research describes our approach to modeling stress paradigms suitable for neuroimaging environments. We showed a short film (4.54 minutes) with high negative emotional valence and high arousal content to 24 healthy male subjects (36.42 years old; SD = 12.14) during fMRI. Independent component analysis (ICA) was used to identify networks based on spatial statistical independence. Through this analysis we identified the sensorimotor system and its influence on the dorsal attention and defaultmode networks, which in turn have reciprocal activity and modulate networks described as emotional.	[Nanni, Melanni; Martinez-Soto, Joel; Gonzalez-Santos, Leopoldo; Barrios, Fernando A.] Univ Nacl Autonoma Mexico, Inst Neurobiol, Queretaro, Mexico; [Martinez-Soto, Joel] Univ Guanajuato, Dept Psychol, Guanajuato, Mexico	Universidad Nacional Autonoma de Mexico; Universidad de Guanajuato	Barrios, FA (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Queretaro, Mexico.	fbarrios@unam.mx	Barrios, Fernando Alejandro/D-1591-2016; Martínez-Soto, Joel/G-9595-2011	Barrios, Fernando Alejandro/0000-0002-5699-4222; Martínez-Soto, Joel/0000-0002-9418-9726	Programa de Maestria en Ciencias (Neurobiologia) of the Universidad Nacional Autonoma de Mexico (UNAM) by the National Council of Science and Technology, Mexico (Consejo Nacional de Ciencia y Tecnologia, CONACYT); DGAPA-UNAM; PASPA program at DGAPA-UNAM; CONACyT [CB167271]	Programa de Maestria en Ciencias (Neurobiologia) of the Universidad Nacional Autonoma de Mexico (UNAM) by the National Council of Science and Technology, Mexico (Consejo Nacional de Ciencia y Tecnologia, CONACYT); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); PASPA program at DGAPA-UNAM; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Programa de Maestria en Ciencias (Neurobiologia) of the Universidad Nacional Autonoma de Mexico (UNAM) for the masters fellowship (MN) supported by the National Council of Science and Technology, Mexico (Consejo Nacional de Ciencia y Tecnologia, CONACYT); DGAPA-UNAM for the Postdoctoral Fellowship (JM-S); the PASPA program at DGAPA-UNAM for the sabbatical fellowship (FAB); and CONACyT for the funding received via grant CB167271 (FAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Bartels A, 2005, NEUROIMAGE, V24, P339, DOI 10.1016/j.neuroimage.2004.08.044; Beauchamp MS, 2003, MAGNET RESON MED, V49, P376, DOI 10.1002/mrm.10345; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bouma EMC, 2009, PSYCHONEUROENDOCRINO, V34, P884, DOI 10.1016/j.psyneuen.2009.01.003; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brand N, 1997, PERCEPT MOTOR SKILL, V84, P455, DOI 10.2466/pms.1997.84.2.455; Broicher SD, 2012, J NEUROL, V259, P2546, DOI 10.1007/s00415-012-6533-3; Cisler JM, 2013, PSYCHIAT RES-NEUROIM, V214, P238, DOI 10.1016/j.pscychresns.2013.06.003; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Cullen KR, 2011, BRAIN CONNECT, V1, P61, DOI 10.1089/brain.2010.0001; David SV, 2009, J NEUROSCI, V29, P3374, DOI 10.1523/JNEUROSCI.5249-08.2009; Dedovic K, 2005, J PSYCHIATR NEUROSCI, V30, P319; Dedovic K, 2009, BRAIN RES, V1293, P49, DOI 10.1016/j.brainres.2009.06.044; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; GERRARDSHESSE A, 1994, BRIT J PSYCHOL, V85, P55, DOI 10.1111/j.2044-8295.1994.tb02508.x; Gonzalez-Santos L, 2007, SALUD MENT, V30, P31; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hasson U, 2006, NOVARTIS FDN S, V270; Hasson U, 2008, NEURON, V57, P452, DOI 10.1016/j.neuron.2007.12.009; Hasson U, 2012, NEUROIMAGE, V62, P1272, DOI 10.1016/j.neuroimage.2012.02.004; Hasson U, 2008, PROJECTIONS, V2, P1, DOI 10.3167/proj.2008.020102; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Hermans EJ, 2011, SCIENCE, V334, P1151, DOI 10.1126/science.1209603; Escarti MJ, 2010, SCHIZOPHR RES, V117, P31, DOI 10.1016/j.schres.2009.12.028; Kanowski M, 2007, J NEUROSCI METH, V160, P10, DOI 10.1016/j.jneumeth.2006.08.001; Kauppi Jukka-Pekka, 2010, Front Neuroinform, V4, P5, DOI 10.3389/fninf.2010.00005; KING MG, 1983, BRIT J PSYCHOL, V74, P473, DOI 10.1111/j.2044-8295.1983.tb01880.x; Lahnakoski JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035215; Malinen S, 2007, NEUROIMAGE, V35, P131, DOI 10.1016/j.neuroimage.2006.11.015; MASON JW, 1968, PSYCHOSOM MED, V30, P576, DOI 10.1097/00006842-196809000-00020; Mathiak K, 2006, HUM BRAIN MAPP, V27, P948, DOI 10.1002/hbm.20234; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Morrison I, 2013, HUM BRAIN MAPP, V34, P1982, DOI 10.1002/hbm.22040; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pajula J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041196; Pruessner JC, 2008, BIOL PSYCHIAT, V63, P234, DOI 10.1016/j.biopsych.2007.04.041; Ptak R, 2010, J NEUROSCI, V30, P12557, DOI 10.1523/JNEUROSCI.2722-10.2010; Qin SZ, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00016; Quadflieg S, 2015, CORTEX, V70, P5, DOI 10.1016/j.cortex.2014.12.020; Romero-Rebollar C, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/2816567; Schultz J, 2009, EXP BRAIN RES, V194, P465, DOI 10.1007/s00221-009-1721-9; Shi HQ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01198; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Sisbot S, 2005, FLOW MEAS INSTRUM, V16, P27, DOI 10.1016/j.flowmeasinst.2004.09.001; Soares JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066500; Spiers HJ, 2007, TRENDS COGN SCI, V11, P356, DOI 10.1016/j.tics.2007.06.002; Straube T, 2010, HUM BRAIN MAPP, V31, P36, DOI 10.1002/hbm.20843; Tohka J, 2008, NEUROIMAGE, V39, P1227, DOI 10.1016/j.neuroimage.2007.10.013; Tregellas JR, 2002, HUM BRAIN MAPP, V17, P237, DOI 10.1002/hbm.10070; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; van den Berg AE, 2003, J ENVIRON PSYCHOL, V23, P135, DOI 10.1016/S0272-4944(02)00111-1; van der Gaag C, 2007, SOC COGN AFFECT NEUR, V2, P93, DOI 10.1093/scan/nsm002; Vanderwal T, 2017, NEUROIMAGE, V157, P521, DOI 10.1016/j.neuroimage.2017.06.027; Nguyen VT, 2016, NEUROIMAGE, V124, P455, DOI 10.1016/j.neuroimage.2015.08.078; Vossel S, 2012, J NEUROSCI, V32, P10637, DOI 10.1523/JNEUROSCI.0414-12.2012; Wang JJ, 2005, P NATL ACAD SCI USA, V102, P17804, DOI 10.1073/pnas.0503082102	66	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198731	10.1371/journal.pone.0198731	http://dx.doi.org/10.1371/journal.pone.0198731			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI7ZT	29883494	Green Published, Green Submitted, gold			2022-12-26	WOS:000434728100038
J	Gu, SD; Ngamcherdtrakul, W; Reda, M; Hu, Z; Gray, JW; Yantasee, W				Gu, Shenda; Ngamcherdtrakul, Worapol; Reda, Moataz; Hu, Zhi; Gray, Joe W.; Yantasee, Wassana			Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FOCAL ADHESION KINASE; TRASTUZUMAB EMTANSINE; MONOCLONAL-ANTIBODY; LAPATINIB; PERTUZUMAB; INHIBITOR; ERBB2; COMBINATION; ACQUISITION	Intrinsic and acquired resistance to current HER2 targeted therapies remains a challenge in clinics. We have developed a therapeutic HER2 siRNA delivered using mesoporous silica nanoparticles modified with polymers and conjugated with HER2 targeting antibodies. Our previous studies have shown that our HER2 siRNA nanoparticles could overcome intrinsic and acquired resistance to trastuzumab and lapatinib in HER2-positive breast cancers. In this study, we investigated the effect of long-term (7 months) treatment using our therapeutic HER2 siRNA. Even after the removal of HER2 siRNA, the long-term treated cells grew much slower (67% increase in doubling time) than cells that have not received any treatment. The treated cells did not undergo epithelial-mesenchymal transition or showed enrichment of tumor initiating cells. Unlike trastuzumab and lapatinib, which induced resistance in BT474 cells after 6 months of treatment, HER2 siRNA did not induce resistance to HER2 siRNA, trastuzumab, or lapatinib. HER2 ablation with HER2 siRNA prevented reactivation of HER2 signaling that was observed in cells resistant to lapatinib. Altogether, our results indicate that a HER2 siRNA based therapeutic provides a more durable inhibition of HER2 signaling in vitro and can potentially be more effective than the existing therapeutic monoclonal antibodies and small molecule inhibitors.	[Gu, Shenda; Ngamcherdtrakul, Worapol; Reda, Moataz; Hu, Zhi; Gray, Joe W.; Yantasee, Wassana] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Ngamcherdtrakul, Worapol; Yantasee, Wassana] PDX Pharmaceut LLC, Portland, OR 97239 USA	Oregon Health & Science University	Yantasee, W (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA.; Yantasee, W (corresponding author), PDX Pharmaceut LLC, Portland, OR 97239 USA.	yantasee@ohsu.edu	Gray, Joe/AAX-9549-2020	Gu, Shenda/0000-0003-2271-0524	National Cancer Institute [HHSN261201300078C, R44CA217534]; Prospect Creek Foundation; PDX Pharmaceuticals, LLC; NCI [CA16672]; NATIONAL CANCER INSTITUTE [R44CA217534, P30CA016672] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prospect Creek Foundation; PDX Pharmaceuticals, LLC; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Cancer Institute (www.cancer.gov), grants HHSN261201300078C (W.Y., W.N., and J.W.G.) and R44CA217534 (W.N., WY., and J.W.G.), and by the Prospect Creek Foundation (WY. and J.W. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. PDX Pharmaceuticals, LLC, a commercial company, provided support in the form of salaries for W.N. and W.Y., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Tiera Liby for maintaining cell lines and the RPPA service provided by MD Anderson's RPPA core facility, which is funded by NCI # CA16672. The authors are grateful to Dr. Tania Vu for her independent review of the data in this paper as required by OHSU conflict of interest guidelines. We also thank Dr. David Castro and Daniel Bejan for editing the manuscript.	Adams CW, 2006, CANCER IMMUNOL IMMUN, V55, P717, DOI 10.1007/s00262-005-0058-x; Albanell J, 1999, DRUGS TODAY, V35, P931; Amin DN, 2012, BIOCHEM J, V447, P417, DOI 10.1042/BJ20120724; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Camirand A, 2002, MED SCI MONITOR, V8, pBR521; Canfield K, 2015, CELL CYCLE, V14, P648, DOI 10.4161/15384101.2014.994966; Christianson TA, 1998, CANCER RES, V58, P5123; Golan T, 2015, ONCOTARGET, V6, P24560, DOI 10.18632/oncotarget.4183; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Gu S, 2016, ONCOTARGET, V7, P14727, DOI 10.18632/oncotarget.7409; Hanker AB, 2017, CLIN CANCER RES, V23, P4323, DOI 10.1158/1078-0432.CCR-16-2287; Hellstrom I, 2001, CANCER RES, V61, P2420; Henjes F, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.16; Joly MM, 2016, CANCER RES, V76, P4752, DOI 10.1158/0008-5472.CAN-15-3393; Kancha RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026760; Kavuri SM, 2015, CANCER DISCOV, V5, P832, DOI 10.1158/2159-8290.CD-14-1211; Lazaro G, 2013, ENDOCR-RELAT CANCER, V20, P691, DOI 10.1530/ERC-13-0019; Li S, 2014, DISCOVERIES REP, V1, DOI [DOI 10.15190/DREP.2014.1, 10.15190/drep.2014.1]; Medina PJ, 2008, CLIN THER, V30, P1426, DOI 10.1016/j.clinthera.2008.08.008; Mitra D, 2009, MOL CANCER THER, V8, P2152, DOI 10.1158/1535-7163.MCT-09-0295; Morry J, 2017, MOL CANCER THER, V16, P763, DOI 10.1158/1535-7163.MCT-16-0644; Nagy P, 2005, CANCER RES, V65, P473; Ngamcherdtrakul W, 2015, ADV FUNCT MATER, V25, P2646, DOI 10.1002/adfm.201404629; Paulson AK, 2013, MOL CANCER RES, V11, P1112, DOI 10.1158/1541-7786.MCR-13-0042; Perez EA, 2017, J CLIN ONCOL, V35, P141, DOI 10.1200/JCO.2016.67.4887; Prat A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju152; Price-Schiavi SA, 2002, INT J CANCER, V99, P783, DOI 10.1002/ijc.10410; Raina D, 2014, ONCOGENE, V33, P3422, DOI 10.1038/onc.2013.308; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Ross, 1998, Oncologist, V3, P237; Saez R, 2006, CLIN CANCER RES, V12, P424, DOI 10.1158/1078-0432.CCR-05-1807; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513; Swain SM, 2013, LANCET ONCOL, V14, P461, DOI 10.1016/S1470-2045(13)70130-X; Tevaarwerk AJ, 2009, CLIN THER, V31, P2332, DOI 10.1016/j.clinthera.2009.11.029; Turpin J, 2016, ONCOGENE, V35, P6053, DOI 10.1038/onc.2016.129; van Geldermalsen M, 2016, ONCOGENE, V35, P3201, DOI 10.1038/onc.2015.381; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; Wang YC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3067; Welslau M, 2014, CANCER-AM CANCER SOC, V120, P642, DOI 10.1002/cncr.28465; Xu XW, 2017, CLIN CANCER RES, V23, P5123, DOI 10.1158/1078-0432.CCR-16-2191	46	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198141	10.1371/journal.pone.0198141	http://dx.doi.org/10.1371/journal.pone.0198141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879129	Green Published, Green Submitted, gold			2022-12-26	WOS:000434384900022
J	Adame, MF; Jardine, TD; Fry, B; Valdez, D; Lindner, G; Nadji, J; Bunn, SE				Adame, Maria Fernanda; Jardine, Timothy D.; Fry, Brian; Valdez, Dominic; Lindner, Garry; Nadji, Jonathan; Bunn, Stuart E.			Estuarine crocodiles in a tropical coastal floodplain obtain nutrition from terrestrial prey	PLOS ONE			English	Article							CROCODYLUS-POROSUS SCHNEIDER; RIVERS REGION KAKADU; NORTHERN AUSTRALIA; TOP-PREDATOR; ISOTOPE; JOHNSTONI; DYNAMICS; DIET; DELTA-N-15; DELTA-C-13	The estuarine crocodile (Crocodylus porosus) is one of the largest and most widespread crocodilians in the world. Although considered an apex species, the role of the estuarine crocodile in aquatic foodwebs is poorly understood; we know what crocodiles ingest, but not what nourishes them. In this study, we used a combination of stable isotope measurements (delta C-13, delta(15) N, and delta S-34) and direct feeding observations to identify the source of nutrition of estuarine crocodiles in Kakadu National Park, Northern Australia. Our results show that most crocodiles sampled (size 850 - 4200mm, with 76% of them being > 2.5 m) consume a large variety of prey, however a large proportion of their nutrition is derived from terrestrial prey. Introduced species such as water buffaloes (Bubalus bubalis) and pigs (Sus scrofa) could contribute between 53 and 84% to the nutrition of the sampled crocodiles. The isotopic composition of large crocodiles (total length > 3 m) suggested possible increase in marine prey consumption with size (R-2 = 0.30; p = 0.005). Additionally, we found crocodiles sampled in the dry season had on average higher terrestrial contributions compared to crocodiles sampled during the wet season (84.1 +/- 2.4% versus 55.4 +/- 7.0%). Overall, we found that terrestrial prey are important source of nutrition for many crocodiles in this region where introduced herbivorous mammals are abundant.	[Adame, Maria Fernanda; Fry, Brian; Valdez, Dominic; Bunn, Stuart E.] Griffith Univ, Australian Rivers Inst, Nathan, Qld, Australia; [Jardine, Timothy D.] Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK, Canada; [Lindner, Garry; Nadji, Jonathan] Kakadu Natl Pk, Jabiru, NT, Australia	Griffith University; University of Saskatchewan	Adame, MF (corresponding author), Griffith Univ, Australian Rivers Inst, Nathan, Qld, Australia.	f.adame@griffith.edu.au	Bunn, Stuart E/B-9065-2008; Jardine, Timothy Donald/AFZ-4837-2022	Bunn, Stuart E/0000-0002-6540-3586; Jardine, Timothy/0000-0002-5917-9792; Adame, Maria Fernanda/0000-0001-9620-9252	Australian Government-National Environmental Research Program; Queensland Government; Advance Queensland Fellowship; Queensland Government through Advance Queensland Fellowship	Australian Government-National Environmental Research Program(Australian Government); Queensland Government; Advance Queensland Fellowship; Queensland Government through Advance Queensland Fellowship	This work was supported by the Australian Government-National Environmental Research Program, SE Bunn, http://www.environment.gov.au/science/nerp; Queensland Government. Advance Queensland Fellowship, MF Adame, http://advance.qld.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the Traditional Owners, the Bininj/Mungguy people, of the land in which this research was done. We thank Kakadu National Park staff for logistic support in the field. We thank ERRISS for providing accommodation in the Park. This research was conducted with the support of funding from the Queensland Government through the Advance Queensland Fellowship granted to MFA.	Adame MF, 2017, BIOTROPICA, V49, P461, DOI 10.1111/btp.12445; Atwood TB, 2013, NAT GEOSCI, V6, P191, DOI 10.1038/ngeo1734; Australian Government, AUSTR BUR MET; Australian Government. Department of Sustainability Environment Water Population and the Communities, 2011, FER PIG SUS SCROF; Barber NA, 2008, ECOLOGY, V89, P2678, DOI 10.1890/08-0395.1; Botha H, 2011, WATER SA, V37, P103; Brett MT, 2014, MAR ECOL PROG SER, V514, P1, DOI 10.3354/meps11017; Campbell HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062127; Carlsson NOL, 2009, FRONT ECOL ENVIRON, V7, P525, DOI 10.1890/080093; DAVENPORT J, 1990, J ZOOL, V220, P569, DOI 10.1111/j.1469-7998.1990.tb04736.x; Delany MF, 1999, PROCEEDINGS OF THE FIFTY-THIRD ANNUAL CONFERENCE OF THE SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P375; Fry B., 2006, STABLE ISOTOPE ECOLO; Fry B, 2013, MAR ECOL PROG SER, V490, P291, DOI 10.3354/meps10536; Fry B, 2013, MAR ECOL PROG SER, V472, P1, DOI 10.3354/meps10168; Fukuda Y, 2011, J WILDLIFE MANAGE, V75, P1253, DOI 10.1002/jwmg.191; Hanson JO, 2015, AUSTRAL ECOL, V40, P275, DOI 10.1111/aec.12212; Jardine TD, 2017, OECOLOGIA, V183, P505, DOI 10.1007/s00442-016-3786-z; Jardine TD, 2011, MAR FRESHWATER RES, V62, P83, DOI 10.1071/MF10211; KAR SK, 1983, BIOL CONSERV, V25, P377, DOI 10.1016/0006-3207(83)90071-X; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; Letnic M, 2008, BIOL CONSERV, V141, P1773, DOI 10.1016/j.biocon.2008.04.031; Magnusson W. E., 1976, AUSTR WILD RES, V3, P153; MAGNUSSON WE, 1987, J HERPETOL, V21, P85, DOI 10.2307/1564468; Manolis S., 2002, FINNISS RIVER NATURA, P65; Marques TS, 2014, J HERPETOL, V48, P332, DOI 10.1670/12-274; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; Nehlich O, 2015, EARTH-SCI REV, V142, P1, DOI 10.1016/j.earscirev.2014.12.002; Nichols T., 2008, URBAN HERPETOLOGY HE, V3, P503; Nifong JC, 2015, J ANIM ECOL, V84, P35, DOI 10.1111/1365-2656.12306; Parnell AC, 2010, SOURCE PARTITIONING, V5, pe9672, DOI [10.1371/journal.pone.0009672, DOI 10.1371/JOURNAL.PONE.0009672]; Phillips D, 2011, OECOLOGIA, V127, P171; Platt SG, 2006, HERPETOL J, V16, P281; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Radloff FGT, 2012, ISOT ENVIRON HEALT S, V48, P439, DOI 10.1080/10256016.2012.667808; Rosenblatt AE, 2013, PHYSIOL BIOCHEM ZOOL, V86, P137, DOI 10.1086/668295; Ross J, 1998, STATUS SRUVEY CONSER; Sah SAM, 1996, J TROP ECOL, V12, P651, DOI 10.1017/S0266467400009858; Schmitz OJ, 2001, ECOLOGY, V82, P2072, DOI 10.1890/0012-9658(2001)082[2072:EOTPSO]2.0.CO;2; Smith JA, 2013, METHODS ECOL EVOL, V4, P612, DOI 10.1111/2041-210X.12048; TAYLOR JA, 1979, AUST WILDLIFE RES, V6, P347, DOI 10.1071/WR9790347; Taylor MD, 2016, J SEA RES, V114, P26, DOI 10.1016/j.seares.2016.05.004; Tucker AD, 1996, COPEIA, P978, DOI 10.2307/1447661; Villamarin F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19918-6; Ward DP, 2016, ECOHYDROLOGY, V9, P1675, DOI 10.1002/eco.1757; Ward DP, 2014, REMOTE SENS ENVIRON, V147, P43, DOI 10.1016/j.rse.2014.02.009; Webb G., 2013, RIRDC PUBLICATION, V12; WEBB GJW, 1978, J HERPETOL, V12, P267, DOI 10.2307/1563426; WEBB GJW, 1982, AUST J ZOOL, V30, P877, DOI 10.1071/ZO9820877; WEBB GJW, 1978, AUST WILDLIFE RES, V5, P263, DOI 10.1071/WR9780263; WEBB GJW, 1991, J HERPETOL, V25, P462, DOI 10.2307/1564770; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x	51	8	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e019715	10.1371/journal.pone.019715	http://dx.doi.org/10.1371/journal.pone.019715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874276				2022-12-26	WOS:000434369400014
J	Diaz, A; Gerard, K; Gonzalez-Wevar, C; Maturana, C; Ferai, JP; David, B; Saucede, T; Poulin, E				Diaz, Angie; Gerard, Karin; Gonzalez-Wevar, Claudio; Maturana, Claudia; Ferai, Jean-Pierre; David, Bruno; Saucede, Thomas; Poulin, Elie			Genetic structure and demographic inference of the regular sea urchin Sterechinus neumayeri (Meissner, 1900) in the Southern Ocean: The role of the last glaciation	PLOS ONE			English	Article							ANTARCTIC POLAR FRONT; MITOCHONDRIAL LINEAGES; TIME DEPENDENCY; CLIMATE-CHANGE; ICE-SHEET; MOLECULAR-BIOLOGY; SHETLAND ISLANDS; POPULATION; MARINE; DIVERSITY	One of the most relevant characteristics of the extant Southern Ocean fauna is its resiliency to survive glacial processes of the Quaternary. These climatic events produced catastrophic habitat reductions and forced some marine benthic species to move, adapt or go extinct. The marine benthic species inhabiting the Antarctic upper continental shelf faced the Quaternary glaciations with different strategies that drastically modified population sizes and thus affected the amount and distribution of intraspecific genetic variation. Here we present new genetic information for the most conspicuous regular sea urchin of the Antarctic continental shelf, Sterechinus neumayeri. We studied the patterns of genetic diversity and structure in this broadcast-spawner across three Antarctic regions: Antarctic Peninsula, the Weddell Sea and Adelie Land in East Antarctica. Genetic analyses based on mitochondrial and nuclear markers suggested that S. neumayeri is a single genetic unit around the Antarctic continent. The species is characterized by low levels of genetic diversity and exhibits a typical star-like haplotype genealogy that supports the hypothesis of a single in situ refugium. Based on two mutation rates standardized for this genus, the Bayesian Skyline plot analyses detected a rapid demographic expansion after the Last Glacial Maximum. We propose a scenario of rapid postglacial expansion and recolonization of Antarctic shallow areas from a less ice-impacted refugium where the species survived the LGM. Considering the patterns of genetic diversity and structure recorded in the species, this refugium was probably located in East Antarctica.	[Diaz, Angie] Univ Concepcion, Dept Zool, Barrio Univ S-N, Concepcion, Chile; [Gerard, Karin] Univ Magallanes, Fac Ciencias, Bulnes, Punta Arenas, Chile; [Gerard, Karin; Gonzalez-Wevar, Claudio] Univ Magallanes, Lab Ecol Mol Antartica & Subantartica, Punta Arenas, Chile; [Gonzalez-Wevar, Claudio] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Gonzalez-Wevar, Claudio; Maturana, Claudia; Poulin, Elie] Univ Chile, Fac Ciencias, IEB, Dept Ciencias Ecol, Santiago, Chile; [Ferai, Jean-Pierre; Saucede, Thomas] Inst Mediterraneen Biodiversite & Ecol Marine & C, IMBE, Stn Marine Endoume, UMR 7263, Chemin Batterie Lions, Marseille, France; [David, Bruno] Univ Bourgogne, CNRS, UMR 6282, Biogeosci, Blvd Gabriel, Dijon, France; [David, Bruno] Museum Natl Hist Nat, Paris, France	Universidad de Concepcion; Universidad de Magallanes; Universidad de Magallanes; Universidad Austral de Chile; Universidad de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Museum National d'Histoire Naturelle (MNHN)	Diaz, A (corresponding author), Univ Concepcion, Dept Zool, Barrio Univ S-N, Concepcion, Chile.	angie.ddl@gmail.com	Poulin, Elie/C-2654-2012; Gérard, Karin/AAC-4911-2021; FERAL, Jean-Pierre/M-9608-2019; FERAL, Jean-Pierre/N-1895-2018; González-Wevar, Claudio Alejandro/AAD-6513-2021; Gerard, Karin/H-6245-2014; Diaz, Angie/I-8033-2016	Poulin, Elie/0000-0001-7736-0969; Gérard, Karin/0000-0003-0596-1348; FERAL, Jean-Pierre/0000-0001-7627-0160; FERAL, Jean-Pierre/0000-0001-7627-0160; Diaz, Angie/0000-0003-4944-588X	Institute Antartico Chileno (INACH) [D05-09]; Comision Nacional de Investigacion Cientifica y Tecnologica (Conicyt) [D-21080136]; Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt) [3130677]; Universidad de Concepcion [217.113.093-1]; Fondecyt [1161358, 1151336, 11140087]; INACH [RG_18-17, DT_04-16]; Conicyt [2115017]; Iniciativa Cientifica Milenio (ICM) projects [P05-002]; Programa de Financiamiento Basal (Institute de Ecologia y Biodiversidad - IEB) [PFB 023]; Programa de Investigacion Asociativa PIA-CONICYT [ACT172065]; Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (FONDAP) [15150003]; Centro de Investigacion Dinamica de Ecosistemas Marinos (IDEAL)	Institute Antartico Chileno (INACH); Comision Nacional de Investigacion Cientifica y Tecnologica (Conicyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Universidad de Concepcion; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); INACH; Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Iniciativa Cientifica Milenio (ICM) projects; Programa de Financiamiento Basal (Institute de Ecologia y Biodiversidad - IEB); Programa de Investigacion Asociativa PIA-CONICYT; Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Centro de Investigacion Dinamica de Ecosistemas Marinos (IDEAL)	This study was funded by the Institute Antartico Chileno (INACH) grant D05-09 and the Comision Nacional de Investigacion Cientifica y Tecnologica (Conicyt) Ph.D. Grant D-21080136 to AD. We also are grateful to the following projects: Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt) Post Ph.D. project 3130677 and Universidad de Concepcion Internal project 217.113.093-1 to AD, regular Fondecyt project 1161358 to KG, regular Fondecyt project 1151336 to KG, Initiation Fondecyt Project 11140087 and INACH RG_18-17 to CAG-W, and Conicyt Ph.D. Grant 2115017 and INACH project DT_04-16 to CM. Finally, we mostly appreciate the support of the Iniciativa Cientifica Milenio (ICM) projects P05-002 and the Programa de Financiamiento Basal PFB 023 (Institute de Ecologia y Biodiversidad - IEB) to EP and CAG-W, the Programa de Investigacion Asociativa PIA-CONICYT ACT172065 to EP, AD, KG and CAG-W, and the Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (FONDAP) project No15150003, Centro de Investigacion Dinamica de Ecosistemas Marinos (IDEAL). There was no additional external funding received for this study. All the specimens were collected under the regulation of the Chilean Antarctic Institute (INACH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gonzalez-Wevar CA, 2012, REV CHIL HIST NAT, V85, P445, DOI 10.4067/S0716-078X2012000400007; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Allcock AL, 2012, TRENDS ECOL EVOL, V27, P520, DOI 10.1016/j.tree.2012.05.009; Allcock AL, 2011, DEEP-SEA RES PT II, V58, P242, DOI 10.1016/j.dsr2.2010.05.016; Amsler CD, 1999, MAR ECOL PROG SER, V183, P105, DOI 10.3354/meps183105; Anderson JB, 2002, QUATERNARY SCI REV, V21, P49, DOI 10.1016/S0277-3791(01)00083-X; Arango CP, 2011, DEEP-SEA RES PT II, V58, P212, DOI 10.1016/j.dsr2.2010.05.019; ARNTZ WE, 1994, OCEANOGR MAR BIOL, V32, P241; Aronson RB, 2001, AM ZOOL, V41, P27, DOI 10.1668/0003-1569(2001)041[0027:GCCATO]2.0.CO;2; Aronson RB, 2007, ANNU REV ECOL EVOL S, V38, P129, DOI 10.1146/annurev.ecolsys.38.091206.095525; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Baird HP, 2011, MOL ECOL, V20, P3439, DOI 10.1111/j.1365-294X.2011.05173.x; Baird HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034363; Barnes DKA, 2010, J BIOGEOGR, V37, P1648, DOI 10.1111/j.1365-2699.2010.02320.x; Barnes DKA, 2006, GLOBAL ECOL BIOGEOGR, V15, P121, DOI 10.1111/j.1466-822x.2006.00216.x; Barnes DKA, 2000, VIE MILIEU, V50, P261; BELKHIR K, 1996, GENETIX LOGICIEL WIN; Billard E, 2015, POLAR BIOL, V38, P2021, DOI 10.1007/s00300-015-1762-4; BOSCH I, 1987, BIOL BULL, V173, P126, DOI 10.2307/1541867; Bowden DA, 2009, MAR BIOL, V156, P2033, DOI 10.1007/s00227-009-1235-9; Brandt A, 2009, DEEP-SEA RES PT I, V56, P2013, DOI 10.1016/j.dsr.2009.06.007; BREY T, 1991, POLAR BIOL, V11, P227; Brey T, 1996, ANTARCT SCI, V8, P3, DOI 10.1017/S0954102096000028; Brey T, 1995, MAR BIOL, V124, P279, DOI 10.1007/BF00347132; Brockington S, 2001, MAR BIOL, V139, P127; Clarke A, 2005, TRENDS ECOL EVOL, V20, P1, DOI 10.1016/j.tree.2004.10.004; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; CLARKE A, 1992, PHILOS T ROY SOC B, V338, P299, DOI 10.1098/rstb.1992.0150; Clarke A., 1989, Geological Society Special Publication, P253; Cofaigh CO, 2014, QUATERNARY SCI REV, V100, P87, DOI 10.1016/j.quascirev.2014.06.023; Convey P, 2008, BIOL REV, V83, P103, DOI 10.1111/j.1469-185X.2008.00034.x; Convey P, 2009, QUATERNARY SCI REV, V28, P3035, DOI 10.1016/j.quascirev.2009.08.015; Cowart DA, 2009, POLAR BIOL, V32, P435, DOI 10.1007/s00300-008-0536-7; Crame JA, 1999, SCI MAR, V63, P1; Dambach J, 2016, MAR ECOL-EVOL PERSP, V37, P1336, DOI 10.1111/maec.12343; David P, 2007, MOL ECOL, V16, P2474, DOI 10.1111/j.1365-294X.2007.03330.x; Dayton P.K., 1990, P631; DELL RK, 1972, ADV MAR BIOL, V10, P1, DOI 10.1016/S0065-2881(08)60416-2; Diaz A, 2011, DEEP-SEA RES PT II, V58, P205, DOI 10.1016/j.dsr2.2010.10.012; Diaz A, 2012, REV CHIL HIST NAT, V85, P457, DOI 10.4067/S0716-078X2012000400008; Dietz L, 2017, ROY SOC OPEN SCI, V2, P140; Domel JS, 2015, J CRUSTACEAN BIOL, V35, P480, DOI 10.1163/1937240X-00002351; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Emerson BC, 2015, MOL ECOL, V24, P702, DOI 10.1111/mec.13070; Filatov DA, 2009, BIOINFORMATICS, V25, P3189, DOI 10.1093/bioinformatics/btp572; Fraser CI, 2012, TRENDS ECOL EVOL, V27, P462, DOI 10.1016/j.tree.2012.04.011; Fraser CI, 2009, P NATL ACAD SCI USA, V106, P3249, DOI 10.1073/pnas.0810635106; Gerard K, 2008, MOL PHYLOGENET EVOL, V49, P84, DOI 10.1016/j.ympev.2008.07.006; Gonzalez-Wevar CA, 2013, MOL ECOL, V22, P5221, DOI 10.1111/mec.12465; Gonzalez-Wevar CA, 2016, POLAR BIOL, V39, P77, DOI 10.1007/s00300-014-1620-9; Gonzalez-Wevar CA, 2011, DEEP-SEA RES PT II, V58, P220, DOI 10.1016/j.dsr2.2010.05.026; Griffiths HJ, 2009, J BIOGEOGR, V36, P162, DOI 10.1111/j.1365-2699.2008.01979.x; GROBE H, 1992, ANTARCT RES SER, V0056; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Hall BL, 2009, QUATERNARY SCI REV, V28, P2213, DOI 10.1016/j.quascirev.2009.06.011; Haye PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088613; Hemery LG, 2012, MOL ECOL, V21, P2502, DOI 10.1111/j.1365-294X.2012.05512.x; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2015, MOL ECOL, V24, P6007, DOI 10.1111/mec.13450; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hoareau TB, 2016, SYST BIOL, V65, P449, DOI 10.1093/sysbio/syv120; Hoffman JI, 2011, MAR BIOL, V158, P287, DOI 10.1007/s00227-010-1558-6; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Hunter RL, 2008, J HERED, V99, P137, DOI 10.1093/jhered/esm119; Huybrechts P, 2002, QUATERNARY SCI REV, V21, P203, DOI 10.1016/S0277-3791(01)00082-8; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Ingolfsson O, 2004, DEV QUA SCI, V2, P3; Janko K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-220; Janosik AM, 2011, POLAR BIOL, V34, P575, DOI 10.1007/s00300-010-0916-7; KENNETT JP, 1977, J GEOPHYS RES-OC ATM, V82, P3843, DOI 10.1029/JC082i027p03843; Khasa PD, 2000, GENOME, V43, P439, DOI 10.1139/gen-43-3-439; King CK, 2001, MAR ECOL PROG SER, V215, P143, DOI 10.3354/meps215143; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawver L. A., 1992, ANTARCT RES SER, V56, P7, DOI DOI 10.1029/AR056P0007; Lee YH, 2004, ANTARCT SCI, V16, P29, DOI 10.1017/S0954102004001786; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Mahon AR, 2008, MAR BIOL, V155, P315, DOI 10.1007/s00227-008-1029-5; Marsh AG, 2001, SCIENCE, V291, P1950, DOI 10.1126/science.1056341; Martinson DG, 2008, DEEP-SEA RES PT II, V55, P1964, DOI 10.1016/j.dsr2.2008.04.038; MCCLINTOCK JB, 1994, MAR ECOL PROG SER, V111, P191, DOI 10.3354/meps111191; Moffat C, 2008, DEEP-SEA RES PT II, V55, P277, DOI 10.1016/j.dsr2.2007.10.003; Moore JK, 1999, J GEOPHYS RES-OCEANS, V104, P3059, DOI 10.1029/1998JC900032; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Pearse JS, 2009, SMITHSONIAN AT THE POLES: CONTRIBUTIONS TO INTERNATIONAL POLAR YEAR SCIENCE, P181, DOI 10.5479/si.097884601X.13; PEARSE JS, 1966, BIOL BULL, V130, P387, DOI 10.2307/1539745; Pearse JS, 2004, DEEP-SEA RES PT II, V51, P1533, DOI 10.1016/j.dsr2.2004.06.023; PEARSE JS, 1991, AM ZOOL, V31, P65; Pfuhl HA, 2005, EARTH PLANET SC LETT, V235, P715, DOI 10.1016/j.epsl.2005.04.025; Pierrat B, 2012, MAR ECOL PROG SER, V463, P215, DOI 10.3354/meps09842; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Post AL, 2011, DEEP-SEA RES PT II, V58, P105, DOI 10.1016/j.dsr2.2010.05.020; Poulin E, 2002, TRENDS ECOL EVOL, V17, P218, DOI 10.1016/S0169-5347(02)02493-X; Poulin E, 2014, GLOBAL PLANET CHANGE, V123, P392, DOI 10.1016/j.gloplacha.2014.07.017; Pritchard JK, 2000, GENETICS, V155, P945; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Raupach MJ, 2010, MAR BIOL, V157, P1783, DOI 10.1007/s00227-010-1451-3; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rohl A., 2016, NETWORK NETW5 0 0 1; Rozen S, 2000, Methods Mol Biol, V132, P365; Sahade R, 1998, POLAR BIOL, V19, P85, DOI 10.1007/s003000050218; Saucede Thomas, 2014, P213; Scher HD, 2006, SCIENCE, V312, P428, DOI 10.1126/science.1120044; Seppelt RD, 2002, ECOL STU AN, V154, P41; Shaw PW, 2004, MAR ECOL PROG SER, V270, P173, DOI 10.3354/meps270173; Shevenell AE, 2004, SCIENCE, V305, P1766, DOI 10.1126/science.1100061; Simms AR, 2011, QUATERNARY SCI REV, V30, P1583, DOI 10.1016/j.quascirev.2011.03.018; SLATKIN M, 1991, GENETICS, V129, P555; Smith JA, 2010, EARTH PLANET SC LETT, V296, P287, DOI 10.1016/j.epsl.2010.05.008; Soler-Membrives A, 2017, ROY SOC OPEN SCI, V4, P1; Sromek L, 2015, MAR ECOL PROG SER, V525, P143, DOI 10.3354/meps11237; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Strugnell JM, 2012, MOL ECOL, V21, P2775, DOI 10.1111/j.1365-294X.2012.05572.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavare A S., LECT MATH LIFE SCI, V17, DOI [10.1093/molbev/msn083, DOI 10.1093/MOLBEV/MSN083]; Thatje S, 2005, TRENDS ECOL EVOL, V20, P534, DOI 10.1016/j.tree.2005.07.010; Thatje S, 2005, ECOLOGY, V86, P619, DOI 10.1890/04-0620; Thatje S, 2008, ECOLOGY, V89, P682, DOI 10.1890/07-0498.1; Thornhill DJ, 2008, MOL ECOL, V17, P5104, DOI 10.1111/j.1365-294X.2008.03970.x; Tripati A, 2005, NATURE, V436, P341, DOI 10.1038/nature03874; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vianna JA, 2017, MOL PHYLOGENET EVOL, V107, P486, DOI 10.1016/j.ympev.2016.12.003; Walker MJC, 2012, J QUATERNARY SCI, V27, P649, DOI 10.1002/jqs.2565; Wilson NG, 2009, MOL ECOL, V18, P965, DOI 10.1111/j.1365-294X.2008.04071.x; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yu Pauline C., 2013, PLoS ONE, V8, P1; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	132	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197611	10.1371/journal.pone.0197611	http://dx.doi.org/10.1371/journal.pone.0197611			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874287	gold, Green Published, Green Submitted			2022-12-26	WOS:000434369400030
J	da Cunha, JDM; Alfredo, TM; dos Santos, JM; Alves, VV; Rabelo, LA; Limas, ES; Boleti, APD; Carollo, CA; dos Santos, EL; Souza, KD				Melo da Cunha, Janielle da Silva; Alfredo, Tamaeh Monteiro; dos Santos, Jessica Maurino; Alves Junior, Valter Vieira; Rabelo, Luiza Antas; Limas, Emerson Silva; Boleti, Ana Paula de Araujo; Carollo, Carlos Alexandre; dos Santos, Edson Lucas; Souza, Kely de Picoli			Antioxidant, antihyperglycemic, and antidiabetic activity of Apis mellifera bee tea	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; DIET-INDUCED OBESITY; OXIDATIVE STRESS; LIPID-PEROXIDATION; GLUT4 TRANSLOCATION; BLOOD-GLUCOSE; RATS; MECHANISMS; VENOM; HYPERGLYCEMIA	Diabetes has emerged as one of the largest global epidemics; it is estimated that by 2035, there will be 592 million diabetic people in the world. Brazilian biodiversity and the knowledge of traditional peoples have contributed to the treatment of several diseases, including diabetes. Apis mellifera bee tea is used by indigenous Brazilians to treat diabetes, and this traditional knowledge needs to be recorded and studied.The objective of this study was to record the use and to evaluate the antioxidant, antihyperglycemic, and antidiabetic activity of Apis mellifera bee tea, which is used by the Guarani and Kaiowa indigenous people for the treatment of diabetes. Semi-structured interviews were performed with Guarani and Kaiowa ethnic indigenous people from the State of Mato Grosso do Sul, Brazil, seeking to identify the animal species used for medicinal purposes. For the experimental procedures, tea prepared with macerated Apis mellifera bees was used. In vitro assays were performed to evaluate antioxidant activity; direct free radical scavenging, protection against oxidative hemolysis, lipid peroxidation were evaluated in human erythrocytes and potential in inhibiting the formation of advanced glycation end products (AGEs). In vivo, normoglycemic Swiss male mice treated with Apis mellifera tea (AmT) were subjected to the oral glucose tolerance test and compared with control and metformin-treated groups. Diet-induced diabetic mice were treated for 21 days with AmT and evaluated for glycemia and malondialdehyde levels in the blood, liver, nervous system, and eyes. During interviews, the indigenous people described the use of Apis mellifera bee tea for the treatment of diabetes. In in vitro assays, AmT showed direct antioxidant activity and reduced oxidative hemolysis and malondialdehyde generation in human erythrocytes. The AmT inhibited the formation of AGEs by albumin-fructose pathways and methylglyoxal products. In vivo, after oral glucose overload, normoglycemic mice treated with AmT had reduced hyperglycemia at all times evaluated up to 180 min. AmT also reduced hyperglycemia and malondialdehyde levels in the blood, liver, nervous system, and eyes of diabetic mice to similar levels as those in metformin-treated mice and normoglycemic controls. In summary, Apis mellifera bee tea showed antioxidant, antihyperglycemic, and antidiabetic activity, which provides support for the therapeutic application of Guarani and Kaiowa indigenous knowledge.	[Melo da Cunha, Janielle da Silva] Fed Univ Amapa UNIFAP, Binational Campus Oiapoque, Amapa, Brazil; [Melo da Cunha, Janielle da Silva; Alfredo, Tamaeh Monteiro; dos Santos, Jessica Maurino; Boleti, Ana Paula de Araujo; dos Santos, Edson Lucas; Souza, Kely de Picoli] Fed Univ Grande Dourados UFGD, Res Grp Biotechnol & Bioprospecting Appl Metab, Dourados, Brazil; [Alves Junior, Valter Vieira; dos Santos, Edson Lucas; Souza, Kely de Picoli] Fed Univ Grande Dourados UFGD, Sch Environm & Biol Sci, Dourados, Brazil; [Rabelo, Luiza Antas] Fed Univ Alagoas UFAL, Nucl Metab Syndrome Biol Sci & Hlth Inst ICBS, Lab Cardiovasc React LRC, Alagoas, Brazil; [Limas, Emerson Silva] Univ Fed Amazonas, Fac Pharmaceut Sci, Manaus, Amazonas, Brazil; [Carollo, Carlos Alexandre] Fed Univ Mato Grosso Sul UFMS, Lab Nat Prod Mass Spectrometry, Campo Grande, MS USA	Universidade Federal da Grande Dourados; Universidade Federal da Grande Dourados; Universidade Federal de Amazonas; Universidade Federal de Mato Grosso do Sul	Souza, KD (corresponding author), Fed Univ Grande Dourados UFGD, Res Grp Biotechnol & Bioprospecting Appl Metab, Dourados, Brazil.; Souza, KD (corresponding author), Fed Univ Grande Dourados UFGD, Sch Environm & Biol Sci, Dourados, Brazil.	kelypicoli@gmail.com	de Picoli Souza, Kely/I-1248-2015; Rabêlo, Luiza A./S-4050-2019; dos Santos, Edson Lucas/AAU-5857-2020; de Picoli Souza, Kely/AAU-5978-2020; Monteiro, Tamaeh A/G-5134-2018; da Saúde, Programa Ciências/ABF-1705-2020; Araujo Boleti, Ana Paula/F-3433-2019	de Picoli Souza, Kely/0000-0001-5764-2125; dos Santos, Edson Lucas/0000-0002-6557-7914; de Picoli Souza, Kely/0000-0001-5764-2125; Monteiro, Tamaeh A/0000-0001-5514-0797; Araujo Boleti, Ana Paula/0000-0003-0253-8907	Foundation to Support to Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FUNDECT/CAPES [27/2015 - PAPOS FASE II, 27/2015 -PAPOS FASE III]; Foundation for Support to the Development of Education, Science and Technology of Mato Grosso do Sul-FUNDECT; National Council for Scientific and Technological Development-CNPq; Brazilian Federal Agency for the Support and Evaluation of Graduate Education-CAPES	Foundation to Support to Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FUNDECT/CAPES; Foundation for Support to the Development of Education, Science and Technology of Mato Grosso do Sul-FUNDECT; National Council for Scientific and Technological Development-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Federal Agency for the Support and Evaluation of Graduate Education-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Foundation to Support to Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) - http://fundect.ledes.net/; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - http://www.capes.gov.br/; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - http://www.cnpq.br/; and Funding announcement FUNDECT/CAPES no. 27/2015 - PAPOS FASE II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the support funding of Foundation for Support to the Development of Education, Science and Technology of Mato Grosso do Sul-FUNDECT, the National Council for Scientific and Technological Development-CNPq, and the Brazilian Federal Agency for the Support and Evaluation of Graduate Education-CAPES, and FUNDECT/CAPES No. 27/2015 -PAPOS FASE III.	Alhaider AA, 2011, CHEM-BIOL INTERACT, V192, P233, DOI 10.1016/j.cbi.2011.03.014; Aluwong T, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050151; Alves RRN, 2011, J ETHNOBIOL ETHNOMED, V7, DOI [10.1186/1746-4269-7-9, 10.1186/1746-4269-7-22]; Aragao DMO, 2010, J ETHNOPHARMACOL, V128, P629, DOI 10.1016/j.jep.2010.01.008; Avogaro A, 2011, DIABETES CARE, V34, pS285, DOI 10.2337/dc11-s239; Azman KF, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1549158; Barros BF, 2012, ETHNOBIOL ETHNOMEDIC, V8, P1, DOI [10.1186/1746-4269-8-37, DOI 10.1186/1746-4269-8-37]; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Becattini B, 2016, FASEB J, V30, P3124, DOI 10.1096/fj.201600393R; Behroozi J, 2014, J MOL LIQ, V199, P371, DOI 10.1016/j.molliq.2014.09.034; Bonamigo Thaliny, 2017, Oxid Med Cell Longev, V2017, P1038153, DOI 10.1155/2017/1038153; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Campos JF, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/296186; Campos JF, 2014, FOOD CHEM TOXICOL, V65, P374, DOI 10.1016/j.fct.2014.01.008; Cao AL, 2016, BIOL PHARM BULL, V39, P1300, DOI 10.1248/bpb.b16-00094; Chaves TP, 2015, SAUDI J BIOL SCI, V22, P404, DOI 10.1016/j.sjbs.2014.12.005; Chen TL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162192; Chiste RC, 2014, LIFE SCI, V99, P52, DOI 10.1016/j.lfs.2014.01.059; Costaneto EM, 1999, HEALING ANIMALS FEIR, V65, P225, DOI [10.1016/S0378-8741(98)00158-5, DOI 10.1016/S0378-8741(98)00158-5]; Dhanya R, 2015, PRECONDITIONING L6 M, P1, DOI [10.1371/journal.pone.0132429, DOI 10.1371/JOURNAL.PONE.0132429]; DRAPER HH, 1993, FREE RADICAL BIO MED, V15, P353, DOI 10.1016/0891-5849(93)90035-S; El-Sayed MIK, 2011, J ETHNOPHARMACOL, V137, P643, DOI 10.1016/j.jep.2011.06.020; Emami Seyed Reza, 2016, J Exerc Nutrition Biochem, V20, P29, DOI 10.20463/jenb.2016.03.20.1.5; Fatani SH, 2016, DIABETES METAB SYND, V10, pS64, DOI 10.1016/j.dsx.2016.01.028; Figueroa-Romero C, 2008, REV ENDOCR METAB DIS, V9, P301, DOI 10.1007/s11154-008-9104-2; Fratini F, 2016, ASIAN PAC J TROP MED, V9, P817, DOI 10.1016/j.apjtm.2016.07.003; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Gupta D, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-13; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Hjartaker A, 2008, ADV EXP MED BIOL, V630, P72; Inubushi T, 2012, J NUTR SCI VITAMINOL, V58, P415, DOI 10.3177/jnsv.58.415; Kahn R, 2001, DIABETES CARE, V24, P775; Kang YH, 2016, ONCOTARGET, V7, P35577, DOI 10.18632/oncotarget.9590; Kang YM, 2017, DIABETES METAB J, V41, P89, DOI 10.4093/dmj.2017.41.2.89; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Khalil SR, 2015, NEUROTOXICOLOGY, V49, P121, DOI 10.1016/j.neuro.2015.05.011; Kiho T, 2004, BIOSCI BIOTECH BIOCH, V68, P200, DOI 10.1271/bbb.68.200; Krishna MS, 2015, J FOOD SCI TECH MYS, V52, P3561, DOI 10.1007/s13197-014-1387-6; Kuliaviene I, 2013, WORLD J GASTROENTERO, V19, P5678, DOI 10.3748/wjg.v19.i34.5678; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Larrauri JA, 1997, J AGR FOOD CHEM, V45, P1390, DOI 10.1021/jf960282f; Leonarduzzi G, 2010, PHARMACOL THERAPEUT, V128, P336, DOI 10.1016/j.pharmthera.2010.08.003; Lev E, 2003, J ETHNOPHARMACOL, V85, P107, DOI 10.1016/S0378-8741(02)00377-X; Likidlilid Atip, 2010, Journal of the Medical Association of Thailand, V93, P682; Madsen-Bouterse SA, 2008, REV ENDOCR METAB DIS, V9, P315, DOI 10.1007/s11154-008-9090-4; Magder S, 2006, REACTIVE OXYGEN SPEC, V8, P1, DOI [10.1186/cc3992, DOI 10.1186/CC3992]; Marycz K, 2016, METFORMIN DECREASES, V2016, DOI [10.1155/2016/9785890, DOI 10.1155/2016/9785890]; Monnier VM, 1996, NEPHROL DIAL TRANSPL, V11, P20; Mousavi SM, 2012, J ARTHROPOD-BORNE DI, V6, P136; NAZRULISLAM SK, 1993, FITOTERAPIA, V2, P176; Noeman SA, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-17; Nunes-souza V, 2016, AGING INCREASES SUSC, V2016, DOI [10.1155/2016/1987960, DOI 10.1155/2016/1987960]; Osawa T, 2005, ANN NY ACAD SCI, V1043, P440, DOI 10.1196/annals.1333.050; Park JH, 2017, TOXINS, V9, DOI 10.3390/toxins9040138; Parkin CG, 2002, CLIN DIABETES, V20, P71, DOI DOI 10.2337/DIACLIN.20.2.71; Rady I, 2017, CANCER LETT, V402, P16, DOI 10.1016/j.canlet.2017.05.010; Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003; Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032; Shibata T, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/1917093; Simonsson E, 2000, BIOCHEM BIOPH RES CO, V272, P539, DOI 10.1006/bbrc.2000.2820; Singh VP, 2014, KOREAN J PHYSIOL PHA, V18, P1, DOI 10.4196/kjpp.2014.18.1.1; Sobral F, 2016, FOOD CHEM TOXICOL, V94, P172, DOI 10.1016/j.fct.2016.06.008; Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466; Takzaree N, 2017, IRAN J PUBLIC HEALTH, V46, P545; TULLOCH AP, 1970, LIPIDS, V5, P247, DOI 10.1007/BF02532476; Umeno A, 2016, MOLECULES, V21, DOI 10.3390/molecules21060708; Veedu RN, 2014, TYPE 2 DIABETES MELL, V115, P4719, DOI [10.1021/cr5002832, DOI 10.1021/CR5002832]; Yamaguchi S, 2005, AM J PHYSIOL-ENDOC M, V289, pE643, DOI 10.1152/ajpendo.00456.2004; Zhang Y, 2016, MOLECULES, V21, DOI 10.3390/molecules21010007; Zhao F, 2016, J NUTR BIOCHEM, V32, P20, DOI 10.1016/j.jnutbio.2016.02.003	70	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0197071	10.1371/journal.pone.0197071	http://dx.doi.org/10.1371/journal.pone.0197071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870561	Green Submitted, Green Published, gold			2022-12-26	WOS:000434128400002
J	Amin, MKBA; Shimizu, A; Zankov, DP; Sato, A; Kurita, S; Ito, M; Maeda, T; Yoshida, T; Sakaue, T; Higashiyama, S; Kawauchi, A; Ogita, H				Amin, Mohammad Khusni B. Ahmat; Shimizu, Akio; Zankov, Dimitar P.; Sato, Akira; Kurita, Souichi; Ito, Masami; Maeda, Toshinaga; Yoshida, Tetsuya; Sakaue, Tomohisa; Higashiyama, Shigeki; Kawauchi, Akihiro; Ogita, Hisakazu			Epithelial membrane protein 1 promotes tumor metastasis by enhancing cell migration via copine-III and Rac1	ONCOGENE			English	Article							PHOSPHOLIPID-BINDING PROTEINS; PROSTATE-CANCER; THERAPEUTIC TARGET; SUPPRESSOR GENE; GROWTH; EMP1; MICROENVIRONMENT; ANGIOGENESIS; RECEPTOR; CD151	Tumor metastasis is the most common cause of cancer death. Elucidation of the mechanism of tumor metastasis is therefore important in the development of novel, effective anti-cancer therapies to reduce cancer mortality. Interaction between cancer cells and surrounding stromal cells in the tumor microenvironment is a key factor in tumor metastasis. Using a co-culture assay system with human prostate cancer LNCaP cells and primary human prostate stromal cells, we identified epithelial membrane protein 1 (EMP1) as a gene with elevated expression in the cancer cells. The orthotopic injection of LNCaP cells overexpressing EMP1 (EMP1-LNCaP cells) into the prostate of nude mice induced lymph node and lung metastases, while that of control LNCaP cells did not. EMP1-LNCaP cells had higher cell motility and Racl activity than control LNCaP cells. These results were also observed in other lines of cancer cells. We newly identified copine-III as an intracellular binding partner of EMP1. Knockdown of copine-III attenuated the increased cell motility and Rac1 activity in EMP1-LNCaP cells. Reduced cell motility and Rac1 activity following knockdown of copine-III in EMP1-LNCaP cells were recovered by reexpression of wild-type copine-III, but not of a copine-III mutant incapable of interacting with EMP1, suggesting the importance of the EMP1-copine-III interaction. Phosphorylated and activated Src and a Rac guanine nucleotide exchange factor Vav2 were found to be involved in the EMP1-induced enhancement of cell motility and Rac1 activation. Moreover, EMP1 was highly expressed in prostate cancer samples obtained from patients with higher Gleason score. These results demonstrate that upregulation of EMP1 significantly increases cancer cell migration that leads to tumor metastasis, suggesting that EMP1 may play an essential role as a positive regulator of tumor metastasis.	[Amin, Mohammad Khusni B. Ahmat; Shimizu, Akio; Zankov, Dimitar P.; Sato, Akira; Kurita, Souichi; Ito, Masami; Maeda, Toshinaga; Ogita, Hisakazu] Shiga Univ Med Sci, Div Mol Med Biochem, Dept Biochem & Mol Biol, Otsu, Shiga, Japan; [Yoshida, Tetsuya; Kawauchi, Akihiro] Shiga Univ Med Sci, Dept Urol, Otsu, Shiga, Japan; [Sakaue, Tomohisa; Higashiyama, Shigeki] Ehime Univ, Div Cell Growth & Tumor Regulat, Proteosci Ctr PROS, Toon, Japan; [Sakaue, Tomohisa] Ehime Univ, Grad Sch Med, Dept Cardiovasc & Thorac Surg, Toon, Japan; [Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Toon, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Ehime University; Ehime University; Ehime University	Ogita, H (corresponding author), Shiga Univ Med Sci, Div Mol Med Biochem, Dept Biochem & Mol Biol, Otsu, Shiga, Japan.	hogita@belle.shiga-med.ac.jp	Ogita, Hisakazu/AAE-4416-2020; Ahmat Amin, Mohammad Khusni Bin/C-7336-2012	Ahmat Amin, Mohammad Khusni Bin/0000-0002-1948-4071; Ogita, Hisakazu/0000-0001-6750-1668	Japan Society for the Promotion of Science; Uehara Memorial Foundation; Takeda Science Foundation; Naito Foundation; Ichiro Kanehara Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Ichiro Kanehara Foundation	We thank Mr. Takefumi Yamamoto, Mr. Akifumi Morinaga, Mr. Akihiro Nishida, Ms. Xiaoling Pang, and Ms. Nor Idayu A. Rahman at Shiga University of Medical Science for their excellent technical assistance in this study. This study was supported by Grants-in-aid for Scientific Research KAKENHI from Japan Society for the Promotion of Science, The Uehara Memorial Foundation, Takeda Science Foundation, The Naito Foundation, and The Ichiro Kanehara Foundation.	Aries IM, 2014, LEUKEMIA, V28, P1828, DOI 10.1038/leu.2014.80; Banyard J, 1998, CANCER METAST REV, V17, P449, DOI 10.1023/A:1006150007710; Ben-Porath I, 1998, GENOMICS, V49, P443, DOI 10.1006/geno.1998.5238; Bid HK, 2013, MOL CANCER THER, V12, P1925, DOI 10.1158/1535-7163.MCT-13-0164; Borsig L, 2014, ONCOGENE, V33, P3217, DOI 10.1038/onc.2013.272; Caudell EG, 2000, BIOCHEMISTRY-US, V39, P13034, DOI 10.1021/bi001250v; Chen J, 2012, ADV CANCER RES, V114, P1, DOI 10.1016/B978-0-12-386503-8.00001-6; Cifuentes FF, 2015, ONCOL LETT, V10, P2142, DOI 10.3892/ol.2015.3522; Creutz CE, 1998, J BIOL CHEM, V273, P1393, DOI 10.1074/jbc.273.3.1393; Detchokul S, 2014, ONCOL REP, V31, P241, DOI 10.3892/or.2013.2823; Fischer M, 2011, CANCER RES, V71, P1520, DOI 10.1158/0008-5472.CAN-10-2817; Fu MY, 2010, CLIN CANCER RES, V16, P3954, DOI 10.1158/1078-0432.CCR-10-0368; Fukumoto Y, 2011, J BIOL CHEM, V286, P43537, DOI 10.1074/jbc.M111.308858; Fumoto S, 2009, CANCER LETT, V274, P25, DOI 10.1016/j.canlet.2008.08.021; Goicoechea SM, 2014, CELL ADHES MIGR, V8, P535, DOI 10.4161/cam.28721; Goubran HA, 2014, CANCER GROWTH METAST, V7, P9, DOI 10.4137/CGM.S11285; Gupta S, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00068; Heinrich C, 2010, ONCOGENE, V29, P1598, DOI 10.1038/onc.2009.456; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Jain A, 2005, P NATL ACAD SCI USA, V102, P11858, DOI 10.1073/pnas.0502113102; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Karlou M, 2010, NAT REV UROL, V7, P494, DOI 10.1038/nrurol.2010.134; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; Majima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068134; Martin TA, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.26518; Mbeunkui F, 2009, CANCER CHEMOTH PHARM, V63, P571, DOI 10.1007/s00280-008-0881-9; Mitsuhashi Y, 2012, HISTOPATHOLOGY, V60, P826, DOI 10.1111/j.1365-2559.2011.04158.x; Narumiya S, 1996, J BIOCHEM-TOKYO, V120, P215; Pang XL, 2016, HYPERTENSION, V68, P630, DOI 10.1161/HYPERTENSIONAHA.116.07357; Qin Y, 2017, J NEURO-ONCOL, V134, P29, DOI 10.1007/s11060-017-2507-8; Qin Y, 2014, J BIOL CHEM, V289, P13974, DOI 10.1074/jbc.M113.543728; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Scott Andrew M, 2012, Cancer Immun, V12, P14; Sleeman JP, 2011, INT J CANCER, V128, P2511, DOI 10.1002/ijc.26027; Sun GG, 2014, TUMOR BIOL, V35, P3185, DOI 10.1007/s13277-013-1416-5; TAYLOR V, 1995, J BIOL CHEM, V270, P28824, DOI 10.1074/jbc.270.48.28824; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tomsig JL, 2002, CELL MOL LIFE SCI, V59, P1467, DOI 10.1007/s00018-002-8522-7; Uemura H, 2005, MOL CANCER THER, V4, P1699, DOI 10.1158/1535-7163.MCT-04-0295; Voss MA, 2011, BRIT J CANCER, V104, P1611, DOI 10.1038/bjc.2011.80; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Wang YW, 2017, BBA-REV CANCER, V1868, P199, DOI 10.1016/j.bbcan.2017.04.004; Wang YW, 2014, J UROLOGY, V192, P242, DOI 10.1016/j.juro.2013.12.001; Wang YW, 2005, LAB INVEST, V85, P1392, DOI 10.1038/labinvest.3700335; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Xue Q, 2013, EXP MOL PATHOL, V95, P313, DOI 10.1016/j.yexmp.2013.07.001; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yoshida A, 2015, BIOL OPEN, V4, P1063, DOI 10.1242/bio.010918; Zankov DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep39335; Zarzynska JM, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/141747	50	31	31	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 4	2018	37	40					5416	5434		10.1038/s41388-018-0286-0	http://dx.doi.org/10.1038/s41388-018-0286-0			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GV7MY	29867202	Green Published, hybrid			2022-12-26	WOS:000446312900004
J	Ma, L; Sun, L; Jin, X; Xiong, SD; Wang, JH				Ma, Li; Sun, Li; Jin, Xia; Xiong, Si-Dong; Wang, Jian-Hua			Scaffold attachment factor B suppresses HIV-1 infection of CD4(+) T cells by preventing binding of RNA polymerase II to HIV-1's long terminal repeat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						viral transcription; virology; virus; HIV; host-pathogen interaction	HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL TRANS-INFECTION; MESSENGER-RNA; LATENT HIV-1; GENE-EXPRESSION; CAPTURE HIV-1; SAF-B; PROTEIN; TRANSCRIPTION; INHIBITION	The 5 end of the HIV, type 1 (HIV-1) long terminal repeat (LTR) promoter plays an essential role in driving viral transcription and productive infection. Multiple host and viral factors regulate LTR activity and modulate HIV-1 latency. Manipulation of the HIV-1 LTR provides a potential therapeutic strategy for combating HIV-1 persistence. In this study, we identified an RNA/DNA-binding protein, scaffold attachment factor B (SAFB1), as a host cell factor that represses HIV-1 transcription. We found that SAFB1 bound to the HIV-1 5 LTR and significantly repressed 5 LTR-driven viral transcription and HIV-1 infection of CD4(+) T cells. Mechanistically, SAFB1-mediated repression of HIV-1 transcription and infection was independent of its RNA- and DNA-binding capacities. Instead, by binding to phosphorylated RNA polymerase II, SAFB1 blocked its recruitment to the HIV-1 LTR. Of note, SAFB1-mediated repression of HIV-1 transcription from proviral DNA maintained HIV-1 latency in CD4(+) T cells. In summary, our findings reveal that SAFB1 binds to the HIV-1 LTR and physically interacts with phosphorylated RNA polymerase II, repressing HIV-1 transcription initiation and elongation. Our findings improve our understanding of host modulation of HIV-1 transcription and latency and provide a new host cell target for improved anti-HIV-1 therapies.	[Ma, Li; Xiong, Si-Dong] Soochow Univ, Inst Biol, Jiangsu Key Lab Infect & Immun, Suzhou 215006, Peoples R China; [Ma, Li; Xiong, Si-Dong] Soochow Univ, Inst Med Sci, Suzhou 215006, Peoples R China; [Ma, Li; Sun, Li; Jin, Xia; Wang, Jian-Hua] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China	Soochow University - China; Soochow University - China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Wang, JH (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	jh_wang@sibs.ac.cn			Chinese Academy of Sciences [QYZDB-SSW-SMC059, YZ201649]; Natural Science Foundation of China [81572001]; National Grant Program on Key Infectious Disease Grant [2018ZX10301101-003-002]; Natural Science Foundation of China-National Institutes of Health [81561128009]	Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Grant Program on Key Infectious Disease Grant; Natural Science Foundation of China-National Institutes of Health	This work was supported by Key Project of the Chinese Academy of Sciences Grant QYZDB-SSW-SMC059 and Instrument Developing Project of the Chinese Academy of Sciences Grant YZ201649, the Natural Science Foundation of China Grant 81572001, the National Grant Program on Key Infectious Disease Grant 2018ZX10301101-003-002, and Natural Science Foundation of China-National Institutes of Health Joint Grant 81561128009 (to J.-H. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfonso-Parra C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010248; Altmeyer M, 2013, MOL CELL, V52, P206, DOI 10.1016/j.molcel.2013.08.025; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Cary DC, 2016, J CLIN INVEST, V126, P448, DOI 10.1172/JCI80565; Debril MB, 2005, J MOL ENDOCRINOL, V35, P503, DOI 10.1677/jme.1.01856; Ding DL, 2013, VIROLOGY, V440, P182, DOI 10.1016/j.virol.2013.02.022; Dong CS, 2009, J VIROL, V83, P3518, DOI 10.1128/JVI.02665-08; Drakouli S, 2017, FEBS J, V284, P2482, DOI 10.1111/febs.14141; Emiliani S, 1996, P NATL ACAD SCI USA, V93, P6377, DOI 10.1073/pnas.93.13.6377; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Francis AC, 2011, CURR MED CHEM, V18, P2904; Garee JP, 2010, J CELL BIOCHEM, V109, P312, DOI 10.1002/jcb.22420; Gordon H, 2013, RNA BIOL, V10, P1714, DOI 10.4161/rna.26542; Hakre S, 2011, CURR OPIN HIV AIDS, V6, P19, DOI 10.1097/COH.0b013e3283412384; Jean-Philippe J, 2014, BBA-GENE REGUL MECH, V1839, P251, DOI 10.1016/j.bbagrm.2014.02.002; Jiang AP, 2016, J VIROL, V90, P2928, DOI 10.1128/JVI.03008-15; Jiang AP, 2015, J VIROL, V89, P8050, DOI 10.1128/JVI.01021-15; Li C, 2017, J VIROL, V91, DOI 10.1128/JVI.01830-16; Li ZC, 2013, NUCLEIC ACIDS RES, V41, P277, DOI 10.1093/nar/gks976; Lin JJ, 2008, J BIOL CHEM, V283, P29681, DOI 10.1074/jbc.M802076200; Liu HW, 2015, NUCLEIC ACIDS RES, V43, P3605, DOI 10.1093/nar/gkv246; Lusic M, 2015, J MOL BIOL, V427, P688, DOI 10.1016/j.jmb.2014.07.022; Ma L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099535; Mahmoudi T, 2012, TRANSCR-AUSTIN, V3, P171, DOI 10.4161/trns.20541; Hernandez-Hernandez JM, 2013, NUCLEIC ACIDS RES, V41, P5704, DOI 10.1093/nar/gkt285; Margolis David M, 2010, Curr HIV/AIDS Rep, V7, P37, DOI 10.1007/s11904-009-0033-9; Mbonye U, 2014, VIROLOGY, V454, P328, DOI 10.1016/j.virol.2014.02.008; McManamy Mary E. Manson, 2014, Antiviral Chemistry & Chemotherapy, V23, P145, DOI 10.3851/IMP2551; Melnik S, 2011, NAT METHODS, V8, P963, DOI [10.1038/NMETH.1705, 10.1038/nmeth.1705]; Mukhopadhyay NK, 2014, ONCOGENE, V33, P3235, DOI 10.1038/onc.2013.294; Nayler O, 1998, NUCLEIC ACIDS RES, V26, P3542, DOI 10.1093/nar/26.15.3542; Norman M, 2016, BIOCHEM J, V473, P4271, DOI 10.1042/BCJ20160649; OBRIEN MC, 1995, BIOCHEM BIOPH RES CO, V207, P903, DOI 10.1006/bbrc.1995.1271; Oesterreich S, 1997, J CELL BIOCHEM, V67, P275, DOI 10.1002/(SICI)1097-4644(19971101)67:2<275::AID-JCB13>3.0.CO;2-E; Omura Y, 2009, BMB REP, V42, P232, DOI 10.5483/BMBRep.2009.42.4.232; Qu XY, 2013, NUCLEIC ACIDS RES, V41, P7771, DOI 10.1093/nar/gkt571; Rafati H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001206; Ren XX, 2016, J BIOL CHEM, V291, P4580, DOI 10.1074/jbc.M115.706135; Renz A, 1996, NUCLEIC ACIDS RES, V24, P843, DOI 10.1093/nar/24.5.843; Schaub MC, 2007, J BIOL CHEM, V282, P13617, DOI 10.1074/jbc.M700774200; Schwartz C, 2017, BIOCHEM PHARMACOL, V146, P10, DOI 10.1016/j.bcp.2017.07.001; Sun WW, 2018, MBIO, V9, DOI 10.1128/mBio.02408-17; Symons J, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-016-0325-2; Tian RR, 2012, ANTIVIR RES, V95, P57, DOI 10.1016/j.antiviral.2012.04.011; Townson SM, 2004, J BIOL CHEM, V279, P26074, DOI 10.1074/jbc.M313726200; Valente ST, 2006, MOL CELL, V23, P597, DOI 10.1016/j.molcel.2006.07.021; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Wolf D, 2008, CELL HOST MICROBE, V4, P398, DOI 10.1016/j.chom.2008.08.013; Woolaway K, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-28; Zhu J, 2012, CELL REP, V2, P807, DOI 10.1016/j.celrep.2012.09.008	51	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12177	12185		10.1074/jbc.RA118.002018	http://dx.doi.org/10.1074/jbc.RA118.002018			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29887524	Green Published, hybrid			2022-12-26	WOS:000440803200016
J	Racz, B; Varadi, A; Kong, J; Allikmets, R; Pearson, PG; Johnson, G; Cioffi, CL; Petrukhin, K				Racz, Boglarka; Varadi, Andras; Kong, Jian; Allikmets, Rando; Pearson, Paul G.; Johnson, Graham; Cioffi, Christopher L.; Petrukhin, Konstantin			A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug design; drug development; drug discovery; pharmacokinetics; pharmacology; molecular pharmacology; retinoid-binding protein; retinal degeneration; retinal metabolism; retina; age-related macular degeneration; lipofuscin; RBP4; Stargardt disease; visual cycle	PIGMENT EPITHELIAL-CELLS; MACULAR DEGENERATION; VITAMIN-A; COMPLEMENT ACTIVATION; FUNDUS AUTOFLUORESCENCE; LIPOFUSCIN ACCUMULATION; POTENTIAL TREATMENT; GEOGRAPHIC ATROPHY; NIGHT BLINDNESS; RPE LIPOFUSCIN	A primary pathological defect in the heritable eye disorder Stargardt disease is excessive accumulation of cytotoxic lipofuscin bisretinoids in the retina. Age-dependent accumulation of lipofuscin in the retinal pigment epithelium (RPE) matches the age-dependent increase in the incidence of the atrophic (dry) form of age-related macular degeneration (AMD) and therefore may be one of several pathogenic factors contributing to AMD progression. Lipofuscin bisretinoid synthesis in the retina depends on the influx of serum retinol from the circulation into the RPE. Formation of the tertiary retinol-binding protein 4 (RBP4)-transthyretin-retinol complex in the serum is required for this influx. Herein, we report the pharmacological effects of the non-retinoid RBP4 antagonist, BPN-14136. BPN-14136 dosing in the Abca4(-/-) mouse model of increased lipofuscinogenesis significantly reduced serum RBP4 levels and inhibited bisretinoid synthesis, and this inhibition correlated with a partial reduction in visual cycle retinoids such as retinaldehydes serving as bisretinoid precursors. BPN-14136 administration at doses inducing maximal serum RBP4 reduction did not produce changes in the rate of the visual cycle, consistent with minimal changes in dark adaptation. Abca4(-/-) mice exhibited dysregulation of the complement system in the retina, and BPN-14136 administration normalized the retinal levels of proinflammatory complement cascade components such as complement factors D and H, C-reactive protein, and C3. We conclude that BPN-14136 has several beneficial characteristics, combining inhibition of bisretinoid synthesis and reduction in retinaldehydes with normalization of the retinal complement system. BPN-14136, or a similar compound, may be a promising drug candidate to manage Stargardt disease and dry AMD.	[Racz, Boglarka; Varadi, Andras; Kong, Jian; Allikmets, Rando; Petrukhin, Konstantin] Columbia Univ, Dept Ophthalmol, New York, NY 10032 USA; [Allikmets, Rando] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Pearson, Paul G.] Pearson Pharma Partners, Westlake Village, CA 91361 USA; [Johnson, Graham] NuPharmAdvise LLC, Sanbornton, NH 03269 USA; [Cioffi, Christopher L.] Albany Coll Pharm & Hlth Sci, Dept Basic & Clin Sci, Albany, NY 12208 USA; [Cioffi, Christopher L.] Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Albany, NY 12208 USA	Columbia University; Columbia University; Albany College of Pharmacy & Health Sciences; Albany College of Pharmacy & Health Sciences	Petrukhin, K (corresponding author), Columbia Univ, Med Ctr, Dept Ophthalmol, 635 West 165th St,Box 27, New York, NY 10032 USA.	kep4@cumc.columbia.edu	Allikmets, Rando/ABD-4533-2021	Varadi, Andras/0000-0001-5591-377X; Petrukhin, Konstantin/0000-0002-5545-6924	NEI [P30 EY019007]; Research to Prevent Blindness (New York, NY); NATIONAL EYE INSTITUTE [P30EY019007, R24EY019861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS074476] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Theresa Swayne and Laura Munteanu for the assistance with confocal microscopy. Research facilities were supported by NEI Grant P30 EY019007 (Core Support for Vision Research) and by unrestricted funds from Research to Prevent Blindness (New York, NY) to the Department of Ophthalmology, Columbia University.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Bavik C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124940; Baylor DA, 1998, EYE, V12, P521, DOI 10.1038/eye.1998.140; BERNI R, 1992, FEBS LETT, V308, P43, DOI 10.1016/0014-5793(92)81046-O; Biesalski HK, 2007, VITAM HORM, V75, P117, DOI 10.1016/S0083-6729(06)75005-1; BIRNBACH CD, 1994, OPHTHALMOLOGY, V101, P1211; Boyer NP, 2012, J BIOL CHEM, V287, P22276, DOI 10.1074/jbc.M111.329235; Brandstetter C, 2015, J BIOL CHEM, V290, P31189, DOI 10.1074/jbc.M115.671180; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Chichili GR, 2005, INVEST OPHTH VIS SCI, V46, P3562, DOI 10.1167/iovs.05-0089; Cioffi CL, 2015, J MED CHEM, V58, P5863, DOI 10.1021/acs.jmedchem.5b00423; Cioffi CL, 2014, J MED CHEM, V57, P7731, DOI 10.1021/jm5010013; Cohen SM, 2009, TOXICOL SCI, V111, P4, DOI 10.1093/toxsci/kfp131; DELAEY JJ, 1995, RETINA-J RET VIT DIS, V15, P399, DOI 10.1097/00006982-199515050-00005; Delori F. C., 1995, RETINAL PIGMENT EPIT, V62, P37; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; Dobri N, 2013, INVEST OPHTH VIS SCI, V54, P85, DOI 10.1167/iovs.12-10050; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; DOREY CK, 1989, INVEST OPHTH VIS SCI, V30, P1691; EAGLE RC, 1980, OPHTHALMOLOGY, V87, P1189; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; Farjo KM, 2012, MOL CELL BIOL, V32, P5103, DOI 10.1128/MCB.00820-12; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Gehrs KM, 2010, ARCH OPHTHALMOL-CHIC, V128, P349, DOI 10.1001/archophthalmol.2010.18; Gibbs D, 2009, INVEST OPHTH VIS SCI, V50, P4386, DOI 10.1167/iovs.09-3471; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Holz FG, 2001, INVEST OPHTH VIS SCI, V42, P1051; Jaakson K, 2003, HUM MUTAT, V22, P395, DOI 10.1002/humu.10263; KENEL MF, 1988, TERATOGEN CARCIN MUT, V8, P1, DOI 10.1002/tcm.1770080102; Kennedy CJ, 1995, EYE, V9, P763, DOI 10.1038/eye.1995.192; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kolesnikov AV, 2017, P NATL ACAD SCI USA, V114, pE9675, DOI 10.1073/pnas.1712405114; Kotnik P, 2011, EUR J ENDOCRINOL, V165, P703, DOI 10.1530/EJE-11-0431; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maiti P, 2006, BIOCHEMISTRY-US, V45, P852, DOI 10.1021/bi0518545; Mata NL, 2013, RETINA-J RET VIT DIS, V33, P498, DOI 10.1097/IAE.0b013e318265801d; Moraes-Vieira PM, 2014, CELL METAB, V19, P512, DOI 10.1016/j.cmet.2014.01.018; Motani A, 2009, J BIOL CHEM, V284, P7673, DOI 10.1074/jbc.M809654200; Palczewski K, 2010, TRENDS PHARMACOL SCI, V31, P284, DOI 10.1016/j.tips.2010.03.001; Petrukhin K, 2007, EXPERT OPIN THER TAR, V11, P625, DOI 10.1517/14728222.11.5.625; Petrukhin Konstantin, 2013, Drug Discov Today Ther Strateg, V10, pe11; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2003, MOL ASPECTS MED, V24, P421, DOI 10.1016/S0098-2997(03)00038-4; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Radu RA, 2003, P NATL ACAD SCI USA, V100, P4742, DOI 10.1073/pnas.0737855100; Radu RA, 2014, J BIOL CHEM, V289, P9113, DOI 10.1074/jbc.M114.548669; Radu RA, 2011, J BIOL CHEM, V286, P18593, DOI 10.1074/jbc.M110.191866; Roberts LJ, 2012, MOL VIS, V18, P280; Samuel W, 2006, J CELL PHYSIOL, V209, P854, DOI 10.1002/jcp.20774; SCHAFFER EM, 1993, J NUTR, V123, P1497, DOI 10.1093/jn/123.9.1497; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Seeliger MW, 1999, INVEST OPHTH VIS SCI, V40, P3; Sieving PA, 2001, P NATL ACAD SCI USA, V98, P1835, DOI 10.1073/pnas.041606498; Smith T, 2016, JAMA OPHTHALMOL, V134, P824, DOI 10.1001/jamaophthalmol.2016.1466; Sparrow JR, 2013, INVEST OPHTH VIS SCI, V54, P8325, DOI 10.1167/iovs.13-13214; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2003, VISION RES, V43, P2983, DOI 10.1016/S0042-6989(03)00475-9; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Thompson CL, 2001, P NATL ACAD SCI USA, V98, P11708, DOI 10.1073/pnas.201301498; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Vives-Bauza C, 2008, J BIOL CHEM, V283, P24770, DOI 10.1074/jbc.M800706200; Vogel S, 2002, BIOCHEMISTRY-US, V41, P15360, DOI 10.1021/bi0268551; vonRuckmann A, 1997, INVEST OPHTH VIS SCI, V38, P478; Walia S, 2009, OPHTHALMIC GENET, V30, P63, DOI 10.1080/13816810802695550; Weber BHF, 2014, DTSCH ARZTEBL INT, V111, DOI 10.3238/arztebl.2014.0133; Wolf G, 1999, NUTR REV, V57, P258; WOLF G, 1995, NUTR REV, V53, P98; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103; Zhou J, 2009, INVEST OPHTH VIS SCI, V50, P1392, DOI 10.1167/iovs.08-2868	71	23	23	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11574	11588		10.1074/jbc.RA118.002062	http://dx.doi.org/10.1074/jbc.RA118.002062			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29871924	hybrid, Green Published			2022-12-26	WOS:000439449700026
J	Oudin, A; Segersson, D; Adolfsson, R; Forsberg, B				Oudin, Anna; Segersson, David; Adolfsson, Rolf; Forsberg, Bertil			Association between air pollution from residential wood burning and dementia incidence in a longitudinal study in Northern Sweden	PLOS ONE			English	Article							ULTRAFINE PARTICLES; EXPOSURE; HEALTH; POPULATION; DISEASE; CHILDREN; MEMORY; COHORT; HEART	Objectives There is highly suggestive evidence for an effect of air pollution exposure on dementia related outcomes, but evidence is not yet present to clearly pinpoint which pollutants are the probable causal agents. The aims of this study was to assess the longitudinal association between exposures of fine ambient particulate matter (PM2.5) from residential wood burning, and vehicle exhaust, with dementia. Method We used data from the Betula study, a longitudinal study of dementia in Umea, Northern Sweden. The study size was 1 806 and the participants were followed from study entry (1993-1995) to 2010. Modelled levels of source-specific fine particulate matter at the residential address were combined with information on wood stoves or wood boilers, and with validated data on dementia diagnosis and individual-level characteristics from the Betula study. Cox proportional hazards models were used to estimate Hazard Ratios (HRs) and their 95% Cls for dementia incidence (vascular dementia and Alzheimer's disease), adjusted for individual-level characteristics. Results The emission of PM2.5 from local residential wood burning was associated with dementia incidence with a hazard ratio of 1.55 fora 1 mu g/m(3) increase in PM2.5 (95% Confidence Interval (CI): 1.00-2.41, p-value 0.05). Study participants with an address in an area with the highest quartile of PM2.5 from residential wood burning and who also had a wood-burning stove were more likely to develop dementia than those in the lower three quartiles without a wood-burning stove with hazard ratios of 1.74 (CI: 1.10-2.75, p-value 0.018). Particulate matter from traffic exhaust seemed to be associated with dementia incidence with hazard ratios of 1.66, (CI: 1.16-2.39), p-value 0.006, and 1.41 (CI: 0.97-2.23), p-value 0.07, in the third and fourth quartiles, respectively. Conclusions If the associations we observed are causal, then air pollution from residential wood burning, and air pollution from traffic, might be independent important risk factors for dementia.	[Oudin, Anna; Forsberg, Bertil] Umea Univ, Dept Publ Hlth & Clin Med, Occupat & Environm Med, Umea, Sweden; [Segersson, David] Swedish Meteorol & Hydrol Inst, Norrkoping, Sweden; [Adolfsson, Rolf] Umea Univ, Dept Clin Sci, Div Psychiat, Umea, Sweden	Umea University; Swedish Meteorological & Hydrological Institute; Umea University	Oudin, A (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Occupat & Environm Med, Umea, Sweden.	anna.oudin@umu.se	Segersson, David/AAP-3056-2021	Segersson, David/0000-0002-5935-962X	Svenska Forskningsradet Formas [2017-00898]	Svenska Forskningsradet Formas(Swedish Research Council Formas)	This work was supported by Svenska Forskningsradet Formas grant no. 2017-00898 to AO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Block ML, 2012, NEUROTOXICOLOGY, V33, P972, DOI 10.1016/j.neuro.2012.08.014; Boraxbekk CJ, 2015, DEMENT GER COGN D EX, V5, P191, DOI 10.1159/000381535; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2003, CURR HYPERTENS REP, V5, P32, DOI 10.1007/s11906-003-0008-y; Cacciottolo M, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.280; Calderon-Garciduenas L, 2008, BRAIN COGNITION, V68, P117, DOI 10.1016/j.bandc.2008.04.008; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Calderon-Garciduenas L, 2011, INT J DEV NEUROSCI, V29, P365, DOI 10.1016/j.ijdevneu.2011.03.007; Calderon-Garciduenas L, 2010, EXP TOXICOL PATHOL, V62, P91, DOI 10.1016/j.etp.2009.02.117; Chang KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103078; Chen H, 2017, LANCET, V389, P718, DOI 10.1016/S0140-6736(16)32399-6; Dutta A, 2013, AIR QUALITY ATMOSPHE, P1; EEA, 2013, ENV IND REP 2013; Hausberger S., 2009, EMISSION FACTORS MOD, VVolume 7; Hosgood HD, 2010, ENVIRON HEALTH PERSP, V118, P1743, DOI 10.1289/ehp.1002217; Jayaraj Richard L, 2017, Curr Environ Health Rep, V4, P166, DOI 10.1007/s40572-017-0142-3; Jung CR, 2015, J ALZHEIMERS DIS, V44, P573, DOI 10.3233/JAD-140855; Krecl P, 2008, ATMOS ENVIRON, V42, P4113, DOI 10.1016/j.atmosenv.2008.01.026; Muala A, 2015, J AEROSOL MED PULM D, V28, P237, DOI 10.1089/jamp.2014.1122; Naeher LP, 2007, INHAL TOXICOL, V19, P67, DOI 10.1080/08958370600985875; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; Nussbaumer T, 2008, PARTICULATE EMISSION; Oberdorster G, 2002, ENVIRON HEALTH PERSP, V110, pA440, DOI 10.1289/ehp.110-a440; Oberdorster G, 2004, INHAL TOXICOL, V16, P437, DOI 10.1080/08958370490439597; Omstedt G, 2014, VEDROK VASTERBOTTEN; Oudin A, 2016, ENVIRON HEALTH PERSP, V124, P306, DOI 10.1289/ehp.1408322; Painschab MS, 2013, HEART, V99, P984, DOI 10.1136/heartjnl-2012-303440; Peters A, 2006, PART FIBRE TOXICOL, V3, DOI 10.1186/1743-8977-3-13; Power MC, 2016, NEUROTOXICOLOGY, V56, P235, DOI 10.1016/j.neuro.2016.06.004; Prince M., 2016, WORLD ALZHEIMER REPO; Qiu CX, 2015, NAT REV CARDIOL, V12, P267, DOI 10.1038/nrcardio.2014.223; Segersson D, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070742; Stafoggia M, 2014, ENVIRON HEALTH PERSP, V122, P919, DOI 10.1289/ehp.1307301; Todorovic J, 2007, SYNTHESIS ANAL EMISS; Wagner F, 2010, 6 NEC IIASA; Wellenius GA, 2005, STROKE, V36, P2549, DOI 10.1161/01.STR.0000189687.78760.47	36	56	57	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198283	10.1371/journal.pone.0198283	http://dx.doi.org/10.1371/journal.pone.0198283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897947	Green Submitted, Green Published, gold			2022-12-26	WOS:000435090700049
J	Ramchand, J; Patel, SK; Srivastava, PM; Farouque, O; Burrell, LM				Ramchand, Jay; Patel, Sheila K.; Srivastava, Piyush M.; Farouque, Omar; Burrell, Louise M.			Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease	PLOS ONE			English	Article							ENHANCES PLAQUE STABILITY; MYOCARDIAL-INFARCTION; ACE2 EXPRESSION; HEART-DISEASE; RABBIT MODEL; ANGIOTENSIN-CONVERTING-ENZYME-2; ASSOCIATION; GENE	Background Angiotensin converting enzyme 2 (ACE2) is an endogenous regulator of the renin angiotensin system. Increased circulating ACE2 predicts adverse outcomes in patients with heart failure (HF), but it is unknown if elevated plasma ACE2 activity predicts major adverse cardiovascular events (MACE) in patients with obstructive coronary artery disease (CAD). Methods We prospectively recruited patients with obstructive CAD (defined as >= 50% stenosis of the left main coronary artery and/or >= 70% stenosis in >= 1 other major epicardial vessel on invasive coronary angiography) and measured plasma ACE2 activity. Patients were followed up to determine if circulating ACE2 activity levels predicted the primary endpoint of MACE (cardiovascular mortality, HF or myocardial infarction). Results We recruited 79 patients with obstructive coronary artery disease. The median (IQR) plasma ACE2 activity was 29.3 pmol/ml/min [21.2-41.2]. Over a median follow up of 10.5 years [9.6-10.8years], MACE occurred in 46% of patients (36 events). On Kaplan-Meier analysis, above-median plasma ACE2 activity was associated with MACE (log-rank test, p = 0.035) and HF hospitalisation (p = 0.01). After Cox multivariable adjustment, log ACE2 activity remained an independent predictor of MACE (hazard ratio (HR) 2.4, 95% confidence interval (CI) 1.24-4.72, p = 0.009) and HF hospitalisation (HR: 4.03, 95% CI: 1.42-11.5, p = 0.009). Conclusions Plasma ACE2 activity independently increased the hazard of adverse long-term cardiovascular outcomes in patients with obstructive CAD.	[Ramchand, Jay; Patel, Sheila K.; Srivastava, Piyush M.; Farouque, Omar; Burrell, Louise M.] Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic, Australia; [Ramchand, Jay; Srivastava, Piyush M.; Farouque, Omar; Burrell, Louise M.] Austin Hlth, Dept Cardiol, Heidelberg, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Burrell, LM (corresponding author), Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic, Australia.; Burrell, LM (corresponding author), Austin Hlth, Dept Cardiol, Heidelberg, Vic, Australia.	l.burrell@unimelb.edu.au	Burrell, Louise/K-1228-2012	Burrell, Louise/0000-0003-1863-7539	National Health & Medical Research Council [APP268914, APP1132717]; National Heart Foundation of Australia	National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia)	This work was supported by National Health & Medical Research Council project grant (APP268914) to Louise M Burrell. Dr. Jay Ramchand is supported by a postgraduate scholarship co-funded by the National Heart Foundation of Australia and National Health & Medical Research Council (APP1132717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; Anguiano L, 2016, ATHEROSCLEROSIS, V253, P135, DOI 10.1016/j.atherosclerosis.2016.08.032; Anguiano L, 2015, NEPHROL DIAL TRANSPL, V30, P1176, DOI 10.1093/ndt/gfv025; Bangalore S, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j4; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Burrell LM, 2013, CLIN SCI, V124, P65, DOI 10.1042/CS20120269; Chong CP, 2012, AM J CARDIOL, V109, P1365, DOI 10.1016/j.amjcard.2011.12.032; Dong B, 2008, ARTERIOSCL THROM VAS, V28, P1270, DOI 10.1161/ATVBAHA.108.164715; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Epelman S, 2009, J CARD FAIL, V15, P565, DOI 10.1016/j.cardfail.2009.01.014; Hicks KA, 2015, CIRCULATION, V132, P302, DOI 10.1161/CIR.0000000000000156; Soler MJ, 2012, NEPHRON CLIN PRACT, V121, pC144, DOI 10.1159/000345508; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Lew RA, 2008, EXP PHYSIOL, V93, P685, DOI 10.1113/expphysiol.2007.040352; Maddox TM, 2014, JAMA-J AM MED ASSOC, V312, P1754, DOI 10.1001/jama.2014.14681; Ortiz-Perez JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061695; Oudit GY, 2003, TRENDS CARDIOVAS MED, V13, P93, DOI 10.1016/S1050-1738(02)00233-5; Palmer BR, 2008, AM HEART J, V156, P752, DOI 10.1016/j.ahj.2008.06.013; Patel SK, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00227; Patel VB, 2014, J MOL CELL CARDIOL, V66, P167, DOI 10.1016/j.yjmcc.2013.11.017; Rice GI, 2006, HYPERTENSION, V48, P914, DOI 10.1161/01.HYP.0000244543.91937.79; Roberts MA, 2013, NEPHROL DIAL TRANSPL, V28, P2287, DOI 10.1093/ndt/gft038; Sluimer JC, 2008, J PATHOL, V215, P273, DOI 10.1002/path.2357; Soro-Paavonen A, 2012, J HYPERTENS, V30, P375, DOI 10.1097/HJH.0b013e32834f04b6; Tesanovic S, 2010, ARTERIOSCL THROM VAS, V30, P1606, DOI 10.1161/ATVBAHA.110.204453; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Walters TE, 2016, EUROPACE; Yang W, 2006, CLIN SCI, V111, P333, DOI 10.1042/CS20060020; Zhang C, 2010, P NATL ACAD SCI USA, V107, P15886, DOI 10.1073/pnas.1001253107; Zhao XQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17939; Zulli A, 2008, EUR J HISTOCHEM, V52, P39; Zulli A, 2006, J HISTOCHEM CYTOCHEM, V54, P147, DOI 10.1369/jhc.5C6782.2005	34	125	129	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198144	10.1371/journal.pone.0198144	http://dx.doi.org/10.1371/journal.pone.0198144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897923	Green Published, gold, Green Submitted			2022-12-26	WOS:000435090700046
J	Shi, LY; Yang, GR; Zhang, ZK; Xia, LX; Liang, Y; Tan, HL; He, JR; Xu, JG; Song, ZZ; Li, W; Wang, P				Shi, Liyuan; Yang, Guirong; Zhang, Zhikai; Xia, Lianxu; Liang, Ying; Tan, Hongli; He, Jinrong; Xu, Jianguo; Song, Zhizhong; Li, Wei; Wang, Peng			Reemergence of human plague in Yunnan, China in 2016	PLOS ONE			English	Article							YERSINIA-PESTIS; PHYLOGENETIC ANALYSIS; TANDEM REPEATS; MICROEVOLUTION; IDENTIFICATION; INSIGHTS; TOOLS; DNA	The third plague pandemic originated from Yunnan Province, China in the middle of the 19th century. The last human plague epidemic in Yunnan occurred from 1986-2005. On June 6, 2016, a case of human plague was reported in the Xishuangbanna Prefecture, Yunnan. The patient suffered from primary septicemic plague after exposure to a dead house rat (Rattus flavipectus), which has been identified as the main plague reservoir in the local epizootic area. Moreover, a retrospective investigation identified another bubonic plague case in this area. Based on these data, human plague reemerged after a silent period of ten years. In this study, three molecular typing methods, including a clustered regularly interspaced short palindromic repeats (CRISPR) analysis, different region analysis (DFR), and multiple-locus variable number of tandem repeats analysis (MLVA), were used to illustrate the molecular characteristics of Yersinia pestis (Y. pestis) strains isolated in Yunnan. The DFR profiles of the strains isolated in Yunnan in 2016 were the same as the strains that had previously been isolated in this Rattus flavipectus plague focus. The c3 spacer present in the previously isolated strains was absent in the spacer arrays of the Ypc CRISPR loci of the strains isolated in 2016. The MLVA analysis using MLVA (14+12) showed that the strains isolated from the human plague case and host animal plague infection in 2016 in Yunnan displayed different molecular patterns than the strains that had previously been isolated from Yunnan and adjacent provinces.	[Shi, Liyuan; Yang, Guirong; Tan, Hongli; Song, Zhizhong; Wang, Peng] Yunnan Inst Endem Dis Control & Prevent, Dali, Yunnan, Peoples R China; [Shi, Liyuan; Yang, Guirong; Tan, Hongli; Song, Zhizhong; Wang, Peng] Yunnan Prov Key Lab Zoonosis Control & Prevent, Dali, Yunnan, Peoples R China; [Zhang, Zhikai; Xia, Lianxu; Liang, Ying; He, Jinrong; Xu, Jianguo; Li, Wei] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Zhikai; Xia, Lianxu; Liang, Ying; He, Jinrong; Xu, Jianguo; Li, Wei] State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zhang, Zhikai; Xia, Lianxu; Liang, Ying; He, Jinrong; Xu, Jianguo; Li, Wei] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Yunnan Institute for Endemic Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Wang, P (corresponding author), Yunnan Inst Endem Dis Control & Prevent, Dali, Yunnan, Peoples R China.; Wang, P (corresponding author), Yunnan Prov Key Lab Zoonosis Control & Prevent, Dali, Yunnan, Peoples R China.; Li, W (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.; Li, W (corresponding author), State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.; Li, W (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.	liwei@icdc.cn; wp030801@126.com		Wang, peng/0000-0002-3350-1835	National Natural Science Foundation of China [81160354]; Yunnan Provincial Training Program of Young Academic and Technical Leader [2014HB037]; National Priority Development Project on Key Science Instrument [2012YQ09019706]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Training Program of Young Academic and Technical Leader; National Priority Development Project on Key Science Instrument	PW was funded by the National Natural Science Foundation of China (81160354) and the Yunnan Provincial Training Program of Young Academic and Technical Leader (2014HB037); WL was funded by the National Priority Development Project on Key Science Instrument (2012YQ09019706). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, Wkly Epidemiol Rec, V74, P447; Barros MPS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108353; Ciammaruconi A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-21; Cui YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002652; Dai EH, 2005, RES MICROBIOL, V156, P785, DOI 10.1016/j.resmic.2005.02.012; Dubyanskiy VM, 2016, ADV EXP MED BIOL, V918, P101, DOI 10.1007/978-94-024-0890-4_5; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Institute of Epidemiology and Microbiology, 1980, EP HIST PLAG CHIN; Klevytska AM, 2001, J CLIN MICROBIOL, V39, P3179, DOI 10.1128/JCM.39.9.3179-3185.2001; [李俊勇 LI Jun-yong], 2008, [中国地方病学杂志, Chinese Journal of Endemiology], V27, P210; [李俊勇 LI Junyong], 2006, [中国地方病学杂志, Chinese Journal of Endemiology], V25, P654; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057130; Li YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006000; Li YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002166; Marraffini LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003765; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Platonov ME, 2013, MOL GENET MICROBIOL+, V28, P41, DOI 10.3103/S0891416813020067; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pourcel C, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-22; Riehm JM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003844; Riehm JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030624; Vergnaud G, 2007, ADV EXP MED BIOL, V603, P327; Zhou DS, 2004, J BACTERIOL, V186, P5138, DOI [10.1128/JB.186.15.5138-5146.2004, 10.1128/jb.186.15.5138-5146.2004]	23	22	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198067	10.1371/journal.pone.0198067	http://dx.doi.org/10.1371/journal.pone.0198067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897940	Green Submitted, gold, Green Published			2022-12-26	WOS:000435090700041
J	Stirling, L; Eke, C; Cain, SM				Stirling, Leia; Eke, Chika; Cain, Stephen M.			Examination of the perceived agility and balance during a reactive agility task	PLOS ONE			English	Article							RUNNING SPEED; MANEUVERABILITY; STABILITY	In vehicle dynamics, it is commonly understood that there is an inverse relationship between stability and maneuverability. However, animal studies have found that stability and maneuverability can coincide. In this study, we examine humans running a reactive agility obstacle and consider the relationship between observational perceived agility and balance, as well as the relationship between quantified surrogates of agility and balance. Recreational athletes (n = 18) completed the agility task while wearing inertial measurement units (IMUs) on their body. The task was also video-recorded. An observational study was completed by a separate group of adults (n = 33) that were asked to view the videos and score each athlete on a Likert scale for balance and for agility. The data from the body-worn IMUs were used to estimate quantified surrogate measures for agility and balance, and to assess if the relationship between the quantified agility and balance was in the same direction as the perceived relationship from the Likert scale responses. Results indicate that athletes that were given a higher Likert agility score were also given a higher balance score (r(s) = 0.75,p < 0.001). Quantitative surrogates of agility and balance also showed this same relationship. Additional insights on technique for this reactive agility task were informed by the quantitative surrogates. We observed the importance of stepping technique in achieving the faster completion times. The fast performing athletes spent a greater proportion of the task in double support and lower overall time in single support indicating increased periods of static stability. The fast performing athletes did not have a higher body speed, but performed the task with a more efficient technique, using foot placement to enable heading changes, and thus may have had a more efficient path. Similar to animal studies, people use technique to enable agile strategies while also enabling increased balance across the task.	[Stirling, Leia] MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA; [Stirling, Leia] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Eke, Chika] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Cain, Stephen M.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Michigan System; University of Michigan	Stirling, L (corresponding author), MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA.; Stirling, L (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leia@mit.edu		Cain, Stephen/0000-0003-1961-4195; Stirling, Leia/0000-0002-0119-1617	US Army Natick Soldier Research, Development and Engineering Center [W911QY-13-C-0011]; National Science Foundation Graduate Research Fellowship [1122374]	US Army Natick Soldier Research, Development and Engineering Center; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This work was supported by US Army Natick Soldier Research, Development and Engineering Center, W911QY-13-C-0011 (LS, SMC, CE); and National Science Foundation Graduate Research Fellowship under Grant No. 1122374 (CE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acasio J, 2017, GAIT POSTURE, V52, P171, DOI 10.1016/j.gaitpost.2016.11.034; Anderson J D, 1999, AIRCRAFT PERFORMANCE; Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; Biewener A a, 2009, J EXP BIOL, V210, P2949; Cain SM, 2016, GAIT POSTURE, V43, P65, DOI 10.1016/j.gaitpost.2015.10.022; Chang YH, 2007, J EXP BIOL, V210, P971, DOI 10.1242/jeb.02728; Daley MA, 2006, P NATL ACAD SCI USA, V103, P15681, DOI 10.1073/pnas.0601473103; Eke C, 2017, INT C APPL HUM FACT; Eke CU, 2017, J BIOMECH, V64, P219, DOI 10.1016/j.jbiomech.2017.09.030; FITTS PM, 1964, J EXP PSYCHOL, V67, P103, DOI 10.1037/h0045689; Full RJ, 2002, INTEGR COMP BIOL, V42, P149, DOI 10.1093/icb/42.1.149; Hasan Z, 2005, J MOTOR BEHAV, V37, P484, DOI 10.3200/JMBR.37.6.484-493; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; Hedrick TL, 2009, SCIENCE, V324, P252, DOI 10.1126/science.1168431; Hof AL, 2008, HUM MOVEMENT SCI, V27, P112, DOI 10.1016/j.humov.2007.08.003; Jindrich DL, 1999, J EXP BIOL, V202, P1603; KIRTLEY C, 1985, J BIOMED ENG, V7, P282, DOI 10.1016/0141-5425(85)90055-X; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Ojeda L, 2007, J NAVIGATION, V60, P391, DOI 10.1017/S0373463307004286; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Raymer DP., 1999, AIRCRAFT DESIGN CONC; Sekulic D, 2014, J STRENGTH COND RES, V28, P3306, DOI 10.1519/JSC.0000000000000515; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; Walker JA, 2000, J EXP BIOL, V203, P3391; Webb PW, 2004, IEEE J OCEANIC ENG, V29, P547, DOI 10.1109/JOE.2004.833220; WINTER DA, 1990, PHYS THER, V70, P340, DOI 10.1093/ptj/70.6.340; WINTER DA, 1990, MED PROG TECHNOL, V16, P31; Young WB, 2002, J SPORT MED PHYS FIT, V42, P282	30	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198875	10.1371/journal.pone.0198875	http://dx.doi.org/10.1371/journal.pone.0198875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897972	Green Published, gold, Green Submitted			2022-12-26	WOS:000435090700076
J	Taylor, WD; Langham, GL; Weed, JL; Rowe, T; Song, W; Isenberg, KA; Xu, XY; Wentworth, DE; Lathrop, G; Powell, N				Taylor, Willie D., Jr.; Langham, Gregory L.; Weed, James L.; Rowe, Thomas; Song, Wei; Isenberg, Kristin A.; Xu, Xiyan; Wentworth, David E.; Lathrop, George; Powell, Nathaniel			The effects of repeated automated plasmapheresis in goats (Capra hircus) in response to vaccination with purified influenza hemagglutinin proteins	PLOS ONE			English	Article							COAGULATION ABNORMALITIES; PLASMA-EXCHANGE; UNITED-STATES; HOSPITALIZATIONS; VIRUS; US	Seasonal influenza is a contagious respiratory illness that annually affects millions of people worldwide. To identify currently circulating influenza virus subtypes, the Centers for Disease Control and Prevention's International Reagent Resource distributes the World Health Organization (WHO) influenza reagent kits, which are used globally by testing laboratories for influenza surveillance. The data generated by the kits aid in strain selection for the influenza vaccine each season. The use of animals to produce high quality and quantities of antibodies is critical to the production of these kits. In this study, we assessed the effects and efficacy of repeated sampling from automated plasmapheresis in goats. Analysis of blood samples demonstrated that repeated automated plasmapheresis procedures did not adversely affect the immediate or long-term health of goats. Further, our results indicate that repeated plasmapheresis in goats was capable of generating 2 liters of antibody-rich plasma per goat per week. This volume is sufficient to produce enough WHO influenza kits to conduct over 1 million tests. Thus, we have shown that the rapid production of plasma in goats can positively impact the public health preparedness and response to influenza.	[Taylor, Willie D., Jr.; Langham, Gregory L.; Weed, James L.; Lathrop, George; Powell, Nathaniel] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Sci Resources, Comparat Med Branch, Atlanta, GA 30333 USA; [Rowe, Thomas; Xu, Xiyan; Wentworth, David E.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Virol Surveillance & Diag Branch, Atlanta, GA USA; [Song, Wei] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Div HIV AIDS Prevent Intervent, Program Evaluat Branch, Atlanta, GA USA; [Isenberg, Kristin A.] Battelle Mem Inst, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Taylor, WD (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Sci Resources, Comparat Med Branch, Atlanta, GA 30333 USA.	KTT1@cdc.gov	Rowe, Thomas/AAW-4899-2020	Taylor, Willie/0000-0002-3602-3293				Chaves SS, 2015, EMERG INFECT DIS, V21, P1543, DOI 10.3201/eid2109.141912; Feige K, 2005, VET J, V169, P102, DOI 10.1016/j.tvjl.2004.01.007; Jagdish K, 2017, Indian J Nephrol, V27, P377, DOI 10.4103/ijn.IJN_64_17; Jain NC, 1993, PLATELETS ESSENTIALS, V1, P105; Jain NC, 1993, HEMATOPOIESIS ESSENT, V1, P72; Jones B., 2003, DESIGN ANAL CROSS OV, V2nd; Jones M., 2011, CENTRAL VET C CVC; KELLER AJ, 1979, BRIT J HAEMATOL, V42, P593, DOI 10.1111/j.1365-2141.1979.tb01172.x; Klages C, 2006, J AM ASSOC LAB ANIM, V45, P49; KLIMAN A, 1964, BLOOD, V23, P647, DOI 10.1182/blood.V23.5.647.647; Lafond KE, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001977; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; National Research Council (U. S.), 2011, COMM UPD GUID CAR US, Vxxv; PANEPINTO LM, 1983, LAB ANIM SCI, V33, P95; Park E, 2009, KOREAN J LAB MED, V29, P1, DOI 10.3343/kjlm.2009.29.1.1; Petrova VN, 2018, NAT REV MICROBIOL, V16, P47, DOI 10.1038/nrmicro.2017.118; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; Smith MC, 1994, GOAT MED, V1, P63; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; VOLKIN RL, 1982, TRANSFUSION, V22, P54, DOI 10.1046/j.1537-2995.1982.22182154218.x; WHO, 2011, MAN LAB DIAGN VIR SU; Wood L, 1986, J Clin Apher, V3, P124, DOI 10.1002/jca.2920030209; Yeh JH, 2001, J CLIN APHERESIS, V16, P139, DOI 10.1002/jca.1026; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	24	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0195903	10.1371/journal.pone.0195903	http://dx.doi.org/10.1371/journal.pone.0195903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897914	Green Submitted, Green Published, gold			2022-12-26	WOS:000435090700004
J	Zhou, J; Diao, XP; Wang, T; Chen, GY; Lin, Q; Yang, XB; Xu, J				Zhou, Jing; Diao, Xiaoping; Wang, Tao; Chen, Guangying; Lin, Qiang; Yang, Xiaobo; Xu, Jing			Phylogenetic diversity and antioxidant activities of culturable fungal endophytes associated with the mangrove species Rhizophora stylosa and R. mucronata in the South China Sea	PLOS ONE			English	Article							PESTALOTIOPSIS-MICROSPORA; CHEMICAL-CONSTITUENTS; OXIDATIVE STRESS; PLANTS; BIODIVERSITY; COMMUNITIES; HYDROLYSATE; PEPTIDES; PRODUCTS	Mangrove endophytic fungi can produce impressive quantities of metabolites with promising antioxidant activities that may be useful to humans as novel physiological agents. In this study, we investigated the phylogenetic diversity and antioxidant potential of 46 fungal endophytes derived from the mangrove species Rhizophora stylosa and R. mucronata from the South China Sea. The fungal isolates were identified using a combination of morphological characteristics and phylogenetic analysis of the internal transcribed spacer (ITS) sequences. Seventeen genera belonging to 8 taxonomic orders of Ascomycota were discovered, specifically, Botryosphaeriales, Capnodiales, Diaporthales, Eurotiales, Glomerellales, Hypocreales, Pleosporales, and Xylariales. The most abundant fungal orders included Xylariales (35.49%) and Diaporthales (27.61%), which were predominantly represented by the culturable species Pestalotiopsis sp. (34.54%) and Diaporthe sp. (18.62%). The stems showed more frequent colonization and species diversity than the roots, leaves, hypocotyls, and flower tissues of the host plant. The antioxidant activities of all the isolated fungal extracts on four different culture media were assessed using improved 2,2'-diphenyl-1-picrylhydrazyl (DPPH) and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonicacid) (ABTS) methods. A relatively high proportion (84.8%) of the isolates displayed antioxidant capacity (%RSA > 50%). Further research also provided the first evidence that HOD-6 could produce flufuran as a significant radical scavenger with IC50 values of 34.85 +/- 1.56 and 9.75 +/- 0.58 mu g/mL, respectively. Our findings suggest that the utilization of a biotope such as that of the endophytic fungal community thriving on the mangrove plants R. stylosa and R. mucronata may be suitable for use as a sustainable resource for natural antioxidants.	[Zhou, Jing; Diao, Xiaoping; Wang, Tao; Yang, Xiaobo; Xu, Jing] Hainan Univ, Coll Mat & Chem Engn, Inst Trop Agr & Forestry, Haikou, Hainan, Peoples R China; [Diao, Xiaoping; Chen, Guangying; Lin, Qiang; Xu, Jing] Hainan Normal Univ, Key Lab Trop Med Plant Chem, Minist Educ, Haikou, Hainan, Peoples R China	Hainan University; Hainan Normal University	Yang, XB; Xu, J (corresponding author), Hainan Univ, Coll Mat & Chem Engn, Inst Trop Agr & Forestry, Haikou, Hainan, Peoples R China.; Xu, J (corresponding author), Hainan Normal Univ, Key Lab Trop Med Plant Chem, Minist Educ, Haikou, Hainan, Peoples R China.	yangfengxb@163.com; happyjing3@163.com			National Natural Science Foundation of China [81660584]; programs for New Century Excellent Talents in University [NCET-13-0760]; Young Talents' Science and Technology Innovation Project of Hainan Association for Science and Technology [201509]; Key Research Program of Hainan Province [ZDYF2017099]; Key lab of tropical pharmaceutical herb chemistry of Hainan province Open Fund in Hainan Normal University [201602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); programs for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Young Talents' Science and Technology Innovation Project of Hainan Association for Science and Technology; Key Research Program of Hainan Province; Key lab of tropical pharmaceutical herb chemistry of Hainan province Open Fund in Hainan Normal University	This study was funded by grants of National Natural Science Foundation of China (No. 81660584), the programs for New Century Excellent Talents in University (NCET-13-0760), Young Talents' Science and Technology Innovation Project of Hainan Association for Science and Technology (No. 201509), Key Research Program of Hainan Province (ZDYF2017099) and Key lab of tropical pharmaceutical herb chemistry of Hainan province Open Fund in Hainan Normal University (No. 201602) are gratefully acknowledged (JX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly AH, 2010, FUNGAL DIVERS, V41, P1, DOI 10.1007/s13225-010-0034-4; Aly AH, 2011, APPL MICROBIOL BIOT, V90, P1829, DOI 10.1007/s00253-011-3270-y; Anjaneyulu ASR, 2001, NAT PROD LETT, V15, P13, DOI 10.1080/10575630108041252; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Baltruschat H, 2008, NEW PHYTOL, V180, P501, DOI 10.1111/j.1469-8137.2008.02583.x; CAMARGO JA, 1992, OIKOS, V64, P605, DOI 10.2307/3545183; Chaeprasert S, 2010, BOT MAR, V53, P555, DOI 10.1515/BOT.2010.074; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Cheng Zhong-shan, 2009, Journal of Forestry Research (Harbin), V20, P63, DOI 10.1007/s11676-009-0012-4; Chi CF, 2015, J FUNCT FOODS, V12, P1, DOI 10.1016/j.jff.2014.10.027; Cribb AB, 1955, MARINE FUNGI QUEENSL, V3, P97; Debbab A, 2013, FUNGAL DIVERS, V61, P1, DOI 10.1007/s13225-013-0243-8; Deng Qin, 2015, Journal of Chemical and Pharmaceutical Research, V7, P986; Harper JK, 2003, TETRAHEDRON, V59, P2471, DOI 10.1016/S0040-4020(03)00255-2; Hecht F, 2016, TUMOR BIOL, V37, P4281, DOI 10.1007/s13277-016-4873-9; Heinig U, 2013, FUNGAL DIVERS, V60, P161, DOI 10.1007/s13225-013-0228-7; HYDE K D, 1990, Asian Marine Biology, V7, P93; Hyde KD, 1998, BIODIVERS CONSERV, V7, P1147, DOI 10.1023/A:1008823515157; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Kjer J, 2010, NAT PROTOC, V5, P479, DOI 10.1038/nprot.2009.233; Klaiklay S, 2012, TETRAHEDRON, V68, P2299, DOI 10.1016/j.tet.2012.01.041; Lin YC, 2001, J ORG CHEM, V66, P6252, DOI 10.1021/jo015522r; Liu Ai-rong, 2007, Yingyong Shengtai Xuebao, V18, P912; Lu XL, 2010, BRAIN RES, V1332, P110, DOI 10.1016/j.brainres.2010.03.071; Newton AC, 1998, NEW PHYTOL, V138, P619, DOI 10.1046/j.1469-8137.1998.00143.x; Poprac P, 2017, TRENDS PHARMACOL SCI, V38, P592, DOI 10.1016/j.tips.2017.04.005; Qadri M, 2014, MICROB ECOL, V67, P877, DOI 10.1007/s00248-014-0379-4; Rahim AA, 2008, FOOD CHEM, V107, P200, DOI 10.1016/j.foodchem.2007.08.005; Ravindran C, 2012, BOT MAR, V55, P269, DOI 10.1515/bot-2011-0095; RODRIGUES KF, 1994, MYCOLOGIA, V86, P376, DOI 10.2307/3760568; Santamaria J, 2005, MICROB ECOL, V50, P1, DOI 10.1007/s00248-004-0002-1; Sarma VV, 2011, FUNGAL DIVERS, V8, P1; Schmit JP, 2004, BOT MAR, V47, P496, DOI 10.1515/BOT.2004.065; Schmit JP, 2003, MYCOTAXON, V85, P423; Song YC, 2005, BIOL PHARM BULL, V28, P506, DOI 10.1248/bpb.28.506; Strobel G, 2002, PHYTOCHEMISTRY, V60, P179, DOI 10.1016/S0031-9422(02)00062-6; Suganthy N, 2016, PHARM BIOL, V54, P118, DOI 10.3109/13880209.2015.1017886; Suryanarayanan TS, 1998, CAN J MICROBIOL, V44, P1003, DOI 10.1139/cjm-44-10-1003; Takahashi JA, 2013, PHYTOCHEM REV, V12, P773, DOI 10.1007/s11101-013-9305-5; Tan RX, 2001, NAT PROD REP, V18, P448, DOI 10.1039/b100918o; Tejesvi MV, 2011, FUNGAL DIVERS, V47, P97, DOI 10.1007/s13225-010-0087-4; Thatoi HN, 2014, ACTA PHYSIOL PLANT, V36, P561, DOI 10.1007/s11738-013-1438-z; Tian X, 2013, J AGR FOOD CHEM, V61, P5511, DOI 10.1021/jf4010725; Toledo-Hernandez C, 2007, CORAL REEFS, V26, P725, DOI 10.1007/s00338-007-0252-8; Wang B, 2014, J FUNCT FOODS, V6, P176, DOI 10.1016/j.jff.2013.10.004; Wang JH, 2015, MAR DRUGS, V13, P4492, DOI 10.3390/md13074492; Wu LS, 2013, CURR MICROBIOL, V66, P40, DOI 10.1007/s00284-012-0235-z; Xing XK, 2011, ECOL RES, V26, P403, DOI 10.1007/s11284-010-0795-y; Xu J, 2011, CURR MED CHEM, V18, P5224, DOI 10.2174/092986711798184307; Xu J, 2015, NATURAL PRODUCTS MAN; Xu J, 2015, RSC ADV, V5, P841, DOI 10.1039/c4ra11756e; Yan XT, 2014, FOOD CHEM, V156, P408, DOI 10.1016/j.foodchem.2014.01.078; Zang LY, 2012, J NAT PROD, V75, P1744, DOI 10.1021/np3004112; Zhou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068392	54	44	50	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197359	10.1371/journal.pone.0197359	http://dx.doi.org/10.1371/journal.pone.0197359			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897911	gold, Green Published, Green Submitted			2022-12-26	WOS:000435090700010
J	Khan, S; Liomba, G; Rosenberg, NE; Stanley, C; Kampani, C; Dhungel, BM; Hosseinipourl, MC				Khan, Shiraz; Liomba, George; Rosenberg, Nora E.; Stanley, Christopher; Kampani, Cocxilly; Dhungel, Bal Mukunda; Hosseinipourl, Mina C.			Utilization of fine needle aspiration cytology at Kamuzu central hospital	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; BIOPSY; PATHOLOGY	Background Fine needle aspiration cytology (FNAC) has been widely accepted to be a safe, accurate, prompt and inexpensive procedure for diagnosis of both neoplastic and infectious diseases in adult and pediatric populations. Despite its value for diagnosis, FNAC is underutilized in resource limited countries. We reviewed the utilization of FNAC after it was introduced at Kamuzu Central Hospital (KCH). Methods A retrospective review of all FNAC performed at KCH laboratory during the period of January 2012 to July 2014 was conducted using an electronic database from KCH laboratory. We evaluated factors associated with a diagnostic sample using multivariate logistic regression model. Results 750 FNAC were reviewed from 722 patients: 56.9% were adults >15 years and 54% were female. The number of FNAC increased annually from 56 (2012) to 379 (2013) to 315 (up to July 2014). Of 750 FNAC, 56.4% were performed by non-pathologists. The most common sites were lymph nodes (38.1%), abdomen (25.8%), breast (16.3%), and head & neck (15.7%). Most of the samples (77.6%) were diagnostic. FNAC was more likely to be diagnostic if performed by pathologists versus non-pathologists (OR 1.78, 95% CI 1.20-2.64), in 2013 compared to 2012 (OR 1.95, 95% CI 1.05-3.56), or performed on a deep lesion versus a subcutaneous lesion (OR 1.71, 95% CI 1.15-2.5), or if samples were taken from the head and neck (OR 2.4, 95% CI: 1.39-4.39), and abdomen (OR 2.66, 95%)CI.1.59-4.42) compared to those from the lymph nodes. The odds of a diagnostic test did not differ significantly according to gender, HIV status, or age groups. Conclusion Most FNACs successfully diagnosed the presence or absence of disease, with substantial improvements over time. However, training for non-pathologists may facilitate more diagnostic results.	[Khan, Shiraz; Liomba, George; Rosenberg, Nora E.; Stanley, Christopher; Kampani, Cocxilly; Dhungel, Bal Mukunda; Hosseinipourl, Mina C.] Univ North Carolina Project, Lilongwe, Malawi; [Liomba, George; Dhungel, Bal Mukunda] Kamuzu Cent Hosp, Lilongwe, Malawi; [Rosenberg, Nora E.; Hosseinipourl, Mina C.] Univ N Carolina, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Khan, S (corresponding author), Univ North Carolina Project, Lilongwe, Malawi.	skhan@unclilongwe.org		Dhungel, Bal Mukunda/0000-0003-3132-9370	Medical Education Partnership Initiative [R24TW008927]; MEPI (Medical education partner initiative) [U54CA190152]; FOGARTY INTERNATIONAL CENTER [R24TW008927] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U54CA190152] Funding Source: NIH RePORTER	Medical Education Partnership Initiative; MEPI (Medical education partner initiative); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research is supported by the Medical Education Partnership Initiative (R24TW008927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MEPI (Medical education partner initiative); U54CA190152; Addressing Herpesvirus-Associated Cancers through the UNC-Malawi Cancer Consortium	Adesina A, 2013, LANCET ONCOL, V14, pE152, DOI 10.1016/S1470-2045(12)70598-3; Agarwal D, 2010, PATHOL LAB MED INT, V2, P131; Das DK, 2003, DIAGN CYTOPATHOL, V28, P345, DOI 10.1002/dc.10289; Etit D, 2011, TURK J MED SCI, V41, P609, DOI 10.3906/sag-1004-763; Florentine BD, 2006, CANCER, V107, P406, DOI 10.1002/cncr.21976; Girosi Federico, 2006, Nature, V444 Suppl 1, P3, DOI 10.1038/nature05441; Gopal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070361; Harder HI, 2009, ARCH PATHOL LAB MED, V133, P1911, DOI 10.1043/1543-2165-133.12.1911; Hay Burgess Deborah C, 2006, Nature, V444 Suppl 1, P1; Ljung BM, 2001, CANCER CYTOPATHOL, V93, P263, DOI 10.1002/cncr.9040; Mabedi C, 2014, MALAWI MED J, V26, P16; Monaco SE, 2014, CANCER CYTOPATHOL, V122, P322, DOI 10.1002/cncy.21401; Montgomery ND, 2016, AM J CLIN PATHOL, V146, P423, DOI [10.1093/AJCP/AQW118, 10.1093/ajcp/aqw118]; Montgomery ND, 2017, CLIN LAB MED, V2017; Patel MM, 2013, NATL J MED RES, V3, P106; Polyzos SA, 2010, J OTOLARYNGOL-HEAD N, V39, P532, DOI 10.2310/7070.2010.090222; Razack R, 2012, DIAGN CYTOPATHOL, V40, P770, DOI 10.1002/dc.21624; Wright CA, 2008, ANN TROP PAEDIATR, V28, P65, DOI 10.1179/146532808X270707; Wu MX, 2006, LARYNGOSCOPE, V116, P1212, DOI 10.1097/01.mlg.0000224507.07560.28	19	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0196561	10.1371/journal.pone.0196561	http://dx.doi.org/10.1371/journal.pone.0196561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894472	Green Submitted, Green Published, gold			2022-12-26	WOS:000435030900002
J	Li, WH; Zheng, HQ; Xu, JK; Cao, SD; Xu, XA; Xiao, P				Li, Weihua; Zheng, Hongqun; Xu, Jiankai; Cao, Shaodong; Xu, Xiuan; Xiao, Peng			Imaging c-Met expression using 18F-labeled binding peptide in human cancer xenografts	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; POSITRON-EMISSION-TOMOGRAPHY; FACTOR-SCATTER FACTOR; MONOCLONAL-ANTIBODIES; FACTOR RECEPTOR; BREAST-CANCER; PET; CARCINOMA; PROTOONCOGENE; METASTASIS	Objectives c-Met is a receptor tyrosine kinase shown inappropriate expression and actively involved in progression and metastasis in most types of human cancer. Development of c-Met-targeted imaging and therapeutic agents would be extremely useful. Previous studies reported that c-Met-binding peptide (Met-pep1, YLFSVHWPPLKA) specifically targets c-Met receptor. Here, we evaluated F-18-labeled Met-pep1 for PET imaging of c-Met positive tumor in human head and neck squamous cell carcinoma (HNSCC) xenografted mice. Methods c-Met-binding peptide, Met-pep1, was synthesized and labeled with 4-nitrophenyl [F-18]-2-fluoropropionate ([F-18]-NPFP) ([F-18]-Met-pep1). The cell uptake, internalization and efflux of [F-18]FP-Met-pep1 were assessed in UM-SCC-22B cells. In vivo pharmacokinetics, blocking and biodistribution of the radiotracers were investigated in tumor-bearing nude mice by microPET imaging. Results The radiolabeling yield for [F-18]FP-Met-pep1 was over 55% with 97% purity. [(18)]FP-Met-pep1 showed high tumor uptake in UM-SCC-22B tumor-bearing mice with clear visualization. The specificity of the imaging tracer was confirmed by significantly decreased tumor uptake after co-administration of unlabeled Met-pep1 peptides. Prominent uptake and rapid excretion of [F-18]FP-Met-pep1 was also observed in the kidney, suggesting this tracer is mainly excreted through the renal-urinary routes. Ex vivo biodistribution showed similar results that were consistent with microPET imaging data. Conclusions These results suggest that F-18-labeled c-Met peptide may potentially be used for imaging c-Met positive HNSCC cancer in vivo and for c-Met-targeted cancer therapy.	[Li, Weihua; Cao, Shaodong; Xu, Xiuan] Harbin Med Univ, Affiliated Hosp 4, Dept Med Imaging & Nucl Med, Harbin, Heilongjiang, Peoples R China; [Zheng, Hongqun] Harbin Med Univ, Affiliated Hosp 4, Dept Surg Oncol & Hepatobiliary Surg, Harbin, Heilongjiang, Peoples R China; [Xu, Jiankai] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Xiao, Peng] Univ Louisiana Lafayette, New Iberia Res Ctr, New Iberia, LA 70560 USA	Harbin Medical University; Harbin Medical University; Harbin Medical University; University of Louisiana Lafayette; New Iberia Research Center	Li, WH (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Dept Med Imaging & Nucl Med, Harbin, Heilongjiang, Peoples R China.; Xiao, P (corresponding author), Univ Louisiana Lafayette, New Iberia Res Ctr, New Iberia, LA 70560 USA.	liweihua27@gmail.com; pxx8317@louisiana.edu	Xiao, Peng/GLS-6934-2022	Xiao, Peng/0000-0002-5308-8400; Xu, Jiankai/0000-0002-9421-4215	National Natural Science Foundation of China [81401456]; WHL	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); WHL	This work was supported by the National Natural Science Foundation of China (81401456). Funding was acquired by WHL.	Aina OH, 2002, BIOPOLYMERS, V66, P184, DOI 10.1002/bip.10257; Arulappu A, 2016, J NUCL MED, V57, P765, DOI 10.2967/jnumed.115.164384; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Burggraaf J, 2015, NAT MED, V21, P955, DOI 10.1038/nm.3641; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; EBERT M, 1994, CANCER RES, V54, P5775; Hay R, 2002, J CELL BIOCHEM, P184, DOI 10.1002/jcb.10441; Hay RV, 2005, CLIN CANCER RES, V11, p7064S, DOI 10.1158/1078-0432.CCR-1004-0014; Hay RV, 2003, CLIN CANCER RES, V9, p3839S; Herynk MH, 2000, IN VIVO, V14, P587; HUMPHREY PA, 1995, AM J PATHOL, V147, P386; Huntsman D, 1999, AM J PATHOL, V155, P343, DOI 10.1016/S0002-9440(10)65130-9; Jagoda EM, 2012, J NUCL MED, V53, P1592, DOI 10.2967/jnumed.111.102293; JUNG W, 1994, J CELL BIOL, V126, P485, DOI 10.1083/jcb.126.2.485; Lau PCP, 2011, ANTI-CANCER DRUG, V22, P665, DOI 10.1097/CAD.0b013e328341879d; Li WH, 2012, EUR J NUCL MED MOL I, V39, P300, DOI 10.1007/s00259-011-1969-8; Luo HM, 2015, J NUCL MED, V56, P758, DOI 10.2967/jnumed.115.154690; Ma PC, 2003, CANCER RES, V63, P6272; Miller PW, 2008, ANGEW CHEM INT EDIT, V47, P8998, DOI 10.1002/anie.200800222; Olberg DE, 2010, CURR TOP MED CHEM, V10, P1669; Perk LR, 2008, EUR J NUCL MED MOL I, V35, P1857, DOI 10.1007/s00259-008-0774-5; Poethko T, 2004, J NUCL MED, V45, P892; Ponzo MG, 2009, P NATL ACAD SCI USA, V106, P12903, DOI 10.1073/pnas.0810402106; Puri N, 2007, CLIN CANCER RES, V13, P2246, DOI 10.1158/1078-0432.CCR-06-0776; REILLY RM, 1995, CLIN PHARMACOKINET, V28, P126, DOI 10.2165/00003088-199528020-00004; SAITOH K, 1994, J PATHOL, V174, P191, DOI 10.1002/path.1711740308; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Somer EJ, 2016, EJNMMI RES, V6, DOI 10.1186/s13550-016-0239-y; Takayama H, 1997, P NATL ACAD SCI USA, V94, P701, DOI 10.1073/pnas.94.2.701; Teare H, 2010, ANGEW CHEM INT EDIT, V49, P6821, DOI 10.1002/anie.201002310; Ueki T, 1997, HEPATOLOGY, V25, P862, DOI 10.1002/hep.510250413; van Scheltinga AGTT, 2014, J NUCL MED, V55, P665, DOI 10.2967/jnumed.113.124941; Xu H, 2011, CLIN CANCER RES, V17, P4425, DOI 10.1158/1078-0432.CCR-10-3339; Yang M, 2011, THERANOSTICS, V1, P220, DOI 10.7150/thno/v01p0220; Zhao J, 2011, HISTOL HISTOPATHOL, V26, P1111, DOI 10.14670/HH-26.1111; Zhao P, 2007, CLIN CANCER RES, V13, P6049, DOI 10.1158/1078-0432.CCR-07-0035	37	8	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0199024	10.1371/journal.pone.0199024	http://dx.doi.org/10.1371/journal.pone.0199024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894497	Green Submitted, Green Published, gold			2022-12-26	WOS:000435030900045
J	Chiou, B; Neal, EH; Bowman, AB; Lippmann, ES; Simpson, IA; Connor, JR				Chiou, Brian; Neal, Emma H.; Bowman, Aaron B.; Lippmann, Ethan S.; Simpson, Ian A.; Connor, James R.			Pharmaceutical iron formulations do not cross a model of the human blood-brain barrier	PLOS ONE			English	Article							OXIDE NANOPARTICLES; H-FERRITIN; DEFICIENCY; DERIVATION; TRANSFERRIN; MECHANISMS; DIAGNOSIS; TRANSPORT; CELLS	Whether iron formulations used therapeutically for a variety of conditions involving iron deficiency can deliver iron to the brain is a significant clinical question given the impact that iron loading has on the brain in neurodegenerative diseases. In this study, we examine the ability of 5 pharmaceutical iron formulations that are given intravenously for treatment of iron deficiency to cross an in vitro model of the blood-brain barrier. The model uses human brain endothelial cells derived from induced pluripotent stem cells. We report that, compared to the natural iron delivery proteins, transferrin and H-ferritin, the pharmaceutical iron formulations neither cross the blood-brain barrier model nor significantly load the endothelial cells with iron. Furthermore, we report that mimicking brain iron sufficiency or deficiency by exposing the endothelial cells to apo- or holo-transferrin does not alter the amount of iron compound transported by or loaded into the cells. Coupled with previous studies, we propose that pharmaceutical iron formulations must first be processed in macrophages to make iron bioavailable. The results of this study have significant clinical and mechanistic implications for the use of therapeutic iron formulations.	[Chiou, Brian; Connor, James R.] Penn State Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Neal, Emma H.; Lippmann, Ethan S.] Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA; [Bowman, Aaron B.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Bowman, Aaron B.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN USA; [Bowman, Aaron B.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN USA; [Lippmann, Ethan S.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Simpson, Ian A.] Penn State Hershey Med Ctr, Dept Neural & Behav Sci, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Connor, JR (corresponding author), Penn State Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA.	jconnor@pennstatehealth.psu.edu		Chiou, Brian/0000-0002-6322-1914	Luitpold Pharmaceuticals Inc.; NIH [R01 NS077678]; National Institutes of Health/National Institute of Environmental Health Sciences [R01 ES016931, R01 ES010563]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016931, R01ES010563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077678] Funding Source: NIH RePORTER	Luitpold Pharmaceuticals Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this study was provided by Luitpold Pharmaceuticals Inc. and NIH R01 NS077678 (JRC). Luitpold Pharmaceuticals Inc. provided support in the form of salaries for author JRC, but did not have any additional role in the study design, data collection, data interpretation, decision to publish, or preparation of the manuscript. Information about Luitpold Pharmaceuticals Inc. can be found at www.luitpold.com. The hiPSC lines used in this study were developed by funding from National Institutes of Health/National Institute of Environmental Health Sciences R01 ES016931 (ABB) and R01 ES010563 (ABB).	Albrecht DS, 2016, ACS CHEM NEUROSCI, V7, P470, DOI 10.1021/acschemneuro.6b00056; Allen RP, 2018, SLEEP MED, V41, P27, DOI 10.1016/j.sleep.2017.11.1126; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Beard JL, 1996, NUTR REV, V54, P295, DOI 10.1111/j.1753-4887.1996.tb03794.x; Briley-Saebo K, 2004, CELL TISSUE RES, V316, P315, DOI 10.1007/s00441-004-0884-8; Burdo JR, 2003, NEUROSCIENCE, V121, P883, DOI 10.1016/S0306-4522(03)00590-6; Camaschella C, 2015, HEMATOL-AM SOC HEMAT, P8, DOI 10.1182/asheducation-2015.1.8; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chiou B, 2018, GLIA, V66, P1317, DOI 10.1002/glia.23313; Cho YW, 2013, SLEEP MED, V14, P274, DOI 10.1016/j.sleep.2012.11.001; Cohen-Solal A, 2014, HEART, V100, P1414, DOI 10.1136/heartjnl-2014-305669; Connor JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125272; CONNOR JR, 1992, J NEUROSCI RES, V31, P75, DOI 10.1002/jnr.490310111; Cortese S, 2012, EXPERT REV NEUROTHER, V12, P1227, DOI [10.1586/ern.12.116, 10.1586/ERN.12.116]; Duck KA, 2017, BIOCHEM BIOPH RES CO, V494, P70, DOI 10.1016/j.bbrc.2017.10.083; Etheridge ML, 2013, NANOMED-NANOTECHNOL, V9, P1, DOI 10.1016/j.nano.2012.05.013; Fisher J, 2007, AM J PHYSIOL-CELL PH, V293, pC641, DOI 10.1152/ajpcell.00599.2006; Ganz T, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0037-2016; Ganz Tomas, 2006, Hematology Am Soc Hematol Educ Program, P29; Grishchuk Y, 2015, DIS MODEL MECH, V8, P1591, DOI 10.1242/dmm.021154; Gustafson HH, 2015, NANO TODAY, V10, P487, DOI 10.1016/j.nantod.2015.06.006; Hagemeier J, 2012, EXPERT REV NEUROTHER, V12, P1467, DOI [10.1586/ERN.12.128, 10.1586/ern.12.128]; Hametner S, 2013, ANN NEUROL, V74, P848, DOI 10.1002/ana.23974; Hollmann EK, 2017, FLUIDS BARRIERS CNS, V14, DOI 10.1186/s12987-017-0059-0; Kalra PA, 2016, CURR OPIN NEPHROL HY, V25, P529, DOI 10.1097/MNH.0000000000000263; Kim BJ, 2013, OSTEOPOROSIS INT, V24, P2627, DOI 10.1007/s00198-013-2363-0; Kumar KK, 2014, SCI REP-UK, V4, DOI 10.1038/srep06801; Lameijer MA, 2013, EXPERT REV MOL DIAGN, V13, P567, DOI 10.1586/14737159.2013.819216; Lippmann ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep04160; Lippmann ES, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-2; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Lippmann ES, 2014, STEM CELLS, V32, P1032, DOI 10.1002/stem.1622; Nakchbandi IA, 2014, WORLD J GASTROENTERO, V20, P9427, DOI 10.3748/wjg.v20.i28.9427; Nixon AM, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1057-0; Pena-Rosas JP, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub5; Peters DG, 2015, NEUROBIOL DIS, V81, P49, DOI 10.1016/j.nbd.2015.08.007; POULIQUEN D, 1991, MAGN RESON IMAGING, V9, P275, DOI 10.1016/0730-725X(91)90412-F; Reynolds A, 2012, PEDIATRICS, V130, pS154, DOI 10.1542/peds.2012-0900M; Shpyleva SI, 2011, BREAST CANCER RES TR, V126, P63, DOI 10.1007/s10549-010-0849-4; Simpson IA, 2015, J CEREBR BLOOD F MET, V35, P48, DOI 10.1038/jcbfm.2014.168; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; SUN AH, 1987, ORL J OTO-RHINO-LARY, V49, P118, DOI 10.1159/000275920; Todorich B, 2011, GLIA, V59, P927, DOI 10.1002/glia.21164; Tsay J, 2010, BLOOD, V116, P2582, DOI 10.1182/blood-2009-12-260083; Unger EL, 2013, NEUROSCIENCE, V246, P179, DOI 10.1016/j.neuroscience.2013.04.049; Wilson HK, 2016, TISSUE ENG PART C-ME, V22, P1085, DOI 10.1089/ten.tec.2016.0345; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	47	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198775	10.1371/journal.pone.0198775	http://dx.doi.org/10.1371/journal.pone.0198775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889872	Green Submitted, gold, Green Published			2022-12-26	WOS:000434786600047
J	Pavlova, MA; Heiz, J; Sokolov, AN; Fallgatter, AJ; Barisnikov, K				Pavlova, Marina A.; Heiz, Julie; Sokolov, Alexander N.; Fallgatter, Andreas J.; Barisnikov, Koviljka			Even subtle cultural differences affect face tuning	PLOS ONE			English	Article							SOCIAL COGNITION; FACIAL EXPRESSIONS; AMYGDALA ACTIVATION; AESTHETIC APPRECIATION; AFRICAN-AMERICAN; EYE-MOVEMENTS; EMOTION; BRAIN; RECOGNITION; PERCEPTION	Culture shapes social cognition in many ways. Yet cultural impact on face tuning remains largely unclear. Here typically developing females and males from the French-speaking part of Switzerland were presented with a set of Arcimboldo-like Face-n-Food images composed of food ingredients and in different degree resembling a face. The outcome had been compared with previous findings obtained in young adults of the South-West Germany. In that study, males exhibit higher thresholds for face tuning on the Face-n-Food task than females. In Swiss participants, no gender differences exist in face tuning. Strikingly, males from the French-speaking part of Switzerland possess higher sensitivity to faces than their German peers, whereas no difference in face tuning occurs between females. The outcome indicates that even relatively subtle cultural differences as well as culture by gender interaction can modulate social cognition. Clarification of the nature of cultural impact on face tuning as well as social cognition at large is of substantial value for understanding a wide range of neuropsychiatric and neurodevelopmental conditions.	[Pavlova, Marina A.; Fallgatter, Andreas J.] Eberhard Karls Univ Tubingen, Med Sch, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Heiz, Julie; Barisnikov, Koviljka] Univ Geneva, Dept Psychol, Child Clin Neuropsychol Unit, Geneva, Switzerland; [Sokolov, Alexander N.] Eberhard Karls Univ Tubingen, Univ Hosp, Womens Hlth Res Inst, Dept Womens Hlth, Tubingen, Germany	Eberhard Karls University of Tubingen; University of Geneva; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Pavlova, MA (corresponding author), Eberhard Karls Univ Tubingen, Med Sch, Dept Psychiat & Psychotherapy, Tubingen, Germany.	marina.pavlova@uni-tuebingen.de		Pavlova, Marina/0000-0001-8239-3589	Reinhold Beitlich Foundation; BBbank foundation; Deutsche Forschungsgemeinschaft (DFG); Open Access Publishing Fund of Eberhard Karls University of Tubingen	Reinhold Beitlich Foundation; BBbank foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publishing Fund of Eberhard Karls University of Tubingen	The Reinhold Beitlich Foundation and BBbank foundation to Marina Pavlova. The authors acknowledge support toward open access publishing by the Deutsche Forschungsgemeinschaft (DFG) and the Open Access Publishing Fund of Eberhard Karls University of Tubingen.	Adams RB, 2010, SOC COGN AFFECT NEUR, V5, P340, DOI 10.1093/scan/nsp047; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Boccia M, 2015, BEHAV BRAIN RES, V278, P147, DOI 10.1016/j.bbr.2014.09.041; Boccia M, 2014, ATTEN PERCEPT PSYCHO, V76, P1516, DOI 10.3758/s13414-014-0739-7; Bubic A, 2014, PERCEPTION, V43, P465, DOI 10.1068/p7671; Busigny T, 2010, NEUROPSYCHOLOGIA, V48, P4057, DOI 10.1016/j.neuropsychologia.2010.09.017; Caharel S, 2013, INT J PSYCHOPHYSIOL, V90, P157, DOI 10.1016/j.ijpsycho.2013.06.024; Caldara R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009708; Chiao JY, 2008, J COGNITIVE NEUROSCI, V20, P2167, DOI 10.1162/jocn.2008.20151; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; Dalrymple KA, 2007, NEUROPSYCHOLOGIA, V45, P871, DOI 10.1016/j.neuropsychologia.2006.07.013; Derntl B, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-54; Derntl B, 2009, SOC NEUROSCI-UK, V4, P294, DOI 10.1080/17470910802571633; Di Giorgio E, 2017, BEHAV BRAIN RES, V325, P90, DOI 10.1016/j.bbr.2016.09.018; Di Giorgio E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26395; Goh JO, 2009, PROG BRAIN RES, V178, P95, DOI 10.1016/S0079-6123(09)17807-X; Goh JOS, 2010, SOC COGN AFFECT NEUR, V5, P227, DOI 10.1093/scan/nsq060; Habel U, 2000, SCHIZOPHR RES, V42, P57, DOI 10.1016/S0920-9964(99)00093-6; Han SH, 2013, ANNU REV PSYCHOL, V64, P335, DOI 10.1146/annurev-psych-071112-054629; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Herrmann MJ, 2007, J NEURAL TRANSM, V114, P951, DOI 10.1007/s00702-007-0624-9; Herrmann MJ, 2006, PSYCHIAT RES, V141, P247, DOI 10.1016/j.psychres.2005.09.015; Herrmann MJ, 2004, AM J PSYCHIAT, V161, P915, DOI 10.1176/appi.ajp.161.5.915; Hills PJ, 2013, COGNITION, V129, P586, DOI 10.1016/j.cognition.2013.08.012; Hoertnagl CM, 2014, CURR OPIN PSYCHIATR, V27, P197, DOI 10.1097/YCO.0000000000000055; Huang YQ, 2001, PSYCHIAT CLIN NEUROS, V55, P479, DOI 10.1046/j.1440-1819.2001.00893.x; Jack RE, 2012, P NATL ACAD SCI USA, V109, P7241, DOI 10.1073/pnas.1200155109; Jakesch M, 2009, Q J EXP PSYCHOL, V62, P2105, DOI 10.1080/17470210903038974; Kelly DJ, 2011, DEVELOPMENTAL SCI, V14, P1176, DOI 10.1111/j.1467-7687.2011.01067.x; Kobayashi M, 2012, J EXP CHILD PSYCHOL, V111, P22, DOI 10.1016/j.jecp.2011.07.008; Koelkebeck K, 2017, SOC NEUROSCI-UK, V12, P102, DOI 10.1080/17470919.2016.1155482; Koelkebeck K, 2015, PSYCHIAT RES, V228, P39, DOI 10.1016/j.psychres.2015.04.005; Lazar SM, 2014, BEHAV BRAIN RES, V263, P1, DOI 10.1016/j.bbr.2014.01.010; Lieberman MD, 2005, NAT NEUROSCI, V8, P720, DOI 10.1038/nn1465; MATSUMOTO D, 1992, J CROSS CULT PSYCHOL, V23, P72, DOI 10.1177/0022022192231005; MATSUMOTO D, 1989, MOTIV EMOTION, V13, P143, DOI 10.1007/BF00992959; Miellet S, 2012, J EYE MOVEMENT RES, V5; Miellet S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00034; Moriguchi Y, 2005, NEUROREPORT, V16, P133, DOI 10.1097/00001756-200502080-00012; Nisbett RE, 2005, TRENDS COGN SCI, V9, P467, DOI 10.1016/j.tics.2005.08.004; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Or CCF, 2015, J VISION, V15, DOI 10.1167/15.13.12; Pavlova MA, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01211; Pavlova MA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02790-1; Pavlova MA, 2017, J NEUROSCI RES, V95, P235, DOI 10.1002/jnr.23871; Pavlova MA, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01131; Pavlova MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157636; Pavlova MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130363; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; Pelphrey KA, 2014, CURR TOP BEHAV NEURO, V16, P215, DOI 10.1007/7854_2013_253; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Pinkham AE, 2008, AM J PSYCHIAT, V165, P639, DOI 10.1176/appi.ajp.2007.07101604; Rodger H, 2010, PERCEPTION, V39, P1491, DOI 10.1068/p6750; Rosenqvist J, 2017, J INT NEUROPSYCH SOC, V23, P367, DOI 10.1017/S1355617716001193; Rossion B, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00225; Tardif J, 2017, J EXP PSYCHOL HUMAN, V43, P294, DOI 10.1037/xhp0000288; Tomasello M., 2000, CULTURAL ORIGINS HUM; Van den Stock J, 2011, SOC NEUROSCI-UK, V6, P537, DOI 10.1080/17470919.2011.568790; Vizioli L, 2010, J VISION, V10, DOI 10.1167/10.1.15	59	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198299	10.1371/journal.pone.0198299	http://dx.doi.org/10.1371/journal.pone.0198299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI8PJ	29889882	gold, Green Published, Green Submitted			2022-12-26	WOS:000434786600022
J	Taciak, B; Bialasek, M; Braniewska, A; Sas, Z; Sawicka, P; Kiraga, L; Rygiel, T; Krol, M				Taciak, Bartlomiej; Bialasek, Maciej; Braniewska, Agata; Sas, Zuzanna; Sawicka, Paulina; Kiraga, Lukasz; Rygiel, Tomasz; Krol, Magdalena			Evaluation of phenotypic and functional stability of RAW 264.7 cell line through serial passages	PLOS ONE			English	Article							GENE-EXPRESSION; MACROPHAGE PLASTICITY; CANCER; NUMBER; LIPOPOLYSACCHARIDE; POLARIZATION; PHAGOCYTOSIS; PARADIGM; TIME	Established cell lines are widely used in research, however an appealing question is the comparability of the cells between various laboratories, their characteristics and stability in time. Problematic is also the cell line misidentification, genetic and phenotypic shift or Mycoplasma contamination which are often forgotten in research papers. The monocyte/macrophage-like cell line RAW 264.7 has been one of the most commonly used myeloid cell line for more than 40 years. Despite its phenotypic and functional stability is often discussed in literature or at various scientific discussion panels, their stability during the consecutive passages has not been confirmed in any solid study. So far, only a few functional features of these cells have been studied, for example their ability to differentiate into osteoclasts. Therefore, in the present paper we have investigated the phenotype and functional stability of the RAW 264.7 cell line from passage no. 5 till passage no. 50. We found out that the phenotype (expression of particular macrophage-characteristic genes and surface markers) and functional characteristics (phagocytosis and NO production) of RAW 264.7 cell line remains stable through passages: from passage no. 10 up to passage no. 30. Overall, our results indicated that the RAW 264.7 cell line should not be used after the passage no. 30 otherwise it may influence the data reliability.	[Taciak, Bartlomiej; Bialasek, Maciej; Sawicka, Paulina; Kiraga, Lukasz; Krol, Magdalena] Warsaw Univ Life Sci, Fac Vet Med, Dept Physiol Sci, Warsaw, Poland; [Braniewska, Agata; Sas, Zuzanna; Rygiel, Tomasz] Med Univ Warsaw, Ctr Biostruct Res, Dept Immunol, Warsaw, Poland	Warsaw University of Life Sciences; Medical University of Warsaw	Krol, M (corresponding author), Warsaw Univ Life Sci, Fac Vet Med, Dept Physiol Sci, Warsaw, Poland.	magdalena_krol@sggw.pl	Braniewska, Agata/AAJ-1627-2021; Krol, Magdalena/A-5554-2019	Braniewska, Agata/0000-0002-2525-1290; Krol, Magdalena/0000-0003-0421-5167; Taciak, Bartlomiej/0000-0003-2623-4860; Rygiel, Tomasz/0000-0003-4746-6505	National Science Centre [UMO-2015/18/E/NZ6/00642 SONATA BIS]	National Science Centre(National Science Centre, Poland)	The research described in this paper was funded by UMO-2015/18/E/NZ6/00642 SONATA BIS grant from the National Science Centre. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research described in this paper was funded by UM0-2015/18/E/NZ6/00642 SONATA BIS grant given to MK from the National Science Centre. The authors would like to thank Mrs. Katarzyna Witt-Jurkowska for her technical work.	Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; BriskeAnderson MJ, 1997, P SOC EXP BIOL MED, V214, P248; Calles K, 2006, BIOTECHNOL PROGR, V22, P394, DOI 10.1021/bp050297a; ChangLiu CM, 1997, CANCER LETT, V113, P77, DOI 10.1016/S0304-3835(97)04599-0; Collin-Osdoby P, 2012, METHODS MOL BIOL, V816, P187, DOI 10.1007/978-1-61779-415-5_13; COOPER PH, 1984, J IMMUNOL, V133, P913; de Lima TM, 2014, MOL IMMUNOL, V60, P8, DOI 10.1016/j.molimm.2014.03.010; Fuentes AL, 2014, J SURG RES, V189, P304, DOI 10.1016/j.jss.2014.03.024; Geraghty RJ, 2014, BRIT J CANCER, V111, P1021, DOI 10.1038/bjc.2014.166; Guo DW, 2012, SCI CHINA LIFE SCI, V55, P898, DOI 10.1007/s11427-012-4382-z; Hartley JW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-1; Lin HK, 2003, J BIOL CHEM, V278, P50902, DOI 10.1074/jbc.M300676200; Lv YD, 2015, EXP THER MED, V9, P143, DOI 10.3892/etm.2014.2071; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Masters JRW, 2000, NAT REV MOL CELL BIO, V1, P233, DOI 10.1038/35043102; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; O'Driscoll L, 2006, J ENDOCRINOL, V191, P665, DOI 10.1677/joe.1.06894; ORTH K, 1994, P NATL ACAD SCI USA, V91, P9495, DOI 10.1073/pnas.91.20.9495; Robbins KS, 2016, FOOD CHEM, V212, P681, DOI 10.1016/j.foodchem.2016.06.018; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Stout Robert D., 1997, Frontiers in Bioscience (online), V2, pD197; Warnes M.G.R., 2016, PACKAGE GPLOTS VARIO; Wenger SL, 2004, BIOSCIENCE REP, V24, P631, DOI 10.1007/s10540-005-2797-5; Wu TT, 2012, J IMMUNOL, V189, P4989, DOI 10.4049/jimmunol.1200068; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1	29	114	115	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							E0198943	10.1371/journal.pone.0198943	http://dx.doi.org/10.1371/journal.pone.0198943			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889899	Green Submitted, Green Published, gold			2022-12-26	WOS:000434786600065
J	Choi, IS; Choi, M; Lee, JH; Kim, JH; Suh, KJ; Lee, JY; Kang, B; Kim, JW; Kim, SH; Kim, JW; Lee, JO; Kim, YJ; Bang, SM; Lee, JS; Lee, KW				Choi, In Sil; Choi, Mihong; Lee, Ju Hyun; Kim, Jee Hyun; Suh, Koung Jin; Lee, Ji Yun; Kang, Beodeul; Kim, Ji-Won; Kim, Se-Hyun; Kim, Jin Won; Lee, Jeong-Ok; Kim, Yu Jung; Bang, Soo-Mee; Lee, Jong Seok; Lee, Keun-Wook			Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study	PLOS ONE			English	Article							PHASE-III TRIAL; SUPPORTIVE CARE; GASTROESOPHAGEAL ADENOCARCINOMA; DOUBLE-BLIND; PLUS; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; IRINOTECAN; 5-FLUOROURACIL	Purpose There is limited data on third-line chemotherapy in patients with metastatic gastric cancer (MGC). This study was conducted to assess third-line treatment patterns, outcomes, and clinical parameters related to survival outcomes in patients with MGC. Methods Using the Korean Health Insurance Review and Assessment Service (HIRA) database, a nationwide population-based outcomes study was conducted. From the HIRA database, patients newly diagnosed in 2010 with MGC were identified (N = 1,871), and of these, 229 patients who had received third-line chemotherapy were finally selected for this study. Results Prior to third-line chemotherapy, more than 90% of patients received fluoropyrimidine and platinum, and 43.7% and 40.6% received taxane and irinotecan, respectively. Various third line chemotherapy regimens containing taxane (docetaxel or paclitaxel), irinotecan, or oxaliplatin were prescribed. The median overall survival (OS) of all patients receiving third-line chemotherapy was 4.4 months. The median time from the start date of first-line chemotherapy to the start date of third-line chemotherapy (TF1T3) was 9.5 months, and a longer TF1T3 was the only factor that was significantly associated with an increased OS. The median OS of patients who had received fluoropyrimidine, platinum, and taxane followed by third-line irinotecan-based therapy was similar to that of patients who had received fluoropyrimidine, platinum, and irinotecan followed by third-line taxane-based therapy (p = 0.894). Conclusion In patients with MGC receiving third-line chemotherapy, TF1 T3 was the only significant factor associated with OS. The sequence of using taxane and irinotecan as subsequent therapy after first-line failure was not shown to impact survival outcome.	[Choi, In Sil] Seoul Natl Univ, Seoul Metropolitan Govt, Dept Internal Med, Coll Med,Boramae Med Ctr, Seoul, South Korea; [Choi, Mihong; Lee, Ju Hyun; Kim, Jee Hyun; Suh, Koung Jin; Lee, Ji Yun; Kang, Beodeul; Kim, Ji-Won; Kim, Se-Hyun; Kim, Jin Won; Lee, Jeong-Ok; Kim, Yu Jung; Bang, Soo-Mee; Lee, Jong Seok; Lee, Keun-Wook] Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Lee, KW (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, Seongnam, South Korea.	hmodoctor@snubh.org		Kang, Beodeul/0000-0001-5177-8937; Kim, Jin Won/0000-0002-1357-7015	Seoul National University Bundang Hospital Research Fund [02-2016-044]	Seoul National University Bundang Hospital Research Fund	This study was partially supported by research grants from the Seoul National University Bundang Hospital Research Fund (02-2016-044) to KWL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ajani JA, 2010, J CLIN ONCOL, V28, P1547, DOI 10.1200/JCO.2009.25.4706; Al-Batran SE, 2008, J CLIN ONCOL, V26, P1435, DOI 10.1200/JCO.2007.13.9378; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Ford HER, 2014, LANCET ONCOL, V15, P78, DOI 10.1016/S1470-2045(13)70549-7; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Glimelius B, 1997, ANN ONCOL, V8, P163, DOI 10.1023/A:1008243606668; Jung KW, 2017, CANCER RES TREAT, V49, P292, DOI 10.4143/crt.2017.118; Kang EJ, 2013, GASTRIC CANCER, V16, P581, DOI 10.1007/s10120-012-0227-5; Kang JH, 2012, J CLIN ONCOL, V30, P1513, DOI 10.1200/JCO.2011.39.4585; Kang YK, 2009, ANN ONCOL, V20, P666, DOI 10.1093/annonc/mdn717; Kang YK, 2017, LANCET, V390, P2461, DOI 10.1016/S0140-6736(17)31827-5; Kim DY, 2003, ANN ONCOL, V14, P383, DOI 10.1093/annonc/mdg106; Kim YS, 2010, CANCER RES TREAT, V42, P24, DOI 10.4143/crt.2010.42.1.24; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-2045(08)70035-4; Lee JH, 2013, KOREAN J INTERN MED, V28, P314, DOI 10.3904/kjim.2013.28.3.314; Lee KW, 2016, J CANCER RES CLIN, V142, P687, DOI 10.1007/s00432-015-2075-2; Lee MJ, 2012, CANCER RES TREAT, V44, P235, DOI 10.4143/crt.2012.44.4.235; PYRHONEN S, 1995, BRIT J CANCER, V71, P587, DOI 10.1038/bjc.1995.114; Shim HJ, 2011, GASTRIC CANCER, V14, P249, DOI 10.1007/s10120-011-0032-6; Shimoyama R, 2009, GASTRIC CANCER, V12, P206, DOI 10.1007/s10120-009-0524-9; Thuss-Patience PC, 2014, EUR J CANCER, V47, P2306; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsuji K, 2012, JPN J CLIN ONCOL, V42, P686, DOI 10.1093/jjco/hys084; Wagner AD, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub4; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6	25	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198544	10.1371/journal.pone.0198544	http://dx.doi.org/10.1371/journal.pone.0198544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879177	gold, Green Published, Green Submitted			2022-12-26	WOS:000434384900052
J	Egawa, Y; Saigo, C; Kito, Y; Moriki, T; Takeuchi, T				Egawa, Yuki; Saigo, Chiemi; Kito, Yusuke; Moriki, Toshiaki; Takeuchi, Tamotsu			Therapeutic potential of CPI-613 for targeting tumorous mitochondrial energy metabolism and inhibiting autophagy in clear cell sarcoma	PLOS ONE			English	Article							SENTINEL NODE BIOPSY; MALIGNANT-MELANOMA; CANCER; AGENT; TRANSLOCATION; ESTABLISHMENT; MOLECULE; GROWTH; MODEL; MICE	Clear cell sarcoma (CCS) is an aggressive type of soft tissue tumor that is associated with high rates of metastasis. In the present study, we found that CPI-613, which targets tumorous mitochondrial energy metabolism, induced autophagosome formation followed by lysosome fusion in HS-MM CCS cells in vitro. Interestingly, CPI-613 along with chloroquine, which inhibits the fusion of autophagosomes with lysosomes, significantly induced necrosis of HS-MM CCS cell growth in vitro. Subsequently, we established a murine orthotropic metastatic model of CCS and evaluated the putative suppressive effect of a combination of CPI-613 and chloroquine on CCS progression. Injection of HS-MM into the aponeuroses of the thigh, the most frequently affected site in CCS, resulted in massive metastasis in SCID-beige mice. By contrast, intraperitoneal administration of CPI-613 (25 mg/kg) and chloroquine (50 mg/kg), two days a week for two weeks, significantly decreased tumor growth at the injection site and abolished metastasis. The present results imply the inhibitory effects of a combination of CPI-613 and chloroquine on the progression of CCS.	[Egawa, Yuki; Saigo, Chiemi; Kito, Yusuke; Takeuchi, Tamotsu] Gifu Univ, Grad Sch Med, Dept Pathol & Translat Res, Gifu, Japan; [Egawa, Yuki; Moriki, Toshiaki] Shizuoka City Shizuoka Hosp, Div Pathol, Shizuoka, Japan	Gifu University	Takeuchi, T (corresponding author), Gifu Univ, Grad Sch Med, Dept Pathol & Translat Res, Gifu, Japan.	takeutit08@gmail.com		, Tamotsu/0000-0002-4264-3632	Ministry of Education of Japan [15K08361, 17K15642]	Ministry of Education of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grants from the Ministry of Education of Japan (Grant nos. KAKEN 15K08361 to T.T. and 17K15642 to C.S.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alistar A, 2017, LANCET ONCOL, V18, P770, DOI 10.1016/S1470-2045(17)30314-5; Anderson NM, 2018, PROTEIN CELL, V9, P216, DOI 10.1007/s13238-017-0451-1; Andreou D, 2013, ANN ONCOL, V24, P1400, DOI 10.1093/annonc/mds650; Andreou Dimosthenis, 2009, V179, P25; CHUNG EB, 1983, AM J SURG PATHOL, V7, P405, DOI 10.1097/00000478-198307000-00003; ENZINGER FM, 1965, CANCER, V18, P1163, DOI 10.1002/1097-0142(196509)18:9<1163::AID-CNCR2820180916>3.0.CO;2-0; Hong SH, 2015, ONCOTARGET, V6, P7151, DOI 10.18632/oncotarget.3345; Iwashita H, 2018, FEBS LETT, V592, P559, DOI 10.1002/1873-3468.12979; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; Kawarada Y, 1997, PANCREAS, V15, P251, DOI 10.1097/00006676-199710000-00006; Kundu N, 1996, JNCI-J NATL CANCER I, V88, P536, DOI 10.1093/jnci/88.8.536; MACDOUGALL JR, 1990, CELL IMMUNOL, V130, P106, DOI 10.1016/0008-8749(90)90165-N; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mavrogenis AF, 2013, HIPPOKRATIA, V17, P298; Pardee TS, 2014, CLIN CANCER RES, V20, P5255, DOI 10.1158/1078-0432.CCR-14-1019; Ponticelli C, 2017, EXPERT OPIN DRUG SAF, V16, P411, DOI 10.1080/14740338.2017.1269168; Sonobe H, 1999, J PATHOL, V187, P594; SONOBE H, 1993, J PATHOL, V169, P317, DOI 10.1002/path.1711690307; Stuart SD, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-4; Takeuchi T, 2000, J NEUROCHEM, V74, P1489, DOI 10.1046/j.1471-4159.2000.0741489.x; Takeuchi T, 2012, CARCINOGENESIS, V33, P548, DOI 10.1093/carcin/bgs001; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Zachar Z, 2011, J MOL MED, V89, P1137, DOI 10.1007/s00109-011-0785-8; ZUCMAN J, 1993, NAT GENET, V4, P341, DOI 10.1038/ng0893-341	24	17	17	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198940	10.1371/journal.pone.0198940	http://dx.doi.org/10.1371/journal.pone.0198940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879220	Green Published, gold, Green Submitted			2022-12-26	WOS:000434384900098
J	Navas-Suarez, PE; Diaz-Delgado, J; Matushima, ER; Favero, CM; Sarmiento, AMS; Sacristan, C; Ewbank, AC; Joppert, AM; Duarte, JMB; dos Santos-Cirqueira, C; Cogliati, B; Mesquite, L; Maiorke, PC; Catao-Dias, JL				Navas-Suarez, Pedro Enrique; Diaz-Delgado, Josue; Matushima, Eliana Reiko; Favero, Cintia Maria; Sanchez Sarmiento, Angelica Maria; Sacristan, Carlos; Ewbank, Ana Carolina; Joppert, Adriana Marques; Barbanti Duarte, Jose Mauricio; dos Santos-Cirqueira, Cinthya; Cogliati, Bruno; Mesquite, Leonardo; Maiorke, Paulo Cesar; Catao-Dias, Jose Luiz			A retrospective pathology study of two Neotropical deer species (1995-2015), Brazil: Marsh deer (Blastocerus dichotomus) and brown brocket deer (Mamma gouazoubira)	PLOS ONE			English	Article							WHITE-TAILED DEER; MALIGNANT CATARRHAL FEVER; VIRAL DIARRHEA VIRUS; HEPATITIS-E-VIRUS; EPIZOOTIC HEMORRHAGIC-DISEASE; CAUSE-SPECIFIC MORTALITY; CHRONIC WASTING DISEASE; AUREOBASIDIUM-PULLULANS; ODOCOILEUS-VIRGINIANUS; OVARIAN DYSGERMINOMA	This retrospective study describes the biological and epidemiological aspects, gross and microscopical findings, and most likely causes of death (CD) in two species of Neotropical deer in Brazil. The animals were collected between 1995 and 2015 and represented 75 marsh deer (MD) and 136 brown brocket deer (BBD). Summarized, pneumonia was diagnosed microscopically in 48 MD and 52 BBD; 76 deer suffered trauma, involving dog attack (14 BBD) and vehicle-collision (14 BBD). Pulmonary edema (50 MD; 55 BBD) and congestion (57 MD; 78 BBD) were the most common findings for both species. Additionally, we diagnosed ruminal and myocardial mycosis in MD and BBD, respectively; ovarian dysgerminoma and pancreatic trematodiasis in BBD; and lesions suggestive of malignant catarrhal fever and orbiviral hemorrhagic disease in both species. The main CD in MD was: respiratory (41/75), alimentary, nutritional, trauma and euthanasia (3/75 each). Correspondingly, in BBD were: trauma (34/131), respiratory (30/131) and euthanasia (9/131). Respiratory disease was often defined by pulmonary edema and pneumonia. We provide evidence that respiratory disease, mainly pneumonia, is a critical pathological process in these Neotropical deer species. Although no etiological agents were identified, there is evidence of bacterial and viral involvement. Our results show trauma, mainly anthropogenic, as a common ailment in BBD. We propose to prioritize respiratory disease in future research focused on South American deer health aspects. We believe anthropogenic trauma may be a primary threat for populations of BBD.	[Navas-Suarez, Pedro Enrique; Diaz-Delgado, Josue; Matushima, Eliana Reiko; Favero, Cintia Maria; Sanchez Sarmiento, Angelica Maria; Sacristan, Carlos; Ewbank, Ana Carolina; Catao-Dias, Jose Luiz] Univ Sao Paulo, Lab Wildlife Comparat Pathol LAPCOM, Sch Vet Med & Anim Sci, Sao Paulo, Brazil; [Joppert, Adriana Marques] Div Tecn Med Vet & Manejo Fauna Silvestre DEPAVE, Sao Paulo, Brazil; [Barbanti Duarte, Jose Mauricio] Sao Paulo State Univ, Dept Anim Sci, Deer Res & Conservat Ctr NUPECCE, Sao Paulo, Brazil; [dos Santos-Cirqueira, Cinthya] Ctr Patol, Inst Adolfo Lutz IAL, Sao Paulo, Brazil; [Cogliati, Bruno] Univ Sao Paulo, Sch Vet Med & Anim Sci, Lab Morphol & Mol Pathol, Sao Paulo, Brazil; [Mesquite, Leonardo; Maiorke, Paulo Cesar] Univ Sao Paulo, Sch Vet Med & Anim Sci, Lab Anim Models, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo	Navas-Suarez, PE (corresponding author), Univ Sao Paulo, Lab Wildlife Comparat Pathol LAPCOM, Sch Vet Med & Anim Sci, Sao Paulo, Brazil.	pedroenasu@gmail.com	CATÃO-DIAS, JOSE LUIZ/C-4897-2012; Sánchez-Sarmiento, Angélica María/AAH-9474-2020; Sanchez-Sarmiento, Angélica María/B-8764-2019; Cogliati, Bruno/E-9956-2012; Ewbank, Ana Carolina/AAE-5147-2022; Duarte, José Maurício Barbanti/AAG-5149-2019; Navas-Suárez, Pedro Enrique/AAV-6548-2020; Sacristán, Carlos/G-7615-2016	CATÃO-DIAS, JOSE LUIZ/0000-0003-2999-3395; Sánchez-Sarmiento, Angélica María/0000-0001-6818-4609; Sanchez-Sarmiento, Angélica María/0000-0001-6818-4609; Cogliati, Bruno/0000-0002-1388-7240; Ewbank, Ana Carolina/0000-0002-5617-9287; Duarte, José Maurício Barbanti/0000-0002-7805-0265; Navas-Suárez, Pedro Enrique/0000-0003-1385-901X; Sacristán, Carlos/0000-0002-6111-6301	FAPESP [2015/04231-2, 2017/02223-8]; CNPq [305349/2015-5]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	PENS is the recipient of a master fellowship by FAPESP (grant: #2015/04231-2), JDD is the recipient of a post-doctoral fellowship by FAPESP (grant: #2017/02223-8). JLCD is the recipient of research fellowship from the CNPq (grant # 305349/2015-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AA, 1999, J WILDLIFE DIS, V35, P753, DOI 10.7589/0090-3558-35.4.753; Ali S, 2014, J VET ANIM SCI, V4, P11; Andreoli E, 2014, VET ITAL, V50, P285, DOI 10.12834/VetIt.1309.06; Ayanegui-Alcerreca MA, 2007, NEW ZEAL VET J, V55, P102, DOI 10.1080/00480169.2007.36750; Baumann CD, 2001, J WILDLIFE DIS, V37, P661, DOI 10.7589/0090-3558-37.4.661; Behrens L, 1998, J IMMUNOL, V161, P5943; Belem P. A. D., 1994, Brazilian Journal of Veterinary Research and Animal Science, V31, P273; Bender LC, 2004, J WILDLIFE MANAGE, V68, P870, DOI 10.2193/0022-541X(2004)068[0870:SCMAHO]2.0.CO;2; Black-Decima Patricia, 2010, P190; Boadella M, 2010, EMERG INFECT DIS, V16, P1994, DOI 10.3201/eid1612.100557; Bolignano G, 2003, J CLIN MICROBIOL, V41, P4483, DOI 10.1128/JCM.41.9.4483-4485.2003; Braga FG, 2012, SERIE ESPECIES AMEAC, V22, DOI DOI 10.1146/annurev.cellbio.24.110707.175302; BROWN CC, 1992, J WILDLIFE DIS, V28, P301, DOI 10.7589/0090-3558-28.2.301; BRUNETTI OA, 1970, J PARASITOL, V56, P1138, DOI 10.2307/3277559; Campbell-Malone R, 2008, J ZOO WILDLIFE MED, V39, P37, DOI 10.1638/2006-0057.1; CARRASCO L, 1995, VET PATHOL, V32, P250, DOI 10.1177/030098589503200306; Caswell JL., JUBB KENNEDY PALMERS, V2015, P490; CEAEA, 2016, PIB AGR BRAS; Chan GF, 2011, FOLIA MICROBIOL, V56, P459, DOI 10.1007/s12223-011-0070-9; Chandra AMS, 1998, VET PATHOL, V35, P308, DOI 10.1177/030098589803500412; CHEATUM EL, 1951, J WILDLIFE MANAGE, V15, P216, DOI 10.2307/3796614; Cianciolo R, 2015, JUBB KENNEDY PALMERS, Vsixth; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; COOK TW, 1979, J WILDLIFE DIS, V15, P405, DOI 10.7589/0090-3558-15.3.405; Cooper BJ, 2015, JUBB KENNEDY PALMERS; Cooper J. E., 2013, WILDLIFE FORENSIC IN; Cordes D O, 1968, N Z Vet J, V16, P65, DOI 10.1080/00480169.1968.33749; Corti P, 2010, J MAMMAL, V91, P690, DOI 10.1644/09-MAMM-A-047.1; Da Costa MM, 2008, VET NOT, V14, P75; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; DAVIDSON WR, 1990, J WILDLIFE DIS, V26, P460, DOI 10.7589/0090-3558-26.4.460; Deem SL, 2004, J WILDLIFE DIS, V40, P92, DOI 10.7589/0090-3558-40.1.92; DelGiudice GD, 2005, WILDLIFE SOC B, V33, P677, DOI 10.2193/0091-7648(2005)33[677:UMOSCC]2.0.CO;2; DENHOLM LJ, 1982, AUST VET J, V58, P81, DOI 10.1111/j.1751-0813.1982.tb00595.x; DINKINES WC, 1992, J WILDLIFE DIS, V28, P391, DOI 10.7589/0090-3558-28.3.391; Driemeier D, 2002, VET REC, V151, P271, DOI 10.1136/vr.151.9.271; Dyer NW, 2002, J VET DIAGN INVEST, V14, P414, DOI 10.1177/104063870201400510; ERIKSEN L, 1988, VET REC, V122, P274, DOI 10.1136/vr.122.12.274; Favero CM, 2013, EMERG INFECT DIS, V19, P346, DOI 10.3201/eid1902.120551; Feng Y, 2007, APPL ENVIRON MICROB, V73, P6475, DOI 10.1128/AEM.01034-07; Fernandez T, 2001, J AM ANIM HOSP ASSOC, V37, P553, DOI 10.5326/15473317-37-6-553; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gardiner CH, ATLAS METAZOAN PARAS; Gardiner CH, 1988, 651 USDA AGR RES SER, V651; GIBBS EPJ, 1975, J COMP PATHOL, V85, P361, DOI 10.1016/0021-9975(75)90022-5; Gomes A.A.B., 2012, Arq. Inst. Biol., V79, P611; Grazziotin AL, 2011, J WILDLIFE DIS, V47, P1005, DOI 10.7589/0090-3558-47.4.1005; Haigh J, 2005, CAN VET J, V46, P507; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hattel AL, 2004, J VET DIAGN INVEST, V16, P515, DOI 10.1177/104063870401600605; Hattel AL, 2007, J VET DIAGN INVEST, V19, P334, DOI 10.1177/104063870701900322; Ilha MRS, 2005, VET PARASITOL, V133, P49, DOI 10.1016/j.vetpar.2005.02.013; Irvine RJ, 2006, PARASITOLOGY, V133, P465, DOI 10.1017/S0031182006000606; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; JACKSON ML, 1985, CAN VET J, V26, P285; Jubb KVF, 2015, JUBB KENNEDY PALMERS; Jung JiYoul, 2015, Korean Journal of Veterinary Research, V55, P149, DOI 10.14405/kjvr.2015.55.2.149; KACZMARSKI EB, 1986, J INFECTION, V13, P289, DOI 10.1016/S0163-4453(86)91388-5; KARESH WB, 1988, J ZOO WILDLIFE MED, V19, P223, DOI 10.2307/20094892; Karns GR, 2009, J WILDLIFE DIS, V45, P196, DOI 10.7589/0090-3558-45.1.196; KARSTAD L., 1967, CAN VET J, V8, P247; Keel MK, 2003, J VET DIAGN INVEST, V15, P179, DOI 10.1177/104063870301500215; Kukielka D, 2016, TRANSBOUND EMERG DIS, V63, pE360, DOI 10.1111/tbed.12311; Kupca AM, 2015, BERL MUNCH TIERARZTL, V128, P285, DOI 10.2376/0005-9366-128-285; Li H, 2000, J CLIN MICROBIOL, V38, P1313, DOI 10.1128/JCM.38.4.1313-1318.2000; LIFSCHITZMERCER B, 1995, HUM PATHOL, V26, P62, DOI 10.1016/0046-8177(95)90115-9; Liu L, 1999, CAN J VET RES, V63, P41; Lopez-Alfaro C, 2012, ECOL MODEL, V244, P104, DOI 10.1016/j.ecolmodel.2012.06.032; Machado RZ, 2006, VET PARASITOL, V139, P262, DOI 10.1016/j.vetpar.2006.02.038; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; Mathias LA, 1999, J WILDLIFE DIS, V35, P112, DOI 10.7589/0090-3558-35.1.112; Matsuura Y, 2007, ARCH VIROL, V152, P1375, DOI 10.1007/s00705-007-0965-6; Mawhinney I, 2010, J COMP PATHOL, V143, P209, DOI 10.1016/j.jcpa.2010.01.010; Mcdonald JE, 2011, WILDLIFE SOC B, V35, P209, DOI 10.1002/wsb.40; MCLENNAN MW, 1977, AUST VET J, V53, P144, DOI 10.1111/j.1751-0813.1977.tb00142.x; Miller RS, 2013, PREV VET MED, V110, P119, DOI 10.1016/j.prevetmed.2012.11.021; Mise N, 2008, PERITON DIALYSIS INT, V28, P679; Moniwa M, 2012, J COMP PATHOL, V147, P330, DOI 10.1016/j.jcpa.2012.01.010; Nettles VF, 2002, J WILDLIFE DIS, V38, P685, DOI 10.7589/0090-3558-38.4.685; Noon TH, 2002, J WILDLIFE DIS, V38, P177, DOI 10.7589/0090-3558-38.1.177; OIE, 2013, MANUAL DIAGNOSTIC TE; Orozco María M, 2013, Mastozool. neotrop., V20, P163; Orr M., 1991, Surveillance (Wellington), V18, P17; PALING RW, 1978, J ZOO ANIM MED, V9, P137, DOI 10.2307/20094394; Palmer MV, 2002, J WILDLIFE DIS, V38, P860, DOI 10.7589/0090-3558-38.4.860; Palomares RA, 2013, VIRUS RES, V173, P260, DOI 10.1016/j.virusres.2013.02.010; Panadero R, 2001, VET PARASITOL, V99, P221, DOI 10.1016/S0304-4017(01)00465-4; Pandolfi JRC, 1998, VIRUS REV RES S1, V3, P56; Pandolfi JRC, 1998, VIRUS REV RES S1, V3, pS56; Park JK, 2009, REPROD DOMEST ANIM, V44, P855, DOI 10.1111/j.1439-0531.2008.01135.x; Passler T, 2007, VET MICROBIOL, V122, P350, DOI 10.1016/j.vetmic.2007.01.028; Patnaik AK, 2005, VET PATHOL, V42, P140, DOI 10.1354/vp.42-2-140; Patnaik AK, 2005, VET PATHOL, V42, P331, DOI 10.1354/vp.42-3-331; Pedersen AB, 2007, CONSERV BIOL, V21, P1269, DOI 10.1111/j.1523-1739.2007.00776.x; Araujo JP, 2010, J WILDLIFE DIS, V46, P939, DOI 10.7589/0090-3558-46.3.939; Pinder L, 1996, BIOL CONSERV, V75, P87, DOI 10.1016/0006-3207(95)00033-X; Preece ND, 2017, BIOL CONSERV, V214, P136, DOI 10.1016/j.biocon.2017.08.014; PRESTWOOD A K, 1974, Journal of Wildlife Diseases, V10, P217; Prophet E. B., 1992, LAB METHODS HISTOTEC; PYBUS MJ, 1990, J WILDLIFE DIS, V26, P453, DOI 10.7589/0090-3558-26.4.453; Quinn ACD, 2014, J WILDLIFE DIS, V50, P250, DOI 10.7589/2012-07-174; Rachid MA, 2011, ARQ BRAS MED VET ZOO, V63, P741, DOI 10.1590/S0102-09352011000300028; Raizman EA, 2009, J WILDLIFE DIS, V45, P653, DOI 10.7589/0090-3558-45.3.653; Lopez-Olvera JR, 2010, VET MICROBIOL, V145, P148, DOI 10.1016/j.vetmic.2010.03.012; RedondoBellon P, 1997, ARCH DERMATOL, V133, P663, DOI 10.1001/archderm.133.5.663; Revankar SG, 2002, CLIN INFECT DIS, V34, P467, DOI 10.1086/338636; RHYAN JC, 1995, VET PATHOL, V32, P215, DOI 10.1177/030098589503200301; Falcao CBR, 2017, PRION, V11, P65, DOI 10.1080/19336896.2016.1274000; Richini-Pereira VB, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-27; Ridpath J, 2010, VET CLIN N AM-FOOD A, V26, P335, DOI 10.1016/j.cvfa.2010.04.003; Robinson WF, 2015, JUBB KENNEDY PALMERS; Rodriguez F, 1996, J COMP PATHOL, V115, P151, DOI 10.1016/S0021-9975(96)80037-5; Rollins KE, 2012, VET PATHOL, V49, P362, DOI 10.1177/0300985812436745; Rosol TJ, 2015, JUBB KENNEDY PALMERS; Ruder MG, 2017, J WILDLIFE DIS, V53, P901, DOI 10.7589/2016-12-284; Rutjes SA, 2010, J VIROL METHODS, V168, P197, DOI 10.1016/j.jviromet.2010.05.014; Salaba O, 2013, PARASITOL RES, V112, P1661, DOI 10.1007/s00436-013-3322-6; SALKIN IF, 1976, SABOURAUDIA, V14, P47; Sambrook J., 1989, LAB MANUAL, P65; Sams MG, 1996, J MAMMAL, V77, P179, DOI 10.2307/1382719; Schlafer DH, 2015, JUBB KENNEDY PALMERS; Scott PR, 2011, CATTLE MEDICINE, P1, DOI 10.1201/b15179; Sexton AC, 2006, EUKARYOT CELL, V5, P1941, DOI 10.1128/EC.00277-06; Shahriar FM, 2002, CAN VET J, V43, P863; Sieber Veronika, 2010, Vet Med Int, V2010, DOI 10.4061/2010/684924; Silva-Rodriguez EA, 2012, BIOL CONSERV, V150, P103, DOI 10.1016/j.biocon.2012.03.008; Silva-Rodriguez EA, 2010, ORYX, V44, P97, DOI 10.1017/S0030605309990445; STAIR EL, 1968, PATHOL VET, V5, P164, DOI 10.1177/030098586800500207; Ferraz JBS, 2010, MEAT SCI, V84, P238, DOI 10.1016/j.meatsci.2009.06.006; Stoian A. C., 2015, Scientific Works. Series C. Veterinary Medicine, V61, P113; Stukenbrock EH, 2006, MOL ECOL, V15, P2895, DOI 10.1111/j.1365-294X.2006.02986.x; Suarez Navas, 2014, DETERMINACION ANTICU; SUMMERS PM, 1975, AUST VET J, V51, P496, DOI 10.1111/j.1751-0813.1975.tb02391.x; Sutherland R.J., 1976, New Zealand Veterinary Journal, V24, P263, DOI 10.1080/00480169.1976.34334; Szabo MPJ, 2007, VET PARASITOL, V143, P147, DOI 10.1016/j.vetpar.2006.08.009; Szabo MPJ, 2003, J MED ENTOMOL, V40, P268, DOI 10.1603/0022-2585-40.3.268; Szabo MPJ, 2000, J ZOO WILDLIFE MED, V31, P576, DOI 10.1638/1042-7260(2000)031[0576:CFCFII]2.0.CO;2; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; THOMSON R. G., 1967, CAN VET J, V8, P189; Tiemann JCH, 2005, VET PARASITOL, V129, P341, DOI 10.1016/j.vetpar.2004.12.016; Toigo C, 2006, ECOGRAPHY, V29, P301, DOI 10.1111/j.2006.0906-7590.04394.x; Tomiyama D, 2009, J VIRAL HEPATITIS, V16, P524, DOI 10.1111/j.1365-2893.2009.01107.x; Turnquist SE, 1998, J VET DIAGN INVEST, V10, P86, DOI 10.1177/104063879801000117; Uhart MM, 2003, J WILDLIFE DIS, V39, P887, DOI 10.7589/0090-3558-39.4.887; Uzal FA, 2015, JUBB KENNEDY PALMERS; Valentine A, 2015, JUBB KENNEDY PALMERS; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; VINCENT JP, 1995, J ZOOL, V236, P371, DOI 10.1111/j.1469-7998.1995.tb02719.x; Vreeland JK, 2004, WILDLIFE SOC B, V32, P542, DOI 10.2193/0091-7648(2004)32[542:SRMCAH]2.0.CO;2; Wan Y, 2008, J GENET GENOMICS, V35, P251, DOI 10.1016/S1673-8527(08)60035-1; Webb SL, 2007, J WILDLIFE MANAGE, V71, P555, DOI 10.2193/2006-189; WELSH MD, 1995, VET IMMUNOL IMMUNOP, V46, P195, DOI 10.1016/0165-2427(94)05366-Z; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wilkinson K, 2011, PHILOS T R SOC B, V366, P1933, DOI 10.1098/rstb.2010.0415; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; WOBESER G, 1975, J WILDLIFE MANAGE, V39, P596, DOI 10.2307/3800403; WORK TM, 1992, J WILDLIFE DIS, V28, P623, DOI 10.7589/0090-3558-28.4.623; Zalar P, 2008, STUD MYCOL, P21, DOI 10.3114/sim.2008.61.02; Zimpel CK, 2015, REV BRAS PARASITOL V, V24, P482, DOI 10.1590/S1984-29612015065	159	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198670	10.1371/journal.pone.0198670	http://dx.doi.org/10.1371/journal.pone.0198670			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879222	Green Submitted, Green Published, gold			2022-12-26	WOS:000434384900067
J	Vassend, O; Roysamb, E; Nielsen, CS; Czajkowski, NO				Vassend, Olav; Roysamb, Espen; Nielsen, Christopher Sivert; Czajkowski, Nikolai Olavi			Fatigue symptoms in relation to neuroticism, anxiety-depression, and musculoskeletal pain. A longitudinal twin study	PLOS ONE			English	Article							CHRONIC WIDESPREAD PAIN; POPULATION-BASED TWIN; ALLOSTATIC LOAD; INTERNALIZING DISORDERS; CENTRAL SENSITIZATION; HEALTH COMPLAINTS; PROLONGED FATIGUE; MENTAL-HEALTH; BIRTH COHORT; PERSONALITY	Background The nature of the relationship between fatigue and its risk factors is poorly understood. In the present study the genetic and environmental association between anxiety-depression, musculoskeletal (MS) pain and fatigue was examined, and the role of neuroticism as a shared risk factor that may possibly explain the co-occurrence between these phenotypes was investigated in a combined cross-sectional and longitudinal twin design. Methods The sample consisted of 746 monozygotic (MZ) and 770 dizygotic (DZ) twins in the age group of 50-65 (mean = 57.11 years, SD = 4.5). Continuous measures of fatigue symptoms and the other phenotypes were employed. Using Cholesky modeling, genetic and environmental influences on the phenotypes, and the associations among them, were determined. Analyses were performed using measures of neuroticism obtained concurrently and 13-19 years earlier. Results Results from multiple regression analyses showed that neuroticism, anxiety-depression symptoms, and MS pain were all significantly associated with fatigue, controlling for sex, education, and general health indices. The best-fitting biometric models included additive genetic and individual-specific environmental effects. Heritabilities in the 0.40-0.53 range were demonstrated. Furthermore, while there was a considerable overlap in genetic risk factors between the four phenotypes, a substantial proportion of the genetic risk shared between anxiety-depression and fatigue, and between MS pain and fatigue, was independent of neuroticism. Conclusion Evidence for a common underlying susceptibility to report fatigue symptoms, genetically linked to neuroticism, anxiety-depression, and MS pain, was found. Both unique and pleiotropic effects appear to be involved in the genetic architecture of the phenotypes.	[Vassend, Olav; Roysamb, Espen; Czajkowski, Nikolai Olavi] Univ Oslo, Dept Psychol, Oslo, Norway; [Roysamb, Espen; Nielsen, Christopher Sivert; Czajkowski, Nikolai Olavi] Norwegian Inst Publ Hlth, Oslo, Norway; [Nielsen, Christopher Sivert] Oslo Univ Hosp, Dept Pain Management & Res, Oslo, Norway	University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo	Vassend, O (corresponding author), Univ Oslo, Dept Psychol, Oslo, Norway.	olav.vassend@psykologi.uio.no		Roysamb, Espen/0000-0001-5133-7170	Department of Psychology, University of Oslo	Department of Psychology, University of Oslo	This work was supported by The Department of Psychology, University of Oslo. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Ball HA, 2011, TWIN RES HUM GENET, V14, P53, DOI 10.1375/twin.14.1.53; Bergman S, 2001, J RHEUMATOL, V28, P1369; Berthelsen M, 2015, IND HEALTH, V53, P280, DOI 10.2486/indhealth.2014-0186; Birley AJ, 2006, PERS INDIV DIFFER, V40, P737, DOI 10.1016/j.paid.2005.09.005; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; BOLGER N, 1991, J PERS, V59, P355, DOI 10.1111/j.1467-6494.1991.tb00253.x; Bourke JH, 2014, PSYCHOL MED, V44, P1545, DOI 10.1017/S0033291713002201; Brahler E., 1983, GIESSENER BESCHWERDE; Burri A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140289; Carey G, 2005, BEHAV GENET, V35, P653, DOI 10.1007/s10519-005-5355-9; Carlin JB, 2005, INT J EPIDEMIOL, V34, P1089, DOI 10.1093/ije/dyi153; Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352; Chapman BP, 2009, BRAIN BEHAV IMMUN, V23, P636, DOI 10.1016/j.bbi.2008.12.009; Charles ST, 2008, HEALTH PSYCHOL, V27, P369, DOI 10.1037/0278-6133.27.3.369; Costa PT, 2007, REVISED NEO PERSONAL; Cuijpers P, 2010, ARCH GEN PSYCHIAT, V67, P1086, DOI 10.1001/archgenpsychiatry.2010.130; De Vries J, 2002, PERS INDIV DIFFER, V33, P1311, DOI 10.1016/S0191-8869(02)00015-6; Deary V, 2018, MOL PSYCHIATR, V23, P609, DOI 10.1038/mp.2017.5; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Edes AN, 2017, AM J PHYS ANTHROPOL, V162, P44, DOI 10.1002/ajpa.23146; Evengard B, 2005, PSYCHOL MED, V35, P1317, DOI 10.1017/S0033291705005052; EYSENCK SBG, 1985, PERS INDIV DIFFER, V6, P21, DOI 10.1016/0191-8869(85)90026-1; Farmer A, 1999, PSYCHOL MED, V29, P279, DOI 10.1017/S0033291798008095; FEIGHTNER JW, 1990, CAN MED ASSOC J, V142, P1215; Ferguson CJ, 2010, J PERS SOC PSYCHOL, V98, P659, DOI 10.1037/a0018770; Friedman HS, 2014, ANNU REV PSYCHOL, V65, P719, DOI 10.1146/annurev-psych-010213-115123; Gale CR, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.56; Gjerde LC, 2011, TWIN RES HUM GENET, V14, P64, DOI 10.1375/twin.14.1.64; Goubert L, 2004, PAIN, V107, P234, DOI 10.1016/j.pain.2003.11.005; Hansell NK, 2012, PSYCHOL MED, V42, P1249, DOI 10.1017/S0033291711002431; Harvey SB, 2008, PSYCHOL MED, V38, P933, DOI 10.1017/S0033291707001900; Hettema JM, 2006, AM J PSYCHIAT, V163, P857, DOI 10.1176/appi.ajp.163.5.857; Hickie I, 1999, PSYCHOL MED, V29, P259, DOI 10.1017/S0033291798007934; Howren MB, 2011, J PERS SOC PSYCHOL, V100, P182, DOI 10.1037/a0021715; Hur YM, 2012, TWIN RES HUM GENET, V15, P720, DOI 10.1017/thg.2012.60; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Kato K, 2009, PSYCHOL MED, V39, P497, DOI 10.1017/S0033291708003784; Kato K, 2006, ARCH INTERN MED, V166, P1649, DOI 10.1001/archinte.166.15.1649; Kato K, 2006, ARCH GEN PSYCHIAT, V63, P1267, DOI 10.1001/archpsyc.63.11.1267; Lahey BB, 2009, AM PSYCHOL, V64, P241, DOI 10.1037/a0015309; Lamers F, 2013, AM J PSYCHIAT, V170, P502, DOI 10.1176/appi.ajp.2012.12040454; Landmark-Hoyvik H, 2010, PM&R, V2, P456, DOI 10.1016/j.pmrj.2010.04.003; MAGNUS P, 1983, CLIN GENET, V24, P103; Maloney EM, 2009, PSYCHOSOM MED, V71, P549, DOI 10.1097/PSY.0b013e3181a4fea8; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Meeus M, 2007, CLIN RHEUMATOL, V26, P465, DOI 10.1007/s10067-006-0433-9; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; MOUM T, 1992, SOC SCI MED, V35, P935, DOI 10.1016/0277-9536(92)90108-3; Mroczek DK, 2004, J PERS, V72, P355, DOI 10.1111/j.0022-3506.2004.00265.x; Neale MC, 2006, TWIN RES HUM GENET, V9, P481; Neeleman J, 2002, PSYCHOL MED, V32, P793, DOI 10.1017/S0033291702005901; Nijrolder I, 2010, PAIN, V150, P351, DOI 10.1016/j.pain.2010.05.030; Nijs J, 2005, MED HYPOTHESES, V64, P558, DOI 10.1016/j.mehy.2004.07.037; Nilsen TS, 2013, TWIN RES HUM GENET, V16, P285, DOI 10.1017/thg.2012.117; Poeschla B, 2013, ANN BEHAV MED, V45, P289, DOI 10.1007/s12160-012-9463-5; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Ranjith G, 2005, OCCUP MED-OXFORD, V55, P13, DOI 10.1093/occmed/kqi012; Reichborn-Kjennerud T, 2002, PSYCHOL MED, V32, P1009, DOI 10.1017/S0033291702005950; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Roy-Byrne P, 2002, BRIT J PSYCHIAT, V180, P29, DOI 10.1192/bjp.180.1.29; Schur E, 2007, TWIN RES HUM GENET, V10, P729, DOI 10.1375/twin.10.5.729; Stephan Y, 2016, PSYCHOSOM MED, V78, P302, DOI 10.1097/PSY.0000000000000281; Sullivan PF, 2005, PSYCHOL MED, V35, P1327, DOI 10.1017/S0033291705005222; Sutin AR, 2010, PSYCHOL MED, V40, P1485, DOI 10.1017/S0033291709992029; TAMBS K, 1995, BEHAV GENET, V25, P33, DOI 10.1007/BF02197240; van der Windt DAWM, 2008, J PSYCHOSOM RES, V64, P265, DOI 10.1016/j.jpsychores.2007.10.003; Vassend O, 1999, J Health Psychol, V4, P465, DOI 10.1177/135910539900400402; Vassend O., 1992, TIDSSKRIFT NORSK PSY, V29, P1150; Wang TT, 2017, BRAIN BEHAV IMMUN, V62, P230, DOI 10.1016/j.bbi.2017.01.007; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Wessely S, 1998, Epidemiol Psichiatr Soc, V7, P10; Wilhelmsen I, 2005, PSYCHONEUROENDOCRINO, V30, P990, DOI 10.1016/j.psyneuen.2005.01.011	73	31	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198594	10.1371/journal.pone.0198594	http://dx.doi.org/10.1371/journal.pone.0198594			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI5BF	29879175	Green Published, Green Submitted, gold			2022-12-26	WOS:000434384900057
J	Dequigiovanni, G; Ramos, SLF; Alves-Pereira, A; Fabri, EG; Picanco-Rodrigues, D; Clement, CR; Gepts, P; Veasey, EA				Dequigiovanni, Gabriel; Ferreyra Ramos, Santiago Linorio; Alves-Pereira, Alessandro; Fabri, Eliane Gomes; Picanco-Rodrigues, Doriane; Clement, Charles Roland; Gepts, Paul; Veasey, Elizabeth Ann			Highly structured genetic diversity of Bixa orellana var. urucurana, the wild ancestor of annatto, in Brazilian Amazonia	PLOS ONE			English	Article							POPULATION-STRUCTURE; R PACKAGE; DOMESTICATION; MODELS; ADAPTATION; PREDICTION; EVOLUTION; SOFTWARE; SYSTEMS; NICHE	Annatto (Bixa orellana L.) is a tropical American crop, commercially valuable due to its application in the food and cosmetics industries as a natural dye. The wild ancestor of cultivated annatto is B. orellana var. urucurana. Although never cultivated, this variety occurs in open forests and anthropogenic landscapes, and is always associated with riparian environments. In this study, we evaluated the genetic diversity and structure of B. orellana var. urucurana populations in Brazilian Amazonia using 16 microsatellite loci. We used Ecological Niche Modeling (ENM) to characterize the potential geographical range of this variety in northern South America. We analyzed 170 samples from 10 municipalities in the states of Rondonia, Para and Roraima. A total of 194 alleles was observed, with an average of 12.1 alleles per locus. Higher levels of expected (H-E) than observed (H-O) heterozygosities were found for all populations. Bayesian analysis, Neighbor-Joining dendrograms and PCAs suggest the existence of three strongly structured groups of populations. A strong and positive correlation between genetic and geographic distances was found, suggesting that genetic differentiation might be caused by geographic isolation. From species distribution modelling, we detected that South Rondonia, Madre di Dios River basin, Llanos de Mojos, Llanos de Orinoco and eastern Ecuador are highly suitable areas for wild annatto to occur, providing additional targets for future exploration and conservation. Climatic adaptation analyses revealed strong differentiation among populations, suggesting that precipitation plays a key role in wild annatto's current and potential distribution patterns.	[Dequigiovanni, Gabriel; Alves-Pereira, Alessandro; Veasey, Elizabeth Ann] Univ Sao Paulo, ESALQ, Dept Genet, Piracicaba, SP, Brazil; [Ferreyra Ramos, Santiago Linorio] Univ Fed Amazonas, Inst Ciencias Exatas & Tecnol Itacoatiara, Itacoatiara, Amazonas, Brazil; [Fabri, Eliane Gomes] Inst Agron Campinas, Ctr Hort, Campinas, SP, Brazil; [Picanco-Rodrigues, Doriane] Univ Fed Amazonas ICB UFAM, Inst Ciencias Biol, Manaus, Amazonas, Brazil; [Clement, Charles Roland] INPA, Manaus, Amazonas, Brazil; [Gepts, Paul] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Universidade de Sao Paulo; Universidade Federal de Amazonas; Instituto Agronomico de Campinas (IAC); Institute Nacional de Pesquisas da Amazonia; University of California System; University of California Davis	Veasey, EA (corresponding author), Univ Sao Paulo, ESALQ, Dept Genet, Piracicaba, SP, Brazil.	eaveasey@usp.br	Alves-Pereira, Alessandro/I-6595-2012; Clement, Charles Roland/G-6081-2010; Gepts, Paul/O-8229-2019; Veasey, Elizabeth A/L-6843-2018; Ramos, Santiago Linorio Ferreyra/AAL-9978-2021; Veasey, Elizabeth/C-4511-2012	Alves-Pereira, Alessandro/0000-0002-3012-6355; Clement, Charles Roland/0000-0002-8421-1029; Gepts, Paul/0000-0002-1056-4665; Ramos, Santiago Linorio Ferreyra/0000-0003-0364-316X; Veasey, Elizabeth/0000-0002-7574-2020; Dequigiovanni, Gabriel/0000-0002-8093-8749	Sao Paulo Research Foundation (FAPESP) [2015/26837-0, 2012/08307-5]; National Council for Scientific and Technological Development (CNPq) CT Amazonia [575588/2008-0]; FAPESP [2013/08884-5, 2016/05912-6]; Coordination for the Improvement of Higher Education Personnel (CAPES); CNPq	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq) CT Amazonia(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This project was financially supported by the Sao Paulo Research Foundation (FAPESP) (2015/26837-0; 2012/08307-5) and by the National Council for Scientific and Technological Development (CNPq) CT Amazonia (575588/2008-0). G.D. was supported by FAPESP with PhD scholarships (2013/08884-5; 2016/05912-6). A.A. P. thanks the Coordination for the Improvement of Higher Education Personnel (CAPES) for a postdoctoral scholarship. E.A.V. and C.R.C. were supported by CNPq research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was financially supported by the Sao Paulo Research Foundation (FAPESP) (2011/10357-8; 2012/08307-5) and by the National Council for Scientific and Technological Development (CNPq) CT Amazonia (575588/2008-0). G. D. was supported by FAPESP with PhD scholarships (2013/08884-5; 2016/05912-6). A.A.P. thanks the Coordination for the Improvement of Higher Education Personnel (CAPES) for a post-doctoral scholarship. E.A.V. and C.R.C. were supported by CNPq research fellowships.	Akshatha V, 2011, J HORTIC SCI BIOTECH, V86, P319, DOI 10.1080/14620316.2011.11512767; Arce J., 1999, EARTH, P149; Baer D, 1976, THESIS; Barthem R., 2003, AQUATIC ECOLOGY RIO; Bonatelli IAS, 2014, MOL ECOL, V23, P3044, DOI 10.1111/mec.12780; Vieira MLC, 2016, GENET MOL BIOL, V39, P312, DOI 10.1590/1678-4685-GMB-2016-0027; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Clement C. R., 2010, Diversity, V2, P72; Clement Charles Roland, 2016, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V11, P193, DOI 10.1590/1981.81222016000100010; Clement CR, 1999, ECON BOT, V53, P188, DOI 10.1007/BF02866498; d'Eeckenbrugge GC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107458; de Carvalho JFRP, 2005, PESQUI AGROPECU BRAS, V40, P653, DOI 10.1590/S0100-204X2005000700005; Dequigiovani G, 2017, GENET RESOUR CROP EV, V64, P1775, DOI 10.1007/s10722-017-0535-z; Dequigiovanni G, 2014, GENET MOL RES, V13, P9097, DOI 10.4238/2014.October.31.25; Dequigiovanni G, 2018, CROP BREED APPL BIOT; Dias F, 2008, U FEDERAL SANTA MARI, V38, P534, DOI [10.1590/S0103-84782008000200039, DOI 10.1590/S0103-84782008000200039]; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Ducke A., 1946, B I AGRONOMICO NORTE, V8, P1; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Erickson CL, 1995, ARCHAEOLOGY LOWLAND, P66; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gepts P., 2004, Plant Breeding Reviews, V24, P1, DOI 10.1002/9780470650288.ch1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; *INPE, 2002, MON BRAZ AM FOR SAT; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jose AR, 1992, REV BRASILEIRA CORAN, V1, P101; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kuntze C., 1925, NATURL PFLANZ, P315; Leal F, 2010, REV UNELL CIENC TEC, V1, P78; Levis C, 2017, SCIENCE, V355, P925, DOI 10.1126/science.aal0157; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Manel S, 2010, MOL ECOL, V19, P3824, DOI 10.1111/j.1365-294X.2010.04716.x; Medina Ada Maureen, 2001, Acta Cientifica Venezolana, V52, P14; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Meyer RS, 2012, NEW PHYTOL, V196, P29, DOI 10.1111/j.1469-8137.2012.04253.x; Moreira PA, 2015, ECON BOT, V69, P127, DOI 10.1007/s12231-015-9304-0; Nisar N, 2015, MOL PLANT, V8, P68, DOI 10.1016/j.molp.2014.12.007; Olsen KM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00290; Osher LJ, 1998, GEODERMA, V83, P143, DOI 10.1016/S0016-7061(97)00133-X; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peres EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121543; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; de Menezes IPP, 2014, GENETICA, V142, P99, DOI 10.1007/s10709-014-9757-6; Piperno D.R., 1998, ORIGINS AGR LOWLAND; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2013, R LANG ENV STAT COMP; Reif JC, 2005, CROP SCI, V45, P1, DOI 10.2135/cropsci2005.0001; Reusch TBH, 2007, MOL ECOL, V16, P3973, DOI 10.1111/j.1365-294X.2007.03454.x; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Rivera-Madrid R, 2006, SCI HORTIC-AMSTERDAM, V109, P165, DOI 10.1016/j.scienta.2006.03.011; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandy-Cuen PM, 2003, BIODIVERSITAS, V7, P7; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schultes RE., 1984, PRECOLUMBIAN PLANT M, V76, P19; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; Stefano R, 2006, NEOTROPICAL SAVANNAS, P96; Valdez-Ojeda R, 2008, HORTSCIENCE, V43, P2013, DOI 10.21273/HORTSCI.43.7.2013; Valdez-Ojeda R, 2010, AGRON J, V102, P1340, DOI 10.2134/agronj2009.0510; VENCOVSKY R, 1994, REV BRAS GENET, V17, P349; Walker JH, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P927, DOI 10.1007/978-0-387-74907-5_46; Wang T, 2016, SCI REP-UK, V6, DOI 10.1038/srep25031; Wiens JJ, 2011, PHILOS T R SOC B, V366, P2336, DOI 10.1098/rstb.2011.0059; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wright S, 1931, GENETICS, V16, P0097	72	8	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198593	10.1371/journal.pone.0198593	http://dx.doi.org/10.1371/journal.pone.0198593			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874280	Green Published, gold, Green Submitted			2022-12-26	WOS:000434369400052
J	Rahman, Z; Hashim, F; Rasid, MFA; Othman, M				Rahman, Ziaur; Hashim, Fazirulhisyam; Rasid, Mohd Fadlee A.; Othman, Mohamed			Totally opportunistic routing algorithm (TORA) for underwater wireless sensor network	PLOS ONE			English	Article							PROTOCOLS	Underwater Wireless Sensor Network (UWSN) has emerged as promising networking techniques to monitor and explore oceans. Research on acoustic communication has been conducted for decades, but had focused mostly on issues related to physical layer such as high latency, low bandwidth, and high bit error. However, data gathering process is still severely limited in UWSN due to channel impairment. One way to improve data collection in UWSN is the design of routing protocol. Opportunistic Routing (OR) is an emerging technique that has the ability to improve the performance of wireless network, notably acoustic network. In this paper, we propose an anycast, geographical and totally opportunistic routing algorithm for UWSN, called TORA. Our proposed scheme is designed to avoid horizontal transmission, reduce end to end delay, overcome the problem of void nodes and maximize throughput and energy efficiency. We use TOA (Time of Arrival) and range based equation to localize nodes recursively within a network. Once nodes are localized, their location coordinates and residual energy are used as a matrix to select the best available forwarder. All data packets may or may not be acknowledged based on the status of sender and receiver. Thus, the number of acknowledgments for a particular data packet may vary from zero to 2-hop. Extensive simulations were performed to evaluate the performance of the proposed scheme for high network traffic load under very sparse and very dense network scenarios. Simulation results show that TORA significantly improves the network performance when compared to some relevant existing routing protocols, such as VBF, HHVBF, VAPR, and H2DAB, for energy consumption, packet delivery ratio, average end-to-end delay, average hop-count and propagation deviation factor. TORA reduces energy consumption by an average of 35% of VBF, 40% of HH-VBF, 15% of VAPR, and 29% of H2DAB, whereas the packet delivery ratio has been improved by an average of 43% of VBF, 26% of HH-VBF, 15% of VAPR, and 25% of H2DAB. Moreover, the average end-to-end delay has been reduced by 70% of VBF, 69% of HH-VBF, 46% of VAPR, and 73% of H2DAB. Furthermore, average hope-count has been improved by 57%, 53%, 16% and 31% as compared to VBF, HHVBF, VAPR, and H2DAB, respectively. Also, propagation delay has been reduced by 34%, 30%, 15% and 23% as compared to VBF, HHVBF, VAPR, and H2DAB, respectively.	[Rahman, Ziaur; Hashim, Fazirulhisyam; Rasid, Mohd Fadlee A.] Univ Putra Malaysia, Fac Engn, Serdang, Selangor Darul, Malaysia; [Othman, Mohamed] Univ Putra Malaysia, Fac Comp Sci & Info Tech, Serdang, Selangor Darul, Malaysia; [Hashim, Fazirulhisyam; Rasid, Mohd Fadlee A.] Univ Putra Malaysia, Res Ctr Excellence Wireless & Photon Networks WiP, Serdang, Selangor Darul, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Rahman, Z (corresponding author), Univ Putra Malaysia, Fac Engn, Serdang, Selangor Darul, Malaysia.	ziaur.buner@gmail.com	Othman, Mohamed/N-6888-2015	Rahman, Ziaur/0000-0001-7217-602X	Universiti Putra Malaysia [GP-IPS/ 2014/9449200]	Universiti Putra Malaysia	This work was funded by the Universiti Putra Malaysia under Grant Agreement GP-IPS/ 2014/9449200. There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyildiz I. F., 2005, Ad Hoc Networks, V3, P257, DOI 10.1016/j.adhoc.2005.01.004; Akyildiz I. F., 2004, SIGBED REV, V1, P3, DOI DOI 10.1145/1121776.1121779; Ayaz M, 2012, COMPUT COMMUN, V35, P475, DOI 10.1016/j.comcom.2011.11.014; Ayaz M, 2011, J NETW COMPUT APPL, V34, P1908, DOI 10.1016/j.jnca.2011.06.009; Biswas S, 2005, ACM SIGCOMM COMP COM, V35, P133, DOI 10.1145/1090191.1080108; Boukerche A, 2015, ACM COMPUT SURV, V47, DOI 10.1145/2635675; Boukerche A, 2011, COMPUT NETW, V55, P3032, DOI 10.1016/j.comnet.2011.05.010; Darehshoorzadeh A, 2014, COMP COMM ISCC 2014; Darehshoorzadeh A, 2015, IEEE COMMUN MAG, V53, P98, DOI 10.1109/MCOM.2015.7321977; Das AP, 2015, ADVANCES IN COMPUTIN; Diao BY, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/781932; Han GJ, 2015, IEEE COMMUN MAG, V53, P72, DOI 10.1109/MCOM.2015.7321974; Ibrahim D. M., 2014, 10 INT C WIR MOB COM; Jiang JF, 2016, J NETW COMPUT APPL, V59, P4, DOI 10.1016/j.jnca.2015.01.005; Leroy CC, 1998, J ACOUST SOC AM, V103, P1346, DOI 10.1121/1.421275; Liu LF, 2012, J NETW COMPUT APPL, V35, P1953, DOI 10.1016/j.jnca.2012.07.017; Nicolaou Nicoletta, 2007, OCEANS 2007 EUROPE; Noh Y, 2013, IEEE T MOBILE COMPUT, V12, P895, DOI 10.1109/TMC.2012.53; Nowsheen N, 2014, NETW COMP APPL NCA 2; Wang K, 2016, IEEE SENS J, V16, P4051, DOI 10.1109/JSEN.2015.2428712; Xie P, 2006, INT C RES NETW; Yan Hai, 2008, INT C RES NETW; Zeng D, 2013, CHIN C WIR SENS NETW	23	30	31	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197087	10.1371/journal.pone.0197087	http://dx.doi.org/10.1371/journal.pone.0197087			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874237	Green Published, Green Submitted, gold			2022-12-26	WOS:000434369400011
J	Chintaluri, K; Goulden, BD; Celmenza, C; Saffi, G; Miraglia, E; Hammond, GRV; Botelho, RJ				Chintaluri, Krishna; Goulden, Brady D.; Celmenza, Camilyn; Saffi, Golam; Miraglia, Emily; Hammond, Gerald R., V; Botelho, Roberto J.			The PH domain from the Toxoplasma gondii PH-containing protein-1 (TgPH1) serves as an ectopic reporter of phosphatidylinositol 3-phosphate in mammalian cells	PLOS ONE			English	Article							PX DOMAIN; BINDING; KINASE; PHOSPHOINOSITIDES; PIKFYVE; 4,5-BISPHOSPHATE; LOCALIZATION; INHIBITOR; REVEALS; MYOTUBULARIN	Phosphoinositide (PtdlnsP) lipids recruit effector proteins to membranes to mediate a variety of functions including signal transduction and membrane trafficking. Each PtdlnsP binds to a specific set of effectors through characteristic protein domains such as the PH, FYVE and PX domains. Domains with high affinity for a single PtdlnsP species are useful as probes to visualize the distribution and dynamics of that PtdlnsP. The endolysosomal system is governed by two primary PtdlnsPs: phosphatidylinositol 3-phosphate [Ptdlns(3)P] and phosphatidylinositol 3,5-bisphosphate [Ptdlns(3,5)P-2], which are thought to localize and control early endosomes and lysosomes/late endosomes, respectively. While Ptdlns(3)P has been analysed with mammalian-derived PX and FYVE domains, Ptdlns(3,5)P-2 indicators remain controversial. Thus, complementary probes against these PtdlnsPs are needed, including those originating from non-mammalian proteins. Here, we characterized in mammalian cells the dynamics of the PH domain from PH-containing protein-1 from the parasite Toxoplasma gondii (TgPH1), which was previously shown to bind Ptdlns(3,5)P-2 in vitro. However, we show that TgPH1 retains membrane-binding in PlKfyve-inhibited cells, suggesting that TgPH1 is not a viable Ptdlns(3,5)P-2 marker in mammalian cells. Instead, Ptdlns (3)P depletion using pharmacological and enzyme-based assays dissociated TgPH1 from membranes. Indeed, TgPH1 co-localized with Rab5-positive early endosomes. In addition, TgPH1 co-localized and behaved similarly to the PX domain of p40phox and FYVE domain of EEA1, which are commonly used as Ptdlns(3)P indicators. Collectively, TgPH1 offers a complementary reporter for Ptdlns(3)P derived from a non-mammalian protein and that is distinct from commonly employed PX and FYVE domain-based probes.	[Chintaluri, Krishna; Saffi, Golam; Miraglia, Emily; Botelho, Roberto J.] Ryerson Univ, Dept Chem, Toronto, ON, Canada; [Chintaluri, Krishna; Saffi, Golam; Botelho, Roberto J.] Ryerson Univ, Mol Sci Grad Program, Toronto, ON, Canada; [Goulden, Brady D.; Celmenza, Camilyn; Hammond, Gerald R., V] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA	Toronto Metropolitan University; Toronto Metropolitan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Botelho, RJ (corresponding author), Ryerson Univ, Dept Chem, Toronto, ON, Canada.; Botelho, RJ (corresponding author), Ryerson Univ, Mol Sci Grad Program, Toronto, ON, Canada.; Hammond, GRV (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA.	ghammond@pitt.edu	Hammond, Gerald R/A-5759-2016; Botelho, Roberto/B-9145-2013	Hammond, Gerald R/0000-0002-6660-3272; Botelho, Roberto/0000-0002-7820-0999; Goulden, Brady/0000-0002-1954-2091	Natural Sciences and Engineering Council of Canada; Ministry of Research and Innovation from the Government of Ontario; Canada Research Chair Award; National Institutes of Health [1R35GM119412-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119412] Funding Source: NIH RePORTER	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ministry of Research and Innovation from the Government of Ontario; Canada Research Chair Award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Discovery grant from the Natural Sciences and Engineering Council of Canada, an Early Researcher Award from the Ministry of Research and Innovation from the Government of Ontario, a Canada Research Chair Award, contributions by Ryerson University to R.J.B., National Institutes of Health grant 1R35GM119412-01 and the Department of Cell Biology, University of Pittsburgh to G.R.V.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bago R, 2014, BIOCHEM J, V463, P413, DOI 10.1042/BJ20140889; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Balla T, 2007, J PHYSIOL-LONDON, V582, P927, DOI 10.1113/jphysiol.2007.132795; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Botelho RJ, 2008, MOL BIOL CELL, V19, P4273, DOI 10.1091/mbc.E08-04-0405; Cai XM, 2013, CHEM BIOL, V20, P912, DOI 10.1016/j.chembiol.2013.05.010; Daher W, 2016, MOL BIOCHEM PARASIT, V207, P39, DOI 10.1016/j.molbiopara.2016.03.011; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; Ellson CD, 2001, CURR BIOL, V11, P1631, DOI 10.1016/S0960-9822(01)00447-X; Fili N, 2006, P NATL ACAD SCI USA, V103, P15473, DOI 10.1073/pnas.0607040103; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hammond GRV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139957; Hammond GRV, 2015, BBA-MOL CELL BIOL L, V1851, P746, DOI 10.1016/j.bbalip.2015.02.013; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; He J, 2011, J BIOL CHEM, V286, P18650, DOI 10.1074/jbc.M111.233015; Ho CY, 2015, J BIOL CHEM, V290, P9919, DOI 10.1074/jbc.M114.613984; Ho CY, 2012, TRAFFIC, V13, P1, DOI 10.1111/j.1600-0854.2011.01246.x; Idevall-Hagren O, 2015, BBA-MOL CELL BIOL L, V1851, P736, DOI 10.1016/j.bbalip.2014.12.008; Ikonomov OC, 2002, J BIOL CHEM, V277, P9206, DOI 10.1074/jbc.M108750200; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Jean S, 2012, NAT REV MOL CELL BIO, V13, P463, DOI 10.1038/nrm3379; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kim SM, 2016, J CLIN INVEST, V126, P4088, DOI 10.1172/JCI87148; Kong AM, 2000, J BIOL CHEM, V275, P24052, DOI 10.1074/jbc.M000874200; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Lenk GM, 2014, METHOD ENZYMOL, V534, P245, DOI 10.1016/B978-0-12-397926-1.00014-7; Li XR, 2013, P NATL ACAD SCI USA, V110, P21165, DOI 10.1073/pnas.1311864110; Liu YZ, 2014, STRUCTURE, V22, P421, DOI 10.1016/j.str.2013.12.011; Lucas N, 2011, J BIOL CHEM, V286, P41265, DOI 10.1074/jbc.M111.300806; McCartney AJ, 2014, BIOESSAYS, V36, P52, DOI 10.1002/bies.201300012; McCrea HJ, 2009, PHYSIOLOGY, V24, P8, DOI 10.1152/physiol.00035.2008; Nakamura S, 2016, AUTOPHAGY, V12, P2500, DOI 10.1080/15548627.2016.1234568; Oatey PB, 1999, BIOCHEM J, V344, P511, DOI 10.1042/0264-6021:3440511; Quinn KV, 2008, J PHYSIOL-LONDON, V586, P2855, DOI 10.1113/jphysiol.2008.153791; Raiborg C, 2001, J CELL SCI, V114, P2255; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Schaletzky J, 2003, CURR BIOL, V13, P504, DOI 10.1016/S0960-9822(03)00132-5; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Song X, 2001, BIOCHEMISTRY-US, V40, P8940, DOI 10.1021/bi0155100; Stahelin RV, 2014, CHEM PHYS LIPIDS, V182, P3, DOI 10.1016/j.chemphyslip.2014.02.002; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Varnai P, 2017, CELL CALCIUM, V64, P72, DOI 10.1016/j.ceca.2016.12.008; Vicinanza M, 2008, CELL MOL LIFE SCI, V65, P2833, DOI 10.1007/s00018-008-8353-2; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069	57	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0198454	10.1371/journal.pone.0198454	http://dx.doi.org/10.1371/journal.pone.0198454			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870544	gold, Green Published, Green Submitted			2022-12-26	WOS:000434128400023
J	Desguin, B; Fellner, M; Riant, O; Hu, J; Hausinger, RP; Hols, P; Soumillion, P				Desguin, Benoit; Fellner, Matthias; Riant, Olivier; Hu, Jian; Hausinger, Robert P.; Hols, Pascal; Soumillion, Patrice			Biosynthesis of the nickel-pincer nucleotide cofactor of lactate racemase requires a CTP-dependent cyclometallase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial metabolism; nickel; lactic acid; natural product biosynthesis; protein structure; cyclometalation; lactate racemase; pincer complex	CONTROLLED GENE-EXPRESSION; ESCHERICHIA-COLI; LACTOCOCCUS-LACTIS; PROTEIN; BINDING; SYSTEM; TRANSFORMATION	Bacterial lactate racemase is a nickel-dependent enzyme that contains a cofactor, nickel pyridinium-3,5-bisthiocarboxylic acid mononucleotide, hereafter named nickel-pincer nucleotide (NPN). The LarC enzyme from the bacterium Lactobacillus plantarum participates in NPN biosynthesis by inserting nickel ion into pyridinium-3,5-bisthiocarboxylic acid mononucleotide. This reaction, known in organometallic chemistry as a cyclometalation, is characterized by the formation of new metal-carbon and metal-sulfur sigma bonds. LarC is therefore the first cyclometallase identified in nature, but the molecular mechanism of LarC-catalyzed cyclometalation is unknown. Here, we show that LarC activity requires Mn2+-dependent CTP hydrolysis. The crystal structure of the C-terminal domain of LarC at 1.85 resolution revealed a hexameric ferredoxin-like fold and an unprecedented CTP-binding pocket. The loss-of-function of LarC variants with alanine variants of acidic residues leads us to propose a carboxylate-assisted mechanism for nickel insertion. This work also demonstrates the in vitro synthesis and purification of the NPN cofactor, opening new opportunities for the study of this intriguing cofactor and of NPN-utilizing enzymes.	[Desguin, Benoit; Hols, Pascal; Soumillion, Patrice] Catholic Univ Louvain, Inst Life Sci, B-1348 Louvain La Neuve, Belgium; [Riant, Olivier] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain La Neuve, Belgium; [Fellner, Matthias; Hu, Jian; Hausinger, Robert P.] Michigan State Univ, Dept Biochem & Mol Genet, E Lansing, MI 48824 USA; [Hu, Jian] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Hausinger, Robert P.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Hols, Pascal] Fond Natl Rech Sci, Liege, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Michigan State University; Michigan State University; Michigan State University; Fonds de la Recherche Scientifique - FNRS	Desguin, B (corresponding author), BBGM ISV, Croix Sud 4-5 Bte L7-07-06, B-1348 Louvain La Neuve, Belgium.	benoit.desguin@uclouvain.be	riant, olivier/AAU-3567-2021; Fellner, Matthias/AFL-6357-2022; Fellner, Matthias/AAG-6443-2022	Fellner, Matthias/0000-0003-3192-6984; Fellner, Matthias/0000-0003-3192-6984; Hausinger, Robert/0000-0002-3643-2054; Desguin, Benoit/0000-0002-5004-6918; riant, olivier/0000-0003-4852-6469	National Science Foundation [CHE-1516126]; Fond National de la Recherche Scientifique; Belgian French Community Actions de Recherche Concertees Programme	National Science Foundation(National Science Foundation (NSF)); Fond National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Belgian French Community Actions de Recherche Concertees Programme	This work was supported by National Science Foundation Grant CHE-1516126 (to R. P. H. and J. H.) and by Fond National de la Recherche Scientifique and Belgian French Community Actions de Recherche Concertees Programme (to P. S. and P. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht M, 2010, CHEM REV, V110, P576, DOI 10.1021/cr900279a; ARCHIBALD F, 1986, CRC CR REV MICROBIOL, V13, P63, DOI 10.3109/10408418609108735; Boer JL, 2014, ARCH BIOCHEM BIOPHYS, V544, P142, DOI 10.1016/j.abb.2013.09.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caliskan N, 2015, TRENDS BIOCHEM SCI, V40, P265, DOI 10.1016/j.tibs.2015.03.006; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Desguin B, 2016, P NATL ACAD SCI USA, V113, P5598, DOI 10.1073/pnas.1600486113; Desguin B, 2015, SCIENCE, V349, P66, DOI 10.1126/science.aab2272; Desguin B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4615; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fellner M, 2017, P NATL ACAD SCI USA, V114, P9074, DOI 10.1073/pnas.1704967114; Fujishiro T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7895; Fujishiro T, 2014, FEBS LETT, V588, P2789, DOI 10.1016/j.febslet.2014.05.059; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; KAMBEROV ES, 1995, J BIOL CHEM, V270, P17797, DOI 10.1074/jbc.270.30.17797; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lecerof D, 2003, J BIOL INORG CHEM, V8, P452, DOI 10.1007/s00775-002-0436-1; McCall KA, 2000, ANAL BIOCHEM, V284, P307, DOI 10.1006/abio.2000.4706; Orzel L, 2008, CHEM-EUR J, V14, P9419, DOI 10.1002/chem.200800991; Palanca C, 2017, ENV MICROBIOL REP, V9, P290, DOI 10.1111/1758-2229.12533; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Sigel R.K.O., 2007, NICKEL ITS SURPRISIN, P109; Sparta KM, 2016, J APPL CRYSTALLOGR, V49, P1085, DOI 10.1107/S1600576716004416; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Zhang GY, 2009, APPL ENVIRON MICROB, V75, P1080, DOI 10.1128/AEM.01416-08; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zheng ZJ, 2016, NUCLEIC ACIDS RES, V44, pD301, DOI 10.1093/nar/gkv1124	34	19	19	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12303	12317		10.1074/jbc.RA118.003741	http://dx.doi.org/10.1074/jbc.RA118.003741			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29887527	hybrid, Green Published			2022-12-26	WOS:000441408500001
J	Pavlova, AV; Muthuri, SG; Cooper, R; Saunders, FR; Gregory, JS; Barr, RJ; Martin, KR; Adams, JE; Kuh, D; Hardy, RJ; Aspden, RM				Pavlova, Anastasia, V; Muthuri, Stella G.; Cooper, Rachel; Saunders, Fiona R.; Gregory, Jennifer S.; Barr, Rebecca J.; Martin, Kathryn R.; Adams, Judith E.; Kuh, Diana; Hardy, Rebecca J.; Aspden, Richard M.			Body mass index and waist circumference in early adulthood are associated with thoracolumbar spine shape at age 60-64: The Medical Research Council National Survey of Health and Development	PLOS ONE			English	Article							EARLY OLD-AGE; LOW-BACK-PAIN; HUMAN LUMBAR SPINE; SAGITTAL ALIGNMENT; LORDOSIS; GROWTH; PELVIS; BONE; CLASSIFICATION; MORPHOLOGY	This study investigated associations between measures of adiposity from age 36 and spine shape at 60-64 years. Thoracolumbar spine shape was characterised using statistical shape modelling on lateral dual-energy x-ray absorptiometry images of the spine from 1529 participants of the MRC National Survey of Health and Development, acquired at age 60-64. Associations of spine shape modes with: 1) contemporaneous measures of total and central adiposity (body mass index (BMI), waist circumference (WC)) and body composition (android:gynoid fat mass ratio and lean and fat mass indices, calculated as whole body (excluding the head) lean or fat mass (kg) divided by height(2) (m)(2)); 2) changes in total and central adiposity between age 36 and 60-64 and 3) age at onset of overweight, were tested using linear regression models. Four modes described 79% of the total variance in spine shape. In men, greater lean mass index was associated with a larger lordosis whereas greater fat mass index was associated with straighter spines. Greater current BMI was associated with a more uneven curvature in men and with larger anterior-posterior (a-p) vertebral diameters in both sexes. Greater WC and fat mass index were also associated with ap diameter in both sexes. There was no clear evidence that gains in BMI and WC during earlier stages of adulthood were associated with spine shape but younger onset of overweight was associated with a more uneven spine and greater a-p diameter. In conclusion, sagittal spine shapes had different associations with total and central adiposity; earlier onset of overweight and prior measures of WC were particularly important.	[Pavlova, Anastasia, V; Saunders, Fiona R.; Gregory, Jennifer S.; Barr, Rebecca J.; Martin, Kathryn R.; Aspden, Richard M.] Univ Aberdeen, Sch Med Med Sci & Nutr, Arthrit & Musculoskeletal Med, Aberdeen, Scotland; [Muthuri, Stella G.; Cooper, Rachel; Kuh, Diana; Hardy, Rebecca J.] UCL, MRC Unit Lifelong Hlth & Ageing, London, England; [Barr, Rebecca J.] Univ Dundee, Sch Med, Div Mol & Clin Med, Med Monitoring Unit MEMO, Dundee, Scotland; [Adams, Judith E.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Royal Infirm, Manchester, Lancs, England	University of Aberdeen; University of London; University College London; University of Dundee; University of Manchester	Aspden, RM (corresponding author), Univ Aberdeen, Sch Med Med Sci & Nutr, Arthrit & Musculoskeletal Med, Aberdeen, Scotland.	r.aspden@abdn.ac.uk	Kuh, Diana/L-6019-2014; Cooper, Rachel/ABE-3768-2021; Hardy, Rebecca/AFR-1989-2022; Saunders, Fiona/AAO-8227-2020; Saunders, Fiona R/B-6302-2012	Kuh, Diana/0000-0001-7386-2857; Cooper, Rachel/0000-0003-3370-5720; Saunders, Fiona/0000-0001-7130-6777; Saunders, Fiona R/0000-0001-7130-6777; Gregory, Jennifer/0000-0002-6328-4560; Barr, Rebecca/0000-0003-4820-4240; Hardy, Rebecca/0000-0001-9949-0799; Muthuri, Stella/0000-0003-0987-7450; Pavlova, Anastasia/0000-0002-1633-3411	UK Medical Research Council; UK Medical Research Council [MC_UU_12019/1, MC_UU_12019/2, MC_UU_12019/4, MR/L010399/1]; MRC [MC_UU_12019/1, MC_UU_12019/4, MR/L010399/1, MC_UU_12019/2] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The National Survey of Health and Development is funded by the UK Medical Research Council (www.mrc.ac.uk) which had no influence on this study or preparation of this manuscript. SGM, RC, RJH and DK are supported by the UK Medical Research Council (Programme codes: MC_UU_12019/1 (Prof Diana Kuh), MC_UU_12019/2 (Prof Rebecca Hardy) and MC_UU_12019/4 (Dr Rachel Coper and Prof Diana Kuh)). This project was funded by the UK Medical Research Council (Grant MR/L010399/1 (Prof Richard Aspden)) which supported SGM, AVP and FRS.	Akosile CO, 2013, J PHYS THER, V8, P18; Ali AHA, 2012, COMPUT METHOD BIOMEC, V15, P167, DOI 10.1080/10255842.2010.518962; Bann D, 2014, INT J OBESITY, V38, P69, DOI 10.1038/ijo.2013.115; Been E, 2014, SPINE J, V14, P87, DOI 10.1016/j.spinee.2013.07.464; Boulay C, 2006, EUR SPINE J, V15, P415, DOI 10.1007/s00586-005-0984-5; Cil A, 2005, SPINE, V30, P93, DOI 10.1097/01.brs.0000149074.21550.32; Cooper R, 2014, J GERONTOL A-BIOL, V69, P1253, DOI 10.1093/gerona/glu039; Delisle A, 1997, IEEE Trans Rehabil Eng, V5, P360, DOI 10.1109/86.650290; Gonzalez-Sanchez M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/935151; Guo Jin-Ming, 2008, Zhongguo Gu Shang, V21, P30; Kuh D, 2014, J BONE MINER RES, V29, P123, DOI 10.1002/jbmr.2008; Kuh Diana, 2011, Int J Epidemiol, V40, pe1, DOI 10.1093/ije/dyq231; Lazennec JY, 2011, CLIN ORTHOP RELAT R, V469, P1103, DOI 10.1007/s11999-010-1732-7; Masharawi Y, 2012, SPINE, V37, P501, DOI 10.1097/BRS.0b013e3182241b04; Meakin JR, 2008, SPINE, V33, P807, DOI 10.1097/BRS.0b013e31816949e6; Meakin JR, 2009, J ANAT, V215, P206, DOI 10.1111/j.1469-7580.2009.01102.x; Milgrom C, 2000, J BONE JOINT SURG BR, V82B, P591, DOI 10.1302/0301-620X.82B4.9677; O'Sullivan P, 2004, GRIEVES MODERN MANUA; Onyemaechi NOC, 2016, PATIENT PREFER ADHER, V10, P291, DOI 10.2147/PPA.S90967; Pavlova AV, 2017, J ANAT, V231, P248, DOI 10.1111/joa.12631; Pavlova Anastasia V, 2014, Eur Spine J, V23 Suppl 1, pS26, DOI 10.1007/s00586-013-3162-1; Pezolato A, 2012, EUR SPINE J, V21, P2158, DOI 10.1007/s00586-012-2286-z; Romero-Vargas S, 2013, EUR SPINE J, V22, P878, DOI 10.1007/s00586-012-2560-0; Roussouly P, 2005, SPINE, V30, P346, DOI 10.1097/01.brs.0000152379.54463.65; Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Smith A, 2008, SPINE, V33, P2101, DOI 10.1097/BRS.0b013e31817ec3b0; Taweetanalarp S, 2015, J PHYS THER SCI, V27, P2343, DOI 10.1589/jpts.27.2343; Urquhart DM, 2011, SPINE, V36, P1320, DOI 10.1097/BRS.0b013e3181f9fb66; Vaz G, 2002, EUR SPINE J, V11, P80, DOI 10.1007/s005860000224; von Stengel S, 2007, BRIT J SPORT MED, DOI [10.1136/0062006.033480, DOI 10.1136/0062006.033480]; von Stengel S, 2007, BRIT J SPORT MED, V41, P649, DOI 10.1136/bjsm.2006.033480; Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201; Whitcome KK, 2007, NATURE, V450, P1075, DOI 10.1038/nature06342; Youdas James W., 2006, Physiotherapy Theory and Practice, V22, P229, DOI 10.1080/09593980600927864	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0197570	10.1371/journal.pone.0197570	http://dx.doi.org/10.1371/journal.pone.0197570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902185	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000435424900006
J	Arai, S; Iwabuchi, N; Takahashi, S; Xiao, JZ; Abe, F; Hachimura, S				Arai, Satoshi; Iwabuchi, Noriyuki; Takahashi, Sachiko; Xiao, Jin-zhong; Abe, Fumiaki; Hachimura, Satoshi			Orally administered heat-killed Lactobacillus paracasei MCC1849 enhances antigen-specific IgA secretion and induces follicular helper T cells in mice	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; B-CELLS; DENDRITIC CELLS; IMMUNE HOMEOSTASIS; VIRUS-INFECTION; RESPONSES; DEFENSE; DIFFERENTIATION; GENERATION; MICROBIOTA	Antigen-specific immunoglobulin (Ig) A plays a major role in host defense against infections in gut mucosal tissue. Follicular helper T (Tfh) cells are located in germinal centers and promote IgA production via interactions with germinal center B cells. Several studies have demonstrated that some lactic acid bacteria (LAB) strains activate the host's acquired immune system, inducing IgA secretion in the intestine. However, the precise molecular mechanisms underlying the effects of LAB on IgA production and Tfh cells are not fully resolved. Lactobacillus paracasei MCC1849 is a probiotic strain isolated from the intestine of a healthy adult. In this study, we investigated the effects of orally administered heat-killed MCC1849 on IgA production in the intestine and on Tfh cell induction in vivo. We found that orally administered MCC1849 induced antigen-specific IgA production in the small intestine, serum and lungs. We also observed that MCC1849 increased the proportion of IgA(+) B cells and Tfh cells in Peyer's patches (PPs). In addition, MCC1849 increased the gene expression of IL-12p40, IL-10, IL-21, STAT4 and Bcl-6 associated with Tfh cell differentiation. These results suggest that orally administered MCC1849 enhances antigen-specific IgA production and likely affects Tfh cell differentiation in PPs.	[Arai, Satoshi; Iwabuchi, Noriyuki; Takahashi, Sachiko; Abe, Fumiaki] Morinaga Milk Ind Co Ltd, Food Ingredients & Technol Inst, Zama, Kanagawa, Japan; [Xiao, Jin-zhong] Morinaga Milk Ind Co Ltd, Next Generat Sci Inst, Zama, Kanagawa, Japan; [Hachimura, Satoshi] Univ Tokyo, Res Ctr Food Safety, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan	Morinaga Milk Industry Company, Ltd; Morinaga Milk Industry Company, Ltd; University of Tokyo	Arai, S (corresponding author), Morinaga Milk Ind Co Ltd, Food Ingredients & Technol Inst, Zama, Kanagawa, Japan.	s-arai@morinagamilk.co.jp			Morinaga Milk Industry Co., Ltd.	Morinaga Milk Industry Co., Ltd.	This work was funded by Morinaga Milk Industry Co., Ltd. S Arai, N. Iwabuchi, S. Takahashi, J-Z Xiao and F. Abe are employees of Morinaga Milk Industry Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki-Yoshida A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158643; Cao AT, 2015, MUCOSAL IMMUNOL, V8, P1072, DOI 10.1038/mi.2014.134; Carey CM, 2013, CAN J MICROBIOL, V59, P9, DOI 10.1139/cjm-2012-0446; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Farooq SM, 2014, BRAIN BEHAV IMMUN, V42, P118, DOI 10.1016/j.bbi.2014.06.010; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Fink LN, 2007, INT IMMUNOL, V19, P1319, DOI 10.1093/intimm/dxm103; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Iwabuchi N, 2012, FEMS IMMUNOL MED MIC, V66, P230, DOI 10.1111/j.1574-695X.2012.01003.x; Izumo Takayuki, 2011, Biosci Microflora, V30, P27, DOI 10.12938/bifidus.30.27; Johnson-Henry KC, 2008, INFECT IMMUN, V76, P1340, DOI 10.1128/IAI.00778-07; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Kato LM, 2014, IMMUNOL CELL BIOL, V92, P49, DOI 10.1038/icb.2013.54; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Kikuchi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086416; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Kunisawa J, 2005, CELL MOL LIFE SCI, V62, P1308, DOI 10.1007/s00018-005-5035-1; LAMM ME, 1995, APMIS, V103, P241, DOI 10.1111/j.1699-0463.1995.tb01101.x; Lee YN, 2013, ANTIVIR RES, V98, P284, DOI 10.1016/j.antiviral.2013.03.013; Lycke NY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00329; Maruyama M, 2016, INT J FOOD SCI NUTR, V67, P67, DOI 10.3109/09637486.2015.1126564; MCGHEE JR, 1991, IMMUNOL RES, V10, P418, DOI 10.1007/BF02919734; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Sakai F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105370; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; Shida K, 1998, INT ARCH ALLERGY IMM, V115, P278, DOI 10.1159/000069458; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Tezuka H, 2011, IMMUNITY, V34, P247, DOI 10.1016/j.immuni.2011.02.002; Tsai YT, 2012, APPL MICROBIOL BIOT, V96, P853, DOI 10.1007/s00253-012-4407-3; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Ventola H, 2012, WORLD J GASTROENTERO, V18, P5925, DOI 10.3748/wjg.v18.i41.5925; Xu W, 2008, J IMMUNOL, V181, P276, DOI 10.4049/jimmunol.181.1.276; Yanagibashi T, 2013, IMMUNOBIOLOGY, V218, P645, DOI 10.1016/j.imbio.2012.07.033; Zhang Y, 2016, IMMUNOL REV, V270, P8, DOI 10.1111/imr.12396	38	36	37	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0199018	10.1371/journal.pone.0199018	http://dx.doi.org/10.1371/journal.pone.0199018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897995	Green Submitted, Green Published, gold			2022-12-26	WOS:000435090700085
J	DeBruler, DM; Zbinden, JC; Baumann, ME; Blackstone, BN; Malara, MM; Bailey, JK; Supp, DM; Powell, HM				DeBruler, Danielle M.; Zbinden, Jacob C.; Baumann, Molly E.; Blackstone, Britani N.; Malara, Megan M.; Bailey, J. Kevin; Supp, Dorothy M.; Powell, Heather M.			Early cessation of pressure garment therapy results in scar contraction and thickening	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; HYPERTROPHIC SCARS; BURN INJURIES; MYOFIBROBLASTS; FIBROBLASTS; WOUNDS; SKIN	Pressure garment therapy is often prescribed to improve scar properties following full-thickness burn injuries. Pressure garment therapy is generally recommended for long periods of time following injury (1-2 years), though it is plagued by extremely low patient compliance. The goal of this study was to examine the effects of early cessation of pressure garment therapy on scar properties. Full-thickness burn injuries were created along the dorsum of red Duroc pigs. The burn eschar was excised and wound sites autografted with split-thickness skin. Scars were treated with pressure garments within 1 week of injury and pressure was maintained for either 29 weeks (continuous pressure) or for 17 weeks followed by cessation of pressure for an additional 12 weeks (pressure released); scars receiving no treatment served as controls. Scars that underwent pressure garment therapy were significantly smoother and less contracted with decreased scar height compared to control scars at 17 weeks. These benefits were maintained in the continuous pressure group until week 29. In the pressure released group, grafts significantly contracted and became more raised, harder and rougher after the therapy was discontinued. Pressure cessation also resulted in large changes in collagen fiber orientation and increases in collagen fiber thickness. The results suggest that pressure garment therapy effectively improves scar properties following severe burn injury; however, early cessation of the therapy results in substantial loss of these improvements.	[DeBruler, Danielle M.; Blackstone, Britani N.; Malara, Megan M.; Powell, Heather M.] Ohio State Univ, Dept Mat Sci & Engn, 116 W 19Th Ave, Columbus, OH 43210 USA; [Zbinden, Jacob C.; Baumann, Molly E.; Powell, Heather M.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Bailey, J. Kevin] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Bailey, J. Kevin] Ohio State Univ, Div Crit Care Trauma & Burns, Columbus, OH 43210 USA; [Bailey, J. Kevin; Supp, Dorothy M.; Powell, Heather M.] Shriners Hosp Children, Res Dept, Cincinnati, OH 45229 USA; [Supp, Dorothy M.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; University of Cincinnati	Powell, HM (corresponding author), Ohio State Univ, Dept Mat Sci & Engn, 116 W 19Th Ave, Columbus, OH 43210 USA.; Powell, HM (corresponding author), Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA.; Powell, HM (corresponding author), Shriners Hosp Children, Res Dept, Cincinnati, OH 45229 USA.	Powell.299@osu.edu	Supp, Dorothy/ABQ-7999-2022	Supp, Dorothy/0000-0002-2429-6630; Baumann, Molly/0000-0002-5462-405X; Powell, Heather/0000-0002-6845-8101	Shriners Research Foundation [85100]	Shriners Research Foundation	This work was funded by a basic science grant from the Shriners Research Foundation (#85100 to HMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Blackstone BN, 2017, WOUND REPAIR REGEN, V25, P618, DOI 10.1111/wrr.12562; CHEN CH, 2017, NANOMATERIALS-BASEL, V7, DOI DOI 10.3390/nano7080219; CLARK JA, 1987, J BIOMECH, V20, P397, DOI 10.1016/0021-9290(87)90047-9; CRAIG RDP, 1975, BRIT J SURG, V62, P741; DARBY I, 1990, LAB INVEST, V63, P21; DOILLON CJ, 1985, COLLAGEN REL RES, V5, P481; Du QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060880; Engrav LH, 2010, BURNS, V36, P975, DOI 10.1016/j.burns.2010.04.014; Flynn BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012337; FUJIMORI R, 1968, PLAST RECONSTR SURG, V42, P322, DOI 10.1097/00006534-196810000-00006; Howes EL, 1939, ARCH SURG-CHICAGO, V38, P934, DOI 10.1001/archsurg.1939.01200110140011; HUANG C, 1977, J BIOMED MATER RES, V11, P137, DOI 10.1002/jbm.820110113; Johnson J, 1994, J Burn Care Rehabil, V15, P180, DOI 10.1097/00004630-199403000-00015; Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200; Kim JY, 2016, BURNS, V42, P384, DOI 10.1016/j.burns.2015.08.027; Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037; LEUNG KS, 1984, BURNS, V10, P434, DOI 10.1016/0305-4179(84)90085-8; LEUNG PC, 1980, BURNS, V6, P244, DOI 10.1016/S0305-4179(80)80007-6; LEVENSON SM, 1965, ANN SURG, V161, P293, DOI 10.1097/00000658-196502000-00019; Li-Tsang CWP, 2015, BURNS, V41, P1008, DOI 10.1016/j.burns.2014.11.017; Malara MM, 2018, J BURN CARE RES; Puzey G., 2001, J TISSUE VIABILITY, V12, P11; Ripper S, 2009, BURNS, V35, P657, DOI 10.1016/j.burns.2009.01.011; ROSE MP, 1985, BURNS, V12, P58, DOI 10.1016/0305-4179(85)90184-6; RYAN GB, 1974, HUM PATHOL, V5, P55, DOI 10.1016/S0046-8177(74)80100-0; Steinstraesser L, 2011, PLAST RECONSTR SURG, V128, p306E, DOI 10.1097/PRS.0b013e3182268c69; Stewart R, 2000, AM J OCCUP THER, V54, P598, DOI 10.5014/ajot.54.6.598; Urioste SS, 1999, SEMIN CUTAN MED SURG, V18, P159, DOI 10.1016/S1085-5629(99)80040-6; Wang XQ, 2011, BURNS, V37, P1367, DOI 10.1016/j.burns.2011.07.018	30	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197558	10.1371/journal.pone.0197558	http://dx.doi.org/10.1371/journal.pone.0197558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897933	gold, Green Submitted, Green Published			2022-12-26	WOS:000435090700018
J	Wagner, CM; Hanson, JE; Meckley, TD; Johnson, NS; Bals, JD				Wagner, C. Michael; Hanson, James E.; Meckley, Trevor D.; Johnson, Nicholas S.; Bals, Jason D.			A simple, cost-effective emitter for controlled release of fish pheromones: Development, testing, and application to management of the invasive sea lamprey	PLOS ONE			English	Article							PETROMYZON-MARINUS; GREAT-LAKES; MIGRATORY PHEROMONE; CHEMICAL CUES; NEOGOBIUS-MELANOSTOMUS; BIODEGRADABLE POLYMERS; ROUND GOBY; TRAPS; BARRIERS; IMPACTS	Semiochemicals that elicit species-specific attraction or repulsion have proven useful in the management of terrestrial pests and hold considerable promise for control of nuisance aquatic species, particularly invasive fishes. Because aquatic ecosystems are typically large and open, use of a semiochemical to control a spatially dispersed invader will require the development of a cost-effective emitter that is easy to produce, environmentally benign, inexpensive, and controls the release of the semiochemical without altering its structure. We examined the release properties of five polymers, and chose polyethylene glycol (PEG) as the best alternative. In a series of laboratory and field experiments, we examined the response of the invasive sea lamprey to PEG, and to a partial sex pheromone emitted from PEG that has proven effective as a trap bait to capture migrating sea lamprey prior to spawning. Our findings confirm that the sea lamprey does not behaviorally respond to PEG, and that the attractant response to the pheromone component was conserved when emitted from PEG. Further, we deployed the pheromone-PEG emitters as trap bait during typical control operations in three Great Lakes tributaries, observing similar improvements in trap performance when compared to a previous study using mechanically pumped liquid pheromone. Finally, the polymer emitters tended to dissolve unevenly in high flow conditions. We demonstrate that housing the emitter stabilizes the dissolution rate at high water velocity. We conclude the performance characteristics of PEG emitters to achieve controlled-release of a semiochemical are sufficient to recommend its use in conservation and management activities related to native and invasive aquatic organisms.	[Wagner, C. Michael; Meckley, Trevor D.; Bals, Jason D.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Hanson, James E.] Seton Hall Univ, Dept Chem & Biochem, S Orange, NJ 07079 USA; [Johnson, Nicholas S.] USGS, Great Lakes Sci Ctr, Hammond Bay Biol Stn, Millersburg, MI USA; [Meckley, Trevor D.] NOAA, Natl Ctr Coastal Ocean Sci, Silver Spring, MD USA; [Bals, Jason D.] 1400 Vet United Dr, Columbia, MO USA	Michigan State University; Seton Hall University; United States Department of the Interior; United States Geological Survey; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS)	Wagner, CM (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	mwagner@msu.edu	Hanson, James E./L-6216-2017	Hanson, James E./0000-0001-7899-2802; Wagner, C/0000-0003-1929-1509	Great Lakes Fishery Commission [2010_HAN_00380, 2009-LIW-00368]	Great Lakes Fishery Commission	Funding for this study was provided by the Great Lakes Fishery Commission (glfc.org) via contract number 2010_HAN_00380 to JEH and 2009-LIW-00368 to NSJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atterholt CA, 1999, J CONTROL RELEASE, V57, P233, DOI 10.1016/S0168-3659(98)00119-9; BERGSTEDT RA, 1995, T AM FISH SOC, V124, P235, DOI 10.1577/1548-8659(1995)124<0235:EFLOHB>2.3.CO;2; Brant CO, 2016, BEHAV ECOL, V27, P810, DOI 10.1093/beheco/arv224; Brant CO, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150009; Bravener GA, 2013, CAN J FISH AQUAT SCI, V70, P1438, DOI 10.1139/cjfas-2012-0473; Buchinger TJ, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0126-9; Buchinger TJ, 2014, CHEM SENSES, V39, P647, DOI 10.1093/chemse/bju039; Burnard D, 2008, J FISH BIOL, V73, P1, DOI 10.1111/j.1095-8649.2008.01872.x; Byford GJ, 2016, N AM J FISH MANAGE, V36, P1090, DOI 10.1080/02755947.2016.1198286; Carde R.T., 1984, Springer Series in Experimental Entomology, V1984, P111; Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7; Chiellini E, 2003, PROG POLYM SCI, V28, P963, DOI 10.1016/S0079-6700(02)00149-1; Christie GC, 2003, J GREAT LAKES RES, V29, P1, DOI 10.1016/S0380-1330(03)70474-2; Corkum LD, 2004, BIOL INVASIONS, V6, P173, DOI 10.1023/B:BINV.0000022136.43502.db; Dawson HA, 2017, J GREAT LAKES RES, V43, P172, DOI 10.1016/j.jglr.2016.10.009; DeBose JL, 2008, J CHEM ECOL, V34, P867, DOI 10.1007/s10886-008-9493-4; Doving KB, 2009, ANN NY ACAD SCI, V1170, P413, DOI 10.1111/j.1749-6632.2009.04111.x; Fine JM, 2010, FISH PHYSIOL BIOCHEM, V36, P1013, DOI 10.1007/s10695-010-9379-6; Greenwald RB, 2001, J CONTROL RELEASE, V74, P159, DOI 10.1016/S0168-3659(01)00331-5; Hamdani EH, 2007, PROG NEUROBIOL, V82, P80, DOI 10.1016/j.pneurobio.2007.02.007; Heuskin S, 2011, BIOTECHNOL AGRON SOC, V15, P459; Johnson NS, 2012, J FISH BIOL, V80, P538, DOI 10.1111/j.1095-8649.2011.03185.x; Johnson NS, 2015, J CHEM ECOL, V41, P913, DOI 10.1007/s10886-015-0626-2; Johnson NS, 2014, J CHEM ECOL, V40, P1152, DOI 10.1007/s10886-014-0511-4; Johnson NS, 2013, CAN J FISH AQUAT SCI, V70, P1101, DOI 10.1139/cjfas-2013-0080; Johnson NS, 2009, P NATL ACAD SCI USA, V106, P1021, DOI 10.1073/pnas.0808530106; Li K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068157; Li WM, 2002, SCIENCE, V296, P138, DOI 10.1126/science.1067797; Little EE, 2011, AM FISH S S, V74, P215; LOSEY GS, 1994, J CHEM ECOL, V20, P1877, DOI 10.1007/BF02066229; Luehring MA, 2011, BIOL INVASIONS, V13, P1589, DOI 10.1007/s10530-010-9916-3; McLaughlin RL, 2007, J GREAT LAKES RES, V33, P7, DOI 10.3394/0380-1330(2007)33[7:RTGUOB]2.0.CO;2; MOORE HH, 1980, CAN J FISH AQUAT SCI, V37, P1851, DOI 10.1139/f80-227; Moore P, 2004, J MARINE SYST, V49, P55, DOI 10.1016/j.jmarsys.2003.05.005; Mullett KM, 2003, J GREAT LAKES RES, V29, P240, DOI 10.1016/S0380-1330(03)70492-4; Munday PL, 1997, J FISH BIOL, V51, P931, DOI 10.1006/jfbi.1997.0498; Murphy CA, 2001, J CHEM ECOL, V27, P443, DOI 10.1023/A:1010376503197; Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017; Noatch MR, 2012, ENVIRON REV, V20, P71, DOI [10.1139/A2012-001, 10.1139/a2012-001]; Peppas NA, 1996, J CONTROL RELEASE, V40, P245, DOI 10.1016/0168-3659(95)00191-3; Piletska EV, 2005, J CONTROL RELEASE, V108, P132, DOI 10.1016/j.jconrel.2005.07.016; Ricciardi A, 2006, DIVERS DISTRIB, V12, P425, DOI 10.1111/j.1366-9516.2006.00262.x; Siefkes MJ, 2005, ANIM BEHAV, V70, P1037, DOI 10.1016/j.anbehav.2005.01.024; Simberloff D, 2009, BIOL INVASIONS, V11, P149, DOI 10.1007/s10530-008-9317-z; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Smith SDP, 2015, ECOL APPL, V25, P717, DOI 10.1890/14-0366.1; Sorensen PW, 2007, J FISH BIOL, V71, P100, DOI 10.1111/j.1095-8649.2007.01681.x; Sorensen PW, 2016, J CHEM ECOL, V42, P698, DOI 10.1007/s10886-016-0729-4; Sorensen PW, 2005, NAT CHEM BIOL, V1, P324, DOI 10.1038/nchembio739; Sorensen PW, 2004, NEW ZEAL J MAR FRESH, V38, P399, DOI 10.1080/00288330.2004.9517248; Stacey N, 2015, FISH PHEROMONES AND RELATED CUES, P33; Twohey MB, 2003, J GREAT LAKES RES, V29, P794, DOI 10.1016/S0380-1330(03)70532-2; Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u; Vrieze LA, 2010, J FISH BIOL, V76, P949, DOI 10.1111/j.1095-8649.2010.02548.x; Vroman I, 2009, MATERIALS, V2, P307, DOI 10.3390/ma2020307; Wagner CM, 2011, CAN J FISH AQUAT SCI, V68, P1157, DOI [10.1139/f2011-072, 10.1139/F2011-072]; Wagner CM, 2009, ANIM BEHAV, V78, P593, DOI 10.1016/j.anbehav.2009.04.027; Waldman J, 2008, BIOL LETTERS, V4, P659, DOI 10.1098/rsbl.2008.0341; Wang HY, 2013, J SEP SCI, V36, P1612, DOI 10.1002/jssc.201300110; Webster DR, 2009, ANNU REV FLUID MECH, V41, P73, DOI 10.1146/annurev.fluid.010908.165240; Witzgall P, 2010, J CHEM ECOL, V36, P80, DOI 10.1007/s10886-009-9737-y; Young M. K., 2003, N AM J FISH MANAGE, V23, P2376; Zada A, 2009, CHEMOECOLOGY, V19, P37, DOI 10.1007/s00049-009-0007-9	63	4	4	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197569	10.1371/journal.pone.0197569	http://dx.doi.org/10.1371/journal.pone.0197569			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897927	gold, Green Published, Green Submitted			2022-12-26	WOS:000435090700019
J	Hullar, MAJ; Lampe, JW; Torok-Storb, BJ; Harkey, MA				Hullar, Meredith A. J.; Lampe, Johanna W.; Torok-Storb, Beverly J.; Harkey, Michael A.			The canine gut microbiome is associated with higher risk of gastric dilatation-volvulus and high risk genetic variants of the immune system	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; INFLAMMATORY-BOWEL-DISEASE; CELIAC-DISEASE; PHYLOGENETIC CHARACTERIZATION; MULTIVARIATE-ANALYSIS; METABOLIC SYNDROME; FECAL BACTERIAL; DOGS; COMMUNITIES; BREED	Background Large and giant dog breeds have a high risk for gastric dilatation-volvulus (GDV) which is an acute, life-threatening condition. Previous work by our group identified a strong risk of GDV linked to specific alleles in innate and adaptive immune genes. We hypothesize that variation in the genes of the immune system act through modulation of the gut microbiome, or through autoimmune mechanisms, or both, to predispose dogs to this condition. Here, we investigate whether differences in the canine fecal microbiome are associated with GDV and are linked to previously identified risk alleles. Methodology/Principle findings Fecal samples from healthy Great Danes (n = 38), and dogs with at least one occurrence of GDV (n = 37) were collected and analyzed by paired-end sequencing of the 16S rRNA gene. Dietary intake and temperament were estimated from a study-specific dietary and temperament questionnaire. Dogs with GDV had significantly more diverse fecal microbiomes than healthy control dogs. Alpha diversity was significantly increased in dogs with GDV, as well as dogs with at least one risk allele for DRB1 and TRL5. We found no significant association of dietary intake and GDV. Dogs with GDV showed a significant expansion of the rare lineage Actinobacteria (p = 0.004), as well as a significantly greater abundance of Firmicutes (p = 0.004) and a significantly lower abundance of Bacteroidetes (p<0.004). There was a significant difference in the abundance of 10 genera but after correction for multiple comparisons, none were significant. Bacterial phyla were significantly different between controls and dogs with GDV and at least one risk allele for DRB1 and TRL5. Actinobacteria were significantly higher in dogs with GDV and with one risk allele for DRB1 and TLR5 but not DLA88 genes. Furthermore, Collinsella was significantly increased in dogs with at least one risk allele for DRB1 and TLR5. Logistic regression showed that a model which included Actinobacteria, at least one risk allele,and temperament, explained 29% of the variation in risk of GDV in Great Danes. Conclusions The microbiome in GDV was altered by an expansion of a minor lineage and was associated with specific alleles of both innate and adaptive immunity genes. These associations are consistent with our hypothesis that immune genes may play a role in predisposition to GDV by altering the gut microbiome. Further research will be required to directly test the causal relationships of immune genes, the gut microbiome and GDV.	[Hullar, Meredith A. J.; Lampe, Johanna W.] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA; [Torok-Storb, Beverly J.; Harkey, Michael A.] Fred Hutchinson Canc Res Ctr, Dept Transplantat Biol, Clin Res Div, 1124 Columbia St, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Hullar, MAJ (corresponding author), Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA.	mhullar@fredhutch.org	Fiumefreddo, Andrea/T-2977-2019		Robert and Rebecca Pohlad and from the Van Sloun Foundation; Canine Large Animal Core of the Core Center of Excellence in Hematology at Fred Hutchinson Cancer Research Center, NIDDK [P30 DK56465]; NIH [U54 DK106829]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK106829] Funding Source: NIH RePORTER	Robert and Rebecca Pohlad and from the Van Sloun Foundation; Canine Large Animal Core of the Core Center of Excellence in Hematology at Fred Hutchinson Cancer Research Center, NIDDK; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was made possible by grants from Robert and Rebecca Pohlad and from the Van Sloun Foundation. DLA typing was performed by the Canine Large Animal Core of the Core Center of Excellence in Hematology at Fred Hutchinson Cancer Research Center, NIDDK grant P30 DK56465. MAH and BJT-S were supported in part by NIH grant U54 DK106829.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Allenspach K, 2010, VET MICROBIOL, V146, P326, DOI 10.1016/j.vetmic.2010.05.025; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birru Talabi M, 2017, AM J EPIDEMIOL; Braun L, 1996, J AM ANIM HOSP ASSOC, V32, P287, DOI 10.5326/15473317-32-4-287; Broome CJ, 2003, NEW ZEAL VET J, V51, P275, DOI 10.1080/00480169.2003.36381; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Catchpole B, 2012, VET J, V194, P7, DOI 10.1016/j.tvjl.2012.03.011; Chassaing B, 2014, GASTROENTEROLOGY, V147, P1363, DOI 10.1053/j.gastro.2014.08.033; Chen J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0299-7; Cruz GI, 2017, ANN RHEUM DIS, V76, P1405, DOI 10.1136/annrheumdis-2016-210662; De Palma G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030791; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Di Bella JM, 2013, J MICROBIOL METH, V95, P401, DOI 10.1016/j.mimet.2013.08.011; Evans KM, 2010, J SMALL ANIM PRACT, V51, P376, DOI 10.1111/j.1748-5827.2010.00949.x; Fu BC, 2016, ANN EPIDEMIOL, V26, P373, DOI 10.1016/j.annepidem.2016.02.009; Glickman LT, 2000, J AM VET MED ASSOC, V216, P40, DOI 10.2460/javma.2000.216.40; Glickman LT, 1997, J AM ANIM HOSP ASSOC, V33, P197, DOI 10.5326/15473317-33-3-197; Gomez A, 2015, CLIN IMMUNOL, V159, P154, DOI 10.1016/j.clim.2015.04.016; Gomez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036095; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Harkey MA, 2017, AM J VET RES, V78, P934, DOI 10.2460/ajvr.78.8.934; Hendriks MM, 2012, NEW ZEAL VET J, V60, P165, DOI 10.1080/00480169.2011.644758; Hugot JP, 2001, INFECT GENET EVOL, V1, P13, DOI 10.1016/S1567-1348(01)00003-X; Hullar MA, 2014, GASTROENTEROLOGY, V146, pS45; Hullar MAJ, 2015, CANCER EPIDEM BIOMAR, V24, P546, DOI 10.1158/1055-9965.EPI-14-0262; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jeffery ND, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170589; Kathrani A, 2014, VET IMMUNOL IMMUNOP, V161, P32, DOI 10.1016/j.vetimm.2014.06.003; Kathrani A, 2011, TISSUE ANTIGENS, V78, P94, DOI 10.1111/j.1399-0039.2011.01707.x; Kathrani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030117; Kathrani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015740; Koning F, 2015, CLIN EXP RHEUMATOL, V33, pS8; Koning F, 2015, NAT REV RHEUMATOL, V11, P450, DOI 10.1038/nrrheum.2015.59; Kuja-Halkola R, 2016, GUT, V65, P1793, DOI 10.1136/gutjnl-2016-311713; Lauten SD, 2006, VET CLIN N AM-SMALL, V36, P1345, DOI 10.1016/j.cvsm.2006.09.003; Leifer CA, 2014, IMMUNOL LETT, V162, P3, DOI 10.1016/j.imlet.2014.07.017; Li QH, 2017, MBIO, V8, DOI [10.1128/mbio.01703-16, 10.1128/mBio.01703-16]; Liu Wen-Xin, 2016, Clin Invest Med, V39, pE182; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Marietta E, 2015, IMMUNOLOGY, V145, P313, DOI 10.1111/imm.12474; Middelbos IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009768; Molloy S, 2014, NAT REV MICROBIOL, V12, DOI 10.1038/nrmicro3194; Monnet E, 2003, VET CLIN N AM-SMALL, V33, P987, DOI 10.1016/S0195-5616(03)00059-7; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Neville BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040592; Pfirschke C, 2015, CANCER CELL, V27, P1, DOI 10.1016/j.ccell.2014.12.008; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Raghavan M, 2006, J AM ANIM HOSP ASSOC, V42, P28, DOI 10.5326/0420028; Raghavan M, 2004, J AM ANIM HOSP ASSOC, V40, P192, DOI 10.5326/0400192; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Rutkowski MR, 2015, CANCER CELL, V27, P27, DOI 10.1016/j.ccell.2014.11.009; Sandri M, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0981-z; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Simpson JM, 2002, MICROB ECOL, V44, P186, DOI 10.1007/s00248-002-0001-z; Suchodolski JS, 2016, VET J, V215, P30, DOI 10.1016/j.tvjl.2016.04.011; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Taneja V, 2014, FEBS LETT, V588, P4244, DOI 10.1016/j.febslet.2014.05.034; Taneja V, 2010, IMMUNOL REV, V233, P62, DOI 10.1111/j.0105-2896.2009.00858.x; Van Kruiningen HJ, 2013, J VET INTERN MED, V27, P1260, DOI 10.1111/jvim.12138; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wu J, 2017, POSTGRAD MED J, DOI [10.1136/postgradmedj-2016-134724, DOI 10.1136/P0STGRADMEDJ-2016-134724]; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x; Zhang W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150943	77	7	7	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0197686	10.1371/journal.pone.0197686	http://dx.doi.org/10.1371/journal.pone.0197686			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889838	Green Submitted, gold, Green Published			2022-12-26	WOS:000434786600007
J	Macklin, PA; Suryaputra, IGNA; Maher, DT; Santos, IR				Macklin, Paul A.; Suryaputra, I. Gusti Ngurah Agung; Maher, Damien T.; Santos, Isaac R.			Carbon dioxide dynamics in a lake and a reservoir on a tropical island (Bali, Indonesia)	PLOS ONE			English	Article							GAS TRANSFER VELOCITIES; ORGANIC-CARBON; GROUNDWATER DISCHARGE; CO2 SUPERSATURATION; WIND-SPEED; TERRESTRIAL; EXCHANGE; RN-222; METHANE; REGULATORS	Water-to-air carbon dioxide fluxes from tropical lakes and reservoirs (artificial lakes) may be an important but understudied component of global carbon fluxes. Here, we investigate the seasonal dissolved carbon dioxide (CO2) dynamics in a lake and a reservoir on a tropical volcanic island (Bali, Indonesia). Observations were performed over four seasonal surveys in Bali's largest natural lake (Lake Batur) and largest reservoir (Palasari Reservoir). Average CO2 partial pressures in the natural lake and reservoir were 263.7 +/- 12.2 mu atm and 785.0 +/- 283.6 mu atm respectively, with the highest area-weighted partial pressures in the wet season for both systems. The strong correlations between seasonal mean values of dissolved oxygen (DO) and pCO(2) in the natural lake (r(2) = 0.92) suggest that surface water metabolism was an important driver of CO2 dynamics in this deep system. Radon (Rn-222, a natural groundwater discharge tracer) explained up to 77% of the variability in pCO(2) in the shallow reservoir, suggesting that groundwater seepage was the major CO2 driver in the reservoir. Overall, the natural lake was a sink of atmospheric CO2 (average fluxes of -2.8 mmol m(-2) d(-1)) while the reservoir was a source of CO2 to the atmosphere (average fluxes of 7.3 mmol m(-2) d(-1)). Reservoirs are replacing river valleys and terrestrial ecosystems, particularly throughout developing tropical regions. While the net effect of this conversion on atmospheric CO2 fluxes remains to be resolved, we speculate that reservoir construction will partially offset the CO2 sink provided by deep, volcanic, natural lakes and terrestrial environments.	[Macklin, Paul A.; Maher, Damien T.; Santos, Isaac R.] Southern Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Macklin, Paul A.; Maher, Damien T.; Santos, Isaac R.] Southern Cross Univ, Sch Environm Sci & Engn, Lismore, NSW, Australia; [Suryaputra, I. Gusti Ngurah Agung] Univ Pendidikan Ganesha, Dept Analyt Chem, Singaraja, Bali, Indonesia	Southern Cross University; Southern Cross University; Ganesha University of Education	Macklin, PA (corresponding author), Southern Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia.; Macklin, PA (corresponding author), Southern Cross Univ, Sch Environm Sci & Engn, Lismore, NSW, Australia.	paul.macklin@gmail.com	Suryaputra, I Gusti Ngurah Agung/S-8427-2016; Santos, Isaac R./A-3960-2019; Maher, Damien/E-3443-2012	Santos, Isaac R./0000-0003-0524-842X; Maher, Damien/0000-0003-1899-005X; Macklin, Paul/0000-0002-6418-9223	Australian Government Research Training Program Scholarship; Australian Research Council [DE140101733, DE150100581, LE120100156]	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Research Council(Australian Research Council)	Paul Anthony Macklin was supported by the Australian Government Research Training Program Scholarship. We acknowledge funding support from the Australian Research Council (DE140101733, DE150100581, and LE120100156) that partially funded IRS and DTM salaries and the portable analytical instrumentation.	Abril G, 2000, CR ACAD SCI II A, V330, P761, DOI 10.1016/S1251-8050(00)00231-7; Atkins ML, 2017, SCI TOTAL ENVIRON, V575, P545, DOI 10.1016/j.scitotenv.2016.09.020; Battin TJ, 2008, NAT GEOSCI, V1, P95, DOI 10.1038/ngeo101; Borges AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109500; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cole JJ, 1998, LIMNOL OCEANOGR, V43, P647, DOI 10.4319/lo.1998.43.4.0647; Cole JJ, 2010, LIMNOL OCEANOGR-METH, V8, P285, DOI 10.4319/lom.2010.8.285; Crusius J, 2003, LIMNOL OCEANOGR, V48, P1010, DOI 10.4319/lo.2003.48.3.1010; Dean WE, 1998, GEOLOGY, V26, P535, DOI 10.1130/0091-7613(1998)026<0535:MASOCB>2.3.CO;2; Dimova NT, 2013, J HYDROL, V486, P112, DOI 10.1016/j.jhydrol.2013.01.043; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Dulaiova H, 2005, J RADIOANAL NUCL CH, V263, P361, DOI 10.1007/s10967-005-0063-8; Gerardo-Nieto O, 2017, SCI TOTAL ENVIRON, V593, P144, DOI 10.1016/j.scitotenv.2017.02.144; Guerin F, 2007, J MARINE SYST, V66, P161, DOI 10.1016/j.jmarsys.2006.03.019; Hagedorn B, 2010, APPL GEOCHEM, V25, P881, DOI 10.1016/j.apgeochem.2010.03.006; Humborg C, 2010, GLOBAL CHANGE BIOL, V16, P1966, DOI 10.1111/j.1365-2486.2009.02092.x; Kessler TJ, 2001, GEOPHYS RES LETT, V28, P279, DOI 10.1029/2000GL011505; Knoll LB, 2013, GLOBAL BIOGEOCHEM CY, V27, P52, DOI 10.1002/gbc.20020; Kortelainen P, 2013, GLOBAL BIOGEOCHEM CY, V27, P363, DOI 10.1002/gbc.20036; Lapierre JF, 2015, GLOBAL CHANGE BIOL, V21, P4425, DOI 10.1111/gcb.13031; Li SY, 2017, J HYDROL, V544, P133, DOI 10.1016/j.jhydrol.2016.11.015; Li SY, 2009, J HAZARD MATER, V165, P317, DOI 10.1016/j.jhazmat.2008.09.123; Looman A, 2016, SCI TOTAL ENVIRON, V550, P645, DOI 10.1016/j.scitotenv.2016.01.082; MacIntyre S, 1995, BIOGENIC TRACE GASES, P5297; Macklin PA, 2014, MAR CHEM, V167, P82, DOI 10.1016/j.marchem.2014.08.002; Maher DT, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004075; Maher DT, 2015, MAR CHEM, V168, P69, DOI 10.1016/j.marchem.2014.10.017; Marce R, 2015, NAT GEOSCI, V8, P107, DOI [10.1038/ngeo2341, 10.1038/NGEO2341]; Marotta H, 2010, BIOGEOSCIENCES, V7, P1607, DOI 10.5194/bg-7-1607-2010; McGillis WR, 2001, J GEOPHYS RES-OCEANS, V106, P16729, DOI 10.1029/2000JC000506; McGowan S, 2016, WIRES WATER, V3, P211, DOI 10.1002/wat2.1130; Moosdorf N, 2015, GRUNDWASSER, V20, P53, DOI 10.1007/s00767-014-0275-3; Perkins AK, 2015, ENVIRON EARTH SCI, V74, P779, DOI 10.1007/s12665-015-4082-7; Postel SL, 2000, ECOL APPL, V10, P941, DOI 10.1890/1051-0761(2000)010[0941:EAEOWS]2.0.CO;2; Prasad M. H. K., 2013, Journal of Water Resource and Protection, V5, P534, DOI 10.4236/jwarp.2013.55054; Rantakari M, 2005, GLOBAL CHANGE BIOL, V11, P1368, DOI 10.1111/j.1365-2486.2005.00982.x; Rasilo T, 2012, VADOSE ZONE J, V11, DOI 10.2136/vzj2011.0039; Raymond PA, 2000, LIMNOL OCEANOGR, V45, P1707, DOI 10.4319/lo.2000.45.8.1707; Raymond PA, 2013, NATURE, V503, P355, DOI 10.1038/nature12760; Sadat-Noori M, 2016, ESTUAR COAST, V39, P639, DOI 10.1007/s12237-015-0042-4; SANFORD WE, 1995, J VOLCANOL GEOTH RES, V64, P269, DOI 10.1016/0377-0273(94)00080-Z; Santos IR, 2015, MAR CHEM, V171, P10, DOI 10.1016/j.marchem.2015.02.005; Santos IR, 2012, ENVIRON SCI TECHNOL, V46, P7685, DOI 10.1021/es301961b; Schubert M, 2012, ENVIRON SCI TECHNOL, V46, P3905, DOI 10.1021/es204680n; Selvam BP, 2014, GLOBAL CHANGE BIOL, V20, P3397, DOI 10.1111/gcb.12575; Sobek S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002264; Sobek S, 2007, LIMNOL OCEANOGR, V52, P1208, DOI 10.4319/lo.2007.52.3.1208; St Louis VL, 2000, BIOSCIENCE, V50, P766, DOI 10.1641/0006-3568(2000)050[0766:RSASOG]2.0.CO;2; Sulastri, 2006, TROPICS, V15, P285, DOI 10.3759/tropics.15.285; Sulman BN, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001862; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Vachon D, 2014, ECOSYSTEMS, V17, P1338, DOI 10.1007/s10021-014-9799-8; Vahatalo AV, 2003, ARCH HYDROBIOL, V156, P287, DOI 10.1127/0003-9136/2003/0156-0287; Van Oost K, 2007, SCIENCE, V318, P626, DOI 10.1126/science.1145724; Varekamp JC, 2000, J VOLCANOL GEOTH RES, V97, P309, DOI 10.1016/S0377-0273(99)00175-4; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Webb JR, 2017, WATER RESOUR RES, V53, P544, DOI 10.1002/2016WR019735; Weiss R.F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2; Williamson CE, 2009, LIMNOL OCEANOGR, V54, P2273, DOI 10.4319/lo.2009.54.6_part_2.2273	60	14	14	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198678	10.1371/journal.pone.0198678	http://dx.doi.org/10.1371/journal.pone.0198678			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889896	Green Submitted, gold, Green Published			2022-12-26	WOS:000434786600034
J	Park, M; Song, I				Park, Mihai; Song, Inmyung			Medical care costs of cancer in the last year of life using national health insurance data in Korea	PLOS ONE			English	Article							END-OF-LIFE; TRENDS; AGGRESSIVENESS; DECEDENTS; DEATH	Background Medical care of cancer patients at the end-of-life is costly. This study aims to describe the monthly trends of EOL medical care, drug therapy, and chemotherapy costs per patient with cancer in the last year of life in the inpatients vs. outpatient setting for the 13 most prevalent cancers in Korea. Methods Using the Health Insurance Review and Assessment Service (HIRA) database, we identified the patients who had been treated for the primary diagnoses of one of the 13 most prevalent cancers in Korea and died between January 1, 2013 and December 31, 2015. We calculated the mean monthly costs of medical care, drug therapy, and chemotherapy per patient in the last year of life by cancer site and patient setting (inpatient vs. outpatient). Results For most cancers, the monthly inpatient costs per patient remain stable or increased gradually from 12 months to 3 months prior to death and then increased steeply from 2 months prior to death. The mean monthly inpatient costs per patient were highest for acute myeloid leukemia (AML) throughout the last year of life; all solid tumors had similar trends of monthly inpatient costs. The mean monthly inpatient costs for AML increased from $5,465 (SD, $5,248) in 12 months prior to death to $15,033 (SD, $11,864) in the last month. The monthly outpatient costs per patient showed similar, gradually decreasing trends for most cancers. The mean outpatient costs were highest for kidney cancer; the costs sharply decreased from $954 (SD, $1,346) in 12 months prior to death to $424 (SD, $736) in the last month. The proportion of inpatients receiving chemotherapy in the last month of life was highest for AML (77%), followed by liver cancer (67%) and breast cancer (56%). Conclusion The monthly inpatient medical care costs per patient with cancer increased as the patient approached death, while the monthly outpatient costs decreased. A considerable proportion of inpatient received chemotherapy in the last month of life. Efforts are needed to optimize EOL care for cancer patients.	[Park, Mihai] Hlth Insurance Review & Assessment Serv, Pharmaceut Benefits Listing Div, Seoul, South Korea; [Song, Inmyung] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea	Sungkyunkwan University (SKKU)	Song, I (corresponding author), Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea.	inmyungs@gmail.com	; Song, Inmyung/J-8250-2016	Park, MiHai/0000-0001-8481-5503; Song, Inmyung/0000-0001-7772-6617				Cannas G, 2015, BLOOD TRANSFUS-ITALY, V13, P205, DOI 10.2450/2014.0080-14; Chastek B, 2012, J ONCOL PRACT, V8, p75S, DOI 10.1200/JOP.2011.000469; Day D, 2015, BJU INT, V116, P36, DOI 10.1111/bju.13176; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Garrido MM, 2016, J PAIN SYMPTOM MANAG, V51, P875, DOI 10.1016/j.jpainsymman.2015.12.323; Health Insurance Review and Assessment Service, 2017 NAT HLTH INS ST; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Hung YN, 2017, ONCOLOGIST, V22, P460, DOI 10.1634/theoncologist.2016-0283; Hwang I, 2016, CANCER RES TREAT, V48, P365, DOI 10.4143/crt.2014.088; Keam B, 2008, JPN J CLIN ONCOL, V38, P381, DOI 10.1093/jjco/hyn031; Kim L, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014008; Kim SG, 2008, EUR J CANCER CARE, V17, P136, DOI 10.1111/j.1365-2354.2007.00818.x; Kim Y, 2014, 201420011 NAT HLTH I; Lee KY, 2014, MACROMOL BIOSCI, V14, P10, DOI 10.1002/mabi.201300298; Lim D, 2015, CANCER EPIDEMIOL, V39, P939, DOI 10.1016/j.canep.2015.10.023; Lim D, 2014, J KOREAN MED SCI, V29, P1597, DOI 10.3346/jkms.2014.29.12.1597; 신현철, 2012, [Health Policy and Mangemnet, 보건행정학회지], V22, P29, DOI 10.4332/KJHPA.2012.22.1.029; Polder JJ, 2006, SOC SCI MED, V63, P1720, DOI 10.1016/j.socscimed.2006.04.018; Rhee YongJoo, 2015, Health, V7, P689, DOI 10.4236/health.2015.76082; Sherman SI, 2010, BIOCHEM PHARMACOL, V80, P592, DOI 10.1016/j.bcp.2010.05.003; Smith TJ, 2011, NEW ENGL J MED, V364, P2060, DOI 10.1056/NEJMsb1013826; Statistics Korea, 2017 ELD POP STAT; Tangka FKL, 2015, HEALTH SERV RES, V50, P690, DOI 10.1111/1475-6773.12259; Tanuseputro P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121759; The Ministry of Health and Welfare, 2012, ART 16 RUL BIOETH SA; Wagstaff J, 2016, ANN ONCOL, V27, P159, DOI 10.1093/annonc/mdv504; Yi JJ, J PREV MED PUBLIC HL, V38, P9; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	28	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0197891	10.1371/journal.pone.0197891	http://dx.doi.org/10.1371/journal.pone.0197891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879136	gold, Green Published, Green Submitted			2022-12-26	WOS:000434384900012
J	Weir, NJM; Pattison, SH; Kearney, P; Stafford, B; Gormley, GJ; Crockard, MA; Gilpin, DF; Tunney, MM; Hughes, CM				Weir, Nichola-Jane M.; Pattison, Sally H.; Kearney, Paddy; Stafford, Bob; Gormley, Gerard J.; Crockard, Martin A.; Gilpin, Deirdre F.; Tunney, Michael M.; Hughes, Carmel M.			Criteria required for an acceptable point-of-care test for UTI detection: Obtaining consensus using the Delphi technique	PLOS ONE			English	Article								Background Urinary Tract Infections (UTIs) are common bacterial infections, second only to respiratory tract infections and particularly prevalent within primary care. Conventional detection of UTIs is culture, however, return of results can take between 24 and 72 hours. The introduction of a point of care (POC) test would allow for more timely identification of UTIs, facilitating improved, targeted treatment. This study aimed to obtain consensus on the criteria required for a POC UTI test, to meet patient need within primary care.\ Methods Criteria for consideration were compiled by the research team. These criteria were validated through a two-round Delphi process, utilising an expert panel of healthcare professionals from across Europe and United States of America. Using web-based questionnaires, panellists recorded their level of agreement with each criterion based on a 5-point Likert Scale, with space for comments. Using median response, interquartile range and comments provided, criteria were accepted/rejected/revised depending on pre-agreed cut-off scores. Results The first round questionnaire presented thirty-three criteria to the panel, of which 22 were accepted. Consensus was not achieved for the remaining 11 criteria. Following response review, one criterion was removed, while after revision, the remaining 10 criteria entered the second round. Of these, four were subsequently accepted, resulting in 26 criteria considered appropriate for a POC test to detect urinary infections. Conclusion This study generated an approved set of criteria for a POC test to detect urinary infections. Criteria acceptance and comments provided by the healthcare professionals also supports the development of a multiplex point of care UTI test.	Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Weir, Nichola-Jane M.; Gilpin, Deirdre F.; Tunney, Michael M.; Hughes, Carmel M.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Pattison, Sally H.] Queens Univ Belfast, Ctr Med Expt, Belfast, Antrim, North Ireland; [Kearney, Paddy] Northern Hlth & Social Care Trust, Bretten Hall, Antrim, North Ireland; [Stafford, Bob] Orchard Carehomes, Hornbeam Pk, Harrogate, England; [Gormley, Gerard J.] Queens Univ Belfast, Dept Gen Practice, Dunluce Hlth Ctr, Belfast, Antrim, North Ireland; [Crockard, Martin A.] Randox Labs Ltd, Crumlin, North Ireland	Queens University Belfast; Queens University Belfast; Queens University Belfast; Queens University Belfast; Randox Laboratories	Hughes, CM (corresponding author), Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland.	c.hughes@qub.ac.uk		Gilpin, Deirdre/0000-0001-6617-233X; TUNNEY, MICHAEL/0000-0002-7433-7074	Department for Employment and Learning (DEL), Northern Ireland; Randox Laboratories Ltd, Northern Ireland	Department for Employment and Learning (DEL), Northern Ireland; Randox Laboratories Ltd, Northern Ireland	This study was supported by the Department for Employment and Learning (DEL), Northern Ireland and Randox Laboratories Ltd, Northern Ireland as part of a PhD studentship. The funder provided support in the form of salaries for author MC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2002, WESTERN J MED, V176, P51, DOI 10.1136/ewjm.176.1.51; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Campbell SM, 2001, J CLIN PHARM THER, V26, P5, DOI 10.1046/j.1365-2710.2001.00331.x; Cooper JA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0484-6; Fallon D, 2003, J CLIN PATHOL, V56, P608, DOI 10.1136/jcp.56.8.608; Genao Liza, 2012, Ann Longterm Care, V20, P33; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Howick J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005611; Hsieh YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014144; Hsu CC, 2007, PARE, V12, P1; Jamieson S, 2004, MED EDUC, V38, P1217, DOI 10.1111/j.1365-2929.2004.02012.x; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V51, P69, DOI 10.1093/jac/dkg028; Kaman WE, 2013, PATIENT PREFER ADHER, V7, P559, DOI 10.2147/PPA.S44889; Kattler H, 2004, MAPP LANDSCAPE DIAGN; Leekha S, 2011, MAYO CLIN PROC, V86, P156, DOI 10.4065/mcp.2010.0639; Lehe JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047459; National Prescribing Centre, 2006, MEREC B, V17; Nichols JH, 2007, CLIN LAB MED, V27, P893, DOI 10.1016/j.cll.2007.07.003; Nouvellet P, 2015, ALL RIGHTS RESERVED, V528, pS109, DOI [10.1038/nature16041, DOI 10.1038/NATURE16041]; Price CP, 2001, BMJ-BRIT MED J, V322, P1285, DOI 10.1136/bmj.322.7297.1285; St John Andrew, 2014, Clin Biochem Rev, V35, P155; Thomas ST, 2016, 0045 HOR SCAN; Turner PJ, 2016, FAM PRACT, V33, P388, DOI 10.1093/fampra/cmw018; Waggoner J, 2016, ACAD MED, V91, P663, DOI 10.1097/ACM.0000000000001092	24	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198595	10.1371/journal.pone.0198595	http://dx.doi.org/10.1371/journal.pone.0198595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879161	Green Published, Green Submitted, gold			2022-12-26	WOS:000434384900058
J	Liley, H; Zhang, J; Firth, EC; Fernandez, JW; Besier, TF				Liley, Helen; Zhang, Ju; Firth, Elwyn C.; Fernandez, Justin W.; Besier, Thor F.			Statistical modeling of the equine third metacarpal bone incorporating morphology and bone mineral density	PLOS ONE			English	Article							HIP FRACTURE RISK; SUBCHONDRAL BONE; METACARPOPHALANGEAL JOINTS; METATARSAL BONES; PROXIMAL FEMUR; SHAPE MODEL; HORSES; GEOMETRY; WOMEN	The objective of this study was to describe the three-dimensional shape and subchondral bone mineral density (BMD) variation of the equine distal third metacarpal bone (MC3) using a statistical shape model. The association between form and function builds upon previous two-dimensional observations of MC3 epiphyseal structure. It was expected that the main source of variation would be an increase in overall MC3 bone size, correlated to an increase in subchondral BMD. Geometry and bone mineral density was obtained from CT image data of 40 healthy Thoroughbred horses. This was used to create a statistical shape model, in which the first ten components described 75% of the variation in geometry and BMD. The first principal component described an increase in overall size of the MC3 distal epiphysis, coupled with higher BMD on the disto-palmar and dorso-proximal surfaces. The second component was qualitatively described as an increased convexity of the sagittal ridge at the dorsal junction of the epiphysis and the metaphysis, coupled to increased BMD in that region. The third component showed an increase in lateral condylar surface area relative to medial condylar area. As the condyle reduced in relative surface area, the BMD at both dorsal condyles increased. The statistical shape analysis produced a compact description of 3-D shape and sub-chondral bone mineral density variation for the third metacarpal bone. This study uniquely illustrates the shape variations in a sample population of MC3 bones, and the corresponding changes in subchondral BMD.	[Liley, Helen; Zhang, Ju; Firth, Elwyn C.; Fernandez, Justin W.; Besier, Thor F.] Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand; [Firth, Elwyn C.] Univ Auckland, Dept Exercise Sci, Auckland, New Zealand; [Fernandez, Justin W.; Besier, Thor F.] Univ Auckland, Dept Engn Sci, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland	Besier, TF (corresponding author), Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand.; Besier, TF (corresponding author), Univ Auckland, Dept Engn Sci, Auckland, New Zealand.	t.besier@auckland.ac.nz	Besier, Thor F/P-6425-2019	Besier, Thor/0000-0003-0818-7554	Equine Trust NZ; Auckland Bioengineering Institute; New Zealand Equine Trust	Equine Trust NZ; Auckland Bioengineering Institute; New Zealand Equine Trust	The authors acknowledge the financial support of the Equine Trust NZ (Elwyn Firth) and the Auckland Bioengineering Institute (PhD scholarship for Helen Liley).; This work was supported by the New Zealand Equine Trust and the Auckland Bioengineering Institute.	Alrtib AM, 2013, ANAT HISTOL EMBRYOL, V42, P9, DOI 10.1111/j.1439-0264.2012.01158.x; Alrtib AM, 2013, RADIOGRAPHIC BONE MO; Bergot C, 2002, OSTEOPOROSIS INT, V13, P542, DOI 10.1007/s001980200071; Bischoff JE, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026258; Brama PAJ, 2009, EQUINE VET J, V41, P564, DOI 10.2746/042516409X429437; Bryan R, 2010, MED ENG PHYS, V32, P57, DOI 10.1016/j.medengphy.2009.10.008; Chan EF, 2013, OSTEOARTHR CARTILAGE, V21, P443, DOI 10.1016/j.joca.2012.12.007; COOTES TF, 1992, IMAGE VISION COMPUT, V10, P289, DOI 10.1016/0262-8856(92)90044-4; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; DALSTRA M, 1993, J BIOMECH, V26, P523, DOI 10.1016/0021-9290(93)90014-6; Davies H M, 1999, Equine Vet J Suppl, P262; Easton KL, 2007, AM J VET RES, V68, P816, DOI 10.2460/ajvr.68.8.816; Eckstein F, 2009, CALCIFIED TISSUE INT, V84, P186, DOI 10.1007/s00223-008-9208-4; Firth EC, 2005, NEW ZEAL VET J, V53, P101, DOI 10.1080/00480169.2005.36487; Fitzpatrick CK, 2011, J BIOMECH, V44, P2446, DOI 10.1016/j.jbiomech.2011.06.025; Gnudi S, 1999, BRIT J RADIOL, V72, P729, DOI 10.1259/bjr.72.860.10624337; Golub GH., 2013, MATRIX COMPUTATIONS; Harrison SM, 2014, J BIOMECH, V47, P65, DOI 10.1016/j.jbiomech.2013.10.001; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kawcak C, 2009, OSTEOARTHR CARTILAGE, V17, p237 ; Kawcak CE, 2000, AM J VET RES, V61, P1252, DOI 10.2460/ajvr.2000.61.1252; McIlwraith C. W., 1996, JOINT DIS HORSE; MCKELLOP H, 1978, J BIOMED MATER RES, V12, P895, DOI 10.1002/jbm.820120611; Merritt JS, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/165730; Michelotti J, 1999, J BONE MINER RES, V14, P1714, DOI 10.1359/jbmr.1999.14.10.1714; Muir P, 2006, BONE, V38, P342, DOI 10.1016/j.bone.2005.08.020; Nielsen P.M., 1987, ANATOMY HEART FINITE; Parkin IDH, 2004, VET REC, V154, P493, DOI 10.1136/vr.154.16.493; Parkin TDH, 2006, VET J, V171, P157, DOI 10.1016/j.tvjl.2004.10.009; Radtke CL, 2003, AM J VET RES, V64, P1110, DOI 10.2460/ajvr.2003.64.1110; Riggs C M, 1999, Equine Vet J Suppl, P555; Sandgren B, 1993, EQUINE VET J, V25, P31, DOI [10.1111/j.2042-3306.1993.tb04851.x, DOI 10.1111/J.2042-3306.1993.TB04851.X]; Schneider MTY, 2015, J BIOMECH, V48, P3420, DOI 10.1016/j.jbiomech.2015.05.031; Stover SM, 2008, VET CLIN N AM-EQUINE, V24, P21, DOI 10.1016/j.cveq.2007.11.009; Strand E, 1998, EQUINE VET J, V30, P520, DOI 10.1111/j.2042-3306.1998.tb04528.x; Vos F, 2004, PATT REC 2004 ICPR 2; Whitton RC, 2010, BONE, V47, P826, DOI 10.1016/j.bone.2010.07.019; Zekas LJ, 1999, EQUINE VET J, V31, P304, DOI 10.1111/j.2042-3306.1999.tb03821.x; Zhang J, 2014, COMP M BIO BIO E-IV, V2, P176, DOI 10.1080/21681163.2013.878668	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0194406	10.1371/journal.pone.0194406	http://dx.doi.org/10.1371/journal.pone.0194406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874224	Green Submitted, Green Published, gold			2022-12-26	WOS:000434369400001
J	Pierzynowska, KG; Lozinska, L; Wolinski, J; Pierzynowski, S				Pierzynowska, Kateryna Goncharova; Lozinska, Liudmyla; Wolinski, Jaroslaw; Pierzynowski, Stefan			The inverse relationship between blood amylase and insulin levels in pigs during development, bariatric surgery, and intravenous infusion of amylase	PLOS ONE			English	Article							PANCREAS; MODEL; DIASTASE; ENZYMES; OBESITY; BYPASS; ORIGIN; NUMBER; SERUM; GENE	The purpose of this research is to explore the link between plasma amylase and insulin levels in growing pigs. Blood was obtained from piglets ranging in age from preterm (8 days to full gestation period), up to postnatal day 90 (2 months post-weaning) that underwent either duodenal-jejunal bariatric interposition surgery or a sham-operation. Plasma amylase activities in preterm and full-term neonates ranged between 500-600 U/L and were decreased by 50% two months post-weaning. Preprandial insulin and C-peptide levels in neonate piglets were not detectable, however they rose gradually after weaning. An increase in plasma amylase activity was observed in the young pigs that underwent duodenal-jejunum bypass (metabolic) surgery. The increase in blood pancreatic amylase activity after an intravenous amylase infusion lowered the subsequent glucose-stimulated insulin/C-peptide release. We suggest a role for blood amylase in the regulation of glucose homeostasis after observing high blood amylase levels in neonate pigs, in pigs that underwent metabolic surgery, and as a result of the reduced glucose-stimulated insulin response following intravenous amylase administration. Blood amylase level is a dynamic physiological parameter, which is not merely a consequence of exocrine pancreatic digestive enzyme production, but rather a regulated factor involved in glucose assimilation and prandial insulin regulation.	[Pierzynowska, Kateryna Goncharova; Lozinska, Liudmyla; Pierzynowski, Stefan] Lund Univ, Dept Biol, Lund, Sweden; [Pierzynowska, Kateryna Goncharova; Pierzynowski, Stefan] Anara AB, Trelleborg, Sweden; [Lozinska, Liudmyla; Pierzynowski, Stefan] PROF, Lublin, Poland; [Lozinska, Liudmyla] Vassyl Stefanyk Precarpathian Natl Univ, Dept Biochem & Biotechnol, Ivano Frankivsk, Ukraine; [Wolinski, Jaroslaw] Polish Acad Sci, Kielanowski Inst Anim Physiol & Nutr, Dept Anim Physiol, Jablonna, Poland; [Pierzynowski, Stefan] Inst Rural Med, Dept Biol, Lublin, Poland	Lund University; Ministry of Education & Science of Ukraine; Vasyl Stefanyk Precarpathian National University; Polish Academy of Sciences; Kielanowski Institute of Animal Physiology & Nutrition of the Polish Academy of Sciences	Pierzynowska, KG; Pierzynowski, S (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.; Pierzynowska, KG; Pierzynowski, S (corresponding author), Anara AB, Trelleborg, Sweden.; Pierzynowski, S (corresponding author), PROF, Lublin, Poland.; Pierzynowski, S (corresponding author), Inst Rural Med, Dept Biol, Lublin, Poland.	Katerina.Goncharova@biol.lu.se; stefan.pierzynowski@biol.lu.se	Woliński, Jarosław/AAH-3109-2021; Pierzynowski, Stefan Grzegorz/AAU-6107-2021	Woliński, Jarosław/0000-0001-8645-1045; Pierzynowski, Stefan Grzegorz/0000-0002-0308-3214; Pierzynowska, Kateryna/0000-0002-3290-339X				Breen DM, 2012, NAT MED, V18, P950, DOI 10.1038/nm.2745; DREILING DA, 1959, AM J DIG DIS, V4, P731, DOI 10.1007/BF02232179; Falchi M, 2014, NAT GENET, V46, P492, DOI 10.1038/ng.2939; HENDERSON JR, 1981, GUT, V22, P158, DOI 10.1136/gut.22.2.158; JANOWITZ HD, 1959, AM J MED, V27, P924, DOI 10.1016/0002-9343(59)90176-7; Jasdanwala SBM, 2015, INTEGR MOL MED, V2, P189, DOI DOI 10.15761/IMM.1000137; Lindqvist A, 2017, PEPTIDES, V90, P78, DOI 10.1016/j.peptides.2017.02.009; Lindqvist A, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0173137, 10.1371/journal.pone.013137]; Lozinska L, 2016, EXP PHYSIOL, V101, P100, DOI 10.1113/EP085431; Lozinska L, 2015, ADV MED SCI-POLAND, V60, P112, DOI 10.1016/j.advms.2015.01.003; Mejia-Bentez MA, 2015, DIABETOLOGIA, V58, P290, DOI 10.1007/s00125-014-3441-3; Muneyuki T, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-80; NOTHMAN MM, 1971, GASTROENTEROLOGY, V60, P82; Pierzynowski SG, 2016, J DIABETES METAB, V7, DOI 10.4172/2155-6156.1000681; PIERZYNOWSKI SG, 1993, J PEDIATR GASTR NUTR, V16, P287, DOI 10.1097/00005176-199304000-00012; Pierzynowski SG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07387-2; Reid C, 1930, Q J EXP PHYSIOL, V20, P305, DOI 10.1113/expphysiol.1930.sp000508; Reid E, 1933, J BIOL CHEM, V99, P607; Sangild PT, 2013, J ANIM SCI, V91, P4713, DOI 10.2527/jas.2013-6359; SEARCY RL, 1967, PEDIATRICS, V39, P294; Somogyi M, 1940, J BIOL CHEM, V134, P315; Viljakainen H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131883; Yadav D, 2002, AM J GASTROENTEROL, V97, P1309, DOI 10.1016/S0002-9270(02)04122-9	23	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198672	10.1371/journal.pone.0198672	http://dx.doi.org/10.1371/journal.pone.0198672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874296	Green Published, gold, Green Submitted			2022-12-26	WOS:000434369400060
J	Silbernagel, N; Walecki, M; Schafer, MKH; Kessler, M; Zobeiri, M; Rinne, S; Kiper, AK; Komadowski, MA; Vowinkel, KS; Wemhoner, K; Fortmuller, L; Schewe, M; Dolga, AM; Scekic-Zahirovic, J; Matschke, LA; Culmsee, C; Baukrowitz, T; Monassier, L; Ullrich, ND; Dupuis, L; Just, S; Budde, T; Fabritz, L; Decher, N				Silbernagel, Nicole; Walecki, Magdalena; Schaefer, Martin K. -H.; Kessler, Mirjam; Zobeiri, Mehrnoush; Rinne, Susanne; Kiper, Aytug K.; Komadowski, Marlene A.; Vowinkel, Kirsty S.; Wemhoener, Konstantin; Fortmueller, Lisa; Schewe, Marcus; Dolga, Amalia M.; Scekic-Zahirovic, Jelena; Matschke, Lina A.; Culmsee, Carsten; Baukrowitz, Thomas; Monassier, Laurent; Ullrich, Nina D.; Dupuis, Luc; Just, Steffen; Budde, Thomas; Fabritz, Larissa; Decher, Niels			The VAMP-associated protein VAPB is required for cardiac and neuronal pacemaker channel function	FASEB JOURNAL			English	Article						HCN channels; ALS; cardiac arrhythmia	HCN CHANNELS; ENDOPLASMIC-RETICULUM; CATION CURRENT; CYCLIC-AMP; LATE-ONSET; TRAFFICKING; TRIP8B; EXPRESSION; MUTATION; FAMILY	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels encode neuronal and cardiac pacemaker currents. The composition of pacemaker channel complexes in different tissues is poorly understood, and the presence of additional HCN modulating subunits was speculated. Here we show that vesicle-associated membrane protein-associated protein B (VAPB), previously associated with a familial form of amyotrophic lateral sclerosis 8, is an essential HCN1 and HCN2 modulator. VAPB significantly increases HCN2 currents and surface expression and has a major influence on the dendritic neuronal distribution of HCN2. Severe cardiac bradycardias in VAPB-deficient zebrafish and VAPB(-/-) mice highlight that VAPB physiologically serves to increase cardiac pacemaker currents. An altered T-wave morphology observed in the ECGs of VAPB(-/-) mice supports the recently proposed role of HCN channels for ventricular repolarization. The critical function of VAPB in native pacemaker channel complexes will be relevant for our understanding of cardiac arrhythmias and epilepsies, and provides an unexpected link between these diseases and amyotrophic lateral sclerosis.Silbernagel, N., Walecki, M., Schafer, M.-K. H., Kessler, M., Zobeiri, M., Rinne, S., Kiper, A. K., Komadowski, M. A., Vowinkel, K. S., Wemhoner, K., Fortmuller, L., Schewe, M., Dolga, A. M., Scekic-Zahirovic, J., Matschke, L. A., Culmsee, C., Baukrowitz, T., Monassier, L., Ullrich, N. D., Dupuis, L., Just, S., Budde, T., Fabritz, L., Decher, N. The VAMP-associated protein VAPB is required for cardiac and neuronal pacemaker channel function.	[Silbernagel, Nicole; Walecki, Magdalena; Rinne, Susanne; Kiper, Aytug K.; Komadowski, Marlene A.; Vowinkel, Kirsty S.; Wemhoener, Konstantin; Matschke, Lina A.; Decher, Niels] Philipps Univ Marburg, Inst Physiol & Pathophysiol, Vegetat Physiol, Deutschhausstr 1-2, D-35037 Marburg, Germany; [Schaefer, Martin K. -H.; Komadowski, Marlene A.] Philipps Univ Marburg, Inst Anat & Cell Biol, Marburg, Germany; [Dolga, Amalia M.; Culmsee, Carsten] Philipps Univ Marburg, Inst Pharmacol & Clin Pharm, Marburg, Germany; [Kessler, Mirjam; Just, Steffen] Univ Hosp Ulm, Dept Internal Med 2, Mol Cardiol, Ulm, Germany; [Fortmueller, Lisa; Fabritz, Larissa] Univ Hosp Munster, Dept Cardiol Electrophysiol 2, Munster, Germany; [Fabritz, Larissa] Univ Hosp Munster, Div Rhythmol, Munster, Germany; [Fabritz, Larissa] Univ Hosp Munster, Dept Genet Epidemiol, Inst Human Genet, Munster, Germany; [Zobeiri, Mehrnoush; Budde, Thomas] Univ Munster, Inst Physiol 1, Munster, Germany; [Schewe, Marcus; Baukrowitz, Thomas] Univ Kiel, Inst Physiol, Kiel, Germany; [Scekic-Zahirovic, Jelena; Monassier, Laurent] Univ Strasbourg, Lab Pharmacol & Toxicol NeuroCardiovasc, Strasbourg, France; [Dupuis, Luc] Univ Strasbourg, Lab Neurobiol & Pharmacol Cardiovasc, Strasbourg, France; [Dupuis, Luc] Univ Strasbourg, INSERM, Fac Med, Strasbourg, France; [Ullrich, Nina D.] Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany; [Fabritz, Larissa] Univ Birmingham, Univ Hosp Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England; [Fabritz, Larissa] Univ Birmingham, Univ Hosp Birmingham, Dept Cardiol, Birmingham, W Midlands, England	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Ulm University; University of Munster; University of Munster; University of Munster; University of Munster; University of Kiel; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Ruprecht Karls University Heidelberg; University of Birmingham; University of Birmingham	Decher, N (corresponding author), Philipps Univ Marburg, Inst Physiol & Pathophysiol, Vegetat Physiol, Deutschhausstr 1-2, D-35037 Marburg, Germany.	decher@staff.uni-marburg.de	Monassier, Laurent/AAE-4446-2022; Decher, Niels/AAF-5002-2020; Kiper, Aytug Kadir/AAG-5093-2019; Dupuis, Luc/A-6981-2012; Dolga, Amalia/C-9664-2018; Culmsee, Carsten/ABC-3120-2021; Kiper, Aytug K/N-2340-2018; Ullrich, Nina/U-8217-2019	Kiper, Aytug Kadir/0000-0003-2850-2523; Culmsee, Carsten/0000-0002-5121-5015; Kiper, Aytug K/0000-0003-2850-2523; Ullrich, Nina/0000-0002-1077-3125; Schewe, Marcus/0000-0002-6192-5651; Dolga, Amalia/0000-0001-5400-5614; Baukrowitz, Thomas/0000-0003-4562-0505; Dupuis, Luc/0000-0002-0902-5824; Fabritz, Larissa/0000-0002-9241-1733	Atrial Fibrillation Network (AFNET), (CATCH ME European Research Consortium) [633196]; British Heart Foundation [FS/13/43/30324]; Leducq Foundation; IZKF Munster grant [Bud3/001/016]; University Medical Center Giessen and Marburg (UKGM); Deutsche Forschungsgemeinschaft [DE 1482/2-1]	Atrial Fibrillation Network (AFNET), (CATCH ME European Research Consortium); British Heart Foundation(British Heart Foundation); Leducq Foundation(Leducq Foundation); IZKF Munster grant; University Medical Center Giessen and Marburg (UKGM); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Oxana Nowak and Andrea Schubert for technical assistance, Nikolaj Klocker (Heinrich Heine University Dusseldorf, Dusseldorf, Germany) for the <SUP>EGFP</SUP>HCN2<INF>Ex</INF><SUP>HA</SUP> construct and technical advice on the ELISA assays, Caspar Hoogenraad (Utrecht University, Utrecht, Netherlands) for the <SUP>HA</SUP>VAPB construct, Bernd Fakler (University of Freiburg, Freiburg, Germany) for the HCN1 and HCN2 pBF1 constructs, and Vijay Renigunta (Philipps-University Marburg, Marburg, Germany) for the HCN4-pBR3-N construct and technical advice on the Y2H screen. The authors thank Omer Guran (University of Birmingham) for expert help with blinded ECG analysis. L.F. was supported, in part, by the Atrial Fibrillation Network (AFNET), (CATCH ME European Research Consortium; 633196), the British Heart Foundation (FS/13/43/30324), and the Leducq Foundation. T.B. was supported by a IZKF Munster grant (Bud3/001/016). S.R. and A.K.K. were supported by a Research Grant of the University Medical Center Giessen and Marburg (UKGM). This work was supported by a grant of the Deutsche Forschungsgemeinschaft (DE 1482/2-1) to N.D. The authors declare no conflicts of interest.	Anagnostou G, 2010, NEUROBIOL AGING, V31, P969, DOI 10.1016/j.neurobiolaging.2008.07.005; Asai H, 2007, J NEUROL SCI, V254, P78, DOI 10.1016/j.jns.2007.01.007; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Biel M, 2002, TRENDS CARDIOVAS MED, V12, P206, DOI 10.1016/S1050-1738(02)00162-7; Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; Chen XD, 2005, J NEUROSCI, V25, P5803, DOI 10.1523/JNEUROSCI.1153-05.2005; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Decher N, 2017, EMBO MOL MED, V9, P403, DOI 10.15252/emmm.201606690; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DiFrancesco JC, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00071; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dolga AM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.30; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fenske S, 2013, CIRCULATION, V128, P2585, DOI 10.1161/CIRCULATIONAHA.113.003712; Fenske S, 2011, TRENDS CARDIOVAS MED, V21, P216, DOI 10.1016/j.tcm.2012.05.013; Fenske S, 2011, CIRC RES, V109, P1015, DOI 10.1161/CIRCRESAHA.111.246173; Finsterer J, 2016, INT J CARDIOL, V203, P508, DOI 10.1016/j.ijcard.2015.10.176; Foster LJ, 2000, TRAFFIC, V1, P512, DOI 10.1034/j.1600-0854.2000.010609.x; Friedrich C, 2014, EMBO MOL MED, V6, P937, DOI 10.15252/emmm.201303783; Gkogkas C, 2008, HUM MOL GENET, V17, P1517, DOI 10.1093/hmg/ddn040; Han Y, 2011, J BIOL CHEM, V286, P20823, DOI 10.1074/jbc.M111.236125; Hofmann F, 2012, CARDIOVASC RES, V95, P317, DOI 10.1093/cvr/cvs184; Hu L, 2013, J GEN PHYSIOL, V142, P599, DOI 10.1085/jgp.201311013; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kabashi E, 2013, HUM MOL GENET, V22, P2350, DOI 10.1093/hmg/ddt080; Kanyshkova T, 2009, J NEUROSCI, V29, P8847, DOI 10.1523/JNEUROSCI.0689-09.2009; Kessler M, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0468-7; Langenbacher AD, 2005, P NATL ACAD SCI USA, V102, P17699, DOI 10.1073/pnas.0502679102; Leroy F, 2014, ELIFE, V3, DOI 10.7554/eLife.04046; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Lvov A, 2008, PFLUG ARCH EUR J PHY, V456, P1121, DOI 10.1007/s00424-008-0468-7; Marques VD, 2008, J CLIN NEUROPHYSIOL, V25, P233, DOI 10.1097/WNP.0b013e31817ed219; Marques VD, 2006, MUSCLE NERVE, V34, P731, DOI 10.1002/mus.20657; Meder B, 2011, BIOCHEM BIOPH RES CO, V408, P218, DOI 10.1016/j.bbrc.2011.03.121; Mitne-Neto M, 2011, HUM MOL GENET, V20, P3642, DOI 10.1093/hmg/ddr284; Murata Y, 1997, ACTA NEUROL SCAND, V96, P118; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; Renigunta V, 2014, MOL BIOL CELL, V25, P1877, DOI [10.1091/mbc.E13-0592, 10.1091/mbc.E13-10-0592]; Roselli F, 2015, NEURON, V85, P901, DOI 10.1016/j.neuron.2014.12.063; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Saponaro A, 2014, P NATL ACAD SCI USA, V111, P14577, DOI 10.1073/pnas.1410389111; Sartiani L, 2002, J PHYSIOL-LONDON, V545, P81, DOI 10.1113/jphysiol.2002.021535; Saxena S, 2013, NEURON, V80, P80, DOI 10.1016/j.neuron.2013.07.027; Shemisa Kamal, 2014, J Med Case Rep, V8, P224, DOI 10.1186/1752-1947-8-224; SHIMIZU T, 1994, J NEUROL SCI, V124, P45, DOI 10.1016/0022-510X(94)90009-4; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	64	9	9	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6159	6173		10.1096/fj.201800246R	http://dx.doi.org/10.1096/fj.201800246R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29879376	hybrid, Green Published			2022-12-26	WOS:000447172000033
J	Dangardt, F; Charakida, M; Chiesa, S; Bhowruth, D; Rapala, A; Thurn, D; Schaefer, F; Deanfield, J; Shroff, R				Dangardt, Frida; Charakida, Marietta; Chiesa, Scott; Bhowruth, Devine; Rapala, Alicja; Thurn, Daniela; Schaefer, Franz; Deanfield, John; Shroff, Rukshana			Intimal and medial arterial changes defined by ultra-high-frequency ultrasound: Response to changing risk factors in children with chronic kidney disease	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; STAGE RENAL-DISEASE; VASCULAR CALCIFICATION; MINERAL METABOLISM; YOUNG-ADULTS; THICKNESS; TRANSPLANT; DIALYSIS; CORONARY; HYPERTENSION	Background Patients with chronic kidney disease (CKD) are exposed to both traditional 'Framingham' and uremia related cardiovascular risk factors that drive atherosclerotic and arteriosclerotic disease, but these cannot be differentiated using conventional ultrasound. We used ultrahigh-frequency ultrasound (UHFUS) to differentiate medial thickness (MT) from intimal thickness (IT) in CKD patients, identify their determinants and monitor their progression. Methods Fifty-four children and adolescents with CKD and 12 healthy controls underwent UHFUS measurements using 55-70MHz transducers in common carotid and dorsal pedal arteries. Annual follow-up imaging was performed in 31 patients. Results CKD patients had higher carotid MT and dorsal pedal IT and MT compared to controls. The carotid MT in CKD correlated with serum phosphate (p<0.001, r = 0.42), PTH (p = 0.03, r = 0.36) and mean arterial pressure (p = 0.03, r = 0.34). Following multivariable analysis, being on dialysis, serum phosphate levels and mean arterial pressure remained the only independent predictors of carotid MT (R-2 64%). Transplanted children had lower carotid and dorsal pedal MT compared to CKD and dialysis patients (p = 0.02 and p = 0.01 respectively). At 1-year follow-up, transplanted children had a decrease in carotid MT (p = 0.01), but an increase in dorsal pedal IT (p = 0.04) that independently correlated with annualized change in BMI. Conclusions Using UHFUS, we have shown that CKD is associated with exclusively medial arterial changes that attenuate when the uremic milieu is ameliorated after transplantation. In contrast, after transplantation intimal disease develops as hypertension and obesity become prevalent, representing rapid vascular remodeling in response to a changing cardiovascular risk factor profile.	[Dangardt, Frida; Charakida, Marietta; Chiesa, Scott; Bhowruth, Devine; Rapala, Alicja; Deanfield, John; Shroff, Rukshana] UCL, Natl Ctr Cardiovasc Prevent & Outcomes, Inst Cardiovasc Sci, Vasc Physiol Unit, London, England; [Dangardt, Frida] Sahlgrenska Acad & Univ Hosp, Queen Silvia Childrens Hosp, Dept Pediat Clin Physiol, Gothenburg, Sweden; [Charakida, Marietta] Kings Coll London, Div Imaging Sci & Biomed Engn, London, England; [Thurn, Daniela] Hannover Med Sch, Dept Pediat Nephrol, Hannover, Germany; [Schaefer, Franz] Heidelberg Univ, Ctr Pediat & Adolescent Med, Div Pediat Nephrol, Heidelberg, Germany; [Shroff, Rukshana] Great Ormond St Hosp Children NHS Fdn Trust, Nephrol Unit, London, England	University of London; University College London; Queen Silvia Children's Hospital; Sahlgrenska University Hospital; University of Gothenburg; University of London; King's College London; Hannover Medical School; Ruprecht Karls University Heidelberg; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Dangardt, F (corresponding author), UCL, Natl Ctr Cardiovasc Prevent & Outcomes, Inst Cardiovasc Sci, Vasc Physiol Unit, London, England.; Dangardt, F (corresponding author), Sahlgrenska Acad & Univ Hosp, Queen Silvia Childrens Hosp, Dept Pediat Clin Physiol, Gothenburg, Sweden.	frida.dangardt@gu.se; mariete.s@gmail.com	Shroff, Rukshana C/C-7347-2008; Dangardt, Frida/AHC-9294-2022; Chiesa, Scott/AAZ-1303-2020; Shroff, Rukshana/AAG-5383-2019; Dangardt, Frida/V-9640-2019	Shroff, Rukshana C/0000-0001-8501-1072; Chiesa, Scott/0000-0003-4323-2189; Shroff, Rukshana/0000-0001-8501-1072; Charakida, Marietta/0000-0003-4214-5059; Dangardt, Frida/0000-0003-4632-3916; Deanfield, John/0000-0001-8806-6052	National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London; National Institute for Health Research (NIHR) [CDF-2016-09-038]; Swedish Heart-Lung Foundation [20130643]; British Heart Foundation Professor of Cardiology [CH/03/002/15570]; German Federal Ministry of Education and Research [01EO0802]	National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London(General Electric); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); British Heart Foundation Professor of Cardiology; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London. RS holds a Career Development Fellowship with the National Institute for Health Research (NIHR, https://www.nihr.ac.uk), grant number CDF-2016-09-038. FD was partly funded by a post-doctoral scholarship from the Swedish Heart-Lung Foundation (https://www.hjart-lungfonden.se), grant number 20130643. JD is a British Heart Foundation Professor of Cardiology, grant number CH/03/002/15570. The Vevo2100 was on loan from Visualsonics Inc. Support for the 4C Study was received from the German Federal Ministry of Education and Research (https:///www.bmbf.de) grant number: 01EO0802. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London. RS holds a Career Development Fellowship with the National Institute for Health Research (NIHR, https://wwwmihnac_uk), grant number CDF-2016-09-038. FD was partly funded by a post-doctoral scholarship from the Swedish Heart-Lung Foundation (https://www.hjart-lungfonden.se), grant number 20130643. JD is a British Heart Foundation Professor of Cardiology, grant number CH/03/002/15570. The Vevo2100 was on loan from Visualsonics Inc. Support for the 4C Study was received from the German Federal Ministry of Education and Research Oilips://www.bmbf.de) grant number: 01EO0802.	Benz K, 2017, CARDIOVASC PATHOL, V27, P57, DOI 10.1016/j.carpath.2017.01.004; Bonthuis M, 2015, CLIN J AM SOC NEPHRO, V10, P767, DOI 10.2215/CJN.06200614; Brady TM, 2012, CLIN J AM SOC NEPHRO, V7, P1930, DOI 10.2215/CJN.03130312; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Dangardt F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057454; Doyon A, 2013, HYPERTENSION, V62, P550, DOI 10.1161/HYPERTENSIONAHA.113.01297; Eklund C, 2014, EUR HEART J-CARD IMG, V15, P769, DOI 10.1093/ehjci/jet285; Gan LM, 2007, ATHEROSCLEROSIS, V190, P313, DOI 10.1016/j.atherosclerosis.2006.03.035; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Jablonski KL, 2013, HEMODIAL INT, V17, pS17, DOI 10.1111/hdi.12084; Johansson M, 2010, ATHEROSCLEROSIS, V211, P159, DOI 10.1016/j.atherosclerosis.2010.01.031; Laughlin MH, 2012, PERIPHERAL CIRCULATI; Litwin M, 2005, J AM SOC NEPHROL, V16, P1494, DOI 10.1681/ASN.2004110932; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Mitsnefes M, 2005, AM J KIDNEY DIS, V45, P309, DOI 10.1053/j.ajkd.2004.11.006; Mitsnefes M, 2010, J AM SOC NEPHROL, V21, P137, DOI 10.1681/ASN.2009060609; Mitsnefes MM, 2012, J AM SOC NEPHROL, V23, P578, DOI 10.1681/ASN.2011111115; Newcomer SC, 2004, J PHYSIOL-LONDON, V556, P1001, DOI 10.1113/jphysiol.2003.059717; Oh J, 2002, CIRCULATION, V106, P100, DOI 10.1161/01.CIR.0000020222.63035.C0; Osika W, 2007, ARTERIOSCL THROM VAS, V27, P671, DOI 10.1161/01.ATV.0000256468.95403.6f; Osika W, 2009, ATHEROSCLEROSIS, V203, P172, DOI 10.1016/j.atherosclerosis.2008.05.054; Querfeld U, 2010, CLIN J AM SOC NEPHRO, V5, P1642, DOI 10.2215/CJN.08791209; Sarkola T, 2012, ATHEROSCLEROSIS, V224, P102, DOI [10.1016/j.atherosclerosis.2012.06.054, DOI 10.1016/J.ATHER0SCLER0SIS.2012.06.054]; Sarkola T, 2012, ARTERIOSCL THROM VAS, V32, P2516, DOI 10.1161/ATVBAHA.112.252114; Sarkola T, 2010, ATHEROSCLEROSIS, V212, P516, DOI 10.1016/j.atherosclerosis.2010.06.043; Shroff R, 2013, J AM SOC NEPHROL, V24, P179, DOI 10.1681/ASN.2011121191; Shroff R, 2011, NAT REV NEPHROL, V7, P642, DOI 10.1038/nrneph.2011.116; Shroff RC, 2008, CIRCULATION, V118, P1748, DOI 10.1161/CIRCULATIONAHA.108.783738; Shroff RC, 2007, J AM SOC NEPHROL, V18, P2996, DOI 10.1681/ASN.2006121397; Vervloet M, 2017, KIDNEY INT, V91, P808, DOI 10.1016/j.kint.2016.09.024; Wilson AC, 2010, PEDIATR TRANSPLANT, V14, P52, DOI 10.1111/j.1399-3046.2009.01141.x	31	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198547	10.1371/journal.pone.0198547	http://dx.doi.org/10.1371/journal.pone.0198547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902198	gold, Green Published, Green Submitted			2022-12-26	WOS:000435424900028
J	Samouda, H; Ruiz-Castell, M; Bocquet, V; Kuemmerle, A; Chioti, A; Dadoun, F; Kandala, NB; Stranges, S				Samouda, Hanen; Ruiz-Castell, Maria; Bocquet, Valery; Kuemmerle, Andrea; Chioti, Anna; Dadoun, Frederic; Kandala, Ngianga-Bakwin; Stranges, Saverio			Geographical variation of overweight, obesity and related risk factors: Findings from the European Health Examination Survey in Luxembourg, 2013-2015	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; SOCIOECONOMIC INEQUALITY; WEIGHT; ASSOCIATIONS; PREVALENCE; EXPOSURE; PROGRAM; FITNESS; BURDEN	The analyses of geographic variations in the prevalence of major chronic conditions, such as overweight and obesity, are an important public health tool to identify "hot spots" and inform allocation of funding for policy and health promotion campaigns, yet rarely performed. Here we aimed at exploring, for the first time in Luxembourg, potential geographic patterns in overweight/obesity prevalence in the country, adjusted for several demographic, socioeconomic, behavioural and health status characteristics. Data came from 720 men and 764 women, 25-64 years old, who participated in the European Health Examination Survey in Luxembourg (2013-2015). To investigate the geographical variation, geo-additive semiparametric mixed model and Bayesian modelisations based on Markov Chain Monte Carlo techniques for inference were performed. Large disparities in the prevalence of overweight and obesity were found between municipalities, with the highest rates of obesity found in 3 municipalities located in the South-West of the country. Bayesian approach also underlined a nonlinear effect of age on overweight and obesity in both genders (significant in men) and highlighted the following risk factors: 1. country of birth for overweight in men born in a non-European country (Posterior Odds Ratio (POR): 3.24 [1.61-8.69]) and women born in Portugal (POR: 2.44 [1.25-4.43]), 2. low educational level (secondary or below) for overweight (POR: 1.66 (1.06-2.72)] and obesity (POR:2.09 [1.05-3.65]) in men, 3. single marital status for obesity in women (POR: 2.20 [1.24-3.91]), 4.fair (men: POR: 3.19 [1.58-6.79], women: POR: 2.24 [1.33-3.73]) to very bad health perception (men: POR: 15.01 [2.16-98.09]) for obesity, 5. sleeping more than 6 hours for obesity in unemployed men (POR: 3.66 [2.02-8.03]). Protective factors highlighted were: 1. single marital status against overweight (POR: [0.60 (0.38-0.96)]) and obesity (POR: 0.39 [0.16-0.84]) in men, 2. the fact to be widowed against overweight in women (POR: [0.30 (0.07-0.86)], as well as a non European country of birth (POR: 0.49 [0.19-0.98]), tertiary level of education (POR: 0.34 [0.18-0.64]), moderate alcohol consumption (POR: 0.54 [0.36-0.90]) and aerobic physical activity practice (POR: 0.44 [0.27-0.77]) against obesity in women. A double burden of environmental exposure due to historic mining and industrial activities and past economic vulnaribility in the South-West of the country may have participated to the higher prevalence of obesity found in this region. Other demographic, socioeconomic, behavioural and health status covariates could have been involved as well.	[Samouda, Hanen; Ruiz-Castell, Maria; Chioti, Anna] Luxembourg Inst Hlth, Populat Hlth Dept, Epidemiol & Publ Hlth Res Unit, Strassen, Luxembourg; [Bocquet, Valery] Luxembourg Inst Hlth, Competence Ctr Methodol & Stat, Strassen, Luxembourg; [Kuemmerle, Andrea] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Dadoun, Frederic] Ctr Hosp Luxembourg, Endocrinol & Diabetol Dept, Luxembourg, Luxembourg; [Kandala, Ngianga-Bakwin] Northumbria Univ, Fac Engn & Environm, Dept Math Phys & Elect Engn, Newcastle Upon Tyne, Tyne & Wear, England; [Stranges, Saverio] Western Univ, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON, Canada	Luxembourg Institute of Health; Luxembourg Institute of Health; University of Basel; Swiss Tropical & Public Health Institute; Luxembourg Hospital Center; Northumbria University; Western University (University of Western Ontario)	Samouda, H (corresponding author), Luxembourg Inst Hlth, Populat Hlth Dept, Epidemiol & Publ Hlth Res Unit, Strassen, Luxembourg.	hanene.samouda@lih.lu	Bocquet, Valéry/GWC-0796-2022	Samouda, Hanen/0000-0003-3450-4189; bocquet, valery/0000-0002-3089-2877; Ruiz-Castell, Maria/0000-0001-9741-7491; Stranges, Saverio/0000-0001-5226-8373	Luxembourg Institute of Health, Luxembourg; Ministry of Culture, Higher Education and Research, Luxembourg; Ministry of Health, Luxembourg	Luxembourg Institute of Health, Luxembourg; Ministry of Culture, Higher Education and Research, Luxembourg; Ministry of Health, Luxembourg	This work was supported by the Luxembourg Institute of Health, Luxembourg; Ministry of Culture, Higher Education and Research, Luxembourg; and the Ministry of Health, Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0317-y; Aitsi-Selmi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090403; Aitsi-Selmi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039507; Alkerwi A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060648; Alkerwi A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-468; Amugsi DA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017344; Atek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075640; Best N, 2005, STAT METHODS MED RES, V14, P35, DOI 10.1191/0962280205sm388oa; Bonauto DK, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130219; Boyes AD, 2009, J SEX MARITAL THER, V35, P282, DOI 10.1080/00926230902851280; Brien SE, 2007, CAN J PUBLIC HEALTH, V98, P121, DOI 10.1007/BF03404322; Burgoine T, 2016, AM J CLIN NUTR, V103, P1540, DOI 10.3945/ajcn.115.128132; Chang SJ, 2015, RES THEOR NURS PRACT, V29, P177, DOI 10.1891/1541-6577.29.3.177; Clements ACA, 2006, TROP MED INT HEALTH, V11, P490, DOI 10.1111/j.1365-3156.2006.01594.x; Conscienhealth, 2016, 29 BLACKB COURS OB M; Delavari M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-458; Devaux M., 2011, OECD J EC STUDIES, V1, P1, DOI [10.1787/eco_studies-2011-5kg5825v1k23, DOI 10.1787/ECO_STUDIES-2011-5KG5825V1K23]; Fahrmeir L, 2010, APPL STAT JRSSC, V50, P201; Finger JD, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0110-z; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Gast J, 2015, AM J HEALTH PROMOT, V29, pE91, DOI 10.4278/ajhp.130305-QUAN-97; Gomez-Arbelaez D, 2014, INT J ENV RES PUB HE, V11, P1834, DOI 10.3390/ijerph110201834; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Grun F, 2009, MOL CELL ENDOCRINOL, V304, P19, DOI 10.1016/j.mce.2009.02.018; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Kandala NB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101103; Kark M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-833; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Le Portail des Statistiques, 2014, POPULATION PARAGE SE; Lin CL, 2018, OBES RES CLIN PRACT, V12, P384, DOI 10.1016/j.orcp.2016.07.005; Lord S, 2013, ANN GEOGR, V2, P99; Mangeri F, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-74; Maqoud Fatima, 2016, Coll Antropol, V40, P9; Monteiro R, 2009, NUTRITION, V25, P699, DOI 10.1016/j.nut.2009.01.001; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Oumeziane AA, 2017, EC RECONVERSION CONS, V109; Patterson KAE, 2017, ANN EPIDEMIOL, V27, P169, DOI 10.1016/j.annepidem.2017.01.007; Rouhani MH, 2016, NUTRITION, V32, P1037, DOI 10.1016/j.nut.2016.03.017; Ruiz-Castell M, 2017, J AFFECT DISORDERS, V222, P41, DOI 10.1016/j.jad.2017.06.056; Ruiz-Castell M, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004758; Rundle AG, 2016, JAMA-J AM MED ASSOC, V315, P2175, DOI 10.1001/jama.2016.5635; Samouda H, 2019, DIABETES METAB, V45, P140, DOI 10.1016/j.diabet.2017.11.007; Scarborough P, 2008, BRIT J NUTR, V100, P677, DOI 10.1017/S0007114508911582; Shields M, 2001, Health Rep, V13, P35; SOBAL J, 1992, SOC SCI MED, V35, P915, DOI 10.1016/0277-9536(92)90106-Z; Stryjecki C, 2018, OBES REV, V19, P62, DOI 10.1111/obr.12604; Tang-Peronard JL, 2011, OBES REV, V12, P622, DOI 10.1111/j.1467-789X.2011.00871.x; Tchicaya Anastase, 2012, BMC Res Notes, V5, P467, DOI 10.1186/1756-0500-5-467; Tolonen H, EHES MANUAL B; Toselli S, 2014, EUR J PUBLIC HEALTH, V24, P31, DOI 10.1093/eurpub/cku103; Van Dyck D, 2015, INT J OBESITY, V39, P199, DOI 10.1038/ijo.2014.115; Wang YF, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111112; Wen M, 2018, AM J HEALTH PROMOT, V32, P400, DOI 10.1177/0890117116689488; Zhang Q, 2004, SOC SCI MED, V58, P1171, DOI 10.1016/S0277-9536(03)00288-0	54	19	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0197021	10.1371/journal.pone.0197021	http://dx.doi.org/10.1371/journal.pone.0197021			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ5MF	29902172	gold, Green Accepted, Green Published			2022-12-26	WOS:000435424900003
J	Sanguigno, L; Casamassa, A; Funel, N; Minale, M; Riccio, R; Riccio, S; Boscia, F; Brancaccio, P; Pollina, LE; Anzilotti, S; Di Renzo, G; Cuomo, O				Sanguigno, Luca; Casamassa, Antonella; Funel, Niccola; Minale, Massimiliano; Riccio, Rodolfo; Riccio, Salvatore; Boscia, Francesca; Brancaccio, Paola; Pollina, Luca Emanuele; Anzilotti, Serenella; Di Renzo, Gianfranco; Cuomo, Ornella			Triticum vulgare extract exerts an anti-inflammatory action in two in vitro models of inflammation in microglial cells	PLOS ONE			English	Article							DENDRITIC CELLS; TISSUE-REPAIR; WOUND REPAIR; IN-VITRO; MACROPHAGES; FIBROSIS; RESPONSES; EFFICACY; PROTEIN; IBA1	Triticum vulgare has been extensively used in traditional medicine thanks to its properties of accelerating tissue repair. The specific extract of Triticum vulgare manufactured by Farma-ceutici Damor (TVE-DAMOR) is already present in some pharmaceutical formulations used in the treatment of decubitus ulcers, skin lesions and burns. It has been recently suggested that this Triticum vulgare extract may possess potential anti-inflammatory properties. In the light of these premises the aim of the present paper was to verify the anti-inflammatory role of TVE, using the LPS-stimulated microglia model of inflammation. In particular the effect of different concentrations of TVE on the release of several mediators of inflammation such as nitric oxide, IL-6, PGE2 and TNF alpha was evaluated. More important, the anti-inflammatory effect of TVE was confirmed also in primary rat microglia cultures. The results of the present study show that TVE exerts anti-inflammatory properties since it reduces the release of all the evaluated markers of inflammation, such as NO, IL6, TNF alpha and PGE2 in LPS-activated BV2 microglial cells. Intriguingly, TVE reduced microglia activation and NO release also in primary microglia. Indeed, to verify the pathway of modulation of the inflammatory markers reported above, we found that TVE restores the cytoplasmic expression of p65 protein, kwown as specific marker associated with activation of inflammatory response. The evidence for an inhibitory activity on inflammation of this specific extract of Triticum vulgare may open the way to the possibility of a therapeutical use of the Triticum vulgare extract as an anti-inflammatory compound in certain pathological states such as burns, decubitus ulcers, folliculitis and inflammation of peripheral nerve.	[Sanguigno, Luca] Federico II Univ Naples, Sch Med, Dept Mol Med & Med Biotechnol, Naples, Italy; [Casamassa, Antonella; Boscia, Francesca; Brancaccio, Paola; Di Renzo, Gianfranco; Cuomo, Ornella] Federico II Univ Naples, Sch Med, Dept Neurosci Reprod & Dent Sci, Div Pharmacol, Naples, Italy; [Funel, Niccola] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Minale, Massimiliano; Riccio, Rodolfo; Riccio, Salvatore] Farmaceut Damor SpA, Naples, Italy; [Pollina, Luca Emanuele] Hosp Pisa, Div Surg Pathol 2, Pisa, Italy; [Anzilotti, Serenella] IRCSS SDN, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Pisa; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN)	Cuomo, O (corresponding author), Federico II Univ Naples, Sch Med, Dept Neurosci Reprod & Dent Sci, Div Pharmacol, Naples, Italy.	orcuomo@yahoo.it	anzilotti, Serenella/I-8686-2018; Brancaccio, Paola/GZL-0449-2022	sanguigno, luca/0000-0002-1375-6304; Funel, Niccola/0000-0002-5028-2363; anzilotti, serenella/0000-0002-8729-0009	Ministero Istruzione e Ricerca (MIUR), Italy [DM285772006]; Fondazione Italiana Sclerosi Multipla FISM [2012/R/1]	Ministero Istruzione e Ricerca (MIUR), Italy(Ministry of Education, Universities and Research (MIUR)); Fondazione Italiana Sclerosi Multipla FISM(Fondazione Italiana Sclerosi Multipla (FISM))	Financial support from Ministero Istruzione e Ricerca (MIUR), Italy, under Grant DM285772006 and from Fondazione Italiana Sclerosi Multipla FISM 2012/R/1 to F.B is gratefully acknowledged. Damor Farmaceutici provided support in the form of salaries for authors ((MM and RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel A, 2013, J PATHOL, V229, P250, DOI 10.1002/path.4108; Boscia F, 2016, MOL NEUROBIOL, V53, P1365, DOI 10.1007/s12035-015-9095-4; Boscia F, 2013, J NEUROCHEM, V126, P428, DOI 10.1111/jnc.12209; Boscia F, 2009, STROKE, V40, P3608, DOI 10.1161/STROKEAHA.109.557439; Chaturvedi A., 2010, J PLASTIC DERMATOLOG, V6, P3; da Silva L, 2011, BBA-MOL CELL RES, V1813, P1863, DOI 10.1016/j.bbamcr.2011.06.018; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; DIPIETRO LA, 1995, SHOCK, V4, P233, DOI 10.1097/00024382-199510000-00001; El Kharrassi Y, 2014, BIOCHEM BIOPH RES CO, V446, P798, DOI 10.1016/j.bbrc.2014.02.074; FARINELLA Z, 1986, INT J TISSUE REACT, V8, P337; Graeber MB, 2011, FEBS LETT, V585, P3798, DOI 10.1016/j.febslet.2011.08.033; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Katholnig K, 2013, BIOCHEM SOC T, V41, P927, DOI 10.1042/BST20130032; Komarcevic A, 2000, Med Pregl, V53, P363; Lech M, 2013, BBA-MOL BASIS DIS, V1832, P989, DOI 10.1016/j.bbadis.2012.12.001; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Martini P, 2011, DERMAT RES PRACT, V2011, DOI 10.1155/2011/978291; Mollica G., 2008, Gazzetta Medica Italiana Archivio per le Scienze Mediche, V167, P87; Portou MJ, 2015, VASC PHARMACOL, V71, P31, DOI 10.1016/j.vph.2015.02.007; Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643; Romanelli M, 2015, DRUG DES DEV THER, V9, P2787, DOI 10.2147/DDDT.S82712; Saih FE, 2017, MOLECULES, V22, DOI 10.3390/molecules22010102; Sanguigno L, 2015, J ETHNOPHARMACOL, V159, P198, DOI 10.1016/j.jep.2014.10.051; Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388; Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004; Serafini G, 2012, DENT CLIN, V3, P35; Soliman ML, 2012, J NEUROCHEM, V123, P555, DOI 10.1111/j.1471-4159.2012.07955.x; Steiling H, 1999, EXP CELL RES, V247, P484, DOI 10.1006/excr.1998.4366; Sugama S, 2009, MED HYPOTHESES, V73, P1031, DOI 10.1016/j.mehy.2009.02.047; Wang YP, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-95; Weiclenbusch M, 2012, J INNATE IMMUN, V4, P463, DOI 10.1159/000336717; Wilson K, 1997, Nurs Crit Care, V2, P291; Xue Liang, 2013, Zhonghua Shao Shang Za Zhi, V29, P62	34	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0197493	10.1371/journal.pone.0197493	http://dx.doi.org/10.1371/journal.pone.0197493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902182	gold, Green Submitted, Green Published			2022-12-26	WOS:000435424900004
J	Liberzon, A; Harrington, K; Daniel, N; Gurka, R; Harari, A; Zilman, G				Liberzon, Alexander; Harrington, Kyra; Daniel, Nimrod; Gurka, Roi; Harari, Ally; Zilman, Gregory			Moth-inspired navigation algorithm in a turbulent odor plume from a pulsating source	PLOS ONE			English	Article							PHEROMONE-MODULATED FLIGHT; UPWIND FLIGHT; OPTOMOTOR ANEMOTAXIS; SCALE STRUCTURE; GYPSY MOTHS; ORIENTATION; STRATEGIES; RESOLUTION; NEURONS; RELEASE	Some female moths attract male moths by emitting series of pulses of pheromone filaments propagating downwind. The turbulent nature of the wind creates a complex flow environment, and causes the filaments to propagate in the form of patches with varying concentration distributions. Inspired by moth navigation capabilities, we propose a navigation strategy that enables a flier to locate an upwind pulsating odor source in a windy environment using a single threshold-based detection sensor. This optomotor anemotaxis strategy is constructed based on the physical properties of the turbulent flow carrying discrete puffs of odor and does not involve learning, memory, complex decision making or statistical methods. We suggest that in turbulent plumes from a pulsating point source, an instantaneously measurable quantity referred as a "puff crossing time", improves the success rate as compared to the navigation strategies based on temporally regular zigzags due to intermittent contact, or an "internal counter", that do not use this information. Using computer simulations of fliers navigating in turbulent plumes of the pulsating point source for varying flow parameters such as turbulent intensities, plume meandering and wind gusts, we obtained statistics of navigation paths towards the pheromone sources. We quantified the probability of a successful navigation as well as the flight parameters such as the time spent searching and the total flight time, with respect to different turbulent intensities, meandering or gusts. The concepts learned using this model may help to design odor-based navigation of miniature airborne autonomous vehicles.	[Liberzon, Alexander; Daniel, Nimrod; Zilman, Gregory] Tel Aviv Univ, Sch Mech Engn, Tel Aviv, Israel; [Harrington, Kyra; Gurka, Roi] Coastal Carolina Univ, Dept Coastal & Marine Syst Sci, Conway, SC USA; [Harari, Ally] Volcani Ctr, Dept Entomol, Bet Dagan, Israel	Tel Aviv University; Coastal Carolina University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Liberzon, A (corresponding author), Tel Aviv Univ, Sch Mech Engn, Tel Aviv, Israel.	alexlib@tauex.tau.ac.il	Liberzon, Alex/A-8596-2008; harari, ally R/C-6566-2011	Liberzon, Alex/0000-0002-6882-4191; harari, ally R/0000-0003-2287-7113; Gurka, Roi/0000-0002-8907-6663	U.S.-Israel Binational Science Foundation (BSF) [2013399]	U.S.-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation)	This study is partially supported by the U.S.-Israel Binational Science Foundation (BSF) under grant 2013399 (http://www.bsf.org.il). The authors received specific funding for this work: AL RG AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	BAKER TC, 1984, PHYSIOL ENTOMOL, V9, P365, DOI 10.1111/j.1365-3032.1984.tb00777.x; Baker TC, 1996, PHYSIOL ENTOMOL, V21, P20, DOI 10.1111/j.1365-3032.1996.tb00831.x; BAKER TC, 1988, P NATL ACAD SCI USA, V85, P9826, DOI 10.1073/pnas.85.24.9826; BAKER TC, 1985, PHYSIOL ENTOMOL, V10, P257, DOI 10.1111/j.1365-3032.1985.tb00045.x; Baker TC, 1997, INSECT PHEROMONE RESEARCH, P248; Balkovsky E, 2002, P NATL ACAD SCI USA, V99, P12589, DOI 10.1073/pnas.192393499; Bau J, 2005, CHEM SENSES, V30, P771, DOI 10.1093/chemse/bji069; Bau J, 2002, J INSECT PHYSIOL, V48, P433, DOI 10.1016/S0022-1910(02)00062-8; Bau J, 2015, INTEGR COMP BIOL, V55, P461, DOI 10.1093/icb/icv036; Belanger JH, 1998, J COMP PHYSIOL A, V183, P345, DOI 10.1007/s003590050261; Boeker E, 2011, ENV PHYS; BRADY J, 1989, PHYSIOL ENTOMOL, V14, P369, DOI 10.1111/j.1365-3032.1989.tb01105.x; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; CARDE RT, 1984, J CHEM ECOL, V10, P25, DOI 10.1007/BF00987640; Carde RT, 1997, INSECT PHEROMONE RESEARCH, P275; CARDE RT, 1984, J CHEM ECOL, V10, P335, DOI 10.1007/BF00987861; CONNER WE, 1980, BEHAV ECOL SOCIOBIOL, V7, P55, DOI 10.1007/BF00302519; DAVID CT, 1983, NATURE, V303, P804, DOI 10.1038/303804a0; DUSENBERY DB, 1989, J CHEM ECOL, V15, P971, DOI 10.1007/BF01015192; ELKINTON JS, 1987, PHYSIOL ENTOMOL, V12, P399, DOI 10.1111/j.1365-3032.1987.tb00766.x; Farrell JA, 2002, ENVIRON FLUID MECH, V2, P143, DOI 10.1023/A:1016283702837; Grant AJ, 1997, PHYSIOL ENTOMOL, V22, P123, DOI 10.1111/j.1365-3032.1997.tb01149.x; Grunbaum D, 2015, MOVEMENT ECOLOGY, V3, P3; Harari AR, 2011, EVOLUTION, V65, P1572, DOI 10.1111/j.1558-5646.2011.01252.x; Kaissling K.-E., 1986, P193; Kaissling KE, 1997, ORIENTATION COMMUNIC, P343; KENNEDY JS, 1983, PHYSIOL ENTOMOL, V8, P109, DOI 10.1111/j.1365-3032.1983.tb00340.x; KENNEDY JS, 1974, SCIENCE, V184, P999, DOI 10.1126/science.184.4140.999; Li W, 2001, ADAPT BEHAV, V9, P143, DOI 10.1177/10597123010093003; Li W, 2010, APPL BIONICS BIOMECH, V7, P3, DOI 10.1080/11762320903537790; MAFRANETO A, 1994, NATURE, V369, P142, DOI 10.1038/369142a0; MAFRANETO A, 1995, PHYSIOL ENTOMOL, V20, P117, DOI 10.1111/j.1365-3032.1995.tb00808.x; MafraNeto A, 1996, EXPERIENTIA, V52, P373, DOI 10.1007/BF01919543; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Murlis J., 1986, MECH INSECT OLFACTIO, P27; Pandis S. N., 2006, ATMOSPHERIC CHEM PHY; PREISS R, 1986, NATURWISSENSCHAFTEN, V73, P555, DOI 10.1007/BF00368166; RUMBO ER, 1989, J COMP PHYSIOL A, V165, P281, DOI 10.1007/BF00619348; SCHAL C, 1987, J CHEM ECOL, V13, P1115, DOI 10.1007/BF01020542; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; SLIFER EH, 1970, ANNU REV ENTOMOL, V15, P121, DOI 10.1146/annurev.en.15.010170.001005; Strand T, 2009, ECOL MODEL, V220, P640, DOI 10.1016/j.ecolmodel.2008.11.018; Thistle HW, 2004, FOREST SCI, V50, P610; TOBIN TR, 1981, SCIENCE, V214, P1147, DOI 10.1126/science.214.4525.1147; Turner DB, 1971, WORKBOOK ATMOSPHERIC; Vergassola M, 2007, NATURE, V445, P406, DOI 10.1038/nature05464; Vickers Neil J., 1999, P63; Vickers NJ, 2006, CHEM SENSES, V31, P155, DOI 10.1093/chemse/bjj011; Vickers NJ, 2000, BIOL BULL, V198, P203, DOI 10.2307/1542524; Willis MA, 1998, J COMP PHYSIOL A, V182, P191, DOI 10.1007/s003590050170; WILLIS MA, 1991, J COMP PHYSIOL A, V169, P427; ZANNETTI P, 1981, J APPL METEOROL, V20, P1203, DOI 10.1175/1520-0450(1981)020<1203:AIPAFP>2.0.CO;2	52	8	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198422	10.1371/journal.pone.0198422	http://dx.doi.org/10.1371/journal.pone.0198422			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897978	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700053
J	Kers, JA; DeFusco, AW; Park, JH; Xu, J; Pulse, ME; Weise, WJ; Handfield, M				Kers, Johan A.; DeFusco, Anthony W.; Park, Jae H.; Xu, Jin; Pulse, Mark E.; Weise, William J.; Handfield, Martin			OG716: Designing a fit-for-purpose lantibiotic for the treatment of Clostridium difficile infections	PLOS ONE			English	Article							MUTACIN 1140; IN-VITRO; LIPID-II; PREVENTION; EPIDERMIN; TARGET; LOCUS; NISIN; DRUG	Lantibiotics continue to offer an untapped pipeline for the development of novel antibiotics. We report here the discovery of a novel lantibiotic for the treatment of C. difficile infection (CDI). The leads were selected from a library of over 300 multiple substitution variants of the lantibiotic Mutacin 1140 (MU1140). Top performers were selected based on testing for superior potency, solubility, manufacturability, and physicochemical and/or metabolic stability in biologically-relevant systems. The best performers in vitro were further evaluated orally in the Golden Syrian hamster model of CDAD. In vivo testing ultimately identified OG716 as the lead compound, which conferred 100% survival and no relapse at 3 weeks post infection. MU1140-derived variants are particularly attractive for further clinical development considering their novel mechanism of action.	[Kers, Johan A.] Intrexon Corp, Ind Prod Div, San Francisco, CA USA; [DeFusco, Anthony W.; Park, Jae H.; Handfield, Martin] Oragenics Inc, Alachua, FL 33634 USA; [Xu, Jin] Univ Massachusetts Lowell, One Univ Ave, Lowell, MA USA; [Pulse, Mark E.; Weise, William J.] UNT Syst Coll Pharm, PreClin Serv, Ft Worth, TX USA; [Kers, Johan A.] Ginkgo Bioworks, Boston, MA USA; [DeFusco, Anthony W.] Brammer Bio LLC, Alachua, FL USA	University of Massachusetts System; University of Massachusetts Lowell	Handfield, M (corresponding author), Oragenics Inc, Alachua, FL 33634 USA.	mhandfield@oragenics.com		Handfield, Martin/0000-0001-5788-8774	Oragenics, Inc.	Oragenics, Inc.	This study was supported by Oragenics, Inc. Intrexon Corp. performed molecular biology and strain engineering, data collection and the initial data analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MO, 2018, MICROB DRUG RESIST, V24, P590, DOI 10.1089/mdr.2017.0147; Boakes S, 2016, J ANTIBIOT, V69, P850, DOI 10.1038/ja.2016.47; Bowes J, 2012, NAT REV DRUG DISCOV, V11, P909, DOI 10.1038/nrd3845; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Centers for Disease Control, 2013, ANTIBIOTIC RESISTANC; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Chen SR, 2013, APPL ENVIRON MICROB, V79, P4015, DOI 10.1128/AEM.00704-13; Clinical and Laboratory Standards Institute, 2018, M07A10 CLSI, V11th, DOI DOI 10.1371/JOURNAL.PPAT.1009338; CLSI, 2012, M11A8 CLSI, V32; de Kruijff B, 2008, PROSTAG LEUKOTR ESS, V79, P117, DOI 10.1016/j.plefa.2008.09.020; Draper LA, 2015, MICROBIOL MOL BIOL R, V79, P171, DOI 10.1128/MMBR.00051-14; Escano J, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00472-16; Field D, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01363; Ghobrial O, 2010, J PHARM SCI-US, V99, P2521, DOI 10.1002/jps.22015; Ghobrial OG, 2009, INT J ANTIMICROB AG, V33, P70, DOI 10.1016/j.ijantimicag.2008.07.028; Gotz F, 2014, INT J MED MICROBIOL, V304, P63, DOI 10.1016/j.ijmm.2013.08.012; Grubaugh D, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00901-17; Hacker C, 2015, J BIOL CHEM, V290, P28869, DOI 10.1074/jbc.M115.679969; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Henninot A, 2018, J MED CHEM, V61, P1382, DOI 10.1021/acs.jmedchem.7b00318; Hillman JD, 1998, INFECT IMMUN, V66, P2743, DOI 10.1128/IAI.66.6.2743-2749.1998; HILLMAN JD, 1984, INFECT IMMUN, V44, P141, DOI 10.1128/IAI.44.1.141-144.1984; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; Kers JA, 2018, SATURATION MUTAGENES; Kers JA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00415; Kufel WD, 2017, PHARMACOTHERAPY, V37, P1298, DOI 10.1002/phar.1990; MACRINA FL, 1983, GENE, V25, P145; McBride SM, 2011, INFECT IMMUN, V79, P167, DOI 10.1128/IAI.00731-10; Ongey EL, 2017, BIOTECHNOL LETT, V39, P473, DOI 10.1007/s10529-016-2279-9; Patey G, 2016, FUTURE MICROBIOL, V11, P991, DOI 10.2217/fmb-2016-0123; Piper Clare, 2012, Int J Microbiol, V2012, P806230, DOI 10.1155/2012/806230; Rogers LA, 1928, J BACTERIOL, V16, P211, DOI 10.1128/JB.16.4.211-229.1928; Ross AC, 2011, J ANTIBIOT, V64, P27, DOI 10.1038/ja.2010.136; Sandiford SK, 2015, EXPERT OPIN DRUG DIS, V10, P315, DOI 10.1517/17460441.2015.1016496; Smith L, 2003, BIOCHEMISTRY-US, V42, P10372, DOI 10.1021/bi034490u; Smith L, 2008, CURR OPIN MICROBIOL, V11, P401, DOI 10.1016/j.mib.2008.09.008; Suarez JM, 2013, J BACTERIOL, V195, P2621, DOI 10.1128/JB.00166-13; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Vaishnavi C, 2015, INDIAN J MED RES, V141, P398, DOI 10.4103/0971-5916.159251; Weiss W, 2014, ANTIMICROB AGENTS CH, V58, P5714, DOI 10.1128/AAC.02903-14; Xu JJ, 2004, CHEM-BIOL INTERACT, V150, P115, DOI 10.1016/j.cbi.2004.09.011	41	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0197467	10.1371/journal.pone.0197467	http://dx.doi.org/10.1371/journal.pone.0197467			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894469	gold, Green Published, Green Submitted			2022-12-26	WOS:000435030900004
J	Koh, W; Kang, K; Lee, YJ; Kim, MR; Shin, JS; Lee, J; Lee, JH; Shin, KM; Ha, IH				Koh, Wonil; Kang, Kyungwon; Lee, Yoon Jae; Kim, Me-riong; Shin, Joon-Shik; Lee, Jinho; Lee, Jun-Hwan; Shin, Kyung-Min; Ha, In-Hyuk			Impact of acupuncture treatment on the lumbar surgery rate for low back pain in Korea: A nationwide matched retrospective cohort study	PLOS ONE			English	Article							ADJACENT SEGMENT DEGENERATION; SPINE SURGERY; REOPERATION RATE; GUIDELINES; MANAGEMENT; TRENDS; NICE; PREVALENCE; DISEASE	Introduction Low back pain (LBP) is a globally prevalent disorder with high social significance. Invasive surgical procedures are increasingly being used to treat LBP despite a lack of solid evidence supporting their long-term benefits. This nationwide retrospective cohort study investigated the association between acupuncture treatment and lumbar surgery rate in patients with LBP. Methods Using the National Health Insurance Service Sample Cohort Database for 2002-2013, we identified newly diagnosed LBP patients in Korea between 2004 and 2010 and divided them into an acupuncture group and control group according to whether or not they received acupuncture. Propensity scores based on age, sex, income, and Charlson Comorbidity Index were matched between the two study groups. The lumbar surgery rate in the two years following the first visit (control group) or the first acupuncture session (acupuncture group) was calculated. In addition to the overall analysis, stratified analyses were also conducted in different age, sex, and income strata. Sensitivity analyses were further performed using varying definitions of acupuncture treatment. Results After matching, 130,089 subjects were included in each study group. The lumbar surgery rate was significantly lower in the acupuncture group than in the control group (hazard ratio [HR] 0.633, 95% confidence interval [CI] 0.576-0.696). Decrease in HR was consistently observed in the acupuncture group for all age strata, except for patients in their 20s (HR 1.031, 95% CI 0.804-1.323). HR for lumbar surgery tended to be further reduced in the older age groups upon acupuncture treatment, with no apparent sex-related differences. Lowered HR in the acupuncture group was continuously observed across all income groups; the higher income group showed a tendency of greater decrease. Sensitivity analyses showed that the number of acupuncture sessions had no major impact on the likelihood of lumbar surgery, but also that more intensive acupuncture treatment was associated with further reduction in lumbar surgery rates. Conclusion The present results found that administration of acupuncture treatment is associated with lower lumbar surgery rates for LBP patients in Korea. Prospective studies are warranted in the future to further investigate the effect of acupuncture treatment on lumbar surgery incidence.	[Koh, Wonil; Kang, Kyungwon; Lee, Yoon Jae; Kim, Me-riong; Shin, Joon-Shik; Lee, Jinho; Ha, In-Hyuk] Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea; [Lee, Jun-Hwan; Shin, Kyung-Min] Korea Inst Oriental Med, Clin Res Div, Daejeon, South Korea; [Lee, Jun-Hwan] UST, Korean Med Life Sci, Campus Korea Inst Oriental Med, Daejeon, South Korea	Korea Institute of Oriental Medicine (KIOM); Korea Institute of Oriental Medicine (KIOM); University of Science & Technology (UST)	Ha, IH (corresponding author), Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea.; Shin, KM (corresponding author), Korea Inst Oriental Med, Clin Res Div, Daejeon, South Korea.	kyungmin7221@kiom.re.kr; hanihata@gmail.com	Lee, Yoon Jae/ABA-8808-2020; Shin, Kyung-Min/AAO-9382-2020	Lee, Yoon Jae/0000-0002-1532-0942; HA, IN-HYUK/0000-0002-5020-6723	Korea Institute of Oriental Medicine [K17123]	Korea Institute of Oriental Medicine	This study was supported by the Korea Institute of Oriental Medicine (grant number: K17123, https://www.kiom.re.kr/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakster C., 1993, HLTH AND WELLBEING, P84; Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Alwhaibi M, 2016, EVIDENCE BASED COMPL, V2016; Bernstein IA, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6748; Carragee EJ, 2005, NEW ENGL J MED, V352, P1891, DOI 10.1056/NEJMcp042054; CHERKIN DC, 1994, SPINE, V19, P1201, DOI 10.1097/00007632-199405310-00001; Chou R, 2009, SPINE, V34, P1094, DOI 10.1097/BRS.0b013e3181a105fc; CLEMENTJONES V, 1980, LANCET, V2, P946; Cummings M, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k970; Dagenais S, 2010, SPINE J, V10, P514, DOI 10.1016/j.spinee.2010.03.032; Dalamagka M., 2015, J PAIN RELIEF, V4, P2; Deyo RA, 2006, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000198726.62514.75; Epstein Nancy E, 2013, Surg Neurol Int, V4, pS353, DOI 10.4103/2152-7806.120774; Epstein NE, 2011, SURG NEUROLOGY INT, V2; FOULADBAKHSH JM, 2007, J COMPLEMENTARY INTE, V4, P1, DOI DOI 10.2202/1553-3840.1035; Furlan AD, 2005, ACUPUNCTURE DRY NEED; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Harris IA, 2012, ANZ J SURG, V82, P625, DOI 10.1111/j.1445-2197.2012.06152.x; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Helgeson MD, 2013, SPINE J, V13, P342, DOI 10.1016/j.spinee.2012.12.009; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Ivanova JI, 2011, SPINE J, V11, P622, DOI 10.1016/j.spinee.2011.03.017; Kardouni JR, 2016, AM J PREV MED, V51, pE129, DOI 10.1016/j.amepre.2016.06.005; Kim CH, 2013, SPINE J, V13, P1230, DOI 10.1016/j.spinee.2013.06.069; Kim CH, 2013, SPINE, V38, P581, DOI 10.1097/BRS.0b013e318274f9a7; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Langevin HM, 2002, FASEB J, V16, P872, DOI 10.1096/fj.01-0925fje; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Lee SM, 2010, PAIN RELATED EFFECTI; Liu L, 2015, EVIDENCE BASED COMPL, V2015; MacPherson H, 2017, J ALTERN COMPLEM MED, V23, P247, DOI 10.1089/acm.2017.0029; Maher C, 2017, LANCET, V389, P736, DOI 10.1016/S0140-6736(16)30970-9; Manheimer E, 2005, ANN INTERN MED, V142, P651, DOI 10.7326/0003-4819-142-8-200504190-00014; Maribo T, 2016, EUR SPINE J, V25, P1211, DOI 10.1007/s00586-015-4118-4; Martin BI, 2007, SPINE, V32, P382, DOI 10.1097/01.brs.0000254104.55716.46; Metcalfe A, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-58; Moritz S, 2011, J ALTERN COMPLEM MED, V17, P1015, DOI 10.1089/acm.2010.0619; Pannell WC, 2015, SPINE J, V15, P1719, DOI 10.1016/j.spinee.2013.10.014; Posadzki P, 2013, CLIN MED, V13, P126, DOI 10.7861/clinmedicine.13-2-126; Pumberger M, 2012, J BONE JOINT SURG BR, V94B, P359, DOI 10.1302/0301-620X.94B3.27825; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rajaee SS, 2012, SPINE, V37, P67, DOI 10.1097/BRS.0b013e31820cccfb; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Roy A, 2014, FASEB J, V28, P2, DOI 10.1096/fj.14-0102LTE; Sahin Nilay, 2017, J Phys Ther Sci, V29, P891, DOI 10.1589/jpts.29.891; Savigny P, 2009, LOW BACK PAIN EARL M, V14; Shapiro CM, 2014, PHYS MED REH CLIN N, V25, P319, DOI 10.1016/j.pmr.2014.01.014; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Trinh KV, 2017, MED ACUPUNCT, V29, P20, DOI 10.1089/acu.2016.1209; Vos T, 2017, LANCET; World Health Organization, 2014, PRIOR DIS REAS INCL; Xia XP, 2013, SPINE, V38, P597, DOI 10.1097/BRS.0b013e318273a2ea; Yanamadala V, 2017, SPINE, V42, pE1016, DOI 10.1097/BRS.0000000000002065; Yuan J, 2008, SPINE, V33, pE887, DOI 10.1097/BRS.0b013e318186b276; Zeng YC, 2015, EUR J INTEGR MED, V7, P94, DOI 10.1016/j.eujim.2014.11.001; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004	58	12	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0199042	10.1371/journal.pone.0199042	http://dx.doi.org/10.1371/journal.pone.0199042			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894499	Green Published, gold, Green Submitted			2022-12-26	WOS:000435030900046
J	Laukkanen, L; Kalske, A; Muola, A; Leimu, R; Mutikainen, P				Laukkanen, Liisa; Kalske, Aino; Muola, Anne; Leimu, Roosa; Mutikainen, Pia			Genetic drift precluded adaptation of an insect seed predator to a novel host plant in a long-term selection experiment	PLOS ONE			English	Article							LYGAEUS-EQUESTRIS HETEROPTERA; TRADE-OFFS; POPULATION-DYNAMICS; RANGE EVOLUTION; FEEDING BUG; FOOD-PLANT; BEETLE; SPECIALIZATION; ARCHITECTURE; GENERALIST	Host specialization is considered a primary driver of the enormous diversity of herbivorous insects. Trade-offs in host use are hypothesized to promote this specialization, but they have mostly been studied in generalist herbivores. We conducted a multi-generation selection experiment to examine the adaptation of the specialist seed-feeding bug, Lygaeus equestris, to three novel host plants (Helianthus annuus, Verbascum thapsus and Centaurea phrygia) and to test whether trade-offs promote specialization. During the selection experiment, body size of L. equestris increased more on the novel host plant H. annuus compared to the primary host plant, Vincetoxicum hirundinaria, but this effect was not observed in other fitness related traits. In addition to selection, genetic drift caused variation among the experimental herbivore populations in their ability to exploit the host plants. Microsatellite data indicated that the level of within-population genetic variation decreased and population differentiation increased more in the selection line feeding on H. annuus compared to V. hirundinaria. We found a negative correlation between genetic differentiation and heterozygosity at the end of the experiment, suggesting that differentiation was significantly affected by genetic drift. We did not find fitness trade-offs between L. equestris feeding on the four hosts. Thus, trade-offs do not seem to promote specialization in L. equestris. Our results suggest that this insect herbivore is not likely to adapt to a novel host species in a time-scale of 20 generations despite sufficient genetic variation and that genetic drift disrupted the response to selection.	[Laukkanen, Liisa; Kalske, Aino; Muola, Anne] Univ Turku, Sect Ecol, Dept Biol, Turku, Finland; [Muola, Anne] Swedish Univ Agr Sci, Dept Plant Protect Biol, Alnarp, Sweden; [Leimu, Roosa] Univ Oxford, Dept Plant Sci, Oxford, England; [Mutikainen, Pia] Swiss Fed Inst Technol, ETH Zentrum, Inst Integrat Biol, Zurich, Switzerland; [Kalske, Aino] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA	University of Turku; Swedish University of Agricultural Sciences; University of Oxford; Swiss Federal Institutes of Technology Domain; ETH Zurich; Cornell University	Kalske, A (corresponding author), Univ Turku, Sect Ecol, Dept Biol, Turku, Finland.; Kalske, A (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA.	amk398@cornell.edu		Kalske, Aino/0000-0003-3850-8996; Muola, Anne/0000-0003-1828-6425	Academy of Finland [109859, 138308]; Turku University Foundation; University of Turku	Academy of Finland(Academy of Finland); Turku University Foundation; University of Turku	This study was financially supported by the Academy of Finland grants 109859 and 138308 (RL; http://www.aka.fi/en), Turku University Foundation (LL; http://www.utu.fi/fi/yksikot/ yliopistosaatio/en/Sivut/home.aspx), and University of Turku (LL).	Agosta SJ, 2009, J EVOLUTION BIOL, V22, P907, DOI 10.1111/j.1420-9101.2009.01694.x; Agrawal AA, 2000, ECOLOGY, V81, P500, DOI 10.1890/0012-9658(2000)081[0500:HREAAT]2.0.CO;2; Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Barnett V., 1994, OUTLIERS STAT DATA; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bramer C, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2346; Forbes AA, 2017, EVOLUTION, V71, P1126, DOI 10.1111/evo.13164; Forister ML, 2007, J EVOLUTION BIOL, V20, P985, DOI 10.1111/j.1420-9101.2007.01310.x; Forister ML, 2015, P NATL ACAD SCI USA, V112, P442, DOI 10.1073/pnas.1423042112; Fry JD, 2003, ECOLOGY, V84, P1672, DOI 10.1890/0012-9658(2003)084[1672:DETUSE]2.0.CO;2; Funk WC, 2016, MOL ECOL, V25, P2176, DOI 10.1111/mec.13605; FUTUYMA DJ, 1995, EVOLUTION, V49, P797, DOI 10.1111/j.1558-5646.1995.tb02316.x; Garcia-Robledo C, 2012, J EVOLUTION BIOL, V25, P38, DOI 10.1111/j.1420-9101.2011.02401.x; Gompert Z, 2016, EVOLUTION, V70, P1249, DOI 10.1111/evo.12933; GOULD F, 1979, EVOLUTION, V33, P791, DOI [10.1111/j.1558-5646.1979.tb04735.x, 10.2307/2407646]; HAMETAHTI L, 1998, RETKEILYKASVIO; Hardy NB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2960; Harvey JA, 2005, J CHEM ECOL, V31, P287, DOI 10.1007/s10886-005-1341-1; HILL WG, 1986, GENET RES, V48, P125, DOI 10.1017/S001667230002485X; Horvath Z., 2004, Helia, V27, P181, DOI 10.2298/HEL0441181H; JAMES AC, 1988, EVOLUTION, V42, P626, DOI [10.2307/2409045, 10.1111/j.1558-5646.1988.tb04166.x]; Jordan MA, 2008, MOL ECOL, V17, P1224, DOI 10.1111/j.1365-294X.2007.03658.x; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kingsolver JG, 2007, P ROY SOC B-BIOL SCI, V274, P977, DOI 10.1098/rspb.2006.0036; KUGELBERG O, 1977, OIKOS, V29, P398, DOI 10.2307/3543579; KUGELBERG O, 1974, Entomologica Scandinavica, V5, P49; KUGELBERG O, 1973, Entomologica Scandinavica, V4, P181; KUGELBERG O, 1973, ENTOMOL EXP APPL, V16, P165, DOI 10.1007/BF00290689; Laukkanen L, 2013, J EVOLUTION BIOL, V26, P141, DOI 10.1111/jeb.12037; Laukkanen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094105; Mackenzie A, 1996, EVOLUTION, V50, P155, DOI 10.1111/j.1558-5646.1996.tb04482.x; Matos M, 2000, J EVOLUTION BIOL, V13, P9, DOI 10.1046/j.1420-9101.2000.00116.x; Meats A, 2004, B ENTOMOL RES, V94, P517, DOI 10.1079/BER2004332; Messina FJ, 2015, J EVOLUTION BIOL, V28, P1882, DOI 10.1111/jeb.12704; Messina FJ, 2014, ENTOMOL EXP APPL, V153, P231, DOI 10.1111/eea.12244; Messina FJ, 2013, ENVIRON ENTOMOL, V42, P733, DOI 10.1603/EN13066; Muola A, 2010, ECOLOGY, V91, P2650, DOI 10.1890/09-0589.1; Otto SP, 1997, GENETICS, V146, P723; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; Rintala T, 2010, SUOMEN LUTEET; ROBERTSON A., 1960, PROC ROY SOC SER B BIOL SCI, V153, P234, DOI 10.1098/rspb.1960.0099; Scheirs J, 2005, EVOL ECOL, V19, P551, DOI 10.1007/s10682-005-2004-y; Schoonhoven L. M., 2005, Insect-plant biology; Sexton JP, 2017, ANNU REV ECOL EVOL S, V48, P183, DOI 10.1146/annurev-ecolsys-110316-023003; SILLENTULLBERG B, 1990, OIKOS, V58, P210, DOI 10.2307/3545428; SOLBRECK C, 1972, Entomologica Scandinavica, V3, P189; SOLBRECK C, 1981, OIKOS, V36, P68, DOI 10.2307/3544381; SOLBRECK C, 1990, OIKOS, V58, P199, DOI 10.2307/3545427; Staerk D, 2000, J NAT PROD, V63, P1584, DOI 10.1021/np0003443; Tullberg BS, 2000, ECOL ENTOMOL, V25, P220, DOI 10.1046/j.1365-2311.2000.00238.x; Ueno H, 2003, J EVOLUTION BIOL, V16, P883, DOI 10.1046/j.1420-9101.2003.00604.x; Via S, 2002, AM NAT, V159, pS76, DOI 10.1086/338374; WASSERMAN SS, 1981, EVOLUTION, V35, P605, DOI 10.1111/j.1558-5646.1981.tb04923.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Wright S., 1969, THEORY GENE FREQUENC, V2, P520	57	2	2	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198869	10.1371/journal.pone.0198869	http://dx.doi.org/10.1371/journal.pone.0198869			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894503	Green Submitted, Green Published, gold			2022-12-26	WOS:000435030900032
J	Suzuki, Y; Kono, Y; Hayakawa, T; Shimozawa, H; Matano, M; Yeda, Y				Suzuki, Yume; Kono, Yumi; Hayakawa, Takahiro; Shimozawa, Hironori; Matano, Miyuki; Yeda, Yukari		Neonatal Res Network Japan	Neonatal factors related to center variation in the incidence of late-onset circulatory collapse in extremely preterm infants	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; GESTATIONAL-AGE; INSUFFICIENCY; PREMATURITY; HYPOTENSION; NEWBORNS; MATURITY; JAPAN	Background Although late-onset circulatory collapse (LCC) is widely recognized in Japan, its etiology and the reason for center variation in its incidence remain unclear. This study's objectives were to identify the perinatal and neonatal factors related to LCC and to estimate the factors related to the center variation in the incidence of LCC. Methods Extremely preterm infants born between 2008 and 2012 who were registered in the database of the Neonatal Research Network, Japan were retrospectively analyzed. LCC was defined as a clinical diagnosis of LCC and the administration of steroids. We first identified the factors that were significantly related to LCC. We then examined the cause of the center variation in the incidence of LCC, using the standardized incidence ratios (SIRs) of LCC and individual factors. Results The factors significantly associated with LCC included low gestational age (odds ratio [OR]: 1.13), small for date (OR: 1.43), male sex (OR: 1.26), antenatal steroid use (OR: 1.19), respiratory distress syndrome (OR: 1.25), chronic lung disease at 36 weeks (OR: 1.16), periventricular leukomalacia (PVL) (OR: 2.57), necrotizing enterocolitis (OR: 0.59), retinopathy of prematurity (ROP) (OR: 1.73), high-frequency oscillating ventilation (HFOV) use (OR: 1.31), parenteral nutrition (OR: 1.38), and red blood cell (RBC) transfusion (OR: 1.94). The SIR of LCC ranged from 0.05 to 2.94, and was positively correlated with SIRs of PVL, ROP, HFOV use and RBC transfusion. Conclusion PVL, ROP, HFOV use and RBC transfusion were found to be correlated with the center variation in the incidence of LCC.	[Suzuki, Yume; Kono, Yumi; Shimozawa, Hironori; Matano, Miyuki; Yeda, Yukari] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan; [Hayakawa, Takahiro] Tochigi Prefectural Off, Med Policy Div, Dept Hlth & Welf Serv, Utsunomiya, Tochigi, Japan	Jichi Medical University	Suzuki, Y (corresponding author), Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan.	yume@jichi.ac.jp		Suzuki, Yume/0000-0002-0778-8940				BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bolt RJ, 2002, PEDIATR RES, V52, P405, DOI 10.1203/01.PDR.0000022343.57970.CF; Fernandez EF, 2009, J PERINATOL, V29, pS44, DOI 10.1038/jp.2009.24; Heckmann M, 1999, ARCH DIS CHILD-FETAL, V81, pF171, DOI 10.1136/fn.81.3.F171; HELBOCK HJ, 1993, PEDIATRICS, V92, P715; Hellstrom A, 2013, LANCET, V382, P1445, DOI 10.1016/S0140-6736(13)60178-6; Kawai M, 2017, PEDIATR INT, V59, P391, DOI 10.1111/ped.13242; Kawai M, 2012, PEDIATR INT, V54, P177, DOI 10.1111/j.1442-200X.2011.03518.x; Kobayashi S, 2008, PEDIATR INT, V50, P225, DOI 10.1111/j.1442-200X.2008.02564.x; Kusuda S, 2006, PEDIATRICS, V118, pE1130, DOI 10.1542/peds.2005-2724; Nakanishi H, 2010, J PERINATOL, V30, P751, DOI 10.1038/jp.2010.41; Ng PC, 2011, PEDIATR RES, V69, P511, DOI 10.1203/PDR.0b013e31821764b1; Ng PC, 2016, ARCH DIS CHILD-FETAL, V101, pF571, DOI 10.1136/archdischild-2016-311289; Ng PC, 2004, ARCH DIS CHILD-FETAL, V89, P119, DOI 10.1136/adc.2002.021972; Ng PC, 2002, J CLIN ENDOCR METAB, V87, P4621, DOI 10.1210/jc.2001-011620; Nykanen P, 2010, HORM RES PAEDIAT, V74, P358, DOI 10.1159/000314970; Osterholm EA, 2012, PSYCHONEUROENDOCRINO, V37, P1719, DOI 10.1016/j.psyneuen.2012.03.005; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Shimokaze T, 2015, TOHOKU J EXP MED, V235, P241, DOI 10.1620/tjem.235.241	19	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198518	10.1371/journal.pone.0198518	http://dx.doi.org/10.1371/journal.pone.0198518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894475	Green Submitted, gold, Green Published			2022-12-26	WOS:000435030900016
J	Yu, YJ; Cheng, DX; Parfrey, P; Liu, G; Savas, S				Yu, Yajun; Cheng, Dangxiao; Parfrey, Patrick; Liu, Geoffrey; Savas, Sevtap			Two functional indel polymorphisms in the promoter region of the Brahma gene (BRM) and disease risk and progression-free survival in colorectal cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LUNG-CANCER; SWI/SNF COMPLEX; SUSCEPTIBILITY LOCI; VARIANTS; NEWFOUNDLAND; BRG1/BRM; OUTCOMES; SUBUNIT; COHORT	Background and objective The Brahma gene (BRM) encodes a catalytic ATPase subunit of the Switch/Sucrose non fermentable (SWI/SNF) complex, which modulates gene expression and many important cellular processes. Two indel polymorphisms in the promoter region of BRM (BRM-741 and BRM-1321) are associated with its reduced expression and the risk of susceptibility or survival outcomes in multiple solid cancers. In this study, we have examined these variants in relation to susceptibility and survival outcomes in colorectal cancer. Methods Genotypes were obtained using TaqMan assays in 427 cases and 408 controls. Multivariate logistic and Cox regression models were fitted to examine the associations of the BRM-741 and BRM-1321 genotypes adjusting for relevant covariates. Sub-group analyses based on tumor location and patient sex were also performed. In all analyses, indels were examined individually as well as in combination. Results Our results showed that there was no association between the BRM polymorphisms and the risk of colorectal cancer. However, genotype combinations of the BRM-741 and BRM-1321 variants were associated with the risk of colon cancer. Particularly, patients having at least one variant allele had increased risk of colon cancer when compared to patients with the double wild-type genotype. In the survival analyses, BRM-741 heterozygosity was associated with longer progression-free survival time in the colorectal cancer patients. A stronger association was detected in the male patients under the recessive genetic model where the homozygosity for the variant allele of BRM-741 was associated with shorter progression free survival time. Conclusions Our analyses suggest that BRM-741 and BRM-1321 indels are associated with the risk of developing colon cancer and the BRM-741 indel is associated with the disease progression in colorectal cancer patients, especially in the male patients. Although our results show a different relationship between these indels and colorectal cancer compared to other cancer sites, they also suggest that BRM and its promoter variants may have biological roles in susceptibility and survival outcomes in colorectal cancers. Performing further analyses in additional and larger cohorts are needed to confirm our conclusions.	[Yu, Yajun; Savas, Sevtap] Mem Univ, Fac Med, Discipline Genet, St John, NF, Canada; [Cheng, Dangxiao; Liu, Geoffrey] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Parfrey, Patrick] Mem Univ, Clin Epidemiol Unit, Fac Med, St John, NF, Canada; [Liu, Geoffrey] Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Dept Med, Toronto, ON, Canada; [Liu, Geoffrey] Univ Toronto, Toronto, ON, Canada; [Liu, Geoffrey] Univ Toronto, Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Savas, Sevtap] Mem Univ, Discipline Oncol, Fac Med, St John, NF, Canada	Memorial University Newfoundland; University of Toronto; Memorial University Newfoundland; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; Memorial University Newfoundland	Savas, S (corresponding author), Mem Univ, Fac Med, Discipline Genet, St John, NF, Canada.; Savas, S (corresponding author), Mem Univ, Discipline Oncol, Fac Med, St John, NF, Canada.	savas@mun.ca		Savas, Sevtap/0000-0002-7324-938X	Alan B. Brown Chair funds; TPMI/NL Support educational funding fellowship	Alan B. Brown Chair funds; TPMI/NL Support educational funding fellowship	This study is supported by the Alan B. Brown Chair funds to GL. YY is supported by TPMI/NL Support educational funding fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Tassan NA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10442; ALTMAN DG, 1995, BRIT J CANCER, V72, P511, DOI 10.1038/bjc.1995.364; Bellera CA, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-20; Canadian Cancer Society's Advisory Committee on Cancer Statistics, 2017, CAN CANC STAT 2017; Gao XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055169; Glaros S, 2007, ONCOGENE, V26, P7058, DOI 10.1038/sj.onc.1210514; Green RC, 2007, FAM CANCER, V6, P53, DOI 10.1007/s10689-006-9104-x; Herpel E, 2017, ANN DIAGN PATHOL, V26, P47, DOI 10.1016/j.anndiagpath.2016.10.006; Jiang KW, 2015, ONCOTARGET, V6, P40327, DOI 10.18632/oncotarget.5530; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Kahali B, 2014, ONCOTARGET, V5, P3316, DOI 10.18632/oncotarget.1945; Korpanty GJ, 2017, ONCOTARGET, V8, P28093, DOI 10.18632/oncotarget.15890; Lemire M, 2015, HUM GENET, V134, P1249, DOI 10.1007/s00439-015-1598-6; Li FY, 2009, J ZHEJIANG UNIV-SC B, V10, P219, DOI 10.1631/jzus.B0820273; Liu G, 2011, ONCOGENE, V30, P3295, DOI 10.1038/onc.2011.81; Liu G, 2017, CLIN CANCER RES, V23, P2460, DOI 10.1158/1078-0432.CCR-16-1640; Matsubara D, 2013, CANCER SCI, V104, P266, DOI 10.1111/cas.12065; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Negandhi AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061469; Pasic I, 2018, MOL CARCINOGEN, V57, P106, DOI 10.1002/mc.22736; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Phipps AI, 2016, CARCINOGENESIS, V37, P87, DOI 10.1093/carcin/bgv161; R Core Team, 2018, R LANG ENV STAT COMP; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reisman DN, 2003, CANCER RES, V63, P560; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Savas S, 2018, CRIT REV ONCOL HEMAT, V123, P114, DOI 10.1016/j.critrevonc.2018.01.009; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Schumacher FR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8138; Segedi M, 2016, INT J CANCER, V139, P2474, DOI 10.1002/ijc.30369; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang HS, 2017, INT J CANCER, V140, P2728, DOI 10.1002/ijc.30687; Wang JR, 2013, CARCINOGENESIS, V34, P1012, DOI 10.1093/carcin/bgt008; Wang PP, 2009, AM J HEALTH BEHAV, V33, P513; Warnes G., 2013, GENETICS POPULATION; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wong KM, 2014, CANCER MED-US, V3, P426, DOI 10.1002/cam4.201; Woods MO, 2010, GUT, V59, P1369, DOI 10.1136/gut.2010.208462; Xu W, 2015, BIOMARK RES, V3, DOI 10.1186/s40364-015-0031-6	43	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198873	10.1371/journal.pone.0198873	http://dx.doi.org/10.1371/journal.pone.0198873			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894502	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000435030900033
J	Zhao, XD; Yuan, XY; Chen, S; Meng, LH; Fu, DQ				Zhao, Xiaodan; Yuan, Xinyu; Chen, Sha; Meng, Lanhuan; Fu, Daqi			Role of the tomato TAGL1 gene in regulating fruit metabolites elucidated using RNA sequence and metabolomics analyses	PLOS ONE			English	Article							SOLANUM-LYCOPERSICON; ISOPROPYLMALATE SYNTHASE; ETHYLENE BIOSYNTHESIS; GLUTAMINE-SYNTHETASE; GABA ACCUMULATION; IDENTIFICATION; HOMOLOGS; EXPRESSION; MUTATION; RIN	Fruit ripening is a complex biological process affecting fruit quality. In tomato the fruit ripening process is delicately regulated by transcription factors (TFs). Among these, the TOMATO AGAMOUS-LIKE 1 (TAGL1) gene plays an important role in both the development and ripening of fruit. In this study, the TAGL1 gene was successfully silenced by virus induced gene silencing technology (VIGS), and the global gene expression and metabolites profiles of TAGL 1-silenced fruits were analyzed by RNA-sequence analysis (RNA-seq) and liquid chromatography mass spectrometry (LC-MS/MS). The TAGL 1-silenced fruits phenotypically displayed an orange pericarp, which was in accordance with the results expected from the down-regulation of genes associated with carotenoid synthesis. Levels of several amino acids and organic acids were lower in the TAGL 1-silenced fruits than in the wild-type fruits, whereas, a-tomatine content was greatly increased (more than 10-fold) in the TAGL1-silenced fruits compared to wild-type fruits. The findings of this study showed that TAGL1 not only regulates the ripening of tomato fruits, but also affects the synthesis and levels of nutrients in the fruit.	[Zhao, Xiaodan] Beijing Technol & Business Univ, Sch Food & Chem Engn, Beijing, Peoples R China; [Yuan, Xinyu; Meng, Lanhuan; Fu, Daqi] China Agr Univ, Coll Food Sci & Nutr Engn, Lab Food Biotechnol, Beijing, Peoples R China; [Chen, Sha] China Acad Chinese Med Sci, Inst Tradit Chinese Med, Beijing, Peoples R China	Beijing Technology & Business University; China Agricultural University; China Academy of Chinese Medical Sciences	Zhao, XD (corresponding author), Beijing Technol & Business Univ, Sch Food & Chem Engn, Beijing, Peoples R China.	docdan@126.com			National Natural Science Foundation of China [31601518]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, 31601518 (http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akihiro T, 2008, PLANT CELL PHYSIOL, V49, P1378, DOI 10.1093/pcp/pcn113; Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Bemer M, 2012, PLANT CELL, V24, P4437, DOI 10.1105/tpc.112.103283; Chen W, 2013, MOL PLANT, V6, P1769, DOI 10.1093/mp/sst080; Chung MY, 2010, PLANT J, V64, P936, DOI 10.1111/j.1365-313X.2010.04384.x; de Kraker JW, 2007, PLANT PHYSIOL, V143, P970, DOI 10.1104/pp.106.085555; Dippe M, 2015, CHEM COMMUN, V51, P3637, DOI 10.1039/c4cc08478k; Eriksson EM, 2004, PLANT PHYSIOL, V136, P4184, DOI 10.1104/pp.104.045765; Friedman M, 2013, J AGR FOOD CHEM, V61, P9534, DOI 10.1021/jf402654e; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Fujisawa M, 2014, PLANT CELL, V26, P89, DOI 10.1105/tpc.113.119453; Fujisawa M, 2013, PLANT CELL, V25, P371, DOI 10.1105/tpc.112.108118; Fujisawa M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-26; Gimenez E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014427; Giovannoni J, 2017, ANNU REV PLANT BIOL, V68, P61, DOI 10.1146/annurev-arplant-042916-040906; Giovannoni JJ, 2007, CURR OPIN PLANT BIOL, V10, P283, DOI 10.1016/j.pbi.2007.04.008; Hacham Y, 2007, PLANT J, V51, P850, DOI 10.1111/j.1365-313X.2007.03184.x; Itkin M, 2013, SCIENCE, V341, P175, DOI 10.1126/science.1240230; Itkin M, 2009, PLANT J, V60, P1081, DOI 10.1111/j.1365-313X.2009.04064.x; Karlova R, 2014, J EXP BOT, V65, P4527, DOI 10.1093/jxb/eru316; Karlova R, 2011, PLANT CELL, V23, P923, DOI 10.1105/tpc.110.081273; Klee HJ, 2011, ANNU REV GENET, V45, P41, DOI 10.1146/annurev-genet-110410-132507; Koike S, 2013, PLANT CELL PHYSIOL, V54, P793, DOI 10.1093/pcp/pct035; Mahesh V, 2007, PLANT MOL BIOL, V64, P145, DOI 10.1007/s11103-007-9141-3; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Negrel J, 2013, PLANT PHYSIOL BIOCH, V66, P77, DOI 10.1016/j.plaphy.2013.02.009; Ning J, 2015, PLANT PHYSIOL, V169, P1821, DOI 10.1104/pp.15.00474; Pan IL, 2010, J EXP BOT, V61, P1795, DOI 10.1093/jxb/erq046; Pesaresi P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00124; Scarpeci TE, 2007, J PLANT PHYSIOL, V164, P137, DOI 10.1016/j.jplph.2006.01.003; Seifi HS, 2013, NEW PHYTOL, V199, P490, DOI 10.1111/nph.12283; Seymour GB, 2013, ANNU REV PLANT BIOL, V64, P219, DOI 10.1146/annurev-arplant-050312-120057; Shelp BJ, 2012, TRENDS PLANT SCI, V17, P57, DOI 10.1016/j.tplants.2011.12.006; Takayama M, 2015, PLANT CELL PHYSIOL, V56, P1533, DOI 10.1093/pcp/pcv075; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Vrebalov J, 2009, PLANT CELL, V21, P3041, DOI 10.1105/tpc.109.066936; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang RH, 2016, PLOS ONE, V11; Yuan XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164335	39	13	14	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0199083	10.1371/journal.pone.0199083	http://dx.doi.org/10.1371/journal.pone.0199083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894500	gold, Green Submitted, Green Published			2022-12-26	WOS:000435030900048
J	Awungafac, G; Amin, ET; Fualefac, A; Takah, NF; Agyingi, LA; Nwobegahay, J; Ondoa, P; Njukeng, PA				Awungafac, George; Amin, Elvis T.; Fualefac, Akemfua; Takah, Noah F.; Agyingi, Lucy A.; Nwobegahay, Julius; Ondoa, Pascale; Njukeng, Patrick A.			Viral load testing and the use of test results for clinical decision making for HIV treatment in Cameroon: An insight into the clinic-laboratory interface	PLOS ONE			English	Article							2ND-LINE ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; DRUG-RESISTANCE; GUIDELINES; OUTCOMES; ADULTS; RATES	Background The viral load (VL) in patients receiving antiretroviral therapy (ART) is the best predictor of treatment outcome. The anticipated benefits of VL monitoring depend on the actual uptake of VL test results for clinical decisions. The objective of this study was to assess the uptake and utilization of VL test results for clinical decisions on HIV treatment in Cameroon, from 2013 to 2017. Methods This was a retrospective cohort analysis of data from files of patients receiving ART at Buea, Limbe, Bamenda and Bafoussam regional hospital HIV treatment centers. A simple random pick of six file blocks was performed in each shelf that corresponded to a year of initiation, and the contents of all selected files were reviewed and the information needed for the study entered a structured questionnaire. The data collected was recorded in Epi Info (version 7.1.5.2), and analyzed using SATA (version 12.1; StataCorp LP). Results Eight hundred and thirty files were reviewed. The mean duration on ART was 39.4 +/- 12 months. Viral load testing uptake was 24.33% and only one VL test had been done by all patients. Approximately 65% of the patients did the first VL after more than 24 months on ART. The median turnaround (TAT) time for VL testing was 6 days (Interquartile range (IQR) 3-7days). Among 201 patients who did a VL test, 94.55% had VL suppression (<= 1000copies/mm(3)). Approximately 54% of the patients with virologic failure were switched to a second-line regimen. Conclusions The uptake of viral load testing is low in North West, South West and West Regions of Cameroon. The current TAT for VL testing is plausible. The rate of switch to second line regimen is low. It is time to strengthen the scale up of VL testing and improve the rate of switch to second-line regimen in Cameroon.	[Awungafac, George; Ondoa, Pascale] African Soc Lab Med, Addis Ababa, Ethiopia; [Awungafac, George; Amin, Elvis T.; Takah, Noah F.] Minist Publ Hlth, Yaounde, Cameroon; [Amin, Elvis T.] Global Res Educ & Hlth Fdn, Buea, Cameroon; [Fualefac, Akemfua; Njukeng, Patrick A.] Global Hlth Syst Solut, Limbe, Cameroon; [Takah, Noah F.] LSHTM, IDC, London, England; [Agyingi, Lucy A.] Univ Dschang, Fac Sci, Dschang, Cameroon; [Nwobegahay, Julius] Mil Hlth Res Ctr CRESAR, Yaounde, Cameroon	University of London; London School of Hygiene & Tropical Medicine	Awungafac, G (corresponding author), African Soc Lab Med, Addis Ababa, Ethiopia.; Awungafac, G (corresponding author), Minist Publ Hlth, Yaounde, Cameroon.	awungafacg@yahoo.com	Awungafac, George/AAV-8385-2020; Awungafac, George/Y-4075-2019	Awungafac, George/0000-0002-5859-0336; Awungafac, George/0000-0002-5859-0336				Abah Isaac Okoh, 2015, J Int Assoc Provid AIDS Care, V14, P348, DOI 10.1177/2325957414565508; ABERG JA, 2014, CLIN INFECT DIS, V58, P1, DOI DOI 10.1093/cid/cit757; Aghokeng AF, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18004; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; CNLS-GTC, RAPP ANN 2014 ACT LU; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Davies MA, 2012, TROP MED INT HEALTH, V17, P1386, DOI 10.1111/j.1365-3156.2012.03073.x; Desmonde S, 2015, AIDS, V29, P1527, DOI 10.1097/QAD.0000000000000707; Hunt GM, 2017, J ANTIMICROB CHEMOTH, V72, P3141, DOI 10.1093/jac/dkx252; Matsuda EM, 2018, AIDS RES HUM RETROV, V34, P156, DOI [10.1089/aid.2017.0052, 10.1089/AID.2017.0052]; Meriki HD, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-5; Minchella PA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173009; MINSANTE, 2017, PLAN OP PASS ECH CHA; MINSANTE, 2013, PLAN NAT MULT LUTT V; MINSANTE/UNAIDS, RAPP NAT SUIV DECL P; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; Ssempijja V, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2680-6; Tsai HC, 2017, INFECT DRUG RESIST, V10, P343, DOI 10.2147/IDR.S146584; UNAIDS, 2014, 90 90 90 AMB TREATM; Westley BP, 2012, CLIN INFECT DIS, V55, P432, DOI 10.1093/cid/cis433; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; World Health Organisation, 2013, CONS GUID US ANT DRU, P272; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2010, ANT THER HIV INF INF	26	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198686	10.1371/journal.pone.019868	http://dx.doi.org/10.1371/journal.pone.019868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889862				2022-12-26	WOS:000434786600036
J	O'Brien, R; Goldberg, SE; Pilnick, A; Beeke, S; Schneider, J; Sartain, K; Thomson, L; Murray, M; Baxendale, B; Harwood, RH				O'Brien, Rebecca; Goldberg, Sarah E.; Pilnick, Alison; Beeke, Suzanne; Schneider, Justine; Sartain, Kate; Thomson, Louise; Murray, Megan; Baxendale, Bryn; Harwood, Rowan H.			The VOICE study - A before and after study of a dementia communication skills training course	PLOS ONE			English	Article							SIMULATED PATIENTS; GENERAL HOSPITALS; OLDER PATIENTS; KNOW ME; CARE; PROGRAM; PEOPLE; PROFESSIONALS; PSYCHOSIS; EDUCATION	Background A quarter of acute hospital beds are occupied by persons living with dementia, many of whom have communication problems. Healthcare professionals lack confidence in dementia communication skills, but there are no evidence-based communication skills training approaches appropriate for professionals working in this context. We aimed to develop and pilot a dementia communication skills training course that was acceptable and useful to healthcare professionals, hospital patients and their relatives. Methods The course was developed using conversation analytic findings from video recordings of healthcare professionals talking to patients living with dementia in the acute hospital, together with systematic review evidence of dementia communication skills training and taking account of expert and service-user opinion. The two-day course was based on experiential learning theory, and included simulation and video workshops, reflective diaries and didactic teaching. Actors were trained to portray patients living with dementia for the simulation exercises. Six courses were run between January and May 2017. 44/45 healthcare professionals attended both days of the course. Evaluation entailed: questionnaires on confidence in dementia communication; a dementia communication knowledge test; and participants' satisfaction. Video-recorded, simulated assessments were used to measure changes in communication behaviour. Results Healthcare professionals increased their knowledge of dementia communication (mean improvement 1.5/10; 95% confidence interval 1.0-2.0; p<0.001). Confidence in dementia communication also increased (mean improvement 5.5/45; 95% confidence interval 4.16.9; p<0.001) and the course was well-received. One month later participants reported using the skills learned in clinical practice. Blind-ratings of simulated patient encounters demonstrated behaviour change in taught communication behaviours to close an encounter, consistent with the training, but not in requesting behaviours. Conclusion We have developed an innovative, evidence-based dementia communication skills training course which healthcare professionals found useful and after which they demonstrated improved dementia communication knowledge, confidence and behaviour.	[O'Brien, Rebecca; Goldberg, Sarah E.; Harwood, Rowan H.] Univ Nottingham, Sch Hlth Sci, Nottingham, England; [Pilnick, Alison; Schneider, Justine] Univ Nottingham, Sch Sociol & Social Policy, Nottingham, England; [Beeke, Suzanne] UCL, Div Psychol & Language Sci, London, England; [Sartain, Kate] Univ Nottingham, Dementia & Frail Older Persons PPI Grp, Nottingham, England; [Thomson, Louise] Univ Nottingham, Div Psychiat & Appl Psychol, Nottingham, England; [Murray, Megan] Simulated Patients Workshop Team, Market Harborough, Leics, England; [Baxendale, Bryn] Nottingham Univ Hosp NHS Trust, Trent Simulat Ctr, Nottingham, England; [Harwood, Rowan H.] Nottingham Univ Hosp NHS Trust, Dept Healthcare Older Person, Nottingham, England	University of Nottingham; University of Nottingham; University of London; University College London; University of Nottingham; University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham University Hospital NHS Trust	Goldberg, SE (corresponding author), Univ Nottingham, Sch Hlth Sci, Nottingham, England.	sarah.goldberg@nottingham.ac.uk		Harwood, Rowan/0000-0002-4920-6718; Goldberg, Sarah/0000-0001-5109-798X; Thomson, Louise/0000-0003-1736-7506	National Institute for Health Research Health Services and Delivery Research Programme [13/114/93]	National Institute for Health Research Health Services and Delivery Research Programme	This project was funded by the National Institute for Health Research Health Services and Delivery Research Programme (https://www.nihr.ac.uk/funding-and-support/funding-for-research-studies/funding-programmes/health-services-and-delivery-research/) (project number 13/114/93). The views and opinions expressed are those of the authors and do not necessarily reflect those of the Health Research Health Services and Delivery Research Programme, National Institute of Health Research, National Health Service or the Department of Health. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript. Authors who received funding were RHH, ROB, SG, SB, KS, JS, LT, SEG.	Alice Still, 2014, STILL ALICE; Allen-Burge R., 2001, J CLIN GEROPSYCHOLOG, V7, P213, DOI DOI 10.1023/A:1011343212424; Allwood R, 2017, SOC SCI MED, V191, P212, DOI 10.1016/j.socscimed.2017.09.014; Alzheimer's Disease International, 2016, WORLD ALZH REP 2016; Alzheimer's Society, 2016, FACTSH COMMUNICATING; Alzheimer's Society, 2009, COUNT COST CAR PEOPL; Beeke Suzanne, 2007, Seminars in Speech and Language, V28, P136, DOI 10.1055/s-2007-970571; Bokken L, 2009, ACAD MED, V84, P958, DOI 10.1097/ACM.0b013e3181a814a3; Brooker D., 2016, PERSON CTR DEMENTIA; Care UK, 2016, EFF COMMUNICATION201; Davies O, 2010, TODAY IS MONDAY FILM; de la Croix A, 2013, MED EDUC, V47, P49, DOI 10.1111/medu.12064; Department of Health, 2009, LIVING WELL DEMENTIA; Eggenberger E, 2013, INT PSYCHOGERIATR, V25, P345, DOI 10.1017/S1041610212001664; Elvish R, 2018, DEMENTIA-LONDON, V17, P96, DOI 10.1177/1471301216634926; Elvish R, 2014, AGING MENT HEALTH, V18, P481, DOI 10.1080/13607863.2013.856860; Goldberg S, 2014, COMMUNICATION; Goldberg S, 2014, DEMENTIA COGNITIVE L; Goldberg S, 2014, CARING PEOPLE DEMENT; Goldberg SE, 2014, INT J NURS STUD, V51, P1332, DOI 10.1016/j.ijnurstu.2014.02.002; Gove D, 2017, ALZHEIMER EUROPES PO; Griffiths A, 2014, AGE AGEING, V43, P521, DOI 10.1093/ageing/aft171; Heritage J, 2007, J GEN INTERN MED, V22, P1429, DOI 10.1007/s11606-007-0279-0; Heritage J, 2006, ANNU REV SOCIOL, V32, P351, DOI 10.1146/annurev.soc.32.082905.093959; Kirkpatrick D., 1967, EVALUATION TRAINING; Kolb D. A, 2014, EXPERIENTIAL LEARNIN; Kruijver IPM, 2000, PATIENT EDUC COUNS, V39, P129, DOI 10.1016/S0738-3991(99)00096-8; McCabe R, 2002, BRIT MED J, V325, P1148, DOI 10.1136/bmj.325.7373.1148; McCabe R, 2008, BRIT J PSYCHIAT, V192, P404, DOI 10.1192/bjp.bp.107.048678; National Institute for Health and Clinical Excellence/Social Care Institute for Excellence, 2006, DEMENTIA SUPPORTING; NHS Choices, 2016, COMM PEOPL DEMENTIA2; O'Brien R, 2017, COMMUNICATION SKILLS; O'Brien R, 6 INT M CONV AN CLIN; Pilnick A, 2017, VOICE VIDEOING IMPRO; RIPICH DN, 1995, GERIATR NURS, V16, P15, DOI 10.1016/S0197-4572(05)80073-4; Royal College of Psychiatrists, 2005, WHO CAR WINS IMPR OU; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Schegloff E. A., 2007, SEQUENCE ORG INTERAC, V1; Sidnell J., 2010, CONVERSATION ANAL IN; Spencer K, 2015, MED CRISES OLDER PEO; Stokoe E, 2013, RES LANG SOC INTERAC, V46, P165, DOI 10.1080/08351813.2013.780341; Surr CA, 2016, INT J NURS STUD, V53, P144, DOI 10.1016/j.ijnurstu.2015.09.009; Teodorczuk A, 2014, CLIN TEACH, V11, P497, DOI 10.1111/tct.12203; Waite J, 2008, DEMENTIA CARE PRACTI; Waugh Anna, 2011, Nurs Stand, V25, P44; White SJ, 2016, AUST J LINGUIST, V36, P257, DOI 10.1080/07268602.2015.1121534; Williams KN, 2006, RES NURS HEALTH, V29, P121, DOI 10.1002/nur.20117; Williams KN, 2012, CLIN GERONTOLOGIST, V35, P376, DOI 10.1080/07317115.2012.702648; Williams KN, 2009, AM J ALZHEIMERS DIS, V24, P11, DOI 10.1177/1533317508318472; Wilson R, 2012, CAN J SPEECH-LANG PA, V36, P314	50	28	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198567	10.1371/journal.pone.0198567	http://dx.doi.org/10.1371/journal.pone.0198567			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI8PJ	29889878	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000434786600028
J	Ueda, Y; Iwakura, H; Bando, M; Doi, A; Ariyasu, H; Inaba, H; Morita, S; Akamizu, T				Ueda, Yoko; Iwakura, Hiroshi; Bando, Mika; Doi, Asako; Ariyasu, Hiroyuki; Inaba, Hidefumi; Morita, Shuhei; Akamizu, Takashi			Differential role of GPR142 in tryptophan-mediated enhancement of insulin secretion in obese and lean mice	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; EXTRACELLULAR CA2+-SENSING RECEPTOR; PROTEIN-COUPLED RECEPTORS; CHOLECYSTOKININ SECRETION; L-PHENYLALANINE; BETA-CELLS; IN-VIVO; AGONISTS; ACID; EXPRESSION	Tryptophan is reportedly the most potent agonist for GPR142. Glucose-stimulated insulin secretion (GSIS) from pancreatic beta cells are enhanced by GPR142-mediated signal. It is not clear, however, if GPR142-mediated signals is solely attributable to GSIS enhancement after tryptophan load in various pathophysiological settings. This study aims to reveal the significance of GPR142 signaling in tryptophan-mediated GSIS enhancement in normal and obese mice. Tryptophan significantly improved glucose tolerance in both lean and DIO mice, but the extent of improvement was bigger in DIO mice with augmented glucose-stimulated insulin secretion (GSIS) enhancement. The same results were obtained in ob/ob mice. GPR142 deletion almost completely blocked tryptophan actions in lean mice, suggesting that GPR142 signaling was solely responsible for the GSIS enhancement. In obese GPR142KO mice, however, a significant amount of tryptophan effects were still observed. Calcium-sensing receptors (CaSR) are also known to recognize tryptophan as ligand. Expression levels of CaSR were significantly elevated in the pancreas of DIO mice, and CaSR antagonist further blocked tryptophan's actions in DIO mice with GPR142 deletion. Although GPR142 signaling had a major role in tryptophan recognition for the enhancement of GSIS in lean mice, other pathways including CaSR signaling also had a significant role in obese mice, which seemed to contribute to the augmented enhancement of GSIS by tryptophan in these animals.	[Ueda, Yoko; Iwakura, Hiroshi; Bando, Mika; Doi, Asako; Ariyasu, Hiroyuki; Inaba, Hidefumi; Morita, Shuhei; Akamizu, Takashi] Wakayama Med Univ, Dept Med 1, Wakayama, Japan	Wakayama Medical University	Iwakura, H (corresponding author), Wakayama Med Univ, Dept Med 1, Wakayama, Japan.	hiwaku@wakayama-med.ac.jp		Akamizu, Takashi/0000-0003-4960-8271; Iwakura, Hiroshi/0000-0001-8033-0736	JSPS KAKENHI [26461331]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI (26461331) (HI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bando M, 2012, AM J PHYSIOL-ENDOC M, V302, pE403, DOI 10.1152/ajpendo.00341.2011; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Busque SM, 2005, AM J PHYSIOL-GASTR L, V289, pG664, DOI 10.1152/ajpgi.00096.2005; Chattopadhyay N, 1998, AM J PHYSIOL-GASTR L, V274, pG122, DOI 10.1152/ajpgi.1998.274.1.G122; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Du XH, 2012, BIOORG MED CHEM LETT, V22, P6218, DOI 10.1016/j.bmcl.2012.08.015; Fredriksson R, 2003, FEBS LETT, V554, P381, DOI 10.1016/S0014-5793(03)01196-7; Hira T, 2008, FEBS J, V275, P4620, DOI 10.1111/j.1742-4658.2008.06604.x; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hu LYA, 2009, J BIOMOL SCREEN, V14, P789, DOI 10.1177/1087057109335744; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Iwakura H, 2005, J BIOL CHEM, V280, P15247, DOI 10.1074/jbc.M411358200; Iwakura H, 2010, ENDOCRINOLOGY, V151, P2940, DOI 10.1210/en.2010-0090; Iwakura H, 2009, AM J PHYSIOL-ENDOC M, V297, pE802, DOI 10.1152/ajpendo.00205.2009; Janssen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040168; Kaku K, 2015, DIABETES OBES METAB, V17, P675, DOI 10.1111/dom.12467; Koyama H, 2016, ENDOCRINOLOGY, V157, P692, DOI 10.1210/en.2015-1784; Lin HV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157298; Liou AP, 2011, AM J PHYSIOL-GASTR L, V300, pG538, DOI 10.1152/ajpgi.00342.2010; Lizarzaburu M, 2012, BIOORG MED CHEM LETT, V22, P5942, DOI 10.1016/j.bmcl.2012.07.063; Lu XP, 2012, AM J PHYSIOL-GASTR L, V303, pG367, DOI 10.1152/ajpgi.00541.2011; Mace OJ, 2012, J PHYSIOL-LONDON, V590, P2917, DOI 10.1113/jphysiol.2011.223800; Mun HC, 2004, J BIOL CHEM, V279, P51739, DOI 10.1074/jbc.M406164/200; Rasoamanana R, 2012, P NUTR SOC, V71, P446, DOI 10.1017/S0029665112000110; Rasschaert J, 1999, BIOCHEM BIOPH RES CO, V264, P615, DOI 10.1006/bbrc.1999.1577; Ray JM, 1997, J CLIN INVEST, V99, P2328, DOI 10.1172/JCI119413; Sheinin Y, 2000, J HISTOCHEM CYTOCHEM, V48, P595, DOI 10.1177/002215540004800503; Squires PE, 2000, DIABETES, V49, P409, DOI 10.2337/diabetes.49.3.409; Susens U, 2006, NEUROPHARMACOLOGY, V50, P512, DOI 10.1016/j.neuropharm.2005.11.003; Toda N, 2013, ACS MED CHEM LETT, V4, P790, DOI 10.1021/ml400186z; Wang JR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154452; Wang Y, 2011, AM J PHYSIOL-GASTR L, V300, pG528, DOI 10.1152/ajpgi.00387.2010; Wilson JE, 2016, BIOORG MED CHEM LETT, V26, P2947, DOI 10.1016/j.bmcl.2016.04.018; Yu M, 2013, ACS MED CHEM LETT, V4, P829, DOI 10.1021/ml4000854; Zhang ZX, 2002, J BIOL CHEM, V277, P33727, DOI 10.1074/jbc.M200976200; Zhang ZX, 2002, J BIOL CHEM, V277, P33736, DOI 10.1074/jbc.M200978200	37	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198762	10.1371/journal.pone.0198762	http://dx.doi.org/10.1371/journal.pone.0198762			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889885	gold, Green Published, Green Submitted			2022-12-26	WOS:000434786600045
J	Schuyler, SC; Wu, YFO; Chen, HY; Ding, YS; Lin, CJ; Chu, YT; Chen, TC; Liao, L; Tsai, WW; Huang, A; Wang, LI; Liao, TW; Jhuo, JH; Cheng, V				Schuyler, Scott C.; Wu, Yueh-Fu Olivia; Chen, Hsin-Yu; Ding, Yi-Shan; Lin, Chia-Jung; Chu, Yu-Ting; Chen, Ting-Chun; Liao, Louis; Tsai, Wei-Wei; Huang, Anna; Wang, Lin-Ing; Liao, Ting-Wei; Jhuo, Jia-Hua; Cheng, Vivien			Peptide inhibitors of the anaphase promoting-complex that cause sensitivity to microtubule poison	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; MITOTIC EXIT; MAD2-BINDING PROTEIN; CRYSTAL-STRUCTURE; MAD2; APC/C; CDC20; ACTIVATION; BINDING; BUBR1	There is an interest in identifying Anaphase Promoting-Complex/Cyclosome (APC/C) inhibitors that lead to sensitivity to microtubule poisons as a strategy for targeting cancer cells. Using budding yeast Saccharomyces cerevisiae, peptides derived from the Mitotic Arrest Deficient 2 (Mad2)-binding motif of Cell Division Cycle 20 (Cdc20) were observed to inhibit both Cdc20- and CDC20 Homology 1 (Cdh1)-dependent APC/C activity. Over expression of peptides in vivo led to sensitivity to a microtubule poison and, in a recovery from a microtubule poison arrest, delayed degradation of yeast Securin protein Precocious Dissociation of Sisters 1 (Pds1). Peptides with mutations in the Cdc20 activating KILR-motif still bound APC/C, but lost the ability to inhibit APC/C in vitro and lost the ability to induce sensitivity to a microtubule poison in vivo. Thus, an APC/C binding and activation motif that promotes mitotic progression, namely the Cdc20 KILR-motif, can also function as an APC/C inhibitor when present in excess. Another activator for mitotic progression after recovery from microtubule poison is p31(comet), where a yeast predicted open-reading frame YBR296C-A encoding a 39 amino acid predicted protein was identified by homology to p31(comet), and named (T) under bar iny (Y) under bar east (C) under bar omet 1 (TYC1). Tyc1 over expression resulted in sensitivity to microtubule poison. Tyc1 inhibited both APC/C-Cdc20 and APC/C-Cdh1 activities in vitro and bound to APC/C. A homologous peptide derived from human p31(comet) bound to and inhibited yeast APC/C demonstrating evolutionary retention of these biochemical activities. Cdc20 Mad2-binding motif peptides and Tyc1 disrupted the ability of the co-factors Cdc20 and Cdh1 to bind to APC/C, and co-over expression of both together in vivo resulted in an increased sensitivity to microtubule poison. We hypothesize that Cdc20 Mad2-binding motif peptides, Tyc1 and human hp31 peptide can serve as novel molecular tools for investigating APC/C inhibition that leads to sensitivity to microtubule poison in vivo.	[Schuyler, Scott C.; Wu, Yueh-Fu Olivia; Chen, Hsin-Yu; Ding, Yi-Shan; Lin, Chia-Jung; Chu, Yu-Ting; Chen, Ting-Chun; Liao, Louis; Tsai, Wei-Wei; Huang, Anna; Wang, Lin-Ing; Liao, Ting-Wei; Jhuo, Jia-Hua; Cheng, Vivien] Chang Gung Univ, Dept Biomed Sci, Coll Med, Taoyuan, Taiwan; [Schuyler, Scott C.] Chang Gung Mem Hosp, Div Colorectal Surg, Dept Surg, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital	Schuyler, SC (corresponding author), Chang Gung Univ, Dept Biomed Sci, Coll Med, Taoyuan, Taiwan.; Schuyler, SC (corresponding author), Chang Gung Mem Hosp, Div Colorectal Surg, Dept Surg, Taoyuan, Taiwan.	schuyler@mail.cgu.edu.tw		Wang, Lin-Ing/0000-0001-7916-9885	Taiwan Ministry of Science and Technology [MOST-103-2311-B-182-005]; Chang Gung Memorial Hospital [CMRPD1E0173, CMRPD1F0352, BMRPC59]	Taiwan Ministry of Science and Technology; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was funded by grants to SCS from the Taiwan Ministry of Science and Technology (MOST-103-2311-B-182-005), and Chang Gung Memorial Hospital (CMRPD1E0173) (CMRPD1F0352) (BMRPC59). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfieri C, 2016, NATURE, V536, P431, DOI 10.1038/nature19083; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Elion EA, 2002, METHOD ENZYMOL, V351, P607; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239; Foe IT, 2011, CURR BIOL, V21, P1870, DOI 10.1016/j.cub.2011.09.051; Foster SA, 2012, MOL CELL, V47, P921, DOI 10.1016/j.molcel.2012.07.031; Giovinazzi S, 2013, CELL CYCLE, V12, P2598, DOI 10.4161/cc.25591; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Habu T, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-562; Hara M, 2015, P NATL ACAD SCI USA, V112, P11252, DOI 10.1073/pnas.1512197112; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Huang HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015724; Huang HC, 2010, CELL CYCLE, V9, P2049, DOI 10.4161/cc.9.11.11918; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Hwang LH, 1998, SCIENCE, V280, P1331; Izawa D, 2012, J CELL BIOL, V199, P27, DOI 10.1083/jcb.201205170; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Kumar A, 2002, NAT BIOTECHNOL, V20, P58, DOI 10.1038/nbt0102-58; Lara-Gonzalez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049041; Larsen NA, 2004, J MOL BIOL, V344, P885, DOI 10.1016/j.jmb.2004.09.094; Larsen NA, 2007, P NATL ACAD SCI USA, V104, P1201, DOI 10.1073/pnas.0610358104; Luo XL, 2000, NAT STRUCT BIOL, V7, P224; Ma HT, 2012, J BIOL CHEM, V287, P21561, DOI 10.1074/jbc.M112.364356; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Melloy PG, 2004, GENETICS, V167, P1079, DOI 10.1534/genetics.103.025478; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Miniowitz-Shemtov S, 2015, P NATL ACAD SCI USA, V112, P11536, DOI 10.1073/pnas.1515358112; Mitchison TJ, 2012, MOL BIOL CELL, V23, P1, DOI 10.1091/mbc.E10-04-0335; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Rahimi Hamzeh, 2017, Adv Biomed Res, V6, P26, DOI 10.4103/2277-9175.201683; Sackton KL, 2014, NATURE, V514, P646, DOI 10.1038/nature13660; Schuyler SC, 2012, J CELL SCI, V125, P4197, DOI 10.1242/jcs.107037; Schuyler SC, 2009, METHODS MOL BIOL, V545, P271, DOI 10.1007/978-1-60327-993-2_17; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Teichner A, 2011, P NATL ACAD SCI USA, V108, P3187, DOI 10.1073/pnas.1100023108; Topham CH, 2013, CURR OPIN CELL BIOL, V25, P780, DOI 10.1016/j.ceb.2013.07.003; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang MJ, 2008, PLOS BIOL, V6, P643, DOI 10.1371/journal.pbio.0060050; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Zeng X, 2012, NAT CHEM BIOL, V8, P383, DOI [10.1038/nchembio.801, 10.1038/NCHEMBIO.801]; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010; Zhang SY, 2016, NATURE, V533, P260, DOI 10.1038/nature17973	55	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198930	10.1371/journal.pone.0198930	http://dx.doi.org/10.1371/journal.pone.0198930			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883473	Green Submitted, Green Published, gold			2022-12-26	WOS:000434728100043
J	Rocha, DFS; Cruz, KS; Santos, CSD; Menescal, LSF; Neto, JRD; Pinheiro, SB; Silva, LM; Trilles, L; de Souza, JVB				Silva Rocha, Diego Fernando; Cruz, Katia Santana; da Silva Santos, Carla Silvana; Fernandes Menescal, Lizandra Stephanny; da Silva Neto, Joao Ricardo; Pinheiro, Silviane Bezerra; Silva, Lucyane Mendes; Trilles, Luciana; Braga de Souza, Joao Vicente			MLST reveals a clonal population structure for Cryptococcus neoformans molecular type VNI isolates from clinical sources in Amazonas, Northern-Brazil	PLOS ONE			English	Article							GATTII SPECIES COMPLEX; EPIDEMIOLOGIC CUTOFF VALUES; END-POINT DISTRIBUTIONS; GLOBAL BURDEN; VAR. GRUBII; MENINGITIS; SUSCEPTIBILITY; FLUCONAZOLE; MORTALITY; STATE	Cryptococcosis is considered endemic in Amazonas state, occurring more frequently in individuals with AIDS, who are predominantly infected by Cryptococcus neoformans molecular type VNI. Infections by Cryptococcus gattii VGII predominate in immunocompetent hosts from the American continent and are associated with outbreaks in North America, particularly the subtypes VGIIa and VGIIb, which are also present in the Brazilian Amazon region. Despite few environmental studies, several aspects of the molecular epidemiology of this disease in Amazonas remain unclear, including the limited use of multilocus sequence typing (MLST) to evaluate the genetic population structure of clinical isolates, mainly C. neoformans. Therefore, we used MLST to identify the sequence types of 38 clinical isolates of C. neoformans VNI and C. gattii VGII and used phylogenetic analysis to evaluate their genetic relationship to global isolates. Records of 30 patients were analyzed to describe the current scenario of cryptococcosis in the region and their associations with the different subtypes. Broth microdilution was also performed to determine the susceptibility profile to the antifungals amphotericin B, fluconazole and itraconazole. MLST identified that patients with HIV (n = 26) were exclusively affected by VNI strains with ST93, and among the VGII strains (n = 4), three STs (ST5, ST172 and the new ST445) were identified. An in-hospital lethality of 54% was observed in the HIV group, and there were no significant differences in the clinical aspects of the disease between the HIV and non-HIV groups of patients. In addition, all isolates were susceptible to the antifungals tested. Therefore, in Amazonas state, VNI isolates are a genetically monotypic group, with ST93 being highly important in HIV individuals.	[Silva Rocha, Diego Fernando; Cruz, Katia Santana; da Silva Santos, Carla Silvana; Fernandes Menescal, Lizandra Stephanny; da Silva Neto, Joao Ricardo] Trop Med Fdn Dr Heitor Vieira Dourado, Med Mycol Lab, Manaus, Amazonas, Brazil; [Silva Rocha, Diego Fernando; Pinheiro, Silviane Bezerra; Silva, Lucyane Mendes; Braga de Souza, Joao Vicente] Natl Res Inst Amazonia, Coordinat Soc Environm & Hlth, Mycol Lab, Manaus, Amazonas, Brazil; [Trilles, Luciana] Fundacao Oswaldo Cruz, Natl Inst Infectol Evandro Chagas, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz	de Souza, JVB (corresponding author), Natl Res Inst Amazonia, Coordinat Soc Environm & Hlth, Mycol Lab, Manaus, Amazonas, Brazil.	joaovicentebragasouza@inpa.gov.br	Souza, Joao V B/M-9116-2014; Rocha, Diego/GRF-5535-2022	Souza, Joao V B/0000-0002-3163-7499; Bezerra Pinheiro, Silviane/0000-0002-1650-4727; CRUZ, KATIA SANTANA/0000-0002-3295-7937	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [442837-2014-3]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico 442837-2014-3 Luciana Trilles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves GSB, 2016, MYCOSES, V59, P509, DOI 10.1111/myc.12499; Beale MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003847; Brito-Santos F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115866; Brizendine KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060431; Carriconde F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016936; Charlier C, 2009, INFECT IMMUN, V77, P120, DOI 10.1128/IAI.01065-08; Chen SCA, 2012, CLIN INFECT DIS, V55, P789, DOI 10.1093/cid/cis529; Chong HS, 2010, J CLIN MICROBIOL, V48, P4115, DOI 10.1128/JCM.01271-10; CLSI, 2008, M27A3 CLSI; Costa MC, 2016, INT J MED MICROBIOL, V306, P187, DOI 10.1016/j.ijmm.2016.03.010; Costa SDSE, 2009, MEM I OSWALDO CRUZ, V104, P662, DOI 10.1590/S0074-02762009000400023; Da Silva BK, 2012, REV IBEROAM MICOL, V29, P40, DOI 10.1016/j.riam.2011.05.003; DUNN IS, 1987, NUCLEIC ACIDS RES, V15, P2677; Ellabib MS, 2016, MYCOPATHOLOGIA, V181, P603, DOI 10.1007/s11046-016-9996-4; Engelthaler DM, 2014, MBIO, V5, DOI 10.1128/mBio.01464-14; Espinel-Ingroff A, 2012, ANTIMICROB AGENTS CH, V56, P5898, DOI 10.1128/AAC.01115-12; Espinel-Ingroff A, 2012, ANTIMICROB AGENTS CH, V56, P3107, DOI 10.1128/AAC.06252-11; Ferreira-Paim K, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005223; Ferreira-Paim K, 2011, MYCOSES, V54, pE294, DOI 10.1111/j.1439-0507.2010.01901.x; Ferrer C, 2001, J CLIN MICROBIOL, V39, P2873, DOI 10.1128/JCM.39.8.2873-2879.2001; Giacomazzi J, 2016, MYCOSES, V59, P145, DOI 10.1111/myc.12427; Saraiva MDG, 2015, REV SOC BRAS MED TRO, V48, P79, DOI 10.1590/0037-8682-0116-2014; Herkert PF, 2016, EUR J CLIN MICROBIOL, V35, P1803, DOI 10.1007/s10096-016-2731-8; Iqbal N, 2010, J CLIN MICROBIOL, V48, P539, DOI 10.1128/JCM.01505-09; Jarvis JN, 2014, CLIN INFECT DIS, V58, P736, DOI 10.1093/cid/cit794; Khayhan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072222; Kwon-Chung Kyung J, 2017, mSphere, V2, DOI 10.1128/mSphere.00357-16; Lee YC, 2011, J MICROBIOL IMMUNOL, V44, P338, DOI 10.1016/j.jmii.2010.08.011; Lessells RJ, 2011, SAMJ S AFR MED J, V101, P251, DOI 10.7196/SAMJ.4378; Freire AKL, 2012, MYCOSES, V55, pe145, DOI 10.1111/j.1439-0507.2012.02173.x; Litvintseva AP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002495; Litvintseva AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019688; Litvintseva AP, 2006, GENETICS, V172, P2223, DOI 10.1534/genetics.105.046672; de Oliveira RDM, 2015, REV SOC BRAS MED TRO, V48, P70, DOI 10.1590/0037-8682-0121-2013; Mazza M, 2013, MYCOSES, V56, P646, DOI 10.1111/myc.12084; Merkler AE, 2015, NEUROHOSPITALIST, V5, P217, DOI 10.1177/1941874415569072; Meyer W, 1999, ELECTROPHORESIS, V20, P1790, DOI 10.1002/(SICI)1522-2683(19990101)20:8&lt;1790::AID-ELPS1790&gt;3.0.CO;2-2; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; Ministerie van Financien, 2012, VOORJ 2012, P1; Mlinaric-Missoni E, 2011, J MED MICROBIOL, V60, P1487, DOI 10.1099/jmm.0.031344-0; Moodley A, 2013, NEURO-OPHTHALMOLOGY, V37, P124, DOI 10.3109/01658107.2013.792359; Mora DJ, 2012, MYCOPATHOLOGIA, V173, P321, DOI 10.1007/s11046-011-9504-9; Palau AEB, 2014, CAN J OPHTHALMOL, V49, P473, DOI 10.1016/j.jcjo.2014.06.012; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Prado M, 2009, MEM I OSWALDO CRUZ, V104, P513, DOI 10.1590/S0074-02762009000300019; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/s1473-3099(17)30243-8, 10.1016/S1473-3099(17)30243-8]; Rajasingham Radha, 2012, J Acquir Immune Defic Syndr, V59, pe85, DOI 10.1097/QAI.0b013e31824c837e; Rhodes J, 2017, GENETICS, V207, P327, DOI 10.1534/genetics.117.203836; Saijo T, 2014, MBIO, V5, DOI 10.1128/mBio.00912-14; Sanchini A, 2014, MED MICROBIOL IMMUN, V203, P333, DOI 10.1007/s00430-014-0341-6; Simwami SP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001343; Sionov E, 2013, ANTIMICROB AGENTS CH, V57, P5127, DOI 10.1128/AAC.00694-13; Sionov E, 2009, ANTIMICROB AGENTS CH, V53, P2804, DOI 10.1128/AAC.00295-09; Souto ACP, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004885; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan ZR, 2016, J NEUROL SCI, V368, P132, DOI 10.1016/j.jns.2016.06.069; Trilles L, 2012, MED MYCOL, V50, P328, DOI 10.3109/13693786.2011.602126; Varma A, 2010, ANTIMICROB AGENTS CH, V54, P2303, DOI 10.1128/AAC.00153-10; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; Vidal JE, 2016, TROP MED INT HEALTH, V21, P1539, DOI 10.1111/tmi.12790; Wiesner DL, 2012, MBIOASMORG, V3, P1, DOI [10.1128/mBio.00196-12, DOI 10.1128/MBI0.00196-12.UPDATED]	62	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0197841	10.1371/journal.pone.0197841	http://dx.doi.org/10.1371/journal.pone.0197841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883489	Green Published, gold, Green Submitted			2022-12-26	WOS:000434728100007
J	Yenilmez, ED; Kokbas, U; Kartlasmis, K; Kayrin, L; Tuli, A				Yenilmez, Ebru Duendar; Kokbas, Umut; Kartlasmis, Kezban; Kayrin, Levent; Tuli, Abdullah			A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; PRENATAL-DIAGNOSIS; HEMOLYTIC-DISEASE; DNA; MANAGEMENT; NEWBORN; FEASIBILITY; EXPERIENCE; IMPACT; FETUS	Prenatal detection of the fetal RHD status can be useful in the management of RhD incompatibility to identify fetuses at risk of hemolytic disease. Hemolytic disease causes morbidity and mortality of the fetus in the neonatal period. The routine use of antenatal and postnatal anti-D prophylaxis has reduced the incidence of hemolytic disease of the fetus and newborn. This study describe the detection of fetal RhD antigens in blood of RhD negative pregnant women using a nanopolymer coated electrochemical biosensor for medical diagnosis. Cell free fetal DNA in maternal plasma was also used to genotyping fetal RHD status using multiplex real-time PCR. Twenty-six RhD negative pregnant women in different gestational ages were included in the study. RhD positive fetal antibodies detected with a developed biosensor in maternal blood of RhD negative mothers. The electrochemical measurements were performed on a PalmSens potentiostat, and corundum ceramic based screen printed gold electrode combined with the reference Ag/AgCl electrode, and the auxiliary Au/Pd (98/2%) electrode. Fetal RHD genotyping performed using fluorescence-based multiplex real-time PCR exons 5 and 7 of the RHD gene. The fetal RHD status of 26 RhD negative cases were detected 21 as RhD positive and 5 as RhD negative with electrochemical biosensor. Fetal RHD status confirmed with extracted fetal DNA in maternal plasma using multiplex real-time PCR RHD genotyping and by serological test after delivery. The new method for fetal RhD detection in early pregnancy is useful and can be carry out rapidly in clinical diagnosis. Using automated biosensors are reproducible, quick and results can be generated within a few minutes compared to noninvasive fetal RHD genotyping from maternal plasma with real-time PCR-based techniques. We suggest the biosensor techniques could become an alternative part of fetal RHD genotyping from maternal plasma as a prenatal screening in the management of RhD incompatibility.	[Yenilmez, Ebru Duendar; Kokbas, Umut; Kartlasmis, Kezban; Kayrin, Levent; Tuli, Abdullah] Univ Cukurova, Dept Med Biochem, Fac Med, Adana, Turkey	Cukurova University	Yenilmez, ED (corresponding author), Univ Cukurova, Dept Med Biochem, Fac Med, Adana, Turkey.	edundar@cu.edu.tr	Dundar Yenilmez, Ebru/H-3265-2013; Kökbaş, Umut/A-3252-2016	Dundar Yenilmez, Ebru/0000-0002-5519-3773; Kökbaş, Umut/0000-0003-4028-3458; KARTLASMIS, KEZBAN/0000-0001-5090-0013				Akkaya A, 2009, ELECTROANAL, V21, P1805, DOI 10.1002/elan.200904606; Benachi A, 2012, EUR J OBSTET GYN R B, V162, P28, DOI 10.1016/j.ejogrb.2012.02.001; Bhalla N, 2016, ESSAYS BIOCHEM, V60, P1, DOI 10.1042/EBC20150001; Bianchi DW, 1999, BRIT J HAEMATOL, V105, P574, DOI 10.1046/j.1365-2141.1999.01383.x; Breveglieri G, 2016, PRENATAL DIAG, V36, P353, DOI 10.1002/pd.4788; Brouard D, 2015, VOX SANG, V108, P197, DOI 10.1111/vox.12207; Bustamante-Aragones A, 2008, MOL GENET METAB, V95, P101, DOI 10.1016/j.ymgme.2008.05.006; Chitty LS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5243; Daniels G, 2009, PRENATAL DIAG, V29, P101, DOI 10.1002/pd.2172; de Haas M, 2015, VOX SANG, V109, P99, DOI 10.1111/vox.12265; Dovc-Drnovsek T, 2013, TRANSFUS MED HEMOTH, V40, P37, DOI 10.1159/000345682; Feriotto G, 2004, LAB INVEST, V84, P796, DOI 10.1038/labinvest.3700106; Finning K, 2008, BRIT MED J, V336, P816, DOI 10.1136/bmj.39518.463206.25; Finning KM, 2008, SEMIN FETAL NEONAT M, V13, P69, DOI 10.1016/j.siny.2007.12.007; Gautier E, 2005, AM J OBSTET GYNECOL, V192, P666, DOI 10.1016/j.ajog.2004.10.632; Gonzalez-Gonzalez C, 2005, J HISTOCHEM CYTOCHEM, V53, P307, DOI 10.1369/jhc.4A6400.2005; Koelewijn JM, 2008, TRANSFUSION, V48, P941, DOI 10.1111/j.1537-2995.2007.01625.x; Kumar S, 2005, BRIT MED J, V330, P1255, DOI 10.1136/bmj.330.7502.1255; Legler TJ, 2009, TRANSFUS MED HEMOTH, V36, P189, DOI 10.1159/000216580; LO YMD, 1993, LANCET, V341, P1147, DOI 10.1016/0140-6736(93)93161-S; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Moina C., 2012, ADV IMMUNOASSAY TECH, P65, DOI [DOI 10.5772/36947, 10.5772/36947]; Muller SP, 2008, TRANSFUSION, V48, P2292, DOI 10.1111/j.1537-2995.2008.01843.x; Oxenford K, 2013, PRENATAL DIAG, V33, P688, DOI 10.1002/pd.4135; Parchure DS, 2016, GJTM, V1, P21; Smits-Wintjens VEHJ, 2008, SEMIN FETAL NEONAT M, V13, P265, DOI 10.1016/j.siny.2008.02.005; Sohda S, 1997, PRENATAL DIAG, V17, P743, DOI 10.1002/(SICI)1097-0223(199708)17:8<743::AID-PD144>3.3.CO;2-V; Boggione CT, 2017, BLOOD TRANSFUS-ITALY, V15, P66, DOI 10.2450/2016.0228-15; Urbaniak SJ, 2000, BLOOD REV, V14, P44, DOI 10.1054/blre.1999.0123; Van der Schoot CE, 2006, TRANSFUS CLIN BIOL, V13, P53, DOI 10.1016/j.tracli.2006.02.021; Yenilmez ED, 2015, INT J CURRENT MED RE, V4, P344	32	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197855	10.1371/journal.pone.0197855	http://dx.doi.org/10.1371/journal.pone.0197855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874251	gold, Green Published, Green Submitted			2022-12-26	WOS:000434369400038
J	Hirata, N; Suizu, F; Matsuda-Lennikov, M; Tanaka, T; Edamura, T; Ishigaki, S; Donia, T; Lithanatudom, P; Obuse, C; Iwanaga, T; Noguchi, M				Hirata, Noriyuki; Suizu, Futoshi; Matsuda-Lennikov, Mami; Tanaka, Tsutomu; Edamura, Tatsuma; Ishigaki, Satoko; Donia, Thoria; Lithanatudom, Pathrapol; Obuse, Chikashi; Iwanaga, Toshihiko; Noguchi, Masayuki			Functional characterization of lysosomal interaction of Akt with VRK2	ONCOGENE			English	Article							CELL-DEATH; PROTEIN-KINASE; MAMMALIAN AUTOPHAGY; INHIBITION; CANCER; PHOSPHORYLATION; MTORC1; GROWTH; LINKS; UBIQUITINATION	Serine-threonine kinase Akt (also known as PKB, protein kinase B), a core intracellular mediator of cell survival, is involved in various human cancers and has been suggested to play an important role in the regulation of autophagy in mammalian cells. Nonetheless, the physiological function of Akt in the lysosomes is currently unknown. We have reported previously that PtdIns (3)P-dependent lysosomal accumulation of the Akt-Phafin2 complex is a critical step for autophagy induction. Here, to characterize the molecular function of activated Akt in the lysosomes in the process of autophagy, we searched for the molecules that interact with the Akt complex at the lysosomes after induction of autophagy. By time-of-flight-mass spectrometry (TOF/MS) analysis, kinases of the VRK family, a unique serine-threonine family of kinases in the human kinome, were identified. VRK2 interacts with Akt1 and Akt2, but not with Akt3; the C terminus of Akt and the N terminus of VRK2 facilitate the interaction of Akt and VRK2 in mammalian cells. The kinase-dead form of VRK2A (KD VRK2A) failed to interact with Akt in coimmunoprecipitation assays. Bimolecular fluorescence complementation (BiFC) experiments showed that, in the lysosomes, Akt interacted with VRK2A but not with VRK2B or KD VRK2A. Immunofluorescent assays revealed that VRK2 and phosphorylated Akt accumulated in the lysosomes after autophagy induction. WT VRK2A, but not KD VRK2A or VRK2B, facilitated accumulation of phosphorylated Akt in the lysosomes. Downregulation of VRK2 abrogated the lysosomal accumulation of phosphorylated Akt and impaired nuclear localization of TFEB; these events coincided to inhibition of autophagy induction. The VRK2-Akt complex is required for control of lysosomal size, acidification, bacterial degradation, and for viral replication. Moreover, lysosomal VRK2-Akt controls cellular proliferation and mitochondria) outer-membrane stabilization. Given the roles of autophagy in the pathogenesis of human cancer, the current study provides a novel insight into the oncogenic activity of VRK2-Akt complexes in the lysosomes via modulation of autophagy.	[Hirata, Noriyuki; Suizu, Futoshi; Matsuda-Lennikov, Mami; Tanaka, Tsutomu; Edamura, Tatsuma; Ishigaki, Satoko; Donia, Thoria; Lithanatudom, Pathrapol; Noguchi, Masayuki] Hokkaido Univ, Div Canc Biol, Inst Genet Med, Sapporo, Hokkaido, Japan; [Donia, Thoria] Tanta Univ, Chem Dept, Fac Sci, Tanta, Egypt; [Obuse, Chikashi] Hokkaido Univ, Div Mol Life Sci, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Iwanaga, Toshihiko] Hokkaido Univ, Lab Histol & Cytol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Lithanatudom, Pathrapol] Chiang Mai Univ, Dept Biol, Fac Sci, Ctr Excellence Bioresources Agr Ind & Med, Chiang Mai 50200, Thailand	Hokkaido University; Egyptian Knowledge Bank (EKB); Tanta University; Hokkaido University; Hokkaido University; Chiang Mai University	Noguchi, M (corresponding author), Hokkaido Univ, Div Canc Biol, Inst Genet Med, Sapporo, Hokkaido, Japan.	m_noguch@igm.hokudai.ac.jp	Suizu, Futoshi/G-3530-2019; Donia, Thoria/I-7715-2019; LITHANATUDOM, PATHRAPOL/AAQ-1131-2021	Suizu, Futoshi/0000-0003-0206-4289; Donia, Thoria/0000-0002-1629-1290; 	Takeda; Naito Foundation; JSPS; Japan Rheumatism Foundation	Takeda(Takeda Pharmaceutical Company Ltd); Naito Foundation(Naito Memorial Foundation); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Rheumatism Foundation(Japan Rheumatism Foundation)	We thank Hiroyuki Miyoshi for the lentivirus and Dr. G. Napolitano and Dr. A. Ballabio for the anti-TFEB antibody. MN is supported by Takeda and Naito Foundation. FS and NH are supported by JSPS and FS by Japan Rheumatism Foundation.	Antal CE, 2013, MOL CELL PROTEOMICS, V12, P3498, DOI 10.1074/mcp.R113.029819; Arias E, 2015, MOL CELL, V59, P270, DOI 10.1016/j.molcel.2015.05.030; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Bach M, 2011, BIOCHEM J, V440, P283, DOI 10.1042/BJ20101894; Bai Y, 2003, GENE THER, V10, P1446, DOI 10.1038/sj.gt.3302026; BANHAM AH, 1992, VIROLOGY, V191, P803, DOI 10.1016/0042-6822(92)90256-O; Bento CF, 2016, ANNU REV BIOCHEM, V85, P685, DOI 10.1146/annurev-biochem-060815-014556; Blanco S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001660; Blanco S, 2006, FEBS J, V273, P2487, DOI 10.1111/j.1742-4658.2006.05256.x; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Chen W, 2005, J BIOL CHEM, V280, P40985, DOI 10.1074/jbc.M502190200; de Duve C, 2005, NAT CELL BIOL, V7, P847, DOI 10.1038/ncb0905-847; Ebner M, 2017, MOL CELL, V65, P416, DOI 10.1016/j.molcel.2016.12.028; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Fredericksen BL, 2002, J VIROL, V76, P11440, DOI 10.1128/JVI.76.22.11440-11446.2002; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Hayakawa A, 2004, J BIOL CHEM, V279, P5958, DOI 10.1074/jbc.M310503200; Hayakawa A, 2007, BIOCHEM SOC SYMP, V74, P95, DOI 10.1042/BSS2007c09; Hirata N, 2014, BIOCHEM BIOPH RES CO, V450, P891, DOI 10.1016/j.bbrc.2014.06.077; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Kenific CM, 2015, TRENDS CELL BIOL, V25, P37, DOI 10.1016/j.tcb.2014.09.001; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Kerppola TK, 2008, METHOD CELL BIOL, V85, P431, DOI 10.1016/S0091-679X(08)85019-4; Kim S, 2014, MOL CELL BIOL, V34, P643, DOI 10.1128/MCB.00756-13; Kimmelman AC, 2017, CELL METAB, V25, P1037, DOI 10.1016/j.cmet.2017.04.004; Klerkx EPF, 2009, HISTOL HISTOPATHOL, V24, P749, DOI 10.14670/HH-24.749; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Lee E, 2016, SCI REP-UK, V6, DOI 10.1038/srep29097; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Li LY, 2006, J GEN VIROL, V87, P2869, DOI 10.1099/vir.0.81953-0; Li Y, 2016, NAT CELL BIOL, V18, P1065, DOI 10.1038/ncb3407; Lien EC, 2017, CURR OPIN CELL BIOL, V45, P62, DOI 10.1016/j.ceb.2017.02.007; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Matsuda M, 2010, BIOCHEM BIOPH RES CO, V395, P312, DOI 10.1016/j.bbrc.2010.03.166; Matsuda-Lennikov M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079795; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moffatt MF, 2008, CURR OPIN ALLERGY CL, V8, P411, DOI 10.1097/ACI.0b013e32830f1dc1; Monsalve DM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.40; Mowers EE, 2017, ONCOGENE, V36, P1619, DOI 10.1038/onc.2016.333; Nabar NR, 2017, YALE J BIOL MED, V90, P301; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Nichols RJ, 2004, J BIOL CHEM, V279, P7934, DOI 10.1074/jbc.M310813200; Noguchi M, 2014, BBA-REV CANCER, V1846, P342, DOI 10.1016/j.bbcan.2014.07.013; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Palmieri M, 2017, CELL CYCLE, V16, P1237, DOI 10.1080/15384101.2017.1337968; Palmieri M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14338; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Planz O, 2013, ANTIVIR RES, V98, P457, DOI 10.1016/j.antiviral.2013.04.008; Rodriguez-Hernandez I, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-23; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Santana-Codina N, 2017, ANNU REV CANC BIOL, V1, P19, DOI 10.1146/annurev-cancerbio-041816-122338; Santanam U, 2016, GENE DEV, V30, P399, DOI 10.1101/gad.274134.115; Sanz-Garcia M., 2010, EMERGING SIGNALING P, P135; Sanz-Garcia M, 2012, J BIOL CHEM, V287, P23757, DOI 10.1074/jbc.M112.353102; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Sha YB, 2017, EMBO J, V36, P2544, DOI 10.15252/embj.201796699; Shen HM, 2011, AUTOPHAGY, V7, P457, DOI 10.4161/auto.7.5.14226; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Stenmark H, 2002, FEBS LETT, V513, P77, DOI 10.1016/S0014-5793(01)03308-7; Suizu F., 2015, AUSTIN J MOL CELL BI, V2, P1004; Suizu F, 2016, EMBO J, V35, P1346, DOI 10.15252/embj.201593003; Suizu F, 2009, DEV CELL, V17, P800, DOI 10.1016/j.devcel.2009.09.007; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wei BDL, 2005, J VIROL, V79, P5705, DOI 10.1128/JVI.79.9.5705-5712.2005; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhang B, 2015, CANCER LETT, V356, P704, DOI 10.1016/j.canlet.2014.10.016; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	105	18	19	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 4	2018	37	40					5367	5386		10.1038/s41388-018-0330-0	http://dx.doi.org/10.1038/s41388-018-0330-0			20	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GV7MY	29872222	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000446312900001
J	Younan, ND; Chen, KF; Rose, RS; Crowther, DC; Viles, JH				Younan, Nadine D.; Chen, Ko-Fan; Rose, Ruth-Sarah; Crowther, Damian C.; Viles, John H.			Prion protein stabilizes amyloid-beta (A beta) oligomers and enhances A beta neurotoxicity in a Drosophila model of Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRUNCATED AMYLOID-BETA((11-40/42)); SYNAPTIC PLASTICITY; LOCOMOTOR-ACTIVITY; PLAQUE-FORMATION; IN-VIVO; TOXICITY; IMPAIRMENT; EXPRESSION; PEPTIDE; NEURODEGENERATION	The cellular prion protein (PrPC) can act as a cell-surface receptor for beta-amyloid (A beta) peptide; however, a role for PrPC in the pathogenesis of Alzheimer's disease (AD) is contested. Here, we expressed a range of A beta isoforms and PrPC in the Drosophila brain. We found that co-expression of A beta and PrPC significantly reduces the lifespan, disrupts circadian rhythms, and increases A beta deposition in the fly brain. In contrast, under the same conditions, expression of A beta or PrPC individually did not lead to these phenotypic changes. In vitro studies revealed that substoichiometric amounts of PrPC trap A beta as oligomeric assemblies and fragment-preformed A beta fibers. The ability of membrane-anchored PrPC to trap A beta as cytotoxic oligomers at the membrane surface and fragment inert A beta fibers suggests a mechanism by which PrPC exacerbates A beta deposition and pathogenic phenotypes in the fly, supporting a role for PrPC in AD. This study provides a second animal model linking PrPC expression with A beta toxicity and supports a role for PrPC in AD pathogenesis. Blocking the interaction of A beta and PrPC represents a potential therapeutic strategy.	[Younan, Nadine D.; Rose, Ruth-Sarah; Viles, John H.] Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England; [Chen, Ko-Fan] UCL, Dept Clin & Expt Epilepsy, Inst Neurol, London WC1N 3BG, England; [Crowther, Damian C.] AstraZeneca, Neurosci IMED Biotech Unit, Granta Pk, Cambridge CB21 6GH, England	University of London; Queen Mary University London; University of London; University College London; AstraZeneca	Viles, JH (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.; Crowther, DC (corresponding author), AstraZeneca, Neurosci IMED Biotech Unit, Granta Pk, Cambridge CB21 6GH, England.	damian.crowther@azneuro.com; j.viles@qmul.ac.uk	Rose, Ruth/AAW-3844-2020; Crowther, Damian/E-1703-2016	Rose, Ruth/0000-0001-6406-137X; Crowther, Damian/0000-0001-7791-1396	Wellcome Trust [093241/Z/10/Z]; Biotechnology and Biological Sciences Research Council [BB/M023877/1]; BBSRC [BB/D005027/1, BB/M023877/1] Funding Source: UKRI; MRC [G0700990] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 093241/Z/10/Z and Biotechnology and Biological Sciences Research Council Grant BB/M023877/1. The authors declare that they have no conflicts of interest with the contents of this article.	Bachhuber T, 2015, NAT MED, V21, P802, DOI 10.1038/nm.3885; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barritt JD, 2017, ANGEW CHEM INT EDIT, V56, P9816, DOI 10.1002/anie.201704618; Barritt JD, 2015, J BIOL CHEM, V290, P27791, DOI 10.1074/jbc.M115.684084; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Bode DC, 2017, J BIOL CHEM, V292, P1404, DOI 10.1074/jbc.M116.762526; Bove-Fenderson E, 2017, J BIOL CHEM, V292, P16858, DOI 10.1074/jbc.M117.789990; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chen KF, 2011, CURR BIOL, V21, P719, DOI 10.1016/j.cub.2011.03.049; Chen KF, 2014, DIS MODEL MECH, V7, P445, DOI 10.1242/dmm.014134; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Dohler F, 2014, BRAIN, V137, P873, DOI 10.1093/brain/awt375; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P49; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; He J, 2013, J NEUROL SCI, V326, P89, DOI 10.1016/j.jns.2013.01.020; Hermann C, 2012, J COMP NEUROL, V520, P970, DOI 10.1002/cne.22742; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; Hu NW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4374; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Iraci N, 2015, VIRUS RES, V207, P62, DOI 10.1016/j.virusres.2014.10.015; Jarosz-Griffiths HH, 2016, J BIOL CHEM, V291, P3174, DOI 10.1074/jbc.R115.702704; Johnson E, 1998, J NEUROGENET, V12, P1, DOI 10.3109/01677069809108552; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; KIM KS, 1990, NEUROSCI RES COMMUN, V7, P113; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2014, J ALZHEIMERS DIS, V38, P227, DOI 10.3233/JAD-130950; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-5; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Long DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106068; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Luo JH, 2016, J BIOL CHEM, V291, P16485, DOI 10.1074/jbc.R116.714576; Moloney A, 2010, TRENDS BIOCHEM SCI, V35, P228, DOI 10.1016/j.tibs.2009.11.004; Morel N, 2004, J BIOL CHEM, V279, P30143, DOI 10.1074/jbc.M403896200; Nicoll AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3416; Nieznanski K, 2014, ACS CHEM NEUROSCI, V5, P340, DOI 10.1021/cn500019c; Nieznanski K, 2012, J BIOL CHEM, V287, P33104, DOI 10.1074/jbc.C112.400614; O'Sullivan DBD, 2009, PROTEIN SCI, V18, P410, DOI 10.1002/pro.44; Pinnock EC, 2016, J ALZHEIMERS DIS, V49, P645, DOI 10.3233/JAD-150482; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Purro SA, 2018, BIOL PSYCHIAT, V83, P358, DOI 10.1016/j.biopsych.2017.11.020; Rahimi J, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0082-1; Resenberger UK, 2012, NEURODEGENER DIS, V10, P298, DOI 10.1159/000332596; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Sarell CJ, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170158; Sarell CJ, 2013, PRION, V7, P359, DOI 10.4161/pri.26415; Scott-McKean JJ, 2016, NEUROBIOL DIS, V91, P124, DOI 10.1016/j.nbd.2016.03.001; Sowade RF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00579-4; Speretta E, 2012, J BIOL CHEM, V287, P20748, DOI 10.1074/jbc.M112.350124; Stokin GB, 2008, HUM MOL GENET, V17, P3474, DOI 10.1093/hmg/ddn240; Thackray AM, 2017, BIOCHEM J, V474, P3253, DOI 10.1042/BCJ20170462; Thackray AM, 2014, BIOCHEM J, V463, P31, DOI 10.1042/BJ20140129; Thackray AM, 2012, BIOCHEM J, V444, P487, DOI 10.1042/BJ20112141; Thackray AM, 2012, EXP MOL PATHOL, V92, P194, DOI 10.1016/j.yexmp.2012.01.005; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yan LM, 2007, ANGEW CHEM INT EDIT, V46, P1246, DOI 10.1002/anie.200604056; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Younan ND, 2015, BIOCHEMISTRY-US, V54, P4297, DOI 10.1021/acs.biochem.5b00309; Younan ND, 2013, FASEB J, V27, P1847, DOI 10.1096/fj.12-222588; Zou WQ, 2011, J BIOL CHEM, V286, P15095, DOI 10.1074/jbc.M110.199356	78	16	16	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13090	13099		10.1074/jbc.RA118.003319	http://dx.doi.org/10.1074/jbc.RA118.003319			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29887525	Green Published, hybrid			2022-12-26	WOS:000442730200010
J	McGrath-Morrow, SA; Ndeh, R; Helmin, KA; Chen, SY; Anekalla, KR; Abdala-Valencia, H; D'Alessio, FR; Collaco, JM; Singer, BD				McGrath-Morrow, Sharon A.; Ndeh, Roland; Helmin, Kathryn A.; Chen, Shang-Yang; Anekalla, Kishore R.; Abdala-Valencia, Hiam; D'Alessio, Franco R.; Collaco, J. Michael; Singer, Benjamin D.			DNA methylation regulates the neonatal CD4(+) T-cell response to pneumonia in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-RESPONSE; RESOLUTION; INDUCTION; EXPRESSION; TOLERANCE; OUTCOMES; BET; LPS	Pediatric acute lung injury, usually because of pneumonia, has a mortality rate of more than 20% and an incidence that rivals that of all childhood cancers combined. CD4(+) T-cells coordinate the immune response to pneumonia but fail to function robustly among the very young, who have poor outcomes from lung infection. We hypothesized that DNA methylation represses a mature CD4(+) T-cell transcriptional program in neonates with pneumonia. Here, we found that neonatal mice (3-4 days old) aspirated with Escherichia coli bacteria had a higher mortality rate than juvenile mice (11-14 days old). Transcriptional profiling with an unsupervised RNA-Seq approach revealed that neonates displayed an attenuated lung CD4(+) T-cell transcriptional response to pneumonia compared with juveniles. Unlike neonates, juveniles up-regulated a robust set of canonical T-cell immune response genes. DNA methylation profiling with modified reduced representation bisulfite sequencing revealed 44,119 differentially methylated CpGs, which preferentially clustered around transcriptional start sites and CpG islands. A methylation difference-filtering algorithm detected genes with a high likelihood of differential promoter methylation regulating their expression; these 731 loci encoded important immune response and tissue-protective T-cell pathway components. Disruption of DNA methylation with the hypomethylating agent decitabine induced plasticity in the lung CD4(+) T-cell marker phenotype. Altogether, multidimensional profiling suggested that DNA methylation within the promoters of a core set of CD4(+) T-cell pathway genes contributes to the hyporesponsive neonatal immune response to pneumonia. These findings also suggest that DNA methylation could serve as a mechanistic target for disease-modifying therapies in pediatric lung infection and injury.	[McGrath-Morrow, Sharon A.; Ndeh, Roland; Collaco, J. Michael] Johns Hopkins Univ, Sch Med, Eudowood Div Pediat Resp Sci, Baltimore, MD USA; [Helmin, Kathryn A.; Chen, Shang-Yang; Anekalla, Kishore R.; Abdala-Valencia, Hiam; Singer, Benjamin D.] Northwestern Univ Feinberg, Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [D'Alessio, Franco R.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Singer, Benjamin D.] Northwestern Univ Feinberg, Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611 USA	Johns Hopkins University; Northwestern University; Feinberg School of Medicine; Johns Hopkins University; Northwestern University; Feinberg School of Medicine	Singer, BD (corresponding author), McGaw Pavil, Ste M 300, Chicago, IL 60611 USA.	benjamin-singer@northwestern.edu	Singer, Benjamin D./P-2392-2019; Chen, Shang-Yang/GXH-3516-2022	Singer, Benjamin D./0000-0001-5775-8427; Chen, Shang-Yang/0000-0002-6864-4713; Anekalla, Kishore/0000-0002-8366-5782	National Institutes of Health award [P30CA006973, P30AR053503]; Feinberg School of Medicine; Center for Genetic Medicine; Feinberg's Department of Biochemistry and Molecular Genetics; Office of the Provost; Northwestern Information Technology; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114800, K08HL128867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053503] Funding Source: NIH RePORTER	National Institutes of Health award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Feinberg School of Medicine; Center for Genetic Medicine; Feinberg's Department of Biochemistry and Molecular Genetics; Office of the Provost; Northwestern Information Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We acknowledge Dr. Alexander V. Misharin for the thoughtful review of this manuscript. We also acknowledge the Sidney Kimmel Cancer Center Experimental and Computational Genomics Core (supported by National Institutes of Health award P30CA006973), the Northwestern University RNA-Seq Center of the Pulmonary and Critical Care Medicine and Rheumatology Divisions, and the Johns Hopkins Bayview Flow Cytometry Core (supported by National Institutes of Health award P30AR053503). This research was supported in part through the computational resources and staff contributions provided by the Genomics Compute Cluster, which is jointly supported by the Feinberg School of Medicine, the Center for Genetic Medicine, and Feinberg's Department of Biochemistry and Molecular Genetics, the Office of the Provost, the Office for Research, and Northwestern Information Technology. The Genomics Compute Cluster is part of Quest, Northwestern University's high performance computing facility, with the purpose to advance research in genomics.	ABRAMOWICZ D, 1990, EUR J IMMUNOL, V20, P1647, DOI 10.1002/eji.1830200805; Cook Donald N, 2015, Nucl Receptor Res, V2; D'Alessio FR, 2016, AM J PHYSIOL-LUNG C, V310, pL733, DOI 10.1152/ajplung.00419.2015; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Delacher M, 2017, NAT IMMUNOL, V18, P1160, DOI 10.1038/ni.3799; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Duke T, 2005, ARCH DIS CHILD-FETAL, V90, P211, DOI 10.1136/adc.2003.048108; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Feng H, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku154; Flori HR, 2005, AM J RESP CRIT CARE, V171, P995, DOI 10.1164/rccm.200404-544OC; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Institute of Medicine (US) and National Research Council (US) National Cancer Policy Board, 2003, EP CHILDH CANC; Kelsey G, 2017, SCIENCE, V358, P69, DOI 10.1126/science.aan6826; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Levy O, 2005, J ENDOTOXIN RES, V11, P113, DOI 10.1179/096805105X37376; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Makar KW, 2004, J IMMUNOL, V173, P4402, DOI 10.4049/jimmunol.173.7.4402; McGrath-Morrow SA, 2017, CYTOKINE, V97, P108, DOI 10.1016/j.cyto.2017.06.002; McGrath-Morrow SA, 2015, AM J RESP CELL MOL, V52, P323, DOI 10.1165/rcmb.2014-0100OC; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Mock JR, 2014, MUCOSAL IMMUNOL, V7, P1440, DOI 10.1038/mi.2014.33; Obata Y, 2014, NAT IMMUNOL, V15, P571, DOI 10.1038/ni.2886; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; POWELL TJ, 1990, J IMMUNOL, V144, P854; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; SCHURMANS S, 1990, J IMMUNOL, V145, P2465; Singer BD, 2016, AM J PHYSIOL-LUNG C, V310, pL796, DOI 10.1152/ajplung.00334.2015; Singer BD, 2015, AM J RESP CELL MOL, V52, P641, DOI 10.1165/rcmb.2014-0327OC; Stricker SH, 2017, NAT REV GENET, V18, P51, DOI 10.1038/nrg.2016.138; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; THURLBECK WM, 1982, THORAX, V37, P564, DOI 10.1136/thx.37.8.564; Wang X, 2017, ONCOTARGET, V8, P56802, DOI 10.18632/oncotarget.18063; Zhang XM, 2017, NAT REV IMMUNOL, V17, P495, DOI 10.1038/nri.2017.54; Zhang Y, 2018, BRIEF BIOINFORM, V19, P374, DOI 10.1093/bib/bbw133; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zimmerman JJ, 2009, PEDIATRICS, V124, P87, DOI 10.1542/peds.2007-2462	42	28	29	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11772	11783		10.1074/jbc.RA118.003589	http://dx.doi.org/10.1074/jbc.RA118.003589			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29866884	Green Published, hybrid			2022-12-26	WOS:000440134500010
J	Arndt, L; Dokas, J; Gericke, M; Kutzner, CE; Muller, S; Jeromin, F; Thiery, J; Burkhardt, R				Arndt, Lilli; Dokas, Janine; Gericke, Martin; Kutzner, Carl Elias; Mueller, Silvana; Jeromin, Franziska; Thiery, Joachim; Burkhardt, Ralph			Tribbles homolog 1 deficiency modulates function and polarization of murine bone marrow-derived macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						macrophage; signal transduction; migration; phagocytosis; Janus kinase (JAK); STAT transcription factor; M1; M2; polarization	REGULATES HEPATIC LIPOGENESIS; SIGNALING PATHWAYS; GENE-EXPRESSION; C/EBP-ALPHA; IMMUNE-RESPONSES; ACTIVATION; TRIB1; RECEPTOR; INFLAMMATION; CELLS	Macrophages are essential for innate immunity and inflammatory responses and differentiate into various functional phenotypes. Tribbles homolog 1 (Trib1), a member of the mammalian Tribbles homolog pseudokinase family, has been implicated in regulation of cell differentiation, proliferation, and metabolism, but its role in macrophage biology has not been fully elucidated. Here, we investigated the consequences of Trib1 deficiency on macrophage functions and M1/M2 polarization. Bone marrow-derived macrophages (BMDMs) from Trib1-deficient (Trib1(-/-)) mice exhibited elevated phagocytic capacity, correlating with up-regulation of several scavenger receptors. Concomitantly, uptake of modified low-density lipoprotein was increased in Trib1(-/-) BMDMs. Trib1(-/-) macrophages also exhibited diminished migration in the presence of the chemokine MCP-1, associated with reduced expression of the MCP-1 receptor Ccr2. Furthermore, Trib1 deficiency attenuated the response of BMDMs to both M1 and M2 stimuli; induction of the M1-marker genes Il6, Il1b, and Nos2 upon LPS/IFN stimulation and of the M2-marker genes Cd206, Fizz1, and Arg1 upon IL-4 stimulation was reduced. Functionally, Trib1 deficiency decreased secretion of proinflammatory cytokines (IL-6, TNF, IL-1, and CXCL1) and reduced nitric oxide and reactive oxygen species production in M1-polarized macrophages. Supporting the attenuated M2 phenotype, IL-4-stimulated Trib1(-/-) macrophages secreted less IL-10 and TGF. Mechanistically, Trib1(-/-) BMDMs displayed lower levels of Janus kinase 1 (JAK1), resulting in reduced activation of LPS/IFN-mediated STAT1 signaling. Likewise, decreased levels of JAK1 along with lower activation of STAT6 and STAT3 were observed in M2-polarized Trib1(-/-) BMDMs. Our findings suggest that Trib1 extensively controls macrophage M1/M2 polarization via the JAK/STAT signaling pathway.	[Arndt, Lilli; Dokas, Janine; Kutzner, Carl Elias; Mueller, Silvana; Jeromin, Franziska; Thiery, Joachim; Burkhardt, Ralph] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Liebigstr 27, D-04103 Leipzig, Germany; [Gericke, Martin] Univ Leipzig, Inst Anat, D-04103 Leipzig, Germany; [Thiery, Joachim; Burkhardt, Ralph] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04103 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Burkhardt, R (corresponding author), Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Liebigstr 27, D-04103 Leipzig, Germany.	ralph.burkhardt@medizin.uni-leipzig.de	Kutzner, Carl Elias/ABI-2268-2020; Gericke, Martin/AAI-8637-2020	Kutzner, Carl Elias/0000-0003-4053-2231; Burkhardt, Ralph/0000-0003-1924-1202	Deutsche Forschungsgemeinschaft, Collaborative Research Centre "Obesity Mechanisms" [SFB1052-B07]; Stiftung fur Pathobiochemie und Molekulare Diagnostik	Deutsche Forschungsgemeinschaft, Collaborative Research Centre "Obesity Mechanisms"(German Research Foundation (DFG)); Stiftung fur Pathobiochemie und Molekulare Diagnostik	This study was supported by Deutsche Forschungsgemeinschaft, Collaborative Research Centre "Obesity Mechanisms" Grant SFB1052-B07 (to R.B.) and a grant from Stiftung fur Pathobiochemie und Molekulare Diagnostik (to J. D. and R. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Bauer RC, 2015, J CLIN INVEST, V125, P3809, DOI 10.1172/JCI77095; Bhattacharjee A, 2013, FREE RADICAL BIO MED, V54, P1, DOI 10.1016/j.freeradbiomed.2012.10.553; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Burkhardt R, 2010, J CLIN INVEST, V120, P4410, DOI 10.1172/JCI44213; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dhakal M, 2014, EUR J IMMUNOL, V44, P842, DOI 10.1002/eji.201343755; Douvris A, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000884; Durzynska I, 2017, STRUCTURE, V25, P287, DOI 10.1016/j.str.2016.12.008; Eyers PA, 2017, TRENDS CELL BIOL, V27, P284, DOI 10.1016/j.tcb.2016.11.002; Guan HT, 2016, SCI REP-UK, V6, DOI 10.1038/srep32667; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Johnston J, 2015, BIOCHEM SOC T, V43, P1069, DOI 10.1042/BST20150095; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee B, 2014, AM J PHYSIOL-ENDOC M, V306, pE1144, DOI 10.1152/ajpendo.00002.2014; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murphy JM, 2015, STRUCTURE, V23, P2111, DOI 10.1016/j.str.2015.08.017; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohmori Y, 1998, J BIOL CHEM, V273, P29202, DOI 10.1074/jbc.273.44.29202; Ostertag A, 2010, DIABETES, V59, P1991, DOI 10.2337/db09-1537; Piras V, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00070; Raes G, 2005, J IMMUNOL, V174, P6561, DOI 10.4049/jimmunol.174.11.6561; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Sung HY, 2007, J BIOL CHEM, V282, P18379, DOI 10.1074/jbc.M610792200; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Teupser D, 2008, ARTERIOSCL THROM VAS, V28, P2009, DOI 10.1161/ATVBAHA.108.175257; Tugal D, 2013, ARTERIOSCL THROM VAS, V33, P1135, DOI 10.1161/ATVBAHA.113.301453; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Wells CA, 2005, J LEUKOCYTE BIOL, V78, P9, DOI 10.1189/jlb.1204710; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Yamamoto M, 2007, J EXP MED, V204, P2233, DOI 10.1084/jem.20070183; Yokoyama T, 2011, CANCER SCI, V102, P1115, DOI 10.1111/j.1349-7006.2011.01914.x; Yokoyama T, 2010, BLOOD, V116, P2768, DOI 10.1182/blood-2009-10-246264; Yoshida A, 2013, BLOOD, V122, P1750, DOI 10.1182/blood-2012-12-476101; Zhang YL, 2005, CELL MOL IMMUNOL, V2, P20	42	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11527	11536		10.1074/jbc.RA117.000703	http://dx.doi.org/10.1074/jbc.RA117.000703			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29899113	Green Published, hybrid			2022-12-26	WOS:000439449700022
J	Katagiri, Y; Morgan, AA; Yu, PP; Bangayan, NJ; Junka, R; Geller, HM				Katagiri, Yasuhiro; Morgan, Ashlea A.; Yu, Panpan; Bangayan, Nathanael J.; Junka, Radoslaw; Geller, Herbert M.			Identification of novel binding sites for heparin in receptor protein-tyrosine phosphatase (RPTP sigma): Implications for proteoglycan signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteoglycan; heparan sulfate; chondroitin sulfate; cell signaling; glycosaminoglycan; receptor tyrosine phosphatase; RPTP sigma	CHONDROITIN SULFATE PROTEOGLYCAN; PTP-SIGMA; IN-VIVO; LAR; DOMAINS; REGENERATION; INHIBITORS; EXTENSION; SYNDECAN; NEURONS	Receptor protein-tyrosine phosphatase RPTP sigma has important functions in modulating neural development and regeneration. Compelling evidence suggests that both heparan sulfate (HS) and chondroitin sulfate (CS) glycosaminoglycans (GAGs) bind to a series of Lys residues located in the first Ig domain of RPTP sigma. However, HS promotes and CS inhibits axonal growth. Mutation of these Lys residues abolished binding and signal transduction of RPTP sigma to CS, whereas HS binding was reduced, and signaling persisted. This activity was mediated through novel heparin-binding sites identified in the juxtamembrane region. Although different functional outcomes of HS and CS have been previously attributed to the differential oligomeric state of RPTP sigma upon GAG binding, we found that RPTP sigma was clustered by both heparin and CS GAG rich in 4,6-O-disulfated disaccharide units. We propose an additional mechanism by which RPTP sigma distinguishes between HS and CS through these novel binding sites.	[Katagiri, Yasuhiro; Morgan, Ashlea A.; Yu, Panpan; Bangayan, Nathanael J.; Junka, Radoslaw; Geller, Herbert M.] NHLBI, Lab Dev Neurobiol, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Yu, Panpan] Jinan Univ, Guangdong Hongkong Macau Inst CNS Regenerat, Minist Educ, Joint Int Res Lab CNS Regenerat, Guangzhou 510632, Guangdong, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Jinan University	Katagiri, Y (corresponding author), NHLBI, Lab Dev Neurobiol, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	katagiry@helix.nih.gov	Yu, Panpan/M-5718-2019	Morgan, Ashlea/0000-0002-3235-2567	Division of Intramural Research, NHLBI, National Institutes of Health; Mizutani Foundation for Glycoscience; NATIONAL CANCER INSTITUTE [T32CA009120] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006021] Funding Source: NIH RePORTER	Division of Intramural Research, NHLBI, National Institutes of Health; Mizutani Foundation for Glycoscience; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Division of Intramural Research, NHLBI, National Institutes of Health, and the Mizutani Foundation for Glycoscience. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Biersmith BH, 2011, J MOL BIOL, V408, P616, DOI 10.1016/j.jmb.2011.03.013; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Briani C, 1998, J NEUROIMMUNOL, V84, P117, DOI 10.1016/S0165-5728(97)00209-9; Brown JM, 2012, P NATL ACAD SCI USA, V109, P4768, DOI 10.1073/pnas.1121318109; Coles CH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6209; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Doody KM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4616; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Krueger NX, 2003, MOL CELL BIOL, V23, P6909, DOI 10.1128/MCB.23.19.6909-6921.2003; Kwon SK, 2010, J BIOL CHEM, V285, P13966, DOI 10.1074/jbc.M109.061127; Lee HS, 2016, BIOORG MED CHEM LETT, V26, P87, DOI 10.1016/j.bmcl.2015.11.026; Ohtake Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37152; Ori A, 2009, MOL CELL PROTEOMICS, V8, P2256, DOI 10.1074/mcp.M900031-MCP200; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Takahashi H, 2013, TRENDS NEUROSCI, V36, P522, DOI 10.1016/j.tins.2013.06.002; Takahashi H, 2012, NAT NEUROSCI, V15, P389, DOI 10.1038/nn.3040; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Thelin MA, 2013, FEBS J, V280, P2431, DOI 10.1111/febs.12214; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Won SY, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00327; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Yi JH, 2014, EXP NEUROL, V255, P12, DOI 10.1016/j.expneurol.2014.02.007; Yu PP, 2018, TRENDS NEUROSCI, V41, P47, DOI 10.1016/j.tins.2017.10.005; Yu PP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059285	28	16	16	4	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11639	11647		10.1074/jbc.RA118.003081	http://dx.doi.org/10.1074/jbc.RA118.003081			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29880643	hybrid, Green Published			2022-12-26	WOS:000439449700031
J	da Cunha, LM; Wilkins, LGE; Menin, L; Ortiz, D; Vocat-Mottier, V; Wedekind, C				da Cunha, Lucas Marques; Wilkins, Laetitia G. E.; Menin, Laure; Ortiz, Daniel; Vocat-Mottier, Veronique; Wedekind, Claus			Consumption of carotenoids not increased by bacterial infection in brown trout embryos (Salmo trutta)	PLOS ONE			English	Article							CHINOOK SALMON; LOCAL ADAPTATION; GENETIC QUALITY; RAINBOW-TROUT; GADUS-MORHUA; ATLANTIC COD; EGG QUALITY; ASTAXANTHIN; FISH; SUPPLEMENTATION	Carotenoids are organic pigment molecules that play important roles in signalling, control of oxidative stress, and immunity. Fish allocate carotenoids to their eggs, which gives them the typical yellow to red colouration and supports their resistance against microbial infections. However, it is still unclear whether carotenoids act mainly as a shield against infection or are used up during the embryos' immune defence. We investigated this question with experimental families produced from wild-caught brown trout (Salmo trutta). Singly raised embryos were either exposed to the bacterial pathogen Pseudomonas fluorescens or sham-treated at one of two stages during their development. A previous study on these experimental families reported positive effects of egg carotenoids on embryo growth and resistance against the infection. Here, we quantified carotenoid consumption, i.e. the active metabolization of carotenoids into compounds that are not other carotenoid types, in these infected and sham-infected maternal sib groups. We found that carotenoid contents mostly decreased during embryogenesis. However, these decreases were neither linked to the virulence induced by the pathogen nor dependent on the time point of infection. We conclude that egg carotenoids are not significantly used up by the embryos' immune defence.	[da Cunha, Lucas Marques; Wilkins, Laetitia G. E.; Vocat-Mottier, Veronique; Wedekind, Claus] Univ Lausanne, Dept Ecol & Evolut, Biophore, Lausanne, Switzerland; [Wilkins, Laetitia G. E.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA USA; [Menin, Laure; Ortiz, Daniel] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn ISIC, Batochime, Lausanne, Switzerland	University of Lausanne; University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Wedekind, C (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Biophore, Lausanne, Switzerland.	claus.wedekind@unil.ch	Wilkins, Laetitia G.E./H-6113-2019	Wilkins, Laetitia G.E./0000-0003-3632-2063; Ortiz, Daniel/0000-0001-9632-8710; Wedekind, Claus/0000-0001-6143-4716	Swiss National Science Foundation [SNF 31003A_159579/1]; Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The Swiss National Science Foundation provided funding (grant to Claus Wedekind - #SNF 31003A_159579/1). Laetitia Wilkins was supported by a fellowship from the Swiss National Science Foundation.	Ahmadi MR, 2006, J APPL ICHTHYOL, V22, P388, DOI 10.1111/j.1439-0426.2006.00770.x; Ambati RR, 2014, MAR DRUGS, V12, P128, DOI 10.3390/md12010128; Anbazahan SM, 2014, FISH SHELLFISH IMMUN, V40, P9, DOI 10.1016/j.fsi.2014.06.011; [Anonymous], 2011, ECOLOGY ATLANTIC SAL; Aris AZ, 2014, ENVIRON INT, V69, P104, DOI 10.1016/j.envint.2014.04.011; Aslani BA, 2016, LIFE SCI, V146, P163, DOI 10.1016/j.lfs.2016.01.014; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Blount JD, 2000, TRENDS ECOL EVOL, V15, P47, DOI 10.1016/S0169-5347(99)01774-7; Boon CS, 2010, CRIT REV FOOD SCI, V50, P515, DOI 10.1080/10408390802565889; Brazzola G, 2014, EVOL APPL, V7, P1084, DOI 10.1111/eva.12216; Brown AC, 2016, ENVIRON BIOL FISH, V99, P439, DOI 10.1007/s10641-016-0485-x; Caldwell DJ, 2012, ENVIRON TOXICOL CHEM, V31, P1396, DOI 10.1002/etc.1825; Clark ES, 2014, FUNCT ECOL, V28, P714, DOI 10.1111/1365-2435.12214; Clark ES, 2013, MOL ECOL, V22, P5256, DOI 10.1111/mec.12457; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Einum S, 1999, P ROY SOC B-BIOL SCI, V266, P2095, DOI 10.1098/rspb.1999.0893; Garner SR, 2010, J FISH BIOL, V76, P1474, DOI 10.1111/j.1095-8649.2010.02579.x; Hansen OJ, 2016, AQUAC RES, V47, P819, DOI 10.1111/are.12540; Jacob A, 2010, MOL ECOL, V19, P5296, DOI 10.1111/j.1365-294X.2010.04884.x; Jensen LF, 2008, P ROY SOC B-BIOL SCI, V275, P2859, DOI 10.1098/rspb.2008.0870; Kolluru GR, 2006, BIOL J LINN SOC, V89, P301, DOI 10.1111/j.1095-8312.2006.00675.x; Lvoll M, 2006, IMMUNOGENETICS, V58, P168, DOI 10.1007/s00251-006-0096-3; Marques daCunha L, 2017, BIORXIV, DOI [10.1101/161570, DOI 10.1101/161570]; Matsuno T, 2001, FISHERIES SCI, V67, P771, DOI 10.1046/j.1444-2906.2001.00323.x; MCCALLUM IM, 1987, AQUACULTURE, V67, P291, DOI 10.1016/0044-8486(87)90214-6; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; OECD-Organisation for Economic Cooperation and Development, 1992, GUID TEST CHEM 203 F; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Palace VP, 2006, SCI MAR, V70, P41, DOI 10.3989/scimar.2006.70s241; Pitcher TE, 2007, CONSERV GENET, V8, P607, DOI 10.1007/s10592-006-9204-z; Pompini M, 2013, BEHAV ECOL SOCIOBIOL, V67, P649, DOI 10.1007/s00265-013-1484-y; R Core Team, 2021, R LANGUAGE ENV STAT; Sawanboonchun J, 2008, AQUACULTURE, V283, P97, DOI 10.1016/j.aquaculture.2008.06.024; Scabini V, 2011, AQUACULT NUTR, V17, P304, DOI 10.1111/j.1365-2095.2010.00766.x; SCHIEDT K, 1985, PURE APPL CHEM, V57, P685, DOI 10.1351/pac198557050685; Skoglund H, 2012, FUNCT ECOL, V26, P104, DOI 10.1111/j.1365-2435.2011.01901.x; Stelkens RB, 2014, CONSERV GENET, V15, P375, DOI 10.1007/s10592-013-0545-0; Stelkens RB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-247; Stelkens RB, 2012, MOL ECOL, V21, P2896, DOI 10.1111/j.1365-294X.2012.05581.x; Tateno H, 2002, DEV COMP IMMUNOL, V26, P543, DOI 10.1016/S0145-305X(02)00007-1; Tyndale ST, 2008, EVOL ECOL RES, V10, P1187; von Siebenthal BA, 2009, FISH SHELLFISH IMMUN, V26, P531, DOI 10.1016/j.fsi.2009.02.008; Wedekind C, 2004, J EVOLUTION BIOL, V17, P11, DOI 10.1046/j.1420-9101.2004.00669.x; Wedekind C, 2010, ECOLOGY, V91, P1251, DOI 10.1890/09-1067.1; Wedekind C, 2002, CURR BIOL, V12, P69, DOI 10.1016/S0960-9822(01)00627-3; Wedekind C, 2001, J EVOLUTION BIOL, V14, P980, DOI 10.1046/j.1420-9101.2001.00349.x; Wilkins LGE, 2017, OECOLOGIA, V185, P351, DOI 10.1007/s00442-017-3952-y; Wilkins LGE, 2017, ECOL EVOL, V7, P5082, DOI 10.1002/ece3.3076; Wilkins LGE, 2015, SCI REP-UK, V5, DOI 10.1038/srep17084; YOUSIF AN, 1994, DIS AQUAT ORGAN, V20, P127, DOI 10.3354/dao020127; Yuangsoi B., 2010, World Applied Sciences Journal, V11, P590	52	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198834	10.1371/journal.pone.0198834	http://dx.doi.org/10.1371/journal.pone.0198834			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897970	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700075
J	Nakano, R; Ohira, M; Yano, T; Imaoka, Y; Tanaka, Y; Ohdan, H				Nakano, Ryosuke; Ohira, Masahiro; Yano, Takuya; Imaoka, Yuki; Tanaka, Yuka; Ohdan, Hideki			Hepatic irradiation persistently eliminates liver resident NK cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; T-CELLS; HEPATOCELLULAR-CARCINOMA; RADIATION; MOUSE; MICE; TRANSPLANTATION; RADIOTHERAPY; PATHWAYS; HUMANS	Hepatic irradiation for the treatment of hepatobiliary malignancies often indirectly damages liver tissue and promotes the development of liver fibrosis. However, little is known concerning the effects of hepatic irradiation on the liver immune system, including natural killer (NK) cells. The aim of this study was therefore to investigate how hepatic irradiation influences the functions and characteristics of liver resident NK cells. An established murine hepatic irradiation model was used to examine the specific effects of hepatic irradiation on immune cell populations and metastasis. This analysis demonstrated that hepatic irradiation decreased the number of liver resident NK cells (DX5(-)TRAIL(+)), but did not affect the total NK number or proportions of NK cells in the liver or spleen. This effect was correlated with the hepatic irradiation dose. Surprisingly, the liver resident NK population had not recovered by two months after hepatic irradiation. We also found that hepatic irradiation limited the cytotoxic effects of liver-derived lymphocytes against a mouse hepatoma cell line and promoted hepatic metastases in an in vivo model, although adoptive transfer of activated NK cells could alleviate metastatic growth. Finally, we demonstrated that hepatic irradiation disrupted the development of liver-resident NK cells, even after the adoptive transfer of precursor cells from the bone marrow, liver, and spleen, suggesting that irradiation had altered the developmental environment of the liver. In summary, our data demonstrated that hepatic irradiation abolished the DX5(-)TRAIL(+) liver-resident NK cell population and dampened antitumor activities in the liver for at least two months. Additionally, hepatic irradiation prevented differentiation of precursor cells into liver-resident NK cells.	[Nakano, Ryosuke; Ohira, Masahiro; Yano, Takuya; Imaoka, Yuki; Tanaka, Yuka; Ohdan, Hideki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Appl Life Sci, Hiroshima, Japan; [Ohira, Masahiro] Hiroshima Univ Hosp, Med Ctr Translat & Clin Res, Div Regenerat & Med, Hiroshima, Japan	Hiroshima University; Hiroshima University	Ohira, M (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Appl Life Sci, Hiroshima, Japan.; Ohira, M (corresponding author), Hiroshima Univ Hosp, Med Ctr Translat & Clin Res, Div Regenerat & Med, Hiroshima, Japan.	mohira@hiroshima-u.ac.jp	Tanaka, Yuka/G-9580-2019; Ohira, Masahiro/G-7350-2019; Ohdan, Hideki/G-4719-2019	Ohdan, Hideki/0000-0002-9066-1288; Ohira, Masahiro/0000-0002-5433-5303	Ministry of Education, Culture, Sports, Science and Technology of Japan [KAKENHI JP15K19893, KAKENHI JP17K10669]; Japan Agency for Medical Research and Development [17fk0210207]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan under Grant Numbers KAKENHI JP15K19893 and KAKENHI JP17K10669 to MO, Japan Agency for Medical Research and Development under Grant Number 17fk0210207 to HO, and Takeda Science Foundation to MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bonorino P, 2009, J HEPATOL, V51, P458, DOI 10.1016/j.jhep.2009.05.030; BOUWENS L, 1987, EUR J IMMUNOL, V17, P37, DOI 10.1002/eji.1830170107; Crotta S, 2014, J IMMUNOL, V192, P2677, DOI 10.4049/jimmunol.1302765; Cuff AO, 2016, J IMMUNOL, V197, P4283, DOI 10.4049/jimmunol.1601424; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; DJEU JY, 1979, J IMMUNOL, V122, P175; Formenti SC, 2009, LANCET ONCOL, V10, P718, DOI 10.1016/S1470-2045(09)70082-8; Gauttier V, 2014, INT J CANCER, V135, P2857, DOI 10.1002/ijc.28943; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; Guha C, 1999, CANCER RES, V59, P5871; Gupta A, 2012, J IMMUNOL, V189, P558, DOI 10.4049/jimmunol.1200563; Huntington ND, 2007, NAT REV IMMUNOL, V7, P703, DOI 10.1038/nri2154; Imaeda M, 2014, J RADIAT RES, V55, P665, DOI 10.1093/jrr/rru005; Ishiyama K, 2006, HEPATOLOGY, V43, P362, DOI 10.1002/hep.21035; Kobayashi K, 2010, CANCER IMMUNOL IMMUN, V59, P1503, DOI 10.1007/s00262-010-0877-2; KOO GC, 1986, J IMMUNOL, V137, P3742; Lischalk JW, 2017, J GASTROINTEST ONCOL, V8, P279, DOI 10.21037/jgo.2016.08.02; Male V, 2017, TRENDS IMMUNOL, V38, P307, DOI 10.1016/j.it.2017.02.008; Matsumura S, 2008, J IMMUNOL, V181, P3099, DOI 10.4049/jimmunol.181.5.3099; Moroso V, 2010, LIVER TRANSPLANT, V16, P895, DOI 10.1002/lt.22080; Ohira M, 2006, TRANSPLANTATION, V82, P1712, DOI 10.1097/01.tp.0000250935.41034.2d; Ohira M, 2009, J CLIN INVEST, V119, P3226, DOI 10.1172/JCI38374; Pan CC, 2010, INT J RADIAT ONCOL, V76, pS94, DOI 10.1016/j.ijrobp.2009.06.092; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Persa E, 2015, CANCER LETT, V368, P252, DOI 10.1016/j.canlet.2015.03.003; Schaue D, 2012, RADIAT RES, V178, P505, DOI 10.1667/RR3031.1; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Tang L, 2016, J AUTOIMMUN, V67, P29, DOI 10.1016/j.jaut.2015.09.004; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vosshenrich CAJ, 2013, CURR OPIN IMMUNOL, V25, P130, DOI 10.1016/j.coi.2013.02.002; Wendel M, 2008, CANCER RES, V68, P8437, DOI 10.1158/0008-5472.CAN-08-1440; Yano T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186997	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198904	10.1371/journal.pone.0198904	http://dx.doi.org/10.1371/journal.pone.0198904			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897952	Green Submitted, gold, Green Published			2022-12-26	WOS:000435090700077
J	Niu, XF; Ah-Fong, AMV; Lopez, LA; Judelson, HS				Niu, Xiaofan; Ah-Fong, Audrey M., V; Lopez, Lilianna A.; Judelson, Howard S.			Transcriptomic and proteomic analysis reveals wall-associated and glucan-degrading proteins with potential roles in Phytophthora infestans sexual spore development	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GENE-EXPRESSION; REAL-TIME; OOSPORE GERMINATION; RICH PROTEINS; POLY(A) TAIL; REPRODUCTION; ULTRASTRUCTURE; MEGASPERMA; INFECTION	Sexual reproduction remains an understudied feature of oomycete biology. To expand our knowledge of this process, we used RNA-seq and quantitative proteomics to examine matings in Phytophthora infestans. Exhibiting significant changes in mRNA abundance in three matings between different A1 and A2 strains compared to nonmating controls were 1170 genes, most being mating-induced. Rising by >10-fold in at least one cross were 455 genes, and 182 in all three crosses. Most genes had elevated expression in a self-fertile strain. Many mating-induced genes were associated with cell wall biosynthesis, which may relate to forming the thick-walled sexual spore (oospore). Several gene families were induced during mating including one encoding histidine, serine, and tyrosine-rich putative wall proteins, and another encoding prolyl hydroxylases which may strengthen the extracellular matrix. The sizes of these families vary >10-fold between Phytophthora species and one exhibits concerted evolution, highlighting two features of genome dynamics within the genus. Proteomic analyses of mature oospores and nonmating hyphae using isobaric tags for quantification identified 835 shared proteins, with 5% showing >2-fold changes in abundance between the tissues. Enriched in oospores were beta-glucanases potentially involved in digesting the oospore wall during germination. Despite being dormant, oospores contained a mostly normal complement of proteins required for core cellular functions. The RNA-seq data generated here and in prior studies were used to identify new housekeeping controls for gene expression studies that are more stable than existing normalization standards. We also observed >2-fold variation in the fraction of polyA(+) RNA between life stages, which should be considered when quantifying transcripts and may also be relevant to understanding translational control during development.	[Niu, Xiaofan; Ah-Fong, Audrey M., V; Lopez, Lilianna A.; Judelson, Howard S.] Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Judelson, HS (corresponding author), Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA.	howard.judelson@ucr.edu			National Science Foundation of the United States [1616339]; National Institute of Food and Agriculture of the United States Department of Agriculture [2016-67013-24815]	National Science Foundation of the United States(National Science Foundation (NSF)); National Institute of Food and Agriculture of the United States Department of Agriculture	This was supported by grants 1616339 from the National Science Foundation of the United States and 2016-67013-24815 from the National Institute of Food and Agriculture of the United States Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamian M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006097; Ah-Fong AMV, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4151-2; Ah-Fong AMV, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3585-x; Alibardi L, 2003, J EXP ZOOL PART A, V297A, P105, DOI 10.1002/jez.a.10232; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arvola RM, 2017, RNA BIOL, V14, P1445, DOI 10.1080/15476286.2017.1306168; BEAKES GW, 1989, MYCOL RES, V93, P321, DOI 10.1016/S0953-7562(89)80159-5; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bruning O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097089; Cassab GI, 1998, ANNU REV PLANT PHYS, V49, P281, DOI 10.1146/annurev.arplant.49.1.281; CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; Chang JM, 2014, MOL BIOL EVOL, V31, P1625, DOI 10.1093/molbev/msu117; Cvitanich C, 2006, MOL GENET GENOMICS, V275, P169, DOI 10.1007/s00438-005-0074-8; Derevnina L, 2016, NEW PHYTOL, V212, P888, DOI 10.1111/nph.14137; Dong SM, 2015, CURR OPIN GENET DEV, V35, P57, DOI 10.1016/j.gde.2015.09.001; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fabritius AL, 2002, MOL MICROBIOL, V45, P1057, DOI 10.1046/j.1365-2958.2002.03073.x; FORSTER H, 1983, PHYTOPATHOLOGY, V73, P442, DOI 10.1094/Phyto-73-442; Franzel B, 2011, PROTEOMICS, V11, P3651, DOI 10.1002/pmic.201100056; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Gao J, 2015, MOL PLANT PATHOL, V16, P61, DOI 10.1111/mpp.12163; Gause M, 2008, CHROMOSOMA, V117, P51, DOI 10.1007/s00412-007-0125-5; Gavino PD, 2000, PLANT DIS, V84, P731, DOI 10.1094/PDIS.2000.84.7.731; Grenville-Briggs LJ, 2013, FUNGAL BIOL-UK, V117, P163, DOI 10.1016/j.funbio.2013.01.001; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo T, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00142; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Heck T, 2013, APPL MICROBIOL BIOT, V97, P461, DOI 10.1007/s00253-012-4569-z; HEMMES DE, 1975, ARCH MICROBIOL, V103, P91, DOI 10.1007/BF00436336; HEMMES DE, 1983, PHYTOPHTHORA ITS BIO, P9; Henniger H, 1963, Z ALLG MIKROBIOL, V3, P126, DOI DOI 10.1002/JOBM.3630030204; Judelson HS, 2005, NAT REV MICROBIOL, V3, P47, DOI 10.1038/nrmicro1064; Kawai Y, 2014, PLANT J, V78, P328, DOI 10.1111/tpj.12479; Kayala MA, 2012, NUCLEIC ACIDS RES, V40, pW553, DOI 10.1093/nar/gks420; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; LEARY JV, 1974, PHYTOPATHOLOGY, V64, P404, DOI 10.1094/Phyto-64-404; Lim J, 2016, GENE DEV, V30, P1671, DOI 10.1101/gad.284802.116; Lima SA, 2017, NAT STRUCT MOL BIOL, V24, P1057, DOI 10.1038/nsmb.3499; Liu F, 2013, P NATL ACAD SCI USA, V110, P9722, DOI 10.1073/pnas.1221743110; Markolovic S, 2015, J BIOL CHEM, V290, P20712, DOI 10.1074/jbc.R115.662627; Montes-Borrego M, 2009, PLANT PATHOL, V58, P1092, DOI 10.1111/j.1365-3059.2009.02141.x; Ojika M, 2011, NAT CHEM BIOL, V7, P591, DOI [10.1038/NCHEMBIO.617, 10.1038/nchembio.617]; Park JE, 2016, MOL CELL, V62, P462, DOI 10.1016/j.molcel.2016.04.007; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; PITTIS JE, 1994, PLANT PATHOL, V43, P387, DOI 10.1111/j.1365-3059.1994.tb02700.x; Ponnala L, 2014, PLANT J, V78, P424, DOI 10.1111/tpj.12482; Prakob W, 2007, FUNGAL GENET BIOL, V44, P726, DOI 10.1016/j.fgb.2006.11.011; RIBEIRO OK, 1976, PHYTOPATHOLOGY, V66, P172, DOI 10.1094/Phyto-66-172; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; RUBEN DM, 1978, AM J BOT, V65, P491, DOI 10.2307/2442581; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Scott PM, 2009, PERSOONIA, V22, P1, DOI 10.3767/003158509X415450; Shinoda K, 2010, BIOINFORMATICS, V26, P576, DOI 10.1093/bioinformatics/btp700; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Smart CD, 1998, FUNGAL GENET BIOL, V25, P134, DOI 10.1006/fgbi.1998.1099; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Tooley PW, 1996, J PHYTOPATHOL, V144, P363, DOI 10.1111/j.1439-0434.1996.tb00307.x; Trost B, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150402; Turkensteen LJ, 2000, PLANT PATHOL, V49, P688, DOI 10.1046/j.1365-3059.2000.00515.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WANG MC, 1974, CARBOHYD RES, V37, P331, DOI 10.1016/S0008-6215(00)82922-5; Welner DH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177591; Wiese S, 2007, PROTEOMICS, V7, P340, DOI 10.1002/pmic.200600422; Wong BW, 2013, TRENDS BIOCHEM SCI, V38, P3, DOI 10.1016/j.tibs.2012.10.004; XU R, 1982, ACTA MYCOL SIN, V1, P40; Yan HZ, 2006, FUNGAL GENET BIOL, V43, P430, DOI 10.1016/j.fgb.2006.01.010; Yang XY, 2015, FUNGAL GENET BIOL, V82, P108, DOI 10.1016/j.fgb.2015.04.023; Yuen JE, 2013, PLANT PATHOL, V62, P485, DOI 10.1111/j.1365-3059.2012.02685.x	72	8	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198186	10.1371/journal.pone.0198186	http://dx.doi.org/10.1371/journal.pone.0198186			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897992	Green Submitted, Green Published, gold			2022-12-26	WOS:000435090700047
J	Hayman, DTS; Luis, AD; Restif, O; Baker, KS; Fooks, AR; Leach, C; Horton, DL; Suu-Ire, R; Cunningham, AA; Wood, JLN; Webb, CT				Hayman, David T. S.; Luis, Angela D.; Restif, Olivier; Baker, Kate S.; Fooks, Anthony R.; Leach, Clint; Horton, Daniel L.; Suu-Ire, Richard; Cunningham, Andrew A.; Wood, James L. N.; Webb, Colleen T.			Maternal antibody and the maintenance of a lyssavirus in populations of seasonally breeding African bats	PLOS ONE			English	Article							COLORED FRUIT BATS; EIDOLON-HELVUM; INFECTIOUS-DISEASES; SPATIAL DYNAMICS; VIRUS-INFECTION; RABIES; HOST; TRANSMISSION; IMMUNITY; ECOLOGY	Pathogens causing acute disease and death or lasting immunity require specific spatial or temporal processes to persist in populations. Host traits, such as maternally-derived antibody (MDA) and seasonal birthing affect infection maintenance within populations. Our study objective is to understand how viral and host traits lead to population level infection persistence when the infection can be fatal. We collected data on African fruit bats and a rabies-related virus, Lagos bat virus (LBV), including through captive studies. We incorporate these data into a mechanistic model of LBV transmission to determine how host traits, including MDA and seasonal birthing, and viral traits, such as incubation periods, interact to allow fatal viruses to persist within bat populations. Captive bat studies supported MDA presence estimated from field data. Captive bat infection-derived antibody decayed more slowly than MDA, and while faster than estimates from the field, supports field data that suggest antibody persistence may be lifelong. Unobserved parameters were estimated by particle filtering and suggest only a small proportion of bats die of disease. Pathogen persistence in the population is sensitive to this proportion, along with MDA duration and incubation period. Our analyses suggest MDA produced bats and prolonged virus incubation periods allow viral maintenance in adverse conditions, such as a lethal pathogen or strongly seasonal resource availability for the pathogen in the form of seasonally pulsed birthing.	[Hayman, David T. S.] Massey Univ, Mol Epidemiol & Publ Hlth Lab mEpiLab, Infect Dis Res Ctr, Hopkirk Res Inst, Palmerston North, New Zealand; [Luis, Angela D.] Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Restif, Olivier; Wood, James L. N.] Univ Cambridge, Dept Vet Med, Dis Dynam Unit, Cambridge, England; [Baker, Kate S.] Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England; [Fooks, Anthony R.] Anim & Plant Hlth Agcy, Wildlife Zoonoses & Vector Borne Dis Res Grp, New Haw, Surrey, England; [Fooks, Anthony R.] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool, Merseyside, England; [Leach, Clint; Webb, Colleen T.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Horton, Daniel L.] Univ Surrey, Sch Vet Med, Guildford, Surrey, England; [Suu-Ire, Richard] Forestry Commiss, Wildlife Div, Accra, Ghana; [Cunningham, Andrew A.] Zool Soc London, Inst Zool, Regents Pk, London, England	Massey University; University of Montana System; University of Montana; University of Cambridge; University of Liverpool; Animal & Plant Health Agency UK; University of Liverpool; Colorado State University; University of Surrey; Zoological Society of London	Hayman, DTS (corresponding author), Massey Univ, Mol Epidemiol & Publ Hlth Lab mEpiLab, Infect Dis Res Ctr, Hopkirk Res Inst, Palmerston North, New Zealand.	D.T.S.Hayman@massey.ac.nz	, orestif/AAA-1532-2019; Baker, Kate/P-2087-2016; Horton, Daniel/D-9909-2011	, orestif/0000-0001-9158-853X; Baker, Kate/0000-0001-5850-1949; Leach, Clinton/0000-0003-4280-0375; Hayman, David/0000-0003-0087-3015; Horton, Daniel/0000-0002-9126-2756	Wellcome Trust [DTSH 086789/Z/08/Z]; David H. Smith Fellowship; RAPIDD program of the Science and Technology Directorate; Fogarty International Center; UK Department for Environment, Food and Rural Affairs (Defra) [SEV3500]; Royal Society Wolfson Research Merit award; Alborada Trust; Wellcome Trust Postdoctoral Training Fellowship for Clinicians [106690/Z/14/Z]; Royal Society of New Zealand Marsden Fast Start [MAU1503]; MRC [MR/P025226/1] Funding Source: UKRI; NERC [NE/J001422/1, NE/J001570/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); David H. Smith Fellowship; RAPIDD program of the Science and Technology Directorate; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); UK Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Royal Society Wolfson Research Merit award(Royal Society of London); Alborada Trust; Wellcome Trust Postdoctoral Training Fellowship for Clinicians; Royal Society of New Zealand Marsden Fast Start(Royal Society of New ZealandMarsden Fund (NZ)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by The Wellcome Trust (DTSH 086789/Z/08/Z), a David H. Smith Fellowship (DTSH), RAPIDD program of the Science and Technology Directorate, Fogarty International Center (DTSH, OR, JLNW, CTW, ADL, ARF). A.R.F. was funded by the UK Department for Environment, Food and Rural Affairs (Defra) by grant SEV3500. CIDC, EU Antigone FP7 and Ecosystem Services for Poverty Alleviation (ESPA, UK), provided further support. MC is supported by a Royal Society Wolfson Research Merit award and JLNW by the Alborada Trust. KSB is in receipt of a Wellcome Trust Postdoctoral Training Fellowship for Clinicians (106690/Z/14/Z) and DTSH a Royal Society of New Zealand Marsden Fast Start (MAU1503).	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Amman BR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002877; Badrane H, 2001, J VIROL, V75, P8096, DOI 10.1128/JVI.75.17.8096-8104.2001; Baker KS, 2014, J ANIM ECOL, V83, P415, DOI 10.1111/1365-2656.12153; Baker KS, 2013, J VIROL, V87, P1348, DOI 10.1128/JVI.01202-12; Banyard AC, 2011, ADV VIRUS RES, V79, P239, DOI 10.1016/B978-0-12-387040-7.00012-3; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Blackwood JC, 2013, P NATL ACAD SCI USA, V110, P20837, DOI 10.1073/pnas.1308817110; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; BOULGER L. R., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P421, DOI 10.1016/0035-9203(58)90127-5; Boulinier T, 2008, TRENDS ECOL EVOL, V23, P282, DOI 10.1016/j.tree.2007.12.006; Brookes SM, 2006, DEV BIOLOGICALS, V125, P185; Buhnerkempe MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022498; Carnell R., 2009, IHS LATIN HYPERCUBE; Crichton E. G., 2000, REPROD BIOL BATS; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Duke-Sylvester SM, 2011, J R SOC INTERFACE, V8, P817, DOI 10.1098/rsif.2010.0475; Dzikwi AA, 2010, J WILDLIFE DIS, V46, P267, DOI 10.7589/0090-3558-46.1.267; EALES LA, 1988, J ZOOL, V216, P584, DOI 10.1111/j.1469-7998.1988.tb02455.x; Epstein JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067584; Freuing CM, 2015, VIRUS RES, V210, P42, DOI 10.1016/j.virusres.2015.07.009; Garnier R, 2012, P ROY SOC B-BIOL SCI, V279, P2033, DOI 10.1098/rspb.2011.2277; Garnier R, 2012, EVOLUTION, V66, P3067, DOI 10.1111/j.1558-5646.2012.01665.x; Georgea DB, 2011, P NATL ACAD SCI USA, V108, P10208, DOI 10.1073/pnas.1010875108; Gilbert AT, 2013, ECOHEALTH, V10, P298, DOI 10.1007/s10393-013-0856-0; Hampson K, 2009, PLOS BIOL, V7, P462, DOI 10.1371/journal.pbio.1000053; Hanlon CA, 2005, VIRUS RES, V111, P44, DOI 10.1016/j.virusres.2005.03.009; Hayman DTS, 2013, ZOONOSES PUBLIC HLTH, V60, P2, DOI 10.1111/zph.12000; Hayman DTS, 2012, EPIDEMIOL INFECT, V140, P2163, DOI 10.1017/S0950268812000167; Hayman DTS, 2008, EMERG INFECT DIS, V14, P926, DOI 10.3201/eid1406.071421; Hayman DTS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005266; Hayman DTS, 2016, SCIENCE, V354, P1099, DOI 10.1126/science.aaj1818; Hayman DTS, 2016, BIOL CONSERV, V200, P131, DOI 10.1016/j.biocon.2016.06.003; Hayman DTS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011978; Hayman DTS, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2591; Hayman DTS, 2012, J MAMMAL, V93, P1393, DOI 10.1644/11-MAMM-A-270.1; Hayman DTS, 2011, J VIROL METHODS, V177, P87, DOI 10.1016/j.jviromet.2011.07.002; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Horton DL, 2010, J VIROL, V84, P11841, DOI 10.1128/JVI.01153-10; Kallio ER, 2010, P ROY SOC B-BIOL SCI, V277, P3783, DOI 10.1098/rspb.2010.1022; Kamins AO, 2011, BIOL CONSERV, V144, P3000, DOI 10.1016/j.biocon.2011.09.003; Keeling, 2008, MODELING INFECT DIS; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; King AA, J STAT SOFTWARE, V69, P1; Kuzmin IV, 2008, J CLIN MICROBIOL, V46, P1451, DOI 10.1128/JCM.00016-08; Lafon M., IMMUNOLOGY, P489; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; Ludecke D., 2017, SJPLOT DATA VISUALIZ; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; Markotter W, 2008, VIRUS RES, V135, P10, DOI 10.1016/j.virusres.2008.02.001; Markotter W, 2006, EMERG INFECT DIS, V12, P504, DOI 10.3201/eid1203.051306; Markotter W, 2006, EMERG INFECT DIS, V12, P1913; MCCRACKEN GF, 1991, ETHOLOGY, V89, P305; MCCRACKEN GF, 1984, SCIENCE, V223, P1090, DOI 10.1126/science.223.4640.1090; Mickleburgh S, 2009, ORYX, V43, P217, DOI 10.1017/S0030605308000938; MUTERE FA, 1967, J ZOOL, V153, P153; Peel AJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2962; Peel AJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22236-6; Peel AJ, 2017, ACTA CHIROPTEROL, V19, P77, DOI 10.3161/15081109ACC2017.19.1.006; Peel AJ, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.49; Peel AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3770; Peel AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030346; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; R Development Core Team, 2012, R LANG ENV STAT COMP; Russell CA, 2005, PLOS BIOL, V3, P382, DOI 10.1371/journal.pbio.0030088; Russell CA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000027; Salkeld DJ, 2010, P NATL ACAD SCI USA, V107, P14247, DOI 10.1073/pnas.1002826107; Shankar V, 2004, J WILDLIFE DIS, V40, P403, DOI 10.7589/0090-3558-40.3.403; Smith DL, 2005, PREV VET MED, V71, P225, DOI 10.1016/j.prevetmed.2005.07.009; Smith DL, 2002, P NATL ACAD SCI USA, V99, P3668, DOI [10.1073/pnas.042400799, 10.1073/pnas.132272199]; Smith GC, 2003, J WILDLIFE DIS, V39, P278, DOI 10.7589/0090-3558-39.2.278; Sohayati AR, 2011, EPIDEMIOL INFECT, V139, P1570, DOI 10.1017/S0950268811000550; STEECE R, 1989, J WILDLIFE DIS, V25, P490, DOI 10.7589/0090-3558-25.4.490; Storm N, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020073; Streicker DG, 2016, P NATL ACAD SCI USA, V113, P10926, DOI 10.1073/pnas.1606587113; Suu-Ire R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006311; Suu-Ire RD, 2017, TROP MED INFECT DIS, V2, DOI 10.3390/tropicalmed2030025; Turmelle AS, 2010, J GEN VIROL, V91, P2360, DOI 10.1099/vir.0.020073-0; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wright E, 2010, VIROLOGY, V408, P183, DOI 10.1016/j.virol.2010.09.014; Wynne JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052930	83	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198563	10.1371/journal.pone.0198563	http://dx.doi.org/10.1371/journal.pone.0198563			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894488	Green Published, Green Submitted, gold			2022-12-26	WOS:000435030900018
J	Liu, YX; Kaljunen, H; Pavic, A; Saarenpaa, T; Himanen, JP; Nikolov, DB; Goldman, A				Liu, Yixin; Kaljunen, Heidi; Pavic, Ana; Saarenpaa, Tuulia; Himanen, Juha P.; Nikolov, Dimitar B.; Goldman, Adrian			Binding of EphrinA5 to RET receptor tyrosine kinase: An in vitro study	PLOS ONE			English	Article							GDNF FAMILY LIGANDS; BLUE-NATIVE PAGE; AXON GUIDANCE; EPH RECEPTORS; CELL-ADHESION; ACTIVATION; GDF15; SIGNALS; DISEASE; LIMB	Eph/Ephrin signaling pathways are crucial in regulating a large variety of physiological processes during development, such as cell morphology, proliferation, migration and axonal guidance. EphrinA (efn-A) ligands, in particular, can be activated by EphA receptors at cellcell interfaces and have been proposed to cause reverse signaling via RET receptor tyrosine kinase. Such association has been reported to mediate spinal motor axon navigation, but conservation of the interactive signaling pathway and the molecular mechanism of the interaction are unclear. Here, we found Danio rerio efn-A5b bound to Mus musculus EphA4 with high affinity, revealing structurally and functionally conserved EphA/efn-A signaling. Interestingly, we observed no interaction between efn-A5b and RET from zebrafish, unlike earlier cell-based assays. Their lack of association indicates how complex efn-A signaling is and suggests that there may be other molecules involved in efn-A5-induced RET signaling.	[Liu, Yixin; Kaljunen, Heidi; Pavic, Ana; Saarenpaa, Tuulia; Goldman, Adrian] Univ Helsinki, Fac Biol & Environm Sci, Mol & Integrat Biosci, Helsinki, Finland; [Himanen, Juha P.; Nikolov, Dimitar B.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA; [Pavic, Ana; Goldman, Adrian] Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Sch Biomed Sci, Leeds, W Yorkshire, England	University of Helsinki; Memorial Sloan Kettering Cancer Center; University of Leeds	Goldman, A (corresponding author), Univ Helsinki, Fac Biol & Environm Sci, Mol & Integrat Biosci, Helsinki, Finland.; Goldman, A (corresponding author), Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Sch Biomed Sci, Leeds, W Yorkshire, England.	adrian.goldman@helsinki.fi		Kaljunen, Heidi/0000-0002-5962-9503; Liu, Yixin/0000-0003-1135-2805; Goldman, Adrian/0000-0001-8032-9700	Centre for International Mobility (CIMO) [TM-16-10170]; Academy of Finland [286429]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M021610/1]; National Institute of Health (NIH) [NS038486]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038486] Funding Source: NIH RePORTER; BBSRC [BB/M021610/1] Funding Source: UKRI	Centre for International Mobility (CIMO); Academy of Finland(Academy of Finland); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by: 1. Centre for International Mobility (CIMO, TM-16-10170) to AG and YL, http://www.cimo.fi/programmes/cimo_scholarships/accessibility_grant; 2. Academy of Finland (No. 286429) to AG, http://www.aka.fi/en; 3. Biotechnology and Biological Sciences Research Council (BBSRC, BB/M021610/1) to AG, https://www.bbsrc.ac.uk/; 4. National Institute of Health (NIH, NS038486) to DBN, www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 2006, BRAIN BEHAV EVOLUT, V68, P181, DOI 10.1159/000094087; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Beauchamp A, 2012, MOL CELL BIOL, V32, P3253, DOI 10.1128/MCB.06791-11; Bisgrove BW, 1997, J NEUROBIOL, V33, P749; Bonanomi D, 2012, CELL, V148, P568, DOI 10.1016/j.cell.2012.01.024; Bowden TA, 2009, STRUCTURE, V17, P1386, DOI 10.1016/j.str.2009.07.018; Chai GL, 2014, NAT NEUROSCI, V17, P1171, DOI 10.1038/nn.3784; Alsina FC, 2016, EMBO REP, V17, P601, DOI 10.15252/embr.201541218; Davy A, 2000, EMBO J, V19, P5396, DOI 10.1093/emboj/19.20.5396; Day B, 2005, J BIOL CHEM, V280, P26526, DOI 10.1074/jbc.M504972200; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Emmerson PJ, 2017, NAT MED, V23, P1215, DOI 10.1038/nm.4393; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Fitzgerald M, 2008, BIOCHEM BIOPH RES CO, V374, P625, DOI 10.1016/j.bbrc.2008.07.110; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Hsu JY, 2017, NATURE, V550, P255, DOI 10.1038/nature24042; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; Keinanen K, 1998, BIOCHEM J, V330, P1461, DOI 10.1042/bj3301461; Kjaer S, 2003, HUM MOL GENET, V12, P2133, DOI 10.1093/hmg/ddg227; Kjaer S, 2010, NAT STRUCT MOL BIOL, V17, P726, DOI 10.1038/nsmb.1808; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; Leppanen VM, 2004, EMBO J, V23, P1452, DOI 10.1038/sj.emboj.7600174; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Luria V, 2008, NEURON, V60, P1039, DOI 10.1016/j.neuron.2008.11.011; Mandai K, 2009, NEURON, V63, P614, DOI 10.1016/j.neuron.2009.07.031; Marler KJM, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-30; Marler KJM, 2008, J NEUROSCI, V28, P12700, DOI 10.1523/JNEUROSCI.1915-08.2008; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392; Oppenheim RW, 2000, J NEUROSCI, V20, P5001; Pabbisetty KB, 2007, PROTEIN SCI, V16, P355, DOI 10.1110/ps.062608807; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Saarenpaa T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176166; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Sergaki MC, 2017, CELL REP, V18, P367, DOI 10.1016/j.celrep.2016.12.039; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Soba P, 2015, ELIFE, V4, DOI 10.7554/eLife.05491; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; Wang XM, 1999, MOL CELL, V4, P903, DOI 10.1016/S1097-2765(00)80220-8; Wasilko DJ, 2009, PROTEIN EXPRES PURIF, V65, P122, DOI 10.1016/j.pep.2009.01.002; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wittig I, 2009, PROTEOMICS, V9, P5214, DOI 10.1002/pmic.200900151; Xu NJ, 2012, SEMIN CELL DEV BIOL, V23, P58, DOI 10.1016/j.semcdb.2011.10.024; Yang LD, 2017, NAT MED, V23, P1158, DOI 10.1038/nm.4394	52	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198291	10.1371/journal.pone.0198291	http://dx.doi.org/10.1371/journal.pone.0198291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889908	Green Published, gold			2022-12-26	WOS:000434786600021
J	McKinley, TJ; Lipschutz-Powell, D; Mitchell, AP; Wood, JLN; Conlan, AJK				McKinley, Trevelyan J.; Lipschutz-Powell, Debby; Mitchell, Andrew P.; Wood, James L. N.; Conlan, Andrew J. K.			Risk factors and variations in detection of new bovine tuberculosis breakdowns via slaughterhouse surveillance in Great Britain	PLOS ONE			English	Article							CATTLE; LESIONS; TESTS	Slaughterhouse surveillance through post-mortem meat inspection provides an important mechanism for detecting bovine tuberculosis (bTB) infections in cattle herds in Great Britain (GB), complementary to the live animal skin test based programme. We explore patterns in the numbers of herd breakdowns detected through slaughterhouse surveillance and develop a Bayesian hierarchical regression model to assess the associations of animal-level factors with the odds of an infected animal being detected in the slaughterhouse, allowing us to highlight slaughterhouses that show atypical patterns of detection. The analyses demonstrate that the numbers and proportions of breakdowns detected in slaughterhouses increased in GB over the period of study (1998 +/- 2013). The odds of an animal being a slaughterhouse case was strongly associated with the region of the country that the animal spent most of its life, with animals living in high-frequency testing areas of England having on average 21 times the odds of detection compared to animals living in Scotland. There was also a strong effect of age, with animals slaughtered at > 60 months of age having 5.3 times the odds of detection compared to animals slaughtered between 0 +/- 18 months of age. Smaller effects were observed for cattle having spent time on farms with a history of bTB, quarter of the year that the animal was slaughtered, movement and test history. Over-and-above these risks, the odds of detection increased by a factor of 1.1 for each year of the study. After adjustment for these variables, there were additional variations in risk between slaughterhouses and breed. Our framework has been adopted into the routine annual surveillance reporting carried out by the Animal Plant Health Agency and may be used to target more detailed investigation of meat inspection practices.	[McKinley, Trevelyan J.] Univ Exeter, Coll Engn Math & Phys Sci, Penryn, Cornwall, England; [Lipschutz-Powell, Debby; Wood, James L. N.; Conlan, Andrew J. K.] Univ Cambridge, Dept Vet Med, Dis Dynam Unit, Cambridge, Cambs, England; [Mitchell, Andrew P.] Anim & Plant Hlth Agcy, Data Syst Grp, Weybridge, Surrey, England	University of Exeter; University of Cambridge; Animal & Plant Health Agency UK	McKinley, TJ (corresponding author), Univ Exeter, Coll Engn Math & Phys Sci, Penryn, Cornwall, England.	t.mckinley@exeter.ac.uk	Conlan, Andrew/Q-3861-2019	Conlan, Andrew/0000-0002-2593-6353; Lipschutz-Powell, Debby/0000-0003-2845-3557	Department of Environment, Food and Rural Affairs (Defra) [SE3133]; BBSRC [BB/I012192/1] Funding Source: UKRI	Department of Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was carried out as part of project SE3133, funded by the Department of Environment, Food and Rural Affairs (Defra) awarded to J.L.N.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy DA, 2013, VET REC, V172, DOI 10.1136/vr.100969; Allen AR, 2010, P ROY SOC B-BIOL SCI, V277, P2737, DOI 10.1098/rspb.2010.0830; Broughan JM, 2014, ANAL BOVINE TUBERCUL; Conlan AJK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002730; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Defra, 2014, FREED INF REQ; Defra, 2018, TEST REG; Downs SH, 2016, VET J, V216, P8, DOI 10.1016/j.tvjl.2016.06.010; Frankena K, 2007, VET REC, V161, P679, DOI 10.1136/vr.161.20.679; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Gelman A, 2012, J RES EDUC EFF, V5, P189, DOI 10.1080/19345747.2011.618213; Goodchild AV, 2015, VET REC, V177, DOI 10.1136/vr.102961; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Karolemeas K, 2011, PREV VET MED, V102, P22, DOI 10.1016/j.prevetmed.2011.06.004; Karolemeas K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043217; Mitchell AP, 2006, P SOC VET EP PREV ME, P70; Olea-Popelka F, 2012, IRISH VET J, V65, DOI 10.1186/2046-0481-65-2; Papaspiliopoulos O, 2003, BAYESIAN STATISTICS 7, P307; Pascual-Linaza AV, 2017, EPIDEMIOL INFECT, V145, P995, DOI 10.1017/S0950268816003095; RCore Team, 2020, R LANG ENV STAT COMP; Shittu A, 2013, PREV VET MED, V110, P395, DOI 10.1016/j.prevetmed.2013.03.001; Skuce Robin A, 2012, Vet Med Int, V2012, P621210, DOI 10.1155/2012/621210	22	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198760	10.1371/journal.pone.0198760	http://dx.doi.org/10.1371/journal.pone.0198760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883466	Green Published, gold, Green Submitted			2022-12-26	WOS:000434728100039
J	Partey, FD; Castberg, FC; Sarbah, EW; Silk, SE; Awandare, GA; Draper, SJ; Opoku, N; Kweku, M; Ofori, MF; Hviid, L; Barfod, L				Partey, Frederica D.; Castberg, Filip C.; Sarbah, Edem W.; Silk, Sarah E.; Awandare, Gordon A.; Draper, Simon J.; Opoku, Nicholas; Kweku, Margaret; Ofori, Michael F.; Hviid, Lars; Barfod, Lea			Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; MEROZOITE SURFACE-ANTIGENS; B-CELL RESPONSES; INVASION; VACCINE; PROTECTION; PFRH5; RH5; HOMOLOG; COMPLEX	Plasmodium falciparum PfRH5 protein binds Ripr, CyRPA and Pf113 to form a complex that is essential for merozoite invasion of erythrocytes. The inter-genomic conservation of the PfRH5 complex proteins makes them attractive blood stage vaccine candidates. However, little is known about how antibodies to PfRH5, CyRPA and Pf113 are acquired and maintained in naturally exposed populations, and the role of PfRH5 complex proteins in naturally acquired immunity. To provide such data, we studied 206 Ghanaian children between the ages of 1-12 years, who were symptomatic, asymptomatic or aparasitemic and healthy. Plasma levels of antigen-specific IgG and IgG subclasses were measured by ELISA at several time points during acute disease and convalescence. On the day of admission with acute P. falciparum malaria, the prevalence of antibodies to PfRH5-complex proteins was low compared to other merozoite antigens (EBA175, GLURP-R0 and GLURP-R2). At convalescence, the levels of RH5-complex-specific IgG were reduced, with the decay of PfRH5-specific IgG being slower than the decay of IgG specific for CyRPA and Pf113. No correlation between IgG levels and protection against P. falciparum malaria was observed for any of the PfRH5 complex proteins. From this we conclude that specific IgG was induced against proteins from the PfRH5-complex during acute P. falciparum malaria, but the prevalence was low and the IgG levels decayed rapidly after treatment. These data indicate that the levels of IgG specific for PfRH5-complex proteins in natural infections in Ghanaian children were markers of recent exposure only.	[Partey, Frederica D.; Sarbah, Edem W.; Awandare, Gordon A.; Ofori, Michael F.] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Partey, Frederica D.; Hviid, Lars] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol, Dept Immunol & Microbiol ISIM, Copenhagen, Denmark; [Partey, Frederica D.; Hviid, Lars] Rigshosp, Univ Hosp, Dept Infect Dis Copenhagen, Copenhagen, Denmark; [Castberg, Filip C.] Copenhagen Univ Hosp, Rigshosp, Dept Clin Microbiol, Copenhagen, Denmark; [Silk, Sarah E.; Draper, Simon J.] Univ Oxford, Jenner Inst, Oxford, England; [Awandare, Gordon A.; Barfod, Lea] Univ Ghana, Dept Biochem Cell & Mol Biol, West Africa Ctr Med Biol Infect Pathogens, Legon, Ghana; [Opoku, Nicholas; Kweku, Margaret] Hohoe Municipal Hosp, Hohoe, Ghana; [Sarbah, Edem W.] Ketu South Municipal Hosp, Aflao, Ghana	University of Ghana; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Oxford; Jenner Institute; University of Ghana	Barfod, L (corresponding author), Univ Ghana, Dept Biochem Cell & Mol Biol, West Africa Ctr Med Biol Infect Pathogens, Legon, Ghana.	lbarfod@sundku.dk	Ofori, Michael F/H-9072-2013; Hviid, Lars/G-3705-2012	Ofori, Michael F/0000-0003-2341-7514; Hviid, Lars/0000-0002-1698-4927; Awandare, Gordon/0000-0002-8793-3641; Draper, Simon/0000-0002-9415-1357; Barfod, Lea/0000-0001-6510-495X; Castberg, Filip Christian/0000-0002-1140-5527	Consultative Committee for Development Research [DFC 12 081RH]; Wellcome Trust [106917/Z/15/Z]; Novo Nordisk Foundation [NNF170C0026778]; MRC [MR/K025554/1] Funding Source: UKRI	Consultative Committee for Development Research; Wellcome Trust(Wellcome TrustEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was mainly supported by The Consultative Committee for Development Research [grant number DFC 12 081RH] http://dfcentre.com. Other funding resources: Wellcome Trust [grant number 106917/Z/15/Z] https://wellcome.ac.uk/ and Novo Nordisk Foundation [grant number NNF170C0026778] http://novonordiskfonden.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Pf113 was a kind gift from Dr. Gavin J. Wright, Wellcome Trust Sanger Institute, Hinxton, Cambridge and GLURP-RO, GLURP-R2 a gift from Dr. Michael Theisen, Statens Serum Institute, Copenhagen. The study supported by The Consultative Committee for Development Research [grant number DFC 12-081RH]. EBA175 was obtained as a gift from Prof. Daniel Dodoo, Immunology Department, Noguchi Memorial Institute for Medical Research. SJD is a Wellcome Trust Senior Fellow [grant number 106917/Z/15/Z], a Lister Institute Research Prize Fellow and a Jenner Investigator. LB s a Novo Nordisk Foundation Young Investigator [grant number NNF170C0026778]. We also thank Joseph J. Illingworth, Jing Jin and Julie Furze (Jenner Institute, University of Oxford) for assistance.	Ampomah P, 2014, J IMMUNOL, V192, P5236, DOI 10.4049/jimmunol.1400325; Ampomah P, 2014, INFECT IMMUN, V82, P1860, DOI 10.1128/IAI.01514-13; Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; Chen L, 2017, ELIFE, V6, DOI [10.7554/elife.21347, 10.7554/eLife.21347.001, 10.7554/eLife.21347]; Chen L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002199; Chiu CYH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00314; Courtin D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007590; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Douglas AD, 2015, CELL HOST MICROBE, V17, P130, DOI 10.1016/j.chom.2014.11.017; Douglas AD, 2014, J IMMUNOL, V192, P245, DOI 10.4049/jimmunol.1302045; Douglas AD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1615; Dreyer AM, 2012, J IMMUNOL, V188, P6225, DOI 10.4049/jimmunol.1103177; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Enevold A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-153; Galaway F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14333; Hjerrild KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep30357; Hviid L, 2005, ACTA TROP, V95, P270, DOI 10.1016/j.actatropica.2005.06.012; Imboumy-Limoukou RK, 2016, ACTA TROP, V163, P149, DOI 10.1016/j.actatropica.2016.08.014; Imboumy-Limoukou RK, 2016, EUR J MICROBIOL IMMU, V6, P287, DOI 10.1556/1886.2016.00027; Jiang LB, 2011, P NATL ACAD SCI USA, V108, P7553, DOI 10.1073/pnas.1104050108; Kweku M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004000; Liang H, 2000, INFECT IMMUN, V68, P3564, DOI 10.1128/IAI.68.6.3564-3568.2000; Murungi LM, 2013, VACCINE, V31, P3936, DOI 10.1016/j.vaccine.2013.06.042; Ord RL, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-326; Osier FH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008705; Patel SD, 2013, J INFECT DIS, V208, P1679, DOI 10.1093/infdis/jit385; Payne RO, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96381; Reddy KS, 2015, P NATL ACAD SCI USA, V112, P1179, DOI 10.1073/pnas.1415466112; Reddy KS, 2014, INFECT IMMUN, V82, P152, DOI 10.1128/IAI.00970-13; Rodriguez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003300; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; THEISEN M, 1995, CLIN DIAGN LAB IMMUN, V2, P30, DOI 10.1128/CDLI.2.1.30-34.1995; Tran TM, 2014, J INFECT DIS, V209, P789, DOI 10.1093/infdis/jit553; Villasis E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-361; Volz JC, 2016, CELL HOST MICROBE, V20, P60, DOI 10.1016/j.chom.2016.06.004; Weaver R, 2016, SCI REP-UK, V6, DOI 10.1038/srep33094; Weiss GE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004670; WHO, 2016, WORLD MAL REP 2016; Wright KE, 2014, NATURE, V515, P427, DOI 10.1038/nature13715	39	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198371	10.1371/journal.pone.0198371	http://dx.doi.org/10.1371/journal.pone.0198371			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883485	Green Published, Green Submitted, gold			2022-12-26	WOS:000434728100020
J	Wojtczak-Kwasniewska, M; Przekoracka-Krawczyk, A; Van der Lubbe, RHJ				Wojtczak-Kwasniewska, Monika; Przekoracka-Krawczyk, Anna; Van der Lubbe, Rob H. J.			The engagement of cortical areas preceding exogenous vergence eye movements	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; MACAQUE MONKEY; DISPARITY SENSITIVITY; SELECTIVE ATTENTION; SUPERIOR COLLICULUS; VOLITIONAL SACCADES; SPATIAL ATTENTION; STRIATE CORTEX; VISUAL-CORTEX	Source analyses on event related potentials (ERPs) derived from the electroencephalogram (EEG) were performed to examine the respective roles of cortical areas preceding exogenously triggered saccades, combined convergences, and combined divergences. All eye movements were triggered by the offset of a central fixation light emitting diode (LED) and the onset of a lateral LED at various depths in an otherwise fully darkened room. Our analyses revealed that three source pairs, two located in the frontal lobe-the frontal eye fields (FEF) and an anterior frontal area-, and one located within the occipital cortex, can account for 99.2% of the observed ERPs. Overall, the comparison between source activities revealed the largest activity in the occipital cortex, while no difference in activity between FEF and the anterior frontal area was obtained. For all sources, increased activity was observed for combined vergences, especially combined convergences, relative to saccades. Behavioral results revealed that onset latencies were longest for combined convergences, intermediate for combined divergences, and the shortest for saccades. Together, these findings fit within a perspective in which both occipital and frontal areas play an important role in retinal disparity detection. In the case of saccades and combined divergences stimulus-locked activity was larger than response-locked activity, while no difference between stimulus-and response-locked activity was observed for combined convergences. These findings seem to imply that the electrophysiological activity preceding exogenous eye movements consists of a sensory-related part that is under cortical control, while subcortical structures may be held responsible for final execution.	[Wojtczak-Kwasniewska, Monika; Przekoracka-Krawczyk, Anna; Van der Lubbe, Rob H. J.] Adam Mickiewicz Univ, Lab Vis Sci & Optometry, Fac Phys, Poznan, Poland; [Wojtczak-Kwasniewska, Monika; Przekoracka-Krawczyk, Anna] Adam Mickiewicz Univ, NanoBioMed Ctr, Vis & Neurosci Lab, Poznan, Poland; [Van der Lubbe, Rob H. J.] Univ Twente, Cognit Psychol & Ergon, Enschede, Netherlands	Adam Mickiewicz University; Adam Mickiewicz University; University of Twente	Wojtczak-Kwasniewska, M (corresponding author), Adam Mickiewicz Univ, Lab Vis Sci & Optometry, Fac Phys, Poznan, Poland.; Wojtczak-Kwasniewska, M (corresponding author), Adam Mickiewicz Univ, NanoBioMed Ctr, Vis & Neurosci Lab, Poznan, Poland.	monika.wojtczak@amu.edu.pl	Przekoracka-Krawczyk, Anna/Z-1606-2018; van+der+Lubbe, Rob/AAJ-8120-2020	Przekoracka-Krawczyk, Anna/0000-0003-2401-4135; van der Lubbe, Rob/0000-0003-3658-0345				Adams DL, 2001, J NEUROPHYSIOL, V86, P2195, DOI 10.1152/jn.2001.86.5.2195; Alkan Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025866; Alvarez TL, 2010, VISION RES, V50, P2163, DOI 10.1016/j.visres.2010.08.018; Alvarez TL, 2002, CAH PSYCHOL COGN, V21, P243; Bacon BA, 1998, ARCH PHYSIOL BIOCHEM, V106, P236, DOI 10.1076/apab.106.3.236.4376; BAHILL AT, 1975, INVEST OPHTH VISUAL, V14, P468; Berchicci M, 2012, NEUROIMAGE, V62, P1750, DOI 10.1016/j.neuroimage.2012.06.031; Berchicci M, 2012, BIOL PSYCHOL, V90, P10, DOI 10.1016/j.biopsycho.2012.02.014; Boynton GM, 2004, CURR BIOL, V14, pR523, DOI 10.1016/j.cub.2004.06.044; Bucci MP, 2012, EXP BRAIN RES, V222, P21, DOI 10.1007/s00221-012-3192-7; BURKHALTER A, 1986, J NEUROSCI, V6, P2327; Chen G, 2008, NEURON, V58, P442, DOI 10.1016/j.neuron.2008.02.032; DIAS EC, 1994, J NEUROPHYSIOL, V72, P2532, DOI 10.1152/jn.1994.72.5.2532; DiGirolamo GJ, 2001, NEUROREPORT, V12, P2065, DOI 10.1097/00001756-200107030-00054; Eifuku S, 1999, J NEUROPHYSIOL, V82, P2462, DOI 10.1152/jn.1999.82.5.2462; Ferraina S, 2000, J NEUROPHYSIOL, V83, P625, DOI 10.1152/jn.2000.83.1.625; Frishkoff GA, 2004, COGNITIVE BRAIN RES, V20, P329, DOI 10.1016/j.cogbrainres.2004.02.009; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Gattass R, 1997, CEREB CORTEX, V7, P110, DOI 10.1093/cercor/7.2.110; Gaymard B, 1998, EXP BRAIN RES, V123, P159, DOI 10.1007/s002210050557; Gaymard B, 2003, EUR J NEUROSCI, V17, P1518, DOI 10.1046/j.1460-9568.2003.02570.x; Gaymard B, 1999, CURR OPIN NEUROL, V12, P13, DOI 10.1097/00019052-199902000-00003; Hegde J, 2004, J NEUROPHYSIOL, V92, P3030, DOI 10.1152/jn.00822.2003; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1970, NATURE, V225, P41, DOI 10.1038/225041a0; Hung GK, 1997, VISION RES, V37, P1197, DOI 10.1016/S0042-6989(97)00271-X; Kapoula Z, 2005, ANN NY ACAD SCI, V1039, P184, DOI 10.1196/annals.1325.018; Kapoula Z, 2002, NEUROREPORT, V13, P1893, DOI 10.1097/00001756-200210280-00012; Kapoula Z, 2001, NEUROREPORT, V12, P4041, DOI 10.1097/00001756-200112210-00037; Koivisto M, 2010, NEUROSCI BIOBEHAV R, V34, P922, DOI 10.1016/j.neubiorev.2009.12.002; Konen CS, 2004, NEUROIMAGE, V22, P304, DOI 10.1016/j.neuroimage.2003.12.039; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Leff AP, 2001, CEREB CORTEX, V11, P918, DOI 10.1093/cercor/11.10.918; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Martinez A, 2001, VISION RES, V41, P1437, DOI 10.1016/S0042-6989(00)00267-4; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; MOSIDZE VM, 1994, BEHAV BRAIN RES, V65, P121, DOI 10.1016/0166-4328(94)90081-7; Muri RM, 2008, BRAIN COGNITION, V68, P284, DOI 10.1016/j.bandc.2008.08.018; Munoz DP, 2002, PROG BRAIN RES, V140, P89; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Neggers SFW, 2005, EUR J NEUROSCI, V21, P2853, DOI 10.1111/j.1460-9568.2005.04129.x; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Petit L, 2009, J NEUROPHYSIOL, V102, P2994, DOI 10.1152/jn.00280.2009; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; Ponce CR, 2006, J VISION, V6, P4, DOI [10.1167/6.6.4, DOI 10.1167/6.6.4]; Przekoracka-krawczyj A, 2018, OPTICA APPL; PTITO M, 1992, EXP BRAIN RES, V89, P521; Purves D., 2001, NEUROSCIENCE; SCHERG M, 1986, ELECTROEN CLIN NEURO, V65, P344, DOI 10.1016/0168-5597(86)90014-6; Scherg M, 1993, Brain Topogr, V5, P419, DOI 10.1007/BF01128700; Schiller PH, 2001, PROG BRAIN RES, V134, P127; Schiller PH, 2005, PROG BRAIN RES, V149, P157, DOI 10.1016/S0079-6123(05)49012-3; Schiller PH, 1998, COGNITIVE NEUROSCIENCE OF ATTENTION, P3; SEGRAVES MA, 1987, J NEUROSCI, V7, P3040; SEMMLOW J, 1979, J OPT SOC AM, V69, P639, DOI 10.1364/JOSA.69.000639; Shulman GL, 2010, J NEUROSCI, V30, P3640, DOI 10.1523/JNEUROSCI.4085-09.2010; STRAUBE A, 1995, VISION RES, V35, P3451, DOI 10.1016/0042-6989(95)00076-Q; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; Tzelepi A, 2004, EXP BRAIN RES, V155, P439, DOI 10.1007/s00221-003-1741-9; Van der Lubbe RHJ, 2010, J COGNITIVE NEUROSCI, V22, P1541, DOI 10.1162/jocn.2009.21285; Van Horn MR, 2013, J NEUROSCI, V33, P7274, DOI 10.1523/JNEUROSCI.2268-12.2013; vanderLubbe RHJ, 1997, BIOL PSYCHOL, V45, P143, DOI 10.1016/S0301-0511(96)05226-X; von der Heydt R, 2000, VISION RES, V40, P1955, DOI 10.1016/S0042-6989(00)00044-4; Wong AMF, 2007, EYE MOVEMENT DISORDE, P15; Yang Q, 2004, INVEST OPHTH VIS SCI, V45, P2231, DOI 10.1167/iovs.03-1291; Yang Q, 2002, INVEST OPHTH VIS SCI, V43, P2939; Yang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020322; Zeki S, 1998, BRAIN, V121, P1669, DOI 10.1093/brain/121.9.1669	75	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198405	10.1371/journal.pone.0198405	http://dx.doi.org/10.1371/journal.pone.0198405			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI7ZT	29883483	Green Published, gold, Green Submitted			2022-12-26	WOS:000434728100022
J	Nagelkerke, LAJ; van Onselen, E; van Kessel, N; Leuven, RSEW				Nagelkerke, Leopold A. J.; van Onselen, Eline; van Kessel, Nils; Leuven, Rob S. E. W.			Functional feeding traits as predictors of invasive success of alien freshwater fish species using a food-fish model	PLOS ONE			English	Article							MORPHOLOGY; PATTERNS; IMPACTS; GOBIES; COMPETITION; RESOURCE; OVERLAP; ECOLOGY; SPREAD	Invasions of Ponto-Caspian fish species into north-western European river basins accelerated since the opening of the Rhine-Main-Danube Canal in 1992. Since 2002, at least five Ponto-Caspian alien fish species have arrived in The Netherlands. Four species belong to the Gobiidae family (Neogobius fluviatilis, Neogobius melanostomus, Ponticola kessleri, and Proterorhinus semilunaris) and one to the Cyprinidae family (Romanogobio These species are expected to be potentially deleterious for the populations of four native benthic fish species: Gobio gobio (Cyprinidae), Barbatula barbatula (Nemacheilidae), Cottus perifretum, and C. rhenanus (Cottidae). Invasion success may be dependent on competitive trophic interactions with native species, which are enabled and/or constrained by feeding-related morphological traits. Twenty-two functional feeding traits were measured in nine species (in total 90 specimens). These traits were quantitatively linked to the mechanical, chemical and behavioral properties of a range of aquatic resource categories, using a previously developed food-fish model (FFM). The FFM was used to predict the trophic profile (TP) of each fish: the combined capacities to feed on each of the resource types. The most extreme TPs belonged to three alien species, indicating that they were most specialized among the studied species. Of these three, only P. kessleri overlapped with the two native Cottusspecies, indicating potential trophic competition. N. fluviatilis and R. belingi did not show any overlap, indicating that there is low trophic competition. The two remaining alien goby species (N. melanostomus and P. semilunaris) had average TPs and could be considered generalist feeders. They overlapped with each other and with G. gobio and B. barbatula, indicating potential trophic competition. This study suggests that both generalist and specialist species can be successful invaders. Since the FFM predicts potential interactions between species, it provides a tool to support horizon scanning and rapid risk assessments of alien species.	[Nagelkerke, Leopold A. J.] Wageningen Univ & Res, Aquaculture & Fisheries Grp, Wageningen, Netherlands; [van Kessel, Nils; Leuven, Rob S. E. W.] Radboud Univ Nijmegen, Dept Anim Ecol & Physiol, Inst Water & Wetland Res, Nijmegen, Netherlands; [van Kessel, Nils] Bur Waardenburg BV, Culemborg, Netherlands; [van Kessel, Nils; Leuven, Rob S. E. W.] Netherlands Ctr Expertise Exot Species NEC E, Nijmegen, Netherlands; [van Onselen, Eline] Arcadis Nederland BV, Team Water, Ecol Grp, Zwolle, Netherlands	Wageningen University & Research; Radboud University Nijmegen	Nagelkerke, LAJ (corresponding author), Wageningen Univ & Res, Aquaculture & Fisheries Grp, Wageningen, Netherlands.	Leo.Nagelkerke@wur.nl	Nagelkerke, Leo/C-4758-2008; Leuven, Rob/A-3303-2012	Nagelkerke, Leo/0000-0003-1130-749X; Leuven, Rob/0000-0001-5434-6005	Arcadis Nederland B.V.; Bureau Waardenburg B.V.	Arcadis Nederland B.V.; Bureau Waardenburg B.V.	Two of the authors are employed by commercial companies. E.v.O. is employed by "Arcadis Nederland B.V.". This author was allowed to contribute to this article during working hours, but already performed most of the research work during her MSc study at Wageningen University. N.v.K. is employed by "Bureau Waardenburg B.V.". This author was allowed to contribute to this article during working hours. Both funders ("Arcadis Nederland B.V." and "Bureau Waardenburg B.V.") only provided support in the form of salaries for the authors [E.v.O. and N.v.K.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albouy C, 2011, MAR ECOL PROG SER, V436, P17, DOI 10.3354/meps09240; Azzurro E, 2014, ECOL LETT, V17, P1455, DOI 10.1111/ele.12351; Bleeker K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174828; Bohn T, 2001, ECOLOGY, V82, P2150, DOI 10.1890/0012-9658(2001)082[2150:TCEOAI]2.0.CO;2; Borcherding J, 2013, LIMNOLOGICA, V43, P49, DOI 10.1016/j.limno.2012.08.003; Brandner J, 2013, J FISH BIOL, V82, P2063, DOI 10.1111/jfb.12137; Brandner J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190777; Brandner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073036; Brandner J, 2013, HYDROBIOLOGIA, V703, P113, DOI 10.1007/s10750-012-1349-9; Byers JE, 2000, ECOLOGY, V81, P1225, DOI 10.2307/177203; Cammaerts R, 2012, AQUAT INVASIONS, V7, P251, DOI 10.3391/ai.2012.7.2.011; Cerwenka AF, 2017, ECOL EVOL, V7, P4076, DOI 10.1002/ece3.2942; Copp G. H., 2008, Aquatic Invasions, V3, P193, DOI 10.3391/ai.2008.3.2.10; Copp GH, 2005, J APPL ICHTHYOL, V21, P242, DOI 10.1111/j.1439-0426.2005.00690.x; Cordova-Tapia F, 2018, ECOL FRESHW FISH, V27, P522, DOI 10.1111/eff.12366; Correa SB, 2014, ECOLOGY, V95, P210, DOI 10.1890/13-0393.1; Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151; Darnaude AM, 2001, J MAR BIOL ASSOC UK, V81, P119, DOI 10.1017/S0025315401003460; David P, 2017, ADV ECOL RES, V56, P1, DOI 10.1016/bs.aecr.2016.10.001; Dick JTA, 2000, P ROY SOC B-BIOL SCI, V267, P977, DOI 10.1098/rspb.2000.1099; Early R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12485; Fitzgerald DB, 2016, GLOBAL CHANGE BIOL, V22, P2440, DOI 10.1111/gcb.13165; Fridley JD, 2014, GLOBAL ECOL BIOGEOGR, V23, P1157, DOI 10.1111/geb.12221; Fryer G, 1972, CICHLID FISHES GREAT; Gallardo B, 2016, GLOBAL CHANGE BIOL, V22, P151, DOI 10.1111/gcb.13004; Griffen BD, 2011, J ANIM ECOL, V80, P854, DOI 10.1111/j.1365-2656.2011.01832.x; Jakubcinova K, 2017, J FISH BIOL, V90, P1999, DOI 10.1111/jfb.13283; Kakareko T, 2013, BIOL INVASIONS, V15, P2519, DOI 10.1007/s10530-013-0470-7; Ketelaars HAM, 2004, NATO SCI S SS IV EAR, V35, P209; Kornis MS, 2012, J FISH BIOL, V80, P235, DOI 10.1111/j.1095-8649.2011.03157.x; Kumar KVA, 2017, DEEP-SEA RES PT I, V119, P16, DOI 10.1016/j.dsr.2016.11.011; L'avrincikova M, 2005, J APPL ICHTHYOL, V21, P328, DOI 10.1111/j.1439-0426.2005.00677.x; Lekevicius Edmundas, 2009, Ekologija, V55, P165; Leuven RSEW, 2009, BIOL INVASIONS, V11, P1989, DOI 10.1007/s10530-009-9491-7; Link JS, 2004, T AM FISH SOC, V133, P655, DOI 10.1577/T02-142.1; Moyle PB, 2006, BIOSCIENCE, V56, P515, DOI 10.1641/0006-3568(2006)56[515:PISFFI]2.0.CO;2; Nagelkerke LAJ, 2014, THEOR ECOL-NETH, V7, P423, DOI 10.1007/s12080-014-0229-5; NORTON SF, 1995, ENVIRON BIOL FISH, V44, P61, DOI 10.1007/BF00005907; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Pennuto CM, 2016, AQUAT ECOL, V50, P45, DOI 10.1007/s10452-015-9551-2; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Piria M, 2016, SCI TOTAL ENVIRON, V540, P386, DOI 10.1016/j.scitotenv.2015.05.125; Polacik M, 2009, ECOL FRESHW FISH, V18, P640, DOI 10.1111/j.1600-0633.2009.00383.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ricciardi A, 2001, CAN J FISH AQUAT SCI, V58, P2513, DOI 10.1139/cjfas-58-12-2513; Ricciardi A, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P211; Sibbing F.A., 1991, Society for Experimental Biology Seminar Series, V44, P57; Sibbing FA, 2001, REV FISH BIOL FISHER, V10, P393; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Smit NJ, 2017, INT J PARASITOL-PAR, V6, P386, DOI 10.1016/j.ijppaw.2017.06.001; Soes D.M., 2005, Lauterbornia, V55, P141; Strayer DL, 2010, FRESHWATER BIOL, V55, P152, DOI 10.1111/j.1365-2427.2009.02380.x; Suzuki R., 2015, PVCLUST HIERARCHICAL; Turbelin AJ, 2017, GLOBAL ECOL BIOGEOGR, V26, P78, DOI 10.1111/geb.12517; Turetsky MR, 2017, ECOSYSTEMS, V20, P23, DOI 10.1007/s10021-016-0055-2; van Beek Ge C.W., 2006, Aquatic Invasions, V1, P42, DOI 10.3391/ai.2006.1.1.10; Van Kessel N, 2011, CURR ZOOL, V57, P844; van Kessel N, 2016, AQUAT INVASIONS, V11, P179, DOI 10.3391/ai.2016.11.2.07; van Kessel Nils, 2009, Aquatic Invasions, V4, P421, DOI 10.3391/ai.2009.4.2.24; WAINWRIGHT PC, 1988, ECOLOGY, V69, P635, DOI 10.2307/1941012; WAINWRIGHT PC, 1995, ENVIRON BIOL FISH, V44, P97, DOI 10.1007/BF00005909	61	11	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197636	10.1371/journal.pone.0197636	http://dx.doi.org/10.1371/journal.pone.0197636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874244	Green Published, Green Submitted, gold			2022-12-26	WOS:000434369400032
J	Tadesse, S; Enqueselassie, F; Hagos, S				Tadesse, Sebsibe; Enqueselassie, Fikre; Hagos, Seifu			Spatial and space-time clustering of tuberculosis in Gurage Zone, Southern Ethiopia	PLOS ONE			English	Article							PREVALENCE; PROGRAM	Introduction Spatial targeting is advocated as an effective method that contributes for achieving tuberculosis control in high-burden countries. However, there is a paucity of studies clarifying the spatial nature of the disease in these countries. This study aims to identify the location, size and risk of purely spatial and space-time clusters for high occurrence of tuberculosis in Gurage Zone, Southern Ethiopia during 2007 to 2016. Materials and methods A total of 15,805 patient data that were retrieved from unit TB registers were included in the final analyses. The spatial and space-time cluster analyses were performed using the global Moran's I, Getis-Ord G(i)* and Kulldorff's scan statistics. Results Eleven purely spatial and three space-time clusters were detected (P <0.001). The clusters were concentrated in border areas of the Gurage Zone. There were considerable spatial variations in the risk of tuberculosis by year during the study period. Conclusions This study showed that tuberculosis clusters were mainly concentrated at border areas of the Gurage Zone during the study period, suggesting that there has been sustained transmission of the disease within these locations. The findings may help intensify the implementation of tuberculosis control activities in these locations. Further study is warranted to explore the roles of various ecological factors on the observed spatial distribution of tuberculosis.	[Tadesse, Sebsibe] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia; [Enqueselassie, Fikre; Hagos, Seifu] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia	University of Gondar; Addis Ababa University	Tadesse, S (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia.	sbsbtadesse90@gmail.com	Tadesse, Sebsibe/AGG-7272-2022	Tadesse, Sebsibe/0000-0002-9153-5400				Ali E, 2010, ETHIOP J HEALTH SCI, V20, P113; Balabanova D, 2011, GOOD HLTH LOW COST 2; Barter DM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-980; Central Statistical Agency, 2007, 2007 POP HOUS CENS E; Dangisso MH, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.29443; Dangisso MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126369; Demissie M, 2002, INT J TUBERC LUNG D, V6, P580; Federal Democratic Republic of Ethiopia Ministry of Health, 2012, GUID CLIN PROGR MAN; Federal Ministry of Health EHNRI, 2011, 1 ETH NAT POP BAS TU; Ge EJ, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0104-2; Gomez-Barroso D, 2013, INT J TUBERC LUNG D, V17, P745, DOI 10.5588/ijtld.12.0702; Kozinska M, 2016, POL ARCH MED WEWN, V126, P32; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 2010, SATSCANTM USER GUIDE; Liu Y, 2012, INT J TUBERC LUNG D, V16, P486, DOI 10.5588/ijtld.11.0255; Melaku YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106781; Shargie EB, 2006, B WORLD HEALTH ORGAN, V84, P112, DOI 10.2471/BLT.05.024489; Shargie EB, 2006, INT J TUBERC LUNG D, V10, P87; Southern Nations Nationalities and Peoples Regional Health Department, 2017, 2016 HLTH REP; Southern Nations Nationalities and Peoples Regional Investment Department, INV OPP; Tadesse S, 2013, J INFECT DIS IMMUN, V5, P29, DOI DOI 10.5897/JIDI2013.0117; Tadesse S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152900; Tadesse T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065022; Tadesse T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028258; Tiwari Neeraj, 2006, Int J Health Geogr, V5, P33, DOI 10.1186/1476-072X-5-33; WHO, 2017, GLOB TUB REP; Zhao F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083605	27	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0198353	10.1371/journal.pone.0198353	http://dx.doi.org/10.1371/journal.pone.0198353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870539	gold, Green Submitted, Green Published			2022-12-26	WOS:000434128400021
J	Ayutthaya, PPN; Chanchao, CP; Chunsrivirot, S				Ayutthaya, Pratchaya Pramoj Na; Chanchao, Chanpen; Chunsrivirot, Surasak			Insight into the substrate specificity change caused by the Y227H mutation of alpha-glucosidase III from the European honeybee (Apis mellifera) through molecular dynamics simulations	PLOS ONE			English	Article							SURFACE-AREA; MM-PBSA; PERFORMANCE; BINDING; PURIFICATION; MM/GBSA; MM/PBSA; DOCKING	Honey from the European honeybee, Apis mellifera, is produced by alpha-glucosidases (HBGases) and is widely used in food, pharmaceutical, and cosmetic industries. Categorized by their substrate specificities, HBGases have three isoforms: HBGase I, II and III. Previous experimental investigations showed that wild-type HBGase III from Apis mellifera (WT) preferred sucrose to maltose as a substrate, while the Y227H mutant (MT) preferred maltose to sucrose. This mutant can potentially be used for malt hydrolysis because it can efficiently hydrolyze maltose. In this work, to elucidate important factors contributing to substrate specificity of this enzyme and gain insight into how the Y227H mutation causes substrate specificity change, WT and MT homology models were constructed, and sucrose/maltose was docked into active sites of the WT and MT. AMBER14 was employed to perform three independent molecular dynamics runs for these four complexes. Based on the relative binding free energies calculated by the MM-GBSA method, sucrose is better than maltose for WT binding, while maltose is better than sucrose for MT binding. These rankings support the experimentally observed substrate specificity that WT preferred sucrose to maltose as a substrate, while MT preferred maltose to sucrose, suggesting the importance of binding affinity for substrate specificity. We also found that the Y227H mutation caused changes in the proximities between the atoms necessary for sucrose/maltose hydrolysis that may affect enzyme efficiency in the hydrolysis of sucrose/maltose. Moreover, the per residue binding free energy decomposition results show that Y227/H227 may be a key residue for preference binding of sucrose/maltose in the WT/MT active site. Our study provides important and novel insight into the binding of sucrose/maltose in the active site of Apis mellifera HBGase III and into how the Y227H mutation leads to the substrate specificity change at the molecular level. This knowledge could be beneficial in the design of this enzyme for increased production of desired products.	[Ayutthaya, Pratchaya Pramoj Na; Chanchao, Chanpen] Chulalongkorn Univ, Fac Sci, Dept Biol, Bangkok, Thailand; [Ayutthaya, Pratchaya Pramoj Na; Chunsrivirot, Surasak] Chulalongkorn Univ, Fac Sci, Dept Biochem, Struct & Computat Biol Res Grp, Bangkok, Thailand; [Chunsrivirot, Surasak] Chulalongkorn Univ, Fac Sci, Dept Biochem, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Chunsrivirot, S (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biochem, Struct & Computat Biol Res Grp, Bangkok, Thailand.; Chunsrivirot, S (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biochem, Bangkok, Thailand.	surasak.ch@chula.ac.th			Structural and Computational Biology Research Group, Special Task Force for Activating Research (STAR), Faculty of Science, Rachadaphiseksomphot Endowment Fund, Chulalongkorn University; Institute for the Promotion of Teaching Science and Technology (IPST) under the Research Fund for DPST Graduate with First Placement [07/2557]; Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project," Chulalongkorn University [RGN_2558_002_01_23]; Thailand Research Fund [TRG5880222, IRG 5780008]	Structural and Computational Biology Research Group, Special Task Force for Activating Research (STAR), Faculty of Science, Rachadaphiseksomphot Endowment Fund, Chulalongkorn University; Institute for the Promotion of Teaching Science and Technology (IPST) under the Research Fund for DPST Graduate with First Placement; Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project," Chulalongkorn University; Thailand Research Fund(Thailand Research Fund (TRF))	This study is supported by Structural and Computational Biology Research Group, Special Task Force for Activating Research (STAR), Faculty of Science, Rachadaphiseksomphot Endowment Fund, Chulalongkorn University. SC would like to also thank the Institute for the Promotion of Teaching Science and Technology (IPST) under the Research Fund for DPST Graduate with First Placement [Grant no. 07/2557], the Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project," Chulalongkorn University [Grant no. RGN_2558_002_01_23], and the Thailand Research Fund [Grant no. TRG5880222 and IRG 5780008] for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bathgate GN, 2016, J I BREWING, V122, P197, DOI 10.1002/jib.332; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cerutti DS, 2008, J CHEM THEORY COMPUT, V4, P1669, DOI 10.1021/ct8002173; Chanchao C, 2008, INSECT SCI, V15, P217, DOI 10.1111/j.1744-7917.2008.00203.x; Chiba S, 1997, BIOSCI BIOTECH BIOCH, V61, P1233, DOI 10.1271/bbb.61.1233; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hou TJ, 2008, J MOL BIOL, V376, P1201, DOI 10.1016/j.jmb.2007.12.054; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kubota M, 2004, BIOSCI BIOTECH BIOCH, V68, P2346, DOI 10.1271/bbb.68.2346; Kuroda A., 1988, HDB AMYLASES RELATED; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Madsen LR, 2017, J FOOD SCI, V82, P401, DOI 10.1111/1750-3841.13623; MATSUSAKA K, 1977, AGR BIOL CHEM TOKYO, V41, P1917, DOI 10.1080/00021369.1977.10862786; Mena-Ulecia K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142774; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Mollica A, 2019, J BIOMOL STRUCT DYN, V37, P726, DOI 10.1080/07391102.2018.1439403; Ngiwsara L, 2012, BIOSCI BIOTECH BIOCH, V76, P1967, DOI 10.1271/bbb.120473; Niinivehmas SP, 2011, J CHEM INF MODEL, V51, P1353, DOI 10.1021/ci1004527; Nishimoto M, 2001, BIOSCI BIOTECH BIOCH, V65, P1610, DOI 10.1271/bbb.65.1610; Niu YZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145219; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seiya C., 1995, ENZYME CHEM MOL BIOL; Shen X, 2015, ACTA CRYSTALLOGR D, V71, P1382, DOI 10.1107/S139900471500721X; Sun HY, 2014, PHYS CHEM CHEM PHYS, V16, P22035, DOI 10.1039/c4cp03179b; Sun HY, 2014, PHYS CHEM CHEM PHYS, V16, P16719, DOI 10.1039/c4cp01388c; Swanson JMJ, 2004, BIOPHYS J, V86, P67, DOI 10.1016/S0006-3495(04)74084-9; TAKEWAKI S, 1980, AGR BIOL CHEM TOKYO, V44, P731, DOI 10.1080/00021369.1980.10864027; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Virtanen SI, 2015, J MOL GRAPH MODEL, V62, P303, DOI 10.1016/j.jmgm.2015.10.012; Xu L, 2013, J PHYS CHEM B, V117, P8408, DOI 10.1021/jp404160y; Xu Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074788; Ylilauri M, 2013, J CHEM INF MODEL, V53, P2626, DOI 10.1021/ci4002475; Zhang XH, 2014, J CHEM INF MODEL, V54, P324, DOI 10.1021/ci4005145; Zuo ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37584	42	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198484	10.1371/journal.pone.0198484	http://dx.doi.org/10.1371/journal.pone.0198484			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864156	gold, Green Submitted, Green Published			2022-12-26	WOS:000434097100034
J	Kouam, PN; Rezniczek, GA; Kochanneck, A; Priesch-Grzeszkowiak, B; Hero, T; Adamietz, IA; Buhler, H				Kouam, Pascaline Nguemgo; Rezniczek, Guenther A.; Kochanneck, Anja; Priesch-Grzeszkowiak, Bettina; Hero, Thomas; Adamietz, Irenaeus A.; Buehler, Helmut			Robo1 and vimentin regulate radiation-induced motility of human glioblastoma cells	PLOS ONE			English	Article							REPULSIVE AXON GUIDANCE; HUMAN GLIOMA-CELLS; EPIGENETIC INACTIVATION; MESENCHYMAL TRANSITION; MALIGNANT GLIOMA; HUMAN CANCERS; HUMAN HOMOLOG; SLIT2 GENE; MIGRATION; IRRADIATION	Glioblastoma is a primary brain tumor with a poor prognosis despite of many treatment regimens. Radiotherapy significantly prolongs patient survival and remains the most common treatment. Slit2 and Robo1 are evolutionarily conserved proteins involved in axon guidance, migration, and branching of neuronal cells. New studies have shown that Slit2 and Robo1 could play important roles in leukocyte chemotaxis and glioblastoma cell migration. Therefore, we investigated whether the Slit2/Robo1 complex has an impact on the motility of glioblastoma cells and whether irradiation with therapeutic doses modulates this effect. Our results indicate that photon irradiation increases the migration of glioblastoma cells in vitro. qPCR and immunoblotting experiments in two different glioblastoma cell lines (U-373 MG and U-87 MG) with different malignancy revealed that both Slit2 and Robo1 are significantly lower expressed in the cell populations with the highest motility and that the expression was reduced after irradiation. Overexpression of Robo1 significantly decreased the motility of glioblastoma cells and inhibited the accelerated migration of wild-type cells after irradiation. Immunoblotting analysis of migration-associated proteins (fascin and focal adhesion kinase) and of the epithelial-mesenchymal-transition-related protein vimentin showed that irradiation affected the migration of glioblastoma cells by increasing vimentin expression, which can be reversed by the overexpression of Slit2 and Robo1. Our findings suggest that Robo1 expression might counteract migration and also radiation-induced migration of glioblastoma cells, a process that might be connected to mesenchymal-epithelial transition.	[Kouam, Pascaline Nguemgo; Kochanneck, Anja; Priesch-Grzeszkowiak, Bettina; Buehler, Helmut] Ruhr Univ Bochum, Med Res Ctr, Inst Mol Oncol Radiobiol & Expt Radiotherapy, Marien Hosp Herne, Herne, Germany; [Rezniczek, Guenther A.] Ruhr Univ Bochum, Med Res Ctr, Marien Hosp Herne, Dept Obstet & Gynecol, Herne, Germany; [Hero, Thomas; Adamietz, Irenaeus A.] Ruhr Univ Bochum, Med Res Ctr, Marien Hosp Herne, Dept Radiotherapy & Radiooncol, Herne, Germany	Ruhr University Bochum; St. Marien Hospital; Ruhr University Bochum; St. Marien Hospital; Ruhr University Bochum; St. Marien Hospital	Kouam, PN (corresponding author), Ruhr Univ Bochum, Med Res Ctr, Inst Mol Oncol Radiobiol & Expt Radiotherapy, Marien Hosp Herne, Herne, Germany.	pascaline.nguemgokouam@rub.de	Rezniczek, Günther/AAO-2963-2020; Rezniczek, Günther/Q-9318-2016	Rezniczek, Günther/0000-0002-0852-6002; Rezniczek, Günther/0000-0002-0852-6002; Buhler, Helmut/0000-0003-2094-8029; Adamietz, Irenaeus/0000-0002-7747-7259	Stiftungsfonds BIOX	Stiftungsfonds BIOX	The study was in part supported by Stiftungsfonds BIOX (http://www.stiftungsfonds-biox.com), unrestricted grant to Helmut Buhler.	Astuti D, 2004, BRIT J CANCER, V90, P515, DOI 10.1038/sj.bjc.6601447; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Buhler H, 2016, IN VIVO, V30, P761, DOI 10.21873/invivo.10992; Buhler H, 2015, ANTICANCER RES, V35, P1977; Buhler H, 2017, IN VIVO, V31, P329, DOI 10.21873/invivo.11063; Dallol A, 2003, ONCOGENE, V22, P4611, DOI 10.1038/sj.onc.1206687; Dallol A, 2003, CANCER RES, V63, P1054; Dallol A, 2002, CANCER RES, V62, P5874; Dallol A, 2002, ONCOGENE, V21, P3020, DOI 10.1038/sj.onc.1205421; Dickinson RE, 2004, BRIT J CANCER, V91, P2071, DOI 10.1038/sj.bjc.6602222; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Dontula Ranadheer, 2013, Genes Cancer, V4, P285, DOI 10.1177/1947601913500141; Goetze K, 2007, INT J RADIAT BIOL, V83, P889, DOI 10.1080/09553000701753826; He EH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126149; Hoa NT, 2015, AM J TRANSL RES, V7, P271; Jansen EPM, 2000, RADIOTHER ONCOL, V56, P151, DOI 10.1016/S0167-8140(00)00216-4; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kleynen CE, 2003, ANTICANCER RES, V23, P4907; Latil A, 2003, INT J CANCER, V103, P306, DOI 10.1002/ijc.10821; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Little JB, 2000, CARCINOGENESIS, V21, P397, DOI 10.1093/carcin/21.3.397; Liu LQ, 2016, SURG ONCOL, V25, P405, DOI 10.1016/j.suronc.2016.09.003; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Mah L-J, 2010, J VIS EXP; Mahabir R, 2014, NEURO-ONCOLOGY, V16, P671, DOI 10.1093/neuonc/not239; Mertsch S, 2008, J NEURO-ONCOL, V87, P1, DOI 10.1007/s11060-007-9484-2; Moncharmont C, 2014, CRIT REV ONCOL HEMAT, V92, P133, DOI 10.1016/j.critrevonc.2014.05.006; Narayan G, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-16; PEDERSEN PH, 1993, CANCER RES, V53, P5158; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Rutka JT, 2008, NEOPLASIA, V10, P149, DOI 10.1593/neo.07909; Scanlon CS, 2013, J DENT RES, V92, P114, DOI 10.1177/0022034512467352; Schmid BC, 2007, BREAST CANCER RES TR, V106, P333, DOI 10.1007/s10549-007-9504-0; Schneider A, 2010, DTSCH ARZTEBL INT, V107, P776, DOI [10.3238/arztebl.2010.0799, 10.3238/arztebl.2010.0776]; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Thakkar JP, 2014, CANCER EPIDEM BIOMAR, V23, P1985, DOI 10.1158/1055-9965.EPI-14-0275; Weller M, 2009, BEST PRACTICE ONKOLO, V4, P4, DOI [10.1007/s11654-008-0108-x, DOI 10.1007/S11654-008-0108-X]; Wild-Bode C, 2001, CANCER RES, V61, P2744; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Xian J, 2004, CANCER RES, V64, P6432, DOI 10.1158/0008-5472.CAN-04-2561; Xian J, 2001, P NATL ACAD SCI USA, V98, P15062, DOI 10.1073/pnas.251407098; Yang L, 2006, NEURON, V52, P595, DOI 10.1016/j.neuron.2006.09.039; Yiin JJ, 2009, NEURO-ONCOLOGY, V11, P779, DOI 10.1215/15228517-2008-017; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001; Zhou WJ, 2011, CELL RES, V21, P609, DOI 10.1038/cr.2011.17	46	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198508	10.1371/journal.pone.0198508	http://dx.doi.org/10.1371/journal.pone.0198508			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864155	Green Published, gold			2022-12-26	WOS:000434097100037
J	Liao, WC; Liao, CK; Tsai, YH; Tseng, TJ; Chuang, LC; Lan, CT; Chang, HM; Liu, CH				Liao, Wen-Chieh; Liao, Chih-Kai; Tsai, You-Huan; Tseng, To-Jung; Chuang, Li-Ching; Lan, Chyn-Tair; Chang, Hung-Ming; Liu, Chiung-Hui			DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; SULFATE HYBRID CHAINS; EMBRYONIC PIG BRAIN; DERMATAN SULFATE; CHONDROITIN SULFATE; FACTOR RECEPTOR; HEPATOCELLULAR-CARCINOMA; NEURITOGENIC ACTIVITY; EXPRESSION; GLYCOSAMINOGLYCAN	Remodeling of the extracellular matrix (ECM) in the tumor microenvironment promotes glioma progression. Chondroitin sulfate (CS) proteoglycans appear in the ECM and on the cell surface, and can be catalyzed by dermatan sulfate epimerase to form chondroitin sulfate/dermatan sulfate (CS/DS) hybrid chains. Dermatan sulfate epimerase 1 (DSE) is overexpressed in many types of cancer, and CS/DS chains mediate several growth factor signals. However, the role of DSE in gliomas has never been explored. In the present study, we determined the expression of DSE in gliomas by consulting a public database and conducting immunohistochemistry on a tissue array. Our investigation revealed that DSE was upregulated in gliomas compared with normal brain tissue. Furthermore, high DSE expression was associated with advanced tumor grade and poor survival. We found high DSE expression in several glioblastoma cell lines, and DSE expression directly mediated DS chain formation in glioblastoma cells. Knockdown of DSE suppressed the proliferation, migration, and invasion of glioblastoma cells. In contrast, overexpression of DSE in GL261 cells enhanced these malignant phenotypes and in vivo tumor growth. Interestingly, we found that DSE selectively regulated heparin-binding EGF-like growth factor (HB-EGF)-induced signaling in glioblastoma cells. Inhibiting epidermal growth factor receptor (EGFR) and ErbB2 with afatinib suppressed DSE-enhanced malignant phenotypes, establishing the critical role of the ErbB pathway in regulating the effects of DSE expression. This evidence indicates that upregulation of DSE in gliomas contributes to malignant behavior in cancer cells. We provide novel insight into the significance of DS chains in ErbB signaling and glioma pathogenesis.	[Liao, Wen-Chieh; Liao, Chih-Kai; Tsai, You-Huan; Tseng, To-Jung; Chuang, Li-Ching; Lan, Chyn-Tair; Liu, Chiung-Hui] Chung Shan Med Univ, Fac Med, Dept Anat, Taichung, Taiwan; [Liao, Wen-Chieh; Liao, Chih-Kai; Tseng, To-Jung; Lan, Chyn-Tair; Liu, Chiung-Hui] Chung Shan Med Univ Hosp, Dept Med Educ, Taichung, Taiwan; [Chang, Hung-Ming] Taipei Med Univ, Coll Med, Sch Med, Dept Anat & Cell Biol, Taipei, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University	Liu, CH (corresponding author), Chung Shan Med Univ, Fac Med, Dept Anat, Taichung, Taiwan.; Liu, CH (corresponding author), Chung Shan Med Univ Hosp, Dept Med Educ, Taichung, Taiwan.	chiunghui.liu@gmail.com		Liu, Chiung-Hui/0000-0002-2656-2576; Liao, Wen Chieh/0000-0001-7848-2124	Ministry of Science and Technology, Taiwan [MOST-105-2320-B-040-033-MY2, MOST-106-2320-B-040-009-MY3, MOST-105-2320-B-040-029-MY3]; Ministry of Science and Technology; Ministry of Education; Chung Shan Medical University	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education; Chung Shan Medical University	This study was supported by the following grants from the Ministry of Science and Technology, Taiwan: MOST-105-2320-B-040-033-MY2 and MOST-106-2320-B-040-009-MY3 (Chiung-Hui Liu), MOST-105-2320-B-040-029-MY3 (Wen-Chieh Liao). TissueFAX Plus Cytometer was performed in the Instrument Center of Chung Shan Medical University, which is supported by Ministry of Science and Technology, Ministry of Education, and Chung Shan Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita K, 2008, STEM CELLS, V26, P798, DOI 10.1634/stemcells.2007-0448; Andersson U, 2004, ACTA NEUROPATHOL, V108, P135, DOI 10.1007/s00401-004-0875-6; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Deakin JA, 2009, J BIOL CHEM, V284, P6311, DOI 10.1074/jbc.M807671200; Denholm EM, 2001, EUR J PHARMACOL, V416, P213, DOI 10.1016/S0014-2999(01)00884-6; Dmitrieva N, 2011, CLIN CANCER RES, V17, P1362, DOI 10.1158/1078-0432.CCR-10-2213; EKSTRAND AJ, 1991, CANCER RES, V51, P2164; FERRO DR, 1990, CARBOHYD RES, V195, P157, DOI 10.1016/0008-6215(90)84164-P; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Iida J, 2007, BIOCHEM J, V403, P553, DOI 10.1042/BJ20061176; Jaime-Ramirez AC, 2017, J GENE MED, V19, DOI 10.1002/jgm.2942; Keough MB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11312; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Liu CH, 2017, CANCER LETT, V403, P280, DOI 10.1016/j.canlet.2017.06.023; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Mishima K, 1998, ACTA NEUROPATHOL, V96, P322, DOI 10.1007/s004010050901; Mizumoto S, 2015, CURR OPIN STRUC BIOL, V34, P35, DOI 10.1016/j.sbi.2015.06.004; Munkley J, 2016, ONCOTARGET, V7, P35478, DOI 10.18632/oncotarget.8155; Nakao M, 2000, J IMMUNOL, V164, P2565, DOI 10.4049/jimmunol.164.5.2565; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Ostrom QT, 2017, NEURO-ONCOLOGY, V19, pV1, DOI 10.1093/neuonc/nox158; Pacheco B, 2009, J BIOL CHEM, V284, P9788, DOI 10.1074/jbc.M809339200; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Ramnarain DB, 2006, CANCER RES, V66, P867, DOI 10.1158/0008-5472.CAN-05-2753; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Salanti A, 2015, CANCER CELL, V28, P500, DOI 10.1016/j.ccell.2015.09.003; Sasatomi T, 2002, CANCER, V94, P1636, DOI 10.1002/cncr.10421; SCHLEGEL J, 1994, J NEURO-ONCOL, V22, P201, DOI 10.1007/BF01052920; Shin CH, 2017, ONCOGENE, V36, P4610, DOI 10.1038/onc.2017.83; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Thelin MA, 2012, CANCER RES, V72, P1943, DOI 10.1158/0008-5472.CAN-11-1351; Trowbridge JM, 2002, J BIOL CHEM, V277, P42815, DOI 10.1074/jbc.M204959200; Viapiano M.S., 2009, CNS CANC MODELS MARK, P1219, DOI DOI 10.1007/978-1-60327-553-8_49; Wade A, 2013, FEBS J, V280, P2399, DOI 10.1111/febs.12109; Wu YM, 2011, CANCER RES, V71, P7270, DOI 10.1158/0008-5472.CAN-11-1161; Yamada Shuhei, 2008, Curr Drug Discov Technol, V5, P289; Zhang CC, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv375	41	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198364	10.1371/journal.pone.0198364	http://dx.doi.org/10.1371/journal.pone.0198364			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864158	Green Published, gold, Green Submitted			2022-12-26	WOS:000434097100030
J	Patil, MJ; Hovhannisyan, AH; Akopian, AN				Patil, Mayur J.; Hovhannisyan, Anahit H.; Akopian, Armen N.			Characteristics of sensory neuronal groups in CGRP-cre-ER reporter mice: Comparison to Nav1.8-cre, TRPV1-cre and TRPV1-GFP mouse lines	PLOS ONE			English	Article							ACUTELY DISSOCIATED CELLS; PRIMARY AFFERENT NEURONS; C-FIBER NOCICEPTORS; TRIGEMINAL GANGLION; MECHANISMS; EXPRESSION; DESENSITIZATION; IDENTIFICATION; SUBPOPULATION; RECEPTORS	Peptidergic sensory neurons play a critical role in nociceptive pathways. To precisely define the function and plasticity of sensory neurons in detail, new tools such as transgenic mouse models are needed. We employed electrophysiology and immunohistochemistry to characterize in detail dorsal root ganglion (DRG) neurons expressing an inducible CGRP(cre-ER )(CGRP-cre(+)); and compared them to DRG neurons expressing Nav1.8(cre) (Nav1.8-cre(+)), TRPV1(cre) (TRPV1-cre(+)) and TRPV1-GFP (V1-GFP(+)). Tamoxifen effectively induced CGRP(cre-ER) production in DRG. approximate to 87% of CGRP(cre-ER)-expressing neurons were co-labeled CGRP antibody. Three small and two medium-large-sized (5HT3a(+)/NPY2R(-) and NPY2R(+)) neuronal groups with unique electrophysiological profiles were CGRP-cre(+). Nav1.8-cre(+) neurons were detected in all CGRP-cre(+) groups, as well as in 5 additional neuronal groups: MrgprD(+)/TRPA1(-), MrgprD(+)/TRPA1(+), TRPV1(+)/CGRP(-), vGLUT3(+) and approximate to 30% of trkC(+) neurons. Differences between TRPV1cre and Nav1.8cre reporters were that unlike TRPV1-cre(+), Nav1.8-cre(+) expression was detected in non-nociceptive vGLUT3(+) and trkC(+) populations. Many TRPV1-cre(+) neurons did not respond to capsaicin. In contrast, V1-GFP(+) neurons were in 4 groups, each of which was capsaicin-sensitive. Finally, none of the analyzed reporter lines showed cre-recombination in trkB(+), calbindin(+), 70% of trkC(+) or parvalbumin(+) neurons, which together encompassed approximate to 20% of Nav1.8-cre(-) DRG neurons. The data presented here increases our knowledge of peptidergic sensory neuron characteristics, while showing the efficiency and specificity manipulation of peptidergic neurons by the CGRP(cre-ER) reporter. We also demonstrate that manipulation of all C- and A-nociceptors is better achieved with TRPV1-cre reporter. Finally, the described approach for detailed characterization of sensory neuronal groups can be applied to a variety of reporter mice.	[Patil, Mayur J.; Hovhannisyan, Anahit H.; Akopian, Armen N.] Univ Texas Hlth Sci Ctr San Antonio, Dept Endodont, San Antonio, TX 78229 USA; [Akopian, Armen N.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Akopian, AN (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Endodont, San Antonio, TX 78229 USA.; Akopian, AN (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA.	akopian@UTHSCSA.edu			NIH/NIGMS [GM112747]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112747] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD012210] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research was supported by GM112747 (to ANA) from NIH/NIGMS.	Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Arcourt A, 2017, NEURON, V93, P179, DOI 10.1016/j.neuron.2016.11.027; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Bai L, 2015, CELL, V163, P1783, DOI 10.1016/j.cell.2015.11.060; Basbaum AI, 2010, TRANSGENIC MOUSE MOD; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Baumgartner U, 2010, SCHMERZ, V24, P105, DOI 10.1007/s00482-010-0904-4; Belugin S, 2013, J BIOL CHEM, V288, P34943, DOI 10.1074/jbc.M113.486571; Benn B, 1998, J COMP NEUROL, V401, P47, DOI 10.1002/(SICI)1096-9861(19981109)401:1<47::AID-CNE4>3.0.CO;2-C; Bertin S., 2016, GUT; Birklein F, 2008, NEUROSCI LETT, V437, P199, DOI 10.1016/j.neulet.2008.03.081; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Chang WP, 2016, P NATL ACAD SCI USA, V113, pE5491, DOI 10.1073/pnas.1610176113; Chen H, 2016, EUR J PHARMACOL, V789, P354, DOI 10.1016/j.ejphar.2016.07.024; Chiu IM, 2014, ELIFE, V3, DOI 10.7554/eLife.04660; Boada MD, 2013, J NEUROPHYSIOL, V109, P749, DOI 10.1152/jn.00693.2012; Diogenes A, 2006, J NEUROSCI, V26, P8126, DOI 10.1523/JNEUROSCI.0793-06.2006; Djouhri L, 2004, BRAIN RES REV, V46, P131, DOI 10.1016/j.brainresrev.2004.07.015; Djouhri L, 1998, J PHYSIOL-LONDON, V513, P857, DOI 10.1111/j.1469-7793.1998.857ba.x; Djouhri L, 2003, J PHYSIOL-LONDON, V550, P739, DOI 10.1113/jphysiol.2003.042127; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Fang X, 2006, J NEUROSCI, V26, P7281, DOI 10.1523/JNEUROSCI.1072-06.2006; Gautron L, 2011, J COMP NEUROL, V519, P3085, DOI 10.1002/cne.22667; Gonzalez-Reyes LE, 2013, EXP NEUROL, V250, P321, DOI 10.1016/j.expneurol.2013.10.010; Han L, 2013, ACTA DERM-VENEREOL, V93, P613; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Hashikawa-Hobara N, 2015, SCI REP-UK, V5, DOI 10.1038/srep12559; Hibberd TJ, 2016, AM J PHYSIOL-GASTR L, V310, pG561, DOI 10.1152/ajpgi.00462.2015; Holzer P, 1998, GEN PHARMACOL, V30, P5, DOI 10.1016/S0306-3623(97)00078-5; Hou QZ, 2011, PAIN, V152, P2036, DOI 10.1016/j.pain.2011.04.033; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Li WC, 2004, J NEUROPHYSIOL, V92, P380, DOI 10.1152/jn.01238.2003; Liu Q, 2012, J NEUROSCI, V32, P14532, DOI 10.1523/JNEUROSCI.3509-12.2012; Lorenzo LE, 2014, J NEUROSCI, V34, P8300, DOI 10.1523/JNEUROSCI.0159-14.2014; Lou S, 2015, J NEUROSCI, V35, P5317, DOI 10.1523/JNEUROSCI.0122-15.2015; Lou S, 2013, J NEUROSCI, V33, P870, DOI 10.1523/JNEUROSCI.3942-12.2013; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Ma FY, 2004, J NEUROCHEM, V90, P431, DOI 10.1111/j.1471-4159.2004.02492.x; McCoy ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036355; Neeb L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017360; NEIJT HC, 1989, J PHYSIOL-LONDON, V411, P257, DOI 10.1113/jphysiol.1989.sp017572; Ninkina N, 1997, J BIOL CHEM, V272, P13019, DOI 10.1074/jbc.272.20.13019; Omar S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171681; Panconesi A, 2009, J HEADACHE PAIN, V10, P317, DOI 10.1007/s10194-009-0130-6; Patil MJ, 2014, CHANNELS, V8, DOI 10.4161/chan.28946; Petruska JC, 2000, J NEUROPHYSIOL, V84, P2365, DOI 10.1152/jn.2000.84.5.2365; Ramachandra R, 2012, J NEUROPHYSIOL, V108, P2230, DOI 10.1152/jn.00219.2012; Renganathan M, 2000, J NEUROPHYSIOL, V84, P710, DOI 10.1152/jn.2000.84.2.710; Reynders A, 2015, CELL REP; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Rutlin M, 2014, CELL, V159, P1640, DOI 10.1016/j.cell.2014.11.038; Salas MM, 2009, EUR J NEUROSCI, V29, P1568, DOI 10.1111/j.1460-9568.2009.06702.x; Schurmans S, 1997, P NATL ACAD SCI USA, V94, P10415, DOI 10.1073/pnas.94.19.10415; Schwaller B, 1999, AM J PHYSIOL-CELL PH, V276, pC395, DOI 10.1152/ajpcell.1999.276.2.C395; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Serra ID, 2016, MOL PAIN, V12, DOI 10.1177/1744806916636387; Song H, 2012, P NATL ACAD SCI USA, V109, P17531, DOI 10.1073/pnas.1207238109; Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015; Stucky CL, 1999, J NEUROSCI, V19, P6497; Uceyler N, 2016, PAIN, V157, pS60, DOI 10.1097/j.pain.0000000000000411; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Wende H, 2012, SCIENCE, V335, P1373, DOI 10.1126/science.1214314; Wooten M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5122; Xu SH, 2010, J NEUROPHYSIOL, V104, P3451, DOI 10.1152/jn.00336.2010	65	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198601	10.1371/journal.pone.0198601	http://dx.doi.org/10.1371/journal.pone.0198601			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864146	Green Published, Green Submitted, gold			2022-12-26	WOS:000434097100039
J	Niesteruk, A; Jonker, HRA; Richter, C; Linhard, V; Sreeramulu, S; Schwalbe, H				Niesteruk, Anna; Jonker, Hendrik R. A.; Richter, Christian; Linhard, Verena; Sreeramulu, Sridhar; Schwalbe, Harald			The domain architecture of PtkA, the first tyrosine kinase from Mycobacterium tuberculosis, differs from the conventional kinase architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-STRUCTURE DETERMINATION; RESISTANT TUBERCULOSIS; ROTATIONAL DIFFUSION; DRUG DEVELOPMENT; CHEMICAL-SHIFTS; NMR-SPECTRA; PHOSPHORYLATION; PHOSPHATASE; RELAXATION; MEMBRANE	The discovery that MptpA (low-molecular-weight protein tyrosine phosphatase A) from Mycobacterium tuberculosis (Mtb) has an essential role for Mtb virulence has motivated research of tyrosine-specific phosphorylation in Mtb and other pathogenic bacteria. The phosphatase activity of MptpA is regulated via phosphorylation on Tyr(128) and Tyr(129). Thus far, only a single tyrosine-specific kinase, protein-tyrosine kinase A (PtkA), encoded by the Rv2232 gene has been identified within the Mtb genome. MptpA undergoes phosphorylation by PtkA. PtkA is an atypical bacterial tyrosine kinase, as its sequence differs from the sequence consensus within this family. The lack of structural information on PtkA hampers the detailed characterization of the MptpA-PtkA interaction. Here, using NMR spectroscopy, we provide a detailed structural characterization of the PtkA architecture and describe its intra- and intermolecular interactions with MptpA. We found that PtkA's domain architecture differs from the conventional kinase architecture and is composed of two domains, the N-terminal highly flexible intrinsically disordered domain (IDDPtkA) and the C-terminal rigid kinase core domain (KCDPtkA). The interaction between the two domains, together with the structural model of the complex proposed in this study, reveal that the IDDPtkA is unstructured and highly dynamic, allowing for a fly-casting-like mechanism of transient interactions with the rigid KCDPtkA. This interaction modulates the accessibility of the KCDPtkA active site. In general, the structural and functional knowledge of PtkA gained in this study is crucial for understanding the MptpA-PtkA interactions, the catalytic mechanism, and the role of the kinase-phosphatase regulatory system in Mtb virulence.	[Niesteruk, Anna; Jonker, Hendrik R. A.; Richter, Christian; Linhard, Verena; Sreeramulu, Sridhar; Schwalbe, Harald] Goethe Univ Frankfurt Main, Ctr Biomol Magnet Resonance BMRZ, Inst Organ Chem & Chem Biol, Max von Laue Str 7, D-60438 Frankfurt, Germany; [Schwalbe, Harald] DFG Funded Cluster Excellence Macromol Complexes, Frankfurt, Germany	Goethe University Frankfurt	Schwalbe, H (corresponding author), Goethe Univ Frankfurt Main, Ctr Biomol Magnet Resonance BMRZ, Inst Organ Chem & Chem Biol, Max von Laue Str 7, D-60438 Frankfurt, Germany.; Schwalbe, H (corresponding author), DFG Funded Cluster Excellence Macromol Complexes, Frankfurt, Germany.	schwalbe@nmr.uni-frankfurt.de	Schwalbe, Harald/AAB-3143-2020; Schwalbe, Harald J/F-9023-2010	Schwalbe, Harald/0000-0001-5693-7909; Schwalbe, Harald J/0000-0001-5693-7909; Linhard, Verena/0000-0002-0278-9792	DFG; European Commission (iNEXT) [653706]; Horizon 2020 program of the European Union; state of Hesse (BMRZ)	DFG(German Research Foundation (DFG)); European Commission (iNEXT)(European Commission); Horizon 2020 program of the European Union; state of Hesse (BMRZ)	This work was supported by DFG, the European Commission (iNEXT, Grant 653706, funded by the Horizon 2020 program of the European Union), and the state of Hesse (BMRZ). The authors declare that they have no conflicts of interest with the contents of this article.	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Bach H, 2009, BIOCHEM J, V420, P155, DOI 10.1042/BJ20090478; Bansal-Mutalik R, 2014, P NATL ACAD SCI USA, V111, P4958, DOI 10.1073/pnas.1403078111; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chao JD, 2014, J BIOL CHEM, V289, P9463, DOI 10.1074/jbc.R113.520015; CHOW K, 1994, FEMS MICROBIOL LETT, V124, P203, DOI 10.1111/j.1574-6968.1994.tb07285.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Goddard T. D., 2002, SPARKY VERSION 3 105; Grangeasse C, 2012, PHILOS T R SOC B, V367, P2640, DOI 10.1098/rstb.2011.0424; Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Koul A, 2000, J BACTERIOL, V182, P5425, DOI 10.1128/JB.182.19.5425-5432.2000; Kusebauch U, 2014, P NATL ACAD SCI USA, V111, P9265, DOI 10.1073/pnas.1323894111; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Lopez-Mendez B, 2006, J AM CHEM SOC, V128, P13112, DOI 10.1021/ja061136l; Niesteruk A, 2018, FEBS LETT, V592, P1233, DOI 10.1002/1873-3468.13022; OSTROVSKY PC, 1995, GENE DEV, V9, P2034, DOI 10.1101/gad.9.16.2034; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pablos-Mendez A, 2002, B WORLD HEALTH ORGAN, V80, P489; Parish T, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0010-2013; Pepio AM, 2001, J BIOL CHEM, V276, P3846, DOI 10.1074/jbc.M006339200; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Stehle T, 2012, J BIOL CHEM, V287, P34569, DOI 10.1074/jbc.M112.399261; Tjandra N, 1997, NAT STRUCT BIOL, V4, P443, DOI 10.1038/nsb0697-443; van den Boogaard J, 2009, ANTIMICROB AGENTS CH, V53, P849, DOI 10.1128/AAC.00749-08; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; VUISTER GW, 1994, J BIOMOL NMR, V4, P193; Wong D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18547-9; Wong D, 2013, TRENDS MICROBIOL, V21, P100, DOI 10.1016/j.tim.2012.09.002; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Wu JG, 1999, P NATL ACAD SCI USA, V96, P13068, DOI 10.1073/pnas.96.23.13068; Zhao X, 2002, J BIOL CHEM, V277, P4722, DOI 10.1074/jbc.M107803200; Zhou PF, 2015, BIOCHEM BIOPH RES CO, V467, P421, DOI 10.1016/j.bbrc.2015.09.124; Zhou PF, 2015, FEBS LETT, V589, P326, DOI 10.1016/j.febslet.2014.12.015; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	46	4	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11823	11836		10.1074/jbc.RA117.000120	http://dx.doi.org/10.1074/jbc.RA117.000120			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29884774	Green Published, hybrid			2022-12-26	WOS:000440134500016
J	Sato, A; Menez, A				Sato, Atsushi; Menez, Andre			External release of entropy by synchronized movements of local secondary structures drives folding of a small, disulfide-bonded protein	PLOS ONE			English	Article							DIFFUSION-COLLISION MODEL; AMINO-ACID-SEQUENCE; ERABUTOXIN-B; PREDICTION; TOXINS; SNAKE; ACCUMULATION; MECHANISMS; NEUROTOXIN	A crucial mechanism to the formation of native, fully functional, 3D structures from local secondary structures is unraveled in this study. Through the introduction of various amino acid substitutions at four canonical (3-turns in a three-fingered protein, Toxin a from Naja nigricollis, we found that the release of internal entropy to the external environment through the globally synchronized movements of local substructures plays a crucial role. Throughout the folding process, the folding species were saturated with internal entropy so that intermediates accumulated at the equilibrium state. Their relief from the equilibrium state was accomplished by the formation of a critical disulfide bridge, which could guide the synchronized movement of one of the peripheral secondary structure. This secondary structure collided with a core central structure, which flanked another peripheral secondary structure. This collision displaced the internal thermal fluctuations from the first peripheral structure to the second peripheral structure, where the displaced thermal fluctuations were ultimately released as entropy. Two protein folding processes that acted in succession were identified as the means to establish the flow of thermal fluctuations. The first process was the time-consuming assembly process, where stochastic combinations of colliding, native-like, secondary structures provided candidate structures for the folded protein. The second process was the activation process to establish the global mutual relationships of the native protein in the selected candidate. This activation process was initiated and propagated by a positive feedback process between efficient entropy release and well-packed local structures, which moved in synchronization. The molecular mechanism suggested by this experiment was assessed with a well-defined 3D structure of erabutoxin b because one of the turns that played a critical role in folding was shared with erabutoxin b.	[Sato, Atsushi] Tohoku Gakuin Univ, Dept Informat Sci, Fac Liberal Arts, Sendai, Miyagi, Japan; [Menez, Andre] CEA, DSV, DIEP, Paris, France	Tohoku Gakuin University; CEA	Sato, A (corresponding author), Tohoku Gakuin Univ, Dept Informat Sci, Fac Liberal Arts, Sendai, Miyagi, Japan.	asato@mail.tohoku-gakuin.ac.jp						EAKER DL, 1967, JPN J MICROBIOL, V11, P353, DOI 10.1111/j.1348-0421.1967.tb00356.x; Englander SW, 2014, P NATL ACAD SCI USA, V111, P15873, DOI 10.1073/pnas.1411798111; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Fersht AR, 1997, CURR OPIN STRUC BIOL, V7, P3, DOI 10.1016/S0959-440X(97)80002-4; Galat A, 2008, FEBS J, V275, P3207, DOI 10.1111/j.1742-4658.2008.06473.x; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Gilquin B, 2003, PROTEIN SCI, V12, P266, DOI 10.1110/ps.0227703; Gross G, 2010, J MOL BIOL, V403, P299, DOI 10.1016/j.jmb.2010.07.048; Hsieh HC, 2006, ARCH BIOCHEM BIOPHYS, V447, P147, DOI 10.1016/j.abb.2006.01.003; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Ianni JC, 2003, COMPUTATIONAL FLUID AND SOLID MECHANICS 2003, VOLS 1 AND 2, PROCEEDINGS, P1368; Jacobs WM, 2016, BIOPHYS J, V111, P925, DOI 10.1016/j.bpj.2016.06.031; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARPLUS M, 1979, BIOPOLYMERS, V18, P1421, DOI 10.1002/bip.1979.360180608; KARPLUS M, 1994, PROTEIN SCI, V3, P650; KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331; LOW BW, 1976, P NATL ACAD SCI USA, V73, P2991, DOI 10.1073/pnas.73.9.2991; MAEDA N, 1977, BIOCHEM J, V167, P289, DOI 10.1042/bj1670289; Marcelino AMC, 2008, BIOPOLYMERS, V89, P380, DOI 10.1002/bip.20960; Meissner M, 2009, PROTEINS, V74, P344, DOI 10.1002/prot.22164; MENEZ A, 1980, BIOCHEMISTRY-US, V19, P4166, DOI 10.1021/bi00559a005; Mourier G, 2000, PROTEIN ENG, V13, P217, DOI 10.1093/protein/13.3.217; Myers JK, 2001, NAT STRUCT BIOL, V8, P552, DOI 10.1038/88626; Naganathan AN, 2010, P NATL ACAD SCI USA, V107, P8611, DOI 10.1073/pnas.1000988107; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Petrosky T, 1996, CHAOS SOLITON FRACT, V7, P441, DOI 10.1016/0960-0779(95)00042-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ruoppolo M, 1998, BIOCHEMISTRY-US, V37, P16060, DOI 10.1021/bi981492j; Ruoppolo M, 2001, BIOCHEMISTRY-US, V40, P15257, DOI 10.1021/bi0111956; Russell J.S., 1844, REP 14 M BRIT ASS AD, P311; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; SMITH JL, 1988, ACTA CRYSTALLOGR A, V44, P357, DOI 10.1107/S0108767388000303; TAMIYA N, 1980, Biochemical Society Transactions, V8, P753; Tossi A, 2002, PEPTIDES 2002, P416; TREMEAU O, 1995, J BIOL CHEM, V270, P9362, DOI 10.1074/jbc.270.16.9362; TSERNOGLOU D, 1976, FEBS LETT, V68, P1, DOI 10.1016/0014-5793(76)80390-0; WEISSMAN JS, 1992, P NATL ACAD SCI USA, V89, P9900, DOI 10.1073/pnas.89.20.9900	39	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198276	10.1371/journal.pone.0198276	http://dx.doi.org/10.1371/journal.pone.0198276			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894484	Green Submitted, Green Published, gold			2022-12-26	WOS:000435030900009
J	Liss, M; Radke, MH; Eckhard, J; Neuenschwander, M; Dauksaite, V; von Kries, JP; Gotthardt, M				Liss, Martin; Radke, Michael H.; Eckhard, Jamina; Neuenschwander, Martin; Dauksaite, Vita; von Kries, Jens-Peter; Gotthardt, Michael			Drug discovery with an RBM20 dependent titin splice reporter identifies cardenolides as lead structures to improve cardiac filling	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; HEART-FAILURE; DIASTOLIC FUNCTION; PASSIVE STIFFNESS; EXERCISE CAPACITY; MOUSE MODEL; GLYCOSIDES; INHIBITION; PHOSPHORYLATION; CARDIOMYOPATHY	Diastolic dysfunction is increasingly prevalent in our ageing society and an important contributor to heart failure. The giant protein titin could serve as a therapeutic target, as its elastic properties are a main determinant of cardiac filling in diastole. This study aimed to develop a high throughput pharmacological screen to identify small molecules that affect titin isoform expression through differential inclusion of exons encoding the elastic PEVK domains. We used a dual luciferase splice reporter assay that builds on the titin splice factor RBM20 to screen -34,000 small molecules and identified several compounds that inhibit the exclusion of PEVK exons. These compounds belong to the class of cardenolides and affect RBM20 dependent titin exon exclusion but did not affect RBFOX1 mediated splicing of FMNL3. We provide evidence that cardenolides do not bind to the RNA interacting domain of RBM20, but reduce RBM20 protein levels and alter transcription of select splicing factors that interact with RBM20. Cardenolides affect titin isoform expression. Understanding their mode of action and harnessing the splice effects through chemical modifications that suppress the effects on ion homeostasis and more selectively affect cardiac splicing has the potential to improve cardiac filling and thus help patients with diastolic heart failure, for which currently no targeted therapy exists.	[Liss, Martin; Radke, Michael H.; Dauksaite, Vita; Gotthardt, Michael] Max Delbrueck Ctr Mol Med Helmholtz Assoc, Neuromuscular & Cardiovasc Cell Biol, Berlin, Germany; [Radke, Michael H.; Gotthardt, Michael] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany; [Eckhard, Jamina; Neuenschwander, Martin; von Kries, Jens-Peter] Leibniz Inst Mol Pharmacol, Screening Unit, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; German Centre for Cardiovascular Research; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Gotthardt, M (corresponding author), Max Delbrueck Ctr Mol Med Helmholtz Assoc, Neuromuscular & Cardiovasc Cell Biol, Berlin, Germany.; Gotthardt, M (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany.	gotthardt@mdc-berlin.de	Gotthardt, Michael/ABE-8274-2021	Gotthardt, Michael/0000-0003-1788-3172; Liss, Martin/0000-0002-0585-7850; Radke, Michael/0000-0003-0112-9917	Deutsche Forschungsgemeinschaft, Bonn, Germany; European Research Council [StG282078]; Bundesministerium fur Bildung and Forschung, Berlin, Germany (CaRNAtion); Deutsches Zentrum fur Herz-Kreislaufforschung	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Bundesministerium fur Bildung and Forschung, Berlin, Germany (CaRNAtion)(Federal Ministry of Education & Research (BMBF)); Deutsches Zentrum fur Herz-Kreislaufforschung	This work was supported by The Deutsche Forschungsgemeinschaft, Bonn, Germany (MG); The European Research Council grant StG282078 (MG); Bundesministerium fur Bildung and Forschung, Berlin, Germany (CaRNAtion, MG); and the Deutsches Zentrum fur Herz-Kreislaufforschung (MG).	Anderson ES, 2012, RNA, V18, P1041, DOI 10.1261/rna.032912.112; Balzan S, 2000, LIFE SCI, V67, P1921, DOI 10.1016/S0024-3205(00)00779-7; Bishu K, 2011, CIRCULATION, V124, P2882, DOI 10.1161/CIRCULATIONAHA.111.048520; Bull M, 2016, CIRC RES, V119, P764, DOI 10.1161/CIRCRESAHA.116.308904; Chung CS, 2013, CIRCULATION; Corioni M, 2011, NUCLEIC ACIDS RES, V39, P1868, DOI 10.1093/nar/gkq1042; Cvitkovic I, 2013, NUCLEIC ACIDS RES, V41, pD132, DOI 10.1093/nar/gks999; Edelmann F, 2013, JAMA-J AM MED ASSOC, V309, P781, DOI 10.1001/jama.2013.905; FOZZARD HA, 1985, J AM COLL CARDIOL, V5, pA10, DOI 10.1016/S0735-1097(85)80458-7; Frese KS, 2015, J CELL SCI, V128, P3030, DOI 10.1242/jcs.166850; Gao C, 2016, J CLIN INVEST, V126, P195, DOI 10.1172/JCI84015; Goldberger ZD, 2012, AM J CARDIOL, V109, P1818, DOI 10.1016/j.amjcard.2012.02.028; Granzier HL, 2009, CIRC RES, V105, P557, DOI 10.1161/CIRCRESAHA.109.200964; Greaser ML, 2005, J MUSCLE RES CELL M, V26, P325, DOI 10.1007/s10974-005-9039-0; Guo W, 2012, NAT MED, V18, P766, DOI 10.1038/nm.2693; Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538; Hidalgo C, 2013, TRENDS CARDIOVAS MED, V23, P165, DOI 10.1016/j.tcm.2012.10.005; Hinze F, 2016, J MOL MED, V94, P1349, DOI 10.1007/s00109-016-1483-3; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Kruger M, 2009, CIRC RES, V104, P87, DOI 10.1161/CIRCRESAHA.108.184408; Kumar Arvind, 2013, Pharmacogn Rev, V7, P131, DOI 10.4103/0973-7847.120512; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lahmers S, 2004, CIRC RES, V94, P505, DOI 10.1161/01.RES.0000115522.52554.86; Langenhan JM, 2005, P NATL ACAD SCI USA, V102, P12305, DOI 10.1073/pnas.0503270102; Maatz H, 2014, J CLIN INVEST, V124, P3419, DOI 10.1172/JCI74523; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Makarenko I, 2004, CIRC RES, V95, P708, DOI 10.1161/01.RES.0000143901.37063.2f; Methawasin M, 2016, CIRCULATION, V134, P1085, DOI 10.1161/CIRCULATIONAHA.116.023003; Methawasin M, 2014, CIRCULATION, V129, P1924, DOI 10.1161/CIRCULATIONAHA.113.005610; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Pawellek A, 2014, J BIOL CHEM, V289, P34683, DOI 10.1074/jbc.M114.590976; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Radke MH, 2007, P NATL ACAD SCI USA, V104, P3444, DOI 10.1073/pnas.0608543104; Redfield MM, 2012, CIRC-HEART FAIL, V5, P653, DOI 10.1161/CIRCHEARTFAILURE.112.969071; Roth GA, 2015, NEW ENGL J MED, V372, P1333, DOI 10.1056/NEJMoa1406656; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Schoner W, 2007, AM J CARDIOVASC DRUG, V7, P173, DOI 10.2165/00129784-200707030-00004; Sharma K, 2014, CIRC RES, V115, P79, DOI 10.1161/CIRCRESAHA.115.302922; Solomon SD, 2007, LANCET, V369, P2079, DOI 10.1016/S0140-6736(07)60980-5; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Withering W, 2014, ACCOUNT FOXGLOVE SOM, P1707; Wu YM, 2000, J MOL CELL CARDIOL, V32, P2151, DOI 10.1006/jmcc.2000.1281; Yancy CW, 2016, CIRCULATION, V134, pE282, DOI 10.1161/CIR.0000000000000435; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Zile MR, 2007, J AM COLL CARDIOL, V49, P982, DOI 10.1016/j.jacc.2006.12.012	50	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198492	10.1371/journal.pone.0198492	http://dx.doi.org/10.1371/journal.pone.0198492			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889873	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000434786600025
J	Barbour, RL; Graber, HL; Barbour, SLS				Barbour, Randall L.; Graber, Harry L.; Barbour, San-Lian S.			Hemoglobin state-flux: A finite-state model representation of the hemoglobin signal for evaluation of the resting state and the influence of disease	PLOS ONE			English	Article							FORMAL LANGUAGE THEORY; NEOADJUVANT CHEMOTHERAPY; CANCER; HEMODYNAMICS; ANGIOGENESIS; SYSTEM	A Summary In this report we introduce a weak-model approach for examination of the intrinsic time-varying properties of the hemoglobin signal, with the aim of advancing the application of functional near infrared spectroscopy (fNIRS) for the detection of breast cancer, among other potential uses. The developed methodology integrates concepts from stochastic network theory with known modulatory features of the vascular bed, and in doing so provides access to a previously unrecognized dense feature space that is shown to have promising diagnostic potential. Notable features of the methodology include access to this information solely from measures acquired in the resting state, and analysis of these by treating the various components of the hemoglobin (Hb) signal as a co-varying interacting system. Approach The principal data-transform kernel projects Hb state-space trajectories onto a coordinate system that constitutes a finite-state representation of covariations among the principal elements of the Hb signal (i.e., its oxygenated (Delta oxyHb) and deoxygenated (Delta deoxyHb) forms and the associated dependent quantities: total hemoglobin (Delta totalHb =Delta oxyHb + Delta deoxyHb), hemoglobin oxygen saturation (Delta HbO(2)Sat = 100 Delta(oxyHb/totalHb)), and tissue-hemoglobin oxygen exchange (Delta HbO(2)Exc = Delta deoxyHb-Delta oxyHb)). The resulting ten-state representation treats the evolution of this signal as a one-space, spatiotemporal network that undergoes transitions from one state to another. States of the network are defined by the algebraic signs of the amplitudes of the time-varying components of the Hb signal relative to their temporal mean values. This assignment produces several classes of coefficient arrays, most with a dimension of 10x10. Biological motivation Motivating our approach is the understanding that effector mechanisms that modulate blood delivery to tissue operate on macroscopic scales, in a spatially and temporally varying manner. Also recognized is that this behavior is sensitive to nonlinear actions of these effectors, which include the binding properties of hemoglobin. Accessible phenomenology includes measures of the kinetics and probabilities of network dynamics, which we treat as surrogates for the actions of feedback mechanisms that modulate tissue-vascular coupling. Findings Qualitative and quantitative features of this space, and their potential to serve as markers of disease, have been explored by examining continuous-wave fNIRS 3D tomographic time series obtained from the breasts of women who do and do not have breast cancer. Inspection of the coefficient arrays reveals that they are governed predominantly by first-order rate processes, and that each array class exhibits preferred structure that is mainly independent of the others. Discussed are strategies that may serve to extend evaluation of the accessible feature space and how the character of this information holds potential for development of novel clinical and preclinical uses.	[Barbour, Randall L.] Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA; [Barbour, Randall L.; Graber, Harry L.; Barbour, San-Lian S.] Photon Migrat Technol Corp, Brooklyn, NY 11232 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Barbour, RL (corresponding author), Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA.; Barbour, RL (corresponding author), Photon Migrat Technol Corp, Brooklyn, NY 11232 USA.	randall.barbour@downstate.edu			National Institutes of Health [R41CA096102]; U.S. Army [DAMD017-03-C-0018]; Susan G. Komen for the Cure [IMG0403022]; New York State Department of Health, Empire Clinical Research Investigator Program; New York State Foundation for Science, Technology and Innovation-Faculty Development and Technology Transfer Incentive Program [C020041]; NIRx Medical Technologies; New York State Foundation for Science, Technology and Innovation Technology Transfer Incentive Program (NYSTAR-TTIP) [C020041]; NATIONAL CANCER INSTITUTE [R41CA096102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army(United States Department of DefenseUnited States Army); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); New York State Department of Health, Empire Clinical Research Investigator Program; New York State Foundation for Science, Technology and Innovation-Faculty Development and Technology Transfer Incentive Program; NIRx Medical Technologies; New York State Foundation for Science, Technology and Innovation Technology Transfer Incentive Program (NYSTAR-TTIP); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (www.nih.gov), Grant No. R41CA096102; the U.S. Army (cdmrp.army.mil), Grant No. DAMD017-03-C-0018; Susan G. Komen for the Cure (ww5.komen.org/), Grant No. IMG0403022; the New York State Department of Health, Empire Clinical Research Investigator Program (www.health.ny.gov/professionals/doctors/graduate_medical_education/ecrip/); the New York State Foundation for Science, Technology and Innovation-Faculty Development and Technology Transfer Incentive Program (esd.ny.gov/faculty-development-and-technology-transfer-incentive-program), Grant No. C020041; and NIRx Medical Technologies (www.nirx.net).; This research was supported by the National Institutes of Health (NIH), Grant No. R41CA096102; the U.S. Army, Grant No. DAMD017-03-C-0018; Susan G. Komen for the Cure, Grant No. IMG0403022; the New York State Department of Health, Empire Clinical Research Investigator Program; the New York State Foundation for Science, Technology and Innovation Technology Transfer Incentive Program (NYSTAR-TTIP), Grant No. C020041; and NIRx Medical Technologies.	Al Abdi R, 2011, J OPT SOC AM A, V28, P2473, DOI 10.1364/JOSAA.28.002473; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Balardin JB, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00258; Barbour RL, 2001, J OPT SOC AM A, V18, P3018, DOI 10.1364/JOSAA.18.003018; Barbour RL, 2000, PROCEEDINGS OF INTER-INSTITUTE WORKSHOP ON IN VIVO OPTICAL IMAGING AT THE NIH, P161; Barbour RL, 2007, HUMAN BRAIN MAPPING; Barbour RL, 2018, United States patent application, Patent No. [US 20180110458, 20180110458]; Bateman RM, 2003, CRIT CARE, V7, P359, DOI 10.1186/cc2353; Button TM, 2004, PHYS MED BIOL, V49, P3105, DOI 10.1088/0031-9155/49/14/005; Chaudhary U, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.1002593; Choudhari SK, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-118; Faeder JR, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-68; Fantini S, 2014, NEUROIMAGE, V85, P202, DOI 10.1016/j.neuroimage.2013.03.065; Feng JC, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.9.090506; Fitch WT, 2012, PHILOS T R SOC B, V367, P1933, DOI 10.1098/rstb.2012.0103; Foster KR, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-94; Gheorghe MA, 2004, COMP FUNCT GENOM, V5, P91, DOI 10.1002/cfg.364; Graber HL, 2015, MED PHYS, V42, P6406, DOI 10.1118/1.4932220; Graber HL, 2002, IEEE T MED IMAGING, V21, P852, DOI 10.1109/TMI.2002.801154; Grosenick D, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.9.091311; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassanpour MS, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.4.041402; Hong KS, 2016, INT J NEURAL SYST, V26, DOI 10.1142/S012906571650012X; Jager G, 2012, PHILOS T R SOC B, V367, P1956, DOI 10.1098/rstb.2012.0077; Kastrup A, 1998, STROKE, V29, P1311, DOI 10.1161/01.STR.29.7.1311; Kato T, 2013, United States patent, Patent No. [US 20080262327, 20080262327]; Kilic F, 2012, EURASIAN J MED, V44, P106, DOI 10.5152/eajm.2012.24; Kumar K. S. S, 2008, ELECT CIRCUITS NETWO; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Kuphaldt T.R., 2006, LESSONS ELECT CIRCUI, V1; Lee K, 2011, WORLD J CLIN ONCOL, V2, P64, DOI 10.5306/wjco.v2.i1.64; Maus C, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-166; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Pakalniskis MG, 2011, RADIOLOGY, V259, P365, DOI 10.1148/radiol.11100699; Parasuraman S, 2011, J PHARMACOL PHARMACO, V2, P74, DOI 10.4103/0976-500X.81895; Patton K. T., 2015, ANATOMY PHYSL; Pei YL, 2001, APPL OPTICS, V40, P5755, DOI 10.1364/AO.40.005755; Piper SK, 2014, NEUROIMAGE, V85, P64, DOI 10.1016/j.neuroimage.2013.06.062; Sarti P, 2012, BBA-BIOENERGETICS, V1817, P610, DOI 10.1016/j.bbabio.2011.09.002; Scaiewicz A, 2015, CURR OPIN GENET DEV, V35, P50, DOI 10.1016/j.gde.2015.08.010; Schmitz CH, 2005, APPL OPTICS, V44, P2140, DOI 10.1364/AO.44.002140; Schreiter NF, 2013, ROFO-FORTSCHR RONTG, V185, P358, DOI 10.1055/s-0032-1330446; Searls DB, 2013, BIOPOLYMERS, V99, P203, DOI 10.1002/bip.22101; Searls DB, 2002, NATURE, V420, P211, DOI 10.1038/nature01255; Sejnowski T, 2012, SCI AM, V307, P54, DOI 10.1038/scientificamerican1012-54; Simons M, 2015, CIRC RES, V116, pE99, DOI 10.1161/RES.0000000000000054; Somvanshi Pramod Rajaram, 2014, Syst Synth Biol, V8, P99, DOI 10.1007/s11693-013-9125-3; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Stepuro TL, 2006, J PHYSIOL PHARMACOL, V57, P29; Strickland E, 2017, IEEE SPECTR HUMAN OS; Taroni P, 2017, SCI REP-UK, V7, DOI 10.1038/srep40683; Taroni P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128941; Tromberg BJ, 2016, CANCER RES, V76, P5933, DOI 10.1158/0008-5472.CAN-16-0346; Vaupel P, 2000, MED RAD DIA IMG, P63; Vaupel P, 2000, MED RAD DIA IMG, P41; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Wholley D, 2014, NAT REV DRUG DISCOV, V13, P791, DOI 10.1038/nrd4439; Wylie GR, 2009, NEUROIMAGE, V47, P473, DOI 10.1016/j.neuroimage.2009.04.056; Yoshino K, 2012, NEUROREPORT, V23, P947, DOI 10.1097/WNR.0b013e328359833b; Zhou Y, 2013, ARXIV13053830V2	60	1	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198210	10.1371/journal.pone.0198210	http://dx.doi.org/10.1371/journal.pone.0198210			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883456	Green Published, Green Submitted, gold			2022-12-26	WOS:000434728100014
J	Dong, YN; Li, SR; Zhao, WH; Wang, YL; Ge, TT; Xiao, JZ; Li, YK				Dong, Yanan; Li, Shirui; Zhao, Wenhui; Wang, Yanlei; Ge, Tingting; Xiao, Jianzhong; Li, Yukun			Changes of MODY signal pathway genes in the endoplasmic reticulum stress in INS-1-3 cells	PLOS ONE			English	Article							PROLIFERATION; INSULIN	Objective Metabolic disturbances induce endoplasmic reticulum stress (ERS) in pancreatic beta cells. This study aims to investigate whether a common pathway exists in the ERS induced by various chemicals, including high levels of glucose and palmitate in INS-1-3 cells. Method ERS in INS-1-3 cells was induced by exposure cells to thapsigargin (TG), tunicamycin (TM) or palmitic acid (PA) +high glucose (HG). Digital gene expression (DGE) profiling technique was used to detect differentially expressed genes. The profile of gene expression was detected by gene oncology (GO) function and pathway enrichment analysis. Nkx6.1 over expression was established in INS-1-3 cell lines by lentivirus infection to revert the inhibition of Nkx6.1 expression found in the situation of ERS. Real time reverse transcription polymerase chain reaction (RT-PCR) was used to verify the expression changes of key genes. Cell viability was measured by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. The apoptosis was determined by flow cytometry. INS-1-3 cell function was measured by glucose stimulated insulin secretion test(GSIS). Results As compared to control, DGE demonstrated that there were 135, 57 and 74 differentially expressed genes in TM, TG and HG+PA groups, respectively. Those differentially expressed genes were enriched to ERS, antigen processing and presentation, protein export pathways, and interestingly, the maturity onset diabetes of the young (MODY) pathway. Nkx6.1 is one of common down-regulated gene in MODY signaling pathway among TM, TG and HG+PA groups. Over-expression of Nkx6.1 ameliorated glucolipotoxicity induced apoptosis rate by 45.4%, and increased proliferation by 40.9%. At the same time, GSIS increased by 1.82 folds. Conclusions MODY pathway genes expression was changed in the state of ERS. Over-expression of Nkx6.1 protected the INS-1-3 cells from glucolipotoxicity.	[Dong, Yanan; Li, Yukun] Hebei Med Univ, Hosp 3, Dept Endocrinol, Shijiazhuang, Hebei, Peoples R China; [Li, Shirui] China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China; [Zhao, Wenhui; Wang, Yanlei; Ge, Tingting; Xiao, Jianzhong] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Endocrinol, Beijing, Peoples R China	Hebei Medical University; China-Japan Friendship Hospital; Tsinghua University	Li, YK (corresponding author), Hebei Med Univ, Hosp 3, Dept Endocrinol, Shijiazhuang, Hebei, Peoples R China.; Xiao, JZ (corresponding author), Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Endocrinol, Beijing, Peoples R China.	xiaojzh858@sina.com; lykun1962@163.com			Natural Science Foundation of China [81370911]; National Basic Research Program of China (973 Program) [2011CB504001]; Tsinghua University Initiative Scientific Research Program [20161080080]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Tsinghua University Initiative Scientific Research Program	JX received financial support from the Natural Science Foundation of China (No. 81370911); National Basic Research Program of China (973 Program) (Grant No. 2011CB504001); Tsinghua University Initiative Scientific Research Program (No. 20161080080).	[Anonymous], 1995, Diabetes, V44, P1249; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Biden TJ, 2014, TRENDS ENDOCRIN MET, V25, P389, DOI 10.1016/j.tem.2014.02.003; Burlison JS, 2008, DEV BIOL, V316, P74, DOI 10.1016/j.ydbio.2008.01.011; He YM, 2018, INT J BIOL MACROMOL, V106, P893, DOI 10.1016/j.ijbiomac.2017.08.089; Hobson A, 2015, ISLETS, V7, DOI 10.1080/19382014.2015.1027854; Hong SW, 2018, ENDOCRINOL METAB, V33, P105, DOI 10.3803/EnM.2018.33.1.105; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Kwak HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176432; Lenin R, 2012, EXP DIABETES RES, DOI 10.1155/2012/356487; Lima MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036481; Marty-Santos L, 2016, DEVELOPMENT, V143, P101, DOI 10.1242/dev.126755; Rojas J, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/9601801; RUDNICK A, 1994, P NATL ACAD SCI USA, V91, P12203, DOI 10.1073/pnas.91.25.12203; Sander M, 2000, DEVELOPMENT, V127, P5533; Schaffer AE, 2010, DEV CELL, V18, P1022, DOI 10.1016/j.devcel.2010.05.015; Schisler JC, 2008, MOL CELL BIOL, V28, P3465, DOI 10.1128/MCB.01791-07; Serup P, 2012, SEMIN CELL DEV BIOL, V23, P663, DOI 10.1016/j.semcdb.2012.06.004; Sun JH, 2015, MOL ASPECTS MED, V42, P105, DOI 10.1016/j.mam.2015.01.001; Taylor BL, 2015, DIABETES, V64, P897, DOI 10.2337/db14-0684; van Wijngaarden RPT, 2017, DIABETES THER, V8, P1097, DOI 10.1007/s13300-017-0301-4; Wang Z, 2015, BIOCHEM BIOPH RES CO, V461, P598, DOI 10.1016/j.bbrc.2015.04.072; Ward MG, 2017, SCI REP-UK, V7, DOI [10.1038/s41598-017-15589-x, 10.1038/s41598-017-10209-0]	23	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198614	10.1371/journal.pone.0198614	http://dx.doi.org/10.1371/journal.pone.0198614			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879176	Green Submitted, Green Published, gold			2022-12-26	WOS:000434384900061
J	Obonyo, M; Fidhow, A; Ofula, V				Obonyo, Mark; Fidhow, Ahmed; Ofula, Victor			Investigation of laboratory confirmed Dengue outbreak in North-eastern Kenya, 2011	PLOS ONE			English	Article							VIRUS-INFECTION; RISK-FACTORS; FEVER; SEROPREVALENCE; TRANSMISSION	The first laboratory confirmed dengue outbreak in Kenya was reported in coastal towns of Malindi and Kilifi in 1982. Since then, no other outbreak had been confirmed in Kenya. Dengue outbreak was confirmed among African Mission soldiers in Somalia (AMISOM) between May to October 2011. From September 2011, an upsurge of febrile patients who were negative for malaria on microscopy were reported in several health facilities in Mandera town, an adjacent area to Somalia in northern Kenya. We investigated a suspected dengue outbreak in Mandera town from 26th September 2011 to 5th October 2011. A suspected case was defined as acute onset of fever with two or more of the following: headache, arthralgia, myalgia, rash and hemorrhages and negative malaria microscopy results in a person presenting to a health facility in Mandera town from 1st August to 2nd October 2011. We prospectively identified new cases meeting the suspect case definition from 2nd October to 5th October 2011 and we collected blood samples from consenting patients. Blood was collected into plastic vacutainers and stored in dry shipper at-80 degrees c to laboratory for dengue virus testing using real time reverse transcriptase polymerase chain reaction (rRT-PCR). We administered a standardized form to obtain clinical information. We calculated descriptive statistics to describe the outbreak. A total of 1,332 patients had been line listed by the district surveillance team, of which 381 (29%) met our suspect case definition of dengue. Cases peaked between 10th September and 1st October 2011 and thereafter declined. We prospectively identified 33 cases meeting the suspect case definition, of whom 30 (91%) were positive for dengue virus serotype 3 by PCR. Among the 30 laboratory confirmed patients, 20 (67%) required hospitalization (Median hospitalization period, two days with a range: 1-4 days)). And of these, 26 (86%) patients reported aches and pain, 16 (53%) reported vomiting, and four (13%) gingival bleeding. Twenty-three (77%) received anti-malarial therapy. Among laboratory-confirmed dengue patients, seven (23%) had malaria co-infection. This was the second confirmed Dengue outbreak in Kenya, and highlighted the need for improved surveillance to better define disease burden and continuous education to medical personnel to improve detection and clinical management. We also recommended enhanced community education for disease prevention.	[Obonyo, Mark; Fidhow, Ahmed] Minist Publ Hlth & Sanitat, Kenya Field Epidemiol & Lab Training Program, Nairobi, Kenya; [Ofula, Victor] Kenya Govt Med Res Ctr, Ctr Virus Res, Arbovirol Viral Hemorrhag Fever Lab, Nairobi, Kenya	Kenya Medical Research Institute	Obonyo, M (corresponding author), Minist Publ Hlth & Sanitat, Kenya Field Epidemiol & Lab Training Program, Nairobi, Kenya.	mobonyo@feltp.or.ke			Kenya MoH, Field epidemiology and laboratory training program (KFELTP)	Kenya MoH, Field epidemiology and laboratory training program (KFELTP)	This investigations was funded by the Kenya MoH, Field epidemiology and laboratory training program (KFELTP). The KFELTP is a competency based program with mandate to build epidemiological capacity of Ministries of health and that of agriculture and irrigation by offering scholarships to employees within the two ministries to pursue a masters degree in field/applied epidemiology. Among the competencies needed to be achieved by the trainees is participating in an outbreak investigations in country or abroad. As at the time of the investigations, all the authors were trainees of the KFELTP. The KFELTP through its mentors assigned to the authors at that time of the investigation, assisted in designing the investigations and conducting preliminary analysis and generation of outbreak report. However the KFELTP had no role in data collection, decision to publish or preparation of the manuscript.	Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515; Baba M, 2016, REV MED VIROL, V26, P183, DOI 10.1002/rmv.1877; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blaylock JM, 2011, TRAVEL MED INFECT DI, V9, P246, DOI 10.1016/j.tmaid.2011.06.005; Boisier P, 1993, DENGUE 1 EPIDEMIC GR, P217; Bosa HK, 2014, INT J INFECT DIS, V21, P3, DOI 10.1016/j.ijid.2014.03.412; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Ellis EM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003733; Franco L, 2010, EUROSURVEILLANCE, V15, P5; JOHNSON BK, 1982, E AFR MED J, V59, P781; Kajeguka DC, 2017, INFECT DIS HEALTH, V22, P65, DOI 10.1016/j.idh.2017.04.005; Lutomiah J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004981; Mease LE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-371; METSELAAR D, 1980, B WORLD HEALTH ORGAN, V58, P937; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; Ndyomugyenyi R, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-39; Ochieng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132645; Programme for Research and Training in Tropical Diseases, 2009, Dengue: guidelines for diagnosis, treatment, prevention and control; Sang RC, 2007, DENGUE IN AFRICA; Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311; Toan DTT, 2015, EPIDEMIOL INFECT, V143, P1594, DOI 10.1017/S0950268814002647; Vairo F, 2012, INT J INFECT DIS, V16, pE44, DOI 10.1016/j.ijid.2011.09.018; Were F, 2012, PAEDIATR INT CHILD H, V32, P18, DOI 10.1179/2046904712Z.00000000048; WHO, 2011, HORN AFR HLTH EM RES; WHO, 2017, WEEK            0610, V24; Wijayanti SPM, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004964, 10.1371/journal.pntd.0004500]	26	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198556	10.1371/journal.pone.0198556	http://dx.doi.org/10.1371/journal.pone.0198556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879159	Green Submitted, Green Published, gold			2022-12-26	WOS:000434384900054
J	Shahrudin, S; Chen, C; David, SC; Singleton, EV; Davies, J; Kirkwood, CD; Hirst, TR; Beard, M; Alsharifi, M				Shahrudin, Shabihah; Chen, Cheng; David, Shannon C.; Singleton, Eve V.; Davies, Justin; Kirkwood, Carl D.; Hirst, Timothy R.; Beard, Michael; Alsharifi, Mohammed			Gamma-irradiated rotavirus: A possible whole virus inactivated vaccine	PLOS ONE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; DEVELOPING-COUNTRIES; IMMUNOGENICITY; INFECTION; CHILDREN; MICE; MONOVALENT; GASTROENTERITIS; PERFORMANCE; INFANTS	Rotavirus (RV) causes significant morbidity and mortality in developing countries, where children and infants are highly susceptible to severe disease symptoms. While live attenuated vaccines are available, reduced vaccine efficacy in developing countries illustrates the need for highly immunogenic alternative vaccines. Here, we studied the possible inactivation of RV using gamma(gamma)-irradiation, and assessed the sterility and immunogenicity of gamma irradiated RV (gamma-RV) as a novel vaccine candidate. Interestingly, the inactivation curve of RV did not show a log-linear regression following exposure to increased doses of gamma-rays, and consequently the radiation dose required to achieve the internationally accepted Sterility Assurance Level could not be calculated. Nonetheless, we performed sterility testing based on serial passages of gamma-RV, and our data clearly illustrate the lack of infectivity of gamma-RV preparations irradiated with 50 kGy. In addition, we tested the immunogenicity of 50 kGy gamma-RV in mice and our data illustrate the induction of strong RV-specific neutralising antibody responses following administration of gamma-RV without using adjuvant. Therefore, whilst gamma-RV may not constitute a replacement for current RV vaccines, this study represents a proof-of-concept that gamma-irradiation can be applied to inactivate RV for vaccine purposes. Further investigation will be required to address whether gamma-irradiation can be applied to improve safety and efficacy of existing live attenuated vaccines.	[Shahrudin, Shabihah; Chen, Cheng; David, Shannon C.; Singleton, Eve V.; Hirst, Timothy R.; Beard, Michael; Alsharifi, Mohammed] Univ Adelaide, Sch Biol Sci, Dept Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia; [Davies, Justin] Australian Nucl Sci & Technol Org, Lucas Heights, NSW, Australia; [Kirkwood, Carl D.] Murdoch Childrens Res Inst, Enter Virus Grp, Parkville, Vic, Australia; [Hirst, Timothy R.; Alsharifi, Mohammed] Gamma Vaccines Pty Ltd, Mountbatten Pk, Yarralumla, ACT, Australia	University of Adelaide; Australian Nuclear Science & Technology Organisation; Murdoch Children's Research Institute	Alsharifi, M (corresponding author), Univ Adelaide, Sch Biol Sci, Dept Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia.; Alsharifi, M (corresponding author), Gamma Vaccines Pty Ltd, Mountbatten Pk, Yarralumla, ACT, Australia.	mohammed.alsharifi@adelaide.edu.au	Beard, Michael/AAS-3477-2020; David, Shannon C./Y-5014-2019	Beard, Michael/0000-0002-4106-1016; David, Shannon C./0000-0003-3345-9443	Australian Institute of Nuclear Science and Engineering (Al NSE) [ALNGRA15517]	Australian Institute of Nuclear Science and Engineering (Al NSE)	Gamma-irradiation performed at ANSTO (Lucas Heights, New South Wales), supported by an Australian Institute of Nuclear Science and Engineering (Al NSE) Research Award (ALNGRA15517; awarded to MA). The authors have no conflicting financial interests. MA is head of the vaccine research group at the University of Adelaide and the Chief Scientific Officer of Gamma Vaccines Pty Ltd. TRH is an affiliated professor at the University of Adelaide and the Executive Chairman of Gamma Vaccines Pty Ltd. This does not alter adherence to policies on sharing data and materials. Gamma Vaccines Pty Ltd has no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Alsharifi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068458; Alsharifi M, 2010, IMMUNOL CELL BIOL, V88, P103, DOI 10.1038/icb.2009.81; Alsharifi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005336; Angel J, 2007, NAT REV MICROBIOL, V5, P529, DOI 10.1038/nrmicro1692; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Assis ASF, 2013, J PEDIAT-BRAZIL, V89, P470, DOI 10.1016/j.jped.2013.02.019; Babb R, 2016, CLIN SCI, V130, P697, DOI 10.1042/CS20150699; Babb R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00267; Bakare N, 2010, VACCINE, V28, P6609, DOI 10.1016/j.vaccine.2010.07.039; Blazevic V, 2011, VACCINE, V29, P8126, DOI 10.1016/j.vaccine.2011.08.026; Boom JA, 2010, PEDIATRICS, V125, pE199, DOI 10.1542/peds.2009-1021; Buttery JP, 2011, PEDIATR INFECT DIS J, V30, pS25, DOI 10.1097/INF.0b013e3181fefdee; Carlin JB, 2013, CLIN INFECT DIS, V57, P1427, DOI 10.1093/cid/cit520; Porta DC, 2016, VIROLOGY, V499, P65, DOI 10.1016/j.virol.2016.09.010; Collins AM, 2016, IMMUNOL CELL BIOL, V94, P949, DOI 10.1038/icb.2016.65; Conner ME, 1996, J INFECT DIS, V174, pS88, DOI 10.1093/infdis/174.Supplement_1.S88; David SC, 2017, VACCINE, V35, P1071, DOI 10.1016/j.vaccine.2016.12.044; ELLIOTT LH, 1982, J CLIN MICROBIOL, V16, P704, DOI 10.1128/JCM.16.4.704-708.1982; Emperador DM, 2016, CLIN INFECT DIS, V62, P150, DOI 10.1093/cid/civ807; Furuya Y, 2010, J VIROL, V84, P4212, DOI 10.1128/JVI.02508-09; Groome MJ, 2017, LANCET INFECT DIS, DOI [10.1371/journal.pone.0005336, DOI 10.1371/JOURNAL.PONE.0005336]; Hansen J.M., 2001, DISINFECTION STERILI, V5, P729; Hewitt P., 2014, GAMMA IRRADIATION TR; IAEA: Good radiation practice (GRP), 1990, GUID IND RAD STER DI; Jiang BM, 2008, HUM VACCINES, V4, P143, DOI 10.4161/hv.4.2.5263; Jiang BM, 2013, HUM VACC IMMUNOTHER, V9, P1634, DOI 10.4161/hv.24958; Jiang BM, 2008, VACCINE, V26, P6754, DOI 10.1016/j.vaccine.2008.10.008; Jiang BM, 1999, VACCINE, V17, P1005, DOI 10.1016/S0264-410X(98)00317-X; Jiang V, 2010, HUM VACCINES, V6, P532, DOI 10.4161/hv.6.7.11278; Kirkwood CD, 2017, VACCINE; Lee JT, 2008, J FORMOS MED ASSOC, V107, P791, DOI 10.1016/S0929-6646(08)60192-8; Lopman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041720; Luna RML, 2002, J VIROL, V76, P3202, DOI 10.1128/JVI.76.7.3202-3211.2002; MALLETT JC, 1991, J FOOD SAFETY, V11, P231, DOI 10.1111/j.1745-4565.1991.tb00055.x; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Patel M, 2012, VACCINE, V30, pA30, DOI 10.1016/j.vaccine.2011.11.093; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Patel MM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3726; Patel NC, 2010, NEW ENGL J MED, V362, P314, DOI 10.1056/NEJMoa0904485; Payne DC, 2010, PEDIATRICS, V125, pE438, DOI 10.1542/peds.2009-1901; Petrushina I, 2003, NEUROSCI LETT, V338, P5, DOI 10.1016/S0304-3940(02)01357-5; Ramig RF, 2004, J VIROL, V78, P10213, DOI 10.1128/JVI.78.19.10213-10220.2004; Shin S, 2012, VACCINE, V30, pA106, DOI 10.1016/j.vaccine.2011.11.091; Shui IM, 2012, JAMA-J AM MED ASSOC, V307, P598, DOI 10.1001/jama.2012.97; Staat MA, 2002, PEDIATR INFECT DIS J, V21, P221, DOI 10.1097/00006454-200203000-00012; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Vesikari T, 2006, J INFECT DIS, V194, P370, DOI 10.1086/505151; Vieira HLA, 2005, J BIOTECHNOL, V120, P72, DOI 10.1016/j.jbiotec.2005.03.026; Vogel FR, 2000, CLIN INFECT DIS, V30, pS266, DOI 10.1086/313883; Wang HP, 2012, VIRUS RES, V167, P48, DOI 10.1016/j.virusres.2012.04.001; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	51	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198182	10.1371/journal.pone.0198182	http://dx.doi.org/10.1371/journal.pone.0198182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879130	Green Published, gold			2022-12-26	WOS:000434384900026
J	Ramsingh, AI; Gray, SJ; Reilly, A; Koday, M; Bratt, D; Koday, MT; Murnane, R; Smedley, J; Hu, YH; Messer, A; Fuller, DH				Ramsingh, Arlene I.; Gray, Steven J.; Reilly, Andrew; Koday, Michael; Bratt, Debbie; Koday, Merika Treants; Murnane, Robert; Smedley, Jeremy; Hu, Yuhui; Messer, Anne; Fuller, Deborah Heydenburg			Sustained AAV9-mediated expression of a non-self protein in the CNS of non-human primates after immunomodulation	PLOS ONE			English	Article							GIANT AXONAL NEUROPATHY; CENTRAL-NERVOUS-SYSTEM; IMMUNE TOLERANCE; GENE DELIVERY; POMPE DISEASE; GIGAXONIN; PATHOGENESIS; RESTORATION; RECEPTOR; VECTORS	A critical issue in transgene delivery studies is immune reactivity to the transgene- encoded protein and its impact on sustained gene expression. Here, we test the hypothesis that immunomodulation by rapamycin can decrease immune reactivity after intrathecal AAV9 delivery of a transgene (GFP) in non-human primates, resulting in sustained GFP expression in the CNS. We show that rapamycin treatment clearly reduced the overall immunogenicity of the AAV9/GFP vector by lowering GFP- and AAV9-specific antibody responses, and decreasing T cell responses including cytokine and cytolytic effector responses. Spinal cord GFP protein expression was sustained for twelve weeks, with no toxicity. Immune correlates of robust transgene expression include negligible GFP-specific CD4 and CD8 T cell responses, absence of GFP-specific IFN-gamma producing T cells, and absence of GFP-specific cytotoxic T cells, which support the hypothesis that decreased T cell reactivity results in sustained transgene expression. These data strongly support the use of modest doses of rapamycin to modulate immune responses for intrathecal gene therapies, and potentially a much wider range of viral vector-based therapeutics.	[Ramsingh, Arlene I.] NYVAX Inc, Miami, FL USA; [Gray, Steven J.; Hu, Yuhui] Univ North Carolina Chapel Hill, Gene Therapy Ctr, Chapel Hill, NC USA; [Gray, Steven J.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX USA; [Reilly, Andrew] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Koday, Michael; Bratt, Debbie; Murnane, Robert; Smedley, Jeremy; Fuller, Deborah Heydenburg] Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; [Koday, Merika Treants; Fuller, Deborah Heydenburg] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Messer, Anne] Neural Stem Cell Inst, Rensselaer, NY USA; [Reilly, Andrew] Delmar, New York, NY USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; State University of New York (SUNY) System; Wadsworth Center; University of Washington; University of Washington Seattle	Fuller, DH (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	fullerdh@wanprc.org	Bratt, Debra/B-1106-2019; , Pathology Services Core/CEZ-2246-2022; Core, Vector/CAF-4832-2022	Smedley, Jeremy/0000-0003-3369-4662; Fuller, Deborah/0000-0001-7315-2441	Hannah's Hope Fund; National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01 NS087175]; National Institutes of Health [P51-0D010425]; National Cancer Institute [3P30CA016086]; UNC University Cancer Research Fund (UCRF); NCI Center Core Support [CA16086]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087175] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	Hannah's Hope Fund; National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UNC University Cancer Research Fund (UCRF); NCI Center Core Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors wish to acknowledge financial support from Hannah's Hope Fund, along with National Institutes of Health/National Institute of Neurological Disorders and Stroke R01 NS087175 (to S.G.) and National Institutes of Health/P51-0D010425 (to WaNPRC via D.H.F. allocation). Indirect administrative support for S.G. was provided by Research to Prevent Blindness to the UNC-CH Department of Ophthalmology. We acknowledge the use of resources at the UNC Translational Pathology Laboratory, which is supported, in part, by grants from the National Cancer Institute (3P30CA016086) and the UNC University Cancer Research Fund (UCRF). Arlene I. Ramsingh is affiliated to NYVAX Inc. but is not a paid employee of NYVAX Inc. which is in the early stage of a start-up. NYVAX Inc. did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; We thank Rachel Bailey, Mary Keener, Clifford Heindel, and Violeta Zaric (UNC) for technical support. We also thank the Department of Primate Resources and Research Services Group at the Washington National Primate Research Center for excellent veterinary support for the procedures and animal care. We acknowledge the use of resources at the UNC Translational Pathology Laboratory which is supported, in part, by an NCI Center Core Support Grant (CA16086) to the UNC Lineberger Comprehensive Cancer Center.	Araki K, 2011, CURR OPIN CELL BIOL, V23, P707, DOI 10.1016/j.ceb.2011.08.006; Demir E, 2005, J NEUROL NEUROSUR PS, V76, P825, DOI 10.1136/jnnp.2003.035162; Doerfler PA, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2015.53; Doerfler PA, 2016, HUM GENE THER, V27, P43, DOI 10.1089/hum.2015.103; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Gray SJ, 2013, GENE THER, V20, P450, DOI 10.1038/gt.2012.101; Grieger JC, 2016, MOL THER, V24, P287, DOI 10.1038/mt.2015.187; Hinderer C, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.51; Jabri B, 2015, NAT REV IMMUNOL, V15, P771, DOI 10.1038/nri3919; Johnson-Kerner BL, 2015, HUM MOL GENET, V24, P1420, DOI 10.1093/hmg/ddu556; Johnson-Kerner BL, 2014, MUSCLE NERVE, V50, P467, DOI 10.1002/mus.24321; Kang JJ, 2016, HUM GENET, V135, P675, DOI 10.1007/s00439-016-1659-5; Kantor B, 2014, ADV GENET, V87, P125, DOI 10.1016/B978-0-12-800149-3.00003-2; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Mingozzi F, 2017, ANNU REV VIROL, V4, P511, DOI 10.1146/annurev-virology-101416-041936; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mussche S, 2013, HUM GENE THER, V24, P209, DOI 10.1089/hum.2012.107; PENA SDJ, 1983, EUR J CELL BIOL, V31, P227; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Rajendran L, 2014, J NEUROSCI, V34, P15482, DOI 10.1523/JNEUROSCI.3258-14.2014; Samaranch L, 2014, MOL THER, V22, P329, DOI 10.1038/mt.2013.266; Schlom J, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22546; Sochocka M, 2017, MOL NEUROBIOL, V54, P8071, DOI 10.1007/s12035-016-0297-1; Soehnlein O, 2017, NAT REV IMMUNOL, V17, P248, DOI 10.1038/nri.2017.10; Spulber S, 2009, BRAIN BEHAV IMMUN, V23, P573, DOI 10.1016/j.bbi.2009.02.015; Sun L, 2015, CYTOKINE, V75, P249, DOI 10.1016/j.cyto.2015.01.030; Takatsu K, 2011, P JPN ACAD B-PHYS, V87, P463, DOI 10.2183/pjab.87.463; Tardieu M, 2017, LANCET NEUROL, V16, P712, DOI 10.1016/S1474-4422(17)30169-2; Tornoe J, 2002, GENE, V297, P21, DOI 10.1016/S0378-1119(02)00878-8; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	31	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198154	10.1371/journal.pone.0198154	http://dx.doi.org/10.1371/journal.pone.0198154			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874260	Green Published, gold, Green Submitted			2022-12-26	WOS:000434369400042
J	Hosford, CJ; Chappie, JS				Hosford, Christopher J.; Chappie, Joshua S.			The crystal structure of the Helicobacter pylori LlaJI.R1 N-terminal domain provides a model for site-specific DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RESTRICTION-ENDONUCLEASE; SHORT HISTORY; B3 DOMAIN; MCRBC; PROTEIN; RECOGNITION; ENZYME; MECHANISM; REVEALS; SYSTEM	Restriction modification systems consist of an endonuclease that cleaves foreign DNA site-specifically and an associated methyltransferase that protects the corresponding target site in the host genome. Modification-dependent restriction systems, in contrast, specifically recognize and cleave methylated and/or glucosylated DNA. The LlaJI restriction system contains two 5-methylcytosine (5mC) methyltransferases (LlaJI.M1 and LlaJI.M2) and two restriction proteins (LlaJI.R1 and LlaJI.R2). LlaJI.R1 and LlaJI.R2 are homologs of McrB and McrC, respectively, which in Escherichia coli function together as a modification-dependent restriction complex specific for 5mC-containing DNA. Lactococcus lactis LlaJI.R1 binds DNA site-specifically, suggesting that the LlaJI system uses a different mode of substrate recognition. Here we present the structure of the N-terminal DNA-binding domain of Helicobacter pylori LlaJI.R1 at 1.97- resolution, which adopts a B3 domain fold. Structural comparison to B3 domains in plant transcription factors and other restriction enzymes identifies key recognition motifs responsible for site-specific DNA binding. Moreover, biochemistry and structural modeling provide a rationale for how H. pylori LlaJI.R1 may bind a target site that differs from the 5-bp sequence recognized by other LlaJI homologs and identify residues critical for this recognition activity. These findings underscore the inherent structural plasticity of B3 domains, allowing recognition of a variety of substrates using the same structural core.	[Hosford, Christopher J.; Chappie, Joshua S.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Chappie, JS (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	chappie@cornell.edu	Chappie, Joshua S./AAV-6076-2021	Chappie, Joshua S./0000-0002-5733-7275	National Institutes of Health [P41 GM103403]; National Institutes of Health-ORIP HEI Grant [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120242, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health-ORIP HEI Grant; DOE Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank April Lee for assistance with initial crystallization experiments, the Northeastern Collaborative Access Team (NE-CAT) beamline staff at the Advanced Photon Source (APS) for assistance with remote X-ray data collection, Dr. Holger Sondermann for critical reading of the manuscript and use of his SEC-MALS instrument, Dr. John O'Donnell for assistance with SEC-MALS data analysis, and Dr. Eric Alani and Dr. Carol Manhart for guidance and assistance with filter binding experiments. This work is based upon research conducted at the NE-CAT beamlines (24-ID-C and 24-ID-E) under the General User Proposals GUP-51113 and GUP-41829 (PI: J. S. C). NE-CAT is funded by National Institutes of Health program project Grant P41 GM103403. The Pilatus 6M detector on 24-ID-C beam line is funded by National Institutes of Health-ORIP HEI Grant S10 RR029205. This research used resources of the Advanced Photon Source, a U.S. Dept. of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bair CL, 2007, J MOL BIOL, V366, P779, DOI 10.1016/j.jmb.2006.11.049; Borgaro JG, 2013, NUCLEIC ACIDS RES, V41, P4198, DOI 10.1093/nar/gkt102; Cohen-Karni D, 2011, P NATL ACAD SCI USA, V108, P11040, DOI 10.1073/pnas.1018448108; Deo RC, 2002, CELL, V108, P71, DOI 10.1016/S0092-8674(01)00632-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gast FU, 1997, BIOL CHEM, V378, P975, DOI 10.1515/bchm.1997.378.9.975; Golovenko D, 2014, NUCLEIC ACIDS RES, V42, P4113, DOI 10.1093/nar/gkt1368; Golovenko D, 2009, NUCLEIC ACIDS RES, V37, P6613, DOI 10.1093/nar/gkp699; Grazulis S, 2005, P NATL ACAD SCI USA, V102, P15797, DOI 10.1073/pnas.0507949102; Hendrickson WA, 2014, Q REV BIOPHYS, V47, P49, DOI 10.1017/S0033583514000018; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horton JR, 2014, NUCLEIC ACIDS RES, V42, P12092, DOI 10.1093/nar/gku871; Horton JR, 2014, NUCLEIC ACIDS RES, V42, P7947, DOI 10.1093/nar/gku497; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kazrani AA, 2014, NUCLEIC ACIDS RES, V42, P5929, DOI 10.1093/nar/gku186; King GJ, 2013, J BIOL CHEM, V288, P3198, DOI 10.1074/jbc.M112.438572; KRUGER T, 1995, EMBO J, V14, P2661, DOI 10.1002/j.1460-2075.1995.tb07264.x; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P20, DOI 10.1093/nar/gkt847; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P3, DOI 10.1093/nar/gkt990; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P56, DOI 10.1093/nar/gkt747; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEISEL A, 1992, NATURE, V355, P467, DOI 10.1038/355467a0; Mulligan EA, 2010, NUCLEIC ACIDS RES, V38, P1997, DOI 10.1093/nar/gkp1120; O'Driscoll J, 2005, MOL MICROBIOL, V57, P1532, DOI 10.1111/j.1365-2958.2005.04769.x; O'Driscoll J, 2004, APPL ENVIRON MICROB, V70, P5546, DOI 10.1128/AEM.70.9.5546-5556.2004; O'Driscoll J, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-40; Panne D, 1999, J MOL BIOL, V290, P49, DOI 10.1006/jmbi.1999.2894; Panne D, 2001, EMBO J, V20, P3210, DOI 10.1093/emboj/20.12.3210; Pieper U, 2002, BIOCHEMISTRY-US, V41, P5236, DOI 10.1021/bi0156862; Pieper U, 2002, BIOCHEMISTRY-US, V41, P5245, DOI 10.1021/bi015687u; Pieper U, 1999, BIOL CHEM, V380, P1225, DOI 10.1515/BC.1999.155; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Pingoud A, 2014, NUCLEIC ACIDS RES, V42, P7489, DOI 10.1093/nar/gku447; Raghavendra NK, 2012, FRONT BIOSCI-LANDMRK, V17, P1094, DOI 10.2741/3975; RALEIGH EA, 1986, P NATL ACAD SCI USA, V83, P9070, DOI 10.1073/pnas.83.23.9070; Boer DR, 2014, CELL, V156, P577, DOI 10.1016/j.cell.2013.12.027; Sasnauskas G, 2017, NUCLEIC ACIDS RES, V45, P9583, DOI 10.1093/nar/gkx634; Shao C, 2014, ACTA CRYSTALLOGR D, V70, P2477, DOI 10.1107/S139900471401606X; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stewart FJ, 2000, J MOL BIOL, V298, P611, DOI 10.1006/jmbi.2000.3697; Sukackaite R, 2012, NUCLEIC ACIDS RES, V40, P7552, DOI 10.1093/nar/gks332; SUTHERLAND E, 1992, J MOL BIOL, V225, P327, DOI 10.1016/0022-2836(92)90925-A; Swaminathan K, 2008, TRENDS PLANT SCI, V13, P647, DOI 10.1016/j.tplants.2008.09.006; Tamulaitiene G, 2014, NUCLEIC ACIDS RES, V42, P14022, DOI 10.1093/nar/gku1237; Waltner JK, 2005, PROTEIN SCI, V14, P2478, DOI 10.1110/ps.051606305; Yamasaki K, 2004, PLANT CELL, V16, P3448, DOI 10.1105/tpc.104.026112; Yamasaki K, 2013, TRENDS PLANT SCI, V18, P267, DOI 10.1016/j.tplants.2012.09.001; Yang XR, 2016, APPL MICROBIOL BIOT, V100, P2289, DOI 10.1007/s00253-015-7141-9; Zhou XYE, 2004, J MOL BIOL, V335, P307, DOI 10.1016/j.jmb.2003.10.030	53	4	4	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11758	11771		10.1074/jbc.RA118.001888	http://dx.doi.org/10.1074/jbc.RA118.001888			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29895618	Green Published, hybrid			2022-12-26	WOS:000440134500009
J	Jin, TC; Brefo-Mensah, E; Fan, WR; Zeng, WH; Li, YJ; Zhang, YZ; Palmer, M				Jin, Tengchuan; Brefo-Mensah, Eric; Fan, Weirong; Zeng, Weihong; Li, Yajuan; Zhang, Yuzhu; Palmer, Michael			Crystal structure of the Streptococcus agalactiae CAMP factor provides insights into its membrane-permeabilizing activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCUS; PORE-FORMING TOXIN; X-RAY-DIFFRACTION; ESCHERICHIA-COLI; DIPHTHERIA-TOXIN; GPI ANCHORS; FACTOR GENE; PROTEIN; EXPRESSION; DOMAIN	Streptococcus agalactiae is an important human opportunistic pathogen that can cause serious health problems, particularly among newborns and older individuals. S. agalactiae contains the CAMP factor, a pore-forming toxin first identified in this bacterium. The CAMP reaction is based on the co-hemolytic activity of the CAMP factor and is commonly used to identify S. agalactiae in the clinic. Closely related proteins are present also in other Gram-positive pathogens. Although the CAMP toxin was discovered more than a half century ago, no structure from this toxin family has been reported, and the mechanism of action of this toxin remains unclear. Here, we report the first structure of this toxin family, revealing a structural fold composed of 5 + 3-helix bundles. Further analysis by protein truncation and site-directed mutagenesis indicated that the N-terminal 5-helix bundle is responsible for membrane permeabilization, whereas the C-terminal 3-helix bundle is likely responsible for host receptor binding. Interestingly, the C-terminal domain inhibited the activity of both full-length toxin and its N-terminal domain. Moreover, we observed that the linker region is highly conserved and has a conserved DLXXXDXAT sequence motif. Structurally, this linker region extensively interacted with both terminal CAMP factor domains, and mutagenesis disclosed that the conserved sequence motif is required for CAMP factor's co-hemolytic activity. In conclusion, our results reveal a unique structure of this bacterial toxin and help clarify the molecular mechanism of its co-hemolytic activity.	[Jin, Tengchuan; Zeng, Weihong; Li, Yajuan] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Innate Immun & Chron Dis, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Jin, Tengchuan; Zeng, Weihong; Li, Yajuan] Univ Sci & Technol China, Med Ctr, Hefei 230027, Anhui, Peoples R China; [Brefo-Mensah, Eric; Palmer, Michael] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada; [Fan, Weirong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, South Campus, Shanghai 201400, Peoples R China; [Zhang, Yuzhu] USDA ARS, Hlth Proc Foods Res Unit, Western Reg Res Ctr, Albany, CA 94706 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Waterloo; Shanghai Jiao Tong University; United States Department of Agriculture (USDA)	Jin, TC (corresponding author), Univ Sci & Technol China, Med Ctr, Hefei 230027, Anhui, Peoples R China.; Jin, TC (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China.	jint@ustc.edu.cn	Zhang, Yuzhu/C-3606-2014; Jin, Tengchuan/B-5883-2014	Zhang, Yuzhu/0000-0001-7882-5692; Jin, Tengchuan/0000-0002-1395-188X; Brefo-Mensah, Eric K./0000-0002-9747-0185	Fundamental Research Funds for the Central Universities Grant [WK2070000108, WK2070000097]; 100 Talents Programme of the Chinese Academy of Sciences; National Natural Science Fund for Young Scholars Grant [31600598]; China Postdoctoral Science Foundation Grant [2015M582007]; Tenth Batch Special Support of China Postdoctoral Science Foundation Grant [2015T100454]; Canadian Natural Sciences and Engineering Research Council (NSERC) Grant [250265-2013]	Fundamental Research Funds for the Central Universities Grant(Fundamental Research Funds for the Central Universities); 100 Talents Programme of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Fund for Young Scholars Grant; China Postdoctoral Science Foundation Grant(China Postdoctoral Science Foundation); Tenth Batch Special Support of China Postdoctoral Science Foundation Grant; Canadian Natural Sciences and Engineering Research Council (NSERC) Grant	Supported by Fundamental Research Funds for the Central Universities Grant WK2070000108 and by the 100 Talents Programme of the Chinese Academy of Sciences.; Supported by National Natural Science Fund for Young Scholars Grant 31600598, China Postdoctoral Science Foundation Grant 2015M582007, Tenth Batch Special Support of China Postdoctoral Science Foundation Grant 2015T100454, and Fundamental Research Funds for the Central Universities Grant WK2070000097.; Supported by Canadian Natural Sciences and Engineering Research Council (NSERC) Grant 250265-2013.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Andreeva A, 2014, NUCLEIC ACIDS RES, V42, pD310, DOI 10.1093/nar/gkt1242; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christie R. N. E. Atkins, 1944, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V22, P197; Collins MD, 2000, INT J SYST EVOL MICR, V50, P1173, DOI 10.1099/00207713-50-3-1173; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; Doxey AC, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-23; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAGER RS, 1973, ANAL BIOCHEM, V53, P290, DOI 10.1016/0003-2697(73)90433-8; Ferguson M. A. J., 2015, ESSENTIALS GLYCOBIOL, P137; Gao J, 2017, CHEM COMMUN, V53, P6227, DOI 10.1039/c7cc03056h; Gase K, 1999, INFECT IMMUN, V67, P4725, DOI 10.1128/IAI.67.9.4725-4731.1999; Gatsogiannis C, 2016, NAT STRUCT MOL BIOL, V23, P884, DOI 10.1038/nsmb.3281; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grandjean F, 2007, PATHOL BIOL, V55, P407, DOI 10.1016/j.patbio.2007.07.008; Hagemans D, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00056; Hensler ME, 2008, MICROB PATHOGENESIS, V44, P84, DOI 10.1016/j.micpath.2007.08.005; Herrmann LM, 1997, PROTEIN SCI, V6, P657; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jiang M, 1996, MICROB PATHOGENESIS, V20, P297, DOI 10.1006/mpat.1996.0028; Jin T, 2008, J AGR FOOD CHEM, V56, P8159, DOI 10.1021/jf801138q; Jin TC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40991; Jin TC, 2013, J BIOL CHEM, V288, P13225, DOI 10.1074/jbc.M113.468033; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kaul P, 1996, PROTEIN SCI, V5, P687; Kienker PK, 1997, J MEMBRANE BIOL, V157, P27, DOI 10.1007/s002329900213; Kinoshita T, 2016, J LIPID RES, V57, P4, DOI 10.1194/jlr.E065417; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lang SH, 2003, J BIOL CHEM, V278, P38167, DOI 10.1074/jbc.M303544200; Lang SH, 2007, MED MICROBIOL IMMUN, V196, P1, DOI 10.1007/s00430-006-0021-2; Liu GJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-775; Liu L, 2014, J FISH DIS, V37, P1067, DOI 10.1111/jfd.12187; Malik Adeel, 2010, Advances in Bioinformatics, V2010, P436036, DOI 10.1155/2010/436036; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Mweu MM, 2014, PREV VET MED, V113, P219, DOI 10.1016/j.prevetmed.2013.10.020; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Ren JH, 1999, BIOCHEMISTRY-US, V38, P976, DOI 10.1021/bi981576s; SCHNEEWIND O, 1988, INFECT IMMUN, V56, P2174, DOI 10.1128/IAI.56.8.2174-2179.1988; Shabayek S, 2010, INDIAN J MED MICROBI, V28, P320, DOI 10.4103/0255-0857.71821; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Shome BR, 2012, TROP ANIM HEALTH PRO, V44, P1981, DOI 10.1007/s11250-012-0167-4; Sillitoe I, 2015, NUCLEIC ACIDS RES, V43, pD376, DOI 10.1093/nar/gku947; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Valanne S, 2005, MICROBIOL-SGM, V151, P1369, DOI 10.1099/mic.0.27788-0; van Montfort BA, 2001, J BIOL CHEM, V276, P12756, DOI 10.1074/jbc.M010728200; van Pee K, 2017, ELIFE, V6, DOI 10.7554/eLife.23644; Verani J.R., 2010, PREVENTION PERINATAL; Wu XM, 2008, CARBOHYD RES, V343, P1718, DOI 10.1016/j.carres.2008.03.033; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Zhao HY, 2014, J COMPUT CHEM, V35, P2177, DOI 10.1002/jcc.23730	56	9	9	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11867	11877		10.1074/jbc.RA118.002336	http://dx.doi.org/10.1074/jbc.RA118.002336			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29884770	hybrid, Green Published			2022-12-26	WOS:000440134500019
J	Alves, BG; Alves, KA; Gastal, GDA; Gastal, MO; Figueiredo, JR; Gastal, EL				Alves, Benner G.; Alves, Kele A.; Gastal, Gustavo D. A.; Gastal, Melba O.; Figueiredo, Jose R.; Gastal, Eduardo L.			Spatial distribution of preantral follicles in the equine ovary	PLOS ONE			English	Article							PICK-UP METHOD; INTERNAL STRUCTURE MICROSCOPY; PRE-ANTRAL FOLLICLES; BIOPSY FRAGMENTS; DENSITY; QUANTIFICATION; VIABILITY; TISSUE	Comprehensive studies on spatial distribution of preantral follicles in the ovary are scarce. Considering that preantral follicles represent the main ovarian reserve, harvesting of these follicles is crucial for the development/use of assisted reproductive techniques. Therefore, knowledge on follicle spatial distribution can be helpful for targeting areas with richer number of preantral follicles through biopsy procedures. The aim of this study was to assess the distribution and localization of equine preantral follicles according to: (i) age, (ii) ovarian portion (lateral and intermediary) and region (dorsal and ventral), (iii) distance from the geometric center, and (iv) follicular class. Ovaries from young and old mares (n = 8) were harvested in a slaughterhouse and submitted to histological processing for further evaluation. For data analyses, a novel methodology was developed according to the geometric center of each histological section for a precise determination of preantral follicle distribution. Results indicated that (i) equine preantral follicles are clustered and located near to the ovarian geometric center, and that aging induced their dispersion through the ovarian cortex; (ii) the distance from the geometric center was shorter for developing follicles than primordial; and (iii) secondary follicles were more distant from the geometric center but closer to the ovulation fossa. In conclusion, the spatial distribution of preantral follicles was successfully determined in the equine ovary and was affected by age, region, and portion.	[Alves, Benner G.; Alves, Kele A.; Gastal, Gustavo D. A.; Gastal, Melba O.; Gastal, Eduardo L.] Southern Illinois Univ, Dept Anim Sci Food & Nutr, Carbondale, IL 62901 USA; [Figueiredo, Jose R.] Univ Estadual Ceara, Lab Manipulat Oocytes & Preantral Follicles LAMOF, Fortaleza, Ceara, Brazil	Southern Illinois University System; Southern Illinois University; Universidade Estadual do Ceara	Gastal, EL (corresponding author), Southern Illinois Univ, Dept Anim Sci Food & Nutr, Carbondale, IL 62901 USA.	egastal@siu.edu	Alves, Benner/D-3599-2014; Alves, Kele Amaral A/P-8422-2015; Gastal, Eduardo Leite/Q-9854-2017; Gastal, Gustavo Desire Antunes/K-7424-2013; Gastal, Eduardo Leite/O-8359-2019	Alves, Benner/0000-0001-9465-8054; Alves, Kele Amaral A/0000-0001-7359-3570; Gastal, Eduardo Leite/0000-0002-8855-6980; Gastal, Gustavo Desire Antunes/0000-0002-5317-2207; Gastal, Eduardo Leite/0000-0002-8855-6980; Figueiredo, Jose Ricardo/0000-0002-5139-0964	Southern Illinois University (SIU), USA; Coordination for the Improvement of Higher Education Personnel (CAPES) [88881.064955/2014-01]; National Council for Scientific and Technological Development (CNPq)	Southern Illinois University (SIU), USA; Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Research was supported by Southern Illinois University (SIU), USA, and Coordination for the Improvement of Higher Education Personnel (CAPES; Special Visiting Researcher Grant #88881.064955/2014-01). K. A. Alves and G. D. A. Gastal were the recipients of PhD sandwich and PhD scholarships, respectively; and B. G. Alves had a post-doctoral fellowship from The National Council for Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts J, 2008, REPROD DOMEST ANIM, V43, P360, DOI 10.1111/j.1439-0531.2007.00915.x; Alves KA, 2017, REPROD FERT DEVELOP, V29, P867, DOI 10.1071/RD15402; Alves KA, 2015, THERIOGENOLOGY, V83, P1048, DOI 10.1016/j.theriogenology.2014.12.004; Alves KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149693; Brandao FAS, 2018, THERIOGENOLOGY, V107, P219, DOI 10.1016/j.theriogenology.2017.10.042; Childs AJ, 2010, STEM CELLS, V28, P1368, DOI 10.1002/stem.440; Dath C, 2010, HUM REPROD, V25, P1734, DOI 10.1093/humrep/deq131; Fabbri R, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/910698; Faire M, 2015, DEV BIOL, V403, P69, DOI 10.1016/j.ydbio.2015.04.006; Fransolet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091073; Gastal GDA, 2017, J EQUINE VET SCI, V53, P86, DOI 10.1016/j.jevs.2016.03.014; Gaytan F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144099; Ginther O.J., 1992, REPROD BIOL MARE BAS; Gleicher N, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-23; Gonzalez SM, 2017, REPROD DOMEST ANIM, V52, P836, DOI 10.1111/rda.12986; Haag KT, 2013, THERIOGENOLOGY, V79, P735, DOI 10.1016/j.theriogenology.2012.10.023; Haag KT, 2013, THERIOGENOLOGY, V79, P599, DOI 10.1016/j.theriogenology.2012.11.012; Hsueh AJW, 2015, ENDOCR REV, V36, P1, DOI 10.1210/er.2014-1020; Kimura J, 2001, ANAT HISTOL EMBRYOL, V30, P309, DOI 10.1046/j.1439-0264.2001.00335.x; Kimura J, 2009, J VET SCI, V10, P161, DOI 10.4142/jvs.2009.10.2.161; Kristensen SG, 2011, HUM REPROD, V26, P157, DOI 10.1093/humrep/deq318; Malhi PS, 2005, BIOL REPROD, V73, P45, DOI 10.1095/biolreprod.104.038745; Malki S, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132118; Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005; Ono M, 2015, J VET MED SCI, V77, P1599, DOI 10.1292/jvms.14-0539; Riley SC, 2001, REPRODUCTION, V121, P553, DOI 10.1530/reprod/121.4.553; Schmidt KLT, 2003, HUM REPROD, V18, P1158, DOI 10.1093/humrep/deg246; Silva-Santos KC, 2011, THERIOGENOLOGY, V76, P1051, DOI 10.1016/j.theriogenology.2011.05.008; Thorne JT, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.121368; van den Hurk R, 2005, THERIOGENOLOGY, V63, P1717, DOI 10.1016/j.theriogenology.2004.08.005; Walt M L, 1979, J Reprod Fertil Suppl, P471; Woodruff TK, 2011, J ASSIST REPROD GEN, V28, P3, DOI 10.1007/s10815-010-9478-4; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046	33	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198108	10.1371/journal.pone.0198108	http://dx.doi.org/10.1371/journal.pone.0198108			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897931	gold, Green Published, Green Submitted			2022-12-26	WOS:000435090700044
J	Dainer-Best, J; Disner, SG; McGeary, JE; Hamilton, BJ; Beevers, CG				Dainer-Best, Justin; Disner, Seth G.; McGeary, John E.; Hamilton, Bethany J.; Beevers, Christopher G.			Negative self-referential processing is associated with genetic variation in the serotonin transporter-linked polymorphic region (5-HTTLPR): Evidence from two independent studies	PLOS ONE			English	Article							PROMOTER REGION; PSYCHOPHYSIOLOGICAL ENDOPHENOTYPES; COGNITIVE VULNERABILITY; BIASED ATTENTION; CANDIDATE GENE; INFORMATION; DEPRESSION; MODEL; CHILDREN; REAPPRAISAL	The current research examined whether carriers of the short 5-HTTLPR allele (in SLC6A4), who have been shown to selectively attend to negative information, exhibit a bias towards negative self-referent processing. The self-referent encoding task (SRET) was used to measure self-referential processing of positive and negative adjectives. Ratcliff's diffusion model isolated and extracted decision-making components from SRET responses and reaction times. Across the initial (N = 183) and replication (N = 137) studies, results indicated that short 5-HTTLPR allele carriers more easily categorized negative adjectives as self-referential (i.e., higher drift rate). Further, drift rate was associated with recall of negative self-referential stimuli. Findings across both studies provide further evidence that genetic variation may contribute to the etiology of negatively biased processing of self-referent information. Large scale studies examining the genetic contributions to negative self-referent processing may be warranted.	[Dainer-Best, Justin; Disner, Seth G.; Hamilton, Bethany J.; Beevers, Christopher G.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Dainer-Best, Justin; Disner, Seth G.; Beevers, Christopher G.] Univ Texas Austin, Inst Mental Hlth Res, Austin, TX 78712 USA; [McGeary, John E.] Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [McGeary, John E.] Providence Vet Affairs Med Ctr, Providence, RI USA; [Disner, Seth G.] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Dainer-Best, J (corresponding author), Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA.; Dainer-Best, J (corresponding author), Univ Texas Austin, Inst Mental Hlth Res, Austin, TX 78712 USA.	dainerbest@utexas.edu	Beevers, Christopher/Z-1965-2019; Disner, Seth/S-8441-2019	Beevers, Christopher/0000-0002-4480-0902; Dainer-Best, Justin/0000-0002-1868-0337	NIDA [DA032457]; NIMH [MH108650]; NIH [1R01AA025593]; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH108650] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIDA (drugabuse.gov) grant DA032457 to CGB, NIMH (nimh.nih.gov) grant MH108650 to CGB and JEM, and NIH (nih.gov) grant 1R01AA025593 to JEM. This material is also the result of work supported with resources and the use of facilities at the Providence Veterans Affairs Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloy LB, 1997, COGNITION EMOTION, V11, P539, DOI 10.1080/026999397379854a; Anokhin AP, 2003, NEUROREPORT, V14, P1975, DOI 10.1097/00001756-200310270-00019; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; Beevers CG, 2009, J ABNORM PSYCHOL, V118, P670, DOI 10.1037/a0016198; Caspi Avshalom, 2010, Am J Psychiatry, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Chabris CF, 2015, CURR DIR PSYCHOL SCI, V24, P304, DOI 10.1177/0963721415580430; Dainer- Best J, PSYCHOL ASSESS; Dannlowski U, 2010, NEUROIMAGE, V53, P893, DOI 10.1016/j.neuroimage.2009.11.073; DAVIS H, 1979, COGNITIVE THER RES, V3, P97, DOI 10.1007/BF01172724; De Raedt R, 2010, COGN AFFECT BEHAV NE, V10, P50, DOI 10.3758/CABN.10.1.50; DERRY PA, 1981, J ABNORM PSYCHOL, V90, P286, DOI 10.1037/0021-843X.90.4.286; Devins G.M., 1988, PSYCHOL HLTH, V2, P139, DOI [10.1080/08870448808400349, DOI 10.1080/08870448808400349]; Disner SG, 2017, COGNITION EMOTION, V31, P632, DOI 10.1080/02699931.2016.1146123; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; DOBSON KS, 1987, J ABNORM PSYCHOL, V96, P34, DOI 10.1037/0021-843X.96.1.34; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Fleurkens P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193787; Freeman B, 1997, BEHAV GENET, V27, P251, DOI 10.1023/A:1025614231190; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Gibb BE, 2013, COGNITION EMOTION, V27, P193, DOI 10.1080/02699931.2012.712950; Gotlib IH, 1998, BEHAV THER, V29, P603, DOI 10.1016/S0005-7894(98)80020-8; Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Hayden EP, 2008, J AFFECT DISORDERS, V107, P227, DOI 10.1016/j.jad.2007.07.028; Hewitt JK, 2012, BEHAV GENET, V42, P1, DOI 10.1007/s10519-011-9504-z; Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62; Iacono WG, 2014, PSYCHOPHYSIOLOGY, V51, P1339, DOI 10.1111/psyp.12358; Iacono WG, 2014, PSYCHOPHYSIOLOGY, V51, P1207, DOI 10.1111/psyp.12343; Lau JYF, 2006, J CHILD PSYCHOL PSYC, V47, P696, DOI 10.1111/j.1469-7610.2005.01532.x; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Lee T, 2012, BEHAV GENET, V42, P528, DOI 10.1007/s10519-012-9526-1; LENCH N, 1988, LANCET, V1, P1356; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Loken E, 2017, SCIENCE, V355, P584, DOI 10.1126/science.aal3618; Malone SM, 2014, PSYCHOPHYSIOLOGY, V51, P1246, DOI 10.1111/psyp.12345; MEULENBELT I, 1995, AM J HUM GENET, V57, P1252; Moore MN, 2013, CLIN PSYCHOL SCI, V1, P316, DOI 10.1177/2167702612472884; Neshat-Doost HT, 1999, PERS INDIV DIFFER, V27, P433; Okbay A, 2015, EMOTION, V15, P531, DOI 10.1037/emo0000076; Perez-Edgar K, 2010, BIOL PSYCHOL, V83, P269, DOI 10.1016/j.biopsycho.2009.08.009; Pergamin-Hight L, 2012, BIOL PSYCHIAT, V71, P373, DOI 10.1016/j.biopsych.2011.10.030; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Rodebaugh TL, 2016, J ABNORM PSYCHOL, V125, P840, DOI 10.1037/abn0000184; Sakakibara E, 2014, NEUROIMAGE, V85, P508, DOI 10.1016/j.neuroimage.2013.03.052; SEGAL ZV, 1988, PSYCHOL BULL, V103, P147, DOI 10.1037/0033-2909.103.2.147; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Spitz E, 1996, BEHAV GENET, V26, P55, DOI 10.1007/BF02361159; Taylor L, 1999, J ABNORM PSYCHOL, V108, P202, DOI 10.1037/0021-843X.108.2.202; Timbremont B, 2004, BEHAV RES THER, V42, P423, DOI 10.1016/S0005-7967(03)00151-7; Venables WN., 2002, MODERN APPL STAT S, V4; Voss A, 2007, BEHAV RES METHODS, V39, P767, DOI 10.3758/BF03192967; Voss A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00336; Voss A, 2013, EXP PSYCHOL, V60, P385, DOI 10.1027/1618-3169/a000218; Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789; White CN, 2010, J MATH PSYCHOL, V54, P39, DOI 10.1016/j.jmp.2010.01.004; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wigg KG, 2006, AM J MED GENET B, V141B, P566, DOI 10.1002/ajmg.b.30247; Zalsman G, 2006, AM J PSYCHIAT, V163, P1588, DOI 10.1176/appi.ajp.163.9.1588	61	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198950	10.1371/journal.pone.0198950	http://dx.doi.org/10.1371/journal.pone.0198950			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ2HI	29897965	gold, Green Submitted, Green Published			2022-12-26	WOS:000435090700081
J	Coetzee, LM; Cassim, N; Sriruttan, C; Mhlanga, M; Govender, NP; Glencross, DK				Coetzee, Lindi-Marie; Cassim, Naseem; Sriruttan, Charlotte; Mhlanga, Mabatho; Govender, Nelesh P.; Glencross, Deborah Kim			Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts < 100 cells/mu l identifies districts in South Africa with advanced burden of disease	PLOS ONE			English	Article							MENINGITIS; SUPPORT	Introduction Cryptococcal meningitis (CM) is an opportunistic fungal disease with a high mortality among HIV-positive patients with severe immunosuppression (CD4 count <100 cells/mu l). Reflexed screening for cryptococcal antigen (CrAg) in remnant blood samples was initially piloted at selected CD4 testing laboratories of the National Health Laboratory Service (NHLS) prior to the implementation of a national screening programme using a lateral flow assay (LFA) (IMMY, Norman, OK, USA). The aim of this study was to assess CrAg positivity nationally, per province and district in combination with the percentage of CD4 samples tested with a CD4 count <100 cells/mu l to identify areas with advanced HIV/CrAg disease burden. Methods CrAg and CD4 laboratory result data were extracted from the NHLS corporate data warehouse. Monthly test volumes were used to assess CrAg test volumes and coverage, while bubble charts were used to display the relationship between CD4 <100 cells/mu l, CrAg positivity and number of positive CrAg samples by district. ArcGIS software was used to spatially report CrAg positivity. Results CrAg screening coverage was stable at around 96% after November 2016. Samples with a CD4 <100 cell/mu l and CrAg positivity were also stable over the study period at 10% and similar to 5% respectively. The highest CrAg positivity was reported for the Kwa-Zulu Natal province (7.3%), which also had the lowest percentage of samples with a CD4 <100 cells/mu l (7.2%). Uthungulu and Umkhanyakude districts had the highest CrAg positivity (9.3% and 8.9% respectively). Ethekwini and Johannesburg Metro districts contributed to 22% of the total number of CrAg-positive samples tested across South Africa for the period reported. Conclusion Existing CD4 testing services were used to rapidly scale up CrAg reflex testing in South Africa. Districts with advanced HIV and CrAg disease burden were identified that need further investigation of patient management interventions.	[Coetzee, Lindi-Marie; Cassim, Naseem; Glencross, Deborah Kim] NHLS, Natl Prior Programmes Unit, Johannesburg, South Africa; [Coetzee, Lindi-Marie; Cassim, Naseem; Glencross, Deborah Kim] Univ Witwatersrand, Dept Mol Med & Haematol, Fac Hlth Sci, Johannesburg, South Africa; [Sriruttan, Charlotte; Mhlanga, Mabatho; Govender, Nelesh P.] Natl Inst Communicable Dis, Div Natl Hlth Lab Serv NHLS, Ctr Healthcare Associated Infect Antimicrobia Res, Johannesburg, South Africa; [Govender, Nelesh P.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa	National Health Laboratory Service; University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand	Coetzee, LM (corresponding author), NHLS, Natl Prior Programmes Unit, Johannesburg, South Africa.; Coetzee, LM (corresponding author), Univ Witwatersrand, Dept Mol Med & Haematol, Fac Hlth Sci, Johannesburg, South Africa.	linda.coetzee@nhls.ac.za	Cassim, Naseem/AFU-5522-2022; Govender, Nelesh/ABI-6429-2020; Cassim, Naseem/GLR-4911-2022	Cassim, Naseem/0000-0003-4389-2849; Cassim, Naseem/0000-0003-4389-2849; Glencross, Deborah/0000-0001-7106-769X; Govender, Nelesh/0000-0001-7869-9462				Coetzee LM, 2017, SAMJ S AFR MED J, V107, P507, DOI [10.7196/SAMJ.2017.v107i6.11311, 10.7196/samj.2017.v107i6.11311]; Coetzee LM, 2017, RAPID SCALE REFLEXED; Coetzee LM, 2017, 11 INT WORKSH; Govender NP, 2014, SAMJ S AFR MED J, V104, P896, DOI 10.7196/SAMJ.9070; Govender NP, 2012, SAMJ S AFR MED J, V102, P914, DOI [10.7196/samj.6228, 10.7196/SAMJ.6228]; Jarvis JN, 2011, SAMJ S AFR MED J, V101, P232, DOI 10.7196/SAMJ.4752; Jarvis JN, 2009, AIDS, V23, P1182, DOI 10.1097/QAD.0b013e32832be0fc; Kozel Thomas R, 2012, Expert Opin Med Diagn, V6, P245, DOI 10.1517/17530059.2012.681300; Lessells RJ, 2011, SAMJ S AFR MED J, V101, P251, DOI 10.7196/SAMJ.4378; Longley N, 2016, CLIN INFECT DIS, V62, P581, DOI 10.1093/cid/civ936; Meintjes G, 2015, S AFR J HIV MED, V16, P4, DOI DOI 10.4102/SAJHIVMED.V16I1.428.]; Mfinanga S, 2015, LANCET, V385, P2173, DOI 10.1016/S0140-6736(15)60164-7; Mhlanga M, 2015, CROSS SECTIONAL LAB; Mokone G, 2017, IMPLEMENTATION NATL; NDoH, 2015, NAT CONS GUID PREV M; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pongsai P, 2010, J INFECTION, V60, P474, DOI 10.1016/j.jinf.2010.03.015; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/s1473-3099(17)30243-8, 10.1016/S1473-3099(17)30243-8]; Sloan DJ, 2014, CLIN EPIDEMIOL, V6, P169, DOI 10.2147/CLEP.S38850	19	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198993	10.1371/journal.pone.0198993	http://dx.doi.org/10.1371/journal.pone.0198993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894509	Green Published, Green Submitted, gold			2022-12-26	WOS:000435030900040
J	Adesokan, HK; Akinseye, VO; Sulaimon, MA				Adesokan, Hezekiah Kehinde; Akinseye, Victor Oluwatoyin; Sulaimon, Mutolib Abiodun			Knowledge and practices about zoonotic tuberculosis prevention and associated determinants amongst livestock workers in Nigeria; 2015	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; UNITED-STATES; RAW-MILK; HEALTH	Zoonotic tuberculosis (TB) is a significant public health disease, but has long been neglected. Information on knowledge and practices of its prevention and influencing factors amongst occupationally exposed individuals is required for designing all-inclusive, informed control programmes. We investigated knowledge and practices related to zoonotic TB prevention and associated determinants amongst herdsmen and abattoir workers in southwestern, south-eastern and north-western Nigeria using semi-structured questionnaire. Data were analysed with STATA 12. A total of 510 respondents (196 herdsmen; 314 abattoir workers) participated in the survey, of which 58.6% and 46.9% respectively were knowledgeable and demonstrated good practices about zoonotic TB prevention. Almost 60% knew that zoonotic TB transmission was preventable and 49.8% knew transmission could be through consumption of infected animal products. However, only 16.7% knew the disease could be transmitted by aerosol. Just 49.4% sought medical check-up when ill, 37.8% used protective clothing and only 29.2% usually condemned TB infected cattle. Respondents with post-primary education were about three times more likely to be knowledgeable (OR = 2.70, 95%CI: 1.68-4.33) and two times more likely to demonstrate good practice (OR = 2.23, 95%CI: 1.45-3.42) than those without formal education. Similarly, abattoir workers were about 6.4 times more likely to be knowledgeable (OR: 6.39, 95%CI: 4.31-9.47) and two times more likely to demonstrate good practice (OR: 2.03, 95%CI: 1.40-2.92) than the herdsmen. There were important knowledge gaps with poor practices about zoonotic TB prevention amongst livestock workers in Nigeria. Strong predictors of knowledge and practice were being an abattoir worker and having post-primary education. Well-designed grassroots enlightenment programmes addressing modes of transmission, handling infected cattle and seeking medical check-up are urgently needed among high risk settings considering the recently launched Road Map for Zoonotic Tuberculosis which resonates that every tuberculosis case counts towards 2030 End-TB Strategy.	[Adesokan, Hezekiah Kehinde; Akinseye, Victor Oluwatoyin] Univ Ibadan, Dept Vet Publ Hlth & Prevent Med, Ibadan, Nigeria; [Sulaimon, Mutolib Abiodun] Minist Agr & Nat Resources, Abakaliki Cent Abattoir, Abakaliki, Ebonyi State, Nigeria	University of Ibadan	Adesokan, HK (corresponding author), Univ Ibadan, Dept Vet Publ Hlth & Prevent Med, Ibadan, Nigeria.	latterglory70@yahoo.co.in	Akinseye, Victor Oluwatoyin/ADX-0541-2022; Adesokan, Hezekiah/R-8488-2019	Akinseye, Victor Oluwatoyin/0000-0003-4616-7239; Adesokan, Hezekiah/0000-0001-5050-8580				Adesokan HK, 2012, INT J TUBERC LUNG D, V16, P1388, DOI 10.5588/ijtld.12.0109; Adesokan HK, 2013, J S AFR VET ASSOC, V84, DOI 10.4102/jsava.v84i1.121; Adesokan HK, 2016, THESIS; Amenu K., 2010, Tropicultura, V28, P205; Aydin FE, 2012, MIKROBIYOL BUL, V46, P283; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Bechir M, 2010, THESIS; Cadmus S, 2006, J CLIN MICROBIOL, V44, P29, DOI 10.1128/JCM.44.1.29-34.2006; Cadmus SIB, 2010, TROP ANIM HEALTH PRO, V42, P1047, DOI 10.1007/s11250-010-9533-2; COLLINS C, 1987, IRISH MED J, V80, P66; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; Ereqat Suheir, 2013, PLoS Negl Trop Dis, V7, pe2417, DOI 10.1371/journal.pntd.0002417; Evans JT, 2007, LANCET, V369, P1270, DOI 10.1016/S0140-6736(07)60598-4; Hambolu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056091; Hlavsa MC, 2008, CLIN INFECT DIS, V47, P168, DOI 10.1086/589240; Ibrahim S, 2012, Vet Med Int, V2012, P865924, DOI 10.1155/2012/865924; Ibrahim S, 2016, J MICROBIOL EXP, V3, DOI DOI 10.15406/JMEN.2016.03.00081; Ismail A., 2014, TANZAN J HLTH RES, V16; John K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009968; Khattak I, 2016, OCCUP MED-OXFORD, V66, P371, DOI 10.1093/occmed/kqw039; Kolo I, 1991, THESIS; Melaku S, 2013, TUBERC RES TREAT, V2013, DOI DOI 10.1155/2013/475605; Michel AL, 2010, VET MICROBIOL, V140, P371, DOI 10.1016/j.vetmic.2009.08.029; National Population Commission, 2006, NAT POP CENS; Ofukwu RA, 2006, THESIS; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Paes AC, 2010, BOVINOCULTURA CORTE, P993; Radostits SM, 1994, VET MED TXB DIS CATT; Rodwell TC, 2008, EMERG INFECT DIS, V14, P909, DOI 10.3201/eid1406.071485; Sa'idu A. S., 2015, British Journal of Medicine and Medical Research, V5, P1220, DOI 10.9734/BJMMR/2015/11650; Saliluddin, 2015, INT J PUBLIC HLTH CL, V2, P45; Samad MA, 2008, ANIMAL HUSBANDRY VET, V1st; Tobin EA, 2013, ANN AFR MED, V12, P148, DOI 10.4103/1596-3519.117623; (WHO) WHO (FAO) F and AO of the UN (OIE) WO for AH Disease Lung IUAT and LD (IUATLD), 2017, 48 UN WORLD C LUNG H; Winters A., 2005, Morbidity and Mortality Weekly Report, V54, P605; World Health Organization (WHO), 2016, WHOHTMTB2016 13; Zaman K, 2010, J HEALTH POPUL NUTR, V28, P111; Zhao Y, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003454; Zinsstag J, 2004, Med Trop (Mars), V64, P449; Zinsstag J, 2006, TROP MED INT HEALTH, V11, P565, DOI 10.1111/j.1365-3156.2006.01615.x	40	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198810	10.1371/journal.pone.0198810	http://dx.doi.org/10.1371/journal.pone.0198810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889870	Green Submitted, gold, Green Published			2022-12-26	WOS:000434786600051
J	Negi, BS; Joshi, SK; Nakazawa, M; Kotaki, T; Bastola, A; Kameoka, M				Negi, Bharat Singh; Joshi, Sunil Kumar; Nakazawa, Minato; Kotaki, Tomohiro; Bastola, Anup; Kameoka, Masanori			Impact of a massive earthquake on adherence to antiretroviral therapy, mental health, and treatment failure among people living with HIV in Nepal	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DRUG-RESISTANCE MUTATIONS; CLINICAL-OUTCOMES; SERVICE PROVISION; SURVIVORS; SYMPTOMS; STIGMA; DETERMINANTS; NONADHERENCE; PREVALENCE	Introduction The April 2015 Nepal earthquake resulted in more than 8,700 deaths and 22,000 casualties including damage to health facilities. The impact of this situation on chronic conditions such as human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) may become a long-lasting public health threat. Therefore, the objectives of this study were i) to assess the association of antiretroviral therapy (ART) adherence with mental health problems, and social behaviors, ii) to examine factors affecting treatment failure, and iii) to investigate changes in ART adherence and post-traumatic stress disorder (PTSD) among people living with HIV 6 and 12 months after the disaster. Methods Study was conducted 6 months after the earthquake in 2015 with a sample size of 305 earthquake victims with HIV and followed after 12 months of the earthquake. A logistic regression analysis was used to examine relationships, while a paired t-test analysis was conducted to assess changes in adherence to ART and PTSD level at 6 months and 12 months after earthquake. Results In the earthquake, 5.2% of the participants lost their family member. Approximately 44% of participants had earthquake-PTSD symptoms and 50% experienced HIV stigma. PTSD and HIV status disclosure were significantly associated with adherence to ART, while HIV stigma and religion were associated with treatment failure. PTSD and adherence levels to ART were significantly improved over the 6-month period. Conclusion Awareness programs for general public to eliminate HIV stigma; promote psychosocial counseling to earthquake victims living with HIV in order to reduce PTSD will contribute to maintaining optimal ART adherence and to prevent treatment failure.	[Negi, Bharat Singh; Nakazawa, Minato; Kotaki, Tomohiro; Kameoka, Masanori] Kobe Univ, Grad Sch Hlth Sci, Dept Int Hlth, Kobe, Hyogo, Japan; [Joshi, Sunil Kumar] Kathmandu Med Coll, Dept Community Med, Kathmandu, Nepal; [Bastola, Anup] Sukraraj Trop & Infect Dis Hosp, Kathmandu, Nepal	Kobe University	Negi, BS (corresponding author), Kobe Univ, Grad Sch Hlth Sci, Dept Int Hlth, Kobe, Hyogo, Japan.	haliobharat@gmail.com	Negi, Bharat Singh/ABG-4957-2021; Joshi, Sunil Kumar/O-3842-2018; Bastola, Anup/AHD-4301-2022	Negi, Bharat Singh/0000-0003-3496-3473; Joshi, Sunil Kumar/0000-0002-2704-5060; Bastola, Anup/0000-0003-3624-4720	Research Center for Urban Safety and Security (RCUSS), Kobe University [L3.TAP15]; Kobe University Graduate School of Health Sciences; Japan Society for the Promotion of Science (JSPS)	Research Center for Urban Safety and Security (RCUSS), Kobe University; Kobe University Graduate School of Health Sciences; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	A part of this study was supported by the field research program, L3.TAP15 by the Research Center for Urban Safety and Security (RCUSS) (MN), Kobe University; a research grant by Kobe University Graduate School of Health Sciences (http://www.rcuss.kobe-u.ac.jp/English/index-e.html); and a Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (JSPS) (MK) (http://www.jsps.go.jp/english/).	Adhikari RR, 2017, CHRISTIANIZATION NEP; Azerbaijan Republic Ministry of Health, 2011, NEP DEM HLTH SURV 20; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bhatta DN, 2017, AIDS BEHAV, V21, P1620, DOI 10.1007/s10461-016-1546-z; Bhusal N, 2016, CURR HIV RES, V14, P517, DOI 10.2174/1570162X14666161003141950; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Chapin E, 2009, PREHOSP DISASTER MED, V24, P326, DOI 10.1017/S1049023X00007056; Chen CC, 2001, PSYCHIAT RES, V105, P13, DOI 10.1016/S0165-1781(01)00334-1; Chen H, 2014, NURS HEALTH SCI, V16, P39, DOI 10.1111/nhs.12127; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Druss BG, 2007, AM J PSYCHIAT, V164, P154, DOI 10.1176/appi.ajp.164.1.154; Fonsah JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170893; Galvan FH, 2008, AIDS PATIENT CARE ST, V22, P423, DOI 10.1089/apc.2007.0169; Gebrezgabher BB, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0143-1; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Haberer JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018505; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; HECKMAN TG, 1998, AIDS BEHAV, V2, P127, DOI DOI 10.1023/A:1022194829791; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Horberg MA, 2008, JAIDS-J ACQ IMM DEF, V47, P384, DOI 10.1097/QAI.0b013e318160d53e; Hu XY, 2016, ARCH PSYCHIAT NURS, V30, P192, DOI 10.1016/j.apnu.2015.08.011; JACOBY A, 1994, SOC SCI MED, V38, P269, DOI 10.1016/0277-9536(94)90396-4; Jia XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121480; Kane JC, 2018, EPIDEMIOL PSYCH SCI, V27, P301, DOI 10.1017/S2045796016001104; Kato H, 1996, ACTA PSYCHIAT SCAND, V93, P477, DOI 10.1111/j.1600-0447.1996.tb10680.x; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kohrt BA, 2009, POLITICAL VIOLENCE M; Kokai M, 2004, PSYCHIAT CLIN NEUROS, V58, P110, DOI 10.1111/j.1440-1819.2003.01203.x; Li K, 1999, JAPANESE J NURSING R, V32, P187; Mahloko JM, 2012, AFR J ODI DISTR S AF, V4, P1, DOI [10.4102/phcfm.v4i1.345, DOI 10.4102/PHCFM.V4I1.345]; Micheni M, 2017, AIDS PATIENT CARE ST, V31, P113, DOI 10.1089/apc.2016.0213; MoHP, 2008, AD HLTH DEV NEP STAT; National Centre for AIDS and STD Control (NCASC) & Ministry of Health and Population, 2015, COUNTR PROGR REP NEP; Negi BS, 2017, AIDS RES HUM RETROV, V33, P960, DOI [10.1089/AID.2017.0047, 10.1089/aid.2017.0047]; NPC, 2015, NEP EARTHQ 2015 POST; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Preston DB, 2004, AIDS EDUC PREV, V16, P291, DOI 10.1521/aeap.16.4.291.40401; Quinn DM, 2011, SOC ISS POLICY REV, V5, P160, DOI 10.1111/j.1751-2409.2011.01029.x; Rimal R, 2016, INT J SOC PSYCHIATR, V62, P487, DOI 10.1177/0020764016651457; Robinson WT, 2011, AIDS CARE, V23, P803, DOI 10.1080/09540121.2010.534437; Schonnesson LN, 2007, AIDS BEHAV, V11, P175, DOI 10.1007/s10461-006-9160-0; Sharan P, 1996, AM J PSYCHIAT, V153, P556; Sharma AJ, 2008, DISASTER MED PUBLIC, V2, P27, DOI 10.1097/DMP.0b013e31816452f0; Shubber Z, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002183; Sumari-de Boer IM, 2012, AIDS BEHAV, V16, P1681, DOI 10.1007/s10461-011-0112-y; Tomio J, 2010, PREHOSPITAL DISASTER, V25, P42, DOI 10.1017/S1049023X00007652; UNAIDS, 2016, GLOB AIDS UPD REP; Vranceanu AM, 2008, AIDS PATIENT CARE ST, V22, P313, DOI 10.1089/apc.2007.0069; Walldorf JA, 2012, AIDS, V26, P1431, DOI 10.1097/QAD.0b013e328352d032; Wasti Sharada Prasad, 2009, Kathmandu Univ Med J (KUMJ), V7, P306; Whetten K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074771; World Health Organization, 2003, ENTR POINTS ANT TREA; Zhang Z, 2012, PSYCHOL MED, V42, P1687, DOI 10.1017/S0033291711002844	54	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198071	10.1371/journal.pone.0198071	http://dx.doi.org/10.1371/journal.pone.0198071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI8PJ	29889840	Green Published, gold, Green Submitted			2022-12-26	WOS:000434786600015
J	Pagnotta, MF; Plomp, G				Pagnotta, Mattia F.; Plomp, Gijs			Time-varying MVAR algorithms for directed connectivity analysis: Critical comparison in simulations and benchmark EEG data	PLOS ONE			English	Article							CORTICAL FUNCTIONAL CONNECTIVITY; EVENT-RELATED POTENTIALS; HIGH-RESOLUTION EEG; GRANGER CAUSALITY; SPECTRAL-ANALYSIS; INFORMATION-FLOW; BRAIN STATES; SIGNALS; COHERENCE; NETWORKS	Human brain function depends on directed interactions between multiple areas that evolve in the subsecond range. Time-varying multivariate autoregressive (tvMVAR) modeling has been proposed as a way to help quantify directed functional connectivity strengths with high temporal resolution. While several tvMVAR approaches are currently available, there is a lack of unbiased systematic comparative analyses of their performance and of their sensitivity to parameter choices. Here, we critically compare four recursive tvMVAR algorithms and assess their performance while systematically varying adaptation coefficients, model order, and signal sampling rate. We also compared two ways of exploiting repeated observations: single-trial modeling followed by averaging, and multi-trial modeling where one tvMVAR model is fitted across all trials. Results from numerical simulations and from benchmark EEG recordings showed that: i) across a broad range of model orders all algorithms correctly reproduced patterns of interactions; ii) signal downsampling degraded connectivity estimation accuracy for most algorithms, although in some cases downsampling was shown to reduce variability in the estimates by lowering the number of parameters in the model; iii) single-trial modeling followed by averaging showed optimal performance with larger adaptation coefficients than previously suggested, and showed slower adaptation speeds than multi-trial modeling. Overall, our findings identify strengths and weaknesses of existing tvMVAR approaches and provide practical recommendations for their application to modeling dynamic directed interactions from electrophysiological signals.	[Pagnotta, Mattia F.; Plomp, Gijs] Univ Fribourg, Dept Psychol, Fribourg, Switzerland	University of Fribourg	Pagnotta, MF (corresponding author), Univ Fribourg, Dept Psychol, Fribourg, Switzerland.	mattia.pagnotta@unifr.ch	Pagnotta, Mattia Federico/K-5555-2019	Pagnotta, Mattia Federico/0000-0003-0304-7253; Plomp, Gijs/0000-0002-9883-3371	Swiss National Science Foundation [PPOOP1_157420]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (grant PPOOP1_157420 to GP; http://pasntch/Proiect157420). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1969, ANN I STAT MATH, V21, P243, DOI 10.1007/BF02532251; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arnold M, 1998, IEEE T BIO-MED ENG, V45, P553, DOI 10.1109/10.668741; Astolfi L, 2008, IEEE T BIO-MED ENG, V55, P902, DOI 10.1109/TBME.2007.905419; Astolfi L, 2007, HUM BRAIN MAPP, V28, P143, DOI 10.1002/hbm.20263; Astolfi L, 2006, IEEE T BIO-MED ENG, V53, P1802, DOI 10.1109/TBME.2006.873692; Babiloni F, 2005, NEUROIMAGE, V24, P118, DOI 10.1016/j.neuroimage.2004.09.036; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Baccala LA, 2007, PROCEEDINGS OF THE 2007 15TH INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING, P163, DOI 10.1109/ICDSP.2007.4288544; BRESSLER SL, 1995, BRAIN RES REV, V20, P288, DOI 10.1016/0165-0173(94)00016-I; Brodbeck V, 2012, NEUROIMAGE, V62, P2129, DOI 10.1016/j.neuroimage.2012.05.060; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Coito A, 2015, EPILEPSIA, V56, P207, DOI 10.1111/epi.12904; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Efron B., 1993, INTRO BOOTSTRAP, P436, DOI [10.1007/978-1-4899-4541-9, DOI 10.1007/978-1-4899-4541-9]; Faes L, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19080408; Fairhall SL, 2007, CEREB CORTEX, V17, P2400, DOI 10.1093/cercor/bhl148; Fallani FDV, 2008, NEUROINFORMATICS, V6, P23, DOI 10.1007/s12021-007-9006-6; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Garcia JO, 2017, NEUROIMAGE, V150, P239, DOI 10.1016/j.neuroimage.2017.02.057; Grunwald P. D., 2007, MINIMUM DESCRIPTION; HANNAN EJ, 1979, J ROY STAT SOC B MET, V41, P190; Hu L, 2012, NEUROIMAGE, V62, P217, DOI 10.1016/j.neuroimage.2012.03.094; ISAKSSON A, 1981, P IEEE, V69, P451, DOI 10.1109/PROC.1981.11988; Lehmann E. L., 1998, THEORY POINT ESTIMAT, DOI [10.1007/b98854, DOI 10.1007/B98854]; Leistritz L, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0616; Liang HL, 2017, P NATL ACAD SCI USA, V114, P8637, DOI 10.1073/pnas.1706183114; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Milde T, 2010, NEUROIMAGE, V50, P960, DOI 10.1016/j.neuroimage.2009.12.110; Moller E, 2003, BIOL CYBERN, V89, P303, DOI 10.1007/s00422-003-0394-x; Moller E, 2001, J NEUROSCI METH, V105, P143, DOI 10.1016/S0165-0270(00)00350-2; Mullen TR, 2014, DYNAMIC BRAIN MODELI; Nowak LG, 1997, CEREBR CORT, V12, P205; Omidvarnia AH, 2011, IEEE ENG MED BIO, P1423, DOI 10.1109/IEMBS.2011.6090335; Omidvarnia A, 2014, IEEE T BIO-MED ENG, V61, P680, DOI 10.1109/TBME.2013.2286394; Omidvarnia AH, 2012, LECT NOTES COMPUT SC, V7664, P683, DOI 10.1007/978-3-642-34481-7_83; Petrichella S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174879; Plomp G, 2015, SCI REP-UK, V5, DOI 10.1038/srep18733; Plomp G, 2015, IEEE ENG MED BIO, P5392, DOI 10.1109/EMBC.2015.7319610; Plomp G, 2014, EUR J NEUROSCI, V40, P3215, DOI 10.1111/ejn.12687; Plomp G, 2014, NEUROIMAGE, V97, P206, DOI 10.1016/j.neuroimage.2014.04.016; Porcaro C, 2009, CLIN NEUROPHYSIOL, V120, P436, DOI 10.1016/j.clinph.2008.11.011; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Quairiaux C, 2011, J NEUROSCI, V31, P9574, DOI 10.1523/JNEUROSCI.5995-10.2011; SCHACK B, 1995, MED BIOL ENG COMPUT, V33, P605, DOI 10.1007/BF02522521; Schelter B, 2006, J NEUROSCI METH, V152, P210, DOI 10.1016/j.jneumeth.2005.09.001; Schelter B, 2009, J NEUROSCI METH, V179, P121, DOI 10.1016/j.jneumeth.2009.01.006; Schlogl A., 2000, ELECTROENCEPHALOGRAM; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seth AK, 2013, NEUROIMAGE, V65, P540, DOI 10.1016/j.neuroimage.2012.09.049; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Sommerlade L, 2012, J NEUROSCI METH, V203, P173, DOI 10.1016/j.jneumeth.2011.08.042; Sommerlade L, 2009, J PHYSIOLOGY-PARIS, V103, P348, DOI 10.1016/j.jphysparis.2009.07.005; Sporns O, 2014, NAT NEUROSCI, V17, P652, DOI 10.1038/nn.3690; Stokes PA, 2017, P NATL ACAD SCI USA, V114, pE7063, DOI 10.1073/pnas.1704663114; Takahashi DY, 2010, BIOL CYBERN, V103, P463, DOI 10.1007/s00422-010-0410-x; Toppi J, 2012, IEEE ENG MED BIO, P6192, DOI 10.1109/EMBC.2012.6347408; Toppi J., 2013, METHODS ESTIMATION C, DOI [10.6092/unibo/amsdottorato/5271, DOI 10.6092/UNIBO/AMSDOTTORATO/5271]; van Mierlo P, 2011, NEUROIMAGE, V56, P1122, DOI 10.1016/j.neuroimage.2011.02.009; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vidaurre D, 2018, NEUROIMAGE, V180, P646, DOI 10.1016/j.neuroimage.2017.06.077; Vidaurre D, 2016, NEUROIMAGE, V126, P81, DOI 10.1016/j.neuroimage.2015.11.047; Wang HE, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00405; Weiss T, 2008, J NEUROPHYSIOL, V99, P2220, DOI 10.1152/jn.00912.2007; Wen XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067428; Wilke C, 2008, IEEE T BIO-MED ENG, V55, P2557, DOI 10.1109/TBME.2008.919885; Winterhalder M, 2005, SIGNAL PROCESS, V85, P2137, DOI 10.1016/j.sigpro.2005.07.011; Wu MH, 2011, COMPUT BIOL MED, V41, P1132, DOI 10.1016/j.compbiomed.2011.06.007	76	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198846	10.1371/journal.pone.0198846	http://dx.doi.org/10.1371/journal.pone.0198846			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889883	Green Published, Green Submitted, gold			2022-12-26	WOS:000434786600059
J	Wan, YF; Atta, S; Wang, XF; Yang, FY; Zhou, CY; Cao, MJ				Wan, Yafei; Atta, Sagheer; Wang, Xuefeng; Yang, Fangyun; Zhou, Changyong; Cao, Mengji			Transcriptome sequencing reveals novel Citrus bark cracking viroid (CBCVd) variants from citrus and their molecular characterization	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; HOST INTERACTIONS; SMALL RNAS; IDENTIFICATION; ORANGE; CLASSIFICATION; PAKISTAN; DISEASE; SCHEME; IV	Citrus bark cracking viroid (CBCVd), previously called Citrus viroid IV, belongs to the genus Cocadviroid within the family Pospiviroidae. CBCVd has been identified as an important causative agent in citrus and hops. In this study, we obtained the full-length genomes of different variants of all detected citrus viroids from Pakistan through transcriptome sequencing. Different CBCVd variants were first found in Pakistan. These newly discovered Pakistani CBCVd variants were provisionally called "CBCVd-LSS" for their low sequence similarity (80.9%-88.9%) with the CBCVd RefSeq sequence (NC-003539). The two most predominant CBCVd sequences from Pakistan had the closest identity, 90.6% and 87.9%, with two CBCVd sequences isolated from hops. Identification and molecular characterization of CBCVd from citrus in Pakistan and China were also reported. The length of CBCVd from China ranged from 282 to 286 nucleotides, while that of the one from Pakistan ranged from 273 to 277 nucleotides. Based on genetic diversity and phylogenetic analysis, two main CBCVd clades were identified. CBCVd sequences from Pakistan, China, and other countries were further divided into six sub-clades. Sequence alignment revealed some nucleotide changes between these sub-clades, and analysis indicated that several mutations could significantly affect the primary and secondary structure of the viroid. Our results indicated that the CBCVd sequences from Pakistan and China were significantly different with respect to genome and secondary structure and Pakistan might be one of the independent geographical origins of CBCVd worldwide.	[Wan, Yafei; Wang, Xuefeng; Yang, Fangyun; Zhou, Changyong; Cao, Mengji] Southwest Univ, Natl Citrus Engn Res Ctr, Citrus Res Inst, Chongqing, Peoples R China; [Wan, Yafei; Wang, Xuefeng; Zhou, Changyong; Cao, Mengji] Southwest Univ, Acad Agr Sci, Chongqing, Peoples R China; [Atta, Sagheer] Ghazi Univ, Fac Agr Sci, Dept Plant Protect, Dera Ghazi Khan, Pakistan	Southwest University - China; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Southwest University - China	Zhou, CY; Cao, MJ (corresponding author), Southwest Univ, Natl Citrus Engn Res Ctr, Citrus Res Inst, Chongqing, Peoples R China.; Zhou, CY; Cao, MJ (corresponding author), Southwest Univ, Acad Agr Sci, Chongqing, Peoples R China.	zhoucy@cric.cn; caomengji@cric.cn	Cao, Mengji/S-5369-2019	Cao, Mengji/0000-0003-0396-262X	Intergovernmental International Science, Technology and Innovation (STI) Collaboration Key Project of China's National Key R&D Programme (NKP) [2017YFE0110900]; National Natural Science Foundation of China [31501611, 31000843]; Fundamental Research Funds for the Central Universities [XDJK2018AA002, XDJK20166021, SWU116012]; Chongqing Research Program of Basic Research and Frontier Technology [cstc2017jcyjBX0016]	Intergovernmental International Science, Technology and Innovation (STI) Collaboration Key Project of China's National Key R&D Programme (NKP); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chongqing Research Program of Basic Research and Frontier Technology	This work was financially supported by grants from the Intergovernmental International Science, Technology and Innovation (STI) Collaboration Key Project of China's National Key R&D Programme (NKP) (2017YFE0110900), National Natural Science Foundation of China (31501611, 31000843), Fundamental Research Funds for the Central Universities (XDJK2018AA002, XDJK20166021, SWU116012), Chongqing Research Program of Basic Research and Frontier Technology (cstc2017jcyjBX0016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernad L, 2006, MOL CELL PROBE, V20, P105, DOI 10.1016/j.mcp.2005.11.001; Cao M, 2017, EUR J PLANT PATHOL, V2017, P1; Cao MJ, 2009, PLANT DIS, V93, P840, DOI 10.1094/PDIS-93-8-0840C; Cao MJ, 2013, EUR J PLANT PATHOL, V135, P11, DOI 10.1007/s10658-012-0034-1; Chaffai M, 2007, ARCH VIROL, V152, P1283, DOI 10.1007/s00705-007-0958-5; Chambers GA, 2018, ARCH VIROL, V163, P215, DOI 10.1007/s00705-017-3591-y; Chiumenti M, 2014, VIRUS RES, V188, P54, DOI 10.1016/j.virusres.2014.03.026; Ding B, 2009, ANNU REV PHYTOPATHOL, V47, P105, DOI 10.1146/annurev-phyto-080508-081927; DURANVILA N, 1988, J GEN VIROL, V69, P3069, DOI 10.1099/0022-1317-69-12-3069; Flores R, 2005, ANNU REV PHYTOPATHOL, V43, P117, DOI 10.1146/annurev.phyto.43.040204.140243; Flores R, 1998, ARCH VIROL, V143, P623, DOI 10.1007/s007050050318; Hadidi A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01325; Ito T, 2002, PHYTOPATHOLOGY, V92, P542, DOI 10.1094/PHYTO.2002.92.5.542; Ito T, 2001, ARCH VIROL, V146, P975, DOI 10.1007/s007050170129; Ito T, 2013, ARCH VIROL, V158, P2629, DOI 10.1007/s00705-013-1772-x; Jakse J, 2015, PLANT PATHOL, V64, P831, DOI 10.1111/ppa.12325; Jiang JH, 2017, VIRUS RES, V240, P1, DOI 10.1016/j.virusres.2017.07.012; KOLTUNOW AM, 1989, INTERVIROLOGY, V30, P194, DOI 10.1159/000150093; Martinez G, 2010, MOL PLANT PATHOL, V11, P347, DOI [10.1111/J.1364-3703.2009.00608.X, 10.1111/j.1364-3703.2009.00608.x]; Mishra AK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3271-4; Pecman A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01998; PUCHTA H, 1991, NUCLEIC ACIDS RES, V19, P6640, DOI 10.1093/nar/19.23.6640; Semancik JS, 2005, ARCH VIROL, V150, P1059, DOI 10.1007/s00705-005-0499-8; Serra P, 2008, VIROLOGY, V370, P102, DOI 10.1016/j.virol.2007.07.033; Verniere C, 2006, PHYTOPATHOLOGY, V96, P356, DOI 10.1094/PHYTO-96-0356; Verniere C, 2004, PLANT DIS, V88, P1189, DOI 10.1094/PDIS.2004.88.11.1189; Wang J, 2013, EUR J PLANT PATHOL, V137, P17, DOI 10.1007/s10658-013-0231-6; Wang XF, 2010, J PHYTOPATHOL, V158, P372, DOI 10.1111/j.1439-0434.2009.01629.x; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Wu QF, 2015, ANNU REV PHYTOPATHOL, V53, P425, DOI 10.1146/annurev-phyto-080614-120030; Wu Q, 2014, EUR J PLANT PATHOL, V139, P13, DOI 10.1007/s10658-014-0380-2; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Zhang ZX, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004553; Zhong XH, 2008, PLANT CELL, V20, P35, DOI 10.1105/tpc.107.056606	34	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198022	10.1371/journal.pone.0198022	http://dx.doi.org/10.1371/journal.pone.0198022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889858	Green Published, gold, Green Submitted			2022-12-26	WOS:000434786600013
J	Kuip, EJM; Oldenmenger, WH; Thijs-Visser, MF; de Bruijn, P; Oosten, AW; Oomen-de Hoop, E; Koolen, SLW; Van der Rijt, CCD; Mathijssen, RHJ				Kuip, Evelien J. M.; Oldenmenger, Wendy H.; Thijs-Visser, Martine F.; de Bruijn, Peter; Oosten, Astrid W.; Oomen-de Hoop, Esther; Koolen, Stijn L. W.; Van der Rijt, Carin C. D.; Mathijssen, Ron H. J.			Effects of smoking and body mass index on the exposure of fentanyl in patients with cancer	PLOS ONE			English	Article							TRANSDERMAL FENTANYL; PHARMACOKINETIC INTERACTION; PAIN; VARIABILITY; ANALGESIA; EFFICACY; MORPHINE; OPIOIDS; FOCUS	The transdermal fentanyl patch is widely used to treat cancer-related pain despite its wide inter-and intrapatient variability in pharmacokinetics. The aim of this study was to investigate whether smoking and body size (i.e. body mass index) influence fentanyl exposure in patients with cancer. These are factors that typically change during treatment and disease trajectories. We performed an explorative cohort study in patients with cancer using transdermal fentanyl patches (Durogesic (R)), by taking a blood sample for pharmacokinetic analysis one day after applying a patch in patients with a stable fentanyl dose. A total of 88 patients were evaluable. Although no statistically significant difference was found, the plasma concentrations of non-smokers was 28% (95% CI [-14%; +89-%]) higher than those of smokers normalizing for a dose of 25 mu g/min. Patients with a low BMI (<20 kg/m2) had almost similar (10% (95% CI [-39%; +97%]) higher) plasma concentrations compared to patients with a high BMI (>25 kg/m2). A wider variation in fentanyl plasma concentrations was found in this study than anticipated. Due to this variation, studies in larger patient cohorts are needed to further investigate the effect of smoking on plasma concentration of fentanyl and thereby clarify the clinical significance of our findings.	[Kuip, Evelien J. M.; Oldenmenger, Wendy H.; Thijs-Visser, Martine F.; de Bruijn, Peter; Oosten, Astrid W.; Oomen-de Hoop, Esther; Koolen, Stijn L. W.; Van der Rijt, Carin C. D.; Mathijssen, Ron H. J.] Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands; [Kuip, Evelien J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, Nijmegen, Netherlands; [Kuip, Evelien J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Care, Nijmegen, Netherlands; [Van der Rijt, Carin C. D.] Netherlands Comprehens Canc Org, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Radboud University Nijmegen; Radboud University Nijmegen	Kuip, EJM (corresponding author), Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands.; Kuip, EJM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, Nijmegen, Netherlands.; Kuip, EJM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Care, Nijmegen, Netherlands.	Evelien.Kuip@radboudumc.nl	Van der Rijt, Carin C.D./CAF-8390-2022; Oomen, Esther/GVS-6890-2022	Van der Rijt, Carin C.D./0000-0001-5996-1242; Koolen, Stijn/0000-0002-0973-7530; Oosten, Astrid/0000-0003-2850-0501; de Hoop, Esther/0000-0003-2506-3852; Oldenmenger, Wendy/0000-0001-6855-6505	Nuts/Ohra Foundation [1104-0203]	Nuts/Ohra Foundation	No sources of funding were used in the preparation of this manuscript. This study was financially supported by Nuts/Ohra Foundation grant 1104-0203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blume-Peytavi U, 2016, GERONTOLOGIST, V56, pS230, DOI 10.1093/geront/gnw003; Boston Collaborative Drug Surveillance Program Boston University Medical Center, 1973, N Engl J Med, V288, P277; Caraceni A, 1999, PAIN, V82, P263, DOI 10.1016/S0304-3959(99)00073-1; Clark AJ, 2004, CURR MED RES OPIN, V20, P1419, DOI 10.1185/030079904X2114; Davis MP, 2011, EXPERT REV NEUROTHER, V11, P1197, DOI [10.1586/ern.11.63, 10.1586/ERN.11.63]; de Graan AJM, 2012, CLIN CANCER RES, V18, P4425, DOI 10.1158/1078-0432.CCR-12-0728; Desai HD, 2001, CNS DRUGS, V15, P469, DOI 10.2165/00023210-200115060-00005; Grond S, 1997, PAIN, V69, P191, DOI 10.1016/S0304-3959(96)03254-X; Grond S, 2000, CLIN PHARMACOKINET, V38, P59, DOI 10.2165/00003088-200038010-00004; Hamilton M, 2006, CLIN CANCER RES, V12, P2166, DOI 10.1158/1078-0432.CCR-05-2235; Heiskanen T, 2009, PAIN, V144, P218, DOI 10.1016/j.pain.2009.04.012; HOLLEY FO, 1988, BRIT J ANAESTH, V60, P608, DOI 10.1093/bja/60.6.608; Jeal W, 1997, DRUGS, V53, P109, DOI 10.2165/00003495-199753010-00011; Kharasch ED, 2004, ANESTHESIOLOGY, V101, P729, DOI 10.1097/00000542-200409000-00022; Kokubun Hideya, 2012, J Pain Palliat Care Pharmacother, V26, P98, DOI 10.3109/15360288.2012.679725; Kuip EJM, 2017, BRIT J CLIN PHARMACO, V83, P294, DOI 10.1111/bcp.13129; Lahmann C, 2001, LANCET, V357, P935, DOI 10.1016/S0140-6736(00)04220-3; Lewis LD, 2012, CLIN CANCER RES, V18, P4219, DOI 10.1158/1078-0432.CCR-12-1713; Martires KJ, 2009, ARCH DERMATOL, V145, P1375, DOI 10.1001/archdermatol.2009.303; Nomura M, 2013, CLIN J PAIN, V29, P487, DOI 10.1097/AJP.0b013e318266f6a5; Oosten AW, 2015, J PAIN, V16, P935, DOI 10.1016/j.jpain.2015.05.006; Simon Steven M, 2014, J Opioid Manag, V10, P207, DOI 10.5055/jom.2014.0209; Solassol I, 2005, ONCOL REP, V14, P1029; Tassinari D, 2008, J PALLIAT MED, V11, P492, DOI 10.1089/jpm.2007.0200; van der Bol JM, 2007, J CLIN ONCOL, V25, P2719, DOI 10.1200/JCO.2006.09.6115; Wrighton SA, 1996, J PHARMACOKINET BIOP, V24, P461, DOI 10.1007/BF02353474; ZECH DFJ, 1992, PAIN, V50, P293, DOI 10.1016/0304-3959(92)90034-9; Zevin S, 1999, CLIN PHARMACOKINET, V36, P425, DOI 10.2165/00003088-199936060-00004; Ziesenitz VC, 2015, J CLIN PHARMACOL, V55, P708, DOI 10.1002/jcph.469	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198289	10.1371/journal.pone.0198289	http://dx.doi.org/10.1371/journal.pone.0198289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883454	Green Published, gold			2022-12-26	WOS:000434728100015
J	Parra, KJ; Hayek, SR				Parra, Karlett J.; Hayek, Summer R.			A lysosomal proton pump turns on when glucose runs out	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							VACUOLAR H+-ATPASE; COMPLEX; ACIDIFICATION	Vacuolar H+-ATPase (V-ATPase) is a glucose-responsive, ATP-driven proton pump that controls the acidity of cellular organelles. Increases in glucose stimulate V-ATPase assembly and activity, and glucose deprivation triggers rapid V-ATPase disassembly and inactivation in yeast. McGuire and Forgac describe the opposite phenomenon in mammalian cells, specifically that V-ATPase assembly and activation increases when glucose is lost, raising new questions about mammalian mechanisms of energy conservation.	[Parra, Karlett J.; Hayek, Summer R.] Univ New Mexico, Sch Med, Hlth Sci Ctr, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Parra, KJ (corresponding author), Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, MSC 08 4670, Albuquerque, NM 87131 USA.	kjparra@salud.unm.edu			American Heart Association [16GRNT27760020]; University of New Mexico Health Sciences Center	American Heart Association(American Heart Association); University of New Mexico Health Sciences Center	This work was supported in part by American Heart Association Grant 16GRNT27760020 (to K. J. P.) and the University of New Mexico Health Sciences Center. The authors declare that they have no conflicts of interest with the contents of this article.	Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; McGuire CM, 2018, J BIOL CHEM, V293, P9113, DOI 10.1074/jbc.RA117.001327; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Parra KJ, 2014, EUKARYOT CELL, V13, P706, DOI 10.1128/EC.00050-14; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Smardon AM, 2015, J BIOL CHEM, V290, P27511, DOI 10.1074/jbc.M115.667634; Weyandt Jamie D, 2017, Am Soc Clin Oncol Educ Book, V37, P825, DOI 10.14694/EDBK_175561; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014	10	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9124	9125		10.1074/jbc.H118.002950	http://dx.doi.org/10.1074/jbc.H118.002950			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29884762	Green Published, hybrid			2022-12-26	WOS:000434941900033
J	Thiem, JD; Wooden, IJ; Baumgartner, LJ; Butler, GL; Forbes, J; Taylor, MD; Watts, RJ				Thiem, Jason D.; Wooden, Ian J.; Baumgartner, Lee J.; Butler, Gavin L.; Forbes, Jamin; Taylor, Matthew D.; Watts, Robyn J.			Abiotic drivers of activity in a large, freeranging, freshwater teleost, Murray cod (Maccullochella peelii)	PLOS ONE			English	Article							HABITAT USE; MOVEMENTS; RIVER; ACCELERATION; TRANSMITTERS; DECAPODA; PREDATOR; FISHES; DIEL	The allocation of time and energy to different behaviours can impact survival and fitness, and ultimately influence population dynamics. Intrinsically, the rate at which animals expend energy is a key component in understanding how they interact with surrounding environments. Activity, derived through locomotion and basic metabolism, represents the principal energy cost for most animals, although it is rarely quantified in the field. We examined some abiotic drivers of variability in locomotor activity of a free-ranging freshwater predatory fish, Murray cod (Maccullochella peelii), for six months using tri-axial accelerometers. Murray cod (n = 20) occupied discrete river reaches and generally exhibited small-scale movements (< 5 km). Activity was highest during crepuscular and nocturnal periods when water temperatures were warmest (19 +/- 30 E degrees C; January +/- March). As water temperatures cooled (9 +/- 21 E degrees C; April +/- June) Murray cod were active throughout the full diel cycle and dormant periods were rarely observed. Light level, water temperature and river discharge all had a significant, non-linear effect on activity. Activity peaked during low light levels, at water temperatures of similar to 20 E degrees C, and at discharge rates of similar to 400 ML d(-1). The temporal changes observed in the behaviour of Murray cod likely reflect the complex interactions between physiological requirements and prey resource behaviour and availability in driving activity, and highlight the importance of empirical field data to inform bioenergetics models.	[Thiem, Jason D.; Wooden, Ian J.] Narrandera Fisheries Ctr, Dept Primary Ind, Narrandera, NSW, Australia; [Thiem, Jason D.; Baumgartner, Lee J.; Forbes, Jamin; Watts, Robyn J.] Charles Sturt Univ, Inst Land Water & Soc, Albury, NSW, Australia; [Butler, Gavin L.] Grafton Fisheries Ctr, Dept Primary Ind, Grafton, NSW, Australia; [Taylor, Matthew D.] Port Stephens Fisheries Inst, Dept Primary Ind, Taylors Beach, NSW, Australia	Charles Sturt University; NSW Department of Primary Industries; NSW Department of Primary Industries	Thiem, JD (corresponding author), Narrandera Fisheries Ctr, Dept Primary Ind, Narrandera, NSW, Australia.; Thiem, JD (corresponding author), Charles Sturt Univ, Inst Land Water & Soc, Albury, NSW, Australia.	jason.thiem@dpi.nsw.gov.au	Thiem, Jason/ABB-2169-2021; Baumgartner, Lee/P-2035-2015	Thiem, Jason/0000-0002-5585-8560; Baumgartner, Lee/0000-0002-1237-5163; Forbes, Jamin/0000-0003-4034-4003; Watts, Robyn/0000-0002-3526-7261; Butler, Gavin/0000-0003-4933-5306	Commonwealth Environmental Water Office under its Long Term Intervention Monitoring Project	Commonwealth Environmental Water Office under its Long Term Intervention Monitoring Project	The telemetry array used for this study was funded by the Commonwealth Environmental Water Office under its Long Term Intervention Monitoring Project for the Edward-Wakool selected area. Funding was awarded to JDT and RJW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner LJ, 2007, J FISH BIOL, V70, P879, DOI 10.1111/j.1095-8649.2007.01352.x; Baumgartner LJ, 2014, FISH FISH, V15, P410, DOI 10.1111/faf.12023; Beamish F.W., 1979, FISH PHYSL LOCOMOTIO, P101, DOI DOI 10.1139/cjfas-2015-0209; BOISCLAIR D, 1989, CAN J FISH AQUAT SCI, V46, P1859, DOI 10.1139/f89-234; Brodie S, 2016, ECOL EVOL, V6, P2262, DOI 10.1002/ece3.2027; Butler GL, 2014, ENDANGER SPECIES RES, V23, P35, DOI 10.3354/esr00557; Butler Gavin L., 2012, Endangered Species Research, V16, P199, DOI 10.3354/esr00406; Butler GL, 2009, MAR FRESHWATER RES, V60, P361, DOI 10.1071/MF08147; Ebner B, 2006, ECOL FRESHW FISH, V15, P510, DOI 10.1111/j.1600-0633.2006.00191.x; Ebner B, 2009, AQUAT ECOL, V43, P569, DOI 10.1007/s10452-008-9192-9; ELLIOTT JM, 1973, OECOLOGIA, V12, P329, DOI 10.1007/BF00345047; Fry F.E.J., 1971, P1; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Harris JH, 1996, FRESHWATER FISHES S, P50; Helfman G.S., 1993, BEHAV TELEOST FISHES, P479, DOI DOI 10.1007/978-94-011-1578-0; Jones MJ, 2007, ECOL FRESHW FISH, V16, P210, DOI 10.1111/j.1600-0633.2006.00213.x; Koehn JD, 2016, J FISH BIOL, V88, P1350, DOI 10.1111/jfb.12884; Koehn JD, 2009, ECOL FRESHW FISH, V18, P594, DOI 10.1111/j.1600-0633.2009.00375.x; LEE CL, 1979, CRUSTACEANA, V37, P219, DOI 10.1163/156854079X01068; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lintermans M., 2007, FISHES MURRAY DARLIN; Payne NL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2363; R Development Core Team, 2016, R LANG ENV STAT COMP; Reebs SG, 2002, REV FISH BIOL FISHER, V12, P349, DOI 10.1023/A:1025371804611; Richardson AJ, 2004, MAR FRESHWATER RES, V55, P295, DOI 10.1071/MF03126; Rowland Stuart J., 1998, Proceedings of the Linnean Society of New South Wales, V120, P147; Schwassmann H.O., 1971, P371; Short JW, 2004, HYDROBIOLOGIA, V525, P1, DOI 10.1023/B:HYDR.0000038871.50730.95; Simpson RR, 2002, ENVIRON BIOL FISH, V65, P401, DOI 10.1023/A:1021129021451; Taylor MK, 2014, RIVER RES APPL, V30, P756, DOI 10.1002/rra.2673; Taylor MK, 2012, ENVIRON REV, V20, P211, DOI [10.1139/A2012-009, 10.1139/a2012-009]; Thiem, 2008, P LINNEAN SOC NEW S, V129, P167; Thiem JD, 2013, ECOL FRESHW FISH, V22, P145, DOI 10.1111/eff.12012; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Watts RJ, 2015, 201415 EDW WAK SEL A; Whiterod NS, 2018, ECOL FRESHW FISH, V27, P686, DOI 10.1111/eff.12384; Whiterod NS, 2013, MAR FRESHW BEHAV PHY, V46, P201, DOI 10.1080/10236244.2013.819155; Whiterod NS, 2013, ECOL FRESHW FISH, V22, P117, DOI 10.1111/eff.12009; Wilson SM, 2013, COMP BIOCHEM PHYS A, V164, P491, DOI 10.1016/j.cbpa.2012.12.002; Wood S.N., 2017, GEN ADDITIVE MODELS; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x; Zuur Alain F., 2009, P1	42	12	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198972	10.1371/journal.pone.0198972	http://dx.doi.org/10.1371/journal.pone.0198972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883481	Green Published, gold			2022-12-26	WOS:000434728100044
J	Geissler, S; Textor, M; Stumpp, S; Seitz, S; Lekaj, A; Brunk, S; Klaassen, S; Schinke, T; Klein, C; Mundlos, S; Kornak, U; Kuhnisch, J				Geissler, Sven; Textor, Martin; Stumpp, Sabine; Seitz, Sebastian; Lekaj, Anja; Brunk, Sabrina; Klaassen, Sabine; Schinke, Thorsten; Klein, Christoph; Mundlos, Stefan; Kornak, Uwe; Kuehnisch, Jirko			Loss of murine Gfil causes neutropenia and induces osteoporosis depending on the pathogen load and systemic inflammation	PLOS ONE			English	Article							BONE-MINERAL DENSITY; CHRONIC IDIOPATHIC NEUTROPENIA; SEVERE CONGENITAL NEUTROPENIA; TRANSCRIPTION FACTOR GFI-1; REPRESSOR GFI1; IMMUNE-SYSTEM; TNF-ALPHA; G-CSF; CELLS; OSTEOCLASTS	Gfi1 is a key molecule in hematopoietic lineage development and mutations in GFI1 cause severe congenital neutropenia (SCN). Neutropenia is associated with low bone mass, but the underlying mechanisms are poorly characterized. Using Gfi1 knock-out mice (Gfil-ko/ko) as SCN model, we studied the relationship between neutropenia and bone mass upon different pathogen load conditions. Our analysis reveals that Gfil-ko/ko mice kept under strict specific pathogen free (SPF) conditions demonstrate normal bone mass and survival. However, Gfil-ko/ko mice with early (nonSPF) or late (SPF+nonSPF) pathogen exposure develop low bone mass. Gfil-ko/ko mice demonstrate a striking rise of systemic inflammatory markers according to elevated pathogen exposure and reduced bone mass. Elevated inflammatory cytokines include for instance 11-1b, 11-6, and Tnf-alpha that regulate osteoclast development. We conclude that low bone mass, due to low neutrophil counts, is caused by the degree of systemic inflammation promoting osteoclastogenesis.	[Geissler, Sven; Textor, Martin; Stumpp, Sabine; Lekaj, Anja; Klaassen, Sabine; Mundlos, Stefan; Kornak, Uwe; Kuehnisch, Jirko] Charite Univ Med Berlin, Berlin, Germany; [Geissler, Sven; Textor, Martin; Stumpp, Sabine; Lekaj, Anja; Klaassen, Sabine; Mundlos, Stefan; Kornak, Uwe; Kuehnisch, Jirko] Humboldt Univ, Freie Univ Berlin, Berlin, Germany; [Geissler, Sven; Textor, Martin; Mundlos, Stefan; Kornak, Uwe] Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin Inst Hlth, Berlin, Germany; [Geissler, Sven; Textor, Martin] Julius Wolff Inst, Berlin Inst Hlth, Berlin, Germany; [Stumpp, Sabine; Lekaj, Anja; Mundlos, Stefan; Kornak, Uwe; Kuehnisch, Jirko] Inst Med Genet & Human Genet, Berlin Inst Hlth, Berlin, Germany; [Seitz, Sebastian] Univ Med Ctr Hamburg Eppendorf, Dept Orthopaed, Hamburg, Germany; [Brunk, Sabrina] Inst Tierpathol, Berlin, Germany; [Klaassen, Sabine; Kuehnisch, Jirko] Berlin Inst Hlth, ECRC, Berlin, Germany; [Klaassen, Sabine] Berlin Inst Hlth, Dept Pediat Cardiol, Berlin, Germany; [Schinke, Thorsten] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany; [Klein, Christoph] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany; [Mundlos, Stefan; Kornak, Uwe; Kuehnisch, Jirko] Max Planck Inst Mol Genet, FG Dev & Dis, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Berlin Institute of Health; Berlin Institute of Health; University of Hamburg; University Medical Center Hamburg-Eppendorf; Berlin Institute of Health; Berlin Institute of Health; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Max Planck Society	Kuhnisch, J (corresponding author), Charite Univ Med Berlin, Berlin, Germany.; Kuhnisch, J (corresponding author), Humboldt Univ, Freie Univ Berlin, Berlin, Germany.; Kuhnisch, J (corresponding author), Inst Med Genet & Human Genet, Berlin Inst Hlth, Berlin, Germany.; Kuhnisch, J (corresponding author), Berlin Inst Hlth, ECRC, Berlin, Germany.; Kuhnisch, J (corresponding author), Max Planck Inst Mol Genet, FG Dev & Dis, Berlin, Germany.	jirko.kuehnisch@mdc-berlin.de	Geißler, Sven/J-7275-2013; Kühnisch, Jirko/L-7761-2013; Mundlos, Stefan/ABH-9585-2020; Kühnisch, Jirko/M-3744-2019	Geißler, Sven/0000-0002-8750-6324; Kühnisch, Jirko/0000-0003-4744-5421; Mundlos, Stefan/0000-0002-9788-3166; Klaassen, Sabine/0000-0001-5925-9912	Deutsche Forschungsgemeinschaft (DFG) [Schwerpunktprogramm SPP 1468]; BMBF (DIMEOS) [01EC1402B]; DFG Research Unit [FOR 2165, GE2512/2-1];  [SPP 1468]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); BMBF (DIMEOS); DFG Research Unit(German Research Foundation (DFG)); 	SM and UK received a Deutsche Forschungsgemeinschaft (DFG) Schwerpunktprogramm SPP 1468 Immunobone research grant. JK, SaS, and AL were supported by the SPP 1468 Immunobone. SG and MT were partially supported by the BMBF (DIMEOS, 01EC1402B) and the DFG Research Unit (FOR 2165; grant GE2512/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardoel BW, 2014, CELL HOST MICROBE, V15, P526, DOI 10.1016/j.chom.2014.04.011; Borzutzky A, 2006, J PEDIAT HEMATOL ONC, V28, P205, DOI 10.1097/01.mph.0000210409.48877.c3; Boztug K, 2009, NEW ENGL J MED, V360, P32, DOI 10.1056/NEJMoa0805051; Calle Y, 2004, BLOOD, V103, P3552, DOI 10.1182/blood-2003-04-1259; Capoccia BJ, 2006, BLOOD, V108, P2438, DOI 10.1182/blood-2006-04-013755; D'Souza S, 2011, BLOOD, V118, P6871, DOI 10.1182/blood-2011-04-346775; Daci E, 2002, HORM RES, V58, P44, DOI 10.1159/000064758; Danks L, 2011, J BONE MINER RES, V26, P182, DOI 10.1002/jbmr.210; Del Fattore Andrea, 2012, Inflammation & Allergy Drug Targets, V11, P181; Duan Zhijun, 2003, Hematology, V8, P339, DOI 10.1080/10245330310001612116; Duan ZJ, 2005, TRENDS MOL MED, V11, P49, DOI 10.1016/j.molmed.2004.12.003; Geissler S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.501; Geissler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052700; Geoffroy V, 2002, MOL CELL BIOL, V22, P6222, DOI 10.1128/MCB.22.17.6222-6233.2002; Hauck F, 2013, CURR OPIN ALLERGY CL, V13, P596, DOI 10.1097/ACI.0000000000000014; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Horwitz MS, 2007, BLOOD, V109, P1817, DOI 10.1182/blood-2006-08-019166; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Kasper G, 2009, STEM CELLS, V27, P1288, DOI 10.1002/stem.49; Keller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6215; Kim W, 2014, BLOOD, V124, P1586, DOI 10.1182/blood-2014-02-556522; Kotani M, 2013, J IMMUNOL, V190, P605, DOI 10.4049/jimmunol.1201345; Kuhnisch J, 2014, BONE, V66, P155, DOI 10.1016/j.bone.2014.06.012; Kuhnisch J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086115; Lari R, 2007, BONE, V40, P323, DOI 10.1016/j.bone.2006.09.003; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Matsuo K, 2009, CURR OPIN NEPHROL HY, V18, P292, DOI 10.1097/MNH.0b013e32832b75f1; McGarry MP, 2010, MOUSE HEMATOLOGY LAB; Moroy T, 2015, BLOOD, V126, P2561, DOI 10.1182/blood-2015-06-655043; Morava E, 2011, J CLIN ENDOCR METAB, V96, pE189, DOI 10.1210/jc.2010-1539; Moutsopoulos NM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007696; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Ozturk ZA, 2013, ARCH GERONTOL GERIAT, V57, P81, DOI 10.1016/j.archger.2013.02.005; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Papadaki HA, 2004, J BONE MINER METAB, V22, P577, DOI 10.1007/s00774-004-0526-y; Papadaki HA, 1999, EUR J HAEMATOL, V62, P311; Papadaki HA, 2001, EUR J HAEMATOL, V67, P35, DOI 10.1034/j.1600-0609.2001.00473.x; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Phan TCA, 2004, HISTOL HISTOPATHOL, V19, P1325, DOI 10.14670/HH-19.1325; Phelan JD, 2010, CURR OPIN HEMATOL, V17, P300, DOI 10.1097/MOH.0b013e32833a06f8; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; Reinke S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004754; Rogier EW, 2014, P NATL ACAD SCI USA, V111, P3074, DOI 10.1073/pnas.1315792111; Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043; Seifert W, 2009, HUM MUTAT, V30, pE404, DOI 10.1002/humu.20886; Shi LZ, 2013, P NATL ACAD SCI USA, V110, pE3198, DOI 10.1073/pnas.1300950110; Sierra MDLL, 2007, BLOOD, V110, P2276, DOI 10.1182/blood-2007-03-081448; Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Teti Anna, 2013, Bonekey Rep, V2, P449, DOI 10.1038/bonekey.2013.183; Treuting PM, 2012, VET PATHOL, V49, P44, DOI 10.1177/0300985811431446; van der Meer LT, 2010, LEUKEMIA, V24, P1834, DOI 10.1038/leu.2010.195; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Yakisan E, 1997, J PEDIATR-US, V131, P592, DOI 10.1016/S0022-3476(97)70068-4; Zhao BH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3379; Zupan J, 2013, BIOCHEM MEDICA, V23, P43, DOI 10.11613/BM.2013.007	59	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198510	10.1371/journal.pone.0198510	http://dx.doi.org/10.1371/journal.pone.0198510			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879182	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000434384900050
J	Lee, H				Lee, Hwankyu			Structures, dynamics, and hydrogen-bond interactions of antifreeze proteins in TIP4P/Ice water and their dependence on force fields	PLOS ONE			English	Article							LINEAR CONSTRAINT SOLVER; ICE CRYSTAL-GROWTH; MOLECULAR-DYNAMICS; LIQUID WATER; COMPUTER-SIMULATION; FREEZING RESISTANCE; MECHANISM; MODEL; ADSORPTION; INHIBITION	Tenebrio molitor antifreeze protein (TmAFP) was simulated with growing ice-water interfaces at a realistic melting temperature using TIP4P/Ice water model. To test compatibility of protein force fields (FFs) with TIP4P/Ice water, CHARMM, AMBER, and OPLS FFs were applied. CHARMM and AMBER FFs predict more beta-sheet structure and lower diffusivity of TmAFP at the ice-water interface than does OPLS FF, indicating that beta-sheet structure is important for the TmAFP-interface binding and antifreeze activity. In particular, CHARMM FF more clearly distinguishes the strengths of hydrogen bonds in the ice-binding and non ice-binding sites of TmAFP than do other FFs, in agreement with experiments, implying that CHARMM FF can be a reasonable choice to simulate proteins with TIP4P/Ice water. Simulations of mutated TmAFPs show that for the same density of Thr residues, continuous arrangement of Thr with the distance of 0.4-0.6 nm induces the higher extent of antifreeze activity than does intermittent arrangement of Thr with larger distances. These findings suggest the choice of CHARMM FF for AFP-TIP4P/Ice simulations and help explain the relationship between Thr-residue arrangement and antifreeze activity.	[Lee, Hwankyu] Dankook Univ, Dept Chem Engn, Yongin, Gyeonggi Do, South Korea	Dankook University	Lee, H (corresponding author), Dankook Univ, Dept Chem Engn, Yongin, Gyeonggi Do, South Korea.	leeh@dankook.ac.kr		Lee, Hwankyu/0000-0002-2036-1490	Creative Materials Discovery Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT [NRF-2017M3D1A1039422]	Creative Materials Discovery Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT	This research was supported by Creative Materials Discovery Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2017M3D1A1039422).	Abascal J.LF., 2005, J CHEM PHYS, V122; Barrett J, 2001, INT J BIOCHEM CELL B, V33, P105, DOI 10.1016/S1357-2725(00)00083-2; Berendsen H., 1981, INTERMOLECULAR FORCE, DOI DOI 10.1007/978-94-015-7658-1_21; BOLCH BW, 1968, AM STAT, V22, P27, DOI 10.2307/2681802; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CARPENTER JF, 1992, P NATL ACAD SCI USA, V89, P8953, DOI 10.1073/pnas.89.19.8953; Chakraborty S, 2017, LANGMUIR, V33, P7202, DOI 10.1021/acs.langmuir.7b01733; Cheng AL, 1997, BIOPHYS J, V73, P2851, DOI 10.1016/S0006-3495(97)78315-2; Dalal P, 2001, PHYSCHEMCOMM, DOI 10.1039/b101331i; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; DAVIES PL, 1990, FASEB J, V4, P2460, DOI 10.1096/fasebj.4.8.2185972; DEVRIES AL, 1969, SCIENCE, V163, P1073, DOI 10.1126/science.163.3871.1073; Drori R, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0526; DUMAN JG, 1993, CRYOBIOLOGY, V30, P322, DOI 10.1006/cryo.1993.1031; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FEENEY RE, 1973, NATURE, V243, P357, DOI 10.1038/243357a0; Gilbert JA, 2005, FEMS MICROBIOL LETT, V245, P67, DOI 10.1016/j.femsle.2005.02.022; Gordienko R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008953; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hew CL, 1992, EUROPEAN J BIOCH, V203; Horn HW, 2004, J CHEM PHYS, V120, P9665, DOI 10.1063/1.1683075; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jeffrey G.A., 2012, HYDROGEN BONDING BIO; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kar RK, 2015, PROG BIOPHYS MOL BIO, V119, P194, DOI 10.1016/j.pbiomolbio.2015.09.001; KNIGHT CA, 1989, SCIENCE, V245, P505, DOI 10.1126/science.245.4917.505; KNIGHT CA, 1991, BIOPHYS J, V59, P409, DOI 10.1016/S0006-3495(91)82234-2; Kuiper MJ, 2015, ELIFE, V4, DOI 10.7554/eLife.05142; KUSALIK PG, 1994, SCIENCE, V265, P1219, DOI 10.1126/science.265.5176.1219; Lieu YC, 2000, PROTEIN EXPRES PURIF, V19, P148, DOI 10.1006/prep.2000.1219; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Liu K, 2016, P NATL ACAD SCI USA, V113, P14739, DOI 10.1073/pnas.1614379114; Luzar A, 2000, J CHEM PHYS, V113, P10663, DOI 10.1063/1.1320826; Luzar A, 1996, NATURE, V379, P55, DOI 10.1038/379055a0; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; MCDONALD SM, 1995, AICHE J, V41, P959, DOI 10.1002/aic.690410426; Meister K, 2015, J PHYS CHEM LETT, V6, P1162, DOI 10.1021/acs.jpclett.5b00281; Meister K, 2014, P NATL ACAD SCI USA, V111, P17732, DOI 10.1073/pnas.1414188111; Midya US, 2017, LANGMUIR, V33, P5499, DOI 10.1021/acs.langmuir.7b01206; Nada H, 2003, J CHEM PHYS, V118, P7401, DOI 10.1063/1.1562610; Nada H, 2008, J PHYS CHEM B, V112, P7111, DOI 10.1021/jp711977g; Nada H, 2012, POLYM J, V44, P690, DOI 10.1038/pj.2012.13; Olijve LLC, 2016, P NATL ACAD SCI USA, V113, P3740, DOI 10.1073/pnas.1524109113; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pertaya N, 2008, BIOPHYS J, V95, P333, DOI 10.1529/biophysj.107.125328; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; Sidebottom C, 2000, NATURE, V406, P256, DOI 10.1038/35018639; Ustun NS, 2015, J FOOD PROCESS PRES, V39, P3189, DOI 10.1111/jfpp.12476; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wierzbicki A, 2007, BIOPHYS J, V93, P1442, DOI 10.1529/biophysj.107.105189; Yeh IC, 2004, J PHYS CHEM B, V108, P15873, DOI 10.1021/jp0477147; Yeh Y, 1996, CHEM REV, V96, P601, DOI 10.1021/cr950260c	63	11	11	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198887	10.1371/journal.pone.0198887	http://dx.doi.org/10.1371/journal.pone.0198887			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879205	Green Submitted, Green Published, gold			2022-12-26	WOS:000434384900095
J	Waudby-Smith, IER; Tran, N; Dubin, JA; Lee, J				Waudby-Smith, Ian E. R.; Nam Tran; Dubin, Joel A.; Lee, Joon			Sentiment in nursing notes as an indicator of out-of-hospital mortality in intensive care patients	PLOS ONE			English	Article							DOCUMENTATION; PREDICTIONS; SCORE; UNIT	Background Nursing notes have not been widely used in prediction models for clinical outcomes, despite containing rich information. Advances in natural language processing have made it possible to extract information from large scale unstructured data like nursing notes. This study extracted the sentiment impressions and attitudes of nurses, and examined how sentiment relates to 30-day mortality and survival. Methods This study applied a sentiment analysis algorithm to nursing notes extracted from MIMIC-Ill, a public intensive care unit (ICU) database. A multiple logistic regression model was fitted to the data to correlate measured sentiment with 30-day mortality while controlling for gender, type of ICU, and SAPS-II score. The association between measured sentiment and 30-day mortality was further examined in assessing the predictive performance of sentiment score as a feature in a classifier, and in a survival analysis for different levels of measured sentiment. Results Nursing notes from 27,477 ICU patients, with an overall 30-day mortality of 11.02%, were extracted. In the presence of known predictors of 30-day mortality, mean sentiment polarity was a highly significant predictor in a multiple logistic regression model (Adjusted OR = 0.4626, p < 0.001, 95% CI: [0.4244, 0.5041]) and led to improved predictive accuracy (AUROC = 0.8189 versus 0.8092, 95% BCI of difference: [0.0070, 0.0126]). The Kaplan Meier survival curves showed that mean sentiment polarity quartiles are positively correlated with patient survival (log-rank test: p < 0.001). Conclusions This study showed that quantitative measures of unstructured clinical notes, such as sentiment of clinicians, correlate with 30-day mortality and survival, thus can also serve as apredictor of patient outcomes in the ICU. Therefore, further research is warranted to study and make use of the wealth of data that clinical notes have to offer.	[Waudby-Smith, Ian E. R.; Dubin, Joel A.] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON, Canada; [Waudby-Smith, Ian E. R.; Nam Tran; Dubin, Joel A.; Lee, Joon] Univ Waterloo, Hlth Data Sci Lab, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada	University of Waterloo; University of Waterloo	Lee, J (corresponding author), Univ Waterloo, Hlth Data Sci Lab, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada.	joon.lee@uwaterloo.ca		Lee, Joon/0000-0001-8593-9321	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2014-04743]; University of Waterloo President's Research Award; Government of Ontario - Ontario Trillium Scholarship; University of Waterloo; President's Research Award from the University of Waterloo; Ontario Trillium Scholarship from the Government of Ontario, Canada	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Waterloo President's Research Award; Government of Ontario - Ontario Trillium Scholarship; University of Waterloo; President's Research Award from the University of Waterloo; Ontario Trillium Scholarship from the Government of Ontario, Canada	JL was partially supported by a Discovery Grant (RGPIN-2014-04743) from the Natural Sciences and Engineering Research Council of Canada (NSERC). IW-S was partially supported by the University of Waterloo President's Research Award (https://uwaterloo.ca/student-awards-financial-aid/undergraduate-awards/presidents-upper-year-awards). NT was partially supported by the Government of Ontario - Ontario Trillium Scholarship (https://uwaterloo.ca/graduate-studies/awards/ontario-trillium-scholarship-ots). JD and JL were supported by the University of Waterloo as faculty members. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a Discovery Grant (RGPIN-2014-04743) from the Natural Sciences and Engineering Research Council of Canada (NSERC), the President's Research Award from the University of Waterloo, and the Ontario Trillium Scholarship from the Government of Ontario, Canada.	Baojun Qiu, 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P274, DOI 10.1109/PASSAT/SocialCom.2011.127; Brabrand M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101739; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Cioffi J, 2000, HEART LUNG, V29, P262, DOI 10.1067/mhl.2000.108327; Collins SA, 2013, AM J CRIT CARE, V22, P306, DOI 10.4037/ajcc2013426; Collins SA, 2012, APPL NURS RES, V25, P251, DOI 10.1016/j.apnr.2011.06.002; De Smedt T, 2018, CLIPS PATTERN SOURCE; De Smedt T, 2014, SUBJECTIVITY LEXICON; Ghassemi MM, 2015, COMPUT CARDIOL CONF, V42, P629, DOI 10.1109/CIC.2015.7410989; Greaves F, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2721; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; King D, 2013, HEALTH POLICY, V110, P291, DOI 10.1016/j.healthpol.2013.02.005; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Liu B., 2012, SYNTHESIS LECT HUMAN, V5, P1, DOI DOI 10.2200/S00416ED1V01Y201204HLT016; Liu B, 2012, MINING TEXT DATA, P415, DOI [10.1007/978-1-4614-3223-4_13, DOI 10.1007/978-1-4614-3223-4_13]; Loria S., 2018, TEXTBLOB DOCUMENTATI; McCoy TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136341; Mitchell L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064417; Myslin M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2534; Odell M, 2009, J ADV NURS, V65, P1992, DOI 10.1111/j.1365-2648.2009.05109.x; Portier Kenneth, 2013, Journal of the National Cancer Institute Monographs, P195, DOI 10.1093/jncimonographs/lgt025; Rocker G, 2004, CRIT CARE MED, V32, P1149, DOI 10.1097/01.CCM.0000126402.51524.52; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Sinuff T, 2006, CRIT CARE MED, V34, P878, DOI 10.1097/01.CCM.0000201881.58644.41; STEVENS SM, 1994, PEDIATRICS, V93, P945; Tran N, 2018, P IEEE EMBS INT C BI; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; WONG DT, 1991, CAN J ANAESTH, V38, P374, DOI 10.1007/BF03007629	30	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198687	10.1371/journal.pone.0198687	http://dx.doi.org/10.1371/journal.pone.0198687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879201	Green Published, gold, Green Submitted			2022-12-26	WOS:000434384900072
J	Zewde, N; Morikis, D				Zewde, Nehemiah; Morikis, Dimitrios			A computational model for the evaluation of complement system regulation under homeostasis, disease, and drug intervention	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; MEMBRANE ATTACK COMPLEX; NONNATURAL AMINO-ACIDS; ALTERNATIVE PATHWAY; C3 GLOMERULOPATHY; ACTIVATING SURFACES; CLASSICAL PATHWAY; STRUCTURAL BASIS; C5 CONVERTASE; CELL-SURFACE	The complement system is an intricate defense network that rapidly removes invading pathogens. Although many complement regulators are present to protect host cells under homeostasis, the impairment of Factor H (FH) regulatory mechanism has been associated with several autoimmune and inflammatory diseases. To understand the dynamics involved in the pivotal balance between activation and regulation, we have developed a comprehensive computational model of the alternative and classical pathways of the complement system. The model is composed of 290 ordinary differential equations with 142 kinetic parameters that describe the state of complement system under homeostasis and disorder through FH impairment. We have evaluated the state of the system by generating concentration-time profiles for the biomarkers C3, C3a-desArg, C5, C5a-desArg, Factor B (FB), Ba, Bb, and fC5b-9 that are influenced by complement dysregulation. We show that FH-mediated disorder induces substantial levels of complement activation compared to homeostasis, by generating reduced levels of C3 and FB, and to a lesser extent C5, and elevated levels of C3a-desArg, Ba, Bb, C5a-desArg, and fC5b-9. These trends are consistent with clinically observed biomarkers associated with complement-mediated diseases. Furthermore, we introduced therapy states by modeling known inhibitors of the complement system, a compstatin variant (C3 inhibitor) and eculizumab (C5 inhibitor). Compstatin demonstrates strong restorative effects for early-stage biomarkers, such as C3a-desArg, FB, Ba, and Bb, and milder restorative effects for late-stage biomarkers, such as C5a-desArg and fC5b-9, whereas eculizumab has strong restorative effects on late-stage biomarkers, and negligible effects on early-stage biomarkers. These results highlight the need for patient-tailored therapies that target early complement activation at the C3 level, or late-stage propagation of the terminal cascade at the C5 level, depending on the specific FH-mediated disease and the manifestations of a patient's genetic profile in complement regulatory function.	[Zewde, Nehemiah; Morikis, Dimitrios] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA	University of California System; University of California Riverside	Morikis, D (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	dmorikis@ucr.edu	Morikis, Dimitrios/L-8527-2013	Morikis, Dimitrios/0000-0003-0083-4665				Angioi A, 2016, KIDNEY INT, V89, P278, DOI 10.1016/j.kint.2015.12.003; Coulthard LG, 2015, J IMMUNOL, V194, P3542, DOI 10.4049/jimmunol.1403068; De Vriese AS, 2015, J AM SOC NEPHROL, V26, P2917, DOI 10.1681/ASN.2015020184; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; Dmytrijuk A, 2008, ONCOLOGIST, V13, P993, DOI 10.1634/theoncologist.2008-0086; Gaboriaud C, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00565; Gorham RD, 2015, J MED CHEM, V58, P814, DOI 10.1021/jm501345y; Gorham RD, 2013, EXP EYE RES, V116, P96, DOI 10.1016/j.exer.2013.07.023; Harboe M, 2017, P NATL ACAD SCI USA, V114, pE534, DOI 10.1073/pnas.1612385114; Hirayama H, 1996, BIOSYSTEMS, V39, P173, DOI 10.1016/0303-2647(96)01617-6; Hourcade DE, 2006, J BIOL CHEM, V281, P2128, DOI 10.1074/jbc.M508928200; Jozsi M, 2015, TRENDS IMMUNOL, V36, P374, DOI 10.1016/j.it.2015.04.008; Korotaevskiy AA, 2009, MATH BIOSCI, V222, P127, DOI 10.1016/j.mbs.2009.10.003; Lang SN, 2018, BIORXIV, DOI [10.1101/250662, DOI 10.1101/250662]; LAW SK, 1977, P NATL ACAD SCI USA, V74, P2701, DOI 10.1073/pnas.74.7.2701; LAW SK, 1979, J IMMUNOL, V123, P1388; Law SKA, 1997, PROTEIN SCI, V6, P263; Liszewski MK, 2017, ANNU REV PATHOL-MECH, V12, P25, DOI 10.1146/annurev-pathol-012615-044145; Liu B, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001059; Lopez de Victoria A, 2011, CHEM BIOL DRUG DES, V77, P431, DOI 10.1111/j.1747-0285.2011.01111.x; Lutz HU, 2006, MOL IMMUNOL, V43, P2, DOI 10.1016/j.molimm.2005.06.020; Mallik B, 2005, J MED CHEM, V48, P274, DOI 10.1021/jm0495531; Mastellos DC, 2015, EUR J CLIN INVEST, V45, P423, DOI 10.1111/eci.12419; MERI S, 1990, EUR J IMMUNOL, V20, P2555, DOI 10.1002/eji.1830201205; MERI S, 1990, IMMUNOLOGY, V71, P1; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Merle NS, 2015, FRONT IMMUNOL; Mohan RR, 2016, MOL VIS, V22, P1280; Morgan BP, 2017, SEMIN CELL DEV BIOL, V72, P124, DOI 10.1016/j.semcdb.2017.06.009; Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; Nester CM, 2016, SEMIN IMMUNOL, V28, P241, DOI 10.1016/j.smim.2016.06.002; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Pickering MC, 2013, KIDNEY INT, V84, P1079, DOI 10.1038/ki.2013.377; Rawal N, 1998, J BIOL CHEM, V273, P16828, DOI 10.1074/jbc.273.27.16828; Rawal N, 2003, J BIOL CHEM, V278, P38476, DOI 10.1074/jbc.M307017200; Rawal N, 2001, J IMMUNOL, V166, P2635, DOI 10.4049/jimmunol.166.4.2635; Ricklin D, 2016, IMMUNOL REV, V274, P33, DOI 10.1111/imr.12500; Ricklin D, 2016, NAT REV NEPHROL, V12, P383, DOI 10.1038/nrneph.2016.70; Risitano AM, 2014, BLOOD, V123, P2094, DOI 10.1182/blood-2013-11-536573; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Sagar A, 2016, BIORXIV, DOI [10.1101/059386, DOI 10.1101/059386]; Schatz-Jakobsen JA, 2016, IMMUNOL REV, V274, P59, DOI 10.1111/imr.12465; Schatz-Jakobsen JA, 2016, J IMMUNOL, V197, P337, DOI 10.4049/jimmunol.1600280; Schmidt CQ, 2016, IMMUNOL REV, V274, P152, DOI 10.1111/imr.12475; Serna M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10587; Servais A, 2007, J MED GENET, V44, P193, DOI 10.1136/jmg.2006.045328; Servais A, 2012, KIDNEY INT, V82, P454, DOI 10.1038/ki.2012.63; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; Vernon KA, 2016, J AM SOC NEPHROL, V27, P1334, DOI 10.1681/ASN.2015030295; Wang G, 2016, MOL CELL, V63, P135, DOI 10.1016/j.molcel.2016.05.016; Zewde N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152337; Zhang YZ, 2014, CLIN J AM SOC NEPHRO, V9, P1876, DOI 10.2215/CJN.01820214; ZICCARDI RJ, 1982, J IMMUNOL, V128, P2500	55	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198644	10.1371/journal.pone.0198644	http://dx.doi.org/10.1371/journal.pone.0198644			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874282	gold, Green Published, Green Submitted			2022-12-26	WOS:000434369400057
J	Willeman, MN; Mennenga, SE; Siniard, AL; Corneveaux, JJ; De Both, M; Hewitt, LT; Tsang, CWS; Caselli, J; Braden, BB; Bimonte-Nelson, HA; Huentelman, MJ				Willeman, Mari N.; Mennenga, Sarah E.; Siniard, Ashley L.; Corneveaux, Jason J.; De Both, Matt; Hewitt, Lauren T.; Tsang, Candy W. S.; Caselli, Jason; Braden, B. Blair; Bimonte-Nelson, Heather A.; Huentelman, Matthew J.			The PKC-beta selective inhibitor, Enzastaurin, impairs memory in middle-aged rats	PLOS ONE			English	Article							PROTEIN-KINASE-C; ANTITUMOR-ACTIVITY; SPATIAL MEMORY; REPLACEMENT; ISOFORM; INJURY; ALPHA; YOUNG	Enzastaurin is a Protein Kinase C-beta selective inhibitor that was developed to treat cancers. Protein Kinase C-beta is an important enzyme for a variety of neuronal functions; in particular, previous rodent studies have reported deficits in spatial and fear-conditioned learning and memory with lower levels of Protein Kinase C-beta. Due to Enzastaurin's mechanism of action, the present study investigated the consequences of Enzastaurin exposure on learning and memory in 12-month-old Fischer-344 male rats. Rats were treated daily with subcutaneous injections of either vehicle or Enzastaurin, and behaviorally tested using the spatial reference memory Morris Water Maze. Rats treated with Enzastaurin exhibited decreased overnight retention and poorer performance on the latter testing day, indicating a mild, but significant, memory impairment. There were no differences during the probe trial indicating that all animals were able to spatially localize the platform to the proper quadrant by the end of testing. RNA isolated from the hippocampus was analyzed using Next Generation Sequencing (lllumina). No statistically significant transcriptional differences were noted. Our findings suggest that acute Enzastaurin treatment can impair hippocampal-based learning and memory performance, with no effects on transcription in the hippocampus. We propose that care should be taken in future clinical trials that utilize Protein Kinase C-SS inhibitors, to monitor for possible cognitive effects, future research should examine if these effects are fully reversible.	[Willeman, Mari N.; Siniard, Ashley L.; Corneveaux, Jason J.; De Both, Matt; Huentelman, Matthew J.] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ 85004 USA; [Willeman, Mari N.; Siniard, Ashley L.; Corneveaux, Jason J.; De Both, Matt; Braden, B. Blair; Bimonte-Nelson, Heather A.; Huentelman, Matthew J.] Arizona Alzheimers Consortium, Phoenix, AZ 85014 USA; [Willeman, Mari N.; Siniard, Ashley L.; Corneveaux, Jason J.; De Both, Matt; Huentelman, Matthew J.] Univ Arizona, Evelyn F McKnight Brain Inst, Tucson, AZ 85721 USA; [Willeman, Mari N.; Mennenga, Sarah E.; Hewitt, Lauren T.; Tsang, Candy W. S.; Caselli, Jason; Braden, B. Blair; Bimonte-Nelson, Heather A.] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA	Translational Genomics Research Institute; University of Arizona; Arizona State University; Arizona State University-Tempe	Huentelman, MJ (corresponding author), Translat Genom Res Inst, Neurogen Div, Phoenix, AZ 85004 USA.; Huentelman, MJ (corresponding author), Arizona Alzheimers Consortium, Phoenix, AZ 85014 USA.; Huentelman, MJ (corresponding author), Univ Arizona, Evelyn F McKnight Brain Inst, Tucson, AZ 85721 USA.	mhuentelman@tgen.org	Mennenga, Sarah E/N-9236-2016	Mennenga, Sarah E/0000-0002-9279-2409; Hewitt, Lauren/0000-0001-7270-7679	NIH-NINDS [R01-NS059873]; State of Arizona DHS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059873] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); State of Arizona DHS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIH-NINDS grant R01-NS059873 (awarded to MJH) (https://www.ninds.nih.gov/) and the State of Arizona DHS (grants awarded to MJH and HAB-N) (http://www.azdhs.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JI, 2009, ENDOCRINOLOGY, V150, P4248, DOI 10.1210/en.2008-1802; Berridge MJ, 2011, NEUROCHEM RES, V36, P1149, DOI 10.1007/s11064-010-0371-4; Bimonte-Nelson HA, 2015, NEUROMETHODS, V94, P441, DOI 10.1007/978-1-4939-2159-1_19; Bourhill T, 2017, CRIT REV ONCOL HEMAT, V112, P72, DOI 10.1016/j.critrevonc.2017.02.003; Braden BB, 2010, MEDORXYPROGESTERONE, V3, P1; Colombo PJ, 1997, P NATL ACAD SCI USA, V94, P14195, DOI 10.1073/pnas.94.25.14195; Cordey M, 2003, J NEUROCHEM, V84, P1340, DOI 10.1046/j.1471-4159.2003.01631.x; de Quervain DJF, 2012, P NATL ACAD SCI USA, V109, P8746, DOI 10.1073/pnas.1200857109; Doyle JJ, 2015, ELIFE, V4, DOI 10.7554/eLife.08648; Engler-Chiurazzi E, 2011, NEUROBIOL AGING, V32, P680, DOI 10.1016/j.neurobiolaging.2009.09.005; Hung MC, 2001, LIFE SCI, V69, P1419, DOI 10.1016/S0024-3205(01)01221-8; Diez-Guerra FJ, 2010, IUBMB LIFE, V62, P597, DOI 10.1002/iub.357; Jian WG, 2009, MOL CANCER THER, V8, P1772, DOI 10.1158/1535-7163.MCT-09-0141; Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930; Lanz TV, 2013, P NATL ACAD SCI USA, V110, P14735, DOI 10.1073/pnas.1302569110; Liu Y, 2015, CLIN SCI, V129, P331, DOI 10.1042/CS20140789; MacLeod CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098018; Markham JA, 2002, HORM BEHAV, V42, P284, DOI 10.1006/hbeh.2002.1819; Moreau AS, 2007, BLOOD, V109, P4964, DOI 10.1182/blood-2006-10-054577; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Morris RGM, 2015, NEUROMETHODS, V94, P73, DOI 10.1007/978-1-4939-2159-1_3; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; Nikoletopoulou Vassiliki, 2012, Frontiers in Genetics, V3, P200, DOI 10.3389/fgene.2012.00200; Paratcha G, 2000, BRAIN RES, V855, P199, DOI 10.1016/S0006-8993(99)02323-9; PASINELLI P, 1995, BEHAV BRAIN RES, V66, P53, DOI 10.1016/0166-4328(94)00124-X; Podar K, 2007, TARGETING PKC MULTIP, V109, P1; Poirier J, 1995, P NATL ACAD SCI USA, V92, P12260, DOI 10.1073/pnas.92.26.12260; Ratia M, 2010, PHARMACOL BIOCHEM BE, V95, P485, DOI 10.1016/j.pbb.2010.03.013; Stavnezer AJ, 2002, BEHAV BRAIN RES, V133, P261, DOI 10.1016/S0166-4328(02)00021-9; Stranahan AM, 2016, J CEREBR BLOOD F MET, V36, P2108, DOI 10.1177/0271678X16642233; Talboom JS, 2008, NEUROBIOL LEARN MEM, V90, P155, DOI 10.1016/j.nlm.2008.04.002; Weeber EJ, 2000, J NEUROSCI, V20, P5906, DOI 10.1523/JNEUROSCI.20-16-05906.2000; Willey CD, 2010, INT J RADIAT ONCOL, V77, P1518, DOI 10.1016/j.ijrobp.2009.06.044	33	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0198256	10.1371/journal.pone.0198256	http://dx.doi.org/10.1371/journal.pone.0198256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870545	Green Published, gold, Green Submitted			2022-12-26	WOS:000434128400017
J	Stratigopoulos, G; De Rosa, MC; LeDuc, CA; Leibel, RL; Doege, CA				Stratigopoulos, George; De Rosa, Maria Caterina; LeDuc, Charles A.; Leibel, Rudolph L.; Doege, Claudia A.			DMSO increases efficiency of genome editing at two non-coding loci	PLOS ONE			English	Article							HUMAN-CELLS; GENE; RNA; DNA; CRISPR/CAS9; DELIVERY; SYSTEM; CAS9; MICE; FTO	Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein-9 (Cas9) has become the tool of choice for genome editing. Despite the fact that it has evolved as a highly efficient means to edit/replace coding sequence, CRISPR/Cas9 efficiency for "clean" editing of non-coding DNA remains low. We set out to introduce a single base-pair substitution in two intronic SNPs at the FTO locus without altering nearby non-coding sequence. Substitution efficiency increased up to 10-fold by treatment of human embryonic stem cells (ESC) with non-toxic levels of DMSO (1%) before CRISPR/Cas9 delivery. Treatment with DMSO did not result in CRISPR/Cas9 off-target effects or compromise the chromosomal stability of the ESC. Twenty-four hour treatment of human ESC with DMSO before CRISPR/Cas9 delivery may prove a simple means to increase editing efficiency of non-coding DNA without incorporation of undesirable mutations.	[Stratigopoulos, George; De Rosa, Maria Caterina; LeDuc, Charles A.; Leibel, Rudolph L.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Stratigopoulos, George; De Rosa, Maria Caterina; LeDuc, Charles A.; Leibel, Rudolph L.; Doege, Claudia A.] Columbia Univ, Naomi Berrie Diabet Ctr, Med Ctr, New York, NY 10027 USA; [De Rosa, Maria Caterina; Doege, Claudia A.] Columbia Univ, Columbia Stem Cell Initiat, Med Ctr, New York, NY USA; [LeDuc, Charles A.; Leibel, Rudolph L.; Doege, Claudia A.] Columbia Univ, New York Obes Nutr Res Ctr, New York, NY USA; [Leibel, Rudolph L.] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA; [Doege, Claudia A.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Stratigopoulos, G (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10027 USA.; Stratigopoulos, G (corresponding author), Columbia Univ, Naomi Berrie Diabet Ctr, Med Ctr, New York, NY 10027 USA.	gs2172@cumc.columbia.edu	Stratigopoulos, George/D-4159-2015	Stratigopoulos, George/0000-0003-4752-9123; LeDuc, Charles/0000-0002-2073-5050	Naomi Berrie Obesity-Neuroscience Initiative pilot grant [DK52431]; MBMG core of the NYNORC [5P30DK026687]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052431, P30DK026687, R01DK110113] Funding Source: NIH RePORTER	Naomi Berrie Obesity-Neuroscience Initiative pilot grant; MBMG core of the NYNORC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work was funded by a Naomi Berrie Obesity-Neuroscience Initiative pilot grant awarded to GS and DK52431 awarded to RLL. CAL, RLL and CAD work for the MBMG core of the NYNORC (grant 5P30DK026687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchschacher GL, 2000, BLOOD, V95, P2499; Canver MC, 2017, METHODS, V121, P118, DOI 10.1016/j.ymeth.2017.03.008; Chakrabarti R, 2001, GENE, V274, P293, DOI 10.1016/S0378-1119(01)00621-7; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chetty S, 2013, NAT METHODS, V10, P553, DOI [10.1038/NMETH.2442, 10.1038/nmeth.2442]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Czysz K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117689; Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Iwatani M, 2006, STEM CELLS, V24, P2549, DOI 10.1634/stemcells.2005-0427; Jiang C, 2017, CELL RES, V27, P440, DOI 10.1038/cr.2017.16; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Montgomery JL, 2014, J MOL DIAGN, V16, P305, DOI 10.1016/j.jmoldx.2014.01.006; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Peters U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003171; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Stratigopoulos G, 2016, J CLIN INVEST, V126, P1897, DOI 10.1172/JCI85526; Stratigopoulos G, 2014, CELL METAB, V19, P767, DOI 10.1016/j.cmet.2014.04.009; Stratigopoulos G, 2011, J BIOL CHEM, V286, P2155, DOI 10.1074/jbc.M110.188482; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; TAKASE K, 1992, CELL GROWTH DIFFER, V3, P515; Thaler R, 2012, EPIGENETICS-US, V7, P635, DOI 10.4161/epi.20163; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21264; Zhang Z, 2017, MOL THER-NUCL ACIDS, V9, P230, DOI 10.1016/j.omtn.2017.09.009; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	35	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198637	10.1371/journal.pone.0198637	http://dx.doi.org/10.1371/journal.pone.0198637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864154	Green Published, gold, Green Submitted			2022-12-26	WOS:000434097100040
J	Bourgoint, C; Rispal, D; Berti, M; Filipuzzi, I; Helliwell, SB; Prouteau, M; Loewith, R				Bourgoint, Clelia; Rispal, Delphine; Berti, Marina; Filipuzzi, Ireos; Helliwell, Stephen B.; Prouteau, Manoel; Loewith, Robbie			Target of rapamycin complex 2-dependent phosphorylation of the coat protein Pan1 by Akl1 controls endocytosis dynamics in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						target of rapamycin (TOR); signal transduction; endocytosis; actin; membrane function; aminophospholipid flippase; Ark1; Prk1 family; Fpk1; in vitro kinase assay; Pan1	SERINE/THREONINE KINASE PRK1P; REGULATES ACTIN POLARIZATION; CELL-GROWTH CONTROL; PLASMA-MEMBRANE; PHOSPHOLIPID TRANSLOCATION; SIGNALING PATHWAY; BUDDING YEAST; CYTOSKELETON; TOR2; FLIPPASES	Target of rapamycin complex 2 (TORC2) is a widely conserved serine/threonine protein kinase. In the yeast Saccharomyces cerevisiae, TORC2 is essential, playing a key role in plasma membrane homeostasis. In this role, TORC2 regulates diverse processes, including sphingolipid synthesis, glycerol production and efflux, polarization of the actin cytoskeleton, and endocytosis. The major direct substrate of TORC2 is the AGC-family kinase Ypk1. Ypk1 connects TORC2 signaling to actin polarization and to endocytosis via the flippase kinases Fpk1 and Fpk2. Here, we report that Fpk1 mediates TORC2 signaling to control actin polarization, but not endocytosis, via aminophospholipid flippases. To search for specific targets of these flippase kinases, we exploited the fact that Fpk1 prefers to phosphorylate Ser residues within the sequence RXS(L/Y)(D/E), which is present approximate to 90 times in the yeast proteome. We observed that 25 of these sequences are phosphorylated by Fpk1 in vitro. We focused on one sequence hit, the Ark/Prk-family kinase Akl1, as this kinase previously has been implicated in endocytosis. Using a potent ATP-competitive small molecule, CMB4563, to preferentially inhibit TORC2, we found that Fpk1-mediated Akl1 phosphorylation inhibits Akl1 activity, which, in turn, reduces phosphorylation of Pan1 and of other endocytic coat proteins and ultimately contributes to a slowing of endocytosis kinetics. These results indicate that the regulation of actin polarization and endocytosis downstream of TORC2 is signaled through separate pathways that bifurcate at the level of the flippase kinases.	[Bourgoint, Clelia; Rispal, Delphine; Berti, Marina; Prouteau, Manoel; Loewith, Robbie] Univ Geneva, Dept Mol Biol, Natl Ctr Competence Res Chem Biol, CH-1211 Geneva, Switzerland; [Bourgoint, Clelia; Rispal, Delphine; Berti, Marina; Prouteau, Manoel; Loewith, Robbie] Univ Geneva, Inst Genet & Genom Geneva iGE3, Natl Ctr Competence Res Chem Biol, CH-1211 Geneva, Switzerland; [Filipuzzi, Ireos; Helliwell, Stephen B.] Novartis Inst Biomed Res, Novartis Campus, CH-4056 Basel, Switzerland	University of Geneva; University of Geneva; Novartis	Prouteau, M (corresponding author), Univ Geneva, Dept Mol Biol, Sci 3 2041, CH-1211 Geneva, Switzerland.; Loewith, R (corresponding author), Univ Geneva, Dept Mol Biol, Sci 3 2045b, CH-1211 Geneva, Switzerland.	manoel.prouteau@unige.ch; robbie.loewith@unige.ch			European Research Council (TORCH Grant); Swiss National Foundation [31003A_160023]; Canton of Geneva	European Research Council (TORCH Grant); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Canton of Geneva	Supported by the European Research Council (TORCH Grant), the Swiss National Foundation (Grant 31003A_160023), and the Canton of Geneva.	Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Catty P, 1997, FEBS LETT, V409, P325, DOI 10.1016/S0014-5793(97)00446-8; Chi RJ, 2012, J CELL SCI, V125, P4728, DOI 10.1242/jcs.098871; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; Das A, 2012, NAT CELL BIOL, V14, P304, DOI 10.1038/ncb2444; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; deHart AKA, 2003, MOL BIOL CELL, V14, P4676, DOI 10.1091/mbc.E03-05-0323; deHart AKA, 2002, J CELL BIOL, V156, P241, DOI 10.1083/jcb.200107135; Frohlich F, 2015, ELIFE, V4, DOI 10.7554/eLife.08712; Gaubitz C, 2015, MOL CELL, V58, P977, DOI 10.1016/j.molcel.2015.04.031; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goode BL, 2015, GENETICS, V199, P315, DOI 10.1534/genetics.112.145540; Graham TR, 2004, TRENDS CELL BIOL, V14, P670, DOI 10.1016/j.tcb.2004.10.008; Hatakeyama R, 2017, J CELL SCI, V130, P1169, DOI 10.1242/jcs.198382; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Helliwell SB, 1998, GENETICS, V148, P99; HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105, DOI 10.1091/mbc.5.1.105; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Nakano K, 2008, MOL BIOL CELL, V19, P1783, DOI 10.1091/mbc.E07-07-0646; Niles BJ, 2014, MOL BIOL CELL, V25, P3962, DOI 10.1091/mbc.E14-06-1122; Noji T, 2006, BIOCHEM BIOPH RES CO, V344, P323, DOI 10.1016/j.bbrc.2006.03.095; Riggi M., 2018, NAT CELL BIOL; Rispal D, 2015, J BIOL CHEM, V290, P14963, DOI 10.1074/jbc.M114.627794; Roelants FM, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00627-16; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Shertz CA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-510; Shimada K, 2013, MOL CELL, V51, P829, DOI 10.1016/j.molcel.2013.08.019; Smythe E, 2003, EMBO REP, V4, P246, DOI 10.1038/sj.embor.embor776; Vlahakis A, 2016, J CELL BIOL, V215, P779, DOI 10.1083/jcb.201605030; Vlahakis A, 2014, AUTOPHAGY, V10, P2085, DOI 10.4161/auto.36262; Vlahakis A, 2014, P NATL ACAD SCI USA, V111, P10586, DOI 10.1073/pnas.1406305111; Watson HA, 2001, MOL BIOL CELL, V12, P3668, DOI 10.1091/mbc.12.11.3668; Zeng GH, 2001, MOL BIOL CELL, V12, P3759, DOI 10.1091/mbc.12.12.3759; Zeng GS, 1999, J CELL BIOL, V144, P71, DOI 10.1083/jcb.144.1.71	46	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12043	12053		10.1074/jbc.RA117.001615	http://dx.doi.org/10.1074/jbc.RA117.001615			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29895620	hybrid, Green Published			2022-12-26	WOS:000440803200006
J	Pan, YC; Zhu, Y; Yang, W; Tycksen, E; Liu, SP; Palucki, J; Zhu, LJ; Sasaki, Y; Sharma, MK; Kim, AH; Zhang, B; Yano, H				Pan, Yanchun; Zhu, Ying; Yang, Wei; Tycksen, Eric; Liu, Shaopeng; Palucki, John; Zhu, Linjian; Sasaki, Yo; Sharma, Mukesh K.; Kim, Albert H.; Zhang, Bo; Yano, Hiroko			The role of Twist1 in mutant huntingtin-induced transcriptional alterations and neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIC FACTOR; DNA METHYLATION; GENE-EXPRESSION; MOUSE MODEL; BDNF GENE; CORTICOSTRIATAL PATHWAY; MOLECULAR PATHOGENESIS; DISEASE PHENOTYPES; TRANSGENIC MICE; PROTEIN	Huntington's disease (HD) is a fatal neurodegenerative disorder caused by an abnormal expansion of polyglutamine repeats in the huntingtin protein (Htt). Transcriptional dysregulation is an early event in the course of HD progression and is thought to contribute to disease pathogenesis, but how mutant Htt causes transcriptional alterations and subsequent cell death in neurons is not well understood. RNA-Seq analysis revealed that expression of a mutant Htt fragment in primary cortical neurons leads to robust gene expression changes before neuronal death. Basic helix-loop-helix transcription factor Twist1, which is essential for embryogenesis and is normally expressed at low levels in mature neurons, was substantially up-regulated in mutant Htt-expressing neurons in culture and in the brains of HD mouse models. Knockdown of Twist1 by RNAi in mutant Htt-expressing primary cortical neurons reversed the altered expression of a subset of genes involved in neuronal function and, importantly, abrogated neurotoxicity. Using brain-derived neurotrophic factor (Bdnf), which is known to be involved in HD pathogenesis, as a model gene, we found that Twist1 knockdown could reverse mutant Htt-induced DNA hypermethylation at the Bdnf regulatory region and reactivate Bdnf expression. Together, these results suggest that Twist1 is an important upstream mediator of mutant Htt-induced neuronal death and may in part operate through epigenetic mechanisms.	[Pan, Yanchun; Zhu, Ying; Palucki, John; Zhu, Linjian; Kim, Albert H.; Yano, Hiroko] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63110 USA; [Yang, Wei; Tycksen, Eric] Washington Univ, Sch Med, Genome Technol Access Ctr, St Louis, MO 63110 USA; [Yang, Wei; Sasaki, Yo; Kim, Albert H.; Yano, Hiroko] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Liu, Shaopeng; Kim, Albert H.; Zhang, Bo] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Sharma, Mukesh K.] Washington Univ, Sch Med, Ctr Biomed Informat, St Louis, MO 63110 USA; [Kim, Albert H.; Zhang, Bo; Yano, Hiroko] Washington Univ, Sch Med, Ctr Regenerat Med, St Louis, MO 63110 USA; [Kim, Albert H.; Yano, Hiroko] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Kim, Albert H.; Yano, Hiroko] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Yano, H (corresponding author), Washington Univ, Sch Med, Dept Neurol Surg Neurol & Genet, St Louis, MO 63110 USA.	yanoh@wustl.edu	Yang, Wei/H-4749-2019; Kim, Albert H./HGF-0057-2022; Zhang, Bo/A-6874-2011	Yang, Wei/0000-0001-8162-033X; Tycksen, Eric/0000-0001-6362-0141; Zhang, Bo/0000-0003-2962-5314	National Institutes of Health [K01 AG033724, R21 NS096603, R01 NS094670]; McDonnell Center for Cellular and Molecular Neurobiology at Washington University; Hope Center for Neurological Disorders at Washington University; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS096603, R01NS094670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG033724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA027995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Center for Cellular and Molecular Neurobiology at Washington University; Hope Center for Neurological Disorders at Washington University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants K01 AG033724 (to H. Y.), R21 NS096603 (to H. Y.), R01 NS094670 (to A. H. K.), the McDonnell Center for Cellular and Molecular Neurobiology at Washington University, and the Hope Center for Neurological Disorders at Washington University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Ansieau S, 2010, ONCOGENE, V29, P3173, DOI 10.1038/onc.2010.92; Apostol BL, 2008, MOL CELL NEUROSCI, V39, P8, DOI 10.1016/j.mcn.2008.04.007; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bouard C, 2016, NUCLEIC ACIDS RES, V44, P5470, DOI 10.1093/nar/gkw334; Cakouros D, 2012, MOL CELL BIOL, V32, P1433, DOI 10.1128/MCB.06315-11; Castanon I, 2001, DEVELOPMENT, V128, P3145; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Cepeda C, 2003, J NEUROSCI, V23, P961; Cepeda C, 2007, PROG NEUROBIOL, V81, P253, DOI 10.1016/j.pneurobio.2006.11.001; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Chen EY, 2012, BIOINFORMATICS, V28, P105, DOI 10.1093/bioinformatics/btr625; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Deshmukh H, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-57; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dobrian Anca D, 2012, Front Endocrinol (Lausanne), V3, P108, DOI 10.3389/fendo.2012.00108; Duan WZ, 2008, NEUROBIOL DIS, V30, P312, DOI 10.1016/j.nbd.2008.01.015; Franco HL, 2011, NUCLEIC ACIDS RES, V39, P1177, DOI 10.1093/nar/gkq890; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; Golson ML, 2016, DEVELOPMENT, V143, P4558, DOI 10.1242/dev.112672; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Gujar AD, 2016, P NATL ACAD SCI USA, V113, pE8247, DOI 10.1073/pnas.1610921114; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Ikegame T, 2013, J HUM GENET, V58, P434, DOI 10.1038/jhg.2013.65; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Kim Sangjune, 2014, Exp Neurobiol, V23, P36, DOI 10.5607/en.2014.23.1.36; Labadorf A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143563; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Langfelder P, 2016, NAT NEUROSCI, V19, P623, DOI 10.1038/nn.4256; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mallo M, 2013, DEVELOPMENT, V140, P3951, DOI 10.1242/dev.068346; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; McFarland KN, 2013, J HUNTINGTONS DIS, V2, P263, DOI 10.3233/JHD-130066; McFarland KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041423; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Milnerwood AJ, 2007, J PHYSIOL-LONDON, V585, P817, DOI 10.1113/jphysiol.2007.142448; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Ng CW, 2013, P NATL ACAD SCI USA, V110, P2354, DOI 10.1073/pnas.1221292110; O'Rourke MP, 2002, INT J DEV BIOL, V46, P401; Pan YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep31022; Podtelezhnikov AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029610; Porcher C, 2017, BLOOD, V129, P2051, DOI 10.1182/blood-2016-12-754051; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; Seredenina T, 2012, NEUROBIOL DIS, V45, P83, DOI 10.1016/j.nbd.2011.07.001; Sheng HZ, 1997, SCIENCE, V278, P1809, DOI 10.1126/science.278.5344.1809; Strand AD, 2007, J NEUROSCI, V27, P11758, DOI 10.1523/JNEUROSCI.2461-07.2007; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Taiwo O, 2012, NAT PROTOC, V7, P617, DOI 10.1038/nprot.2012.012; Valor LM, 2013, J NEUROSCI, V33, P10471, DOI 10.1523/JNEUROSCI.0670-13.2013; Vashishtha M, 2013, P NATL ACAD SCI USA, V110, pE3027, DOI 10.1073/pnas.1311323110; Vesuna F, 2012, ONCOGENE, V31, P3223, DOI 10.1038/onc.2011.483; Villar-Menendez I, 2013, NEUROMOL MED, V15, P295, DOI 10.1007/s12017-013-8219-0; von Schimmelmann M, 2016, NAT NEUROSCI, V19, P1321, DOI 10.1038/nn.4360; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wang FL, 2013, HUM MOL GENET, V22, P3641, DOI 10.1093/hmg/ddt214; Xie YX, 2010, J NEUROSCI, V30, P14708, DOI 10.1523/JNEUROSCI.1637-10.2010; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yano H, 2014, NAT NEUROSCI, V17, P822, DOI 10.1038/nn.3721; Zhao X, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.16; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2008, BRAIN PATHOL, V18, P225, DOI 10.1111/j.1750-3639.2007.00111.x; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	81	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11850	11866		10.1074/jbc.RA117.001211	http://dx.doi.org/10.1074/jbc.RA117.001211			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29891550	Green Published, hybrid			2022-12-26	WOS:000440134500018
J	Rijal, D; Ariana, A; Wight, A; Kim, K; Alturki, NA; Aamir, Z; Ametepe, ES; Korneluk, RG; Tiedje, C; Menon, MB; Gaestel, M; McComb, S; Sad, S				Rijal, Dikchha; Ariana, Ardeshir; Wight, Andrew; Kim, Kwangsin; Alturki, Norah A.; Aamir, Zoya; Ametepe, Emmanuelle S.; Korneluk, Robert G.; Tiedje, Christopher; Menon, Manoj B.; Gaestel, Matthias; McComb, Scott; Sad, Subash			Differentiated macrophages acquire a pro-inflammatory and cell death-resistant phenotype due to increasing XIAP and p38-mediated inhibition of RipK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MARROW-DERIVED MACROPHAGES; TNF-ALPHA; ACTIVATION; KINASE; NECROPTOSIS; APOPTOSIS; CANCER; CIAP1; RIPOPTOSOME	Monocytes differentiate into macrophages, which deactivate invading pathogens. Macrophages can be resistant to cell death mechanisms in some situations, and the mechanisms involved are not clear. Here, using mouse immune cells, we investigated whether the differentiation of macrophages affects their susceptibility to cell death by the ripoptosome/necrosome pathways. We show that treatment of macrophages with a mimetic of second mitochondrial activator of caspases (SMAC) resulted in ripoptosome-driven cell death that specifically depended on tumor necrosis factor (TNF alpha) expression and the receptor-interacting serine/threonine protein kinase 1 (RipK1)-RipK3-caspase-8 interaction in activated and cycling macrophages. Differentiation of macrophages increased the expression of pro-inflammatory cytokines but reduced RipK1-dependent cell death and the RipK3-caspase-8 interaction. The expression of the anti-apoptotic mediators, X-linked inhibitor of apoptosis protein (XIAP) and caspase-like apoptosis regulatory protein (cFLIP(L)), also increased in differentiated macrophages, which inhibited caspase activation. The resistance to cell death was abrogated in XIAP-deficient macrophages. However, even in the presence of increased XIAP expression, inhibition of the mitogen-activated protein kinase (MAPK) p38 and MAPK-activated protein kinase 2 (MK2) made differentiated macrophages susceptible to cell death. These results suggest that the p38/MK2 pathway overrides apoptosis inhibition by XIAP and that acquisition of resistance to cell death by increased expression of XIAP and cFLIP(L) may allow inflammatory macrophages to participate in pathogen control for a longer duration.	[Rijal, Dikchha; Ariana, Ardeshir; Wight, Andrew; Kim, Kwangsin; Alturki, Norah A.; Aamir, Zoya; Ametepe, Emmanuelle S.; Sad, Subash] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M8, Canada; [Korneluk, Robert G.] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 5B2, Canada; [Tiedje, Christopher; Menon, Manoj B.; Gaestel, Matthias] Hannover Med Sch, Inst Cell Biochem, D-30625 Hannover, Germany; [Tiedje, Christopher] Univ Copenhagen, Dept Cellular & Mol Med, DK-1165 Copenhagen, Denmark; [McComb, Scott] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, Ottawa, ON K1A 0R6, Canada; [Sad, Subash] uOttawa Ctr Infect Immun & Inflammat, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; Hannover Medical School; University of Copenhagen; National Research Council Canada	Sad, S (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M8, Canada.	subash.sad@uottawa.ca	Gaestel, Matthias/A-6560-2013; Menon, Manoj B./P-1543-2015	Gaestel, Matthias/0000-0002-4944-4652; Menon, Manoj B./0000-0001-5859-0347; Tiedje, Christopher/0000-0002-3013-6967; Wight, Andrew/0000-0003-3116-8722; Ariana, Ardeshir/0000-0003-2206-9829; Sad, Subash/0000-0002-2462-7137; alturki, Norah/0000-0003-0608-4797	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Institutes of Health Research (to S. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Beug ST, 2012, TRENDS IMMUNOL, V33, P535, DOI 10.1016/j.it.2012.06.004; Blander JM, 2014, NAT REV IMMUNOL, V14, P601, DOI 10.1038/nri3720; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Chamberlain LM, 2015, J BIOMED MATER RES A, V103, P2864, DOI 10.1002/jbm.a.35415; Chavez-Valdez R, 2012, NEUROSCIENCE, V219, P192, DOI 10.1016/j.neuroscience.2012.05.002; Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dondelinger Y, 2017, NAT CELL BIOL, V19, P1237, DOI 10.1038/ncb3608; Dondelinger Y, 2015, MOL CELL, V60, P63, DOI 10.1016/j.molcel.2015.07.032; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hofer-Warbinek R, 2000, J BIOL CHEM, V275, P22064, DOI 10.1074/jbc.M910346199; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jaco I, 2017, MOL CELL, V66, P698, DOI 10.1016/j.molcel.2017.05.003; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Krepler C, 2013, CLIN CANCER RES, V19, P1784, DOI 10.1158/1078-0432.CCR-12-2518; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lalaoui N, 2016, CANCER CELL, V29, P145, DOI 10.1016/j.ccell.2016.01.006; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Marsh RA, 2010, BLOOD, V116, P1079, DOI 10.1182/blood-2010-01-256099; McComb S, 2012, CELL DEATH DIFFER, V19, P1791, DOI 10.1038/cdd.2012.59; McComb S, 2014, P NATL ACAD SCI USA, V111, pE3206, DOI 10.1073/pnas.1407068111; McComb S, 2014, J IMMUNOL, V192, P5671, DOI 10.4049/jimmunol.1303380; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Menon MB, 2017, NAT CELL BIOL, V19, P1248, DOI 10.1038/ncb3614; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Muller-Sienerth N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021556; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Northington FJ, 2011, J CEREBR BLOOD F MET, V31, P178, DOI 10.1038/jcbfm.2010.72; OBRIEN AD, 1982, CELL IMMUNOL, V67, P325, DOI 10.1016/0008-8749(82)90224-6; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Olayioye MA, 2005, CELL DEATH DIFFER, V12, P87, DOI 10.1038/sj.cdd.4401524; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; SAD S, 1995, IMMUNITY, V2, P271, DOI 10.1016/1074-7613(95)90051-9; Schilling R, 2014, METHOD ENZYMOL, V545, P83, DOI 10.1016/B978-0-12-801430-1.00004-4; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shutinoski B, 2016, CELL DEATH DIFFER, V23, P1628, DOI 10.1038/cdd.2016.51; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Tabas I, 2007, CURR DRUG TARGETS, V8, P1288, DOI 10.2174/138945007783220623; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vogt G, 2011, J CLIN INVEST, V121, P3889, DOI 10.1172/JCI57235; WALKER EB, 1985, J LEUKOCYTE BIOL, V37, P121, DOI 10.1002/jlb.37.2.121; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; WARREN MK, 1985, J IMMUNOL, V134, P982; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yabal M, 2014, CELL REP, V7, P1796, DOI 10.1016/j.celrep.2014.05.008; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	73	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11913	11927		10.1074/jbc.RA118.003614	http://dx.doi.org/10.1074/jbc.RA118.003614			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29899110	Green Published, hybrid			2022-12-26	WOS:000440134500023
J	Bork, CS; Veno, SK; Lundbye-Christensen, S; Jakobsen, MU; Tjonneland, A; Calder, PC; Overvad, K; Schmidt, EB				Bork, Christian Sorensen; Veno, Stine Krogh; Lundbye-Christensen, Soren; Jakobsen, Marianne Uhre; Tjonneland, Anne; Calder, Philip C.; Overvad, Kim; Schmidt, Erik Berg			Adipose tissue content of alpha-linolenic acid and the risk of ischemic stroke and ischemic stroke subtypes: A Danish case-cohort study	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; POLYUNSATURATED FATTY-ACIDS; HEART-DISEASE; MYOCARDIAL-INFARCTION; SERUM PHOSPHOLIPIDS; FISH CONSUMPTION; SPANISH SUBJECTS; INCIDENT STROKE; DIETARY-INTAKE; DEATH	Background The plant-derived omega-3 fatty acid alpha-linolenic acid (ALA) may reduce the risk of cardiovascular disease. Objective We have investigated associations between the content of ALA in adipose tissue and the risk of ischemic stroke and its subtypes. Methods Incident cases of ischemic stroke among participants enrolled into the Danish Diet, Cancer and Health cohort (n = 57,053) were identified by linkage with the Danish National Patient Register. Subsequently, all potential cases were validated and classified into ischemic stroke subtypes. The fatty acid composition of adipose tissue was determined by gas chromatography in cases and in a randomly drawn sub-cohort (n = 3500). Statistical analyses were performed using weighted Cox regression. Results During a median of 13.4 years of follow-up, 1735 cases of total ischemic stroke were identified including 297 cases of large artery atherosclerosis, 772 cases of small-vessel occlusion, 99 cases of cardio-embolism, 91 cases with stroke of other etiology and 476 cases with stroke of undetermined etiology. The median content of ALA in adipose tissue within the sub-cohort was 0.84% (95% central range: 0.53-1.19%). Multivariable analyses showed a U-shaped association between adipose tissue content of ALA and the rate of total ischemic stroke, but this association was not statistically significant (p = 0.172). In analyses of ischemic stroke subtypes, we observed a statistically significant U-shaped association between ALA and the rate of ischemic stroke due to large artery atherosclerosis (p = 0.017), whereas no appreciable association was observed between ALA and the rate of small-vessel occlusion (p = 0.427). A positive but statistically non-significant association was observed between ALA and the rate of ischemic stroke due to cardio-embolism (p = 0.162). Conclusions The content of ALA in adipose tissue was statistically non-significantly U-shaped associated with risk of total ischemic stroke. For ischemic stroke subtypes a statistically significant, U-shaped association with large artery atherosclerosis was observed.	[Bork, Christian Sorensen; Veno, Stine Krogh; Overvad, Kim; Schmidt, Erik Berg] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Bork, Christian Sorensen; Calder, Philip C.] Univ Southampton, Southampton Gen Hosp MP887, Human Dev & Hlth Acad Unit, Fac Med, Southampton, Hants, England; [Veno, Stine Krogh; Schmidt, Erik Berg] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Lundbye-Christensen, Soren] Aalborg Univ Hosp, Unit Clin Biostat, Aalborg, Denmark; [Lundbye-Christensen, Soren] Aalborg Univ Hosp, Atrial Fibrillat Study Grp, Aalborg, Denmark; [Jakobsen, Marianne Uhre] Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark; [Tjonneland, Anne] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Calder, Philip C.] Univ Hosp Southampton NHS Fdn Trust, Southampton Biomed Res Ctr, Natl Inst Hlth Res, Southampton, Hants, England; [Calder, Philip C.] Univ Southampton, Southampton, Hants, England; [Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Sect Epidemiol, Aarhus, Denmark	Aalborg University; Aalborg University Hospital; University of Southampton; Aalborg University; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Technical University of Denmark; Danish Cancer Society; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; Aarhus University	Bork, CS (corresponding author), Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark.; Bork, CS (corresponding author), Univ Southampton, Southampton Gen Hosp MP887, Human Dev & Hlth Acad Unit, Fac Med, Southampton, Hants, England.	c.bork@rn.dk	Calder, Philip C/E-9739-2013	Calder, Philip C/0000-0002-6038-710X; Jakobsen, Marianne Uhre/0000-0001-6518-4136; Overvad, Kim/0000-0001-6429-7921; Bork, Christian/0000-0001-5233-2902	Danish Heart Foundation [17-R115-A7415-22060]	Danish Heart Foundation	This work was supported by The Danish Heart Foundation, grant number 17-R115-A7415-22060 (http://hjerteforeningen.dk/forskning/). The grant was given to CSB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Albert CM, 2005, CIRCULATION, V112, P3232, DOI 10.1161/CIRCULATIONAHA.105.572008; Andersen TF, 1999, DAN MED BULL, V46, P263; Arab L, 2002, PUBLIC HEALTH NUTR, V5, P865, DOI 10.1079/PHN2002391; BEYNEN AC, 1985, AM J CLIN NUTR, V42, P317, DOI 10.1093/ajcn/42.2.317; Bork CS, 2016, AM J CLIN NUTR, V104, P41, DOI 10.3945/ajcn.115.127019; Daneshmand R, 2016, BRIT J NUTR, V115, P1851, DOI 10.1017/S0007114516000982; De Goede J, 2013, NUTR METAB CARDIOVAS, V23, P737, DOI 10.1016/j.numecd.2012.03.001; de Goede J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017967; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; de Lorgeril M, 2007, J CARDIOVASC MED, V8, pS38, DOI 10.2459/01.JCM.0000289268.90482.7b; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; DOLECEK TA, 1992, P SOC EXP BIOL MED, V200, P177, DOI 10.3181/00379727-200-43413; Fretts AM, 2014, BRIT J NUTR, V112, P1206, DOI 10.1017/S0007114514001925; Gebauer SK, 2006, AM J CLIN NUTR, V83, p1526S, DOI 10.1093/ajcn/83.6.1526S; Harrell FE, 2001, REGRESSION MODELING; He K, 2002, JAMA-J AM MED ASSOC, V288, P3130, DOI 10.1001/jama.288.24.3130; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hu FB, 1999, AM J CLIN NUTR, V69, P890; Iso H, 2002, STROKE, V33, P2086, DOI 10.1161/01.STR.0000023890.25066.50; Joensen AM, 2011, CIRCULATION, V124, P1232, DOI 10.1161/CIRCULATIONAHA.110.987057; KALBFLEISCH JD, 1988, STAT MED, V7, P149, DOI 10.1002/sim.4780070116; Koh AS, 2015, EUR J PREV CARDIOL, V22, P364, DOI 10.1177/2047487313517576; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Larsson SC, 2012, ATHEROSCLEROSIS, V221, P282, DOI 10.1016/j.atherosclerosis.2011.12.043; Lopez-Garcia E, 2004, J NUTR, V134, P1806, DOI 10.1093/jn/134.7.1806; Luhdorf P, 2017, SCAND J PUBLIC HEALT, V45, P630, DOI 10.1177/1403494817716582; Mozaffarian D, 2005, CIRCULATION, V111, P157, DOI 10.1161/01.CIR.0000152099.87287.83; Oomen CM, 2001, AM J CLIN NUTR, V74, P457; OVERVAD K, 1991, INT J EPIDEMIOL, V20, P900, DOI 10.1093/ije/20.4.900; OWREN PA, 1964, LANCET, V2, P975; Petersen L, 2003, STAT MED, V22, P3795, DOI 10.1002/sim.1672; Rajaram S, 2014, AM J CLIN NUTR, V100, p443S, DOI 10.3945/ajcn.113.071514; Rallidis LS, 2003, ATHEROSCLEROSIS, V167, P237, DOI 10.1016/S0021-9150(02)00427-6; Rhee JJ, 2017, AM J PREV MED, V52, P10, DOI 10.1016/j.amepre.2016.07.020; Sala-Vila A, 2011, ATHEROSCLEROSIS, V214, P209, DOI 10.1016/j.atherosclerosis.2010.10.026; Sala-Vila A, 2010, AM J CLIN NUTR, V92, P186, DOI 10.3945/ajcn.2009.28807; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Vedtofte MS, 2014, BRIT J NUTR, V112, P735, DOI 10.1017/S000711451400138X; Wiberg B, 2006, STROKE, V37, P2898, DOI 10.1161/01.STR.0000249056.24657.8b; Yaemsiri S, 2013, STROKE, V44, P2710, DOI 10.1161/STROKEAHA.111.000834; Yamagishi K, 2013, CEREBROVASC DIS, V36, P38, DOI [10.1159/000351205, 10.1159/000351151]	43	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198927	10.1371/journal.pone.0198927	http://dx.doi.org/10.1371/journal.pone.0198927			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889889	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000434786600063
J	Lomonaco, S; Crawford, MA; Lascols, C; Timme, RE; Anderson, K; Hodge, DR; Fisher, DJ; Pillai, SP; Morse, SA; Khan, E; Hughes, MA; Allard, MW; Sharma, SK				Lomonaco, Sara; Crawford, Matthew A.; Lascols, Christine; Timme, Ruth E.; Anderson, Kevin; Hodge, David R.; Fisher, Debra J.; Pillai, Segaran P.; Morse, Stephen A.; Khan, Erum; Hughes, Molly A.; Allard, Marc W.; Sharma, Shashi K.			Resistome of carbapenem-and colistin-resistant Klebsiella pneumoniae clinical isolates	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASE; ENTEROBACTERIACEAE STRAINS; MOLECULAR CHARACTERIZATION; ANTIBIOTIC-RESISTANCE; CLONAL DISSEMINATION; HIGH PREVALENCE; WEB SERVER; 1ST REPORT; NDM-1; PLASMIDS	The emergence and dissemination of carbapenemases, bacterial enzymes able to inactivate most beta-lactam antibiotics, in Enterobacteriaceae is of increasing concern. The concurrent spread of resistance against colistin, an antibiotic of last resort, further compounds this challenge further. Whole-genome sequencing (WGS) can play a significant role in the rapid and accurate detection/characterization of existing and emergent resistance determinants, an essential aspect of public health surveillance and response activities to combat the spread of antimicrobial resistant bacteria. In the current study, WGS data was used to characterize the genomic content of antimicrobial resistance genes, including those encoding carbapenemases, in 10 multidrug-resistant Klebsiella pneumoniae isolates from Pakistan. These clinical isolates represented five sequence types: ST11 (n = 3 isolates), ST14 (n = 3), ST15 (n = 1), ST101 (n = 2), and ST307 (n = 1). Resistance profiles against 25 clinicallyrelevant antimicrobials were determined by broth microdilution; resistant phenotypes were observed for at least 15 of the 25 antibiotics tested in all isolates except one. Specifically, 8/10 isolates were carbapenem-resistant and 7/10 isolates were colistin-resistant. The bla(NDM-1) and bla(OXA-48) carbapenemase genes were present in 7/10 and 5/10 isolates, respectively; including 2 isolates carrying both genes. No plasmid-mediated determinants for colistin resistance (e.g. mcr) were detected, but disruptions and mutations in chromosomal loci (i.e. mgrB and pmrB) previously reported to confer colistin resistance were observed. A bla(OXA-48)-carrying IncL/M-type plasmid was found in all bla(OXA-48)-positive isolates. The application of WGS to molecular epidemiology and surveillance studies, as exemplified here, will provide both a more complete understanding of the global distribution of MDR isolates and a robust surveillance tool useful for detecting emerging threats to public health.	[Lomonaco, Sara; Timme, Ruth E.; Allard, Marc W.; Sharma, Shashi K.] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA; [Crawford, Matthew A.; Fisher, Debra J.; Hughes, Molly A.] Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA USA; [Lascols, Christine; Morse, Stephen A.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Lascols, Christine] IHRC Inc, Atlanta, GA USA; [Anderson, Kevin; Hodge, David R.] US Dept Homeland Secur, Sci & Technol Directorate, Washington, DC USA; [Pillai, Segaran P.] US FDA, Off Commissioner, Silver Spring, MD USA; [Morse, Stephen A.] Ctr Dis Control & Prevent, Div Select Agents, Atlanta, GA USA; [Khan, Erum] Aga Khan Univ, Dept Pathol & Lab Med, Karachi, Pakistan	US Food & Drug Administration (FDA); University of Virginia; Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA; Aga Khan University	Lomonaco, S (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.	sara.lomonaco@fda.hhs.gov	Lascols, Christine/I-2593-2019	Lomonaco, Sara/0000-0001-8242-6280; Timme, Ruth/0000-0002-9705-5897; Crawford, Matthew/0000-0003-0404-0061	U.S. National Institutes of Health [F32 AI108249, R01 AI099097]; U.S. Department of Homeland Security, Science and Technology Directorate [HSHQPM-16-X-00066]; Henry Rose Carter Research Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099097, F32AI108249] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Homeland Security, Science and Technology Directorate(United States Department of Homeland Security (DHS)); Henry Rose Carter Research Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SL received support by appointment to the Research Participation Program at the Center for Food Safety and Applied Nutrition, U.S. Food & Drug Administration, administered by the Oak Ridge Institute for Science and Education (https://orise.orau.gov) through an interagency agreement between the U.S. Department of Energy and the U.S. Food & Drug Administration. MAC was supported by U.S. National Institutes of Health (https://www.nih.gov/) grant F32 AI108249. CL received support from the U.S. Department of Homeland Security, Science and Technology Directorate (https://www.dhs.gov/science-and-technology) Agreement no. HSHQPM-16-X-00066. MAH was supported by the U.S. National Institutes of Health (https://www.nih.gov/) grant R01 AI099097 and a Henry Rose Carter Research Award (https://med.virginia.edu/office-for-research/funding-opportunities/). The funders listed above provided support in the form of salaries for authors [SL, MAC, CL, MAH], but did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. IHRC, Inc., a commercial entity that provides scientific personnel for the US government, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Abouddihaj B, 2013, APMIS, V121, P675, DOI 10.1111/apm.12034; Allard MW, 2016, J CLIN MICROBIOL, V54, P1975, DOI 10.1128/JCM.00081-16; Andrade LN, 2011, ANTIMICROB AGENTS CH, V55, P3579, DOI 10.1128/AAC.01783-10; Arena F, 2013, J CLIN MICROBIOL, V51, P4067, DOI 10.1128/JCM.01982-13; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Avolio M, 2017, FUTURE MICROBIOL, V12, P1119, DOI 10.2217/fmb-2017-0041; Ben Nasr A, 2013, ANTIMICROB AGENTS CH, V57, P4089, DOI 10.1128/AAC.00536-13; Bialvaei AZ, 2015, IRAN J MICROBIOL, V7, P226; Brisse S, 2013, J CLIN MICROBIOL, V51, P4073, DOI 10.1128/JCM.01924-13; Broberg CA, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00924-14; Cannatelli A, 2014, ANTIMICROB AGENTS CH, V58, P5696, DOI 10.1128/AAC.03110-14; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Castanheira M, 2013, MICROB DRUG RESIST, V19, P295, DOI 10.1089/mdr.2012.0238; CDC, 2013, ANTIBIOTIC RESISTANC; Center for Disease Dynamics Economics & Policy, 2015, STAT WORLDS ANT; Chen YT, 2016, MICROB DRUG RESIST, V22, P109, DOI 10.1089/mdr.2015.0132; Chen YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048737; Cheng YH, 2015, ANTIMICROB AGENTS CH, V59, P2909, DOI 10.1128/AAC.04763-14; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Cizmeci Z, 2017, J CHEMOTHERAPY, V29, P344, DOI 10.1080/1120009X.2017.1323149; CLSI, 2016, M100 PERF STAND ANT, V26; CLSI, 2017, PERFORMANCE STANDARD, V26; CLSI Clinical and Laboratory Standards Institute, 2015, M07 CLSI; Crawford MA, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01419-16; Crawford MA, 2017, MBIO, V8, DOI 10.1128/mBio.01549-17; Czobor I, 2016, INT J ANTIMICROB AG, V48, P223, DOI 10.1016/j.ijantimicag.2016.05.004; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dash N, 2014, MICROB DRUG RESIST, V20, P52, DOI 10.1089/mdr.2013.0040; de Man TJB, 2018, MBIO, V9, DOI 10.1128/mBio.00440-18; Dortet L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249856; Duvernay C, 2011, MICROBIOL-SGM, V157, P496, DOI 10.1099/mic.0.043885-0; EUCAST The European Committee on Antimicrobial Susceptibility Testing, 2021, BREAKP TABL INT MICS; Fakhuruddin, 2014, J PAK MED ASSOC, V64, P519; Garcia-Fulgueiras V, 2017, J GLOB ANTIMICROB RE, V9, P68, DOI 10.1016/j.jgar.2017.01.008; Girlich D, 2014, CLIN MICROBIOL INFEC, V20, P350, DOI 10.1111/1469-0691.12325; Grose JH, 2014, VIROLOGY, V468, P421, DOI 10.1016/j.virol.2014.08.024; Guducuoglu H, 2018, MICROB DRUG RESIST, V24, P966, DOI 10.1089/mdr.2017.0173; Habeeb MA, 2013, INT J ANTIMICROB AG, V41, P524, DOI 10.1016/j.ijantimicag.2013.02.017; Haeili M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02470; Hashimoto A, 2014, JPN J INFECT DIS, V67, P120, DOI 10.7883/yoken.67.120; He SS, 2015, MBIO, V6, DOI 10.1128/mBio.00762-15; Jayol A, 2014, ANTIMICROB AGENTS CH, V58, P4762, DOI 10.1128/AAC.00084-14; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Khan AU, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1012-8; Kilic A, 2015, ANN LAB MED, V35, P382, DOI 10.3343/alm.2015.35.3.382; Kim JO, 2017, DIAGN MICR INFEC DIS, V87, P343, DOI 10.1016/j.diagmicrobio.2016.12.012; Kim M, 2012, J VIROL, V86, P10894, DOI 10.1128/JVI.01796-12; Lee CR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00895; Lees JA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12797; Lin WH, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01403-16; Liu Y, 2017, MICROB DRUG RESIST, V23, P901, DOI 10.1089/mdr.2016.0222; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Long SW, 2017, MBIO, V8, DOI [10.1128/mBio.00489-17, 10.1128/mbio.00489-17]; Loucif L, 2016, ANTIMICROB AGENTS CH, V60, P7494, DOI 10.1128/AAC.00525-16; Magi A, 2012, BIOINFORMATICS, V28, P470, DOI 10.1093/bioinformatics/btr707; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mairi A, 2018, EUR J CLIN MICROBIOL, V37, P587, DOI 10.1007/s10096-017-3112-7; Markovska R, 2015, APMIS, V123, P887, DOI 10.1111/apm.12433; Aires CAM, 2016, ANTIMICROB AGENTS CH, V60, P6969, DOI 10.1128/AAC.01456-16; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; Mshana SE, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-466; Navon-Venezia S, 2017, FEMS MICROBIOL REV, V41, P252, DOI 10.1093/femsre/fux013; Nordmann P, 2012, CLIN MICROBIOL INFEC, V18, P432, DOI 10.1111/j.1469-0691.2012.03815.x; Nordmann P, 2016, EMERG INFECT DIS, V22, P1038, DOI 10.3201/eid2206.151840; Novovic K, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02550-16; Ocampo AM, 2016, ANTIMICROB AGENTS CH, V60, P332, DOI 10.1128/AAC.01775-15; Oteo J, 2016, J ANTIMICROB CHEMOTH, V71, P3392, DOI 10.1093/jac/dkw321; Pecor ND, 2015, MBIO, V6, DOI 10.1128/mBio.01030-15; Pesesky MW, 2015, EMERG INFECT DIS, V21, P1034, DOI 10.3201/eid2106.141504; Pragasam AK, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02135; Rhouma M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01789; Richter M, 2016, BIOINFORMATICS, V32, P929, DOI 10.1093/bioinformatics/btv681; Robinson TP, 2016, T ROY SOC TROP MED H, V110, P377, DOI 10.1093/trstmh/trw048; Samuelsen O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187832; Seiffert SN, 2014, INT J ANTIMICROB AG, V44, P260, DOI 10.1016/j.ijantimicag.2014.05.008; Sepehri S, 2014, CAN J INFECT DIS MED, V25, P229, DOI 10.1155/2014/657047; Shaw E, 2018, J ANTIMICROB CHEMOTH, V73, P1104, DOI 10.1093/jac/dkx496; Sidjabat HE, 2015, ANTIMICROB AGENTS CH, V59, P4059, DOI 10.1128/AAC.04378-14; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Solgi H, 2017, EUR J CLIN MICROBIOL, V36, P2127, DOI 10.1007/s10096-017-3035-3; Sonnevend A, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00418-17, 10.1128/aac.00418-17]; Souza RD, 2017, NEW MICROBIOL, V40, P38; Szekely E, 2013, INT J MED MICROBIOL, V303, P697, DOI 10.1016/j.ijmm.2013.10.001; Uwaezuoke NS, 2017, INT J INFECT DIS, V61, P1, DOI 10.1016/j.ijid.2017.05.004; van Duin D, 2017, VIRULENCE, V8, P460, DOI 10.1080/21505594.2016.1222343; Villa L, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00213-16; Wang XJ, 2017, INT J ANTIMICROB AG, V50, P536, DOI 10.1016/j.ijantimicag.2017.05.009; World Health Organization, 2014, ANT RES GLOB REP SUR; Xie LY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00133; Zankari E, 2017, J ANTIMICROB CHEMOTH, V72, P2764, DOI 10.1093/jac/dkx217; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhou K, 2016, SCI REP-UK, V6, DOI 10.1038/srep20840	92	36	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198526	10.1371/journal.pone.0198526	http://dx.doi.org/10.1371/journal.pone.0198526			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883490	Green Published, gold, Green Submitted			2022-12-26	WOS:000434728100026
J	Na, SK; Choi, GH; Lee, HC; Shin, YM; Ant, J; Lee, D; Shim, JH; Kim, KM; Lim, YS; Chung, YH; Lee, YS				Na, Seong Kyun; Choi, Gwang Hyeon; Lee, Han Chu; Shin, Yong Moon; Ant, Jihyun; Lee, Danbi; Shim, Ju Hyun; Kim, Kang Mo; Lim, Young-Suk; Chung, Young-Hwa; Lee, Yung Sang			The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; IMAGING FEATURES; CLINICOPATHOLOGICAL SIGNIFICANCE; INTRAHEPATIC CHOLANGIOCARCINOMA; LIVER-TRANSPLANTATION; CARCINOMA; COMPONENTS; MANAGEMENT; PROGNOSIS; SURVIVAL	Background Combined hepatocellular-cholangiocarcinoma (cHCC-CC) can present as a hypervascular or peripherally enhancing tumor in dynamic imaging. We evaluated the effect of transarterial chemoembolization (TACE) on prognosis according to post-operative recurrence imaging patterns. Methods We retrospectively analyzed 42 cHCC-CC and 59 hepatocellular carcinoma (HCC-control) patients at the Asan Medical Center. We classified recurrent cHCC-CC according to enhancement pattern (globally enhancing: GE cHCC-CC, peripherally enhancing: PE cHCC-CC) and evaluated tumor response, time-to-local progression (TTPlocal), and overall survival (OS). Results The GE cHCC-CC group had a significantly higher best objective response rate (complete remission + partial response) than the PE cHCC-CC group (36% vs 0%, P= 0.005), and it was comparable to that of the HCC-control group (35.6%, P= 0.97). TTPlocal in the GE cHCC-CC group was significantly shorter than in the HCC-control group (6.6 vs 27.1 months, P < 0.001), and was not significantly different from that in the PE cHCC-CC group (5.3 months, P= 0.12). OS was 12.4 months, 52.8 months, and 67.5 months in the PE cHCC-CC, GE cHCC-CC, and HCC-control groups, respectively (Ps < 0.05). The adjusted hazard ratios (HRs) for TTPlocal and OS revealed an independent association with enhancement pattern of recurrent cHCC-CC (TTPlocal: HR 2.46; 95% CI 1.10-5.46; P= 0.03; OS: HR 5.97; 95% CI 2.38-14.96; P< 0.001). Conclusions The GE cHCC-CC group showed better response and prognosis after TACE than the PE cHCC-CC group, but poorer response and prognosis than the HCC-control group. Enhancement patterns at recurrence were crucially associated with tumor response and overall survival.	[Na, Seong Kyun] Jeju Natl Univ, Dept Internal Med, Jeju Natl Univ Hosp, Sch Med, Jeju, South Korea; [Choi, Gwang Hyeon; Lee, Han Chu; Ant, Jihyun; Lee, Danbi; Shim, Ju Hyun; Kim, Kang Mo; Lim, Young-Suk; Chung, Young-Hwa; Lee, Yung Sang] Univ Ulsan, Dept Gastroenterol, Asan Liver Ctr, Asan Med Ctr,Coll Med, Seoul, South Korea; [Shin, Yong Moon] Univ Ulsan, Dept Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea; [Shin, Yong Moon] Univ Ulsan, Res Inst Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea	Jeju National University; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Lee, HC (corresponding author), Univ Ulsan, Dept Gastroenterol, Asan Liver Ctr, Asan Med Ctr,Coll Med, Seoul, South Korea.	hch@amc.seoul.kr		Shim, Ju Hyun/0000-0002-7336-1371; An, Jihyun/0000-0002-0110-0965; Lee, Han Chu/0000-0002-7631-4124				Aishima S, 2006, HUM PATHOL, V37, P283, DOI 10.1016/j.humpath.2005.08.019; Akiba J, 2013, AM J SURG PATHOL, V37, P496, DOI 10.1097/PAS.0b013e31827332b0; ALLEN RA, 1949, AM J PATHOL, V25, P647; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Chu KJ, 2014, EUR J GASTROEN HEPAT, V26, P192, DOI 10.1097/MEG.0b013e3283625df9; Ebied O, 2003, J COMPUT ASSIST TOMO, V27, P117, DOI 10.1097/00004728-200303000-00003; Edge S, 2010, AJCC CANC STAGING MA, V7th; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fowler KJ, 2013, AM J ROENTGENOL, V201, P332, DOI 10.2214/AJR.12.9488; Hwang J, 2012, J MAGN RESON IMAGING, V36, P881, DOI 10.1002/jmri.23728; Ikeda H, 2013, AM J CLIN PATHOL, V140, P329, DOI 10.1309/AJCP66AVBANVNTQJ; Kassahun WT, 2008, INT J CLIN PRACT, V62, P1271, DOI 10.1111/j.1742-1241.2007.01694.x; Kim JH, 2010, RADIOLOGY, V255, P270, DOI 10.1148/radiol.09091076; Kopek N, 2010, RADIOTHER ONCOL, V94, P47, DOI 10.1016/j.radonc.2009.11.004; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Li R, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2156-x; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Mao Y, 2017, CLIN RADIOL, V72, P129, DOI 10.1016/j.crad.2016.11.003; Network NCC, HEP CANC; Park SH, 2017, J MAGN RESON IMAGING, V46, P267, DOI 10.1002/jmri.25568; Park YH, 2013, TRANSPL P, V45, P3038, DOI 10.1016/j.transproceed.2013.08.056; Sasaki M, 2015, LIVER INT, V35, P1024, DOI 10.1111/liv.12563; Shibahara J, 2016, AM J SURG PATHOL, V40, P608, DOI 10.1097/PAS.0000000000000579; Shim JH, 2012, RADIOLOGY, V262, P708, DOI 10.1148/radiol.11110282; Shin CI, 2007, J COMPUT ASSIST TOMO, V31, P109, DOI 10.1097/01.rct.0000235072.34808.9b; Theise N.D., 2010, WHO CLASSIFICATION T, V4th; Vilchez V, 2016, HPB, V18, P29, DOI 10.1016/j.hpb.2015.10.001; Wang AQ, 2016, WORLD J GASTROENTERO, V22, P4459, DOI 10.3748/wjg.v22.i18.4459; Yin X, 2012, ANN SURG ONCOL, V19, P2869, DOI 10.1245/s10434-012-2328-0; Yoon YI, 2016, J GASTROINTEST SURG, V20, P411, DOI 10.1007/s11605-015-3045-3; Zeng ZC, 2006, CANCER J, V12, P113	32	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198138	10.1371/journal.pone.0198138	http://dx.doi.org/10.1371/journal.pone.0198138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879137	Green Submitted, Green Published, gold			2022-12-26	WOS:000434384900021
J	Nam, Y; Jung, SM; Rim, YA; Jung, H; Lee, K; Park, N; Kim, J; Jang, Y; Park, YB; Park, SH; Ju, JH				Nam, Yoojun; Jung, Seung Min; Rim, Yeri Alice; Jung, Hyerin; Lee, Kijun; Park, Narae; Kim, Juryun; Jang, Yeonsue; Park, Yong-Beom; Park, Sung-Hwan; Ju, Ji Hyeon			Intraperitoneal infusion of mesenchymal stem cell attenuates severity of collagen antibody induced arthritis	PLOS ONE			English	Article							REGULATORY T-CELLS; ANTIGEN-INDUCED ARTHRITIS; MARROW STROMAL CELLS; BONE-MARROW; SDF-1/CXCR4 AXIS; INTRAARTICULAR INJECTION; TH17 CELLS; MIGRATION; IMMUNE; REPAIR	It is unclear how systemic administration of mesenchymal stem cells (MSCs) controls local inflammation. The aim of this study was to evaluate the therapeutic effects of human MSCs on inflammatory arthritis and to identify the underlying mechanisms. Mice with collagen antibody-induced arthritis (CAIA) received two intraperitoneal injections of human bone marrow-derived MSCs. The clinical and histological features of injected CAIA were then compared with those of non-injected mice. The effect of MSCs on induction of regulatory T cells was examined both in vitro and in vivo. We also examined multiple cytokines secreted by peritoneal mononuclear cells, along with migration of MSCs in the presence of stromal cell-derived factor-1 alpha (SDF-1 alpha) and/or regulated on activation, normal T cell expressed and secreted (RANTES). Sections of CAIA mouse joints and spleen were stained for human anti-nuclear antibodies (ANAs) to confirm migration of injected human MSCs. The results showed that MSCs alleviated the clinical and histological signs of synovitis in CAIA mice. Peritoneal lavage cells from mice treated with MSCs expressed higher levels of SDF-1 alpha and RANTES than those from mice not treated with MSCs. MSC migration was more prevalent in the presence of SDF-1 alpha and/or RANTES. MSCs induced CD4+ T cells to differentiate into regulatory T cells in vitro, and expression of FOXP3 mRNA was upregulated in the forepaws of MSC-treated CAIA mice. Synovial and splenic tissues from CAIA mice receiving human MSCs were positive for human ANA, suggesting recruitment of MSCs. Taken together, these results suggest that MSCs migrate into inflamed tissues and directly induce the differentiation of CD4+ T cells into regulatory T cells, which then suppress inflammation. Thus, systemic administration of MSCs may be a therapeutic option for rheumatoid arthritis.	[Nam, Yoojun; Rim, Yeri Alice; Jung, Hyerin; Lee, Kijun; Park, Narae; Kim, Juryun; Jang, Yeonsue; Ju, Ji Hyeon] Catholic Univ Korea, Coll Med, Catholic iPSC Res Ctr, CiSTEM Lab, Seoul, South Korea; [Nam, Yoojun; Rim, Yeri Alice; Jung, Hyerin; Lee, Kijun; Park, Narae; Kim, Juryun; Jang, Yeonsue; Park, Sung-Hwan; Ju, Ji Hyeon] Catholic Univ Korea, Div Rheumatol, Dept Internal Med, Coll Med, Seoul, South Korea; [Jung, Seung Min; Park, Yong-Beom] Yonsei Univ, Div Rheumatol, Dept Internal Med, Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Yonsei University; Yonsei University Health System	Ju, JH (corresponding author), Catholic Univ Korea, Coll Med, Catholic iPSC Res Ctr, CiSTEM Lab, Seoul, South Korea.; Ju, JH (corresponding author), Catholic Univ Korea, Div Rheumatol, Dept Internal Med, Coll Med, Seoul, South Korea.	juji@catholic.ac.kr		Jung, Seung Min/0000-0003-3465-2181	National Research Foundation of Korea (NRF) [2014R1A1A2057957]; Korea National Institute of Health, Ministry of Food and Drug Safety [14172MFDS974]; Korea Healthcare Technology R&D project, Ministry for Health, Welfare and Family Affairs, Republic of Korea Food and Drug Administration [HI16C2177]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea National Institute of Health, Ministry of Food and Drug Safety; Korea Healthcare Technology R&D project, Ministry for Health, Welfare and Family Affairs, Republic of Korea Food and Drug Administration	This work was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) (2014R1A1A2057957) and by a grant from Korea National Institute of Health, Ministry of Food and Drug Safety (14172MFDS974) and Korea Healthcare Technology R&D project, Ministry for Health, Welfare and Family Affairs, Republic of Korea Food and Drug Administration (HI16C2177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldinucci A, 2010, J IMMUNOL, V185, P5102, DOI 10.4049/jimmunol.1001332; Alunno A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/751793; Alvaro-Gracia JM, 2017, ANN RHEUM DIS, V76, P196, DOI 10.1136/annrheumdis-2015-208918; Augello A, 2007, ARTHRITIS RHEUM-US, V56, P1175, DOI 10.1002/art.22511; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Byng-Maddick R, 2015, RHEUMATOLOGY, V54, P768, DOI 10.1093/rheumatology/keu487; Cao YX, 2008, J IMMUNOL, V180, P922, DOI 10.4049/jimmunol.180.2.922; Cencioni C, 2012, CARDIOVASC RES, V94, P400, DOI 10.1093/cvr/cvs132; Chen MG, 2013, ARTHRITIS RHEUM-US, V65, P1181, DOI 10.1002/art.37894; Chen W, 2013, CELL BIOCHEM BIOPHYS, V67, P1181, DOI 10.1007/s12013-013-9632-6; Choi MS, 2008, CELL TRANSPLANT, V17, P899, DOI 10.3727/096368908786576471; Ciccocioppo R, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0122-1; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; Erkers T, 2013, STEM CELLS DEV, V22, P2596, DOI 10.1089/scd.2013.0079; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; Ghadge SK, 2011, PHARMACOL THERAPEUT, V129, P97, DOI 10.1016/j.pharmthera.2010.09.011; Gong J, 2014, MOL MED REP, V9, P1575, DOI 10.3892/mmr.2014.2053; Gonzalez MA, 2009, ARTHRITIS RHEUM-US, V60, P1006, DOI 10.1002/art.24405; Greish Sahar, 2012, World J Stem Cells, V4, P101, DOI 10.4252/wjsc.v4.i10.101; Hernandez-Lopez C, 2002, BLOOD, V99, P546, DOI 10.1182/blood.V99.2.546; Hu CJ, 2013, J SURG RES, V183, P427, DOI 10.1016/j.jss.2013.01.019; Huang H, 2009, CELL DEATH DIFFER, V16, P1332, DOI 10.1038/cdd.2009.74; Huber M, 2008, INT IMMUNOL, V20, P223, DOI 10.1093/intimm/dxm139; Huckel M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1869; Hynes K, 2016, SEMIN ARTHRITIS RHEU, V46, P1, DOI 10.1016/j.semarthrit.2016.02.008; Kawai T, 1999, J IMMUNOL, V163, P3269; Kehoe O, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-157; Khachigian LM, 2006, NAT PROTOC, V1, P2512, DOI 10.1038/nprot.2006.393; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Klinker MW, 2015, WORLD J STEM CELLS, V7, P556, DOI 10.4252/wjsc.v7.i3.556; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Lai XF, 2016, MOLECULES, V21, DOI 10.3390/molecules21111565; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Lee K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193086; Leibacher J, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-015-0271-2; Liu NM, 2013, AM J PHYSIOL-RENAL, V305, pF1064, DOI 10.1152/ajprenal.00178.2013; Liu XL, 2011, PROTEIN CELL, V2, P845, DOI 10.1007/s13238-011-1097-z; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Lu L, 2015, J DENT RES, V94, P1601, DOI 10.1177/0022034515604621; Luz-Crawford P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt216; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Marquez-Curtis LA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/561098; Marshall J, 2011, METHODS MOL BIOL, V769, P97, DOI 10.1007/978-1-61779-207-6_8; Mojsilovic S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/470458; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Park KH, 2016, CELL TRANSPLANT, V25, P1057, DOI 10.3727/096368915X687949; Park N, 2017, SCI REP-UK, V7, DOI 10.1038/srep39593; Parolini O, 2014, ARTHRITIS RHEUMATOL, V66, P327, DOI 10.1002/art.38206; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Ringe J, 2007, J CELL BIOCHEM, V101, P135, DOI 10.1002/jcb.21172; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Sullivan C, 2013, STEM CELLS DEV, V22, P3203, DOI 10.1089/scd.2013.0248; Toupet K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114962; Toupet K, 2013, ARTHRITIS RHEUM-US, V65, P1786, DOI 10.1002/art.37960; Wang LT, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0289-5; Wang M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30696; Wang WH, 2012, RHEUMATOL INT, V32, P887, DOI 10.1007/s00296-010-1710-0; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Xu S, 2010, CELL MOL IMMUNOL, V7, P164, DOI 10.1038/cmi.2010.21; Xu X, 2013, CELLS TISSUES ORGANS, V197, P103, DOI 10.1159/000342921; Yu J, 2010, J CARDIOVASC PHARM, V55, P496, DOI 10.1097/FJC.0b013e3181d7a384	64	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198740	10.1371/journal.pone.0198740	http://dx.doi.org/10.1371/journal.pone.0198740			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879214	gold, Green Submitted, Green Published			2022-12-26	WOS:000434384900079
J	Nilles, EJ; Manaia, A; Ruaia, B; Huppatz, C; Ward, C; George, P; Sies, C; Cangiano, A; Sejvar, J; Reiffer, A; Tira, T				Nilles, Eric J.; Manaia, Atarota; Ruaia, Bineta; Huppatz, Clare; Ward, Catherine; George, Peter; Sies, Christiaan; Cangiano, Alessio; Sejvar, James; Reiffer, Andre; Tira, Teatoa			Re-emergence of thiamine deficiency disease in the Pacific islands (2014-15): A case-control study	PLOS ONE			English	Article							WEST-AFRICA; BERIBERI; OUTBREAK; INFANTS; POPULATION; THAILAND; GAMBIA; BRAZIL; PRISON; STATE	Background From late 2014 multiple atolls in Kiribati reported an unusual and sometimes fatal illness. We conducted an investigation to identify the etiology of the outbreak on the most severely affected atoll, Kuria, and identified thiamine deficiency disease as the cause. Thiamine deficiency disease has not been reported in the Pacific islands for >5 decades. We present the epidemiological, clinical, and laboratory findings of the investigation. Methodology/Principal findings We initially conducted detailed interviews and examinations on previously identified cases to characterize the unknown illness and develop a case definition. Active and passive surveillance was then conducted to identify additional cases. A questionnaire to identify potential risk factors and blood samples to assay biochemical indices were collected from cases and asymptomatic controls. Thiamine hydrochloride treatment was implemented and the response to treatment was systematically monitored using a five-point visual analogue scale and by assessing resolution of previously abnormal neurological examination findings. Risk factors and biochemical results were assessed by univariate and multivariate analyses. 69 cases were identified on Kuria (7% attack rate) including 34 confirmed and 35 unconfirmed. Most were adults (median age 28 years [range 0-62]) and 83% were male. Seven adult males and two infants died (13% case fatality rate). Resolution of objective clinical signs (78%) or symptoms (94%) were identified within one week of starting treatment. Risk factors included having a friend with thiamine deficiency disease and drinking kava; drinking yeast alcohol reduced the risk of disease. Higher chromium (p<0.001) but not thiamine deficiency (p = 0.66) or other biochemical indices were associated with disease by univariate analyses. Chromium (p<0.001) and thiamine deficiency (p = 0.02) were associated with disease by multivariate analysis. Conclusions/Significance An outbreak of thiamine deficiency disease (beriberi) in Kiribati signals the re-emergence of a classic nutritional disease in the Pacific islands after five decades. Although treatment is safe and effective, the underlying reason for the re-emergence remains unknown. Chromium was highly and positively correlated with disease in this study raising questions about the potential role of factors other than thiamine in the biochemistry and pathophysiology of clinical disease.	[Nilles, Eric J.; Huppatz, Clare; Ward, Catherine] WHO, Div Pacific Tech Support, Emerging Dis Surveillance & Response, Suva, Fiji; [Manaia, Atarota] Minist Hlth & Med Serv, Kuria, Kiribati; [Ruaia, Bineta] Minist Hlth & Med Serv, Nawerewere, Tarawa, Kiribati; [George, Peter; Sies, Christiaan] Canterbury Hlth Labs, Christchurch, New Zealand; [George, Peter] Univ Otago, Christchurch, New Zealand; [Cangiano, Alessio] Univ South Pacific, Suva, Fiji; [Sejvar, James] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Reiffer, Andre] WHO, Nawerewere, Tarawa, Kiribati; [Nilles, Eric J.] Harvard Humanitarian Initiat, Cambridge, MA 02138 USA; [Nilles, Eric J.] Brigham & Womens Hosp, Div Int Emergency Med & Humanitarian Programs, 75 Francis St, Boston, MA 02115 USA; [Nilles, Eric J.] Harvard Med Sch, Boston, MA 02115 USA	World Health Organization; Canterbury Health Laboratories; University of Otago; University of the South Pacific; Centers for Disease Control & Prevention - USA; World Health Organization; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Nilles, EJ (corresponding author), WHO, Div Pacific Tech Support, Emerging Dis Surveillance & Response, Suva, Fiji.; Nilles, EJ (corresponding author), Harvard Humanitarian Initiat, Cambridge, MA 02138 USA.; Nilles, EJ (corresponding author), Brigham & Womens Hosp, Div Int Emergency Med & Humanitarian Programs, 75 Francis St, Boston, MA 02115 USA.; Nilles, EJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	enilles@bwh.harvard.edu	Nilles, Eric/ABA-4757-2021	Nilles, Eric/0000-0001-7044-5257	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Ahoua L, 2007, FOOD NUTR BULL, V28, P283, DOI 10.1177/156482650702800304; Lima HCAV, 2010, TROP DOCT, V40, P95, DOI 10.1258/td.2009.090439; [Anonymous], 2012, REP KIR 2010 CENS PO; Barennes H, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003581; Canterbury Health Laboratories, CANT HLTH LAB TEST R; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; Cerroni MP, 2010, AM J TROP MED HYG, V83, P1093, DOI 10.4269/ajtmh.2010.10-0345; Chen KT, 2003, PUBLIC HEALTH REP, V118, P59, DOI 10.1016/S0033-3549(04)50217-0; Chundawat RS, 2005, TOXICOLOGY, V211, P124, DOI 10.1016/j.tox.2005.03.004; Coats D, 2012, J PEDIATR-US, V161, P843, DOI 10.1016/j.jpeds.2012.05.006; de Montmollin D, 2002, TROP DOCT, V32, P234, DOI 10.1177/004947550203200419; Doung-ngern P., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P130; Fattal-Valevski A, 2005, PEDIATRICS, V115, pE233, DOI 10.1542/peds.2004-1255; Keating EM, 2014, PAEDIAT CHILD HLTH; Krol E, 2012, BIOL TRACE ELEM RES, V150, P350, DOI 10.1007/s12011-012-9515-5; MaciasMatos C, 1996, AM J CLIN NUTR, V64, P347, DOI 10.1093/ajcn/64.3.347; Mellion M, 2011, MUSCLE NERVE, V43, P309, DOI 10.1002/mus.21946; Nguyen Ha Ai Phan CP, 2014, OUTBREAK INVESTIGATI, V7, P1; Nosten F., 2015, PAEDIATR INT CHILD H; PONGPANICH B, 1974, AM J CLIN NUTR, V27, P1399, DOI 10.1093/ajcn/27.12.1399; Restier J, 2012, Bull Soc Pathol Exot, V105, P49, DOI 10.1007/s13149-011-0198-5; ROLFE M, 1993, T ROY SOC TROP MED H, V87, P114, DOI 10.1016/0035-9203(93)90449-Z; San Sebastian M, 1998, ACTA TROP, V70, P193, DOI 10.1016/S0001-706X(98)00009-6; SAUBERLICH HE, 1967, AM J CLIN NUTR, V20, P528, DOI 10.1093/ajcn/20.6.528; TAKAHASHI K, 1981, International Journal of Neurology, V15, P245; TANG CM, 1989, LANCET, V2, P206; Watson JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028345; WILLIAMS RR, 1953, J CLIN NUTR, V1, P513; World Health Organization, 1999, THIAM DEF ITS PREV C	29	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198590	10.1371/journal.pone.0198590	http://dx.doi.org/10.1371/journal.pone.0198590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879174	Green Submitted, gold, Green Published			2022-12-26	WOS:000434384900056
J	Barratt, AS; Arnoult, MH; Ahmadi, BV; Rich, KM; Gunn, GJ; Stott, AW				Barratt, Alyson S.; Arnoult, Matthieu H.; Ahmadi, Bouda Vosough; Rich, Karl M.; Gunn, George J.; Stott, Alistair W.			A framework for estimating society's economic welfare following the introduction of an animal disease: The case of Johne's disease	PLOS ONE			English	Article							AVIUM SUBSPECIES PARATUBERCULOSIS; PSEUDORABIES ERADICATION PROGRAM; ENDEMIC LIVESTOCK DISEASES; MYCOBACTERIUM-PARATUBERCULOSIS; MILK-PRODUCTION; GREAT-BRITAIN; DAIRY OPERATIONS; HEAT-RESISTANCE; UNITED-KINGDOM; RISK-FACTORS	Animal diseases are global issues affecting the productivity and financial profitability of affected farms. Johne's disease is distributed on farms worldwide and is an endemic contagious bacterial infection in ruminants caused by Mycobacterium avium subspecies paratuberculosis. In cattle, the clinical disease manifests itself as chronic enteritis resulting in reduced production, weight loss, and eventually death. Johne's disease is prevalent in the UK, including Scotland. Direct costs and losses associated with Johne's disease have been estimated in previous research, confirming an important economic impact of the disease in UK herds. Despite this, the distributional impact of Johne's disease among milk consumers and producers in Scotland has not been estimated. In this paper, we evaluate the change in society's economic welfare, namely to dairy producers (i.e. infected and uninfected herds) and milk consumers in Scotland induced by the introduction of Johne's disease in the national Scottish dairy herd. At the national-level, we conclude that the economic burden falls mainly on producers of infected herds and, to a lesser extent, milk consumers, while producers of uninfected herds benefit from the presence of Johne's. An infected producer's loss per cow is approximately two times larger in magnitude than that of an uninfected producer's gain. Such economic welfare estimates are an important comparison of the relative costs of national herd prevalence and the wider economic welfare implications for both producers and consumers. This is particularly important from a policy, public good, cost sharing, and human health perspective. The economic welfare framework presented in this paper can be applied to other diseases to examine the relative burden of society's economic welfare of alternative livestock disease scenarios. In addition, the sensitivity analysis evaluates uncertainty in economic welfare given limited data and uncertainty in the national herd prevalence, and other input parameters, associated with Johne's disease in Scotland. Therefore, until the prevalence of Johne's is better understood, the full economic cost Scottish dairy herds remains uncertain but in the meantime the sensitivity analysis evaluates the robustness of economic welfare to such uncertainties.	[Barratt, Alyson S.; Ahmadi, Bouda Vosough] Scotlands Rural Coll SRUC, Land Econ Environm & Soc Res Grp, Edinburgh, Midlothian, Scotland; [Arnoult, Matthieu H.] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England; [Rich, Karl M.] ILRI, East & Southeast Asia Reg Off, Hanoi, Vietnam; [Gunn, George J.] Scotlands Rural Coll SRUC, Epidemiol Res Unit, Inverness, Scotland; [Stott, Alistair W.] Scotlands Rural Coll SRUC, Future Farming Syst Grp, Edinburgh, Midlothian, Scotland	Scotland's Rural College; University of Reading; Scotland's Rural College; Scotland's Rural College	Barratt, AS (corresponding author), Scotlands Rural Coll SRUC, Land Econ Environm & Soc Res Grp, Edinburgh, Midlothian, Scotland.	alyson.barratt@sruc.ac.uk		Barratt, Alyson/0000-0002-7663-7070; Arnoult, Matthieu/0000-0001-7001-4318; Vosough Ahmadi, Bouda/0000-0002-9414-2944	Rural and Environment Science and Analytical Services Division, Epidemiology, Population health and Infectious disease Control (EPIC) centre of expertise; Scottish Government's centre of expertise EPIC (Epidemiology, Population health and Infectious disease Control); Scottish Government's Centre of Expertise on Animal Disease Outbreaks (EPIC); Scottish Funding Council; 6th Framework of the European Commission; Strategic Research Programme of the Rural & Environment Science & Analytical Services Division of the Scottish Government	Rural and Environment Science and Analytical Services Division, Epidemiology, Population health and Infectious disease Control (EPIC) centre of expertise; Scottish Government's centre of expertise EPIC (Epidemiology, Population health and Infectious disease Control); Scottish Government's Centre of Expertise on Animal Disease Outbreaks (EPIC); Scottish Funding Council; 6th Framework of the European Commission(European Commission); Strategic Research Programme of the Rural & Environment Science & Analytical Services Division of the Scottish Government	This work was supported by the Rural and Environment Science and Analytical Services Division, Epidemiology, Population health and Infectious disease Control (EPIC) centre of expertise, Prof George J Gunn. This work was supported by The Scottish Government's centre of expertise EPIC (Epidemiology, Population health and Infectious disease Control), websiteat: http://epicscotland.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by The Scottish Government's Centre of Expertise on Animal Disease Outbreaks (EPIC). The authors are grateful for assistance from colleagues involved with the Scottish Funding Council funded project 'Paraban' (Knowledge exchange for the control of Johne's disease), the project 'ParaTBTools' funded by the 6th Framework of the European Commission and the Strategic Research Programme of the Rural & Environment Science & Analytical Services Division of the Scottish Government. The authors thank Habtu Weldegebriel for his contributions towards an earlier draft of the paper.	Adams P, 2002, MMRF GREEN DYNAMIC M; Agrawal R, 1972, METHODS AGR DECISION, P179; AHDB, 2015, AV UK MILK YIELD; Andersson H, 1997, PREV VET MED, V29, P311, DOI 10.1016/S0167-5877(96)01073-2; [Anonymous], 1965, LOGIC COLLECTIVE ACT; [Anonymous], 2015, BBC; Atreya R, 2014, INT J MED MICROBIOL, V304, P858, DOI 10.1016/j.ijmm.2014.07.006; Badiola J, 2000, POSSIBLE LINKS CROHN, P76; Bannock G, 1992, PENGIUN DICT EC; Barkema HW, 2010, PARATUBERCULOSIS: ORGANISM, DISEASE, CONTROL, P10, DOI 10.1079/9781845936136.0010; Bate A, 2016, UK DAIRY IND STAT, P10; BBC,, 2011, BBC; Begg DJ, 2005, INFECT IMMUN, V73, P5603, DOI 10.1128/IAI.73.9.5603-5611.2005; Bellman R., 1957, DYNAMIC PROGRAMMING; BENEDICTUS G, 1987, VET REC, V121, P142, DOI 10.1136/vr.121.7.142; Benedictus G, 2000, VET MICROBIOL, V77, P399, DOI 10.1016/S0378-1135(00)00325-4; Bennett R, 2005, J AGR ECON, V56, P135, DOI 10.1111/j.1477-9552.2005.tb00126.x; Bennett R, 2003, J AGR ECON, V54, P55, DOI 10.1111/j.1477-9552.2003.tb00048.x; Bennett R, 1999, PREV VET MED, V39, P155, DOI 10.1016/S0167-5877(99)00003-3; Bennett R, 2012, EUROCHOICES, V11, P5, DOI 10.1111/j.1746-692X.2012.00227.x; Blair P. D., 2009, INPUT OUTPUT ANAL FD, DOI DOI 10.1017/CBO9780511626982; Britton LE, 2016, VET J, V209, P32, DOI 10.1016/j.tvjl.2015.10.033; Butler AJ, 2015, FOODBORNE PATHOG DIS, V12, P367, DOI 10.1089/fpd.2014.1844; Caldow G, 2000, ASSESSMENT SURVEILLA, P245; Carslake D, 2011, PHILOS T R SOC B, V366, P1975, DOI 10.1098/rstb.2010.0396; Cetinkaya B, 1998, VET REC, V143, P265, DOI 10.1136/vr.143.10.265; Collins MT, 2003, IRISH VET J, V56, P565; Colman D, 2004, FUTURE UK DAIRY FARM, P28; Costa-Font M, 2018, EMPIRICAL ANAL UK MI; Davidson RS, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-159; Defra, 2010, GUID CONTR JOHN DIS, P1; EBEL ED, 1992, AM J AGR ECON, V74, P638, DOI 10.2307/1242576; FAO, 2016, EC AN AN DIS, P73; Forbes D, 1999, IMPROVING LONGEVITY; FORSYTHE KW, 1994, AM J AGR ECON, V76, P968, DOI 10.2307/1243760; GARDNER BL, 1975, AM J AGR ECON, V57, P399, DOI 10.2307/1238402; Geraghty T, 2014, PREV VET MED, V116, P1, DOI 10.1016/j.prevetmed.2014.06.003; Gitlin L, 2012, J CLIN GASTROENTEROL, V46, P649, DOI 10.1097/MCG.0b013e31825f2bce; Grant IR, 2001, INT J DAIRY TECHNOL, V54, P2, DOI 10.1046/j.1471-0307.2001.00009.x; Groenendaal H, 2002, PREV VET MED, V54, P225, DOI 10.1016/S0167-5877(02)00027-2; Havrila A, 1991, 35 ANN C AUSTR AGR E, P24; Hueth D.L., 1982, APPL WELFARE EC PUBL; LARSEN AB, 1975, AM J VET RES, V36, P255; LICHTENBERG E, 1988, AM J AGR ECON, V70, P867, DOI 10.2307/1241928; Lombard JE, 2005, JAVMA-J AM VET MED A, V227, P1975, DOI 10.2460/javma.2005.227.1975; Losinger WC, 2006, J DAIRY RES, V73, P33, DOI 10.1017/S0022029905001378; Lovell R, 1944, J COMP PATHOL, V54, P120, DOI DOI 10.1016/S0368-1742(44)80013-3; Mangen MJJ, 2003, EUR REV AGRIC ECON, V30, P125, DOI 10.1093/erae/30.2.125; Marce C, 2009, THERIOGENOLOGY, V71, P807, DOI 10.1016/j.theriogenology.2008.10.017; Massaro T, 2013, J BIOL SYST, V21, DOI 10.1142/S021833901340010X; McKenna SLB, 2006, CAN VET J, V47, P1089; National Commission on Forensic Science, 2015, ENS FOR AN IS BAS TA, P1; National Statistics, 2015, REP PROD DEP ENV FOO, P99; NICHOLSON W, 1995, MICROECONOMIC THEORY; Nielsen SS, 2009, PREV VET MED, V88, P1, DOI 10.1016/j.prevetmed.2008.07.003; NML, 2011, JOHN DIS TEST TOOLK, P12; NMR, 2012, VET GUID JOHN TEST S, P26; Oanda, 2017, AV EXCH RAT; OGLETHORPE DR, 1995, J AGR ECON, V46, P227, DOI 10.1111/j.1477-9552.1995.tb00768.x; ONS, 2015, STAT B, P1; ONS. RPI, 2018, RPI AV PRIC MILK PAS; Ott SL, 1999, PREV VET MED, V40, P179, DOI 10.1016/S0167-5877(99)00037-9; ParaTBTools, 2017, DEV IMPR TOOLS DET P; Pendell D. L., 2007, Journal of Agricultural and Applied Economics, V39, P19; Ha PV, 2017, ECON MODEL, V67, P102, DOI 10.1016/j.econmod.2016.10.015; Ha PV, 2015, J AGR ECON, V66, P280, DOI 10.1111/1477-9552.12087; Pritchard TC, 2017, J DAIRY SCI, V100, P679, DOI 10.3168/jds.2016-11323; Pritchett J.G., 2005, INT FOOD AGRIBUS MAN, V8, P23, DOI [10.22004/ag.econ.8177, DOI 10.22004/AG.ECON.8177]; R Core Team, 2013, R LANG ENV STAT COMP; Raizman EA, 2007, PREV VET MED, V78, P179, DOI 10.1016/j.prevetmed.2006.10.006; Revoredo-Giha C, 2017, SRUC FMR FOOD SUPPLY; Revoredo-Giha C, 2017, DEMAND ELASTICITIES; Rich KM, 2014, FOOD POLICY, V44, P248, DOI 10.1016/j.foodpol.2013.09.018; Rich KM, 2005, REV SCI TECH OIE, V24, P833, DOI 10.20506/rst.24.3.1618; Rich KM, 2005, REV SCI TECH OIE, V24, P847, DOI 10.20506/rst.24.3.1617; Rowe MT, 2000, IRISH J AGR FOOD RES, V39, P203; Runge MC, 2011, BIOL CONSERV, V144, P1214, DOI 10.1016/j.biocon.2010.12.020; Rushton J, 2009, ECONOMICS OF ANIMAL HEALTH AND PRODUCTION, P144, DOI 10.1079/9781845931940.0144; SAC, 2012, FARM MAN HDB 2012 13; SAC, 2014, FARM MAN HDB 2014 15; Scottish Government, 2014, RES JUN 2014 SCOTT A, P1; Stabel JR, 2000, J DAIRY SCI, V83, P1659, DOI 10.3168/jds.S0022-0302(00)75034-X; Stabel JR, 2001, J DAIRY SCI, V84, P524, DOI 10.3168/jds.S0022-0302(01)74503-1; Stott A, 2005, 56 ANN M EUR ASS AN; Stott AW, 2005, VET REC, V156, P825, DOI 10.1136/vr.156.26.825; Thompson D, 2002, NATL FOOD SURVEY 200, P213; UK Farm Animal Welfare Committee, 2011, Economics and farm animal welfare; Uzoigwe JC, 2007, EPIDEMIOL INFECT, V135, P1057, DOI 10.1017/S0950268807008448; van Asseldonk M, 2003, RISK FINANCING MODEL, P55; VANARENDONK JAM, 1985, AGR SYST, V16, P157, DOI 10.1016/0308-521X(85)90010-1; Velthuis A. G. J., 2006, P 11 S INT SOC VET E, P313; Vidal-Diez A, SB4022; Weldegebriel HT, 2009, PREV VET MED, V88, P49, DOI 10.1016/j.prevetmed.2008.07.001; Whitlock RH, 1996, VET CLIN N AM-FOOD A, V12, P345, DOI 10.1016/S0749-0720(15)30410-2; WHO-OIE, 2014, OP FRAM GOOD GOV HUM, P86; WILSON DJ, 1995, AGRI-PRACTICE, V16, P12; Windsor PA, 2010, VET J, V184, P37, DOI 10.1016/j.tvjl.2009.01.007; Withers J, 2013, SCOTTISH DAIRY REV A, P15; WOOD PDP, 1967, NATURE, V216, P164, DOI 10.1038/216164a0	99	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198436	10.1371/journal.pone.0198436	http://dx.doi.org/10.1371/journal.pone.0198436			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI4VN	29874292	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000434369400049
J	Schulz, A; Lautner, S; Fromm, J; Fischer, M				Schulz, Anna; Lautner, Silke; Fromm, Joerg; Fischer, Markus			Not stealing from the treasure chest (or just a bit): Analyses on plant derived writing supports and non-invasive DNA sampling	PLOS ONE			English	Article							ANCIENT DNA; MITOCHONDRIAL-DNA; SEQUENCE DATA; PLASTID DNA; EXTRACTION; WOOD; PCR; RBCL; CIRCUMSCRIPTION; PHYLOGENETICS	Written communication plays a crucial role in the history of modern civilizations as manuscripts do not only exist contemporarily, but are passed on to subsequent generations. Besides a document's content, information is stored in the materials used for its production. Analyses of the composition allow, for example, identifying the biological origins of materials, dating, and help to understand degradation patterns. A combination of microscopic and DNA approaches was applied in order to analyze various plant derived writing sheets. Given their diversity and abundance in museum collections, plant based writing supports are yet an underexplored target for DNA studies. DNA retrieval of paper is low compared to raw paper plant material, which is likely due to the loss of organic components during paper production. Optimizing DNA extraction for each respective material drastically increased DNA recovery. Finally, we present a non-invasive DNA sampling method that utilizes nylon membranes, commonly used for bacterial DNA sampling and that is applicable to delicate material. Although bacterial infestation was visible on one sample, as indicated by scanning electron microscopy, endogenous DNA was retrieved. The results presented here are promising as they extend the scope of sources for DNA analyses by demonstrating that DNA molecules can be retrieved from a variety of plant derived writing supports. In future, such analyses can help to explore the biological diversity not only of plants and of additives utilized for producing writing supports, but also of the plenty products made from paper.	[Schulz, Anna; Fischer, Markus] Univ Hamburg, Hamburg Sch Food Sci, Hamburg, Germany; [Lautner, Silke; Fromm, Joerg] Univ Hamburg, Ctr Wood Sci, Hamburg, Germany	University of Hamburg; University of Hamburg	Fischer, M (corresponding author), Univ Hamburg, Hamburg Sch Food Sci, Hamburg, Germany.	markus.fischer@uni-hamburg.de	Fischer, Markus/AFT-1856-2022	Fischer, Markus/0000-0001-7243-4199; Schulz, Anna/0000-0003-4685-7328				Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Alverson WS, 1998, AM J BOT, V85, P876, DOI 10.2307/2446423; Angeles J. G. C., 2005, Plant Molecular Biology Reporter, V23, P297, DOI 10.1007/BF02772760; Asmussen CB, 2001, AM J BOT, V88, P1103, DOI 10.2307/2657094; Bicchieri M, 2013, ANAL BIOANAL CHEM, V405, P2713, DOI 10.1007/s00216-012-6681-4; Bonello P, 2003, J CHEM ECOL, V29, P1167, DOI 10.1023/A:1023833707382; Bower MA, 2010, J INST CONSERV, V33, P1, DOI 10.1080/19455220903509937; Bugler JH, 2008, J FORENSIC SCI, V53, P982, DOI 10.1111/j.1556-4029.2008.00745.x; Burger J, 2000, THERMOCHIM ACTA, V365, P141, DOI 10.1016/S0040-6031(00)00621-3; Castalanelli MA, 2010, J ASIA-PAC ENTOMOL, V13, P243, DOI 10.1016/j.aspen.2010.04.003; Cho WB, 2018, CONSERV GENET RESOUR, V10, P103, DOI 10.1007/s12686-017-0774-5; Consolandi C, 2008, EUR FOOD RES TECHNOL, V227, P1429, DOI 10.1007/s00217-008-0863-5; CORNISHBOWDEN A, 1985, NUCLEIC ACIDS RES, V13, P3021, DOI 10.1093/nar/13.9.3021; Dalen L, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060169; Deguilloux MF, 2002, P ROY SOC B-BIOL SCI, V269, P1039, DOI 10.1098/rspb.2002.1982; Di Bernardo G, 2007, BIOTECHNOL PROGR, V23, P297, DOI 10.1021/bp060182m; Dong WP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08348; Dumolin-Lapegue S, 1999, MOL ECOL, V8, P2137, DOI 10.1046/j.1365-294x.1999.00788.x; Fiddyment S, 2015, P NATL ACAD SCI USA, V112, P15066, DOI 10.1073/pnas.1512264112; Fromm J, 2003, J STRUCT BIOL, V143, P77, DOI 10.1016/S1047-8477(03)00119-9; FROMM J, 1995, PLANT PHYSIOL, V109, P375, DOI 10.1104/pp.109.2.375; Gilbert MTP, 2004, CURR BIOL, V14, pR463, DOI 10.1016/j.cub.2004.06.008; Givnish TJ, 2010, ANN MO BOT GARD, V97, P584, DOI 10.3417/2010023; Glocke I, 2017, GENOME RES, V27, P1230, DOI 10.1101/gr.219675.116; Hahn WJ, 2002, SYST BIOL, V51, P92, DOI 10.1080/106351502753475899; Hansen HB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170940; Hansson MC, 2008, J ARCHAEOL SCI, V35, P1169, DOI 10.1016/j.jas.2007.08.009; Helman-Wazny Agnieszka, 2016, TIBETAN MANUSCRIPTS, V4, P171; Hu YC, 2005, PLANTA, V220, P838, DOI 10.1007/s00425-004-1401-8; Huggett Jim F, 2008, BMC Res Notes, V1, P70, DOI 10.1186/1756-0500-1-70; Hunter D., 1943, PAPERMAKING HIST TEC, P398; Kalyankar VB, 2012, MULTILOGIC SCI INT R, V2, P11; Kistler L, 2017, NUCLEIC ACIDS RES, V45, P6310, DOI 10.1093/nar/gkx361; Kistler L, 2012, METHODS MOL BIOL, V840, P71, DOI 10.1007/978-1-61779-516-9_10; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langer K, 2004, PLANT J, V37, P828, DOI 10.1111/j.0960-7412.2003.02008.x; Leach B., 2009, UCLA ENCY EGYPTOLOGY, P1; Liepelt S, 2006, ANN BOT-LONDON, V98, P1107, DOI 10.1093/aob/mcl188; Lopez-Montalvo E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172225; Marota I, 2002, AM J PHYS ANTHROPOL, V117, P310, DOI 10.1002/ajpa.10045; Moncada X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056549; Mozir A, 2012, ANAL BIOANAL CHEM, V402, P1559, DOI 10.1007/s00216-011-5392-6; Muasya AM, 2009, BOT REV, V75, P2, DOI 10.1007/s12229-008-9019-3; Nasab HM, 2010, J AGR SCI TECH-IRAN, V12, P459; Nguyen-Hieu Tung, 2012, BMC Res Notes, V5, P528, DOI 10.1186/1756-0500-5-528; O'Sullivan NJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31279; Oskam CL, 2010, P ROY SOC B-BIOL SCI, V277, P1991, DOI 10.1098/rspb.2009.2019; Pangallo D, 2010, J ARCHAEOL SCI, V37, P1202, DOI 10.1016/j.jas.2009.12.018; Pinar G, 2015, ENV MICROBIOL REP, V7, P849, DOI 10.1111/1758-2229.12313; Pollmann B, 2005, J ARCHAEOL SCI, V32, P1471, DOI 10.1016/j.jas.2005.04.002; Poulakakis N, 2007, J ARCHAEOL SCI, V34, P675, DOI 10.1016/j.jas.2006.06.013; Principi P, 2011, MICROB ECOL, V61, P214, DOI 10.1007/s00248-010-9741-3; Puskarova A, 2016, SCI REP-UK, V6, DOI 10.1038/srep20810; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; REID ID, 1995, CAN J BOT, V73, pS1011, DOI 10.1139/b95-351; Richardin P, 2010, J CULT HERIT, V11, P398, DOI 10.1016/j.culher.2010.05.001; Rohland N, 2004, BIOTECHNIQUES, V36, P814, DOI 10.2144/04365ST05; Sarkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043808; Sakulsathaporn Arpakorn, 2017, BMC Res Notes, V10, P740, DOI 10.1186/s13104-017-3077-8; Schaefer H, 2011, ECOL LETT, V14, P389, DOI 10.1111/j.1461-0248.2011.01600.x; Schelm S, 2017, J AGR FOOD CHEM, V65, P516, DOI 10.1021/acs.jafc.6b04457; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Sedlackova T, 2013, BIOL PROCED ONLINE, V15, DOI 10.1186/1480-9222-15-5; Shepherd LD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183555; Simbolo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062692; Smith AH, 2007, FOREST PATHOL, V37, P361, DOI 10.1111/j.1439-0329.2007.00502.x; Staats M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028448; Stone J. E., 1965, J POLYM SCI C, V11, P13, DOI [10.1002/polc.5070110104, DOI 10.1002/POLC.5070110104]; Strlic M, 2010, TALANTA, V81, P412, DOI 10.1016/j.talanta.2009.12.017; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Sytsma KJ, 2002, AM J BOT, V89, P1531, DOI 10.3732/ajb.89.9.1531; Teasdale MD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0379; Teasdale MD, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170988; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Van der Bank M, 2002, TAXON, V51, P329, DOI 10.2307/1554901; Vuissoz A, 2007, J ARCHAEOL SCI, V34, P823, DOI 10.1016/j.jas.2006.09.002; Weiss CL, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160239; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	78	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198513	10.1371/journal.pone.0198513	http://dx.doi.org/10.1371/journal.pone.0198513			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI4VN	29874294	Green Published, gold, Green Submitted			2022-12-26	WOS:000434369400050
J	Kim, SM; Sung, JH; Kuk, JY; Cha, HH; Choi, SJ; Oh, SY; Roh, CR				Kim, Seon-Mi; Sung, Ji-Hee; Kuk, Jin-Yi; Cha, Hyun-Hwa; Choi, Suk-Joo; Oh, Soo-young; Roh, Cheong-Rae			Short- and long-term neonatal outcomes according to differential exposure to antenatal corticosteroid therapy in preterm births prior to 24 weeks of gestation	PLOS ONE			English	Article							EXTREMELY PREMATURE-INFANTS; GROSS MOTOR FUNCTION; NEURODEVELOPMENTAL OUTCOMES; ASSOCIATION; MATURATION; HEMORRHAGE; PRESSURE; STEROIDS; CHILDREN; SYSTEM	Aim To assess the effects of differential exposure to antenatal corticosteroid (ACS) on short and long-term outcomes of infants born before 24 weeks of gestation. Methods This is a retrospective cohort study of 147 infants delivered by 116 women at 21-23 weeks of gestation between January 2001 and December 2016 at a tertiary referral hospital in Seoul, Korea. Eligible subjects were categorized into the following three groups according to ACS exposure: non-user (n = 53), partial-course (n = 44), and complete-course (n = 50). Univariable and multivariable analyses were used to compare neonatal mortality, neonatal morbidities including intraventricular hemorrhage (IVH), and neurodevelopmental impairment including cerebral palsy among the three groups. Results Neonatal mortality rate was significantly lower in the ACS-user groups (non-user, 52.8%; partial-course, 27.3%; complete-course, 28.0%; P = 0.01), but complete-course of ACS therapy had no advantages over partial-course. A lower incidence of IVH was observed in the complete-course group (non-users, 54.8%; partial-course, 48.6%; complete-course, 20.5%; P = 0.003). Multiple logistic regression analysis showed that ACS therapy, either partial- or complete-course, was associated with a lower rate of neonatal mortality (adjusted odds ratio (aOR) 0.375; 95% confidence interval (CI) 0.141-0.996 in partial-course; aOR 0.173; 95% CI 0.052-0.574) in complete-course). IVH (aOR 0.191; 95% CI 0.071-0.516) was less likely to occur in the complete-course group than in the non-user group. Neurodevelopmental impairment of survivors at 18-22 month after birth was not significantly different among the three groups. Conclusion ACS therapy in preterm births at 21-23 weeks of gestation was associated with significantly reduced rates of neonatal mortality and IVH, especially with complete administration.	[Kim, Seon-Mi; Kuk, Jin-Yi; Choi, Suk-Joo; Oh, Soo-young; Roh, Cheong-Rae] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Sung, Ji-Hee] Sungkyunkwan Univ, Sch Med, Dept Obstet & Gynecol, Kangbuk Samsung Hosp, Seoul, South Korea; [Cha, Hyun-Hwa] Kyungpook Natl Univ, Sch Med, Dept Obstet & Gynecol, Kyungpook Natl Univ Hosp, Daegu, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Kyungpook National University; Kyungpook National University Hospital	Choi, SJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea.	drmaxmix.choi@samsung.com	Kim, Seonmi/ABE-6241-2020	Choi, Suk-Joo/0000-0002-8946-4789	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [H114C0306]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported in part by the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: H114C0306) to Suk-Joo Choi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaany D, 2015, AM J PERINAT, V32, P839, DOI 10.1055/s-0034-1543950; American College of Obstetricians and Gynecologists Committee on Obstetric Practice, 2016, Obstet Gynecol, V128, pe187, DOI 10.1097/AOG.0000000000001715; [Anonymous], 2016, Obstet Gynecol, V127, pe157, DOI 10.1097/AOG.0000000000001483; Antenatal Corticosteroids Clinical Practice Guidelines Panel, 2015, ANT CORT GIV WOM PRI; Bayley N, 1993, BAYLEY SCALES INFANT; Bayley N., 2019, BAYLEY SCALES INFANT; Carlo WA, 2011, JAMA-J AM MED ASSOC, V306, P2348, DOI 10.1001/jama.2011.1752; Chawla S, 2016, JAMA PEDIATR, V170, P1164, DOI 10.1001/jamapediatrics.2016.1936; Crane Joan, 2003, J Obstet Gynaecol Can, V25, P45; CROWLEY PA, 1995, AM J OBSTET GYNECOL, V173, P322, DOI 10.1016/0002-9378(95)90222-8; Crowther CA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003935.pub3; FRANKENBURG WK, 1992, PEDIATRICS, V89, P91; Freeman CI, 2015, OBSTET MED, V8, P172, DOI 10.1177/1753495X15601772; Gyamfi-Bannerman C, 2016, NEW ENGL J MED, V374, P1311, DOI 10.1056/NEJMoa1516783; Kuk JY, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.06.020; LANGSTON C, 1984, AM REV RESPIR DIS, V129, P607; Lohle M, 2005, J PHYSIOL-LONDON, V564, P575, DOI 10.1113/jphysiol.2004.077537; Mori R, 2011, J PEDIATR-US, V159, P110, DOI 10.1016/j.jpeds.2010.12.039; Newnham JP, 2009, SEMIN FETAL NEONAT M, V14, P157, DOI 10.1016/j.siny.2008.11.005; Onland W, 2011, AM J PERINAT, V28, P33, DOI 10.1055/s-0030-1262509; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Palisano RJ, 2006, DEV MED CHILD NEUROL, V48, P424, DOI 10.1017/S0012162206000934; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Roberts D., 2010, ANTENATAL CORTICOSTE; Shane AL, 2014, J INFECTION, V68, pS24, DOI 10.1016/j.jinf.2013.09.011; Sotiriadis A, 2015, OBSTET GYNECOL, V125, P1385, DOI 10.1097/AOG.0000000000000748; Tsuji M, 2000, PEDIATRICS, V106, P625, DOI 10.1542/peds.106.4.625; Vinukonda G, 2010, STROKE, V41, P1766, DOI 10.1161/STROKEAHA.110.588400; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Wong D, 2014, ARCH DIS CHILD-FETAL, V99, pF12, DOI 10.1136/archdischild-2013-304705; Zea-Vera A, 2015, J TROP PEDIATRICS, V61, P1, DOI 10.1093/tropej/fmu079	32	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198471	10.1371/journal.pone.0198471	http://dx.doi.org/10.1371/journal.pone.0198471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864169	Green Submitted, Green Published, gold			2022-12-26	WOS:000434097100032
J	Lee, H; Kim, N; Yoo, YJ; Kim, H; Jeong, E; Choi, S; Moon, SU; Oh, SH; Mills, GB; Yoon, S; Kim, WY				Lee, Hani; Kim, Nayoung; Yoo, Young Ji; Kim, Hyejin; Jeong, Euna; Choi, SeokGyeong; Moon, Sung Un; Oh, Seung Hyun; Mills, Gordon B.; Yoon, Sukjoon; Kim, Woo-Young			beta-catenin/TCF activity regulates IGF-1R tyrosine kinase inhibitor sensitivity in colon cancer	ONCOGENE			English	Article							GROWTH-FACTOR-I; RAS SIGNALING PATHWAYS; ADVANCED SOLID TUMORS; COLORECTAL-CANCER; PLASMA-LEVELS; PHASE-I; TRANSCRIPTIONAL ACTIVITY; NUCLEAR-LOCALIZATION; BINDING PROTEIN-3; INSULIN-RECEPTORS	The availability of large-scale drug screening data on cell line panels provides a unique opportunity to identify predictive biomarkers for targeted drug efficacy. Analysis of diverse drug data on similar to 990 cancer cell lines revealed enhanced sensitivity of insulin-like growth factor 1 receptor/Insulin Receptor (IGF-1R/IR) tyrosine kinase inhibitors (TKIs) in colon cancer cells. Interestingly, beta-catenin/TCF(T cell factor)-responsive promoter activity exhibited a significant positive association with IGF-1R/IR TM response, while the mutational status of direct upstream genes, such as CTNNB1 and APC, was not significantly associated with the response. The beta-catenin/TCF activity high cell lines express components of IGF-1R/IR signaling more than the low cell lines explaining their enhanced sensitivity against IGF-1R/IR TKI. Reinforcing beta-catenin/TCF responsive promoter activity by introducing CTNNB1 gain-of-function mutations into IGF-1R/IR TM-resistant cells increased the expression and activity of IGF-1R/IR signaling components and also sensitized the cells to IGF-1R/IR TKIs in vitro and in vivo. Analysis of TCGA data revealed that the stronger beta-catenin/TCF responsive promoter activity was associated with higher IGF-1R and IGF2 transcription in human colon cancer specimens as well. Collectively, compared to the mutational status of upstream genes, beta-catenin/TCF responsive promoter activity has potential to be a stronger predictive positive biomarker for IGF-1R/IR TM responses in colon cancer cells. The present study highlights the potential of transcriptional activity as therapeutic biomarkers for targeted therapies, overcoming the limited ability of upstream genetic mutations to predict responses.	[Lee, Hani; Yoo, Young Ji; Kim, Hyejin; Choi, SeokGyeong; Kim, Woo-Young] Sookmyung Womens Univ, Res Ctr Cell Fate Control, Coll Pharm, Seoul 04310, South Korea; [Lee, Hani; Kim, Nayoung; Yoo, Young Ji; Kim, Hyejin; Jeong, Euna; Choi, SeokGyeong; Moon, Sung Un; Yoon, Sukjoon; Kim, Woo-Young] Sookmyung Womens Univ, Ctr Adv Bioinformat & Syst Med, Seoul 04310, South Korea; [Kim, Nayoung; Yoon, Sukjoon] Sookmyung Womens Univ, Dept Biol Sci, Seoul 04310, South Korea; [Oh, Seung Hyun] Gachon Univ, Coll Pharm, Incheon 21936, South Korea; [Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Syst Biol, Houston, TX 77030 USA	Sookmyung Women's University; Sookmyung Women's University; Sookmyung Women's University; Gachon University; University of Texas System; UTMD Anderson Cancer Center	Kim, WY (corresponding author), Sookmyung Womens Univ, Res Ctr Cell Fate Control, Coll Pharm, Seoul 04310, South Korea.; Yoon, S; Kim, WY (corresponding author), Sookmyung Womens Univ, Ctr Adv Bioinformat & Syst Med, Seoul 04310, South Korea.; Yoon, S (corresponding author), Sookmyung Womens Univ, Dept Biol Sci, Seoul 04310, South Korea.	yoonsj@sookmyung.ac.kr; wykim@sookmyung.ac.kr		Mills, Gordon/0000-0002-0144-9614	National Research Foundation of Korea [NRF-2018R1A2B6009313, NRF-2017R1A2B2007745, NRF-2016R1A5A1011974, NRF-2012M3A9B6055466, NRF-2015R1D1A1A01056594, NRF-2011-0030074]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea, [NRF-2018R1A2B6009313 to EJ], [NRF-2017R1A2B2007745, and NRF-2016R1A5A1011974 to SY] and [NRF-2012M3A9B6055466, NRF-2015R1D1A1A01056594, and NRF-2011-0030074 to W-YK].	Agaram NP, 2008, GENE CHROMOSOME CANC, V47, P853, DOI 10.1002/gcc.20589; Beneit N, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0477-3; Bommer GT, 2010, J BIOL CHEM, V285, P1928, DOI 10.1074/jbc.M109.060319; Cai J, 2015, GENE DEV, V29, P1493, DOI 10.1101/gad.264515.115; Califano A, 2017, NAT REV CANCER, V17, P116, DOI 10.1038/nrc.2016.124; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Di Cosimo S, 2015, CLIN CANCER RES, V21, P49, DOI 10.1158/1078-0432.CCR-14-0940; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fassnacht M, 2015, LANCET ONCOL, V16, P426, DOI 10.1016/S1470-2045(15)70081-1; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Greshock J, 2010, CANCER RES, V70, P3677, DOI 10.1158/0008-5472.CAN-09-3788; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Hlubek F, 2007, INT J CANCER, V121, P1941, DOI 10.1002/ijc.22916; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Jass JR, 2002, GASTROENTEROLOGY, V123, P862, DOI 10.1053/gast.2002.35392; Jones RA, 2009, ONCOGENE, V28, P2152, DOI 10.1038/onc.2009.79; Jones RL, 2015, CLIN CANCER RES, V21, P693, DOI 10.1158/1078-0432.CCR-14-0265; Kim N, 2012, INT J CANCER, V131, P2456, DOI 10.1002/ijc.27529; Kubo T, 2009, INT J CANCER, V124, P1778, DOI 10.1002/ijc.24150; Ma J, 1999, JNCI-J NATL CANCER I, V91, P2052, DOI 10.1093/jnci/91.23.2052; Ma J, 2000, GROWTH HORM IGF RES, V10, pS28, DOI 10.1016/S1096-6374(00)90013-3; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Michor F, 2004, NAT REV CANCER, V4, P197, DOI 10.1038/nrc1295; Min HY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0392-3; Najdi R, 2009, ONCOGENE, V28, P4133, DOI 10.1038/onc.2009.271; Ohashi K, 2012, P NATL ACAD SCI USA, V109, pE2127, DOI 10.1073/pnas.1203530109; Ormanns S, 2014, ONCOTARGET, V5, P2999, DOI 10.18632/oncotarget.1626; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pollak M, 2008, BEST PRACT RES CL EN, V22, P625, DOI 10.1016/j.beem.2008.08.004; Pollak MN, 2007, AM J CLIN NUTR, V86, p820S, DOI 10.1093/ajcn/86.3.820S; Puzanov I, 2015, CLIN CANCER RES, V21, P701, DOI 10.1158/1078-0432.CCR-14-0303; Qu X, 2017, ONCOTARGET, V8, P29501, DOI 10.18632/oncotarget.15704; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Sabbatini P, 2009, MOL CANCER THER, V8, P2811, DOI 10.1158/1535-7163.MCT-09-0423; Saunders NA, 2012, EMBO MOL MED, V4, P675, DOI 10.1002/emmm.201101131; Sclafani F, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv258; Spano JP, 2005, ANN ONCOL, V16, P189, DOI 10.1093/annonc/mdi057; Sparks AB, 1998, CANCER RES, V58, P1130; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Takayama T, 2001, GASTROENTEROLOGY, V121, P599, DOI 10.1053/gast.2001.27203; Tap WD, 2012, J CLIN ONCOL, V30, P1849, DOI 10.1200/JCO.2011.37.2359; Tatematsu T, 2014, MOL CLIN ONCOL, V2, P725, DOI 10.3892/mco.2014.318; Tognon CE, 2012, EXPERT OPIN THER TAR, V16, P33, DOI 10.1517/14728222.2011.638626; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Wang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088291; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Wu YP, 2002, CANCER RES, V62, P1030; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151; Zenonos K, 2013, WORLD J GASTRO ONCOL, V5, P97, DOI 10.4251/wjgo.v5.i5.97; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhong H, 2017, ONCOGENE, V36, P797, DOI 10.1038/onc.2016.248	55	8	8	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 4	2018	37	40					5466	5475		10.1038/s41388-018-0362-5	http://dx.doi.org/10.1038/s41388-018-0362-5			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GV7MY	29895971				2022-12-26	WOS:000446312900007
J	Cho, EJ; Mysliwiec, MR; Carlson, CD; Ansari, A; Schwartz, RJ; Lee, YS				Cho, Eunjin; Mysliwiec, Matthew R.; Carlson, Clayton D.; Ansari, Aseem; Schwartz, Robert J.; Lee, Youngsook			Cardiac-specific developmental and epigenetic functions of Jarid2 during embryonic development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heart development; epigenetics; gene regulation; gene expression; histone modification; Congenital heart disease; Jarid2	REPRESSIVE COMPLEX 2; STEM-CELLS; HISTONE METHYLATION; GENE-EXPRESSION; TARGET GENE; JUMONJI; ISL1; DIFFERENTIATION; NKX2-5; PRC2	Epigenetic regulation is critical in normal cardiac development. We have demonstrated that the deletion of Jarid2 (Jumonji (Jmj) A/T-rich interaction domain 2) in mice results in cardiac malformations recapitulating human congenital cardiac disease and dysregulation of gene expression. However, the precise developmental and epigenetic functions of Jarid2 within the developing heart remain to be elucidated. Here, we determined the cardiac-specific functions of Jarid2 and the genetic networks regulated by Jarid2. Jarid2 was deleted using different cardiac-specific Cre mice. The deletion of Jarid2 by Nkx2.5-Cre mice (Jarid2(Nkx)) caused cardiac malformations including ventricular septal defects, thin myocardium, hypertrabeculation, and neonatal lethality. Jarid2(Nkx) mice exhibited elevated expression of neural genes, cardiac jelly, and other key factors including Isl1 and Bmp10 in the developing heart. By employing combinatorial genome-wide approaches and molecular analyses, we showed that Jarid2 in the myocardium regulates a subset of Jarid2 target gene expression and H3K27me3 enrichment during heart development. Specifically, Jarid2 was required for PRC2 occupancy and H3K27me3 at the Isl1 promoter locus, leading to the proper repression of Isl1 expression. In contrast, Jarid2 deletion in differentiated cardiomyocytes by cTnt-Cre mice caused no gross morphological defects or neonatal lethality. Thus, the early deletion of Jarid2 in cardiac progenitors, prior to the differentiation of cardiac progenitors into cardiomyocytes, results in morphogenetic defects manifested later in development. Our studies reveal that there is a critical window during early cardiac progenitor differentiation when Jarid2 is crucial to establish the epigenetic landscape at later stages of development.	[Cho, Eunjin; Mysliwiec, Matthew R.; Lee, Youngsook] Univ Wisconsin Madison, Dept Cell & Regenerat Biol, Madison, WI 53705 USA; [Cho, Eunjin; Lee, Youngsook] Univ Wisconsin Madison, Mol & Cellular Pharmacol Grad Program, Madison, WI 53705 USA; [Ansari, Aseem] Univ Wisconsin Madison, Dept Biochem, Madison, WI 53705 USA; [Carlson, Clayton D.] Trinity Christian Coll, Dept Biol, Palos Hts, IL 60463 USA; [Schwartz, Robert J.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Houston System; University of Houston	Lee, YS (corresponding author), Wisconsin Inst Med Res II, 1111 Highland Ave, Madison, WI 53705 USA.	youngsooklee@wisc.edu			National Institutes of Health [HL067050]; American Heart Association [12GRNT12070021]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL067050 and American Heart Association Grant 12GRNT12070021 (to Y. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Albert M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003461; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Brody MJ, 2013, J MOL CELL CARDIOL, V62, P237, DOI 10.1016/j.yjmcc.2013.05.020; Brody MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051621; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chen DY, 2015, DEV BIOL, V407, P195, DOI 10.1016/j.ydbio.2015.09.016; Chen HY, 2013, DEVELOPMENT, V140, P1946, DOI 10.1242/dev.089920; Chen HY, 2009, PEDIATR CARDIOL, V30, P626, DOI 10.1007/s00246-009-9406-5; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; da Rocha ST, 2014, MOL CELL, V53, P301, DOI 10.1016/j.molcel.2014.01.002; Delgado-Olguin P, 2012, NAT GENET, V44, P343, DOI 10.1038/ng.1068; Dimitrova E, 2015, EMBO REP, V16, P1620, DOI 10.15252/embr.201541113; Dorn T, 2015, STEM CELLS, V33, P1113, DOI 10.1002/stem.1923; FFRENCHCONSTANT C, 1988, DEVELOPMENT, V104, P369; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; He AB, 2012, CIRC RES, V110, P406, DOI 10.1161/CIRCRESAHA.111.252205; Huang JH, 2012, J CLIN INVEST, V122, P3678, DOI 10.1172/JCI63635; Ilagan R, 2006, DEVELOPMENT, V133, P2435, DOI 10.1242/dev.02408; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Johansson C, 2014, EPIGENOMICS-UK, V6, P89, DOI 10.2217/epi.13.79; Jones A, 2010, PROTEIN CELL, V1, P1056, DOI 10.1007/s13238-010-0142-7; Jung J, 2005, J BIOL CHEM, V280, P30916, DOI 10.1074/jbc.M414482200; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; Kim DH, 2013, MOL CELL BIOL, V33, P4936, DOI 10.1128/MCB.00601-13; Kim TG, 2003, J BIOL CHEM, V278, P42247, DOI 10.1074/jbc.M307386200; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Leavesley DI, 2013, IUBMB LIFE, V65, P807, DOI 10.1002/iub.1203; Lee Y, 2000, CIRC RES, V86, P932, DOI 10.1161/01.RES.86.9.932; Li DQ, 2011, DEVELOPMENT, V138, P303, DOI 10.1242/dev.055566; Li YQ, 2013, STEM CELLS, V31, P1213, DOI 10.1002/stem.1362; Liang XQ, 2015, J CLIN INVEST, V125, P3256, DOI 10.1172/JCI68257; Lockhart M, 2011, BIRTH DEFECTS RES A, V91, P535, DOI 10.1002/bdra.20810; Lu HF, 2014, MOL CELL BIOCHEM, V391, P183, DOI 10.1007/s11010-014-2001-y; Luxan G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Miller EM, 2012, AM J MED GENET A, V158A, P533, DOI 10.1002/ajmg.a.34426; Morita Y, 2016, J MOL CELL CARDIOL, V92, P158, DOI 10.1016/j.yjmcc.2016.02.008; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Mysliwiec MR, 2006, GENESIS, V44, P407, DOI 10.1002/dvg.20221; Mysliwiec MR, 2012, J BIOL CHEM, V287, P1235, DOI 10.1074/jbc.M111.315945; Mysliwiec MR, 2011, J BIOL CHEM, V286, P17193, DOI 10.1074/jbc.M110.205146; Mysliwiec MR, 2007, FEBS LETT, V581, P2633, DOI 10.1016/j.febslet.2007.05.006; Nandadasa S, 2014, MATRIX BIOL, V35, P34, DOI 10.1016/j.matbio.2014.01.005; Panzer AA, 2017, SCI REP-UK, V7, DOI 10.1038/srep46438; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Pereira RM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5540; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Takeuchi T, 1999, MECH DEVELOP, V86, P29, DOI 10.1016/S0925-4773(99)00100-8; Terada R, 2011, CARDIOVASC RES, V91, P289, DOI 10.1093/cvr/cvr037; Tian XY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00118-1; Tian XY, 2014, SCIENCE, V345, P90, DOI 10.1126/science.1251487; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Towbin JA, 2015, LANCET, V386, P813, DOI 10.1016/S0140-6736(14)61282-4; Vizan P, 2015, FEBS J, V282, P1723, DOI 10.1111/febs.13083; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zhang CG, 2009, BIOCHEM BIOPH RES CO, V390, P258, DOI 10.1016/j.bbrc.2009.09.101; Zhang WJ, 2013, AM J MED GENET C, V163, P144, DOI 10.1002/ajmg.c.31369; Zhang Z, 2011, STEM CELLS, V29, P229, DOI 10.1002/stem.578	65	12	12	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11659	11673		10.1074/jbc.RA118.002482	http://dx.doi.org/10.1074/jbc.RA118.002482			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29891551	Green Published, hybrid			2022-12-26	WOS:000440134500002
J	Peruchetti, DD; Silva-Aguiar, RP; Siqueira, GM; Dias, WB; Caruso-Neves, C				Peruchetti, Diogo de Barros; Silva-Aguiar, Rodrigo Pacheco; Siqueira, Gabriela Marques; Dias, Wagner Barbosa; Caruso-Neves, Celso			High glucose reduces megalin-mediated albumin endocytosis in renal proximal tubule cells through protein kinase B O-GlcNAcylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kidney; signal transduction; O-GlcNAcylation; mTOR complex (mTORC); Akt PKB; albumin endocytosis; diabetic nephropathy; high glucose; megalin expression; proximal tubule	LINKED N-ACETYLGLUCOSAMINE; EPITHELIAL-CELLS; ANGIOTENSIN-II; MAMMALIAN TARGET; MTOR COMPLEXES; REABSORPTION; APOPTOSIS; GLCNAC; INJURY; ROLES	The role of albumin reabsorption in proximal tubule (PT) cells has emerged as an important factor in the genesis of albuminuria observed in the early stages of diabetes. Evidence has shown that a decrease in megalin expression could be the key mechanism in this process. In the present work, we investigated the molecular mechanism underlying the modulation of albumin endocytosis in LLC-PK1 cells, a model of PT cells. High glucose concentrations (HG) inhibited megalin expression and albumin endocytosis after 48 h of incubation. This inhibitory effect involves the entrance of glucose into PT cells through SGLT located at the luminal membrane. Once inside PT cells, glucose is diverted to the hexosamine biosynthetic pathway (HBP) increasing O-GlcNAcylation of several intracellular proteins, including PKB. This process promotes the inhibition of PKB activity measured by its phosphorylation at Thr-308 and Ser-473 and phosphorylation of specific substrates, glycogen synthase kinase 3 (GSK3) and tuberous sclerosis complex 2. The decrease in PKB activity led to a decrease in megalin expression and, consequently, reducing albumin endocytosis in LLC-PK1 cells. HG did not change mammalian target of rapamycin (mTOR) C2 activity, responsible for phosphorylated PKB at Ser-473. In addition, HG activated the mTORC1/S6K pathway, but this effect was not correlated to the decrease in megalin expression or albumin endocytosis. Taken together, our data help to clarify the current understanding underlying the genesis of tubular albuminuria induced by hyperglycemia in the early stage of diabetes pathogenesis.	[Peruchetti, Diogo de Barros; Silva-Aguiar, Rodrigo Pacheco; Siqueira, Gabriela Marques; Dias, Wagner Barbosa; Caruso-Neves, Celso] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ave Carlos Chagas Filho 373,Bloco C,Sala 34, BR-21941904 Rio De Janeiro, Brazil; [Caruso-Neves, Celso] INCT Regenera, Inst Nacl Ciencia & Tecnol Med Regenerat, BR-21941902 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Caruso-Neves, C (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ave Carlos Chagas Filho 373,Bloco C,Sala 34, BR-21941904 Rio De Janeiro, Brazil.	caruso@biof.ufrj.br	Caruso-Neves, Celso/C-4014-2013; Silva-Aguiar, Rodrigo Pacheco/AAH-7924-2020; Peruchetti, Diogo B/L-3706-2017; Dias, Wagner/B-1401-2016	Caruso-Neves, Celso/0000-0002-2415-7753; Silva-Aguiar, Rodrigo Pacheco/0000-0003-1975-8033; Peruchetti, Diogo B/0000-0002-7572-9731; Dias, Wagner/0000-0002-8378-8846	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [456997/2014-8]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ [E-26/110.085/2014, E-26/201.197/2014, E-26/202.950/2016]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grant 456997/2014-8 and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ Grants E-26/110.085/2014, E-26/201.197/2014, and E-26/202.950/2016. The authors declare that they have no conflicts of interest with the contents of this article.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Akan I, 2018, J NEUROCHEM, V144, P7, DOI 10.1111/jnc.14242; Akimoto Yoshihiro, 2011, Clin Proteomics, V8, P15, DOI 10.1186/1559-0275-8-15; Ali MAM, 2017, FUND CLIN PHARMACOL, V31, P546, DOI 10.1111/fcp.12296; Allen DA, 2003, FASEB J, V17, P908, DOI 10.1096/fj.02-0130fje; Arnaud-Batista FJ, 2016, BBA-GEN SUBJECTS, V1860, P1431, DOI 10.1016/j.bbagen.2016.04.012; Baines RJ, 2012, AM J PHYSIOL-RENAL, V303, pF1006, DOI 10.1152/ajprenal.00021.2012; Banerjee PS, 2016, MOL ASPECTS MED, V51, P1, DOI 10.1016/j.mam.2016.05.005; Bertinat R, 2016, J CELL PHYSIOL, V231, P1635, DOI 10.1002/jcp.25286; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Brunskill NJ, 1998, J CLIN INVEST, V101, P2140, DOI 10.1172/JCI1923; Campion Carole G, 2017, Can J Kidney Health Dis, V4, p2054358117705371, DOI 10.1177/2054358117705371; Caruso-Neves C, 2005, P NATL ACAD SCI USA, V102, P17513, DOI 10.1073/pnas.0507255102; Caruso-Neves C, 2006, P NATL ACAD SCI USA, V103, P18810, DOI 10.1073/pnas.0605029103; Chang AS, 2016, AM J PHYSIOL-RENAL, V310, pF689, DOI 10.1152/ajprenal.00502.2015; Christensen EI, 2013, NAT REV NEPHROL, V9, P700, DOI 10.1038/nrneph.2013.212; Comper WD, 2014, NAT REV NEPHROL, V10, pE1, DOI 10.1038/nrneph.2013.58-c1; de Queirozl RM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00132; Degrell P, 2009, LIFE SCI, V84, P389, DOI 10.1016/j.lfs.2009.01.007; Dias WB, 2012, BIOCHEM BIOPH RES CO, V422, P224, DOI 10.1016/j.bbrc.2012.04.124; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Dickson LE, 2014, J AM SOC NEPHROL, V25, P443, DOI 10.1681/ASN.2013090950; Doshi SM, 2017, CLIN J AM SOC NEPHRO, V12, P1366, DOI 10.2215/CJN.11111016; Fantus D, 2016, NAT REV NEPHROL, V12, P587, DOI 10.1038/nrneph.2016.108; Ferrer CM, 2016, J MOL BIOL, V428, P3282, DOI 10.1016/j.jmb.2016.05.028; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; Gekle M, 2003, J PHYSIOL-LONDON, V552, P471, DOI 10.1113/jphysiol.2003.048074; Gekle M, 2005, ANNU REV PHYSIOL, V67, P573, DOI 10.1146/annurev.physiol.67.031103.154845; Gellai R, 2016, AM J PHYSIOL-RENAL, V311, pF1172, DOI 10.1152/ajprenal.00545.2015; Gena P, 2010, ENVIRON HEALTH PERSP, V118, P1551, DOI 10.1289/ehp.0901874; Gilbert RE, 2017, DIABETES, V66, P791, DOI 10.2337/db16-0796; Gong QY, 2016, BIOCHEM BIOPH RES CO, V469, P183, DOI 10.1016/j.bbrc.2015.11.092; Grahammer F, 2017, J AM SOC NEPHROL, V28, P230, DOI 10.1681/ASN.2015111224; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Harwood SM, 2007, KIDNEY INT, V71, P655, DOI 10.1038/sj.ki.5002106; Ishibashi F, 2004, DIABETES RES CLIN PR, V65, P217, DOI 10.1016/j.diabres.2004.02.003; Ishibashi F, 2006, DIABETES RES CLIN PR, V72, P223, DOI 10.1016/j.diabres.2005.10.019; Ji S, 2011, AMINO ACIDS, V40, P809, DOI 10.1007/s00726-010-0698-9; Jiao XC, 2016, BIOCHEM BIOPH RES CO, V480, P387, DOI 10.1016/j.bbrc.2016.10.060; Kawanami D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051083; Kojima N, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12436; Koral K, 2012, AM J PHYSIOL-RENAL, V302, pF1013, DOI 10.1152/ajprenal.00289.2011; Landgraf SS, 2011, AM J PHYSIOL-RENAL, V300, pF499, DOI 10.1152/ajprenal.00384.2010; Landgraf SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107549; Li X, 2009, J BIOL CHEM, V284, P19248, DOI 10.1074/jbc.M109.005678; Lieberthal W, 2012, AM J PHYSIOL-RENAL, V303, pF180, DOI 10.1152/ajprenal.00015.2012; Lima VV, 2016, CLIN SCI, V130, P871, DOI 10.1042/CS20150777; Lima VV, 2012, CLIN SCI, V123, P473, DOI 10.1042/CS20110638; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lungkaphin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096236; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Mariappan MM, 2014, J BIOL CHEM, V289, P35363, DOI 10.1074/jbc.M114.587840; Mazzocchi LC, 2017, AM J PHYSIOL-LUNG C, V313, pL807, DOI 10.1152/ajplung.00569.2016; Moeller MJ, 2014, NAT REV NEPHROL, V10, pE2, DOI 10.1038/nrneph.2013.58-c2; Nielsen R, 2016, KIDNEY INT, V89, P58, DOI 10.1016/j.kint.2015.11.007; Ojima A, 2015, HORM METAB RES, V47, P686, DOI 10.1055/s-0034-1395609; Palm W, 2015, CELL, V162, P259, DOI 10.1016/j.cell.2015.06.017; Peruchetti DB, 2014, J BIOL CHEM, V289, P16790, DOI 10.1074/jbc.M114.549717; Peruchetti DB, 2011, J BIOL CHEM, V286, P45041, DOI 10.1074/jbc.M111.260737; Peterson SB, 2016, CRIT REV BIOCHEM MOL, V51, P150, DOI 10.3109/10409238.2015.1135102; Risso G, 2015, BIOCHEM J, V468, P203, DOI 10.1042/BJ20150041; Russo LM, 2009, J AM SOC NEPHROL, V20, P489, DOI 10.1681/ASN.2008050503; Salminen A, 2010, CELL SIGNAL, V22, P573, DOI 10.1016/j.cellsig.2009.10.006; Shi JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep14500; Susztak K, 2005, PLOS MED, V2, P152, DOI 10.1371/journal.pmed.0020045; Tang SCW, 2012, NEPHROL DIAL TRANSPL, V27, P3049, DOI 10.1093/ndt/gfs260; Tang SCW, 2011, CONTRIB NEPHROL, V170, P124, DOI 10.1159/000325647; Theilig F, 2007, J AM SOC NEPHROL, V18, P1824, DOI 10.1681/ASN.2006111266; Tojo A, 2003, HYPERTENS RES, V26, P413, DOI 10.1291/hypres.26.413; Tojo A, 2001, HISTOCHEM CELL BIOL, V116, P269, DOI 10.1007/s004180100317; Tong YN, 2018, BIOMED PHARMACOTHER, V98, P701, DOI 10.1016/j.biopha.2017.12.112; Vallon V, 2017, DIABETOLOGIA, V60, P215, DOI 10.1007/s00125-016-4157-3; Wang JY, 2015, J DIABETES COMPLICAT, V29, P621, DOI 10.1016/j.jdiacomp.2015.04.014; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Zhou L, 2011, AM J NEPHROL, V34, P468, DOI 10.1159/000332040; Zoja C, 2015, NEPHROL DIAL TRANSPL, V30, P706, DOI 10.1093/ndt/gfu261	77	27	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11388	11400		10.1074/jbc.RA117.001337	http://dx.doi.org/10.1074/jbc.RA117.001337			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29871929	Green Published, hybrid			2022-12-26	WOS:000439449700010
J	Cruz-Flores, M; Militao, T; Ramos, R; Gonzalez-Solis, J				Cruz-Flores, Marta; Militao, Teresa; Ramos, Raul; Gonzalez-Solis, Jacob			Using marine isoscapes to infer movements of oceanic migrants: The case of Bulwer's petrel, Bulweria bulwerii, in the Atlantic Ocean	PLOS ONE			English	Article							CONSERVATION; SEABIRDS; ECOGEOCHEMISTRY; STRATEGIES; MANAGEMENT; MEGAFAUNA; DIOMEDEA; TRACKING; ANIMALS; MOLT	Studying the movements of oceanic migrants has been elusive until the advent of several tracking devices, such as the light-level geolocators. Stable isotope analysis (SIA) offers a complementary approach to infer areas used year-round, but its suitability in oceanic environments remains almost unexplored. To evaluate SIA as a tool for inferring movements of oceanic migrants, we sampled an oceanic seabird, the Bulwer's petrel, Bulweria bulwerii, in four breeding colonies spread along its Atlantic distribution. We first studied the species moulting pattern from 29 corpses collected in the colonies. Secondly, based on this moult knowledge, we selected three feathers from tracked birds to infer their breeding and non breeding grounds using SIA: the 1st primary (P1), the 8th secondary (S8) and the 6th rectrix (R6) feathers. Birds migrated to two main non-breeding areas, the Central or the South Atlantic Ocean. P1 showed similar isotopic values among petrels from different breeding colonies, suggesting this feather is replaced early in the non-breeding period in a common area used by most birds, the Central Atlantic. S8 and R6 feathers correctly assigned 92% and 81%, respectively, of the birds to their non-breeding areas, suggesting they were replaced late in season, when birds were settled in their main non-breeding grounds. Our results showed that the isotopic baseline levels of the Central and South Atlantic are propagated through the food web until reaching top predators, suggesting these ratios can be used to infer the movement of long-distance migrants among oceanic water masses.	[Cruz-Flores, Marta] Univ Barcelona, Nstitut Recerca Biodiversitat IRBio, Barcelona, Spain; Univ Barcelona, Dept Biol Evolut Ecol & Ciencies Ambientals, Barcelona, Spain	University of Barcelona; University of Barcelona	Cruz-Flores, M (corresponding author), Univ Barcelona, Nstitut Recerca Biodiversitat IRBio, Barcelona, Spain.	martacruzflores@ub.edu	Gonzalez-Solis, Jacob/C-3942-2008; Gonzalez-Solis, Jacob/AAZ-5338-2021; Ramos, Raül/S-3112-2016; Cruz-Flores, Marta/AAA-8817-2021; González-Solís, Jacob/AAB-1161-2019; Militao, Teresa/AAA-6151-2019	Gonzalez-Solis, Jacob/0000-0002-8691-9397; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Ramos, Raül/0000-0002-0551-8605; Cruz-Flores, Marta/0000-0001-9905-4727; Militao, Teresa/0000-0002-2862-1592	Ministerio de Ciencia e Inovacion [CGL2009-11278/BOS]; Ministerio de Economia y Competitividad [CGL2013-42585-P, CGL2016-78530-R]; Fondos FEDER; SEO/BirdLife [LIFE +INDEMARES: LIFE07NAT/E/000732]; University of Barcelona [D/134000500/P2017G/G00]; Juan de la Cierva programs from the Spanish Ministry of Economy, Industry and Competitiveness [JCI-2012-11848]	Ministerio de Ciencia e Inovacion(Spanish Government); Ministerio de Economia y Competitividad(Spanish Government); Fondos FEDER(European Commission); SEO/BirdLife; University of Barcelona; Juan de la Cierva programs from the Spanish Ministry of Economy, Industry and Competitiveness	This project was funded by the Ministerio de Ciencia e Inovacion (CGL2009-11278/BOS), Ministerio de Economia y Competitividad (CGL2013-42585-P, CGL2016-78530-R), Fondos FEDER and SEO/BirdLife (project LIFE +INDEMARES: LIFE07NAT/E/000732) to J.G. M.C. was supported by a PhD grant from the University of Barcelona (D/134000500/P2017G/G00) and R. R. was supported by postdoctoral contract of Juan de la Cierva programs from the Spanish Ministry of Economy, Industry and Competitiveness (JCI-2012-11848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso H, 2009, J ORNITHOL, V150, P329, DOI 10.1007/s10336-008-0354-2; Ambrosini R, 2009, J THEOR BIOL, V257, P203, DOI 10.1016/j.jtbi.2008.11.019; Austin D, 2003, MAR MAMMAL SCI, V19, P371, DOI 10.1111/j.1748-7692.2003.tb01115.x; Authier M, 2017, DEEP-SEA RES PT II, V141, P1, DOI 10.1016/j.dsr2.2017.05.002; Brooke M, 2004, ALBATROSSES PETRELS; Burger AE, 2008, AUK, V125, P253, DOI 10.1525/auk.2008.1408; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; ESRI, 2018, ARCGIS DESKTOP RELEA; Flood B., 2011, MULTIMEDIA IDENTIFIC, V2nd; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Hays GC, 2016, TRENDS ECOL EVOL, V31, P463, DOI 10.1016/j.tree.2016.02.015; Hobson KA, 2008, TERR ECOL SER, V2, P1; HOWELL SNG, 2012, PETRELS ALBATROSSES; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Kays R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2478; Lascelles B, 2014, AQUAT CONSERV, V24, P111, DOI 10.1002/aqc.2512; Lindberg MS, 2007, J WILDLIFE MANAGE, V71, P1002, DOI 10.2193/2005-696; Lopez-Lopez P, 2016, ARDEOLA, V63, P103, DOI 10.13157/arla.63.1.2016.rp5; Magozzi S, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1763; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; McMahon KW, 2013, OCEANOGR MAR BIOL, V51, P327; McMahon KW, 2013, LIMNOL OCEANOGR, V58, P697, DOI 10.4319/lo.2013.58.2.0697; Monteiro LR, 1996, COLON WATERBIRD, V19, P82, DOI 10.2307/1521810; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; R Development Core Team, 2016, R LANG ENV STAT COMP; Ramos R, 2015, J BIOGEOGR, V42, P1651, DOI 10.1111/jbi.12541; Ramos R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006236; Ramos R, 2009, IBIS, V151, P151, DOI 10.1111/j.1474-919X.2008.00877.x; Ramos R, 2012, FRONT ECOL ENVIRON, V10, P258, DOI 10.1890/110140; Rodriguez Beneharo, 2003, Atlantic Seabirds, V5, P41; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Somes CJ, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003767; Waap S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01312-3; West JB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P1, DOI 10.1007/978-90-481-3354-3; Zajkova Z, 2017, MAR ECOL PROG SER, V579, P169, DOI 10.3354/meps12269	35	10	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198667	10.1371/journal.pone.0198667	http://dx.doi.org/10.1371/journal.pone.0198667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894489	Green Submitted, Green Published, gold			2022-12-26	WOS:000435030900022
J	Janssens, B; Vanobbergen, J; Petrovic, M; Jacquet, W; Schols, JMGA; De Visschere, L				Janssens, Barbara; Vanobbergen, Jacques; Petrovic, Mirko; Jacquet, Wolfgang; Schols, Jos M. G. A.; De Visschere, Luc			The impact of a preventive and curative oral healthcare program on the prevalence and incidence of oral health problems in nursing home residents	PLOS ONE			English	Article							CONTROLLED CLINICAL-TRIAL; OLDER-PEOPLE; NONSUPERVISED IMPLEMENTATION; DENTAL SERVICES; CARIES; GUIDELINE; KNOWLEDGE; PROTOCOL; ATTITUDE; AUSTRIA	Aims To assess the impact of an oral healthcare program in nursing homes on the initial treatment backlog and residents' oral health stability. Materials and methods The study is a longitudinal cohort study in nursing home residents in Flanders, Belgium, to evaluate the oral healthcare programme Gerodent. The program consisted of: (1) the introduction of an oral healthcare team, (2) oral health education, (3) the implementation of oral health guidelines and protocols, and (4) regular visits of a mobile dental team. Data were extracted from the oral health records of 381 residents from 21 nursing homes who received treatments from the mobile dental team between October 2010 and March 2014 (mean follow-up period of 22.5 months). Oral health and treatment need between baseline and follow-up were compared. Results The mean age at baseline was 82.4 years and the mean number of consultations per resident was 3.61 during the follow-up period. The proportion of residents with an oral treatment need was reduced from 65.9% to 31.3%. Among residents with natural teeth, there was significantly lower prevalence of caries (from 70.5% at baseline to 36.5% at follow-up; p<0.001), residual roots (from 54.2% to 25.1%; p<0.001), and need for fillings (from 31.9% to 17.1%; p<0.001) or extractions (from 64.3% to 31.6%; p<0.001). In the group with partial or full dentures (n = 223), 38.1% needed a repair, rebasing or renewal of their existing dentures at baseline and the respective figure at follow-up was 9.0% (p<0.001). In terms of oral health stability, 53% of the residents had no incident restorative and prosthetic treatment need throughout the follow-up period. A lower number of natural teeth at baseline (p<0.001) and a shorter follow-up period (p = 0.002) were associated with higher chances of oral health stability. Conclusion The oral healthcare program Gerodent significantly reduced the treatment backlog and contributed to a considerable proportion of residents being stable in terms of oral health without any incident treatment needs.	[Janssens, Barbara; Vanobbergen, Jacques; De Visschere, Luc] Univ Ghent, Dent Sch, Community Dent & Oral Publ Hlth, Ghent, Belgium; [Petrovic, Mirko] Ghent Univ Hosp, Dept Geriatr, C Heymanslaan 10, Ghent, Belgium; [Jacquet, Wolfgang] Vrije Univ Brussel, Fac Med & Pharm, Dept Oral Hlth Sci ORHE, Brussels, Belgium; [Jacquet, Wolfgang] Vrije Univ Brussel, Fac Psychol & Educ Sci, Dept Educ Sci EDWE LOCI, Brussels, Belgium; [Schols, Jos M. G. A.] Maastricht Univ, CAPHRI, Dept Family Med, Maastricht, Netherlands; [Schols, Jos M. G. A.] Maastricht Univ, Dept Hlth Serv Res, Maastricht, Netherlands	Ghent University; Ghent University; Ghent University Hospital; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University	Janssens, B (corresponding author), Univ Ghent, Dent Sch, Community Dent & Oral Publ Hlth, Ghent, Belgium.	barbarae.janssens@ugent.be	Jacquet, Wolfgang/L-8518-2019; Janssens, Barbara/I-2585-2019	Janssens, Barbara/0000-0003-3490-0114; Jacquet, Wolfgang/0000-0002-1245-6297				Belsi A, 2013, COMMUNITY DENT HLTH, V30, P77, DOI 10.1922/CDH_2949Gallagher06; Chalmers J M, 2002, Gerodontology, V19, P80; Chen X, 2015, GERODONTOLOGY, V32, P53, DOI 10.1111/ger.12061; Chen X, 2013, GERODONTOLOGY, V30, P49, DOI 10.1111/j.1741-2358.2012.00644.x; da Fonseca ACC, 2009, GERODONTOLOGY, V26, P302, DOI 10.1111/j.1741-2358.2009.00288.x; de Visschere L, 2011, COMMUNITY DENT ORAL, V39, P416, DOI 10.1111/j.1600-0528.2011.00610.x; De Visschere L, 2016, CLIN ORAL INVEST, V20, P1903, DOI 10.1007/s00784-015-1652-8; De Visschere L, 2015, GERODONTOLOGY, V32, P115, DOI 10.1111/ger.12062; De Visschere L, 2012, GERODONTOLOGY, V29, pE96, DOI 10.1111/j.1741-2358.2010.00418.x; De Visschere LMJ, 2011, GERODONTOLOGY, V28, P307, DOI 10.1111/j.1741-2358.2010.00406.x; Delwel S, 2017, CLIN ORAL INVEST, V21, P17, DOI 10.1007/s00784-016-1934-9; Ferro R, 2008, COMMUNITY DENT HLTH, V25, P231, DOI 10.1922/CDH_1994Ferro06; Gaszynska E, 2014, CLIN INTERV AGING, V9, P1637, DOI 10.2147/CIA.S69790; Gerritsen PFM, 2013, SPEC CARE DENT, V33, P227, DOI 10.1111/j.1754-4505.2012.00317.x; Ghezzi EM, 2014, GERODONTOLOGY, V31, P31, DOI 10.1111/ger.12081; Gluhak C, 2010, GERODONTOLOGY, V27, P47, DOI 10.1111/j.1741-2358.2009.00281.x; Helgeson M J, 1996, Spec Care Dentist, V16, P153, DOI 10.1111/j.1754-4505.1996.tb00852.x; Helgeson M, 2013, SPEC CARE DENT, V33, P177, DOI 10.1111/scd.12038; Jacobi Deborah, 2015, J Calif Dent Assoc, V43, P453; Janssens B, 2018, CLIN ORAL INVEST, V22, P281, DOI 10.1007/s00784-017-2110-6; Janssens B, 2017, COMMUNITY DENT HLTH, V34, P143, DOI 10.1922/CDH_4086Janssens09; Janssens B, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.06.003; Janssens B, 2016, GERODONTOLOGY, V33, P275, DOI 10.1111/ger.12164; Kassebaum NJ, 2015, J DENT RES, V94, P650, DOI 10.1177/0022034515573272; Kiyak H Asuman, 2005, J Dent Educ, V69, P975; Lee E E, 2001, Spec Care Dentist, V21, P153, DOI 10.1111/j.1754-4505.2001.tb00245.x; Lundqvist M, 2015, COMMUNITY DENT HLTH, V32, P39, DOI 10.1922/CDH_3407Lundqvist05; MacEntee MI, 2015, GERODONTOLOGY, V32, P81, DOI 10.1111/ger.12193; Morgan MZ, 2015, GERODONTOLOGY, P1, DOI [10.1111/ger.12178, DOI 10.1111/GER.12178]; Niesten D, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-61; Nitschke Ina, 2005, Gerodontology, V22, P123, DOI 10.1111/j.1741-2358.2005.00078.x; Paley Glenys A, 2004, Gerodontology, V21, P146, DOI 10.1111/j.1741-2358.2004.00020.x; Paley GA, 2009, GERODONTOLOGY, V26, P97, DOI 10.1111/j.1741-2358.2008.00230.x; Pretty IA, 2014, GERODONTOLOGY, V31, P77, DOI 10.1111/ger.12098; Samson H, 2008, ACTA ODONTOL SCAND, V66, P368, DOI 10.1080/00016350802378654; Sjogren P, 2010, BRIT DENT J, V208, P549, DOI 10.1038/sj.bdj.2010.546; Sjogren P., 2016, Health, V8, P1112, DOI 10.4236/health.2016.811116; Sjogren P, 2015, COMMUNITY DENT HLTH, V32, DOI 10.1922/CDH_3659Sjogren05; Smith BJ, 2005, SPEC CARE DENT, V25, P150, DOI 10.1111/j.1754-4505.2005.tb01426.x; Sweeney MP, 2007, COMMUNITY DENT HLTH, V24, P37; van der Putten G J, 2008, Tijdschr Gerontol Geriatr, V39, P202; van der Putten GJ, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-17	42	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198910	10.1371/journal.pone.0198910	http://dx.doi.org/10.1371/journal.pone.0198910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894494	Green Published, Green Submitted, gold			2022-12-26	WOS:000435030900035
J	Ojikutu, BO; Srinivasan, S; Bogart, LM; Subramanian, SV; Mayer, KH				Ojikutu, Bisola O.; Srinivasan, Sumeeta; Bogart, Laura M.; Subramanian, S., V; Mayer, Kenneth H.			Mass incarceration and the impact of prison release on HIV diagnoses in the US South	PLOS ONE			English	Article							INMATES; CARE	Background The purpose of this study was to determine the impact of prison release on HIV incidence in the southern region of the United States, the region with the highest rates of both incarceration and new HIV diagnoses nationwide. Methods 5-year HIV diagnoses rates were calculated at the ZIP code level for nine cities and metropolitan statistical areas in the US South (ZIP codes, N = 600). Multilevel regression models were constructed and adjusted rate ratios (ARRs) were estimated for overall, male and female HIV diagnoses rates. Results Across the nine cities, in multilevel, multivariate analysis, controlling for income inequality (GINI coefficient), percent living in poverty and percent Non-Hispanic Black population, the ZIP code level overall HIV diagnosis rate was significantly associated with prison release [ARR 1.004 (95%Cl 1.0007, 1.006), p<0.01]. A 10-person increase in prison release rate would result in a 4% increase in overall 5-year HIV diagnosis rate-approximately 9.4 additional cases per 100,000 population. In gender-stratified models, prison release rate was significantly associated with the ZIP code level HIV diagnosis rate for males [ARR 1.004 (95%Cl 1.0004, 1.007), p<0.01], but not for females. Conclusions In the southern region of the US, prison release is significantly associated with HIV incidence. HIV prevention interventions should promote timely linkage to ongoing treatment for released inmates living with HIV.	[Ojikutu, Bisola O.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Srinivasan, Sumeeta] Tufts Univ, Boston, MA 02111 USA; [Bogart, Laura M.] RAND Corp, Santa Monica, CA USA; [Subramanian, S., V] Harvard Sch Publ Hlth, Boston, MA USA; [Mayer, Kenneth H.] Fenway Inst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Tufts University; RAND Corporation; Harvard University; Harvard T.H. Chan School of Public Health	Ojikutu, BO (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	bojikutu@partners.org		Ojikutu, Bisola/0000-0001-7957-8881	National Institutes of Mental Health [K23 MH107316]; Centers for AIDS Research at Harvard University [P30 A1060354]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH107316, P30MH058107] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Centers for AIDS Research at Harvard University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by The National Institutes of Mental Health (Ojikutu-K23 MH107316) and The Centers for AIDS Research at Harvard University (Mayer and Ojikutu - P30 A1060354).	Althoff AL, 2013, AIDS BEHAV, V17, P156, DOI 10.1007/s10461-012-0372-1; [Anonymous], 2015, WASHINGTON POST; [Anonymous], 2009, HIV TEST IMPL GUID C; Baillargeon J, 2009, JAMA-J AM MED ASSOC, V301, P848, DOI 10.1001/jama.2009.202; Baillargeon JG, 2010, PUBLIC HEALTH REP, V125, P64, DOI 10.1177/00333549101250S109; Beckwith CG, 2010, JAIDS-J ACQ IMM DEF, V55, pS49, DOI 10.1097/QAI.0b013e3181f9c0f7; Buot MLG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091711; Centers for Disease Control and Prevention, HIV US GEOGR DISTR; Centers for Disease Control and Prevention, 2015, DIAGN HIV US DEP AR; Centers for Disease Prevention and Control, HIV INC POP; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Goldstein H., 1995, MULTILEVEL MODELS ED; Human Rights Watch, PAYING PRIC FAIL DEL; National Institute on Drug Abuse, SEX GEND DIFF DRUG U; Smoyer Amy, 2004, DRUG POLICY DEFINITI; Solomon L, 2014, HEALTH AFFAIR, V33, P434, DOI 10.1377/hlthaff.2013.1115; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558; Springer SA, 2011, CLIN INFECT DIS, V53, P469, DOI 10.1093/cid/cir446; The Pew Charitable Trust, COLL COST INC; U.S. Census Bureau, 2008, AM COMM SURV 5 YEAR; U. S. Census Bureau, 2012, AM COMM SURV 5 YEAR; U.S. Census Bureau, 2010 CENS POP P94 17; U.S. Department of Justice Bureau of Justice Statistics, 2014, PRIS 2014; US Census Bureau, ZIP COD TAB AR ZCTA; US Department of Justice, JAIL INM 2015; Vaughan AS, 2014, AM J PUBLIC HEALTH, V104, pE77, DOI 10.2105/AJPH.2014.301997; World Bank, GINI IND WORLD BANK	27	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198258	10.1371/journal.pone.0198258	http://dx.doi.org/10.1371/journal.pone.0198258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI8PJ	29889837	Green Published, Green Submitted, gold			2022-12-26	WOS:000434786600020
J	Qu, C; Wang, R; Che, WN; Zhu, X; Li, FQ; Luo, C				Qu, Cheng; Wang, Ran; Che, Wunan; Zhu, Xun; Li, Fengqi; Luo, Chen			Selection and evaluation of reference genes for expression analysis using quantitative real-time PCR in the Asian Ladybird Harmonia axyridis (Coleoptera: Coccinellidae)	PLOS ONE			English	Article							HARLEQUIN LADYBIRD; STARVATION; INVASION; HEAT	Harmonia axyridis (Coleoptera: Coccinellidae) is a polyphagous insect that is an important biological agent used to control agricultural and forestry pests. The role of functional genes in H. axyridis based on quantitative real-time PCR (qRT-PCR) is increasingly well understood to investigate biology, physiology, feeding behavior and the role of important genes in physiological processes. Quantitative real-time PCR (qRT-PCR) is a powerful and reliable technique to quantify gene expression. Using qRT-PCR, expression levels of target genes are determined based on the levels of internal reference genes; therefore, reference genes need to be stably expressed under specific experimental conditions. However, there have been no studies on the stability of reference genes used in H. axyridis. In this study, we systematically investigated expression profiles of nine candidate reference genes from H. axyridis, including beta-actin (ACTIN); elongation factor 1 alpha (EF1A); ribosomal proteins L10, L18, L28, S13, and S15 (RPL10, RPL18, RPL28, RPS13 and RPS15); glyceraldehyde-3-phosphate dehydrogenase (GAPDH); and superoxide dismutase (SOD). Four analytical methods (geNorm, BestKeeper, NormFinder, and the ACt method) were used to evaluate the suitability of these genes as internal reference genes for three biotic factors (developmental stage, tissue, and sex) and two abiotic treatments (temperature and photoperiod). Ref Finder, a comprehensive evaluation platform integrating the four analytical methods, was used to rank the overall stability of these reference genes. Among the nine candidate genes, different reference genes were identified as having the most stable expression across biotic and abiotic factors. Genes encoding ribosomal proteins typically had the most stable expression, though EF1A was the most stable across developmental stages and photoperiods. To validate the suitability of these reference genes, heat shock protein 90 (HSP90) was chosen as a target. Significant upregulation in HSP90 expression level in response to both low and high temperature was observed when using the most suitable reference genes but not when using an arbitrarily selected reference gene. The reference genes identified in this study will provide the basis for future functional genomics research in H. axyridis and will also facilitate the establishment of a standardized qRT-PCR program for other related insects.	[Qu, Cheng; Wang, Ran; Li, Fengqi; Luo, Chen] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Che, Wunan] Shenyang Agr Univ, Dept Pesticide Sci, Shenyang, Liaoning, Peoples R China; [Zhu, Xun] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry; Shenyang Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Luo, C (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China.	luochen1010@126.com		Wang, Ran/0000-0002-8199-6895	National Key Research and Developing Plan [2017YFD0200400]; China Agriculture Research System [CARS-24-C-03]	National Key Research and Developing Plan; China Agriculture Research System	This work was supported by the National Key Research and Developing Plan (2017YFD0200400) and the China Agriculture Research System (CARS-24-C-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XK, 2016, J ECON ENTOMOL, V109, P879, DOI 10.1093/jee/tov333; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baumann A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135093; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; de Boer ME, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-54; Du WX, 2016, SCI REP-UK, V6, DOI 10.1038/srep39109; Durieux D, 2015, INSECT SCI, V22, P670, DOI 10.1111/1744-7917.12144; Frost P, 2003, VET PARASITOL, V118, P169, DOI 10.1016/j.vetpar.2003.09.020; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Haelewaters D, 2017, BIOCONTROL, V62, P355, DOI 10.1007/s10526-016-9766-8; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Ladror DT, 2014, BIOCHEM BIOPH RES CO, V445, P535, DOI 10.1016/j.bbrc.2014.01.040; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lord Jeffrey C., 2009, Entomological Research, V39, P155, DOI 10.1111/j.1748-5967.2009.00208.x; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Meijering RAM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00036; Pan HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125868; Parker JD, 2004, INSECT MOL BIOL, V13, P587, DOI 10.1111/j.0962-1075.2004.00515.x; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Qin QJ, 2016, BIOCONTROL SCI TECHN, V26, P116, DOI 10.1080/09583157.2015.1078873; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reznik SY, 2015, J APPL ENTOMOL, V139, P241, DOI 10.1111/jen.12158; Roy HE, 2016, BIOL INVASIONS, V18, P997, DOI 10.1007/s10530-016-1077-6; Shakeel M, 2015, J ASIA-PAC ENTOMOL, V18, P123, DOI 10.1016/j.aspen.2015.01.001; Shen QD, 2015, J ENTOMOL SCI, V50, P168; Shi CH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071034; Shi ZK, 2017, BIOL OPEN, V6, P1096, DOI 10.1242/bio.025189; Shi ZK, 2016, COMP BIOCHEM PHYS B, V198, P10, DOI 10.1016/j.cbpb.2016.03.002; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036366; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Strube C, 2008, GENE, V425, P36, DOI 10.1016/j.gene.2008.08.001; Sun M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115979; Sun W, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20801; Tang B, 2017, COMP BIOCHEM PHYS D, V22, P78, DOI 10.1016/j.cbd.2017.01.004; Teng XL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.6001; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vilcinskas A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2113; Wang HJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00060; Wang S, 2015, B ENTOMOL RES, V105, P245, DOI 10.1017/S0007485315000036; Waters ER, 2008, CELL STRESS CHAPERON, V13, P127, DOI 10.1007/s12192-008-0023-7; Yang CX, 2015, SCI REP-UK, V5, DOI 10.1038/srep18201; Yang CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130593; Yang CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120833; Yang CX, 2016, FRONTIERS PLANT SCI, V7; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Zheng YT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0111369, DOI 10.1371/J0URNAL.P0NE.0111369]; Zhu X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084730, DOI 10.1371/J0URNAL.P0NE.0084730]; Zhu X, 2015, INT J MOL SCI, V16, P8310, DOI 10.3390/ijms16048310	53	20	22	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0192521	10.1371/journal.pone.0192521	http://dx.doi.org/10.1371/journal.pone.0192521			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889877	Green Published, gold, Green Submitted			2022-12-26	WOS:000434786600002
J	Adusumilli, G; Lancia, S; Levasseur, VA; Amblee, V; Orchard, M; Wagner, JM; Naismith, RT				Adusumilli, Gautam; Lancia, Samantha; Levasseur, Victoria A.; Amblee, Vaishak; Orchard, Megan; Wagner, Joanne M.; Naismith, Robert T.			Turning is an important marker of balance confidence and walking limitation in persons with multiple sclerosis	PLOS ONE			English	Article							OUTCOME MEASURES; SCALE; PEOPLE; VALIDITY; IMPACT; SPEED; TESTS	The standard functional tool for gait assessment in multiple sclerosis (MS) clinical trials has been the 25-Foot Timed Walk Test, a measure of gait speed. Straight-line gait assessment may not reflect adequately upon balance and coordination. Walking tests with turns may add additional information towards understanding gait and balance status, and be more reflective of ambulation in the community. Understanding the impact of turn parameters on patient-reported outcomes of balance and walking would help MS clinicians better formulate treatment plans for persons with gait limitations. In this study, ninety-one persons with MS (Expanded Disability Status Score; EDSS, range: 0-6.5) were enrolled in an initial crosssectional study. Twenty-four subjects (EDSS, range:1.0-6.0) completed a follow-up visit an average of 12 months later. Spatiotemporal gait analysis was collected at both visits using APDM Opal wireless body-worn sensors while performing the Timed-Up-and-Go (TUG) and 6-Minute Walk Test (6MWT). For both cross-sectional and longitudinal data, regression analyses determined the impact on the addition of turning parameters to stride velocity (SV), in the prediction of self-reported balance confidence (Activities-Specific Balance Confidence Scale (ABC)) and walking limitation (12-item Multiple Sclerosis Walking Scale (MSWS-12)). The addition of 6MWT peak turn velocity (PTV) to 6MWT SV increased the predictive power of the 6MWT for the ABC from 20% to 33%, and increased the predictive power from 28% to 41% for the MSWS-12. TUG PTV added to TUG SV also strengthened the relationship of the TUG for the ABC from 19% to 28%, and 27% to 36% for the MSWS-12. For those with 1 year follow-up, percent change in turn number of steps (INS%A) during the 6MWT added to 6MWT SV%A improved the modeling of ABC%A from 24% to 33%. 6MWT PTV%0 added to 6MWT SV%0 increased the predictive power of MSWS-12%0 from 8% to 27%. Conclusively, turn parameters improved modeling of self-perceived balance confidence and walking limitations when added to the commonly utilized measure of gait speed. Tests of longer durations with multiple turns, as opposed to shorter durations with a single turn, modeled longitudinal change more accurately. Turn speed and stability should be qualitatively assessed during the clinic visit, and use of multi -faceted tests such as the TUG or 6MWT may be required to fully understand gait deterioration in persons with MS.	[Adusumilli, Gautam; Lancia, Samantha; Levasseur, Victoria A.; Orchard, Megan; Naismith, Robert T.] Washington Univ St Louis, Dept Neurol, Sch Med, St Louis, MO 63130 USA; [Levasseur, Victoria A.] Univ Missouri, Sch Med, Columbia, MO USA; [Amblee, Vaishak] Univ Illinois, Sch Med, Chicago, IL USA; [Wagner, Joanne M.] St Louis Univ, Dept Phys Therapy & Athlet Training, St Louis, MO 63103 USA; [Wagner, Joanne M.] Acorda Therapeut, Ardsley, NY USA; [Amblee, Vaishak] Macneal Mem Hosp, Transit Year Residency Program, Berwyn, IL USA	Washington University (WUSTL); University of Missouri System; University of Missouri Columbia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Saint Louis University	Adusumilli, G (corresponding author), Washington Univ St Louis, Dept Neurol, Sch Med, St Louis, MO 63130 USA.	gautam.adusumilli@wustl.edu		Adusumilli, Gautam/0000-0003-1707-6370; Levasseur, Victoria/0000-0001-9460-6772; Naismith, Robert/0000-0003-0520-4283	National MS Society [PP1940]; National Institutes of Health [K12-HD055931]	National MS Society(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Primary funding for this study was acquired through the following grants: National MS Society PP1940 (Wagner, Naismith); National Institutes of Health K12-HD055931 (Wagner). Personnel salary for the following individuals was also obtained from summer National MS Society grants: Victoria Levasseur and Gautam Adusumilli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon Kalron, 2017, NEUROREHABILITATION, P1; [Anonymous], 2014, MOB LAB US GUID; Balcer LJ, 2001, J NEURO-OPHTHALMOL, V21, P296, DOI 10.1097/00041327-200112000-00014; Bethoux Francois, 2011, Int J MS Care, V13, P4, DOI 10.7224/1537-2073-13.1.4; Cohen JA, 2014, JAMA NEUROL, V71, P1386, DOI 10.1001/jamaneurol.2014.1895; Costelloe L, 2007, J NEUROL NEUROSUR PS, V78, P841, DOI 10.1136/jnnp.2006.105759; Dalgas U, 2014, J REHABIL MED, V46, P59, DOI 10.2340/16501977-1231; Feys P, 2014, J NEUROL SCI, V338, P183, DOI 10.1016/j.jns.2014.01.001; Greene BR, 2014, ENG MED BIOL SOC EMB; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; Kelleher KJ, 2010, DISABIL REHABIL, V32, P1242, DOI 10.3109/09638280903464497; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lam T, 2008, SPINAL CORD, V46, P246, DOI 10.1038/sj.sc.3102134; Mancini M, 2011, J BIOENG BIOMED SCI, P007, DOI DOI 10.4172/2155-9538.S1-007; Mancini M, 2016, EXPERT REV MED DEVIC, V13, P455, DOI 10.1586/17434440.2016.1153421; Motl RW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125002; Muro-de-la-Herran A, 2014, SENSORS-BASEL, V14, P3362, DOI 10.3390/s140203362; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; Sebastiao E, 2016, ARCH PHYS MED REHAB, V97, P1072, DOI 10.1016/j.apmr.2015.12.031; Spain RI, 2012, GAIT POSTURE, V35, P573, DOI 10.1016/j.gaitpost.2011.11.026; Sprint Gina, 2015, IEEE Rev Biomed Eng, V8, P64, DOI 10.1109/RBME.2015.2390646; Steffen T, 2008, PHYS THER, V88, P733, DOI 10.2522/ptj.20070214; Washabaugh EP, 2017, GAIT POSTURE, V55, P87, DOI 10.1016/j.gaitpost.2017.04.013	25	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198178	10.1371/journal.pone.0198178	http://dx.doi.org/10.1371/journal.pone.0198178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879144	Green Published, Green Submitted, gold			2022-12-26	WOS:000434384900025
J	Mukhtar, AYA; Munyakazi, JB; Ouifki, R; Clark, AE				Mukhtar, Abdulaziz Y. A.; Munyakazi, Justin B.; Ouifki, Rachid; Clark, Allan E.			Modelling the effect of bednet coverage on malaria transmission in South Sudan	PLOS ONE			English	Article							PARAMETER-ESTIMATION; MONTE-CARLO; NETS; IMPACT	A campaign for malaria control, using Long Lasting Insecticide Nets (LLINs) was launched in South Sudan in 2009. The success of such a campaign often depends upon adequate available resources and reliable surveillance data which help officials understand existing infections. An optimal allocation of resources for malaria control at a sub-national scale is therefore paramount to the success of efforts to reduce malaria prevalence. In this paper, we extend an existing SIR mathematical model to capture the effect of LLINs on malaria transmission. Available data on malaria is utilized to determine realistic parameter values of this model using a Bayesian approach via Markov Chain Monte Carlo (MCMC) methods. Then, we explore the parasite prevalence on a continued rollout of LLINs in three different settings in order to create a sub-national projection of malaria. Further, we calculate the model's basic reproductive number and study its sensitivity to LLINs' coverage and its efficacy. From the numerical simulation results, we notice a basic reproduction number, Rip confirming a substantial increase of incidence cases if no form of intervention takes place in the community. This work indicates that an effective use of LLINs may reduce RD and hence malaria transmission. We hope that this study will provide a basis for recommending a scaling-up of the entry point of LLINs' distribution that targets households in areas at risk of malaria.	[Mukhtar, Abdulaziz Y. A.; Munyakazi, Justin B.] Univ Western Cape, Dept Math & Appl Math, Private Bag X17, ZA-7535 Bellville, South Africa; [Mukhtar, Abdulaziz Y. A.] Univ Witwatersrand, DST NRF Ctr Excellence Math & Stat Sci CoE Mass, Private Bag 3, ZA-2050 Johannesburg, Gauteng, South Africa; [Ouifki, Rachid] Univ Pretoria, Dept Math & Appl Math, Fac Nat & Agr Sci, Private Bag X20, ZA-0028 Hatfield, South Africa; [Clark, Allan E.] Univ Cape Town, Dept Stat Sci, Private Bag X3, ZA-7701 Cape Town, South Africa; [Clark, Allan E.] Univ Cape Town, Ctr Stat Ecol Environm & Conservat SEEC, Cape Town, South Africa	University of the Western Cape; University of Witwatersrand; University of Pretoria; University of Cape Town; University of Cape Town	Mukhtar, AYA (corresponding author), Univ Western Cape, Dept Math & Appl Math, Private Bag X17, ZA-7535 Bellville, South Africa.; Mukhtar, AYA (corresponding author), Univ Witwatersrand, DST NRF Ctr Excellence Math & Stat Sci CoE Mass, Private Bag 3, ZA-2050 Johannesburg, Gauteng, South Africa.	amukhtar@uwc.ac.za	Munyakazi, Justin/U-5010-2019; Ouifki, Rachid/A-4064-2017; Clark, Allan Ernest/S-1063-2019	Munyakazi, Justin/0000-0001-7420-6595; Ouifki, Rachid/0000-0001-7697-1792; Mukhtar, Abdulaziz/0000-0002-3420-1148	DST-NRF Centre of Excellence in Mathematical and Statistical Sciences (CoE-MaSS); DST-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA); DST/NRF SARChI Chair M3B2 [82770]	DST-NRF Centre of Excellence in Mathematical and Statistical Sciences (CoE-MaSS); DST-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA)(Department of Science & Technology (India)); DST/NRF SARChI Chair M3B2	Abdulaziz Y.A. Mukhtar acknowledges the support of the DST-NRF Centre of Excellence in Mathematical and Statistical Sciences (CoE-MaSS) and DST-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA) towards this research. Rachid Ouifki acknowledges the support of the DST/NRF SARChI Chair M3B2 grant 82770. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Robert Snow for the valuable discussions and insights provided at the early stages of this work. They are also grateful to Thomas Ujjiga for availing the data used in this research. Abdulaziz Y.A. Mukhtar acknowledges the support of the DST-NRF Centre of Excellence in mathematical and Statistical Sciences (CoE-MaSS) and DST-NRF Centre of Excellence in Epidemiological modelling and Analysis (SACEMA) towards this research. Rachid Ouifki acknowledges the support of the DST/NRF SARChI Chair M3B2 grant 82770. Opinions expressed and conclusions arrived at, are those of the author and are not necessary to be attributed to the CoE-MaSS, SACEMA or the SARChI Chair M3B2 grant.	Briet OJT, 2013, MALARIA J, V12, P12; Chanda E, 2014, B WORLD HEALTH ORGAN, V92, P290, DOI 10.2471/BLT.13.126862; Chanda E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-59; Chitnis N, 2010, AM J TROP MED HYG, V83, P230, DOI 10.4269/ajtmh.2010.09-0179; Chiyaka C, 2008, APPL MATH COMPUT, V195, P641, DOI 10.1016/j.amc.2007.05.016; Cornelio C. O., 2011, Southern Sudan Medical Journal, V4, P7; Draebel T, 2013, INT HEALTH, V5, P211, DOI 10.1093/inthealth/iht008; Eyobo MB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-45; Filipe JAN, 2007, PLOS COMPUT BIOL, V3, P2569, DOI 10.1371/journal.pcbi.0030255; Ghasemi O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S9; GoSS, 2006, MAL CONTR STRAT PLAN; Griffin JT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4136; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Hamra G, 2013, INT J EPIDEMIOL, V42, P627, DOI 10.1093/ije/dyt043; Huang YX, 2006, BIOMETRICS, V62, P413, DOI 10.1111/j.1541-0420.2005.00447.x; Huppert A, 2013, CLIN MICROBIOL INFEC, V19, P999, DOI 10.1111/1469-0691.12308; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; KOELLA JC, 1991, ACTA TROP, V49, P1, DOI 10.1016/0001-706X(91)90026-G; Kwong GPS, 2012, B MATH BIOL, V74, P1912, DOI 10.1007/s11538-012-9739-8; Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10; Malik R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146253; Manoja L., 2011, HLTH SECTOR DEV PLAN; Ngonghala CN, 2016, J THEOR BIOL, V397, P179, DOI 10.1016/j.jtbi.2016.03.003; Ngonghala CN, 2014, J THEOR BIOL, V363, P247, DOI 10.1016/j.jtbi.2014.08.018; Nguyen C., 2016, MALARIA RAVAGES S SU; Okell LC, 2008, PLOS MED, V5, P1617, DOI 10.1371/journal.pmed.0050226; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-17; Pasquale H, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-374; Putter H, 2002, STAT MED, V21, P2199, DOI 10.1002/sim.1211; Silal SP, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-297; Smith DL, 2009, TRENDS PARASITOL, V25, P511, DOI 10.1016/j.pt.2009.08.002; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i03; Sovi A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-319; SSCCSE, 2010, S SUD COUNTS TABL 5; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Wallace DI, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-268; White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153	40	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198280	10.1371/journal.pone.0198280	http://dx.doi.org/10.1371/journal.pone.0198280			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879166	Green Published, Green Submitted, gold			2022-12-26	WOS:000434384900028
J	Omuse, G; Maine, D; Mwangi, J; Wambua, C; Radia, K; Kanyua, A; Kagotho, E; Hoffman, M; Ojwang, P; Premji, Z; Ichihara, K; Erasmus, R				Omuse, Geoffrey; Maine, Daniel; Mwangi, Jane; Wambua, Caroline; Radia, Kiran; Kanyua, Alice; Kagotho, Elizabeth; Hoffman, Mariza; Ojwang, Peter; Premji, Zul; Ichihara, Kiyoshi; Erasmus, Rajiv			Complete blood count reference intervals from a healthy adult urban population in Kenya	PLOS ONE			English	Article							REFERENCE VALUES; REFERENCE RANGES; GLOBAL MULTICENTER; IRON-DEFICIENCY; DERIVATION; THROMBOPOIETIN; ERYTHROPOIETIN; ANALYTES	Background There are racial, ethnic and geographical differences in complete blood count (CBC) reference intervals (Rls) and therefore it is necessary to establish Rls that are population specific. Several studies have been carried out in Africa to derive CBC Rls but many were not conducted with the rigor recommended for RI studies hence limiting the adoption and generalizability of the results. Method By use of a Beckman Coulter ACT 5 DIFF CP analyser, we measured CBC parameters in samples collected from 528 healthy black African volunteers in a largely urban population. The latent abnormal values exclusion (LAVE) method was used for secondary exclusion of individuals who may have had sub-clinical diseases. The Rls were derived by both parametric and non-parametric methods with and without LAVE for comparative purposes. Results Haemoglobin (Hb) levels were lower while platelet counts were higher in females across the 4 age stratifications. The lower limits for Hb and red blood cell parameters significantly increased after applying the LAVE method which eliminated individuals with latent anemia and inflammation. We adopted Rls by parametric method because 90% confidence intervals of the RI limits were invariably narrower than those by the non-parametric method. The male and female Rls for Hb after applying the LAVE method were 14.5-18.7 g/dL and 12.016.5 g/dL respectively while the platelet count Rls were 133-356 and 152-443 x10(3) per mu L respectively. Conclusion Consistent with other studies from Sub-Saharan Africa, Hb and neutrophil counts were lower than Caucasian values. Our finding of higher Hb and lower eosinophil counts compared to other studies conducted in rural Kenya most likely reflects the strict recruitment criteria and healthier reference population after secondary exclusion of individuals with possible sub-clinical diseases.	[Omuse, Geoffrey; Maine, Daniel; Kagotho, Elizabeth] Aga Khan Univ Hosp Nairobi, Dept Pathol, Nairobi, Kenya; [Omuse, Geoffrey; Hoffman, Mariza; Erasmus, Rajiv] Stellenbosch Univ, Dept Pathol, Div Chem Pathol, Cape Town, South Africa; [Mwangi, Jane; Wambua, Caroline; Radia, Kiran] PathCare Kenya Ltd, Nairobi, Kenya; [Kanyua, Alice] Karen Hosp, Nairobi, Kenya; [Ojwang, Peter] Maseno Univ, Dept Pathol, Maseno, Kenya; [Premji, Zul] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Ichihara, Kiyoshi] Yamaguchi Univ, Grad Sch Med, Fac Hlth Sci, Ube, Yamaguchi, Japan	Stellenbosch University; University of Cape Town; Maseno University; Muhimbili University of Health & Allied Sciences; Yamaguchi University	Omuse, G (corresponding author), Aga Khan Univ Hosp Nairobi, Dept Pathol, Nairobi, Kenya.; Omuse, G (corresponding author), Stellenbosch Univ, Dept Pathol, Div Chem Pathol, Cape Town, South Africa.	g_omuse@yahoo.com	OMUSE, GEOFFREY/EVF-7884-2022	Kagotho, Elizabeth/0000-0002-7697-3808; OMUSE, GEOFFREY/0000-0002-3866-5118	Aga Khan University Research Council grant (URC) [1420088A]; Medical research council South Africa [94261, 004_94479]; PathCare Kenya Limited	Aga Khan University Research Council grant (URC); Medical research council South Africa; PathCare Kenya Limited	Part of this study was funded by an Aga Khan University Research Council grant (URC Project ID: 1420088A to GO) and Medical research council South Africa grants (Grant 94261 to RE and 004_94479 to MH). PathCare Kenya Limited provided support in the form of salaries for authors JM, CW and KR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	Beutler E, 2005, BLOOD, V106, P740, DOI 10.1182/blood-2005-02-0713; Bilic E, 2003, J PEDIAT HEMATOL ONC, V25, P675, DOI 10.1097/00043426-200308000-00023; Borai A, 2016, CLIN CHEM LAB MED, V54, P843, DOI 10.1515/cclm-2015-0490; BROUDY VC, 1995, BLOOD, V85, P1719, DOI 10.1182/blood.V85.7.1719.bloodjournal8571719; CLSI, 2008, DEF EST VER REF INT; Dosoo DK, 2012, HAEMATOLOGICAL BIOCH, V7, P1; Gahutu J, 2013, IBRR, V1, P22; Hershman D, 2003, J NATL CANCER I, V95, P1545, DOI 10.1093/jnci/djg073; Ichihara K, 2008, CLIN CHEM, V54, P356, DOI 10.1373/clinchem.2007.091843; Ichihara K, 2017, CLIN CHIM ACTA, V467, P70, DOI 10.1016/j.cca.2016.09.016; Ichihara K, 2014, CLIN CHIM ACTA, V432, P108, DOI 10.1016/j.cca.2014.01.025; Ichihara K, 2013, CLIN CHEM LAB MED, V51, P1429, DOI 10.1515/cclm-2012-0421; Ichihara K, 2010, CLIN CHEM LAB MED, V48, P1537, DOI 10.1515/CCLM.2010.319; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Kueviakoe IM, 2016, ISRN HEMATOL, V2011; Kulnigg-Dabsch S, 2013, INFLAMM BOWEL DIS, V19, pE85, DOI [10.1097/MIB.0b013e3182a508b1, 10.1097/MIB.0b013e3182a50899]; Lawrie D, 2009, SAMJ S AFR MED J, V99, P243; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; McGrath JW, 2001, J ACQ IMMUN DEF SYND, V27, P381, DOI 10.1097/00126334-200108010-00009; Odhiambo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123140; Ozarda Y, 2013, CLIN CHEM LAB MED, V51, P1027, DOI 10.1515/cclm-2013-0249; Petitclerc C, 2004, CLIN CHEM LAB MED, V42, P698, DOI 10.1515/CCLM.2004.119; Saathoff E, 2008, TROP MED INT HEALTH, V13, P612, DOI 10.1111/j.1365-3156.2008.02047.x; Schloesser LL, 1937, J LAB CLIN MED, V66, P107; Segolodi TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093034; Tarimo EAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014619; Thobakgale CF, 2014, CURR OPIN HEMATOL, V21, P50, DOI 10.1097/MOH.0000000000000007; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; World Health Organization, 2011, HAEM CONC DIAGN AN A	31	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198444	10.1371/journal.pone.0198444	http://dx.doi.org/10.1371/journal.pone.0198444			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879171	Green Submitted, Green Published, gold			2022-12-26	WOS:000434384900046
J	Mishra, AK; Tramacere, F; Guarino, R; Pugno, NM; Mazzolai, B				Mishra, Anand Kumar; Tramacere, Francesca; Guarino, Roberto; Pugno, Nicola Maria; Mazzolai, Barbara			A study on plant root apex morphology as a model for soft robots moving in soil	PLOS ONE			English	Article							DISCRETE ELEMENT MODEL; OGIVE-NOSE PROJECTILES; MAIZE ZEA-MAYS; PENETRATION; GROWTH; RESISTIVITY; PARAMETERS; PRESSURES; MECHANICS; ENERGY	Plants use many strategies to move efficiently in soil, such as growth from the tip, tropic movements, and morphological changes. In this paper, we propose a method to translate morphological features of Zea mays roots into a new design of soft robots that will be able to move in soil. The method relies on image processing and curve fitting techniques to extract the profile of Z. mays primary root. We implemented an analytic translation of the root profile in a 3D model (CAD) to fabricate root-like probes by means of 3D printing technology. Then, we carried out a comparative analysis among the artificial root-like probe and probes with different tip shapes (cylindrical, conical, elliptical, and parabolic) and diameters (11, 9, 7, 5, and 3 mm). The results showed that the energy consumption and the penetration force of the bioinspired probe are better with respect to the other shapes for all the diameters of the developed probes. For 100 mm of penetration depth and 7 mm of probe diameter, the energy consumption of the bioinspired probe is 89% lesser with respect to the cylindrical probe and 26% lesser with respect to the conical probe. The penetration performance of the considered tip shapes was evaluated also by means of numerical simulations, obtaining a good agreement with the experimental results. Additional investigations on plant root morphology , movement strategies, and material properties can allow the development of innovative bioinspired solutions exploitable in challenging environments. This research can bring to breakthrough scenarios in different fields, such as exploration tasks, environmental monitoring, geotechnical studies, and medical applications.	[Mishra, Anand Kumar; Tramacere, Francesca; Mazzolai, Barbara] Ist Italiano Tecnol, Ctr MicrobioRobot, Pontedera, Italy; [Mishra, Anand Kumar] Scuola Super Sant Anna, BioRobot Inst, Pontedera, Italy; [Guarino, Roberto; Pugno, Nicola Maria] Univ Trento, Dept Civil Environm & Mech Engn, Lab Bioinspired & Graphene Nanomech, Trento, Italy; [Pugno, Nicola Maria] Italian Space Agcy, Edoardo Amaldi Fdn, Ket Lab, Rome, Italy; [Pugno, Nicola Maria] Queen Mary Univ London, Sch Engn & Mat Sci, London, England	Istituto Italiano di Tecnologia - IIT; Scuola Superiore Sant'Anna; University of Trento; Agenzia Spaziale Italiana (ASI); University of London; Queen Mary University London	Mishra, AK; Tramacere, F; Mazzolai, B (corresponding author), Ist Italiano Tecnol, Ctr MicrobioRobot, Pontedera, Italy.; Mishra, AK (corresponding author), Scuola Super Sant Anna, BioRobot Inst, Pontedera, Italy.	anand.mishra@iit.it; francesca.tramacere@iit.it; barbara.mazzolai@iit.it	Mishra, Anand Kumar/H-4753-2018; Mazzolai, Barbara/I-8876-2016	Mishra, Anand Kumar/0000-0001-7423-7850; Mazzolai, Barbara/0000-0003-0722-8350; Guarino, Roberto/0000-0002-8415-2305	Bonfiglioli Riduttori SpA; European Commission [785219, 732344]; European Comission	Bonfiglioli Riduttori SpA; European Commission(European CommissionEuropean Commission Joint Research Centre); European Comission(European CommissionEuropean Commission Joint Research Centre)	RG is supported by Bonfiglioli Riduttori SpA. NMP is supported by the European Commission H2020 under the Graphene Flagship Core 2 No. 785219 (WP14 "Polymer Composites") and FET Proactive "Neurofibres" grant No. 732344. BM is supported by the European Comission under the FLAG-ERA Joint Transnational Call (JTC) 2016, RoboCom++. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLA AM, 1969, J AGR ENG RES, V14, P236, DOI 10.1016/0021-8634(69)90126-7; Asaf Z, 2007, SOIL TILL RES, V92, P227, DOI 10.1016/j.still.2006.03.006; Bar- Cohen Y, 2001, SPIES 8 ANN INT S SM; Bengough AG, 2012, PLANT SOIL, V360, P15, DOI 10.1007/s11104-012-1428-8; BENGOUGH AG, 1990, J SOIL SCI, V41, P341, DOI 10.1111/j.1365-2389.1990.tb00070.x; Bengough AG, 1997, J EXP BOT, V48, P885, DOI 10.1093/jxb/48.4.885; Blake LS, 2013, CIVIL ENG REFERENCE; Capetillo RF, 2014, LEADING EDGE, V33, P758; Clayton CR, 1982, SITE INVESTIGATION; Clayton CR, 1995, STANDARD PENETRATION; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47, DOI 10.1680/geot.1979.29.1.47; DAVIS JL, 1989, GEOPHYS PROSPECT, V37, P531, DOI 10.1111/j.1365-2478.1989.tb02221.x; FORRESTAL MJ, 1994, INT J IMPACT ENG, V15, P395, DOI 10.1016/0734-743X(94)80024-4; Gouache T., 2010, WOOD WASP INSPIRED S; Gui M, 1998, GUIDELINES CONE PENE; Guirgis S, 2009, NUCL ENG DES, V239, P819, DOI 10.1016/j.nucengdes.2008.11.016; HUNTER JA, 1984, GEOPHYSICS, V49, P1381, DOI 10.1190/1.1441766; Iijima M, 2004, ANN BOT-LONDON, V94, P473, DOI 10.1093/aob/mch166; Iijima M, 2008, PLANT PROD SCI, V11, P17, DOI 10.1626/pps.11.17; Johnson K. L., 1985, CONTACT MECH, DOI 10.1201/b17110-2; Jorat ME, 2014, ADV NAT TECH HAZ RES, V37, P55, DOI 10.1007/978-3-319-00972-8_6; Mak J, 2012, SOIL TILL RES, V118, P117, DOI 10.1016/j.still.2011.10.019; Matsumoto T, 2015, SOILS FOUND, V55, P201, DOI 10.1016/j.sandf.2014.12.016; Mazzolai B, 2011, IEEE-ASME T MECH, V16, P201, DOI 10.1109/TMECH.2009.2038997; MISRA RK, 1986, PLANT SOIL, V95, P315, DOI 10.1007/BF02374612; Moon S, 2013, 30 INT S AUT ROB CON; Odebrecht E, 2005, J GEOTECH GEOENVIRON, V131, P1252, DOI 10.1061/(ASCE)1090-0241(2005)131:10(1252); Peck R.B., 1974, FDN ENG, V2nd ed.; Popova L, 2012, BIOLOGIA, V67, P517, DOI 10.2478/s11756-012-0023-z; Qian LX, 2000, INT J IMPACT ENG, V24, P947; ROBERTSON PK, 1990, CAN GEOTECH J, V27, P151, DOI 10.1139/t90-014; Rogers JD, 2006, ENVIRON ENG GEOSCI, V12, P161, DOI 10.2113/12.2.161; Sadeghi A, 2013, ROB AUT ICRA 2013 IE; Sadeghi A, 2017, SOFT ROBOT, V4, P211, DOI 10.1089/soro.2016.0080; Sadeghi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090139; Samouelian A, 2005, SOIL TILL RES, V83, P173, DOI 10.1016/j.still.2004.10.004; Sanglerat G., 2012, PENETROMETER SOIL EX; Schiefelbein JW, 2000, PLANT PHYSIOL, V124, P1525, DOI 10.1104/pp.124.4.1525; Schnaid F, 2007, GEOMECH GEOENGIN, V2, P137, DOI 10.1080/17486020701383825; Schnaid F, 2009, J GEOTECH GEOENVIRON, V135, P1092, DOI 10.1061/(ASCE)GT.1943-5606.0000059; STONE EL, 1991, FOREST ECOL MANAG, V46, P59, DOI 10.1016/0378-1127(91)90245-Q; Stone MB, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041301; Tabbagh A, 2000, GEODERMA, V97, P393, DOI 10.1016/S0016-7061(00)00047-1; Tamas K, 2013, SOIL TILL RES, V134, P223, DOI 10.1016/j.still.2013.09.001; Thakoor S., 2000, J SPACE MISSION ARCH, V2, P49; Tonazzini A, 2012, BIOM ROB BIOM BIOROB; Wang Y, 2013, CAN GEOTECH J, V50, P766, DOI 10.1139/cgj-2013-0004; Winter AG, 2011, BIOL INSPIRED MECH B; Yang Gao, 2005, International Journal of Advanced Robotic Systems, V2, P281; Yang SY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2715; YANKELEVSKY DZ, 1980, INT J NUMER ANAL MET, V4, P233, DOI 10.1002/nag.1610040304; Zacny K, 2008, ASTROBIOLOGY, V8, P665, DOI 10.1089/ast.2007.0179; Zacny K., 2009, DRILLING EXTREME ENV, P347; Zacny K, 2012, AER C 2012 IEEE	54	12	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197411	10.1371/journal.pone.0197411	http://dx.doi.org/10.1371/journal.pone.0197411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874267	Green Submitted, Green Published, gold			2022-12-26	WOS:000434369400021
J	Li, D; Wang, L; Maziuk, BF; Yao, XD; Wolozin, B; Cho, YK				Li, Dan; Wang, Lei; Maziuk, Brandon F.; Yao, Xudong; Wolozin, Benjamin; Cho, Yong Ku			Directed evolution of a picomolar-affinity, high-specificity antibody targeting phosphorylated tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurodegeneration; antibody; tau protein (tau); protein phosphorylation; immunochemistry; affinity; anti-PTM antibody; phospho-specific; post-translational modification; antibody specificity	SINGLE-CHAIN ANTIBODY; PAIRED HELICAL FILAMENTS; YEAST SURFACE DISPLAY; SACCHAROMYCES-CEREVISIAE; POSTTRANSLATIONAL MODIFICATIONS; ALZHEIMERS-DISEASE; MOUSE MODEL; TYROSINE PHOSPHORYLATION; POLYPEPTIDE LIBRARIES; CEREBROSPINAL-FLUID	Antibodies are essential biochemical reagents for detecting protein post-translational modifications (PTMs) in complex samples. However, recent efforts in developing PTM-targeting antibodies have reported frequent nonspecific binding and limited affinity of such antibodies. To address these challenges, we investigated whether directed evolution could be applied to improve the affinity of a high-specificity antibody targeting phosphothreonine 231 (pThr-231) of the human microtubule-associated protein tau. On the basis of existing structural information, we hypothesized that improving antibody affinity may come at the cost of loss in specificity. To test this hypothesis, we developed a novel approach using yeast surface display to quantify the specificity of PTM-targeting antibodies. When we affinity-matured the single-chain variable antibody fragment through directed evolution, we found that its affinity can be improved >20-fold over that of the WT antibody, reaching a picomolar range. We also discovered that most of the high-affinity variants exhibit cross-reactivity toward the nonphosphorylated target site but not to the phosphorylation site with a scrambled sequence. However, systematic quantification of the specificity revealed that such a tradeoff between the affinity and specificity did not apply to all variants and led to the identification of a picomolar-affinity variant that has a matching high specificity of the original phosphotau antibody. In cell- and tissue-imaging experiments, the high-affinity variant gave significantly improved signal intensity while having no detectable nonspecific binding. These results demonstrate that directed evolution is a viable approach for obtaining high-affinity PTM-specific antibodies and highlight the importance of assessing the specificity in the antibody engineering process.	[Li, Dan] Univ Connecticut, Dept Biomed Engn, Storrs, CT 06269 USA; [Wang, Lei] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA; [Cho, Yong Ku] Univ Connecticut, Dept Chem & Biomol Engn, Storrs, CT 06269 USA; [Yao, Xudong; Cho, Yong Ku] Univ Connecticut, Inst Syst Genom, Storrs, CT 06269 USA; [Maziuk, Brandon F.; Wolozin, Benjamin] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; Boston University	Cho, YK (corresponding author), Univ Connecticut, Inst Syst Genom, Dept Chem & Biomol Engn, Storrs, CT 06269 USA.; Cho, YK (corresponding author), Univ Connecticut, Inst Syst Genom, Dept Biomed Engn, Storrs, CT 06269 USA.	cho@uconn.edu		Cho, Yong Ku/0000-0001-5621-521X	National Institutes of Health [NS099903, AG050471, NS089544, ES020395, NS106751]; National Science Foundation [1706743]; Brain and Behavior Research Foundation (National Alliance for Research on Schizophrenia and Depression Young Investigator); BrightFocus Foundation; Alzheimer Association; Cure Alzheimer's Fund; Edward N. and Della L. Thome Memorial Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS106751, R01NS089544, R03NS099903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG050471, P30AG013846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Brain and Behavior Research Foundation (National Alliance for Research on Schizophrenia and Depression Young Investigator); BrightFocus Foundation(BrightFocus Foundation); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Cure Alzheimer's Fund; Edward N. and Della L. Thome Memorial Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant NS099903, National Science Foundation Grant 1706743, and the Brain and Behavior Research Foundation (National Alliance for Research on Schizophrenia and Depression Young Investigator) (to Y. K. C.); National Institutes of Health Grants AG050471, NS089544, and ES020395 and the BrightFocus Foundation, Alzheimer Association, Cure Alzheimer's Fund, and Edward N. and Della L. Thome Memorial Foundation (to B. W.); and National Institutes of Health Grant NS106751 (to B. M.). B. W. is cofounder and chief scientific officer of Aquinnah Pharmaceuticals Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adhikary R, 2015, BIOCHEMISTRY-US, V54, P2085, DOI 10.1021/bi501417q; Amniai L, 2009, FASEB J, V23, P1146, DOI 10.1096/fj.08-121590; Arai H, 2000, EXP NEUROL, V166, P201, DOI 10.1006/exnr.2000.7501; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Baybutt H, 1997, GENE, V184, P125, DOI 10.1016/S0378-1119(96)00600-2; Bayes A, 2009, NAT REV NEUROSCI, V10, P635, DOI 10.1038/nrn2701; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Bock I, 2011, EPIGENETICS-US, V6, P256, DOI 10.4161/epi.6.2.13837; Boder ET, 1998, BIOTECHNOL PROGR, V14, P55, DOI 10.1021/bp970144q; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Brumbaugh K, 2011, METHODS MOL BIOL, V717, P3, DOI 10.1007/978-1-61779-024-9_1; Burns ML, 2014, APPL ENVIRON MICROB, V80, P5732, DOI 10.1128/AEM.01466-14; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Cho YK, 2009, J IMMUNOL METHODS, V341, P117, DOI 10.1016/j.jim.2008.11.005; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Coutadeur S, 2015, J NEUROCHEM, V133, P440, DOI 10.1111/jnc.13018; CZERNIK AJ, 1991, METHOD ENZYMOL, V201, P264; d'Abramo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062402; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Ercan E, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0229-1; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Fuchs SM, 2011, CURR BIOL, V21, P53, DOI 10.1016/j.cub.2010.11.058; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Hackel BJ, 2006, PHARM RES-DORDR, V23, P790, DOI 10.1007/s11095-006-9778-7; Hampel H, 2005, ARCH NEUROL-CHICAGO, V62, P770, DOI 10.1001/archneur.62.5.770; Helma J, 2015, J CELL BIOL, V209, P633, DOI 10.1083/jcb.201409074; Hoffmann NA, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-82; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Huang D, 2005, BIOTECHNOL PROGR, V21, P349, DOI 10.1021/bp0497482; Irwin DJ, 2013, AM J PATHOL, V183, P344, DOI 10.1016/j.ajpath.2013.04.025; Ising C, 2017, J EXP MED, V214, P1227, DOI 10.1084/jem.20162125; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Kehoe JW, 2006, MOL CELL PROTEOMICS, V5, P2350, DOI 10.1074/mcp.M600314-MCP200; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Koerber JT, 2013, NAT BIOTECHNOL, V31, P916, DOI 10.1038/nbt.2672; Kohnken R, 2000, NEUROSCI LETT, V287, P187, DOI 10.1016/S0304-3940(00)01178-2; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Krishnaswamy S, 2014, J NEUROSCI, V34, P16835, DOI 10.1523/JNEUROSCI.2755-14.2014; Kurosawa N, 2016, SCI REP-UK, V6, DOI 10.1038/srep25174; Li CZ, 2017, NAT REV DRUG DISCOV, V16, P863, DOI 10.1038/nrd.2017.155; Liu HL, 2016, RADIOLOGY, V281, P99, DOI 10.1148/radiol.2016152444; Lothrop AP, 2013, FEBS LETT, V587, P1247, DOI 10.1016/j.febslet.2013.01.047; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; Min SW, 2015, NAT MED, V21, P1154, DOI 10.1038/nm.3951; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Nisbet RM, 2017, BRAIN, V140, P1220, DOI 10.1093/brain/awx052; OI VT, 1982, J CELL BIOL, V93, P981, DOI 10.1083/jcb.93.3.981; Petry FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094251; Prabakaran S, 2012, WIRES SYST BIOL MED, V4, P565, DOI 10.1002/wsbm.1185; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Rosseels J, 2015, J BIOL CHEM, V290, P4059, DOI 10.1074/jbc.M114.627919; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Shih HH, 2012, J BIOL CHEM, V287, P44425, DOI 10.1074/jbc.M112.415935; Shusta EV, 1998, NAT BIOTECHNOL, V16, P773, DOI 10.1038/nbt0898-773; Sun YL, 2017, JOVE-J VIS EXP, DOI 10.3791/56188; Swers JS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh030; Tak H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081682; Uhlen M, 2016, NAT METHODS, V13, P823, DOI [10.1038/nmeth.3995, 10.1038/NMETH.3995]; van der Mijn JC, 2015, J PROTEOMICS, V127, P259, DOI 10.1016/j.jprot.2015.04.006; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Yin J, 2003, J MOL BIOL, V330, P651, DOI 10.1016/S0022-2836(03)00631-4; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049	73	9	9	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12081	12094		10.1074/jbc.RA118.003557	http://dx.doi.org/10.1074/jbc.RA118.003557			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29899114	Green Published, hybrid			2022-12-26	WOS:000440803200009
J	Hofer, S; Raisch, J; Toussaint, M; Brock, O				Hoefer, Sebastian; Raisch, Joerg; Toussaint, Marc; Brock, Oliver			No free lunch in ball catching: A comparison of Cartesian and angular representations for control	PLOS ONE			English	Article							ACCELERATION CANCELLATION THEORY; PERCEPTUAL NAVIGATION STRATEGY; OPTIMAL FEEDBACK-CONTROL; INTERCEPTION	How to run most effectively to catch a projectile, such as a baseball, that is flying in the air for a long period of time? The question about the best solution to the ball catching problem has been subject to intense scientific debate for almost 50 years. It turns out that this scientific debate is not focused on the ball catching problem alone, but revolves around the research question what constitutes the ingredients of intelligent decision making. Over time, two opposing views have emerged: the generalist view regarding intelligence as the ability to solve any task without knowing goal and environment in advance, based on optimal decision making using predictive models; and the specialist view which argues that intelligent decision making does not have to be based on predictive models and not even optimal, advocating simple and efficient rules of thumb (heuristics) as superior to enable accurate decisions. We study two types of approaches to the ball catching problem, one for each view, and investigate their properties using both a theoretical analysis and a broad set of simulation experiments. Our study shows that neither of the two types of approaches can be regarded as superior in solving all relevant variants of the ball catching problem: each approach is optimal under a different realistic environmental condition. Therefore, predictive models neither guarantee nor prevent success a priori, and we further show that the key difference between the generalist and the specialist approach to ball catching is the type of input representation used to control the agent. From this finding, we conclude that the right solution to a decision making or control problem is orthogonal to the generalist and specialist approach, and thus requires a reconciliation of the two views in favor of a representation-centric view.	[Hoefer, Sebastian; Brock, Oliver] Tech Univ Berlin, Robot & Biol Lab RBO, Berlin, Germany; [Hoefer, Sebastian; Toussaint, Marc] Amazon Res, Berlin, Germany; [Raisch, Joerg] Tech Univ Berlin, Control Syst Grp, Berlin, Germany; [Toussaint, Marc] Univ Stuttgart, Machine Learning & Robot Lab MLR, Stuttgart, Germany	Technical University of Berlin; Technical University of Berlin; University of Stuttgart	Hofer, S (corresponding author), Tech Univ Berlin, Robot & Biol Lab RBO, Berlin, Germany.; Hofer, S (corresponding author), Amazon Res, Berlin, Germany.	mail@sebastianhoefer.de			Alexander von Humboldt foundation - German Federal Ministry of Education and Research; German Research Foundation (DFG) [BR 2248/3-1]	Alexander von Humboldt foundation - German Federal Ministry of Education and Research; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the Alexander von Humboldt foundation through an Alexander von Humboldt professorship (funded by the German Federal Ministry of Education and Research) (https://www.humboldt-foundation.de/web/alexander-von-humboldt-professorship.html) and German Research Foundation (DFG), BR 2248/3-1 (https://ipvs.informatik.uni-stuttgart.de/mlr/spp-wordpress/projekte/projects-entries/?wcteid=18). SH and MT are or were employed by and own stock from Amazon Research. All work presented in this paper has been conducted before SHs and MTs employments at Amazon Research. The specific roles of these authors are articulated in the author contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboufadel E, 1996, AM MATH MON, V103, P870, DOI 10.2307/2974611; Allain R, 2012, MAXIMUM ACCELERATION; Atkeson CG, 1997, IEEE INT CONF ROBOT, P3557, DOI 10.1109/ROBOT.1997.606886; Belousov B., 2016, ADV NEURAL INFORM PR, P1426; Bengio Y., 2009, P INT C MACH LEARN N, DOI 10.1145/ 1553374.1553380; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Bertsekas D. P., 2005, DYNAMIC PROGRAMMING; Birbach Oliver, 2011, 2011 IEEE International Conference on Robotics and Automation (ICRA 2011), P5955, DOI 10.1109/ICRA.2011.5980138; Borgstadt J. A., 2000, Proceedings 2000 ICRA. Millennium Conference. IEEE International Conference on Robotics and Automation. Symposia Proceedings (Cat. No.00CH37065), P3189, DOI 10.1109/ROBOT.2000.845154; BRANCAZIO PJ, 1985, AM J PHYS, V53, P849, DOI 10.1119/1.14350; Brouwer AM, 2002, PERCEPT PSYCHOPHYS, V64, P1160, DOI 10.3758/BF03194764; CHAPMAN S, 1968, AM J PHYS, V36, P868, DOI 10.1119/1.1974297; Diaz GJ, 2009, EXP BRAIN RES, V195, P345, DOI 10.1007/s00221-009-1794-5; DIENES Z, 1993, PERCEPTION, V22, P1427, DOI 10.1068/p221427; Fajen BR, 2007, EXP BRAIN RES, V180, P303, DOI 10.1007/s00221-007-0859-6; Flash T, 2001, CURR OPIN NEUROBIOL, V11, P655, DOI 10.1016/S0959-4388(01)00265-3; Forsyth DA, 2002, PRENT HALL PROF TECH; GEMAN S, 1992, NEURAL COMPUT, V4, P1, DOI 10.1162/neco.1992.4.1.1; Gigerenzer G.E., 2011, HEURISTICS FDN ADAPT; Gigerenzer G, 2009, TOP COGN SCI, V1, P107, DOI 10.1111/j.1756-8765.2008.01006.x; GIGERENZER GERD, 2008, GUT FEELINGS INTELLI; Hamlin RP, 2017, TOP COGN SCI, V9, P264, DOI 10.1111/tops.12253; Hansen N, 2003, EVOL COMPUT, V11, P1, DOI 10.1162/106365603321828970; Hayhoe M. M., 2004, J VISION CHARLOTTESV, V4, P156, DOI DOI 10.1167/4.8.156; Hutter M, 2005, TEXTS THEORETICAL CO, P141; Januszkiewicz K, 2010, SPEED FASTEST HUMAN; Jonschkowski R, 2016, NIPS 2016 WORKSH DEE; Jonschkowski R, 2015, AUTON ROBOT, V39, P407, DOI 10.1007/s10514-015-9459-7; Khomut B, 2007, J VISION, V7, P146, DOI [10.1167/7.9.146, DOI 10.1167/7.9.146]; Kistemaker DA, 2009, HUM MOVEMENT SCI, V28, P236, DOI 10.1016/j.humov.2008.11.001; Kober J, 2012, IEEE-RAS INT C HUMAN, P875, DOI 10.1109/HUMANOIDS.2012.6651623; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kosinski R.A., 2010, LIT REV REACTION TIM; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Luan SH, 2011, PSYCHOL REV, V118, P316, DOI 10.1037/a0022684; Marken RS, 2001, AM J PSYCHOL, V114, P259, DOI 10.2307/1423517; MCBEATH MK, 1995, SCIENCE, V268, P569, DOI 10.1126/science.7725104; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; McLeod P, 2006, J EXP PSYCHOL HUMAN, V32, P139, DOI 10.1037/0096-1523.32.1.139; McLeod P, 2008, VISION RES, V48, P1479, DOI 10.1016/j.visres.2008.03.016; Meurer A, 2017, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.103; Mori R, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P281, DOI 10.1109/IRDS.2002.1041402; Mundhra K, 2003, IEEE INT CONF ROBOT, P3461; NASA, 2015, DRAG BAS; Nathan AM, 2013, FAR DID FLY BALL TRA; Pennings TJ, 2003, COLL MATH J, V34, P178, DOI [10.2307/3595798, DOI 10.2307/3595798]; Salimans T., 2017, ARXIV170303864; Shaffer DM, 2013, PERCEPTION, V42, P813, DOI 10.1068/p7503; Shaffer DM, 2013, ATTEN PERCEPT PSYCHO, V75, P1496, DOI 10.3758/s13414-013-0500-7; Shaffer DM, 2004, PSYCHOL SCI, V15, P437, DOI 10.1111/j.0956-7976.2004.00698.x; Silver D, 2017, NATURE, V550, P354, DOI 10.1038/nature24270; Simon H. A., 1969, SCI ARTIFICIAL; Sugar TG, 2006, AUTON ROBOT, V21, P43, DOI 10.1007/s10514-006-8487-8; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; TRESILIAN JR, 1995, Q J EXP PSYCHOL-A, V48, P688, DOI 10.1080/14640749508401411; Tversky A, 1975, UTILITY PROBABILITY, P141, DOI DOI 10.1007/978-94-010-1834-0_8; VALIANT LG, 1984, COMMUN ACM, V27, P1134, DOI 10.1145/1968.1972; VAPNIK VN, 1971, THEOR PROBAB APPL+, V16, P264, DOI 10.1137/1116025; Wang Z, 2006, IEEE INT CONF ROBOT, P2713, DOI 10.1109/ROBOT.2006.1642111; Watter Manuel, 2015, ADV NEURAL INFORM PR, V2, P2746; Wolpert DH, 1996, NEURAL COMPUT, V8, P1341, DOI 10.1162/neco.1996.8.7.1341; WOODS JW, 1972, IEEE T INFORM THEORY, V18, P232, DOI 10.1109/TIT.1972.1054786; Wu J., 2015, ADV NEURAL INFORM PR	66	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0197803	10.1371/journal.pone.0197803	http://dx.doi.org/10.1371/journal.pone.0197803			48	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ5MF	29902180	Green Submitted, Green Published, gold			2022-12-26	WOS:000435424900007
J	Smith, DP; Calopedos, R; Bang, A; Yu, XQ; Egger, S; Chambers, S; O'Connell, DL				Smith, David P.; Calopedos, Ross; Bang, Albert; Yu, Xue Qin; Egger, Sam; Chambers, Suzanne; O'Connell, Dianne L.			Increased risk of suicide in New South Wales men with prostate cancer: Analysis of linked population-wide data	PLOS ONE			English	Article							QUALITY-OF-LIFE; MARITAL-STATUS; HEALTH; MORTALITY; IDEATION; CARE; TRENDS; DEATH	Background An elevated risk of suicide after a diagnosis of prostate cancer has been reported previously in the USA and Sweden. We aimed to identify whether prostate cancer survivors resident in New South Wales Australia are at higher risk of suicide and if so, who is most at risk. Methods Data were obtained from the New South Wales (NSW) Cancer Registry for all men diagnosed with prostate cancer in NSW during 1997 to 2007. These were linked by the Centre for Health Record Linkage (CHeReL) to Australian Bureau of Statistics Mortality Data to the end of 2007 to determine vital status and cause of death. We compared the number of suicides observed for prostate cancer survivors with the expected number of suicides based on age-and calendar year-specific rates for the NSW male population using standardised mortality ratios (SMRs). Suicide rate ratios (RR) by disease and patients' characteristics were estimated using multivariable negative binomial regression to determine the most at risk groups. Results During the study period 51,924 NSW men were diagnosed with prostate cancer. Forty nine of these men were subsequently recorded as committing suicide up to 10 years after diagnosis with an SMR of 1.70 (95% Cl:1.26-2.25). Twenty six (53%) of these suicides occurred within 12 months after diagnosis. Risk diminished over time since diagnosis (RR in 1-2 years after diagnosis = 0.29, 95% Cl: 0.12-0.71, 2-4 years RR = 0.30, 95% Cl: 0.14-0.16 and 4+ years RR = 0.26, 95% Cl: 0.11-0.60 compared with <1 year since diagnosis). Men with non-localised disease had a higher risk of suicide compared to men with localised disease (RR = 2.68, 95% Cl: 1.15-6.23). Men living outside major cities had lower risk of suicide compared to those resident in major cities (rate ratio = 0.42, 95% Cl: 0.20-0.87). Single, divorced, widowed or separated men were more likely to commit suicide than married men (RR = 4.18, 95% Cl: 2.36-7.42). Conclusion Risk of suicide is higher for NSW men diagnosed with prostate cancer than the general age matched male population. Vulnerable or lonely men and those with pre-existing depression or suicidal ideation who are diagnosed with prostate cancer should be offered additional psychological support.	[Smith, David P.; Calopedos, Ross; Bang, Albert; Yu, Xue Qin; Egger, Sam; O'Connell, Dianne L.] Canc Council NSW, Canc Res Div, Sydney, NSW, Australia; [Smith, David P.; Yu, Xue Qin; O'Connell, Dianne L.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Smith, David P.; Chambers, Suzanne] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Calopedos, Ross] Wollongong Hosp, Wollongong, NSW, Australia; [O'Connell, Dianne L.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia	Cancer Council New South Wales; University of Sydney; Griffith University; Menzies Health Institute Queensland; Wollongong Hospital; University of Newcastle	Smith, DP (corresponding author), Canc Council NSW, Canc Res Div, Sydney, NSW, Australia.; Smith, DP (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia.; Smith, DP (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia.	dsmith@nswcc.org.au	Calopedos, Ross/ABG-4579-2021; Yu, Xue Qin/E-7405-2013; Chambers, Suzanne K/H-5957-2012	Calopedos, Ross/0000-0003-0074-0001; Yu, Xue Qin/0000-0001-8638-7979; Chambers, Suzanne K/0000-0003-2369-6111; Egger, Sam/0000-0003-1808-6909; Smith, David/0000-0002-1474-3214	Australian National Health and Medical Research Council Training Fellowship [App1016598]; Cancer Institute NSW Career Development Fellowship [E16/00130]	Australian National Health and Medical Research Council Training Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW Career Development Fellowship	David Smith was supported by an Australian National Health and Medical Research Council Training Fellowship (App1016598) and was the recipient of a Cancer Institute NSW Career Development Fellowship (E16/00130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmedani BK, 2014, J GEN INTERN MED, V29, P870, DOI 10.1007/s11606-014-2767-3; Anguiano L, 2012, CANCER NURS, V35, pE14, DOI 10.1097/NCC.0b013e31822fc76c; [Anonymous], 2016, CAUS DEATH AUSTR 201; Australian Bureau of Statistics (ABS), 1996, CENS POP HOUS SOC IN; Australian Institute of Health and Welfare, 2017, GRIM GEN REC INC MOR; Australian Institute of Health and Welfare (AIHW)., 2017, AUSTR CANC INC MORT; Australian Institute of Health and Welfare (AIHW), 2004, RUR REG REM HLTH GUI; Baade PD, 2009, MOL NUTR FOOD RES, V53, P171, DOI 10.1002/mnfr.200700511; Bill-Axelson A, 2011, EUR J CANCER, V47, P2195, DOI 10.1016/j.ejca.2011.04.022; Bill-Axelson A, 2010, EUR UROL, V57, P390, DOI 10.1016/j.eururo.2009.10.035; Carlsson S, 2013, EUR J CANCER, V49, P1588, DOI 10.1016/j.ejca.2012.12.018; Chambers SK, 2013, PROSCARE PSYCHOL CAR; Chambers SK, 2017, PSYCHO-ONCOLOGY, V26, P1576, DOI 10.1002/pon.4342; Chambers SK, 2014, PSYCHO-ONCOLOGY, V23, P195, DOI 10.1002/pon.3391; Chambers SK, 2011, PATIENT EDUC COUNS, V85, pE75, DOI 10.1016/j.pec.2011.01.027; Chipperfield K, 2013, PSYCHO-ONCOLOGY, V22, P2478, DOI 10.1002/pon.3310; Dalela D, 2015, BJU INT; De Leo D, 2010, MED J AUSTRALIA, V192, P452; Drummond FJ, 2015, J CANCER SURVIV, V9, P361, DOI 10.1007/s11764-014-0419-6; Fall K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000197; Fang F, 2010, JNCI-J NATL CANCER I, V102, P307, DOI 10.1093/jnci/djp537; Herr HW, 2000, J UROLOGY, V163, P1743, DOI 10.1016/S0022-5347(05)67533-7; Holland J, 2011, PSYCHO-ONCOLOGY, V20, P677, DOI 10.1002/pon.1978; Hyde MK, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12497; ISOMETSA E, 1995, BRIT MED J, V310, P1366, DOI 10.1136/bmj.310.6991.1366; Jayadevappa R, 2012, PSYCHO-ONCOLOGY, V21, P1338, DOI 10.1002/pon.2032; Jensen OM, 1991, CANC REGISTRATION PR; K Hughes Mary, 2016, J Adv Pract Oncol, V7, P101; Klaassen Z, 2018, UROL ONCOL-SEMIN ORI, V36, P60, DOI 10.1016/j.urolonc.2017.09.007; Kposowa AJ, 2000, J EPIDEMIOL COMMUN H, V54, P254, DOI 10.1136/jech.54.4.254; McLaren S, 2015, INT PSYCHOGERIATR, V27, P145, DOI 10.1017/S1041610214001501; Pashayan N, 2009, BRIT J CANCER, V100, P1198, DOI 10.1038/sj.bjc.6604973; Recklitis CJ, 2014, CANCER-AM CANCER SOC, V120, P3393, DOI 10.1002/cncr.28880; Smith DP, 2007, J CLIN ONCOL, V25, P2560, DOI 10.1200/JCO.2006.09.8046; Thorsteinsdottir T, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-154; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; United Nations Department of Economic and Social Affairs, 2015, WORLD POPULATION PRO; Wong MCS, 2016, EUR UROL, V70, P862, DOI 10.1016/j.eururo.2016.05.043; Yousaf U, 2005, BRIT J CANCER, V92, P995, DOI 10.1038/sj.bjc.6602424; Zhou ES, 2015, J CANCER SURVIV, V9, P59, DOI 10.1007/s11764-014-0385-z	41	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198679	10.1371/journal.pone.0198679	http://dx.doi.org/10.1371/journal.pone.0198679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897979	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700066
J	Thomas, JM; Surendran, S; Abraham, M; Sasankan, D; Bhaadri, S; Rajavelu, A; Kartha, CC				Thomas, Jaya Mary; Surendran, Sumi; Abraham, Mathew; Sasankan, Dhakshmi; Bhaadri, Sridutt; Rajavelu, Arumugam; Kartha, Chandrasekharan C.			Gene expression analysis of nidus of cerebral arteriovenous malformations reveals vascular structures with deficient differentiation and maturation	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ENDOTHELIAL-CELLS; SMOOTH-MUSCLE; VESSEL MATURATION; CAPILLARIES; NETWORKS; ARTERIAL; IDENTITY; ULTRASTRUCTURE; ASTROCYTES	Objective Arteriovenous malformations (AVMs) are characterised by tangles of dysplastic blood vessels which shunt blood from arteries to veins with no intervening capillary bed. It is not known at what stage of development and differentiation, AVM vessels became aberrant. To address this, we have analysed the expression of vascular differentiation, vascular maturation and brain capillary specific genes in AVM nidus. Methodology We performed immunohistochemistry and western blot analysis of vascular differentiation (HEY2, DLL4, EFNB2, and COUP-TFII), vascular maturation (ENG and KLF2) and brain capillary specific genes (GGTP and GLUT1) on ten surgically excised human brain AVMs and ten normal human brain tissues. Results Immunohistochemical analysis revealed that AVM vessels co-express both artery and vein differentiation genes. H-score analysis revealed that there is statistically significant (P < 0.0001) increase in expression of these proteins in AVM vessels compared to control vessels. These findings were further confirmed by western blot analysis and found to be statistically significant (P < 0.0001 and P < 0.001) for all proteins except Hey2. Both immunostaining and western blot analysis revealed that AVM vessels express GGTP and GLUT1, markers specific to brain capillaries. Immunofluorescent staining demonstrated that expression of KLF2, a vascular maturation marker is significantly (P < 0.001) decreased in AVM vessels and was further confirmed by western blot analysis (P < 0.001). Immunohistochemical and western blot analysis demonstrated that another vascular maturation protein Endoglin had high expression in AVM vessels compared to control vessels. The results were found to be statistically significant (P < 0.0001). Summary Our findings suggest that vascular structures of AVMs co-express markers specific for arteries, veins and capillaries. We conclude that AVM nidus constitutes of aberrant vessels which are not terminally differentiated and inadequately matured.	[Thomas, Jaya Mary; Surendran, Sumi; Sasankan, Dhakshmi; Rajavelu, Arumugam; Kartha, Chandrasekharan C.] Raj Gandhi Ctr Biotechnol, Cardio Vasc Dis & Diabet Biol Program, Thiruvananthapuram, Kerala, India; [Thomas, Jaya Mary] Manipal Acad Higher Educ, Manipal, Karnataka, India; [Abraham, Mathew; Bhaadri, Sridutt] Sree Chitra Tirunal Inst Med Sci & Technol, Dept Neurosurg, Thiruvananthapuram, Kerala, India; [Rajavelu, Arumugam] Raj Gandhi Ctr Biotechnol, Trop Dis Biol Program, Thiruvananthapuram, Kerala, India	Manipal Academy of Higher Education (MAHE); Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST)	Rajavelu, A; Kartha, CC (corresponding author), Raj Gandhi Ctr Biotechnol, Cardio Vasc Dis & Diabet Biol Program, Thiruvananthapuram, Kerala, India.; Rajavelu, A (corresponding author), Raj Gandhi Ctr Biotechnol, Trop Dis Biol Program, Thiruvananthapuram, Kerala, India.	arajavelu@rgcb.res.in; cckartha@rgcb.res.in		Kartha, CC/0000-0002-6782-4456; S, Sumi/0000-0002-1162-0219; Rajavelu, Arumugam/0000-0001-6666-8925	Dr. N. Radhakrishan trust foundation for research on venous disease; Kerala Biotechnology Commission by KSCSTE, Government of Kerala [022/YIPB/KBC/2015/CSTE]	Dr. N. Radhakrishan trust foundation for research on venous disease; Kerala Biotechnology Commission by KSCSTE, Government of Kerala	This study was supported by Dr. N. Radhakrishan trust foundation for research on venous disease and Kerala Biotechnology Commission by KSCSTE, Government of Kerala (022/YIPB/KBC/2015/CSTE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Aranguren XL, 2013, J CELL SCI, V126, P1164, DOI 10.1242/jcs.116293; Attia W, 2003, J NEUROSURG, V98, P823, DOI 10.3171/jns.2003.98.4.0823; Azuma K, 2009, BIOCHEM BIOPH RES CO, V380, P620, DOI 10.1016/j.bbrc.2009.01.135; Bai J, 2014, J INT MED RES, V42, P405, DOI 10.1177/0300060513478091; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bozoyan L, 2012, J NEUROSCI, V32, P1687, DOI 10.1523/JNEUROSCI.5531-11.2012; BRAVERMAN IM, 1990, J INVEST DERMATOL, V95, P422, DOI 10.1111/1523-1747.ep12555569; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9; DALLAIRE L, 1991, BIOCHEM J, V276, P745, DOI 10.1042/bj2760745; Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127; Davis RB, 2013, DEVELOPMENT, V140, P1272, DOI 10.1242/dev.087379; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; FUWA I, 1988, Neurological Surgery, V16, P887; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Hill-Felberg S, 2015, J CELL MOL MED, V19, P1986, DOI 10.1111/jcmm.12580; Iso T, 2006, BIOCHEM BIOPH RES CO, V341, P708, DOI 10.1016/j.bbrc.2006.01.020; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Jabbour MN, 2009, NEUROSURGERY, V64, P139, DOI 10.1227/01.NEU.0000334417.56742.24; Kim JH, 2006, J BIOCHEM MOL BIOL, V39, P339; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lillie RD, 1965, HISTOPATHOLOGIC TECH, P78; LOJDA Z, 1979, HISTOCHEMISTRY, V59, P153, DOI 10.1007/BF00495663; Mancini ML, 2009, DEV DYNAM, V238, P2479, DOI 10.1002/dvdy.22066; Matsubara S, 2000, STROKE, V31, P2653, DOI 10.1161/01.STR.31.11.2653; McCarty JH, 2009, CURR OPIN HEMATOL, V16, P209, DOI 10.1097/MOH.0b013e32832a07eb; MRAZKOVA O, 1986, AM J ANAT, V177, P141, DOI 10.1002/aja.1001770203; Murphy PA, 2008, P NATL ACAD SCI USA, V105, P10901, DOI 10.1073/pnas.0802743105; ONDRA SL, 1990, J NEUROSURG, V73, P387, DOI 10.3171/jns.1990.73.3.0387; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pardridge WM, 1999, J NEUROVIROL, V5, P556, DOI 10.3109/13550289909021285; Rhee WJ, 2010, P NATL ACAD SCI USA, V107, P6858, DOI 10.1073/pnas.1000444107; Sato S, 2004, NEUROSURGERY, V54, P163, DOI 10.1227/01.NEU.0000097518.57741.BE; Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Shoemaker LD, 2014, ANN CLIN TRANSL NEUR, V1, P982, DOI 10.1002/acn3.142; Simon MC, 2004, DEV CELL, V6, P479, DOI 10.1016/S1534-5807(04)00106-6; Smith AB., 2012, J AM OSTEOPATH COLL, V1, P10; Stapleton CJ, 2011, NEUROSURGERY, V68, P1342, DOI 10.1227/NEU.0b013e31820c0a68; Surendran S, 2016, LAB INVEST, V96, P399, DOI 10.1038/labinvest.2015.167; Swift MR, 2014, DEV BIOL, V390, P116, DOI 10.1016/j.ydbio.2014.03.018; Torres-Vaazquez J, 2003, CELL TISSUE RES, V314, P43, DOI 10.1007/s00441-003-0771-8; Tu J, 2006, NEUROSURGERY, V58, P961, DOI 10.1227/01.NEU.0000210248.39504.B5; Verhoeff-Van Gieson, STAINING PROTOCOL EL; Vijayashree R, 2015, J CLIN DIAGN RES, V9, pEC01, DOI 10.7860/JCDR/2015/12432.5628; Weinstein BM, 2005, CELL, V120, P299, DOI 10.1016/j.cell.2005.01.010; WOLBURG H, 1994, J CELL SCI, V107, P1347; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; ZhuGe QC, 2009, BRAIN, V132, P3231, DOI 10.1093/brain/awp246	52	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198617	10.1371/journal.pone.0198617	http://dx.doi.org/10.1371/journal.pone.0198617			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897969	gold, Green Submitted, Green Published			2022-12-26	WOS:000435090700060
J	Wang, Y; Masaki, T; Khan, SG; Tamura, D; Kuschal, C; Rogers, M; DiGiovanna, JJ; Kraemer, KH				Wang, Yun; Masaki, Taro; Khan, Sikandar G.; Tamura, Deborah; Kuschal, Christiane; Rogers, Megan; DiGiovanna, John J.; Kraemer, Kenneth H.			Four-dimensional, dynamic mosaicism is a hallmark of normal human skin that permits mapping of the organization and patterning of human epidermis during terminal differentiation	PLOS ONE			English	Article							XERODERMA-PIGMENTOSUM; SOMATIC MUTATIONS; STEM-CELLS; PIGMENTATION; HOMEOSTASIS; ARCHITECTURE; ICHTHYOSIS; MECHANISMS; POPULATION; REVERSION	Recent findings of mosaicism (DNA sequence variation) challenge the dogma that each person has a stable genetic constitution. Copy number variations, point mutations and chromosome abnormalities in normal or diseased tissues have been described. We studied normal skin mosaicism of a single nucleotide polymorphism (SNP) [rs1426654, p.Thr111Ala] in SLC24A5, an ion transporter gene. This SNP is unusual in that more than 90% of people of European descent have homozygous germline A/A alleles, while more than 90% of East Asians and Blacks have homozygous germline G/G alleles. We found mosaicism in neonatal foreskins as well as in 69% of nearly 600 skin surface scraping samples from 114 donors of different ages. Strikingly, donors with germline (buccal or blood) A/A, A/G or G/G genotypes had all three sequences (A/A, A/G or G/G) in the skin surface scrapings. SNP sequence differences extended within the epidermis in the vertical dimension from basal cell layer to the stratum corneum at the surface, as well as across the two-dimensions of the skin surface. Furthermore, repeated scrapings in the same location revealed variation in the sequences in the same individuals over time, adding a fourth dimension to this variation. We then used this mosaicism to track the movement of epidermal cells during normal differentiation and characterize the patterning of epidermal cells during terminal differentiation. In this coordinated proliferation model of epidermal differentiation, the skin surface is alternatively populated by synchronous, cycling of waves of cells, with each group having a different DNA sequence. These groups of cells abruptly flatten into large sheets at the surface providing patches of uniform SNP sequence. This four-dimensional mosaicism is a normal, previously unrecognized form of dynamic mosaicism in human skin.	[Wang, Yun; Masaki, Taro; Khan, Sikandar G.; Tamura, Deborah; Kuschal, Christiane; Rogers, Megan; DiGiovanna, John J.; Kraemer, Kenneth H.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wang, Yun] Peking Univ, Dept Dermatol, Hosp 1, Beijing, Peoples R China; [Masaki, Taro] Kobe Univ, Dept Dermatol, Sch Med, Kobe, Hyogo, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Peking University; Kobe University	Kraemer, KH (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	kraemerk@nih.gov		DiGiovanna, John J./0000-0002-2750-2313	NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC004517] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.; This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. We thank Drs. Douglas Brash, Isaac Brownell, and Thomas Kunkel for helpful discussions, Mr. Alan Hoofring for medical illustrations and to Dr. Valery Bliskovsky and Mr. Steven Shema for performing digital droplet PCR assays. Sanger sequencing and digital droplet PCR were conducted at the CCR Genomics Core at the National Cancer Institute, NIH, Bethesda, MD 20892.	Abyzov A, 2017, GENOME RES, V27, P512, DOI 10.1101/gr.215517.116; Acuna-Hidalgo R, 2015, AM J HUM GENET, V97, P67, DOI 10.1016/j.ajhg.2015.05.008; ALLEN TD, 1976, NATURE, V264, P545, DOI 10.1038/264545a0; Amagai M, 2000, NAT MED, V6, P1275, DOI 10.1038/81385; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; BERGSTRESSER PR, 1977, BRIT J DERMATOL, V96, P503, DOI 10.1111/j.1365-2133.1977.tb07152.x; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Choate KA, 2015, J CLIN INVEST, V125, P1703, DOI 10.1172/JCI64415; Choate KA, 2010, SCIENCE, V330, P94, DOI 10.1126/science.1192280; Choi YS, 2013, CELL STEM CELL, V13, P720, DOI 10.1016/j.stem.2013.10.003; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Hoath SB, 2003, J INVEST DERMATOL, V121, P1440, DOI 10.1046/j.1523-1747.2003.12606.x; Huang AY, 2014, CELL RES, V24, P1311, DOI 10.1038/cr.2014.131; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Jones P, 2008, NAT REV MOL CELL BIO, V9, P82, DOI 10.1038/nrm2292x; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Khan SG, 2002, NUCLEIC ACIDS RES, V30, P3624, DOI 10.1093/nar/gkf469; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lee S H, 1986, Yonsei Med J, V27, P213; Lodato MA, 2015, SCIENCE, V350, P94, DOI 10.1126/science.aab1785; Lujan SA, 2014, GENOME RES, V24, P1751, DOI 10.1101/gr.178335.114; Lujan SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003016; Mallick CB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003912; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Mascia F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005773; Matsumura T, 1999, J CUTAN PATHOL, V26, P197, DOI 10.1111/j.1600-0560.1999.tb01828.x; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P21070, DOI 10.1073/pnas.1013048107; PALLER AS, 1994, NEW ENGL J MED, V331, P1408, DOI 10.1056/NEJM199411243312103; Pasmooij AMG, 2012, DISCOV MED, V14, P167; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Samuels ME, 2015, GENES-BASEL, V6, P216, DOI 10.3390/genes6020216; Shlien A, 2015, NAT GENET, V47, P257, DOI 10.1038/ng.3202; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Soejima M, 2007, INT J LEGAL MED, V121, P36, DOI 10.1007/s00414-006-0112-z; STENN KS, 1989, J INVEST DERMATOL, V93, P287, DOI 10.1111/1523-1747.ep12277593; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Valenzuela RK, 2010, J FORENSIC SCI, V55, P315, DOI 10.1111/j.1556-4029.2009.01317.x; Wang Y, 2009, P NATL ACAD SCI USA, V106, P6279, DOI 10.1073/pnas.0812401106; WEINSTEIN GD, 1985, J INVEST DERMATOL, V85, P579, DOI 10.1111/1523-1747.ep12283594; Yokouchi M, 2016, ELIFE, V5, DOI [10.7554/eLife.19593, 10.7554/elife.19593]; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	44	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198011	10.1371/journal.pone.0198011	http://dx.doi.org/10.1371/journal.pone.0198011			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897937	gold, Green Published, Green Submitted			2022-12-26	WOS:000435090700039
J	Kuwabara, Y; Katayama, A; Kurihara, S; Orimo, H; Takeshita, T				Kuwabara, Yoshimitsu; Katayama, Akira; Kurihara, Sachiko; Orimo, Hideo; Takeshita, Toshiyuki			Immunoproteomic identification of anti-C9 autoimmune antibody in patients with seronegative obstetric antiphospholipid syndrome	PLOS ONE			English	Article							COMPLEMENT ACTIVATION; PREGNANCY; OUTCOMES; PROTEIN; SYSTEM	Immunoproteomic analysis was performed to identify unknown, pathology-related molecules in patients with seronegative (SN) obstetric antiphospholipid syndrome (APS) who clinically satisfied the diagnostic criteria for APS, but not the serological criteria. We collected peripheral blood from 13 SN-APS outpatients with known thrombotic predisposition, 13 with no known thrombotic predisposition, and four multiparous women with no history of miscarriage (control). Plasma proteins from volunteers were purified and used as plasma protein antigens. Two-dimensional immunoblotting was performed using pooled control or SN-APS serum samples as the primary antibodies. Mass spectrometry of reactive spots specific to SN-APS serum led to the identification of complement molecule C9. Western blotting using commercial purified alkylated C9 was performed to detect autoantibodies. Examination of individual patient serum identified reactivity in one patient with, and in two patients without known thrombotic predisposition. This study suggests that SN-APS pathologies were associated with autoantibodies that react to specific C9 epitopes.	[Kuwabara, Yoshimitsu; Kurihara, Sachiko; Takeshita, Toshiyuki] Nippon Med Sch, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo, Japan; [Katayama, Akira; Kurihara, Sachiko; Orimo, Hideo] Nippon Med Sch, Dept Mol Biol & Biochem, Bunkyo Ku, Tokyo, Japan	Nippon Medical School; Nippon Medical School	Kuwabara, Y (corresponding author), Nippon Med Sch, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo, Japan.	kuwa@nms.ac.jp			Japan Society for the Promotion of Science (JSPS; JSPS KAKENHI) [25462578]	Japan Society for the Promotion of Science (JSPS; JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS; JSPS KAKENHI Grant Number 25462578 to T.T., https://www.jsps.go.jp/english/e-grants/).	Audrain MAP, 2002, RHEUMATOLOGY, V41, P550, DOI 10.1093/rheumatology/41.5.550; Bates SM, 2012, CHEST, V141, pE691S, DOI 10.1378/chest.11-2300; Dudkina NV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10588; Gini B, 2008, J NEUROIMMUNOL, V196, P153, DOI 10.1016/j.jneuroim.2008.02.015; Girardi G, 2006, MOL IMMUNOL, V43, P68, DOI 10.1016/j.molimm.2005.06.017; Girardi G, 2004, NAT MED, V10, P1222, DOI 10.1038/nm1121; HAYAMA K, 1989, INT ARCH ALLER A IMM, V90, P400, DOI 10.1159/000235061; Heikal NM, 2015, CLIN EXP IMMUNOL, V180, P218, DOI 10.1111/cei.12573; Jara LJ, 2017, ISR MED ASSOC J, V19, P382; Lefranc D, 2007, ARTHRITIS RHEUM-US, V56, P3420, DOI 10.1002/art.22863; Mekinian A, 2012, J REPROD IMMUNOL, V94, P222, DOI 10.1016/j.jri.2012.02.004; Noris M, 2013, SEMIN NEPHROL, V33, P479, DOI 10.1016/j.semnephrol.2013.08.001; Pieper R, 2003, PROTEOMICS, V3, P1345, DOI 10.1002/pmic.200300449; Regal JF, 2015, MOL IMMUNOL, V67, P56, DOI 10.1016/j.molimm.2015.02.030; Sakurai T, 2011, J NEUROIMMUNOL, V233, P175, DOI 10.1016/j.jneuroim.2010.11.003; TEDESCO F, 1990, CLIN EXP IMMUNOL, V80, P236; Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F; Yamada Hideto, 2012, ISRN Obstet Gynecol, V2012, P512732; Zhou Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081662	19	6	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198472	10.1371/journal.pone.0198472	http://dx.doi.org/10.1371/journal.pone.0198472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894483	Green Published, Green Submitted, gold			2022-12-26	WOS:000435030900014
J	Chen, YH; Lu, HI; Lo, CM; Wang, YM; Chou, SY; Huang, CH; Shih, LH; Chen, SW; Li, SH				Chen, Yen-Hao; Lu, Hung-, I; Lo, Chien-Ming; Wang, Yu-Ming; Chou, Shang-Yu; Huang, Cheng-Hua; Shih, Li-Hsueh; Chen, Su-Wei; Li, Shau-Hsuan			The clinical impact of supraclavicular lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy	PLOS ONE			English	Article							LONG-TERM SURVIVAL; TNM CLASSIFICATION; PROGNOSTIC-FACTORS; JUNCTIONAL CANCER; SURGERY; CHEMOTHERAPY; RESECTION; DISEASE; TRIAL	Background To evaluate the clinical significance of supraclavicular lymph node (SCLN) in patients with locally advanced esophageal squamous cell carcinoma (ESCC) receiving curative concurrent chemoradiotherapy (CCRT). Materials and methods We retrospectively analyzed all 369 locally advanced ESCC patients treated with CCRT between 2000 and 2015, including 70 patients with SCLN metastasis and 299 patients without SCLN metastasis. Results For these locally advanced ESCC patients treated with curative CCRT, NO-2 were significantly associated with superior progression-free survival (PFS) and overall survival (OS) in univariate and multivariable analyses. However, there were no significant differences in PFS and OS between the SCLN metastasis and non-SCLN metastasis groups; a subgroup analysis also revealed there was no significant differences in PFS and OS between patients with and without SCLN metastasis either in the NO-2 or in the N3 subgroup analysis. Conclusions Our study suggests that SCLN metastasis is not a prognostic factor in locally advanced ESCC patients receiving curative CCRT, and that SCLNs should be considered to be regional LNs and treated with curative intent.	[Chen, Yen-Hao; Huang, Cheng-Hua; Li, Shau-Hsuan] Kaohsiung Chang Gung Mem Hosp, Dept Hematol Oncol, Kaohsiung, Taiwan; [Chen, Yen-Hao; Lu, Hung-, I; Lo, Chien-Ming; Wang, Yu-Ming; Chou, Shang-Yu; Huang, Cheng-Hua; Li, Shau-Hsuan] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chen, Yen-Hao] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Chen, Yen-Hao] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lu, Hung-, I; Lo, Chien-Ming] Kaohsiung Chang Gung Mem Hosp, Dept Thorac & Cardiovasc Surg, Kaohsiung, Taiwan; [Wang, Yu-Ming; Chou, Shang-Yu] Kaohsiung Chang Gung Mem Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Shih, Li-Hsueh] Kaohsiung Chang Gung Mem Hosp, Dept Nursing, Kaohsiung, Taiwan; [Chen, Su-Wei] Kaohsiung Med Univ Hosp, Dept Anesthesia, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chung Shan Medical University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Li, SH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Hematol Oncol, Kaohsiung, Taiwan.; Li, SH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.	lee.a0928@msa.hinet.net		Wang, Yu-Ming/0000-0002-2441-7551	Chang Gung Memorial Hospital [CMRPG8E1533, CMRPG8G0891, CMRPG8E0592]; National Science Council [NSC 105-2314-B-182A-029, 106-2314-13-182A-159-MY3, MOST 106-2320-B-182A-015]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by Chang Gung Memorial Hospital, CMRPG8E1533 and CMRPG8G0891, Dr. Shau-Hsuan Li; National Science Council (TW), NSC 105-2314-B-182A-029, Dr. Yen-Hao Chen; Chang Gung Memorial Hospital, CMRPG8E0592, Dr. Yen-Hao Chen; National Science Council, 106-2314-13-182A-159-MY3 and MOST 106-2320-B-182A-015, Dr. Shau-Hsuan Li.	AKIYAMA H, 1994, ANN SURG, V220, P364, DOI 10.1097/00000658-199409000-00012; Bancewicz J, 2002, LANCET, V359, P1727; Burmeister BH, 2005, LANCET ONCOL, V6, P659, DOI 10.1016/S1470-2045(05)70288-6; Bus P, 2014, J SURG ONCOL, V109, P465, DOI 10.1002/jso.23513; Chen SB, 2013, J THORAC ONCOL, V8, P495, DOI 10.1097/JTO.0b013e3182829e2c; Cho WK, 2017, ONCOTARGET, V8, P3542, DOI 10.18632/oncotarget.12200; Donohoe CL, 2013, ANN SURG, V258, P784, DOI 10.1097/SLA.0b013e3182a66588; Edge SB, 2010, AJCC CANC STAGING MA; Hsu PK, 2010, ANN THORAC SURG, V89, P1024, DOI 10.1016/j.athoracsur.2010.01.017; Kelsen DP, 2007, J CLIN ONCOL, V25, P3719, DOI 10.1200/JCO.2006.10.4760; Kelsen DP, 1998, NEW ENGL J MED, V339, P1979, DOI 10.1056/NEJM199812313392704; Lee PC, 2009, ANN THORAC SURG, V88, P186, DOI 10.1016/j.athoracsur.2009.03.079; Lerut T, 2004, ANN SURG, V240, P962, DOI 10.1097/01.sla.0000145925.70409.d7; Lin CS, 2009, ANN THORAC SURG, V87, P1056, DOI 10.1016/j.athoracsur.2008.11.051; Miyata H, 2015, ANN SURG, V262, P280, DOI 10.1097/SLA.0000000000000933; National Department of Health, CANC REG ANN REP 197; Peyre CG, 2008, ANN SURG, V248, P979, DOI 10.1097/SLA.0b013e3181904f3c; Schneider PM, 2005, ANN SURG, V242, P684, DOI 10.1097/01.sla.0000186170.38348.7b; Shimada H, 2007, HEPATO-GASTROENTEROL, V54, P100; Tachimori Y, 1998, J THORAC CARDIOV SUR, V116, P954, DOI 10.1016/S0022-5223(98)70046-7; Tachimori Y, 2014, J THORAC CARDIOV SUR, V148, P1224, DOI 10.1016/j.jtcvs.2014.02.008; Talsma K, 2012, ANN SURG ONCOL, V19, P2142, DOI 10.1245/s10434-012-2218-5; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Xing J, 2016, ONCOTARGETS THER, V9, P5803, DOI 10.2147/OTT.S111800; Yamasaki M, 2014, ANN SURG ONCOL, V21, P2850, DOI 10.1245/s10434-014-3696-4; Zhang HD, 2016, ONCOTARGET, V7, P66623, DOI 10.18632/oncotarget.11286; Zheng YZ, 2017, ONCOTARGET, V8, P41563, DOI 10.18632/oncotarget.14892	28	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198800	10.1371/journal.pone.0198800	http://dx.doi.org/10.1371/journal.pone.0198800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889869	Green Published, Green Submitted, gold			2022-12-26	WOS:000434786600049
J	Federico, L; Yang, LP; Brandon, J; Panchatcharam, M; Ren, HM; Mueller, P; Sunkara, M; Escalante-Alcalde, D; Morris, AJ; Smyth, SS				Federico, Lorenzo; Yang, Liping; Brandon, Jason; Panchatcharam, Manikandan; Ren, Hongmei; Mueller, Paul; Sunkara, Manjula; Escalante-Alcalde, Diana; Morris, Andrew J.; Smyth, Susan S.			Lipid phosphate phosphatase 3 regulates adipocyte sphingolipid synthesis, but not developmental adipogenesis or diet-induced obesity in mice	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID PRODUCTION; SACCHAROMYCES-CEREVISIAE; INSULIN-RESISTANCE; METABOLISM; AUTOTAXIN; ADIPOSE; DIFFERENTIATION; LIPODYSTROPHY; INVOLVEMENT; EXPRESSION	Dephosphorylation of phosphatidic acid (PA) is the penultimate step in triglyceride synthesis. Adipocytes express soluble intracellular PA-specific phosphatases (Lipins) and broader specificity membrane-associated lipid phosphate phosphatases (LPPs) that can also dephosphorylate PA. Inactivation of lipin1 causes lipodystrophy in mice due to defective developmental adipogenesis. Triglyceride synthesis is diminished but not ablated by inactivation of lipin1 in differentiated adipocytes implicating other PA phosphatases in this process. To investigate the possible role of LPPs in adipocyte lipid metabolism and signaling we made mice with adipocyte-targeted inactivation of LPP3 encoded by the PIpp3(Ppap2b) gene. Adipocyte LPP3 deficiency resulted in blunted ceramide and sphingomyelin accumulation during diet-induced adipose tissue expansion, accumulation of the LPP3 substrate sphingosine 1-phosphate, and reduced expression of serine palmitoyl transferase. However, adiposity was unaffected by LPP3 deficiency on standard, high fat diet or Western diets, although Western diet-fed mice with adipocyte LPP3 deficiency exhibited improved glucose tolerance. Our results demonstrate functional compartmentalization of lipid phosphatase activity in adipocytes and identify an unexpected role for LPP3 in the regulation of diet-dependent sphingolipid synthesis that may impact on insulin signaling.	[Federico, Lorenzo; Yang, Liping; Brandon, Jason; Panchatcharam, Manikandan; Ren, Hongmei; Mueller, Paul; Sunkara, Manjula; Morris, Andrew J.; Smyth, Susan S.] Univ Kentucky, Div Cardiovasc Med, Gill Heart & Vasc Inst, Lexington, KY 40506 USA; [Escalante-Alcalde, Diana] Univ Nacl Autonoma Mexico, Div Neurociencias, Inst Fisiol Celular, Ciudad De Mexico, Cdmx, Mexico; [Morris, Andrew J.; Smyth, Susan S.] Dept Vet Affairs Med Ctr, Lexington, KY 40502 USA	University of Kentucky; Universidad Nacional Autonoma de Mexico; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Smyth, SS (corresponding author), Univ Kentucky, Div Cardiovasc Med, Gill Heart & Vasc Inst, Lexington, KY 40506 USA.; Smyth, SS (corresponding author), Dept Vet Affairs Med Ctr, Lexington, KY 40502 USA.	SusanSmyth@uky.edu	sunkara, Manjula/H-7944-2016; Mueller, Paul/ABF-5278-2021	sunkara, Manjula/0000-0001-6151-1929; Mueller, Paul/0000-0001-9315-0152; Panchatcharam, Manikandan/0000-0002-7691-8948; Escalante-Alcalde, Diana/0000-0003-0325-6602	NIH by the National Institutes of Heart Lung and Blood [R01HL120507]; U.S. Department of Veterans Affairs [210CX001550]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021753] Funding Source: NIH RePORTER; Veterans Affairs [I01CX001550, IS1BX003153] Funding Source: NIH RePORTER	NIH by the National Institutes of Heart Lung and Blood; U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH R01HL120507 to SSS and AJM by the National Institutes of Heart Lung and Blood and the U.S. Department of Veterans Affairs Award 210CX001550 to AJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Breart B, 2011, J EXP MED, V208, P1267, DOI 10.1084/jem.20102551; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Deevska G, 2014, J LIPID RES, V55, P2041, DOI 10.1194/jlr.M048223; Deevska GM, 2012, BIOSCIENCE REP, V32, P479, DOI 10.1042/BSR20120036; Dusaulcy R, 2011, J LIPID RES, V52, P1247, DOI 10.1194/jlr.M014985; Dwyer JR, 2012, P NATL ACAD SCI USA, V109, pE2486, DOI 10.1073/pnas.1205221109; Escalante-Alcalde D, 2003, DEVELOPMENT, V130, P4623, DOI 10.1242/dev.00635; Escalante-Alcalde D, 2007, GENESIS, V45, P465, DOI 10.1002/dvg.20314; Federico L, 2012, MOL ENDOCRINOL, V26, P786, DOI 10.1210/me.2011-1229; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Gellett AM, 2012, BIOCHEM BIOPH RES CO, V422, P758, DOI 10.1016/j.bbrc.2012.05.077; Gesta S, 2002, J LIPID RES, V43, P904; Ile KE, 2013, FLY, V7, DOI 10.4161/fly.22938; Kang S, 2005, MOL CELL BIOL, V25, P1272, DOI 10.1128/MCB.25.4.1272-1282.2005; Kim C, 2013, STEM CELLS, V31, P500, DOI 10.1002/stem.1291; Lopez-Juarez A, 2011, GLIA, V59, P577, DOI 10.1002/glia.21126; Mendoza A, 2012, CELL REP, V2, P1104, DOI 10.1016/j.celrep.2012.09.021; Mitra MS, 2013, P NATL ACAD SCI USA, V110, P642, DOI 10.1073/pnas.1213493110; Morris A. J., 2013, LYSOPHOSPHOLIPID REC, P229, DOI [10.1002/9781118531426.ch12, DOI 10.1002/9781118531426.CH12]; Nadra K, 2012, MOL CELL BIOL, V32, P4794, DOI 10.1128/MCB.00512-12; Panchatcharam M, 2013, ARTERIOSCL THROM VAS, V33, P52, DOI 10.1161/ATVBAHA.112.300527; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Rancoule C, 2014, BIOCHIMIE, V96, P140, DOI 10.1016/j.biochi.2013.04.010; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Selim S, 2011, CLIN SCI, V121, P565, DOI 10.1042/CS20110236; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; Simon MF, 2002, J BIOL CHEM, V277, P23131, DOI 10.1074/jbc.M201530200; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; Tigyi G, 2013, BBA-MOL CELL BIOL L, V1831, P1, DOI 10.1016/j.bbalip.2012.09.011; Tomsig JL, 2009, BIOCHEM J, V419, P611, DOI 10.1042/BJ20081888; Venkatraman G, 2013, LIPID PHOSPHATE PHOS, P201; Yanovski SZ, 2011, NEW ENGL J MED, V364, P987, DOI 10.1056/NEJMp1009229; Zhang N, 2000, GENESIS, V27, P137, DOI 10.1002/1526-968X(200008)27:4<137::AID-GENE10>3.0.CO;2-4	41	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198063	10.1371/journal.pone.0198063	http://dx.doi.org/10.1371/journal.pone.0198063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889835	Green Submitted, Green Published, gold			2022-12-26	WOS:000434786600014
J	Messaritakis, I; Stogiannitsi, M; Koulouridi, A; Sfakianaki, M; Voutsina, A; Sotiriou, A; Athanasakis, E; Xynos, E; Mavroudis, D; Tzardi, M; Souglakos, J				Messaritakis, Ippokratis; Stogiannitsi, Maria; Koulouridi, Asimina; Sfakianaki, Maria; Voutsina, Alexandra; Sotiriou, Afroditi; Athanasakis, Elias; Xynos, Evangelos; Mavroudis, Dimitris; Tzardi, Maria; Souglakos, John			Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer	PLOS ONE			English	Article							GASTRIC-CANCER; ULCERATIVE-COLITIS; THR399ILE POLYMORPHISMS; GENE POLYMORPHISMS; CROHNS-DISEASE; EXPRESSION; RISK; SUSCEPTIBILITY; ASSOCIATION; CELLS	Background Toll-like receptors (TLRs) play essential role in innate and acquired immunity, are expressed in various cell types, and are associated with altered susceptibility to many diseases, and cancers. The aim of this study was to investigate TLR2 (-196 to-174del), TLR4 (Asp299Gly and Thr399Ile) and TLR9 (T1237C and T1486C) gene polymorphisms at risk of colorectal cancer (CRC) development and progression. Methods Peripheral blood was obtained from 397 patients with adjuvant (stage II/III, n = 202) and metastatic (n = 195) CRC. Moreover, blood samples from 50 healthy volunteers and 40 patients with adenomatous polyps were also included as control groups. DNA from patients and controls was analyzed using PCR and PCR-RFLP for genotyping functional polymorphism within TLR2, TLR4 and TLR9 genotypes. Results TLR2 - 196 to-174del/del genotype was detected in 76.6% of the patients and was significantly higher that the controls groups (p<0.001). TLR4 Asp299Gly, TLR4 Thr399Ile, TLR9 T1237C and T1486C homozygous genotypes were detected in 70.5%, 70.5%, 61.5% and 61.5% of the patients respectively, and were also significantly higher than that in the control groups (p<0.001). All polymorphisms detected were also significantly associated with the metastatic disease (p<0.001) leading to shorter overall survival (p<0.001); whereas, TLR4 Asp299Gly and Thr399Ile polymorphisms were significantly associated with KRAS mutations. Conclusions The detection of higher frequencies of the TLR2, TLR4 and/or TLR9 polymorphisms in CRC patients compared with the control groups highlight the role of these polymorphism in CRC development and cancer progression.	[Messaritakis, Ippokratis; Stogiannitsi, Maria; Koulouridi, Asimina; Sfakianaki, Maria; Voutsina, Alexandra; Sotiriou, Afroditi; Mavroudis, Dimitris; Souglakos, John] Univ Crete, Med Sch, Lab Translat Oncol, Iraklion, Crete, Greece; [Koulouridi, Asimina] Venizeleio Pananeio Gen Hosp, Dept Internal Med B, Iraklion, Crete, Greece; [Athanasakis, Elias] Heraklion Univ Hosp, Dept Gen Surg, Iraklion, Crete, Greece; [Xynos, Evangelos] Crete Interclin Hosp Heraklion, Iraklion, Greece; [Mavroudis, Dimitris; Souglakos, John] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece; [Tzardi, Maria] Univ Gen Hosp Heraklion, Lab Pathol, Iraklion, Greece	University of Crete; University Hospital of Heraklion; University Hospital of Heraklion; University Hospital of Heraklion	Souglakos, J (corresponding author), Univ Crete, Med Sch, Lab Translat Oncol, Iraklion, Crete, Greece.; Souglakos, J (corresponding author), Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece.	oncsec@uoc.gr	Messaritakis, Ippokratis/H-6668-2019	Sotiriou, Afroditi I/0000-0002-4534-7185; Messaritakis, Ippokratis/0000-0003-1877-500X; Athanasakis, Elias/0000-0002-5508-4251	Hellenic Society of Medical Oncology (HeSMO); Gastrointestinal Cancer Study Group (GIC-SG)	Hellenic Society of Medical Oncology (HeSMO); Gastrointestinal Cancer Study Group (GIC-SG)	This work was fully supported by research grants from the Hellenic Society of Medical Oncology (HeSMO; https://www.hesmo.gr/en/) and the Gastrointestinal Cancer Study Group (GIC-SG; https://www.emkapes.gr/?lang=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Belmont L, 2014, INT J CANCER, V134, P765, DOI 10.1002/ijc.28413; Brand S, 2005, INFLAMM BOWEL DIS, V11, P645, DOI 10.1097/01.MIB.0000168372.94907.d2; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Davoodi H, 2011, IRAN J ALLERGY ASTHM, V10, P91, DOI 010.02/ijaai.9199; de Oliveira JG, 2012, WORLD J GASTROENTERO, V18, P1235, DOI 10.3748/wjg.v18.i11.1235; Fan YJ, 2015, EXP THER MED, V9, P1455, DOI 10.3892/etm.2015.2258; Garza-Gonzalez E, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-70; Gatti G, 2009, PROSTATE, V69, P1387, DOI 10.1002/pros.20984; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Gunter MJ, 2006, CANCER RES, V66, P2483, DOI 10.1158/0008-5472.CAN-05-3631; Harsch M, 2001, AM J PATHOL, V158, P1985, DOI 10.1016/S0002-9440(10)64669-X; Hishida A, 2010, GASTRIC CANCER, V13, P251, DOI 10.1007/s10120-010-0567-y; Holldack J, 2014, DRUG DISCOV TODAY, V19, P379, DOI 10.1016/j.drudis.2013.08.020; Jing JJ, 2012, GENE, V499, P237, DOI 10.1016/j.gene.2012.03.045; Kinugasa T, 2016, WORLD J GASTRO ONCOL, V8, P351, DOI 10.4251/wjgo.v8.i4.351; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Lammers KM, 2005, WORLD J GASTROENTERO, V11, P7323, DOI 10.3748/wjg.v11.i46.7323; Liu SZ, 2015, SAUDI J GASTROENTERO, V21, P95, DOI 10.4103/1319-3767.153832; Lorenz E, 2001, BIOTECHNIQUES, V31, P22, DOI 10.2144/01311bm01; Lowe EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013027; Makni L, 2017, TURK J MED SCI, V47, P1216, DOI 10.3906/sag-1608-17; Medvedev AE, 2013, J INTERF CYTOK RES, V33, P467, DOI 10.1089/jir.2012.0140; Ng MW, 2005, RHEUMATOLOGY, V44, P1456, DOI 10.1093/rheumatology/kei120; Niedzielska I, 2009, J PHYSIOL PHARMACOL, V60, P65; Nihon-Yanagi Y, 2012, CANCER IMMUNOL IMMUN, V61, P71, DOI 10.1007/s00262-011-1085-4; Noguchi E, 2004, CLIN EXP ALLERGY, V34, P177, DOI 10.1111/j.1365-2222.2004.01839.x; Oostenbrug LE, 2005, INFLAMM BOWEL DIS, V11, P567, DOI 10.1097/01.MIB.0000161305.81198.0f; Pandey S, 2006, IMMUNOL CELL BIOL, V84, P333, DOI 10.1111/j.1440-1711.2006.01444.x; Pradere JP, 2014, ONCOGENE, V33, P3485, DOI 10.1038/onc.2013.302; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Priyadarshini Anjali, 2013, Indian J Urol, V29, P37, DOI 10.4103/0970-1591.109982; Rahman AH, 2009, IMMUNOL RES, V45, P25, DOI 10.1007/s12026-009-8113-x; Rosa R, 2011, CLIN CANCER RES, V17, P6531, DOI 10.1158/1078-0432.CCR-10-3376; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Sanchez-Munoz F, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-138; Semlali A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146333; Shen XY, 2010, DIGESTION, V81, P69, DOI 10.1159/000260417; Sheng WY, 2015, ARCH MED SCI, V11, P699, DOI 10.5114/aoms.2015.53288; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Slattery ML, 2012, INT J CANCER, V130, P2974, DOI 10.1002/ijc.26314; Sommariva M, 2011, CANCER RES, V71, P6382, DOI 10.1158/0008-5472.CAN-11-1285; Tahara T, 2007, CANCER SCI, V98, P1790, DOI 10.1111/j.1349-7006.2007.00590.x; Tannock GW, 2008, MUCOSAL IMMUNOL, V1, pS15, DOI 10.1038/mi.2008.54; Torok P, 2009, AM J GASTROENTEROL, V104, P1723, DOI 10.1038/ajg.2009.184; Trejo-de la O A, 2008, CLIN IMMUNOL, V129, P333, DOI 10.1016/j.clim.2008.07.009; Wang EL, 2010, BRIT J CANCER, V102, P908, DOI 10.1038/sj.bjc.6605558; Yu L, 2008, CANCER IMMUNOL IMMUN, V57, P1271, DOI 10.1007/s00262-008-0459-8	49	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0197327	10.1371/journal.pone.0197327	http://dx.doi.org/10.1371/journal.pone.0197327			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883450	Green Submitted, Green Published, gold			2022-12-26	WOS:000434728100004
J	Chat-Uthai, N; Vejvisithsakul, P; Udommethapom, S; Meesiri, P; Danthanawanit, C; Wongchai, Y; Teerapakpinyo, C; Shuangshoti, S; Poungvarin, N				Chat-Uthai, Nunthawut; Vejvisithsakul, Pichpisith; Udommethapom, Sutthirat; Meesiri, Puttarakun; Danthanawanit, Chetiya; Wongchai, Yannawan; Teerapakpinyo, Chinachote; Shuangshoti, Shanop; Poungvarin, Naravat			Development of ultra-short PCR assay to reveal BRAF V600 mutation status in Thai colorectal cancer tissues	PLOS ONE			English	Article							RESOLUTION MELTING ANALYSIS; REAL-TIME PCR; MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; FORMALIN-FIXED TISSUES; PIK3CA MUTATIONS; CHINESE PATIENTS; VE1 ANTIBODY; K-RAS; DNA; MELANOMA	The protein kinase BRAF is one of the key players in regulating cellular responses to extra cellular signals. Somatic mutations of the BRAF gene, causing constitutive activation of BRAF, have been found in various types of human cancers such as malignant melanoma, and colorectal cancer. BRAF V600E and V600K, most commonly observed mutations in these cancers, may predict response to targeted therapies. Many techniques suffer from a lack of diagnostic sensitivity in mutation analysis in clinical samples with a low cancer cell percentage or poor-quality fragmented DNA. Here we present allele-specific real-time PCR assay for amplifying 35- to 45-base target sequences in BRAF gene. Forward primer designed for BRAF V600E detection is capable of recognizing both types of BRAF V600E mutation, i.e. V600E1 (c.1799T>A) and V600E2 (c.1799_1800deITGinsAA), as well as complex tandem mutation caused by nucleotide changes in codons 600 and 601. We utilized this assay to analyze Thai formalin-fixed paraffin-embedded tissues. Forty-eight percent of 178 Thai colorectal cancer tissues has KRAS mutation detected by highly sensitive commercial assays. Although these DNA samples contain low overall yield of amplifiable DNA, our newly-developed assay successfully revealed BRAF V600 mutations in 6 of 93 formalin-fixed paraffin-embedded colorectal cancer tissues which KRAS mutation was not detected. Ultra-short PCR assay with forward mutation-specific primers is potentially useful to detect BRAF V600 mutations in highly fragmented DNA specimens from cancer patients.	[Chat-Uthai, Nunthawut; Vejvisithsakul, Pichpisith; Wongchai, Yannawan] Mahidol Univ, Fac Med, Siriraj Hosp, Res Div, Bangkok, Thailand; [Udommethapom, Sutthirat; Meesiri, Puttarakun; Danthanawanit, Chetiya; Poungvarin, Naravat] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Clin Pathol,Clin Mol Pathol Lab, Bangkok, Thailand; [Teerapakpinyo, Chinachote; Shuangshoti, Shanop] Chulalongkorn Univ, Chulalongkorn GenePRO Ctr, Res Affairs, Fac Med, Bangkok, Thailand; [Shuangshoti, Shanop] Chulalongkorn Univ, Fac Med, Dept Pathol, Bangkok, Thailand	Mahidol University; Mahidol University; Chulalongkorn University; Chulalongkorn University	Poungvarin, N (corresponding author), Mahidol Univ, Fac Med, Siriraj Hosp, Dept Clin Pathol,Clin Mol Pathol Lab, Bangkok, Thailand.	naravat.pou@mahidol.ac.th		Vejvisithsakul, Pichpisith Pierre/0000-0001-7745-9854; Poungvarin, Naravat/0000-0002-5608-5803	Health Systems Research Institute (HSRI) [HSRI 58-043]; National Research Council of Thailand (NRCT)	Health Systems Research Institute (HSRI); National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT))	The work was supported by the grant HSRI 58-043 funded by the Health Systems Research Institute (HSRI) (https://www.hsri.or.th) and National Research Council of Thailand (NRCT) (http://www.nrct.go.th) to NP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S, 2012, ARCH PATHOL LAB MED, V136, P1385, DOI 10.5858/arpa.2011-0505-OA; Ascierto PA, 2016, LANCET ONCOL, V17, P1248, DOI 10.1016/S1470-2045(16)30122-X; Ballantyne AD, 2013, DRUGS, V73, P1367, DOI 10.1007/s40265-013-0095-2; Bonin S, 2003, J CLIN PATHOL-MOL PA, V56, P184, DOI 10.1136/mp.56.3.184; Brownie J, 1997, NUCLEIC ACIDS RES, V25, P3235, DOI 10.1093/nar/25.16.3235; Cantwell-Dorris ER, 2011, MOL CANCER THER, V10, P385, DOI 10.1158/1535-7163.MCT-10-0799; Capper D, 2012, ACTA NEUROPATHOL, V123, P223, DOI 10.1007/s00401-011-0887-y; Capper D, 2011, ACTA NEUROPATHOL, V122, P11, DOI 10.1007/s00401-011-0841-z; Carter J, 2015, AM J CLIN PATHOL, V144, P620, DOI 10.1309/AJCP85ATMJOZOUDJ; Chaiyapan W, 2013, ASIAN PAC J CANCER P, V14, P329, DOI 10.7314/APJCP.2013.14.1.329; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Didelot A, 2013, CLIN CHEM, V59, P815, DOI 10.1373/clinchem.2012.193409; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Eckhart L, 2000, BIOCHEM BIOPH RES CO, V271, P726, DOI 10.1006/bbrc.2000.2716; Garnock-Jones KP, 2015, DRUGS, V75, P1645, DOI 10.1007/s40265-015-0463-1; Gautschi O, 2012, J THORAC ONCOL, V7, pE23, DOI 10.1097/JTO.0b013e3182629903; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0; Gonzalez-Cao M, 2015, MELANOMA RES, V25, P486, DOI 10.1097/CMR.0000000000000187; Halait H, 2012, DIAGN MOL PATHOL, V21, P1, DOI 10.1097/PDM.0b013e31823b216f; Hanna MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074950; Heinzerling L, 2013, BRIT J CANCER, V108, P2164, DOI 10.1038/bjc.2013.143; Hofman V, 2013, J INVEST DERMATOL, V133, P1378, DOI 10.1038/jid.2012.485; Hsieh LL, 2012, CLIN CHIM ACTA, V413, P1605, DOI 10.1016/j.cca.2012.04.029; Ihle MA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-13; Jarry A, 2004, MOL CELL PROBE, V18, P349, DOI 10.1016/j.mcp.2004.05.004; Jayasekara H, 2017, INT J CANCER, V140, P1485, DOI 10.1002/ijc.30568; Jeong D, 2012, KOREAN J PATHOL, V46, P61, DOI 10.4132/KoreanJPathol.2012.46.1.61; Jones RT, 2015, MODERN PATHOL, V28, P596, DOI 10.1038/modpathol.2014.150; Keating GM, 2016, DRUGS, V76, P605, DOI 10.1007/s40265-016-0562-7; Kim B, 2014, WORLD J GASTROENTERO, V20, P4370, DOI 10.3748/wjg.v20.i15.4370; Korphaisarn K, 2015, WORLD J GASTROENTERO, V21, P926, DOI 10.3748/wjg.v21.i3.926; Lade-Keller J, 2013, J MOL DIAGN, V15, P70, DOI 10.1016/j.jmoldx.2012.08.003; Lee SR, 2015, AM J CLIN PATHOL, V143, P437, DOI 10.1309/AJCPOBI5CUZIBMO1; Leelatian N, 2014, EXP MOL PATHOL, V96, P85, DOI 10.1016/j.yexmp.2013.12.006; Li WB, 2015, ONCOTARGET, V6, P39607, DOI 10.18632/oncotarget.5551; Lopez-Rios F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053733; Ma BB, 2015, ASIA-PAC J CLIN ONCO, V11, P160, DOI 10.1111/ajco.12342; Matsubayashi H, 1998, J GASTROENTEROL, V33, P662; McArthur GA, 2014, LANCET ONCOL, V15, P323, DOI 10.1016/S1470-2045(14)70012-9; Molina-Vila MA, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.11.23; Naguib A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-99; Nakanishi R, 2013, INT J CLIN ONCOL, V18, P1042, DOI 10.1007/s10147-012-0501-x; Ogino S, 2018, GUT; Ogino S, 2012, CLIN CANCER RES, V18, P890, DOI 10.1158/1078-0432.CCR-11-2246; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Pichler M, 2009, J MOL DIAGN, V11, P140, DOI 10.2353/jmoldx.2009.080100; Pinzani P, 2010, CLIN CHIM ACTA, V411, P1319, DOI 10.1016/j.cca.2010.05.024; Planchard D, 2016, LANCET ONCOL, V17, P642, DOI 10.1016/S1470-2045(16)00077-2; Richter A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01659; Ritterhouse LL, 2015, SEMIN DIAGN PATHOL, V32, P400, DOI 10.1053/j.semdp.2015.02.010; Sahadudheen K, 2016, CASE REP ONCOL MED, V2016, DOI 10.1155/2016/2672671; Seekhuntod S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147672; Sinicrope FA, 2015, GASTROENTEROLOGY, V148, P88, DOI 10.1053/j.gastro.2014.09.041; Skorokhod A, 2012, J AM ACAD DERMATOL, V67, P488, DOI 10.1016/j.jaad.2012.03.022; Teerapakpinyo C, 2015, ASIAN BIOMED, V9, P61, DOI 10.5372/1905-7415.0901.369; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Whitcombe D, 1998, CLIN CHEM, V44, P918; Wright CJM, 2013, DRUGS, V73, P1245, DOI 10.1007/s40265-013-0096-1	61	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198795	10.1371/journal.pone.0198795	http://dx.doi.org/10.1371/journal.pone.0198795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879227	Green Published, Green Submitted, gold			2022-12-26	WOS:000434384900082
J	Nonaka, L; Yamamoto, T; Maruyama, F; Hirose, Y; Onishi, Y; Kobayashi, T; Suzuki, S; Nomura, N; Masuda, M; Yano, H				Nonaka, Lisa; Yamamoto, Tatsuya; Maruyama, Fumito; Hirose, Yuu; Onishi, Yuki; Kobayashi, Takeshi; Suzuki, Satoru; Nomura, Nobuhiko; Masuda, Michiaki; Yano, Hirokazu			Interplay of a non-conjugative integrative element and a conjugative plasmid in the spread of antibiotic resistance via suicidal plasmid transfer from an aquaculture Vibrio isolate	PLOS ONE			English	Article							CHROMOSOMAL INSERTION; COMPARATIVE GENOMICS; GENES; STRAIN; SITE; DIVERSITY; EXCISION; SEAWATER; NIGRIPULCHRITUDO; RECOMBINATION	The capture of antimicrobial resistance genes (ARGs) by mobile genetic elements (MGEs) plays a critical role in resistance acquisition for human-associated bacteria. Although aqua culture environments are recognized as important reservoirs of ARGs, intra-and intercellular mobility of MGEs discovered in marine organisms is poorly characterized. Here, we show a new pattern of interspecies ARGs transfer involving a 'non-conjugative' integrative element. To identify active MGEs in a Vibrio ponticus isolate, we conducted whole-genome sequencing of a transconjugant obtained by mating between Escherichia coli and Vibrio ponticus. This revealed integration of a plasmid (designated pSEA1) into the chromosome, consisting of a self-transmissible plasmid backbone of the MOBH group, ARGs, and a 13.8-kb integrative element Tn 6283. Molecular genetics analysis suggested a two-step gene transfer model. First, Tn 6283 integrates into the recipient chromosome during suicidal plasmid transfer, followed by homologous recombination between the Tn6283copy in the chromosome and that in the newly transferred pSEA1. Tn 6283 is unusual among integrative elements in that it apparently does not encode transfer function and its excision barely generates unoccupied donor sites. Thus, its movement is analogous to the transposition of insertion sequences rather than to that of canonical integrative and conjugative elements. Overall, this study reveals the presence of a previously unrecognized type of MGE in a marine organism, highlighting diversity in the mode of interspecies gene transfer.	[Nonaka, Lisa; Masuda, Michiaki] Dokkyo Med Univ, Dept Microbiol, Sch Med, Mibu, Tochigi, Japan; [Yamamoto, Tatsuya; Nomura, Nobuhiko; Yano, Hirokazu] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Maruyama, Fumito] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Hirose, Yuu] Toyohashi Univ Technol, Dept Environm & Life Sci, Tempaku Ku, Toyohashi, Aichi, Japan; [Onishi, Yuki; Suzuki, Satoru] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime, Japan; [Kobayashi, Takeshi] Ehime Univ, Grad Sch Med, To On, Ehime, Japan; [Yano, Hirokazu] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi, Japan	Dokkyo Medical University; University of Tsukuba; Kyoto University; Toyohashi University of Technology; Ehime University; Ehime University; Tohoku University	Nonaka, L (corresponding author), Dokkyo Med Univ, Dept Microbiol, Sch Med, Mibu, Tochigi, Japan.; Yano, H (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.; Yano, H (corresponding author), Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi, Japan.	nonaka@dokkyomed.ac.jp; yano.hirokazu@ige.tohoku.ac.jp	Maruyama, Fumito/AAK-5928-2020; Yano, Hirokazu/O-7933-2015; Nomura, Nobuhiko/AAR-1915-2021	Maruyama, Fumito/0000-0003-2347-616X; Yano, Hirokazu/0000-0001-5144-3459; Nomura, Nobuhiko/0000-0003-1103-9157	JSPS KAKENHI [JP15K07531, JP18K05790, JP16H01782]; Fundamental Research Developing Association for Shipbuilding and Offshore; Japan Prize Foundation; Japan Science and Technology Agency ERATO [JPMJER1502]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Fundamental Research Developing Association for Shipbuilding and Offshore; Japan Prize Foundation(Japan Prize Foundation); Japan Science and Technology Agency ERATO	This research was supported by JSPS (https://www.jsps.go.jp/english/index.html) KAKENHI grant number JP15K07531 (LN), JP18K05790 (LN), JP16H01782 (SS), and funds from Fundamental Research Developing Association for Shipbuilding and Offshore (https://www.sajn.or.jp/redas/) to LN, The Japan Prize Foundation (http://www.japanprize.jp/en/) to LN. This research was also supported by Japan Science and Technology Agency ERATO (http://www.jst.go.jp/erato/)project number JPMJER1502 (NN, TY, HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BENDER J, 1991, GENETICS, V128, P687; BRETON AM, 1985, J BACTERIOL, V161, P523, DOI 10.1128/JB.161.2.523-528.1985; Burrus V, 2003, J BACTERIOL, V185, P5045, DOI 10.1128/JB.185.17.5045-5054.2003; Cabello FC, 2013, ENVIRON MICROBIOL, V15, P1917, DOI 10.1111/1462-2920.12134; CAMPBELL AM, 1992, J BACTERIOL, V174, P7495, DOI 10.1128/JB.174.23.7495-7499.1992; CAPARON MG, 1989, CELL, V59, P1027, DOI 10.1016/0092-8674(89)90759-9; Carraro Nicolas, 2017, Mob Genet Elements, V7, P1, DOI 10.1080/2159256X.2017.1304193; Carraro N, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0008-2014; Chandler M, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0031-2014; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng Y, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0100-6; FOSTER TJ, 1981, CELL, V23, P215, DOI 10.1016/0092-8674(81)90286-5; Fricke WF, 2009, J BACTERIOL, V191, P4750, DOI 10.1128/JB.00189-09; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Ghinet MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027846; Ghosh S, 2005, CURR MICROBIOL, V50, P28, DOI 10.1007/s00284-004-4370-z; Goudenege D, 2013, ISME J, V7, P1985, DOI 10.1038/ismej.2013.90; HAGEMANN AT, 1993, GENETICS, V133, P9; Harrison Ellie, 2016, Mob Genet Elements, V6, pe1179074, DOI 10.1080/2159256X.2016.1179074; Hochhut B, 1999, MOL MICROBIOL, V32, P99, DOI 10.1046/j.1365-2958.1999.01330.x; INAGAKI K, 1993, BIOSCI BIOTECH BIOCH, V57, P1770, DOI 10.1271/bbb.57.1770; Jeong W, 2000, J BIOL CHEM, V275, P2924, DOI 10.1074/jbc.275.4.2924; Johnson CM, 2015, ANNU REV GENET, V49, P577, DOI 10.1146/annurev-genet-112414-055018; Johnson Timothy J, 2012, Mob Genet Elements, V2, P55; Juiz-Rio S, 2005, MICROBIOL-SGM, V151, P2659, DOI 10.1099/mic.0.27891-0; Kahm M, 2010, J STAT SOFTW, V33, P1; Kim SR, 2004, FEMS MICROBIOL LETT, V237, P147, DOI [10.1016/j.femsle.2004.06.026, 10.1111/j.1574-6968.2004.tb09690.x]; Landy A, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0051-2014; Le Roux F, 2011, ENVIRON MICROBIOL, V13, P296, DOI 10.1111/j.1462-2920.2010.02329.x; Lee CA, 2007, MOL MICROBIOL, V66, P1356, DOI 10.1111/j.1365-2958.2007.06000.x; Lee C, 2008, APPL MICROBIOL BIOT, V78, P371, DOI 10.1007/s00253-007-1300-6; Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149; Marra D, 1999, MOL MICROBIOL, V31, P609, DOI 10.1046/j.1365-2958.1999.01201.x; Martinez JL, 2015, NAT REV MICROBIOL, V13, P116, DOI 10.1038/nrmicro3399; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Morii H, 2004, J AQUAT ANIM HEALTH, V16, P197, DOI 10.1577/H03-059.1; Nicolas E, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0060-2014; Nikolakopoulou TL, 2008, J MICROBIOL, V46, P633, DOI 10.1007/s12275-008-0080-8; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Nonaka L, 2015, LETT APPL MICROBIOL, V61, P1, DOI 10.1111/lam.12414; Nonaka L, 2007, MICROBES ENVIRON, V22, P355, DOI 10.1264/jsme2.22.355; Nonaka L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00152; Nonaka L, 2012, MICROBES ENVIRON, V27, P263, DOI 10.1264/jsme2.ME11338; OHTSUBO E, 1980, COLD SPRING HARB SYM, V45, P283, DOI 10.1101/SQB.1981.045.01.041; Ohtsubo Y, 2012, J BACTERIOL, V194, P4237, DOI 10.1128/JB.00352-12; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Pitkanen LK, 2011, MICROBES ENVIRON, V26, P205, DOI 10.1264/jsme2.ME11119; Poele EMT, 2008, ANTON LEEUW INT J G, V94, P127, DOI 10.1007/s10482-008-9255-x; Rajeev L, 2009, MICROBIOL MOL BIOL R, V73, P300, DOI 10.1128/MMBR.00038-08; Rapa RA, 2015, ENVIRON MICROBIOL, V17, P1090, DOI 10.1111/1462-2920.12512; Ravatn R, 1998, J BACTERIOL, V180, P5505, DOI 10.1128/JB.180.21.5505-5514.1998; Reith ME, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-427; Roberts AP, 2011, FEMS MICROBIOL REV, V35, P856, DOI 10.1111/j.1574-6976.2011.00283.x; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Rodriguez-Blanco A, 2012, ANTIMICROB AGENTS CH, V56, P2619, DOI 10.1128/AAC.05997-11; Saltikov CW, 2003, APPL ENVIRON MICROB, V69, P2800, DOI 10.1128/AEM.69.5.2800-2809.2003; Schwarz S, 2004, FEMS MICROBIOL REV, V28, P519, DOI 10.1016/j.femsre.2004.04.001; Skold O, 2001, VET RES, V32, P261, DOI 10.1051/vetres:2001123; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Song YZ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-214; Sugimoto Y, 2017, J GLOB ANTIMICROB RE, V10, P47, DOI 10.1016/j.jgar.2017.03.015; Van Duyne GD, 2005, CURR BIOL, V15, pR658, DOI 10.1016/j.cub.2005.08.031; Watts JEM, 2017, MAR DRUGS, V15, DOI 10.3390/md15060158; Wood MM, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0020-2014; World Health Organization; Food and Agriculture Organization of the United Nations; International Office of Epizootics, 2006, REP JOINT FAO OIE WH; Yano H, 2016, MOL MICROBIOL, V101, P743, DOI 10.1111/mmi.13407	68	3	4	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198613	10.1371/journal.pone.0198613	http://dx.doi.org/10.1371/journal.pone.0198613			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879198	Green Published, Green Submitted, gold			2022-12-26	WOS:000434384900060
J	Park, J; Soh, DH; Singh, D; Lee, S; Lee, JS; Lee, CH				Park, Jinyong; Soh, Dong Ho; Singh, Digar; Lee, Sarah; Lee, Jong Seok; Lee, Choong Hwan			Systematic metabolic profiling and bioactivity assays for bioconversion of Aceraceae family	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; ANTIOXIDANT ACTIVITY; ASPERGILLUS-ORYZAE; SECONDARY METABOLITES; FERMENTATION; MS/MS; BIOTRANSFORMATION; IDENTIFICATION; EXTRACTION; COMPONENTS	Plants are an important and inexhaustible source of bioactive molecules in food, medicine, agriculture, and industry. In this study, we performed systematic liquid chromatography mass spectrometry (LC-MS)-based metabolic profiling coupled with antioxidant assays for indigenous plant family extracts. Partial least-squares discriminant analysis of LC-MS data sets for the extracts of 34 plant species belonging to the families Aceraceae, Asteraceae, and Rosaceae showed that these species were clustered according to their respective phylogenies. In particular, seven Aceraceae species were clearly demarcated with higher average antioxidant activities, rationalizing their application for bioconversion studies. On the basis of further evaluation of the interspecies variability of metabolic profiles and antioxidant activities among Aceraceae family plants, we found that Acer tataricum (TA) extracts were clearly distinguished from those of other species, with a higher relative abundance of tannin derivatives. Further, we detected a strong positive correlation between most tannin derivatives and the observed higher antioxidant activities. Following Aspergillus oryzae-mediated fermentative bioconversion of Acerplant extracts, we observed a time-correlated (0-8 days) linear increase in antioxidant phenotypes for all species, with TA having the highest activity. Temporal analysis of the MS data revealed tannin bioconversion mechanisms with a relatively higher abundance of gallic acid (m/z 169) accumulated at the end of 8 days, particularly in TA. Similarly, quercetin precursor (glycoside) metabolites were also transformed to quercetin aglycones (m/z 301) in most Acerplant extracts. The present study underscores the efficacy of fermentative bioconversion strategies aimed at enhancing the quality and availability of bioactive metabolites from plant extracts.	[Park, Jinyong; Soh, Dong Ho; Singh, Digar; Lee, Choong Hwan] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Lee, Sarah; Lee, Jong Seok] Natl Inst Biol Resources, Environm Res Complex, Incheon, South Korea	Konkuk University; National Institute of Biological Resources	Lee, CH (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea.	chlee123@konkuk.ac.kr			Konkuk University	Konkuk University	This paper was supported by Konkuk University in 2016.	Abdel-Nabey M. A., 2011, Biotechnology, V10, P149; Abu-Reidah IM, 2015, FOOD CHEM, V166, P179, DOI 10.1016/j.foodchem.2014.06.011; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bessada SMP, 2015, IND CROP PROD, V76, P604, DOI 10.1016/j.indcrop.2015.07.073; Bi W, 2016, J ETHNOPHARMACOL, V189, P31, DOI 10.1016/j.jep.2016.04.021; Chan EWL, 2014, PHYTOCHEMISTRY, V107, P148, DOI 10.1016/j.phytochem.2014.07.028; Cheng L, 2009, J CHROMATOGR A, V1216, P4859, DOI 10.1016/j.chroma.2009.04.031; Choudhary RK, 2011, NAT PROD RES, V25, P1101, DOI 10.1080/14786419.2010.498372; Dall'Asta M, 2012, NUTRITION, V28, P197, DOI 10.1016/j.nut.2011.06.005; de Brito ES, 2007, FOOD CHEM, V105, P1112, DOI 10.1016/j.foodchem.2007.02.009; De Jong P., 1994, MAPLES OF THE WORLD; Dietz BM, 2005, CHEM RES TOXICOL, V18, P1296, DOI 10.1021/tx050058x; Duenas M, 2005, J SCI FOOD AGR, V85, P297, DOI 10.1002/jsfa.1924; Farag MA, 2015, PHYTOCHEMISTRY, V119, P41, DOI 10.1016/j.phytochem.2015.09.004; Gallage NJ, 2015, MOL PLANT, V8, P40, DOI 10.1016/j.molp.2014.11.008; Gruz J, 2008, FOOD CHEM, V111, P789, DOI 10.1016/j.foodchem.2008.05.014; Gu DY, 2013, PHYTOCHEM ANALYSIS, V24, P661, DOI 10.1002/pca.2451; Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073; He Z, 2007, FOOD CHEM, V105, P1307, DOI 10.1016/j.foodchem.2007.04.049; Hossain MK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040569; Hur SJ, 2014, FOOD CHEM, V160, P346, DOI 10.1016/j.foodchem.2014.03.112; John KMM, 2013, FOOD RES INT, V54, P487, DOI 10.1016/j.foodres.2013.07.045; Kim MJ, 2013, FOOD RES INT, V53, P670, DOI 10.1016/j.foodres.2012.12.053; Lee M, 2015, J AGR FOOD CHEM, V63, P6102, DOI 10.1021/acs.jafc.5b01730; Lee S, 2014, BIOSCI BIOTECH BIOCH, V78, P167, DOI 10.1080/09168451.2014.877827; Li H, 2017, PEERJ, V5, DOI 10.7717/peerj.3264; Martins S, 2011, BIOTECHNOL ADV, V29, P365, DOI 10.1016/j.biotechadv.2011.01.008; Meyers KJ, 2006, J AGR FOOD CHEM, V54, P7686, DOI 10.1021/jf061264t; Huynh NT, 2016, BIOCHEM ENG J, V116, P27, DOI 10.1016/j.bej.2015.12.005; Rajak RC, 2017, BIOCATAL BIOTRANSFOR, V35, P27, DOI 10.1080/10242422.2016.1278210; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Schaab MR, 2006, BIOCHEMISTRY-US, V45, P1009, DOI 10.1021/bi051571c; Singh HB, 2010, BIORESOURCE TECHNOL, V101, P6444, DOI 10.1016/j.biortech.2010.03.057; Son SY, 2016, PLANT CELL REP, V35, P1917, DOI 10.1007/s00299-016-2006-y; Suh DH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149022; Tohma H, 2016, ANTIOXIDANTS-BASEL, V5, DOI 10.3390/antiox5040038; Tomas-Barberan FA, 2001, J AGR FOOD CHEM, V49, P4748, DOI 10.1021/jf0104681; Truchado P, 2011, J CHROMATOGR A, V1218, P7601, DOI 10.1016/j.chroma.2011.07.049; Wu QX, 2006, NAT PROD REP, V23, P699, DOI 10.1039/b606168k; Zhang CZ, 2007, PROCESS BIOCHEM, V42, P83, DOI 10.1016/j.procbio.2006.07.019; Zheng ZX, 2000, J AGR FOOD CHEM, V48, P895, DOI 10.1021/jf990972u; Zhou JW, 2014, CURR OPIN BIOTECH, V25, P17, DOI 10.1016/j.copbio.2013.08.009	42	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198739	10.1371/journal.pone.0198739	http://dx.doi.org/10.1371/journal.pone.0198739			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879203	Green Submitted, Green Published, gold			2022-12-26	WOS:000434384900078
J	Curnoe, D; Datan, I; Zhao, JX; Ung, CLM; Aubert, M; Sauffi, MS; Mei, GH; Mendoza, R; Tacon, PSC				Curnoe, Darren; Datan, Ipoi; Zhao, Jian-xin; Ung, Charles Leh Moi; Aubert, Maxime; Sauffi, Mohammed S.; Mei, Goh Hsiao; Mendoza, Raynold; Tacon, Paul S. C.			Rare Late Pleistocene-early Holocene human mandibles from the Niah Caves (Sarawak, Borneo)	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; HOMO-SAPIENS; HUMAN SKELETON; TIMOR-LESTE; MORPHOLOGY; DISPERSALS; HISTORY; BONE; ASIA; AGE	The skeletal remains of Late Pleistocene-early Holocene humans are exceptionally rare in island Southeast Asia. As a result, the identity and physical adaptations of the early inhabitants of the region are poorly known. One archaeological locality that has historically been important for understanding the peopling of island Southeast Asia is the Niah Caves in the northeast of Borneo. Here we present the results of direct Uranium-series dating and the first published descriptions of three partial human mandibles from the West Mouth of the Niah Caves recovered during excavations by the Harrissons in 1957. One of them (mandible E/B1 100") is somewhat younger than the 'Deep Skull' with a best dating estimate of c30-28 ka (at 2 sigma), while the other two mandibles (D/N5 42-48" and E/W 33 24-36") are dated to a minimum of c11.0-10.5 ka (at 2 sigma) and c10.0-9.0 ka (at 2 sigma). Jaw E/B1 100" is unusually small and robust compared with other Late Pleistocene mandibles suggesting that it may have been ontogenetically altered through masticatory strain under a model of phenotypic plasticity. Possible dietary causes could include the consumption of tough or dried meats or palm plants, behaviours which have been documented previously in the archaeological record of the Niah Caves. Our work suggests a long history back to before the LGM of economic strategies involving the exploitation of raw plant foods or perhaps dried and stored meat resources. This offers new insights into the economic strategies of Late Pleistocene-early Holocene hunter-gatherers living in, or adjacent to, tropical rainforests.	[Curnoe, Darren; Mei, Goh Hsiao; Mendoza, Raynold] Univ New South Wales, ARC Ctr Excellence Australian Biodivers & Heritag, Palaeontol Geobiol & Earth Arch Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Datan, Ipoi; Ung, Charles Leh Moi; Sauffi, Mohammed S.] Sarawak Museum Dept, Jalan Barak, Kuching, Sarawak, Malaysia; [Zhao, Jian-xin] Univ Queensland, Sch Earth & Environm Sci, Brisbane, Qld, Australia; [Aubert, Maxime] Griffith Univ, Griffith Ctr Social & Cultural Res, Australian Res Ctr Human Evolut, Gold Coast Campus, Southport, Qld, Australia; [Mei, Goh Hsiao] Univ Sains Malaysia, Ctr Global Archaeol Res, George Town, Malaysia; [Tacon, Paul S. C.] Griffith Univ, PERAHU, Griffith Ctr Social & Cultural Res, Sch Humanities Languages & Social Sci, Gold Coast Campus, Southport, Qld, Australia	University of New South Wales Sydney; University of Queensland; Griffith University; Universiti Sains Malaysia; Griffith University	Curnoe, D (corresponding author), Univ New South Wales, ARC Ctr Excellence Australian Biodivers & Heritag, Palaeontol Geobiol & Earth Arch Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	d.curnoe@unsw.edu.au	CABAH, ARC/T-6419-2019; Aubert, Maxime/AAT-6198-2020; Zhao, Jian-xin/A-5938-2008	Aubert, Maxime/0000-0002-4189-531X; Curnoe, Darren/0000-0001-8622-4141; Zhao, Jian-xin/0000-0002-2413-6178; Tacon, Paul/0000-0002-0280-4366	Australian Research Council [FT120100168, LP120200144, CE170100015]	Australian Research Council(Australian Research Council)	This work was funded by the Australian Research Council (grants FT120100168 to Darren Curnoe, LP120200144 to Darren Curnoe and Paul Tacon, and CE170100015 to Darren Curnoe), http://www.am.gov.au.	Aubert M, 2014, NATURE, V514, P223, DOI 10.1038/nature13422; BAILEY RC, 1989, AM ANTHROPOL, V91, P59, DOI 10.1525/aa.1989.91.1.02a00040; Barker G., 2016, ARCHAEOLOGY NIAH CAV; Barker G, 2013, ARCHAEOLOGY NIAH CAV, V1; Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; Barton H., 2005, ASIAN PERSPECT, V44, P56, DOI DOI 10.1353/ASI.2005.0005; BROTHWELL DR, 1960, SARAWAK MUS J, V9, P323; Bulbeck D, 2011, HOMO, V62, P1, DOI 10.1016/j.jchb.2010.10.002; Bulbeck D, 2007, TERRA AUSTRALIS, V22, P255; CHAMBERLAIN AT, 1985, AM J PHYS ANTHROPOL, V66, P399, DOI 10.1002/ajpa.1330660408; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; Clark TR, 2012, GEOCHIM COSMOCHIM AC, V78, P99, DOI 10.1016/j.gca.2011.11.032; Curnoe D, 2016, FRONT ECOL EVOL, V4, P1, DOI [10.3389/fevo.2016, DOI 10.3389/FEVO.2016]; Dennell R, 2012, QUATERNARY SCI REV, V47, P15, DOI 10.1016/j.quascirev.2012.05.002; Detroit F, 2004, CR PALEVOL, V3, P705, DOI 10.1016/j.crpv.2004.06.004; Detroit F, 2013, HUM BIOL, V85, P45, DOI 10.3378/027.085.0303; Dizon E, 2002, CURR ANTHROPOL, V43, P660, DOI 10.1086/342432; Dobson SD, 2002, J HUM EVOL, V43, P67, DOI 10.1006/jhev.2002.0563; Dubois E, 1922, P K AKAD WET-AMSTERD, V23, P1013; Dubois E., 1894, PITHECANTHROPUS EREC; Fox R.B., 1970, TABON CAVES ARCHAEOL; Gilbertson D., 2013, RAINFOREST FORAGING, P71; Grun R, 2014, PALAEOGEOGR PALAEOCL, V416, P150, DOI 10.1016/j.palaeo.2014.07.023; Grun R, 2009, RADIAT MEAS, V44, P472, DOI 10.1016/j.radmeas.2009.02.011; Harrisson B., 1967, SARAWAK MUS J, V15, P166; HARRISSON T, 1970, ASIAN PERSPECT, V13, P17; Harrisson T., 1964, J R SOC ARTS, V112, P174; Hawkins S, 2017, QUATERNARY SCI REV, V171, P58, DOI 10.1016/j.quascirev.2017.07.008; Higham T., 2016, ARCHAEOLOGICAL INVES, V2, P219; Higham TFG, 2009, J QUATERNARY SCI, V24, P189, DOI 10.1002/jqs.1197; Holmes MA, 2011, AM J PHYS ANTHROPOL, V145, P615, DOI 10.1002/ajpa.21554; Hooijer D. A., 1963, Sarawak Museum Journal, V11, P196; Hoover KC, 2016, QUATERN INT, V405, P101, DOI 10.1016/j.quaint.2015.01.030; HOWELLS WW, 1989, PAPERS PEABODY MUSEU, V79; Hunt C., 2014, SO ASIA AUSTR SEARCH, P90, DOI DOI 10.1017/CBO9781139084741.008; Hutchison CS., 2005, GEOLOGY NW BORNEO SA; Kaifu Y, 2011, ANTHROPOL SCI, V119, P137, DOI 10.1537/ase.090424; KENNEDY KAR, 1977, ASIAN PERSPECT, V20, P32; Krigbaum J., 2005, PERAK MAN OTHER PREH, P131; Krigbaum J., 2001, THESIS; Langley MC, 2016, J HUM EVOL, V97, P1, DOI 10.1016/j.jhevol.2016.04.005; Lieberman DE, 2004, J HUM EVOL, V46, P655, DOI 10.1016/j.jhevol.2004.03.005; Lloyd-Smith L., 2016, MCDONALD I MONOGRAPH, V2, P375; Ludwig K. R., 2012, BERKELEY GEOCHRONOLO, V3, P75; Majid Z., 1982, SARAWAK MUSEUM J SPE, V3, P31; Martin R., 1928, LEHRBUCH ANTHR; Matsumura H, 2005, HOMO, V56, P93, DOI 10.1016/j.jchb.2005.05.004; Matsumura H, 2005, AM J PHYS ANTHROPOL, V127, P182, DOI 10.1002/ajpa.20067; Matsumura H, 1999, AM J PHYS ANTHROPOL, V109, P327, DOI 10.1002/(SICI)1096-8644(199907)109:3<327::AID-AJPA4>3.0.CO;2-5; Matsumura H, 2001, Z MORPHOL ANTHROPOL, V1, P59; Pike A., 2016, ARCHAEOLOGICAL INVES, V2, P233; Pike AWG, 2002, GEOCHIM COSMOCHIM AC, V66, P4273, DOI 10.1016/S0016-7037(02)00997-3; Piper PJ, 2009, INT J OSTEOARCHAEOL, V19, P551, DOI 10.1002/oa.1046; Rabett RJ, 2018, NAT ECOL EVOL, V2, P212, DOI 10.1038/s41559-017-0436-8; Reynolds T, 2016, MCDONALD I MONOGRAPH, V2, P31; Mijares AS, 2010, J HUM EVOL, V59, P123, DOI 10.1016/j.jhevol.2010.04.008; Sambridge M, 2012, QUAT GEOCHRONOL, V9, P42, DOI 10.1016/j.quageo.2012.02.010; Shang H., 2010, TEXAS A M U ANTHR SE, V14; Shang H, 2007, P NATL ACAD SCI USA, V104, P6573, DOI 10.1073/pnas.0702169104; Soficaru A, 2006, P NATL ACAD SCI USA, V103, P17196, DOI 10.1073/pnas.0608443103; Storm P., 1995, SCRIPTA GEOL, V110, P1, DOI DOI 10.1016/0034-6667(77)90031-8; Thorne AG, 1975, THESIS; Trinkaus E, 2003, EARLY MODERN HUMAN P, P100; von Cramon-Taubadel N, 2011, P NATL ACAD SCI USA, V108, P19546, DOI 10.1073/pnas.1113050108; Westaway KE, 2017, NATURE, V548, P322, DOI 10.1038/nature23452; Wu X.Z., 1995, HUMAN EVOLUTION CHIN; Zhao JX, 2009, QUAT GEOCHRONOL, V4, P423, DOI 10.1016/j.quageo.2009.01.012	67	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0196633	10.1371/journal.pone.0196633	http://dx.doi.org/10.1371/journal.pone.0196633			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI4VN	29874227	Green Submitted, Green Published, gold			2022-12-26	WOS:000434369400005
J	Vet, S; de Buyl, S; Faust, K; Danckaert, J; Gonze, D; Gelens, L				Vet, Stefan; de Buyl, Sophie; Faust, Karoline; Danckaert, Jan; Gonze, Didier; Gelens, Lendert			Bistability in a system of two species interacting through mutualism as well as competition: Chemostat vs. Lotka-Volterra equations	PLOS ONE			English	Article							MICROBIAL INTERACTIONS; COEXISTENCE; DYNAMICS; COOPERATION; NETWORKS; GROWTH	We theoretically study the dynamics of two interacting microbial species in the chemostat. These species are competitors for a common resource, as well as mutualists due to crossfeeding. In line with previous studies (Assaneo, et al., 2013; Holland, et al., 2010; Iwata, et al., 2011), we demonstrate that this system has a rich repertoire of dynamical behavior, including bistability. Standard Lotka-Volterra equations are not capable to describe this particular system, as these account for only one type of interaction (mutualistic or competitive). We show here that the different steady state solutions can be well captured by an extended Lotka-Volterra model, which better describe the density-dependent interaction (mutualism at low density and competition at high density). This two-variable model provides a more intuitive description of the dynamical behavior than the chemostat equations.	[Vet, Stefan; de Buyl, Sophie; Faust, Karoline; Danckaert, Jan; Gonze, Didier] ULB, Interuniv Inst Bioinformat Brussels IB2, VUB, Brussels, Belgium; [Vet, Stefan; de Buyl, Sophie; Danckaert, Jan; Gelens, Lendert] VUB, Appl Phys Res Grp, Brussels, Belgium; [Vet, Stefan; Gonze, Didier] ULB, Unite Chronobiol Theor, Brussels, Belgium; [Faust, Karoline] Katholieke Univ Leuven, Lab Mol Bacteriol, Leuven, Belgium; [Gelens, Lendert] Katholieke Univ Leuven, Lab Dynam Biol Syst, Leuven, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Universite Libre de Bruxelles; KU Leuven; KU Leuven	Gelens, L (corresponding author), VUB, Appl Phys Res Grp, Brussels, Belgium.; Gelens, L (corresponding author), Katholieke Univ Leuven, Lab Dynam Biol Syst, Leuven, Belgium.	lendert.gelens@kuleuven.be	Faust, Karoline/P-7578-2017; Gelens, Lendert/E-6348-2010	Faust, Karoline/0000-0001-7129-2803; Danckaert, Jan/0000-0002-7204-0031; Gelens, Lendert/0000-0001-7290-9561; de Buyl, Sophie/0000-0002-3314-9616; Vet, Stefan/0000-0001-7427-4459	Research Council of the Vrije Universiteit Brussel; Belgian Science Policy Office (BelSPO); Interuniversity Institute of Bioinformatics in Brussels (IB2)	Research Council of the Vrije Universiteit Brussel; Belgian Science Policy Office (BelSPO)(Belgian Federal Science Policy Office); Interuniversity Institute of Bioinformatics in Brussels (IB2)	This research was funded by the Research Council of the Vrije Universiteit Brussel, the Belgian Science Policy Office (BelSPO) and by the Interuniversity Institute of Bioinformatics in Brussels (IB2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2011, P NATL ACAD SCI USA, V108, P5638, DOI 10.1073/pnas.1014428108; Assaneo F, 2013, ECOL COMPLEX, V14, P64, DOI 10.1016/j.ecocom.2012.10.004; Bairey E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12285; Barabas G, 2016, AM NAT, V188, pE1, DOI 10.1086/686901; BENISRAEL A, 1966, J MATH ANAL APPL, V15, P243, DOI 10.1016/0022-247X(66)90115-6; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; CHESSON P, 1990, THEOR POPUL BIOL, V37, P26, DOI 10.1016/0040-5809(90)90025-Q; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; Cremer J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00281; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; de Vos MGJ, 2017, P NATL ACAD SCI USA, V114, P10666, DOI 10.1073/pnas.1713372114; Denison RF, 2003, ECOLOGY, V84, P838, DOI 10.1890/0012-9658(2003)084[0838:CITRAT]2.0.CO;2; Dormann CF, 2005, P ROY SOC B-BIOL SCI, V272, P1279, DOI 10.1098/rspb.2005.3066; El Hajji Miled, 2009, Journal of Biological Dynamics, V3, P635, DOI 10.1080/17513750902915978; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Friedman J, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0109; Goldford JE, 2017, BIORXIV, DOI DOI 10.1101/205831; Gonze D, 2017, ISME J, V11, P2159, DOI 10.1038/ismej.2017.60; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hassani MA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0445-0; Holland JN, 2010, ECOLOGY, V91, P1286, DOI 10.1890/09-1163.1; Huisman J, 2002, ECOL RES, V17, P175, DOI 10.1046/j.1440-1703.2002.00477.x; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Iwata S, 2011, ECOL MODEL, V222, P2042, DOI 10.1016/j.ecolmodel.2011.04.009; Jones E., 2001, SCIPY OPEN SOURCE SC; Larimer AL, 2014, ECOLOGY, V95, P1045, DOI 10.1890/13-0025.1; Li BT, 2003, MATH BIOSCI, V184, P115, DOI 10.1016/S0025-5564(03)00060-9; Lima-Mendez G, 2015, SCIENCE, V348, DOI 10.1126/science.1262073; MACARTHUR R, 1970, Theoretical Population Biology, V1, P1, DOI 10.1016/0040-5809(70)90039-0; Marino S, 2014, P NATL ACAD SCI USA, V111, P439, DOI 10.1073/pnas.1311322111; May RM, 2001, STABILITY AND COMPLE; MEGEE RD, 1972, CAN J MICROBIOL, V18, P1733, DOI 10.1139/m72-269; Momeni B, 2017, ELIFE, V6, DOI 10.7554/eLife.25051; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Morgan JAW, 2005, J EXP BOT, V56, P1729, DOI 10.1093/jxb/eri205; Munoz-Tamayo R, 2011, FEMS MICROBIOL ECOL, V76, P615, DOI 10.1111/j.1574-6941.2011.01085.x; Pavlou S., 2006, CHEM IND CHEM ENG Q, V12, P71, DOI [10.2298/CICEQ0601071P, DOI 10.2298/CICEQ0601071P]; Riviere A, 2015, APPL ENVIRON MICROB, V81, P7767, DOI 10.1128/AEM.02089-15; Schmidt JK, 2011, BIOTECHNOL BIOENG, V108, P1900, DOI 10.1002/bit.23126; Smith HL, 1995, THE THEORY OF THE CH; Sole A RV, 2012, SELF ORGANIZATION IN; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Volterra V., 1928, Journal du Conseil Copenhague, P3; Wang YS, 2011, MATH COMPUT MODEL, V53, P1654, DOI 10.1016/j.mcm.2010.12.033; WANGERSKY PJ, 1978, ANNU REV ECOL SYST, V9, P189, DOI 10.1146/annurev.es.09.110178.001201; Weedermann M, 2015, NONLINEAR DYNAM, V81, P1097, DOI 10.1007/s11071-015-2051-z; Widder S, 2016, ISME J, V10, P2557, DOI 10.1038/ismej.2016.45; Zhang ZB, 2003, ECOL MODEL, V164, P271, DOI 10.1016/S0304-3800(03)00069-3	51	17	18	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197462	10.1371/journal.pone.0197462	http://dx.doi.org/10.1371/journal.pone.0197462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874266	Green Published, gold			2022-12-26	WOS:000434369400023
J	Xie, SQ; Cooley, A; Armendariz, D; Zhou, P; Hon, GC				Xie, Shiqi; Cooley, Anne; Armendariz, Daniel; Zhou, Pei; Hon, Gary C.			Frequent sgRNA-barcode recombination in single-cell perturbation assays	PLOS ONE			English	Article							GENETIC SCREENS; RNA GENOMES; CIRCUITS; ERROR; SEQ	Simultaneously detecting CRISPR-based perturbations and induced transcriptional changes in the same cell is a powerful approach to unraveling genome function. Several lentiviral approaches have been developed, some of which rely on the detection of distally located genetic barcodes as an indirect proxy of sgRNA identity. Since barcodes are often several kilobases from their corresponding sgRNAs, viral recombination-mediated swapping of barcodes and sgRNAs is feasible. Using a self-circularization-based sgRNA-barcode library preparation protocol, we estimate the recombination rate to be similar to 50% and we trace this phenomenon to the pooled viral packaging step. Recombination is random, and decreases the signal-to-noise ratio of the assay. Our results suggest that alternative approaches can increase the throughput and sensitivity of single-cell perturbation assays.	[Xie, Shiqi; Cooley, Anne; Armendariz, Daniel; Zhou, Pei; Hon, Gary C.] Univ Texas Southwestern Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dept Obstet & Gynecol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Hon, GC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dept Obstet & Gynecol, Dallas, TX 75390 USA.	gary.hon@utsouthwestern.edu		Xie, Shiqi/0000-0002-0516-3621; Armendariz, Daniel/0000-0002-5857-1282	Cancer Prevention Research Institute of Texas (CPRIT) [RR140023]; National Institute of General Medical Sciences [DP2GM128203]; Department of Defense [PR172060]; Welch Foundation [I-1926-20170325]; Green Center for Reproductive Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM128203] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas (CPRIT); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Defense(United States Department of Defense); Welch Foundation(The Welch Foundation); Green Center for Reproductive Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the Cancer Prevention Research Institute of Texas (CPRIT) (www.cprit.state.tx.us, RR140023, G.C.H.), National Institute of General Medical Sciences (www.nigms.nih.gov, DP2GM128203, G.C.H.), the Department of Defense (cdmrp.army.mil/funding, PR172060, G.C.H.), the Welch Foundation (www.welch1.org, I-1926-20170325, G.C.H.), and the Green Center for Reproductive Biology. S.X. is an American Heart Association fellow (heart.org, 16POST29910007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson B., 2018, BIORXIV, V298349, DOI [10.1101/298349, DOI 10.1101/298349]; Datlinger P, 2017, NAT METHODS, V14, P297, DOI [10.1038/NMETH.4177, 10.1038/nmeth.4177]; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Feldman D., 2018, LENTIVIRAL COPACKAGI, DOI [10.1101/262121, DOI 10.1101/262121]; Hill AJ, 2018, NAT METHODS, V15, P271, DOI [10.1038/NMETH.4604, 10.1038/nmeth.4604]; HU WS, 1990, P NATL ACAD SCI USA, V87, P1556, DOI 10.1073/pnas.87.4.1556; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Nikolaitchik OA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003249; Paillart JC, 2004, NAT REV MICROBIOL, V2, P461, DOI 10.1038/nrmicro903; PELISKA JA, 1992, SCIENCE, V258, P1112, DOI 10.1126/science.1279806; Sack LM, 2016, G3-GENES GENOM GENET, V6, P2781, DOI 10.1534/g3.116.030973; Schlub TE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000766; Xie SQ, 2017, MOL CELL, V66, P285, DOI 10.1016/j.molcel.2017.03.007; ZHANG JY, 1994, J VIROL, V68, P2409, DOI 10.1128/JVI.68.4.2409-2414.1994	15	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198635	10.1371/journal.pone.0198635	http://dx.doi.org/10.1371/journal.pone.0198635			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874289	Green Published, gold, Green Submitted			2022-12-26	WOS:000434369400055
J	Dudakovic, A; Camilleri, ET; Paradise, CR; Samsonraj, RM; Gluscevic, M; Paggi, CA; Begun, DL; Khani, F; Pichurin, O; Ahmed, FS; Elsayed, R; Elsalanty, M; McGee-Lawrence, ME; Karperien, M; Riester, SM; Thaler, R; Westendorf, JJ; van Wijnen, AJ				Dudakovic, Amel; Camilleri, Emily T.; Paradise, Christopher R.; Samsonraj, Rebekah M.; Gluscevic, Martina; Paggi, Carlo Alberto; Begun, Dana L.; Khani, Farzaneh; Pichurin, Oksana; Ahmed, Farah S.; Elsayed, Ranya; Elsalanty, Mohammed; McGee-Lawrence, Meghan E.; Karperien, Marcel; Riester, Scott M.; Thaler, Roman; Westendorf, Jennifer J.; van Wijnen, Andre J.			Enhancer of zeste homolog 2 (Ezh2) controls bone formation and cell cycle progression during osteogenesis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						osteoblast; epigenetics; histone methylation; histone; bone; chromatin regulation; bone development; enhancer of zeste homolog; methyltransferase; osteogenesis; skeleton	MESENCHYMAL STEM-CELLS; INTEGRATIVE GENOMICS VIEWER; OSTEOCALCIN GENE; EPIGENETIC CONTROL; OSTEOBLAST DIFFERENTIATION; METHYLTRANSFERASE EZH2; LINEAGE SPECIFICATION; HISTONE MODIFICATIONS; SKELETAL GROWTH; CHROMATIN	Epigenetic mechanisms control skeletal development and osteoblast differentiation. Pharmacological inhibition of the histone 3 Lys-27 (H3K27) methyltransferase enhancer of zeste homolog 2 (EZH2) in WT mice enhances osteogenesis and stimulates bone formation. However, conditional genetic loss of Ezh2 early in the mesenchymal lineage (i.e. through excision via Prrx1 promoter-driven Cre) causes skeletal abnormalities due to patterning defects. Here, we addressed the key question of whether Ezh2 controls osteoblastogenesis at later developmental stages beyond patterning. We show that Ezh2 loss in committed pre-osteoblasts by Cre expression via the osterix/Sp7 promoter yields phenotypically normal mice. These Ezh2 conditional knock-out mice (Ezh2 cKO) have normal skull bones, clavicles, and long bones but exhibit increased bone marrow adiposity and reduced male body weight. Remarkably, in vivo Ezh2 loss results in a low trabecular bone phenotype in young mice as measured by micro-computed tomography and histomorphometry. Thus, Ezh2 affects bone formation stage-dependently. We further show that Ezh2 loss in bone marrow-derived mesenchymal cells suppresses osteogenic differentiation and impedes cell cycle progression as reflected by decreased metabolic activity, reduced cell numbers, and changes in cell cycle distribution and in expression of cell cycle markers. RNA-Seq analysis of Ezh2 cKO calvaria revealed that the cyclin-dependent kinase inhibitor Cdkn2a is the most prominent cell cycle target of Ezh2. Hence, genetic loss of Ezh2 in mouse pre-osteoblasts inhibits osteogenesis in part by inducing cell cycle changes. Our results suggest that Ezh2 serves a bifunctional role during bone formation by suppressing osteogenic lineage commitment while simultaneously facilitating proliferative expansion of osteoprogenitor cells.	[Dudakovic, Amel; Camilleri, Emily T.; Samsonraj, Rebekah M.; Begun, Dana L.; Khani, Farzaneh; Pichurin, Oksana; Ahmed, Farah S.; Riester, Scott M.; Thaler, Roman; Westendorf, Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA; [Dudakovic, Amel; Westendorf, Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA; [Paradise, Christopher R.; Gluscevic, Martina] Mayo Clin, Grad Sch Biomed Sci, Rochester, MN 55905 USA; [Paradise, Christopher R.] Mayo Clin, Ctr Regenerat Med, Rochester, MN 55905 USA; [Paggi, Carlo Alberto; Karperien, Marcel] Univ Twente, Dept Dev BioEngn, NL-7522 NB Enschede, Netherlands; [Elsayed, Ranya; Elsalanty, Mohammed] Augusta Univ, Dept Oral Biol, Augusta, GA 30912 USA; [McGee-Lawrence, Meghan E.] Augusta Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [McGee-Lawrence, Meghan E.] Augusta Univ, Med Coll Georgia, Dept Orthoped Surg, Augusta, GA 30912 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Twente; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	van Wijnen, AJ (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.; van Wijnen, AJ (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	vanwijnen.andre@mayo.edu	van Wijnen, Andre J./AAG-3578-2019; paggi, carlo alberto/ABH-4872-2020; Karperien, Marcel/R-3270-2018	van Wijnen, Andre J./0000-0002-4458-0946; Karperien, Marcel/0000-0003-0751-0604; Dudakovic, Amel/0000-0002-8850-3977; Camilleri, Emily/0000-0001-8982-6770	National Institutes of Health [R01 AR049069, R01 AR68103, F32 AR066508, T32 AR056950]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069, T32AR056950, R01AR068103, F32AR066508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR049069 (to A. v. W.), R01 AR68103 (to J. J. W.), F32 AR066508 (to A. D.), and T32 AR056950 (to D. L. B.). This work was also supported by William H. and Karen J. Eby and the charitable foundation in their names. M. K. is founder and shareholder of Hy2Care B.V. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Addison WN, 2014, MOL CELL BIOL, V34, P3076, DOI 10.1128/MCB.00185-14; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Carpio LR, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf3273; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; Chen YH, 2016, STEM CELLS, V34, P2183, DOI 10.1002/stem.2400; Chen YH, 2011, J BIOL CHEM, V286, P10671, DOI 10.1074/jbc.M110.199612; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; Dudakovic A., 2017, CURR MOL BIOL REP, V3, P94, DOI [10.1007/s40610-017-0064-8, DOI 10.1007/S40610-017-0064-8]; Dudakovic A, 2017, GENE, V609, P28, DOI 10.1016/j.gene.2017.01.019; Dudakovic A, 2016, J BIOL CHEM, V291, P24594, DOI 10.1074/jbc.M116.740571; Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345; Dudakovic A, 2014, J CELL BIOCHEM, V115, P1816, DOI 10.1002/jcb.24852; Dudakovic A, 2013, J BIOL CHEM, V288, P28783, DOI 10.1074/jbc.M113.489732; Fang C, 2016, J IMMUNOL, V196, P4452, DOI 10.4049/jimmunol.1501466; Ge K, 2012, BBA-GENE REGUL MECH, V1819, P727, DOI 10.1016/j.bbagrm.2011.12.008; Gordon JAR, 2015, BONE, V81, P739, DOI 10.1016/j.bone.2015.03.011; Hakelien AM, 2014, STEM CELLS, V32, P2780, DOI 10.1002/stem.1759; Hemming S, 2017, FASEB J, V31, P1011, DOI 10.1096/fj.201600748R; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Jing H, 2016, MOL THER, V24, P217, DOI 10.1038/mt.2015.152; Khani F, 2017, J CELL BIOCHEM, V118, P1262, DOI 10.1002/jcb.25787; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Li CJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01509-0; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.25079, 10.4161/psb.23864, 10.1371/journal.pone.0065361]; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Lui JC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13685; Marchesi I, 2014, CELL CYCLE, V13, P516, DOI 10.4161/cc.27921; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McGee-Lawrence ME, 2016, J BONE MINER RES, V31, P116, DOI 10.1002/jbmr.2602; McGee-Lawrence ME, 2013, BONE, V52, P296, DOI 10.1016/j.bone.2012.10.015; Meyer MB, 2016, J BIOL CHEM, V291, P17829, DOI 10.1074/jbc.M116.736538; Mirzamohammadi F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12047; Montecino M, 1999, BIOCHEMISTRY-US, V38, P1338, DOI 10.1021/bi982171a; Montecino M, 1996, BIOCHEMISTRY-US, V35, P5093, DOI 10.1021/bi952489s; MONTECINO M, 1994, BIOCHEMISTRY-US, V33, P348, DOI 10.1021/bi00167a045; Pierce JL, 2019, BONE, V118, P2, DOI 10.1016/j.bone.2018.05.019; Pike JW, 2015, BONE, V81, P757, DOI 10.1016/j.bone.2015.03.012; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Samsonraj RM, 2018, STEM CELL TRANSL MED, V7, P197, DOI 10.1002/sctm.17-0086; Samsonraj RM, 2017, TISSUE ENG PART C-ME, V23, P686, DOI [10.1089/ten.tec.2017.0205, 10.1089/ten.TEC.2017.0205]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Schwarz D, 2014, DEVELOPMENT, V141, P867, DOI 10.1242/dev.094342; Sen B, 2017, STEM CELLS, V35, P1624, DOI 10.1002/stem.2617; Shen J, 2003, MOL ENDOCRINOL, V17, P743, DOI 10.1210/me.2002-0122; Soreide E, 2018, J CELL BIOCHEM, V119, P5715, DOI 10.1002/jcb.26755; Stein GS, 2010, CRIT REV EUKAR GENE, V20, P149, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.50; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Thaler R, 2016, J BIOL CHEM, V291, P6754, DOI 10.1074/jbc.M115.678235; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; van Kemenade FJ, 2001, BLOOD, V97, P3896, DOI 10.1182/blood.V97.12.3896; van Wijnen AJ, 2013, CURR OSTEOPOROS REP, V11, P72, DOI 10.1007/s11914-013-0143-6; Varela N, 2016, J CELL PHYSIOL, V231, P1001, DOI 10.1002/jcp.25188; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wassef M, 2017, J MOL BIOL, V429, P1978, DOI 10.1016/j.jmb.2016.10.012; Wu H, 2017, BBA-GENE REGUL MECH, V1860, P438, DOI 10.1016/j.bbagrm.2017.01.003; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Zhong YB, 2018, NUCLEIC ACIDS RES, V46, P3382, DOI 10.1093/nar/gky101	66	41	42	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12894	12907		10.1074/jbc.RA118.002983	http://dx.doi.org/10.1074/jbc.RA118.002983			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29899112	hybrid, Green Published			2022-12-26	WOS:000442203500021
J	Ramos, RS; Kumar, L; Shabani, F; Picanco, MC				Ramos, Rodrigo Soares; Kumar, Lalit; Shabani, Farzin; Picanco, Marcelo Coutinho			Mapping global risk levels of Bemisia tabaci in areas of suitability for open field tomato cultivation under current and future climates	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; LEAF-CURL-VIRUS; PLANT-VIRUSES; NICHE MODELS; HEMIPTERA; TRANSMISSION; PERFORMANCE; WHITEFLIES; PREDICTION; VEGETABLES	The whitefly, Bemisia tabaci, is a major threat to tomato Solanum lycopersicum and ranks as one of the world's 100 most invasive pests. This is the first study of B. tabaci (Biotype B and Q) global distribution, focusing on risk levels of this invasive pest, in areas projected to be suitable for open field S. lycopersicum cultivation under climate change. This study aims to identify levels of risk of invasive B. tabaci for areas of suitability for open field S. lycopersicum cultivation for the present, 2050 and 2070 using MaxEnt and the Global Climate Model, HadGEM2_ES under RCP45. Our results show that 5% of areas optimal for open field S. lycopersicum cultivation are currently at high risk of B. tabaci. Among the optimal areas for S. lycopersicum, the projections for 2050 compared to the current time showed an extension of 180% in areas under high risk, and a shortening of 67 and 27% in areas under medium and low risk of B. tabaci, respectively, while projections for 2070 showed an extension of 164, and a shortening of 49 and 64% under high, medium and low risk, respectively. The basis of these projections is that predicted temperature increases could affect the pest, which has great adaptability to different climate conditions, but could also impose limitations on the growth of S. lycopersicum. These results may be used in designing strategies to prevent the introduction and establishment of B. tabaci for open-field tomato crops, and assist the implementation of pest management programs.	[Ramos, Rodrigo Soares; Picanco, Marcelo Coutinho] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Ramos, Rodrigo Soares; Kumar, Lalit; Shabani, Farzin] UNE, Sch Environm & Rural Sci, Ecosyst Management, Armidale, NSW, Australia; [Shabani, Farzin] Flinders Univ S Australia, Coll Sci & Engn, Global Ecol, Adelaide, SA, Australia	Universidade Federal de Vicosa; University of New England; Flinders University South Australia	Ramos, RS (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.; Ramos, RS (corresponding author), UNE, Sch Environm & Rural Sci, Ecosyst Management, Armidale, NSW, Australia.	rodrigosragro@gmail.com	Kumar, Lalit/A-6397-2011; shabani, Farzin/P-1033-2019; Picanço, Marcelo Coutinho/P-6172-2019; Ramos, Rodrigo S/Y-7855-2018; Picanço, Marcelo/AAQ-2477-2020	Kumar, Lalit/0000-0002-9205-756X; shabani, Farzin/0000-0002-5100-8921; Picanço, Marcelo/0000-0002-1294-6210; Ramos, Rodrigo/0000-0002-7659-834X	National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq); Brazilian Federal Agency, for the Support and Evaluation of Graduate Education (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior - CAPES); Minas Gerais State Foundation for Research Aid (FAPEMIG); School of Environmental and Rural Science of the University of New England (UNE), Armidale, Australia	National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Federal Agency, for the Support and Evaluation of Graduate Education (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior - CAPES); Minas Gerais State Foundation for Research Aid (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); School of Environmental and Rural Science of the University of New England (UNE), Armidale, Australia	This research was supported by the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq), the Brazilian Federal Agency, for the Support and Evaluation of Graduate Education (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior - CAPES), the Minas Gerais State Foundation for Research Aid (FAPEMIG), and the School of Environmental and Rural Science of the University of New England (UNE), Armidale, Australia. The simulations were carried out using computational facilities at UNE.	Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132; Aljaryian R, 2016, CROP PROT, V88, P137, DOI 10.1016/j.cropro.2016.06.008; Anderson RP, 2013, ANN NY ACAD SCI, V1297, P8, DOI 10.1111/nyas.12264; Andrews T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051607; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Bacon SJ, 2014, DIVERS DISTRIB, V20, P84, DOI 10.1111/ddi.12149; Biber-Freudenberger L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153237; Blackman RL, 1998, B ENTOMOL RES, V88, P213, DOI 10.1017/S0007485300025785; Bonato O, 2007, PHYSIOL ENTOMOL, V32, P50, DOI 10.1111/j.1365-3032.2006.00540.x; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Boykin LM, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00045; Brown J.K., 2007, APSNET FEATUR, V1, P25, DOI [10.1094/APSnetFeature-2007-0107, DOI 10.1094/APSNETFEATURE-2007-0107, DOI 10.1094/APSNETFEATURE-2007-010]; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Cornelissen T, 2011, NEOTROP ENTOMOL, V40, P155, DOI 10.1590/S1519-566X2011000200001; Galdino TVD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159450; da Silva RS, 2017, PEST MANAG SCI, V73, P616, DOI 10.1002/ps.4344; Daly C, 2006, INT J CLIMATOL, V26, P707, DOI 10.1002/joc.1322; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Leite GL, 2006, PESQUI AGROPECU BRAS, V41, P1241, DOI 10.1590/S0100-204X2006000800005; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dike VN, 2015, INT J CLIMATOL, V35, P1784, DOI 10.1002/joc.4084; Dormann CF, 2008, ECOLOGY, V89, P3371, DOI 10.1890/07-1772.1; Du ZH, 2014, INT J INFECT DIS, V26, P1, DOI 10.1016/j.ijid.2014.04.006; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Friedmann M, 1998, J AM SOC HORTIC SCI, V123, P1004, DOI 10.21273/JASHS.123.6.1004; Gilioli G, 2014, PEST MANAG SCI, V70, P1611, DOI 10.1002/ps.3734; Hatfield JL, 2015, WEATHER CLIM EXTREME, V10, P4, DOI 10.1016/j.wace.2015.08.001; Health EPoP, 2013, EFSA J, V11; Heffernan O, 2010, NATURE, V463, P1014, DOI 10.1038/4631014a; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Inoue-Nagata AK, 2016, HORTIC BRAS, V34, P8, DOI 10.1590/S0102-053620160000100002; Jarnevich CS, 2015, ECOL INFORM, V29, P6, DOI 10.1016/j.ecoinf.2015.06.007; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Koo KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134043; Kriticos D, ADAPTIVE PEST MANAGE; Kumar L, 2016, PEST MANAG SCI; Kumar S., 2009, J ECOLOGY NATURAL EN, V1, P94, DOI 10.5897/ JENE.9000071; Kumar S, 2015, J ECON ENTOMOL, V108, P1708, DOI 10.1093/jee/tov166; Kumar S, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00050.1; Kumar S, 2014, J ECON ENTOMOL, V107, P1032, DOI 10.1603/EC14052; Kumar S, 2009, FRONT ECOL ENVIRON, V7, P415, DOI 10.1890/080054; Kutywayo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073432; Lapidot M, 2010, PHYTOPATHOLOGY, V100, P798, DOI 10.1094/PHYTO-100-8-0798; Lapidot M, 1997, PLANT DIS, V81, P1425, DOI 10.1094/PDIS.1997.81.12.1425; Leke W. N., 2015, Agriculture and Food Security, V4; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; MARKHAM PG, 1994, PESTIC SCI, V42, P123, DOI 10.1002/ps.2780420209; McDowell WG, 2014, FRESHWATER BIOL, V59, P847, DOI 10.1111/fwb.12308; McKenzie CL, 2009, J ECON ENTOMOL, V102, P670, DOI 10.1603/029.102.0227; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Munoz-Valencia V, 2013, REV COLOMB ENTOMOL, V39, P18; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; Ning WX, 2015, SCI REP-UK, V5, DOI 10.1038/srep10744; Owens HL, 2013, ECOL MODEL, V263, P10, DOI 10.1016/j.ecolmodel.2013.04.011; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034817; Papayiannis LC, 2010, J VIROL METHODS, V165, P238, DOI 10.1016/j.jviromet.2010.02.003; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peet M, 2002, HEAT STRESS INCREASE, P209; PERRING TM, 1993, SCIENCE, V259, P74, DOI 10.1126/science.8418497; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Ramirez-Cabral NYZ, J PHYTOPATHOL, DOI [10.1111/jph.12609, DOI 10.1111/JPH.12609]; Rasdi Z. M., 2009, Journal of Agricultural Science (Toronto), V1, P27; Santini A, 2013, NEW PHYTOL, V197, P238, DOI 10.1111/j.1469-8137.2012.04364.x; Sato S, 2000, PLANT CELL ENVIRON, V23, P719, DOI 10.1046/j.1365-3040.2000.00589.x; Schreinemachers P, 2015, CROP PROT, V75, P115, DOI 10.1016/j.cropro.2015.05.012; Shabani F, 2016, J AGR SCI-CAMBRIDGE, V154, P175, DOI 10.1017/S0021859615000398; Shabani F, 2016, ECOL EVOL, V6, P5973, DOI 10.1002/ece3.2332; Shabani F, 2016, J SCI FOOD AGR, V96, P1132, DOI 10.1002/jsfa.7195; Tay WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050550; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040969; Thompson WMO, 2011, WHITEFLY, BEMISIA TABACI (HOMOPTERA: ALEYRODIDAE) INTERACTION WITH GEMINIVIRUS-INFECTED HOST PLANTS: BEMISIA TABACI, HOST PLANTS AND GEMINIVIRUSES, P1, DOI 10.1007/978-94-007-1524-0; Tsueda H, 2011, ENTOMOL EXP APPL, V141, P197, DOI 10.1111/j.1570-7458.2011.01189.x; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Wan FH, 2008, J INSECT SCI, V8, P49; Ward NL, 2007, GLOBAL CHANGE BIOL, V13, P1605, DOI 10.1111/j.1365-2486.2007.01399.x; West AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117893	83	29	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198925	10.1371/journal.pone.0198925	http://dx.doi.org/10.1371/journal.pone.0198925			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902221	Green Published, gold, Green Submitted			2022-12-26	WOS:000435424900061
J	Allaway, R; Angus, SP; Beauchamp, RL; Blakeley, JO; Bott, M; Burns, SS; Carlstedt, A; Chang, LS; Chen, X; Clapp, DW; Desouza, PA; Erdin, S; Fernandez-Valle, C; Guinney, J; Gusella, JF; Haggerty, SJ; Johnson, GL; La Rosa, S; Morrison, H; Petrilli, AM; Plotkin, SR; Pratap, A; Ramesh, V; Sciaky, N; Stemmer-Rachamimov, A; Stuhlmiller, TJ; Talkowski, ME; Welling, DB; Yates, CW; Zawistowski, JS; Zhao, WN				Allaway, Robert; Angus, Steve P.; Beauchamp, Roberta L.; Blakeley, Jaishri O.; Bott, Marga; Burns, Sarah S.; Carlstedt, Annemarie; Chang, Long-Sheng; Chen, Xin; Clapp, D. Wade; Desouza, Patrick A.; Erdin, Serkan; Fernandez-Valle, Cristina; Guinney, Justin; Gusella, James F.; Haggerty, Stephen J.; Johnson, Gary L.; La Rosa, Salvatore; Morrison, Helen; Petrilli, Alejandra M.; Plotkin, Scott R.; Pratap, Abhishek; Ramesh, Vijaya; Sciaky, Noah; Stemmer-Rachamimov, Anat; Stuhlmiller, Tim J.; Talkowski, Michael E.; Welling, D. Bradley; Yates, Charles W.; Zawistowski, Jon S.; Zhao, Wen-Ning		Synodos NF2 Consortium	Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; GROWTH-FACTOR; PHASE-II; VESTIBULAR SCHWANNOMAS; THERAPEUTIC TARGET; MOLECULE INHIBITOR; KINASE INHIBITOR; MENINGIOMA CELLS; ACTIVATION; LAPATINIB	Neurofibromatosis 2 (NF2) is a rare tumor suppressor syndrome that manifests with multiple schwannomas and meningiomas. There are no effective drug therapies for these benign tumors and conventional therapies have limited efficacy. Various model systems have been created and several drug targets have been implicated in NF2-driven tumorigenesis based on known effects of the absence of merlin, the product of the NF2 gene. We tested priority compounds based on known biology with traditional dose-concentration studies in meningioma and schwann cell systems. Concurrently, we studied functional kinome and gene expression in these cells pre- and post-treatment to determine merlin deficient molecular phenotypes. Cell viability results showed that three agents (GSK2126458, Panobinostat, CUDC-907) had the greatest activity across schwannoma and meningioma cell systems, but merlin status did not significantly influence response. In vivo, drug effect was tumor specific with meningioma, but not schwannoma, showing response to GSK2126458 and Panobinostat. In culture, changes in both the transcriptome and kinome in response to treatment clustered predominantly based on tumor type. However, there were differences in both gene expression and functional kinome at baseline between meningioma and schwannoma cell systems that may form the basis for future selective therapies. This work has created an openly accessible resource (www.synapse.org/SynodosNF2) of fully characterized isogenic schwannoma and meningioma cell systems as well as a rich data source of kinome and transcriptome data from these assay systems before and after treatment that enables single and combination drug discovery based on molecular phenotype.	[La Rosa, Salvatore; Synodos NF2 Consortium] Childrens Tumor Fdn, New York, NY 10005 USA; [Allaway, Robert; Guinney, Justin; Pratap, Abhishek] Sage Bionetworks, Seattle, WA USA; [Angus, Steve P.; Chen, Xin; Johnson, Gary L.; Sciaky, Noah; Stuhlmiller, Tim J.; Zawistowski, Jon S.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Beauchamp, Roberta L.; Desouza, Patrick A.; Erdin, Serkan; Gusella, James F.; Haggerty, Stephen J.; Plotkin, Scott R.; Ramesh, Vijaya; Stemmer-Rachamimov, Anat; Talkowski, Michael E.; Zhao, Wen-Ning] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Beauchamp, Roberta L.; Desouza, Patrick A.; Erdin, Serkan; Gusella, James F.; Haggerty, Stephen J.; Plotkin, Scott R.; Ramesh, Vijaya; Stemmer-Rachamimov, Anat; Talkowski, Michael E.; Zhao, Wen-Ning] Harvard Med Sch, Boston, MA 02115 USA; [Blakeley, Jaishri O.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Bott, Marga; Fernandez-Valle, Cristina; Petrilli, Alejandra M.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Lake Nona Orlando, FL USA; [Burns, Sarah S.; Chang, Long-Sheng] Ohio State Univ, Coll Med, Ctr Childhood Canc & Blood Dis, Res Inst,Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Burns, Sarah S.; Chang, Long-Sheng] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Carlstedt, Annemarie; Morrison, Helen] FLI, Leibniz Inst Aging, Jena, Germany; [Clapp, D. Wade; Yates, Charles W.] Indiana Univ, Sch Med, Indianapolis, IN USA; [Pratap, Abhishek] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA; [Welling, D. Bradley] Massachusetts Gen Hosp, Dept Otolaryngol, Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Welling, D. Bradley] Harvard Univ, Boston, MA 02115 USA; [Stuhlmiller, Tim J.] Spyryx Biosci Inc, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; State University System of Florida; University of Central Florida; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Indiana University System; Indiana University-Purdue University Indianapolis; University of Washington; University of Washington Seattle; Harvard University; Massachusetts Eye & Ear Infirmary; Massachusetts General Hospital; Harvard University	La Rosa, S (corresponding author), Childrens Tumor Fdn, New York, NY 10005 USA.; Gusella, JF; Plotkin, SR (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.; Gusella, JF; Plotkin, SR (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Blakeley, JO (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.; Clapp, DW (corresponding author), Indiana Univ, Sch Med, Indianapolis, IN USA.	jblakel3@jhmi.edu; dclapp@iu.edu; gusella@helix.mgh.harvard.edu; slarosa@ctf.org; splotkin@partners.org	Welling, D Bradley/H-1503-2014; Morrison, Helen/F-9748-2014; Erdin, Serkan/B-4988-2008; Allaway, Robert/ABE-1264-2021; Erdin, Serkan/AAE-4288-2019	Morrison, Helen/0000-0003-4938-1409; Erdin, Serkan/0000-0001-6587-2625; Allaway, Robert/0000-0003-3573-3565; Chang, Long-Sheng/0000-0002-5178-2992; Angus, Steven/0000-0002-7655-657X; Chen, Xin/0000-0002-5208-2154; Plotkin, Scott/0000-0002-6109-6419; Pratap, Abhishek/0000-0002-5289-6932; Welling, D. Bradley/0000-0002-9963-469X; La Rosa, Salvatore/0000-0003-2010-4328	Children's Tumor Foundation through its Synodos for NF2 Consortium program [2014-18-001A, 2014-18-001B, 2014-18-001C, 2014-18-001D, 2014-18-001E, 2014-18-001F, 2014-18-001G, 2014-18-001H, 2014-04-008]	Children's Tumor Foundation through its Synodos for NF2 Consortium program	The work in this manuscript was fully sponsored and managed by the Children's Tumor Foundation (www.ctf.org) through its Synodos for NF2 Consortium program (CTF grants: 2014-18-001A to Gary L Johnson, 2014-18-001B to James F Gusella, 2014-18-001C to Jaishri O Blakeley, 2014-18-001D to D. Wade Clapp, 2014-18-001E to D Bradley Welling, 2014-18-001F to Cristina Fernandez-Valle, 2014-18-001G to Helen Morrison, 2014-18-001H to Long-Sheng Chang, 2014-04-008 to Justin Guinney).	Abrams TJ, 2003, MOL CANCER THER, V2, P1011; Ammoun S, 2008, CANCER RES, V68, P5236, DOI 10.1158/0008-5472.CAN-07-5849; Ammoun S, 2012, GLIA, V60, P1721, DOI 10.1002/glia.22391; Ammoun S, 2010, NEURO-ONCOLOGY, V12, P834, DOI 10.1093/neuonc/noq012; Ammoun S, 2010, NEUROBIOL DIS, V37, P141, DOI 10.1016/j.nbd.2009.09.017; Angus SP, 2018, NEUROONCOLOGY; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balasubramaniam A, 2007, NEURO-ONCOLOGY, V9, P447, DOI 10.1215/15228517-2007-027; Banerjee S, 2014, BIOCHEM J, V457, P215, DOI 10.1042/BJ20131152; Beauchamp RL, 2015, ONCOTARGET, V6, P16981, DOI 10.18632/oncotarget.4858; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blakeley JO, 2016, J CLIN ONCOL, V34, P1669, DOI 10.1200/JCO.2015.64.3817; Boin A, 2014, NEURO-ONCOLOGY, V16, P1196, DOI 10.1093/neuonc/nou020; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Brastianos PK, 2013, NAT GENET, V45, P285, DOI 10.1038/ng.2526; Burns SS, 2016, METHODS MOL BIOL, V1427, P59, DOI 10.1007/978-1-4939-3615-1_4; Burns SS, 2013, CANCER RES, V73, P792, DOI 10.1158/0008-5472.CAN-12-1888; Bush ML, 2011, NEURO-ONCOLOGY, V13, P983, DOI 10.1093/neuonc/nor072; Chang Q, 2008, BRIT J CANCER, V99, P1074, DOI 10.1038/sj.bjc.6604676; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Domingues P, 2015, ONCOTARGET, V6, P10671, DOI 10.18632/oncotarget.3870; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Evans D G R, 2015, Handb Clin Neurol, V132, P87, DOI 10.1016/B978-0-444-62702-5.00005-6; Faraway J. J., 2009, LINEAR MODELS R; Fujii M, 2012, CELL CYCLE, V11, P3373, DOI 10.4161/cc.21397; Gehlhausen JR, 2015, HUM MOL GENET, V24, P1, DOI 10.1093/hmg/ddu414; Giovannini M, 2000, GENE DEV, V14, P1617; Goutagny S, 2017, J NEURO-ONCOL, V133, P443, DOI 10.1007/s11060-017-2447-3; Gusella JF, 1999, BBA-REV CANCER, V1423, pM29, DOI 10.1016/S0304-419X(99)00005-0; Hexter A, 2015, J MED GENET, V52, P699, DOI 10.1136/jmedgenet-2015-103290; Hoelder S, 2012, MOL ONCOL, V6, P155, DOI 10.1016/j.molonc.2012.02.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jacob A, 2008, OTOL NEUROTOL, V29, P58, DOI 10.1097/mao.0b013e31816021f7; Jacob A, 2012, LARYNGOSCOPE, V122, P174, DOI 10.1002/lary.22392; James MF, 2008, NEUROBIOL DIS, V29, P278, DOI 10.1016/j.nbd.2007.09.002; James MF, 2012, MOL CANCER RES, V10, P649, DOI 10.1158/1541-7786.MCR-11-0425-T; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Jones SF, 2015, INVEST NEW DRUG, V33, P1100, DOI 10.1007/s10637-015-0282-y; Karajannis MA, 2014, NEURO-ONCOLOGY, V16, P292, DOI 10.1093/neuonc/not150; Karajannis MA, 2012, NEURO-ONCOLOGY, V14, P1163, DOI 10.1093/neuonc/nos146; Knight SD, 2010, ACS MED CHEM LETT, V1, P39, DOI 10.1021/ml900028r; Koch H, 2015, J PROTEOME RES, V14, P2617, DOI 10.1021/acs.jproteome.5b00161; Koschny R, 2014, J NEUROPATH EXP NEUR, V73, P1034, DOI 10.1097/NEN.0000000000000129; Lang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep31126; Mallory GW, 2014, NEUROSURGERY, V74, P292, DOI 10.1227/NEU.0000000000000264; Manfredi MG, 2011, CLIN CANCER RES, V17, P7614, DOI 10.1158/1078-0432.CCR-11-1536; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Morrow KA, 2016, ONCOTARGET, V7, P17991, DOI 10.18632/oncotarget.7494; Ostrom QT, 2016, NEURO-ONCOLOGY, V18, P1, DOI 10.1093/neuonc/nov297; Petrilli AM, 2016, ONCOGENE, V35, P537, DOI 10.1038/onc.2015.125; Petrilli AM, 2014, AM J TRANSL RES, V6, P471; Plotkin SR, 2009, NEW ENGL J MED, V361, P358, DOI 10.1056/NEJMoa0902579; Puttmann S, 2005, LAB INVEST, V85, P1163, DOI 10.1038/labinvest.3700307; Qian CG, 2012, CLIN CANCER RES, V18, P4104, DOI 10.1158/1078-0432.CCR-12-0055; Qian DZ, 2006, CLIN CANCER RES, V12, P634, DOI 10.1158/1078-0432.CCR-05-1132; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Schulz A, 2016, ACTA NEUROPATHOL, V132, P289, DOI 10.1007/s00401-016-1583-8; Stuhlmiller TJ, 2015, CELL REP, V11, P390, DOI 10.1016/j.celrep.2015.03.037; Sun SB, 2014, J NEUROSURG, V121, P143, DOI 10.3171/2014.8.GKS141503; Tanaka K, 2013, CLIN CANCER RES, V19, P3856, DOI 10.1158/1078-0432.CCR-12-3167; Welling D Bradley, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P341, DOI 10.1097/MOO.0b013e3282b97310; Wong HK, 2010, CANCER RES, V70, P3483, DOI 10.1158/0008-5472.CAN-09-3107	64	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197350	10.1371/journal.pone.0197350	http://dx.doi.org/10.1371/journal.pone.0197350			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897904	gold, Green Published, Green Submitted			2022-12-26	WOS:000435090700009
J	Lu, R; Yang, J; Wei, R; Ke, J; Tian, Q; Yu, F; Liu, JL; Zhang, JJ; Hong, TP				Lu, Ran; Yang, Jin; Wei, Rui; Ke, Jing; Tian, Qing; Yu, Fei; Liu, Junling; Zhang, Jingjing; Hong, Tianpei			Synergistic anti-tumor effects of liraglutide with metformin on pancreatic cancer cells	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; TYPE-2 DIABETES-MELLITUS; ENDOTHELIAL DYSFUNCTION; GLUCOSE-CONCENTRATION; RECEPTOR ACTIVATION; INHIBITS GROWTH; GLP-1 RECEPTOR; RISK; APOPTOSIS; ASSOCIATION	Either metformin or liraglutide has been reported to have anti-tumor effects on pancreatic cancer cells. However, it is not clear whether their combined treatment has additive or synergistic anti-tumor effects on pancreatic cancer cells. In this study, the human pancreatic cancer cell line MiaPaca-2 was incubated with liraglutide and/or metformin. The cell Counting Kit-8 (CCK-8), colony formation, flow cytometry, and wound-healing and transwell migration assays were used to detect cell viability, clonogenic survival, cell cycle and cell migration, respectively. RT-PCR and western blot analyses were used to determine the mRNA and protein levels of related molecules. Results showed that combination treatment with liraglutide (100 nmol/L) and metformin (0.75 mmol/L) significantly decreased cell viability and colony formation, caused cell cycle arrest, upregulated the level of pro-apoptotic proteins Box and cleaved caspase-3, and inhibited cell migration in the cells, although their single treatment did not exhibit such effects. Combination index value for cell viability indicated a synergistic interaction of liraglutide and metformin. Moreover, the combined treatment with liraglutide and metformin could activate the phosphorylation of AMP-activated protein kinase (AMPK) more potently than their single treatment in the cells. These results suggest that liraglutide in combination with metformin has a synergistic anti-tumor effect on the pancreatic cancer cells, which may be at least partly due to activation of AMPK signaling. Our study provides new insights into the treatment of patients with type 2 diabetes and pancreatic cancer.	[Lu, Ran; Yang, Jin; Wei, Rui; Ke, Jing; Tian, Qing; Yu, Fei; Liu, Junling; Zhang, Jingjing; Hong, Tianpei] Peking Univ, Dept Endocrinol & Metab, Hosp 3, Beijing, Peoples R China	Peking University	Hong, TP (corresponding author), Peking Univ, Dept Endocrinol & Metab, Hosp 3, Beijing, Peoples R China.	tpho66@bjmu.edu.cn	lu, ran/HHC-8613-2022; Zhang, Jing/HII-4294-2022	Yang, Jin/0000-0001-6004-955X; Wei, Rui/0000-0002-8838-703X; Hong, Tianpei/0000-0002-5744-5129	National Key Research and Development Program of China [2016YFA0100501]; National Natural Science Foundation of China [91749101, 81770768, 81570692, 81400767, 81500626]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the National Key Research and Development Program of China (2016YFA0100501 TPH), the National Natural Science Foundation of China (91749101 TPH, 81770768 RW, 81570692 TPH, 81400767 JY and 81500626 JJZ).	Ambe CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151632; American Diabetes Association, 2018, Diabetes Care, V41, pS73, DOI 10.2337/dc18-S008; Bartosch-Harlid A, 2010, PANCREATOLOGY, V10, P423, DOI 10.1159/000264676; Butler AE, 2013, DIABETES, V62, P2595, DOI 10.2337/db12-1686; Chang SC, 2016, CRIT REV ONCOL HEMAT, V108, P146, DOI 10.1016/j.critrevonc.2016.11.003; Chari ST, 2008, GASTROENTEROLOGY, V134, P95, DOI 10.1053/j.gastro.2007.10.040; De Souza A, 2016, CANCER CHEMOTH PHARM, V77, P235, DOI 10.1007/s00280-015-2948-8; De Souza AL, 2014, J PANCREAS, V15, P118, DOI 10.6092/1590-8577/2286; Drab SR, 2016, CURR DIABETES REV, V12, P403, DOI 10.2174/1573399812666151223093841; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Gandini S, 2014, CANCER PREV RES, V7, P867, DOI 10.1158/1940-6207.CAPR-13-0424; Garber AJ, 2018, ENDOCR PRACT, V24, P91, DOI 10.4158/CS-2017-0153; Gier B, 2012, DIABETES, V61, P1250, DOI 10.2337/db11-1109; Gou SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063969; Karnevi E, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-235; Ke J, 2017, SCI REP-UK, V7, DOI 10.1038/srep41085; Kisfalvi K, 2013, PANCREAS, V42, P781, DOI 10.1097/MPA.0b013e31827aec40; Koehler JA, 2006, DIABETES, V55, P1369, DOI 10.2337/db05-1145; Koehler JA, 2015, DIABETES, V64, P1046, DOI 10.2337/db14-0883; Koehler JA, 2011, ENDOCRINOLOGY, V152, P3362, DOI 10.1210/en.2011-1201; Li NN, 2016, BIOCHEM BIOPH RES CO, V478, P46, DOI 10.1016/j.bbrc.2016.07.095; Ligumsky H, 2012, BREAST CANCER RES TR, V132, P449, DOI 10.1007/s10549-011-1585-0; Marso SP, 2016, NEW ENGL J MED, V375, P1834, DOI 10.1056/NEJMoa1607141; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Mulherin AJ, 2011, ENDOCRINOLOGY, V152, P4610, DOI 10.1210/en.2011-1485; Oh BY, 2016, J CANCER RES CLIN, V142, P1377, DOI 10.1007/s00432-016-2148-x; Pan QR, 2009, HORM METAB RES, V41, P799, DOI 10.1055/s-0029-1234043; Pfeffer MA, 2015, NEW ENGL J MED, V373, P2247, DOI 10.1056/NEJMoa1509225; Queiroz EAIF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098207; Salvatore T, 2015, INT J SURG, V21, pS72, DOI 10.1016/j.ijsu.2015.06.063; Singh S, 2013, JAMA INTERN MED, V173, P534, DOI 10.1001/jamainternmed.2013.2720; Sinnett-Smith J, 2013, BIOCHEM BIOPH RES CO, V430, P352, DOI 10.1016/j.bbrc.2012.11.010; Suarez EA, 2014, CURR MED RES OPIN, V30, P2471, DOI 10.1185/03007995.2014.960515; Thondam SK, 2012, DIABETIC MED, V29, pE205, DOI 10.1111/j.1464-5491.2012.03675.x; Wang Z, 2014, DIABETES RES CLIN PR, V106, P19, DOI 10.1016/j.diabres.2014.04.007; Zhang HH, 2016, CANCER CHEMOTH PHARM, V78, P13, DOI 10.1007/s00280-016-3037-3; Zhao H, 2014, DIABETES OBES METAB, V16, P850, DOI 10.1111/dom.12291; Zhao HJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE1431, DOI 10.1152/ajpendo.00017.2014; Zordoky BNM, 2014, BBA-GEN SUBJECTS, V1840, P1943, DOI 10.1016/j.bbagen.2014.01.023	40	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198938	10.1371/journal.pone.0198938	http://dx.doi.org/10.1371/journal.pone.0198938			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897998	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700079
J	Soga, R; Shiramatsu, TI; Takahashi, H				Soga, Ryo; Shiramatsu, Tomoyo Isoguchi; Takahashi, Hirokazu			Preference test of sound among multiple alternatives in rats	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; PRIMARY AUDITORY-CORTEX; MAMMALIAN COCHLEA; VISUAL-STIMULI; MUSIC; MONKEYS; MICE; DISCRIMINATION; RECOGNITION; PLASTICITY	Conditioned place preference (CPP) tests in rodents have been well established to measure preference induced by secondary reinforcing properties, but conventional assays are not sensitive enough to measure innate, weak preference, or the primary reinforcing property of a conditioned stimulus. We designed a novel CPP assay with better sensitivity and efficiency in quantifying and ranking preference of particular sounds among multiple alternatives. Each test tone was presented according to the location of free-moving rats in the arena, where assignment of location to each tone changed in every 20-s session. We demonstrated that our assay was able to rank tone preference among 4 alternatives within 12.5 min (125 s (habituation) + 25 s/sessions x 25 sessions). In order to measure and rank sound preference, we attempted to use sojourn times with each test sound (T), and a preference index (PI) based on transition matrices of initial and end sounds in every session. Both T and PI revealed similar trends of innate preference in which rats preferred test conditions in the following order: silence, 40-, 20-, then 10-kHz tones. Further, rats exhibited a change in preference after an classical conditioning of the 20-kHz tone with a rewarding microstimulation of the dopaminergic system. We also demonstrated that PI was a more robust and sensitive indicator than T when the locomotion activity level of rats became low due to habituation to the assay repeated over sessions. Thus, our assay offers a novel method of evaluating auditory preference that is superior to conventional CPP assays, offering promising prospects in the field of sensory neuroscience.	[Soga, Ryo; Shiramatsu, Tomoyo Isoguchi; Takahashi, Hirokazu] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan	University of Tokyo	Takahashi, H (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan.	takahashi@i.u-tokyo.ac.jp			KAKENHI Grant [26242040, 16H01604, 17K20090]; Tateisi Science and Technology Foundation	KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tateisi Science and Technology Foundation	This work was supported by KAKENHI Grant Number 26242040 (H.T.), KAKENHI Grant Number 16H01604 (H.T.), KAKENHI Grant Number 17K20090 (H.T.), https://www.jsps.go.jp/english/index.html; and Tateisi Science and Technology Foundation (H.T. and T.I.S.), http://www.tateisi-f.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschlimann L, 2008, BRAIN TOPOGR, V20, P239, DOI 10.1007/s10548-008-0051-8; Anderson JR, 2005, J EXP PSYCHOL-ANIM B, V31, P71, DOI 10.1037/0097-7403.31.1.71; Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BARDO MT, 1995, NEUROSCI BIOBEHAV R, V19, P39, DOI 10.1016/0149-7634(94)00021-R; Berlyne DE, 1950, B J PSYCHOL-GEN SECT, V41, P68, DOI 10.1111/j.2044-8295.1950.tb00262.x; Blatter K, 2006, EXP BRAIN RES, V168, P541, DOI 10.1007/s00221-005-0114-y; Bouton ME, 2004, NEUROSCI BIOBEHAV R, V28, P663, DOI 10.1016/j.neubiorev.2004.09.001; Brattico P, 2017, FRONTIERS NEUROSCIEN, P11; Chikahisa S, 2006, BEHAV BRAIN RES, V169, P312, DOI 10.1016/j.bbr.2006.01.021; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Feduccia AA, 2008, BRAIN RES BULL, V77, P189, DOI 10.1016/j.brainresbull.2008.07.007; FUJITA K, 1987, PRIMATES, V28, P353, DOI 10.1007/BF02381018; FUJITA K, 1995, AM J PRIMATOL, V37, P253, DOI 10.1002/ajp.1350370307; Funamizu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063655; HALPERN DL, 1986, PERCEPT PSYCHOPHYS, V39, P77, DOI 10.3758/BF03211488; HASENOHRL RU, 1989, J NEUROSCI METH, V30, P141, DOI 10.1016/0165-0270(89)90060-5; Hauser MD, 2003, NAT NEUROSCI, V6, P663, DOI 10.1038/nn1080; Humphrey N K, 1972, Perception, V1, P395, DOI 10.1068/p010395; Huston JP, 2013, TRENDS PHARMACOL SCI, V34, P162, DOI 10.1016/j.tips.2013.01.004; Ikkatai Y, 2011, ANIM COGN, V14, P227, DOI 10.1007/s10071-010-0356-3; JOHANSON IB, 1980, BEHAV NEURAL BIOL, V29, P132, DOI 10.1016/S0163-1047(80)92596-0; JOUHANEAU J, 1984, J COMP PSYCHOL, V98, P318, DOI 10.1037/0735-7036.98.3.318; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Koelsch S, 2014, NAT REV NEUROSCI, V15, P170, DOI 10.1038/nrn3666; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Marzban M, 2011, BASIC CLIN NEUROSCI, V2, P21; McDermott JH, 2016, NATURE; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; OSWALT RM, 1973, PERCEPT MOTOR SKILL, V36, P907, DOI 10.2466/pms.1973.36.3.907; Otsuka Y, 2009, BEHAV PROCESS, V80, P121, DOI 10.1016/j.beproc.2008.10.009; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Polston JE, 2011, BEHAV NEUROSCI, V125, P674, DOI 10.1037/a0024341; Polston JE, 2011, PHARMACOL BIOCHEM BE, V98, P54, DOI 10.1016/j.pbb.2010.11.024; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Shinozuka K, 2013, BEHAV PROCESS, V99, P26, DOI 10.1016/j.beproc.2013.06.009; Sugimoto T, 2010, PRIMATES, V51, P7, DOI 10.1007/s10329-009-0160-3; Takahashi H, 2011, NEUROSCIENCE, V199, P243, DOI 10.1016/j.neuroscience.2011.09.046; Takebayashi M, 2009, PSYCHOLOGIA, V52, P147, DOI 10.2117/psysoc.2009.147; Trainor LJ, 2002, MUSIC PERCEPT, V20, P187, DOI 10.1525/mp.2002.20.2.187; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Ulfendahl M, 1997, PROG NEUROBIOL, V53, P331, DOI 10.1016/S0301-0082(97)00040-3; VEZINA P, 1987, PSYCHOPHARMACOLOGY, V93, P257; WATANABE S, 1995, J EXP ANAL BEHAV, V63, P165, DOI 10.1901/jeab.1995.63-165; Watanabe S, 1998, BEHAV PROCESS, V43, P211, DOI 10.1016/S0376-6357(98)00014-X; Watanabe S, 2001, Anim Cogn, V4, P147, DOI 10.1007/s100710100112; Watanabe S., 2013, PLOS ONE, V8; Watanabe S, 2009, PHILOSOPHY, V121, P1; Watanabe S, 2016, ANIM COGN, V19, P523, DOI 10.1007/s10071-016-0953-x; Watanabe S, 2011, ANIM COGN, V14, P797, DOI 10.1007/s10071-011-0412-7; Watanabe S, 2010, ANIM COGN, V13, P75, DOI 10.1007/s10071-009-0246-8; WILSON FAW, 1994, BEHAV BRAIN RES, V60, P79, DOI 10.1016/0166-4328(94)90066-3; Yang EJ, 2012, P NATL ACAD SCI USA, V109, P17213, DOI 10.1073/pnas.1200705109	54	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197361	10.1371/journal.pone.0197361	http://dx.doi.org/10.1371/journal.pone.0197361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897906	Green Submitted, Green Published, gold			2022-12-26	WOS:000435090700011
J	Umehara, T				Umehara, Toshihiro			Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: Cross-sectional study in US adults	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; SURVEY NHANES-III; VITAMIN-D; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; INSULIN-RESISTANCE; UNITED-STATES; OLDER MEN; NAFLD	Background Nonalcoholic fatty liver disease (NAFLD) has been reported to have a negative effect on bone mineral density (BMD) in Asian populations. Whether such an association exists in Western populations is less clear. Methods This cross-sectional analysis of data from NHANES III, a United States national health survey conducted from 1988 to 1994, included 6089 participants aged 40-75 years, selected after excluding people with hepatitis virus serology, elevated alcohol consumption, decreased renal function, or steroid use, and pregnant females. The main outcome, BMD at the femoral neck, was measured using dual-energy X-ray absorptiometry. The primary exposure, NAFLD, was defined as moderate or severe hepatic steatosis diagnosed using abdominal ultrasonography. Result After controlling for gender and menopausal status, race/ethnicity, age and body mass index, NAFLD was not significantly associated with BMD (beta coefficient:-0.006, 95% CI:-0.016, 0.003). A secondary analysis categorized participants with NAFLD according to their serum alanine aminotransferase (ALT) levels into high and normal ALT NAFLD groups, and compared these with the non-NAFLD group. NAFLD with higher levels of ALT was associated with lower levels of BMD (beta coefficient:-0.023, 95% CI:-0.044, -0.002). Conclusion This study showed a relationship between NAFLD with high ALT and lower BMD in the general U.S. population.	[Umehara, Toshihiro] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Umehara, Toshihiro] Saitama Med Univ, Saitama Med Ctr, Dept Endocrinol & Diabet, Kawagoe, Saitama, Japan; [Umehara, Toshihiro] St Lukes Int Univ, Grad Sch Publ Hlth, Tokyo, Japan	Emory University; Rollins School Public Health; Saitama Medical University; St. Luke's International Hospital	Umehara, T (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.; Umehara, T (corresponding author), Saitama Med Univ, Saitama Med Ctr, Dept Endocrinol & Diabet, Kawagoe, Saitama, Japan.; Umehara, T (corresponding author), St Lukes Int Univ, Grad Sch Publ Hlth, Tokyo, Japan.	toshihiro.umehara@alumni.emory.edu		Umehara, Toshihiro/0000-0001-7015-621X				Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Angulo P, 2013, GASTROENTEROLOGY, V145, P782, DOI 10.1053/j.gastro.2013.06.057; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Campbell JR, 2007, ENVIRON HEALTH PERSP, V115, P1018, DOI 10.1289/ehp.9716; Cauley JA, 2005, OSTEOPOROSIS INT, V16, P1525, DOI 10.1007/s00198-005-1866-8; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Cui R, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/396545; Eliades M, 2015, WORLD J GASTROENTERO, V21, P1718, DOI 10.3748/wjg.v21.i6.1718; George A, 2003, J BONE MINER RES, V18, P2238, DOI 10.1359/jbmr.2003.18.12.2238; Goessling W, 2008, GASTROENTEROLOGY, V135, P1935, DOI 10.1053/j.gastro.2008.09.018; Hao YP, 2014, ACTA PHARMACOL SIN, V35, P1150, DOI 10.1038/aps.2014.48; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kalkwarf HJ, 2003, AM J CLIN NUTR, V77, P257, DOI 10.1093/ajcn/77.1.257; Kim D, 2017, CLIN GASTROENTEROL H, V15, P474, DOI 10.1016/j.cgh.2016.08.028; Kwo PY, 2017, AM J GASTROENTEROL, V112, P18, DOI 10.1038/ajg.2016.517; Kwok RM, 2013, HEPATOLOGY, V58, P1166, DOI 10.1002/hep.26390; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Lee SH, 2016, J ENDOCRINOLOGICAL I; Li M, 2012, J CLIN ENDOCR METAB, V97, P2033, DOI 10.1210/jc.2011-3010; Lonardo A, 2017, WORLD J GASTROENTERO, V23, P6571, DOI 10.3748/wjg.v23.i36.6571; Lonardo A, 2017, DIGEST LIVER DIS, V49, P471, DOI 10.1016/j.dld.2017.01.147; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Looker AC, 1997, J BONE MINER RES, V12, P1761, DOI 10.1359/jbmr.1997.12.11.1761; Martin-Rodriguez JL, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006770; Mantovani A, 2017, NONALCOHOLIC FATTY L; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Maximos M, 2015, HEPATOLOGY, V61, P153, DOI 10.1002/hep.27395; Moon SS, 2012, ENDOCRINE, V42, P423, DOI 10.1007/s12020-012-9639-6; Muhidin SO, 2012, J OBES, V2012, DOI 10.1155/2012/637538; National Center for Health Statistics, 3 NAT HLTH NUT EX SU; National Center for Health Statistics, 1996, AN REP GUID 3 NAT HL; National Center for Health Statistics, 1996, NHAN 3 HOUS ADULT DA; National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988, NHANES 3 HIP BONE GE; Neyestani TR, 2012, J CLIN ENDOCR METAB, V97, P2005, DOI 10.1210/jc.2011-3465; Plan and operation of the Third National Health and Nutrition Examination Survey, 1994, PROGR COLL PROC V 1, V32, P1; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Ruhl CE, 2012, HEPATOLOGY, V55, P447, DOI 10.1002/hep.24725; Sanna C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050717; Schindhelm RK, 2007, ATHEROSCLEROSIS, V191, P391, DOI 10.1016/j.atherosclerosis.2006.04.006; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Sookoian S, 2017, ALIMENT PHARM THER, V46, P85, DOI 10.1111/apt.14112; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Targher G, 2006, DIABETES CARE, V29, P1325, DOI 10.2337/dc06-0135; Targher G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057183; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Vaidya A, 2012, OBESITY, V20, P186, DOI 10.1038/oby.2011.210; VanWagner LB, 2015, HEPATOLOGY, V62, P773, DOI 10.1002/hep.27869; Vilar-Gomez E, 2017, J HEPATOLOGY; WAHNER HW, 1994, J BONE MINER RES, V9, P951; Weiss J, 2014, DTSCH ARZTEBL INT, V111, P447, DOI 10.3238/arztebl.2014.0447; Wu WC, 2012, ALIMENT PHARM THER, V36, P560, DOI 10.1111/j.1365-2036.2012.05224.x; Zhou JJ, 2013, BONE, V57, P30, DOI 10.1016/j.bone.2013.07.013	55	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197900	10.1371/journal.pone.0197900	http://dx.doi.org/10.1371/journal.pone.0197900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897928	gold, Green Published, Green Submitted			2022-12-26	WOS:000435090700033
J	Manso, R; Martinez-Magunacelaya, N; Erana-Tomas, I; Monsalvez, V; Rodriguez-Peralto, JL; Ortiz-Romero, PL; Santonja, C; Cristobal, I; Piris, MA; Rodriguez-Pinilla, SM				Manso, Rebeca; Martinez-Magunacelaya, Nerea; Erana-Tomas, Itziar; Monsalvez, Veronica; Rodriguez-Peralto, Jose L.; Ortiz-Romero, Pablo-L; Santonja, Carlos; Cristobal, Ion; Piris, Miguel A.; Rodriguez-Pinilla, Socorro M.			Mycosis fungoides progression could be regulated by microRNAs	PLOS ONE			English	Article							CUTANEOUS T-CELL; NF-KAPPA-B; EXPRESSION; APOPTOSIS; IDENTIFICATION; ACTIVATION; LYMPHOMA; GENES; STAT3; VALIDATION	Differentiating early mycosis fungoides (MF) from inflammatory dermatitis is a challenge. We compare the differential expression profile of early-stage MF samples and benign inflammatory dermatoses using microRNA (miRNA) arrays. 114 miRNAs were found to be dysregulated between these entities. The seven most differentially expressed miRNAs between these two conditions were further analyzed using RT-PCR in two series comprising 38 samples of early MFs and 18 samples of inflammatory dermatitis. A series of 51 paraffin embedded samples belonging to paired stages of 16 MF patients was also analyzed. MiRNAs 26a, 222, 181a and 146a were differentially expressed between tumoral and inflammatory conditions. Two of these miRNAs (miRNA-181a and miRNA-146a) were significantly deregulated between early and advanced MF stages. Bioinformatic analysis showed FOXP3 expression to be regulated by these miRNAs. Immunohistochemistry revealed the level of FOXP3 expression to be lower in tumoral MFs than in plaque lesions in paraffin embedded tissue. A functional study confirmed that both miRNAs diminished FOXP3 expression when overexpressed in CTCL cells. The data presented here suggest that the analysis of a restricted number of miRNAs (26a, 222, 181a and 146a) could be sufficient to differentiate tumoral from reactive conditions. Moreover, these miRNAs seem to be involved in MF progression.	[Manso, Rebeca; Santonja, Carlos; Piris, Miguel A.; Rodriguez-Pinilla, Socorro M.] UAM, Dept Pathol, Fdn Jimenez Diaz, CIBERONC, Madrid, Spain; [Martinez-Magunacelaya, Nerea] Fdn Marques Valdecilla, Lab Genom Canc, IDIVAL, Santander, Spain; [Erana-Tomas, Itziar] Hosp Torrejon, Dept Pathol, Madrid, Spain; [Monsalvez, Veronica; Ortiz-Romero, Pablo-L] Hosp Univ 12 Octubre, Dept Dermatol, Madrid, Spain; [Rodriguez-Peralto, Jose L.] Hosp Univ 12 Octubre, Dept Pathol, CIBERONC, Madrid, Spain; [Cristobal, Ion] UAM, Fdn Jimenez Diaz, IIS, Translat Oncol Div,Oncohlth Inst, Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Hospital Universitario 12 de Octubre; Autonomous University of Madrid; Fundacion Jimenez Diaz	Rodriguez-Pinilla, SM (corresponding author), UAM, Dept Pathol, Fdn Jimenez Diaz, CIBERONC, Madrid, Spain.	smrodriguez@fjd.es	Magunacelaya, Nerea Martinez/M-5040-2016; Piris, Miguel A/AAP-1445-2020	Magunacelaya, Nerea Martinez/0000-0002-3983-0867; Piris, Miguel A/0000-0001-5839-3634; Rodriguez-Peralto, Jose Luis/0000-0002-6578-7153; Santonja Garriga, Carlos/0000-0002-1335-0339	Institute de Salud Carlos III; Ministerio de Economia, lndustria y Competitividad [SAF2013-47416-R, PI14/00221, PIE14/0064, PIE15/0081, PIE16/01294]; Asociacion Espanola Contra el Cancer, Spain; Sociedad para el Desarrollo Regional de Cantabria (SODERCAN)	Institute de Salud Carlos III(Instituto de Salud Carlos III); Ministerio de Economia, lndustria y Competitividad; Asociacion Espanola Contra el Cancer, Spain; Sociedad para el Desarrollo Regional de Cantabria (SODERCAN)	This work was supported by grants from the Institute de Salud Carlos III, from the Ministerio de Economia, lndustria y Competitividad (SAF2013-47416-R, CIBERONC-ISCIII, ISCIII-MINECO AES-FEDER (Plan Estatal I+D+I 2013-2016): PI14/00221, PIE14/0064, PIE15/0081 and PIE16/01294) and the Asociacion Espanola Contra el Cancer, Spain. The Institute de Investigacion Marques de Valdecilla (IDIVAL) is partly funded by the Sociedad para el Desarrollo Regional de Cantabria (SODERCAN).	Ach RA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-69; Agar NS, 2010, J CLIN ONCOL, V28, P4730, DOI 10.1200/JCO.2009.27.7665; Avalle Lidia, 2012, JAKSTAT, V1, P65, DOI 10.4161/jkst.20045; Bai Y, 2012, J IMMUNOL, V188, P5293, DOI 10.4049/jimmunol.1102371; Ballabio E, 2010, BLOOD, V116, P1105, DOI 10.1182/blood-2009-12-256719; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Dusilkova N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102136; Fabbri M, 2011, CURR OPIN HEMATOL, V18, P266, DOI 10.1097/MOH.0b013e3283476012; Florell SR, 2006, AM J CLIN PATHOL, V125, P727, DOI 10.1309/3JK2H6Y988NUAY37; Fragoso R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002855; Galicia JC, 2014, GENES IMMUN, V15, P333, DOI 10.1038/gene.2014.24; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Izban KF, 2000, HUM PATHOL, V31, P1482, DOI 10.1053/hupa.2000.20370; Jima DD, 2010, BLOOD, V116, pE118, DOI 10.1182/blood-2010-05-285403; Johnson VE, 2014, J EUR ACAD DERMATOL, V28, P1431, DOI 10.1111/jdv.12299; Kamstrup MR, 2010, BLOOD, V116, P2504, DOI 10.1182/blood-2009-12-260216; Kasprzycka M, 2008, J IMMUNOL, V181, P2506, DOI 10.4049/jimmunol.181.4.2506; Kirsch IR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9122; Kopp KL, 2013, CELL CYCLE, V12, P1939, DOI 10.4161/cc.24987; Krejsgaard T, 2012, LEUKEMIA, V26, P424, DOI 10.1038/leu.2011.237; Krejsgaard T, 2009, BLOOD, V113, P5896, DOI 10.1182/blood-2008-09-181024; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lawrie CH, 2008, J CELL MOL MED, V12, P1432, DOI 10.1111/j.1582-4934.2008.00399.x; Lindahl LM, 2018, BLOOD, V131, P759, DOI 10.1182/blood-2017-06-788950; Liu RH, 2015, CANCER RES, V75, P1714, DOI 10.1158/0008-5472.CAN-14-2109; Liu RH, 2015, CANCER RES, V75, P1703, DOI 10.1158/0008-5472.CAN-14-2108; Maj J, 2012, BRIT J DERMATOL, V166, P331, DOI 10.1111/j.1365-2133.2011.10669.x; Marosvari D, 2015, PATHOL ONCOL RES, V21, P821, DOI 10.1007/s12253-015-9897-8; Marstrand T, 2014, LEUKEMIA LYMPHOMA, V55, P957, DOI 10.3109/10428194.2013.815352; McGirt LY, 2015, BLOOD, V126, P508, DOI 10.1182/blood-2014-11-611194; McGirt LY, 2014, J INVEST DERMATOL, V134, P1101, DOI 10.1038/jid.2013.461; Meisgen F, 2014, J INVEST DERMATOL, V134, P1931, DOI 10.1038/jid.2014.89; Meisgen F, 2014, EXP DERMATOL, V23, P281, DOI 10.1111/exd.12361; Mohnle P, 2015, EUR J IMMUNOL, V45, P260, DOI 10.1002/eji.201444667; Nakayama T, 2001, INT IMMUNOL, V13, P95, DOI 10.1093/intimm/13.1.95; Narducci MG, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.32; Ni X, 2015, CLIN CANCER RES, V21, P274, DOI 10.1158/1078-0432.CCR-14-0830; Nielsen M, 1997, P NATL ACAD SCI USA, V94, P6764, DOI 10.1073/pnas.94.13.6764; Nielsen M, 1999, LEUKEMIA, V13, P735, DOI 10.1038/sj.leu.2401415; Papadavid E, 2003, BRIT J DERMATOL, V148, P709, DOI 10.1046/j.1365-2133.2003.05224.x; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Ralfkiaer U, 2014, ANTICANCER RES, V34, P7207; Ralfkiaer U, 2011, BLOOD, V118, P5891, DOI 10.1182/blood-2011-06-358382; Roncador G, 2005, EUR J IMMUNOL, V35, P1681, DOI 10.1002/eji.200526189; Sadlon TJ, 2010, J IMMUNOL, V185, P1071, DOI 10.4049/jimmunol.1000082; Saunes M, 2009, BRIT J DERMATOL, V160, P376, DOI 10.1111/j.1365-2133.2008.08852.x; Sekulovic LK, 2009, J DERMATOL SCI, V55, P53, DOI 10.1016/j.jdermsci.2009.02.005; Shen XY, 2018, J INVEST DERMATOL, V138, P2024, DOI 10.1016/j.jid.2018.03.1500; Sun XX, 2015, CELL CYCLE, V14, P243, DOI 10.4161/15384101.2014.977112; Swerdlow SH., 2017, WHO CLASSIFICATION T, V2, P453; Swindell WR, 2016, J INVEST DERMATOL, V136, P1820, DOI 10.1016/j.jid.2016.04.035; Tensen CP, 1998, J INVEST DERMATOL, V111, P222, DOI 10.1046/j.1523-1747.1998.00263.x; Tiemessen MM, 2006, J INVEST DERMATOL, V126, P2217, DOI 10.1038/sj.jid.5700371; van Kester MS, 2011, MOL ONCOL, V5, P273, DOI 10.1016/j.molonc.2011.02.003; Vaque JP, 2014, BLOOD, V123, P2034, DOI 10.1182/blood-2013-05-504308; Wada DA, 2010, J CUTAN PATHOL, V37, P535, DOI 10.1111/j.1600-0560.2009.01381.x; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Xie WD, 2013, BIOCHEM BIOPH RES CO, V430, P647, DOI 10.1016/j.bbrc.2012.11.097; Yang Y, 2016, EUR REV MED PHARMACO, V20, P1764; Zhou Y, 2016, J LEUKOCYTE BIOL, V100, P1201, DOI 10.1189/jlb.5A0316-119RR	63	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198477	10.1371/journal.pone.0198477	http://dx.doi.org/10.1371/journal.pone.0198477			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894486	Green Published, Green Submitted, gold			2022-12-26	WOS:000435030900015
J	Martins, TS; Catita, J; Rosa, IM; Silva, OABDE; Henriques, AG				Martins, Tania Soares; Catita, Jose; Rosa, Ilka Martins; da Cruz e Silva, Odete A. B.; Henriques, Ana Gabriela			Exosome isolation from distinct biofluids using precipitation and column-based approaches	PLOS ONE			English	Article							TUMOR-DERIVED EXOSOMES; ASSOCIATION; VESICLES; DISEASE; DEMENTIA; CELLS	The potential of exosomes as biomarker resources for diagnostics, prognostics and even for therapeutics is an area of intense research. Despite the various approaches available, there is no consensus with respect to the best methodology for isolating exosomes and to provide substantial yields with reliable quality. Differential centrifugation is the most commonly used method but it is time-consuming and requires large sample volumes, thus alternative methods are urgently needed. In this study two precipitation-based methods and one column-based approach were compared for exosome isolation from distinct biofluids (serum, plasma and cerebrospinal fluid). Exosome characterization included morphological analyses, determination of particle concentration, stability and exosome preparations' purity, using different complementary approaches such as Nanoparticle Tracking Analysis, Electrophoretic Light Scattering, Transmission Electron Microscopy, EXOCET colorimetric assay, protein quantification methods and western blotting. The three commercial kits tested successfully isolated exosomes from the biofluids under study, although ExoS showed the best performance in terms of exosome yield and purity. Data shows that methods other than differential centrifugation can be applied to quickly and efficiently isolate exosomes from reduced biofluid volumes. The possibility to use small volumes is fundamental in the context of translational and clinical research, thus the results here presented contribute significantly in this respect.	[Martins, Tania Soares; Rosa, Ilka Martins; da Cruz e Silva, Odete A. B.; Henriques, Ana Gabriela] Univ Aveiro, Inst Biomed iBiMED, Dept Med Sci, Neurosci & Signalling Grp, Aveiro, Portugal; [Catita, Jose] Univ Fernando Pessoa, CEBIMED Fac Hlth Sci, Porto, Portugal; [Catita, Jose] Paralab SA, Gondomar, Portugal; [da Cruz e Silva, Odete A. B.] Discovery CTR, Univ Aveiro Campus, Aveiro, Portugal	Universidade de Aveiro; Universidade Fernando Pessoa	Henriques, AG (corresponding author), Univ Aveiro, Inst Biomed iBiMED, Dept Med Sci, Neurosci & Signalling Grp, Aveiro, Portugal.	aghenriques@ua.pt	Rosa, Ilka/AAL-2852-2021; Henriques, Ana Gabriela/F-8414-2011; Cruz e Silva, Odete/AAH-5595-2020; da Cruz e Silva, Odete A B/F-4072-2010; Catita, Jose/AAD-4710-2021	Rosa, Ilka/0000-0001-6536-8728; Henriques, Ana Gabriela/0000-0003-0851-6979; da Cruz e Silva, Odete A B/0000-0003-3718-9874; Catita, Jose/0000-0001-7270-5702; Martins, Tania/0000-0003-3017-2092	Institute de Biomedicina (iBiMED) [UID/BIM/04501/2013, POCI-01-0145-FEDER-007628]; Fundacao para a Ciencia e Tecnologia (FCT) of the Ministerio da Educacao e Ciencia, COMPETE program; QREN; European Union (Fundo Europeu de Desenvolvimento Regional);  [PTDC/DTPPIC/5587/2014]	Institute de Biomedicina (iBiMED); Fundacao para a Ciencia e Tecnologia (FCT) of the Ministerio da Educacao e Ciencia, COMPETE program; QREN; European Union (Fundo Europeu de Desenvolvimento Regional); 	This work was funded by PTDC/DTPPIC/5587/2014 and supported by Institute de Biomedicina (iBiMED)-UID/BIM/04501/2013 and POCI-01-0145-FEDER-007628, the Fundacao para a Ciencia e Tecnologia (FCT) of the Ministerio da Educacao e Ciencia, COMPETE program, the QREN and the European Union (Fundo Europeu de Desenvolvimento Regional). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Andreu Z, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.31655; Bhattacharjee S, 2016, J CONTROL RELEASE, V235, P337, DOI 10.1016/j.jconrel.2016.06.017; Bosch S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36162; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Caradec J, 2014, CLIN BIOCHEM, V47, P1286, DOI 10.1016/j.clinbiochem.2014.06.011; Conde-Vancells J, 2012, ISOLATION URINARY EX, P321; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Deregibus MC, 2016, INT J MOL MED, V38, P1359, DOI 10.3892/ijmm.2016.2759; Dinkins MB, 2015, J ALZHEIMERS DIS, V46, P55, DOI 10.3233/JAD-150088; EL Andaloussi S, 2013, ADV DRUG DELIVER REV, V65, P391, DOI 10.1016/j.addr.2012.08.008; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Grigor'eva A. E., 2017, Biomeditsinskaya Khimiya, V63, P91, DOI 10.18097/PBMC2017630191; Helwa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170628; Henriques AG, 2005, J ALZHEIMERS DIS, V7, P201; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jiang X, 2017, AM J PHYSIOL-HEART C, V312, pH818, DOI 10.1152/ajpheart.00673.2016; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594; Lee M, 2016, BIOTECHNOL BIOPROC E, V21, P299, DOI 10.1007/s12257-015-0781-x; Li P, 2017, THERANOSTICS, V7, P789, DOI 10.7150/thno.18133; Lobb RJ, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27031; Momen-Heravi F, 2013, BIOL CHEM, V394, P1253, DOI 10.1515/hsz-2013-0141; Momen-Heravi F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00162; Poliakov A, 2009, PROSTATE, V69, P159, DOI 10.1002/pros.20860; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Ramasamy I, 2014, CLIN CHEM LAB MED, V52, P1695, DOI 10.1515/cclm-2013-0358; Rider MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep23978; Rosa IM, 2018, J ALZHEIMERS DIS, V61, P157, DOI 10.3233/JAD-170501; Rosa IM, 2017, DEMENT GERIATR COGN, V43, P15, DOI 10.1159/000452485; Saenz-Cuesta M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00050; Savina A, 2002, J CELL SCI, V115, P2505; Skriner K, 2006, ARTHRITIS RHEUM, V54, P3809, DOI 10.1002/art.22276; Stuendl A, 2016, BRAIN, V139, P481, DOI 10.1093/brain/awv346; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang YJ, 2015, INT J CARDIOL, V192, P61, DOI 10.1016/j.ijcard.2015.05.020; Webber J, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19861; Welton JL, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27269; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Yagi Y, 2017, NEUROSCI LETT, V636, P48, DOI 10.1016/j.neulet.2016.10.042; Yakimchuk K, 2015, MAT METHODS, V5, P1450, DOI [DOI 10.13070/MM.EN.5.1450, 10.13070/mm.en.5.1450]	48	176	179	11	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198820	10.1371/journal.pone.0198820	http://dx.doi.org/10.1371/journal.pone.0198820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889903	Green Published, Green Submitted, gold			2022-12-26	WOS:000434786600054
J	Raedkjaer, M; Maretty-Kongstad, K; Bead-Hansen, T; Jorgensen, PH; Safwat, A; Vedsted, P; Petersen, MM; Hovgaard, T; Nymark, T; Keller, J				Raedkjaer, Mathias; Maretty-Kongstad, Katja; Bead-Hansen, Thomas; Jorgensen, Peter Holmberg; Safwat, Akmal; Vedsted, Peter; Petersen, Michael Mork; Hovgaard, Thea; Nymark, Tine; Keller, Johnny			The impact of comorbidity on mortality in Danish sarcoma patients from 2000-2013: A nationwide population-based multicentre study	PLOS ONE			English	Article							SOFT-TISSUE SARCOMA; CELL LUNG-CANCER; BREAST-CANCER; COMPETING RISKS; AGE SPECTRUM; CO-MORBIDITY; SURVIVAL; REGISTER; COHORT; DENMARK	Introduction Sarcoma is a rare type of cancer. The incidence increases with age and elderly patients may have comorbidity that affects the prognosis. The aim of this study was to describe the type and prevalence of comorbidity in a nationwide population-based study in Denmark from 2000-2013 and to analyse the impact of the different comorbidities on mortality. Material and methods The Danish Sarcoma Registry is a national clinical database containing all patients with sarcoma in the extremities or trunk wall from 2000 and onwards. By linking data to other registries, we were able to get patient information on an individual level including date and cause of death as well as the comorbidity type up to 10 years prior to the sarcoma diagnosis. Based on diseases in the Charlson Comorbidity Index, we pooled the patients into six categories: no comorbidity, cardiopulmonary disease, gastrointestinal disease, neurovascular disease, malignant neoplasms, and miscellaneous (diabetes, renal and connective tissue diseases). 2167 patients were included. Results The prevalence of comorbidity was 20%. For patients with localized disease, comorbidity increased the disease-specific mortality significantly (HR 1.70 (95% CI 1.36-2.13)). For patients with metastatic disease at the time of diagnosis, comorbidity did not affect the disease-specific mortality (HR 1.05 (95% CI 0.78-1.42)). The presence of another cancer diagnosis within 10 years prior to the sarcoma diagnosis was the only significant independent prognostic factor of disease-specific mortality with an increase of 66% in mortality rate compared to patients with no comorbidity (HR 1,66 (95% CI 1.22-2.25)). Conclusion Comorbidity is a strong independent prognostic factor of mortality in patients with localized disease. This study emphasizes the need for optimizing the general health of comorbid patients in order to achieve a survival benefit from treatment of patients with localized disease, as this is potentially modifiable.	[Raedkjaer, Mathias; Bead-Hansen, Thomas; Jorgensen, Peter Holmberg; Keller, Johnny] Aarhus Univ Hosp, Dept Orthopaed Surg, Aarhus, Denmark; [Raedkjaer, Mathias; Petersen, Michael Mork; Hovgaard, Thea] Univ Copenhagen, Rigshosp, Dept Orthopaed Surg, Copenhagen, Denmark; [Raedkjaer, Mathias] Aarhus Univ Hosp, Dept Expt Clin Oncol, Aarhus, Denmark; [Maretty-Kongstad, Katja] Aarhus Univ Hosp, Dept Pathol, Aarhus, Denmark; [Safwat, Akmal] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark; [Vedsted, Peter] Aarhus Univ, Res Unit Gen Practice, Aarhus, Denmark; [Vedsted, Peter] Aarhus Univ, Silkeborg Hosp, Dept Clin Med, Aarhus, Denmark; [Nymark, Tine] Odense Univ Hosp, Dept Orthopaed Surg, Odense, Denmark	Aarhus University; Rigshospitalet; University of Copenhagen; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; University of Southern Denmark; Odense University Hospital	Raedkjaer, M (corresponding author), Aarhus Univ Hosp, Dept Orthopaed Surg, Aarhus, Denmark.; Raedkjaer, M (corresponding author), Univ Copenhagen, Rigshosp, Dept Orthopaed Surg, Copenhagen, Denmark.; Raedkjaer, M (corresponding author), Aarhus Univ Hosp, Dept Expt Clin Oncol, Aarhus, Denmark.	raedkjaer@dadlnet.dk	Vedsted, Peter/C-2583-2008	Vedsted, Peter/0000-0003-2113-5599; Baad-Hansen, Thomas/0000-0003-4826-8412; Hovgaard, Thea Bechmann/0000-0003-2859-9142; Safwat, Akmal/0000-0002-6020-2320; Raedkjaer, Mathias/0000-0002-8515-5268; Petersen, Michael Mork/0000-0002-2324-6420	Danish Cancer Society [R94-A5948-14-521]; Inge og Max Worzners Mindelegat; Radiumstationens Forskningsfond; A. P. Moller Fonden til LaNevidenskabens Fremme	Danish Cancer Society(Danish Cancer Society); Inge og Max Worzners Mindelegat; Radiumstationens Forskningsfond; A. P. Moller Fonden til LaNevidenskabens Fremme	This study received financial support from Danish Cancer Society, grant number R94-A5948-14-521, wm.cancer.dk, 'Inge og Max Worzners Mindelegat', 'Radiumstationens Forskningsfond' and 'A. P. Moller Fonden til LaNevidenskabens Fremme' (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerholm-Pedersen Ninna, 2014, Sarcoma, V2014, P690316, DOI 10.1155/2014/690316; Andersen TF, 1999, DAN MED BULL, V46, P263; Asmis TR, 2008, J CLIN ONCOL, V26, P54, DOI 10.1200/JCO.2007.12.8322; Berglund A, 2012, BREAST CANCER RES TR, V135, P281, DOI 10.1007/s10549-012-2176-4; Bjerregaard B, 2011, SCAND J PUBLIC HEALT, V39, P72, DOI 10.1177/1403494810393563; Boje CR, 2013, ACTA ONCOL, V52, P285, DOI 10.3109/0284186X.2012.742964; Bradley CJ, 2008, ARCH INTERN MED, V168, P521, DOI 10.1001/archinternmed.2007.82; Carlsen K, 2008, EUR J CANCER, V44, P1996, DOI 10.1016/j.ejca.2008.06.027; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cronin-Fenton DP, 2007, BRIT J CANCER, V96, P1462, DOI 10.1038/sj.bjc.6603717; Dalton SO, 2007, INT J CANCER, V121, P2524, DOI 10.1002/ijc.22979; Danmarks Statistik SD, 2017, FOLK DANM DAN POP FI; Dansk Sarkom Gruppe Danish Sarcoma Group, 2009, VEDT REG DAN; DMCG Danske Multidiplicinnare Cancer Grupper Danish Multidiplicinary Cancer Groups.  the Danish Health and Medicines Authority, 2015, FOLL UP PROGR SACR D; Ducimetiere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020294; Dyrop HB, 2013, HEALTH POLICY, V113, P110, DOI 10.1016/j.healthpol.2013.09.012; FEINSTEIN AR, 1970, J CHRON DIS, V23, P455, DOI 10.1016/0021-9681(70)90054-8; Ferrari A, 2011, PEDIATR BLOOD CANCER, V57, P943, DOI 10.1002/pbc.23252; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Iversen LH, 2009, DIS COLON RECTUM, V52, P71, DOI 10.1007/DCR.0b013e3181974384; Jorgensen TL, 2012, BRIT J CANCER, V106, P1353, DOI 10.1038/bjc.2012.46; Kang S, 2015, CLIN ORTHOP SURG, V7, P120, DOI 10.4055/cios.2015.7.1.120; Kim HT, 2007, CLIN CANCER RES, V13, P559, DOI 10.1158/1078-0432.CCR-06-1210; Land LH, 2012, BREAST CANCER RES TR, V131, P1013, DOI 10.1007/s10549-011-1819-1; Luchtenborg M, 2012, EUR J CANCER, V48, P3386, DOI 10.1016/j.ejca.2012.06.012; Lund L, 2009, J UROLOGY, V182, P35, DOI 10.1016/j.juro.2009.02.136; Lund L, 2009, J UROLOGY, V182, P35, DOI 10.1016/j.juro.2009.02.136; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Maretty-Nielsen K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-682; Maretty-Nielsen K, 2014, ACTA ONCOL, V53, P1188, DOI 10.3109/0284186X.2014.888494; Maretty-Nielsen Katja, 2013, Clin Epidemiol, V5, P45, DOI 10.2147/CLEP.S41835; Matsumoto S, 2018, J ORTHOP SCI, pS0949; Morris EJA, 2011, GUT, V60, P806, DOI 10.1136/gut.2010.232181; Mosbech J, 1995, Ugeskr Laeger, V157, P3741; Nakamura T, 2013, EUR J CANCER, V49, P377, DOI 10.1016/j.ejca.2012.09.004; Nguyen-Nielsen Mary, 2013, Clin Epidemiol, V5, P47, DOI 10.2147/CLEP.S47153; Nickelsen T N, 2001, Ugeskr Laeger, V164, P33; Ording Anne Gulbech, 2013, Clin Epidemiol, V5, P39, DOI 10.2147/CLEP.S47152; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Piccirillo JF, 2008, CRIT REV ONCOL HEMAT, V67, P124, DOI 10.1016/j.critrevonc.2008.01.013; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Skubitz KM, 2007, MAYO CLIN PROC, V82, P1409, DOI 10.4065/82.11.1409; Sundhedsstyrelsen, 2008, CANC; Sundhedsstyrelsen The Danish Health and Medicines Authority, 2016, FAST TRACK CANC PAT; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83	47	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198933	10.1371/journal.pone.0198933	http://dx.doi.org/10.1371/journal.pone.0198933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889880	Green Submitted, Green Published, gold			2022-12-26	WOS:000434786600064
J	Tsai, YT; Huang, EI; Chang, GH; Tsai, MS; Hsu, CM; Yang, YH; Lin, MH; Liu, CY; Li, HY				Tsai, Yao-Te; Huang, Ethan, I; Chang, Geng-He; Tsai, Ming-Shao; Hsu, Cheng-Ming; Yang, Yao-Hsu; Lin, Meng-Hung; Liu, Chia-Yen; Li, Hsueh-Yu			Risk of acute epiglottitis in patients with preexisting diabetes mellitus: A population-based case-control study	PLOS ONE			English	Article							INFLUENZAE TYPE-B; COMPLICATIONS SEVERITY INDEX; INSURANCE RESEARCH DATABASE; ADULT ACUTE EPIGLOTTITIS; SEX-DIFFERENCES; NECROTIZING FASCIITIS; IMMUNE-RESPONSES; HONG-KONG; CHILDREN; VACCINATION	Objective Studies have revealed that 3.5%-26.6% of patients with epiglottitis have comorbid diabetes mellitus (DM). However, whether preexisting DM is a risk factor for acute epiglottitis remains unclear. In this study, our aim was to explore the relationship between preexisting DM and acute epiglottitis in different age and sex groups by using population-based data in Taiwan. Methods We analyzed data between January 2000 and December 2013 obtained from the Taiwan National Health Insurance Research Database. The case group consisted of 2,393 patients with acute epiglottitis. The control group comprised 9,572 individuals without epiglottitis, frequency matched by sex, age, urbanization level, and income. Underlying DM was retrospectively assessed in the cases and controls. Univariate and multivariate logistic regression analyses were used to investigate the associations between underlying DM and acute epiglottitis. Results Of the 2,393 patients, 180 (7.5%) had preexisting DM, whereas only 530 (5.5%) of the 9,572 controls had preexisting DM. Multivariate logistic regression analyses indicated that preexisting DM was significantly associated with acute epiglottitis (adjusted odds ratio [aOR] = 1.42, 95% confidence interval [CI] = 1.15-1.75, P= 0.004). Subgroup analysis showed that the association between DM and epiglottitis remained significant for men (aOR = 1.57, 95% CI: 1.19-2.08, p = 0.002) but not for women. Age-stratified analysis revealed a significant association between DM and acute epiglottitis in patients aged 35-64 years. Use of anti-diabetic agents was not significantly associated with the development of acute epiglottitis among diabetic patients, including oral hypoglycemic agents (OHA) alone (aOR = 0.88, 95% CI = 0.53-1.46, p= 0.616), and OHA combined with insulin/ insulin alone (aOR = 1.30, 95% CI = 0.76-2.22, p = 0.339). The association between presence of diabetes complications and the occurrence of acute epiglottitis was also not significant among diabetic patients in this study setting (aOR = 0.86, 95% CI = 0.59-1.26, p= 0.439). Conclusions The results of our large-scale population-based case-control study indicate that preexisting DM is one of the possible factors associated with the development of acute epiglottitis. Physicians should pay attention to the symptoms and signs of acute epiglottitis in DM patients, particularly in men aged 35-64 years.	[Tsai, Yao-Te; Huang, Ethan, I; Chang, Geng-He; Tsai, Ming-Shao; Hsu, Cheng-Ming] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Chiayi, Taiwan; [Tsai, Yao-Te; Huang, Ethan, I; Chang, Geng-He; Tsai, Ming-Shao; Hsu, Cheng-Ming] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Yang, Yao-Hsu] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan; [Yang, Yao-Hsu] Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Taoyuan, Taiwan; [Lin, Meng-Hung; Liu, Chia-Yen] Chang Gung Mem Hosp, Hlth Informat & Epidemiol Lab, Chiayi, Taiwan; [Li, Hsueh-Yu] Linkou Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; National Taiwan University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Li, HY (corresponding author), Linkou Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taoyuan, Taiwan.	kilikkilik121415@gmail.com	Lin, Meng-Hung/F-5730-2010; Lin, Meng-Hung/AAJ-5470-2020; Tsai, Ming-Shao/B-3187-2017; 楊, 曜旭/A-3450-2019	Lin, Meng-Hung/0000-0002-8594-3360; Lin, Meng-Hung/0000-0002-8594-3360; Tsai, Ming-Shao/0000-0002-9314-5940; 楊, 曜旭/0000-0002-8080-0504; Hsu, Cheng-Ming/0000-0003-3792-3784				ALHO OP, 1995, ARCH OTOLARYNGOL, V121, P898; Berg S, 1996, SCAND J INFECT DIS, V28, P261, DOI 10.3109/00365549609027168; Berger G, 2003, AM J OTOLARYNG, V24, P374, DOI 10.1016/S0196-0709(03)00083-8; Bizaki AJ, 2011, LARYNGOSCOPE, V121, P2107, DOI 10.1002/lary.22147; Briem B, 2009, AURIS NASUS LARYNX, V36, P46, DOI 10.1016/j.anl.2008.03.012; CARENFELT C, 1989, CLIN OTOLARYNGOL, V14, P489, DOI 10.1111/j.1365-2273.1989.tb00410.x; Chalmers C, 2010, J LARYNGOL OTOL, V124, P807, DOI 10.1017/S0022215109992076; Chang GH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2531-5; Chang HY, 2012, AM J MANAG CARE, V18, P721; Chang YL, 2005, OTOLARYNG HEAD NECK, V132, P689, DOI 10.1016/j.otohns.2005.01.011; Chen HL, 2014, J DIABETES COMPLICAT, V28, P612, DOI 10.1016/j.jdiacomp.2014.05.011; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheung CSK, 2009, EUR J EMERG MED, V16, P221, DOI 10.1097/MEJ.0b013e328320ad2f; CHONG WH, 1990, THORAX, V45, P491, DOI 10.1136/thx.45.6.491; Chroboczek T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125736; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; Falagas ME, 2007, RESP MED, V101, P1845, DOI 10.1016/j.rmed.2007.04.011; Falguera K, 2005, CHEST, V128, P3233, DOI 10.1378/chest.128.5.3233; Fischer J, 2015, INFECTION, V43, P399, DOI 10.1007/s15010-015-0791-9; FRANTZ TD, 1994, JAMA-J AM MED ASSOC, V272, P1358, DOI 10.1001/jama.272.17.1358; Gagnon R, 2002, ANN ALLERG ASTHMA IM, V88, P513, DOI 10.1016/S1081-1206(10)62391-5; GALLACHER SJ, 1995, DIABETIC MED, V12, P916, DOI 10.1111/j.1464-5491.1995.tb00396.x; Garpenholt O, 1999, PEDIATR INFECT DIS J, V18, P490, DOI 10.1097/00006454-199906000-00003; Ge RM, 2012, DIABETES RES CLIN PR, V95, pE31, DOI 10.1016/j.diabres.2011.10.010; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; Guldfred LA, 2008, J LARYNGOL OTOL, V122, P818, DOI 10.1017/S0022215107000473; Harris C, 2012, INFECT DIS REP, V4, P6, DOI 10.4081/idr.2012.e3; Hebert PC, 1998, LARYNGOSCOPE, V108, P64, DOI 10.1097/00005537-199801000-00012; Hsiao YH, 2015, SLEEP, V38, P581, DOI 10.5665/sleep.4574; Hsu WT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183808; Isakson M, 2011, J LARYNGOL OTOL, V125, P390, DOI 10.1017/S0022215110002446; Katori H, 2005, J LARYNGOL OTOL, V119, P967, DOI 10.1258/002221505775010823; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Kudchadkar SR, 2014, J EMERG MED, V46, pE43, DOI 10.1016/j.jemermed.2013.08.033; LASCOLEA LJ, 1985, J INFECT DIS, V151, P1162, DOI 10.1093/infdis/151.6.1162; Mashimoto H, 1992, Kansenshogaku Zasshi, V66, P648; MAYOSMITH MF, 1995, CHEST, V108, P1640, DOI 10.1378/chest.108.6.1640; McEwan J, 2003, INT J PEDIATR OTORHI, V67, P317, DOI 10.1016/S0165-5876(02)00393-2; Midwinter KI, 1999, CLIN OTOLARYNGOL, V24, P447, DOI 10.1046/j.1365-2273.1999.00291.x; MURPHY TV, 1993, JAMA-J AM MED ASSOC, V269, P246, DOI 10.1001/jama.269.2.246; Ng HL, 2008, EMERG MED J, V25, P253, DOI 10.1136/emj.2007.050153; Price Ira M, 2005, CJEM, V7, P387; Richardson DK, 2012, J EMERG MED, V43, P634, DOI 10.1016/j.jemermed.2010.05.025; Shah RK, 2010, LARYNGOSCOPE, V120, P1256, DOI 10.1002/lary.20921; Shah RK, 2004, LARYNGOSCOPE, V114, P557, DOI 10.1097/00005537-200403000-00031; Solomon P, 1998, J OTOLARYNGOL, V27, P332; Suzuki S, 2015, LARYNGOSCOPE, V125, P2072, DOI 10.1002/lary.25114; Tateya I, 2003, EUR ARCH OTO-RHINO-L, V260, P128, DOI 10.1007/s00405-002-0528-0; VALERIUS NH, 1982, ACTA MED SCAND, V211, P463; Vardakas KZ, 2007, DIABETIC MED, V24, P1168, DOI 10.1111/j.1464-5491.2007.02234.x; Wu DY, 2008, J LEUKOCYTE BIOL, V84, P900, DOI 10.1189/jlb.0108023; WURTELE P, 1990, OTOLARYNG HEAD NECK, V103, P902, DOI 10.1177/019459989010300603; Yang YH, 2015, J HEPATOL, V63, P1111, DOI 10.1016/j.jhep.2015.07.006; Yoon TM, 2010, CLIN OTOLARYNGOL, V35, P18, DOI 10.1111/j.1749-4486.2009.02069.x; Young BA, 2008, AM J MANAG CARE, V14, P15	56	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0199036	10.1371/journal.pone.0199036	http://dx.doi.org/10.1371/journal.pone.0199036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889887	Green Submitted, Green Published, gold			2022-12-26	WOS:000434786600072
J	Castro, N; Mendoza, JM; Tampke, EC; Vitevitch, MS				Castro, Nichol; Mendoza, Joshua M.; Tampke, Elizabeth C.; Vitevitch, Michael S.			An account of the Speech-to-Song Illusion using Node Structure Theory	PLOS ONE			English	Article							PHONOTACTIC PROBABILITY; VERBAL TRANSFORMATIONS; LEXICAL COMPETITION; ILLUSORY CHANGES; WORD PERCEPTION; SPOKEN WORDS; LANGUAGE; MUSIC; NEIGHBORHOODS; REPETITION	In the Speech-to-Song Illusion, repetition of a spoken phrase results in it being perceived as if it were sung. Although a number of previous studies have examined which characteristics of the stimulus will produce the illusion, there is, until now, no description of the cognitive mechanism that underlies the illusion. We suggest that the processes found in Node Structure Theory that are used to explain normal language processing as well as other auditory illusions might also account for the Speech-to-Song Illusion. In six experiments we tested whether the satiation of lexical nodes, but continued priming of syllable nodes may lead to the Speech-to-Song Illusion. The results of these experiments provide evidence for the role of priming, activation, and satiation as described in Node Structure Theory as an explanation of the Speech-to-Song Illusion.	[Castro, Nichol; Mendoza, Joshua M.; Tampke, Elizabeth C.; Vitevitch, Michael S.] Univ Kansas, Dept Psychol, Spoken Language Lab, Lawrence, KS 66045 USA	University of Kansas	Vitevitch, MS (corresponding author), Univ Kansas, Dept Psychol, Spoken Language Lab, Lawrence, KS 66045 USA.	mvitevit@ku.edu	Castro, Nichol/AGK-6706-2022	Castro, Nichol/0000-0001-8691-7968; Vitevitch, Michael/0000-0002-1209-0838	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000052] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Asaridou SS, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00321; Bashford JA, 2006, J ACOUST SOC AM, V119, pEL55, DOI 10.1121/1.2181186; Bashford JA, 2008, J ACOUST SOC AM, V123, pEL32, DOI 10.1121/1.2839069; Bassett MF, 1919, AM J PSYCHOL, V30, P415, DOI 10.2307/1413679; Brancazio L, 2005, PERCEPT PSYCHOPHYS, V67, P759, DOI 10.3758/BF03193531; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; CHOE CS, 1975, PERCEPT PSYCHOPHYS, V18, P55, DOI 10.3758/BF03199367; Christiner M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00874; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coren S., 1978, SEEING IS DECEIVING; der Nederlanden CMV, 2015, COGNITION, V143, P135, DOI 10.1016/j.cognition.2015.06.015; Deutsch D, 2003, PHANTOM WORDS OTHER; Deutsch D, 1995, MUSICAL ILLUSIONS PA; Deutsch D, 2011, J ACOUST SOC AM, V129, P2245, DOI 10.1121/1.3562174; Dziubalska-Kolaczyk K, 2002, BEATS AND BINDING PH; Falk S, 2014, J EXP PSYCHOL HUMAN, V40, P1491, DOI 10.1037/a0036858; Fay K, 2010, ENCY RES DESIGN, P422; GREGORY RL, 1968, PROC R SOC SER B-BIO, V171, P279, DOI 10.1098/rspb.1968.0071; Heffner CC, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01962; Hymers M, 2015, NEUROIMAGE, V108, P225, DOI 10.1016/j.neuroimage.2014.12.010; Jack BN, 2013, J EXP PSYCHOL HUMAN, V39, P1496, DOI 10.1037/a0033594; Jackendoff R, 2009, MUSIC PERCEPT, V26, P195, DOI 10.1525/MP.2009.26.3.195; Jaisin K, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00662; Ju M, 2004, PSYCHOL SCI, V15, P314, DOI 10.1111/j.0956-7976.2004.00675.x; JUSCZYK PW, 1993, CHILD DEV, V64, P675, DOI 10.2307/1131210; Kaminska Z, 2002, EUR J COGN PSYCHOL, V14, P315, DOI 10.1080/09541440143000087; Koelsch S, 2002, NEUROIMAGE, V17, P956, DOI 10.1016/S1053-8119(02)91154-7; Luce PA, 1998, EAR HEARING, V19, P1, DOI 10.1097/00003446-199802000-00001; Ludke KM, 2014, MEM COGNITION, V42, P41, DOI 10.3758/s13421-013-0342-5; MacKay D.G, 1984, NATURE TREATMENT STU, P261; MacKay D.G., 1990, AGING COGNITION KNOW, V71, P213, DOI [10.1016/S0166-4115(08)60159-4, DOI 10.1016/S0166-4115(08)60159-4]; MacKay DG, 1998, J MEM LANG, V38, P28, DOI 10.1006/jmla.1997.2544; MACKAY DG, 1992, CONSCIOUS COGN, V1, P199, DOI 10.1016/1053-8100(92)90061-E; MACKAY DG, 1993, J MEM LANG, V32, P624, DOI 10.1006/jmla.1993.1032; MacKay DonaldG., 1987, ORG PERCEPTION ACTIO; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Margulis Elizabeth., 2013, REPEAT MUSIC PLAYS M; Margulis EH, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00048; Margulis EH, 2016, MUSIC PERCEPT, V33, P509, DOI 10.1525/MP.2016.33.4.509; Margulis EH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00167; Marian V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043230; McGowan RW, 2011, MUSIC PERCEPT, V28, P307, DOI 10.1525/MP.2011.28.3.307; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Merrill J, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01108; Mok PKP, 2012, J ACOUST SOC AM, V132, P2711, DOI 10.1121/1.4747010; Neuhoff JG, 2014, LANG SPEECH, V57, P563, DOI 10.1177/0023830914520837; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; Pilotti M, 2000, PSYCHOL AGING, V15, P313, DOI 10.1037//0882-7974.15.2.313; Pitt MA, 2002, J EXP PSYCHOL HUMAN, V28, P150, DOI 10.1037//0096-1523.28.1.150; Quinto L, 2010, ATTEN PERCEPT PSYCHO, V72, P1450, DOI 10.3758/APP.72.6.1450; Rathcke T., 2010, SPEECH PROSODY 2010, V100169, P1; REMEZ RE, 1981, SCIENCE, V212, P947, DOI 10.1126/science.7233191; Remez RE, 2001, PSYCHOL SCI, V12, P24, DOI 10.1111/1467-9280.00305; Shoaf LC, 2002, PERCEPT PSYCHOPHYS, V64, P795, DOI 10.3758/BF03194746; Tang C, 2017, SCIENCE, V357, P797, DOI 10.1126/science.aam8577; Taylor S, 2014, J ANXIETY DISORD, V28, P580, DOI 10.1016/j.janxdis.2014.06.003; Tierney A, 2016, P 14 INT C MUS PERC, P369; Tierney A, 2013, CEREB CORTEX, V23, P249, DOI 10.1093/cercor/bhs003; Vitevitch MS, 2016, ANNU REV LINGUIST, V2, P75, DOI 10.1146/annurev-linguistics-030514-124832; Vitevitch MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079701; Vitevitch MS, 2012, PSYCHOL RES-PSYCH FO, V76, P693, DOI 10.1007/s00426-011-0374-z; Vitevitch MS, 2012, BILING-LANG COGN, V15, P167, DOI 10.1017/S1366728911000149; Vitevitch MS, 2008, LANG SPEECH, V51, P361, DOI 10.1177/0023830908099070; Vitevitch MS, 1997, LANG SPEECH, V40, P47, DOI 10.1177/002383099704000103; Vitevitch MS, 2005, J MEM LANG, V52, P193, DOI 10.1016/j.jml.2004.10.003; Vitevitch MS, 2004, J EXP PSYCHOL LEARN, V30, P514, DOI 10.1037/0278-7393.30.2.514; Vitevitch MS, 2003, MEM COGNITION, V31, P491, DOI 10.3758/BF03196091; Vitevitch MS, 1998, PSYCHOL SCI, V9, P325, DOI 10.1111/1467-9280.00064; WARREN RM, 1970, SCIENCE, V167, P392, DOI 10.1126/science.167.3917.392; WARREN RM, 1958, AM J PSYCHOL, V71, P612, DOI 10.2307/1420267; WARREN RM, 1961, BRIT J PSYCHOL, V52, P249, DOI 10.1111/j.2044-8295.1961.tb00787.x; Whalen DH, 1996, PERCEPT PSYCHOPHYS, V58, P857, DOI 10.3758/BF03205488; Yamomoto F, 1996, J HIMEJI DOKKYO U GA, V9, P224; Yin C, 1992, COGN AG C ATL GA; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; Zhang S, 2011, BIENN M SOC MUS PERC	78	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198656	10.1371/journal.pone.0198656	http://dx.doi.org/10.1371/journal.pone.0198656			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI7ZT	29883451	gold, Green Published, Green Submitted			2022-12-26	WOS:000434728100036
J	Cully, P; Nielsen, B; Lancaster, B; Martin, J; McGreevy, P				Cully, Paulette; Nielsen, Brian; Lancaster, Bryony; Martin, Jessica; McGreevy, Paul			The laterality of the gallop gait in Thoroughbred racehorses	PLOS ONE			English	Article							MOTOR LATERALITY; ASYMMETRY; PERFORMANCE; PREFERENCE; FORELIMB	Laterality can be observed as side biases in locomotory behaviour which, in the horse, manifest inter alia as forelimb preferences, most notably in the gallop. The current study investigated possible leading-leg preferences at the population and individual level in Thoroughbred racehorses (n = 2095) making halt-to-gallop transitions. Videos of flat races in the UK (n = 350) were studied to record, for each horse, the lead-leg preference of the initial stride into gallop from the starting stalls. Races from clockwise (C) and anti-clockwise (AC) tracks were chosen alternately at random to ensure equal representation. Course direction, horse age and sex, position relative to the inside rail and finishing position were also noted. On C courses, the left/right ratio was 1.15, which represents a significant bias to the left (z = - 2.29, p = 0.022), while on AC courses it was 0.92 (z = 0.51, p = 0.610). In both course directions, there was no significant difference between winning horses that led with the left leading leg versus the right (C courses, z = -1.32, p = 0.19 and AC courses, z = -0.74, p = 0.46). Of the 2,095 horses studied 51.26% led with their L fore and 48.74% with their R, with no statistically significant difference (z = -1.16, p = 0.25). Therefore, there was no evidence of a population level motor laterality. Additionally, 22 male and 22 female horses were randomly chosen for repeated measures of leading leg preference. A laterality index was calculated for each of the 44 horses studied using the repeated measures: 22 exhibited right laterality (of which two were statistically significant) and 21 exhibited left laterality (eight being statistically significant); one horse was ambilateral. Using these data, left lateralized horses were more strongly lateralized on an individual level than the right lateralized horses (t = 2.28, p = 0.03, DF = 34) and mares were more left lateralized than males (t = 2.4, p = 0.03, DF = 19).	[Cully, Paulette; Lancaster, Bryony; Martin, Jessica] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush Campus, Edinburgh, Midlothian, Scotland; [Cully, Paulette; Lancaster, Bryony; Martin, Jessica] Univ Edinburgh, Roslin Inst, Easter Bush Campus, Edinburgh, Midlothian, Scotland; [Nielsen, Brian] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [McGreevy, Paul] Univ Sydney, Sydney Sch Vet Sci, Fac Sci, Sydney, NSW, Australia	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Michigan State University; University of Sydney	McGreevy, P (corresponding author), Univ Sydney, Sydney Sch Vet Sci, Fac Sci, Sydney, NSW, Australia.	paul.mcgreevy@sydney.edu.au	Martin, Jessica/AGC-5181-2022	Martin, Jessica/0000-0003-0294-8770; McGreevy, Paul/0000-0001-7220-8378; Nielsen, Brian/0000-0002-2570-5731; Cully, Paulette/0000-0003-2198-2480				Austin NP, 2007, LATERALITY, V12, P464, DOI 10.1080/13576500701495307; Back W., 2013, EQUINE LOCOMOTION, V2nd; Carter R., 2009, THE HUMAN BRAIN BOOK; Corballis MC, 2009, PHILOS T R SOC B, V364, P867, DOI 10.1098/rstb.2008.0232; DALIN G, 1985, EQUINE VET J, V17, P292, DOI 10.1111/j.2042-3306.1985.tb02501.x; de La Gueriniere FR, 1736, ECOLE DE CAVALERIE; de Pluvinel A, 1666, INSTRUCTION ROY LEXE; DEKUNFFY C, 1992, ATHLETIC DEV DRESSAG; DEUEL NR, 1987, J BIOMECH, V20, P645, DOI 10.1016/0021-9290(87)90285-5; Drummond K, 1998, ESSENTIALS HORSEMANS; Durost WN, 1934, GENET PSYCHOL MONOG, V16, P225; Fagard J, 2015, LATERALITY, V20, P543, DOI 10.1080/1357650X.2015.1009089; FAGOT J, 1991, PSYCHOL BULL, V109, P76, DOI 10.1037/0033-2909.109.1.76; Grzimek B, 1968, MAN ANIMAL STUDIES B, P37; Harris J, 2015, PROCESS TRAINING RAC; HARTLEYEDWARDS E, 1990, HORSEMANS MANUAL COM; Hiraga Atsushi, 1994, Journal of Equine Science, V5, P127, DOI 10.1294/jes.5.127; Kai M., 1993, Bulletin of Equine Research Institute, P26; Kaufman KR, 1996, J PEDIATR ORTHOPED, V16, P144, DOI 10.1097/01241398-199603000-00002; Kilgannon C, 2008, NY TIMES, V83; Koch H, 1933, GENETIC PSYCHOL MONO, V13, P117; LEACH DH, 1983, EQUINE VET J, V15, P93, DOI 10.1111/j.2042-3306.1983.tb01726.x; LITTAUER MA, 1969, ANTIQUITY, V43, P289, DOI 10.1017/S0003598X00040734; Mairinger F, 1983, HORSES ARE MADE BE H; Maupas E, 1999, CLIN BIOMECH, V14, P403, DOI 10.1016/S0268-0033(99)00005-4; McAfee G, 2011, MASTER MATH; McGowan C., 2016, ANIMAL PHYSIOTHERAPY; McGreevy P., 1996, WHY DOES MY HORSE; McGreevy PD, 2006, APPL ANIM BEHAV SCI, V99, P183, DOI 10.1016/j.applanim.2005.09.010; McGreevy PD, 2005, APPL ANIM BEHAV SCI, V92, P337, DOI 10.1016/j.applanim.2004.11.012; McManus I.C., 2002, RIGHT HAND LEFT HAND; Murphy J, 2005, APPL ANIM BEHAV SCI, V91, P297, DOI 10.1016/j.applanim.2004.11.001; Murphy J, 2008, BEHAV PROCESS, V79, P7, DOI 10.1016/j.beproc.2008.03.006; Parkin TDH, 2006, PREV VET MED, V74, P44, DOI 10.1016/j.prevetmed.2006.01.006; Ratzlaff M. H., 1987, Equine exercise physiology 2., P574; RATZLAFF MH, 1990, J EQUINE VET SCI, V10, P23, DOI 10.1016/S0737-0806(06)80079-1; Reddon A.R., 2009, BIOSCI HYPOTHESES, V2, P383, DOI [10.1016/j.bihy.2009.06.007, DOI 10.1016/J.BIHY.2009.06.007]; Rogers L.J., 1980, Bird Behaviour, V2, P1; Rogers L. J., 2015, INT ENCY SOCIAL BEHA, V2, P799, DOI DOI 10.1016/B978-0-08-097086-8.53082-7; Rogers L.J., 2013, DIVIDED BRAINS BIOL; Rooney JR, 1989, THE LAME HORSE; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Schilling MF, 2002, AM STAT, V56, P223, DOI 10.1198/00031300265; Siniscalchi M, 2014, BEHAV PROCESS, V107, P61, DOI 10.1016/j.beproc.2014.07.018; UEDA Y, 1993, J EQUINE VET SCI, V13, P707, DOI 10.1016/S0737-0806(06)81572-8; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; van Heel MCV, 2010, EQUINE VET J, V42, P444, DOI 10.1111/j.2042-3306.2010.00064.x; Warren-Smith A, 2010, J VET BEHAV, V5, P177, DOI 10.1016/j.jveb.2009.12.023; Watson KM, 2003, EQUINE VET J, V35, P712, DOI 10.2746/042516403775696348; Westergaard GC, 1998, J COMP PSYCHOL, V112, P55, DOI 10.1037//0735-7036.112.1.55; Whishaw IQ, 2015, LATERALITY, V20, P604, DOI 10.1080/1357650X.2015.1023732; Williams DE, 2007, ANIM BEHAV, V74, P941, DOI 10.1016/j.anbehav.2007.01.014; Williams J, 2011, VET NURSE, V4, P434; Wilson GH, 2009, EQUINE VET J, V41, P238, DOI 10.2746/042516409X395561; Zucca P, 2011, BEHAV PROCESS, V88, P63, DOI 10.1016/j.beproc.2011.06.012	55	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198545	10.1371/journal.pone.0198545	http://dx.doi.org/10.1371/journal.pone.0198545			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI7ZT	29883459	Green Published, Green Submitted, gold			2022-12-26	WOS:000434728100030
J	Kiyoi, T; Liu, S; Sahid, MNA; Shudou, M; Maeyama, K; Mogi, M				Kiyoi, Takeshi; Liu, Shuang; Sahid, Muhammad Novrizal Abdi; Shudou, Masachika; Maeyama, Kazutaka; Mogi, Masaki			High-throughput screening system for dynamic monitoring of exocytotic vesicle trafficking in mast cells	PLOS ONE			English	Article							VESICULAR MONOAMINE TRANSPORTER-2; P-GLYCOPROTEIN; HISTAMINE; GRANULE; MATURATION; EXPRESSION; RELEASE; BRAIN; MOUSE; VMAT2	Mast cells, in addition to endocrine cells and neurons, are typical secretory cells. Their function in allergic inflammation is to secrete inflammatory mediators from secretory vesicles. Intracellular synthesized inflammatory mediators are transported by vesicular monoamine transporters (VMATs) to vesicles where they are stored. After stimulation, the contents of the secretory vesicles are released via exocytosis. This study established a high throughput imaging screening system to monitor the functions of secretory vesicles in mast cells, including molecular uptake via VMAT2 and the exocytotic process, by using a novel fluorescent probe, FFN206, which was developed as a VMAT2 substrate. After loading with FFN206, the rapid uptake of FFN206 was observed and secretory vesicles in mouse bone marrow derived mast cells and a cultured mast cell line were clearly visualized. FFN206 uptake by secretory vesicles was time-dependent and was blocked by reserpine. Furthermore, exocytotic trafficking was monitored dynamically by real-time high-throughput fluorescence quantitation. In the present study, we verified the application of FFN206 for the monitoring of functional vesicles. This high-throughput screening system may benefit instinctive drug evaluation.	[Kiyoi, Takeshi; Liu, Shuang; Maeyama, Kazutaka; Mogi, Masaki] Ehime Univ, Grad Sch Med, Dept Pharmacol, Toon, Ehime, Japan; [Kiyoi, Takeshi; Shudou, Masachika] Ehime Univ, Adv Res Support Ctr, Div Analyt Biomed, Toon, Ehime, Japan; [Sahid, Muhammad Novrizal Abdi] Gadjah Mada Univ, Fac Pharm, Dept Pharmaceut Chem, Sekip Utara, Yogyakarta, Indonesia	Ehime University; Ehime University; Gadjah Mada University	Liu, S (corresponding author), Ehime Univ, Grad Sch Med, Dept Pharmacol, Toon, Ehime, Japan.	liussmzk@m.ehime-u.ac.jp	Shuang, Liu/AAW-2695-2020	Shuang, Liu/0000-0002-6401-7317	Japan Society for the Promotion of Science, KAKENHI [25462220, 15K19575]	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MM's work was funded by the Japan Society for the Promotion of Science, KAKENHI Grant 25462220 (https://www.jsps.go.jp/). SL was supported by the Japan Society for the Promotion of Science, KAKENHI Grant 15K19575 (https://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Ali H, 2016, J IMMUNOBIOL, V1; Anlauf M, 2006, J HISTOCHEM CYTOCHEM, V54, P201, DOI 10.1369/jhc.5A6739.2005; Beghdadi W, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00037; Bernstein AI, 2014, NEUROCHEM INT, V73, P89, DOI 10.1016/j.neuint.2013.12.003; Blank U, 2002, MOL IMMUNOL, V38, P1341, DOI 10.1016/S0161-5890(02)00085-8; CHI EY, 1978, J HISTOCHEM CYTOCHEM, V26, P131, DOI 10.1177/26.2.624833; CHI EY, 1975, J HISTOCHEM CYTOCHEM, V23, P117, DOI 10.1177/23.2.46876; Cohen R, 2012, J CELL SCI, V125, P2986, DOI 10.1242/jcs.102632; CROWLE PK, 1983, EXP CELL BIOL, V51, P130; Freyberg Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10652; Gubernator NG, 2009, SCIENCE, V324, P1441, DOI 10.1126/science.1172278; Hu G, 2013, ACS CHEM BIOL, V8, P1947, DOI 10.1021/cb400259n; MERICKEL A, 1995, NEUROPHARMACOLOGY, V34, P1543, DOI 10.1016/0028-3908(95)00148-Y; Nakaichi M, 2007, J VET MED SCI, V69, P111, DOI 10.1292/jvms.69.111; Nakazawa S, 2014, EUR J IMMUNOL, V44, P204, DOI 10.1002/eji.201343838; Ohtsu H, 2008, J PHARMACOL SCI, V106, P347, DOI 10.1254/jphs.FM0070294; OKAMURA N, 1993, J PHARMACOL EXP THER, V266, P1614; Schneider E, 2005, J EXP MED, V202, P387, DOI 10.1084/jem.20050195; SHIRVAN A, 1994, FEBS LETT, V356, P145, DOI 10.1016/0014-5793(94)01252-0; Tachibana M, 2008, ALLERGY, V63, P1136, DOI 10.1111/j.1398-9995.2008.01677.x; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Travis ER, 2000, P NATL ACAD SCI USA, V97, P162, DOI 10.1073/pnas.97.1.162; Ueda K, 2011, BIOSCI BIOTECH BIOCH, V75, P401, DOI 10.1271/bbb.100816; Vergo S, 2007, BRAIN RES, V1185, P18, DOI 10.1016/j.brainres.2007.09.028; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Wilson JD, 2016, TRAFFIC, V17, P1027, DOI 10.1111/tra.12418; YAMATODANI A, 1985, J CHROMATOGR, V344, P115, DOI 10.1016/S0378-4347(00)82012-5	28	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198785	10.1371/journal.pone.0198785	http://dx.doi.org/10.1371/journal.pone.0198785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883480	gold, Green Published, Green Submitted			2022-12-26	WOS:000434728100040
J	Almonte-Becerril, M; Gimeno-LLuch, I; Villarroya, O; Benito-Jardon, M; Kouri, JB; Costell, M				Almonte-Becerril, Maylin; Gimeno-LLuch, Irene; Villarroya, Olga; Benito-Jardon, Maria; Bautista Kouri, Juan; Costell, Mercedes			Genetic abrogation of the fibronectin-alpha 5 beta 1 integrin interaction in articular cartilage aggravates osteoarthritis in mice	PLOS ONE			English	Article							ALPHA-5-BETA-1 INTEGRIN; FIBRONECTIN FRAGMENTS; MATRIX; CHONDROCYTES; COLLAGEN; EXPRESSION; SURVIVAL; DEGRADATION; PROGRESSION; SIGNALS	The balance between synthesis and degradation of the cartilage extracellular matrix is severely altered in osteoarthritis, where degradation predominates. One reason for this imbalance is believed to be due to the ligation of the alpha 5 beta 1 integrin, the classic fibronectin (FN) receptor, with soluble FN fragments instead of insoluble FN fibrils, which induces matrix metalloproteinase (MMP) expression. Our objective was to determine whether the lack of alpha 5 beta 1-FN binding influences cartilage morphogenesis in vivo and whether non-ligated alpha 5 beta 1 protects or aggravates the course of osteoarthritis in mice. We engineered mice (Col2a-Cre;Fn1(RGE/fl)), whose chondrocytes express an alpha 5 beta 1 binding-deficient FN, by substituting the aspartic acid of the RGD cell-binding motif with a glutamic acid (FN-RGE). At an age of 5 months the knee joints were stressed either by forced exercise (moderate mechanical load) or by partially resecting the meniscus followed by forced exercise (high mechanical load). Sections of femoral articular knees were analysed by Safranin-O staining and by immunofluorescence to determine tissue morphology, extracellular matrix proteins and matrix metalloproteinase expression. The articular cartilage from untrained control and Col2a-Cre;Fn1(RGE/fl) mice was normal, while the exposure to high mechanical load induced osteoarthritis characterized by proteoglycan and collagen type ll loss. In the Col2a-Cre;Fn1(RGE/fl) articular cartilage osteoarthritis progressed significantly faster than in wild type mice. Mechanistically, we observed increased expression of MMP-13 and MMP-3 metalloproteinases in FN-RGE expressing articular cartilage, which severely affected matrix remodelling. Our results underscore the critical role of FN-alpha 5 beta 1 adhesion as ECM sensor in circumstances of articular cartilage regeneration.	[Almonte-Becerril, Maylin; Gimeno-LLuch, Irene; Villarroya, Olga; Benito-Jardon, Maria; Costell, Mercedes] Univ Valencia, Dept Biochem & Mol Biol, Burjassot, Spain; [Almonte-Becerril, Maylin; Gimeno-LLuch, Irene; Villarroya, Olga; Benito-Jardon, Maria; Costell, Mercedes] Univ Valencia, Estruct Reserca Interdisciplinar Biotecnol & Biom, Burjassot, Spain; [Almonte-Becerril, Maylin; Bautista Kouri, Juan] CINVESTAV IPN, Dept Infectom & Patogenesis Mol, Ctr Invest & Estudios Avanzados, Mexico City, DF, Mexico	University of Valencia; University of Valencia; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Costell, M (corresponding author), Univ Valencia, Dept Biochem & Mol Biol, Burjassot, Spain.; Costell, M (corresponding author), Univ Valencia, Estruct Reserca Interdisciplinar Biotecnol & Biom, Burjassot, Spain.	mercedes.costell@uv.es	Costell, Mercedes/H-7850-2015; ALMONTE-BECERRIL, MAYLIN/F-2830-2019	Costell, Mercedes/0000-0001-6146-996X; 	Spanish Ministry for Economy and Competitiveness (MINECO); Fondo Europeo de Desarrollo Regional (FEDER) [Mat2012-38359, Mat2015- 69315]; CONACYT [168328]; Conselleria Valenciana d'Educacio i Ciencia	Spanish Ministry for Economy and Competitiveness (MINECO); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Conselleria Valenciana d'Educacio i Ciencia	The authors would like to acknowledge the support by the Spanish Ministry for Economy and Competitiveness (MINECO) and Fondo Europeo de Desarrollo Regional (FEDER): Mat2012-38359 (MINECO) and Mat2015- 69315 (MINECO/FEDER). MA-B was supported by CONACYT 168328. MB-J and OV were supported by contracts from the Conselleria Valenciana d'Educacio i Ciencia.	Almonte-Becerril M, 2010, APOPTOSIS, V15, P631, DOI 10.1007/s10495-010-0458-z; Almonte-Becerril M, 2014, J ORTHOP RES, V32, P1161, DOI 10.1002/jor.22649; [Anonymous], 1989, SIGNAL TRANSDUCTION, V109, P877; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; BROWN RA, 1990, J RHEUMATOL, V17, P65; Candela ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156783; Del Carlo M, 2007, FREE RADICAL BIO MED, V42, P1350, DOI 10.1016/j.freeradbiomed.2007.01.035; Forsyth CB, 2002, ARTHRITIS RHEUM, V46, P2368, DOI 10.1002/art.10502; Giros A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022002; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Homandberg GA, 2006, OSTEOARTHR CARTILAGE, V14, P793, DOI 10.1016/j.joca.2006.02.003; Homandberg GA, 2002, OSTEOARTHR CARTILAGE, V10, P381, DOI 10.1053/joca.2002.0524; Jungel A, 2010, ANN RHEUM DIS, V69, P898, DOI 10.1136/ard.2008.106021; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Kurtis MS, 2003, ARTHRITIS RHEUM-US, V48, P110, DOI 10.1002/art.10704; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Li SH, 2003, AM J PATHOL, V163, P1045, DOI 10.1016/S0002-9440(10)63464-5; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Loeser R. F., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P303; Loeser RF, 2014, MATRIX BIOL, V39, P11, DOI 10.1016/j.matbio.2014.08.007; MCDONALD JA, 1982, J CELL BIOL, V92, P485, DOI 10.1083/jcb.92.2.485; Perera PM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3039; Pfander D, 1999, J RHEUMATOL, V26, P386; Pulai JI, 2002, ARTHRITIS RHEUM, V46, P1528, DOI 10.1002/art.10334; Sakai K, 2001, MATRIX BIOL, V19, P761, DOI 10.1016/S0945-053X(00)00122-0; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Singh A, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4423; Singh P, 2012, J CELL SCI, V125, P3703, DOI 10.1242/jcs.095786; Sofat N, 2009, INT J EXP PATHOL, V90, P463, DOI 10.1111/j.1365-2613.2009.00676.x; Stanton H, 2002, BIOCHEM J, V364, P181, DOI 10.1042/bj3640181; Stoffels JMJ, 2013, CELL MOL LIFE SCI, V70, P4243, DOI 10.1007/s00018-013-1350-0; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; Tian J, 2015, RHEUMATOL INT, V35, P787, DOI 10.1007/s00296-014-3137-5; VARNER JA, 1995, MOL BIOL CELL, V6, P725, DOI 10.1091/mbc.6.6.725; Wang MN, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4133; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; Wright MO, 1997, J ORTHOPAED RES, V15, P742, DOI 10.1002/jor.1100150517; Yasuda T, 2002, ARTHRITIS RHEUM, V46, P138, DOI 10.1002/1529-0131(200201)46:1<138::AID-ART10051>3.0.CO;2-K; Yasuda Tadashi, 2006, Mod Rheumatol, V16, P197	42	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0198559	10.1371/journal.pone.0198559	http://dx.doi.org/10.1371/journal.pone.0198559			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870552	gold, Green Published, Green Submitted			2022-12-26	WOS:000434128400029
J	Yui, OM; Benitez, JA; Plouffe, SW; Ryback, D; Klein, A; Smith, J; Greenbaum, J; Delatte, B; Rao, A; Guan, KL; Furnari, FB; Chaim, OM; Miyamoto, S; Brown, JH				Yui, Olivia M.; Benitez, Jorge A.; Plouffe, Steven W.; Ryback, Daniel; Klein, Andrea; Smith, Jeff; Greenbaum, Jason; Delatte, Benjamin; Rao, Anjana; Guan, Kun-Liang; Furnari, Frank B.; Chaim, Olga Meiri; Miyamoto, Shigeki; Brown, Joan Heller			YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene expression, are critical for glioblastoma tumorigenicity	ONCOGENE			English	Article							PROTEIN-COUPLED RECEPTOR; YES-ASSOCIATED PROTEIN; NUCLEOTIDE EXCHANGE FACTOR; TISSUE FACTOR EXPRESSION; LEUKEMIA-ASSOCIATED RHO; CELL-PROLIFERATION; THROMBIN RECEPTOR; CAUSES TRANSFORMATION; RAS TRANSFORMATION; ACTIVATES YAP/TAZ	The role of YAP (Yes-associated protein 1) and MRTF-A (myocardin-related transcription factor A), two transcriptional coactivators regulated downstream of GPCRs (G protein-coupled receptors) and RhoA, in the growth of glioblastoma cells and in vivo glioblastoma multiforme (GBM) tumor development was explored using human glioblastoma cell lines and tumor-initiating cells derived from patient-derived xenografts (PDX). Knockdown of these co-activators in GSC-23 PDX cells using short hairpin RNA significantly attenuated in vitro self-renewal capability assessed by limiting dilution, oncogene expression, and neurosphere formation. Orthotopic xenografts of the MRTF-A and YAP knockdown PDX cells formed significantly smaller tumors and were of lower morbidity than wild-type cells. In vitro studies used PDX and 1321N1 glioblastoma cells to examine functional responses to sphingosine 1-phosphate (S1P), a GPCR agonist that activates RhoA signaling, demonstrated that YAP signaling was required for cell migration and invasion, whereas MRTF-A was required for cell adhesion; both YAP and MRTF-A were required for proliferation. Gene expression analysis by RNA-sequencing of S1P-treated MRTF-A or YAP knockout cells identified 44 genes that were induced through RhoA and highly dependent on YAP, MRTF-A, or both. Knockdown of F3 (tissue factor (TF)), a target gene regulated selectively through YAP, blocked cell invasion and migration, whereas knockdown of HBEGF (heparin-binding epidermal growth factor-like growth factor), a gene selectively induced through MRTF-A, prevented cell adhesion in response to S1P. Proliferation was sensitive to knockdown of target genes regulated through either or both YAP and MRTF-A. Expression of TF and HBEGF was also selectively decreased in tumors from PDX cells lacking YAP or MRTF-A, indicating that these transcriptional pathways are regulated in preclinical GBM models and suggesting that their activation through GPCRs and RhoA contributes to growth and maintenance of human GBM.	[Yui, Olivia M.; Plouffe, Steven W.; Ryback, Daniel; Klein, Andrea; Smith, Jeff; Guan, Kun-Liang; Chaim, Olga Meiri; Miyamoto, Shigeki; Brown, Joan Heller] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Yui, Olivia M.; Plouffe, Steven W.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Benitez, Jorge A.; Furnari, Frank B.] Ludwig Inst Canc Res, San Diego Branch, San Diego, CA USA; [Greenbaum, Jason; Delatte, Benjamin; Rao, Anjana] La Jolla Inst Allergy & Immunol, Div Signaling & Gene Express, La Jolla, CA USA; [Rao, Anjana; Guan, Kun-Liang; Furnari, Frank B.; Brown, Joan Heller] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA; [Rao, Anjana; Furnari, Frank B.] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Chaim, Olga Meiri] Univ Fed Parana, Dept Cell Biol, Curitiba, Parana, Brazil	University of California System; University of California San Diego; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; La Jolla Institute for Immunology; University of California System; University of California San Diego; University of California System; University of California San Diego; Universidade Federal do Parana	Brown, JH (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Brown, JH (corresponding author), Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA.	jhbrown@ucsd.edu	Miyamoto, Shigeki/L-4004-2019; Chaim, Olga M/H-5179-2012; Delatte, Benjamin/AAE-9276-2020; Chaim, Olga Meiri/Y-7559-2019; Guan, Kun-Liang/ADK-7088-2022	Chaim, Olga M/0000-0002-3854-3292; Chaim, Olga Meiri/0000-0002-3854-3292; Klein, Andrea/0000-0003-4146-3493; Delatte, Benjamin/0000-0002-6798-0600	NIH [GM036927, HL028143, HL085577, CA170682, HL097037, NS080939, AI40127, AI109842];  [T32 GM007752];  [T32 DK00754]; NATIONAL CANCER INSTITUTE [R35CA196878, R01CA218859] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085577, R37HL028143, R01HL097037, R01HL028143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI109842, R56AI109842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080939] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH Grants GM036927, HL028143, HL085577. and CA170682 to JHB; HL097037 to SM; NS080939 to FBF and JAB; AI40127 and AI109842 to AR. OMY and SWP were supported by T32 GM007752; OMY also received support from T32 DK00754; BD is an HHMI postdoctoral fellow from the Jane Coffin Childs Fund; OMC is a PDE fellow from The Brazilian National Council for Scientific and Technological Development.	Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Annibali D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5632; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Balasubramaniyan V, 2015, ONCOTARGET, V6, P31007, DOI 10.18632/oncotarget.5219; Bien-Moller S, 2016, ONCOTARGET, V7, P13031, DOI 10.18632/oncotarget.7366; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Cheng G, 2015, TUMOR BIOL, V36, P2869, DOI 10.1007/s13277-014-2915-8; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cui YD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7333; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Ensign SPF, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00241; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Feng X, 2016, J BIOL CHEM, V291, P18947, DOI 10.1074/jbc.M116.739722; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Gaviglio AL, 2017, FASEB J, V31, P1903, DOI 10.1096/fj.201600828R; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Hamada K, 1996, CANCER, V77, P1877, DOI 10.1002/(SICI)1097-0142(19960501)77:9<1877::AID-CNCR18>3.0.CO;2-X; Haseley A, 2012, CANCER RES, V72, P1353, DOI 10.1158/0008-5472.CAN-11-2526; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Hua Y, 2005, J THROMB HAEMOST, V3, P1917, DOI 10.1111/j.1538-7836.2005.01446.x; JIANG HP, 1993, FEBS LETT, V330, P319, DOI 10.1016/0014-5793(93)80896-3; Juneja J, 2009, BRIT J PHARMACOL, V158, P32, DOI 10.1111/j.1476-5381.2009.00180.x; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; Kishi Y, 2006, J BIOL CHEM, V281, P17492, DOI 10.1074/jbc.M601803200; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li L, 2014, ONCOGENE, V33, P4253, DOI 10.1038/onc.2013.400; Magnus N, 2014, BIOCHEM BIOPH RES CO, V454, P262, DOI 10.1016/j.bbrc.2014.10.041; Magnus N, 2014, P NATL ACAD SCI USA, V111, P3544, DOI 10.1073/pnas.1314118111; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; Menendez JA, 2005, ONCOGENE, V24, P761, DOI 10.1038/sj.onc.1208238; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mishima K, 1998, ACTA NEUROPATHOL, V96, P322, DOI 10.1007/s004010050901; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Park HW, 2015, CELL, V162, P780, DOI 10.1016/j.cell.2015.07.013; Plouffe SW, 2015, TRENDS MOL MED, V21, P212, DOI 10.1016/j.molmed.2015.01.003; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Post GR, 1996, MOL BIOL CELL, V7, P1679, DOI 10.1091/mbc.7.11.1679; Qiao YT, 2017, CELL REP, V19, P1495, DOI 10.1016/j.celrep.2017.04.075; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Quan TH, 2014, AM J PATHOL, V184, P937, DOI 10.1016/j.ajpath.2013.12.017; Rak J, 2009, BEST PRACT RES CL HA, V22, P71, DOI 10.1016/j.beha.2008.12.008; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reuther GW, 2001, J BIOL CHEM, V276, P27145, DOI 10.1074/jbc.M103565200; Rossol-Allisone J, 2009, CELL SIGNAL, V21, P1559, DOI 10.1016/j.cellsig.2009.05.010; Ruf W, 2011, J THROMB HAEMOST, V9, P306, DOI 10.1111/j.1538-7836.2011.04318.x; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sarkaria JN, 2007, MOL CANCER THER, V6, P1167, DOI 10.1158/1535-7163.MCT-06-0691; Sarkaria JN, 2006, CLIN CANCER RES, V12, P2264, DOI 10.1158/1078-0432.CCR-05-2510; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shah SR, 2016, NEUROSURGERY, V63, P185, DOI DOI 10.1227/01.NEU.0000489786.22041.2D; Siney EJ, 2017, MOL NEUROBIOL, V54, P3893, DOI 10.1007/s12035-016-0053-6; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; TOKSOZ D, 1994, ONCOGENE, V9, P621; Walsh CT, 2008, FASEB J, V22, P4011, DOI 10.1096/fj.08-113266; Wang J., 2008, PLOS ONE, V3, P3769; Wang SB, 2016, THROMB RES, V141, pS65, DOI 10.1016/S0049-3848(16)30369-3; Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; Yotsumoto F, 2008, BIOCHEM BIOPH RES CO, V365, P555, DOI 10.1016/j.bbrc.2007.11.015; Yu FX, 2014, CANCER CELL, V25, P822, DOI 10.1016/j.ccr.2014.04.017; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu OM, 2016, MOL CELL BIOL, V36, P39, DOI 10.1128/MCB.00772-15; Yu OM, 2015, MOL PHARMACOL, V88, P171, DOI 10.1124/mol.115.097857; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2009, CANCER RES, V69, P1089, DOI 10.1158/0008-5472.CAN-08-2997	78	38	41	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 11	2018	37	41					5492	5507		10.1038/s41388-018-0301-5	http://dx.doi.org/10.1038/s41388-018-0301-5			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GW5QO	29887596	Green Accepted, Green Published			2022-12-26	WOS:000446991200002
J	Wilkening, A; Rub, C; Sylvester, M; Voos, W				Wilkening, Anne; Rueb, Cornelia; Sylvester, Marc; Voos, Wolfgang			Analysis of heat-induced protein aggregation in human mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; protein aggregation; translation; protein import; proteomics; heat stress; mitochondrial elongation factor Tu; Tufm	SYNTHESIS ELONGATION-FACTOR; FACTOR EF-TU; TRANSLATIONAL CONTROL; ESCHERICHIA-COLI; OXIDATIVE STRESS; QUALITY CONTROL; MOLECULAR CHAPERONES; SHOCK RESPONSE; HOMEOSTASIS; DEGRADATION	Proteins in mammalian cells exhibit optimal stability at physiological temperatures, and even small temperature variations may cause unfolding and nonspecific aggregation. Because this process leads to a loss of function of the affected polypeptides and to cytotoxic stress, formation of protein aggregates has been recognized as a major pathogenic factor in human diseases. In this study, we determined the impact of physiological heat stress on mitochondria isolated from HeLa cells. We found that the heat-stressed mitochondria had lower membrane potential and ATP level and exhibited a decreased production of reactive oxygen species. An analysis of the mitochondrial proteome by 2D PAGE showed that the overall solubility of endogenous proteins was only marginally affected by elevated temperatures. However, a small subset of polypeptides exhibited an high sensitivity to heat stress. The mitochondrial translation elongation factor Tu (Tufm), a protein essential for organellar protein biosynthesis, was highly aggregation-prone and lost its solubility already under mild heat-stress conditions. Moreover, mitochondrial translation and the import of cytosolic proteins were defective in the heat-stressed mitochondria. Both types of nascent polypeptides, produced by translation or imported into the mitochondria, exhibited a strong tendency to aggregate in the heat-exposed mitochondria. We propose that a fast and specific inactivation of elongation factors may prevent the accumulation of misfolded nascent polypeptides and may thereby attenuate proteotoxicity under heat stress.	[Wilkening, Anne; Rueb, Cornelia; Sylvester, Marc; Voos, Wolfgang] Friedrich Wilhelm Univ, Inst Biochem & Mol Biol, D-53115 Bonn, Germany	University of Bonn	Voos, W (corresponding author), Inst Biochem & Mol Biol, Nussallee 11, D-53115 Bonn, Germany.	wolfgang.voos@uni-bonn.de		Sylvester, Marc/0000-0002-4275-0200	Deutsche Forschungsgemeinschaft [VO 657/5-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant VO 657/5-2 (to W. V.). The authors declare that they have no conflicts of interest with the contents of this article.	ARAI KI, 1974, J BIOCHEM-TOKYO, V76, P293, DOI 10.1093/oxfordjournals.jbchem.a130571; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Becker D, 2012, J BIOL CHEM, V287, P22969, DOI 10.1074/jbc.M112.365700; Bender T, 2011, MOL BIOL CELL, V22, P541, DOI 10.1091/mbc.E10-08-0718; Bender T, 2010, PROTEOMICS, V10, P1426, DOI 10.1002/pmic.200800619; Bezawork-Geleta A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17397; Bhadula SK, 2001, PLANTA, V212, P359, DOI 10.1007/s004250000416; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Bruderek M, 2018, MOL BIOL CELL, V29, P256, DOI 10.1091/mbc.E17-01-0027; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cai YC, 2000, J BIOL CHEM, V275, P20308, DOI 10.1074/jbc.M001899200; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chang RL, 2013, SCIENCE, V340, P1220, DOI 10.1126/science.1234012; CHAPUT M, 1983, BIOCHIMIE, V65, P501, DOI 10.1016/S0300-9084(83)80132-1; Cherkasov V, 2013, CURR BIOL, V23, P2452, DOI 10.1016/j.cub.2013.09.058; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; DUNCAN R, 1984, J BIOL CHEM, V259, P1882; Evans SS, 2015, NAT REV IMMUNOL, V15, P335, DOI 10.1038/nri3843; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Fu J, 2012, J BOT, V2012, P1, DOI DOI 10.1155/2012/835836; Germaniuk A, 2002, J BIOL CHEM, V277, P27801, DOI 10.1074/jbc.M201756200; Ghosh K, 2010, BIOPHYS J, V99, P3996, DOI 10.1016/j.bpj.2010.10.036; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Huang HM, 2003, BBA-MOL BASIS DIS, V1637, P119, DOI 10.1016/S0925-4439(02)00222-3; Jovaisaite V, 2015, CURR OPIN CELL BIOL, V33, P74, DOI 10.1016/j.ceb.2014.12.003; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kudlicki W, 1997, J BIOL CHEM, V272, P32206, DOI 10.1074/jbc.272.51.32206; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lackner LL, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-35; Leuenberger P, 2017, SCIENCE, V355, DOI 10.1126/science.aai7825; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LUCASLENARD J, 1971, ANNU REV BIOCHEM, V40, P409, DOI 10.1146/annurev.bi.40.070171.002205; Mai N, 2017, CELL TISSUE RES, V367, P5, DOI 10.1007/s00441-016-2456-0; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Nillegoda NB, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00057; Osiewacz HD, 2010, EXP GERONTOL, V45, P465, DOI 10.1016/j.exger.2010.05.001; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Ott M, 2016, ANNU REV BIOCHEM, V85, P77, DOI 10.1146/annurev-biochem-060815-014334; Quiros PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Rao D, 2004, EUR J BIOCHEM, V271, P3684, DOI 10.1111/j.1432-1033.2004.04309.x; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Ristic Z, 2008, J PLANT PHYSIOL, V165, P192, DOI 10.1016/j.jplph.2007.03.003; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rottgers K, 2002, J BIOL CHEM, V277, P45829, DOI 10.1074/jbc.M207152200; Schmitt M, 1996, J CELL BIOL, V134, P1375, DOI 10.1083/jcb.134.6.1375; Suzuki H, 2007, J BIOL CHEM, V282, P4076, DOI 10.1074/jbc.M608187200; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Voos W, 2013, BBA-MOL CELL RES, V1833, P388, DOI 10.1016/j.bbamcr.2012.06.005; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; WELCH WJ, 1985, J CELL BIOL, V101, P1198, DOI 10.1083/jcb.101.4.1198	59	21	21	5	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11537	11552		10.1074/jbc.RA118.002122	http://dx.doi.org/10.1074/jbc.RA118.002122			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29895621	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000439449700023
J	Gilbert, BM; Avenant-Oldewage, A				Gilbert, Beric M.; Avenant-Oldewage, Annemarie			Trace element biomineralisation in the carapace in male and female Argulus japonicus	PLOS ONE			English	Article							TRANSITION-METALS; ZINC; MANDIBLES; BRANCHIURA; MANGANESE; HARDNESS; CADMIUM; FISH; DETOXIFICATION; OVIPOSITORS	Parasites of fishes have been shown to be effective bioindicators of the aquatic environment. Few investigations have been conducted on ectoparasite models and therefore little is known about the fate of trace elements and metals which they accumulate. In this study trace element sequestration was observed in the carapace of the fish louse, Argulus japonicus and found to relate to the sex of the parasite, as well as, the degree of sclerotization of the carapace. Adults of A. japonicus were collected from cyprinid hosts in the Vaal Dam, South Africa. Parasites were removed and flash frozen in liquid nitrogen before being sectioned with a cryomicrotome. Sections and whole mounts of parasites were prepared and treated with Phen Green (TM) FL cell-permeant diacetate. Cryosections were assessed for trace elements and metals using a scanning electron microscope equipped with energy dispersive spectroscopy. Results indicated that in both male and female parasites, trace elements become bound to the carapace and produce more intense fluorescence than in soft tissues. Sexual dimorphic differences were further observed between male and female parasites. The intensity of the fluorescence signals was greater in the carapace of male parasites than in females, particularly when comparing the carapace of the ventral side of the thorax. In females, an amorphous layer of material surrounding the eggs was observed and produced an intense fluorescent signal. Levels of trace elements and metals detected were not significantly different between male and female parasites. Results observed serve as a demonstration for the first time of trace element sequestration in a freshwater crustacean parasite and possible mechanisms employed to reduce body burdens of trace elements and metals.	[Gilbert, Beric M.; Avenant-Oldewage, Annemarie] Univ Johannesburg, Dept Zool, Johannesburg, Gauteng, South Africa	University of Johannesburg	Avenant-Oldewage, A (corresponding author), Univ Johannesburg, Dept Zool, Johannesburg, Gauteng, South Africa.	aoldewage@uj.ac.za	Avenant-Oldewage, Annemarie/A-7778-2011; Gilbert, Beric Michael/ABB-7255-2021	Avenant-Oldewage, Annemarie/0000-0001-8820-7679; Gilbert, Beric Michael/0000-0002-5681-8528	National Research Foundation [80789]; Faculty Research Council of the University of Johannesburg [SASOLD-0107]	National Research Foundation; Faculty Research Council of the University of Johannesburg	Thanks are extended to the National Research Foundation (Grant nr. 80789) and Faculty Research Council of the University of Johannesburg (Grant nr. SASOLD-0107) for providing financial support to MO. The Spectrum analytical facility at the University of Johannesburg is thanked for providing infrastructure for acquiring images of sections. The University of Johannesburg is thanked for providing GES postdoctoral funding (GES PDRF bursary) to BMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn GA, 2004, J COMP PHYSIOL B, V174, P439, DOI 10.1007/s00360-004-0438-0; Alsarakibi M, 2014, PARASITOL RES, V113, P769, DOI 10.1007/s00436-013-3708-5; Avenant-Oldewage A, 2010, EXP PARASITOL, V126, P232, DOI 10.1016/j.exppara.2010.05.011; Bergey LL, 2007, MAR ENVIRON RES, V64, P556, DOI 10.1016/j.marenvres.2007.04.009; Brabec J, 2015, INT J PARASITOL, V45, P761, DOI 10.1016/j.ijpara.2015.05.006; Broomell CC, 2008, ACTA BIOMATER, V4, P2045, DOI 10.1016/j.actbio.2008.06.017; Conley JM, 2009, ENVIRON SCI TECHNOL, V43, P7952, DOI 10.1021/es9016377; Cribb BW, 2010, ACTA BIOMATER, V6, P3152, DOI 10.1016/j.actbio.2010.02.009; Cribb BW, 2008, NATURWISSENSCHAFTEN, V95, P17, DOI 10.1007/s00114-007-0288-1; Degger N, 2009, AFR ZOOL, V44, P204, DOI 10.3377/004.044.0208; Edwards Ashley J., 1993, Cell Biology International, V17, P697, DOI 10.1006/cbir.1993.1125; FRYER G, 1960, Q J MICROSC SCI, V101, P407; Ghara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023642; Gilbert BM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177558; GRESTY KA, 1993, PHILOS T ROY SOC B, V339, P119, DOI 10.1098/rstb.1993.0009; Haug JT, 2011, J MICROSC-OXFORD, V244, P259, DOI 10.1111/j.1365-2818.2011.03534.x; Hauglund RP, 2005, HDB A GUIDE FLUORESC; HILLERTON JE, 1984, J STORED PROD RES, V20, P133, DOI 10.1016/0022-474X(84)90020-1; Ikuta K, 1997, J CRUSTACEAN BIOL, V17, P45, DOI 10.2307/1549461; Jonusaite S, 2016, J COMP PHYSIOL B, V186, P17, DOI 10.1007/s00360-015-0937-1; Kaya M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115531; Keteles KA, 2001, MAR POLLUT BULL, V42, P1397, DOI 10.1016/S0025-326X(01)00172-2; Khalil M, 2009, INT J PARASITOL, V39, P1093, DOI 10.1016/j.ijpara.2009.02.023; Khan FR, 2010, AQUAT TOXICOL, V96, P124, DOI 10.1016/j.aquatox.2009.10.010; Lichtenegger HC, 2003, P NATL ACAD SCI USA, V100, P9144, DOI 10.1073/pnas.1632658100; Melnick CA, 1996, J MATER RES, V11, P2903, DOI 10.1557/JMR.1996.0367; Milne SJ, 2006, ONDERSTEPOORT J VET, V73, P149; Morgan TD, 2003, J STORED PROD RES, V39, P65, DOI 10.1016/S0022-474X(02)00019-X; Quicke DLJ, 1998, ZOOL J LINN SOC-LOND, V124, P387, DOI 10.1006/zjls.1997.0146; Quicke DLJ, 2004, AFR ENTOMOL, V12, P259; Raessler M, 2005, SCI TOTAL ENVIRON, V337, P83, DOI 10.1016/j.scitotenv.2004.07.008; Rainbow PS, 2002, ENVIRON POLLUT, V120, P497, DOI 10.1016/S0269-7491(02)00238-5; RAMALING.K, 1973, EXP PARASITOL, V34, P115, DOI 10.1016/0014-4894(73)90069-6; RIGGS MR, 1987, J PARASITOL, V73, P893, DOI 10.2307/3282507; Robinson KA, 2003, ENVIRON POLLUT, V122, P159, DOI 10.1016/S0269-7491(02)00302-0; Scheef G, 2000, PARASITOL RES, V86, P688, DOI 10.1007/PL00008553; Schofield RMS, 2002, NATURWISSENSCHAFTEN, V89, P579, DOI 10.1007/s00114-002-0381-4; Schofield RMS, 2003, J INSECT PHYSIOL, V49, P31, DOI 10.1016/S0022-1910(02)00224-X; SHAFIR A, 1986, J ZOOL, V210, P401; Sures B, 1997, PARASITOL RES, V83, P618, DOI 10.1007/s004360050307; WHARTON DA, 1983, PARASITOLOGY, V86, P85, DOI 10.1017/S003118200005085X; Wong W.P., 2012, PRODUCTION PLANNING, P1, DOI [DOI 10.1017//S0031182009990680, 10.1017//S0031182009990680]; Wu XY, 2011, J FOOD COMPOS ANAL, V24, P62, DOI 10.1016/j.jfca.2010.03.030	43	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197804	10.1371/journal.pone.0197804	http://dx.doi.org/10.1371/journal.pone.0197804			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897941	Green Submitted, Green Published, gold			2022-12-26	WOS:000435090700028
J	Susset, EC; Hemptinne, JL; Danchin, E; Magro, A				Susset, Eline Catherine; Hemptinne, Jean-Louis; Danchin, Etienne; Magro, Alexandra			Overwintering aggregations are part of Hippodamia undecimnotata's (Coleoptera: Coccinellidae) mating system	PLOS ONE			English	Article							FUNGUS BEETLE; DIAPAUSE; MALES; EVOLUTION; SELECTION; ECOLOGY; BIOLOGY; LEKS; SIZE	Aggregation during diapause is a common phenomenon in arthropods that nevertheless remains poorly understood. The most commonly claimed benefit is that survival is higher in aggregations but animal aggregations could also be driven by sexual selection. In this perspective, we investigated whether aggregations in insects could be part of their mating system. We studied the overwintering aggregations of the ladybird Hippodamia undecimnotata (Schneider), an aphidophagous species from Southern and Eastern Europe as well as Asia. We collected ladybirds at three aggregation sites in Southwest France, during two overwintering periods (2013-2014 and 2014-2015). We checked their reproductive status by counting the viable sperm cells in the sperm storage organs of both males and females, and by assessing the ovarian status of females. We also investigated if mating behaviour occurred in these aggregations. We found that males have a high quantity of viable sperm cells (70-95%) in their reproductive organs throughout the overwintering periods. In contrast, although most females (85-95%) had empty spermatheca at the onset of the aggregations in autumn, the majority (65-91%) had numerous viable sperm in their spermatheca at the time of dispersal from the aggregation in early spring. Furthermore, frequent copulations were observed towards the end of the overwintering period, few weeks before dispersal. These results suggest that finding sexual mates may have been involved in overwintering aggregations in H. undecimnotata.	[Susset, Eline Catherine; Hemptinne, Jean-Louis; Magro, Alexandra] Univ Toulouse 3 Paul Sabatier, CNRS, ENSFEA, EDB UMR5174,Lab Evolut & Diversite Biol, Toulouse, France; [Susset, Eline Catherine; Hemptinne, Jean-Louis; Danchin, Etienne] Univ Paul Sabatier, CNRS, EDB UMR5174, Toulouse, France; [Danchin, Etienne; Magro, Alexandra] Univ Toulouse 3 Paul Sabatier, ENSFEA, CNRS, EDB UMR5174,Lab Evolut & Diversite Biol, Castanet Tolosan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Susset, EC (corresponding author), Univ Toulouse 3 Paul Sabatier, CNRS, ENSFEA, EDB UMR5174,Lab Evolut & Diversite Biol, Toulouse, France.; Susset, EC (corresponding author), Univ Paul Sabatier, CNRS, EDB UMR5174, Toulouse, France.	eline.susset@educagri.fr	Magro, Alexandra/G-8328-2011; Danchin, Etienne/AAB-2091-2021	Magro, Alexandra/0000-0002-7043-0845; Danchin, Etienne/0000-0002-5013-9612	French Laboratory of Excellence project "TULIP" [ANR-10-LABX-41, ANR-11-IDEX-0002-02]	French Laboratory of Excellence project "TULIP"	This work was supported by the French Laboratory of Excellence project "TULIP" (ANR-10-LABX-41; ANR-11-IDEX-0002-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOCK J, 1987, J NAT HIST, V21, P319, DOI 10.1080/00222938700771041; Awad M, 2015, APPL ENTOMOL ZOOL, V50, P427, DOI 10.1007/s13355-015-0348-5; Awad M, 2013, BIOCONTROL, V58, P657, DOI 10.1007/s10526-013-9512-4; Bates D, 2008, ENTOMOLOGISTE; Beatty CD, 2005, ANIM BEHAV, V70, P199, DOI 10.1016/j.anbehav.2004.09.023; BRADBURY J, 1986, ANIM BEHAV, V34, P1694, DOI 10.1016/S0003-3472(86)80257-3; Bradbury J.W., 1981, P138; Bradshaw WE, 1990, INSECT LIFE CYCLES G, P43; Brower LP, 2008, J LEPID SOC, V62, P177; Capinera J.L, 2008, ENCY ENTOMOLOGY; Ceryngier P, 2004, INVERTEBR REPROD DEV, V45, P127, DOI 10.1080/07924259.2004.9652582; Cockburn A, 2009, BEHAV ECOL, V20, P501, DOI 10.1093/beheco/arp024; Cuddington K, 2015, THEOR ECOL-NETH, V8, P333, DOI 10.1007/s12080-015-0254-z; Damiens D, 2002, PHYSIOL ENTOMOL, V27, P97, DOI 10.1046/j.1365-3032.2002.00274.x; Danchin E, 1997, TRENDS ECOL EVOL, V12, P342, DOI 10.1016/S0169-5347(97)01124-5; Danks H.V., 1987, INSECT DORMANCY ECOL; Doligez B, 2003, ANIM BEHAV, V66, P973, DOI 10.1006/anbe.2002.2270; Dzerefos CM, 2009, J APPL ENTOMOL, V133, P749, DOI 10.1111/j.1439-0418.2009.01425.x; El Hariri G, 1966, PHYSIOL ENTOMOL, V41, P10; Fursch H, 2007, TAXONOMY COCCINELLID, V6; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Gress BE, 2011, CAN J ZOOL, V89, P1231, DOI 10.1139/Z11-103; Guven O, 2015, EUR J ENTOMOL, V112, P41, DOI 10.14411/eje.2015.002; HAGEN KS, 1962, ANNU REV ENTOMOL, V7, P289, DOI 10.1146/annurev.en.07.010162.001445; HEMPTINNE J L, 1987, Mededelingen van de Faculteit Landbouwwetenschappen Universiteit Gent, V52, P225; HODEK I, 1971, Entomophaga, V16, P239, DOI 10.1007/BF02371174; HODEK I, 1983, ENTOMOL EXP APPL, V34, P9, DOI 10.1007/BF00300893; Hodek I., 1960, AS ESKOSLOV SPOL ENT, V57, P1; Hodek I, 2012, ECOLOGY BEHAV LADYBI, DOI DOI 10.1002/9781118223208; HOLMBERG RG, 1984, J ARACHNOL, V12, P195; Iablokoff-Khnzorian SM, 1982, COCCINELLES COLE COC; IPERTI G, 1976, Annales de Zoologie Ecologie Animale, V8, P17; Isvaran K, 2013, ANIM BEHAV, V86, P417, DOI 10.1016/j.anbehav.2013.05.036; KITCHING R L, 1981, Journal of the Lepidopterists' Society, V35, P106; Klok CJ, 1999, FUNCT ECOL, V13, P417, DOI 10.1046/j.1365-2435.1999.00324.x; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Krause J, 2002, LIVING GROUPS; KREITER S, 1984, Travaux du Museum d'Histoire Naturelle "Grigore Antipa", V25, P151; Majerus M. E. N, 1994, LADYBIRDS; Malcolm S. B., 1993, BIOL CONSERVATION MO; MONTEITH G B, 1982, Memoirs of the Queensland Museum, V20, P533; NAKAMURA K, 1979, RES POPUL ECOL, V20, P297, DOI 10.1007/BF02512634; OKUDA T, 1989, REGULATION OF INSECT REPRODUCTION IV, P385; Parrish J., 1997, ANIMAL GROUPS 3 DIME; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; PASTEELS JM, 1983, ANNU REV ENTOMOL, V28, P263, DOI 10.1146/annurev.en.28.010183.001403; Perry JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081934; Pullin AS, 1996, EUR J ENTOMOL, V93, P121; R Development Core Team, 2012, R LANG ENV STAT COMP; Ripley B., PACKAGE MASS; ROLLEY F, 1974, Annales de Zoologie Ecologie Animale, V6, P53; Roubik DW, 2001, COLEOPTS BULL, V55, P249, DOI 10.1649/0010-065X(2001)055[0249:SSATAF]2.0.CO;2; Sabu TK, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.0101; Sarthou JP, 2009, ENTOMOLOGISTE, V2, P107; Savoiskaya G. I., 1970, T ALMA ATINSKOGO GOS, V9, P163; Schutz D, 2016, ANIM BEHAV, V112, P153, DOI 10.1016/j.anbehav.2015.11.022; Slipiriski A, 2007, AUSTR LADYBIRD BEETL; STAMPS JA, 1988, AM NAT, V131, P329, DOI 10.1086/284793; Susset EC, 2017, COLEOPTS BULL, V71, P556, DOI 10.1649/0010-065X-71.3.556; Susset EC, 2017, ECOL ENTOMOL, V42, P345, DOI 10.1111/een.12392; TANAKA S, 1987, BIOTROPICA, V19, P252, DOI 10.2307/2388343; TANAKA S, 1988, PHYSIOL ENTOMOL, V13, P239, DOI 10.1111/j.1365-3032.1988.tb00928.x; Tarof SA, 2005, BEHAV ECOL, V16, P207, DOI 10.1093/beheco/arh155; TAYLOR F, 1984, INT J INVER REP DEV, V7, P297, DOI 10.1080/01688170.1984.10510105; Toyama M, 2006, APPL ENTOMOL ZOOL, V41, P309, DOI 10.1303/aez.2006.309; Vulinec K, 1990, INSECT DEFENCES ADAP; Wagner RH, 2000, BEHAV ECOL, V11, P572, DOI 10.1093/beheco/11.5.572; WAGNER RH, 1993, J THEOR BIOL, V163, P333, DOI 10.1006/jtbi.1993.1123; Wagner Richard H., 1998, Ornithological Monographs, V49, P123; WELLS H, 1990, J THEOR BIOL, V147, P115, DOI 10.1016/S0022-5193(05)80255-3; YODER JA, 1992, ENTOMOL EXP APPL, V63, P203, DOI 10.1007/BF00343579; Zuur Alain F., 2009, P1	72	5	5	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197108	10.1371/journal.pone.0197108	http://dx.doi.org/10.1371/journal.pone.0197108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897918	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700006
J	van der Werf, P; Seabrook, JA; Gilliland, JA				van der Werf, Paul; Seabrook, Jamie A.; Gilliland, Jason A.			The quantity of food waste in the garbage stream of southern Ontario, Canada households	PLOS ONE			English	Article							MUNICIPAL SOLID-WASTE; METHODOLOGY; GENERATION; CONSUMER; LOSSES	There is little consensus on the amount of worldwide food waste generation because many current estimates are indirect and link back to the same limited primary datasets, with much of the data originating from fieldwork undertaken in the 1970s and 1980s. Direct measurement of waste streams, through waste composition studies, can be used to develop accurate estimates of food waste disposal. In Ontario, Canada, municipalities that undertake household waste composition studies all use a common direct measurement methodology that includes a broad range of waste categories, including food waste. The purpose of this research was to estimate the quantity of food waste disposed, in the garbage stream, by households in southern Ontario, Canada, and determine if this common methodology could be expanded and serve as the basis of a standardized and rigorous household food waste measurement methodology. Household waste composition study data (2012-2015), including a single "food waste" category, were gathered from 9 Ontario municipalities, aggregated and analyzed to develop estimates of food waste in the garbage stream. On average, households disposed 2.40 kg/week of food waste in the garbage, which comprised 35.4% of this waste stream. This does not include any food waste otherwise disposed (e.g., sink) or recycled (e.g., composted). Urban households disposed significantly greater amounts of food waste compared to rural households in the spring (p = 0.01) and summer (p = 0.02). Households with access to a green bin program disposed significantly less food waste than those with no access to a green bin program in the spring (p = 0.03) and summer (p<0.01). The common methodology used to develop these estimates shows promise as the basis of a household food waste measurement methodology. This future methodology would include dividing food waste into avoidable and unavoidable food waste categories, as well as adding subcategories (e.g., avoidable fruits and vegetables).	[van der Werf, Paul; Seabrook, Jamie A.; Gilliland, Jason A.] Univ Western Ontario, Human Environm Anal Lab, London, ON, Canada; [van der Werf, Paul; Gilliland, Jason A.] Western Univ, Dept Geog, London, ON, Canada; [Seabrook, Jamie A.; Gilliland, Jason A.] Western Univ, Dept Paediat, London, ON, Canada; [Seabrook, Jamie A.] Western Univ, Brescia Univ Coll, Sch Food & Nutr Sci, London, ON, Canada; [Seabrook, Jamie A.] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [Seabrook, Jamie A.; Gilliland, Jason A.] Western Univ, Sch Hlth Studies, London, ON, Canada; [Gilliland, Jason A.] Lawson Hlth Res Inst, London, ON, Canada; [Gilliland, Jason A.] Childrens Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	van der Werf, P (corresponding author), Univ Western Ontario, Human Environm Anal Lab, London, ON, Canada.; van der Werf, P (corresponding author), Western Univ, Dept Geog, London, ON, Canada.	pvande2@uwo.ca	University, HEAL Western/T-1323-2019; Gilliland, Jason A/E-3393-2019	Gilliland, Jason A/0000-0002-2909-2178; van der Werf, Paul/0000-0002-4389-832X				Abdulla M, 2012, J AGRIC FOOD SYST CO, V3, P137; Aschemann-Witzel J, 2015, SUSTAINABILITY-BASEL, V7, P6457, DOI 10.3390/su7066457; Barr S, 2013, APPL GEOGR, V39, P67, DOI 10.1016/j.apgeog.2012.11.006; Beretta C, 2013, WASTE MANAGE, V33, P764, DOI 10.1016/j.wasman.2012.11.007; Bernstad A, 2013, RESOUR CONSERV RECY, V73, P94, DOI 10.1016/j.resconrec.2012.12.012; Bernstad A, 2012, WASTE MANAGE RES, V30, P200, DOI 10.1177/0734242X11410113; BIS, 2010, PREP STUD FOOD WAST; Brautigam KR, 2014, WASTE MANAGE RES, V32, P683, DOI 10.1177/0734242X14545374; Bulkeley H, 2009, ENVIRON PLANN A, V41, P929, DOI 10.1068/a40261; Burnley SJ, 2007, RESOUR CONSERV RECY, V49, P264, DOI 10.1016/j.resconrec.2006.03.015; Buzby JC, 2012, FOOD POLICY, V37, P561, DOI 10.1016/j.foodpol.2012.06.002; DEFRA, 2010, REV MUN WAST COMP AN; Edjabou ME, 2015, WASTE MANAGE, V36, P12, DOI 10.1016/j.wasman.2014.11.009; Eriksson M, 2012, RESOUR CONSERV RECY, V68, P14, DOI 10.1016/j.resconrec.2012.08.001; European Commission, 2004, METH AN SOL WAST SWA; Evans D, 2012, SOCIOLOGY, V46, P41, DOI 10.1177/0038038511416150; Evans D, 2011, CRIT PUBLIC HEALTH, V21, P429, DOI 10.1080/09581596.2011.608797; Fao I., 2015, WFP 2015 STATE FOOD; FLW Protocol (Food Losses and Waste Protocol), 2016, FOOD LOSS WAST ACC R; Fusions, 2014, DRIV CURR FOOD WAST; GAY AE, 1993, J ENVIRON ENG-ASCE, V119, P631, DOI 10.1061/(ASCE)0733-9372(1993)119:4(631); Griffin M, 2009, AGR HUM VALUES, V26, P67, DOI 10.1007/s10460-008-9178-1; Gustavsson J., 2011, GLOBAL FOOD LOSSES F; Harrison G. G., 1975, Journal of Nutrition Education, V7, P13; Healy MA, 2012, SPAT SPATIO-TEMPORAL, V3, P55, DOI 10.1016/j.sste.2012.02.006; Hodges R.J., 2010, J AGR SCI, V191, P1; Katajajuuri JM, 2014, J CLEAN PROD, V73, P322, DOI 10.1016/j.jclepro.2013.12.057; Langley J, 2010, WASTE MANAGE RES, V28, P220, DOI 10.1177/0734242X08095348; Langley J, 2009, WASTE MANAGE RES, V27, P199, DOI 10.1177/0734242X08095231; Lebersorger S, 2011, WASTE MANAGE, V31, P1924, DOI 10.1016/j.wasman.2011.05.023; Lisa D, 2008, WASTE MANAGE, V28, P1100, DOI 10.1016/j.wasman.2007.08.014; Mariani J.F., 2014, ENCY AM FOOD DRINK; MATSUTO T, 1990, WASTE MANAGE RES, V8, P229, DOI 10.1177/0734242X9000800139; MAYSTRE LY, 1995, WASTE MANAGE RES, V13, P207, DOI 10.1177/0734242X9501300303; Munro R., 1995, Food choice and the consumer., P313; Newenhouse SC, 2000, WASTE MANAGE RES, V18, P105, DOI 10.1177/0734242X0001800202; Okazaki WK, 2008, WASTE MANAGE, V28, P2483, DOI 10.1016/j.wasman.2008.01.016; Parfitt JP, 1997, APPL GEOGR, V17, P231, DOI 10.1016/S0143-6228(96)00031-8; Parfitt J, 2010, PHILOS T R SOC B, V365, P3065, DOI 10.1098/rstb.2010.0126; Parizeau K, 2015, WASTE MANAGE, V35, P207, DOI 10.1016/j.wasman.2014.09.019; Porpino G., 2016, J ASSOC CONSUM RES, V1, P41, DOI DOI 10.1086/684528; Reynolds C, 2016, J MATER CYCLES WASTE, V18, P677, DOI 10.1007/s10163-015-0363-1; Reynolds CJ, 2014, WASTE MANAGE RES, V32, DOI 10.1177/0734242X14549797; RPRA, 2018, DAT DAT ORG; Rugg F.M., 1997, ENV ENG HDB, P1158; Sahimaa O, 2015, WASTE MANAGE, V46, P3, DOI 10.1016/j.wasman.2015.08.032; Sharma M, 2007, WASTE MANAGE, V27, P337, DOI 10.1016/j.wasman.2006.02.007; Silvennoinen K, 2014, BRIT FOOD J, V116, P1058, DOI 10.1108/BFJ-12-2012-0311; Statistics Canada, 2017, CENS POP 2011; Stewardship Ontario, 2005, WAST AUD GUID; Stewardship Ontario, 2014, CURBS SINGL MULT WAS, p1 ; US EPA (US Environ. Prot. Agency), 2014, MUN SOL WAST GEN REC; USDA-ERS, 2014, LOSS ADJ FOOD AV DOC; USEPA, 2009, MUN SOL WAST GEN REC; van der Werf P, 2017, P I CIVIL ENG WASTE; VANGARDE SJ, 1987, J AM DIET ASSOC, V87, P322; Waste Diversion Ontario, 2002, RES CURBS WAST AUD G; Waste Diversion Ontario, 2015, TERMS REF CURBS MULT; Watson M, 2012, SOCIOL REV, V60, P102, DOI 10.1111/1467-954X.12040; WENLOCK RW, 1980, BRIT J NUTR, V43, P53, DOI 10.1079/BJN19800064; WRAP, 2013, HOUS FOOD DRINK WAST; WRAP, 2013, ANN 2 METH US HOUS F; WRAP (The Waste and Resources Action Programme), 2009, HOUS FOOD DRINK WAST; WRAP (Waste and Resource Action Program), 2013, EST WAST FOOD DRINK	64	22	22	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198470	10.1371/journal.pone.0198470	http://dx.doi.org/10.1371/journal.pone.0198470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ2HI	29897964	Green Published, gold, Green Submitted			2022-12-26	WOS:000435090700054
J	van Wijngaarden, E; van der Wedden, H; Henning, Z; Komen, R; The, AM				van Wijngaarden, Els; van der Wedden, Hugo; Henning, Zerline; Komen, Rikke; The, Anne-Mei			Entangled in uncertainty: The experience of living with dementia from the perspective of family caregivers	PLOS ONE			English	Article							QUALITY-OF-LIFE; RISK-FACTOR; INDIVIDUALS; BURDEN; IMPACT; GRIEF	Introduction Too often dementia care is still fragmented and unresponsive to the needs of people living with dementia and their family caregivers. To develop effective health care services, indepth insight into the experiences of family caregivers is a prerequisite. Methods This Dutch study is a qualitative interview study. The aim was twofold: 1) to develop an indepth understanding of what it means to live with dementia and 2) to gain insight into what constitutes the art of living with dementia, both from the perspective of family caregivers. Data were gathered through 47 interviews with individuals and 6 focus group interviews. The analysis followed a phenomenologically inspired thematic approach. Results The findings show that living with dementia can be understood as becoming entangled in uncertainty and isolation. The following themes illustrate this experience in various phases of the disease: a) Before the diagnosis: a growing uneasy feeling that something is amiss; b) The diagnostic disclosure: an uncertain and upsetting relief; c) Dementia at home: entangled in an isolated and exhausting life; d) Capitulation to relocation: torn between relief and grief. In addition, the study shows that the art of living with dementia is associated with: a) The ability to face tragedy; b) The discovery of meaning and dignity in the context of illness; c) Retaining a sense of connection and bond; d) The primacy of attention and recognition by others. Discussion and conclusion Our findings show that dealing with what Boss (2011) called 'ambiguous loss-experiences' is one of the most demanding aspects of living with dementia. Based on the findings, we have developed a model that depicts how people handle contingency and seek balance along the continuum of facing and resisting. Our study shows that resilience in the context of living with dementia should not be understood as merely an individual mental ability, nor as a set of behaviours, but rather as a social-ecological enterprise.	[van Wijngaarden, Els] Univ Humanist Studies, Res Grp Care Eth, Utrecht, Netherlands; [van Wijngaarden, Els; van der Wedden, Hugo; Henning, Zerline; Komen, Rikke; The, Anne-Mei] Res Org Tao Care, Amsterdam, Netherlands; [The, Anne-Mei] Univ Amsterdam, Fac Social & Behav Sci, Amsterdam, Netherlands	University of Amsterdam	van Wijngaarden, E (corresponding author), Univ Humanist Studies, Res Grp Care Eth, Utrecht, Netherlands.; van Wijngaarden, E (corresponding author), Res Org Tao Care, Amsterdam, Netherlands.	e.vanwijngaarden@uvh.nl	van Wijngaarden, Els/AAH-3414-2021; The, Anne-Mei/AAE-3468-2020	van Wijngaarden, Els/0000-0002-2940-9163; 				Bergman M, 2016, MED HEALTH CARE PHIL, V19, P341, DOI 10.1007/s11019-016-9696-3; Blandin K, 2017, DEMENTIA-LONDON, V16, P67, DOI 10.1177/1471301215581081; Boss P, 2007, FAM RELAT, V56, P105, DOI 10.1111/j.1741-3729.2007.00444.x; Boss P, 2010, PASTOR PSYCHOL, V59, P137, DOI 10.1007/s11089-009-0264-0; Boss Pauline, 2011, LOVING SOMEONE WHO H; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Coe NB, 2009, HEALTH ECON, V18, P991, DOI 10.1002/hec.1512; Dahlberg K., 2008, REFLECTIVE LIFEWORLD, V2nd ed.; Ducharme F, 2013, AM J ALZHEIMERS DIS, V28, P634, DOI 10.1177/1533317513494443; Dupuis S.L., 2002, J GERONTOLOGICAL SOC, V37, P93, DOI [10.1300/J083v37n02_08, DOI 10.1300/J083V37N02_08, DOI 10.1300/J083V37N02_]; Evers J., 2019, KWALITATIEF INTERVIE; Evers J, 2007, KWALITATIEVE INTERVI; Finlay L, 2011, PHENOMENOLOGY FOR THERAPISTS: RESEARCHING THE LIVED WORLD, P1, DOI 10.1002/9781119975144; Frank Jacquelyn B, 2007, Am J Alzheimers Dis Other Demen, V22, P516, DOI 10.1177/1533317507307787; Holley CK, 2009, GERONTOLOGIST, V49, P388, DOI 10.1093/geront/gnp061; Joling K. J., 2017, INT J GERIATRIC PSYC; Ekwall AK, 2007, J ADV NURS, V57, P584, DOI 10.1111/j.1365-2648.2006.03994.x; Lavretsky H., 2005, STRESS DEPRESSION IN; Meyer J, 2016, BRIT J COMMUNITY NUR, V21; O'Dwyer ST, 2016, AGING MENT HEALTH, V20, P1174, DOI 10.1080/13607863.2015.1065793; Oliva D, 2017, INTEL SYST REF LIBR, V117, P1, DOI 10.1007/978-3-319-48550-8; Oliveira D, 2017, DEMENTIA; Palmer JL, 2013, GERIATR NURS, V34, P224, DOI 10.1016/j.gerinurse.2013.03.001; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Prince M., 2016, WORLD ALZHEIMER REPO; Ratcliffe J, 2013, HEALTH SOC CARE COMM, V21, P35, DOI 10.1111/j.1365-2524.2012.01085.x; Roth DL, 2009, QUAL LIFE RES, V18, P679, DOI 10.1007/s11136-009-9482-2; Schulz R, 2004, AM J GERIAT PSYCHIAT, V12, P240, DOI 10.1176/appi.ajgp.12.3.240; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Serrano-Aguilar PG, 2006, NEUROEPIDEMIOLOGY, V27, P136, DOI 10.1159/000095760; Sikes P, 2017, EVERY TIME 1 SEE HIM, P1; Svanstrom R, 2004, WESTERN J NURS RES, V26, P671, DOI 10.1177/0193945904265920; Taylor JS, 2008, MED ANTHROPOL Q, V22, P313, DOI 10.1111/j.1548-1387.2008.00036.x; The A.-M., 2017, DAGELIJKS LEVEN MET; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Van Manen Max., 2014, PHENOMENOLOGY PRACTI, V13; van Wijngaarden E, 2017, QUAL HEALTH RES, V27, P1738, DOI 10.1177/1049732317711133; Vellone E, 2008, J ADV NURS, V61, P222, DOI 10.1111/j.1365-2648.2007.04494.x; Vitaliano PP, 2004, CURR DIR PSYCHOL SCI, V13, P13, DOI 10.1111/j.0963-7214.2004.01301004.x	39	24	24	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198034	10.1371/journal.pone.0198034	http://dx.doi.org/10.1371/journal.pone.0198034			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ2HI	29897922	gold, Green Published, Green Submitted			2022-12-26	WOS:000435090700040
J	Yan, LL; Zhao, C; Zhang, J; Qiu, LH; Chen, ZZ				Yan, Lulu; Zhao, Chao; Zhang, Jun; Qiu, Lihua; Chen, Zuozhi			Transcriptomic analyses of gastrointestinal function in the "dwarf" and "medium" forms of Sthenoteuthis oualaniensis during sexual maturation	PLOS ONE			English	Article							HEPATIC GLUCOSE-METABOLISM; SOUTH CHINA SEA; SQUID; EXPRESSION; PACIFIC; ENZYMES; GROWTH; FISH	Sthenoteuthis oualaniensis (SA) is an important squid species in the South China Sea. Based on SA samples collected in 2016, SA was divided into the "dwarf" form (DF) and "medium" form (MF). To understand the changes in gastrointestinal function in SA during sexual maturation, we undertook transcriptomic analyses of the stomach and intestine tissues of the mature and immature DF and MF of SA using the deep-sequencing platform Illumina HiSeq (TM). We exploited a high-throughput method to delineate differentially expressed genes (DEGs) in the DF and MF of SA. A total of 135464 unigenes (68627 unigenes of the DG and 66837 unigenes of the MF) were generated. We identified 7965 and 4051 relative DEGs in the intestine and stomach tissues of the mature DF of SA compared with those of the immature DF of SA; and 22138 and 18460 DEGs in the intestine and stomach of the mature MF of SA compared with those of the immature MF of SA. Gastrointestinal function related to the metabolism of lipids, amino acids, glucose, and energy were changed in SA during sexual maturation. This work is the first to identify a set of genes associated with gastrointestinal function during sexual maturation in SA.	[Yan, Lulu; Zhao, Chao; Zhang, Jun; Qiu, Lihua; Chen, Zuozhi] Chinese Acad Fishery Sci, South China Sea Fisheries Res Inst, Guangzhou, Guangdong, Peoples R China; [Yan, Lulu; Zhao, Chao] Minist Agr, Key Lab South China Sea Fishery Resources Exploit, Guangzhou, Guangdong, Peoples R China; [Zhang, Jun; Chen, Zuozhi] Minist Agr, Key Lab Open Sea Fishery Dev, Guangzhou, Guangdong, Peoples R China; [Qiu, Lihua] Minist Agr, Key Lab Aquat Genom, Beijing, Peoples R China	Chinese Academy of Fishery Sciences; South China Sea Fisheries Research Institute, CAFS; Chinese Academy of Fishery Sciences; South China Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs	Chen, ZZ (corresponding author), Chinese Acad Fishery Sci, South China Sea Fisheries Res Inst, Guangzhou, Guangdong, Peoples R China.; Chen, ZZ (corresponding author), Minist Agr, Key Lab Open Sea Fishery Dev, Guangzhou, Guangdong, Peoples R China.	zzchen2000@163.com		chen, zuozhi/0000-0003-4045-1212	National Basic Research Program of China [2014C6441500]; Ministry of Agriculture [NFZX2013]	National Basic Research Program of China(National Basic Research Program of China); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	This study was supported by National Basic Research Program of China (No. 2014C6441500) and Financial Fund of the Ministry of Agriculture (No. NFZX2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja P, 2010, J CLIN INVEST, V120, P1494, DOI 10.1172/JCI38331; [Anonymous], 1993, POPULATION STRUCTURE; Beninger PG, 2003, BIOL BULL-US, V205, P83, DOI 10.2307/1543448; Canback B, 2002, P NATL ACAD SCI USA, V99, P6097, DOI 10.1073/pnas.082112499; Cetica P, 2003, REPRODUCTION, V126, P753, DOI 10.1530/rep.0.1260753; Chen XJ, 2007, FISH RES, V83, P98, DOI 10.1016/j.fishres.2006.09.005; Enes P, 2006, COMP BIOCHEM PHYS A, V143, P89, DOI 10.1016/j.cbpa.2005.10.027; Enes P, 2009, FISH PHYSIOL BIOCHEM, V35, P519, DOI 10.1007/s10695-008-9259-5; Fan JiangTao, 2015, Animal Husbandry and Feed Science, V7, P119; Fang Z, 2015, FISHERIES SCI, V81, P443, DOI 10.1007/s12562-015-0857-8; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hong Hye-Ryun, 2014, J Exerc Nutrition Biochem, V18, P361, DOI 10.5717/jenb.2014.18.4.361; Juanico M., 1983, ADV ASSESSMENT WORLD; Kaira K, 2008, BRIT J CANCER, V98, P742, DOI 10.1038/sj.bjc.6604235; Kumar P, 2015, BIOL RHYTHM RES, V46, P601, DOI 10.1080/09291016.2015.1034974; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Li P, 2009, AMINO ACIDS, V37, P43, DOI 10.1007/s00726-008-0171-1; Marei WF, 2009, BIOL REPROD, V81, P1064, DOI 10.1095/biolreprod.109.076851; Meister A., 2009, ADV ENZYMOLOGY RELAT; Mouneyrac C, 2008, GEN COMP ENDOCR, V157, P133, DOI 10.1016/j.ygcen.2008.04.010; MOURENTE G, 1994, MAR BIOL, V121, P187, DOI 10.1007/BF00349488; Sabet Saeed Shafiei, 2009, Journal of Cell and Animal Biology, V3, P208; SHCHETINNIKOV AS, 1992, J MAR BIOL ASSOC UK, V72, P849, DOI 10.1017/S0025315400060082; Sui LY, 2011, AQUACULT INT, V19, P269, DOI 10.1007/s10499-010-9379-7; Tanomman S, 2013, COMP BIOCHEM PHYS B, V166, P148, DOI 10.1016/j.cbpb.2013.07.011; Turchini G. M., 2010, FISH OIL REPLACEMENT; Wang J Y, 2002, BIOCHEMISTRY; Wang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084921; Wang XH, 2017, CHIN J OCEANOL LIMN, V35, P902, DOI 10.1007/s00343-017-6115-4; Zangerle R, 2010, BRAIN BEHAV IMMUN, V24, P403, DOI 10.1016/j.bbi.2009.11.004; Zhang J, 2015, FISH RES, V169, P45, DOI 10.1016/j.fishres.2015.05.003; Zhang Peng, 2015, Nanfang Shuichan, V11, P11	32	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0199053	10.1371/journal.pone.0199053	http://dx.doi.org/10.1371/journal.pone.0199053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897993	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700090
J	Le, PY; Ambrose, C				Le, P. Yen; Ambrose, Chris			CLASP promotes stable tethering of endoplasmic microtubules to the cell cortex to maintain cytoplasmic stability in Arabidopsis meristematic cells	PLOS ONE			English	Article							CORTICAL MICROTUBULES; PLANT-CELLS; PLUS-END; IMMUNOFLUORESCENCE MICROSCOPY; INTERPHASE MICROTUBULES; ROOT EPIDERMIS; ORGANIZATION; GROWTH; ACTIN; PROTEINS	Following cytokinesis in plants, Endoplasmic MTs (EMTs) assemble on the nuclear surface, forming a radial network that extends out to the cell cortex, where they attach and incorporate into the cortical microtubule (CMT) array. We found that in these post-cytokinetic cells, the MT-associated protein CLASP is enriched at sites of EMT-cortex attachment, and is required for stable EMT tethering and growth into the cell cortex. Loss of EMT-cortex anchoring in clasp-1 mutants results in destabilized EMT arrays, and is accompanied by enhanced mobility of the cytoplasm, premature vacuolation, and precocious entry into cell elongation phase. Thus, EMTs appear to maintain cells in a meristematic state by providing a structural scaffold that stabilizes the cytoplasm to counteract actomyosin-based cytoplasmic streaming forces, thereby preventing premature establishment of a central vacuole and rapid cell elongation.	[Le, P. Yen; Ambrose, Chris] Univ Saskatchewan, Dept Biol, Coll Arts & Sci, Saskatoon, SK, Canada	University of Saskatchewan	Ambrose, C (corresponding author), Univ Saskatchewan, Dept Biol, Coll Arts & Sci, Saskatoon, SK, Canada.	jca790@mail.usask.ca		Chris, Ambrose/0000-0003-2234-7075	University of Saskatchewan College of Arts and Science Faculty and Recruitment Retention Plan's New Investigator Award; NSERC Discovery [2015-05938]	University of Saskatchewan College of Arts and Science Faculty and Recruitment Retention Plan's New Investigator Award; NSERC Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the University of Saskatchewan College of Arts and Science Faculty and Recruitment Retention Plan's New Investigator Award and by NSERC Discovery Grant 2015-05938. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the University of Saskatchewan College of Arts and Science Faculty and Recruitment Retention Plan's New Investigator Award, and by NSERC Discovery Grant 2015-05938.	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Al-Bassam J, 2010, DEV CELL, V19, P245, DOI 10.1016/j.devcel.2010.07.016; Ambrose C, 2014, PLANT CELL PHYSIOL, V55, P1636, DOI 10.1093/pcp/pcu094; Ambrose C, 2013, DEV CELL, V24, P649, DOI 10.1016/j.devcel.2013.02.007; Ambrose C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1444; Ambrose JC, 2008, MOL BIOL CELL, V19, P4730, DOI 10.1091/mbc.E08-06-0665; Ambrose JC, 2007, PLANT CELL, V19, P2763, DOI 10.1105/tpc.107.053777; Ambrose JC, 2008, MOL PLANT, V1, P950, DOI 10.1093/mp/ssn054; BAKHUIZEN R, 1985, PROTOPLASMA, V128, P43, DOI 10.1007/BF01273234; BALUSKA F, 1992, J CELL SCI, V103, P191; Baluska F, 2001, J PLANT GROWTH REGUL, V20, P170, DOI 10.1007/s003440010013; Baskin TI, 2001, PROTOPLASMA, V215, P150, DOI 10.1007/BF01280311; Berger F, 1998, DEV BIOL, V194, P235, DOI 10.1006/dbio.1997.8813; Bichet A, 2001, PLANT J, V25, P137, DOI 10.1046/j.1365-313x.2001.00946.x; Brandizzi F, 2013, PLANT J, V75, P339, DOI 10.1111/tpj.12227; Bratman SV, 2007, DEV CELL, V13, P812, DOI 10.1016/j.devcel.2007.10.015; BROWN RC, 1992, CELL MOTIL CYTOSKEL, V22, P72, DOI 10.1002/cm.970220108; Burk DH, 2001, PLANT CELL, V13, P807, DOI 10.1105/tpc.13.4.807; Chan J, 2010, J CELL SCI, V123, P3490, DOI 10.1242/jcs.074641; Chi ZH, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0703-x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collings DA, 2006, NEW PHYTOL, V170, P275, DOI 10.1111/j.1469-8137.2006.01671.x; Collings DA, 2005, CAN J BOT, V83, P579, DOI [10.1139/B05-032, 10.1139/b05-032]; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; DOLAN L, 1994, DEVELOPMENT, V120, P2465; DOONAN JH, 1985, J CELL SCI, V75, P131; Field CM, 2011, CURR BIOL, V21, pR825, DOI 10.1016/j.cub.2011.07.043; FLANDERS DJ, 1989, DEVELOPMENT, V106, P531; Fujita M, 2011, PLANT J, V66, P915, DOI 10.1111/j.1365-313X.2011.04552.x; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Hamada T, 2014, INT REV CEL MOL BIO, V312, P1, DOI 10.1016/B978-0-12-800178-3.00001-4; Hannak E, 2006, J CELL BIOL, V172, P19, DOI 10.1083/jcb.200508180; Hashimoto T, 2006, CURR OPIN PLANT BIOL, V9, P5, DOI 10.1016/j.pbi.2005.11.005; Hunter PR, 2007, PLANT PHYSIOL, V145, P1371, DOI 10.1104/pp.107.103945; Kirik V, 2007, J CELL SCI, V120, P4416, DOI 10.1242/jcs.024950; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; KUBIAK JZ, 1987, CYTOLOGIA, V52, P781, DOI 10.1508/cytologia.52.781; Kumagai F, 2003, EUR J CELL BIOL, V82, P43, DOI 10.1078/0171-9335-00292; Landrein B, 2015, J EXP BOT, V66, P1317, DOI 10.1093/jxb/eru482; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Littlejohn GR, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00140; LIU B, 1993, J CELL SCI, V104, P1217; Lloyd C, 2006, NAT REV MOL CELL BIO, V7, P147, DOI 10.1038/nrm1831; Maiato H, 2003, CELL CYCLE, V2, P511, DOI 10.4161/cc.2.6.576; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mimori-Kiyosue Y, 2003, J BIOCHEM, V134, P321, DOI 10.1093/jb/mvg148; MIZUNO K, 1993, PROTOPLASMA, V173, P77, DOI 10.1007/BF01378864; Oda Y, 2009, INT REV CEL MOL BIO, V277, P103, DOI 10.1016/S1937-6448(09)77003-0; Oda Y, 2009, PLANT CELL PHYSIOL, V50, P855, DOI 10.1093/pcp/pcp031; PANTERIS E, 1991, PROTOPLASMA, V165, P173, DOI 10.1007/BF01322288; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Pietra S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3779; Royer LA, 2015, NAT METHODS, V12, P480, DOI 10.1038/nmeth.3372; Saito C, 2002, PLANT J, V29, P245, DOI 10.1046/j.0960-7412.2001.01189.x; Scheuring D, 2016, P NATL ACAD SCI USA, V113, P452, DOI 10.1073/pnas.1517445113; Schneider K, 1997, DEVELOPMENT, V124, P1789; SEAGULL RW, 1987, J CELL BIOL, V104, P995, DOI 10.1083/jcb.104.4.995; SHIMMEN T, 1995, PROTOPLASMA, V185, P188, DOI 10.1007/BF01272859; Sousa A, 2007, CELL MOTIL CYTOSKEL, V64, P605, DOI 10.1002/cm.20208; van der Honing HS, 2007, BBA-MOL CELL RES, V1773, P604, DOI 10.1016/j.bbamcr.2006.07.009; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; WICK SM, 1985, CELL BIOL INT REP, V9, P357, DOI 10.1016/0309-1651(85)90031-1	64	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198521	10.1371/journal.pone.0198521	http://dx.doi.org/10.1371/journal.pone.0198521			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894477	Green Published, gold, Green Submitted			2022-12-26	WOS:000435030900017
J	Lei, XJ; Yang, XQ				Lei, Xiujuan; Yang, Xiaoqin			A new method for predicting essential proteins based on participation degree in protein complex and subgraph density	PLOS ONE			English	Article							IDENTIFYING ESSENTIAL PROTEINS; CENTRALITY; IDENTIFICATION; GENOME; INTERACTOME; HUBS	Essential proteins are crucial to living cells. Identification of essential proteins from protein protein interaction (PPI) networks can be applied to pathway analysis and function prediction, furthermore, it can contribute to disease diagnosis and drug design. There have been some experimental and computational methods designed to identify essential proteins, however, the prediction precision remains to be improved. In this paper, we propose a new method for identifying essential proteins based on Participation degree of a protein in protein Complexes and Subgraph Density, named as PCSD. In order to test the performance of PCSD, four PPI datasets (DIP, Krogan, MIPS and Gavin) are used to conduct experiments. The experiment results have demonstrated that PCSD achieves a better performance for predicting essential proteins compared with some competing methods including DC, SC, EC, IC, LAC, NC, WDC, PeC, UDoNC, and compared with the most recent method LBCC, PCSD can correctly predict more essential proteins from certain numbers of top ranked proteins on the DIP dataset, which indicates that PCSD is very effective in discovering essential proteins in most case.	[Lei, Xiujuan; Yang, Xiaoqin] Shaanxi Normal Univ, Sch Comp Sci, Xian, Shaanxi, Peoples R China	Shaanxi Normal University	Lei, XJ (corresponding author), Shaanxi Normal Univ, Sch Comp Sci, Xian, Shaanxi, Peoples R China.	xjlei@snnu.edu.cn			National Natural Science Foundation of China [61672334, 61502290, 61401263]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This paper is supported by the National Natural Science Foundation of China (61672334, 61502290, 61401263). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, INT C RES COMP MOL B; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Cullen LM, 2005, IMMUNOL CELL BIOL, V83, P217, DOI 10.1111/j.1440-1711.2005.01332.x; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Fan C, 2017, INT C INT COMP; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lei X, 2017, INFORM SCI; Lei XJ, 2016, KNOWL-BASED SYST, V105, P270, DOI 10.1016/j.knosys.2016.05.019; Li M, 2018, J THEORETICAL BIOL; Li M, 2019, IEEE ACM T COMPUT BI, V16, P1386, DOI 10.1109/TCBB.2017.2665482; Li M, 2017, IEEE ACM T COMPUT BI, V14, P370, DOI 10.1109/TCBB.2015.2394487; Li M, 2016, TSINGHUA SCI TECHNOL, V21, P668, DOI 10.1109/TST.2016.7787009; Li M, 2015, IEEE ACM T COMPUT BI, V12, P372, DOI 10.1109/TCBB.2014.2361350; Li M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-15; Li M, 2011, COMPUT BIOL CHEM, V35, P143, DOI 10.1016/j.compbiolchem.2011.04.002; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Luo JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131418; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Peng W, 2015, IEEE ACM T COMPUT BI, V12, P276, DOI 10.1109/TCBB.2014.2338317; Peng W, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-87; Pu SY, 2007, PROTEOMICS, V7, P944, DOI 10.1002/pmic.200600636; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Qi Y, 2016, PREDICTION ESSENTIAL, P1170; Qin C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161042; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Shang XQ, 2016, SCI CHINA INFORM SCI, V59, DOI 10.1007/s11432-016-5583-z; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; STEPHENSON K, 1989, SOC NETWORKS, V11, P1, DOI 10.1016/0378-8733(89)90016-6; Tang XW, 2014, IEEE ACM T COMPUT BI, V11, P407, DOI 10.1109/TCBB.2013.2295318; Tang Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/j.biosystems.2014.11.005; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Vallabhajosyula RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005344; Wang JX, 2013, PROTEOMICS, V13, P301, DOI 10.1002/pmic.201200277; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wuchty S, 2003, J THEOR BIOL, V223, P45, DOI 10.1016/S0022-5193(03)00071-7; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhang YJ, 2013, IEEE ACM T COMPUT BI, V10, P729, DOI 10.1109/TCBB.2013.86; Zhao JJ, 2017, J STROKE CEREBROVASC, V26, P2695, DOI 10.1016/j.jstrokecerebrovasdis.2016.10.012; Zhu L, 2017, AM J BIOCH BIOTECHNO, V13, P242	48	10	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198998	10.1371/journal.pone.0198998	http://dx.doi.org/10.1371/journal.pone.0198998			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894517	Green Published, gold, Green Submitted			2022-12-26	WOS:000435030900042
J	Qiao, H; Jiang, FW; Xiong, YW; Jiang, SF; Fu, HT; Li, F; Zhang, WY; Sun, SM; Jin, SB; Gong, YS; Wu, Y				Qiao, Hui; Jiang, Fengwei; Xiong, Yiwei; Jiang, Sufei; Fu, Hongtuo; Li, Fei; Zhang, Wenyi; Sun, Shengming; Jin, Shubo; Gong, Yongsheng; Wu, Yan			Characterization, expression patterns of molt-inhibiting hormone gene of Macrobrachium nipponense and its roles in molting and growth	PLOS ONE			English	Article							CRUSTACEAN HYPERGLYCEMIC HORMONE; SHRIMP METAPENAEUS-ENSIS; ORIENTAL RIVER PRAWN; MARSUPENAEUS-JAPONICUS; ECDYSTEROID SECRETION; EYESTALK ABLATION; RNA INTERFERENCE; CARCINUS-MAENAS; SHORE CRAB; CLONING	The oriental river prawn, Macrobrachium nipponense, is an important commercial aquaculture resource in China. In order to overwinter, M. nipponense displays decreased physiological activity and less consumption of energy. Sudden warming would trigger molting and cause an extensive death, resulting in huge economic losses. Therefore, it is of great practical significance to study the molting mechanism of oriental river prawns. Molt-inhibiting hormone gene (MIH) plays a major role in regulating molting in crustaceans. In this study, a full length MIH cDNA of M. nipponense (Mn-MIH) was cloned from the eyestalk. The total length of the Mn-MIH was 925 bp, encoding a protein of 119 amino acids. Tissue distribution analysis showed that Mn-MIH was highly expressed in the eyestalk, and that it had relatively low expression in gill, ovary, and abdominal ganglion. Mn-MIH was detected in all developmental stages, and changed regularly in line with the molting cycle of the embryo and larva. Mn-MIH varied in response to the molting cycle, suggesting that Mn-MIH negatively regulates ecdysteroidogenesis. Mn-MIH inhibition by RNAi resulted in a significant acceleration of molting cycles in both males and females, confirming the inhibitory role of MIH in molting. After long-term RNAi males, but not females had significant weight gain, confirming that Mn-MIH plays an important role in growth of M. nipponense. Our work contributes to a better understanding of the role of Mn-MIH in crustacean molting and growth.	[Qiao, Hui; Xiong, Yiwei; Jiang, Sufei; Fu, Hongtuo; Zhang, Wenyi; Sun, Shengming; Jin, Shubo; Gong, Yongsheng; Wu, Yan] Chinese Acad Fishery Sci, Minist Agr, Freshwater Fisheries Res Ctr, Key Lab Freshwater Fisheries & Germplasm Resource, Wuxi, Peoples R China; [Jiang, Fengwei; Fu, Hongtuo; Li, Fei] Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Peoples R China	Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Fu, HT (corresponding author), Chinese Acad Fishery Sci, Minist Agr, Freshwater Fisheries Res Ctr, Key Lab Freshwater Fisheries & Germplasm Resource, Wuxi, Peoples R China.; Fu, HT (corresponding author), Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Peoples R China.	fuht@ffrc.cn		Jin, Shubo/0000-0002-6550-9268	Central Public-interest Scientific Institution Basal Research Fund CAFS [2017JBFZ05]; National Natural Science Foundation of China [31572617]; Science & Technology Supporting Program of Jiangsu Province [BE2016308]; China Agriculture Research System-48(CARS-48); Fund of Independent Innovation of Agricultural Sciences of Jiangsu province [CX (15)1012-4)]; Science and Technology Development Fund of Wuxi [CLEO2N1514]	Central Public-interest Scientific Institution Basal Research Fund CAFS; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Supporting Program of Jiangsu Province; China Agriculture Research System-48(CARS-48); Fund of Independent Innovation of Agricultural Sciences of Jiangsu province; Science and Technology Development Fund of Wuxi	The authors are grateful for the financial support from Central Public-interest Scientific Institution Basal Research Fund CAFS (2017JBFZ05); National Natural Science Foundation of China (31572617); Science & Technology Supporting Program of Jiangsu Province (BE2016308); China Agriculture Research System-48(CARS-48); Fund of Independent Innovation of Agricultural Sciences of Jiangsu province (CX (15)1012-4); Science and Technology Development Fund of Wuxi (CLEO2N1514).	Bureau of Fishery, 2017, CHIN FISH YB, P236; Chan SM, 1998, GENE, V224, P23, DOI 10.1016/S0378-1119(98)00517-4; Chang ES, 2011, GEN COMP ENDOCR, V172, P323, DOI 10.1016/j.ygcen.2011.04.003; Chen HY, 2007, GEN COMP ENDOCR, V151, P72, DOI 10.1016/j.ygcen.2006.11.016; Chen Ying, 2012, Journal of Shanghai Ocean University, V21, P33; Chung JS, 2005, ENDOCRINOLOGY, V146, P5545, DOI 10.1210/en.2005-0859; de Souza AS, 2017, J EXP MAR BIOL ECOL, V497, P134, DOI 10.1016/j.jembe.2017.09.017; Diarte-Plata G, 2012, APPL ANIM BEHAV SCI, V140, P172, DOI 10.1016/j.applanim.2012.06.002; Fu HT, 2012, AQUAC RES, V43, P993, DOI 10.1111/j.1365-2109.2011.03085.x; Gu PL, 1998, MOL MAR BIOL BIOTECH, V7, P214; Gu PL, 2002, PEPTIDES, V23, P1875, DOI 10.1016/S0196-9781(02)00178-X; HOPKINS PM, 1992, AM ZOOL, V32, P450; Huang HY, 2015, AQUAC RES, V46, P2665, DOI 10.1111/are.12421; Lee KJ, 2002, J EXP ZOOL, V292, P41, DOI 10.1002/jez.1141; Li FJ, 2015, GENE, V561, P68, DOI 10.1016/j.gene.2015.02.012; Liang HF, 2019, PEPTIDES, V122, DOI 10.1016/j.peptides.2017.10.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loredo-Ranjel R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175046; McDonald AA, 2011, COMP BIOCHEM PHYS A, V158, P150, DOI 10.1016/j.cbpa.2010.10.013; Nakatsuji T, 2004, GEN COMP ENDOCR, V135, P358, DOI 10.1016/j.ygcen.2003.11.001; Nakatsuji T, 2009, COMP BIOCHEM PHYS A, V152, P139, DOI 10.1016/j.cbpa.2008.10.012; Ohira T, 2005, PEPTIDES, V26, P259, DOI 10.1016/j.peptides.2004.09.003; Ohira T, 1997, ZOOL SCI, V14, P785, DOI 10.2108/zsj.14.785; Okumura T, 2005, ZOOL SCI, V22, P317, DOI 10.2108/zsj.22.317; Pamuru RR, 2012, GEN COMP ENDOCR, V178, P227, DOI 10.1016/j.ygcen.2012.05.007; Qiao H, 2015, COMP BIOCHEM PHYS A, V185, P1, DOI [10.1016/j.cbpa.2015.03.005, 10.1016/j.hemonc.2014.09.004]; Tiu SHK, 2007, FEBS J, V274, P4385, DOI 10.1111/j.1742-4658.2007.05968.x; Treerattrakool S, 2013, AQUACULTURE, V404, P116, DOI 10.1016/j.aquaculture.2013.04.024; Umphrey HR, 1998, MOL CELL ENDOCRINOL, V136, P145, DOI 10.1016/S0303-7207(97)00226-8; Ventura T, 2018, HYDROBIOLOGIA, V825, P47, DOI 10.1007/s10750-017-3445-3; Yang WJ, 2001, BIOCHEM BIOPH RES CO, V289, P407, DOI 10.1006/bbrc.2001.6019; Zhang YC, 2011, GEN COMP ENDOCR, V173, P467, DOI 10.1016/j.ygcen.2011.07.010; Zhu DF, 2011, CRUSTACEANA, V84, P1481, DOI 10.1163/156854011X607051; Zmora Nilli, 2009, Saline Syst, V5, P6, DOI 10.1186/1746-1448-5-6	34	21	21	6	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198861	10.1371/journal.pone.0198861	http://dx.doi.org/10.1371/journal.pone.0198861			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889902	Green Published, Green Submitted, gold			2022-12-26	WOS:000434786600060
J	Larson, JH; Maki, RP; Vondra, BA; Peterson, KE				Larson, James H.; Maki, Ryan P.; Vondra, Benjamin A.; Peterson, Kevin E.			Before-after, control-impact analysis of evidence for the impacts of water level on Walleye, Northern Pike and Yellow Perch in lakes of the Rainy-Namakan complex (MN, USA and ON, CA)	PLOS ONE			English	Article							AQUATIC COMMUNITIES; FLUCTUATIONS; MANAGEMENT; MINNESOTA; ABUNDANCE; RESERVOIR	Water level (WL) fluctuations in lakes influence many aspects of ecosystem processes. Concern about the potential impact of WL fluctuations on fisheries was one of the factors that motivated the decision in 2000 to alter the management of WL in the Rainy-Namakan reservoir complex (on the border between the U.S. state of Minnesota and the Canadian province of Ontario). We used a Before-After, Control-Impact (BACI) framework to identify potential impacts of the change in WL management to Walleye, Northern Pike and Yellow Perch catch per unit effort (CPUE). The CPUE of these species from 1990-1999 and from 2005-2014 were compared in four impact lakes (Lake Kabetogama, Namakan Lake, Rainy Lake and Sand Point Lake) and two control lakes (Lake of the Woods and Lake Vermilion) using a simple Bayesian model. Changes in fish CPUE in the impact lakes were often similar to changes that occurred in at least one control lake. The only change that was not similar to changes in control lakes was an increase of Yellow Perch in Lake Kabetogama. The two control lakes often differed substantially from each other, such that if only one had been available our conclusions about the role of WL management on fisheries would be very different. In general, identifying cause-and-effect relationships in observational field data is very difficult, and the BACI analysis used here does not specify a causative mechanism, so co-occurring environmental and management changes may obscure the effect of WL management.	[Larson, James H.] US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI 54601 USA; [Maki, Ryan P.] Natl Pk Serv, Voyageurs Natl Pk, Grand Rapids, MN USA; [Vondra, Benjamin A.; Peterson, Kevin E.] Minnesota Dept Nat Resources, Int Falls, MN USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior	Larson, JH (corresponding author), US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI 54601 USA.	jhlarson@usgs.gov						[Anonymous], 2000, NON TRADITIONAL REF; Aroviita J, 2008, HYDROBIOLOGIA, V613, P45, DOI 10.1007/s10750-008-9471-4; Becker G. C., 1983, FISHES WISCONSIN; Bethke BJ, 2015, T AM FISH SOC, V144, P68, DOI 10.1080/00028487.2014.965345; CHEVALIER JR, 1977, J FISH RES BOARD CAN, V34, P1696, DOI 10.1139/f77-234; Christensen VG, 2015, J AM WATER RESOUR AS, V51, P99, DOI 10.1111/jawr.12234; COHEN Y, 1993, CAN J FISH AQUAT SCI, V50, P1934, DOI 10.1139/f93-216; Dembkowski DJ, 2014, FISHERIES MANAG ECOL, V21, P89, DOI 10.1111/fme.12047; Gausch H, 2012, EMERGING PRIORITY PO, V19, DOI [10.1007/978-3-642-25722-3_7, DOI 10.1007/978-3-642-25722-3_7]; Haxton TJ, 2008, CAN J FISH AQUAT SCI, V65, P437, DOI 10.1139/F07-175; Hudon C, 2005, HYDROBIOLOGIA, V539, P205, DOI 10.1007/s10750-004-4872-5; Jirsa MA, 2005, M 163 BEDROCK GEOLOG; Kallemeyn L.W., 1987, North American Journal of Fisheries Management, V7, P513, DOI 10.1577/1548-8659(1987)7<513:CORLLA>2.0.CO;2; Kallemeyn LW, 2003, 20030001 ENV RES; Kitchell J, 1996, REV PROPOSED CHANGES; Larson JH, 2016, N AM J FISH MANAGE, V36, P1425, DOI 10.1080/02755947.2016.1214645; Leira M, 2008, HYDROBIOLOGIA, V613, P171, DOI 10.1007/s10750-008-9465-2; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; McEwen DC, 2010, FRESHWATER BIOL, V55, P1086, DOI 10.1111/j.1365-2427.2009.02382.x; Plummer M, 2014, RJAGS BAYESIAN GRAPH; R Development Core Team, 2014, R LANG ENV STAT COMP; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Sharp RW, 1941, 30 FISH RES INV, P17; Smith E. P., 2013, ENCY ENV, V1, P141, DOI DOI 10.1002/9780470057339.VAB001.PUB2; Underwood A. J., 1997, EXPT ECOLOGY THEIR L, P1, DOI DOI 10.1016/J.PORGCOAT.2011.04.008; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; Wantzen KM, 2008, HYDROBIOLOGIA, V613, P1, DOI 10.1007/s10750-008-9466-1; White MS, 2008, HYDROBIOLOGIA, V613, P21, DOI 10.1007/s10750-008-9469-y; WILCOX DA, 1991, CAN J BOT, V69, P1542, DOI 10.1139/b91-198; Wingate P. J., 1984, SPECIAL PUBLICATION, V140	30	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198612	10.1371/journal.pone.0198612	http://dx.doi.org/10.1371/journal.pone.0198612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879158	Green Submitted, gold, Green Published			2022-12-26	WOS:000434384900059
J	Xia, SJ; Yamakawa, T				Xia, Shujuan; Yamakawa, Takashi			A size-structured matrix model to simulate dynamics of marine community size spectrum	PLOS ONE			English	Article							BODY-SIZE; NATURAL MORTALITY; PELAGIC FISH; ENERGY-FLOW; ECOSYSTEM; BIOMASS; LIFE; PREDATION; ABUNDANCE; PATTERNS	Several types of size-based models have been developed to model the size spectra of marine communities, in which abundance scales strongly with body size, using continuous differential equations. In this study, we develop a size-structured matrix model, which can be seen as a discretization of the Mckendrick-von Foerster equation, to simulate the dynamics of marine communities. The developed model uses a series of simple body size power functions to describe the basic processes of predator-prey interactions, reproduction, metabolism, and non-predation mortality based on the principle of mass balance. Linear size spectra with slopes of approximately-1 are successfully reproduced by this model. Several examples of numerical simulations are provided to demonstrate the model's behavior. Size spectra with cut-offs and/or waves are also found for certain parameter values. The matrix model is flexible and can be freely manipulated by users to answer different questions and is executed over a shorter numerical calculation running time than continuous models.	[Xia, Shujuan; Yamakawa, Takashi] Univ Tokyo, Dept Aquat Biosci, Grad Sch Agr & Life Sci, Tokyo, Japan	University of Tokyo	Xia, SJ; Yamakawa, T (corresponding author), Univ Tokyo, Dept Aquat Biosci, Grad Sch Agr & Life Sci, Tokyo, Japan.	xiashujuan0001@hotmail.com; ayamakw@mail.ecc.u-tokyo.ac.jp		Xia, Shujuan/0000-0003-0525-4176				Andersen KH, 2006, AM NAT, V168, P54, DOI 10.1086/504849; Andersen KH, 2016, ANNU REV MAR SCI, V8, P217, DOI 10.1146/annurev-marine-122414-034144; Andersen KH, 2010, P ROY SOC B-BIOL SCI, V277, P795, DOI 10.1098/rspb.2009.1512; Barnes C, 2010, ECOLOGY, V91, P222, DOI 10.1890/08-2061.1; Benoit E, 2004, J THEOR BIOL, V226, P9, DOI 10.1016/S0022-5193(03)00290-X; Blanchard JL, 2017, TRENDS ECOL EVOL, V32, P174, DOI 10.1016/j.tree.2016.12.003; Blanchard JL, 2009, J ANIM ECOL, V78, P270, DOI 10.1111/j.1365-2656.2008.01466.x; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Caswell, 2000, MATRIX POPULATION MO; Cury P, 2000, ECOL RES, V15, P101, DOI 10.1046/j.1440-1703.2000.00321.x; Datta S, 2016, CAN J FISH AQUAT SCI, V73, P598, DOI 10.1139/cjfas-2015-0468; Datta S, 2010, B MATH BIOL, V72, P1361, DOI 10.1007/s11538-009-9496-5; GAEDKE U, 1992, LIMNOL OCEANOGR, V37, P1202, DOI 10.4319/lo.1992.37.6.1202; Gascuel D, 2005, ICES J MAR SCI, V62, P443, DOI 10.1016/j.icesjms.2004.12.013; Gelpi CG, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC003820; Hall SJ, 2006, CAN J FISH AQUAT SCI, V63, P1344, DOI 10.1139/F06-039; Hartvig M, 2011, J THEOR BIOL, V272, P113, DOI 10.1016/j.jtbi.2010.12.006; Jacobsen NS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2701; Jennings S, 2001, J ANIM ECOL, V70, P934, DOI 10.1046/j.0021-8790.2001.00552.x; Kolding J, 2016, CAN J FISH AQUAT SCI, V73, P644, DOI 10.1139/cjfas-2015-0098; Law R, 2009, ECOLOGY, V90, P802, DOI 10.1890/07-1900.1; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Maury O, 2007, PROG OCEANOGR, V74, P479, DOI 10.1016/j.pocean.2007.05.002; Maury O, 2007, PROG OCEANOGR, V74, P500, DOI 10.1016/j.pocean.2007.05.001; Maury O, 2013, J THEOR BIOL, V324, P52, DOI 10.1016/j.jtbi.2013.01.018; Mccoy MW, 2008, ECOL LETT, V11, P710, DOI 10.1111/j.1461-0248.2008.01190.x; MCGURK MD, 1986, MAR ECOL PROG SER, V34, P227, DOI 10.3354/meps034227; Peters RH, 1983, ECOLOGICAL IMPLICATI, P71, DOI [10.1016/j.jtbi.2013.01.018, DOI 10.1016/J.JTBI.2013.01.018]; Pfister CA, 2002, ECOLOGY, V83, P59; Plank MJ, 2012, THEOR ECOL-NETH, V5, P465, DOI 10.1007/s12080-011-0137-x; Platt T., 1978, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V173, P60; Scott F, 2014, METHODS ECOL EVOL, V5, P1121, DOI 10.1111/2041-210X.12256; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327; SILVERT W, 1978, LIMNOL OCEANOGR, V23, P813, DOI 10.4319/lo.1978.23.4.0813; Stock CA, 2008, J MARINE SYST, V74, P134, DOI 10.1016/j.jmarsys.2007.12.004; THIEBAUX ML, 1992, J THEOR BIOL, V159, P147, DOI 10.1016/S0022-5193(05)80699-X; URSIN E, 1973, Meddelelser fra Danmarks Fiskeri- og Havundersogelser, V7, P85; WARE DM, 1978, J FISH RES BOARD CAN, V35, P220, DOI 10.1139/f78-036; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122	40	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198415	10.1371/jourrial.pone.0198415	http://dx.doi.org/10.1371/jourrial.pone.0198415			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879156				2022-12-26	WOS:000434384900043
J	Aryani, A; Conrad, M; Schmidtke, D; Jacobs, A				Aryani, Arash; Conrad, Markus; Schmidtke, David; Jacobs, Arthur			Why 'piss' is ruder than 'pee'? The role of sound in affective meaning making	PLOS ONE			English	Article							VOCAL EXPRESSION; WORD RECOGNITION; EMOTION; LANGUAGE; ICONICITY; COMMUNICATION; EMBODIMENT; VOICES; SPEECH; REPRESENTATION	Most language users agree that some words sound harsh (e.g. grotesque) whereas others sound soft and pleasing (e.g. lagoon). While this prominent feature of human language has always been creatively deployed in art and poetry, it is still largely unknown whether the sound of a word in itself makes any contribution to the word's meaning as perceived and interpreted by the listener. In a large-scale lexicon analysis, we focused on the affective substrates of words' meaning (i.e. affective meaning) and words' sound (i.e. affective sound); both being measured on a two-dimensional space of valence (ranging from pleasant to unpleasant) and arousal (ranging from calm to excited). We tested the hypothesis that the sound of a word possesses affective iconic characteristics that can implicitly influence listeners when evaluating the affective meaning of that word. The results show that a significant portion of the variance in affective meaning ratings of printed words depends on a number of spectral and temporal acoustic features extracted from these words after converting them to their spoken form (study1). In order to test the affective nature of this effect, we independently assessed the affective sound of these words using two different methods: through direct rating (study2a), and through acoustic models that we implemented based on pseudoword materials (study2b). In line with our hypothesis, the estimated contribution of words' sound to ratings of words' affective meaning was indeed associated with the affective sound of these words; with a stronger effect for arousal than for valence. Further analyses revealed crucial phonetic features potentially causing the effect of sound on meaning: For instance, words with short vowels, voiceless consonants, and hissing sibilants (as in 'piss') feel more arousing and negative. Our findings suggest that the process of meaning making is not solely determined by arbitrary mappings between formal aspects of words and concepts they refer to. Rather, even in silent reading, words' acoustic profiles provide affective perceptual cues that language users may implicitly use to construct words' overall meaning.	[Aryani, Arash; Schmidtke, David; Jacobs, Arthur] Free Univ Berlin, Dept Expt & Neurocognit Psychol, Berlin, Germany; [Conrad, Markus] Univ La Laguna, Dept Cognit Social & Org Psychol, San Cristobal la Laguna, Spain; [Jacobs, Arthur] CCNB, Berlin, Germany	Free University of Berlin; Universidad de la Laguna	Aryani, A (corresponding author), Free Univ Berlin, Dept Expt & Neurocognit Psychol, Berlin, Germany.	Arash.Aryani@fu-berlin.de	Conrad, Markus/N-3184-2014	Conrad, Markus/0000-0003-1335-437X; Jacobs, Arthur/0000-0002-7910-3955				[Anonymous], 1999, C1 CTR RES PSYCH, DOI DOI 10.1002/PER.2410010304; Aryani A, 2016, PSYCHOL AESTHET CREA, V10, P191, DOI 10.1037/aca0000033; Aryani A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00654; Auracher J, 2011, DISCOURSE PROCESS, V48, P1, DOI 10.1080/01638531003674894; B?hler K., 1934, SPRACHTHEORIE; Baayen R Harald, 1993, CELEX LEXICAL DATA B; Bachorowski JA, 1999, CURR DIR PSYCHOL SCI, V8, P53, DOI 10.1111/1467-8721.00013; BACHOROWSKI JA, 1995, PSYCHOL SCI, V6, P219, DOI 10.1111/j.1467-9280.1995.tb00596.x; Baxter S, 2011, J CONSUM MARK, V28, P516, DOI 10.1108/07363761111181509; Bergen BK, 2004, LANGUAGE, V80, P290, DOI 10.1353/lan.2004.0056; Blasi DE, 2016, P NATL ACAD SCI USA, V113, P10818, DOI 10.1073/pnas.1605782113; Boiten FA, 1998, BIOL PSYCHOL, V49, P29, DOI 10.1016/S0301-0511(98)00025-8; Bowers JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022341; Braun M, 2009, HUM BRAIN MAPP, V30, P1977, DOI 10.1002/hbm.20643; Breen M, 2014, LANG LINGUIST COMPAS, V8, P37, DOI 10.1111/lnc3.12061; Briesemeister BB, 2015, COGN AFFECT BEHAV NE, V15, P287, DOI 10.3758/s13415-014-0327-2; Briesemeister BB, 2014, BRAIN RES, V1564, P62, DOI 10.1016/j.brainres.2014.03.045; Bruck C, 2014, SOC COGN AFFECT NEUR, V9, P1819, DOI 10.1093/scan/nst180; Bruck C, 2011, PHYS LIFE REV, V8, P383, DOI 10.1016/j.plrev.2011.10.002; Carlin G., 1990, DOIN IT AGAIN; Christiansen MH, 2016, TOP COGN SCI, V8, P610, DOI 10.1111/tops.12164; Clements G. N., 1990, PAPERS LAB PHONOLOGY, VI, P283, DOI DOI 10.1017/CBO9780511627736.017; Darwin C., 1888, DESCENT MAN SELECTIO; De Saussure F., 2011, COURSE GEN LINGUISTI; Dingemanse M, 2015, TRENDS COGN SCI, V19, P603, DOI 10.1016/j.tics.2015.07.013; Duddington J., 2008, ESPEAK 1 36; Dutoit T, 1996, ICSLP 96 - FOURTH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, PROCEEDINGS, VOLS 1-4, P1393, DOI 10.1109/ICSLP.1996.607874; Farmer TA, 2006, P NATL ACAD SCI USA, V103, P12203, DOI 10.1073/pnas.0602173103; Fruhholz S, 2016, NEUROSCI BIOBEHAV R, V68, P96, DOI 10.1016/j.neubiorev.2016.05.002; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Glenberg AM, 2010, WIRES COGN SCI, V1, P586, DOI 10.1002/wcs.55; Glenberg AM, 2009, EMOT REV, V1, P151, DOI 10.1177/1754073908100440; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Imai M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0298; Jacobs A. M., 2018, METAPHOR SYMB; Jacobs A. M., 2016, SCI STUDY LIT, V6, P87, DOI DOI 10.3758/S13415-015-0396-X; Jacobs AM., 2017, SCI STUDY LIT, V7, P4, DOI [10.1075/ssol.7.1.02jac, DOI 10.1075/SSOL.7.1.02JAC]; Jacobs AM, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00622; Jacobs AM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01836; Jacobs AM, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00186; Jakobson R., 1960, STYLE LANG, P350; Jakobson R., 1937, LECT SOUND MEANING; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Keuleers E, 2010, BEHAV RES METHODS, V42, P627, DOI 10.3758/BRM.42.3.627; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; Kousta ST, 2009, COGNITION, V112, P473, DOI 10.1016/j.cognition.2009.06.007; Kraxenberger M, 2016, FRONT PSYCHOL, V7, DOI [10.3389/fpsyg.2016.02051, 10.3389/fpsyg.2016.01779]; Ku┬hler W., 1947, GESTALT PSYCHOL; Kuhlmann M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30718; Leiner DJ, 2015, SOSCI SURVEY VERSION, V20; Lockwood G., 2015, FRONT PSYCHOL, V6, P1, DOI DOI 10.3389/fpsyg.2015.01246; Ludtke J, 2014, PSYCHOL AESTHET CREA, V8, P363, DOI 10.1037/a0036826; Ma WY, 2015, P NATL ACAD SCI USA, V112, P14563, DOI 10.1073/pnas.1515087112; Mehrabian Albert, 1980, BASIC DIMENSIONS GEN, DOI DOI 10.1145/2901739.2901752; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Meteyard L, 2012, CORTEX, V48, P788, DOI 10.1016/j.cortex.2010.11.002; Monaghan P, 2007, COGNITIVE PSYCHOL, V55, P259, DOI 10.1016/j.cogpsych.2006.12.001; Monaghan P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0299; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; Myers-Schulz B, 2013, COGNITION EMOTION, V27, P1105, DOI 10.1080/02699931.2012.754739; Nyklcek I, 1997, J PSYCHOPHYSIOL; Ohala JJ, 1996, ICSLP 96 - FOURTH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, PROCEEDINGS, VOLS 1-4, P1812, DOI 10.1109/ICSLP.1996.607982; Ohala John J., 1994, SOUND SYMBOLISM, P325; OSGOOD CE, 1952, PSYCHOL BULL, V49, P197, DOI 10.1037/h0055737; Panksepp J, 2010, HBK BEHAV NEUROSCI, V19, P201, DOI 10.1016/B978-0-12-374593-4.00020-6; Perniss P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2014.0179; Perrone-Bertolotti M, 2012, J NEUROSCI, V32, P17554, DOI 10.1523/JNEUROSCI.2982-12.2012; Poe EA, 1881, THE BELLS; Roberts G, 2015, COGNITION, V141, P52, DOI 10.1016/j.cognition.2015.04.001; Sapir E., 1929, JSTOR, P207; Sauter DA, 2010, Q J EXP PSYCHOL, V63, P2251, DOI 10.1080/17470211003721642; Scherer KR, 2003, SPEECH COMMUN, V40, P227, DOI 10.1016/S0167-6393(02)00084-5; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Schmidtke DS, 2015, PHYS LIFE REV, V13, P83, DOI 10.1016/j.plrev.2015.04.024; Schmidtke DS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00080; Schrott R., 2011, GEHIRN GEDICHT WIE W; Spence C, 2012, J CONSUM PSYCHOL, V22, P37, DOI 10.1016/j.jcps.2011.09.004; Stenneken P, 2005, BRAIN LANG, V95, P280, DOI 10.1016/j.bandl.2005.01.013; Thompson PD, 2011, Q J EXP PSYCHOL, V64, P2392, DOI 10.1080/17470218.2011.605898; Tsur R., 1992, WHAT MAKES SOUND PAT; Ullrich S, 2017, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.02073; Ullrich S, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01200; van Bezooijen R, 1997, HDB STANDARDS RESOUR, P481; van Heuven VJ, 1993, ANAL SYNTHESIS SPEEC; Vigliocco G, 2006, LANG COGNITIVE PROC, V21, P790, DOI 10.1080/016909600824070; Vigliocco G, 2009, LANG COGN, V1, P219, DOI 10.1515/LANGCOG.2009.011; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Weenink D., 1996, PRAAT SYSTEM DOING P; Whissell C, 1999, PERCEPT MOTOR SKILL, V89, P19, DOI 10.2466/PMS.89.5.19-48; Whissell C, 2000, PERCEPT MOTOR SKILL, V91, P617, DOI 10.2466/PMS.91.6.617-648; WUNDT W M, 1908, VOLKERPSYCHOLOGIE UN; Yarkoni T, 2008, PSYCHON B REV, V15, P971, DOI 10.3758/PBR.15.5.971; ZIEGLER JC, 1995, J MEM LANG, V34, P567, DOI 10.1006/jmla.1995.1026	93	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198430	10.1371/journal.pone.0198430	http://dx.doi.org/10.1371/journal.pone.0198430			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI4VN	29874293	Green Published, Green Submitted, gold			2022-12-26	WOS:000434369400048
J	De Palo, P; Maggiolino, A; Albenzio, M; Casalino, E; Neglia, G; Centoducati, G; Tateo, A				De Palo, Pasquale; Maggiolino, Aristide; Albenzio, Marzia; Casalino, Elisabetta; Neglia, Gianluca; Centoducati, Gerardo; Tateo, Alessandra			Survey of biochemical and oxidative profile in donkey foals suckled with one natural and one semi-artificial technique	PLOS ONE			English	Article							FATTY-ACIDS; SERUM; AGE; EXERCISE; STRESS; BREED; ELECTROPHORESIS; HEMATOLOGY; HORSES; SEX	Dairy donkey milking procedures require separating foals from their dams for a few hours a day. Artificial suckling in this species is a good technique for improving milk production and foal welfare. The aim of the work is to compare the effect of two different diets on donkey foals when separated from jennies for milking procedures with and without a milk replacer. Forty newborn Martina Franca donkey foals were subdivided into two experimental groups. Both groups were separated from their respective dams from 8.00 to 20.00to allow the jennies to be milked. During the separation, all the foals had access ad libitum to water, hay and feed. During the separation period, one group had the availability of a mechanical milk replacer dispenser, so foals were partially artificially suckled (AS), while the other group had no milk replacer available, and so were totally naturally suckled (NS). The AS group had milk replacer availability until 120 +/- 7d of life. Both groups were naturally weaned at 168 +/- 7d. Blood samples were collected weekly starting from birth until two wks after weaning (i.e. at 182d), from all the foals included in the trial. Almost all the analytes were influenced by suckling technique and age of foals. Alanine-aminotransferase, aspartate-aminotransferase, alkaline phosphatase, NEFA, lipid hydroperoxides, serum proteins showed the greatest differences between the two experimental groups. Separating foals from their dams for 12hdaily for 24 weeks does not lead to pathological subclinical and metabolic conditions, thus confirming the high rusticity and resistance of the donkey.	[De Palo, Pasquale; Maggiolino, Aristide; Casalino, Elisabetta; Tateo, Alessandra] Univ A Moro Bari, Dept Vet Med, Bari, Italy; [Albenzio, Marzia] Univ Foggia, Dept Agr Food & Environm Sci, Foggia, Italy; [Neglia, Gianluca] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy; [Centoducati, Gerardo] Univ Bari, Dept Soil Plant & Food Sci, Bari, Italy	Universita degli Studi di Bari Aldo Moro; University of Foggia; University of Naples Federico II; Universita degli Studi di Bari Aldo Moro	Maggiolino, A (corresponding author), Univ A Moro Bari, Dept Vet Med, Bari, Italy.	aristide.maggiolino@uniba.it	Maggiolino, Aristide/K-2444-2019; De Palo, Pasquale/J-6407-2019	Maggiolino, Aristide/0000-0001-7128-8556; De Palo, Pasquale/0000-0002-5612-1691; Albenzio, Marzia/0000-0003-3201-1102; casalino, elisabetta/0000-0001-9330-350X	MIPAAF (Ministero Politiche Agricole e Forestali) PC	MIPAAF (Ministero Politiche Agricole e Forestali) PC	Financial support was provided by MIPAAF (Ministero Politiche Agricole e Forestali) PC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberghina D, 2013, J EQUINE VET SCI, V33, P433, DOI 10.1016/j.jevs.2012.07.012; Caldin M., 2005, COMP CLIN PATHOL, V14, P5, DOI [DOI 10.1007/S00580-005-0544-8, 10.1007/s00580-005-0544-8]; Cavalcante PH, 2012, TURK J VET ANIM SCI, V36, P9, DOI 10.3906/vet-1011-565; Centoducati P, 2012, J DAIRY SCI, V95, P5770, DOI 10.3168/jds.2012-5513; D'Alessandro AG, 2015, J DAIRY RES, V82, P121, DOI 10.1017/S0022029914000648; De Moffarts B, 2007, VET J, V174, P113, DOI 10.1016/j.tvjl.2006.06.001; De Palo P, 2017, MEAT SCI, V134, P128, DOI 10.1016/j.meatsci.2017.07.025; De Palo P, 2016, TROP ANIM HEALTH PRO, V48, P167, DOI 10.1007/s11250-015-0940-2; De Paloa P, 2017, ANIM PROD SCI, V57, P2110, DOI 10.1071/AN15551; Dyer J, 2002, EQUINE VET J, V34, P349, DOI 10.2746/042516402776249209; Frank N, 2002, AM J VET RES, V63, P1018, DOI 10.2460/ajvr.2002.63.1018; French J. M., 1995, Equine Veterinary Education, V7, P33, DOI 10.1111/j.2042-3292.1995.tb01179.x; French JM, 1998, APPL ANIM BEHAV SCI, V60, P253, DOI 10.1016/S0168-1591(98)00173-7; Girardi A. M., 2014, Comparative Clinical Pathology, V23, P941, DOI 10.1007/s00580-013-1718-4; HANK AM, 1993, J VET INTERN MED, V7, P20, DOI 10.1111/j.1939-1676.1993.tb03164.x; Hong Y L, 2010, CLIN BIOCHEM, V33, P619; IZRAELY H, 1989, Q J EXP PHYSIOL CMS, V74, P1; Jordana J, 1998, RES VET SCI, V64, P7, DOI 10.1016/S0034-5288(98)90107-2; Kinnunen S, 2005, J SPORT SCI MED, V4, P415; Kinnunen S, 2005, EUR J APPL PHYSIOL, V93, P496, DOI 10.1007/s00421-004-1162-x; Knottenbelt DC, 2004, EQUINENEONATOLOGY ME; Lykkesfeldt J, 2007, VET J, V173, P502, DOI 10.1016/j.tvjl.2006.06.005; Martin-Rosset W, 1990, ALIMENTATION CHEVAUX; McLean AK, 2018, J EQUINE VET SCI; Milinkovic-Tur Suzana, 2005, Veterinarski Arhiv, V75, P195; Murray MJ, 1999, EQUINE VET EDUC, V11, P199, DOI 10.1111/j.2042-3292.1999.tb00948.x; Piccione G., 2003, Slovenian Veterinary Research, V40, P69; Polidori P, 2009, ITAL J ANIM SCI, V8, P677, DOI 10.4081/ijas.2009.s2.677; Quartuccio M, 2015, ARCH TIERZUCHT, V58, DOI 10.5194/aab-58-123-2015; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; SAS, 1999, APPL STAT SAS PROGRA; Sgorbini M, 2013, J EQUINE VET SCI, V33, P35, DOI 10.1016/j.jevs.2012.04.010; Tateo A, 2013, J VET BEHAV, V8, P162, DOI 10.1016/j.jveb.2012.04.006; Veronesi MC, 2014, THERIOGENOLOGY, V82, P294, DOI 10.1016/j.theriogenology.2014.04.004	34	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198774	10.1371/journal.pone.0198774	http://dx.doi.org/10.1371/journal.pone.0198774			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874272	Green Published, Green Submitted, gold			2022-12-26	WOS:000434369400064
J	Polterovich, A; Jankowski, MM; Nelken, I				Polterovich, Ana; Jankowski, Maciej M.; Nelken, Israel			Deviance sensitivity in the auditory cortex of freely moving rats	PLOS ONE			English	Article							STIMULUS-SPECIFIC ADAPTATION; MISMATCH NEGATIVITY; ELECTROPHYSIOLOGICAL EVIDENCE; HIERARCHICAL ORGANIZATION; INFERIOR COLLICULUS; CORTICAL-NEURONS; FIELD POTENTIALS; RESPONSES; BRAIN; MODELS	Deviance sensitivity is the specific response to a surprising stimulus, one that violates expectations set by the past stimulation stream. In audition, deviance sensitivity is often conflated with stimulus-specific adaptation (SSA), the decrease in responses to a common stimulus that only partially generalizes to other, rare stimuli. SSA is usually measured using oddball sequences, where a common (standard) tone and a rare (deviant) tone are randomly intermixed. However, the larger responses to a tone when deviant does not necessarily represent deviance sensitivity. Deviance sensitivity is commonly tested using a control sequence in which many different tones serve as the standard, eliminating the expectations set by the standard ('deviant among many standards'). When the response to a tone when deviant (against a single standard) is larger than the responses to the same tone in the control sequence, it is concluded that true deviance sensitivity occurs. In primary auditory cortex of anesthetized rats, responses to deviants and to the same tones in the control condition are comparable in size. We recorded local field potentials and multiunit activity from the auditory cortex of awake, freely moving rats, implanted with 32-channel drivable microelectrode arrays and using telemetry. We observed highly significant SSA in the awake state. Moreover, the responses to a tone when deviant were significantly larger than the responses to the same tone in the control condition. These results establish the presence of true deviance sensitivity in primary auditory cortex in awake rats.	[Polterovich, Ana; Jankowski, Maciej M.; Nelken, Israel] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [Polterovich, Ana; Jankowski, Maciej M.; Nelken, Israel] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Neurosci, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Nelken, I (corresponding author), Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel.; Nelken, I (corresponding author), Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Neurosci, Jerusalem, Israel.	israel.nelken@mail.huji.ac.il	Jankowski, Maciej Michal/AGR-2179-2022; Nelken, Israel/B-7753-2011	Nelken, Israel/0000-0002-6645-107X; Jankowski, Maciej M./0000-0001-9589-3929; Polterovich, Ana/0000-0001-9274-3343	European Research Council (ERC) [GA-340063]; F.I.R.S.T. grant from Israel Science Foundation [1075/2013]; Gatsby Charitable Foundation; Edmond and Lily Safra Center for Brain Sciences (ELSC) at the Hebrew University	European Research Council (ERC)(European Research Council (ERC)); F.I.R.S.T. grant from Israel Science Foundation; Gatsby Charitable Foundation; Edmond and Lily Safra Center for Brain Sciences (ELSC) at the Hebrew University	This work was supported by a European Research Council (ERC) advanced grant GA-340063 (project RATLAND) to IN, by F.I.R.S.T. grant no. 1075/2013 from the Israel Science Foundation to IN, and by a grant from the Gatsby Charitable Foundation. MMJ and AP were partially supported by the Edmond and Lily Safra Center for Brain Sciences (ELSC) at the Hebrew University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Astikainen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024208; Contreras EJB, 2013, NEURON, V79, P555, DOI 10.1016/j.neuron.2013.06.013; Farley BJ, 2010, J NEUROSCI, V30, P16475, DOI 10.1523/JNEUROSCI.2793-10.2010; Fishman YI, 2012, J NEUROSCI, V32, P15747, DOI 10.1523/JNEUROSCI.2835-12.2012; Grimm S, 2011, J NEUROSCI, V6, P1; Grimm S, 2012, INT J PSYCHOPHYSIOL, V85, P88, DOI 10.1016/j.ijpsycho.2011.05.012; Grimm S, 2011, PSYCHOPHYSIOLOGY, V48, P377, DOI 10.1111/j.1469-8986.2010.01073.x; Harms L, 2018, SCHIZOPHR RES, V191, P43, DOI 10.1016/j.schres.2017.03.042; Harms L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110892; Hershenhoren I, 2014, J NEUROSCI, V34, P3303, DOI 10.1523/JNEUROSCI.2166-13.2014; Imada A, 2013, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00127; Jacobsen T, 2003, CLIN NEUROPHYSIOL, V114, P1133, DOI 10.1016/S1388-2457(03)00043-9; Jacobsen T, 2003, NEUROSCI LETT, V344, P79, DOI 10.1016/S0304-3940(03)00408-7; Jung F, 2013, PLOS ONE, V8; Klein C, 2014, BRAIN TOPOGR, V27, P599, DOI 10.1007/s10548-014-0376-4; Kurkela JLO, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21411-z; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Moshitch D, 2006, J NEUROPHYSIOL, V95, P3756, DOI 10.1152/jn.00822.2005; Musall S, 2015, CEREB CORTEX, V27; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; Nakamura T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00367; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; Nelken I, 2014, BIOL CYBERN, V108, P655, DOI 10.1007/s00422-014-0585-7; Nieto-Diego J, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002397; Nir Y, 2015, CEREB CORTEX, V25, P1362, DOI 10.1093/cercor/bht328; Pachitariu M, 2015, J NEUROSCI, V35, P2058, DOI 10.1523/JNEUROSCI.3318-14.2015; Parras GG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02038-6; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pincze Z, 2001, CLIN NEUROPHYSIOL, V112, P778, DOI 10.1016/S1388-2457(01)00509-0; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Richardson BD, 2013, J NEUROPHYSIOL, V110, P1892, DOI 10.1152/jn.00403.2013; Ruusuvirta T, 1998, NEUROSCI LETT, V248, P45, DOI 10.1016/S0304-3940(98)00330-9; Shiramatsu TI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082663; Slabu L, 2010, EUR J NEUROSCI, V32, P859, DOI 10.1111/j.1460-9568.2010.07324.x; Smith PH, 2012, J COMP NEUROL, V520, P34, DOI 10.1002/cne.22682; Szymanski FD, 2009, J NEUROPHYSIOL, V102, P1483, DOI 10.1152/jn.00240.2009; Taaseh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023369; Thomas JM, 2012, HEARING RES, V291, P34, DOI 10.1016/j.heares.2012.06.004; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009; Yaron A, 2012, NEURON, V76, P603, DOI 10.1016/j.neuron.2012.08.025	44	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197678	10.1371/journal.pone.0197678	http://dx.doi.org/10.1371/journal.pone.0197678			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874246	Green Published, gold, Green Submitted			2022-12-26	WOS:000434369400034
J	Oerum, S; Roovers, M; Rambo, RP; Kopec, J; Bailey, HJ; Fitzpatrick, F; Newman, JA; Newman, WG; Amberger, A; Zschocke, J; Droogmans, L; Oppermann, U; Yue, WW				Oerum, Stephanie; Roovers, Martine; Rambo, Robert P.; Kopec, Jola; Bailey, Henry J.; Fitzpatrick, Fiona; Newman, Joseph A.; Newman, William G.; Amberger, Albert; Zschocke, Johannes; Droogmans, Louis; Oppermann, Udo; Yue, Wyatt W.			Structural insight into the human mitochondrial tRNA purine N1-methyltransferase and ribonuclease P complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribonuclease P (RNase P); transfer RNA (tRNA); RNA methyltransferase; RNA methylation; complex; HSD10; HSD17B10; MRPP; PRORP; TRMT10C	CRYSTAL-STRUCTURE; MODIFIED NUCLEOTIDES; ALZHEIMERS-DISEASE; PROTEIN COMPLEX; METHYLTRANSFERASE; BINDING; ACID; DEHYDROGENASE; RECOGNITION; MECHANISM	Mitochondrial tRNAs are transcribed as long polycistronic transcripts of precursor tRNAs and undergo posttranscriptional modifications such as endonucleolytic processing and methylation required for their correct structure and function. Among them, 5'-end processing and purine 9 N1-methylation of mitochondrial tRNA are catalyzed by two proteinaceous complexes with overlapping subunit composition. The Mg2+-dependent RNase P complex for 5'-end cleavage comprises the methyltransferase domain-containing protein tRNA methyltransferase 10C, mitochondrial RNase P subunit (TRMT10C/MRPP1), short-chain oxidoreductase hydroxysteroid 17 beta-dehydrogenase 10 (HSD17B10/MRPP2), and metallonuclease KIAA0391/MRPP3. An MRPP1-MRPP2 subcomplex also catalyzes the formation of 1-methyladenosine/1-methylguanosine at position 9 using S-adenosyl-l-methionine as methyl donor. However, a lack of structural information has precluded insights into how these complexes methylate and process mitochondrial tRNA. Here, we used a combination of X-ray crystallography, interaction and activity assays, and small angle X-ray scattering (SAXS) to gain structural insight into the two tRNA modification complexes and their components. The MRPP1 N terminus is involved in tRNA binding and monomer-monomer self-interaction, whereas the C-terminal SPOUT fold contains key residues for S-adenosyl-l-methionine binding and N1-methylation. The entirety of MRPP1 interacts with MRPP2 to form the N1-methylation complex, whereas the MRPP1-MRPP2-MRPP3 RNase P complex only assembles in the presence of precursor tRNA. This study proposes low-resolution models of the MRPP1-MRPP2 and MRPP1-MRPP2-MRPP3 complexes that suggest the overall architecture, stoichiometry, and orientation of subunits and tRNA substrates.	[Oerum, Stephanie; Kopec, Jola; Bailey, Henry J.; Fitzpatrick, Fiona; Newman, Joseph A.; Oppermann, Udo; Yue, Wyatt W.] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7BN, England; [Roovers, Martine] Inst Rech Labiris, B-1070 Anderlecht, Belgium; [Rambo, Robert P.] Harwell Sci & Innovat Ctr, Diamond Light Source, Didcot OX11 0QG, Oxon, England; [Newman, William G.] Univ Manchester, Manchester Univ NHS Fdn Trust, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Amberger, Albert; Zschocke, Johannes] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria; [Droogmans, Louis] Univ Libre Bruxelles, Lab Microbiol, B-1050 Brussels, Belgium; [Oppermann, Udo] NIHR Oxford Biomed Res Unit, Botnar Res Ctr, Oxford OX3 7LD, England	University of Oxford; Diamond Light Source; University of Manchester; Medical University of Innsbruck; Universite Libre de Bruxelles; University of Oxford	Oppermann, U; Yue, WW (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7BN, England.; Oppermann, U (corresponding author), NIHR Oxford Biomed Res Unit, Botnar Res Ctr, Oxford OX3 7LD, England.	udo.oppermann@sgc.ox.ac.uk; wyatt.yue@sgc.ox.ac.uk	Zschocke, Johannes/C-5885-2013	Zschocke, Johannes/0000-0002-0046-8274; Oerum, Stephanie/0000-0001-9525-7295; Newman, William/0000-0002-6382-4678	AbbVie; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; Fonds Brachet; Fonds Van Buuren; Action Medical Research [GN2494]; MRC [1790341] Funding Source: UKRI	AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Fonds Brachet; Fonds Van Buuren; Action Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust (Grant 092809/Z/10/Z). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Fonds Brachet and the Fonds Van Buuren.; Supported by Action Medical Research GN2494.	Anantharaman V, 2002, J MOL MICROB BIOTECH, V4, P71; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Barbas A, 2013, BIOCHEM BIOPH RES CO, V430, P218, DOI 10.1016/j.bbrc.2012.10.091; Barraud P, 2008, J MOL BIOL, V377, P535, DOI 10.1016/j.jmb.2008.01.041; Beckmann BM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10127; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Christian T, 2010, J MOL BIOL, V400, P204, DOI 10.1016/j.jmb.2010.05.003; Czerwoniec A, 2009, NUCLEIC ACIDS RES, V37, pD118, DOI 10.1093/nar/gkn710; Deutschmann AJ, 2014, HUM MOL GENET, V23, P3618, DOI 10.1093/hmg/ddu072; Elkins PA, 2003, J MOL BIOL, V333, P931, DOI 10.1016/j.jmb.2003.09.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez MR, 2007, CELL MOL LIFE SCI, V64, P1419, DOI 10.1007/s00018-007-7091-1; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Frank R, 1996, Methods Mol Biol, V66, P149; Gillis D, 2014, J MED GENET, V51, P581, DOI 10.1136/jmedgenet-2014-102282; Gobert A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2358; Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812; He XY, 2005, MOL CELL ENDOCRINOL, V229, P111, DOI 10.1016/j.mce.2004.08.011; Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045; Howard MJ, 2013, RNA BIOL, V10, P909, DOI 10.4161/rna.24513; Howard MJ, 2012, P NATL ACAD SCI USA, V109, P16149, DOI 10.1073/pnas.1209062109; Igoillo-Esteve M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003888; Ito T, 2015, P NATL ACAD SCI USA, V112, pE4197, DOI 10.1073/pnas.1422981112; Jackman JE, 2003, RNA, V9, P574, DOI 10.1261/rna.5070303; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kempenaers M, 2010, NUCLEIC ACIDS RES, V38, P6533, DOI 10.1093/nar/gkq451; Kissinger CR, 2004, J MOL BIOL, V342, P943, DOI 10.1016/j.jmb.2004.07.071; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li FZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09878; Liu RJ, 2013, NUCLEIC ACIDS RES, V41, P7828, DOI 10.1093/nar/gkt568; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Lv FJ, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.37; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Metodiev MD, 2016, AM J HUM GENET, V98, P993, DOI 10.1016/j.ajhg.2016.03.010; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Motorin Y, 2010, BIOCHEMISTRY-US, V49, P4934, DOI 10.1021/bi100408z; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oerum S, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010020; Petoukhov MV, 2015, ACTA CRYSTALLOGR D, V71, P1051, DOI 10.1107/S1399004715002576; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Powell AJ, 2000, J MOL BIOL, V303, P311, DOI 10.1006/jmbi.2000.4139; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Reinhard L, 2015, NUCLEIC ACIDS RES, V43, P5664, DOI 10.1093/nar/gkv481; Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060; Sen A, 2016, NUCLEIC ACIDS RES, V44, P6409, DOI 10.1093/nar/gkw338; Shafqat N, 2003, BIOCHEM J, V376, P49, DOI 10.1042/BJ20030877; Shao ZH, 2014, NUCLEIC ACIDS RES, V42, P509, DOI 10.1093/nar/gkt869; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Taschner A, 2012, CELL REP, V2, P19, DOI 10.1016/j.celrep.2012.05.021; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Van Laer B, 2016, NUCLEIC ACIDS RES, V44, P940, DOI 10.1093/nar/gkv1369; Vilardo E, 2015, NUCLEIC ACIDS RES, V43, P5112, DOI 10.1093/nar/gkv408; Vilardo E, 2012, NUCLEIC ACIDS RES, V40, P11583, DOI 10.1093/nar/gks910; Voigts-Hoffmann F, 2007, J AM CHEM SOC, V129, P13382, DOI 10.1021/ja075520+; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang SY, 2009, P NATL ACAD SCI USA, V106, P14820, DOI 10.1073/pnas.0902377106	66	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12862	12876		10.1074/jbc.RA117.001286	http://dx.doi.org/10.1074/jbc.RA117.001286			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29880640	Green Published, hybrid			2022-12-26	WOS:000442203500019
J	Hughey, CC; Trefts, E; Bracy, DP; James, FD; Donahue, EP; Wasserman, DH				Hughey, Curtis C.; Trefts, Elijah; Bracy, Deanna P.; James, Freyja D.; Donahue, E. Patrick; Wasserman, David H.			Glycine N-methyltransferase deletion in mice diverts carbon flux from gluconeogenesis to pathways that utilize excess methionine cycle intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; HUMAN HEPATOCELLULAR-CARCINOMA; KNOCKOUT MOUSE MODEL; S-ADENOSYLMETHIONINE; GLUTATHIONE SYNTHESIS; PYRUVATE-CARBOXYLASE; GLUCOSE-METABOLISM; ACID SYNTHESIS; MALONYL-COA; RAT-LIVER	Glycine N-methyltransferase (GNMT) is the most abundant liver methyltransferase regulating the availability of the biological methyl donor, S-adenosylmethionine (SAM). Moreover, GNMT has been identified to be down-regulated in hepatocellular carcinoma (HCC). Despite its role in regulating SAM levels and association of its down-regulation with liver tumorigenesis, the impact of reduced GNMT on metabolic reprogramming before the manifestation of HCC has not been investigated in detail. Herein, we used H-2/C-13 metabolic flux analysis in conscious, unrestrained mice to test the hypothesis that the absence of GNMT causes metabolic reprogramming. GNMT-null (KO) mice displayed a reduction in blood glucose that was associated with a decline in both hepatic glycogenolysis and gluconeogenesis. The reduced gluconeogenesis was due to a decrease in liver gluconeogenic precursors, citric acid cycle fluxes, and anaplerosis and cataplerosis. A concurrent elevation in both hepatic SAM and metabolites of SAM utilization pathways was observed in the KO mice. Specifically, the increase in metabolites of SAM utilization pathways indicated that hepatic polyamine synthesis and catabolism, transsulfuration, and de novo lipogenesis pathways were increased in the KO mice. Of note, these pathways utilize substrates that could otherwise be used for gluconeogenesis. Also, this metabolic reprogramming occurs before the well-documented appearance of HCC in GNMT-null mice. Together, these results indicate that GNMT deletion promotes a metabolic shift whereby nutrients are channeled away from glucose formation toward pathways that utilize the elevated SAM.	[Hughey, Curtis C.; Trefts, Elijah; Bracy, Deanna P.; James, Freyja D.; Donahue, E. Patrick; Wasserman, David H.] Vanderbilt Univ, Dept Mol Physiol & Biophys, 823 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA; [Bracy, Deanna P.; James, Freyja D.; Wasserman, David H.] Vanderbilt Univ, Mouse Metab Phenotyping Ctr, Nashville, TN 37232 USA	Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University	Hughey, CC (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 823 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	curtis.hughey@vanderbilt.edu			NIDDK, National Institutes of Health [DK050277, DK054902]; Diabetes Canada Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, R01DK050277, U2CDK059637, U24DK059637, R37DK050277, P60DK020593, R56DK054902, P30DK058404, R01DK054902] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Diabetes Canada Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health, Grants DK050277 and DK054902 (to D. H. W.) and a Diabetes Canada Postdoctoral Fellowship (to C. C. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adeva-Andany MM, 2016, BBA CLIN, V5, P85, DOI 10.1016/j.bbacli.2016.02.001; Avila MA, 2004, INT J BIOCHEM CELL B, V36, P2125, DOI 10.1016/j.biocel.2003.11.016; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; Ayala JE, 2011, JOVE-J VIS EXP, DOI 10.3791/3188; Bellentani S, 2017, LIVER INT, V37, P81, DOI 10.1111/liv.13299; Brosnan ME, 2009, AM J CLIN NUTR, V90, p857S, DOI 10.3945/ajcn.2009.27462Z; Chen MQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025564; Chen YMA, 1998, INT J CANCER, V75, P787, DOI 10.1002/(SICI)1097-0215(19980302)75:5<787::AID-IJC20>3.0.CO;2-2; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Foster DW, 2012, J CLIN INVEST, V122, P1958, DOI 10.1172/JCI63967; Foster DW, 2004, ANN NY ACAD SCI, V1033, P1, DOI 10.1196/annals.1320.001; Hasenour CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170382; Hasenour CM, 2015, AM J PHYSIOL-ENDOC M, V309, pE191, DOI 10.1152/ajpendo.00003.2015; HEMS R, 1966, BIOCHEM J, V101, P284, DOI 10.1042/bj1010284; Hirata H, 2016, CANCER RES, V76, P3265, DOI 10.1158/0008-5472.CAN-15-2601; Huang ZZ, 2001, FASEB J, V15, P19, DOI 10.1096/fj.00-0445fje; Hughey CC, 2017, J BIOL CHEM, V292, P20125, DOI 10.1074/jbc.M117.811547; Jacobs RL, 2001, J BIOL CHEM, V276, P43740, DOI 10.1074/jbc.M107553200; KEECH DB, 1963, J BIOL CHEM, V238, P2609; Liao YJ, 2012, MOL MED, V18, P412, DOI 10.2119/molmed.2011.00258; Liao YJ, 2009, INT J CANCER, V124, P816, DOI 10.1002/ijc.23979; Liu SP, 2007, HEPATOLOGY, V46, P1413, DOI 10.1002/hep.21863; Liu SP, 2011, INT J CANCER, V128, P511, DOI 10.1002/ijc.25386; Long MD, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010015; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Lu SC, 2012, PHYSIOL REV, V92, P1515, DOI 10.1152/physrev.00047.2011; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Luka Z, 2006, TRANSGENIC RES, V15, P393, DOI 10.1007/s11248-006-0008-1; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Ma RH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3508; Martinez-Chantar ML, 2008, HEPATOLOGY, V47, P1191, DOI 10.1002/hep.22159; Martinez-Una M, 2015, J HEPATOL, V62, P673, DOI 10.1016/j.jhep.2014.10.019; Martinez-Una M, 2013, HEPATOLOGY, V58, P1296, DOI 10.1002/hep.26399; MCGARRY JD, 1978, J BIOL CHEM, V253, P8294; MORGAN CR, 1965, DIABETES, V14, P669, DOI 10.2337/diab.14.10.669; Mounier C, 2014, INT J ONCOL, V45, P485, DOI 10.3892/ijo.2014.2441; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; SAVARESE TM, 1981, BIOCHEM PHARMACOL, V30, P189, DOI 10.1016/0006-2952(81)90077-0; Savic LJ, 2016, HEPAT ONCOL, V3, DOI 10.2217/hep.15.36; SCRUTTON MC, 1974, J BIOL CHEM, V249, P5405; Shang RZ, 2016, WORLD J GASTROENTERO, V22, P9933, DOI 10.3748/wjg.v22.i45.9933; Varela-Rey M, 2010, HEPATOLOGY, V52, P105, DOI 10.1002/hep.23639; VONGLUTZ G, 1976, FEBS LETT, V72, P299, DOI 10.1016/0014-5793(76)80991-X; YEO EJ, 1994, P NATL ACAD SCI USA, V91, P210, DOI 10.1073/pnas.91.1.210; Younossi ZM, 2015, HEPATOLOGY, V62, P1723, DOI 10.1002/hep.28123; Zubiete-Franco I, 2016, J HEPATOL, V64, P409, DOI 10.1016/j.jhep.2015.08.037	48	25	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11944	11954		10.1074/jbc.RA118.002568	http://dx.doi.org/10.1074/jbc.RA118.002568			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29891549	hybrid, Green Published			2022-12-26	WOS:000440134500025
J	Fix, LE; Khoury, J; Moores, RR; Linkous, L; Brandes, M; Rozycki, HJ				Fix, Laura Ellwein; Khoury, Joseph; Moores, Russell R., Jr.; Linkous, Lauren; Brandes, Matthew; Rozycki, Henry J.			Theoretical open-loop model of respiratory mechanics in the extremely preterm infant	PLOS ONE			English	Article							PRESSURE-VOLUME CURVE; NORMAL HUMAN LUNG; MATHEMATICAL-MODEL; NEWBORN MAMMALS; NONLINEAR MODEL; BIRTH-WEIGHT; VENTILATION; RECRUITMENT; EQUATION; TIME	Non-invasive ventilation is increasingly used for respiratory support in preterm infants, and is associated with a lower risk of chronic lung disease. However, this mode is often not successful in the extremely preterm infant in part due to their markedly increased chest wall compliance that does not provide enough structure against which the forces of inhalation can generate sufficient pressure. To address the continued challenge of studying treatments in this fragile population, we developed a nonlinear lumped-parameter respiratory system mechanics model of the extremely preterm infant that incorporates nonlinear lung and chest wall compliances and lung volume parameters tuned to this population. In particular we developed a novel empirical representation of progressive volume loss based on compensatory alveolar pressure increase resulting from collapsed alveoli. The model demonstrates increased rate of volume loss related to high chest wall compliance, and simulates laryngeal braking for elevation of end-expiratory lung volume and constant positive airway pressure (CPAP). The model predicts that low chest wall compliance (chest stiffening) in addition to laryngeal braking and CPAP enhance breathing and delay lung volume loss. These results motivate future data collection strategies and investigation into treatments for chest wall stiffening.	[Fix, Laura Ellwein; Linkous, Lauren] Virginia Commonwealth Univ, Dept Math & Appl Math, Richmond, VA 23284 USA; [Khoury, Joseph; Moores, Russell R., Jr.; Rozycki, Henry J.] Virginia Commonwealth Univ, Childrens Hosp Richmond, Div Neonatal Med, Richmond, VA USA; [Brandes, Matthew] Virginia Commonwealth Univ, VCU Sch Med, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Fix, LE (corresponding author), Virginia Commonwealth Univ, Dept Math & Appl Math, Richmond, VA 23284 USA.	lellwein@vcu.edu		Fix, Laura/0000-0001-8680-8585	Atlantic Pediatric Device Consortium via FDA grant [5P50FD004193-07]; VCU College of Humanities and Sciences Faculty Research Council award; Atlantic Pediatric Device Consortium / FDA; VCU College of Humanities and Sciences Faculty Research Council	Atlantic Pediatric Device Consortium via FDA grant; VCU College of Humanities and Sciences Faculty Research Council award; Atlantic Pediatric Device Consortium / FDA; VCU College of Humanities and Sciences Faculty Research Council	This research was supported in part by the Atlantic Pediatric Device Consortium via FDA grant 5P50FD004193-07 (to HJR, LEF, MB). This work was also supported in part by the VCU College of Humanities and Sciences Faculty Research Council award (to LEF, LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by the Atlantic Pediatric Device Consortium / FDA (HJR, LEF, MB) and the VCU College of Humanities and Sciences Faculty Research Council (LEF, LL).	ABBASI S, 1990, PEDIATR PULM, V8, P89, DOI 10.1002/ppul.1950080206; Agostoni E., 1986, HDB PHYSL SECTION 3, P113; Albanese A, 2016, AM J PHYSIOL-HEART C, V310, pH899, DOI 10.1152/ajpheart.00230.2014; Albert SP, 2009, J APPL PHYSIOL, V106, P757, DOI 10.1152/japplphysiol.90735.2008; Athanasiades A, 2000, J BIOL SYST, V8, P115, DOI 10.1142/S0218339000000080; Avanzolini G, 2001, ANN BIOMED ENG, V29, P575, DOI 10.1114/1.1380418; BARTLETT D, 1971, RESP PHYSIOL, V12, P230, DOI 10.1016/0034-5687(71)90055-7; Bates JHT, 2009, LUNG MECHANICS: AN INVERSE MODELING APPROACH, P1, DOI 10.1017/CBO9780511627156; Bates JHT, 2002, J APPL PHYSIOL, V93, P705, DOI 10.1152/japplphysiol.01274.2001; Beltrand J, 2008, PEDIATR RES, V64, P86, DOI 10.1203/PDR.0b013e318174e6d8; BENDIXEN HH, 1963, NEW ENGL J MED, V269, P991, DOI 10.1056/NEJM196311072691901; Bhandari V, 2013, SEMIN PERINATOL, V37, P108, DOI 10.1053/j.semperi.2013.01.007; CHIARI L, 1995, COMPUTER SIMULATIONS IN BIOMEDICINE, P87; COLEBATCH HJH, 1979, J APPL PHYSIOL, V46, P387, DOI 10.1152/jappl.1979.46.2.387; Crotti S, 2001, AM J RESP CRIT CARE, V164, P131, DOI 10.1164/ajrccm.164.1.2007011; DAVIS GM, 1994, PEDIATR PULM, V17, P26, DOI 10.1002/ppul.1950170106; Diekman CO, 2017, J NEUROPHYSIOL, V118, P2194, DOI 10.1152/jn.00170.2017; Donn SM, 1998, NEONATAL PEDIAT PULM; Duggan M, 2005, ANESTHESIOLOGY, V102, P838, DOI 10.1097/00000542-200504000-00021; Ferreira JC, 2011, CLINICS, V66, P1157, DOI 10.1590/S1807-59322011000700006; FERRIS BG, 1960, J CLIN INVEST, V39, P143, DOI 10.1172/JCI104012; Frappell PB, 2005, RESP PHYSIOL NEUROBI, V149, P143, DOI 10.1016/j.resp.2005.05.028; Frazer DG, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023372; GERHARDT T, 1980, ACTA PAEDIATR SCAND, V69, P359, DOI 10.1111/j.1651-2227.1980.tb07093.x; Goetz I, 2001, EUR RESPIR J, V17, P449, DOI 10.1183/09031936.01.17304490; Goldsmith J. P., 2011, ASSISTED VENTILATION; Habib RH, 2003, J APPL PHYSIOL, V94, P1933, DOI 10.1152/japplphysiol.00927.2002; Hamlington KL, 2016, J APPL PHYSIOL, V121, P106, DOI 10.1152/japplphysiol.00096.2016; Harris R Scott, 2005, Respir Care, V50, P78; Jallon JF, 2009, PHILOS T R SOC A, V367, P4741, DOI 10.1098/rsta.2009.0137; Kovacs CS, 2015, EARLY HUM DEV, V91, P623, DOI 10.1016/j.earlhumdev.2015.08.007; Le Rolle V, 2013, ACTA BIOTHEOR, V61, P91, DOI 10.1007/s10441-013-9175-7; Liu CH, 1998, J APPL PHYSIOL, V84, P1447, DOI 10.1152/jappl.1998.84.4.1447; LOVE WG, 1953, AMA AM J DIS CHILD, V86, P423, DOI 10.1001/archpedi.1953.02050080435003; Manley BJ, 2013, NEW ENGL J MED, V369, P1425, DOI 10.1056/NEJMoa1300071; Markhorst DG, 2004, INTENS CARE MED, V30, P2086, DOI 10.1007/s00134-004-2446-7; MEAD J, 1961, PHYSIOL REV, V41, P281, DOI 10.1152/physrev.1961.41.2.281; MEAD J, 1959, J APPL PHYSIOL, V14, P669, DOI 10.1152/jappl.1959.14.5.669; Mecklenburgh JS, 1998, BRIT J ANAESTH, V80, P434, DOI 10.1093/bja/80.4.434; Miller TL, 2005, PEDIATR PULM, V39, P512, DOI 10.1002/ppul.20197; MORTOLA JP, 1987, PHYSIOL REV, V67, P187, DOI 10.1152/physrev.1987.67.1.187; MORTOLA JP, 1983, AM REV RESPIR DIS, V128, pS69; Narusawa U, 2001, J APPL PHYSIOL, V91, P201, DOI 10.1152/jappl.2001.91.1.201; NETO GS, 1995, PEDIATR RES, V37, P617, DOI 10.1203/00006450-199505000-00010; Neumann RP, 2015, NEONATOLOGY, V107, P43, DOI 10.1159/000366153; OLENDER MF, 1976, IEEE T BIO-MED ENG, V23, P445, DOI 10.1109/TBME.1976.324602; Oliveira CLN, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00073; Pandit PB, 2000, J APPL PHYSIOL, V88, P997, DOI 10.1152/jappl.2000.88.3.997; Pereira C, 2003, J APPL PHYSIOL, V95, P2064, DOI 10.1152/japplphysiol.00385.2003; Peters RM, 1973, ENG PRINCIPLES PHYSL, VII, P183; PRIMIANO FP, 1982, J BIOMECH, V15, P919, DOI 10.1016/0021-9290(82)90010-0; Qureshi M, 2009, NEONATOLOGY, V96, P43, DOI 10.1159/000201738; RATJEN FA, 1992, PEDIATR PULM, V12, P73, DOI 10.1002/ppul.1950120203; Rohrer F, 1915, ARCH GES PHYSL, V162, P225; Schmalisch G, 2005, BMC Pediatr, V5, P36, DOI 10.1186/1471-2431-5-36; Siew ML, PLOS ONE, V10, P1039; Singh R, 2012, J APPL PHYSIOL, V112, P1105, DOI 10.1152/japplphysiol.01120.2011; Smith CA, 1976, PHYSL NEWBORN INFANT; Stoll BJ, 1993, JAMA-J AM MED ASSOC, V314, P1039, DOI DOI 10.1001/JAMA.2015.10244; Sundaresan A, 2009, COMPUT METH PROG BIO, V95, P166, DOI 10.1016/j.cmpb.2009.02.008; Thomas MR, 2004, AM J RESP CRIT CARE, V169, P868, DOI 10.1164/rccm.200310-1425OC; Uzawa Y, 2015, RESP PHYSIOL NEUROBI, V205, P16, DOI 10.1016/j.resp.2014.09.008; Venegas JG, 1998, J APPL PHYSIOL, V84, P389, DOI 10.1152/jappl.1998.84.1.389; VENEGAS JG, 1994, CRIT CARE MED, V22, pS49, DOI 10.1097/00003246-199422091-00004; Waugh JB, 1999, RAPID INTERPRETATION; WILLIAMS JV, 1966, J APPL PHYSIOL, V21, P819, DOI 10.1152/jappl.1966.21.3.819	66	6	6	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198425	10.1371/journal.pone.0198425	http://dx.doi.org/10.1371/journal.pone.0198425			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902195	Green Published, Green Submitted, gold			2022-12-26	WOS:000435424900022
J	Adams, O; Janser, FA; Dislich, B; Berezowska, S; Humbert, M; Seiler, CA; Kroell, D; Slotta-Huspenina, J; Feith, M; Ott, K; Tschan, MP; Langer, R				Adams, Olivia; Janser, Felice A.; Dislich, Bastian; Berezowska, Sabina; Humbert, Magali; Seiler, Christian A.; Kroell, Dino; Slotta-Huspenina, Julia; Feith, Marcus; Ott, Katja; Tschan, Mario P.; Langer, Rupert			A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; CANCER-CELLS; P62/SEQUESTOSOME 1; OVARIAN-CANCER; AUTOPHAGY; CARCINOMA; TUMOR; PROGRESSION; INHIBITION; PACLITAXEL	Paclitaxel is a powerful chemotherapeutic drug, used for the treatment of many cancer types, including esophageal adenocarcinomas (EAC). Autophagy is a lysosome-dependent degradation process maintaining cellular homeostasis. Defective autophagy has been implicated in cancer biology and therapy resistance. We aimed to assess the impact of autophagy on chemotherapy response in EAC, with a special focus on paclitaxel. Responsiveness of EAC cell lines, OE19, FLO-1, OE33 and SK-GT-4, to paclitaxel was assessed using Alamar Blue assays. Autophagic flux upon paclitaxel treatment in vitro was assessed by immunoblotting of LC3B-II and quantitative assessment of WIP1 mRNA. Immunohistochemistry for the autophagy markers LC3B and p62 was applied on tumor tissue from 149 EAC patients treated with neoadjuvant chemotherapy, including pre- and post-therapeutic samples (62 matched pairs). Tumor response was assessed by histology. For comparison, previously published data on 114 primary resected EAC cases were used. EAC cell lines displayed differing responsiveness to paclitaxel treatment; however this was not associated with differential autophagy regulation. High p62 cytoplasmic expression on its own (p <= 0.001), or in combination with low LC3B (p = 0.034), was associated with nonresponse to chemotherapy, regardless of whether or not the regiments contained paclitaxel, but there was no independent prognostic value of LC3B or p62 expression patterns for EAC after neoadjuvant treatment. p62 and related pathways, most likely other than autophagy, play a role in chemotherapeutic response in EAC in a clinical setting. Therefore p62 could be a novel therapeutic target to overcome chemoresistance in EAC.	[Adams, Olivia; Janser, Felice A.; Dislich, Bastian; Berezowska, Sabina; Humbert, Magali; Tschan, Mario P.; Langer, Rupert] Univ Bern, Inst Pathol, Bern, Switzerland; [Adams, Olivia; Janser, Felice A.; Tschan, Mario P.] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Seiler, Christian A.; Kroell, Dino] Univ Hosp Bern, Inselspital, Dept Visceral Surg & Med, Bern, Switzerland; [Seiler, Christian A.; Kroell, Dino] Univ Bern, Bern, Switzerland; [Slotta-Huspenina, Julia] Tech Univ Munich, Inst Pathol, Munich, Germany; [Feith, Marcus] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, Munich, Germany; [Ott, Katja] RoMED Klinikum, Dept Surg, Rosenheim, Germany	University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; Technical University of Munich; Technical University of Munich	Langer, R (corresponding author), Univ Bern, Inst Pathol, Bern, Switzerland.	rupert.langer@pathology.unibe.ch	Berezowska, Sabina/AAJ-4557-2021; Langer, Rupert/AAU-1174-2021; Humbert, Magali/AAC-8951-2020	Berezowska, Sabina/0000-0001-5442-9791; Langer, Rupert/0000-0001-9491-3609; Humbert, Magali/0000-0003-3820-0297	Swiss Cancer League [KFS-3083-02-2013]	Swiss Cancer League	This study was supported by a grant from the Swiss Cancer League (KFS-3083-02-2013) awarded to RL.	Adams O, 2016, ONCOTARGET, V7, P39241, DOI 10.18632/oncotarget.9649; Bao LL, 2014, EXP MOL PATHOL, V96, P149, DOI 10.1016/j.yexmp.2013.12.002; Becker K, 2003, CANCER-AM CANCER SOC, V98, P1521, DOI 10.1002/cncr.11660; Britschgi C, 2008, BRIT J HAEMATOL, V141, P179, DOI 10.1111/j.1365-2141.2008.06992.x; Brown University, 2017, NATURE, V541, P169, DOI [DOI 10.1038/NATURE20805, 10.1038/nature20805]; Chien MH, 2015, CLIN CANCER RES, V21, P4719, DOI 10.1158/1078-0432.CCR-14-2880; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; El-Mashed S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1574-5; Fitzwalter BE, 2015, FEBS J, V282, P4279, DOI 10.1111/febs.13515; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Ge J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110293; Hu C, 2012, TOXICOL LETT, V210, P78, DOI 10.1016/j.toxlet.2012.01.019; Huang SB, 2011, J BIOL CHEM, V286, P40002, DOI 10.1074/jbc.M111.297432; Jiang PD, 2015, METHODS, V75, P13, DOI 10.1016/j.ymeth.2014.11.021; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Langer R, 2014, ANN SURG ONCOL, V21, P915, DOI 10.1245/s10434-013-3410-y; Langer R, 2009, MODERN PATHOL, V22, P1555, DOI 10.1038/modpathol.2009.123; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li LQ, 2016, TUMOR BIOL, V37, P653, DOI 10.1007/s13277-015-3842-z; Liu SL, 2015, INT J ONCOL, V46, P2399, DOI 10.3892/ijo.2015.2937; Maskey D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3130; Mohamed A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00070; Napier KJ, 2014, WORLD J GASTRO ONCOL, V6, P112, DOI 10.4251/wjgo.v6.i5.112; O'Donovan TR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134676; O'Donovan TR, 2011, AUTOPHAGY, V7, P509, DOI 10.4161/auto.7.5.15066; Ott K, 2013, LANGENBECK ARCH SURG, V398, P239, DOI 10.1007/s00423-012-1039-0; Pankiv S, 2010, J BIOL CHEM, V285, P5941, DOI 10.1074/jbc.M109.039925; Park JM, 2013, CANCER BIOL THER, V14, P100, DOI 10.4161/cbt.22954; Qian HR, 2016, ONCOTARGET, V7, P17641, DOI 10.18632/oncotarget.7508; Roesly HB, 2012, AM J PHYSIOL-GASTR L, V302, pG864, DOI 10.1152/ajpgi.00340.2011; Rubenstein JH, 2015, GASTROENTEROLOGY, V149, P302, DOI 10.1053/j.gastro.2015.04.053; Schlafli AM, 2015, EUR J HISTOCHEM, V59, P137, DOI 10.4081/ejh.2015.2481; Sobin LH., 2010, TNM CLASSIFICATION M; Springfeld C, 2015, ANN SURG ONCOL, V22, pS905, DOI 10.1245/s10434-015-4617-x; Stein AV, 2017, PATHOLOGY, V49, P30, DOI 10.1016/j.pathol.2016.10.005; Su YX, 2005, CLIN IMMUNOL, V116, P118, DOI 10.1016/j.clim.2005.04.004; Tang JC, 2016, CHINESE MED J-PEKING, V129, P456, DOI 10.4103/0366-6999.176069; Tschan MP, 2010, LEUKEMIA RES, V34, P393, DOI 10.1016/j.leukres.2009.08.037; Tschan MP, 2003, J BIOL CHEM, V278, P42750, DOI 10.1074/jbc.M307067200; Wen J, 2015, BREAST CANCER RES TR, V149, P619, DOI 10.1007/s10549-015-3283-9; Yang C, 2016, TUMOR BIOL, V37, P15489, DOI 10.1007/s13277-015-3775-6; Yu H, 2011, EUR J CANCER, V47, P1585, DOI 10.1016/j.ejca.2011.01.019; Zhang Hui-Qing, 2015, Asian Pac J Cancer Prev, V16, P3907; Zhang SF, 2015, AUTOPHAGY, V11, P225, DOI 10.1080/15548627.2014.998931; Zlobec I, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-104	45	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197610	10.1371/journal.pone.0197610	http://dx.doi.org/10.1371/journal.pone.0197610			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897944	gold, Green Published, Green Submitted			2022-12-26	WOS:000435090700022
J	Ali, SA; Malakar, D; Kaushik, JK; Mohanty, AK; Kumar, S				Ali, Syed Azmal; Malakar, Dhruba; Kaushik, Jai Kumar; Mohanty, Ashok Kumar; Kumar, Sudarshan			Recombinant purified buffalo leukemia inhibitory factor plays an inhibitory role in cell growth	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; FACTOR LIF; MAMMARY-GLAND; MOUSE EMBRYOS; EXPRESSION; DIFFERENTIATION; PLURIPOTENCY; IMPLANTATION; GENERATION; CULTURE	Leukemia Inhibitory Factor (LIF) is a polyfunctional cytokine, involved in numerous regulatory effects in vivo and in vitro, varying from cell proliferation to differentiation, and has therapeutic potential for treating various diseases. In the current study, a COS-1 cell line overexpressing recombinant Buffalo LIF (rBuLIF) was established. The rBuLIF was purified to homogeneity from the total cell lysate of COS-1 cells using a two-step affinity chromatography. The purified LIF was confirmed by western blot and mass spectrometer (MS/MS). Particularly, high-resolution MS has identified the rBuLIF with 73% of sequence coverage with highest confidence parameters and with the search engine score of 4580. We determined the molecular weight of rBuLIF protein to be 58.99 kDa and 48.9 kDa with and without glycosylation, respectively. Moreover, the purified rBuLIF was verified to be functionally active by measuring the growth inhibition of M1 myeloid leukemia cells, revealing a maximum inhibition at 72 hours and half maximal effective concentration (EC50) of 0.0555 ng/ml, corresponding to a specific activity of >1.6x10(7) units/mg. Next, we evaluated the effect of rBuLIF on buffalo mammary epithelial cell lines for its role in involution and also identified the IC50 value for BuMEC migrating cells to be 77.8 ng/ml. Additionally, the treatment of MECs (BuMEC and EpH4) displayed significant (P < 0.05) reduction in growth progression, as confirmed by qRT-PCR analysis, suggesting its strong involvement in the involution of the mammary gland in vivo. Thus, we conclude that the glycosylated rBuLIF, purified from COS-1 cells was found to be functionally active as its natural counterpart.	[Ali, Syed Azmal; Malakar, Dhruba; Kaushik, Jai Kumar; Mohanty, Ashok Kumar; Kumar, Sudarshan] Natl Dairy Res Inst, Anim Biotechnol Ctr, Prote & Cell Biol Lab, Kernel, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute	Mohanty, AK; Kumar, S (corresponding author), Natl Dairy Res Inst, Anim Biotechnol Ctr, Prote & Cell Biol Lab, Kernel, Haryana, India.	ashokmohanty1@gmail.com; kumarsudershan@gmail.com	Ali, Syed Azmal/AAM-9532-2021	Ali, Syed Azmal/0000-0003-3024-9379; Kumar, Sudarshan/0000-0002-9816-4307	Indian Council of Agricultural Research (ICAR), Government of India [NASF/GTR-5008-2015-16]	Indian Council of Agricultural Research (ICAR), Government of India(Indian Council of Agricultural Research (ICAR))	This research was funded by Indian Council of Agricultural Research (ICAR) (NASF/GTR-5008-2015-16), Government of India. We would also like to thank the Director of National Dairy Research Institute (NDRI), India for providing the necessary facilities to carry out research work.	Ali SA, 2017, J PROTEOMICS, V168, P37, DOI 10.1016/j.jprot.2017.07.014; Anand T, 2011, REPROD DOMEST ANIM, V46, P50, DOI 10.1111/j.1439-0531.2009.01564.x; Anand V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040469; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Cullinan EB, 1996, P NATL ACAD SCI USA, V93, P3115, DOI 10.1073/pnas.93.7.3115; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GEARING DP, 1987, EMBO J, V6, P3995, DOI 10.1002/j.1460-2075.1987.tb02742.x; Gong GC, 2010, CELL REPROGRAM, V12, P151, DOI 10.1089/cell.2009.0049; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Imsoonthornruksa S, 2011, J BIOTECHNOL, V151, P295, DOI 10.1016/j.jbiotec.2010.12.020; Iwasaki S, 2000, BIOL REPROD, V62, P470, DOI 10.1095/biolreprod62.2.470; Kaur G, 2017, J PROTEOMICS, V167, P36, DOI 10.1016/j.jprot.2017.08.008; Kaur G, 2017, CYTOGENET GENOME RES, V151, P119, DOI 10.1159/000465507; Kritikou EA, 2003, DEVELOPMENT, V130, P3459, DOI 10.1242/dev.00578; Lian JZ, 2009, APPL MICROBIOL BIOT, V82, P463, DOI 10.1007/s00253-008-1774-x; Lotfan M, 2018, GENE, V654, P127, DOI 10.1016/j.gene.2018.02.038; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Metcalf D, 2003, STEM CELLS, V21, P5, DOI 10.1634/stemcells.21-1-5; Mitalipova M, 2001, Cloning, V3, P59, DOI 10.1089/15204550152475563; Pragya P, 2017, J PROTEOMICS, V152, P121, DOI 10.1016/j.jprot.2016.10.016; Saito S, 2003, BIOCHEM BIOPH RES CO, V309, P104, DOI 10.1016/S0006-291X(03)01536-5; Schere-Levy C, 2003, EXP CELL RES, V282, P35, DOI 10.1006/excr.2002.5666; SHEN MM, 1992, P NATL ACAD SCI USA, V89, P8240, DOI 10.1073/pnas.89.17.8240; Smith A, 2001, COLD SPRING HARBOR M, P205; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; STAHL J, 1990, J BIOL CHEM, V265, P8833; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Strelchenko N, 1996, THERIOGENOLOGY, V45, P131, DOI 10.1016/0093-691X(95)00362-C; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Takahashi Y, 2008, MOL ENDOCRINOL, V22, P1673, DOI 10.1210/me.2008-0058; TOMIDA M, 1984, FEBS LETT, V178, P291, DOI 10.1016/0014-5793(84)80619-5; Wang L, 2005, BIOL REPROD, V73, P149, DOI 10.1095/biolreprod.104.037150; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Youngblood BA, 2014, J BIOTECHNOL, V172, P67, DOI 10.1016/j.jbiotec.2013.12.012	36	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198523	10.1371/journal.pone.0198523	http://dx.doi.org/10.1371/journal.pone.0198523			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897967	gold, Green Submitted, Green Published			2022-12-26	WOS:000435090700058
J	Behrens, NE; Wertheimer, A; Klotz, SA; Ahmad, N				Behrens, Nicole E.; Wertheimer, Anne; Klotz, Stephen A.; Ahmad, Nafees			Reduction in terminally differentiated T cells in virologically controlled HIV-infected aging patients on long-term antiretroviral therapy	PLOS ONE			English	Article							DISEASE PROGRESSION; IMMUNE ACTIVATION; IN-VIVO; NAIVE; CYTOKINES; EXPRESSION; DEPLETION; AGE; REPLICATION; SUPPRESSION	Several studies have shown an increased accumulation of terminally differentiated T cells during HIV infection, suggestive of exhaustion/senescence, causing dysregulation of T cell homeostasis and function and rapid HIV disease progression. We have investigated whether long-term antiretroviral therapy (ART), which controls viremia and restores CD4 T cell counts, is correlated with reduction in terminally differentiated T cells, improved ratios of na ve to memory and function of T cells in 100 virologically controlled HIV-infected patients. We show that while the median frequencies of terminally differentiated CD4(+) and CD8(+) T cells (CD28(-), CD27(-), CD57(+) and CD28-CD57(+)), were higher in the virologically controlled HIV-infected patients' cohort compared with uninfected individuals' cohort, the frequencies of these cells significantly decreased with increasing CD4 T cell counts in HIV-infected patients. Although, the naive CD4+ and CD8+ T cells were lower in HIV patients' cohort than uninfected cohort, there was a significant increase in both na ve CD4(+) and CD8(+) T cells with increasing CD4 T cell counts in HIV-infected patients. The underlying mechanism behind this increased naive CD4(+) and CD8(+) T cells in HIV-infected patients was due to an increase in recent thymic emigrants, CD4(+)CD31(+), as compared to CD4(+)CD31(-). The CD4+ T cells of HIV-infected patients produced cytokines, including IL-2, IL-10 and IFN-gamma comparable to uninfected individuals. In conclusion, virologically controlled HIV-infected patients on longterm ART show a significant reduction in terminally differentiated T cells, suggestive of decreased exhaustion/senescence, and improvement in the ratios of na ve to memory and function of T cells.	[Behrens, Nicole E.; Wertheimer, Anne; Ahmad, Nafees] Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85721 USA; [Wertheimer, Anne; Klotz, Stephen A.] Univ Arizona, Coll Med, Dept Med, Tucson, AZ USA; [Wertheimer, Anne] Univ Arizona, Inst Bio5, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona	Ahmad, N (corresponding author), Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85721 USA.	nafees@email.arizona.edu	Wertheimer, Anne/ABF-7802-2021; Wertheimer, Anne/E-5132-2019	Wertheimer, Anne/0000-0002-6627-4974; Ahmad, Nafees/0000-0001-7717-9115	Arizona Biomedical Research Commission, Arizona Department of Health Services [ADHS14-082984]	Arizona Biomedical Research Commission, Arizona Department of Health Services	This work was supported by a grant (ADHS14-082984) from the Arizona Biomedical Research Commission, Arizona Department of Health Services. The authors received no specific funding for this work.	Appay V, 2002, TRENDS IMMUNOL, V23, P580, DOI 10.1016/S1471-4906(02)02338-4; Appay V, 2017, VIRULENCE, V8, P529, DOI 10.1080/21505594.2016.1195536; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Boucher N, 1998, EXP GERONTOL, V33, P267, DOI 10.1016/S0531-5565(97)00132-0; Bourgeois C, 2008, P NATL ACAD SCI USA, V105, P8691, DOI 10.1073/pnas.0803732105; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; Cao W, 2009, JAIDS-J ACQ IMM DEF, V50, P137, DOI 10.1097/QAI.0b013e3181926c28; Dion ML, 2007, BLOOD, V109, P2912, DOI 10.1182/blood-2006-09-047308; EFFROS RB, 1994, EXP GERONTOL, V29, P601, DOI 10.1016/0531-5565(94)90073-6; Gelpi M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1930-3; Haynes L, 1999, J EXP MED, V190, P1013, DOI 10.1084/jem.190.7.1013; Haynes L, 2004, J IMMUNOL, V172, P5194, DOI 10.4049/jimmunol.172.9.5194; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hazenberg MD, 2003, AIDS, V17, P1419, DOI 10.1097/00002030-200307040-00001; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Kalayjian RC, 2005, J INFECT DIS, V192, P1577, DOI 10.1086/466527; Kalayjian RC, 2003, J INFECT DIS, V187, P1924, DOI 10.1086/375372; Kedzierska K, 2003, REV MED VIROL, V13, P39, DOI 10.1002/rmv.369; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mueller YM, 2001, IMMUNITY, V15, P871, DOI 10.1016/S1074-7613(01)00246-1; MURASKO DM, 1987, CLIN EXP IMMUNOL, V70, P440; Nikolich-Zugich J, 2005, J EXP MED, V201, P837, DOI 10.1084/jem.20050341; Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x; Pallikkuth S, 2018, AIDS, V32, P1085, DOI 10.1097/QAD.0000000000001774; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Pathai S, 2014, J GERONTOL A-BIOL, V69, P833, DOI 10.1093/gerona/glt168; Ronsholt FF, 2012, JAIDS-J ACQ IMM DEF, V61, P270, DOI 10.1097/QAI.0b013e31825e7ac1; Rosado-Sanchez I, 2017, CLIN INFECT DIS, V64, P152, DOI 10.1093/cid/ciw711; Sauce D, 2011, BLOOD, V117, P5142, DOI 10.1182/blood-2011-01-331306; Valenzuela HF, 2002, CLIN IMMUNOL, V105, P117, DOI 10.1006/clim.2002.5271	33	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0199101	10.1371/journal.pone.0199101	http://dx.doi.org/10.1371/journal.pone.0199101			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897981	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000435090700093
J	Sruthi, CK; Prakash, M				Sruthi, C. K.; Prakash, Meher			Amino acid impact factor	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEASE INHIBITORS; DIHYDROFOLATE-REDUCTASE; RESISTANCE MUTATIONS; ESCHERICHIA-COLI; DRUG-RESISTANCE; NETWORK; EVOLUTION; FAMILIES; DATABASE	Amino acid mutations in proteins are random and those mutations which are beneficial or neutral survive during the course of evolution. Conservation or co-evolution analyses are performed on the multiple sequence alignment of homologous proteins to understand how important different amino acids or groups of them are. However, these traditional analyses do not explore the directed influence of amino acid mutations, such as compensatory effects. In this work we develop a method to capture the directed evolutionary impact of one amino acid on all other amino acids, and provide a visual network representation for it. The method developed for these directed networks of inter-and intra-protein evolutionary interactions can also be used for noting the differences in amino acid evolution between the control and experimental groups. The analysis is illustrated with a few examples, where the method identifies several directed interactions of functionally critical amino acids. The impact of an amino acid is quantified as the number of amino acids that are influenced as a consequence of its mutation, and it is intended to summarize the compensatory mutations in large evolutionary sequence data sets as well as to rationally identify targets for mutagenesis when their functional significance can not be assessed using structure or conservation.	[Sruthi, C. K.; Prakash, Meher] Jawaharlal Nehru Ctr Adv Sci Res, Theoret Sci Unit, Bangalore 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Prakash, M (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Theoret Sci Unit, Bangalore 560064, Karnataka, India.	meher@jncasr.ac.in		Prakash, Meher/0000-0002-0091-4158				Ackerman SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047108; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Baird TT, 2006, PROTEIN SCI, V15, P1229, DOI 10.1110/ps.062179006; Barabasi A.-L., 2016, NETWORK SCI; Baussand J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000488; Borman AM, 1996, J GEN VIROL, V77, P419, DOI 10.1099/0022-1317-77-3-419; Bremm S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-330; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Cameron CE, 1997, BIOCHEMISTRY-US, V36, P15792, DOI 10.1021/bi9716231; Carbone A., 2014, DISCRETE TOPOLOGICAL; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Deforche K, 2006, BIOINFORMATICS, V22, P2975, DOI 10.1093/bioinformatics/btl508; Doyon L, 1996, J VIROL, V70, P3763, DOI 10.1128/JVI.70.6.3763-3769.1996; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gatanaga H, 2002, J BIOL CHEM, V277, P5952, DOI 10.1074/jbc.M108005200; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Kar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000601; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Levin BR, 2000, GENETICS, V154, P985; Li GD, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-014-0031-8; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Maguire MF, 2002, J VIROL, V76, P7398, DOI 10.1128/JVI.76.15.7398-7406.2002; Maisnier-Patin S, 2004, RES MICROBIOL, V155, P360, DOI 10.1016/j.resmic.2004.01.019; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Rod TH, 2003, P NATL ACAD SCI USA, V100, P6980, DOI 10.1073/pnas.1230801100; Rohl CA, 2002, J AM CHEM SOC, V124, P2723, DOI 10.1021/ja016880e; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Tesileanu T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004091; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Wellner A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003665	37	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198645	10.1371/journal.pone.0198645	http://dx.doi.org/10.1371/journal.pone.0198645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897971	Green Submitted, Green Published, gold			2022-12-26	WOS:000435090700063
J	Agetsuma, N				Agetsuma, Naoki			A simple method for calculating minimum estimates of previous population sizes of wildlife from hunting records	PLOS ONE			English	Article							SIKA-DEER POPULATION; ENVIRONMENTAL STOCHASTICITY; JAPAN; OVERABUNDANCE; LANDSCAPE; DENSITY; IMPACT; ISLAND	Hunting records have proven useful for examining the historical status of wildlife populations. The number of animals harvested can provide information on past population sizes that would have been required to support harvest yields. Therefore, when statistical data on annual harvests are available, a minimum estimate of past population sizes can be calculated. A very simple method for estimating the sizes of historic wildlife populations using only annual hunting records and the maximum annual population increase rate is presented in this study. This method was applied to estimate past population sizes for Japanese sika deer (Census nippon yesoensis) in Hokkaido Island, Japan, using hunting records from 1873 to 1882, and assuming 15% and 35% population increase rates. The annual number of deer harvested during 1873 to 1882 ranged from 15,000 to 129,000. The minimum population size in 1873 was estimated as 349,000-473,000. This method was validated by applying it to the eastern population of Hokkaido Island in 1993 when the population size was approximately 260,000, and population sizes estimated by this method were 0.50-1.17 times the nominal population size. Thus, the population estimates from this method were approximately equal to or less than the expected population sizes, and this method can be used to obtain minimum estimates of wildlife populations. Because shorter durations of hunting records result in population size underestimates, it would be better to use hunting record of 10 years or longer in this method. In addition, the degree of underestimation may change with hunting pressure intensity on the populations, other causes of mortality, and maximum annual increase rates of the species. The method can be applied to any wildlife species for which records of annual harvest and maximum annual population increase rates of the species are available. The estimates obtained can provide benchmarks for the population size required for ecosystem conservation, and can be useful for wildlife management as they indicate the lowest limit to maintain the population.	[Agetsuma, Naoki] Hokkaido Univ, Tomakomai Expt Forest, Field Sci Ctr Northern Biosphere, Tomakomai, Hokkaido, Japan	Hokkaido University	Agetsuma, N (corresponding author), Hokkaido Univ, Tomakomai Expt Forest, Field Sci Ctr Northern Biosphere, Tomakomai, Hokkaido, Japan.	agetsuma@fsc.hokudai.ac.jp	Agetsuma, Naoki/A-4329-2012	Agetsuma, Naoki/0000-0003-4093-5276	JSPS KAKENHI [18380086]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI 18380086 to NA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agetsuma N, 2007, ECOL RES, V22, P390, DOI 10.1007/s11284-007-0358-z; Augustine DJ, 2003, ECOSCIENCE, V10, P472, DOI 10.1080/11956860.2003.11682795; FISCHER JR, 1995, J WILDLIFE DIS, V31, P30, DOI 10.7589/0090-3558-31.1.30; Hodges KE, 2001, ECOSYSTEM DYNAMICS OF THE BOREAL FOREST, P141; Hokkaido Prefecture, 1987, REP AN DISTR; Hokkaido Prefecture, 2007, REV EZ SIK DEER CONS; Hokkaido Prefecture, 2017, EZO SIKA DEER MANAGE; Hurley PM, 2012, BIOL CONSERV, V146, P62, DOI 10.1016/j.biocon.2011.10.034; Inukai T., 1952, REPORT NO CULTURAL R, V7, P1; Japan Nature Conservation Society, 1991, WILDLIFE CONSERVATIO; Kaji K, 2004, J WILDLIFE MANAGE, V68, P889, DOI 10.2193/0022-541X(2004)068[0889:IOACSD]2.0.CO;2; Kaji K., 2006, CONSERVATION MANAGEM; Kay CE, 1998, WILDLIFE SOC B, V26, P484; MacLulich DA, 1973, U TORONTO STUDIES BI, V43, P1; Matsuda H, 1999, RES POPUL ECOL, V41, P139, DOI 10.1007/s101440050016; Matsuda H, 2002, WILDLIFE SOC B, V30, P1160; Ou W, 2014, POPUL ECOL, V56, P311, DOI 10.1007/s10144-013-0425-y; ROSEBERRY JL, 1969, J WILDLIFE MANAGE, V33, P791, DOI 10.2307/3799308; Saether BE, 1998, AM NAT, V151, P441, DOI 10.1086/286131; Saltz D, 2006, CONSERV BIOL, V20, P1402, DOI 10.1111/j.1523-1739.2006.00486.x; Sibly RM, 2003, WILDLIFE POPULATION; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; SKOGLAND T, 1991, OIKOS, V61, P401, DOI 10.2307/3545248; Suzuki M, 2008, ECOL RES, V23, P151, DOI 10.1007/s11284-007-0348-1; Turchin P, 1997, OIKOS, V78, P355, DOI 10.2307/3546303; Umeki K., 2015, RES J GRAD STUDENTS, V15, P35	26	2	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198794	10.1371/journal.pone.0198794	http://dx.doi.org/10.1371/journal.pone.0198794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894510	Green Submitted, Green Published, gold			2022-12-26	WOS:000435030900026
J	Bi, YH; Chen, HM; Li, YH; Yu, ZP; Han, XW; Ren, JZ				Bi, Yonghua; Chen, Hongmei; Li, Yahua; Yu, Zepeng; Han, Xinwei; Ren, Jianzhuang			Rabbit aortic aneurysm model with enlarging diameter capable of better mimicking human aortic aneurysm disease	PLOS ONE			English	Article							PERIARTERIAL APPLICATION; SIMULTANEOUS INHIBITION; TOPICAL APPLICATION; KAPPA-B; ELASTASE; INFLAMMATION; PERFORMANCE; RATS; ETS	The self-healing phenomenon can be found in the elastase-induced abdominal aortic aneurysm (AAA) model, and an enlarging AAA model was successfully induced by coarctation. Unfortunately, aortic coarctation in these enlarging models is generally not found in human AAA disease. This study aimed to create an experiment model of enlarging AAA in rabbits to better mimic human aortic aneurysm disease. Eighty-four male New Zealand white rabbits were randomly divided into three equal groups: two aneurysm groups (A and B) and a SHAM group. Aneurysm group rabbits underwent extrinsic aortic stenosis below the right renal artery and received a 10-minute incubation of 60 mu l elastase (1 unit/mu l). Absorbable suture was used in Group A and nonabsorbable cotton thread was used in Group B. A sham operation was performed in the SHAM group. Aortic diameter was measured after 1, 3, 7, and 15 weeks; thereafter animals were sacrificed for histopathological, immunohistochemical and quantitative studies. Two rabbits died at 29 and 48 days, respectively, after operation in Group B. All aneurysms formed and enlarged progressively by 3 weeks in the Aneurysm groups. However, diameter enlargement in Group A was significantly lower than that in Group B at 7 weeks. Aneurysm groups developed intimal hyperplasia; intima-media thickness (IMT) increased significantly by week 7, and aortic media thickness and intimamedia ratio (IMR) increased significantly by week 15. Marked destruction of elastin fibers and smooth muscle cells (SMCs) occurred 1 week later and increased progressively thereafter. Intimal hyperplasia and SMCs content in Group A increased significantly by week 15 compared with Group B. Aneurysm groups exhibited strong expression of matrix metalloproteinases 2 and 9 and RAM11 by week 1, and decreased progressively thereafter. In conclusion, this novel rabbit AAA model enlarges progressively without coarctation and is capable of better mimicking human aortic aneurysm disease.	[Bi, Yonghua; Li, Yahua; Yu, Zepeng; Han, Xinwei; Ren, Jianzhuang] Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent Radiol, Zhengzhou, Henan, Peoples R China; [Chen, Hongmei] Zhengzhou Univ, Med Coll, Dept Histol & Embryol, Zhengzhou, Henan, Peoples R China; [Chen, Hongmei] Zhengzhou Univ, Zhengzhou Cent Hosp, Dept Ultrasound, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University	Han, XW; Ren, JZ (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent Radiol, Zhengzhou, Henan, Peoples R China.	dreamweaver08@126.com; rrjjzzjrk@126.com	han, wei/ABG-2691-2021		National Natural Science Foundation of China [81501569]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (81501569 to YB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANIDJAR S, 1990, CIRCULATION, V82, P973, DOI 10.1161/01.CIR.82.3.973; Bi Y, 2013, EUR J VASC ENDOVASC, V45, P145, DOI 10.1016/j.ejvs.2012.11.015; Bi YH, 2017, ANN MED SURG, V18, P24, DOI 10.1016/j.amsu.2017.05.004; Bi YH, 2015, J VASC SURG, V62, P1054, DOI 10.1016/j.jvs.2014.02.062; Bi YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068476; Bi YH, 2012, J VASC INTERV RADIOL, V23, P1529, DOI 10.1016/j.jvir.2012.08.007; Cockerill GW, 2013, EUR J VASC ENDOVASC, V45, P153, DOI 10.1016/j.ejvs.2012.11.018; ERNST CB, 1993, NEW ENGL J MED, V328, P1167; Freestone T, 1997, ARTERIOSCL THROM VAS, V17, P10, DOI 10.1161/01.ATV.17.1.10; GERTZ SD, 1988, J CLIN INVEST, V81, P649, DOI 10.1172/JCI113368; Isenburg JC, 2007, CIRCULATION, V115, P1729, DOI 10.1161/CIRCULATIONAHA.106.672873; LILIENFELD DE, 1987, ARTERIOSCLEROSIS, V7, P637, DOI 10.1161/01.ATV.7.6.637; Mata KM, 2011, INT J EXP PATHOL, V92, P26, DOI 10.1111/j.1365-2613.2010.00746.x; Miyake T, 2006, GENE THER, V13, P695, DOI 10.1038/sj.gt.3302704; Miyake T, 2007, CIRC RES, V101, P1175, DOI 10.1161/CIRCRESAHA.107.148668; Molacek J, 2009, J VASC RES, V46, P1, DOI 10.1159/000135659; Origuchi N, 1998, INT ANGIOL, V17, P113; POWELL J, 1991, ATHEROSCLEROSIS, V87, P93, DOI 10.1016/0021-9150(91)90011-Q; ROACH M R, 1970, Circulation Research, V27, P985; Sasaki K, 2004, NEUROL MED-CHIR, V44, P467, DOI 10.2176/nmc.44.467; Sasaki T, 2004, NEUROL MED-CHIR, V44, P473; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Sho E, 2002, EXP MOL PATHOL, V73, P142, DOI 10.1006/exmp.2002.2457; Tanaka A, 2009, J VASC SURG, V50, P1423, DOI 10.1016/j.jvs.2009.08.062; White JV, 1996, ANN NY ACAD SCI, V800, P97, DOI 10.1111/j.1749-6632.1996.tb33302.x; Zhong HS, 2009, J VASC SURG, V50, P1433, DOI 10.1016/j.jvs.2009.07.071	26	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							E0198818	10.1371/journal.pone.0198818	http://dx.doi.org/10.1371/journal.pone.0198818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889909	Green Submitted, Green Published, gold			2022-12-26	WOS:000434786600053
J	Hazim, M; Anuar, NB; Ab Razak, MF; Abdullah, NA				Hazim, Mohamad; Anuar, Nor Badrul; Ab Razak, Mohd Faizal; Abdullah, Nor Aniza			Detecting opinion spams through supervised boosting approach	PLOS ONE			English	Article							REVIEWS; GENERATION; PREDICTION; REGRESSION; SENTIMENT; STRENGTH	Product reviews are the individual's opinions, judgement or belief about a certain product or service provided by certain companies. Such reviews serve as guides for these companies to plan and monitor their business ventures in terms of increasing productivity or enhancing their product/service qualities. Product reviews can also increase business profits by convincing future customers about the products which they have interest in. In the mobile application marketplace such as Google Playstore, reviews and star ratings are used as indicators of the application quality. However, among all these reviews, hereby also known as opinions, spams also exist, to disrupt the online business balance. Previous studies used the time series and neural network approach (which require a lot of computational power) to detect these opinion spams. However, the detection performance can be restricted in terms of accuracy because the approach focusses on basic, discrete and document level features only thereby, projecting little statistical relationships. Aiming to improve the detection of opinion spams in mobile application marketplace, this study proposes using statistical based features that are modelled through the supervised boosting approach such as the Extreme Gradient Boost (XGBoost) and the Generalized Boosted Regression Model (GBM) to evaluate two multilingual datasets (i.e. English and Malay language). From the evaluation done, it was found that the XGBoost is most suitable for detecting opinion spams in the English dataset while the GBM Gaussian is most suitable for the Malay dataset. The comparative analysis also indicates that the implementation of the proposed statistical based features had achieved a detection accuracy rate of 87.43 per cent on the English dataset and 86.13 per cent on the Malay dataset.	[Hazim, Mohamad; Anuar, Nor Badrul; Ab Razak, Mohd Faizal; Abdullah, Nor Aniza] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Comp Syst & Technol, Kuala Lumpur, Malaysia; [Ab Razak, Mohd Faizal] Univ Malaysia Pahang, Fac Comp Syst & Software Engn, Lebuhraya Tun Razak, Kuantan, Pahang, Malaysia	Universiti Malaya; Universiti Malaysia Pahang	Anuar, NB (corresponding author), Univ Malaya, Fac Comp Sci & Informat Technol, Dept Comp Syst & Technol, Kuala Lumpur, Malaysia.	badrul@um.edu.my	Anuar, Nor Badrul/B-3101-2010; Abdullah, Nor Aniza/B-2768-2010; Hanif, Hazim/GOV-5540-2022; Razak, Mohd Faizal Ab/O-2027-2018	Anuar, Nor Badrul/0000-0003-4380-5303; Abdullah, Nor Aniza/0000-0001-6218-8772; Hanif, Hazim/0000-0002-9140-6625; Razak, Mohd Faizal Ab/0000-0002-7388-4340	University Malaya Research Grant Programme (Equitable Society) [RP032B-16SBS]	University Malaya Research Grant Programme (Equitable Society)	The work of the authors is supported by University Malaya Research Grant Programme (Equitable Society) under grant RP032B-16SBS. The funder has a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work of the authors is supported by University Malaya Research Grant Programme (Equitable Society) under grant RP032B-16SBS.	Ab Razak MF, 2016, J NETW COMPUT APPL, V75, P58, DOI 10.1016/j.jnca.2016.08.022; Afifi F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162627; Akoglu L, 2013, OPINION FRAUD DETECT; Bekkerman R., 2015, PRESENT FUTURE KDD C; Bing L, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P179, DOI 10.1109/icdm.2003.1250918; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Fei G., 2013, P INT AAAI C WEB SOC; da Silva NFF, 2016, INFORM SCIENCES, V355, P348, DOI 10.1016/j.ins.2016.02.002; Figueiredo F, 2016, INFORM SCIENCES, V349, P172, DOI 10.1016/j.ins.2016.02.025; Firdaus A, 2017, MULTIMEDIA TOOLS APP; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Geetha M, 2017, TOURISM MANAGE, V61, P43, DOI 10.1016/j.tourman.2016.12.022; Harris CG, 2012, 26 AAAI C ART INT; Heydari A, 2016, EXPERT SYST APPL, V58, P83, DOI 10.1016/j.eswa.2016.03.020; Ho-Dac NN, 2013, J MARKETING, V77, P37, DOI 10.1509/jm.11.0011; Jindal N., 2008, P INT C WEB SEARCH W, V2008, P219, DOI DOI 10.1145/1341531.1341560; Jindal N., 2007, P INT C WORLD WID WE, P1189, DOI DOI 10.1145/1242572.1242759; Jindal N, 2007, 7 IEEE INT C DAT MIN; Johnson NE, 2017, WASTE MANAGE, V62, P3, DOI 10.1016/j.wasman.2017.01.037; Kang M, 2017, EXPERT SYSTEMS APPL; Li H, 2015, ANAL DETECTING OPINI; Li HY, 2014, IEEE DATA MINING, P899, DOI 10.1109/ICDM.2014.47; Li JW, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P1566; Li L, 2017, NEUROCOMPUTING; Lin Y, 2014, 2014 IEEE ACM INT C; Mukherjee A., 2013, P AAAI; Ott M., 2011, P 49 ANN M ASS COMP, V1, P309, DOI DOI 10.1145/2567948.2577293; Panda B, 2009, PROC VLDB ENDOW, V2, P1426, DOI 10.14778/1687553.1687569; Penalver-Martinez I, 2014, EXPERT SYST APPL, V41, P5995, DOI 10.1016/j.eswa.2014.03.022; Persson C, 2017, SOL ENERGY, V150, P423, DOI 10.1016/j.solener.2017.04.066; Pierdzioch C, 2016, RESOUR POLICY, V47, P95, DOI 10.1016/j.resourpol.2016.01.003; Ping Lu, 2010, Proceedings 2010 Second WRI Global Congress on Intelligent Systems (GCIS 2010), P302, DOI 10.1109/GCIS.2010.57; Prieto A, 2016, NEUROCOMPUTING, V214, P242, DOI 10.1016/j.neucom.2016.06.014; Qingxi Peng, 2014, Journal of Software, V9, P2065, DOI 10.4304/jsw.9.8.2065-2072; Rayana S, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P985, DOI 10.1145/2783258.2783370; Ren Y, 2014, POSITIVE UNLABELED L; Ren YF, 2017, INFORM SCIENCES, V385, P213, DOI 10.1016/j.ins.2017.01.015; Ren YF, 2016, INFORM SCIENCES, V369, P188, DOI 10.1016/j.ins.2016.06.040; RIDGEWAY G, 2006, R PACKAGE VERSION, V1, P55; Savage D, 2015, EXPERT SYST APPL, V42, P8650, DOI 10.1016/j.eswa.2015.07.019; SCHAPIRE RE, 1990, MACH LEARN, V5, P197, DOI 10.1023/A:1022648800760; Sharma Kuldeep, 2013, P 51 ACM SE C, P1; Statista, 2017, NUMB AV APPL GOOGL P; Tyree S., 2011, P 20 INT C WORLD WID, P387, DOI DOI 10.1145/1963405.1963461; Wang G, 2011, ICDM, V2011, P1242, DOI DOI 10.1109/ICDM.2011.124; Xu C, 2013, PROCEEDINGS OF THE 22ND ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM'13), P979, DOI 10.1145/2505515.2505700; Yan Z, 2017, INFORM FUSION, V36, P172, DOI 10.1016/j.inffus.2016.11.011; Ye J., 2009, P 18 ACM C INFORM KN, P2061, DOI [DOI 10.1145/1645953.1646301, 10.1145/1645953.1646301]; Ye JT, 2015, LECT NOTES ARTIF INT, V9284, P267, DOI 10.1007/978-3-319-23528-8_17; Zhu F, 2010, J MARKETING, V74, P133, DOI 10.1509/jmkg.74.2.133; Zieba M, 2016, EXPERT SYST APPL, V58, P93, DOI 10.1016/j.eswa.2016.04.001	55	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198884	10.1371/journal.pone.0198884	http://dx.doi.org/10.1371/journal.pone.0198884			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI8PJ	29889897	Green Published, Green Submitted, gold			2022-12-26	WOS:000434786600061
J	Sips, PY; Shi, X; Musso, G; Nath, AK; Zhao, YB; Nielson, J; Morningstar, J; Kelly, AE; Mikell, B; Buys, E; Bebarta, V; Rutter, J; Davisson, VJ; Mahon, S; Brenner, M; Boss, GR; Peterson, RT; Gerszten, RE; MacRae, CA				Sips, Patrick Y.; Shi, Xu; Musso, Gabriel; Nath, Anjali K.; Zhao, Yanbin; Nielson, Jason; Morningstar, Jordan; Kelly, Amy E.; Mikell, Brittney; Buys, Eva; Bebarta, Vikhyat; Rutter, Jared; Davisson, V. Jo; Mahon, Sari; Brenner, Matthew; Boss, Gerry R.; Peterson, Randall T.; Gerszten, Robert E.; MacRae, Calum A.			Identification of specific metabolic pathways as druggable targets regulating the sensitivity to cyanide poisoning	PLOS ONE			English	Article							GENE; ANTIDOTES; MECHANISM	Cyanide is a potent toxic agent, and the few available antidotes are not amenable to rapid deployment in mass exposures. As a result, there are ongoing efforts to exploit different animal models to identify novel countermeasures. We have created a pipeline that combines high-throughput screening in zebrafish with subsequent validation in two mammalian small animal models as well as a porcine large animal model. We found that zebrafish embryos in the first 3 days post fertilization (dpf) are highly resistant to cyanide, becoming progressively more sensitive thereafter. Unbiased analysis of gene expression in response to several hours of ultimately lethal doses of cyanide in both 1 and 7 dpf zebrafish revealed modest changes in iron-related proteins associated with the age-dependent cyanide resistance. Metabolomics measurements demonstrated significant age-dependent differences in energy metabolism during cyanide exposure which prompted us to test modulators of the tricarboxylic acid cycle and related metabolic processes as potential antidotes. In cyanide sensitive 7 dpf larvae, we identified several such compounds that offer significant protection against cyanide toxicity. Modulators of the pyruvate dehydrogenase complex, as well as the small molecule sodium glyoxylate, consistently protected against cyanide toxicity in 7 dpf zebrafish larvae. Together, our results indicate that the resistance of zebrafish embryos to cyanide toxicity during early development is related to an altered regulation of cellular metabolism, which we propose may be exploited as a potential target for the development of novel antidotes against cyanide poisoning.	[Sips, Patrick Y.; Musso, Gabriel; Zhao, Yanbin; Kelly, Amy E.; Mikell, Brittney; Buys, Eva; MacRae, Calum A.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Sips, Patrick Y.; Musso, Gabriel; Zhao, Yanbin; Kelly, Amy E.; Mikell, Brittney; Buys, Eva; MacRae, Calum A.] Harvard Med Sch, Boston, MA 02115 USA; [Sips, Patrick Y.] Univ Ghent, Dept Pediat & Med Genet, Ctr Med Genet Ghent, Ghent, Belgium; [Shi, Xu; Nath, Anjali K.; Morningstar, Jordan; Gerszten, Robert E.] Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, Boston, MA 02215 USA; [Nath, Anjali K.; Peterson, Randall T.] Massachusetts Gen Hosp, Div Cardiol, Dept Med, Cardiovasc Res Ctr, Charlestown, MA USA; [Nath, Anjali K.; Nielson, Jason; Peterson, Randall T.; Gerszten, Robert E.; MacRae, Calum A.] Broad Inst, Cambridge, MA 02142 USA; [Nielson, Jason; Peterson, Randall T.] Univ Utah, Dept Pharmacol & Toxicol, Coll Pharm, 112 Skaggs Hall, Salt Lake City, UT 84112 USA; [Bebarta, Vikhyat] Univ Colorado, Sch Med, Dept Emergency Med, Aurora, CO USA; [Rutter, Jared] Univ Utah, Dept Biochem, Salt Lake City, UT USA; [Rutter, Jared] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT USA; [Davisson, V. Jo] Purdue Coll Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN USA; [Mahon, Sari; Brenner, Matthew] Univ Calif Irvine, Dept Med, Beckman Laser Inst, Irvine, CA 92717 USA; [Boss, Gerry R.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Ghent University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Utah System of Higher Education; University of Utah; University of Colorado System; University of Colorado Anschutz Medical Campus; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; University of California System; University of California Irvine; University of California System; University of California San Diego	Sips, PY; MacRae, CA (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.; Sips, PY; MacRae, CA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Sips, PY (corresponding author), Univ Ghent, Dept Pediat & Med Genet, Ctr Med Genet Ghent, Ghent, Belgium.; MacRae, CA (corresponding author), Broad Inst, Cambridge, MA 02142 USA.	Patrick.Sips@UGent.be; cmacrae@bwh.harvard.edu	Sips, Patrick/AAS-8985-2021	Sips, Patrick/0000-0001-9241-5980; Morningstar, Jordan/0000-0003-2168-9671; Musso, Gabriel/0000-0001-8778-8248; Davisson, Vincent Jo/0000-0003-1182-0007; Boss, Gerry/0000-0002-9758-8714; Peterson, Randall/0000-0003-0727-3469	National Institutes of Health [U54NS079201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK091317, P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS063563, U54NS079201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (www.nih.gov) grant U54NS079201 to RTP and CAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berriz GF, 2008, BIOINFORMATICS, V24, P2272, DOI 10.1093/bioinformatics/btn424; Broderick KE, 2006, EXP BIOL MED, V231, P641; Chan A, 2015, J MED CHEM, V58, P1750, DOI 10.1021/jm501565k; CHEN KK, 1952, JAMA-J AM MED ASSOC, V149, P113, DOI 10.1001/jama.1952.02930190015004; Cummings TF, 2004, OCCUP MED-OXFORD, V54, P82, DOI 10.1093/occmed/kqh020; Elmariah S, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002712; FRANKENBERG L, 1975, ARCH TOXICOL, V33, P81, DOI 10.1007/BF00353233; Gracia R, 2004, PHARMACOTHERAPY, V24, P1358, DOI 10.1592/phco.24.14.1358.43149; Isom GE, 1995, TOXICOL LETT, V82-3, P795, DOI 10.1016/0378-4274(95)03521-4; Johnson F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007100; Kimberly WT, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92989; Kondrashov FA, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-31; MacRae CA, 2016, ANN NY ACAD SCI, V1378, P58, DOI 10.1111/nyas.13224; Marrs TC, 2016, CLIN TOXICOL, V54, P609, DOI 10.1080/15563650.2016.1186804; Mendelsohn BA, 2008, DEV DYNAM, V237, P1780, DOI 10.1002/dvdy.21581; MUSHETT CW, 1952, P SOC EXP BIOL MED, V81, P234, DOI 10.3181/00379727-81-19831; Musso G, 2015, GENOM DATA, V6, P199, DOI 10.1016/j.gdata.2015.09.015; Nath AK, 2017, CELL CHEM BIOL, V24, P565, DOI 10.1016/j.chembiol.2017.03.013; Nath AK, 2013, FASEB J, V27, P1928, DOI 10.1096/fj.12-225037; NICHOLLS P, 1972, BIOCHIM BIOPHYS ACTA, V275, P279, DOI 10.1016/0005-2728(72)90208-3; NORRIS JC, 1990, TOXICOLOGY, V62, P275, DOI 10.1016/0300-483X(90)90051-H; Pathak RK, 2014, ACS CHEM BIOL, V9, P1178, DOI 10.1021/cb400944y; Petrikovics Ilona, 2015, World J Methodol, V5, P88, DOI 10.5662/wjm.v5.i2.88; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Strahle U, 2012, REPROD TOXICOL, V33, P128, DOI 10.1016/j.reprotox.2011.06.121; Strittmatter L, 2014, HUM MOL GENET, V23, P2313, DOI 10.1093/hmg/ddt624; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; WAY JL, 1984, ANNU REV PHARMACOL, V24, P451, DOI 10.1146/annurev.pa.24.040184.002315; WILSON MT, 1994, J BIOL CHEM, V269, P24114; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380	32	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0193889	10.1371/journal.pone.0193839	http://dx.doi.org/10.1371/journal.pone.0193839			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879736	Green Submitted, gold, Green Published			2022-12-26	WOS:000434384900001
J	Coringa, R; de Sousa, EM; Botelho, JN; Diniz, RS; de Sa, JC; da Cruz, MCFN; Paschoal, MAB; Goncalves, LM				Coringa, Ricardo; de Sousa, Eduardo Martins; Botelho, Juliana Nunes; Diniz, Rafael Soares; de Sa, Joicy Cortez; Fontoura Nogueira da Cruz, Maria Carmen; Beninni Paschoal, Marco Aurelio; Goncalves, Leticia Machado			Bone substitute made from a Brazilian oyster shell functions as a fast stimulator for bone-forming cells in an animal model	PLOS ONE			English	Article							SOLUBLE MATRIX-FRACTION; MOLLUSK PINCTADA-MAXIMA; MARROW STROMAL CELLS; TRICALCIUM PHOSPHATE; CLINICAL PROCEDURES; ORGANIC MATRIX; NACRE SURFACE; IN-VITRO; GRAFT; HYDROXYAPATITE	Despite their demonstrated biocompatibility and osteogenic properties, oyster shells have been reported as a potential alternative to other commonly used materials for bone substitution. This study evaluated whether an experimental bone substitute (EBS) made from a typical oyster shell of Northeastern Brazil (Crassostrea rhizophora) has effects on bone development using an animal model. Oysters were collected from a biologically assisted vivarium, and their inner layer was used for preparing an EBS. Chemical and surface characterization of EBS was performed using Individually Coupled Plasma Optical Emission Spectrometry (ICP-OES) and Scanning Electron Microscope (SEM), respectively. Seventytwo rats were randomly assigned to groups according to the treatment of bone defects created in the submandibular area: Negative Control (-C), Positive Control (+C; Bio-Oss (R)) and EBS. Euthanasia occurred at 7, 21, 42 and 56 days postoperatively. The bone pieces were stained with hematoxylin and eosin (H&E). The formation of bone tissue was evaluated histologically and histomorphometrically. Data were analyzed through the Kruskal-Wallis test and ANOVA considering a significant level of 5%. The main element found in EBS was calcium (71.68%), and it presented heterogeneity in the particle size and a porosity aspect at SEM analysis. Histological results revealed the absence of inflammatory cells in all groups, being that EBS presented the most accelerated process of bone formation with a statistically significant difference between this group and the +C and -C groups in the 21-day time-point (p < 0.05). After 21 days, the bone formation process was similar between all groups (p > 0.05), showing an immature lamellar bone pattern after 56 days of experimentation (p > 0.05). Within the limitations of this study, it was possible to conclude that EBS presented good biocompatibility and promoted fast stimulation for bone-forming cells in an animal model.	[Coringa, Ricardo; Diniz, Rafael Soares; Beninni Paschoal, Marco Aurelio; Goncalves, Leticia Machado] CEUMA Univ, Dept Dent, Sao Luis, Maranhao, Brazil; [de Sousa, Eduardo Martins; de Sa, Joicy Cortez] CEUMA Univ, Dept Immunol & Microbiol Resp Tract Infect, Postgrad Program Parasite Biol, Sao Luis, Maranhao, Brazil; [Botelho, Juliana Nunes] Univ Talca, Dept Oral Rehabil, Talca, Chile; [Fontoura Nogueira da Cruz, Maria Carmen] Univ Fed Maranhao, Dept Dent, Sao Luis, Maranhao, Brazil	Universidade Ceuma; Universidade Ceuma; Universidad de Talca; Universidade Federal do Maranhao	Goncalves, LM (corresponding author), CEUMA Univ, Dept Dent, Sao Luis, Maranhao, Brazil.	lets.mg@gmail.com	Paschoal, Marco Aurélio Benini/AAC-8345-2020; de Sousa, Eduardo Martins/AAT-9294-2020; de Sá Sousa, Joicy Cortez/AAH-1694-2019; Botelho, Juliana N/B-1995-2016; Paschoal, Marco Aurélio/D-4469-2015	Paschoal, Marco Aurélio Benini/0000-0002-3396-4688; de Sousa, Eduardo Martins/0000-0002-2506-169X; Paschoal, Marco Aurélio/0000-0002-3396-4688; Botelho, Juliana/0000-0002-1917-3812				Almeida MJ, 2000, J EXP ZOOL, V288, P327, DOI 10.1002/1097-010X(20001215)288:4<327::AID-JEZ5>3.0.CO;2-#; Asvanund P, 2012, IMPLANT DENT, V21, P248, DOI 10.1097/ID.0b013e3182563ae0; Bahar H, 2003, J PERIODONTOL, V74, P366, DOI 10.1902/jop.2003.74.3.366; Balmain J, 1999, J BIOMED MATER RES, V48, P749, DOI 10.1002/(SICI)1097-4636(1999)48:5<749::AID-JBM22>3.0.CO;2-P; Boyan BD, 2006, J PERIODONTOL, V77, P1555, DOI 10.1902/jop.2006.060019; Buser D, 1996, J ORAL MAXILLOFAC SU, V54, P432; Chiapasco M, 2006, CLIN ORAL IMPLAN RES, V17, P136, DOI 10.1111/j.1600-0501.2006.01357.x; Flausse A, 2013, J BIOMED MATER RES A, V101, P3211, DOI 10.1002/jbm.a.34629; Gerhard EM, 2017, ACTA BIOMATER, V54, P21, DOI 10.1016/j.actbio.2017.03.003; Goldberg VM, 2000, CLIN ORTHOP RELAT R, P68; Hamza S, 2013, MAT SCI ENG C-MATER, V33, P537, DOI 10.1016/j.msec.2012.09.028; Harris CT, 2004, J BIOMED MATER RES A, V68A, P747, DOI 10.1002/jbm.a.20107; Joshi A, 2004, BRIT DENT J, V196, P215, DOI 10.1038/sj.bdj.4810987; Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0; Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6; Lang NP, 2004, INT J ORAL MAX IMPL, V19, P150; Li H, 2000, Clin Implant Dent Relat Res, V2, P110, DOI 10.1111/j.1708-8208.2000.tb00113.x; Liao HH, 2002, BIOMATERIALS, V23, P2693, DOI 10.1016/S0142-9612(01)00421-5; Lohmann H, 2007, ARCH ORTHOP TRAUM SU, V127, P345, DOI 10.1007/s00402-006-0277-4; Lye KW, 2008, J ORAL MAXIL SURG, V66, P1580, DOI 10.1016/j.joms.2007.12.003; Milet C, 2004, CR PALEVOL, V3, P493, DOI 10.1016/j.crpv.2004.07.010; Misch CE, 2008, IMPLANT DENT, V17, P5, DOI 10.1097/ID.0b013e3181676059; Miyashita T, 2008, BIOSCI BIOTECH BIOCH, V72, P37, DOI 10.1271/bbb.70302; Mouries LP, 2002, COMP BIOCHEM PHYS B, V132, P217; Ni M, 2003, BIOMATERIALS, V24, P4323, DOI 10.1016/S0142-9612(03)00236-9; Penarrocha-Diago Miguel, 2017, J Clin Exp Dent, V9, pe712, DOI 10.4317/jced.53759; Perry CR, 1999, CLIN ORTHOP RELAT R, P71; Pretel H, 2007, LASER SURG MED, V39, P788, DOI 10.1002/lsm.20585; Raghoebar GM, 2001, CLIN ORAL IMPLAN RES, V12, P503, DOI 10.1034/j.1600-0501.2001.120511.x; Rousseau M, 2003, COMP BIOCHEM PHYS B, V135, P1, DOI 10.1016/S1096-4959(03)00032-0; Sakkas A, 2017, INT J IMPLANT DENT, V3, DOI 10.1186/s40729-017-0084-4; Schwartz-Arad Devorah, 2005, Implant Dent, V14, P131, DOI 10.1097/01.id.0000165031.33190.0d; Sciadini MF, 1997, J ORTHOP RES, V15, P844, DOI 10.1002/jor.1100150609; Shen YT, 2006, BIOMATERIALS, V27, P281, DOI 10.1016/j.biomaterials.2005.05.088; Tay BKB, 1999, ORTHOP CLIN N AM, V30, P615, DOI 10.1016/S0030-5898(05)70114-0; Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798; Zhang GG, 2017, J BIOMED MATER RES A, V105, P662, DOI 10.1002/jbm.a.35939	37	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0198697	10.1371/journal.pone.0198697	http://dx.doi.org/10.1371/journal.pone.0198697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870546	Green Published, Green Submitted, gold			2022-12-26	WOS:000434128400035
J	Kim, H; Lee, CH; Kim, SH; Kim, YD				Kim, Hyungtae; Lee, Cheol-Hyeong; Kim, Sung-Hun; Kim, Yeon-Dong			Epidemiology of complex regional pain syndrome in Korea: An electronic population health data study	PLOS ONE			English	Article							REFLEX SYMPATHETIC DYSTROPHY; SYNDROME-TYPE-I	Chronic regional pain syndrome (CRPS) is an inflammatory and neuropathic pain disorder characterized by the involvement of the autonomic nervous system with sensory, autonomic, motor, skin, and bone changes. At present, universally accepted consensus criteria for CRPS are not yet established, despite the diagnostic criteria proposed by the International Association for the Study of Pain (IASP). Various hypotheses for the pathophysiology of CRPS have been proposed; as a result, current therapeutic modalities are varied. General epidemiological data on CRPS are necessary for effective management. However, recent data on the epidemiology of CRPS in Korea are scarce. The aim of this study was to evaluate the incidence and other epidemiological features of CRPS in the general population in Korea. In this study on the epidemiology of CRPS in Korea, population-based medical data acquired from 51,448,491 subscribers to the National Health Insurance Service (NHIS) from 2011 to 2015 were analyzed, including the incidence, distribution by the CRPS type, regional distribution, monthly distribution, medical costs, and healthcare resource-utilization. The findings indicated that the incidence of CRPS in Korea was 29.0 per 100,000 person-years in 2015 and was correlated with patient age and sex. CRPS types included type I (63%) and type II (37%); moreover, the number of individuals with CRPS I have shown a growing trend since 2011. There was no monthly distribution, but there was regional variation according to the province. The medical departments managing CRPS I the most were orthopedics, internal medicine, anesthesiology and pain medicine, in order; however, patients with CRPS spent more money per visit in the departments of rehabilitation medicine, and anesthesiology and pain medicine. The incidence rate of CRPS in Korea was 29.0 per 100,000 person-years with an increasing trend, which was correlated with patient age in the 70s and female sex. CRPS type I was more common than CRPS type II; in addition, constant increase in medical expenses, regional imbalance, and differences in medical expense among medical specialties should be considered for early management of patients to reduce the disease burden in Korea. Sharing of knowledge about the diagnostic criteria of CRPS are also needed.	[Kim, Hyungtae] Presbyterian Med Ctr, Dept Anesthesiol & Pain Med, Jeonju, South Korea; [Lee, Cheol-Hyeong; Kim, Sung-Hun; Kim, Yeon-Dong] Wonkwang Univ, Dept Anesthesiol & Pain Med, Coll Med, Iksan, South Korea; [Kim, Yeon-Dong] Wonkwang Univ, Wonkwang Inst Sci, Coll Med, Iksan, South Korea	Wonkwang University; Wonkwang University	Kim, YD (corresponding author), Wonkwang Univ, Dept Anesthesiol & Pain Med, Coll Med, Iksan, South Korea.; Kim, YD (corresponding author), Wonkwang Univ, Wonkwang Inst Sci, Coll Med, Iksan, South Korea.	kydpain@hanmail.net	김, 연동/HII-9114-2022	김, 연동/0000-0003-0404-2657; Kim, Hyungtae/0000-0003-2488-9986	Wonkwang University	Wonkwang University	This work was supported by Wonkwang University 2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 1999, PAIN, V80, P539, DOI 10.1016/S0304-3959(98)00246-2; Birklein F, 2005, J NEUROL, V252, P131, DOI 10.1007/s00415-005-0737-8; Bruehl S, 2002, PAIN, V95, P119, DOI 10.1016/S0304-3959(01)00387-6; Choi YS, 2008, J KOREAN MED SCI, V23, P772, DOI 10.3346/jkms.2008.23.5.772; Cocchiarella L, 2001, GUIDES EVALUATION PE, P336; Coderre TJ, 2004, PAIN, V112, P94, DOI 10.1016/j.pain.2004.08.001; Harden RN, 2007, PAIN MED, V8, P326, DOI 10.1111/j.1526-4637.2006.00169.x; Jeon GS., 2010, J KOREAN ACAD PUBLIC, V24, P182; Kim YC, 2004, KOREAN J PAIN, V17, pS104; Kim YC, 2007, KOREAN J PAIN, V20, P1; Mos D, 2007, PAIN, V129, P12, DOI [10.1016/j.pain.2006.09.008, DOI 10.1016/J.PAIN.2006.09.008]; Sandroni P, 2003, PAIN, V103, P199, DOI 10.1016/S0304-3959(03)00065-4; SCHWARTZMAN RJ, 1990, NEUROLOGY, V40, P57, DOI 10.1212/WNL.40.1.57; Shin Sun Mi, 2009, J Prev Med Public Health, V42, P403, DOI 10.3961/jpmph.2009.42.6.403; Stanton-Hicks M, 1998, CLIN J PAIN, V14, P155, DOI 10.1097/00002508-199806000-00012; Stanton-Hicks Michael D, 2002, Pain Pract, V2, P1, DOI 10.1046/j.1533-2500.2002.02009.x; STANTONHICKS M, 1995, PAIN, V63, P127, DOI 10.1016/0304-3959(95)00110-E; Tran DQH, 2010, CAN J ANAESTH, V57, P149, DOI 10.1007/s12630-009-9237-0; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; Zollinger PE, 1999, LANCET, V354, P2025, DOI 10.1016/S0140-6736(99)03059-7	20	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198147	10.1371/journal.pone.0198147	http://dx.doi.org/10.1371/journal.pone.0198147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864152	Green Published, Green Submitted, gold			2022-12-26	WOS:000434097100023
J	Petrov, E; Menon, G; Rohde, PR; Battle, AR; Martinac, B; Solioz, M				Petrov, Evgeny; Menon, Gopalakrishnan; Rohde, Paul R.; Battle, Andrew R.; Martinac, Boris; Solioz, Marc			Xenon-inhibition of the MscL mechano-sensitive channel and the CopB copper ATPase under different conditions suggests direct effects on these proteins	PLOS ONE			English	Article							MECHANOSENSITIVE ION-CHANNEL; HIGH HYDROSTATIC-PRESSURE; ENTEROCOCCUS-HIRAE; ESCHERICHIA-COLI; PATCH-CLAMP; NITROUS-OXIDE; GLYCINE SITE; ANESTHESIA; NEUROPROTECTION; BINDING	Xenon is frequently used as a general anesthetic in humans, but the mechanism remains an issue of debate. While for some membrane proteins, a direct interaction of xenon with the protein has been shown to be the inhibitory mechanism, other membrane protein functions could be affected by changes of membrane properties due to partitioning of the gas into the lipid bilayer. Here, the effect of xenon on a mechanosensitive ion channel and a copper ion-translocating ATPase was compared under different conditions. Xenon inhibited spontaneous gating of the Escherichia coli mechano-sensitive mutant channel MscL-G22E, as shown by patch-clamp recording techniques. Under high hydrostatic pressure, MscL-inhibition was reversed. Similarly, the activity of the Enterococcus hirae CopB copper ATPase, reconstituted into proteoliposomes, was inhibited by xenon. However, the CopB ATPase activity was also inhibited by xenon when CopB was in a solubilized state. These findings suggest that xenon acts by directly interacting with these proteins, rather than via indirect effects by altering membrane properties. Also, inhibition of copper transport may be a novel effect of xenon that contributes to anesthesia.	[Petrov, Evgeny; Menon, Gopalakrishnan; Solioz, Marc] Tomsk State Univ, Lab Biochem & Mol Biol, Tomsk, Russia; [Rohde, Paul R.; Battle, Andrew R.; Martinac, Boris] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Battle, Andrew R.] QUT, Sch Biomed Sci, Brisbane, Qld, Australia; [Martinac, Boris] Univ New South Wales, St Vincents Clin Sch, Darlinghurst, NSW, Australia; [Solioz, Marc] Univ Bern, Dept Clin Res, Bern, Switzerland	Tomsk State University; Victor Chang Cardiac Research Institute; Queensland University of Technology (QUT); University of New South Wales Sydney; University of Bern	Solioz, M (corresponding author), Tomsk State Univ, Lab Biochem & Mol Biol, Tomsk, Russia.; Solioz, M (corresponding author), Univ Bern, Dept Clin Res, Bern, Switzerland.	marc@solioz-scientific.ch	Martinac, Boris/A-7178-2018; Solioz, Marc/I-3162-2013; Petrov, Evgeniy/C-9821-2017; Menon, Gopalakrishnan/D-3749-2014	Martinac, Boris/0000-0001-8422-7082; Solioz, Marc/0000-0002-7989-6721; Menon, Gopalakrishnan/0000-0002-8869-9885; Petrov, Evgeny/0000-0002-4055-6981; Battle, Andrew/0000-0002-7447-3519	Russian Federation Ministry of Education and Science [14.Z50.31.0011]; Australian National Health and Medical Research Council; Carlsbergfondet, Denmark [CF14-0613]	Russian Federation Ministry of Education and Science(Ministry of Education and Science, Russian Federation); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Carlsbergfondet, Denmark	All the funding or sources of support received during this specific study have been declared. They were the following: Russian Federation Ministry of Education and Science grant no. 14.Z50.31.0011 to MS; Australian National Health and Medical Research Council grant no. 00 to BM; and Carlsbergfondet, Denmark grant no. CF14-0613 to BM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apponyi Margit A., 2008, V426, P257, DOI 10.1007/978-1-60327-058-8_16; Banks P, 2010, ANESTHESIOLOGY, V112, P614, DOI 10.1097/ALN.0b013e3181cea398; Bantel C, 2010, ANESTHESIOLOGY, V112, P623, DOI 10.1097/ALN.0b013e3181cf894a; Bissig KD, 2001, BIOCHEM J, V357, P217, DOI 10.1042/0264-6021:3570217; Bissig KD, 2001, FEBS LETT, V507, P367, DOI 10.1016/S0014-5793(01)03009-5; Booker RD, 2013, BBA-BIOMEMBRANES, V1828, P1347, DOI 10.1016/j.bbamem.2013.01.016; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cantor RS, 1997, BIOCHEMISTRY-US, V36, P2339, DOI 10.1021/bi9627323; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cranfield CG, 2012, MECH GATED CHANNELS, P1, DOI [10.1007/978-94-007-5073-9_1, DOI 10.1007/978-94-007-5073-9_1]; CULLEN SC, 1951, SCIENCE, V113, P580, DOI 10.1126/science.113.2942.580; DELCOUR AH, 1989, BIOPHYS J, V56, P631, DOI 10.1016/S0006-3495(89)82710-9; Dickinson R, 2010, CRIT CARE, V14, DOI 10.1186/cc9051; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Graesboll K, 2014, BIOPHYS J, V106, P2143, DOI 10.1016/j.bpj.2014.04.014; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hapfelmeier G, 2000, ANESTH ANALG, V91, P1542, DOI 10.1097/00000539-200012000-00045; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; HASE CC, 1995, J BIOL CHEM, V270, P18329, DOI 10.1074/jbc.270.31.18329; La Fontaine S, 2015, AM J PHYSIOL-CELL PH, V309, pC719, DOI 10.1152/ajpcell.00258.2015; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lawrence J. H., 1946, JOUR PHYSIOL, V105, P197; Li Q, 2013, HEART LUNG CIRC, V22, P276, DOI 10.1016/j.hlc.2012.10.016; Luna VM, 2008, BIOCHEMISTRY-US, V47, P4657, DOI 10.1021/bi800045y; Macdonald AG, 1999, FEMS MICROBIOL LETT, V173, P327, DOI 10.1111/j.1574-6968.1999.tb13521.x; MARKIN VS, 1991, BIOPHYS J, V60, P1120, DOI 10.1016/S0006-3495(91)82147-6; Meyer HZur, 1899, ARCH EXP PATHOL PHAR, V42, P109, DOI [10.1007/BF01834479, DOI 10.1007/BF01834479]; Mukherjee N, 2014, FASEB J, V28, P4292, DOI 10.1096/fj.14-251579; Nomura T, 2012, P NATL ACAD SCI USA, V109, P8770, DOI 10.1073/pnas.1200051109; ODERMATT A, 1995, J BIOL CHEM, V270, P4349, DOI 10.1074/jbc.270.9.4349; Overton E., 1901, STUDIEN NARKOSE ZUGL; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Petrov E, 2007, EUR BIOPHYS J BIOPHY, V36, P95, DOI 10.1007/s00249-006-0109-z; Petrov E, 2011, BIOPHYS J, V100, P1635, DOI 10.1016/j.bpj.2011.02.016; Powl AM, 2008, BIOCHEMISTRY-US, V47, P4317, DOI 10.1021/bi702409t; Prange T, 1998, PROTEINS, V30, P61, DOI 10.1002/(SICI)1097-0134(19980101)30:1<61::AID-PROT6>3.0.CO;2-N; Salmi E, 2008, ANESTH ANALG, V106, P129, DOI 10.1213/01.ane.0000287658.14763.13; Sauguet L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149795; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; Solioz M, 2003, FEMS MICROBIOL REV, V27, P183, DOI 10.1016/S0168-6445(03)00053-6; Stimson LM, 2005, CELL MOL BIOL LETT, V10, P563; Telianidis J, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00044; Weinrich M, 2013, J PHYS CHEM B, V117, P16141, DOI 10.1021/jp411261g; WylerDuda P, 1996, FEBS LETT, V399, P143, DOI 10.1016/S0014-5793(96)01306-3; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2	49	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198110	10.1371/journal.pone.0198110	http://dx.doi.org/10.1371/journal.pone.0198110			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864148	gold, Green Published			2022-12-26	WOS:000434097100021
J	Li, BZ; Xu, HX; Han, HY; Song, S; Zhang, XJ; Ouyang, L; Qian, CA; Hong, YT; Qiu, YC; Zhou, WQ; Huang, ML; Zhuang, WZ				Li, Bingzong; Xu, Hongxia; Han, Huiying; Song, Sha; Zhang, Xiaojuan; Ouyang, Lu; Qian, Chen'ao; Hong, Yating; Qiu, Yingchun; Zhou, Wenqi; Huang, Moli; Zhuang, Wenzhuo			Exosome-mediated transfer of IncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis	ONCOGENE			English	Article							LONG NONCODING RNA; MESENCHYMAL STEM-CELLS; NATURAL ANTISENSE; SECRETED EXOSOMES; CANCER METASTASIS; BONE-DISEASE; TRANSCRIPTION; EXPRESSION; DIFFERENTIATION; INHIBITION	Multiple myeloma (MM) is characterized by the decreased osteogenic potential of mesenchymal stem cells (MSCs). Communication between cancer cells and cancer stromal cells is a driving factor in tumor progression. Understanding the myeloma-stroma interactions is critical to the development of effective strategies that can reverse bone diseases. Here we identified that bioactive lncRNA RUNX2-AS1 in myeloma cells could be packed into exosomes and transmitted to MSCs, thus repressing the osteogenesis of MSCs. RUNX2-AS1, which arises from the antisense strand of RUNX2, was enriched in MSCs derived from MM patients (MM-MSCs). RUNX2-AS1 was capable of forming an RNA duplex with RUNX2 pre-mRNA at overlapping regions and this duplex transcriptionally repressed RUNX2 expression by reducing the splicing efficiency, resulting in decreased osteogenic potential of MSCs. In vivo mouse models, administered an inhibitor of exosome secretion, GW4869, was found to be effective in preventing bone loss, sustained by both bone formation and anticatabolic activities. Therefore, exosomal lncRNA RUNX2-AS1 may serve as a potential therapeutic target for bone lesions in MM. In summary, our results indicated a key role of exosomal lncRUNX2-AS1 in transferring from MM cells to MSCs in osteogenic differentiation, through a unique exosomal lncRUNX2-AS1/RUNX2 pathway.	[Li, Bingzong; Hong, Yating] Soochow Univ, Affiliated Hosp 2, Dept Haematol, Suzhou, Peoples R China; [Xu, Hongxia; Han, Huiying; Song, Sha; Zhang, Xiaojuan; Ouyang, Lu; Qiu, Yingchun; Zhou, Wenqi; Zhuang, Wenzhuo] Soochow Univ, Dept Cell Biol, Sch Biol & Basic Med Sci, Suzhou, Peoples R China; [Qian, Chen'ao; Huang, Moli] Soochow Univ, Dept Bioinformat, Sch Biol & Basic Med Sci, Suzhou, Peoples R China	Soochow University - China	Zhuang, WZ (corresponding author), Soochow Univ, Dept Cell Biol, Sch Biol & Basic Med Sci, Suzhou, Peoples R China.; Huang, ML (corresponding author), Soochow Univ, Dept Bioinformat, Sch Biol & Basic Med Sci, Suzhou, Peoples R China.	huangml@suda.edu.cn; zhuangwenzhuo@suda.edu.cn	li, bz/GVR-7133-2022; li, bing/GWQ-9617-2022	Huang, Moli/0000-0001-5543-9334	National Natural Science Foundation of China [81673448, 81670191]; Natural Science Foundation of Jiangsu Province China [BK 20161218, BK20161223]; Applied Basic Research Programs of Suzhou City [SYS201546]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province China(Natural Science Foundation of Jiangsu Province); Applied Basic Research Programs of Suzhou City; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported in part by National Natural Science Foundation of China (81673448, 81670191), Natural Science Foundation of Jiangsu Province China (BK 20161218, BK20161223), The Applied Basic Research Programs of Suzhou City (SYS201546), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Boelens MC, 2014, CELL, V159, P499, DOI 10.1016/j.cell.2014.09.051; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Challagundla KB, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv135; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Franceschi RT, 2003, CONNECT TISSUE RES, V44, P109, DOI 10.1080/03008200390152188; Gezer U, 2014, CELL BIOL INT, V38, P1076, DOI 10.1002/cbin.10301; Giuliani N, 2006, BLOOD, V108, P3992, DOI 10.1182/blood-2006-05-026112; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; He CS, 2016, MOL CELL, V64, P416, DOI 10.1016/j.molcel.2016.09.034; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hsu YL, 2017, ONCOGENE, V36, P4929, DOI 10.1038/onc.2017.105; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Hudson WH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6395; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Koppers-Lalic D, 2014, CELL REP, V8, P1649, DOI 10.1016/j.celrep.2014.08.027; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Li BZ, 2007, STEM CELLS DEV, V16, P921, DOI 10.1089/scd.2007.0074; Li Q, 2015, TUMOR BIOL, V36, P2007, DOI 10.1007/s13277-014-2807-y; Lister N, 2017, P NATL ACAD SCI USA, V114, P9942, DOI 10.1073/pnas.1621490114; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Lokody I, 2014, NAT REV GENET, V15, P362, DOI 10.1038/nrg3741; Luga V, 2013, CANCER RES, V73, P6843, DOI 10.1158/0008-5472.CAN-13-1791; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Mohankumar S, 2016, BRIEF FUNCT GENOMICS, V15, P249, DOI 10.1093/bfgp/elv058; Qu L, 2016, CANCER CELL, V29, P653, DOI 10.1016/j.ccell.2016.03.004; Raje N, 2011, CLIN CANCER RES, V17, P1278, DOI 10.1158/1078-0432.CCR-10-1804; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Saldana-Meyer R, 2014, GENE DEV, V28, P723, DOI 10.1101/gad.236869.113; Scarola M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8631; Shah S, 2014, GENE DEV, V28, P231, DOI 10.1101/gad.230177.113; Shao HL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7999; Shurtleff MJ, 2016, ELIFE, V5, DOI 10.7554/eLife.19276; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2014, MOL CANCER RES, V12, P1377, DOI 10.1158/1541-7786.MCR-13-0636; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wahlestedt C, 2006, DRUG DISCOV TODAY, V11, P503, DOI 10.1016/j.drudis.2006.04.013; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wang YY, 2015, CELL STEM CELL, V16, P413, DOI 10.1016/j.stem.2015.03.003; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007; Zhuang WZ, 2015, STEM CELLS, V33, P1985, DOI 10.1002/stem.1989	45	85	90	5	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 11	2018	37	41					5508	5519		10.1038/s41388-018-0359-0	http://dx.doi.org/10.1038/s41388-018-0359-0			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GW5QO	29895968				2022-12-26	WOS:000446991200003
J	Tan, ZY; Song, LB; Wu, WJ; Zhou, YQ; Zhu, JR; Wu, GY; Cao, LX; Song, JW; Li, J; Zhang, W				Tan, Zhanyao; Song, Libing; Wu, Wenjiao; Zhou, Yanqing; Zhu, Jinrong; Wu, Geyan; Cao, Lixue; Song, Junwei; Li, Jun; Zhang, Wei			TRIM14 promotes chemoresistance in gliomas by activating Wnt/beta-catenin signaling via stabilizing Dvl2	ONCOGENE			English	Article							MEDIATES CHEMORESISTANCE; MALIGNANT GLIOMA; BREAST-CANCER; CELL; AUTOPHAGY; OVEREXPRESSION; PROLIFERATION; RADIOTHERAPY; PROTEINS; GENETICS	Gliomas are a lethal class of brain cancer, with a median survival below 15 months in spite of therapeutic advances. The poor prognosis of this disease is largely attributed to acquired chemotherapy resistance, and new strategies are urgently needed to target resistant glioma cells. Herein, our study demonstrated that tripartite motif-containing 14 (TRIM14) overexpressed in glioma specimens (including tissues and cell lines), and that high level of TRIM14 predicted poor outcome of glioma patients. Furthermore, we found that upregulation of TRIM14 in glioma cells conferred chemoresistance to temozolomide in vitro and in vivo; conversely, silencing TRIM14 sensitized glioma cells to temozolomide. These findings demonstrated that TRIM14 stabilized dishevelled (Dvl2) and subsequently activated the canonical Wnt signaling and promoted chemoresistance. Moreover, inhibition of Dvl2 reversed the oncogenic effect of TRIM14 on chemoresistance. Importantly, consistent with the abovementioned results, we found that TRIM14 expression was significantly associated with hyperactivation of canonical Wnt pathway in clinical glioma specimens. Collectively, the study reveals a new molecular mechanism driving chemotherapy resistance in gliomas, and suggests an opportunity to develop novel therapeutic interventions against gliomas.	[Tan, Zhanyao; Zhu, Jinrong; Wu, Geyan; Cao, Lixue; Song, Junwei; Li, Jun] Sun Yat Sen Univ, Key Lab Liver Dis Guangdong Prov, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Tan, Zhanyao; Zhu, Jinrong; Wu, Geyan; Cao, Lixue; Song, Junwei; Li, Jun] Sun Yat Sen Univ, Guangdong Prov Key Lab Brain Funct & Dis, Dept Biochem, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China; [Song, Libing] Sun Yat Sen Univ, State Key Lab Oncol Southern China, Dept Expt Res, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Song, Libing] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Key Lab Prot Modificat & Degradat, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China; [Wu, Wenjiao] Jinan Univ, Dept Neurosurg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Zhou, Yanqing; Zhang, Wei] Guangdong Pharmaceut Univ, Neurosurg Res Inst, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Guangzhou Medical University; Jinan University; Guangdong Pharmaceutical University	Li, J (corresponding author), Sun Yat Sen Univ, Key Lab Liver Dis Guangdong Prov, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China.; Li, J (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Brain Funct & Dis, Dept Biochem, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China.; Zhang, W (corresponding author), Guangdong Pharmaceut Univ, Neurosurg Res Inst, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	lijun37@mail.sysu.edu.cn; 18666003902@163.com	wu, ge/ABE-3285-2020; Song, LB/AAL-1968-2020		Natural Science Foundation of China [91740119, 91529301, 91740118, 81530082, 81621004]; Guangzhou Science and Technology Plan Projects [201803010098, 201510010292]; Natural Science Foundation of Guangdong Province [2017A030313799]; Fundamental Research Funds for the Central Universities [17ykjc02]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science and Technology Plan Projects; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by Natural Science Foundation of China (Nos. 91740119, 91529301, 91740118, 81530082 and 81621004); Guangzhou Science and Technology Plan Projects (201803010098, 201510010292); Natural Science Foundation of Guangdong Province (2017A030313799); The Fundamental Research Funds for the Central Universities [No. 17ykjc02].	Ahn SM, 2014, HEPATOLOGY, V60, P1972, DOI 10.1002/hep.27198; [Anonymous], 2016, Cancer Discov, V6, pOF2, DOI 10.1158/2159-8290.CD-NB2016-053; Belanich M, 1996, CANCER RES, V56, P783; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Chen MX, 2016, MOL CELL, V64, P105, DOI 10.1016/j.molcel.2016.08.025; Chen XT, 2013, J CLIN INVEST, V123, P2576, DOI 10.1172/JCI68143; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Edamoto Y, 2003, INT J CANCER, V106, P334, DOI 10.1002/ijc.11254; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Flahaut M, 2009, ONCOGENE, V28, P2245, DOI 10.1038/onc.2009.80; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Goodenberger ML, 2012, CANCER GENET-NY, V205, P613, DOI 10.1016/j.cancergen.2012.10.009; Hai J, 2017, SCI REP-UK, V7, DOI 10.1038/srep39692; Han P, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0583-1; Harris TM, 2015, ARCH PATHOL LAB MED, V139, P494, DOI 10.5858/arpa.2014-0131-OA; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Kramer N, 2017, ONCOGENE, V36, P5460, DOI 10.1038/onc.2017.144; Laperriere N, 2002, RADIOTHER ONCOL, V64, P259, DOI 10.1016/S0167-8140(02)00078-6; Lau T, 2013, CANCER RES, V73, P3132, DOI 10.1158/0008-5472.CAN-12-4562; Lei ZJ, 2015, ONCOGENE, V34, P3188, DOI 10.1038/onc.2015.129; Lin C, 2015, ONCOGENE, V34, P332, DOI 10.1038/onc.2013.559; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; Metcalfe C, 2010, CANCER RES, V70, P6629, DOI 10.1158/0008-5472.CAN-10-1616; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nenasheva VV, 2014, IN VITRO CELL DEV-AN, V50, P121, DOI 10.1007/s11626-013-9683-4; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Song XM, 2015, ONCOL LETT, V10, P2283, DOI 10.3892/ol.2015.3623; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Su X, 2016, ONCOTARGET, V7, P9939, DOI 10.18632/oncotarget.6941; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tao JY, 2016, HEPATOLOGY, V64, P1587, DOI 10.1002/hep.28601; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Wang NX, 2008, DRUG NEWS PERSPECT, V21, P137, DOI 10.1358/dnp.2008.21.3.1203409; Wang Y, 2017, ONCOTARGET, V8, P37511, DOI 10.18632/oncotarget.16400; Wickstrom M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9904; Xing JJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00101-w; Xu GX, 2017, SCI REP-UK, V7, DOI 10.1038/srep42411; Zeng ZL, 2012, CLIN CANCER RES, V18, P4059, DOI 10.1158/1078-0432.CCR-11-3156; Zhang ZM, 2016, ONCOGENE, V35, P4787, DOI 10.1038/onc.2016.10; Zhou Z, 2014, P NATL ACAD SCI USA, V111, pE245, DOI 10.1073/pnas.1316941111	45	41	44	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 4	2018	37	40					5403	5415		10.1038/s41388-018-0344-7	http://dx.doi.org/10.1038/s41388-018-0344-7			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GV7MY	29867201				2022-12-26	WOS:000446312900003
J	Rege, NK; Wickramasinghe, NP; Tustan, AN; Phillips, NFB; Yee, VC; Ismail-Beigi, F; Weiss, MA				Rege, Nischay K.; Wickramasinghe, Nalinda P.; Tustan, Alisar N.; Phillips, Nelson F. B.; Yee, Vivien C.; Ismail-Beigi, Faramarz; Weiss, Michael A.			Structure-based stabilization of insulin as a therapeutic protein assembly via enhanced aromatic-aromatic interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular pharmacology; protein design; insulin; protein self-assembly; molecular dynamics	FREE-ENERGY SIMULATIONS; MOLECULAR RECOGNITION; MONOMERIC INSULINS; RECEPTOR-BINDING; SIDE-CHAIN; DYNAMICS; HEXAMER; PROTRACTION; RESIDUES; ANALOGS	Key contributions to protein structure and stability are provided by weakly polar interactions, which arise from asymmetric electronic distributions within amino acids and peptide bonds. Of particular interest are aromatic side chains whose directional -systems commonly stabilize protein interiors and interfaces. Here, we consider aromatic-aromatic interactions within a model protein assembly: the dimer interface of insulin. Semi-classical simulations of aromatic-aromatic interactions at this interface suggested that substitution of residue Tyr(B26) by Trp would preserve native structure while enhancing dimerization (and hence hexamer stability). The crystal structure of a [Trp(B26)]insulin analog (determined as a T3R3f zinc hexamer at a resolution of 2.25 ) was observed to be essentially identical to that of WT insulin. Remarkably and yet in general accordance with theoretical expectations, spectroscopic studies demonstrated a 150-fold increase in the in vitro lifetime of the variant hexamer, a critical pharmacokinetic parameter influencing design of long-acting formulations. Functional studies in diabetic rats indeed revealed prolonged action following subcutaneous injection. The potency of the Trp(B26)-modified analog was equal to or greater than an unmodified control. Thus, exploiting a general quantum-chemical feature of protein structure and stability, our results exemplify a mechanism-based approach to the optimization of a therapeutic protein assembly.	[Rege, Nischay K.; Wickramasinghe, Nalinda P.; Phillips, Nelson F. B.; Yee, Vivien C.; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Tustan, Alisar N.; Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Weiss, Michael A.] Indiana Univ Sch Med, Dept Biochem, Indianapolis, IN 46202 USA	Case Western Reserve University; Case Western Reserve University; Indiana University System; Indiana University Bloomington	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.; Weiss, MA (corresponding author), Indiana Univ Sch Med, Dept Biochem, Indianapolis, IN 46202 USA.	weissma@iu.edu	Wickramasinghe, Nalinda P/F-9465-2010	Wickramasinghe, Nalinda P./0000-0002-8700-2775	United States Department of Energy (DOE), Office of Science and Office of Basic Energy Sciences [DE-AC02-76SF00515]; National Institutes of Health NIGMS [P41GM103393]; DOE Office of Biological and Environmental Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949, F30DK112644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, T32GM007250] Funding Source: NIH RePORTER	United States Department of Energy (DOE), Office of Science and Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. El-Hage, M. Lawrence, M. Meuwly, and V. Pandyarajan for helpful discussion; K. Carr, R. Grabowski, P. Macklis, and M. Swain for assistance with rat studies; V. Kumar and F. van den Akker for advice regarding X-ray crystallography; J. Whittaker and L. Whittaker for advice regarding IR-binding assays; P. De Meyts (Novo Nordisk) for the gift of radiolabeled insulin; and M. C. Lawrence for assistance preparing Fig. 9. Use of the Stanford Synchrotron Radiation Lightsource at the SLAC National Accelerator Laboratory is supported by United States Department of Energy (DOE), Office of Science and Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and National Institutes of Health NIGMS Grant P41GM103393.	ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aleksandrov A, 2010, J MOL RECOGNIT, V23, P117, DOI 10.1002/jmr.980; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Baron R, 2013, ANNU REV PHYS CHEM, V64, P151, DOI 10.1146/annurev-physchem-040412-110047; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; BENTLEY GA, 1992, J MOL BIOL, V228, P1163, DOI 10.1016/0022-2836(92)90323-C; BERGER M, 1979, DIABETOLOGIA, V17, P97, DOI 10.1007/BF01222209; Bhattacharyya R, 2002, PROTEIN ENG, V15, P91, DOI 10.1093/protein/15.2.91; Birnbaum DT, 1996, BIOCHEMISTRY-US, V35, P5366, DOI 10.1021/bi9600557; Birnbaum DT, 1997, PHARMACEUT RES, V14, P25, DOI 10.1023/A:1012095115151; Blundell T., 1972, ADV PROTEIN CHEM, V26, P279; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; BLUNDELL TL, 1972, DIABETES, V21, P492, DOI 10.2337/diab.21.2.S492; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Brange J, 1999, ADV DRUG DELIVER REV, V35, P307, DOI 10.1016/S0169-409X(98)00079-9; BRANGE J, 1990, DIABETES CARE, V13, P923, DOI 10.2337/diacare.13.9.923; Brange J, 1997, Pharm Biotechnol, V10, P343; Brange J., 1984, U. S. Patent and Trademark Office patent full-text database, Patent No. [A61K, 61]; BREMS DN, 1992, PROTEIN ENG, V5, P527, DOI 10.1093/protein/5.6.527; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; BURLEY SK, 1986, J AM CHEM SOC, V108, P7995, DOI 10.1021/ja00285a019; Chang XQ, 1997, BIOCHEMISTRY-US, V36, P9409, DOI 10.1021/bi9631069; Chodera JD, 2013, ANNU REV BIOPHYS, V42, P121, DOI 10.1146/annurev-biophys-083012-130318; CHOTHIA C, 1983, NATURE, V302, P500, DOI 10.1038/302500a0; Christensen M, 2010, CURR DIABETES REP, V10, P124, DOI 10.1007/s11892-010-0102-x; CISZAK E, 1994, BIOCHEMISTRY-US, V33, P1512, DOI 10.1021/bi00172a030; Conlon JM, 2001, PEPTIDES, V22, P1183, DOI 10.1016/S0196-9781(01)00423-5; Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9; DeFelippis MR, 2001, CRIT REV THER DRUG, V18, P201; Derewenda U., 1987, PROTEIN ENG, V222, P425; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; DODSON GG, 1993, BIOCHEM SOC T, V21, P609, DOI 10.1042/bst0210609; Dong J, 2003, J MOL BIOL, V330, P431, DOI 10.1016/S0022-2836(03)00536-9; Dougherty DA, 2000, CURR OPIN CHEM BIOL, V4, P645, DOI 10.1016/S1367-5931(00)00148-4; El Hage K, 2016, J BIOL CHEM, V291, P27023, DOI 10.1074/jbc.M116.761015; El Hage K, 2016, J CHEM THEORY COMPUT, V12, P3008, DOI 10.1021/acs.jctc.6b00202; Forbes Briony E, 2012, Front Endocrinol (Lausanne), V3, P38, DOI 10.3389/fendo.2012.00038; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Freire E, 2009, CHEM BIOL DRUG DES, V74, P468, DOI 10.1111/j.1747-0285.2009.00880.x; Frisch G. W., 2013, GAUSSIAN 09; Gillies PS, 2000, DRUGS, V59, P253, DOI 10.2165/00003495-200059020-00009; Glidden MD, 2018, J BIOL CHEM, V293, P69, DOI 10.1074/jbc.M117.808667; Guvench O, 2005, J AM CHEM SOC, V127, P4668, DOI 10.1021/ja043492e; Hassiepen U, 1999, BIOPHYS J, V77, P1638, DOI 10.1016/S0006-3495(99)77012-8; HEIDENREICH KA, 1985, BIOCHEM BIOPH RES CO, V126, P1138, DOI 10.1016/0006-291X(85)90304-3; Holleman F, 1997, NEW ENGL J MED, V337, P176, DOI 10.1056/NEJM199707173370307; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; HU SQ, 1993, J PROTEIN CHEM, V12, P741, DOI 10.1007/BF01024932; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua Qing-Xin, 2011, Front Endocrinol (Lausanne), V2, P48, DOI 10.3389/fendo.2011.00048; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; INOUYE K, 1979, J AM CHEM SOC, V101, P751, DOI 10.1021/ja00497a051; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; Jekl V, 2011, J SMALL ANIM PRACT, V52, P107, DOI 10.1111/j.1748-5827.2010.01028.x; Jonassen I, 2012, PHARM RES-DORDR, V29, P2104, DOI 10.1007/s11095-012-0739-z; Joosten RP, 2009, ACTA CRYSTALLOGR D, V65, P176, DOI 10.1107/S0907444908037591; Kamerlin SCL, 2009, J PHYS CHEM B, V113, P1253, DOI 10.1021/jp8071712; Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753; Keller D, 2001, BIOCHEMISTRY-US, V40, P10732, DOI 10.1021/bi0108150; Kramer C, 2012, J COMPUT CHEM, V33, P1673, DOI 10.1002/jcc.22996; Kurtzhals P, 1995, BIOCHEM J, V312, P725, DOI 10.1042/bj3120725; Lee LC, 2009, BBA-PROTEINS PROTEOM, V1794, P1467, DOI 10.1016/j.bbapap.2009.06.008; Lieblich SA, 2017, J AM CHEM SOC, V139, P8384, DOI 10.1021/jacs.7b00794; Liu M, 2009, J BIOL CHEM, V284, P35259, DOI 10.1074/jbc.M109.046888; MacKerell A.D., 2002, ENCYCL COMPUT CHEM, V1, P271; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARKUSSEN J, 1987, PROTEIN ENG, V1, P205, DOI 10.1093/protein/1.3.205; MARKUSSEN J, 1987, PROTEIN ENG, V1, P215, DOI 10.1093/protein/1.3.215; Markussen J., 2003, U. S. patent, Patent No. [US 10620651, 10620651]; Marshall GR, 2013, J COMPUT AID MOL DES, V27, P107, DOI 10.1007/s10822-013-9634-x; Mayer JP, 2007, BIOPOLYMERS, V88, P687, DOI 10.1002/bip.20734; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; NAKAGAWA SH, 1986, J BIOL CHEM, V261, P7332; O'Halloran TV, 2013, J CLIN INVEST, V123, P4136, DOI 10.1172/JCI72325; Pandyarajan V, 2016, J BIOL CHEM, V291, P12978, DOI 10.1074/jbc.M115.708347; Pandyarajan V, 2014, J BIOL CHEM, V289, P34709, DOI 10.1074/jbc.M114.608562; Pandyarajan V, 2014, J BIOL CHEM, V289, P23367, DOI 10.1074/jbc.M114.588277; RahuelClermont S, 1997, BIOCHEMISTRY-US, V36, P5837, DOI 10.1021/bi963038q; Reha D, 2002, J AM CHEM SOC, V124, P3366, DOI 10.1021/ja011490d; RIEMEN MW, 1983, BIOCHEMISTRY-US, V22, P1507, DOI 10.1021/bi00275a027; ROY M, 1989, J BIOL CHEM, V264, P19081; Salsali Afshin, 2006, Am J Ther, V13, P349, DOI 10.1097/00045391-200607000-00012; Samanta U, 1999, ACTA CRYSTALLOGR D, V55, P1421, DOI 10.1107/S090744499900726X; Scholfield MR, 2013, PROTEIN SCI, V22, P139, DOI 10.1002/pro.2201; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; Sikosek T, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0419; Sinnokrot MO, 2006, J PHYS CHEM A, V110, P10656, DOI 10.1021/jp0610416; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Steward LE, 1998, METH MOL B, V77, P325; SZYPERSKI T, 1993, J BIOMOL NMR, V3, P151; Tamaki M, 2013, J CLIN INVEST, V123, P4513, DOI 10.1172/JCI68807; van Gunsteren WF, 2018, ANGEW CHEM INT EDIT, V57, P884, DOI 10.1002/anie.201702945; Wan ZL, 2008, J BIOL CHEM, V283, P21198, DOI 10.1074/jbc.M800235200; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Waters ML, 2002, CURR OPIN CHEM BIOL, V6, P736, DOI 10.1016/S1367-5931(02)00359-9; Weiss MA, 2018, DIABETES OBES METAB, V20, P51, DOI 10.1111/dom.13402; Weiss MA, 2009, VITAM HORM, V80, P33, DOI 10.1016/S0083-6729(08)00602-X; Willighagen E., 2007, NATURE PREC, DOI [10.1038/npre.2007.50.1, DOI 10.1038/NPRE.2007.50.1, 10.1038/NPRE.2007.50.1]; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796	107	12	12	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10895	10910		10.1074/jbc.RA118.003650	http://dx.doi.org/10.1074/jbc.RA118.003650			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29880646	hybrid, Green Published			2022-12-26	WOS:000438882800005
J	Kurze, E; Lo Scalzo, R; Campanelli, G; Schwab, W				Kurze, Elisabeth; Lo Scalzo, Roberto; Campanelli, Gabriele; Schwab, Wilfried			Effect of tomato variety, cultivation, climate and processing on Sola l 4, an allergen from Solanum lycopersicum	PLOS ONE			English	Article							BIRCH POLLEN ALLERGEN; BET V 1; FOOD ALLERGENS; CROSS-REACTIVITY; MAJOR ALLERGEN; PROTEINS; EXTRACTS; EPITOPES; BET-V-1; QUALITY	Tomatoes (Solanum lycopersicum) are one of the most consumed vegetables worldwide. However, tomato allergies in patients suffering from birch pollen allergy occur frequently. Due to highly similar protein structures of the tomato allergen Sola l 4 and the major birch pollen allergen Bet v 1, patients cross-react with allergenic proteins from tomato as well as other fruits or vegetables. The aim of this study was to quantify Sola l 4 in various tomatoes differing in color, size and shape for identification of varieties with a reduced allergen level. Therefore, an indirect competitive ELISA using a specific polyclonal Sola l 4 antibody was developed. In addition, two varieties, both cultivated either conventionally or organically and furthermore dried with different methods, were analyzed to investigate the influence of the cultivation method and processing techniques on Sola l 4 level. Within 23 varieties, Sola l 4 content varied significantly between 0.24 and 1.71 mu g Sola l 4/g FW. The tomato cultivars Rugantino and Rhianna showed the significantly lowest level, whereas in cultivars Farbini and Bambello the significantly highest concentration was determined. Drying of tomatoes in the oven and by sun resulted in a significant decrease. The thermal instability was verified for the recombinant Sola l 4 emphasizing the results for the native protein in dried tomato samples. Overall, the Sola l 4 content is cultivar-dependent and no correlation between color and Sola l 4 amount was found. During the drying process of tomatoes Sola l 4 level was significantly reduced due to thermal instability. Growing conditions have a minor effect whereas seasonal effects show a more pronounced impact. These findings could extend the knowledge about the allergen level of different tomato varieties and may help to improve food safety to potentially increase the life quality of patients suffering from birch pollen allergy.	[Kurze, Elisabeth; Schwab, Wilfried] Tech Univ Munich, Biotechnol Nat Prod, Freising Weihenstephan, Germany; [Lo Scalzo, Roberto; Campanelli, Gabriele] Consiglio Ric Agr & Anal Econ Agr, Unita Ric Proc Ind Agroalimentare CREA IT, Milan, Italy	Technical University of Munich; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Schwab, W (corresponding author), Tech Univ Munich, Biotechnol Nat Prod, Freising Weihenstephan, Germany.	wilfried.schwab@tum.de		Kurze, Elisabeth/0000-0001-8625-0737; Schwab, Wilfried/0000-0002-9753-3967	Bundesanstalt fur Landwirtschaft and Ernahrung (BLE) [140E008]	Bundesanstalt fur Landwirtschaft and Ernahrung (BLE)	This work was supported by Bundesanstalt fur Landwirtschaft and Ernahrung (BLE) (https://www.ble.de) "FaVOR-DeNonDe: Drying, Juices and Jams of Organic Fruit and Vegetables: What happens to Desired and Non Desired compounds?" (project number 140E008).	Asero R, 2013, J INVEST ALLERG CLIN, V23, P37; Besler M, 2001, J CHROMATOGR B, V756, P207, DOI 10.1016/S0378-4347(01)00110-4; BJORKSTEN F, 1980, ALLERGY, V35, P671, DOI 10.1111/j.1398-9995.1980.tb02020.x; Breiteneder H, 2000, J ALLERGY CLIN IMMUN, V106, P27, DOI 10.1067/mai.2000.106929; Bufe A, 1996, PLANTA, V199, P413, DOI 10.1007/BF00195733; Dolle S, 2011, CLIN EXP ALLERGY, V41, P1643, DOI 10.1111/j.1365-2222.2011.03841.x; Dolle S, 2011, J SCI FOOD AGR, V91, P2234, DOI 10.1002/jsfa.4443; Fernandes H, 2013, FEBS J, V280, P1169, DOI 10.1111/febs.12114; Foetisch K, 2001, EUR FOOD RES TECHNOL, V213, P259, DOI 10.1007/s002170100343; Franz-Oberdorf K, 2016, J AGR FOOD CHEM, V64, P3688, DOI 10.1021/acs.jafc.6b00488; Ghiani A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155803; Giovannucci E, 1999, JNCI-J NATL CANCER I, V91, P317, DOI 10.1093/jnci/91.4.317; Gruber P, 2004, J AGR FOOD CHEM, V52, P4002, DOI 10.1021/jf035458+; Hierno K, 2006, PROTEOMICS, V6, P1574, DOI 10.1002/pmic.200500469; Hoffmann-Sommergruber K, 2000, INT ARCH ALLERGY IMM, V122, P155, DOI 10.1159/000024392; Karamloo F, 2001, J CHROMATOGR B, V756, P281, DOI 10.1016/S0378-4347(01)00087-1; Kaul S, 2003, J ALLERGY CLIN IMMUN, V111, P1262, DOI 10.1067/mai.2003.1510; Kofler S, 2014, J BIOL CHEM, V289, P540, DOI 10.1074/jbc.M113.518795; Larramendi CH, 2008, CLIN EXP ALLERGY, V38, P169, DOI 10.1111/j.1365-2222.2007.02865.x; Lascombe MB, 2000, J BIOL CHEM, V275, P21572, DOI 10.1074/jbc.M002854200; Liao ZH, 2004, PREP BIOCHEM BIOTECH, V34, P209, DOI 10.1081/PB-200026790; Maleki SJ, 2000, J IMMUNOL, V164, P5844, DOI 10.4049/jimmunol.164.11.5844; Martin-Pedraza L, 2016, MOL NUTR FOOD RES, V60, P1172, DOI 10.1002/mnfr.201500782; Matthes A, 2009, J AGR FOOD CHEM, V57, P10548, DOI 10.1021/jf901938q; ORTOLANI C, 1989, J ALLERGY CLIN IMMUN, V83, P683, DOI 10.1016/0091-6749(89)90083-3; Petersen A, 1996, J ALLERGY CLIN IMMUN, V98, P805, DOI 10.1016/S0091-6749(96)70130-6; Pravettoni V, 2009, J AGR FOOD CHEM, V57, P10749, DOI 10.1021/jf9022367; Sancho AI, 2006, J AGR FOOD CHEM, V54, P5917, DOI 10.1021/jf060880m; Scholl I, 2005, J IMMUNOL, V175, P6645, DOI 10.4049/jimmunol.175.10.6645; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; Sinha M, 2014, SCI WORLD J, DOI 10.1155/2014/543195; Verdino P, 2002, EMBO J, V21, P5007, DOI 10.1093/emboj/cdf526; Vieths S, 2002, ANN NY ACAD SCI, V964, P47; Vieths S, 1998, ALLERGY, V53, P65, DOI 10.1111/j.1398-9995.1998.tb04965.x; Wangorsch A, 2015, MOL NUTR FOOD RES, V59, P582, DOI 10.1002/mnfr.201300620	35	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0197971	10.1371/journal.pone.0197971	http://dx.doi.org/10.1371/journal.pone.0197971			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902173	Green Submitted, Green Published, gold			2022-12-26	WOS:000435424900010
J	Eastham, NT; Coates, A; Cripps, P; Richardson, H; Smith, R; Oikonomou, G				Eastham, Neil T.; Coates, Amy; Cripps, Peter; Richardson, Henry; Smith, Robert; Oikonomou, Georgios			Associations between age at first calving and subsequent lactation performance in UK Holstein and Holstein-Friesian dairy cows	PLOS ONE			English	Article							SOMATIC-CELL COUNT; MILK-YIELD; FUNCTIONAL LONGEVITY; CLINICAL MASTITIS; PRODUCTIVE LIFE; SURVIVAL; FERTILITY; HEIFERS; IMPACT; REPRODUCTION	Lactation records from 396,534 pedigree Holstein and Holstein-Friesian primiparous cows from 6,985 UK milk recorded herds, calving for the first time during the period between the 1st of January 2006 and the 31st of December 2008, were examined in order to determine the associations between age at first calving (AFC) and subsequent production, udder health, fertility and survivability parameters. Heifers were grouped by AFC into single month classes ranging from 21 to 42 months. Mixed effects multivariable regression modelling was used for data analysis. Mean and median AFC were 29.1 and 28 months respectively. Within the study, only 48,567 heifers (12.3% of the studied population) calved for the first time at 24 months of age or younger. 162,157 heifers (40.9%) were 30 months or older at their first calving. An increased AFC was associated with increased first lactation milk, fat and protein yields. The lowest predicted mean 305-day yield (6,617kgs; 95% confidence interval (CI): 6,546-6,687 kgs) was recorded for the 21 month AFC class, significantly lower than any other class. The 36 month AFC class had the highest predicted mean (7,774 kgs; 95% CI: 7,737-7,811 kgs). However, an increased AFC was also associated with increased calving interval and increased first lactation somatic cell count (SCC). Animals calving at 21 months had a predicted mean lactation SCC of 72,765 (95% CI: 68427-77378). Animals calving at 36 months of age had a predicted mean lactation SCC of 86,648 (95% CI: 84,499-88,853). Importantly, an increased AFC was also associated with decreased lifetime daily milk yield and decreased likelihood of calving fora second successive time. Animals calving at 22 months of age had a predicted mean daily lifetime milk yield of 15.24 kgs (95% CI: 15.06-15.35); animals calving at 36 months of age had a predicted mean daily lifetime milk yield of 12.83 kgs (95% CI: 12.76-12.91). Our results highlight the importance of achieving a lower age at first calving which was here associated with improved udder health, increased lifetime daily milk yield, improved reproductive performance and increased likelihood of calving for a second time.	[Eastham, Neil T.] Bishopton Vet Grp, Ripon, N Yorkshire, England; [Eastham, Neil T.; Coates, Amy; Cripps, Peter; Smith, Robert; Oikonomou, Georgios] Univ Liverpool, Inst Vet Sci, Dept Livestock Hlth & Welf, Leahurst Campus, Neston, Wirral, England; [Richardson, Henry] Natl Bovine Data Ctr, Speir House,Stafford Pk 1, Telford, Shrops, England; [Oikonomou, Georgios] Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Leahurst Campus, Neston, Wirral, England	University of Liverpool; University of Liverpool	Oikonomou, G (corresponding author), Univ Liverpool, Inst Vet Sci, Dept Livestock Hlth & Welf, Leahurst Campus, Neston, Wirral, England.; Oikonomou, G (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Leahurst Campus, Neston, Wirral, England.	goikon@liv.ac.uk		Smith, Robert/0000-0003-0944-310X				Archer SC, 2013, J DAIRY SCI, V96, P2939, DOI 10.3168/jds.2012-6115; Berry DP, 2009, LIVEST SCI, V123, P44, DOI 10.1016/j.livsci.2008.10.005; Boulton A. C., 2015, Open Journal of Animal Sciences, V5, P185, DOI 10.4236/ojas.2015.52021; Brickell JS, 2009, THERIOGENOLOGY, V72, P408, DOI 10.1016/j.theriogenology.2009.03.015; Caraviello DZ, 2005, J DAIRY SCI, V88, P804, DOI 10.3168/jds.S0022-0302(05)72745-4; Chirinos Z, 2007, LIVEST SCI, V106, P120, DOI 10.1016/j.livsci.2006.07.006; COFFEY EM, 1986, J DAIRY SCI, V69, P552, DOI 10.3168/jds.S0022-0302(86)80437-4; Cooke J. S., 2013, Open Journal of Animal Sciences, V3, P1, DOI 10.4236/ojas.2013.31001; Curran R. D., 2013, Professional Animal Scientist, V29, P1; De Vliegher S, 2012, J DAIRY SCI, V95, P1025, DOI 10.3168/jds.2010-4074; De Vliegher S, 2005, J DAIRY SCI, V88, P560, DOI 10.3168/jds.S0022-0302(05)72718-1; De Vliegher S, 2005, J DAIRY SCI, V88, P938, DOI 10.3168/jds.S0022-0302(05)72761-2; Dematawewa CMB, 1997, J DAIRY SCI, V80, P754, DOI 10.3168/jds.S0022-0302(97)75995-2; Do C, 2013, ASIAN AUSTRAL J ANIM, V26, P1511, DOI 10.5713/ajas.2013.13105; Ettema JF, 2004, J DAIRY SCI, V87, P2730, DOI 10.3168/jds.S0022-0302(04)73400-1; Evans RD, 2006, LIVEST SCI, V100, P216, DOI 10.1016/j.livprodsci.2005.09.003; Fox DG, 1999, J DAIRY SCI, V82, P1968, DOI 10.3168/jds.S0022-0302(99)75433-0; Froidmont E, 2013, ANIMAL, V7, P665, DOI 10.1017/S1751731112001577; Hare E, 2006, J DAIRY SCI, V89, P3713, DOI 10.3168/jds.S0022-0302(06)72412-2; Hoffman PC, 1997, J ANIM SCI, V75, P836; Hossein-Zadeh NG, 2011, TROP ANIM HEALTH PRO, V43, P967, DOI 10.1007/s11250-011-9791-7; Hutchison JL, 2017, J DAIRY SCI, V100, P6853, DOI 10.3168/jds.2016-12060; International Committee for Animal Recording (ICAR), 2012, INT AGR REC PRACT; Krpalkova L, 2014, J DAIRY SCI, V97, P6573, DOI 10.3168/jds.2013-7497; LIN CY, 1986, J DAIRY SCI, V69, P760, DOI 10.3168/jds.S0022-0302(86)80465-9; LUND T, 1994, LIVEST PROD SCI, V39, P243, DOI 10.1016/0301-6226(94)90203-8; MARTINEZ ML, 1983, J DAIRY SCI, V66, P1494, DOI 10.3168/jds.S0022-0302(83)81964-X; Nilforooshan MA, 2004, J DAIRY SCI, V87, P2130, DOI 10.3168/jds.S0022-0302(04)70032-6; Ojango JMK, 2001, J ANIM SCI, V79, P1742; Pirlo G, 2000, J DAIRY SCI, V83, P603, DOI 10.3168/jds.S0022-0302(00)74919-8; Poso J, 1996, J DAIRY SCI, V79, P1284, DOI 10.3168/jds.S0022-0302(96)76483-4; Sewalem A, 2006, J DAIRY SCI, V89, P3609, DOI 10.3168/jds.S0022-0302(06)72400-6; Sherwin VE, 2016, ANIMAL, V10, P1877, DOI 10.1017/S1751731116000689; Van Amburgh ME, 1998, J DAIRY SCI, V81, P527, DOI 10.3168/jds.S0022-0302(98)75604-8; Wathes DC, 2008, ANIMAL, V2, P1135, DOI 10.1017/S1751731108002322; Wathes DC, 2014, ANIMAL, V8, P91, DOI 10.1017/S1751731114000755; Wu JJ, 2012, ANIM PROD SCI, V52, P11, DOI 10.1071/AN11146	37	30	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197764	10.1371/journal.pone.0197764	http://dx.doi.org/10.1371/journal.pone.0197764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897929	Green Submitted, Green Published, gold			2022-12-26	WOS:000435090700027
J	Nichols, CA; Alexander, K				Nichols, Carol Anne; Alexander, Kathleen			Creeping in the night: What might ecologists be missing?	PLOS ONE			English	Article							WILD BANDED MONGOOSES; SCENT MARKING; INTRASEXUAL OVERMARKING; BEHAVIOR; PRIMATES; PATTERNS; LEMUR	Wildlife activity patterns tend to be defined by terms such as diurnal and nocturnal that might not fully depict the complexity of a species' life history strategy and behavior in a given system. These activity pattern categories often influence the methodological approaches employed, including the temporal period of study (daylight or nighttime). We evaluated banded mongoose (Mungos mungo) behavior in Northern Botswana through the use of remote sensing cameras at active den sites in order to characterize early morning behavior for this diurnal species. Our approach, however, provided the facility to capture unexpected nocturnal activity in a species that had otherwise only been studied during daylight hours. Camera traps were deployed for 215 trap days (24 hour data capture period) at den sites, capturing 5,472 photos over all events. Nocturnal activity was identified in 3% of trap days at study den sites with both vigilant and non-vigilant nocturnal behaviors identified. While vigilant behaviors involved troop fleeing responses, observations of non-vigilant behaviors suggest nonresident mongoose may investigate den sites of other troops during nocturnal time periods. There was no association between the occurrence of nocturnal activity and lunar phase (Fisher's exact test, n = 215, p = 0.638) and thus, increased moonlight was not identified as a factor influencing nocturnal behavior. The drivers and fitness consequences of these nocturnal activities remain uncertain and present intriguing areas for future research. Our findings highlight the need for ecological studies to more explicitly address and evaluate the potential for temporal variability in activity periods. Modifying our approach and embracing variation in wildlife activity patterns might provide new insights into the interaction between ecological phenomenon and species biology that spans the diurnal-nocturnal spectrum.	[Nichols, Carol Anne; Alexander, Kathleen] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Nichols, Carol Anne; Alexander, Kathleen] Ctr Conservat African Resources Anim Communities, Kasane, Botswana	Virginia Polytechnic Institute & State University	Alexander, K (corresponding author), Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.; Alexander, K (corresponding author), Ctr Conservat African Resources Anim Communities, Kasane, Botswana.	kathyalalx@vt.edu			National Science Foundation as part of the joint NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program [1518663]	National Science Foundation as part of the joint NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program	This work was funded by the National Science Foundation (Grant Number #1518663) (KA) as part of the joint NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program. The funders had no role in study design, data collection and analysis, or the decision to submit the work for publication, or preparation of the manuscript. https://www.nsf.gov/.	Ashby K.R., 1972, Mammal Rev, V1, P171, DOI 10.1111/j.1365-2907.1972.tb00088.x; Bearder SK, 2006, FOLIA PRIMATOL, V77, P50, DOI 10.1159/000089695; BRIGHAM RM, 1992, AUK, V109, P315, DOI 10.2307/4088200; Broekhuis F, 2014, BEHAV ECOL, V25, P1268, DOI 10.1093/beheco/aru122; Cant MA, 2002, ETHOLOGY, V108, P541, DOI 10.1046/j.1439-0310.2002.00795.x; Cozzi G, 2012, ECOLOGY, V93, P2590, DOI 10.1890/12-0017.1; Curtis DJ, 2002, EVOL ANTHROPOL, V11, P83, DOI 10.1002/evan.10064; DERRICKSON KC, 1988, CONDOR, V90, P592, DOI 10.2307/1368348; Fairbanks BM, 2013, BIDIRECTIONAL INTERA; Hill RA, 2006, FOLIA PRIMATOL, V77, P72, DOI 10.1159/000089696; Jordan NR, 2010, J ZOOL, V280, P72, DOI 10.1111/j.1469-7998.2009.00646.x; Jordan NR, 2011, ANIM BEHAV, V81, P43, DOI 10.1016/j.anbehav.2010.07.009; Jordan NR, 2011, ANIM BEHAV, V81, P31, DOI 10.1016/j.anbehav.2010.07.010; Jordan NR, 2011, ANIM BEHAV, V81, P51, DOI 10.1016/j.anbehav.2010.10.007; Kay RF, 2000, AM J PHYS ANTHROPOL, V113, P235, DOI 10.1002/1096-8644(200010)113:2<235::AID-AJPA7>3.0.CO;2-9; Keay JM, 2006, J ZOO WILDLIFE MED, V37, P234, DOI 10.1638/05-050.1; Klinka DR, 2002, CAN J ZOOL, V80, P1317, DOI 10.1139/Z02-123; Laver PN, 2013, FORAGING ECOLOGY BAN; PICKETT STA, 1995, SCIENCE, V269, P331, DOI 10.1126/science.269.5222.331; Rasmussen GSA, 2012, J ZOOL, V286, P232, DOI 10.1111/j.1469-7998.2011.00874.x; ROOD J P, 1975, East African Wildlife Journal, V13, P89; Scheiner S.M., 2011, THEORY ECOLOGY; TATTERSALL I, 1987, FOLIA PRIMATOL, V49, P200, DOI 10.1159/000156323; TATTERSALL I, 1979, J MAMMAL, V60, P314, DOI 10.2307/1379802; Thompson FJ, 2017, ANIM BEHAV, V126, P31, DOI 10.1016/j.anbehav.2017.01.017; vanSchaik CP, 1996, ETHOLOGY, V102, P915; Veron G, 2004, MOL PHYLOGENET EVOL, V30, P582, DOI 10.1016/S1055-7903(03)00229-X; Ward MP, 2014, ANIM BEHAV, V88, P175, DOI 10.1016/j.anbehav.2013.11.024; Wielebnowski N, 2007, ISR J ECOL EVOL, V53, P439, DOI 10.1560/IJEE.53.3.439; Wright PC, 1999, YEARB PHYS ANTHROPOL, V42, P31; York JE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0970	31	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198277	10.1371/journal.pone.0198277	http://dx.doi.org/10.1371/journal.pone.0198277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ2HI	29897948	Green Published, gold, Green Submitted			2022-12-26	WOS:000435090700048
J	Stojanovska, V; McQuade, RM; Fraser, S; Prakash, M; Gondalia, S; Stavely, R; Palombo, E; Apostolopoulos, V; Sakkal, S; Nurgali, K				Stojanovska, Vanesa; McQuade, Rachel M.; Fraser, Sarah; Prakash, Monica; Gondalia, Shakuntla; Stavely, Rhian; Palombo, Enzo; Apostolopoulos, Vasso; Sakkal, Samy; Nurgali, Kulmira			Oxaliplatin-induced changes in microbiota, TLR4+cells and enhanced HMGB1 expression in the murine colon	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; TOLL-LIKE RECEPTORS; DELTA T-CELLS; GROUP BOX 1; DENDRITIC CELLS; GASTROINTESTINAL TOXICITY; ULTRASTRUCTURAL EVIDENCE; INTESTINAL MACROPHAGES; GUT MICROBIOTA; STRANDED-RNA	Oxaliplatin is a platinum-based chemotherapeutic used for cancer treatment. Its use associates with peripheral neuropathies and chronic gastrointestinal side-effects. Oxaliplatin induces immunogenic cell death by provoking the presentation of damage associated molecular patterns. The damage associated molecular patterns high-mobility group box 1 (HMGB1) protein exerts pro-inflammatory cytokine-like activity and binds to toll-like receptors (namely TLR4). Gastrointestinal microbiota may influence chemotherapeutic efficacy and contribute to local and systemic inflammation. We studied effects of oxaliplatin treatment on 1) TLR4 and high-mobility group box 1 expression within the colon; 2) gastrointestinal microbiota composition; 3) inflammation within the colon; 4) changes in Peyer's patches and mesenteric lymph nodes immune populations in mice. TLR4(+) cells displayed pseudopodia-like extensions characteristic of antigen sampling co-localised with high-mobility group box 1-overexpressing cells in the colonic lamina propria from oxaliplatin-treated animals. Oxaliplatin treatment caused significant reduction in Parabacteroides and Prevotella(1), but increase in Prevotella(2) and Odoribacter bacteria at the genus level. Downregulation of pro inflammatory cytokines and chemokines in colon samples, a reduction in macrophages and dendritic cells in mesenteric lymph nodes were found after oxaliplatin treatment. In conclusion, oxaliplatin treatment caused morphological changes in TLR4+ cells, increase in gram negative microbiota and enhanced HMGB1 expression associated with immunosuppression in the colon.	[Stojanovska, Vanesa; McQuade, Rachel M.; Fraser, Sarah; Prakash, Monica; Stavely, Rhian; Apostolopoulos, Vasso; Sakkal, Samy; Nurgali, Kulmira] Victoria Univ, Coll Hlth & Biomed, Inst Hlth & Sport, Melbourne, Vic, Australia; [Gondalia, Shakuntla] Swinburne Univ Technol, Ctr Human Psychopharmacol, Melbourne, Vic, Australia; [Palombo, Enzo] Swinburne Univ Technol, Dept Chem & Biotechnol, Melbourne, Vic, Australia; [Nurgali, Kulmira] Univ Melbourne, Australian Inst Musculoskeletal Sci AIMSS, Dept Med Western Hlth, Regenerat Med & Stem Cells Program, Melbourne, Vic, Australia	Victoria University; Swinburne University of Technology; Swinburne University of Technology; University of Melbourne	Nurgali, K (corresponding author), Victoria Univ, Coll Hlth & Biomed, Inst Hlth & Sport, Melbourne, Vic, Australia.	kulmira.nurgali@vu.edu.au	Palombo, Enzo/AAV-8632-2021; Prakash, Monica/AAK-1548-2021; Gondalia, Shakuntla/ABH-9045-2020; Apostolopoulos, Vasso/Q-4525-2019; Heidari-Beni, Motahar/I-2972-2018; Adetunji, Adeniyi Temitope/J-5023-2018; Gafforov, Yusufjon/C-5507-2015; Smirnov, Alexey/AAB-2521-2020	Palombo, Enzo/0000-0001-5889-1393; Gondalia, Shakuntla/0000-0002-9658-0307; Mbatha, Blessing/0000-0001-8128-2035; Prakash, Monica/0000-0002-2814-7560; Said, BOUARFA/0000-0001-5392-7537; Heidari-Beni, Motahar/0000-0001-5543-5536; Sakkal, Samy/0000-0003-0430-4012; Nurgali, Kulmira/0000-0002-2597-6929; Heritier, UWIKUNDA SERONDO/0000-0003-3694-6503; Adetunji, Adeniyi Temitope/0000-0003-1282-3904; Gafforov, Yusufjon/0000-0003-3076-4709; McQuade, Rachel/0000-0002-3510-1288; Orazi, Stephen/0000-0003-2322-9089; Stavely, Rhian/0000-0002-5099-3704; Smirnov, Alexey/0000-0001-5361-8232; JAFARI.MJ, MILAD/0000-0003-2301-9612	Victoria University Research Support grant; Centre for Chronic Disease; College of Health and Biomedicine; Victoria University	Victoria University Research Support grant; Centre for Chronic Disease; College of Health and Biomedicine; Victoria University	This work was supported by Victoria University Research Support grant (KN), the Centre for Chronic Disease (VA), College of Health and Biomedicine (VS), Victoria University.	Alcindor T, 2011, CURR ONCOL, V18, P18; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alhawi M, 2009, J MED MICROBIOL, V58, P1015, DOI 10.1099/jmm.0.009936-0; Allen RC, 2011, INFECT IMMUN, V79, P474, DOI 10.1128/IAI.00910-09; Andersen MH, 2006, J INVEST DERMATOL, V126, P32, DOI 10.1038/sj.jid.5700001; Aratani Y, 2000, J INFECT DIS, V182, P1276, DOI 10.1086/315843; Baranov MV, 2014, J CELL SCI, V127, P1052, DOI 10.1242/jcs.141226; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bezu L, 2015, FRONT IMMUNOL, V6; Boismenu R, 2000, IMMUNOL RES, V21, P123, DOI 10.1385/IR:21:2-3:123; Borish Larry C., 2003, Journal of Allergy and Clinical Immunology, V111, pS460; Boussios S, 2012, ANN GASTROENTEROL, V25, P106; Canta A, 2015, TOXICS, V3, P198, DOI 10.3390/toxics3020198; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/B978-0-12-381300-8.00008-3, 10.1016/S0065-2776(10)07001-X]; Darveau RP, 1998, CURR OPIN MICROBIOL, V1, P36, DOI 10.1016/S1369-5274(98)80140-9; DePaolo RW, 2005, INFECT IMMUN, V73, P6514, DOI 10.1128/IAI.73.10.6514-6522.2005; Di Fiore F, 2009, BEST PRACT RES CL GA, V23, P113, DOI 10.1016/j.bpg.2008.11.016; DVORAK AM, 1980, J IMMUNOL, V125, P460; Elias D, 2004, ANN ONCOL, V15, P1558, DOI 10.1093/annonc/mdh398; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fernandez CS, 2012, J IMMUNOL METHODS, V382, P150, DOI 10.1016/j.jim.2012.05.019; Forghani R, 2012, RADIOLOGY, V263, P451, DOI 10.1148/radiol.12111593; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Goldszmid RS, 2015, CANCER IMMUNOL RES, V3, P103, DOI 10.1158/2326-6066.CIR-14-0225; Hakansson A, 2011, NUTRIENTS, V3, P637, DOI 10.3390/nu3060637; Hall LJ, 2013, INFECT IMMUN, V81, P460, DOI 10.1128/IAI.00953-12; Hamilton JA, 2002, TRENDS IMMUNOL, V23, P403, DOI 10.1016/S1471-4906(02)02260-3; Hato SV, 2014, CLIN CANCER RES, V20, P2831, DOI 10.1158/1078-0432.CCR-13-3141; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Heumann D, 2002, CLIN CHIM ACTA, V323, P59, DOI 10.1016/S0009-8981(02)00180-8; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Ishikawa K, 1998, JPN J CLIN ONCOL, V28, P374, DOI 10.1093/jjco/28.6.374; Ivanova D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/413982; Janes K, 2015, BRAIN BEHAV IMMUN, V44, P91, DOI 10.1016/j.bbi.2014.08.010; Janssens S, 2003, CLIN MICROBIOL REV, V16, P637, DOI 10.1128/CMR.16.4.637-646.2003; Jawairia M, 2012, ISRN GASTROENTEROL, V2012; Jiang Y, 2014, MEMBRANES-BASEL, V4, P630, DOI 10.3390/membranes4030630; Jounai N, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00168; Jung C, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/823710; Jung Y, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1556-z; Jung Y, 2014, J IMMUNOL, V193, P999, DOI 10.4049/jimmunol.1400413; Kato M, 2001, INT ARCH ALLERGY IMM, V125, P55, DOI 10.1159/000053855; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Kim C, 2016, MOLECULES, V21, DOI 10.3390/molecules21091253; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Klebanoff SJ, 2013, J LEUKOCYTE BIOL, V93, P185, DOI 10.1189/jlb.0712349; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Kwon MJ, 2015, J NEUROSCI, V35, P15934, DOI 10.1523/JNEUROSCI.1924-15.2015; Lapaque N, 2006, CELL MICROBIOL, V8, P401, DOI 10.1111/j.1462-5822.2005.00629.x; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Lee CS, 2014, WORLD J GASTROENTERO, V20, P3751, DOI 10.3748/wjg.v20.i14.3751; Lee SA, 2014, YONSEI MED J, V55, P1165, DOI 10.3349/ymj.2014.55.5.1165; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Lin XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039764; Linden DR, 2005, NEUROGASTROENT MOTIL, V17, P751, DOI 10.1111/j.1365-2982.2005.00703.x; Liu AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035379; Lomax AE, 2007, AM J PHYSIOL-GASTR L, V292, pG482, DOI 10.1152/ajpgi.00355.2006; Loria V, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/135625; Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; Maeshima N, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00003; Magna M, 2014, MOL MED, V20, P138, DOI 10.2119/molmed.2013.00164; Mailloux AW, 2009, J IMMUNOL, V182, P2753, DOI 10.4049/jimmunol.0801124; Makker PGS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170814; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Martinotti S, 2015, IMMUNOTARGETS THER, V4, P101, DOI 10.2147/ITT.S58064; Martins A, 2010, IUBMB LIFE, V62, P611, DOI 10.1002/iub.361; Masoodi I, 2011, GER MED SCI, V9; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; McQuade R.M., 2014, INT J CLIN MED, V5, P393, DOI [10.4236/ijcm.2014.57054, DOI 10.4236/IJCM.2014.57054]; McQuade RM, 2016, BR J PHARM; Mechtcheriakova D, 2012, CANCER IMMUNOL IMMUN, V61, P1591, DOI 10.1007/s00262-012-1255-z; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Molinaro A, 2015, CHEM-EUR J, V21, P500, DOI 10.1002/chem.201403923; Mullbacher A, 2002, J IMMUNOL, V169, P145, DOI 10.4049/jimmunol.169.1.145; Nurgali Kulmira, 2011, J Physiol, V589, P325, DOI 10.1113/jphysiol.2010.197707; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; OGAWA T, 1993, FEBS LETT, V332, P197, DOI 10.1016/0014-5793(93)80512-S; Olza J, 2012, DIABETES CARE, V35, P2373, DOI 10.2337/dc12-0614; Ottosson L, 2012, ANN RHEUM DIS, V71, DOI 10.1136/annrheumdis-2011-201238.22; OWEN RL, 1986, J INFECT DIS, V153, P1108, DOI 10.1093/infdis/153.6.1108; Parrish AB, 2013, COLD SPRING HARBOR P, V5; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Pinho V, 2003, J LEUKOCYTE BIOL, V73, P356, DOI 10.1189/jlb.0502243; Podratz JL, 2011, NEUROBIOL DIS, V41, P661, DOI 10.1016/j.nbd.2010.11.017; Poutahidis T, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00157; Pulli B, 2015, RADIOLOGY, V275, P480, DOI 10.1148/radiol.14141495; Renn CL, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-29; Robinson AM, 2016, J HISTOCHEM CYTOCHEM, V64, P530, DOI 10.1369/0022155416656842; Rothenberg ME, 2001, IMMUNOL REV, V179, P139, DOI 10.1034/j.1600-065X.2001.790114.x; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395; Sheridan BS, 2013, IMMUNITY, V39, P184, DOI 10.1016/j.immuni.2013.06.015; Shreedhar VK, 2003, INFECT IMMUN, V71, P504, DOI 10.1128/IAI.71.1.504-509.2003; Siebers A, 1996, TRENDS MICROBIOL, V4, P22, DOI 10.1016/0966-842X(96)81501-0; Sierra-Filardi E, 2014, J IMMUNOL, V192, P3858, DOI 10.4049/jimmunol.1302821; Siew YY, 2015, INT IMMUNOL, V27, P621, DOI 10.1093/intimm/dxv041; Smith PD, 2011, MUCOSAL IMMUNOL, V4, P31, DOI 10.1038/mi.2010.66; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Stein Alexander, 2010, Ther Adv Med Oncol, V2, P51, DOI 10.1177/1758834009355164; Stojanovska V, 2015, AM J PHYSIOL-GASTR L, V308, pG223, DOI 10.1152/ajpgi.00212.2014; Straumann A, 2004, ALLERGY, V59, P15, DOI 10.1046/j.1398-9995.2003.00382.x; Stringer AM, 2008, CANCER BIOL THER, V7, P1919, DOI 10.4161/cbt.7.12.6940; Stringer AM, 2009, CANCER CHEMOTH PHARM, V64, P123, DOI 10.1007/s00280-008-0855-y; Stringer AM, 2009, EXP BIOL MED, V234, P430, DOI 10.3181/0810-RM-301; Sutton CE, 2012, EUR J IMMUNOL, V42, P2221, DOI 10.1002/eji.201242569; Syvak L A, 2012, Lik Sprava, P25; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Topham NJ, 2009, IMMUNOLOGY, V128, P7, DOI 10.1111/j.1365-2567.2009.03123.x; TORPIER G, 1988, CLIN EXP IMMUNOL, V74, P404; Urbonaviciute V, 2009, AUTOIMMUNITY, V42, P305, DOI 10.1080/08916930902831803; Van Acker HH, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1021538; Van Steenwinckel J, 2011, J NEUROSCI, V31, P5865, DOI 10.1523/JNEUROSCI.5986-10.2011; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Viaud S, 2015, CELL DEATH DIFFER, V22, P199, DOI 10.1038/cdd.2014.56; Wafai L, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00030; Wang HQ, 2013, CLIN CANCER RES, V19, P3764, DOI 10.1158/1078-0432.CCR-12-3725; Weickhardt A, 2011, J ONCOL, V2011, DOI 10.1155/2011/201593; WEINTRAUB A, 1989, EUR J BIOCHEM, V183, P425, DOI 10.1111/j.1432-1033.1989.tb14945.x; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wu D, 2005, P NATL ACAD SCI USA, V102, P1351, DOI 10.1073/pnas.0408696102; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Yang ZJ, 2006, CLIN CANCER RES, V12, P5817, DOI 10.1158/1078-0432.CCR-06-1037; Yu Y, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00093; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zitvogel L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010473	136	21	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198359	10.1371/journal.pone.0198359	http://dx.doi.org/10.1371/journal.pone.0198359			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894476	Green Accepted, Green Published, gold			2022-12-26	WOS:000435030900011
J	Zafar, B; Ashraf, R; Ali, N; Ahmed, M; Jabber, S; Chatzichristofis, SA				Zafar, Bushra; Ashraf, Rehan; Ali, Nouman; Ahmed, Mudassar; Jabber, Sohail; Chatzichristofis, Savvas A.			Image classification by addition of spatial information based on histograms of orthogonal vectors	PLOS ONE			English	Article							SCENE CLASSIFICATION; NEURAL-NETWORKS; OBJECT BANK; REPRESENTATION; RETRIEVAL; FEATURES	The Bag-of-Visual-Words (BoVW) model is widely used for image classification, object recognition and image retrieval problems. In BoVW model, the local features are quantized and 2-D image space is represented in the form of order-less histogram of visual words. The image classification performance suffers due to the order-less representation of image. This paper presents a novel image representation that incorporates the spatial information to the inverted index of BoVW model. The spatial information is added by calculating the global relative spatial orientation of visual words in a rotation invariant manner. For this, we computed the geometric relationship between triplets of identical visual words by calculating an orthogonal vector relative to each point in the triplets of identical visual words. The histogram of visual words is calculated on the basis of the magnitude of these orthogonal vectors. This calculation provides the unique information regarding the relative position of visual words when they are collinear. The proposed image representation is evaluated by using four standard image benchmarks. The experimental results and quantitative comparisons demonstrate that the proposed image representation outperforms the existing state-of-the-art in terms of classification accuracy.	[Zafar, Bushra; Ashraf, Rehan; Ahmed, Mudassar; Jabber, Sohail] Natl Text Univ, Dept Comp Sci, Faisalabad, Pakistan; [Ali, Nouman] Mirpur Univ Sci & Technol, Dept Software Engn, Mirpur, Azad Kashmir, Pakistan; [Chatzichristofis, Savvas A.] Neapolis Univ, Dept Informat Sci, Paphos, Cyprus	National Textile University - Pakistan	Ashraf, R (corresponding author), Natl Text Univ, Dept Comp Sci, Faisalabad, Pakistan.	rehan@ntu.edu.pk	Ashraf, Rehan/AAC-8637-2020; Ali, Nouman/X-7462-2019; Chatzichristofis, Savvas/AAA-2698-2020	Ashraf, Rehan/0000-0002-6627-9820; Ali, Nouman/0000-0002-0721-201X; Chatzichristofis, Savvas/0000-0002-4657-4435; Jabbar, Sohail/0000-0002-2127-1235	Advanced Study Research Board of National Textile University, Faisalabad, Pakistan	Advanced Study Research Board of National Textile University, Faisalabad, Pakistan	We would like to say thanks to Advanced Study Research Board of National Textile University, Faisalabad, Pakistan for their support during this research.	Ali N, 2017, ARXIV170308492, DOI [10.1007/s10976-017-0880-7, DOI 10.1007/S10976-017-0880-7]; Ali N, 2016, COMPUT ELECTR ENG, V54, P539, DOI 10.1016/j.compeleceng.2016.04.002; Ali N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157428; Anwar H, 2014, LECT NOTES COMPUT SC, V8753, P443, DOI 10.1007/978-3-319-11752-2_36; ASHRAF R, 2014, J BASIC APPL SCI RES, V4, P136; Ashraf R, 2018, J MED SYST, V42, DOI 10.1007/s10916-017-0880-7; Ashraf R, 2016, J INF SCI ENG, V32, P245; Ashraf R, 2015, ENTROPY-SWITZ, V17, P3552, DOI 10.3390/e17063552; Bian XY, 2017, IEEE J-STARS, V10, P2889, DOI 10.1109/JSTARS.2017.2683799; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chatzichristofis SA, 2014, MULTIMED TOOLS APPL, V70, P1767, DOI 10.1007/s11042-012-1192-z; Chatzichristofis SA, 2013, IEEE T CYBERNETICS, V43, P192, DOI 10.1109/TSMCB.2012.2203300; Chatzichristofis SA, 2011, COMM COM INF SC, V129, P49; Chen C, 2016, SIGNAL IMAGE VIDEO P, V10, P745, DOI 10.1007/s11760-015-0804-2; Csurka G., 2004, WORKSHOP STAT LEARNI, P1, DOI DOI 10.1234/12345678; Fei-Fei L, 2005, PROC CVPR IEEE, P524; Ge Zhou, 2010, 2010 International Conference on Image Analysis and Signal Processing (IASP 2010), P176, DOI 10.1109/IASP.2010.5476136; Karmakar P., 2015, DIG IM COMP TECHN AP, P1; Khan R, 2015, COMPUT VIS IMAGE UND, V132, P102, DOI 10.1016/j.cviu.2014.09.005; Khan R, 2012, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2012, DOI 10.5244/C.26.89; Koniusz P, 2011, IEEE IMAGE PROC, P661; Kopf S, 2016, P INT C IM PROC COMP; Krapac J, 2011, IEEE I CONF COMP VIS, P1487, DOI 10.1109/ICCV.2011.6126406; Lazebnik S., 2006, P IEEE INT C COMP VI, V2, P2169, DOI DOI 10.1109/CVPR.2006.68; Li LJ, 2014, INT J COMPUT VISION, V107, P20, DOI 10.1007/s11263-013-0660-x; Liu D, 2008, PROC CVPR IEEE, P480; Mehmood Z, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/8217250; Mekhalfi ML, 2015, IEEE GEOSCI REMOTE S, V12, P2155, DOI 10.1109/LGRS.2015.2453130; Mu GY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131164; Nowak E, 2006, LECT NOTES COMPUT SC, V3954, P490; O'Hara S., 2011, ARXIV11013354, P1; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Lopez-Monroya AP, 2016, NEUROCOMPUTING, V175, P768, DOI 10.1016/j.neucom.2015.10.053; Penatti Otavio A. B., 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), P44, DOI 10.1109/CVPRW.2015.7301382; Penatti OAB, 2014, PATTERN RECOGN, V47, P705, DOI 10.1016/j.patcog.2013.08.012; Petscharnig S, 2017, PROCEEDINGS OF THE 15TH INTERNATIONAL WORKSHOP ON CONTENT-BASED MULTIMEDIA INDEXING (CBMI), DOI 10.1145/3095713.3095737; Qin JZ, 2010, PATTERN RECOGN, V43, P1874, DOI 10.1016/j.patcog.2009.11.009; Sanchez J, 2012, PATTERN RECOGN LETT, V33, P2216, DOI 10.1016/j.patrec.2012.07.019; Savarese S., 2006, CVPR, V2, P2033, DOI DOI 10.1109/CVPR.2006.102; Scott GJ, 2017, IEEE GEOSCI REMOTE S, V14, P1638, DOI 10.1109/LGRS.2017.2722988; Scott GJ, 2017, IEEE GEOSCI REMOTE S, V14, P549, DOI 10.1109/LGRS.2017.2657778; Sivic J, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1470, DOI 10.1109/iccv.2003.1238663; Song XH, 2015, PROC CVPR IEEE, P1312, DOI 10.1109/CVPR.2015.7298736; Song Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103575; Vassou S.A., 2017, P 15 INT WORKSH CONT, P30; Vedaldi A, 2012, PROC CVPR IEEE, P2320, DOI 10.1109/CVPR.2012.6247943; Yang Y., 2010, P 18 SIGSPATIAL INT, P270, DOI DOI 10.1145/1869790.1869829; Yang Y, 2011, IEEE I CONF COMP VIS, P1465, DOI 10.1109/ICCV.2011.6126403; Zang MJ, 2018, EXPERT SYST APPL, V94, P250, DOI 10.1016/j.eswa.2017.10.057; Zhang CX, 2016, 2016 9TH INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING, BIOMEDICAL ENGINEERING AND INFORMATICS (CISP-BMEI 2016), P417, DOI 10.1109/CISP-BMEI.2016.7852747; Zhang DS, 2012, PATTERN RECOGN, V45, P346, DOI 10.1016/j.patcog.2011.05.013; Zhang E., 2010, Proceedings 2010 International Conference on Digital Image Computing: Techniques and Applications (DICTA 2010), P208, DOI 10.1109/DICTA.2010.46; Zhang E, 2010, 2010 25 INT C IM VIS, P1, DOI DOI 10.1109/IVCNZ.2010.6148795; Zhang F, 2016, IEEE T GEOSCI REMOTE, V54, P1793, DOI 10.1109/TGRS.2015.2488681; Zhang J, 2007, INT J COMPUT VISION, V73, P213, DOI 10.1007/s11263-006-9794-4; Zhang S., 2009, ACM INT C MULT, DOI DOI 10.1145/1631272.1631285; Zhang SL, 2011, IEEE T IMAGE PROCESS, V20, P2664, DOI 10.1109/TIP.2011.2128333; Zhao LJ, 2014, IEEE J-STARS, V7, P4620, DOI 10.1109/JSTARS.2014.2339842; Zhu QQ, 2016, IEEE GEOSCI REMOTE S, V13, P747, DOI 10.1109/LGRS.2015.2513443; Zou JY, 2016, INFORM SCIENCES, V348, P209, DOI 10.1016/j.ins.2016.02.021	61	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198175	10.1371/journal.pone.0198175	http://dx.doi.org/10.1371/journal.pone.0198175			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883455	gold, Green Published, Green Submitted			2022-12-26	WOS:000434728100012
J	Lutchmansingh, FK; Hsu, JW; Bennett, FI; Badaloo, AV; McFarlane-Anderson, N; Gordon-Strachan, GM; Wright-Pascoe, RA; Jahoor, F; Boyne, MS				Lutchmansingh, Fallon K.; Hsu, Jean W.; Bennett, Franklyn I.; Badaloo, Asha V.; McFarlane-Anderson, Norma; Gordon-Strachan, Georgiana M.; Wright-Pascoe, Rosemarie A.; Jahoor, Farook; Boyne, Michael S.			Glutathione metabolism in type 2 diabetes and its relationship with microvascular complications and glycemia	PLOS ONE			English	Article							OXIDATIVE STRESS; LIPID-PEROXIDATION; ANTIOXIDANT STATUS; BLOOD GLUTATHIONE; MELLITUS; SUPPLEMENTATION; CYSTEINE	Aims/Hypotheses We hypothesized that there is decreased synthesis of glutathione (GSH) in type 2 diabetes (T2DM) especially in the presence of microvascular complications, and this is dependent on the degree of hyperglycemia. Methods In this case-control study, we recruited 16 patients with T2DM (7 without and 9 with micro vascular complications), and 8 age- and sex-matched non-diabetic controls. We measured GSH synthesis rate using an infusion of [H-2(2)]-glycine as isotopic tracer and collection of blood samples for liquid chromatography mass spectrometric analysis. Results Compared to the controls, T2DM patients had lower erythrocyte GSH concentrations (0.90 +/- 0.42 vs. 0.35 +/- 0.30 mmol/L; P = 0.001) and absolute synthesis rates (1.03 +/- 0.55 vs. 0.50 +/- 0.69 mmol/Uday; P = 0.01), but not fractional synthesis rates (114 +/- 45 vs. 143 +/- 82%/day; P = 0.07). The magnitudes of changes in patients with complications were greater for both GSH concentrations and absolute synthesis rates (P-values <= 0.01) compared to controls. There were no differences in GSH concentrations and synthesis rates between T2DM patients with and without complications (P-values > 0.1). Fasting glucose and HbA1 c did not correlate with GSH concentration or synthesis rates (P-values > 0.17). Conclusions Compared to non-diabetic controls, patients with T2DM have glutathione deficiency, especially if they have microvascular complications. This is probably due to reduced synthesis and increased irreversible utilization by non-glycemic mechanisms.	[Lutchmansingh, Fallon K.; McFarlane-Anderson, Norma] Univ West Indies, Dept Basic Med Sci, Mona, Jamaica; [Hsu, Jean W.; Jahoor, Farook] Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Bennett, Franklyn I.] Univ Hosp West Indies, Dept Pathol, Mona, Jamaica; [Badaloo, Asha V.; Boyne, Michael S.] Univ West Indies, Caribbean Inst Hlth Res, Mona, Jamaica; [Gordon-Strachan, Georgiana M.] Univ West Indies, Fac Med Sci, Hlth Res Unit, Mona, Jamaica; [Wright-Pascoe, Rosemarie A.; Boyne, Michael S.] Univ West Indies, Dept Med, Mona, Jamaica	University West Indies Mona Jamaica; Baylor College of Medicine; University West Indies Mona Jamaica; University Hospital West Indies; University West Indies Mona Jamaica; University West Indies Mona Jamaica; University West Indies Mona Jamaica	Boyne, MS (corresponding author), Univ West Indies, Caribbean Inst Hlth Res, Mona, Jamaica.; Boyne, MS (corresponding author), Univ West Indies, Dept Med, Mona, Jamaica.	michael.boyne@uwimona.edu.jm	Boyne, Michael S/I-2242-2013; Boyne, Michael/AAC-3675-2020; Gordon-Strachan, Georgiana/AAS-5589-2021; Hsu, Jean W./D-1806-2014	Boyne, Michael S/0000-0002-5227-2492; Boyne, Michael/0000-0002-5227-2492; Hsu, Jean W./0000-0002-5666-3132; badaloo, asha/0000-0001-9555-3967	Caribbean Public Health Agency; Children's Nutrition Research Center, Baylor College of Medicine	Caribbean Public Health Agency; Children's Nutrition Research Center, Baylor College of Medicine	This work was supported by a grant from the Caribbean Public Health Agency as well as funding by the Children's Nutrition Research Center, Baylor College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almdal T, 2004, ARCH INTERN MED, V164, P1422, DOI 10.1001/archinte.164.13.1422; Ataman SL, 1996, J CLIN EPIDEMIOL, V49, P869, DOI 10.1016/0895-4356(96)00111-4; Boyne M.S., 2009, INSULIN, V4, P94, DOI [10.1016/S1557-0843(09)80018-3, DOI 10.1016/S1557-0843(09)80018-3]; Bravi MC, 2006, METABOLISM, V55, P691, DOI 10.1016/j.metabol.2006.01.003; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Buldak L, 2014, PHARMACOL REP, V66, P418, DOI 10.1016/j.pharep.2013.11.008; Nguyen D, 2014, J CLIN ENDOCR METAB, V99, P169, DOI 10.1210/jc.2013-2376; Darmaun D, 2012, METABOLISM, V61, P373, DOI 10.1016/j.metabol.2011.07.015; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Ferguson TS, 2010, W INDIAN MED J, V59, P259; FORRESTER TE, 1990, EUR J CLIN NUTR, V44, P847; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gougeon R, 2008, DIABETES CARE, V31, P128, DOI 10.2337/dc07-1268; Halvatsiotis P, 2002, DIABETES, V51, P2395, DOI 10.2337/diabetes.51.8.2395; Khalilzadeh Saeedhossein, 2014, Electron Physician, V6, P856, DOI 10.14661/2014.856-862; Lagman M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118436; Memisogullari R, 2003, CELL BIOCHEM FUNCT, V21, P291, DOI 10.1002/cbf.1025; Mendez MM, 2015, J DIABETES COMPLICAT, V29, P923, DOI 10.1016/j.jdiacomp.2015.05.023; MURAKAMI K, 1989, METABOLISM, V38, P753, DOI 10.1016/0026-0495(89)90061-9; Nishikawa T, 2007, DIABETES RES CLIN PR, V77, pS41, DOI 10.1016/j.diabres.2007.01.031; Reid M, 2000, Curr Opin Clin Nutr Metab Care, V3, P385, DOI 10.1097/00075197-200009000-00010; Sekhar RV, 2011, DIABETES CARE, V34, P162, DOI 10.2337/dc10-1006; Sundaram RK, 1996, CLIN SCI, V90, P255, DOI 10.1042/cs0900255; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Unger J., 2008, INSULIN, V3, P176, DOI [DOI 10.1016/S1557-0843(08)80037-1, 10.1016/S1557-0843(08)80037-1]; Vats P, 2015, FREE RADICAL RES, V49, P17, DOI 10.3109/10715762.2014.971782; Whiting PH, 2008, BRIT J BIOMED SCI, V65, P71, DOI 10.1080/09674845.2008.11732800; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	30	69	71	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198626	10.1371/journal.pone.0198626	http://dx.doi.org/10.1371/journal.pone.0198626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879181	Green Submitted, Green Published, gold			2022-12-26	WOS:000434384900062
J	Gulban, OF; Schneider, M; Marquardt, I; Haast, RAM; De Martino, F				Gulban, Omer Faruk; Schneider, Marian; Marquardt, Ingo; Haast, Roy A. M.; De Martino, Federico			A scalable method to improve gray matter segmentation at ultra high field MRI	PLOS ONE			English	Article							MULTIDIMENSIONAL TRANSFER-FUNCTIONS; HUMAN BRAIN; FMRI; ACTIVATION; NUMEROSITY; CONTRAST; LAYERS; IMAGES; MODEL; AREAS	High-resolution (functional) magnetic resonance imaging (MRI) at ultra high magnetic fields (7 Tesla and above) enables researchers to study how anatomical and functional properties change within the cortical ribbon, along surfaces and across cortical depths. These studies require an accurate delineation of the gray matter ribbon, which often suffers from inclusion of blood vessels, dura mater and other non-brain tissue. Residual segmentation errors are commonly corrected by browsing the data slice-by-slice and manually changing labels. This task becomes increasingly laborious and prone to error at higher resolutions since both work and error scale with the number of voxels. Here we show that many mislabeled, nonbrain voxels can be corrected more efficiently and semi-automatically by representing threedimensional anatomical images using two-dimensional histograms. We propose both a unimodal (based on first spatial derivative) and multi-modal (based on compositional data analysis) approach to this representation and quantify the benefits in 7 Tesla MRI data of nine volunteers. We present an openly accessible Python implementation of these approaches and demonstrate that editing cortical segmentations using two-dimensional histogram representations as an additional post-processing step aids existing algorithms and yields improved gray matter borders. By making our data and corresponding expert (ground truth) segmentations openly available, we facilitate future efforts to develop and test segmentation algorithms on this challenging type of data.	[Gulban, Omer Faruk; Schneider, Marian; Marquardt, Ingo; Haast, Roy A. M.; De Martino, Federico] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Haast, Roy A. M.] Maastricht Univ, Maastricht Ctr Syst Biol, Maastricht, Netherlands; [De Martino, Federico] Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN USA	Maastricht University; Maastricht University; University of Minnesota System; University of Minnesota Twin Cities	Gulban, OF; Schneider, M (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	faruk.gulban@maastrichtuniversity.nl; marian.schneider@maastrichtuniversity.nl	De Martino, Federico/I-1817-2012; De Martino, Federico/ABF-9850-2021; Haast, Roy/ABB-1311-2020	De Martino, Federico/0000-0002-0352-0648; De Martino, Federico/0000-0002-0352-0648; Haast, Roy/0000-0001-8543-2467; Marquardt, Ingo/0000-0001-5178-9951; Gulban, Omer Faruk/0000-0001-7761-3727; Schneider, Marian/0000-0003-3192-5316	Netherlands Organisation for Scientific Research (NWO); NWO VIDI grant [864-13-012]; NWO [406-14-108, 406-14-085]; Technology Foundation STW [12724]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO VIDI grant(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO)); Technology Foundation STW(Technologiestichting STW)	This work was financed by the Netherlands Organisation for Scientific Research (NWO; https://www.nwo.nl/en). The authors O.F.G. and F.D.M. as well as data acquisition for the MPRAGE data set were supported by NWO VIDI grant 864-13-012. Author M.S. was supported by NWO research talent grant 406-14-108. Author I. M. was supported by NWO research talent grant 406-14-085. Author R.H. and acquisition of the MP2RAGE was funded by Technology Foundation STW (http://www.stw.nI/en/) grant 12724.; We would like to express our appreciation for the comments and suggestions of the reviewers which helped to improve the manuscript. We would also like to thank Thomas Emmerling for his guidance and advise on software implementation as well as Nikolaus Weiskopf, Rainer Goebel and Christophe Lenglet for valuable discussions of our early ideas. This work was financed by the Netherlands Organisation for Scientific Research (NWO). The authors O.F.G. and F.D.M. as well as data acquisition for the MPRAGE data set were supported by NWO VIDI grant 864-13-012. Author M.S. was supported by NWO research talent grant 406-14-108. Author I.M. was supported by NWO research talent grant 406-14-085. Author R.H. and acquisition of the MP2RAGE was funded by Technology Foundation STW (grant 12724).	AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139; Aitchison J., 2003, CDA WORKSHOP GIRONA, P1, DOI [10.2307/4355794, DOI 10.1016/J.ENVEXPB0T.2014.07.014.GIR0NA]; Amunts K, 2013, SCIENCE, V340, P1472, DOI 10.1126/science.1235381; [Anonymous], 2004, NEUROIMAGE, V23, pS151; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Aubert-Broche B, 2006, IEEE T MED IMAGING, V25, P1410, DOI 10.1109/TMI.2006.883453; Aubert-Broche B, 2006, NEUROIMAGE, V32, P138, DOI 10.1016/j.neuroimage.2006.03.052; Bazin PL, 2014, NEUROIMAGE, V93, P201, DOI 10.1016/j.neuroimage.2013.03.077; Borg I., 2005, MODERN MULTIDIMENSIO, P100; Brett M, 2017, NIPY NIBABEL 2 2 0, DOI [10.5281/zenodo.1011207, DOI 10.5281/ZENODO.1011207]; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; De Martino F, 2018, NEUROIMAGE, V168, P366, DOI 10.1016/j.neuroimage.2017.03.060; De Martino F, 2015, P NATL ACAD SCI USA, V112, P16036, DOI 10.1073/pnas.1507552112; De Martino F, 2015, CEREB CORTEX, V25, P3394, DOI 10.1093/cercor/bhu150; De Martino F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060514; Despotovic I, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/450341; Dick F, 2012, J NEUROSCI, V32, P16095, DOI 10.1523/JNEUROSCI.1712-12.2012; Dumoulin SO, 2018, NEUROIMAGE, V168, P345, DOI 10.1016/j.neuroimage.2017.01.028; Duyn JH, 2012, NEUROIMAGE, V62, P1241, DOI 10.1016/j.neuroimage.2011.10.065; Egozcue JJ, 2003, MATH GEOL, V35, P279, DOI 10.1023/A:1023818214614; Flood, 1993, MOBIUS HIS BAND MATH; Fracasso A, 2016, NEUROIMAGE, V139, P427, DOI 10.1016/j.neuroimage.2016.06.048; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Goncalves NR, 2015, J NEUROSCI, V35, P3056, DOI 10.1523/JNEUROSCI.3047-14.2015; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Gulban OF, 2018, COMPODA V0 3 3, DOI [10.5281/zenodo.1209137, DOI 10.5281/ZENODO.1209137]; Gulban OF, 2017, SEGMENTATOR V1 5 0, DOI [10.5281/zenodo.1219243, DOI 10.5281/ZENODO.1219243]; Gulban OF, 2017, DATASET SCALABLE MET, DOI [10.5281/zenodo.1117859, DOI 10.5281/ZENODO.1117859]; Gulban OF, 2017, RELATION COLOR SPACE, DOI [10.1109/42.712135, DOI 10.1109/42.712135]; Haast RAM, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00112; Harvey BM, 2013, SCIENCE, V341, P1123, DOI 10.1126/science.1239052; Harvey BM, 2015, P NATL ACAD SCI USA, V112, P13525, DOI 10.1073/pnas.1515414112; Helms G, 2006, J MAGN RESON IMAGING, V24, P790, DOI 10.1002/jmri.20692; Helms G, 2016, MAGN RESON MATER PHY, V29, P111, DOI 10.1007/s10334-015-0518-z; Huber L, 2017, NEURON, V96, P1253, DOI 10.1016/j.neuron.2017.11.005; Huber L, 2015, NEUROIMAGE, V107, P23, DOI 10.1016/j.neuroimage.2014.11.046; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ip CY, 2012, IEEE T VIS COMPUT GR, V18, P2355, DOI 10.1109/TVCG.2012.231; Jahne B, 2000, HDB COMPUTER VISION, V2; Jain V., 2011, ADV NEURAL INFORM PR, P648; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Jones E., 2001, SCIPY OPEN SOURCE SC; Kashyap S, 2017, IMPACT ACQUISITION A; Kemper VG, 2018, NEUROIMAGE, V164, P48, DOI 10.1016/j.neuroimage.2017.03.058; Kindlmann G, 1998, IEEE SYMPOSIUM ON VOLUME VISUALIZATION, P79, DOI 10.1109/SVV.1998.729588; Kniss J, 2002, IEEE T VIS COMPUT GR, V8, P270, DOI 10.1109/TVCG.2002.1021579; Kniss J, 2001, IEEE VISUAL, P255, DOI 10.1109/VISUAL.2001.964519; Kok P, 2016, CURR BIOL, V26, P371, DOI 10.1016/j.cub.2015.12.038; Koopmans PJ, 2011, NEUROIMAGE, V56, P1276, DOI 10.1016/j.neuroimage.2011.02.042; LANCASTER HO, 1965, AM MATH MON, V72, P4, DOI 10.2307/2312989; Liu T, 2012, WATERSHED MERGE TREE, V2012, P3; Ljung P, 2016, COMPUT GRAPH FORUM, V35, P669, DOI 10.1111/cgf.12934; Lusebrink F, 2017, SCI DATA, V4, P1; Marques JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069294; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Mirebeau J, 2015, CORR; Muckli L, 2015, CURR BIOL, V25, P2690, DOI 10.1016/j.cub.2015.08.057; Munkres J. R., 1984, ELEMENTS ALGEBRAIC T; Nasr S, 2016, J NEUROSCI, V36, P1841, DOI 10.1523/JNEUROSCI.3518-15.2016; Nunez-Iglesias J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071715; Pawlowsky-Glahn V., 2015, MODELLING ANAL COMPO; Polimeni JR, 2018, NEUROIMAGE, V168, P296, DOI 10.1016/j.neuroimage.2017.04.053; Polimeni JR, 2010, NEUROIMAGE, V52, P1334, DOI 10.1016/j.neuroimage.2010.05.005; Renvall V, 2016, NEUROIMAGE, V134, P338, DOI 10.1016/j.neuroimage.2016.04.004; Scharr H, 2000, OPTIMALE OPERATOREN; Schneider M, 2018, PROCESSING SCRIPTS S, DOI [10.5281/zenodo.1217084, DOI 10.5281/ZENODO.1217084]; Sereno MI, 2013, CEREB CORTEX, V23, P2261, DOI 10.1093/cercor/bhs213; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Taha AA, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0068-x; Teeuwisse WM, 2012, MAGN RESON MED, V67, P1285, DOI 10.1002/mrm.23108; Tootell RBH, 2017, J NEUROSCI; Toro R, 2014, BRAIN CATALOGUE OPEN; Trampel R., 2017, NEUROIMAGE, P1, DOI [10.1016/j.neuruirnage.2017.09.037, DOI 10.1016/J.NEURUIRNAGE.2017.09.037]; Tsagris MT, 2011, DATA BASED POWER TRA, P1, DOI [10.1002/hbm.10062, DOI 10.1002/HBM.10062]; Ugurbil K, 2014, IEEE T BIO-MED ENG, V61, P1364, DOI 10.1109/TBME.2014.2313619; Valverde S, 2015, J MAGN RESON IMAGING, V41, P93, DOI 10.1002/jmri.24517; Van de Moortele PF, 2009, NEUROIMAGE, V46, P432, DOI 10.1016/j.neuroimage.2009.02.009; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van der Walt S, 2014, PEERJ, V2, DOI 10.7717/peerj.453; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156; Venkataraju KU, 2009, I S BIOMED IMAGING, P1039, DOI 10.1109/ISBI.2009.5193233; Viviani R, 2017, FRONTIERS NEUROSCIEN, V11, P1; Viviani R, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00012; Waehnert MD, 2014, NEUROIMAGE, V93, P210, DOI 10.1016/j.neuroimage.2013.03.078; Weickert J., 1998, IMAGE ROCHESTER NY, V256, P170; Yacoub E, 2008, P NATL ACAD SCI USA, V105, P10607, DOI 10.1073/pnas.0804110105; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zimmermann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028716; [No title captured], DOI DOI 10.1016/B978-012387582-2/50011-3	93	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198335	10.1371/journal.pone.0198335	http://dx.doi.org/10.1371/journal.pone.0198335			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874295	Green Submitted, Green Published, gold			2022-12-26	WOS:000434369400046
J	do Amaral, RB; Lourenco, EC; Famadas, KM; Garcia, AB; Machado, RZ; Andre, MR				do Amaral, Renan Bressianini; Lourenco, Elizabete Captivo; Famadas, Katie Maria; Garcia, Amanda Barbosa; Machado, Rosangela Zacarias; Andre, Marcos Rogerio			Molecular detection of Bartonella spp. and Rickettsia spp. in bat ectoparasites in Brazil	PLOS ONE			English	Article							TICKS ORNITHODOROS-HASEI; AMBLYOMMA-PARVUM TICKS; FEVER GROUP RICKETTSIA; FLIES NYCTERIBIIDAE; SEROLOGIC SURVEY; RESERVOIR HOSTS; WILD MAMMALS; IQ-TREE; DIPTERA; ACARI	The family Streblidae comprises a monophyletic group of Hippoboscoidea, hematophagous dipterans that parasitize bats. Bartonella spp. and Rickettsia spp. have been reported in bats sampled in Europe, Africa, Asia, North, Central and South America. However, there are few reports on the Bartonella and Rickettsia bacteria infecting Hippoboscoidea flies and mites. While Spinturnicidae mites are ectoparasites found only in bats, those belonging to the family Macronyssidae comprise mites that also parasitize other mammal species. This study investigates the occurrence and assesses the phylogenetic positioning of Bartonella spp. and Rickettsia spp. found in Streblidae flies and Spinturnicidae and Macronyssidae mites collected from bats captured in Brazil. From May 2011 to April 2012 and September 2013 to December 2014, 400 Streblidae flies, 100 Macronyssidaes, and 100 Spinturnicidae mites were collected from bats captured in two sites in northeastern Nova Iguacu, Rio de Janeiro, southeastern Brazil. Forty (19.8%) out of 202 Streblidae flies were positive for Bartonella spp. in qPCR assays based on the nuoG gene. Among the flies positive for the bacterium, six (18%) were Paratrichobius longicrus, seven (29%) Strebla guajiro, two (40%) Aspidoptera phyllostomatis, five (11%) Aspidoptera falcate, one (10%) Trichobius anducei, one (25%) Megistopoda aranea, and 18 (32%) Trichobius joblingi, and collected from bats of the following species: Artibeus lituratus, Carollia perspicillata, Artibeus planirostris, Stumira lilium, and Artibeus obscurus. Six sequences were obtained for Bartonella (nuoG [n = 2], gltA [n = 2], rpoB [n = 1], ribC = 1]). The phylogenetic analysis based on gltA (750pb) gene showed that the Bartonella sequences clustered with Bartonella genotypes detected in bats and ectoparasites previously sampled in Latin America, including Brazil. Only one sample (0.49%) of the species Trichobius joblingi collected from a specimen of Carollia perspicillata was positive for Rickettsia sp. in cPCR based on the gltA gene (401bp). This sequence was clustered with a 'Candidatus Rickettsia andaenae" genotype detected in an Amblyomma parvum tick collected from a rodent in the southern region of Brazilian Pantanal. The sampled Macronyssidae and Spinturnicidae mites were negative for Bartonella spp. and Rickettsia spp. This study demonstrated the first occurrence of Bartonella spp. and Rickettsia spp. DNA in Streblidae flies collected from bats in Brazil.	[do Amaral, Renan Bressianini; Garcia, Amanda Barbosa; Machado, Rosangela Zacarias; Andre, Marcos Rogerio] Univ Estadual Paulista, UNESP, Sch Agr & Veterinarian Sci, Lab Immunoparasitol,Dept Vet Pathol, Jaboticabal, SP, Brazil; [do Amaral, Renan Bressianini; Garcia, Amanda Barbosa; Machado, Rosangela Zacarias; Andre, Marcos Rogerio] Univ Estadual Paulista, UNESP, Sch Agr & Veterinarian Sci, Agr & Livestock Microbiol Graduat Program, Jaboticabal, SP, Brazil; [Lourenco, Elizabete Captivo; Famadas, Katie Maria] UFRRJ, Inst Vet, Dept Anim Parasitol, Lab Parasite Arthropods, Seropedica, RJ, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal Rural do Rio de Janeiro (UFRRJ)	Andre, MR (corresponding author), Univ Estadual Paulista, UNESP, Sch Agr & Veterinarian Sci, Lab Immunoparasitol,Dept Vet Pathol, Jaboticabal, SP, Brazil.; Andre, MR (corresponding author), Univ Estadual Paulista, UNESP, Sch Agr & Veterinarian Sci, Agr & Livestock Microbiol Graduat Program, Jaboticabal, SP, Brazil.	marcos_andre@fcav.unesp.br	Famadas, Kátia Maria/H-3461-2013; André, Marcos Rogério/C-4395-2012	Famadas, Kátia Maria/0000-0002-0157-962X; André, Marcos Rogério/0000-0002-1713-5222; Lourenco, ELIZABETE/0000-0002-6136-708X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo" (FAPESP) [2015/14896-1, 2016/12574-0]; "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq) [302420/2017-7]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo" (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We would like to thank "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" and "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo" (FAPESP) for the financial support (#2015/14896-1) and for the MSc grant (#2016/12574-0) awarded to Renan Bressianini do Amaral. MRA is a fellowship researcher of "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq Process number # 302420/2017-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andre MR, 2016, J FELINE MED SURG, V18, P783, DOI 10.1177/1098612X15593787; Bai Ying, 2012, Am J Trop Med Hyg, V87, P518, DOI 10.4269/ajtmh.2012.12-0097; Bai Y, 2011, EMERG INFECT DIS, V17, P1269, DOI 10.3201/eid1707.101867; Barker EW, 1952, INTRO ACAROLOGY; Benson DA, 2016, NUCL ACIDS RES, DOI 10.1093/nar/gkw1070; Billeter SA, 2012, PARASITOLOGY, V139, P324, DOI 10.1017/S0031182011002113; Breitschwerdt EB, 2014, ILAR J, V55, P46, DOI 10.1093/ilar/ilu015; Brook CE, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003532; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009011; Cicuttin GL, 2017, COMP IMMUNOL MICROB, V52, P1, DOI 10.1016/j.cimid.2017.04.004; Colborn JM, 2010, J CLIN MICROBIOL, V48, P4630, DOI 10.1128/JCM.00470-10; Concannon R, 2005, PARASITOLOGY, V131, P489, DOI 10.1017/S0031182005008097; D'Auria SRN, 2010, VECTOR-BORNE ZOONOT, V10, P459, DOI 10.1089/vbz.2009.0070; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davoust B, 2016, VECTOR-BORNE ZOONOT, V16, P516, DOI 10.1089/vbz.2015.1918; Dias D, 2008, REV BRAS ZOOL, V25, P333, DOI 10.1590/S0101-81752008000200023; Dick C.W., 2010, MANUAL CENTRAL AM DI, V2, P1249; Dick CW, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P179, DOI 10.1007/978-4-431-36025-4_11; Dick CW, 2005, J PARASITOL, V91, P1015, DOI 10.1645/GE-536R.1; Dick CW, 2006, CHECKLIST WORLD STRE; Dietrich M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152077; Dittmar K, 2015, PARASITE DIVERSITY AND DIVERSIFICATION: EVOLUTIONARY ECOLOGY MEETS PHYLOGENETICS, P246; Ellis BA, 1999, J INFECT DIS, V180, P220, DOI 10.1086/314824; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ferrari FAG, 2013, J MED ENTOMOL, V50, P1118, DOI 10.1603/ME13010; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Furman D., 1966, ECTOPARASITES PANAMA, P861; Gardner AL, 2007, MAMMALS S AM, V1, P187, DOI DOI 10.7208/CHICAG0/9780226282428.001.0001; Goncalves LR, 2016, APPL ENVIRON MICROB, V82, P7154, DOI 10.1128/AEM.02447-16; Graciolli G, 2008, MORCEGOS BRASIL BIOL, P123; Graciolli Gustavo, 2001, Revista Brasileira de Zoologia, V18, P907, DOI 10.1590/S0101-81752001000300026; Guerrero R, 1998, ACTA PARASITOL, V43, P86; Guerrero Ricardo, 1995, Acta Biologica Venezuelica, V15, P1; Guerrero Ricardo, 1996, Acta Biologica Venezuelica, V16, P1; Guerrero Ricardo, 1994, Acta Biologica Venezuelica, V15, P1; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harms A, 2012, CLIN MICROBIOL REV, V25, P42, DOI 10.1128/CMR.05009-11; Harrus S, 2007, AM J TROP MED HYG, V77, P133, DOI 10.4269/ajtmh.2007.77.133; Herrin CS, 1975, BRIGH YOUNG U SCI, V20, P172; Ikeda P., 2017, Epidemiology and Infection, V145, P2038, DOI 10.1017/s0950268817000966; Johnson G, 2003, J CLIN MICROBIOL, V41, P1069, DOI 10.1128/JCM.41.3.1069-1072.2003; Judson SD, 2015, ZOONOSES PUBLIC HLTH, V62, P609, DOI 10.1111/zph.12188; Kamani J, 2018, TICKS TICK-BORNE DIS, V9, P86, DOI 10.1016/j.ttbdis.2017.10.004; Kamani J, 2014, VECTOR-BORNE ZOONOT, V14, P625, DOI 10.1089/vbz.2013.1541; KOHLS GM, 1969, ANN ENTOMOL SOC AM, V62, P1035, DOI 10.1093/aesa/62.5.1035; Kosoy M, 2010, EMERG INFECT DIS, V16, P1875, DOI 10.3201/eid1612.100601; Kutty SN, 2010, SYST ENTOMOL, V35, P614, DOI 10.1111/j.1365-3113.2010.00536.x; La Scola B, 2003, TRENDS MICROBIOL, V11, P318, DOI 10.1016/S0966-842X(03)00143-4; Labruna MB, 2004, J MED ENTOMOL, V41, P1073, DOI 10.1603/0022-2585-41.6.1073; Labruna MB, 2004, J MED ENTOMOL, V41, P533, DOI 10.1603/0022-2585-41.3.533; Lack JB, 2011, J HERED, V102, P705, DOI 10.1093/jhered/esr090; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Landulfo GA, 2012, EXP APPL ACAROL, V58, P69, DOI 10.1007/s10493-012-9567-4; Leulmi H, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1316-9; Lilley TM, 2017, VECTOR-BORNE ZOONOT, V17, P243, DOI 10.1089/vbz.2016.2080; Lilley TM, 2015, VECTOR-BORNE ZOONOT, V15, P706, DOI 10.1089/vbz.2015.1783; Lin EY, 2010, EMERG INFECT DIS, V16, P500, DOI 10.3201/eid1603.081673; Lin JW, 2012, VET MICROBIOL, V156, P119, DOI 10.1016/j.vetmic.2011.09.031; Loftis AD, 2005, J MED ENTOMOL, V42, P473, DOI 10.1603/0022-2585(2005)042[0473:DORBAB]2.0.CO;2; Loftis AD, 2006, AM J TROP MED HYG, V75, P41, DOI 10.4269/ajtmh.2006.75.41; Lord CC, 2002, J MED ENTOMOL, V39, P417, DOI 10.1603/0022-2585-39.3.417; Lugarini C, 2015, TICKS TICK-BORNE DIS, V6, P364, DOI 10.1016/j.ttbdis.2015.02.011; MACHADO-ALLISON C. E., 1965, ACTA BIOL VENEZUELICA, V4, P259; Maggi RG, 2005, J MOL MICROB BIOTECH, V9, P44, DOI 10.1159/000088145; Maggi RG, 2005, J CLIN MICROBIOL, V43, P1171, DOI 10.1128/JCM.43.3.1171-1176.2005; Mancina Carlos A., 2010, Mammalian Species, P41, DOI 10.1644/852.1; Mannerings AO, 2016, EMERG INFECT DIS, V22, P922, DOI 10.3201/eid2205.151908; de Sousa KCM, 2018, MICROB ECOL, V76, P544, DOI 10.1007/s00248-017-1138-0; de Sousa KCM, 2018, TICKS TICK-BORNE DIS, V9, P10, DOI 10.1016/j.ttbdis.2017.10.015; Miller J, 2001, BAT FLIES LA SELVA D; Miller M.A., 2010, P GAT COMP ENV WORKS; Morse SF, 2012, INFECT GENET EVOL, V12, P1717, DOI 10.1016/j.meegid.2012.06.009; Muhldorfer K, 2013, ZOONOSES PUBLIC HLTH, V60, P93, DOI 10.1111/j.1863-2378.2012.01536.x; Nieri-Bastos FA, 2014, MEM I OSWALDO CRUZ, V109, P259, DOI 10.1590/0074-0276140283; NORMAN AF, 1995, J CLIN MICROBIOL, V33, P1797, DOI 10.1128/JCM.33.7.1797-1803.1995; Nunes H, 2017, URBAN ECOSYST, V20, P953, DOI 10.1007/s11252-016-0632-3; Ogrzewalska M, 2014, TICKS TICK-BORNE DIS, V5, P83, DOI 10.1016/j.ttbdis.2013.08.004; Olival KJ, 2015, J WILDLIFE DIS, V51, P274, DOI 10.7589/2014-04-113; Pacheco RC, 2007, EXP APPL ACAROL, V43, P63, DOI 10.1007/s10493-007-9099-5; Paziewska A, 2011, MICROB ECOL, V61, P134, DOI 10.1007/s00248-010-9735-1; Pereira JS, 2017, PESQUI VET BRASIL, V37, P741, DOI [10.1590/S0100-736X2017000700015, 10.1590/s0100-736x2017000700015]; Petersen FT, 2007, MOL PHYLOGENET EVOL, V45, P111, DOI 10.1016/j.ympev.2007.04.023; Piksa K, 2016, PARASITOL RES, V115, P1727, DOI 10.1007/s00436-016-4936-2; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Radovsky R J, 1966, J Med Entomol, V3, P93; Redondo RAF, 2008, MOL PHYLOGENET EVOL, V49, P44, DOI 10.1016/j.ympev.2008.07.001; Reeves WK, 2007, EXP APPL ACAROL, V41, P101, DOI 10.1007/s10493-006-9040-3; Reeves WK, 2006, J VECTOR ECOL, V31, P386, DOI 10.3376/1081-1710(2006)31[386:SSOEFF]2.0.CO;2; Reeves WK, 2005, J VECTOR ECOL, V30, P339; Reeves WK, 2005, J VECTOR ECOL, V30, P310; Reeves WK, 2016, J MED ENTOMOL, V9; REGNERY RL, 1991, J BACTERIOL, V173, P1576, DOI 10.1128/jb.173.5.1576-1589.1991; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roux V, 2000, INT J SYST EVOL MICR, V50, P1449, DOI 10.1099/00207713-50-4-1449; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Socolovschi C, 2012, EMERG INFECT DIS, V18, P1966, DOI 10.3201/eid1812.111237; Solari S, 2009, ACTA CHIROPTEROL, V11, P279, DOI 10.3161/150811009X485521; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Stuckey MJ, 2017, AM J TROP MED HYG, V97, P413, DOI 10.4269/ajtmh.16-0680; Stuckey MJ, 2017, EMERG INFECT DIS, V23, P539, DOI 10.3201/eid2303.160934; Tahir D, 2016, TICKS TICK-BORNE DIS, V7, P1089, DOI 10.1016/j.ttbdis.2016.09.004; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Veikkolainen V, 2014, EMERG INFECT DIS, V20, P960, DOI 10.3201/eid2006.130956; Venzal Jose M., 2004, Systematic and Applied Acarology, V9, P37; Wenzel R.L., 1976, Science Bull Brigham Young Univ ( Biol), V20, P1; Wenzel R. L., 1966, P405; Wilkinson DA, 2016, APPL ENVIRON MICROB, V82, P1778, DOI 10.1128/AEM.03505-15; Witter R, 2016, TICKS TICK-BORNE DIS, V7, P415, DOI 10.1016/j.ttbdis.2015.12.019; Wray AK, 2016, ECOHEALTH, V13, P761, DOI 10.1007/s10393-016-1183-z; Zeaiter Z, 2002, INT J SYST EVOL MICR, V52, P165, DOI 10.1099/00207713-52-1-165	115	10	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0198629	10.1371/journal.pone.0198629	http://dx.doi.org/10.1371/journal.pone.0198629			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870549	Green Published, gold, Green Submitted			2022-12-26	WOS:000434128400032
J	Wang, XF; Liu, XS; Li, F; Zhou, H; Li, JF; Wang, YY; Liu, LH; Liu, SJ; Feng, Y; Wang, N				Wang, Xianfeng; Liu, Xiaosong; Li, Feng; Zhou, Hong; Li, Jiefang; Wang, Yingying; Liu, Lihua; Liu, Shujun; Feng, Yi; Wang, Ning			Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014-2015	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PREVALENCE; SEX; MEN; TRANSMISSION; REGIMENS; CRF01-AE	Background The widespread use of antiretroviral therapy (ART) has led to considerable concerns about the prevalence of transmitted drug resistance (TDR). Sexual contact, particularly men who have sex with men (MSM) was the most prevalent form of HIV transmission in Shijiazhuang. Hence, we conducted an epidemiological surveillance study on TDR among newly diagnosed individuals who infected-HIV through sexual contact in from 2014-2015. Methods Genotypic resistance mutations were defined using the WHO-2009 surveillance list. Potential impact on antiretroviral drug was predicted according to the Stanford HIV db program version 7.0. The role of transmission clusters in drug resistant strains was evaluated by phylogenetic and network analyses. Results In this study, 589 individuals were recruited and 542 samples were amplified and sequenced successfully. The over prevalence of TDR was 6.1%: 1.8% to nucleoside reverse transcriptase inhibitors (NRTIs), 2.0% to non- NRTIs (NNRTIs) and 2.4% to protease inhibitors (Pis), respectively. We did not find significant differences in the TDR prevalence by demographic and clinical characteristics (p > 0.05). Using network and phylogenetic analysis, almost 60.0% sequences were clustered together. Of these clusters, 2 included at least two individuals carrying the same resistance mutation, accounting for 21.2% (7/33) individuals with TDR. No significant difference was observed in the clustering rate between the individuals with and without TDR. Conclusions We obtained a moderate level TDR rate in studied region. These findings enhance our understanding of HIV-1 drug resistance prevalence in Shijiazhuang, and may be helpful for the comprehensive prevention and control of HIV-1.	[Wang, Xianfeng; Liu, Xiaosong; Li, Feng; Zhou, Hong; Li, Jiefang; Wang, Yingying; Liu, Lihua; Liu, Shujun] Shijiazhuang Ctr Dis Control & Prevent, Shijiazhuang, Hebei, Peoples R China; [Wang, Xianfeng; Feng, Yi; Wang, Ning] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, N (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wangnbj@163.com	Li, jie/GXG-4583-2022; wang, yi/GVT-8516-2022; wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022	Wang, Xianfeng/0000-0003-4382-9129	Ministry of Science and Technology of China 12th Five-Year Plan of China [2012ZX10001-001]; Ministry of Science and Technology of China [2012ZX10001-001]	Ministry of Science and Technology of China 12th Five-Year Plan of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the Ministry of Science and Technology of China 12th Five-Year Plan of China (2012ZX10001-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Ministry of Science and Technology of China (2012ZX10001-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P1047, DOI 10.1093/jac/dkm082; Chen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087033; Dai LL, 2014, VIRAL IMMUNOL, V27, P392, DOI 10.1089/vim.2014.0025; Feng Y, 2013, AIDS, V27, P1793, DOI 10.1097/QAD.0b013e328360db2d; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Hao MQ, 2017, AIDS RES HUM RETROV, V33, P970, DOI [10.1089/aid.2017.0053, 10.1089/AID.2017.0053]; Hattori J, 2016, JAIDS-J ACQ IMM DEF, V71, P367, DOI 10.1097/QAI.0000000000000861; Hauser A, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.2.30436; Hofstra LM, 2016, CLIN INFECT DIS, V62, P655, DOI 10.1093/cid/civ963; Li HP, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1928-x; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075777; Li L, 2011, INFECT GENET EVOL, V11, P1487, DOI 10.1016/j.meegid.2011.05.017; Li LN, 2014, AIDS RES HUM RETROV, V30, P160, DOI [10.1089/aid.2013.0144, 10.1089/AID.2013.0144]; Li XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129559; Liao LJ, 2012, CLIN INFECT DIS, V54, pS320, DOI 10.1093/cid/cir1016; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Lin B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181997; Lu XL, 2017, AIDS RES HUM RETROV, V33, P359, DOI [10.1089/aid.2016.0231, 10.1089/AID.2016.0231]; Onywera H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171124; Oster AM, 2015, JAIDS-J ACQ IMM DEF, V70, P444, DOI 10.1097/QAI.0000000000000809; Panichsillapakit T, 2016, JAIDS-J ACQ IMM DEF, V71, P228, DOI 10.1097/QAI.0000000000000831; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Sallam Malik, 2017, Infection Ecology & Epidemiology, V7, P1328964, DOI 10.1080/20008686.2017.1328964; Su YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110652; Tang MW, 2012, INTERVIROLOGY, V55, P98, DOI 10.1159/000331998; Todesco E, 2017, HIV MED, V18, P696, DOI 10.1111/hiv.12508; Tostevin A, 2017, HIV MED, V18, P204, DOI 10.1111/hiv.12414; Vega Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125699; Velasco-de-Castro CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087622; Wang XC, 2015, CLIN INFECT DIS, V61, P1462, DOI 10.1093/cid/civ526; Wertheim JO, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex008; Wertheim JO, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006000; Wertheim JO, 2014, J INFECT DIS, V209, P304, DOI 10.1093/infdis/jit524; Xing H, 2015, J ANTIMICROB CHEMOTH, V70, P2097, DOI 10.1093/jac/dkv078; Yang J, 2013, ARCH VIROL, V158, P839, DOI 10.1007/s00705-012-1557-7; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zhang J, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000894; Zhao B, 2015, JAIDS-J ACQ IMM DEF, V68, P250, DOI 10.1097/QAI.0000000000000467; Zhao J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28703	41	9	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0198005	10.1371/journal.pone.0198005	http://dx.doi.org/10.1371/journal.pone.0198005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870534	Green Published, gold, Green Submitted			2022-12-26	WOS:000434128400012
J	Bolduc, JA; Nelson, KJ; Haynes, AC; Lee, J; Reisz, JA; Graff, AH; Clodfelter, JE; Parsonage, D; Poole, LB; Furdui, CM; Lowther, WT				Bolduc, Jesalyn A.; Nelson, Kimberly J.; Haynes, Alexina C.; Lee, Jingyun; Reisz, Julie A.; Graff, Aaron H.; Clodfelter, Jill E.; Parsonage, Derek; Poole, Leslie B.; Furdui, Cristina M.; Lowther, W. Todd			Novel hyperoxidation resistance motifs in 2-Cys peroxiredoxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; ANTIOXIDANT; REVEALS; INTERMEDIATE; INACTIVATION; SENSITIVITY; REDUCTASE	2-Cys peroxiredoxins (Prxs) modulate hydrogen peroxide (H2O2)-mediated cell signaling. At high H2O2 levels, eukaryotic Prxs can be inactivated by hyperoxidation and are classified as sensitive Prxs. In contrast, prokaryotic Prxs are categorized as being resistant to hyperoxidation and lack the GGLG and C-terminal YF motifs present in the sensitive Prxs. Additional molecular determinants that account for the subtle differences in the susceptibility to hyperoxidation remain to be identified. A comparison of a new, 2.15-angstrom-resolution crystal structure of Prx2 in the oxidized, disulfide-bonded state with the hyperoxidized structure of Prx2 and Prx1 in complex with sulfiredoxin revealed three structural regions that rearrange during catalysis. With these regions in hand, focused sequence analyses were performed comparing sensitive and resistant Prx groups. From this combinatorial approach, we discovered two novel hyperoxidation resistance motifs, motifs A and B, which were validated using mutagenesis of sensitive human Prxs and resistant Salmonella enterica serovar Typhimurium AhpC. Introduction and removal of these motifs, respectively, resulted in drastic changes in the sensitivity to hyperoxidation with Prx1 becoming 100-fold more resistant to hyperoxidation and AhpC becoming 800-fold more sensitive to hyperoxidation. The increased sensitivity of the latter AhpC variant was also confirmed in vivo. These results support the function of motifs A and B as primary drivers for tuning the sensitivity of Prxs to different levels of H2O2, thus enabling the initiation of variable signaling or antioxidant responses in cells.	[Bolduc, Jesalyn A.; Nelson, Kimberly J.; Haynes, Alexina C.; Graff, Aaron H.; Clodfelter, Jill E.; Parsonage, Derek; Poole, Leslie B.; Lowther, W. Todd] Wake Forest Sch Med, Struct Biol Ctr, Dept Biochem, Winston Salem, NC 27157 USA; [Reisz, Julie A.; Furdui, Cristina M.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Lee, Jingyun; Poole, Leslie B.; Furdui, Cristina M.; Lowther, W. Todd] Wake Forest Sch Med, Wake Forest Baptist Comprehens Canc Ctr, Winston Salem, NC 27157 USA; [Poole, Leslie B.; Furdui, Cristina M.; Lowther, W. Todd] Wake Forest Sch Med, Ctr Redox Biol & Med, Winston Salem, NC 27157 USA; [Poole, Leslie B.; Furdui, Cristina M.; Lowther, W. Todd] Wake Forest Univ, Ctr Mol Signaling, Winston Salem, NC 27101 USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest University	Lowther, WT (corresponding author), Wake Forest Sch Med, Struct Biol Ctr, Dept Biochem, Winston Salem, NC 27157 USA.	tlowther@wakehealth.edu		Nelson, Kimberly/0000-0003-2464-7696; Bolduc, Jesalyn/0000-0002-3950-7453; Furdui, Cristina M./0000-0003-3771-7999; Poole, Leslie/0000-0003-0334-7328	National Institutes of Health [GM072866, GM050389, GM119227]; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119227, R01GM050389, R01GM072866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM072866 (to W. T. L.) and GM050389 and GM119227 (to L. B. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Cao Z, 2007, J MOL BIOL, V372, P1022, DOI 10.1016/j.jmb.2007.07.018; Cao ZB, 2011, J BIOL CHEM, V286, P42257, DOI 10.1074/jbc.M111.298810; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Cox AG, 2009, BIOCHEM J, V421, P51, DOI 10.1042/BJ20090242; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dvorak P, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0393-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Haynes AC, 2013, J BIOL CHEM, V288, P29714, DOI 10.1074/jbc.M113.473470; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jara M, 2008, GENES CELLS, V13, P171, DOI 10.1111/j.1365-2443.2007.01160.x; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Kim SU, 2013, J NEUROIMMUNOL, V259, P26, DOI 10.1016/j.jneuroim.2013.03.006; Koo KH, 2002, ARCH BIOCHEM BIOPHYS, V397, P312, DOI 10.1006/abbi.2001.2700; Lee WS, 2007, J BIOL CHEM, V282, P22011, DOI 10.1074/jbc.M610330200; Leichert LI, 2015, BIOL CHEM, V396, P389, DOI 10.1515/hsz-2014-0314; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Lowther WT, 2011, ANTIOXID REDOX SIGN, V15, P99, DOI 10.1089/ars.2010.3564; Milev NB, 2015, TRENDS ENDOCRIN MET, V26, P430, DOI 10.1016/j.tem.2015.05.012; Morinaka A, 2011, ONCOGENE, V30, P4208, DOI 10.1038/onc.2011.139; Nelson KJ, 2013, METHOD ENZYMOL, V527, P21, DOI 10.1016/B978-0-12-405882-8.00002-7; Nelson Kimberly J, 2011, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0710s49; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace PE, 2013, BIOCHEM J, V453, P475, DOI 10.1042/BJ20130030; Park JG, 2011, CIRC RES, V109, P739, DOI 10.1161/CIRCRESAHA.111.245530; Park MH, 2016, PHARMACOL THERAPEUT, V163, P1, DOI 10.1016/j.pharmthera.2016.03.018; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Perkins A, 2016, STRUCTURE, V24, P1668, DOI 10.1016/j.str.2016.07.012; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Perkins A, 2014, BIOCHEMISTRY-US, V53, P7693, DOI 10.1021/bi5013222; Perkins A, 2013, BIOCHEMISTRY-US, V52, P8708, DOI 10.1021/bi4011573; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Poole LB, 1996, BIOCHEMISTRY-US, V35, P56, DOI 10.1021/bi951887s; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2016, FREE RADICAL BIO MED, V99, P120, DOI 10.1016/j.freeradbiomed.2016.07.029; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sayed AA, 2004, J BIOL CHEM, V279, P26159, DOI 10.1074/jbc.M401748200; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Winterbourn CC, 2013, METHOD ENZYMOL, V528, P3, DOI 10.1016/B978-0-12-405881-1.00001-X; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m	54	31	32	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11901	11912		10.1074/jbc.RA117.001690	http://dx.doi.org/10.1074/jbc.RA117.001690			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29884768	hybrid, Green Published			2022-12-26	WOS:000440134500022
J	Snider, SA; Margison, KD; Ghorbani, P; LeBlond, ND; O'Dwyer, C; Nunes, JRC; Nguyen, T; Xu, HB; Bennett, SAL; Fullerton, MD				Snider, Shayne A.; Margison, Kaitlyn D.; Ghorbani, Peyman; LeBlond, Nicholas D.; O'Dwyer, Conor; Nunes, Julia R. C.; Thao Nguyen; Xu, Hongbin; Bennett, Steffany A. L.; Fullerton, Morgan D.			Choline transport links macrophage phospholipid metabolism and inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						choline; macrophage; inflammation; phosphatidylcholine; phospholipid; choline transport; CTL1; Slc44a1; de novo lipogenesis	PROTEIN-KINASE-C; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; PHOSPHATIDYLCHOLINE SYNTHESIS; FUNCTIONAL-CHARACTERIZATION; PERITONEAL-MACROPHAGES; ENDOPLASMIC-RETICULUM; CYTOKINE SECRETION; ACTIVATION; EXPRESSION	Choline is an essential nutrient that is required for synthesis of the main eukaryote phospholipid, phosphatidylcholine. Macrophages are innate immune cells that survey and respond to danger and damage signals. Although it is well-known that energy metabolism can dictate macrophage function, little is known as to the importance of choline homeostasis in macrophage biology. We hypothesized that the uptake and metabolism of choline are important for macrophage inflammation. Polarization of primary bone marrow macrophages with lipopolysaccharide (LPS) resulted in an increased rate of choline uptake and higher levels of PC synthesis. This was attributed to a substantial increase in the transcript and protein expression of the choline transporter-like protein-1 (CTL1) in polarized cells. We next sought to determine the importance of choline uptake and CTL1 for macrophage immune responsiveness. Chronic pharmacological or CTL1 antibody-mediated inhibition of choline uptake resulted in altered cytokine secretion in response to LPS, which was associated with increased levels of diacylglycerol and activation of protein kinase C. These experiments establish a previously unappreciated link between choline phospholipid metabolism and macrophage immune responsiveness, highlighting a critical and regulatory role for macrophage choline uptake via the CTL1 transporter.	[Snider, Shayne A.; Margison, Kaitlyn D.; Ghorbani, Peyman; LeBlond, Nicholas D.; O'Dwyer, Conor; Nunes, Julia R. C.; Thao Nguyen; Xu, Hongbin; Bennett, Steffany A. L.; Fullerton, Morgan D.] Univ Ottawa, Ctr Infect Immun & Inflammat, Fac Med, Ottawa, ON K1H 8M5, Canada; [Snider, Shayne A.; Margison, Kaitlyn D.; Ghorbani, Peyman; LeBlond, Nicholas D.; O'Dwyer, Conor; Nunes, Julia R. C.; Thao Nguyen; Xu, Hongbin; Bennett, Steffany A. L.; Fullerton, Morgan D.] Univ Ottawa, Ctr Catalysis Res & Innovat, Fac Med, Ottawa, ON K1H 8M5, Canada; [Thao Nguyen; Xu, Hongbin; Bennett, Steffany A. L.] Univ Ottawa, Fac Med, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Thao Nguyen; Xu, Hongbin; Bennett, Steffany A. L.; Fullerton, Morgan D.] Univ Ottawa, Fac Med, Brain & Mind Inst, Ottawa, ON K1H 8M5, Canada; [Snider, Shayne A.; Margison, Kaitlyn D.; Ghorbani, Peyman; LeBlond, Nicholas D.; O'Dwyer, Conor; Nunes, Julia R. C.; Thao Nguyen; Xu, Hongbin; Bennett, Steffany A. L.; Fullerton, Morgan D.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, 4109A Roger Guindon Hall,451 Smyth Rd, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa	Fullerton, MD (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, 4109A Roger Guindon Hall,451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	morgan.fullerton@uottawa.ca	Nguyen-Tran, Thao/ABE-1326-2021; xu, hong/GSD-8903-2022	Nguyen-Tran, Thao/0000-0002-5507-618X; Nunes, Julia/0000-0003-2095-8972; Ghorbani, Peyman/0000-0002-7398-5141	Natural Science and Engineering Research Council (NSERC) of Canada [RGPIN-2015-04004, RGPIN-2015-5377]; Canadian Institutes of Health [MOP 311838]; NSERC Canadian Graduate Scholarship; Ontario Graduate Scholarship; Canadian Institutes of Health Research New Investigator Award [MSH141981]; Ontario Ministry of Research, Innovation; Science Early Researcher Award	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); NSERC Canadian Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research, Innovation(Ministry of Research and Innovation, Ontario); Science Early Researcher Award	This work was supported by Natural Science and Engineering Research Council (NSERC) of Canada Discovery Grants RGPIN-2015-04004 (to M. D. F.) and RGPIN-2015-5377 (to S. A. L. B.) and Canadian Institutes of Health Research Grant MOP 311838 (to S. A. L. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an NSERC Canadian Graduate Scholarship.; Supported by an Ontario Graduate Scholarship.; Supported by Canadian Institutes of Health Research New Investigator Award MSH141981 and recipient of an Ontario Ministry of Research, Innovation, and Science Early Researcher Award.	Artyomov MN, 2016, SEMIN IMMUNOL, V28, P417, DOI 10.1016/j.smim.2016.10.004; Asehnoune K, 2005, CELL SIGNAL, V17, P385, DOI 10.1016/j.cellsig.2004.08.005; Balsinde J, 1997, J BIOL CHEM, V272, P20373, DOI 10.1074/jbc.272.33.20373; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHU AJ, 1992, INT J BIOCHEM, V24, P317, DOI 10.1016/0020-711X(92)90264-2; Cornell RB, 2015, PROG LIPID RES, V59, P147, DOI 10.1016/j.plipres.2015.07.001; da Costa KA, 2014, FASEB J, V28, P2970, DOI 10.1096/fj.14-249557; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Ecker J, 2010, P NATL ACAD SCI USA, V107, P7817, DOI 10.1073/pnas.0912059107; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Feingold KR, 2012, J LEUKOCYTE BIOL, V92, P829, DOI 10.1189/jlb.1111537; Foey AD, 2004, IMMUNOLOGY, V112, P44, DOI 10.1111/j.1365-2567.2004.01852.x; Fujita T, 2006, NEUROSCI LETT, V393, P216, DOI 10.1016/j.neulet.2005.09.069; Fullerton MD, 2006, AM J PHYSIOL-CELL PH, V290, pC1230, DOI 10.1152/ajpcell.00255.2005; Fullerton MD, 2015, J LIPID RES, V56, P1025, DOI 10.1194/jlr.M058875; Fullerton MD, 2009, J BIOL CHEM, V284, P25704, DOI 10.1074/jbc.M109.023846; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Gorboulev V, 1997, DNA CELL BIOL, V16, P871, DOI 10.1089/dna.1997.16.871; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; GROVE RI, 1990, J LEUKOCYTE BIOL, V48, P38, DOI 10.1002/jlb.48.1.38; Haga T, 2014, J BIOCHEM, V156, P181, DOI 10.1093/jb/mvu047; Huang YL, 2014, J BIOL CHEM, V289, P3001, DOI 10.1074/jbc.M113.524587; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Inazu M, 2005, J NEUROCHEM, V94, P1427, DOI 10.1111/j.1471-4159.2005.03299.x; Ishiguro N, 2008, PHARM RES-DORDR, V25, P417, DOI 10.1007/s11095-007-9362-9; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Langston PK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00061; Lennartz MR, 1999, INT J BIOCHEM CELL B, V31, P415, DOI 10.1016/S1357-2725(98)00108-3; Leonardi R, 2009, J BIOL CHEM, V284, P27077, DOI 10.1074/jbc.M109.031336; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manderson AP, 2007, J CELL BIOL, V178, P57, DOI 10.1083/jcb.200612131; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Michel V, 2009, FASEB J, V23, P2749, DOI 10.1096/fj.08-121491; Murray RZ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00538; Nishitoh H, 2012, J BIOCHEM, V151, P217, DOI 10.1093/jb/mvr143; Norata GD, 2015, IMMUNITY, V43, P421, DOI 10.1016/j.immuni.2015.08.023; Okuda T, 2000, NAT NEUROSCI, V3, P120, DOI 10.1038/72059; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Rowley TJ, 2010, BRIT J ANAESTH, V105, P201, DOI 10.1093/bja/aeq113; Ryan SD, 2009, P NATL ACAD SCI USA, V106, P20936, DOI 10.1073/pnas.0905654106; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; Selathurai A, 2015, CELL METAB, V21, P718, DOI 10.1016/j.cmet.2015.04.001; Sweet DH, 2001, J BIOL CHEM, V276, P41611, DOI 10.1074/jbc.M108472200; Tian Y, 2008, J CELL BIOL, V181, P945, DOI 10.1083/jcb.200706152; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Traiffort E, 2013, MOL ASPECTS MED, V34, P646, DOI 10.1016/j.mam.2012.10.011; Treede I, 2007, J BIOL CHEM, V282, P27155, DOI 10.1074/jbc.M704408200; Van der Sanden MHM, 2003, BIOCHEM J, V369, P643, DOI 10.1042/BJ20020285; Whitehead SN, 2007, ANAL CHEM, V79, P8539, DOI 10.1021/ac0712291; Wille S, 2001, J IMMUNOL, V167, P5795, DOI 10.4049/jimmunol.167.10.5795; Xu HB, 2013, FEBS J, V280, P5652, DOI 10.1111/febs.12423; Yen CLE, 1999, FASEB J, V13, P135, DOI 10.1096/fasebj.13.1.135; Yuan ZF, 2006, PHYSIOL GENOMICS, V26, P76, DOI 10.1152/physiolgenomics.00107.2005; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061; Zhang CP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00341-2; Zhou XY, 2006, J BIOL CHEM, V281, P31337, DOI 10.1074/jbc.M602739200	59	46	48	6	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11600	11611		10.1074/jbc.RA118.003180	http://dx.doi.org/10.1074/jbc.RA118.003180			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29880645	hybrid, Green Published			2022-12-26	WOS:000439449700028
J	Boillat-Blanco, N; Mbarack, Z; Samaka, J; Mlaganile, T; Mamin, A; Genton, B; Kaiser, L; Calandra, T; D'Acremont, V				Boillat-Blanco, Noemie; Mbarack, Zainab; Samaka, Josephine; Mlaganile, Tarsis; Mamin, Aline; Genton, Blaise; Kaiser, Laurent; Calandra, Thierry; D'Acremont, Valerie			Prognostic value of quickSOFA as a predictor of 28-day mortality among febrile adult patients presenting to emergency departments in Dar es Salaam, Tanzania	PLOS ONE			English	Article							ORGAN FAILURE ASSESSMENT; INTERNATIONAL CONSENSUS DEFINITIONS; INFLAMMATORY RESPONSE SYNDROME; SUSPECTED INFECTION; SEPSIS; CRITERIA; MALARIA; SCORES; FEVER; QSOFA	Background Quick Sequential Organ Failure Assessment (qSOFA) is a three-item clinical instrument for bedside identification of sepsis patients at risk of poor outcome. qSOFA could be a valuable triage tool in emergency departments of low-income countries, yet its performance in resource-limited settings remains unknown. The prognostic accuracy of qSOFA for 28-day all-cause mortality in febrile adults treated at the EDs in a low-income country was evaluated. Methods Retrospective analysis of a prospective cohort study of consecutive patients (>= 18 years) with fever (tympanic temperature >= 38 degrees C and fever <= 7 days) who presented between July 2013 and May 2014 at four emergency departments in Dar es Salaam, Tanzania. Medical history, clinical examination, laboratory and microbiological data were collected to document the cause of fever. Variables for the previous and new sepsis criteria were collected at inclusion and qSOFA, SOFA and SIRS were measured at inclusion. Patients were followed up by phone at day 28. The performance (sensitivity, specificity and area under the receiver operating curve [AUROC]) of qSOFA (score >= 2), SOFA (increase of >= 2 points) and SIRS (>= 2 criteria) as predictors of 28-day all-cause mortality was evaluated. Results Among the 519 patients (median age: 30 years) included in the analysis, 47% were female and 25% were HIV positive. Overall, 85% had a microbiologically and/or clinically documented infection and 15% a fever of unknown origin. The most common site and causes of infections were the respiratory tract (43%), dengue (26%), malaria (6%) and typhoid fever (5%). Twenty-eight-day all-cause mortality was 6%: 3% for patients with a qSOFA <2 and 24% for those with a score >= 2 (absolute difference, 21%; 95% CI 12%31%). The prognostic accuracy of qSOFA (AUROC 0.80, 95% CI 0.73-0.87) for 28-day mortality was similar to SOFA (AUROC 0.79, 0.71-0.87; p = 0.1) and better than SIRS (AUROC 0.61, 0.52-0.71; p<0.001). Conclusions Among patients with fever at emergency departments in Tanzania, qSOFA had a prognostic accuracy for 28-day mortality comparable to SOFA and superior to SIRS. These results support the use of qSOFA as a triage tool to identify patients with sepsis and at risk of poor outcome in resource-limited countries.	[Boillat-Blanco, Noemie; Genton, Blaise; D'Acremont, Valerie] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Boillat-Blanco, Noemie; Genton, Blaise; D'Acremont, Valerie] Univ Basel, Basel, Switzerland; [Boillat-Blanco, Noemie; Samaka, Josephine; Mlaganile, Tarsis] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Boillat-Blanco, Noemie; Genton, Blaise; Calandra, Thierry] Univ Hosp Lausanne, Infect Dis Serv, Lausanne, Switzerland; [Mbarack, Zainab] Mwananyamala Hosp, Dar Es Salaam, Tanzania; [Mamin, Aline; Kaiser, Laurent] Univ Geneva Hosp, Infect Dis Serv, Lab Virol, Geneva, Switzerland; [Genton, Blaise; D'Acremont, Valerie] Univ Hosp Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Kaiser, Laurent] Univ Geneva, Med Sch, Geneva, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Ifakara Health Institute; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva	Boillat-Blanco, N (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Boillat-Blanco, N (corresponding author), Univ Basel, Basel, Switzerland.; Boillat-Blanco, N (corresponding author), Ifakara Hlth Inst, Dar Es Salaam, Tanzania.; Boillat-Blanco, N (corresponding author), Univ Hosp Lausanne, Infect Dis Serv, Lausanne, Switzerland.	noemie.boillat@chuv.ch	Boillat-Blanco, Noémie/GLT-5579-2022; Calandra, Thierry/D-9017-2015	Calandra, Thierry/0000-0003-3051-1285; de Kaenel, Isabelle/0000-0002-6124-7846; Boillat-Blanco, Noemie/0000-0002-2490-8174; Kaiser, Laurent/0000-0002-0857-2252	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by Bill and Melinda Gates Foundation. The funding body had no role in the design of the study and collection, analysis and interpretation of data and in writing the manuscript.	Churpek MM, 2017, AM J RESP CRIT CARE, V195, P906, DOI 10.1164/rccm.201604-0854OC; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Dunser MW, 2012, INTENS CARE MED, V38, P557, DOI [10.1007/s00134-012-2468-5, 10.1007/s00134-012-2521-4]; Finkelsztein EJ, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1658-5; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Freund Y, 2017, JAMA-J AM MED ASSOC, V317, P301, DOI 10.1001/jama.2016.20329; Giamarellos-Bourboulis EJ, 2017, CLIN MICROBIOL INFEC, V23, P104, DOI 10.1016/j.cmi.2016.11.003; Huson MAM, 2017, TRAVEL MED INFECT DI, V15, P76, DOI 10.1016/j.tmaid.2016.10.014; Park HK, 2017, J CRIT CARE, V42, P12, DOI 10.1016/j.jcrc.2017.06.020; Peters RPH, 2004, TROP MED INT HEALTH, V9, P928, DOI 10.1111/j.1365-3156.2004.01288.x; PETIT PLC, 1995, J TROP MED HYG, V98, P217; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Singer AJ, 2017, ANN EMERG MED, V69, P475, DOI 10.1016/j.annemergmed.2016.10.007; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Wang JY, 2016, AM J EMERG MED, V34, P1788, DOI 10.1016/j.ajem.2016.06.015	17	20	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0197982	10.1371/journal.pone.0197982	http://dx.doi.org/10.1371/journal.pone.0197982			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902174	Green Published, gold, Green Accepted			2022-12-26	WOS:000435424900011
J	Niu, K; Homminga, J; Sluiter, VI; Sprengers, A; Verdonschot, N				Niu, Kenan; Homminga, Jasper; Sluiter, Victor, I; Sprengers, Andre; Verdonschot, Nico			Feasibility of A-mode ultrasound based intraoperative registration in computer-aided orthopedic surgery: A simulation and experimental study	PLOS ONE			English	Article							ASSISTED NAVIGATION; KNEE; ULTRASONOGRAPHY; ARTHROPLASTY; IMAGES; HIP	Purpose A fast and accurate intraoperative registration method is important for Computer-Aided Orthopedic Surgery (CAOS). A-mode ultrasound (US) is able to acquire bone surface data in a non-invasive manner. To utilize A-mode US in CAOS, a suitable registration algorithm is necessary with a small number of registration points and the presence of measurement errors. Therefore, we investigated the effects of (1) the number of registration points and (2) the Ultrasound Point Localization Error (UPLE) on the overall registration accuracy. Methods We proposed a new registration method (ICP-PS), including the Iterative Closest Points (ICP) algorithm and a Perturbation Search algorithm. This method enables to avoid getting stuck in the local minimum of ICP iterations and to find the adjacent global minimum. This registration method was subsequently validated in a numerical simulation and a cadaveric experiment using a 3D-tracked A-mode US system. Results The results showed that ICP-PS outperformed the standard ICP algorithm. The registration accuracy improved with the addition of ultrasound registration points. In the numerical simulation, for 25 sample points with zero UPLE, the averaged registration error of ICP-PS reached 0.25 mm, while 1.71 mm for ICP, decreasing by 85.38%. In the cadaver experiment, using 25 registration points, ICP-PS achieved an RMSE of 2.81 mm relative to 5.84 mm for the ICP, decreasing by 51.88%. Conclusions The simulation approach provided a well-defined framework for estimating the necessary number of ultrasound registration points and acceptable level of UPLE for a given required level of accuracy for intraoperative registration in CAOS. ICP-PS method is suitable for A mode US based intraoperative registration. This study would facilitate the application of A mode US probe in registering the point cloud to a known shape model, which also has the potential for accurately estimating bone position and orientation for skeletal motion tracking and surgical navigation.	[Niu, Kenan; Homminga, Jasper; Sluiter, Victor, I; Verdonschot, Nico] Univ Twente, Fac Engn Technol, MIRA Inst, Lab Biomech Engn, Enschede, Netherlands; [Sprengers, Andre; Verdonschot, Nico] Radboud Univ Nijmegen, Orthopaed Res Lab, Med Ctr, Nijmegen, Netherlands	University of Twente; Radboud University Nijmegen	Niu, K (corresponding author), Univ Twente, Fac Engn Technol, MIRA Inst, Lab Biomech Engn, Enschede, Netherlands.	niukenan@gmail.com	Niu, Kenan/L-4147-2018; Verdonschot, N.J.J./H-8104-2014	Niu, Kenan/0000-0002-5498-4311; Verdonschot, N.J.J./0000-0002-7531-6523	European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant [323091]	European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement n.[323091] (https://erc.europa.eu/projects-figures/erc-funded-projects/results?search_api_views_fulltext=Verdonschot,Verdorschot). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin Devin V, 2003, Comput Aided Surg, V8, P1, DOI 10.3109/10929080309146097; Amiot LP, 2004, CLIN ORTHOP RELAT R, P77, DOI 10.1097/01.blo.0000126866.29933.42; Amstutz C, 2003, ARCH OTOLARYNGOL, V129, P1310, DOI 10.1001/archotol.129.12.1310; Anderson KC, 2005, J ARTHROPLASTY, V20, P132, DOI 10.1016/j.arth.2005.05.009; Azhari H., 2010, APPENDIX A TYPICAL A, P313; Bachler R, 2001, Comput Aided Surg, V6, P143; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Caversaccio M, 1999, Comput Aided Surg, V4, P328, DOI 10.1002/(SICI)1097-0150(1999)4:6<328::AID-IGS5>3.0.CO;2-Y; Chang T. C., 2009, Proceedings 25th Southern Biomedical Engineering Conference (IFMBE 2009), P97, DOI 10.1007/978-3-642-01697-4_34; De Lorenzo D, 2009, MED IMAGING 2009 ULT; DiGioia AM, 2003, J ARTHROPLASTY, V18, P123, DOI 10.1054/arth.2003.50025; Fieten L, 2009, INT J COMPUT ASS RAD, V4, P225, DOI 10.1007/s11548-009-0288-z; FRIEDMAN JH, 1975, IEEE T COMPUT, V24, P1000, DOI 10.1109/T-C.1975.224110; Hamidzada WA, 1999, VET RADIOL ULTRASOUN, V40, P502, DOI 10.1111/j.1740-8261.1999.tb00382.x; Heger S, 2005, IEEE ENG MED BIOL, V24, P85, DOI 10.1109/MEMB.2005.1411353; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Jenny JY, 2007, CLIN ORTHOP RELAT R, P58, DOI 10.1097/BLO.0b013e318126c077; Jian B, 2011, IEEE T PATTERN ANAL, V33, P1633, DOI 10.1109/TPAMI.2010.223; Livyatan H, 2003, IEEE T MED IMAGING, V22, P1395, DOI 10.1109/TMI.2003.819288; Ma B, 2003, MED IMAGE ANAL, V7, P237, DOI 10.1016/S1361-8415(02)00133-0; Marotti J, 2013, OR SURG OR MED OR PA, V115, P819, DOI 10.1016/j.oooo.2013.03.012; Maurer CR, 1997, IEEE T MED IMAGING, V16, P447, DOI 10.1109/42.611354; Maurer CR, 1999, LECT NOTES COMPUT SC, V1679, P953; Maurer CR, 1998, IEEE T MED IMAGING, V17, P753, DOI 10.1109/42.736031; Mavrogenis AF, 2013, ORTHOPEDICS, V36, P631, DOI 10.3928/01477447-20130724-10; Mozes A, 2010, INT J MED ROBOT COMP, V6, P91, DOI 10.1002/rcs.294; Oszwald M, 2008, J ORTHOP RES, V26, P860, DOI 10.1002/jor.20551; Otake Y, 2012, IEEE T MED IMAGING, V31, P948, DOI 10.1109/TMI.2011.2176555; Pellikaan P, 2014, J BIOMECH, V47, P1144, DOI 10.1016/j.jbiomech.2013.12.010; Popovic A, 2005, INT CONGR SER, V1281, P821, DOI 10.1016/j.ics.2005.03.297; Sikorski JM, 2003, J BONE JOINT SURG BR, V85B, P319, DOI 10.1302/0301-620X.85B3.14212; Simon DA, 1997, LECT NOTES COMPUT SC, V1205, P181, DOI 10.1007/BFb0029237; Wolfsberger S, 2002, NEUROSURG REV, V25, P68, DOI 10.1007/s10143-001-0201-x	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0199136	10.1371/journal.pone.0199136	http://dx.doi.org/10.1371/journal.pone.0199136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897987	gold, Green Submitted, Green Published			2022-12-26	WOS:000435090700094
J	Fonseca-Alves, CE; Kobayashi, PE; Calderon, LGR; Felisbino, SL; Rinaldi, JD; Drigo, SA; Rogatto, SR; Laufer-Amorim, R				Fonseca-Alves, Carlos Eduardo; Kobayashi, Priscila Emiko; Rivera Calderon, Luis Gabriel; Felisbino, Sergio Luis; Rinaldi, Jaqueline de Carvalho; Drigo, Sandra Aparecida; Rogatto, Silvia Regina; Laufer-Amorim, Renee			Immunohistochemical panel to characterize canine prostate carcinomas according to aberrant p63 expression	PLOS ONE			English	Article							BASAL-CELLS; RADICAL-PROSTATECTOMY; CANCER MORTALITY; GENE-EXPRESSION; STEM-CELL; DOGS; MYC; CARCINOGENESIS; ADENOCARCINOMA; PROTEIN	An unusual variant of prostate adenocarcinoma (PC) expressing nuclear p63 in secretory cells instead of the typical basal expression has been reported in men. Nevertheless, the biological behavior and clinical significance of this phenomenon is unknown. In dogs, this unusual PC subtype has not been described. In this study, p63 immunoexpression was investigated in 90 canine PCs and 20 normal prostate tissues (NT). The p63 expression pattern in luminal or basal cells was confirmed in a selected group of 26 PCs and 20 NT by immunohistochemistry and/or Western blotting assays. Eleven canine PC samples aberrantly expressing p63 (p63+) in secretory cells were compared with 15 p63 negative (p63-) cases in the context of several molecular markers (high molecular weight cytokeratin-HMWC, CK8/18, CK5, AR, PSA, chromogranin, NKX3.1, PTEN, AKT and C-MYC). P63+ samples were positive for CK5, HMWC and CK8/18 and negative for PSA, NKX3.1, PTEN and chromogranin. Five p63+ PCs were negative for AR, and the remaining six samples had low AR expression. In contrast, p63- PC showed AR and PSA positive expression in all 15 samples. Only five p63- PCs were positive for CK5. Both p63+ and p63- PC samples showed higher cytoplasmic AKT expression and nuclear C-MYC staining in comparison with normal tissues. Metastatic (N = 12) and non-metastatic (N = 14) PCs showed similar immunoexpression for all markers tested. In contrast to human PC, canine PC aberrantly expressing p63 showed higher expression levels of HMWC and CK5 and lower levels of NKX3.1. Canine p63+ PC is a very rare PC group showing a distinct phenotype compared to typical canine PC, including AR and PSA negative expression. Although in a limited number of cases, p63 expression was not associated with metastasis in canine PC, and cytoplasmic p63 expression was observed in animals with shorter survival time, similar to human PC cases.	[Fonseca-Alves, Carlos Eduardo; Kobayashi, Priscila Emiko; Rivera Calderon, Luis Gabriel; Drigo, Sandra Aparecida; Laufer-Amorim, Renee] Sao Paulo State Univ UNESP, Sch Vet Med & Anim Sci, Dept Vet Clin, Botucatu, SP, Brazil; [Felisbino, Sergio Luis; Rinaldi, Jaqueline de Carvalho] Sao Paulo State Univ UNESP, Inst Biociencias, Dept Morphol, Botucatu, SP, Brazil; [Rogatto, Silvia Regina] Univ Southern Denmark, Vejle Hosp, Dept Clin Genet, Vejle, Denmark; [Rogatto, Silvia Regina] Univ Southern Denmark, Inst Reg Hlth Res, Vejle, Denmark	Universidade Estadual Paulista; Universidade Estadual Paulista; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark	Laufer-Amorim, R (corresponding author), Sao Paulo State Univ UNESP, Sch Vet Med & Anim Sci, Dept Vet Clin, Botucatu, SP, Brazil.	renee@fmvz.unesp.br	Drigo, Sandra A/I-6514-2012; Felisbino, Sergio L/K-7641-2012; LINDE, SANDRA/S-3128-2019; Rogatto, Silvia R/E-6535-2012; Fonseca-Alves, Carlos Eduardo/G-7554-2012; Rivera Calderon, Luis Gabriel/H-1996-2012	Drigo, Sandra A/0000-0001-6747-6642; LINDE, SANDRA/0000-0001-6747-6642; Fonseca-Alves, Carlos Eduardo/0000-0002-6702-6139; Kobayashi, Priscila Emiko/0000-0003-4958-5081; Rivera Calderon, Luis Gabriel/0000-0003-4455-8404; Rogatto, Silvia/0000-0003-4637-5687	Sao Paulo Research Foundation (FAPESP) [2012/18426-1, 2012/16068-0, 2010/13774-6]; National Council for Scientific and Technological Development (CNPq) [443884/2014-5]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by The ao Paulo Research Foundation (FAPESP # 2012/18426-1; 2012/16068-0 and 2010/13774-6); and the National Council for Scientific and Technological Development (CNPq # 443884/2014-5).	Akter SH, 2015, VET PATHOL, V52, P1027, DOI 10.1177/0300985815574008; Anderson PD, 2012, J CLIN INVEST, V122, P1907, DOI 10.1172/JCI58540; BOSTWICK DG, 1987, CANCER, V59, P788, DOI 10.1002/1097-0142(19870215)59:4<788::AID-CNCR2820590421>3.0.CO;2-I; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dhillon PK, 2009, CANCER EPIDEM BIOMAR, V18, P595, DOI 10.1158/1055-9965.EPI-08-0785; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Alves CEF, 2010, ARQ BRAS MED VET ZOO, V62, P596, DOI 10.1590/S0102-09352010000300014; Fonseca-Alves CE, 2013, MICROSC RES TECHNIQ, V76, P1250, DOI 10.1002/jemt.22292; Fonseca-Alves CE, 2018, RES VET SCI, V118, P365, DOI 10.1016/j.rvsc.2018.04.001; Fonseca-Alves CE, 2015, RES VET SCI, V102, P122, DOI 10.1016/j.rvsc.2015.08.007; Fonseca-Alves CE, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-88; Fonseca-Alves CE, 2015, RES VET SCI, V99, P1; Giannico GA, 2013, AM J SURG PATHOL, V37, P1401, DOI 10.1097/PAS.0b013e31828d5c32; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Lai CL, 2008, PROSTATE, V68, P477, DOI 10.1002/pros.20720; Leav I, 2001, PROSTATE, V47, P149, DOI 10.1002/pros.1058; Leite KRM, 2010, INT BRAZ J UROL, V36, P583, DOI 10.1590/S1677-55382010000500008; LeRoy BE, 2009, VET J, V180, P149, DOI 10.1016/j.tvjl.2008.07.012; Lu TL, 2013, AM J PATHOL, V182, P975, DOI 10.1016/j.ajpath.2012.11.025; Magalhaes GM, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-205; Matsuzaki P, 2010, J COMP PATHOL, V142, P84, DOI 10.1016/j.jcpa.2009.06.005; Moulay M, 2013, ANTICANCER RES, V33, P5421; Osunkoya AO, 2008, AM J SURG PATHOL, V32, P461, DOI 10.1097/PAS.0b013e318157020e; Palmieri C, 2015, RES VET SCI, V103, P11, DOI 10.1016/j.rvsc.2015.09.004; Paner GP, 2008, ARCH PATHOL LAB MED, V132, P1388, DOI 10.1043/1543-2165(2008)132[1388:BPIDIP]2.0.CO;2; Priolo C, 2014, CANCER RES, V74, P7198, DOI 10.1158/0008-5472.CAN-14-1490; Reuter VE., 2016, WHO CLASSIFICATION T; Rivera-Calderon LG, 2016, RES VET SCI, V106, P56, DOI 10.1016/j.rvsc.2016.03.008; Romanucci M, 2016, VET COMP ONCOL, V14, P337, DOI 10.1111/vco.12113; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Tani HL, 2015, MODERN PATHOL, V28, P446, DOI 10.1038/modpathol.2014.115; Teske E, 2002, MOL CELL ENDOCRINOL, V197, P251, DOI 10.1016/S0303-7207(02)00261-7; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Zhou M, 2003, AM J SURG PATHOL, V27, P365, DOI 10.1097/00000478-200303000-00010	34	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0199173	10.1371/journal.pone.0199173	http://dx.doi.org/10.1371/journal.pone.0199173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894516	Green Published, Green Submitted, gold			2022-12-26	WOS:000435030900050
J	Zhuang, KJ; Jiang, YJ; Feng, XH; Li, L; Dang, FF; Zhang, W; Man, CX				Zhuang, Kejin; Jiang, Yujun; Feng, Xiaohan; Li, Li; Dang, Fangfang; Zhang, Wei; Man, Chaoxin			Transcriptomic response to GABA-producing Lactobacillus plantarum CGMCC 1.2437(T) induced by L-MSG	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; COMPLETE GENOME SEQUENCE; GLUTAMATE-DECARBOXYLASE; LACTOCOCCUS-LACTIS; EXPRESSION; BACTERIA; GENE; IDENTIFICATION; METABOLISM; PYRUVATE	Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter found in the central nervous system of mammals. A range of bacterial species can synthesize GABA, including Lactobacillus plantarum of which L-monosodium glutamate (L-MSG) is an inducer of its production. In order to synthesize GABA in high concentrations, L-MSG was utilized as the single inducing factor, a chemically defined medium (CDM) was used as the fermentation substrate, with L. plantarum CGMCC 1.2437(T) cultured in medium supplemented with or without L-MSG. High-throughput transcriptome sequencing was used to explore the differential genes expression of bacterial cells at 36 h of fermentation, where the GABA concentration of CDM with L-MSG reached the peak value and was 7.7 times higher than that of medium without L-MSG at the same timepoint. A total of 87 genes showed significant differential expression induced by L-MSG: of these, 69 were up-regulated genes and 18 were down-regulated. The up-regulated genes were assigned to biological processes and molecular function, while the down-regulated genes covered biological process, cellular process and molecular function. Interrogation of results using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, indicated carbohydrate metabolism, fatty acid synthesis and amino acid metabolism were closely associated with GABA synthesis induced by L-MSG. This study provides insights into L. plantarum-mediated GABA fermentation at the molecular level and will provide a new approach for further studies related to GABA production by the other Lactic acid bacteria.	[Zhuang, Kejin; Jiang, Yujun; Feng, Xiaohan; Li, Li; Dang, Fangfang; Zhang, Wei; Man, Chaoxin] Northeast Agr Univ, Coll Food Sci & Technol, Minist Educ, Key Lab Dairy Sci, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Man, CX (corresponding author), Northeast Agr Univ, Coll Food Sci & Technol, Minist Educ, Key Lab Dairy Sci, Harbin, Heilongjiang, Peoples R China.	mcxwh2006@qq.com			"Academic Backbone" Project of Northeast Agricultural University [15XG26]; National High-level Talents Special Support Program of China	"Academic Backbone" Project of Northeast Agricultural University; National High-level Talents Special Support Program of China	This study was supported by Academic Backbone Project of Northeast Agricultural University (15XG26), http://www.neau.cn/info/1175/5879.htm, and National High-level Talents Special Support Program of China, http://rencai.people.com.cn/n1/2016/0620/c244800-28463348.html.	Adeghate E, 2002, TISSUE CELL, V34, P1, DOI 10.1054/tice.2002.0217; Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Broadbent JR, 2010, J BACTERIOL, V192, P2445, DOI 10.1128/JB.01618-09; Clark SM, 2009, J EXP BOT, V60, P1743, DOI 10.1093/jxb/erp044; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Silva DMD, 2009, J NEUROSCI METH, V177, P289, DOI 10.1016/j.jneumeth.2008.10.011; Di Cagno R, 2010, APPL MICROBIOL BIOT, V86, P731, DOI 10.1007/s00253-009-2370-4; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; DOVER S, 1972, J BACTERIOL, V110, P165, DOI 10.1128/JB.110.1.165-170.1972; Fan EY, 2012, ANN MICROBIOL, V62, P689, DOI 10.1007/s13213-011-0307-5; FATH MJ, 1993, MICROBIOL REV, V57, P995, DOI 10.1128/MMBR.57.4.995-1017.1993; Feehily C, 2013, J APPL MICROBIOL, V114, P11, DOI 10.1111/j.1365-2672.2012.05434.x; Feehily C, 2013, APPL ENVIRON MICROB, V79, P74, DOI 10.1128/AEM.02184-12; Fernandez A, 2008, PROTEOMICS, V8, P3154, DOI 10.1002/pmic.200700974; Fernandez M, 2006, CRIT REV MICROBIOL, V32, P155, DOI 10.1080/10408410600880643; Hagiwara H, 2004, BIOSCI BIOTECH BIOCH, V68, P444, DOI 10.1271/bbb.68.444; Higuchi T, 1997, J BACTERIOL, V179, P3362, DOI 10.1128/JB.179.10.3362-3364.1997; Hovik H, 2012, J BACTERIOL, V194, P100, DOI 10.1128/JB.06385-11; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Kim JY, 2009, INT J FOOD MICROBIOL, V130, P12, DOI 10.1016/j.ijfoodmicro.2008.12.028; Kleerebezem M, 2002, J BIOTECHNOL, V98, P199, DOI 10.1016/S0168-1656(02)00132-3; Kleerebezem M, 2000, ENZYME MICROB TECH, V26, P840, DOI 10.1016/S0141-0229(00)00180-0; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Komatsuzaki N, 2005, FOOD MICROBIOL, V22, P497, DOI 10.1016/j.fm.2005.01.002; Kook MC, 2010, J KOREAN SOC APPL BI, V53, P816, DOI 10.3839/jksabc.2010.123; Koponen J, 2012, J PROTEOMICS, V75, P1357, DOI 10.1016/j.jprot.2011.11.009; Leimena MM, 2012, APPL ENVIRON MICROB, V78, P4141, DOI 10.1128/AEM.00470-12; Li HX, 2010, AMINO ACIDS, V39, P1107, DOI 10.1007/s00726-010-0582-7; Li HX, 2010, AMINO ACIDS, V38, P1439, DOI 10.1007/s00726-009-0355-3; Li L, 2014, FOOD FUNCT, V5, P3261, DOI [10.1039/c4fo00565a, 10.1039/C4FO00565A]; Liao WC, 2013, J FUNCT FOODS, V5, P1108, DOI 10.1016/j.jff.2013.03.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mazzoli R, 2010, AMINO ACIDS, V39, P727, DOI 10.1007/s00726-010-0507-5; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nomura M, 1999, MICROBIOL-UK, V145, P1375, DOI 10.1099/13500872-145-6-1375; Oh Suk-Heung, 2003, Journal of Medicinal Food, V6, P115; Park JY, 2014, BIOTECHNOL LETT, V36, P1791, DOI 10.1007/s10529-014-1539-9; Pearl PL, 2006, FUTUR NEUROL, V1, P631, DOI 10.2217/14796708.1.5.631; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Pessione E, 2005, PROTEOMICS, V5, P687, DOI 10.1002/pmic.200401116; Pessione E, 2009, PROTEOMICS, V9, P2695, DOI 10.1002/pmic.200800780; POOLMAN B, 1993, FEMS MICROBIOL REV, V12, P125, DOI 10.1111/j.1574-6976.1993.tb00015.x; Rea K, 2005, J NEUROCHEM, V94, P672, DOI 10.1111/j.1471-4159.2005.03218.x; Siragusa S, 2007, APPL ENVIRON MICROB, V73, P7283, DOI 10.1128/AEM.01064-07; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Teusink B, 2005, APPL ENVIRON MICROB, V71, P7253, DOI 10.1128/AEM.71.11.7253-7262.2005; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vadeboncoeur C, 1997, FEMS MICROBIOL REV, V19, P187, DOI 10.1016/S0168-6445(96)00029-0; Van Cauwenberghe OR, 2002, CAN J BOT, V80, P933, DOI [10.1139/B02-087, 10.1139/b02-087]; van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wong T, 2003, ANN NEUROLOGY, V54; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Yadav R, 2017, CRITICAL REV FOOD SC, P1; Yadav R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01683; Yadav R, 2018, CURR PROTEIN PEPT SC, V19, P68, DOI 10.2174/1389203718666161111130157; Yadav R, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02116; Yadav R, 2017, CRIT REV FOOD SCI, V57, P3233, DOI 10.1080/10408398.2015.1108957; Yang SY, 2008, AMINO ACIDS, V34, P473, DOI 10.1007/s00726-007-0544-x; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhai ZY, 2014, ENVIRON MICROBIOL, V16, P1524, DOI 10.1111/1462-2920.12280; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	67	14	14	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0199021	10.1371/journal.pone.0199021	http://dx.doi.org/10.1371/journal.pone.0199021			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894506	gold, Green Submitted, Green Published			2022-12-26	WOS:000435030900044
J	Economou, NT; Ilias, I; Velentza, L; Papachatzakis, Y; Zarogoulidis, P; Kallianos, A; Trakada, G				Economou, Nicholas-Tiberio; Ilias, Ioannis; Velentza, Lemonia; Papachatzakis, Yiannis; Zarogoulidis, Paul; Kallianos, Anastasios; Trakada, Georgia			Sleepiness, fatigue, anxiety and depression in Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea - Overlap - Syndrome, before and after continuous positive airways pressure therapy	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; SCALE; COPD; POPULATION; VALIDATION; DISORDERS; SEVERITY; SYMPTOMS; TRIAL	Patients with Chronic Obstructive Pulmonary Disease (COPD) and / or Obstructive Sleep Apnea (OSA) often complain about sleepiness, fatigue, anxiety and depression. However, common screening questionnaires, like Epworth Sleepiness Scale (ESS), Fatigue Severity Scale (FSS) and Hospital Anxiety and Depression Scale (HADS) have not been previous evaluated in patients with overlap-coexisting COPD and OSA-syndrome versus patients with OSA alone. Our study compared ESS, FSS and HADS between patients with overlap syndrome and patients with OSA, before and after treatment with Continuous Positive Airways Pressure (CPAP). We examined 38 patients with coexisting COPD and OSA versus 38 patients with OSA-only and 28 subjects without respiratory disease, serving as controls. All patients underwent pulmonary function tests (PFTs), oximetry and overnight polysomnography and completed the questionnaires, before and after 3 months of CPAP therapy. The two patient groups did not differ significantly in terms of age, Body Mass Index (BMI), neck, waist and hip circumferences, and arterial blood pressure values. They also had similar comorbidities. They differed significantly, as expected, in PFTs (Forced Vital Capacity- FVC, 2.53 +/- 0.73 vs 3.08 +/- 0.85 It, p = 0.005, Forced Expiratory Volume in 1sec-FEV1, 1.78 +/- 0.53 vs 2.60 +/- 0.73 It/min, p<0.001) and in daytime oximetry (94.75 +/- 2.37 vs 96.13 +/- 1.56%, p = 0.007). ESS, HADS-Anxiety and HADS-Depression scores did not differ statistically significant between these two groups, whereas overlap syndrome patients expressed significantly more fatigue (FSS) than OSA-only patients, a finding that persisted even after 3 months of CPAP therapy. We conclude that sleepiness, anxiety and depression were similar in both groups, whereas fatigue was more prominent in patients with overlap syndrome than in sleep apneic patients and did not ameliorate after treatment.	[Economou, Nicholas-Tiberio; Velentza, Lemonia; Papachatzakis, Yiannis; Kallianos, Anastasios; Trakada, Georgia] Univ Athens, Alexandra Hosp, Dept Clin Therapeut, Div Pulmonol,Sch Med, Athens, Greece; [Ilias, Ioannis] Elena Venizelou Hosp, Endocrine Unit, Athens, Greece; [Zarogoulidis, Paul] Aristotle Univ Thessaloniki, G Papanikolaou Gen Hosp, Pulm Dept, Oncol Unit, Thessaloniki, Greece	Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens; Aristotle University of Thessaloniki; George Papanikolaou General Hospital of Thessaloniki	Trakada, G (corresponding author), Univ Athens, Alexandra Hosp, Dept Clin Therapeut, Div Pulmonol,Sch Med, Athens, Greece.	gtrakada@hotmail.com	Ilias, Ioannis/AAA-2927-2020; Trakada, Georgia/S-3844-2019; ILIAS, IOANNIS/AAI-4033-2020	Trakada, Georgia/0000-0003-0037-1269; ILIAS, IOANNIS/0000-0001-5718-7441; Zarogoulidis, Paul/0000-0001-5119-2207				American Academy of Sleep Medicine, 2014, INT CLASSLEEP DIS; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Biswas D, 2017, J CLIN DIAGN RES, V11, pOC24, DOI 10.7860/JCDR/2017/24203.9393; Bixler EO, 2005, J CLIN ENDOCR METAB, V90, P4510, DOI 10.1210/jc.2005-0035; Chervin RD, 2000, CHEST, V118, P372, DOI 10.1378/chest.118.2.372; Christodoulou Chr, 2010, Psychiatriki, V21, P279; Chugh DK, 2002, LUNG BIOL HEALTH DIS, V166, P265; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Faria AC, 2015, INT J GEN MED, V8, P275, DOI 10.2147/IJGM.S86479; FLENLEY DC, 1985, CLIN CHEST MED, V6, P651; Gupta MA, 2016, SLEEP MED REV, V28, P55, DOI 10.1016/j.smrv.2015.07.002; Inal-Ince D, 2010, MULTIDISCIP RESP MED, V5, P162, DOI 10.1186/2049-6958-5-3-162; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kapur VK, 2005, SLEEP, V28, P472, DOI 10.1093/sleep/28.4.472; Kentson M, 2016, THER ADV RESPIR DIS, V10, P410, DOI 10.1177/1753465816661930; KINSMAN RA, 1983, CHEST, V83, P755, DOI 10.1378/chest.83.5.755; KLINK M, 1987, CHEST, V91, P540, DOI 10.1378/chest.91.4.540; Law M, 2014, J CLIN SLEEP MED, V10, P683, DOI 10.5664/jcsm.3802; Law M, 2014, J CLIN SLEEP MED, V10, P163, DOI 10.5664/jcsm.3444; Mermigkis C, 2007, INT J CLIN PRACT, V61, P207, DOI 10.1111/j.1742-1241.2006.01213.x; Mikkelsen RL, 2004, NORD J PSYCHIAT, V58, P65, DOI 10.1080/08039480310000824; Price D, 2011, P 4 WORLD ASTHM COPD; Saunamaeki T, 2007, ACTA NEUROL SCAND, V116, P277, DOI 10.1111/j.1600-0404.2007.00901.x; Tomfohr LM, 2011, SLEEP, V34, P121, DOI 10.1093/sleep/34.1.121; Valko PO, 2008, SLEEP, V31, P1601, DOI 10.1093/sleep/31.11.1601; Vgontzas AN, 2008, SLEEP MED, V9, P712, DOI 10.1016/j.sleep.2008.05.001; Weaver TE, 2007, SLEEP, V30, P711, DOI 10.1093/sleep/30.6.711; Weitzenblum Emmanuel, 2008, Proc Am Thorac Soc, V5, P237, DOI 10.1513/pats.200706-077MG; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	30	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0197342	10.1371/journal.pone.0197342	http://dx.doi.org/10.1371/journal.pone.0197342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889828	Green Published, Green Submitted, gold			2022-12-26	WOS:000434786600005
J	Ivanizs, L; Farkas, A; Linc, G; Molnar-Lang, M; Molnar, I				Ivanizs, Laszlo; Farkas, Andras; Linc, Gabriella; Molnar-Lang, Marta; Molnar, Istvan			Molecular cytogenetic and morphological characterization of two wheat-barley translocation lines	PLOS ONE			English	Article							MEIOTIC PAIRING BEHAVIOR; IN-SITU HYBRIDIZATION; WINTER-WHEAT; AGRONOMIC TRAITS; ADDITION LINES; DWARFING GENES; QTL ANALYSIS; IDENTIFICATION; CHROMOSOMES; GENOME	Barley chromosome 5H, carrying important QTLs for plant adaptation and tolerance to abiotic stresses, is extremely instable in the wheat genetic background and is eliminated in the early generations of wheat-barley crosses. A spontaneous wheat-barley 5HS-7DS.7DL translocation was previously obtained among the progenies of the Mv9kr1 x Igri hybrid. The present work reports on the transfer of the 5HS-7DS.7DL translocation into a modern wheat cultivar, Mv Bodri, in order to use it in the wheat breeding program. The comparison of the hybridization bands of DNA repeats HvT01, pTa71, (GAA)(n) and the barley centromere-specific (AGGGAG)(n) in Igri barley and the 5HS-7DS.7DL translocation, together with the visualization of the barley chromatin made it possible to determine the size of the introgressed barley segment, which was approximately 74% of the whole 5HS. Of the 29 newly developed PCR markers, whose source ESTs were selected from the Genome Zipper of barley chromosome 5H, 23 were mapped in the introgressed 1-0.26 FL 5HS bin, three were located in the missing C-0.26 FL region, while three markers were specific for 5HL. The translocation breakpoint was flanked by markers Hv7502 and Hv3949. A comparison of the parental wheat cultivars and the wheat-barley introgression lines indicated that the presence of the translocation improved tillering ability in the Mv9kr1 and Mv Bodri genetic background. The similar or better yield components under high- or low-input cultivation environments, respectively, indicated that the 5HS-7DS.7DL translocation had little or no negative effect on yield components, making it a promising genotype to improve wheat genetic diversity. These results promise to accelerate functional genomic studies on barley chromosome 5H and to support pre-breeding and breeding research on wheat.	[Ivanizs, Laszlo; Farkas, Andras; Linc, Gabriella; Molnar-Lang, Marta; Molnar, Istvan] Hungarian Acad Sci, Ctr Agr Res, Agr Inst, Brunszvik U 2, Martonvasar, Hungary; [Molnar, Istvan] Czech Acad Sci IEB, Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Slechtitelu 31, Olomouc, Czech Republic	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Molnar, I (corresponding author), Hungarian Acad Sci, Ctr Agr Res, Agr Inst, Brunszvik U 2, Martonvasar, Hungary.; Molnar, I (corresponding author), Czech Acad Sci IEB, Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Slechtitelu 31, Olomouc, Czech Republic.	molnar.istvan@agrar.mta.hu	Molnar, istvan/L-9779-2019; Farkas, András/AAA-5663-2022	Molnar, Istvan/0000-0002-7167-9319	Hungarian National Research Fund [OTKA K116277]; "Wheat and Barley Legacy for Breeding Improvement" - WHEALBI EU FP7 project [613556]; Marie Curie Fellowship Grant AEGILWHEAT under the H2020 framework programme of the European Union [H2020-MSCA-IF-2016-746253]	Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); "Wheat and Barley Legacy for Breeding Improvement" - WHEALBI EU FP7 project; Marie Curie Fellowship Grant AEGILWHEAT under the H2020 framework programme of the European Union	This work was funded by the Hungarian National Research Fund (http://www.otka.hu/en/) [OTKA K116277] and by the "Wheat and Barley Legacy for Breeding Improvement" - WHEALBI EU FP7 project (613556) (http://www.whealbi.eu/). I.M. gratefully acknowledges support from a Marie Curie Fellowship Grant AEGILWHEAT [H2020-MSCA-IF-2016-746253] under the H2020 framework programme of the European Union (http://cordis.europa.eu/project/rcn/208891_en.html).	Borner A, 1996, EUPHYTICA, V89, P69, DOI 10.1007/BF00015721; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Cseh A, 2013, ANN APPL BIOL, V163, P142, DOI 10.1111/aab.12043; Cseh A, 2011, GENOME, V54, P795, DOI 10.1139/g11-044; Darko E., 2012, American Journal of Plant Sciences, V3, P1462; Darko E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174170; Darko E, 2015, EUPHYTICA, V203, P491, DOI 10.1007/s10681-014-1245-7; Dolezel J, 1998, ANN BOT-LONDON, V82, P17, DOI 10.1006/anbo.1998.0730; Farkas A, 2014, EUPHYTICA, V195, P45, DOI 10.1007/s10681-013-0970-7; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Gulyas G., 2011, Acta Agronomica Hungarica, V59, P249, DOI 10.1556/AAgr.59.2011.3.8; Hudakova S, 2001, NUCLEIC ACIDS RES, V29, P5029, DOI 10.1093/nar/29.24.5029; ISLAM AKMR, 1981, HEREDITY, V46, P161, DOI 10.1038/hdy.1981.24; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Jukanti AK, 2008, PHYSIOL PLANTARUM, V132, P426, DOI 10.1111/j.1399-3054.2007.01044.x; Karsai I., 2006, Acta Agronomica Hungarica, V54, P15, DOI 10.1556/AAgr.54.2006.1.2; Khlestkina EK, 2010, MOL BREEDING, V25, P251, DOI 10.1007/s11032-009-9326-3; KOBA T, 1991, THEOR APPL GENET, V81, P285, DOI 10.1007/BF00228665; Kruppa K, 2013, J APPL GENET, V54, P251, DOI 10.1007/s13353-013-0152-2; Linc G, 1999, GENOME, V42, P497, DOI 10.1139/gen-42-3-497; Mascher M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00208; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Mayer KFX, 2009, PLANT PHYSIOL, V151, P496, DOI 10.1104/pp.109.142612; McCartney CA, 2005, GENOME, V48, P870, DOI 10.1139/g05-055; Miko P, 2014, EUPHYTICA, V199, P69, DOI 10.1007/s10681-014-1171-8; Moln?r-L?ng M., 2015, ALIEN INTROGRESSION, DOI [10.1007/978-3-319-23494-6, DOI 10.1007/978-3-319-23494-6]; Molnar-Lang M, 2000, GENOME, V43, P1045, DOI 10.1139/gen-43-6-1045; Molnar-Lang M, 2005, PLANT BREEDING, V124, P247, DOI 10.1111/j.1439-0523.2005.01097.x; Molnar-Lang M, 2000, EUPHYTICA, V112, P117, DOI 10.1023/A:1003840200744; MolnarLang M, 1996, EUPHYTICA, V90, P301, DOI 10.1007/BF00027480; MolnarLang M, 1996, CEREAL RES COMMUN, V24, P275; Nagy ED, 2002, GENOME, V45, P1238, DOI [10.1139/g02-068, 10.1139/G02-068]; Naz AA, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0107-6; Pedersen C, 1994, CHROMOSOME RES, V2, P65, DOI 10.1007/BF01539456; Peighambari SA, 2005, PLANT SCI, V169, P1008, DOI 10.1016/j.plantsci.2005.05.018; READER SM, 1994, TRENDS GENET, V10, P265, DOI 10.1016/0168-9525(90)90007-S; Schubert I, 1998, PLANT J, V14, P489, DOI 10.1046/j.1365-313X.1998.00125.x; Siahsar BA, 2014, J FOOD AGRIC ENVIRON, V8, P2; Spannagl M, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-35; Suchankova P, 2006, THEOR APPL GENET, V113, P651, DOI 10.1007/s00122-006-0329-8; Szakacs E, 2007, GENOME, V50, P43, DOI 10.1139/G06-134; Szakacs E, 2010, GENOME, V53, P35, DOI [10.1139/g09-085, 10.1139/G09-085]; Szopko D, 2017, PHOTOSYNTHETICA, V55, P317, DOI 10.1007/s11099-016-0241-7; Teulat B, 2001, THEOR APPL GENET, V103, P161, DOI 10.1007/s001220000503; Toojinda T, 1998, THEOR APPL GENET, V96, P123, DOI 10.1007/s001220050718; Turkosi E, 2014, GENOME, V57, P601, DOI 10.1139/gen-2014-0187; Vales MI, 2005, THEOR APPL GENET, V111, P1260, DOI 10.1007/s00122-005-0043-y; Vrana J, 2000, GENETICS, V156, P2033	49	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198758	10.1371/journal.pone.0198758	http://dx.doi.org/10.1371/journal.pone.0198758			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889875	Green Published, Green Submitted, gold			2022-12-26	WOS:000434786600044
J	Cao, L; Graham, SL; Pilowsky, PM				Cao, Lei; Graham, Stuart L.; Pilowsky, Paul M.			Carbohydrate ingestion induces differential autonomic dysregulation in normal-tension glaucoma and primary open angle glaucoma	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; POWER SPECTRAL-ANALYSIS; HEART-RATE-VARIABILITY; BAROREFLEX SENSITIVITY; INSULIN SENSITIVITY; BLOOD-FLOW; PRESSURE; RESPONSES; SYSTEM; MUSCLE	Background It is reported that glaucoma may be associated with vascular dysregulation. Normal tension glaucoma (NTG) and primary open angle glaucoma (POAG), which feature different intraocular pressure levels, may manifest differential features of systemic autonomic dysregulation. Methods and results We investigated autonomic regulation to carbohydrate ingestion and postural change in 37 glaucoma patients (19 NTG and 18 POAG) and 36 controls. Subjects were age and gender matched, normotensive, and had normal comparable insulin sensitivity. Continuous finger arterial pressure and ECG was recorded in supine and standing positions before and after carbohydrate ingestion. Low frequency (LF, 0.04-0.15Hz) and high frequency (HF, 0.15-0.4Hz) spectral power of heart rate and systolic blood pressure variability (HRV and SBPV) were calculated to estimate sympathovagal function. Overall comparison glaucoma (N = 37) and controls (N = 36) showed an increased sympathetic excitation, vagal withdrawal and unstable mean arterial pressure after carbohydrate ingestion in glaucoma patients. Glaucoma severity by retinal nerve fibre layer (RNFL) thickness is positively correlated to autonomic responses (HRV LF power and HF power in normalised units (nu), and HRV LF/HF ratio) after carbohydrate ingestion. Early (30 minutes) following carbohydrate ingestion, SBP LF power and HRV parameters remained unchanged in controls; while POAG showed abnormal autonomic responses, with a paradoxical vagal enhancement (increased HRV HF power in nu) and sympathetic inhibition (decreased HRV LF power nu and HRV LF/HF ratio), and associated hypotension. Later (60-120 minutes) following carbohydrate ingestion, HRV parameters remained unaltered in controls; whereas NTG manifested vagal withdrawal (reduced HRV HF power nu) and sympathetic hyper-responsiveness (increased HRV LF power nu and HRV LF/HF ratio), despite increased SBP LF power in both controls and NTG. Both NTG and POAG exhibited attenuated autonomic responses to postural stress. Conclusions NTG and POAG both manifest some systemic autonomic cardiovascular dysregulation. However, the two forms of glaucoma respond differentially to carbohydrate ingestion, irrespective of insulin resistance.	[Cao, Lei; Pilowsky, Paul M.] Univ Sydney, Heart Res Inst, Newtown, NSW, Australia; [Graham, Stuart L.] Macquarie Univ, Australian Sch Adv Med, N Ryde, NSW, Australia	University of Sydney; Heart Research Institute; Macquarie University	Pilowsky, PM (corresponding author), Univ Sydney, Heart Res Inst, Newtown, NSW, Australia.	paul.pilowsky@hri.org.au	Pilowsky, Em M/ABB-7436-2020	Pilowsky, Em M/0000-0003-3500-467X; Graham, Stuart/0000-0001-7519-969X	National Health and Medical Research Council of Australia [1065485, 1082215, 1024489]; Heart Research Institute; University of Sydney	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Heart Research Institute(University of Sydney); University of Sydney(University of Sydney)	Work in the author's laboratory is supported by funding from the National Health and Medical Research Council of Australia (Grants 1065485, 1082215 and 1024489), the Heart Research Institute and the University of Sydney.	ANDERSON EA, 1991, J CLIN INVEST, V87, P2246, DOI 10.1172/JCI115260; BERNE C, 1989, J CLIN INVEST, V84, P1403, DOI 10.1172/JCI114313; BERTINIERI G, 1985, J HYPERTENS, V3, pS79; Brooks VL, 2010, J PHYSIOL-LONDON, V588, P3629, DOI 10.1113/jphysiol.2010.197830; Brooks VL, 2010, AM J PHYSIOL-REG I, V298, pR419, DOI 10.1152/ajpregu.00441.2009; Brown CM, 2002, CLIN SCI, V102, P623, DOI 10.1042/CS20010242; Camm AJ, 1996, EUR HEART J, V17, P354; Cao L, 2016, AM J PHYSIOL-REG I, V311, pR49, DOI 10.1152/ajpregu.00486.2015; Cao L, 2014, AUTON NEUROSCI-BASIC, V185, P112, DOI 10.1016/j.autneu.2014.07.007; Cassaglia PA, 2011, J PHYSIOL-LONDON, V589, P1643, DOI 10.1113/jphysiol.2011.205575; Choi JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174377; Cioffi GA, 2004, ARCH OPHTHALMOL-CHIC, V122, P1517, DOI 10.1001/archopht.122.10.1517; FAGIUS J, 1994, CLIN SCI, V86, P159, DOI 10.1042/cs0860159; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Flammer J, 2007, SURV OPHTHALMOL, V52, pS162, DOI 10.1016/j.survophthal.2007.08.012; Flammer J, 2013, EUR HEART J, V34, P1270, DOI 10.1093/eurheartj/eht023; Furlan R, 1998, CIRCULATION, V98, P1756, DOI 10.1161/01.CIR.98.17.1756; Gherghel D, 2004, INVEST OPHTH VIS SCI, V45, P3546, DOI 10.1167/iovs.04-0290; Gherghel D, 2013, INVEST OPHTH VIS SCI, V54, P3333, DOI 10.1167/iovs.12-11256; Girkin CA, 2004, AM J OPHTHALMOL, V138, pS11, DOI 10.1016/j.ajo.2004.04.060; GRAHAM SL, 1995, OPHTHALMOLOGY, V102, P61; Hayreh SS, 1999, AM J OPHTHALMOL, V128, P301, DOI 10.1016/S0002-9394(99)00160-9; Hijmering ML, 2002, J AM COLL CARDIOL, V39, P683, DOI 10.1016/S0735-1097(01)01786-7; KAISER HJ, 1995, GRAEF ARCH CLIN EXP, V233, P484, DOI 10.1007/BF00183429; Kang JH, 2016, JAMA OPHTHALMOL, V134, P294, DOI 10.1001/jamaophthalmol.2015.5601; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; La Rovere MT, 1998, LANCET, V351, P478; Laitinen T, 1999, DIABETES, V48, P1295, DOI 10.2337/diabetes.48.6.1295; Laitinen T, 2004, J APPL PHYSIOL, V96, P2333, DOI 10.1152/japplphysiol.00444.2003; Laude D, 2004, AM J PHYSIOL-REG I, V286, pR226, DOI 10.1152/ajpregu.00709.2002; LEMBO G, 1992, J CLIN INVEST, V90, P24, DOI 10.1172/JCI115842; Lin HC, 2015, JAMA OPHTHALMOL, V133, P915, DOI 10.1001/jamaophthalmol.2015.1440; LIPSITZ LA, 1993, CIRCULATION, V87, P391, DOI 10.1161/01.CIR.87.2.391; Lucini D, 2005, HYPERTENSION, V46, P1201, DOI 10.1161/01.HYP.0000185147.32385.4b; Lucini D, 2002, CIRCULATION, V106, P2673, DOI 10.1161/01.CIR.0000039106.89299.AB; Lucini D, 2002, HYPERTENSION, V39, P184, DOI 10.1161/hy0102.100784; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mancia G, 2007, J HYPERTENS, V25, P909, DOI 10.1097/HJH.0b013e328048d004; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mosqueda-Garcia R, 2000, CIRCULATION, V102, P2898; Mroczkowska S, 2013, JAMA OPHTHALMOL, V131, P36, DOI 10.1001/2013.jamaophthalmol.1; Newman-Casey PA, 2011, OPHTHALMOLOGY, V118, P1318, DOI 10.1016/j.ophtha.2010.11.022; Nicolela MT, 2003, INVEST OPHTH VIS SCI, V44, P2565, DOI 10.1167/iovs.02-0913; Pagani M, 1997, CIRCULATION, V95, P1441; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; PARATI G, 1988, HYPERTENSION, V12, P214, DOI 10.1161/01.HYP.12.2.214; Park HYL, 2014, INVEST OPHTH VIS SCI, V55, P2557, DOI 10.1167/iovs.13-13742; RADAELLI A, 1994, HYPERTENSION, V24, P556, DOI 10.1161/01.HYP.24.5.556; Scherrer U, 1997, CIRCULATION, V96, P4104; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Singleton CD, 2003, CIRCULATION, V108, P2349, DOI 10.1161/01.CIR.0000097114.11038.26; Someya N, 2008, AM J PHYSIOL-REG I, V294, pR1790, DOI 10.1152/ajpregu.00553.2007; Sommer A, 2011, ARCH OPHTHALMOL-CHIC, V129, P785, DOI 10.1001/archophthalmol.2011.117; Straznicky NE, 2012, DIABETES, V61, P2506, DOI 10.2337/db12-0138; van Lieshout JJ, 2003, J APPL PHYSIOL, V94, P833, DOI 10.1152/japplphysiol.00260.2002; WAALER BA, 1990, ACTA PHYSIOL SCAND, V140, P167, DOI 10.1111/j.1748-1716.1990.tb08988.x; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; WESSELING KH, 1993, J APPL PHYSIOL, V74, P2566, DOI 10.1152/jappl.1993.74.5.2566; Wierzbowska J, 2012, BRIT J OPHTHALMOL, V96, P624, DOI 10.1136/bjophthalmol-2011-300945; Young CN, 2010, J PHYSIOL-LONDON, V588, P3593, DOI 10.1113/jphysiol.2010.191866	61	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198432	10.1371/journal.pone.0198432	http://dx.doi.org/10.1371/journal.pone.0198432			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879162	gold, Green Submitted, Green Published			2022-12-26	WOS:000434384900045
J	Craig, AT; Joshua, CA; Sio, AR; Teobasi, B; Dofai, A; Dalipanda, T; Hardie, K; Kaldor, J; Kolbe, A				Craig, Adam T.; Joshua, Cynthia A.; Sio, Alison R.; Teobasi, Bobby; Dofai, Alfred; Dalipanda, Tenneth; Hardie, Kate; Kaldor, John; Kolbe, Anthony			Enhanced surveillance during a public health emergency in a resource-limited setting: Experience from a large dengue outbreak in Solomon Islands, 2016-17	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; PCR ASSAY; VIRUS; SYSTEM	Between August-2016 and April-2017, Solomon Islands experienced the largest and longest-running dengue outbreak on record in the country, with 12,329 suspected cases, 877 hospitalisations and 16 deaths. We conducted a retrospective review of related data and documents, and conducted key informant interviews to characterise the event and investigate the adaptability of syndromic surveillance for enhanced and expanded data collection during a public health emergency in a low resource country setting. While the outbreak quickly consumed available public and clinical resources, we found that authorities were able to scale up the conventional national syndrome-based early warning surveillance system to support the increased information demands during the event demonstrating the flexibility of the system and syndromic surveillance more broadly. Challenges in scaling up included upskilling and assisting staff with no previous experience of the tasks required; managing large volumes of data; maintaining data quality for the duration of the outbreak; harmonising routine and enhanced surveillance data and maintaining surveillance for other diseases; producing information optimally useful for response planning; and managing staff fatigue. Solomon Islands, along with other countries of the region remains vulnerable to outbreaks of dengue and other communicable diseases. Ensuring surveillance systems are robust and able to adapt to changing demands during emergencies should be a health protection priority.	[Craig, Adam T.; Kaldor, John] Univ New South Wales, Fac Med, Kirby Inst, Sydney, NSW, Australia; [Joshua, Cynthia A.; Sio, Alison R.; Teobasi, Bobby; Dofai, Alfred; Dalipanda, Tenneth] Solomon Isl Minist Hlth & Med Serv, Honiara, Solomon Islands; [Hardie, Kate; Kolbe, Anthony] WHO, Div Pacific Tech Support, Suva, Fiji	University of New South Wales Sydney; Kirby Institute; World Health Organization	Craig, AT (corresponding author), Univ New South Wales, Fac Med, Kirby Inst, Sydney, NSW, Australia.	acraig@kirby.unsw.edu.au		Craig, Adam/0000-0002-9287-8755	Australian Government Research Training Program Scholarship	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	AC was the recipient of an Australian Government Research Training Program Scholarship while this research was being conducted. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Other authors received no specific funding for this work.	[Anonymous], 2016, INT HLTH REG, V3rd; Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1034, DOI 10.3201/eid2006.131413; Cao-Lormeau VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029555; Chretien Jean-Paul, 2008, BMC Proc, V2 Suppl 3, pS1; Craig AT, 2017, B WORLD HEALTH ORGAN, V95, P69, DOI 10.2471/BLT.16.171892; Dengue virus net, 2017, HIST OR DENG VIR; Diau J, 2015, WEST PAC SURVEILL RE, V6, P17, DOI [10.5365/wpsar.2015.6.2.001, 10.5365/WPSAR.2015.6.2.001]; Durski KN, 2016, WEST PAC SURVEILL RE, V7, P10, DOI 10.5365/wpsar.2015.6.4.005; Ghosn Nada, 2008, BMC Proc, V2 Suppl 3, pS2; Hoy D, 2016, WEST PAC SURVEILL RE, V7, DOI 10.5365/wpsar.2016.7.1.004; Hunsperger EA, 2016, J CLIN MICROBIOL, V54, P2090, DOI 10.1128/JCM.00521-16; Iniakwala I, 2002, INFORM ACTION    AUG, P1; International Federation of the Red Cross, 2016, EM PLAN ACT SOL ISL; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; Jones FK, 2016, EMERG INFECT DIS, V22, P875, DOI 10.3201/eid2205.151743; Karuri J, 2013, DATA DRIVEN DECISION; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015; Lepers C., 2002, INFORM ACTION, V13, P1; Lepers C., 2008, INFORM ACTION, V29; Li DS, 2010, EMERG INFECT DIS, V16, P123, DOI 10.3201/eid1601.091275; Marsland M, 2017, DENGUE PACIFIC ISLAN; Menkes M, 2015, EVOLUTION DENGUE EPI; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Negin J, 2012, GLOB PUBLIC HEALTH, V7, P137, DOI 10.1080/17441692.2011.584326; Nogareda F, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.2.013, 10.5365/WPSAR.2013.4.2.013]; Pacific Public Health Surveillance Network, 2016, PACNET LISTS POS; Rafiei N, 2016, MED J AUSTRALIA, V204; Rosewell A, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1910-0; Rosewell A, 2013, EMERG INFECT DIS, V19, P1811, DOI 10.3201/eid1911.121843; Roth A, 2014, EURO SURVEILL, V19; Runge-Ranzinger S, 2014, TROP MED INT HEALTH, V19, P1116, DOI 10.1111/tmi.12333; Sharp TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108445; Shortus M, 2016, WEST PAC SURVEILL RE, V7, P38, DOI 10.5365/wpsar.2015.6.3.004; Siswoyo Hadi, 2008, BMC Proc, V2 Suppl 3, pS3; Solomon Islands National Statistics Office, 2017, PROJ POP PROV 2010 2; Solomon Islands National Statistics Office, 2012, STAT B, V6; Soto Giselle, 2008, BMC Proc, V2 Suppl 3, pS4; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; United Nations Statistics Division, 2016, UN COUNTR PROF SOL I; United States Centres for Disease Control and Prevention, 2013, MMWR-MORBID MORTAL W, V62, P570; Warrilow D, 2002, J MED VIROL, V66, P524, DOI 10.1002/jmv.2176; Warrilow D, 2003, J MED VIROL, V71, P473, DOI 10.1002/jmv.10512; White P, 2018, WEST PAC SURVEILL RE, V9, DOI 10.5365/wpsar.2016.7.4.001; White P, 2017, WEST PAC SURVEILL RE, V8, DOI [10.5365/WPSAR.2016.7.4.002, 10.5365/wpsar.2016.7.4.002]; World Bank, 2017, DATA; World Bank, 2010, SOL ISL HLTH FIN OPT; World Health Organization, 2017, US MOB TECHN POSTD E; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2012, SOL ISL MIN HLTH MED; World Health Organization, WEEKL PAC SYNDR SURV	57	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198487	10.1371/journal.pone.0198487	http://dx.doi.org/10.1371/journal.pone.0198487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879179	gold, Green Published, Green Submitted			2022-12-26	WOS:000434384900048
J	Nakashima, S; Yamanashi, H; Komiya, S; Tanaka, K; Maeda, T				Nakashima, Shuji; Yamanashi, Hirotomo; Komiya, Satomi; Tanaka, Katsumi; Maeda, Takahiro			Prevalence of pressure injuries in Japanese older people: A population-based cross-sectional study	PLOS ONE			English	Article							LONG-TERM-CARE; QUALITY-OF-LIFE; HEALTH-CARE; ULCERS; INDICATORS; COMMUNITY; RISK	Objectives The prevalence of pressure injuries is an essential indicator of prevention and quality of care. Population-based prevalence data on pressure injuries are scarce in Japan. This study aimed to estimate the prevalence of pressure injuries per 1000 adults and per 1000 older people in Japan. Design Cross-sectional survey. Setting This study was conducted in Goto, a city located on a remote rural archipelago in Japan. In 2017, the population was 37,855; older people aged >= 65 years accounted for 37.7%. Participants Participants were enrolled in various facilities in the city. In total, 1126 participants (median age 85 years) were assessed to calculate age-specific numbers of people with pressure injuries. Measurements Participants were directly evaluated by the research team between August and September 2017, and pressure injuries were classified using DESIGN-R schema. We calculated the number of adults with pressure injuries in Goto based on the proportion of pressure injuries in specific age categories. In these prevalence estimations, we assumed that all cases aged >= 65 years were long-term care insurance-certified older people, and all cases aged 18-64 years were people with physical disabilities who received social welfare services. Results Of the 1126 participants, 113 (10%) had one or more pressure injuries. Overall, the estimated number of adults with pressure injuries in Goto was 301.4. The prevalence rate of pressure injuries was 9.2 per 1000 population in adults aged >= 18 years (95% confidence interval [CI] 8.1-10.2), 20.3 in those aged >= 65 years (95% CI 18.1-22.7), and 44.6 in those aged >= 80 years (95% CI 39.5-50.2). Conclusions This study revealed a high population-based prevalence of pressure injuries in a rural Japanese community. A key reason for this high disease burden in Japan appears to be the susceptibility of the aged population to pressure injuries.	[Nakashima, Shuji] Nagasaki Prefecture Tomie Hosp, Nagasaki, Japan; [Yamanashi, Hirotomo; Maeda, Takahiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Isl & Community Med, Nagasaki, Japan; [Yamanashi, Hirotomo] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki, Japan; [Komiya, Satomi] Nagasaki Prefecture Goto Cent Hosp, Nagasaki, Japan; [Tanaka, Katsumi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Plast & Reconstruct Surg, Nagasaki, Japan; [Maeda, Takahiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Community Med, Nagasaki, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University	Yamanashi, H (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Isl & Community Med, Nagasaki, Japan.; Yamanashi, H (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki, Japan.	yamanashi@nagasaki-u.ac.jp						Allen J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-346; ALLMAN RM, 1995, JAMA-J AM MED ASSOC, V273, P865, DOI 10.1001/jama.273.11.865; [Anonymous], ARE WE READY THIS CH; Baharestani MM, 2009, INT WOUND J, V6, P97, DOI 10.1111/j.1742-481X.2009.00593.x; BARBENEL JC, 1977, LANCET, V2, P548; Bates-Jensen BM, 2001, ANN INTERN MED, V135, P744, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00014; Bennett G, 2004, AGE AGEING, V33, P230, DOI 10.1093/ageing/afh086; Callahan CM, 2015, J AM GERIATR SOC, V63, P1495, DOI 10.1111/jgs.13540; Chiari P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169909; Coleman S, 2013, INT J NURS STUD, V50, P974, DOI 10.1016/j.ijnurstu.2012.11.019; Franks PJ, 2002, WOUND REPAIR REGEN, V10, P133, DOI 10.1046/j.1524-475X.2002.11002.x; Garrido FAS, 2014, GERIATR GERONTOL INT, V14, P301, DOI 10.1111/ggi.12098; Gorecki C, 2009, J AM GERIATR SOC, V57, P1175, DOI 10.1111/j.1532-5415.2009.02307.x; Igarashi A, 2013, ARCH GERONTOL GERIAT, V56, P220, DOI 10.1016/j.archger.2012.08.011; Kaltenthaler E, 2001, J Wound Care, V10, P530; Matsui Y, 2011, WOUND REPAIR REGEN, V19, P309, DOI 10.1111/j.1524-475X.2011.00674.x; Sanada H, 2008, WOUNDS, V20, P176; Sanada H, 2010, INT J NURS STUD, V47, P279, DOI 10.1016/j.ijnurstu.2009.08.001; Spetz J, 2013, J NURS ADMIN, V43, P235, DOI 10.1097/NNA.0b013e3182895a3c; Stevenson R, 2013, INT J NURS STUD, V50, P1550, DOI 10.1016/j.ijnurstu.2013.04.001; Takeda T, 2015, JPN J PRESS ULCERS, V17, P58; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; the Ministry of Health Labour and Welfare, 2014 REV REIMB MED F; Thomas DR, 1996, J AM GERIATR SOC, V44, P1435, DOI 10.1111/j.1532-5415.1996.tb04067.x; Tsutsui T, 2005, J AM GERIATR SOC, V53, P522, DOI 10.1111/j.1532-5415.2005.53175.x; Whittington Kathy T, 2004, Adv Skin Wound Care, V17, P490, DOI 10.1097/00129334-200411000-00016	26	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198073	10.1371/journal.pone.0198073	http://dx.doi.org/10.1371/journal.pone.0198073			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI5BF	29879151	Green Published, gold, Green Submitted			2022-12-26	WOS:000434384900018
J	Qiu, LP; Levine, K; Gajiwala, KS; Cronin, CN; Nagata, A; Johnson, E; Krause, M; Tatlock, J; Kania, R; Foley, T; Sun, SX				Qiu, Luping; Levine, Kymberly; Gajiwala, Ketan S.; Cronin, Ciaran N.; Nagata, Asako; Johnson, Eric; Krause, Michelle; Tatlock, John; Kania, Robert; Foley, Timothy; Sun, Shaoxian			Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers	PLOS ONE			English	Article							BRK TYROSINE KINASE; GASTROINTESTINAL-TRACT; SMALL-INTESTINE; TUMOR KINASE; EXPRESSION; DISCOVERY; ACTIVATION; CARCINOMA; DOMAIN; CELLS	Protein tyrosine kinase 6 (PTK6, or BRK) is aberrantly expressed in breast cancers, and emerging as an oncogene that promotes tumor cell proliferation, migration and evasion. Both kinase-dependent and-independent functions of PTK6 in driving tumor growth have been described, therefore targeting PTK6 kinase activity by small molecule inhibitors as a therapeutic approach to treat cancers remains to be validated. In this study, we identified novel, potent and selective PTK6 kinase inhibitors as a means to investigate the role of PTK6 kinase activity in breast tumorigenesis. We report here the crystal structures of apo-PTK6 and inhibitor-bound PTK6 complexes, providing the structural basis for small molecule interaction with PTK6. The kinase inhibitors moderately suppress tumor cell growth in 2D and 3D cell cultures. However, the tumor cell growth inhibition shows neither correlation with the PTK6 kinase activity inhibition, nor the total or activated PTK6 protein levels in tumor cells, suggesting that the tumor cell growth is independent of PTK6 kinase activity. Furthermore, in engineered breast tumor cells overexpressing PTK6, the inhibition of PTK6 kinase activity does not parallel the inhibition of tumor cell growth with a >500-fold shift in compound potencies (IC50 values). Overall, these findings suggest that the kinase activity of PTK6 does not play a significant role in tumorigenesis, thus providing important evidence against PTK6 kinase as a potential therapeutic target for breast cancer treatment.	[Qiu, Luping; Levine, Kymberly; Sun, Shaoxian] Pfizer Inc, Ctr Therapeut Innovat, New York, NY 10017 USA; [Gajiwala, Ketan S.; Cronin, Ciaran N.; Nagata, Asako; Johnson, Eric; Krause, Michelle; Tatlock, John; Kania, Robert] Pfizer Inc, Worldwide Med Chem, San Diego, CA USA; [Foley, Timothy] Pfizer Inc, Primary Pharmacol, Groton, CT 06340 USA; [Sun, Shaoxian] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA	Pfizer; Pfizer; Pfizer; Regeneron	Sun, SX (corresponding author), Pfizer Inc, Ctr Therapeut Innovat, New York, NY 10017 USA.; Sun, SX (corresponding author), Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	shaoxian@yahoo.com	Foley, Timothy/O-7281-2018	Foley, Timothy/0000-0002-5987-5253; Johnson, Eric/0000-0002-2909-865X	Pfizer	Pfizer(Pfizer)	The funder (Pfizer) provided support in the form of salaries for all the authors listed on the manuscript, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section. Regeneron is listed as my (Shaoxian Sun) current employer since I have moved from Pfizer to Regeneron, however all the work described in this manuscript was conducted in Pfizer when I worked in Pfizer. Regeneron has no role in this manuscript and no financial support.	Aubele M, 2008, BRIT J CANCER, V99, P1089, DOI 10.1038/sj.bjc.6604660; Aubele M, 2009, VIRCHOWS ARCH, V455, P117, DOI 10.1007/s00428-009-0809-8; Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; Born M, 2005, J PATHOL, V205, P592, DOI 10.1002/path.1720; Brauer PM, 2010, BBA-REV CANCER, V1806, P66, DOI 10.1016/j.bbcan.2010.02.003; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Derry JJ, 2003, ONCOGENE, V22, P4212, DOI 10.1038/sj.onc.1206465; Goel RK, 2015, BBA-REV CANCER, V1856, P39, DOI 10.1016/j.bbcan.2015.05.001; Haegebarth A, 2006, MOL CELL BIOL, V26, P4949, DOI 10.1128/MCB.01901-05; Harvey AJ, 2003, ONCOGENE, V22, P5006, DOI 10.1038/sj.onc.1206577; Irie HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011729; Ito K, 2016, CANCER RES, V76, P4406, DOI 10.1158/0008-5472.CAN-15-3445; Jiang J, 2017, CANCER RES, V77, P175, DOI 10.1158/0008-5472.CAN-16-1038; Kim HI, 2009, J BIOCHEM, V146, P133, DOI 10.1093/jb/mvp050; Kim HI, 2005, J BIOL CHEM, V280, P28973, DOI 10.1074/jbc.M504568200; Liu AMF, 2006, J BIOL CHEM, V281, P35812, DOI 10.1074/jbc.M605288200; Llor X, 1999, CLIN CANCER RES, V5, P1767; Mahmoud KA, 2014, BIOORG MED CHEM LETT, V24, P1948, DOI 10.1016/j.bmcl.2014.03.002; Mathur PS, 2016, MOL CANCER RES, V14, P563, DOI 10.1158/1541-7786.MCR-15-0450; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ono H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096060; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Park SH, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0594-z; Peng MY, 2014, ONCOTARGET, V5, P6038, DOI 10.18632/oncotarget.2153; Petro BJ, 2004, ORAL ONCOL, V40, P1040, DOI 10.1016/j.oraloncology.2004.05.010; Qiu HQ, 2005, ONCOGENE, V24, P5656, DOI 10.1038/sj.onc.1208721; Qiu HQ, 2002, J BIOL CHEM, V277, P34634, DOI 10.1074/jbc.M203877200; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; Shim HJ, 2014, BIOORG MED CHEM LETT, V24, P4659, DOI 10.1016/j.bmcl.2014.08.036; SIYANOVA EY, 1994, ONCOGENE, V9, P2053; Thakur MK, 2016, BIOCHEM BIOPH RES CO, V478, P637, DOI 10.1016/j.bbrc.2016.07.121; Tsui T, 2015, BIOCHEMISTRY-US, V54, P3173, DOI 10.1021/acs.biochem.5b00303; VASIOUKHIN V, 1995, ONCOGENE, V10, P349; Weaver AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1794; Zeng HB, 2011, BIOORG MED CHEM LETT, V21, P5870, DOI 10.1016/j.bmcl.2011.07.101; Zeng XF, 2011, BIOORG MED CHEM LETT, V21, P4742, DOI 10.1016/j.bmcl.2011.06.075; Zhang P, 2005, J BIOL CHEM, V280, P1982, DOI 10.1074/jbc.M412038200; Zheng Y, 2013, ONCOGENE, V32, P4304, DOI 10.1038/onc.2012.427; Zheng Y, 2012, J BIOL CHEM, V287, P148, DOI 10.1074/jbc.M111.298117; Zheng Y, 2010, MOL CELL BIOL, V30, P4280, DOI 10.1128/MCB.00024-10	40	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198374	10.1371/journal.pone.0198374	http://dx.doi.org/10.1371/journal.pone.0198374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879184	Green Submitted, gold, Green Published			2022-12-26	WOS:000434384900037
J	Grottenthaler, JM; Werner, CR; Steurer, M; Spengler, U; Berg, T; Engelmann, C; Wedemeyer, H; von Hahn, T; Stremmel, W; Pathil, A; Seybold, U; Schott, E; Blessin, U; Sarrazin, C; Welker, MW; Harrer, E; Scholten, S; Hinterleitner, C; Lauer, UM; Malek, NP; Berg, CP				Grottenthaler, Julia M.; Werner, Christoph R.; Steurer, Martina; Spengler, Ulrich; Berg, Thomas; Engelmann, Cornelius; Wedemeyer, Heiner; von Hahn, Thomas; Stremmel, Wolfgang; Pathil, Anita; Seybold, Ulrich; Schott, Eckart; Blessin, Usha; Sarrazin, Christoph; Welker, Martin-Walter; Harrer, Ellen; Scholten, Stefan; Hinterleitner, Clemens; Lauer, Ulrich M.; Malek, Nisar P.; Berg, Christoph P.			Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; HCV GENOTYPE 1; DACLATASVIR PLUS SOFOSBUVIR; OPEN-LABEL; GRAZOPREVIR MK-5172; ELBASVIR MK-8742; INFECTION; RIBAVIRIN; EFFICACY	Objectives The aim of this multicenter retrospective study was to investigate safety and efficacy of direct acting antiviral (DAA) treatment in the rare subgroup of patients with HCV/HIV-coinfection and advanced liver cirrhosis on the liver transplant waiting list or after liver transplantation, respectively. Methods When contacting 54 German liver centers (including all 23 German liver transplant centers), 12 HCV/HIV-coinfected patients on antiretroviral combination therapy were reported having received additional DAA therapy while being on the waiting list for liver transplantation (patient characteristics: Child-Pugh A (n = 6), B (n = 5), C (n = 1); MELD range 7-21; HCC (n = 2); HCV genotype la (n = 8), 1 b (n = 2), 4 (n = 2)). Furthermore, 2 HCV/HIV-coinfected patients were denoted having received DAA therapy after liver transplantation (characteristics: HCV genotype 1a (n = 1), 4 (n = 1)). Results Applied DAA regimens were SOF/DAC (n = 7), SOF/LDV/RBV (n = 3), SOF/RBV (n = 3), PTV/r/OBV/DSV (n = 1), or PTV/r/OBV/DSV/RBV (n = 1), respectively. All patients achieved SVR 12, in the end. In one patient, HCV relapse occurred after 24 weeks of SOF/DAC therapy; subsequent treatment with 12 weeks PTV/r/OBV/DSV achieved SVR 12. One patient underwent liver transplantation while on DAA treatment. Analysis of liver function revealed either stable parameters or even significant improvement during DAA therapy and in followup. MELD scores were found to improve in 9/13 therapies in patients on the waiting list for liver transplantation; in only 2 patients a moderate increase of MELD scores persisted at the end of follow-up. Conclusion DAA treatment was safe and highly effective in this nation-wide cohort of patients with HCV/HIV-coinfection awaiting liver transplantation or being transplanted.	[Grottenthaler, Julia M.; Werner, Christoph R.; Steurer, Martina; Malek, Nisar P.; Berg, Christoph P.] Univ Hosp Tuebingen, Dept Gastroenterol Hepatol & Infectiol, Tubingen, Germany; [Grottenthaler, Julia M.; Werner, Christoph R.; Steurer, Martina; Spengler, Ulrich; Wedemeyer, Heiner; von Hahn, Thomas; Stremmel, Wolfgang; Pathil, Anita; Seybold, Ulrich; Hinterleitner, Clemens; Lauer, Ulrich M.; Malek, Nisar P.; Berg, Christoph P.] German Ctr Infect Res DZIF Partner Site, Munich, Germany; [Spengler, Ulrich] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Berg, Thomas; Engelmann, Cornelius] Univ Hosp Leipzig, Div Gastroenterol & Hepatol, Leipzig, Germany; [Wedemeyer, Heiner; von Hahn, Thomas] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Stremmel, Wolfgang; Pathil, Anita] Univ Hosp Heidelberg, Dept Internal Med 4, Heidelberg, Germany; [Seybold, Ulrich] Univ Munich, Med Poliklin Innenstadt, Div Infect Dis, Munich, Germany; [Schott, Eckart; Blessin, Usha] Charite Univ Med Berlin, Dept Gastroenterol & Hepatol, Berlin, Germany; [Sarrazin, Christoph; Welker, Martin-Walter] Univ Hosp Frankfurt, Dept Gastroenterol & Hepatol, Frankfurt, Germany; [Harrer, Ellen] Univ Hosp Erlangen, Inst Clin Immunol, Dept Internal Med 3, Erlangen, Germany; [Hinterleitner, Clemens] Univ Hosp Tuebingen, Dept Med Oncol Haematol Immunol Rheumatol & Pulmo, Tubingen, Germany; [Lauer, Ulrich M.] Univ Hosp Tuebingen, Dept Clin Tumor Biol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; German Center for Infection Research; University of Bonn; Leipzig University; Hannover Medical School; Ruprecht Karls University Heidelberg; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Erlangen Nuremberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Berg, CP (corresponding author), Univ Hosp Tuebingen, Dept Gastroenterol Hepatol & Infectiol, Tubingen, Germany.; Berg, CP (corresponding author), German Ctr Infect Res DZIF Partner Site, Munich, Germany.	christoph.berg@med.uni-tuebingen.de		Stremmel, Wolfgang/0000-0002-8545-1753; Grottenthaler, Julia/0000-0001-9122-0962				Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Araiz JJ, 2016, LIVER TRANSPLANT, V22, P1186, DOI 10.1002/lt.24474; Belli LS, 2016, J HEPATOL, V65, P524, DOI 10.1016/j.jhep.2016.05.010; Borentain P, 2015, ANTIVIR THER, V20, P353, DOI 10.3851/IMP2841; Bourliere M, 2015, LANCET INFECT DIS, V15, P397, DOI 10.1016/S1473-3099(15)70050-2; Bunchorntavakul C, 2016, J VIRAL HEPATITIS, V23, P408, DOI 10.1111/jvh.12534; Castells L, 2017, ANN HEPATOL, V16, P86, DOI 10.5604/16652681.1226819; Charlton M, 2015, GASTROENTEROLOGY, V149, P649, DOI 10.1053/j.gastro.2015.05.010; Charlton M, 2015, GASTROENTEROLOGY, V148, P108, DOI 10.1053/j.gastro.2014.10.001; Ciesek S, 2016, TRANSPL INFECT DIS, V18, P326, DOI 10.1111/tid.12524; Coilly A, 2016, J HEPATOL, V65, P711, DOI 10.1016/j.jhep.2016.05.039; Curry MP, 2015, NEW ENGL J MED, V373, P2618, DOI 10.1056/NEJMoa1512614; Del Bello D, 2015, CURR OPIN HIV AIDS, V10, P337, DOI 10.1097/COH.0000000000000182; El-Sherif O, 2015, CURR OPIN HIV AIDS, V10, P348, DOI 10.1097/COH.0000000000000185; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Feld JJ, 2016, J HEPATOL, V64, P301, DOI 10.1016/j.jhep.2015.10.005; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Forns X, 2015, HEPATOLOGY, V61, P1485, DOI 10.1002/hep.27681; Foster GR, 2016, J HEPATOL, V64, P1224, DOI 10.1016/j.jhep.2016.01.029; Grant JL, 2016, AIDS, V30, P93, DOI 10.1097/QAD.0000000000000887; Guaraldi G, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx065; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Lawitz E, 2015, LANCET, V385, P1075, DOI 10.1016/S0140-6736(14)61795-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Locke JE, 2016, TRANSPLANTATION, V100, P141, DOI 10.1097/TP.0000000000000829; Luetkemeyer AF, 2016, CLIN INFECT DIS, V62, P1489, DOI 10.1093/cid/ciw163; Manns M, 2016, LANCET INFECT DIS, V16, P685, DOI 10.1016/S1473-3099(16)00052-9; Martel-Laferriere V, 2015, TRANSPL INFECT DIS, V17, P527, DOI 10.1111/tid.12395; Martinello M, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw105; Mindikoglu AL, 2008, TRANSPLANTATION, V85, P359, DOI 10.1097/TP.0b013e3181605fda; Naggie S, 2015, NEW ENGL J MED, V373, P705, DOI 10.1056/NEJMoa1501315; Platt L, 2016, LANCET INFECT DIS, V16, P797, DOI 10.1016/S1473-3099(15)00485-5; Poordad F, 2016, HEPATOLOGY, V63, P1493, DOI 10.1002/hep.28446; Reddy KR, 2015, HEPATOLOGY, V62, P79, DOI 10.1002/hep.27826; Righi E, 2015, WORLD J GASTROENTERO, V21, P10760, DOI 10.3748/wjg.v21.i38.10760; Rockstroh JK, 2015, LANCET HIV, V2, pE319, DOI 10.1016/S2352-3018(15)00114-9; Sulkowski M, 2015, LANCET, V385, P1087, DOI 10.1016/S0140-6736(14)61793-1; Sulkowski MS, 2015, JAMA-J AM MED ASSOC, V313, P1223, DOI 10.1001/jama.2015.1328; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; van der Meer AJ, 2016, J HEPATOL, V65, pS95, DOI 10.1016/j.jhep.2016.07.039; Werner CR, 2016, WORLD J GASTROENTERO, V22, P8050, DOI 10.3748/wjg.v22.i35.8050; Wyles DL, 2015, NEW ENGL J MED, V373, P714, DOI 10.1056/NEJMoa1503153; Zopf S, 2016, WORLD J HEPATOL, V8, P139, DOI 10.4254/wjh.v8.i3.139	44	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197544	10.1371/journal.pone.0197544	http://dx.doi.org/10.1371/journal.pone.0197544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874250	gold, Green Published, Green Submitted			2022-12-26	WOS:000434369400026
J	Wang, YF; Wang, HY; Chang, SH; Avram, A				Wang, Yufang; Wang, Haiyan; Chang, Shuhua; Avram, Adrian			Prediction of daily PM2.5 concentration in China using partial differential equations	PLOS ONE			English	Article							GROUND-LEVEL PM2.5; PARTICULATE MATTER; REGIONAL TRANSPORT; SATELLITE DATA; PM10; POLLUTION; NETWORKS; MODIS; MODEL	Accurate reporting and forecasting of PM2.5 concentration are important for improving public health. In this paper, we propose a partial differential equation (PDE) model, specially, a linear diffusive equation, to describe the spatial-temporal characteristics of PM2.5 in order to make short-term prediction. We analyze the temporal and spatial patterns of a real dataset from China's National Environmental Monitoring and validate the PDE-based model in terms of predicting the PM2.5 concentration of the next day by the former days' history data. Our experiment results show that the PDE model is able to characterize and predict the process of PM2.5 transport. For example, for 300 continuous days of 2016, the average prediction accuracy of the PDE model over all city-regions is 93% or 83% based on different accuracy definitions. To our knowledge, this is the first attempt to use PDE-based model to study PM2.5 prediction in both temporal and spatial dimensions.	[Wang, Yufang] Tianjin Univ Finance & Econ, Dept Stat, Tianjin, Peoples R China; [Wang, Yufang; Chang, Shuhua] Tianjin Univ Finance & Econ, Coordinated Innovat Ctr Computable Modeling Manag, Tianjin, Peoples R China; [Wang, Haiyan; Avram, Adrian] Arizona State Univ, Sch Math & Nat Sci, Tempe, AZ USA	Tianjin University of Finance & Economics; Tianjin University of Finance & Economics; Arizona State University; Arizona State University-Tempe	Chang, SH (corresponding author), Tianjin Univ Finance & Econ, Coordinated Innovat Ctr Computable Modeling Manag, Tianjin, Peoples R China.	shuhua55@126.com	Zhang, Shuhua/U-2908-2019	Wang, Haiyan/0000-0002-5204-967X	Major Research Plan of the National Natural Science Foundation of China [91430108]; National Basic Research Program [2012CB955804]; National Natural Science Foundation of China [11171251, 11771322, 11571324]; National Science Foundation [DMS-1737861]; Major Program of Tianjin University of Finance and Economics [ZD1302]; Science Research Project of Tianjin Education Commission [20175K108]	Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); Major Program of Tianjin University of Finance and Economics; Science Research Project of Tianjin Education Commission	This work was supported by the Major Research Plan of the National Natural Science Foundation of China, (91430108) to SHC; the National Basic Research Program (2012CB955804) and the National Natural Science Foundation of China (11171251,11771322, 11571324) to SHC; the National Science Foundation (DMS-1737861) to HYW; the Major Program of Tianjin University of Finance and Economics (ZD1302) to SHC; and Science Research Project of Tianjin Education Commission (20175K108) to YFW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benas N, 2013, ATMOS ENVIRON, V79, P448, DOI 10.1016/j.atmosenv.2013.07.012; Brauer F., 2001, MATH MODELS POPULATI, V40; Brauer F, 2008, LECT NOTES MATH, V1945, P19; Cantrell RS, 2004, SPATIAL ECOLOGY VIA; Chen DS, 2017, SCI TOTAL ENVIRON, V583, P280, DOI 10.1016/j.scitotenv.2017.01.066; Chuang MT, 2011, ATMOS ENVIRON, V45, P6241, DOI 10.1016/j.atmosenv.2011.06.071; Diekmann O., 2000, MATH EPIDEMIOLOGY IN, V5; Emili E, 2010, REMOTE SENS ENVIRON, V114, P2485, DOI 10.1016/j.rse.2010.05.024; Feng Wang, 2012, Proceedings of the 2012 32nd International Conference on Distributed Computing Systems Workshops (ICDCS Workshops), P133, DOI 10.1109/ICDCSW.2012.16; Friedman A., 2008, PARTIAL DIFFERENTIAL; Kwon KH, 2016, INT J COMMUNICATION, V10, P19; Kwon KH, 2015, P 2015 INT C SOC MED, P4; Li C, 2011, ATMOS ENVIRON, V45, P3663, DOI 10.1016/j.atmosenv.2011.04.032; Logan J. D., 2013, TRANSPORT MODELING H, V15; Logan J.D., 2014, APPL PARTIAL DIFFERE; Lu F, 2015, ENVIRON RES, V136, P196, DOI 10.1016/j.envres.2014.06.029; Ma ZW, 2014, ENVIRON SCI TECHNOL, V48, P7436, DOI 10.1021/es5009399; Mao X, 2017, ATMOS POLLUT RES, V8, P1005, DOI 10.1016/j.apr.2017.04.002; Nguyen MV, 2017, METEOROL ATMOS PHYS, V129, P35, DOI 10.1007/s00703-016-0456-y; Murray J. D., 2002, PHOTOSYNTHETICA, V40, P414, DOI 10.1023/A:1022616217603; Khanh NH, 2016, ACTA MATH SCI, V36, P49, DOI 10.1016/S0252-9602(15)30077-1; Piqueira JRC, 2009, APPL MATH COMPUT, V213, P355, DOI 10.1016/j.amc.2009.03.023; Temam R, 1984, NAVIER STOKES EQUATI, V2; Teschl G., 2012, ORDINARY DIFFERENTIA, V140; Tian GJ, 2014, ENVIRON POLLUT, V192, P266, DOI 10.1016/j.envpol.2014.04.036; Tian J, 2010, REMOTE SENS ENVIRON, V114, P221, DOI 10.1016/j.rse.2009.09.011; Wang F, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0545-y; Wang F, 2013, INT CON DISTR COMP S, P307, DOI 10.1109/ICDCS.2013.14; Wang HL, 2016, J CLEAN PROD, V112, P1302, DOI 10.1016/j.jclepro.2015.04.099; Wang SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep26156; Wang YF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13614-7; Yahya K, 2014, ATMOS ENVIRON, V92, P318, DOI 10.1016/j.atmosenv.2014.04.024; Zhang YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12558; Zheng GJ, 2015, ATMOS CHEM PHYS, V15, P2969, DOI 10.5194/acp-15-2969-2015	35	17	17	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197666	10.1371/journal.pone.0197666	http://dx.doi.org/10.1371/journal.pone.0197666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874245	gold, Green Submitted, Green Published			2022-12-26	WOS:000434369400033
J	Setzer, F; Schmidt, B; Hueter, L; Schwarzkopf, K; Sanger, J; Schreiber, T				Setzer, Florian; Schmidt, Barbara; Hueter, Lars; Schwarzkopf, Konrad; Saenger, Joerg; Schreiber, Torsten			Characterization of the seven-day course of pulmonary response following unilateral lung acid injury in rats	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; NECROSIS-FACTOR-ALPHA; MECHANICAL VENTILATION; TIDAL VOLUME; EXPERIMENTAL-MODEL; MOUSE MODEL; ASPIRATION; PATHOGENESIS; INFLAMMATION; PNEUMONIA	Background Aspiration of gastric acid is an important cause of acute lung injury. The time course of the pulmonary response to such an insult beyond the initial 48 hours is incompletely characterized. The purpose of this study was to comprehensively describe the pulmonary effects of focal lung acid injury over a seven day period in both directly injured and not directly injured lung tissue. Methods Male Wistar rats underwent left-endobronchial instillation with hydrochloric acid and were sacrificed at 4, 24, 48, 96 or 168 h after the insult. Healthy non-injured animals served as controls. We assessed inflammatory cell counts and cytokine levels in right and left lung lavage fluid and blood, arterial oxygen tension, alterations in lung histology, lung wet-to-dry weight ratio and differential lung perfusion. Results Lung acid instillation induced an early strong inflammatory response in the directly affected lung, peaking at 4-24 hours, with only partial resolution after 7 days. A less severe response with complete resolution after 4 days was seen in the opposite lung. Alveolar cytokine levels, with exception of IL-6, only partially reflected the localization of lung injury and the time course of the functional and histologic alterations. Alveolar leucocyte subpopulations exhibited different time courses in the acid injured lung with persistent elevation of alveolar lymphocytes and macrophages. After acid instillation there was an early transient decrease in arterial oxygen tension and lung perfusion was preferentially distributed to the non-injured Conclusion These findings provide a basis for further research in the field of lung acid injury and for studies exploring effects of mechanical ventilation on injured lungs. Incomplete recovery in the directly injured lung 7 days after acid instillation suggests that increased vulnerability and susceptibility to further noxious stimuli are still present at that time.	[Setzer, Florian] Univ Bern, Bern Univ Hosp, Dept Intens Care Med, Inselspital, Bern, Switzerland; [Setzer, Florian; Schmidt, Barbara; Hueter, Lars; Schreiber, Torsten] Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Jena, Germany; [Hueter, Lars; Schreiber, Torsten] Zent Klin Bad Berka, Dept Anesthesia & Intens Care, Bad Berka, Germany; [Schwarzkopf, Konrad] Klinikum Saarbrucken, Dept Anesthesia & Intens Care, Saarbrucken, Germany; [Saenger, Joerg] Zent Klin Bad Berka, Lab Pathol & Cytol, Bad Berka, Germany	University of Bern; University Hospital of Bern; Friedrich Schiller University of Jena; Zentralklinik Bad Berka; Zentralklinik Bad Berka	Setzer, F (corresponding author), Univ Bern, Bern Univ Hosp, Dept Intens Care Med, Inselspital, Bern, Switzerland.; Setzer, F (corresponding author), Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Jena, Germany.	florian.setzer@insel.ch						Altemeier WA, 2004, AM J PHYSIOL-LUNG C, V287, pL533, DOI 10.1152/ajplung.00004.2004; Amigoni M, 2008, ANESTHESIOLOGY, V108, P1037, DOI 10.1097/ALN.0b013e318173f64f; Bauer R, 1996, EXP TOXICOL PATHOL, V48, P415; Beck-Schimmer B, 2005, ANESTHESIOLOGY, V103, P556, DOI 10.1097/00000542-200509000-00019; Beck-Schimmer B, 2011, EUR J ANAESTH, V28, P78, DOI 10.1097/EJA.0b013e32834205a8; Bregeon F, 2005, ANESTHESIOLOGY, V102, P331; CAPLAN RA, 1990, ANESTHESIOLOGY, V72, P828, DOI 10.1097/00000542-199005000-00010; Chang CY, 2013, STROKE, V44, P1182, DOI 10.1161/STROKEAHA.111.000663; Chiumello D, 1999, AM J RESP CRIT CARE, V160, P109, DOI 10.1164/ajrccm.160.1.9803046; CORBRIDGE TC, 1990, AM REV RESPIR DIS, V142, P311, DOI 10.1164/ajrccm/142.2.311; Davidson BA, 1999, ANESTHESIOLOGY, V91, P486, DOI 10.1097/00000542-199908000-00024; Dreyfuss D, 2003, AM J RESP CRIT CARE, V167, P1467, DOI 10.1164/rccm.200206-611CP; Frank JA, 2002, AM J RESP CRIT CARE, V165, P242, DOI 10.1164/ajrccm.165.2.2108087; Gattinoni L, 2001, AM J RESP CRIT CARE, V164, P1701, DOI 10.1164/ajrccm.164.9.2103121; GATTINONI L, 1988, ANESTHESIOLOGY, V69, P824, DOI 10.1097/00000542-198812000-00005; Glenny RW, 2000, J APPL PHYSIOL, V89, P499, DOI 10.1152/jappl.2000.89.2.499; GOLDMAN G, 1993, SURGERY, V114, P13; GOLDMAN G, 1995, SURGERY, V117, P83, DOI 10.1016/S0039-6060(05)80233-8; Goodman LR, 1999, RADIOLOGY, V213, P545, DOI 10.1148/radiology.213.2.r99nv42545; Haitsma JJ, 2000, INTENS CARE MED, V26, P1515, DOI 10.1007/s001340000648; Hannawi Y, 2013, CEREBROVASC DIS, V35, P430, DOI 10.1159/000350199; Hubmayr RD, 2005, J APPL PHYSIOL, V99, P384, DOI 10.1152/japplphysiol.00357.2005; KENNEDY TP, 1989, ANESTH ANALG, V69, P87; KNIGHT PR, 1992, ANESTHESIOLOGY, V77, P772, DOI 10.1097/00000542-199210000-00023; Marini JJ, 2007, CRIT CARE MED, V35, P1796, DOI 10.1097/01.CCM.0000269357.52578.FB; Motosugi H, 1998, AM J RESP CRIT CARE, V157, P192, DOI 10.1164/ajrccm.157.1.9602095; Patel BV, 2012, EUR RESPIR J, V39, P1162, DOI 10.1183/09031936.00093911; Richter T, 2013, ANESTHESIOLOGY, V119, P890, DOI 10.1097/ALN.0b013e3182a17e5b; Rosenthal C, 1998, CRIT CARE MED, V26, P912, DOI 10.1097/00003246-199805000-00027; Schreiber T, 2006, INTENS CARE MED, V32, P740, DOI 10.1007/s00134-006-0117-6; Schreiber T, 2006, ANESTHESIOLOGY, V104, P133, DOI 10.1097/00000542-200601000-00019; Schreiber T, 2007, CRIT CARE MED, V35, P1741, DOI 10.1097/01.CCM.0000269374.85160.BF; Shanley TP, 2000, CRIT CARE MED, V28, P2437, DOI 10.1097/00003246-200007000-00041; STJOHN RC, 1993, J APPL PHYSIOL, V74, P1994, DOI 10.1152/jappl.1993.74.4.1994; Wallace WAH, 2007, INT J EXP PATHOL, V88, P103, DOI 10.1111/j.1365-2613.2006.00515.x; Wilson MR, 2003, J APPL PHYSIOL, V95, P1385, DOI 10.1152/japplphysiol.00213.2003; Zambelli V, 2012, INTENS CARE MED, V38, P694, DOI 10.1007/s00134-011-2456-1; Zilberberg MD, 1998, AM J RESP CRIT CARE, V157, P1159, DOI 10.1164/ajrccm.157.4.9704088	38	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198440	10.1371/journal.pone.0198440	http://dx.doi.org/10.1371/journal.pone.0198440			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864150	gold, Green Submitted, Green Published			2022-12-26	WOS:000434097100031
J	Zeng, KX; Chen, XX; Hu, XX; Liu, XX; Xu, T; Sun, HL; Pan, YQ; He, BS; Wang, SK				Zeng, Kaixuan; Chen, Xiaoxiang; Hu, Xiuxiu; Liu, Xiangxiang; Xu, Tao; Sun, Huiling; Pan, Yuqin; He, Bangshun; Wang, Shukui			LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NUCLEAR EXPORT; MUTANT P53; IN-VIVO; MDM2; PROTEIN; PATHWAY; PROMOTES; ORIGINS; CELLS	Colorectal cancer (CRC) is one of the most common aggressive malignancies. Like other solid tumors, inactivation of tumor suppressor genes and activation of oncogenes occur during CRC development and progression. Recently, a novel tumor suppressor, LACTB, was proposed to inhibit tumor progression, but the functional and clinical significance of this tumor suppressor in CRC remains unexplored. Herein, we found LACTB was significantly downregulated in CRC due to promoter methylation and histone deacetylation, which was associated with metastasis and advanced clinical stage. CRC patients with low LACTB expression had poorer overall survival and LACTB also determined to be an independent prognostic factor for poorer outcome. Ectopic expression of LACTB suppressed CRC cells proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) in vitro and inhibited CRC growth and metastasis in vivo, while knockout of LACTB by CRISPR/Cas9 gene editing technique resulted in an opposite phenotype. Interestingly, LACTB could exert antitumorigenic effect only in HCT116 and HCT8 cells harboring wild-type TP53, but not in HT29 and SW480 cells harboring mutant TP53 or HCT116 p53(-/-) cells. Mechanistic studies demonstrated that LACTB could directly bind to the C terminus of p53 to inhibit p53 degradation by preventing MDM2 from interacting with p53. Moreover, ablation of p53 attenuated the antitumorigenic effects of LACTB overexpression in CRC. Collectively, our findings successfully demonstrate for the first time that LACTB is a novel epigenetic silenced tumor suppressor through modulating the stability of p53, supporting the pursuit of LACTB as a potential therapeutic target for CRC.	[Zeng, Kaixuan; Chen, Xiaoxiang; Wang, Shukui] Southeast Univ, Sch Med, Nanjing 210009, Jiangsu, Peoples R China; [Zeng, Kaixuan; Chen, Xiaoxiang; Hu, Xiuxiu; Liu, Xiangxiang; Xu, Tao; Sun, Huiling; Pan, Yuqin; He, Bangshun; Wang, Shukui] Nanjing Med Univ, Nanjing Hosp 1, Gen Clin Res Ctr, Nanjing 210006, Jiangsu, Peoples R China	Southeast University - China; Nanjing Medical University	Wang, SK (corresponding author), Southeast Univ, Sch Med, Nanjing 210009, Jiangsu, Peoples R China.; Wang, SK (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Gen Clin Res Ctr, Nanjing 210006, Jiangsu, Peoples R China.	sk_wang@njmu.edu.cn			National Nature Science Foundation of China [81472027, 81501820]; Innovation team of Jiangsu provincial health-strengthening engineering by science and education	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation team of Jiangsu provincial health-strengthening engineering by science and education	This project was supported by grants from the National Nature Science Foundation of China (No. 81472027, 81501820) to SKW and YQP; Innovation team of Jiangsu provincial health-strengthening engineering by science and education to SKW.	Bains RK, 2004, ENDOCRINOLOGY, V145, P2666, DOI 10.1210/en.2003-1608; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chen YC, 2007, J CELL BIOCHEM, V100, P981, DOI 10.1002/jcb.21079; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hirano Y, 2006, CELL, V127, P675, DOI 10.1016/j.cell.2006.11.003; Inoue T, 2001, J BIOL CHEM, V276, P45255, DOI 10.1074/jbc.M107477200; Joerger AC, 2016, ANNU REV BIOCHEM, V85, P375, DOI 10.1146/annurev-biochem-060815-014710; Keckesova Z, 2017, NATURE, V543, P681, DOI 10.1038/nature21408; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lang V, 2014, MOL ONCOL, V8, P1026, DOI 10.1016/j.molonc.2014.04.002; Leslie PL, 2016, ONCOGENE, V35, P6157, DOI 10.1038/onc.2016.88; Lessel D, 2017, J CLIN INVEST, V127, P3598, DOI 10.1172/JCI92171; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li HT, 2019, ONCOL RES, V27, P423, DOI 10.3727/096504017X15030178624579; Liu Q, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0654-3; Lu JB, 2016, ARCH BIOCHEM BIOPHYS, V590, P64, DOI 10.1016/j.abb.2015.11.007; Ma YL, 2016, GUT, V65, P1494, DOI 10.1136/gutjnl-2014-308392; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Mukhopadhyay S, 2017, BLOOD, V129, P3245, DOI 10.1182/blood-2016-07-727180; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Nomura K, 2017, NAT STRUCT MOL BIOL, V24, P578, DOI 10.1038/nsmb.3414; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Peitsaro N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-26; Polianskyte Z, 2009, P NATL ACAD SCI USA, V106, P18960, DOI 10.1073/pnas.0906734106; Powell E, 2014, CANCER DISCOV, V4, P405, DOI 10.1158/2159-8290.CD-13-0136; Russo A, 2013, CELL CYCLE, V12, P76, DOI 10.4161/cc.22963; Sarkar S, 2017, MOL CANCER RES, V15, P1678, DOI 10.1158/1541-7786.MCR-17-0287; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smith TS, 2001, GENOMICS, V78, P12, DOI 10.1006/geno.2001.6643; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Walerych D, 2016, NAT CELL BIOL, V18, P897, DOI 10.1038/ncb3380; Willer Cristen J, 2013, Nat Genet, V45, P1274, DOI 10.1038/ng.2797; Xia LM, 2017, CANCER CELL, V31, P653, DOI 10.1016/j.ccell.2017.04.005; Ye J, 2017, ONCOGENE, V36, P6391, DOI 10.1038/onc.2017.241; Yuan XW, 2013, J BIOL CHEM, V288, P31206, DOI 10.1074/jbc.M113.480285; Zeng KX, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1185582	41	46	48	0	23	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 11	2018	37	41					5534	5551		10.1038/s41388-018-0352-7	http://dx.doi.org/10.1038/s41388-018-0352-7			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GW5QO	29899406				2022-12-26	WOS:000446991200005
J	Zou, QL; Gang, K; Yang, QF; Liu, XL; Tang, XM; Lu, HQ; He, JB; Luo, LF				Zou, Qingliang; Gang, Kai; Yang, Qifen; Liu, Xiaolin; Tang, Xuemei; Lu, Huiqiang; He, Jianbo; Luo, Lingfei			The CCCH-type zinc finger transcription factor Zc3h8 represses NF-B-mediated inflammation in digestive organs in zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; inflammation; NF- B (NF-B); zebrafish; zinc finger; degeneration; digestive organ	FACTOR-KAPPA-B; LIVER FIBROSIS; MESSENGER-RNA; FETAL LIVER; TRISTETRAPROLIN; CELLS; PROTEIN; SYSTEM; ALPHA; REGENERATION	Degenerative diseases of organs lead to their impaired function. The cellular and molecular mechanisms underlying organ degeneration are therefore of great research and clinical interest but are currently incompletely characterized. Here, using a forward-genetic screen for genes regulating liver development and function in zebrafish, we identified a cq5 mutant that exhibited a liver-degeneration phenotype at 5 days postfertilization, the developmental stage at which a functional liver develops. Positional cloning revealed that the liver degeneration was caused by a single point mutation in the gene zc3h8 (zinc finger CCCH-type containing 8), changing a highly conserved histidine to glutamine at position 353 of the Zc3h8 protein. The zc3h8 mutation-induced liver degeneration in the mutant was accompanied by reduced proliferation, increased apoptosis, and macrophage phagocytosis of hepatocytes. Transcriptional profile analyses revealed up-regulation and activation of both proinflammatory cytokines and the NF-B signaling pathway in the zc3h8 mutant. Suppression of NF-B signaling activity efficiently rescued the proinflammatory cytokine response, as well as the inflammation-mediated liver degeneration phenotype of the mutant. Of note, the zc3h8 mutation-induced degeneration of several other organs, including the gut and exocrine pancreas, indicating that Zc3h8 is a general repressor of inflammation in zebrafish. Collectively, our findings demonstrate that Zc3h8 maintains organ homeostasis by inhibiting the NF-B-mediated inflammatory response in zebrafish and that Zc3h8 dysfunction causes degeneration of multiple organs, including the liver, gut, and pancreas.	[Zou, Qingliang; Gang, Kai; Yang, Qifen; Liu, Xiaolin; Tang, Xuemei; Lu, Huiqiang; He, Jianbo; Luo, Lingfei] Southwest Univ, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Chongqing 400715, Peoples R China; [Zou, Qingliang; Gang, Kai; Yang, Qifen; Liu, Xiaolin; Tang, Xuemei; Lu, Huiqiang; He, Jianbo; Luo, Lingfei] Southwest Univ, Lab Mol Dev Biol, Sch Life Sci, Chongqing 400715, Peoples R China	Southwest University - China; Southwest University - China	Luo, LF (corresponding author), Southwest Univ, Sch Life Sci, Lab Mol Dev Biol, Key Lab Freshwater Fish Reprod & Dev,Minist Educ, Chongqing 400715, Peoples R China.	lluo@swu.edu.cn			National Key Basic Research Program of China [2015CB942800]; National Natural Science Foundation of China [31330051, 31730060, 31371483, 91539201]; Natural Science Foundation Project of Chongqing [cstc2014jcyjA10062, cstc2014jcyjA10088]; Fundamental Research Funds for the Central Universities [XDJK2015B011]; 111 Program [B14037]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing(Natural Science Foundation of Chongqing); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 Program(Ministry of Education, China - 111 Project)	This work was supported by National Key Basic Research Program of China Grant 2015CB942800; National Natural Science Foundation of China Grants 31330051, 31730060, 31371483, and 91539201; Natural Science Foundation Project of Chongqing Grants cstc2014jcyjA10062 and cstc2014jcyjA10088; Fundamental Research Funds for the Central Universities Grant XDJK2015B011; and 111 Program B14037. The authors declare that they have no conflicts of interest with the contents of this article.	Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, BLOOD, V98, P2389, DOI 10.1182/blood.V98.8.2389; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Choi TY, 2014, GASTROENTEROLOGY, V146, P776, DOI 10.1053/j.gastro.2013.10.019; Cox AG, 2015, CURR OPIN GENET DEV, V32, P153, DOI 10.1016/j.gde.2015.03.002; Dahm K, 2001, GENOMICS, V73, P194, DOI 10.1006/geno.2000.6480; Dong PDS, 2007, NAT GENET, V39, P397, DOI 10.1038/ng1961; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Gao B, 2011, AM J PHYSIOL-GASTR L, V300, pG516, DOI 10.1152/ajpgi.00537.2010; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Grabher C, 2004, METHOD CELL BIOL, V77, P381; He JB, 2014, GASTROENTEROLOGY, V146, P789, DOI 10.1053/j.gastro.2013.11.045; Hou YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep36853; Huang H, 2008, DEVELOPMENT, V135, P3209, DOI 10.1242/dev.024406; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hwang ES, 2002, IMMUNOLOGY, V106, P464, DOI 10.1046/j.1365-2567.2002.01455.x; Hwang ES, 2002, J IMMUNOL, V169, P248, DOI 10.4049/jimmunol.169.1.248; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Karin M, 2006, MOL CARCINOGEN, V45, P355, DOI 10.1002/mc.20217; Kawamoto S, 1996, GENE, V174, P151, DOI 10.1016/0378-1119(96)00512-4; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Lu HQ, 2013, DEV CELL, V24, P543, DOI 10.1016/j.devcel.2013.01.021; Luedde T, 2008, P NATL ACAD SCI USA, V105, P9733, DOI 10.1073/pnas.0800198105; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Mudumana SP, 2004, DEV DYNAM, V230, P165, DOI 10.1002/dvdy.20032; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; O'Neill LAJ, 2006, NAT REV DRUG DISCOV, V5, P549, DOI 10.1038/nrd2070; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Pack M, 1996, DEVELOPMENT, V123, P321; Qi F, 2010, HEPATOLOGY, V52, P2158, DOI 10.1002/hep.23945; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shen H, 2014, HEPATOLOGY, V60, P2065, DOI 10.1002/hep.27348; Sunami Y, 2012, HEPATOLOGY, V56, P1117, DOI 10.1002/hep.25711; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	52	11	13	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					11971	11983		10.1074/jbc.M117.802975	http://dx.doi.org/10.1074/jbc.M117.802975			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29871925	Green Published, hybrid			2022-12-26	WOS:000440803200001
J	Greb-Markiewicz, B; Zarebski, M; Ozyhar, A				Greb-Markiewicz, Beata; Zarebski, Miroslaw; Ozyhar, Andrzej			Multiple sequences orchestrate subcellular trafficking of neuronal PAS domain-containing protein 4 (NPAS4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						basic helix-loop-helix transcription factor (bHLH); cell culture; intracellular trafficking; microscopic imaging; protein expression; bHLH-PAS; glucose concentration effect; NES; NLS; NPAS4	ARYL-HYDROCARBON RECEPTOR; TRANSCRIPTION FACTOR NPAS4; NUCLEAR EXPORT SIGNALS; PANCREATIC BETA-CELLS; CEREBRAL-ISCHEMIA; GENE-EXPRESSION; LEPTOMYCIN B; LOCALIZATION; PREDICTION; IDENTIFICATION	Neuronal Per-Arnt-Sim (PAS) domain-containing protein 4 (NPAS4) is a basic helix-loop-helix (bHLH)-PAS transcription factor first discovered in neurons in the neuronal layer of the mammalian hippocampus and later discovered in pancreatic -cells. NPAS4 has been proposed as a therapeutic target not only for depression and neurodegenerative diseases associated with synaptic dysfunction but also for type 2 diabetes and pancreas transplantation. The ability of bHLH-PAS proteins to fulfil their function depends on their intracellular trafficking, which is regulated by specific sequences, i.e. the nuclear localization signal (NLS) and the nuclear export signal (NES). However, until now, no study examining the subcellular localization signals of NPAS4 has been published. We show here that Rattus norvegicus NPAS4 was not uniformly localized in the nuclei of COS-7 and N2a cells 24 h after transfection. Additionally, cytoplasmic localization of NPAS4 was leptomycin B-sensitive. We demonstrate that NPAS4 possesses a unique arrangement of localization signals. Its bHLH domain contains an overlapping NLS and NES. We observed that its PAS-2 domain contains an NLS, an NES, and a second, proximally located, putative NLS. Moreover, the C terminus of NPAS4 contains two active NESs that overlap with a putative NLS. Our data indicate that glucose concentration could be one of the factors influencing NPAS4 localization. The presence of multiple localization signals and the differentiated localization of NPAS4 suggest a precise, multifactor-dependent regulation of NPAS4 trafficking, potentially crucial for its ability to act as a cellular stress sensor and transcription factor.	[Greb-Markiewicz, Beata; Ozyhar, Andrzej] Wroclaw Univ Sci & Technol, Dept Biochem, Fac Chem, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland; [Zarebski, Miroslaw] Jagiellonian Univ, Dept Cell Biophys, Fac Biochem Biophys & Biotechnol, Gronostajowa 7, PL-30387 Krakow, Poland	Wroclaw University of Science & Technology; Jagiellonian University	Greb-Markiewicz, B (corresponding author), Wroclaw Univ Sci & Technol, Dept Biochem, Fac Chem, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.	beata.greb-markiewicz@pwr.edu.pl	Greb-Markiewicz, Beata/AAB-5246-2020	Greb-Markiewicz, Beata/0000-0002-2831-439X; OZYHAR, Andrzej/0000-0002-5874-784X	Polish National Science Center (NCN) [2013/11/B/NZ3/00189]	Polish National Science Center (NCN)	Technical assistance from Barbara CzubaPelech, Engineer, and Miroslawa Ostrowska, Engineer, is gratefully acknowledged. Confocal fluorescence microscopy imaging was supported by Grant 2013/11/B/NZ3/00189 from the Polish National Science Center (NCN).	Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Bersten DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085768; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Cartwright P, 2000, CELL MOL LIFE SCI, V57, P1193, DOI 10.1007/PL00000759; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Choy FC, 2016, J CEREBR BLOOD F MET, V36, P1449, DOI 10.1177/0271678X15606146; Choy FC, 2015, INT J MOL SCI, V16, P29011, DOI 10.3390/ijms161226144; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Davis JR, 2007, PHARM RES-DORDR, V24, P17, DOI 10.1007/s11095-006-9133-z; Dinkel H, 2007, BIOINFORMATICS, V23, P3297, DOI 10.1093/bioinformatics/btm524; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Eguchi H, 1997, J BIOL CHEM, V272, P17640, DOI 10.1074/jbc.272.28.17640; Esser JS, 2017, CARDIOVASC RES, V113, P222, DOI 10.1093/cvr/cvw248; Fan WH, 2016, J MOL NEUROSCI, V58, P401, DOI 10.1007/s12031-015-0692-5; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Fu SC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr493; Furness SGB, 2007, FEBS LETT, V581, P3616, DOI 10.1016/j.febslet.2007.04.011; GERACE L, 1995, CELL, V82, P341, DOI 10.1016/0092-8674(95)90420-4; Greb-Markiewicz B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133307; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; Hung MC, 2011, J CELL SCI, V124, P3381, DOI 10.1242/jcs.089110; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kumar S, 2006, MOL CELL ENDOCRINOL, V246, P147, DOI 10.1016/j.mce.2005.11.028; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Luo XT, 2016, AGING DIS, V7, DOI 10.14336/AD.2015.0702; Michael A.K., 2013, OA BIOCH, V1, P16, DOI [10.13172/2052-9651-1-2-1123, DOI 10.13172/2052-9651-1-2-1123]; Moser M, 2004, MOL BRAIN RES, V128, P141, DOI 10.1016/j.molbrainres.2004.06.023; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Ooe N, 2009, BBA-GENE REGUL MECH, V1789, P192, DOI 10.1016/j.bbagrm.2009.01.003; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Rollen K, 2016, J MOL BIOL, V428, P3721, DOI 10.1016/j.jmb.2016.05.027; Sabatini PV, 2015, TRENDS ENDOCRIN MET, V26, P49, DOI 10.1016/j.tem.2014.11.002; Sabatini PV, 2013, DIABETES, V62, P2808, DOI 10.2337/db12-1527; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Scott MS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-317; Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; Shamloo M, 2006, EUR J NEUROSCI, V24, P2705, DOI 10.1111/j.1460-9568.2006.05172.x; Shi SP, 2015, MOL BIOSYST, V11, P819, DOI 10.1039/c4mb00646a; Speckmann T, 2016, J BIOL CHEM, V291, P2682, DOI 10.1074/jbc.M115.704098; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Sullivan AE, 2016, FEBS J, V283, P3488, DOI 10.1111/febs.13824; Sun QX, 2013, P NATL ACAD SCI USA, V110, P1303, DOI 10.1073/pnas.1217203110; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Wu DL, 2016, ELIFE, V5, DOI 10.7554/eLife.18790; Xu DR, 2015, BIOINFORMATICS, V31, P1357, DOI 10.1093/bioinformatics/btu826; Yoshihara S, 2014, CELL REP, V8, P843, DOI 10.1016/j.celrep.2014.06.056; Zhang ZH, 2014, NEUROL SCI, V35, P277, DOI 10.1007/s10072-013-1505-7	62	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11255	11270		10.1074/jbc.RA118.001812	http://dx.doi.org/10.1074/jbc.RA118.001812			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29899116	hybrid, Green Published			2022-12-26	WOS:000439449700001
J	Ameztegui, A; Solarik, KA; Parkins, JR; Houle, D; Messier, C; Gravel, D				Ameztegui, Aitor; Solarik, Kevin A.; Parkins, John R.; Houle, Daniel; Messier, Christian; Gravel, Dominique			Perceptions of climate change across the Canadian forest sector: The key factors of institutional and geographical environment	PLOS ONE			English	Article							RISK PERCEPTION; BOREAL FOREST; ADAPTATION; BELIEF; POLICY; DETERMINANTS; STRATEGIES; ATTITUDES; IMPACTS	Assessing the perception of key stakeholders within the forest sector is critical to evaluating their readiness to engage in adapting to climate change. Here, we report the results of the most comprehensive survey carried out in the Canadian forestry sector to date regarding perceptions of climate change. A total of 1158 individuals, representing a wide range of stakeholders across the five most important forestry provinces in Canada, were asked about climate change, its impact on forest ecosystems, and the suitability of current forest management for addressing future impacts. Overall, we found that respondents were more concerned about climate change than the general population. More than 90% of respondents agreed with the anthropogenic origins of climate change, and > 50% considered it a direct threat to their welfare. Political view was the main driver of general beliefs about the causes of climate change and its future consequences, while the province of origin proved to be the best predictor of perceived current impacts on forest ecosystems and its associated risks; and type of stakeholder was the main driver of perceived need for adaptation. Industrial stakeholders were the most skeptical about the anthropogenic cause(s) of climate change (18% disagreed with this statement, compared to an average of 8% in the other stakeholders), its impacts on forest ecosystems (28% for industry vs. 10% for other respondents), and the need for new management practices (18% vs. 7%). Although the degree of awareness and the willingness to implement adaptive practices were high even for the most skeptical groups, our study identified priority sectors or areas for action when designing awareness campaigns. We suggest that the design of a strategic framework for implementing climate adaptation within the Canadian forest sector should focus on the relationship between climate change and changes in disturbance regimes, and above all on the economic consequences of these changes, but it should also take into account the positions shown by each of the actors in each province.	[Ameztegui, Aitor] Univ Lleida, Dept Agr & Forest Engn EAGROF, Lleida, Spain; [Ameztegui, Aitor; Solarik, Kevin A.; Messier, Christian] Univ Quebec, CEF, Dept Sci Biol, Montreal, PQ, Canada; [Ameztegui, Aitor] Forest Sci Ctr Catalonia CTFC, Solsona, Spain; [Parkins, John R.] Univ Alberta, Dept Resource Econ & Environm Sociol, Edmonton, AB, Canada; [Houle, Daniel] Minist Forets Faune & Parcs, Foret Quebec, Direct Rech Forestiere, Quebec City, PQ, Canada; [Houle, Daniel] Consortium Reg Climatol & Adaptat Climate Change, Montreal, PQ, Canada; [Messier, Christian] Univ Quebec Outaouais, Inst Sci Foret Temperee, Dept Sci Nat, Ripon, PQ, Canada; [Gravel, Dominique] Univ Sherbrooke, Dept Biol, 2500 Boul Univ, Sherbrooke, PQ, Canada	Universitat de Lleida; University of Quebec; University of Quebec Montreal; Centre Tecnologic Forestal de Catalunya (CTFC); University of Alberta; University of Quebec; University Quebec Outaouais; University of Sherbrooke	Ameztegui, A (corresponding author), Univ Lleida, Dept Agr & Forest Engn EAGROF, Lleida, Spain.; Ameztegui, A (corresponding author), Univ Quebec, CEF, Dept Sci Biol, Montreal, PQ, Canada.; Ameztegui, A (corresponding author), Forest Sci Ctr Catalonia CTFC, Solsona, Spain.	ameztegui@gmail.com	Ameztegui, Aitor/C-2587-2009	Ameztegui, Aitor/0000-0003-2006-1559; Solarik, Kevin/0000-0002-0198-0595	Natural Sciences and Engineering Research Council of Canada (NSERC) [430393-12]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) through a strategic grant 430393-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archie KM, 2012, ECOL SOC, V17, DOI 10.5751/ES-05187-170420; Bergeron Y, 2010, INT J WILDLAND FIRE, V19, P1127, DOI 10.1071/WF09092; Blennow K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155137; Blennow K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050182; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brunette M, 2018, FORESTS, V9, DOI 10.3390/f9010020; Canadian Forest Service, 2014, STATE CANADAS FOREST; Colombo SJ, 2006, OMNR STAFF PERCEIVE; Fauria MM, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000760; Gauthier S, 2014, ENVIRON REV, V22, P256, DOI 10.1139/er-2013-0064; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Genuer R, 2015, R J, V7, P19; Hamilton LC, 2009, INT J CLIMATOL, V29, P2348, DOI 10.1002/joc.1930; Hornsey MJ, 2016, NAT CLIM CHANGE, V6, P622, DOI [10.1038/nclimate2943, 10.1038/NCLIMATE2943]; Johnston M, 2010, CLIMATE CHANGE FORES; Johnston M. H., 2009, VULNERABILITY CANADA; Keenan RJ, 2015, ANN FOREST SCI, V72, P145, DOI 10.1007/s13595-014-0446-5; Laatsch J, 2015, J FOREST, V113, P335, DOI 10.5849/jof.14-128; Lachapelle E, 2012, REV POLICY RES, V29, P334, DOI 10.1111/j.1541-1338.2012.00563.x; Lachapelle Erick, 2014, ISSUES ENERGY ENV PO, V11, P1; Larsen JN, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1567; Lee TM, 2015, NAT CLIM CHANGE, V5, P1014, DOI 10.1038/NCLIMATE2728; Legagneux P, 2018, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00175; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; Lempriere TC, 2008, IMPORTANCE FOREST SE; Lenart M, 2014, J FOREST, V112, P553, DOI 10.5849/jof.13-051; Marsden PV, 2010, HANDBOOK OF SURVEY RESEARCH, 2ND EDITION, P1; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; Mildenberger M, 2016, SOC SCI RES NETWORK, DOI [10.2139/ssrn.2732935, DOI 10.2139/SSRN.2732935]; Morin MB, 2015, FOREST CHRON, V91, P395, DOI 10.5558/tfc2015-069; Myers TA, 2013, NAT CLIM CHANGE, V3, P343, DOI [10.1038/nclimate1754, 10.1038/NCLIMATE1754]; Nelson HW, 2016, FOREST ECOL MANAG, V360, P388, DOI 10.1016/j.foreco.2015.09.038; Price DT, 2013, ENVIRON REV, V21, P322, DOI 10.1139/er-2013-0042; Qualtiere E, 2014, COMPENDIUM FORESTRY; R Development Core Team, 2014, R LANG ENV STAT COMP; Rodriguez-Franco C, 2015, J SUSTAIN FOREST, V34, P423, DOI 10.1080/10549811.2015.1025079; Seidl R, 2015, SENSITIVITY CURRENT, P1, DOI [10.1007/s13280-014-0540-9, DOI 10.1007/S13280-014-0540-9]; Sousa-Silva R, 2016, FOR ECOSYST, V3, DOI 10.1186/s40663-016-0082-7; Spittlehouse DL, 2005, FOREST CHRON, V81, P691, DOI 10.5558/tfc81691-5; Stedman RC, 2004, RISK ANAL, V24, P1395, DOI 10.1111/j.0272-4332.2004.00534.x; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; van der Linden S, 2015, J ENVIRON PSYCHOL, V41, P112, DOI 10.1016/j.jenvp.2014.11.012; Wang XL, 2015, CLIMATIC CHANGE, V130, P573, DOI 10.1007/s10584-015-1375-5; Williamson TB, 2010, CLIMATIC CHANGE, V99, P589, DOI 10.1007/s10584-009-9656-5; Williamson T.B., 2009, CLIMATE CHANGE CANAD; Williamson TB, 2005, FOREST CHRON, V81, P710, DOI 10.5558/tfc81710-5; Williamson TB, 2012, ADAPTING SUSTAINABLE; Yousefpour R, 2015, CLIMATIC CHANGE, V130, P273, DOI 10.1007/s10584-015-1330-5; Zaval L, 2014, NAT CLIM CHANGE, V4, P143, DOI 10.1038/NCLIMATE2093	50	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197689	10.1371/journal.pone.0197689	http://dx.doi.org/10.1371/journal.pone.0197689			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ2HI	29897977	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700025
J	Olive, JF; Qin, YB; DeCristo, MJ; Laszewski, T; Greathouse, F; McAllister, SS				Olive, Jessica F.; Qin, Yuanbo; DeCristo, Molly J.; Laszewski, Tyler; Greathouse, Frances; McAllister, Sandra S.			Accounting for tumor heterogeneity when using CRISPR-Cas9 for cancer progression and drug sensitivity studies	PLOS ONE			English	Article							ELEVATED PLASMA OSTEOPONTIN; METASTATIC BREAST-CANCER; ANTIBIOTIC-RESISTANCE; MAMMARY-CARCINOMA; GENE-EXPRESSION; CELL-LINES; EVOLUTION; GENOME; SURVIVAL; OVEREXPRESSION	Gene editing protocols often require the use of a subcloning step to isolate successfully edited cells, the behavior of which is then compared to the aggregate parental population and/or other non-edited subclones. Here we demonstrate that the inherent functional heterogeneity present in many cell lines can render these populations inappropriate controls, resulting in erroneous interpretations of experimental findings. We describe a novel CRISPR/Cas9 protocol that incorporates a single-cell cloning step prior to gene editing, allowing for the generation of appropriately matched, functionally equivalent control and edited cell lines. As a proof of concept, we generated matched control and osteopontin-knockout Her2(+) and Estrogen receptor-negative murine mammary carcinoma cell lines and demonstrated that the osteopontin-knockout cell lines exhibit the expected biological phenotypes, including unaffected primary tumor growth kinetics and reduced metastatic outgrowth in female FVB mice. Using these matched cell lines, we discovered that osteopontin-knockout mammary tumors were more sensitive than control tumors to chemotherapy in vivo. Our results demonstrate that heterogeneity must be considered during experimental design when utilizing gene editing protocols and provide a solution to account for it.	[Olive, Jessica F.; Qin, Yuanbo; DeCristo, Molly J.; Laszewski, Tyler; Greathouse, Frances; McAllister, Sandra S.] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Olive, Jessica F.; Qin, Yuanbo; DeCristo, Molly J.; McAllister, Sandra S.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [McAllister, Sandra S.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [McAllister, Sandra S.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	McAllister, SS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA.; McAllister, SS (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; McAllister, SS (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; McAllister, SS (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	smcallister1@beh.harvard.edu			Presidential Early Career Award for Scientists and Engineers; Department of Defense BCMRP Era of Hope Scholar Award [W81XWH-14-1-0191];  [NIH-NCI-R01CA166284]; NATIONAL CANCER INSTITUTE [R01CA166284] Funding Source: NIH RePORTER	Presidential Early Career Award for Scientists and Engineers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense BCMRP Era of Hope Scholar Award; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support provided by NIH-NCI-R01CA166284 (https://www.cancer.gov/about-ncl), Presidential Early Career Award for Scientists and Engineers and the Department of Defense BCMRP Era of Hope Scholar Award W81XWH-14-1-0191 (http://cdmrp/armv.mil/bcrp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sanchez-Romero MA, 2014, P NATL ACAD SCI USA, V111, P355, DOI 10.1073/pnas.1316084111; Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Campbell MJ, 2002, IN VITRO CELL DEV-AN, V38, P326; Chait R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10333; Cook AC, 2005, MOL CARCINOGEN, V43, P225, DOI 10.1002/mc.20105; Ding K, 2015, ONCOL REP, V34, P3297, DOI 10.3892/or.2015.4306; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Feng F, 2000, BREAST CANCER RES TR, V63, P71, DOI 10.1023/A:1006466516192; Goldberg DE, 2012, CELL, V148, P1271, DOI 10.1016/j.cell.2012.02.021; Graudens E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r19; Gu T, 2009, LUNG CANCER, V66, P176, DOI 10.1016/j.lungcan.2009.02.004; Guernet A, 2017, METHODS, V121, P130, DOI 10.1016/j.ymeth.2017.03.007; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Harrod A, 2017, ONCOGENE, V36, P2286, DOI 10.1038/onc.2016.382; Jia RJ, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.422; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Laughney AM, 2015, CELL REP, V12, P809, DOI 10.1016/j.celrep.2015.06.065; Levin-Reisman I, 2017, SCIENCE, V355, P826, DOI 10.1126/science.aaj2191; Liu GK, 2016, CANCER LETT, V383, P171, DOI 10.1016/j.canlet.2016.09.033; Luo SD, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/508587; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Neggers JE, 2015, CHEM BIOL, V22, P107, DOI 10.1016/j.chembiol.2014.11.015; Ng L, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/247892; Pang H, 2011, CANCER BIOTHER RADIO, V26, P165, DOI 10.1089/cbr.2010.0838; Plumer A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-38; Ramankulov A, 2007, J CANCER RES CLIN, V133, P643, DOI 10.1007/s00432-007-0215-z; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Sangaletti S, 2014, CANCER RES, V74, P4706, DOI 10.1158/0008-5472.CAN-13-3334; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Singhal H, 1997, CLIN CANCER RES, V3, P605; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wai PY, 2005, CARCINOGENESIS, V26, P741, DOI 10.1093/carcin/bgi027; Wei R, 2017, J CANCER, V8, P2173, DOI 10.7150/jca.20480; Wein L, 2017, BREAST, V34, pS27, DOI 10.1016/j.breast.2017.06.023; Xu YY, 2015, MOL CLIN ONCOL, V3, P357, DOI 10.3892/mco.2014.480; Yang Luhan, 2014, Curr Protoc Mol Biol, V107, DOI 10.1002/0471142727.mb3101s107	44	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198790	10.1371/journal.pone.0198790	http://dx.doi.org/10.1371/journal.pone.0198790			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897959	gold, Green Published, Green Submitted			2022-12-26	WOS:000435090700068
J	Doi, Y; Murakami, Y; Imano, N; Takeuchi, Y; Takahashi, I; Nishibuchi, I; Kimura, T; Nagata, Y				Doi, Yoshiko; Murakami, Yuji; Imano, Nobuki; Takeuchi, Yuki; Takahashi, Ippei; Nishibuchi, Ikuno; Kimura, Tomoki; Nagata, Yasushi			Quantifying esophageal motion during free-breathing and breath-hold using fiducial markers in patients with early-stage esophageal cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; 4-DIMENSIONAL COMPUTED-TOMOGRAPHY; DEFINITIVE CHEMORADIOTHERAPY; RADIATION-THERAPY; RESPIRATORY MOTION; PHASE-II; RADIOTHERAPY; RISK; DISPLACEMENT; DISEASE	Introduction Cardiac toxicity after definitive chemoradiotherapy for esophageal cancer is a critical issue. To reduce irradiation doses to organs at risk, individual internal margins need to be identified and minimized. The purpose of this study was to quantify esophageal motion using fiducial makers based on four-dimensional computed tomography, and to evaluate the inter-CBCT session marker displacement using breath-hold. Materials and methods Sixteen patients with early stage esophageal cancer, who received endoscopy-guided metallic marker placement for treatment planning, were included; there were 35 markers in total, with 9, 15, and 11 markers in the upper thoracic, middle thoracic, and lower thoracic/esophagogastric junction regions, respectively. We defined fiducial marker motion as motion of the centroidal point of the markers. Respiratory esophageal motion during free-breathing was defined as the amplitude of individual marker motion between the consecutive breathing and end-expiration phases, derived from four-dimensional computed tomography. The inter-CBCT session marker displacement using breath-hold was defined as the amplitudes of marker motion between the first and each cone beam computed tomography image. Marker motion was analyzed in the three regions (upper thoracic, middle thoracic, and lower thoracic/esophagogastric junction) and in three orthogonal directions (right-left; anterior-posterior; and superior-inferior). Results Respiratory esophageal motion during free-breathing resulted in median absolute maximum amplitudes (interquartile range), in right-left, anterior-posterior, and superior-inferior directions, of 1.7 (1.4) mm, 2.0 (1.5) mm, and 3.6 (4.1) mm, respectively, in the upper thoracic region, 0.8 (1.1) mm, 1.4 (1.2) mm, and 4.8 (3.6) mm, respectively, in the middle thoracic region, and 1.8 (0.8) mm, 1.9 (2.0) mm, and 8.0 (4.5) mm, respectively, in the lower thoracic/esophagogastric region. The inter-CBCT session marker displacement using breath-hold resulted in median absolute maximum amplitudes (interquartile range), in right-left, anterior-posterior, and superior-inferior directions, of 1.3 (1.0) mm, 1.1 (0.7) mm, and 3.3 (1.8) mm, respectively, in the upper thoracic region, 0.7 (0.7) mm, 1.1 (0.4) mm, and 3.4 (1.4) mm, respectively, in the middle thoracic region, and 2.0 (0.8) mm, 2.6 (2.2) mm, and 3.5 (1.8) mm, respectively, in the lower thoracic/esophagogastric region. Conclusions During free-breathing, esophageal motion in the superior-inferior direction in all sites was large, compared to the other directions, and amplitudes showed substantial inter-individual variability. The breath-hold technique is feasible for minimizing esophageal displacement during radiotherapy in patients with esophageal cancer.	[Doi, Yoshiko; Murakami, Yuji; Imano, Nobuki; Takeuchi, Yuki; Takahashi, Ippei; Nishibuchi, Ikuno; Kimura, Tomoki; Nagata, Yasushi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Radiat Oncol, Hiroshima, Japan	Hiroshima University	Doi, Y (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Radiat Oncol, Hiroshima, Japan.	yoshikod@hiroshima-u.ac.jp		Imano, Nobuki/0000-0002-7668-1506	JSPS KAKENHI [JP 26861002]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP 26861002 to YD.	Adams MJ, 2003, CRIT REV ONCOL HEMAT, V45, P55, DOI 10.1016/S1040-8428(01)00227-X; Beukema JC, 2015, RADIOTHER ONCOL, V114, P85, DOI 10.1016/j.radonc.2014.11.037; Chan MF, 2015, TECHNOL CANCER RES T, V14, P298, DOI 10.1177/1533034614547447; Dieleman EMT, 2007, INT J RADIAT ONCOL, V67, P775, DOI 10.1016/j.ijrobp.2006.09.054; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Frandsen J, 2015, J GASTROINTEST ONCOL, V6, P516, DOI 10.3978/j.issn.2078-6891.2015.040; Fukada J, 2013, INT J RADIAT ONCOL, V85, P991, DOI 10.1016/j.ijrobp.2012.07.2358; Handsfield LL, 2012, J APPL CLIN MED PHYS, V13, P181, DOI 10.1120/jacmp.v13i5.3976; Ishikura S, 2003, J CLIN ONCOL, V21, P2697, DOI 10.1200/JCO.2003.03.055; Ito H, 2017, J RADIAT RES, V58, P106, DOI 10.1093/jrr/rrw078; Jin P, 2016, RADIOTHER ONCOL, V118, P492, DOI 10.1016/j.radonc.2016.01.005; Jin P, 2015, RADIOTHER ONCOL, V117, P412, DOI 10.1016/j.radonc.2015.10.005; Kato H, 2009, JPN J CLIN ONCOL, V39, P638, DOI 10.1093/jjco/hyp069; Kato K, 2011, INT J RADIAT ONCOL, V81, P684, DOI 10.1016/j.ijrobp.2010.06.033; Kimura T, 2004, INT J RADIAT ONCOL, V60, P1307, DOI 10.1016/j.ijrobp.2004.07.718; Kincaid RE, 2018, ACTA ONCOL, V57, P1017, DOI 10.1080/0284186X.2018.1427885; Kobayashi Yuta, 2016, Adv Radiat Oncol, V1, P222, DOI 10.1016/j.adro.2016.08.006; Lin SH, 2016, CANCER-AM CANCER SOC, V122, P917, DOI 10.1002/cncr.29857; Lin SH, 2012, INT J RADIAT ONCOL, V84, P1078, DOI 10.1016/j.ijrobp.2012.02.015; Liu FH, 2016, ACTA ONCOL, V55, P1040, DOI 10.3109/0284186X.2016.1167953; Murakami Y, 2015, INT J CLIN ONCOL, V20, P897, DOI 10.1007/s10147-015-0819-2; Ohtsu A, 1999, J CLIN ONCOL, V17, P2915, DOI 10.1200/JCO.1999.17.9.2915; Patel AA, 2009, INT J RADIAT ONCOL, V74, P290, DOI 10.1016/j.ijrobp.2008.12.060; Sheng Y, 2017, INT J RADIAT ONCOL, V98, P473, DOI 10.1016/j.ijrobp.2017.02.089; Wang JY, 2012, INT J RADIAT ONCOL, V83, pE273, DOI 10.1016/j.ijrobp.2011.12.048; Yamashita H, 2011, INT J RADIAT ONCOL, V79, P588, DOI 10.1016/j.ijrobp.2010.03.045; Yamashita H, 2010, ACTA ONCOL, V49, P485, DOI 10.3109/02841861003652574; Yaremko BP, 2008, INT J RADIAT ONCOL, V70, P145, DOI 10.1016/j.ijrobp.2007.05.031; Zhao KT, 2007, RADIOTHER ONCOL, V84, P283, DOI 10.1016/j.radonc.2007.07.008	29	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198844	10.1371/journal.pone.0198844	http://dx.doi.org/10.1371/journal.pone.0198844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889910	Green Submitted, Green Published, gold			2022-12-26	WOS:000434786600058
J	Royer, S; de Campos, PA; Araujo, BF; Ferreira, ML; Goncalves, IR; Batistao, DWD; Brigido, RTES; Cerdeira, LT; Machado, LG; de Brito, CS; Gontijo, PP; Ribes, RM				Royer, Sabrina; de Campos, Paola Amaral; Araujo, Bruna Fuga; Ferreira, Melina Lorraine; Goncalves, Iara Rossi; da Fonseca Batistao, Deivid William; Brigido, Rebecca Tavares e Silva; Cerdeira, Louise Teixeira; Machado, Luiz Gustavo; de Brito, Cristiane Silveira; Gontijo-Filho, Paulo Pinto; Ribes, Rosineide Marques			Molecular characterization and clonal dynamics of nosocomial bla(OXA-23) producing XDR Acinetobacter baumannii	PLOS ONE			English	Article							RESISTANT PSEUDOMONAS-AERUGINOSA; INTENSIVE-CARE-UNIT; CARBAPENEM RESISTANCE; INTERNATIONAL CLONES; HIGH PREVALENCE; EFFLUX PUMPS; 2 INTEGRONS; MAJOR ROLE; MECHANISMS; SPREAD	The emergence of infections associated to new antimicrobial resistance in Acinetobacter baumannii (Ab) genotypes represents a major challenge. In this context, this study aimed to determine the diversity of resistance mechanisms and investigate clonal dissemination and predominant sequence types (STs) in multidrug-resistant Ab strains of clinical (tracheal aspirate, n = 17) and environmental (surface, n = 6) origins. Additionally, the major clones found in clinical (A) and environmental (H) strains had their complete genomes sequenced. All strains were submitted to polymerase chain reactions (PCR) for the detection of the I SAbal/bia(OXA-51-like) and I SAbal /bla(OXA-23-like) genes, while the expression of genes encoding the carO porin, AdeABC (adeB), AdeFGH (adeG), and AdeIJK (adeJ) efflux pumps was determined by real time PCR (qPCR). Most of the strains were characterized as extensively drug-resistant (XDR) with high minimal inhibitory concentrations (MICs) detected for tigecycline and carbapenems. Associations between I SAba //OXA-51 and I SAba //OXA-23 were observed in 91.3% and 52.2% of the strains, respectively. Only the adeB gene was considered hyper-expressed. Furthermore, most of the strains analyzed by the MuLtilocus Sequence-Typing (MLST) were found to belong to the clonal complex 113 (CC113). In addition, a new ST, ST1399, belonging to CC229, was also discovered herein. Strains analyzed by whole genome sequencing presented resistance genes linked to multidrug-resistance phenotypes and confirmed the presence of Tn2008, which provides high levels carbapenem-resistance.	[Royer, Sabrina; de Campos, Paola Amaral; Araujo, Bruna Fuga; Ferreira, Melina Lorraine; Goncalves, Iara Rossi; Machado, Luiz Gustavo; de Brito, Cristiane Silveira; Gontijo-Filho, Paulo Pinto; Ribes, Rosineide Marques] Univ Fed Uberlandia, Inst Biomed Sci ICBIM, Lab Mol Microbiol, Uberlandia, MG, Brazil; [da Fonseca Batistao, Deivid William] Univ Fed Uberlandia, Sch Med FAMED, Uberlandia, MG, Brazil; [Brigido, Rebecca Tavares e Silva] Univ Fed Uberlandia, Clin Hosp, Natl Reference Ctr Sanit Dermatol & Leprosy CREDE, Uberlandia, MG, Brazil; [Cerdeira, Louise Teixeira] Univ Sao Paulo, Sch Pharm, Dept Clin Anal, Sao Paulo, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade de Sao Paulo	Royer, S (corresponding author), Univ Fed Uberlandia, Inst Biomed Sci ICBIM, Lab Mol Microbiol, Uberlandia, MG, Brazil.	sabriroyer@yahoo.com.br	Goncalves, Iara/GRO-4035-2022; Batistão, Deivid William da Fonseca/V-7770-2018; Cerdeira, Louise Teixeira/AAR-4668-2020; Cerdeira, Louise/C-3749-2013; Gonçalves, Iara Rossi/AAJ-6326-2020	Batistão, Deivid William da Fonseca/0000-0002-4928-3473; Cerdeira, Louise/0000-0002-4495-2615; Gonçalves, Iara Rossi/0000-0001-5594-7099; Royer, Sabrina/0000-0002-2678-227X; Campos, Paola Amaral de/0000-0001-9384-7582	FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We thank FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) for the financial support and scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANVISA National Health Surveillance Agency, 2014, NEWSL PAT SAF QUAL H; Araujo BF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155914; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Brown S, 2006, J ANTIMICROB CHEMOTH, V57, P1, DOI 10.1093/jac/dki425; Cardoso JP, 2016, DIAGN MICR INFEC DIS, V85, P90, DOI 10.1016/j.diagmicrobio.2016.01.018; Carvalho KR, 2009, INT J ANTIMICROB AG, V34, P25, DOI 10.1016/j.ijantimicag.2008.12.009; Casal M, 2009, J ANTIMICROB CHEMOTH, V64, P69, DOI 10.1093/jac/dkp169; Catel-Ferreira M, 2011, J ANTIMICROB CHEMOTH, V66, P2053, DOI 10.1093/jac/dkr267; Chen YS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00163; Climaco EC, 2013, INFECT GENET EVOL, V19, P127, DOI 10.1016/j.meegid.2013.06.024; Clinical and Laboratory Standards Institute (CLSI), 2015, M100S25 CLSI; Coelho-Souza T, 2013, CLIN MICROBIOL INFEC, V19, pE241, DOI 10.1111/1469-0691.12145; Costello SE, 2016, MICROB DRUG RESIST, V22, P253, DOI 10.1089/mdr.2015.0168; Coyne S, 2011, ANTIMICROB AGENTS CH, V55, P947, DOI 10.1128/AAC.01388-10; Dalla-Costa LM, 2003, J CLIN MICROBIOL, V41, P3403, DOI 10.1128/JCM.41.7.3403-3406.2003; Damier-Piolle L, 2008, ANTIMICROB AGENTS CH, V52, P557, DOI 10.1128/AAC.00732-07; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; Fonseca EL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-245; Gao L, 2017, CHINESE MED J-PEKING, V130, P659, DOI 10.4103/0366-6999.201601; Gerson S, 2018, J ANTIMICROB CHEMOTH, V73, P1501, DOI 10.1093/jac/dky083; Chagas TPG, 2014, DIAGN MICR INFEC DIS, V79, P468, DOI 10.1016/j.diagmicrobio.2014.03.006; Grosso F, 2011, J ANTIMICROB CHEMOTH, V66, P62, DOI 10.1093/jac/dkq406; Hamidian M, 2013, J ANTIMICROB CHEMOTH, V68, P2682, DOI 10.1093/jac/dkt233; Higgins PG, 2010, INT J ANTIMICROB AG, V35, P305, DOI 10.1016/j.ijantimicag.2009.10.014; Huang GT, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01717; Jasemi S, 2016, LETT APPL MICROBIOL, V63, P466, DOI 10.1111/lam.12669; Jiang XB, 2014, DIAGN MICR INFEC DIS, V79, P381, DOI 10.1016/j.diagmicrobio.2014.03.025; Jones RN, 2014, DIAGN MICR INFEC DIS, V78, P429, DOI 10.1016/j.diagmicrobio.2013.10.008; Kamolvit W, 2015, MICROB DRUG RESIST, V21, P424, DOI 10.1089/mdr.2014.0234; Karah N, 2016, ANTIMICROB AGENTS CH, V60, P1801, DOI 10.1128/AAC.02143-15; Karah N, 2012, DRUG RESIST UPDATE, V15, P237, DOI 10.1016/j.drup.2012.06.001; Kempf M, 2012, INT J ANTIMICROB AG, V39, P105, DOI 10.1016/j.ijantimicag.2011.10.004; Labarca JA, 2016, CRIT REV MICROBIOL, V42, P276, DOI 10.3109/1040841X.2014.940494; Lee CR, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00055; Leite GC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151270; Lin L, 2009, INT J ANTIMICROB AG, V33, P27, DOI 10.1016/j.ijantimicag.2008.06.027; Lu PL, 2009, J ANTIMICROB CHEMOTH, V63, P641, DOI 10.1093/jac/dkn553; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Rodriguez-Martinez JM, 2011, J INFECT CHEMOTHER, V17, P149, DOI 10.1007/s10156-010-0120-2; Martins AF, 2009, INFECTION, V37, P474, DOI 10.1007/s15010-009-9003-9; Martins N, 2012, TRANSPL INFECT DIS, V14, P316, DOI 10.1111/j.1399-3062.2011.00701.x; Martins N, 2015, ANTIMICROB AGENTS CH, V59, P698, DOI 10.1128/AAC.02415-14; Martins N, 2013, MICROB DRUG RESIST, V19, P216, DOI 10.1089/mdr.2012.0174; Medeiros M, 2013, BRAZ J PATHOL LAB ME, V49, P391, DOI DOI 10.1590/S1676-24442013000600003; Mostachio AK, 2012, INT J ANTIMICROB AG, V39, P396, DOI 10.1016/j.ijantimicag.2012.01.021; Anh NT, 2017, J MED MICROBIOL, V66, P46, DOI 10.1099/jmm.0.000418; Nigro SJ, 2016, J ANTIMICROB CHEMOTH, V71, P1135, DOI 10.1093/jac/dkv440; Novovic K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122793; Opazo A., 2011, J INFECTION, V6, P311; Pagano M, 2013, EPIDEMIOL INFECT, V141, P330, DOI 10.1017/S095026881200074X; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/eri.13.12, 10.1586/ERI.13.12]; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Rahal JJ, 2006, CLIN INFECT DIS, V43, pS95, DOI 10.1086/504486; Ramirez MS, 2015, EPIDEMIOL INFECT, V143, P3118, DOI 10.1017/S0950268815000060; Rossi F, 2017, BRAZ J INFECT DIS, V21, P98, DOI 10.1016/j.bjid.2016.09.011; Rossi F, 2009, J MED MICROBIOL, V58, P1522, DOI 10.1099/jmm.0.011080-0; Royer S, 2015, BRAZ J INFECT DIS, V19, P350, DOI 10.1016/j.bjid.2015.03.009; Ruiz M, 2007, CLIN MICROBIOL INFEC, V13, P1192, DOI 10.1111/j.1469-0691.2007.01825.x; Segal H, 2005, FEMS MICROBIOL LETT, V243, P425, DOI 10.1016/j.femsle.2005.01.005; Sen B, 2016, J APPL MICROBIOL, V120, P619, DOI 10.1111/jam.13037; Stietz MS, 2013, INFECT GENET EVOL, V14, P294, DOI 10.1016/j.meegid.2012.12.020; Turton JF, 2006, FEMS MICROBIOL LETT, V258, P72, DOI 10.1111/j.1574-6968.2006.00195.x; Vasconcelos ATR, 2015, DIAGN MICR INFEC DIS, V83, P382, DOI 10.1016/j.diagmicrobio.2015.08.006; Viana GF, 2016, AM J INFECT CONTROL, V44, P593, DOI 10.1016/j.ajic.2015.11.020; Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509; Wang XH, 2011, DIAGN MICR INFEC DIS, V69, P218, DOI 10.1016/j.diagmicrobio.2010.10.018; Yoon EJ, 2015, MBIO, V6, DOI 10.1128/mBio.00309-15; Yoon EJ, 2013, ANTIMICROB AGENTS CH, V57, P2989, DOI 10.1128/AAC.02556-12; Zavascki AP, 2010, EXPERT REV ANTI-INFE, V8, P71, DOI 10.1586/ERI.09.108; Zong Z, 2008, INT J ANTIMICROB AG, V31, P50, DOI 10.1016/j.ijantimicag.2007.08.019	71	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198643	10.1371/journal.pone.0198643	http://dx.doi.org/10.1371/journal.pone.0198643			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889876	gold, Green Published, Green Submitted			2022-12-26	WOS:000434786600033
J	Hartman, H; Wang, YG; Schroeder, HW; Cui, XQ				Hartman, Holly; Wang, Yuge; Schroeder, Harry W., Jr.; Cui, Xiangqin			Absorbance summation: A novel approach for analyzing high-throughput ELISA data in the absence of a standard	PLOS ONE			English	Article							CALIBRATION; MODELS	We have developed a very simple method, termed absorbance summation (AS), for comparing protein concentrations between samples in ELISA assays without a standard. This method sums the observed absorbance values from all dilutions to obtain one data point for each sample to be used for comparison. AS is less computationally intensive than fitting sigmoidal curves, and it avoids the difficulty of parameter estimation for samples with absorbance values lying primarily at the lower tail of the curve. Our simulation studies showed that it performs much better than the sigmoidal curve fitting method and the conventional endpoint titer method. The power of this simple method is as high as the formal curve fitting followed by the estimation of area under the curve (AUC).	[Hartman, Holly; Cui, Xiangqin] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Wang, Yuge; Schroeder, Harry W., Jr.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Schroeder, Harry W., Jr.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Cui, XQ (corresponding author), Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA.	xiangqin.cui@emory.edu		Hartman, Holly/0000-0002-9101-4381; Schroeder, Harry/0000-0002-3767-6878	NIH [AI117703, P60AR064172]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR064172] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH AI117703 (to Harry W. Schroeder, Jr) and NIH P60AR064172 (to Xiangqin Cui). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Cumberland WN, 2015, J BIOPHARM STAT, V25, P972, DOI 10.1080/10543406.2014.920345; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Gelman A, 2004, BIOMETRICS, V60, P407, DOI 10.1111/j.0006-341X.2004.00185.x; Herman RA, 2008, J IMMUNOL METHODS, V339, P245, DOI 10.1016/j.jim.2008.09.001; KARPINSKI KF, 1987, J IMMUNOL METHODS, V103, P189, DOI 10.1016/0022-1759(87)90289-4; Khass M, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf6628; KIRKHAM PM, 1992, EMBO J, V11, P603, DOI 10.1002/j.1460-2075.1992.tb05092.x; OCONNELL MA, 1993, CHEMOMETR INTELL LAB, V20, P97, DOI 10.1016/0169-7439(93)80008-6; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rodbard D, 1974, RADIOIMMUNOASSAY REL, P166; Schroeder HW, 2010, CRIT REV IMMUNOL, V30, P327; Wang YG, 2016, IMMUNOGENETICS, V68, P145, DOI 10.1007/s00251-015-0890-x; Yu XM, 2014, STAT BIOPHARM RES, V4, P1	13	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198528	10.1371/journal.pone.0198528	http://dx.doi.org/10.1371/journal.pone.0198528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883460	gold, Green Published, Green Submitted			2022-12-26	WOS:000434728100027
J	Frick, C; Dettinger, P; Renkawitz, J; Jauch, A; Berger, CT; Recher, M; Schroeder, T; Mehling, M				Frick, Corina; Dettinger, Philip; Renkawitz, Joerg; Jauch, Annaise; Berger, Christoph T.; Recher, Mike; Schroeder, Timm; Mehling, Matthias			Nano-scale microfluidics to study 3D chemotaxis at the single cell level	PLOS ONE			English	Article							MIGRATION; EXPRESSION; CHEMOKINE; QUANTIFICATION; LYMPHOCYTE; SUBSETS	Directed migration of cells relies on their ability to sense directional guidance cues and to interact with pericellular structures in order to transduce contractile cytoskeletal-into mechanical forces. These biomechanical processes depend highly on microenvironmental factors such as exposure to 2D surfaces or 3D matrices. In vivo, the majority of cells are exposed to 3D environments. Data on 3D cell migration are mostly derived from intravital microscopy or collagen-based in vitro assays. Both approaches offer only limited controllability of experimental conditions. Here, we developed an automated microfluidic system that allows positioning of cells in 3D microenvironments containing highly controlled diffusion based chemokine gradients. Tracking migration in such gradients was feasible in real time at the single cell level. Moreover, the setup allowed on-chip immunocytochemistry and thus linking of functional with phenotypical properties in individual cells. Spatially defined retrieval of cells from the device allows down-stream off-chip analysis. Using dendritic cells as a model, our setup specifically allowed us for the first time to quantitate key migration characteristics of cells exposed to identical gradients of the chemokine CCL1 9 yet placed on 2D vs in 3D environments. Migration properties between 2D and 3D migration were distinct. Morphological features of cells migrating in an in vitro 3D environment were similar to those of cells migrating in animal tissues, but different from cells migrating on a surface. Our system thus offers a highly controllable in vitro-mimic of a 3D environment that cells traffic in vivo.	[Frick, Corina; Jauch, Annaise; Berger, Christoph T.; Recher, Mike; Mehling, Matthias] Basel Univ, Dept Biomed, Basel, Switzerland; [Frick, Corina; Jauch, Annaise; Berger, Christoph T.; Recher, Mike; Mehling, Matthias] Univ Hosp Basel, Basel, Switzerland; [Dettinger, Philip; Schroeder, Timm] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Renkawitz, Joerg] Inst Sci & Technol Austria IST Austria, Klosterneuburg, Austria; [Mehling, Matthias] Univ Hosp Basel, Dept Neurol Dept, Basel, Switzerland	University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich; Institute of Science & Technology - Austria; University of Basel	Mehling, M (corresponding author), Basel Univ, Dept Biomed, Basel, Switzerland.; Mehling, M (corresponding author), Univ Hosp Basel, Basel, Switzerland.; Mehling, M (corresponding author), Univ Hosp Basel, Dept Neurol Dept, Basel, Switzerland.	matthias.mehling@unibas.ch	Renkawitz, Jörg/AAD-5932-2022; Berger, Christoph T/I-6126-2019	Renkawitz, Jörg/0000-0003-2856-3369; Berger, Christoph T/0000-0002-1730-8824; Schroeder, Timm/0000-0001-9320-0252; Recher, Mike/0000-0002-9121-6936; Mehling, Matthias/0000-0001-8599-1226	Swiss National Science Foundation [323530_164221, 323630_151483, PZ00P3_144863, 31003A_156431, PZ00P3_148000, PZ00P3_154733]; Novartis FreeNovation grant; EMBO long-term fellowship - European Commission (LTFCOFUND) [ALTF 1396-2014, GA-2013-609409]; Gebert Ruf Foundation [GRS 058/14]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis FreeNovation grant; EMBO long-term fellowship - European Commission (LTFCOFUND); Gebert Ruf Foundation	This work was supported by the Swiss National Science Foundation (MD-PhD fellowships, 323530_164221 to C.F.; and 323630_151483 to A.J.; grant PZ00P3_144863 to M.R, grant 31003A_156431 to T.S.; PZ00P3_148000 to C.T.B.; PZ00P3_154733 to M.M.), a Novartis FreeNovation grant to M.M. and T.S. and an EMBO long-term fellowship (ALTF 1396-2014) co-funded by the European Commission (LTFCOFUND2013, GA-2013-609409) to J.R.. M.R. was supported by the Gebert Ruf Foundation (GRS 058/14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizel K, 2017, LAB CHIP, V17, P3851, DOI 10.1039/c7lc00649g; Amirabadi HE, 2017, BIOMED MICRODEVICES, V19, DOI 10.1007/s10544-017-0234-8; Anguiano M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171417; Antoni D, 2015, INT J MOL SCI, V16, P5517, DOI 10.3390/ijms16035517; Bear JE, 2014, CURR OPIN CELL BIOL, V30, P74, DOI 10.1016/j.ceb.2014.06.005; Bouma G, 2009, IMMUNOBIOLOGY, V214, P778, DOI 10.1016/j.imbio.2009.06.009; Buisson S, 2003, VACCINE, V21, P862, DOI 10.1016/S0264-410X(02)00533-9; Bzymek R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25016; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chen MB, 2017, NAT PROTOC, V12, P865, DOI 10.1038/nprot.2017.018; Desmetz C, 2006, IMMUNOLOGY, V119, P551, DOI 10.1111/j.1365-2567.2006.02470.x; Duval K, 2017, PHYSIOLOGY, V32, P266, DOI 10.1152/physiol.00036.2016; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Farahat WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037333; Frank T, 2013, LAB CHIP, V13, P1273, DOI 10.1039/c3lc41076e; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Kellogg RA, 2014, NAT PROTOC, V9, P1713, DOI 10.1038/nprot.2014.120; Kim BJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057460, 10.1371/journal.pone.0068422]; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; LORBER MI, 1982, J IMMUNOL, V128, P2798; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Mehling M, 2015, LAB CHIP, V15, P1276, DOI 10.1039/c4lc01038h; Petrie RJ, 2016, CURR OPIN CELL BIOL, V42, P7, DOI 10.1016/j.ceb.2016.03.025; Petrie RJ, 2012, J CELL SCI, V125, P5917, DOI 10.1242/jcs.093732; Qin SX, 1996, EUR J IMMUNOL, V26, P640, DOI 10.1002/eji.1830260320; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Schwarz J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36440; Skylaki S, 2016, NAT BIOTECHNOL, V34, P1137, DOI 10.1038/nbt.3713; Stein JV, 2017, J ALLERGY CLIN IMMUN, V139, P12, DOI 10.1016/j.jaci.2016.11.008; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Toetsch S, 2009, INTEGR BIOL-UK, V1, P170, DOI 10.1039/b814567a; Weber Michele, 2013, Methods Mol Biol, V1013, P215, DOI 10.1007/978-1-62703-426-5_14; WESTERMANN J, 1992, CLIN INVESTIGATOR, V70, P539; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Wu PH, 2014, P NATL ACAD SCI USA, V111, P3949, DOI 10.1073/pnas.1318967111	38	21	21	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198330	10.1371/journal.pone.0198330	http://dx.doi.org/10.1371/journal.pone.0198330			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879160	Green Published, Green Submitted, gold			2022-12-26	WOS:000434384900031
J	Huang, YM; Zeng, XC; Cao, HP				Huang, Youming; Zeng, Xiaochun; Cao, Heping			Hormonal regulation of floret closure of rice (Oryza sativa)	PLOS ONE			English	Article							METHYL JASMONATE; PLANT-GROWTH; ETHYLENE; NIL	Plant hormones play important roles in regulating every aspect of growth, development, and metabolism of plants. We are interested in understanding hormonal regulation of floret opening and closure in plants. This is a particularly important problem for hybrid rice because regulation of flowering time is vitally important in hybrid rice seed production. However, little was known about the effects of plant hormones on rice flowering. We have shown that jasmonate and methyl jasmonate play significant roles in promoting rice floret opening. In this study, we investigated the effects of auxins including indole-3-acidic acid (IAA), indole-3-butyric acid (IBA), 1-naphthalene-acetic acid (NAA), 2,4-dichlorophenoxy acetic acid (2,4-D) and 3,6-dichloro-2-methoxybenzoic acid (DIC) and abscisic acid (ABA) on floret closure of four fertile and three sterile varieties of rice. The results from field studies in three growing seasons in 2013-2015 showed that the percentages of closed florets were significantly lower in plants treated with IAA, IBA, 2,4-D, DIC and NAA and that the durations of floret opening were significantly longer in plants treated with the same auxins. The auxins exhibited time- and concentration-dependant effects on floret closure. ABA displayed opposite effects of auxins because it increased the percentages of floret closure and decreased the length of floret opening of rice varieties. The degree of auxin-inhibiting and ABA-promoting effects on floret closure was varied somewhat but not significantly different among the rice varieties. Endogenous IAA levels were the highest in florets collected shortly before opening followed by a sharp decline in florets with maximal angles of opening and a significant jump of IAA levels shortly after floret closure in both fertile and sterile rice plants. ABA levels showed an opposite trend in the same samples. Our results showed that auxins delayed but ABA promoted the closure of rice floret regardless of the varieties.	[Huang, Youming; Zeng, Xiaochun] Jiangxi Agr Univ, Minist Educ, Key Lab Crop Physiol Ecol & Genet Breeding, Nanchang, Jiangxi, Peoples R China; [Huang, Youming; Zeng, Xiaochun] Yichun Univ, Dept Life Sci & Environm Resources, Yichun, Jiangxi, Peoples R China; [Cao, Heping] ARS, USDA, Southern Reg Res Ctr, Commod Utilizat Res Unit, New Orleans, LA USA	Jiangxi Agricultural University; Yichun University; United States Department of Agriculture (USDA)	Zeng, XC (corresponding author), Jiangxi Agr Univ, Minist Educ, Key Lab Crop Physiol Ecol & Genet Breeding, Nanchang, Jiangxi, Peoples R China.; Zeng, XC (corresponding author), Yichun Univ, Dept Life Sci & Environm Resources, Yichun, Jiangxi, Peoples R China.; Cao, HP (corresponding author), ARS, USDA, Southern Reg Res Ctr, Commod Utilizat Res Unit, New Orleans, LA USA.	xchzeng2013@163.com; Heping.Cao@ars.usda.gov	Cao, Heping/AAC-1666-2021	Cao, Heping/0000-0002-0958-1468	Science and Technology Projects for Universities in Jiangxi Province, China [KJLD12092]; Project of Gan Po Excellence 555 Plan of Jiangxi Province, China; USDA-ARS Quality and Utilization of Agricultural Products Research Program 306 [CRIS 6054-41000-103-00D]	Science and Technology Projects for Universities in Jiangxi Province, China; Project of Gan Po Excellence 555 Plan of Jiangxi Province, China; USDA-ARS Quality and Utilization of Agricultural Products Research Program 306	This work was supported by the Science and Technology Projects for Universities in Jiangxi Province, China (KJLD12092), the Project of Gan Po Excellence 555 Plan of Jiangxi Province, China and USDA-ARS Quality and Utilization of Agricultural Products Research Program 306 through CRIS 6054-41000-103-00D. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. USDA is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao H, 1997, J PLANT GROWTH REGUL, V16, P137, DOI 10.1007/PL00006987; Cao HP, 2011, J AGR FOOD CHEM, V59, P2739, DOI 10.1021/jf103527x; CAO HP, 1995, PLANT GROWTH REGUL, V16, P189, DOI 10.1007/BF00029540; Cao JianDong, 2008, Acta Agriculturae Shanghai, V24, P69; Fan XM, 2017, J AGR FOOD CHEM, V65, P10332, DOI 10.1021/acs.jafc.7b03755; Gao XQ, 2004, PLANT GROWTH REGUL, V43, P269, DOI 10.1023/B:GROW.0000046004.77424.1d; Ge HB, 1998, ACTA HORTICULTURAE S, V25, P89; Gu Yun-Jie, 1993, Acta Phytophysiologica Sinica, V19, P345; Jin Y, 1996, CHINESE B BOT, V13, P34; KAIHARA S, 1983, PLANT CELL PHYSIOL, V24, P309; KONING RE, 1986, AM J BOT, V73, P152, DOI 10.2307/2444287; Li Z., 1996, PLANT HORMONE IMMUNO; [刘淑英 LIU Shuying], 2007, [麦类作物学报, Journal of Triticeae Crops], V27, P593; Lu J, 2001, JIANGSU AGR SCI, V2001, P41; PARTHIER B, 1991, BOT ACTA, V104, P446, DOI 10.1111/j.1438-8677.1991.tb00257.x; Staswick Paul E., 1995, P179; Steel RGD, 1980, PRINCIPLES PROCEDURE; Sun J, 2008, BARLEY CEREAL SCI, V2008, P54; [王大伟 WANG Dawei], 2007, [麦类作物学报, Journal of triticeae crops], V27, P293; Wang Z., 1992, Scientia Agricultura Sinica, V25, P22; Yang JianJu, 2006, Hybrid Rice, V21, P57; Yang Z, 2010, PLANT DOCTOR, V23, P4; Yoshida S, 1981, FUNDAMENTALS RICE CR, P56; Yuan S, 2000, CROPS, V2000, P20; Zeng XC, 1999, J PLANT GROWTH REGUL, V18, P153, DOI 10.1007/PL00007063; Zeng XiaoChun, 2004, Scientia Agricultura Sinica, V37, P188; Zhang W, 2000, HYBRID RICE, V15, P15	27	5	8	7	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198828	10.1371/journal.pone.0198828	http://dx.doi.org/10.1371/journal.pone.0198828			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879200	gold, Green Submitted, Green Published			2022-12-26	WOS:000434384900085
J	Zhang, FB; Xu, WJ; Liu, J; Liu, XY; Huo, BJ; Li, B; Wang, Z				Zhang, Fengbin; Xu, Wenjuan; Liu, Jun; Liu, Xiaoyan; Huo, Bingjie; Li, Bing; Wang, Zhong			Optimizing miRNA-module diagnostic biomarkers of gastric carcinoma via integrated network analysis	PLOS ONE			English	Article							CANCER	Several microRNAs (miRNAs) have been suggested as novel biomarkers for diagnosing gastric cancer (GC) at an early stage, but the single-marker strategy may ignore the co-regulatory relationships and lead to low diagnostic specificity. Thus, multi-target modular diagnostic biomarkers are urgently needed. In this study, a Z(summary) and NetSVM-based method was used to identify GC-related hub miRNAs and activated modules from clinical miRNA co-expression networks. The NetSVM-based sub-network consisting of the top 20 hub miRNAs reached a high sensitivity and specificity of 0.94 and 0.82. The Z(summary) algorithm identified an activated module (miR-486, miR-451, miR-185, and miR-600) which might serve as diagnostic biomarker of GC. Three members of this module were previously suggested as biomarkers of GC and its 24 target genes were significantly enriched in pathways directly related to cancer. The weighted diagnostic ROC AUC of this module was 0.838, and an optimized module unit (miR-451 and miR-185) obtained a higher value of 0.904, both of which were higher than that of individual miRNAs. These hub miRNAs and module have the potential to become robust biomarkers for early diagnosis of GC with further validations. Moreover, such modular analysis may offer valuable insights into multi-target approaches to cancer diagnosis and treatment.	[Zhang, Fengbin; Huo, Bingjie] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China; [Xu, Wenjuan] Beijing Univ Chinese Med, Sch Life Sci, Beijing, Peoples R China; [Liu, Jun; Li, Bing; Wang, Zhong] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China; [Liu, Xiaoyan] TCM Hosp Hebei Prov, Shijiazhuang, Hebei, Peoples R China; [Li, Bing] China Acad Chinese Med Sci, Inst Informat Tradit Chinese Med, Beijing, Peoples R China; [Li, Bing] Shanxi Buchang Pharmaceut Co Ltd, Xian, Shaanxi, Peoples R China	Hebei Medical University; Beijing University of Chinese Medicine; China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS; China Academy of Chinese Medical Sciences; Institute of Information on Traditional Chinese Medicine, CACMS	Li, B; Wang, Z (corresponding author), China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China.; Li, B (corresponding author), China Acad Chinese Med Sci, Inst Informat Tradit Chinese Med, Beijing, Peoples R China.; Li, B (corresponding author), Shanxi Buchang Pharmaceut Co Ltd, Xian, Shaanxi, Peoples R China.	libingtcm@163.com; zhonwtcm@sina.com	HUO, bingjie/AGJ-1037-2022; Wang, Zhong/AAY-7574-2020	Li, Bing/0000-0002-4613-1327	National Major Scientific and Technological Special Project for "Significant New Drugs Development" [2017ZX09301059]; National Natural Science Foundation of China [81673833, 81703947]; Natural Science Foundation of Hebei province [H2015206461]	National Major Scientific and Technological Special Project for "Significant New Drugs Development"; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei province(Natural Science Foundation of Hebei Province)	The authors' work is funded by The National Major Scientific and Technological Special Project for "Significant New Drugs Development"(2017ZX09301059 to ZW), the National Natural Science Foundation of China (81673833 to JL, 81703947 to ZW) and The Natural Science Foundation of Hebei province (H2015206461 to FZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi K, 2014, WORLD J GASTROENTERO, V20, P13741, DOI 10.3748/wjg.v20.i38.13741; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Carcas Lauren Peirce, 2014, J Carcinog, V13, P14, DOI 10.4103/1477-3163.146506; Chen Z, 2013, CANCER-AM CANCER SOC, V119, P1985, DOI 10.1002/cncr.28002; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fu SY, 2017, EXPERT REV PROTEOMIC, V14, P351, DOI 10.1080/14789450.2017.1299006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin NN, 2015, SCI REP-UK, V5, DOI 10.1038/srep11566; Kim CH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-79; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Konishi H, 2012, BRIT J CANCER, V106, P740, DOI 10.1038/bjc.2011.588; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li B, 2016, CPT-PHARMACOMET SYST, V5, P575, DOI 10.1002/psp4.12127; Li Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.148; Liu R, 2015, GENE, V563, P56, DOI 10.1016/j.gene.2015.03.008; Liu XP, 2016, ONCOTARGETS THER, V9, P5701, DOI 10.2147/OTT.S113281; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Oba K, 2013, EUR J CANCER, V49, P1565, DOI 10.1016/j.ejca.2012.12.016; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Ren CL, 2016, J CANCER RES CLIN, V142, P2489, DOI 10.1007/s00432-016-2243-z; Sales-Pardo M, 2017, SCIENCE, V357, P128, DOI 10.1126/science.aan8075; Scartozzi M, 2010, CURR ONCOL REP, V12, P175, DOI 10.1007/s11912-010-0101-8; Shi WJ, 2016, WORLD J GASTRO ONCOL, V8, P673, DOI 10.4251/wjgo.v8.i9.673; Shi X, 2017, PLOS ONE, V1; Tan ZQ, 2014, MOL CELL BIOCHEM, V386, P223, DOI 10.1007/s11010-013-1860-y; Tsai MM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060945; Wang Z, 2012, EXPERT OPIN DRUG DIS, V7, P667, DOI 10.1517/17460441.2012.692673; Wei S, 2016, ONCOTARGET, V7, P75185, DOI 10.18632/oncotarget.12092; Yao QY, 2013, CANCER LETT, V335, P219, DOI 10.1016/j.canlet.2013.02.031; Zhang HY, 2016, ONCOL REP, V35, P1135, DOI 10.3892/or.2015.4451; Zhang X, 2015, PLOS ONE, V2; Zheng Q, 2017, ONCOTARGET, V8, P46611, DOI 10.18632/oncotarget.16679; Zhu C, 2014, BRIT J CANCER, V110, P2291, DOI 10.1038/bjc.2014.119	37	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198445	10.1371/journal.pone.0198445	http://dx.doi.org/10.1371/journal.pone.0198445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879180	Green Published, Green Submitted, gold			2022-12-26	WOS:000434384900047
J	Hayashi, T; Krebs, WN; Saito-Kato, M; Tanimura, Y				Hayashi, Tatsuya; Krebs, William N.; Saito-Kato, Megumi; Tanimura, Yoshihiro			The turnover of continental planktonic diatoms near the middle/late Miocene boundary and their Cenozoic evolution	PLOS ONE			English	Article							SP-NOV BACILLARIOPHYTA; INDIAN-OCEAN DIPOLE; LIGHT-ABSORPTION; ASIAN MONSOON; CELL-SIZE; SOUTHERN-OSCILLATION; EURASIAN CLIMATE; POTWAR PLATEAU; SIWALIK GROUP; PHYTOPLANKTON	Fossil evidence indicates that modern assemblages of temperate nonmarine planktonic diatoms began near the middle/late Miocene boundary when the genus Actinocyclus, an important constituent of lacustrine planktonic diatom assemblages during the early to middle Miocene, was replaced by genera of the family Stephanodiscaceae. This floral turnover has been confirmed in many regions of the world, except eastern Asia where taxonomic data about early and middle Miocene planktonic diatom assemblages have until recently been scarce. Our analysis of Lower and Middle Miocene lacustrine diatomaceous rocks in Japan confirms that species of nonmarine Actinocyclus were important constituents of lake phytoplankton there as well. The appearance of nonmarine Actinocyclus species near the beginning of the Miocene may have resulted from the introduction of euryhaline species into lacustrine environments during a highstand of sea level at that time. Similarly, it is possible that species of Stephanodiscaceae evolved from marine thalassiosiroid ancestors that invaded high latitude lacustrine environments during multiple Paleogene highstands, resulting in a polyphyletic origin of the family. The turnover from nonmarine Actinocyclus to Stephanodiscaceae genera near the middle/late Miocene boundary may be linked to a contemporaneous increase in silica concentrations in lakes caused by active volcanism, increased weathering of silicate rocks due to orogeny, and the expansion of C-4 grasslands. This turnover may also have been influenced by enhanced seasonal environmental changes in the euphotic zone caused by the initiation of monsoon conditions and a worldwide increase in meridional temperature gradients during the late Miocene. Morphological characteristics of Stephanodiscaceae genera, such as strutted processes and small size, suggest their species were better adapted to seasonal environmental changes than non-marine species of Actinocyclus because of their superiority in floating and drifting capabilities and possibly metabolism, intrinsic growth rate, and reproductivity. As climates deteriorated during the late Miocene, Stephanodiscaceae species may have spread from high latitudes to temperate lakes where they diversified, ultimately displacing Actinocyclus.	[Hayashi, Tatsuya] Kyushu Univ, Fac Social & Cultural Studies, Dept Environm Changes, Nishi Ku, Fukuoka, Japan; [Hayashi, Tatsuya] Mifune Dinosaur Museum, Kumamoto, Japan; [Saito-Kato, Megumi; Tanimura, Yoshihiro] Natl Museum Nat & Sci, Dept Geol & Paleontol, Tsukuba, Ibaraki, Japan	Kyushu University; National Museum of Nature and Science	Hayashi, T (corresponding author), Kyushu Univ, Fac Social & Cultural Studies, Dept Environm Changes, Nishi Ku, Fukuoka, Japan.; Hayashi, T (corresponding author), Mifune Dinosaur Museum, Kumamoto, Japan.	t.hayashi.diatom@gmail.com			JSPS KAKENHI [JP18H03358]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP18H03358.	Abram NJ, 2007, NATURE, V445, P299, DOI 10.1038/nature05477; Abrantes F, 2000, EARTH PLANET SC LETT, V176, P7, DOI 10.1016/S0012-821X(99)00312-X; Alexandre A, 1997, GEOCHIM COSMOCHIM AC, V61, P677, DOI 10.1016/S0016-7037(97)00001-X; Alverson AJ, 2007, MOL PHYLOGENET EVOL, V45, P193, DOI 10.1016/j.ympev.2007.03.024; Alverson AJ, 2014, PALEOBIOLOGY, V40, P91, DOI 10.1666/12055; [Anonymous], DIATOMS APPL ENV EAR; Ashok K, 2001, GEOPHYS RES LETT, V28, P4499, DOI 10.1029/2001GL013294; Awasthi N., 1994, HIMAL GEOL, V15, P107; AXELROD DI, 1994, PALEOBIOS, V16, P1; Barron J. A, 1987, SILICEOUS SEDIMENTAR, P164; BARRY JC, 1982, PALAEOGEOGR PALAEOCL, V37, P95, DOI 10.1016/0031-0182(82)90059-1; Bartoli G, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001185; Bond GC, 1999, GEOPH MONOG SERIES, V112, P35; BRADBURY J P, 1982, Acta Geologica Academiae Scientiarum Hungaricae, V25, P97; Bradbury J.P., 1995, 1543A US GEOL SURV, V1543, P1, DOI DOI 10.3133/PP1543AB; Bradbury JP, 1995, SHORT COURSES PALEON, V8, P119; Bramlette M.N., 1946, US GEOL SURV PROFESS, V212, P1; BROCCOLI AJ, 1992, J CLIMATE, V5, P1181, DOI 10.1175/1520-0442(1992)005<1181:TEOOOM>2.0.CO;2; Bronmark C., 2005, BIOL LAKES PONDS; Busby CJ, 2009, INT GEOL REV, V51, P670, DOI 10.1080/00206810902978265; Crosta X, 2009, DEEP-SEA RES PT I, V56, P1983, DOI 10.1016/j.dsr.2009.06.009; DANSGAARD W, 1989, PHYS CH EAR, V8, P287; Darwin C, 1859, ORIGIN SPECIES MEANS; Falkowski PG, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P429; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Farias M, 2008, TECTONICS, V27, DOI 10.1029/2006TC002046; Finkel ZV, 2000, J THEOR BIOL, V204, P361, DOI 10.1006/jtbi.2000.2020; Finkel ZV, 2001, LIMNOL OCEANOGR, V46, P86, DOI 10.4319/lo.2001.46.1.0086; FLOWER BP, 1994, PALAEOGEOGR PALAEOCL, V108, P537, DOI 10.1016/0031-0182(94)90251-8; FLYNN LJ, 1982, PALAEOGEOGR PALAEOCL, V38, P129, DOI 10.1016/0031-0182(82)90067-0; FOURTANIER E, 1988, CR ACAD SCI II, V306, P1401; Fourtanier Elisabeth, 1993, Diatom Research, V8, P13; GASSE F, 1991, J AFR EARTH SCI, V12, P325, DOI 10.1016/0899-5362(91)90081-9; Gasse F., 1980, REV ALGOL MEM HORSSE, V3, P1; Gasse F., 1990, MEMOIR, P19; Gasse F., 1986, BIBLIOTHECA DIATOMOL; Guerrero JM, 2002, DIATOM RES, V17, P141; HAHN DG, 1975, J ATMOS SCI, V32, P1515, DOI 10.1175/1520-0469(1975)032<1515:TROMIT>2.0.CO;2; Hajos M., 1976, Initial Rep Deep Sea Drilling Project, V35, P817, DOI 10.2973/dsdp.proc.35.29chap1.1976; Hakansson H, 2002, DIATOM RES, V17, P1; HANNA G. DALLAS, 1932, PROC CALIFORNIA ACND SCI, V20, P161; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; HARPER MA, 1986, NEW ZEAL J MAR FRESH, V20, P107, DOI 10.1080/00288330.1986.9516135; Harwood DM, 1999, DIATOMS APPL ENV EAR, P570; HASLE GR, 1977, PHYCOLOGIA, V16, P321, DOI 10.2216/i0031-8884-16-3-321.1; Hayashi T, 2010, GEOCHEM GEOPHY GEOSY, V11, P1; Hayashi T, 2007, PHYCOLOGIA, V46, P353, DOI 10.2216/06-60.1; Hayashi T, 2012, PHYCOLOGIA, V51, P98, DOI 10.2216/11-17.1; Hayashi T, 2009, QUATERNARY RES, V72, P377, DOI 10.1016/j.yqres.2009.07.003; Herbert TD, 2016, NAT GEOSCI, V9, P843, DOI [10.1038/NGEO2813, 10.1038/ngeo2813]; Hisatomi K, 1994, HIMALAYAN GEOLOGY, V15, P161; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; Horne A.J., 1994, LIMNOLOGY; Huete-Ortega M., 2012, P R SOC B, V279, P1824, DOI DOI 10.1098/RSPB.2011.2193PMID:22113027; Huh Y, 1999, GEOCHIM COSMOCHIM AC, V63, P967, DOI 10.1016/S0016-7037(99)00045-9; Huzioka K, 1963, KASEKI FOSSILS, V5, P39; ICHIKAWA W, 1955, J GEOLOGICAL SOC JAP, V61, P381; Ishida S, 1970, MEMOIRS NATL SCI MUS, V3, P49; JOHNSON GD, 1982, PALAEOGEOGR PALAEOCL, V37, P63, DOI 10.1016/0031-0182(82)90058-X; JOHNSON NM, 1982, PALAEOGEOGR PALAEOCL, V37, P17, DOI 10.1016/0031-0182(82)90056-6; JOHNSON NM, 1985, J GEOL, V93, P27, DOI 10.1086/628917; Jordan RW, 2016, 24 INT DIAT S 21 26; Kaczmarska I, 2006, J PHYCOL, V42, P121, DOI 10.1111/j.1529-8817.2006.00161.x; Kano K., 1989, BULL GEOL SURV JPN, V40, P647; Khursevich G, 1994, MEMOIRS CALIFORNIA A, V17, P257; KHURSEVICH G K, 1982, Acta Geologica Academiae Scientiarum Hungaricae, V25, P123; Khursevich G, 2012, NOVA HEDWIGIA, P315; Kidder DL, 2005, PALAIOS, V20, P198, DOI 10.2110/palo.2003.p03-108; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; KLEIBER MAX, 1932, HILGARDIA, V6, P315; KLOOTWIJK CT, 1992, GEOLOGY, V20, P395, DOI 10.1130/0091-7613(1992)020<0395:AEIACP>2.3.CO;2; KOCIOLEK JP, 1989, PHYCOLOGIA, V28, P438, DOI 10.2216/i0031-8884-28-4-438.1; KOIZUMI I, 1978, MAR GEOL, V26, P231, DOI 10.1016/0025-3227(78)90061-0; Koizumi I, 1979, NIHONKAI JAPAN SEA, P69; Koizumi I., 1988, J PALEONTOL SOC KOR, V4, P6; Konomatsu M, 1997, J GEOLOGICAL SOC JAP, V103, P265; KREBS W N, 1987, Palaios, V2, P505, DOI 10.2307/3514621; Krebs W. N., 1994, MEMOIRS CALIFORNIA A, P485; Krebs W.N., 1995, US GEOLOGICAL SURVEY, P53; Krishnamurthy V, 2000, J CLIMATE, V13, P579, DOI 10.1175/1520-0442(2000)013<0579:IMEROI>2.0.CO;2; Kroon D., 1991, Proceedings of the Ocean Drilling Program Scientific Results, V117, P257, DOI 10.2973/odp.proc.sr.117.126.1991; KUTZBACH JE, 1993, J GEOL, V101, P177, DOI 10.1086/648215; Lau KM, 1998, CLIM DYNAM, V14, P759, DOI 10.1007/s003820050253; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; LOGINOVA L P, 1982, Acta Geologica Academiae Scientiarum Hungaricae, V25, P149; Loginova L.P., 1990, P 10 INT DIAT S, P47; LOGINOVA LP, 1984, DOKL AKAD NAUK BELAR, V28, P170; Lopez-Sandoval DC, 2014, J EXP MAR BIOL ECOL, V457, P151, DOI 10.1016/j.jembe.2014.04.013; LOWE RL, 1975, J PHYCOL, V11, P415, DOI 10.1111/j.1529-8817.1975.tb02805.x; MAC ARTHUR ROBERT H., 1967; MANABE S, 1990, SCIENCE, V247, P192, DOI 10.1126/science.247.4939.192; MANABE S, 1974, J ATMOS SCI, V31, P3, DOI 10.1175/1520-0469(1974)031<0003:TEOMOT>2.0.CO;2; Mann David G., 1999, P1; Maranon E, 2008, J PLANKTON RES, V30, P157, DOI 10.1093/plankt/fbm087; Maranon E, 2007, LIMNOL OCEANOGR, V52, P2190, DOI 10.4319/lo.2007.52.5.2190; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; MATSUO H., 1963, TERTIARY FLORAS JAPA, P219; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; MOREL A, 1981, DEEP-SEA RES, V28, P1375, DOI 10.1016/0198-0149(81)90039-X; Mulch A, 2008, P NATL ACAD SCI USA, V105, P6819, DOI 10.1073/pnas.0708811105; Nakov T, 2015, PHYTOTAXA, V217, P249, DOI 10.11646/phytotaxa.217.3.2; Noda M., 1962, REGIONAL GEOLOGY JAP; Ogg JG, 2016, CONCISE GEOLOGIC TIME SCALE 2016, P1; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; PRELL WL, 1992, NATURE, V360, P647, DOI 10.1038/360647a0; QUADE J, 1989, NATURE, V342, P163, DOI 10.1038/342163a0; QUADE J, 1995, GEOL SOC AM BULL, V107, P1381, DOI 10.1130/0016-7606(1995)107<1381:LMECIN>2.3.CO;2; Radionova E.P., 1987, METHODS ZONAL STRATI, V29, P141; Radionova EP, 1990, 11 INT S LIV FOSS DI; Ramage Colin S, 1971, INT GEOPHYS SERIES, V15; Ramstein G, 1997, NATURE, V386, P788, DOI 10.1038/386788a0; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Rea DK, 1992, AM GEOPHYS UNION GEO, V70; Retallack GJ, 1997, PALAIOS, V12, P380, DOI 10.2307/3515337; Retallack GJ, 2001, J GEOL, V109, P407, DOI 10.1086/320791; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Ross R, 1979, NOVA HEDWIGIA S, V64, P513; Round F. E., 1990, DIATOMS BIOL MORPHOL; Ruddiman W. F., 1997, TECTONIC UPLIFT CLIM; Saito-Kato Megumi, 2014, Bulletin of the National Museum of Nature and Science Series C-Geology & Paleontology, V40, P15; Sakai H., 2001, J NEPAL GEOL SOC, V25, P19, DOI 10.3126/jngs.v25i0.32043; Servant-Vildary S, 1978, TRAVAUX DOCUMENTS OR, V2, P84; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Stewart JH, 1976, CENOZOIC ROCKS NEVAD, V52, P1; Taliaferro N. L., 1933, B DEP GEOL U CALIF, V23, P1; Tanai T., 1961, J FS HOKKAIDO U, V11, P119; Tanaka H., 2014, DIATOM, V30, P157; Tanaka H., 2014, ATLAS FRESHWATER FOS; Temniskova-Topalova D., 1994, MEMOIRS CALIFORNIA A, P301; Trenberth KE, 2000, J CLIMATE, V13, P3969, DOI 10.1175/1520-0442(2000)013<3969:TGMAST>2.0.CO;2; Tsoy I. B., 2016, STRATIGRAPHY GEOL CO, V24, P62, DOI DOI 10.7868/S0869592X16020071; Tsoy I, 2017, DIATOM RES, V32, P277, DOI 10.1080/0269249X.2017.1367726; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Usoltseva M, 2010, PLANT ECOL EVOL, V143, P352, DOI 10.5091/plecevo.2010.410; VANLANDINGHAM SL, 1985, MICROPALEONTOLOGY, V31, P167, DOI 10.2307/1485483; WALSBY AE, 1977, BRIT PHYCOL J, V12, P215, DOI 10.1080/00071617700650231; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Webster PJ, 1998, J GEOPHYS RES-OCEANS, V103, P14451, DOI 10.1029/97JC02719; Whitney JD., 1867, P CALIFORNIA ACAD SC, V3, P319; Wolfe AP, 2009, AM J BOT, V96, P487, DOI 10.3732/ajb.0800307; Wutrich M, 1980, SCHWEIZ Z HYDROL, V42, P269; Yamamoto T., 1996, J GEOLOGICAL SOC JAP, V102, P730; Yanagisawa Y., 2014, DIATOM, V30, P147; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	145	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0198003	10.1371/journal.pone.0198003	http://dx.doi.org/10.1371/journal.pone.0198003			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870528	Green Published, gold, Green Submitted			2022-12-26	WOS:000434128400011
J	Lee, JS; Cole, SR; Achenbach, CJ; Dittmer, DP; Richardson, DB; Miller, WC; Mathews, C; Althoff, KN; Moore, RD; Eron, JJ				Lee, Jennifer S.; Cole, Stephen R.; Achenbach, Chad J.; Dittmer, Dirk P.; Richardson, David B.; Miller, William C.; Mathews, Christopher; Althoff, Keri N.; Moore, Richard D.; Eron, Joseph J., Jr.		Ctr AIDS Res CFAR Network Integr	Cancer risk in HIV patients with incomplete viral suppression after initiation of antiretroviral therapy	PLOS ONE			English	Article							INTEGRATED-CLINICAL-SYSTEMS; INVERSE PROBABILITY WEIGHTS; AIDS-RESEARCH-NETWORK; INFECTED PERSONS; UNITED-STATES; SURVIVAL CURVES; COHORT; IMMUNODEFICIENCY; INFLAMMATION; PEOPLE	Background Cancer causes significant morbidity and mortality among HIV patients in the US due to extended life expectancy with access to effective antiretroviral therapy. Low, detectable HIV RNA has been studied as a risk factor for adverse health outcomes, but its clinical impact on cancer risk remains unclear. The objective of this study was to determine whether HIV RNA <1,000 copies/mL six months after starting therapy was associated with 10-year first cancer risk. Methods We followed 7,515 HIV therapy initiators from a US-based multicenter clinical cohort from 1998 to 2014. We used nonparametric multiple imputation to account for viral loads that fell below assay detection limits, and categorized viral loads six months after therapy initiation into four groups: <20, 20-199, 200-999, and >999 copies/mL. We calculated estimates of the cumulative incidence of cancer diagnosis, accounting for death as a competing event. Inverse probability of exposure and censoring weights were used to control for confounding and differential loss to follow up, respectively. Results Crude 10-year first cancer risk in the study sample was 7.03% (95% CI: 6.08%, 7.98%), with the highest risk observed among patients with viral loads between 200 and 999 copies/mL six months after ART initiation (10.7%). After controlling for baseline confounders, 10-year first cancer risk was 6.90% (95% CI: 5.69%, 8.12%), and was similar across viral load categories. Conclusion Overall risk of first cancer was not associated with incomplete viral suppression; however, cancer remains a significant threat to HIV patients after treatment initiation. As more HIV patients gain access to treatment in the current "treat all" era, occurrences of incomplete viral suppression will be observed more frequently in clinical practice, which supports continued study of the role of low-level HIV RNA on cancer development.	[Lee, Jennifer S.; Cole, Stephen R.; Richardson, David B.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Lee, Jennifer S.; Cole, Stephen R.; Althoff, Keri N.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21218 USA; [Cole, Stephen R.; Eron, Joseph J., Jr.] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC USA; [Achenbach, Chad J.] Northwest Univ, Feinberg Sch Med, Ctr Global Hlth, Div Infect Dis,Dept Med, Chicago, IL USA; [Dittmer, Dirk P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Miller, William C.] Ohio State Univ, Div Epidemiol, Columbus, OH 43210 USA; [Mathews, Christopher] Univ Calif San Diego, San Diego, CA 92103 USA; [Moore, Richard D.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Eron, Joseph J., Jr.] Univ N Carolina, Dept Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University; Feinberg School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University; University of California System; University of California San Diego; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill	Lee, JS (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.; Lee, JS (corresponding author), Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21218 USA.	islee@jhu.edu	Achenbach, Chad/AAQ-4035-2020; Miller, William C/H-4800-2014; Dittmer, Dirk/AAH-3535-2021; Dittmer, Dirk/GPW-7423-2022; Althoff, Keri N/HGC-5595-2022; Mathews, William Christopher/E-4451-2010	Miller, William C/0000-0002-1934-7827; Dittmer, Dirk/0000-0003-4968-5656; Mathews, William Christopher/0000-0002-2352-0725; Althoff, Keri/0000-0002-5068-6595; Lee, Jennifer/0000-0003-3971-0766	National Institutes of Health [T32 AI007001, R01 AI100654, U01 AI069918, R01 AG053100]; NIH by the National Institute of Allergy and Infectious Diseases (NIAID) [R24 AI067039]; National Heart, Lung, and Blood Institute (NHLBI); Univ of Alabama at Birmingham [P30 AI027767]; Univ of Washington [P30 AI027757]; Univ of California San Diego [P30 AI036214]; Univ of California San Francisco [P30 AI027763]; Case Western Reserve Univ [P30 AI036219]; Johns Hopkins Univ [P30 AI094189, U01 DA036935]; Fenway Health/Harvard [P30 AI060354]; Univ of North Carolina Chapel Hill [P30 AI50410]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069918, R01AI100654, R24AI067039, P30AI050410, T32AI007001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG053100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH by the National Institute of Allergy and Infectious Diseases (NIAID); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Univ of Alabama at Birmingham; Univ of Washington(University of Washington); Univ of California San Diego(University of California System); Univ of California San Francisco(University of California System); Case Western Reserve Univ; Johns Hopkins Univ(Johns Hopkins University); Fenway Health/Harvard; Univ of North Carolina Chapel Hill; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants T32 AI007001, R01 AI100654, U01 AI069918, and R01 AG053100. CNICS is an NIH-funded program (R24 AI067039) made possible by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Heart, Lung, and Blood Institute (NHLBI). The CFAR sites involved in CNICS include Univ of Alabama at Birmingham (P30 AI027767), Univ of Washington (P30 AI027757), Univ of California San Diego (P30 AI036214), Univ of California San Francisco (P30 AI027763), Case Western Reserve Univ (P30 AI036219), Johns Hopkins Univ (P30 AI094189, U01 DA036935), Fenway Health/Harvard (P30 AI060354), and Univ of North Carolina Chapel Hill (P30 AI50410). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach CJ, 2011, AIDS, V25, P691, DOI 10.1097/QAD.0b013e3283437f77; Bruyand M, 2009, CLIN INFECT DIS, V49, P1109, DOI 10.1086/605594; Buchanan AL, 2014, AIDS RES HUM RETROV, V30, P1170, DOI [10.1089/aid.2014.0037, 10.1089/AID.2014.0037]; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crum-Cianflone N, 2009, AIDS, V23, P41, DOI 10.1097/QAD.0b013e328317cc2d; Dubrow R, 2017, JAIDS-J ACQ IMM DEF, V75, P382, DOI 10.1097/QAI.0000000000001394; Eastburn A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026320; Engels EA, 2008, INT J CANCER, V123, P187, DOI 10.1002/ijc.23487; Engels EA, 2009, AIDS, V23, P875, DOI 10.1097/QAD.0b013e328329216a; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gopal S, 2014, CLIN INFECT DIS, V59, P279, DOI 10.1093/cid/ciu270; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Helsel D, 2010, ANN OCCUP HYG, V54, P257, DOI 10.1093/annhyg/mep092; Howe CJ, 2011, EPIDEMIOLOGY, V22, P874, DOI 10.1097/EDE.0b013e31823029dd; Jin Y, 2011, ANN OCCUP HYG, V55, P97, DOI 10.1093/annhyg/meq061; Kitahata MM, 2008, INT J EPIDEMIOL, V37, P948, DOI 10.1093/ije/dym231; Lee JS, 2017, AIDS, V31, P1989, DOI 10.1097/QAD.0000000000001573; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2016, GUIDELINES USE ANTIR; PETO R, 1973, ROY STAT SOC C-APP, V22, P86; Reus S, 2013, JAIDS-J ACQ IMM DEF, V62, P129, DOI 10.1097/QAI.0b013e3182745ab0; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Silverberg MJ, 2015, ANN INTERN MED, V163, P507, DOI 10.7326/M14-2768; Silverberg MJ, 2011, CANCER EPIDEM BIOMAR, V20, P2551, DOI 10.1158/1055-9965.EPI-11-0777; Silverberg MJ, 2009, AIDS, V23, P2337, DOI 10.1097/QAD.0b013e3283319184; TURNBULL BW, 1976, J R STAT SOC B, V38, P290; Xu J, 2012, NCHS DATA BRIEF, V2014, P168	29	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0197665	10.1371/journal.pone.0197665	http://dx.doi.org/10.1371/journal.pone.0197665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870537	Green Published, Green Submitted, gold			2022-12-26	WOS:000434128400006
J	Ilic, M; Sipetic, SG; Ristic, B; Ilic, I				Ilic, Milena; Sipetic, Sandra Grujicic; Ristic, Branko; Ilic, Irena			Myocardial infarction and alcohol consumption: A case-control study	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; HEAVY DRINKING OCCASIONS; CARDIOVASCULAR-DISEASE; RISK-FACTORS; CASE-CROSSOVER; 52 COUNTRIES; FOLLOW-UP; METAANALYSIS; MORTALITY; PATTERNS	Background Although epidemiological evidence for the beneficial effect of low alcohol consumption on myocardial infarction is strong, the impact of heavy drinking episodes is less clear. Objectives The aim of this study was to investigate a possible association between the risk for acute myocardial infarction occurrence and alcohol consumption. Methods Our hospital-based case-control study comprised 374 participants (187 newly diagnosed patients with myocardial infarction and 187 controls, individually matched by gender, age, and place of residence). This study was performed in Kragujevac (a city in Serbia) during 2010. Logistic regression analysis was used to determine odds ratio (OR) with 95% confidence intervals (95% CI). Results The history of alcohol consumption in patients with acute myocardial infarction and their controls did not differ significantly: the percentage of those that were consuming alcohol was slightly higher in cases (54.5%) than in controls (50.3%). The habit of binge drinking during the previous 12 months was significantly more common in cases (25.1%) than in controls (12.8%): adjusted OR = 2.2 (95%CI= 1.2-4.2, p = 0.017), p for trend = 0.015. Analysis of binge drinking by age, gender and place of residence revealed that the increase in risk for acute myocardial infarction was associated with older age (adjusted OR = 5.1, 95%CI= 1.7-15.1, p for trend = 0.010), male gender (adjusted OR = 2.3, 95%CI = 1.1-5.2, p for trend = 0.028) and rural place of residence (adjusted OR = 4.8, 95%CI = 1.3-18.5, p for trend = 0.033). Conclusion Our results suggest that binge drinking is associated with twice the risk for myocardial infarction compared to not drinking. Since consumption of alcohol is very common in the Serbian population, the effect of binge drinking on myocardial infarction should be considered an important public health issue.	[Ilic, Milena] Univ Kragujevac, Fac Med Sci, Dept Epidemiol, Kragujevac, Serbia; [Sipetic, Sandra Grujicic] Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia; [Ristic, Branko] Univ Kragujevac, Fac Med Sci, Clin Ctr Kragujevac, Clin Orthoped Surg & Traumatol, Kragujevac, Serbia; [Ilic, Irena] Univ Belgrade, Fac Med, Belgrade, Serbia	University of Kragujevac; University of Belgrade; University of Kragujevac; University of Belgrade	Ilic, M (corresponding author), Univ Kragujevac, Fac Med Sci, Dept Epidemiol, Kragujevac, Serbia.	drmilenailic@yahoo.com	Ilic, Milena/W-1498-2019; Ilic, Irena/T-8121-2019; Filipovic, Nenad/GSN-0499-2022	Ilic, Irena/0000-0001-5347-3264; Ilic, Milena/0000-0003-3229-4990	Ministry of Education and Science of Republic of Serbia [175042]	Ministry of Education and Science of Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education and Science of Republic of Serbia, through contract no. 175042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand SS, 2008, EUR HEART J, V29, P932, DOI 10.1093/eurheartj/ehn018; Barnes AJ, 2010, J GEN INTERN MED, V25, P840, DOI 10.1007/s11606-010-1341-x; Bazzano LA, 2009, INT J CARDIOL, V135, P78, DOI 10.1016/j.ijcard.2008.03.038; Blazer DG, 2009, AM J PSYCHIAT, V166, P1162, DOI 10.1176/appi.ajp.2009.09010016; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Dawson DA, 2015, DRUG ALCOHOL DEPEN, V148, P56, DOI 10.1016/j.drugalcdep.2014.12.016; Dorn JM, 2007, ADDICTION, V102, P730, DOI 10.1111/j.1360-0443.2007.01765.x; Fernandez-Jarne E, 2003, CLIN CARDIOL, V26, P313, DOI 10.1002/clc.4950260704; Gerlich MG, 2009, EUR ADDICT RES, V15, P143, DOI 10.1159/000213641; Ghiasmand M, 2017, EGYPT HEART J, V69, P223, DOI 10.1016/j.ehj.2017.03.003; Gmel G., 2003, SUCHT, V49, P105, DOI [https://doi.org/10.1024/suc.2003.49.2.105, DOI 10.1024/SUC.2003.49.2.105]; Hammar N, 1997, J INTERN MED, V241, P125, DOI 10.1046/j.1365-2796.1997.92106000.x; HOJNACKI JL, 1991, ATHEROSCLEROSIS, V88, P49, DOI 10.1016/0021-9150(91)90256-3; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Ilomaki J, 2012, EUR J PUBLIC HEALTH, V22, P825, DOI 10.1093/eurpub/ckr013; Institute of Public Health of Serbia, 2015, INC MORT AC COR SYN; Kabagambe EK, 2005, AM J CLIN NUTR, V82, P1336, DOI 10.1093/ajcn/82.6.1336; Kanny Dafna, 2012, Morbidity and Mortality Weekly Report, V61, P14; Kauhanen J, 1997, BMJ-BRIT MED J, V315, P846, DOI 10.1136/bmj.315.7112.846; King DE, 2008, AM J MED, V121, P201, DOI 10.1016/j.amjmed.2007.12.004; Klatsky AL, 2006, AM J CARDIOL, V98, P1063, DOI 10.1016/j.amjcard.2006.05.029; Leong DP, 2014, CIRCULATION, V130, P390, DOI 10.1161/CIRCULATIONAHA.113.007627; Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3; MarquesVidal P, 1996, AM J EPIDEMIOL, V143, P1089, DOI 10.1093/oxfordjournals.aje.a008683; McElduff P, 1997, BRIT MED J, V314, P1159, DOI 10.1136/bmj.314.7088.1159; McGorrian C, 2011, EUR HEART J, V32, P581, DOI 10.1093/eurheartj/ehq448; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Ministry of Health Republic of Serbia, 2014, NAT HLTH SURV SERB 2; Mladenovic I., 2014, RESPONSIBLE DRINKING; Mostofsky E, 2015, EPIDEMIOLOGY, V26, P143, DOI 10.1097/EDE.0000000000000227; Mukamal KJ, 2010, J AM COLL CARDIOL, V55, P1328, DOI 10.1016/j.jacc.2009.10.056; Mukamal KJ, 2005, CIRCULATION, V112, P1406, DOI 10.1161/CIRCULATIONAHA.105.537704; Pajak A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065856; Peasey A, 2005, ALCOHOL ALCOHOLISM, V40, P431, DOI 10.1093/alcalc/agh161; Puddey IB, 1999, ADDICTION, V94, P649, DOI 10.1046/j.1360-0443.1999.9456493.x; Roerecke M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0182-6; Roerecke M, 2011, INT J EPIDEMIOL, V40, P1401, DOI 10.1093/ije/dyr129; Roerecke M, 2010, AM J EPIDEMIOL, V171, P633, DOI 10.1093/aje/kwp451; Romelsjo A, 2012, ALCOHOL ALCOHOLISM, V47, P322, DOI 10.1093/alcalc/ags021; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Ruidavets JB, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6077; Schroder H, 2007, NUTR METAB CARDIOVAS, V17, P609, DOI 10.1016/j.numecd.2006.04.010; Smyth A, 2015, LANCET, V386, P1945, DOI 10.1016/S0140-6736(15)00235-4; Statistical Office of the Republic of Serbia, 2015, DEM YB REP SERB 1991; Tavani A, 2001, EUR J EPIDEMIOL, V17, P1131, DOI 10.1023/A:1021276932160; Thygesen K, 2007, EUR HEART J, V28, P2525; URBANOMARQUEZ A, 1989, NEW ENGL J MED, V320, P409, DOI 10.1056/NEJM198902163200701; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2015, EUR HLTH ALL DAT HFA; WHO Regional Office for Europe, 2015, CARDIOVASCULAR DIS; Wilkins JT, 2012, JAMA-J AM MED ASSOC, V308, P1795, DOI 10.1001/jama.2012.14312; World Health Organization, 2000, OBS PREV MAN GLOB EP; World Health Organization, 2021, WHO MORT DAT; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhang XY, 2015, NUTRIENTS, V7, P6582, DOI 10.3390/nu7085300; Zhang YZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178070	56	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198129	10.1371/journal.pone.0198129	http://dx.doi.org/10.1371/journal.pone.0198129			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI0YU	29864160	Green Submitted, Green Published, gold			2022-12-26	WOS:000434097100022
J	Zhang, Y; Zhou, XX; Li, Y; Xu, YY; Lu, K; Li, PP; Wang, X				Zhang, Ya; Zhou, Xiangxiang; Li, Ying; Xu, Yangyang; Lu, Kang; Li, Peipei; Wang, Xin			Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia	ONCOGENE			English	Article							GLIOMA STEM-CELLS; LARGE GENE LISTS; CANCER CELLS; JNK/MITOCHONDRIAL PATHWAY; HEPATOCELLULAR-CARCINOMA; IBRUTINIB RESISTANCE; EXPRESSION SIGNATURE; DISEASE PROGRESSION; MELK EXPRESSION; LUNG-CANCER	TP53 pathway defects contributed to therapy resistance and adverse clinical outcome in chronic lymphocytic leukemia (CLL), which represents an unmet clinical need with few therapeutic options. Maternal embryonic leucine zipper kinase (MELK) is a novel oncogene, which plays crucial roles in mitotic progression and stem cell maintenance. OTSSP167, an orally administrated inhibitor targeting MELK, is currently in a phase I/II clinical trial in patients with advanced breast cancer and acute myeloid leukemia. Yet, no investigation has been elucidated to date regarding the oncogenic role of MELK and effects of OTSSP167 in chronic lymphocytic leukemia (CLL). Previous studies confirmed MELK inhibition abrogated cancer cell survival via p53 signaling pathway. Thus, we aimed to determine the biological function of MELK and therapeutic potential of OTSSP167 in CLL. Herein, MELK over-expression was observed in CLL cells, and correlated with higher WBC count, advanced stage, elevated LDH, increased beta 2-MG level, unmutated IGHV, positive ZAP-70, deletion of 17p13 and inferior prognosis of CLL patients. In accordance with functional enrichment analyses in gene expression profiling, CLL cells with depletion or inhibition of MELK exhibited impaired cell proliferation, enhanced fast-onset apoptosis, induced G2/M arrest, attenuated cell chemotaxis and promoted sensitivity to fludarabine and ibrutinib. However, gain-of-function assay showed increased cell proliferation and cell chemotaxis. In addition, OTSSP167 treatment reduced phosphorylation of AKT and ERK1/2. It decreased FoxM1 phosphorylation, expression of FoxM1, cyclin B1 and CDK1, while up-regulating p53 and p21 expression. Taken together, MELK served as a candidate of therapeutic target in CLL. OTSSP167 exhibits potent anti-tumor activities in CLL cells, highlighting a novel molecule-based strategy for leukemic interventions.	[Zhang, Ya; Zhou, Xiangxiang; Li, Ying; Xu, Yangyang; Lu, Kang; Li, Peipei; Wang, Xin] Shandong Univ, Dept Hematol, Shandong Prov Hosp, Jinan 250021, Shandong, Peoples R China; [Wang, Xin] Shandong Univ, Sch Med, Jinan 250012, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Wang, X (corresponding author), Shandong Univ, Dept Hematol, Shandong Prov Hosp, Jinan 250021, Shandong, Peoples R China.; Wang, X (corresponding author), Shandong Univ, Sch Med, Jinan 250012, Shandong, Peoples R China.	xinw@sdu.edu.cn			National Natural Science Foundation [81270598, 81473486, 81770210]; Key Research and Development Program of Shandong Province [2018CXGC1213, 2016GSF201029]; Natural Science Foundation of Shandong Province [ZR2012HZ003]; Technology Development Projects of Shandong Province [2014GSF118021]; Program of Shandong Medical Leading Talent; Taishan Scholar Foundation of Shandong Province	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key Research and Development Program of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Technology Development Projects of Shandong Province; Program of Shandong Medical Leading Talent; Taishan Scholar Foundation of Shandong Province	This study was partly supported by: National Natural Science Foundation (No. 81270598, No. 81473486, No. 81770210), Key Research and Development Program of Shandong Province (No. 2018CXGC1213, No. 2016GSF201029), Natural Science Foundation of Shandong Province (No. ZR2012HZ003), Technology Development Projects of Shandong Province (No. 2014GSF118021), Program of Shandong Medical Leading Talent, and Taishan Scholar Foundation of Shandong Province.	Alachkar H, 2014, ONCOTARGET, V5, P12371, DOI 10.18632/oncotarget.2642; Beke L, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150194; Bolomsky A, 2018, HAEMATOLOGICA, V103, P325, DOI 10.3324/haematol.2017.172973; Buchner M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7471; Choi S, 2011, BIOCHEM BIOPH RES CO, V412, P207, DOI 10.1016/j.bbrc.2011.07.060; Chuang HY, 2012, BLOOD, V120, P2639, DOI 10.1182/blood-2012-03-416461; Chung S, 2016, ONCOTARGET, V7, P18171, DOI 10.18632/oncotarget.7685; Chung SY, 2012, ONCOTARGET, V3, P1629; Ciccone M, 2014, CANCER CELL, V26, P770, DOI 10.1016/j.ccell.2014.10.020; Cui J, 2016, ONCOGENE, V35, P4708, DOI 10.1038/onc.2016.14; Davezac N, 2002, ONCOGENE, V21, P7630, DOI 10.1038/sj.onc.1205870; Du T, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-100; Ghia P, 2016, LANCET ONCOL, V17, P1342, DOI 10.1016/S1470-2045(16)30442-9; Giuliano CJ, 2018, ELIFE, V7, DOI 10.7554/eLife.32838; Gu CY, 2013, STEM CELLS, V31, P870, DOI 10.1002/stem.1322; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Halasi M, 2013, MOL CANCER THER, V12, P245, DOI 10.1158/1535-7163.MCT-12-0712; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hasegawa K, 2018, J IMMUNOTHER, V41, P201, DOI 10.1097/CJI.0000000000000214; Herold T, 2011, LEUKEMIA, V25, P1639, DOI 10.1038/leu.2011.125; Herold T, 2013, LEUKEMIA LYMPHOMA, V54, P1652, DOI 10.3109/10428194.2012.753445; Hiwatashi K, 2016, ANTICANCER RES, V36, P5183, DOI 10.21873/anticanres.11088; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HT, 2017, ELIFE, V6, DOI 10.7554/eLife.26693; Inoue H, 2016, ONCOTARGET, V7, P13621, DOI 10.18632/oncotarget.7297; Janostiak R, 2017, CELL REP, V21, P2829, DOI 10.1016/j.celrep.2017.11.033; Ji WB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153518; Joshi K, 2013, STEM CELLS, V31, P1051, DOI 10.1002/stem.1358; Jurmeister S, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708274; Kaur V, 2017, ANN HEMATOL, V96, P1175, DOI 10.1007/s00277-017-2973-2; Khan I, 2017, LEUKEMIA, V31, P251, DOI 10.1038/leu.2016.270; Khongkow P, 2016, ONCOGENE, V35, P990, DOI 10.1038/onc.2015.152; Kim SH, 2015, STEM CELL REP, V4, P226, DOI 10.1016/j.stemcr.2014.12.006; Klaeger S, 2017, SCIENCE, V358, DOI 10.1126/science.aan4368; Kohler RS, 2017, GYNECOL ONCOL, V145, P159, DOI 10.1016/j.ygyno.2017.02.016; Kohlmann A, 2008, BRIT J HAEMATOL, V142, P802, DOI 10.1111/j.1365-2141.2008.07261.x; Komarova NL, 2014, P NATL ACAD SCI USA, V111, P13906, DOI 10.1073/pnas.1409362111; Krishnan A, 2017, J CELL BIOCHEM, V118, P797, DOI 10.1002/jcb.25754; Kwok CTD, 2016, STEM CELL RES, V16, P651, DOI 10.1016/j.scr.2016.03.007; Lenz G, 2017, J CLIN ONCOL, V35, P1451, DOI 10.1200/JCO.2016.72.0102; Li PP, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0479-5; Li S, 2016, ONCOTARGET, V7, P6266, DOI 10.18632/oncotarget.6673; Lin A, 2017, ELIFE, V6, DOI 10.7554/eLife.24179; Liu Y, 2015, NEOPLASMA, V62, P61, DOI 10.4149/neo_2015_008; Longo PG, 2007, LEUKEMIA, V21, P110, DOI 10.1038/sj.leu.2404417; Lu K, 2015, CANCER LETT, V359, P250, DOI 10.1016/j.canlet.2015.01.021; Lu K, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-55; Matsuda T, 2017, ONCOTARGET, V8, P57938, DOI 10.18632/oncotarget.18488; Mertens D, 2017, BLOOD, V129, P1407, DOI 10.1182/blood-2017-01-761536; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Motiwala T, 2015, LEUKEMIA, V29, P1350, DOI 10.1038/leu.2014.341; Mraz M, 2014, BLOOD, V124, P84, DOI 10.1182/blood-2013-09-527234; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Parikh SA, 2016, SEMIN ONCOL, V43, P233, DOI 10.1053/j.seminoncol.2016.02.009; Pickard MR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2350; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Simon M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172832; Speers C, 2016, CLIN CANCER RES, V22, P5864, DOI 10.1158/1078-0432.CCR-15-2711; Stefka AT, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.71; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051277; Svirnovski A. I., 2010, Experimental Oncology, V32, P258; Trojani A, 2012, CANCER BIOMARK, V11, P15, DOI 10.3233/CBM-2012-0259; Wang K, 2016, ACTA BIOCH BIOPH SIN, V48, P804, DOI 10.1093/abbs/gmw072; Wang YB, 2014, ELIFE, V3, DOI 10.7554/eLife.01763; Wiestner A, 2015, HAEMATOLOGICA, V100, P1495, DOI 10.3324/haematol.2014.119123; Xia HP, 2016, CANCER LETT, V383, P85, DOI 10.1016/j.canlet.2016.09.017; Zhou XX, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0391-5	69	31	31	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 11	2018	37	41					5520	5533		10.1038/s41388-018-0333-x	http://dx.doi.org/10.1038/s41388-018-0333-x			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GW5QO	29895969				2022-12-26	WOS:000446991200004
J	Luck, JC; Puchkov, D; Ullrich, F; Jentsch, TJ				Lueck, Jennifer C.; Puchkov, Dmytro; Ullrich, Florian; Jentsch, Thomas J.			LRRC8/VRAC anion channels are required for late stages of spermatid development in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRE RECOMBINASE ACTIVITY; MALE GERM-CELLS; VOLUME REGULATION; MALE-INFERTILITY; MOUSE MODELS; ESSENTIAL COMPONENT; MALE-FERTILITY; PROTEINS; ABNORMALITIES; TRANSPORTERS	Spermatogenesis is a highly complex developmental process that occurs primarily in seminiferous tubules of the testes and requires additional maturation steps in the epididymis and beyond. Mutations in many different genes can lead to defective spermatozoa and hence to male infertility. Some of these genes encode for ion channels and transporters that play roles in various processes such as cellular ion homeostasis, signal transduction, sperm motility, and the acrosome reaction. Here we show that germ cell-specific, but not Sertoli cell-specific, disruption of Lrrc8a leads to abnormal sperm and male infertility in mice. LRRC8A (leucine-rich repeat containing 8A) is the only obligatory subunit of heteromeric volume-regulated anion channels (VRACs). Its ablation severely compromises cell volume regulation by completely abolishing the transport of anions and osmolytes through VRACs. Consistent with impaired volume regulation, the cytoplasm of late spermatids appeared swollen. These cells failed to properly reduce their cytoplasm during further development into spermatozoa and later displayed severely disorganized mitochondrial sheaths in the midpiece region, as well as angulated or coiled flagella. These changes, which progressed in severity on the way to the epididymis, resulted in dramatically reduced sperm motility. Our work shows that VRAC, probably through its role in cell volume regulation, is required in a cell-autonomous manner for proper sperm development and explains the male infertility of Lrrc8a(-/-) mice and the spontaneous mouse mutant ebouriffe.	[Lueck, Jennifer C.; Puchkov, Dmytro; Ullrich, Florian; Jentsch, Thomas J.] Leibniz Forschungsinst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Lueck, Jennifer C.; Ullrich, Florian; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Lueck, Jennifer C.] Free Univ Berlin, Grad Program, D-14195 Berlin, Germany; [Jentsch, Thomas J.] Charite, Neurocure Cluster Excellence, D-10117 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jentsch, TJ (corresponding author), FMP MDC, Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de	Ullrich, Florian/AAA-6043-2019	Ullrich, Florian/0000-0002-1153-2040; Puchkov, Dmytro/0000-0001-8341-4847; Jentsch, Thomas/0000-0002-3509-2553	Advanced Grants for the European Research Council (ERC) Advanced Grant [294435 Cytovolion, 740537 Volsignal]; Prix Louis Jeantet de Medecine	Advanced Grants for the European Research Council (ERC) Advanced Grant; Prix Louis Jeantet de Medecine	This work was supported by Advanced Grants for the European Research Council (ERC) Advanced Grant 294435 Cytovolion and 740537 Volsignal and the Prix Louis Jeantet de Medecine (to T.J.J.). The authors declare that they have no conflicts of interest with the contents of this article.	Abascal F, 2012, BIOESSAYS, V34, P551, DOI 10.1002/bies.201100173; Avenarius MR, 2009, AM J HUM GENET, V84, P505, DOI 10.1016/j.ajhg.2009.03.004; Blanz J, 2007, J NEUROSCI, V27, P6581, DOI 10.1523/JNEUROSCI.0338-07.2007; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; Bouchard MJ, 2000, MOL CELL BIOL, V20, P2865, DOI 10.1128/MCB.20.8.2865-2873.2000; Carlson AE, 2005, J BIOL CHEM, V280, P32238, DOI 10.1074/jbc.M501430200; Chen H, 2012, HUM REPROD UPDATE, V18, P703, DOI 10.1093/humupd/dms027; Chung JJ, 2017, ELIFE, V6, DOI [10.7554/eLife.23082, 10.7547/elife.23082.001]; Chung JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1153; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Cooper TG, 2007, CURR PHARM DESIGN, V13, P3222, DOI 10.2174/138161207782341240; Cooper TG, 2003, MICROSC RES TECHNIQ, V61, P28, DOI 10.1002/jemt.10314; Cooper TG, 2004, MOL CELL ENDOCRINOL, V216, P55, DOI 10.1016/j.mce.2003.10.076; Cooper TG, 2011, ASIAN J ANDROL, V13, P130, DOI 10.1038/aja.2010.97; Davis FM, 2016, CELL CALCIUM, V59, P189, DOI 10.1016/j.ceca.2016.02.007; De Kretser DM, 1999, J CLIN ENDOCR METAB, V84, P3443, DOI 10.1210/jc.84.10.3443; Deneka D, 2018, NATURE, V558, P254, DOI 10.1038/s41586-018-0134-y; Di Bella D, 2014, NEUROLOGY, V83, P1217, DOI 10.1212/WNL.0000000000000812; Escalier D, 2006, HUM REPROD UPDATE, V12, P449, DOI 10.1093/humupd/dml013; Haschek WM, 2010, FUNDAMENTALS OF TOXICOLOGIC PATHOLOGY, 2ND EDITION, P553, DOI 10.1016/B978-0-12-370469-6.00018-0; Hasuwa H, 2010, EXP ANIM TOKYO, V59, P105, DOI 10.1538/expanim.59.105; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Huynh T, 2002, HUM REPROD UPDATE, V8, P183, DOI 10.1093/humupd/8.2.183; Ittner LM, 2007, NAT PROTOC, V2, P1206, DOI 10.1038/nprot.2007.145; Jentsch TJ, 2016, NAT REV MOL CELL BIO, V17, P293, DOI 10.1038/nrm.2016.29; Joseph A, 2010, BIOL REPROD, V82, P958, DOI 10.1095/biolreprod.109.080366; Kumar L, 2014, J EXP MED, V211, P929, DOI 10.1084/jem.20131379; Lalouette A, 1996, BIOL REPROD, V55, P355, DOI 10.1095/biolreprod55.2.355; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Lutter D, 2017, J CELL SCI, V130, P1122, DOI 10.1242/jcs.196253; Milenkovic A, 2015, P NATL ACAD SCI USA, V112, pE2630, DOI 10.1073/pnas.1418840112; Nilius B, 1997, PROG BIOPHYS MOL BIO, V68, P69, DOI 10.1016/S0079-6107(97)00021-7; O'Donnell L., 2014, SPERMATOGENESIS, V4, pe979623, DOI [10.4161/21565562.2014.979623, DOI 10.4161/21565562.2014.979623]; O'Donnell Liza, 2011, Spermatogenesis, V1, P14; Oberheide K, 2017, J BIOL CHEM, V292, P10845, DOI 10.1074/jbc.M117.784108; Oh S, 2008, J PHYSIOL-LONDON, V586, P2445, DOI 10.1113/jphysiol.2008.150805; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Pedersen SF, 2016, PFLUG ARCH EUR J PHY, V468, P371, DOI 10.1007/s00424-015-1781-6; Pilder SH, 1997, J ANDROL, V18, P663; Planells-Cases R, 2015, EMBO J, V34, P2993, DOI 10.15252/embj.201592409; Platt CD, 2017, J ALLERGY CLIN IMMUN, V140, P1651, DOI 10.1016/j.jaci.2016.12.974; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Stuhlmann T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04353-y; Suzuki-Toyota F, 2004, ARCH HISTOL CYTOL, V67, P361, DOI 10.1679/aohc.67.361; Suzuki-Toyota F, 2007, BIOL REPROD, V77, P71, DOI 10.1095/biolreprod.106.058735; Syeda R, 2016, CELL, V164, P499, DOI 10.1016/j.cell.2015.12.031; Ullrich F, 2016, J BIOL CHEM, V291, P17040, DOI 10.1074/jbc.M116.739342; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wambergue C, 2016, HUM REPROD, V31, P1164, DOI 10.1093/humrep/dew083; Weissgerber P, 2011, SCI SIGNAL, V4, P6, DOI 10.1126/scisignal.2001791; Yeung CH, 2006, MOL CELL ENDOCRINOL, V250, P98, DOI 10.1016/j.mce.2005.12.030; Yeung CH, 2004, J ANDROL, V25, P216; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036	58	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11796	11808		10.1074/jbc.RA118.003853	http://dx.doi.org/10.1074/jbc.RA118.003853			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29880644	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000440134500014
J	Sankar, SB; Donegan, RK; Shah, KJ; Reddi, AR; Wood, LB				Sankar, Sitara B.; Donegan, Rebecca K.; Shah, Kajol J.; Reddi, Amit R.; Wood, Levi B.			Heme and hemoglobin suppress amyloid -mediated inflammatory activation of mouse astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid-beta (AB); astrocyte; heme; hemoglobin; Alzheimer disease	BLOOD-BRAIN-BARRIER; A-BETA CLEARANCE; ALZHEIMERS-DISEASE; CARBON-MONOXIDE; CELL-DEATH; INTRACELLULAR HEME; COGNITIVE DECLINE; PRIMARY CULTURES; LABILE HEME; PROTEIN	Glial immune activity is a key feature of Alzheimer's disease (AD). Given that the blood factors heme and hemoglobin (Hb) are both elevated in AD tissues and have immunomodulatory roles, here we sought to interrogate their roles in modulating -amyloid (A)-mediated inflammatory activation of astrocytes. We discovered that heme and Hb suppress immune activity of primary mouse astrocytes by reducing expression of several proinflammatory cytokines (e.g. RANTES (regulated on activation normal T cell expressed and secreted)) and the scavenger receptor CD36 and reducing internalization of A(1-42) by astrocytes. Moreover, we found that certain soluble (>75-kDa) A(1-42) oligomers are primarily responsible for astrocyte activation and that heme or Hb association with these oligomers reverses inflammation. We further found that heme up-regulates phosphoprotein signaling in the phosphoinositide 3-kinase (PI3K)/Akt pathway, which regulates a number of immune functions, including cytokine expression and phagocytosis. The findings in this work suggest that dysregulation of Hb and heme levels in AD brains may contribute to impaired amyloid clearance and that targeting heme homeostasis may reduce amyloid pathogenesis. Altogether, we propose heme as a critical molecular link between amyloid pathology and AD risk factors, such as aging, brain injury, and stroke, which increase Hb and heme levels in the brain.	[Sankar, Sitara B.; Shah, Kajol J.; Wood, Levi B.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Donegan, Rebecca K.; Reddi, Amit R.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Reddi, Amit R.; Wood, Levi B.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Wood, Levi B.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Reddi, AR (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.; Wood, LB (corresponding author), Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.	amit.reddi@chemistry.gatech.edu; levi.wood@me.gatech.edu		Sankar, Sitara/0000-0002-2255-7331	Parker H. Petit Institute for Bioengineering and Bioscience; Blanchard faculty fellowship; National Science Foundation [MCB1552791]; National Institutes of Health [ES025661]; Georgia Tech President's Undergraduate Research Award; Div Of Molecular and Cellular Bioscience [1552791] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R33ES025661, R21ES025661] Funding Source: NIH RePORTER	Parker H. Petit Institute for Bioengineering and Bioscience; Blanchard faculty fellowship; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Tech President's Undergraduate Research Award; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Parker H. Petit Institute for Bioengineering and Bioscience (to A.R.R. and L.B.W.), start-up support from the George W. Woodruff School of Mechanical Engineering (to L.B.W.), start-up support from the School of Chemistry and Biochemistry (to A.R.R.), a Blanchard faculty fellowship (to A.R.R.), National Science Foundation Grant MCB1552791 (to A.R.R.), and National Institutes of Health Grant ES025661 (to A.R.R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of the Georgia Tech President's Undergraduate Research Award.	Abraham NG, 2006, CIRC RES, V99, P911, DOI 10.1161/01.RES.0000249616.10603.d6; Abshire JR, 2017, P NATL ACAD SCI USA, V114, pE2068, DOI 10.1073/pnas.1615195114; Atamna H, 2006, P NATL ACAD SCI USA, V103, P3381, DOI 10.1073/pnas.0600134103; Atamna H, 2004, P NATL ACAD SCI USA, V101, P11153, DOI 10.1073/pnas.0404349101; Atamna H, 2009, ARCH BIOCHEM BIOPHYS, V487, P59, DOI 10.1016/j.abb.2009.05.003; Atwood CS, 2002, PEPTIDES, V23, P1343, DOI 10.1016/S0196-9781(02)00070-0; Bao Y, 2012, J CEREBR BLOOD F MET, V32, P1567, DOI 10.1038/jcbfm.2012.52; Basak JM, 2012, J BIOL CHEM, V287, P13959, DOI 10.1074/jbc.M111.288746; Biron KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023789; Borda JT, 2008, AM J PATHOL, V172, P725, DOI 10.2353/ajpath.2008.070848; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Cao L, 2016, MOL NEUROBIOL, V53, P4417, DOI 10.1007/s12035-015-9377-x; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chuang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033120; Codeluppi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092649; Collins-Praino LE, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0083-0; Covarrubias AJ, 2015, SEMIN IMMUNOL, V27, P286, DOI 10.1016/j.smim.2015.08.001; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; Eriksson L., 2006, MULTIAND MEGAVARIATE, P63; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Fernandez PL, 2010, J BIOL CHEM, V285, P32844, DOI 10.1074/jbc.M110.146076; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Ghosh C, 2016, INORG CHEM, V55, P1748, DOI 10.1021/acs.inorgchem.5b02683; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gouveia Z, 2017, FEBS J, V284, P3278, DOI 10.1111/febs.14192; Griffin W Sue T, 2011, F1000 Med Rep, V3, P24, DOI 10.3410/M3-24; Hampton DW, 2010, J NEUROSCI, V30, P9973, DOI 10.1523/JNEUROSCI.0834-10.2010; Hanna DA, 2017, BIOCHEMISTRY-US, V56, P1815, DOI 10.1021/acs.biochem.7b00007; Hanna DA, 2016, P NATL ACAD SCI USA, V113, P7539, DOI 10.1073/pnas.1523802113; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Huang WC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-28; Iadecola C, 2015, NEURON, V85, P231, DOI 10.1016/j.neuron.2014.12.056; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Janes KA, 2006, CURR OPIN CHEM BIOL, V10, P73, DOI 10.1016/j.cbpa.2005.12.016; Jarosz-Griffiths HH, 2016, J BIOL CHEM, V291, P3174, DOI 10.1074/jbc.R115.702704; Jiang JH, 2015, NEUROCHEM RES, V40, P1929, DOI 10.1007/s11064-015-1686-y; Johnstone M, 1999, J NEUROIMMUNOL, V93, P182, DOI 10.1016/S0165-5728(98)00226-4; Jones RS, 2013, J NEUROIMMUNE PHARM, V8, P301, DOI 10.1007/s11481-012-9427-3; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Kim HS, 2008, AM J PHYSIOL-GASTR L, V295, pG146, DOI 10.1152/ajpgi.00105.2007; Ko EM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-105; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Krabbe G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060921; Krajcovic M, 2013, MOL BIOL CELL, V24, P3736, DOI 10.1091/mbc.E13-07-0408; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lange SC, 2012, NEUROCHEM RES, V37, P2569, DOI 10.1007/s11064-012-0868-0; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; LEE SC, 1994, GLIA, V12, P309, DOI 10.1002/glia.440120407; Li CY, 2015, NEUROCHEM INT, V83-84, P9, DOI 10.1016/j.neuint.2015.03.001; Lian H, 2016, J NEUROSCI, V36, P577, DOI 10.1523/JNEUROSCI.2117-15.2016; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lisi L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-1; Liu CC, 2017, J NEUROSCI, V37, P4023, DOI 10.1523/JNEUROSCI.3442-16.2017; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Maresca B, 2015, J MOL NEUROSCI, V56, P35, DOI 10.1007/s12031-014-0465-6; Meda L, 2001, NEUROBIOL AGING, V22, P885, DOI 10.1016/S0197-4580(01)00307-4; Michener JK, 2012, P NATL ACAD SCI USA, V109, P19504, DOI 10.1073/pnas.1212287109; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Nagamoto-Combs K, 2014, J NEUROSCI METH, V233, P187, DOI 10.1016/j.jneumeth.2014.05.021; NAKAGAMI T, 1993, BIOCHIM BIOPHYS ACTA, V1158, P189, DOI 10.1016/0304-4165(93)90013-X; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Parajuli B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-268; Patel NS, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-9; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Perry George, 1998, J Alzheimers Dis, V1, P45; Prince M., 2016, WORLD ALZHEIMER REPO; Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Reddi AR, 2016, ACCOUNTS CHEM RES, V49, P1104, DOI 10.1021/acs.accounts.5b00553; Robinson SR, 2009, REDOX REP, V14, P228, DOI 10.1179/135100009X12525712409931; Rodriguez-Arellano JJ, 2016, NEUROSCIENCE, V323, P170, DOI 10.1016/j.neuroscience.2015.01.007; Saura J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-26; Schaer CA, 2006, CIRC RES, V99, P943, DOI 10.1161/01.RES.0000247067.34173.1b; Schildge S, 2013, JOVE-J VIS EXP, DOI 10.3791/50079; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Seyfried NT, 2017, CELL SYST, V4, P60, DOI 10.1016/j.cels.2016.11.006; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shen J, 2014, CELL REP, V7, P180, DOI 10.1016/j.celrep.2014.02.042; Silva G, 2009, J BIOL CHEM, V284, P29582, DOI 10.1074/jbc.M109.045344; Simoes RL, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/946878; Snider BJ, 2009, ARCH NEUROL-CHICAGO, V66, P638, DOI 10.1001/archneurol.2009.55; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Sokolova A, 2009, BRAIN PATHOL, V19, P392, DOI 10.1111/j.1750-3639.2008.00188.x; Song YQ, 2015, ACS CHEM BIOL, V10, P1610, DOI 10.1021/cb5009734; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Sutton E. T., 1999, Journal of Submicroscopic Cytology and Pathology, V31, P313; Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49; Wegiel B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00047; Wood LB, 2015, SCI REP-UK, V5, DOI 10.1038/srep16622; Wu B, 2004, J NEUROCHEM, V91, P1164, DOI 10.1111/j.1471-4159.2004.02805.x; Wu CW, 2004, NEUROBIOL DIS, V17, P367, DOI 10.1016/j.nbd.2004.08.014; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Xiao QL, 2014, J NEUROSCI, V34, P9607, DOI 10.1523/JNEUROSCI.3788-13.2014; Xue ZF, 2014, EUR J PHARMACOL, V741, P195, DOI 10.1016/j.ejphar.2014.08.006; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yuan XJ, 2016, P NATL ACAD SCI USA, V113, pE5144, DOI 10.1073/pnas.1609865113; Zhang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072744	105	21	22	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11358	11373		10.1074/jbc.RA117.001050	http://dx.doi.org/10.1074/jbc.RA117.001050			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29871926	hybrid, Green Published			2022-12-26	WOS:000439449700008
J	Maki, H; Sakti, S; Tanaka, H; Nakamura, S				Maki, Hayato; Sakti, Sakriani; Tanaka, Hiroki; Nakamura, Satoshi			Quality prediction of synthesized speech based on tensor structured EEG signals	PLOS ONE			English	Article							CORE AFFECT; EMOTION; ASYMMETRY; ACTIVATION; MUSIC; POWER	This study investigates quality prediction methods for synthesized speech using EEG. Training a predictive model using EEG is challenging due to a small number of training trials, a low signal-to-noise ratio, and a high correlation among independent variables. When a predictive model is trained with a machine learning algorithm, the features extracted from multi-channel EEG signals are usually organized as a vector and their structures are ignored even though they are highly structured signals. This study predicts the subjective rating scores of synthesized speeches, including their overall impression, valence, and arousal, by creating tensor structured features instead of vectorized ones to exploit the structure of the features. We extracted various features to construct a tensor feature that maintained their structure. Vectorized and tensorial features were used to predict the rating scales, and the experimental result showed that prediction with tensorial features achieved the better predictive performance. Among the features, the alpha and beta bands are particularly more effective for predictions than other features, which agrees with previous neurophysiological studies.	[Maki, Hayato; Sakti, Sakriani; Tanaka, Hiroki; Nakamura, Satoshi] Nara Inst Sci & Technol, Grad Sch Informat Sci, Ikoma, Nara, Japan	Nara Institute of Science & Technology	Maki, H (corresponding author), Nara Inst Sci & Technol, Grad Sch Informat Sci, Ikoma, Nara, Japan.	maki.hayato.lt3@is.naist.jp		Tanaka, Hiroki/0000-0002-0548-6252	JSPS KAKENHI [JP17H06101, JP17K00237, JP16K16172]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Part of this work was supported by JSPS KAKENHI (Grant Numbers JP17H06101 to SN, JP17K00237 to SS, and JP16K16172 to HT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aftanas L I, 2004, Neurosci Behav Physiol, V34, P859, DOI 10.1023/B:NEAB.0000038139.39812.eb; Altenmuller E, 2002, NEUROPSYCHOLOGIA, V40, P2242, DOI 10.1016/S0028-3932(02)00107-0; American Clinical Neurophysiology Society, 1996, J CLIN NEUROPHYSIOL, V8, P200; [Anonymous], 2001, ITU T RECOMMENDATION; [Anonymous], 1996, P85 ITU INT TEL UN; Antons J.-N., 2015, NEURAL CORRELATES QU; Antons JN, 2013, INT WORK QUAL MULTIM, P148, DOI 10.1109/QoMEX.2013.6603228; Antons JN, 2012, IEEE J-STSP, V6, P721, DOI 10.1109/JSTSP.2012.2191936; Antons JN, 2010, AUDIO ENG SOC CONVEN, V129; Antons JN, 2017, P 4 INT C QUAL MULT, P63; Arndt S., 2016, ELECT IMAG, V2016, P1, DOI [10.2352/ISSN.2470-1173.2016.16.HVEI-125, DOI 10.2352/ISSN.2470-1173.2016.16.HVEI-125]; Arndt S, P 6 INT IEEE ENG MED; Asgari M, 2014, INT CONF ACOUST SPEE, DOI 10.1109/ICASSP.2014.6853740; Balconi M, 2010, LATERALITY, V15, P361, DOI 10.1080/13576500902886056; Benoit C, 1996, SPEECH COMMUN, V18, P381, DOI 10.1016/0167-6393(96)00026-X; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; CCITT, 1984, ABS CAT RAT ACR METH; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; Costa T, 2006, NEUROSCI LETT, V406, P159, DOI 10.1016/j.neulet.2006.06.039; DAVIDSON RJ, 1992, BRAIN COGNITION, V20, P125, DOI 10.1016/0278-2626(92)90065-T; Friedman J, 2001, SPRINGER SERIES STAT, V1; Glauser ESD, 2008, BRAIN TOPOGR, V20, P224, DOI 10.1007/s10548-008-0048-3; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gupta Rishabh, 2015, 2015 IEEE Workshop on Applications of Signal Processing to Audio and Acoustics (WASPAA). Proceedings, P1, DOI 10.1109/WASPAA.2015.7336888; Gupta R., 2017, QUALITY USER EXPERIE, P2, DOI [DOI 10.1007/S41233-017-0005-6, 10.1007/s41233-017-0005-6]; Gupta R, 2016, HUM-CENT COMPUT INFO, V6, DOI 10.1186/s13673-016-0062-5; Gupta R, 2016, NEUROCOMPUTING, V174, P875, DOI 10.1016/j.neucom.2015.09.085; Huster RJ, 2009, INT J PSYCHOPHYSIOL, V72, P212, DOI 10.1016/j.ijpsycho.2008.12.009; Jekosch U., 2006, VOICE SPEECH QUALITY; JONES NA, 1992, BRAIN COGNITION, V20, P280, DOI 10.1016/0278-2626(92)90021-D; Kadri H., 2016, ADV NEURAL INFORM PR, P1867; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Lee YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095415; Lin YP, 2010, IEEE T BIO-MED ENG, V57, P1798, DOI 10.1109/TBME.2010.2048568; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Mariniak A, 1993, P 3 EUR C SPEECH COM; Mayo C, 2011, SPEECH COMMUN, V53, P311, DOI 10.1016/j.specom.2010.10.003; Moller S, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P1325; Mognon A, 2011, PSYCHOPHYSIOLOGY, V48, P229, DOI 10.1111/j.1469-8986.2010.01061.x; Mwangi B, 2014, NEUROINFORMATICS, V12, P229, DOI 10.1007/s12021-013-9204-3; Nicolaou MA, 2011, IEEE T AFFECT COMPUT, V2, P92, DOI 10.1109/T-AFFC.2011.9; Norrenbrock CR, 2015, SPEECH COMMUN, V66, P17, DOI 10.1016/j.specom.2014.06.003; Phan KL, 2003, BIOL PSYCHIAT, V53, P211, DOI 10.1016/S0006-3223(02)01485-3; Rubin DC, 2009, MEMORY, V17, P802, DOI 10.1080/09658210903130764; Rubin DC, 1994, J BEHAV THER EXP PSY, V25, P49; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; RUSSELL JA, 1977, J RES PERS, V11, P273, DOI 10.1016/0092-6566(77)90037-X; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Sarlo M, 2005, NEUROSCI LETT, V382, P291, DOI 10.1016/j.neulet.2005.03.037; Schmidt LA, 2001, COGNITION EMOTION, V15, P487, DOI 10.1080/0269993004200187; Srinivasan R, 2007, J NEUROSCI METH, V166, P41, DOI 10.1016/j.jneumeth.2007.06.026; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Zhao QB, 2014, WIRES DATA MIN KNOWL, V4, P104, DOI 10.1002/widm.1120; Zhao QB, 2013, IEEE T PATTERN ANAL, V35, P1660, DOI 10.1109/TPAMI.2012.254	56	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0193521	10.1371/journal.pone.0193521	http://dx.doi.org/10.1371/journal.pone.0193521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902169	Green Published, gold, Green Submitted			2022-12-26	WOS:000435424900001
J	Shin, M; Choi, Y; Mazuka, R				Shin, Minha; Choi, Youngon; Mazuka, Reiko			Development of fricative sound perception in Korean infants: The role of language experience and infants' initial sensitivity	PLOS ONE			English	Article							ADULT-DIRECTED SPEECH; JAPANESE INFANTS; DISCRIMINATION; PATTERNS	In this paper, we report data on the development of Korean infants' perception of a rare fricative phoneme distinction. Korean fricative consonants have received much interest in the linguistic community due to the language's distinct categorization of sounds. Unlike many fricative contrasts utilized in most of the world's languages, Korean fricatives (/s*/-/s/) are all voiceless. Moreover, compared with other sound categories, fricatives have received very little attention in the speech perception development field and no studies thus far have examined Korean infants' development of native phonology in this domain. Using a visual habituation paradigm, we tested 4-6-month-old and 7-9-month-old Korean infants on their abilities to discriminate the Korean fricative pair in the [a] vowel context, /s*a/-/sa/, which can be distinguished based on acoustic cues, such as the durations of aspiration and frication noise. Korean infants older than 7 months were able to reliably discriminate the fricative pair but younger infants did not show clear signs of such discrimination. These results add to the growing evidence that there are native sound contrasts infants cannot discriminate early on without a certain amount of language exposure, providing further data to help delineate the specific nature of early perceptual capacity.	[Shin, Minha; Choi, Youngon] Chung Ang Univ, Dept Psychol, Seoul, South Korea; [Mazuka, Reiko] RIKEN Ctr Brain Sci, Lab Language Dev, Tokyo, Japan; [Mazuka, Reiko] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	Chung Ang University; RIKEN; Duke University	Choi, Y (corresponding author), Chung Ang Univ, Dept Psychol, Seoul, South Korea.	yochoi@cau.ac.kr	Mazuka, Reiko/N-7400-2015	Mazuka, Reiko/0000-0001-7862-7768; Choi, Youngon/0000-0002-0698-1511	Chung-Ang University Graduate Research Scholarship; Korean National Research Foundation [NRF-2014R1A1A2054072]; Japanese Society for Promotion of Science [16H06319]; Japanese Ministry of Education, Culture, Sports, Science and Technology [4903, 17H06382]	Chung-Ang University Graduate Research Scholarship; Korean National Research Foundation(National Research Foundation of Korea); Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Chung-Ang University Graduate Research Scholarship in 2018 to M. Shin, by a Korean National Research Foundation grant (NRF-2014R1A1A2054072) to Y. Choi, and by a Japanese Society for Promotion of Science Grant in-Aid for Scientific Research S(16H06319), Japanese Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Innovative Areas #4903 (17H06382) to R. Mazuka.	[Anonymous], 1991, EMERGENCE NATIVE LAN; Best C. T., 1994, DEV SPEECH PERCEPTIO, P167; Best CC, 2003, LANG SPEECH, V46, P183, DOI 10.1177/00238309030460020701; Burns TC, 2007, APPL PSYCHOLINGUIST, V28, P455, DOI 10.1017/S0142716407070257; Chang C. B., 2007, KOREAN FRICATIVES PR, P20; Chang CB, 2013, KOREAN LINGUIST, V15, P7, DOI 10.1075/kl.15.1.02cha; Cheon H, 1998, DEV KOREAN S S NORMA; Cho TH, 2002, J PHONETICS, V30, P193, DOI 10.1006/jpho.2001.0153; Choi Y, 2017, INT C STUD CHILD LAN, P37; EILERS RE, 1975, J SPEECH HEAR RES, V18, P158, DOI 10.1044/jshr.1801.158; EILERS RE, 1977, J SPEECH HEAR RES, V20, P766, DOI 10.1044/jshr.2004.766; EILERS RE, 1979, CHILD DEV, V50, P14; EILERS RE, 1977, J ACOUST SOC AM, V61, P1321, DOI 10.1121/1.381435; EIMAS PD, 1971, SCIENCE, V171, P303, DOI 10.1126/science.171.3968.303; Hong G, 2002, KOREAN J COMMUNICATI, V7, P106; Hoonhorst I, 2009, J EXP CHILD PSYCHOL, V104, P353, DOI 10.1016/j.jecp.2009.07.005; Hyunkee Ahn，, 2009, [Korean Journal of English Language and Linguistics, 영어학], V9, P281; Jongman A, 2000, J ACOUST SOC AM, V108, P1252, DOI 10.1121/1.1288413; Kim M, 2011, J CHILD LANG, V38, P316, DOI 10.1017/S0305000909990353; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; Kuhl PK, 2006, DEVELOPMENTAL SCI, V9, DOI [10.1111/j.1467-7687.2006.00468.x/full, DOI 10.1111/J.1467-7687.2006.00468.X/FULL]; LASKY RE, 1975, J EXP CHILD PSYCHOL, V20, P215, DOI 10.1016/0022-0965(75)90099-5; Lee K, 1999, KOREAN LINGUIST, V10, P47; Lee S, 2008, J CHILD LANG, V35, P591, DOI 10.1017/S0305000908008684; Lee SAS, 2010, J CHILD LANG, V37, P767, DOI 10.1017/S0305000909009568; Liu LQ, 2015, INFANT BEHAV DEV, V38, P27, DOI 10.1016/j.infbeh.2014.12.004; Maurer D, 2014, DEV PSYCHOBIOL, V56, P154, DOI 10.1002/dev.21177; Mazuka R, 2014, DEV PSYCHOBIOL, V56, P192, DOI 10.1002/dev.21193; Narayan CR, 2010, DEVELOPMENTAL SCI, V13, P407, DOI 10.1111/j.1467-7687.2009.00898.x; Polka L, 1996, J ACOUST SOC AM, V100, P577, DOI 10.1121/1.415884; Polka L, 2001, J ACOUST SOC AM, V109, P2190, DOI 10.1121/1.1362689; Sato Y, 2012, DEV PSYCHOL, V48, P18, DOI 10.1037/a0025528; Sato Y, 2010, DEV PSYCHOL, V46, P106, DOI 10.1037/a0016718; Schneider W., 2012, E PRIME 2 0; Shin J, 2004, SYSTEM OUR SPEECH BA; Stager CL, 1997, NATURE, V388, P381, DOI 10.1038/41102; Tsuji S, 2014, J CHILD LANG, V41, P1276, DOI 10.1017/S0305000913000469; Werker JF, 2005, LANG LEARN DEV, V1, P197, DOI 10.1080/15475441.2005.9684216; Werker JF, 2012, CURR DIR PSYCHOL SCI, V21, P221, DOI 10.1177/0963721412449459; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3; Yoon K., 1999, MID LING C	41	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0199045	10.1371/journal.pone.0199045	http://dx.doi.org/10.1371/journal.pone.0199045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ2HI	29897999	Green Submitted, Green Published, gold			2022-12-26	WOS:000435090700089
J	Ohdate, T; Omura, F; Hatanaka, H; Zhou, Y; Takagi, M; Goshima, T; Akao, T; Ono, E				Ohdate, Takumi; Omura, Fumihiko; Hatanaka, Haruyo; Zhou, Yan; Takagi, Masami; Goshima, Tetsuya; Akao, Takeshi; Ono, Eiichiro			MAL73, a novel regulator of maltose fermentation, is functionally impaired by single nucleotide polymorphism in sake brewing yeast	PLOS ONE			English	Article							KYOKAI NO. 7; SACCHAROMYCES-CEREVISIAE; SEQUENCE ALIGNMENT; ACTIVATOR; MAL63; IDENTIFICATION; TRANSPORTER; EXPRESSION; MUTATIONS; KINETICS	For maltose fermentation, budding yeast Saccharomyces cerevisiae operates a mechanism that involves transporters (MALT), maltases (MALS) and regulators (MALR) collectively known as MAL genes. However, functional relevance of MAL genes during sake brewing process remains largely elusive, since sake yeast is cultured under glucose-rich condition achieved by the co-culture partner Aspergillusspp.. Here we isolated an ethyl methane sulfonate (EMS)-mutagenized sake yeast strain exhibiting enhanced maltose fermentation compared to the parental strain. The mutant carried a single nucleotide insertion that leads to the extension of the C-terminal region of a previously uncharacterized MALR gene YPR196W-2, which was renamed as MAL73. Introduction of the mutant allele MAL73L with extended C-terminal region into the parental or other sake yeast strains enhanced the growth rate when fed with maltose as the sole carbon source. In contrast, disruption of endogenous MAL73 in the sake yeasts decreased the maltose fermentation ability of sake yeast, confirming that the original MAL73 functions as a MALR. Importantly, the MAL73L-expressing strain fermented more maltose in practical condition compared to the parental strain during sake brewing process. Our data show that MAL73(L) is a novel MALR gene that regulates maltose fermentation, and has been functionally attenuated in sake yeast by single nucleotide deletion during breeding history. Since the MAL73L-expressing strain showed enhanced ability of maltose fermentation, MAL73L might also be a valuable tool for enhancing maltose fermentation in yeast in general.	[Ohdate, Takumi; Omura, Fumihiko; Hatanaka, Haruyo; Ono, Eiichiro] Suntory Global Innovat Ctr SIC Ltd, Res Inst, Seika, Kyoto, Japan; [Zhou, Yan; Takagi, Masami; Goshima, Tetsuya; Akao, Takeshi] Natl Res Inst Brewing, Hiroshima, Japan	Suntory Holdings Ltd	Ohdate, T (corresponding author), Suntory Global Innovat Ctr SIC Ltd, Res Inst, Seika, Kyoto, Japan.	T_Odate@suntory.co.jp			SIC	SIC	TO, FO, HH and EO are employees of Suntory Global Innovation Center Ltd (SIC), a company affiliated to Suntory Holdings Ltd. SIC financially provides salaries of TO, FO, HH and EO and research materials of this study. The specific roles of these authors are articulated in the 'author contributions' section. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akao T., 2014, Kagaku to Seibutsu, V52, P223; Akao T, 2011, DNA RES, V18, P423, DOI 10.1093/dnares/dsr029; Amberg DC., 2005, METHODS YEAST GENETI; Asano T., 2007, Seibutsu-kogaku Kaishi, V85, P63; Baba S, 1974, SOC BREW JAPAN, V69, P453; Barnett J A, 1976, Adv Carbohydr Chem Biochem, V32, P125, DOI 10.1016/S0065-2318(08)60337-6; Brown CA, 2010, CURR BIOL, V20, P895, DOI 10.1016/j.cub.2010.04.027; CHARRON MJ, 1989, GENETICS, V122, P307; CHARRON MJ, 1986, MOL CELL BIOL, V6, P3891, DOI 10.1128/MCB.6.11.3891; CHARRON MJ, 1988, GENETICS, V120, P83; CHOW THC, 1989, MOL GEN GENET, V217, P60, DOI 10.1007/BF00330943; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Danzi SE, 2003, CURR GENET, V44, P173, DOI 10.1007/s00294-003-0429-9; Danzi SE, 2000, CURR GENET, V38, P233, DOI 10.1007/s002940000161; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; DUBIN RA, 1988, MOL CELL BIOL, V8, P1027, DOI 10.1128/MCB.8.3.1027; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gibson AW, 1997, GENETICS, V146, P1287; GOLDENTHAL MJ, 1987, MOL GEN GENET, V209, P508, DOI 10.1007/BF00331157; Goshima T, 2016, BIOSCI BIOTECH BIOCH, V80, P1657, DOI 10.1080/09168451.2016.1184963; HAN EK, 1995, MOL MICROBIOL, V17, P1093, DOI 10.1111/j.1365-2958.1995.mmi_17061093.x; Hansen J, 2003, FEMS YEAST RES, V4, P323, DOI 10.1016/S1567-1356(03)00178-8; Hatanaka H, 2009, J BIOL CHEM, V284, P15448, DOI 10.1074/jbc.M808151200; Hu Z, 1999, CURR GENET, V36, P1, DOI 10.1007/s002940050466; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Katou T, 2008, YEAST, V25, P799, DOI 10.1002/yea.1634; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Ozcan S, 1998, EMBO J, V17, P2566, DOI 10.1093/emboj/17.9.2566; Peter J, 2018, NATURE, V556, P339, DOI 10.1038/s41586-018-0030-5; Pougach K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5868; REECE RJ, 1993, SCIENCE, V261, P909, DOI 10.1126/science.8346441; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SERRANO R, 1977, EUR J BIOCHEM, V80, P97, DOI 10.1111/j.1432-1033.1977.tb11861.x; SIRENKO OI, 1995, CURR GENET, V27, P509, DOI 10.1007/BF00314440; Sorensen SPL, 1907, BIOCHEM Z, V7, P45; Suzuki H, 2009, ANAL SCI, V25, P1039, DOI 10.2116/analsci.25.1039; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANLEEUWEN CCM, 1992, BIOCHEM J, V284, P441, DOI 10.1042/bj2840441; VANONI M, 1989, PROG NUCLEIC ACID RE, V37, P281; Vidgren V, 2011, YEAST, V28, P579, DOI 10.1002/yea.1888; Watanabe D, 2011, J BIOSCI BIOENG, V112, P54, DOI 10.1016/j.jbiosc.2011.03.007; WEUSTHUIS RA, 1993, APPL ENVIRON MICROB, V59, P3102, DOI 10.1128/AEM.59.9.3102-3109.1993; Yoshizawa K., 1973, Journal of the Society of Brewing, Japan [Nihon Jozo Kyokai Zasshi], V68, P59	45	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198744	10.1371/journal.pone.0198744	http://dx.doi.org/10.1371/journal.pone.0198744			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894505	Green Submitted, Green Published, gold			2022-12-26	WOS:000435030900024
J	Bigelman, E; Cohen, L; Aharon-Hananel, G; Levy, R; Rozenbaum, Z; Saada, A; Keren, G; Entin-Meer, M				Bigelman, Einat; Cohen, Lena; Aharon-Hananel, Genya; Levy, Ran; Rozenbaum, Zach; Saada, Ann; Keren, Gad; Entin-Meer, Michel			Pathological presentation of cardiac mitochondria in a rat model for chronic kidney disease	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CHRONIC HEART-FAILURE; CARDIORENAL SYNDROME; HYPERTENSION; DYSFUNCTION; LOSARTAN; FIBROBLASTS; MYOCARDIUM; DEFICIENCY; FIBROSIS	Background Mitochondria hold crucial importance in organs with high energy demand especially the heart. We investigated whether chronic kidney disease (CKD), which eventually culminates in cardiorenal syndrome, could affect cardiac mitochondria and assessed the potential involvement of angiotensin II (AngII) in the process. Methods Male Lewis rats underwent 5/6 nephrectomy allowing CKD development for eight months or for eleven weeks. Short-term CKD rats were administered with AngII receptor blocker (ARB). Cardiac function was assessed by echocardiography and cardiac sections were evaluated for interstitial fibrosis and cardiomyocytes' hypertrophy. Electron microscopy was used to explore the spatial organization of the cardiomyocytes. Expression levels of mitochondrial content and activity markers were tested in order to delineate the underlying mechanisms for mitochondrial pathology in the CKD setting with or without ARB administration. Results CKD per-se resulted in induced cardiac interstitial fibrosis and cardiomyocytes' hypertrophy combined with a marked disruption of the mitochondrial structure. Moreover, CKD led to enhanced cytochrome C leakage to the cytosol and to enhanced PARP-1 cleavage which are associated with cellular apoptosis. ARB treatment did not improve kidney function but markedly reduced left ventricular mass, cardiomyocytes' hypertrophy and interstitial fibrosis. Interestingly, ARB administration improved the spatial organization of cardiac mitochondria and reduced their increased volume compared to untreated CKD animals. Nevertheless, ARB did not improve mitochondrial content, mitochondrial biogenesis or the respiratory enzyme activity. ARB mildly upregulated protein levels of mitochondrial fusion-related proteins. Conclusions CKD results in cardiac pathological changes combined with mitochondrial damage and elevated apoptotic markers. We anticipate that the increased mitochondrial volume mainly represents mitochondrial swelling that occurs during the pathological process of cardiac hypertrophy. Chronic administration of ARB may improve the pathological appearance of the heart. Further recognition of the molecular pathways leading to mitochondrial insult and appropriate intervention is of crucial importance.	[Bigelman, Einat; Cohen, Lena; Rozenbaum, Zach; Keren, Gad; Entin-Meer, Michel] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Bigelman, Einat; Cohen, Lena; Levy, Ran; Rozenbaum, Zach; Keren, Gad; Entin-Meer, Michel] Tel Aviv Sourasky Med Ctr, Dept Cardiol, Lab Cardiovasc Res, Tel Aviv, Israel; [Aharon-Hananel, Genya] Tel Aviv Sourasky Med Ctr, Internal Med Unit T, Tel Aviv, Israel; [Saada, Ann] Hadassah Hebrew Univ, Med Ctr, Dept Genet & Metab Dis, Jerusalem, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Entin-Meer, M (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.; Entin-Meer, M (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Cardiol, Lab Cardiovasc Res, Tel Aviv, Israel.	michale@tlvmc.gov.il	Rozenbaum, Zach/GQH-4884-2022; rozenbaum, zach/AAN-3130-2020; Saada, Ann/J-6864-2017	Rozenbaum, Zach/0000-0003-4953-7696; rozenbaum, zach/0000-0003-4953-7696; Saada, Ann/0000-0003-2951-0656	Israel Science Foundation [49/11]; Alza & Abramson and Samuel Shalit Tel-Aviv University [0601243812]	Israel Science Foundation(Israel Science Foundation); Alza & Abramson and Samuel Shalit Tel-Aviv University	This work was partially supported by the Israel Science Foundation No. 49/11 and by the Alza & Abramson and Samuel Shalit Tel-Aviv University research grants No. 0601243812. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; Clementi A, 2013, CARDIORENAL MED, V3, P63, DOI 10.1159/000350397; Correa F, 2013, FREE RADICAL BIO MED, V61, P119, DOI 10.1016/j.freeradbiomed.2013.03.017; Cottone S, 1998, AM J HYPERTENS, V11, P548, DOI 10.1016/S0895-7061(98)00027-2; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; Di Lullo L, 2015, HEART FAIL REV, V20, P259, DOI 10.1007/s10741-014-9460-9; Disatnik MH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000461; Dominic EA, 2014, HEART, V100, P611, DOI 10.1136/heartjnl-2013-304657; Eirin A, 2014, EUR HEART J, V35, P3258, DOI 10.1093/eurheartj/ehu436; Entin-Meer M, 2012, CLIN EXPT CARDIOL, V3, P2; Entin-Meer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105055; Entin-Meer M, 2012, AM J NEPHROL, V36, P190, DOI 10.1159/000341651; Havakuk O, 2013, ISR MED ASSOC J, V15, P693; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kuzmicic J, 2011, REV ESP CARDIOL, V64, P916, DOI 10.1016/j.recesp.2011.05.018; Lambers Heerspink HJ, 2013, NAT REV NEPHROL, V9, P112, DOI 10.1038/nrneph.2012.281; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Mariappan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046568; Ortega-Hernandez J, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0640-0; Piratello AC, 2010, CLINICS, V65, P1345, DOI 10.1590/S1807-59322010001200019; Raffaella T, 2012, LIFE SCI, V91, P237, DOI 10.1016/j.lfs.2012.06.041; Ronco C, 2009, BLOOD PURIFICAT, V27, P114, DOI 10.1159/000167018; Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240; Saada A, 2004, ANAL BIOCHEM, V335, P66, DOI 10.1016/j.ab.2004.08.015; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Saada A, 2014, INT J BIOCHEM CELL B, V48, P60, DOI 10.1016/j.biocel.2013.12.010; Saada A, 2011, MOL GENET METAB, V104, P39, DOI 10.1016/j.ymgme.2011.07.016; Santos JM, 2011, INVEST OPHTH VIS SCI, V52, P8791, DOI 10.1167/iovs.11-8203; Santulli G, 2017, J PHYSIOL-LONDON, V595, P3041, DOI 10.1113/JP272781; Sarkissian SD, 2013, J AM SOC HYPERTENS, V7, P118, DOI 10.1016/j.jash.2013.01.002; Schindler R, 2004, NEPHROL DIAL TRANSPL, V19, P34, DOI 10.1093/ndt/gfh1054; Sharov VG, 1998, J MOL CELL CARDIOL, V30, P1757, DOI 10.1006/jmcc.1998.0739; Shimada YJ, 2013, JACC-HEART FAIL, V1, P480, DOI 10.1016/j.jchf.2013.09.001; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI [10.1089/ars.2008.2331, 10.1089/ARS.2008.2331]; Sviglerova J, 2012, EXP BIOL MED, V237, P1056, DOI 10.1258/ebm.2012.012045; Tanaka H, 2004, J CARD FAIL, V10, P412, DOI 10.1016/j.cardfail.2004.01.007; Tang Y, 2014, CARDIOVASC PATHOL, V23, P101, DOI 10.1016/j.carpath.2013.11.002; TorreAmione G, 1996, J AM COLL CARDIOL, V27, P1201, DOI 10.1016/0735-1097(95)00589-7; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zakynthinos E, 2005, ANGIOLOGY, V56, P439, DOI 10.1177/000331970505600412	42	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198196	10.1371/journal.pone.0198196	http://dx.doi.org/10.1371/journal.pone.0198196			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889834	gold, Green Submitted, Green Published			2022-12-26	WOS:000434786600017
J	Huang, B; Li, J; Wang, Q; Guo, MX; Yan, DD; Fang, WS; Ren, ZJ; Wang, QX; Ouyang, CB; Li, Y; Cao, AC				Huang, Bin; Li, Jun; Wang, Qian; Guo, Meixia; Yan, Dongdong; Fang, Wensheng; Ren, Zongjie; Wang, Qiuxia; Ouyang, Canbin; Li, Yuan; Cao, Aocheng			Effect of soil fumigants on degradation of abamectin and their combination synergistic effect to root-knot nematode	PLOS ONE			English	Article							METHYL-BROMIDE; FUMIGATION; EFFICACY; ALTERNATIVES; CHLOROPICRIN; CUCUMBER; PLANTS; OXYFLUORFEN; PESTICIDE; KINETICS	Background Root-knot nematode (Meloidogyne spp., RKN) causes a disease that significantly reduces the yield of greenhouse cucumber crops year after year. Chemical control based on a single pesticide is now unreliable mainly due to pest resistance. Fumigant and non-fumigant pesticide combinations can potentially result in effective and economic RKN control. Results Combining the insecticide abamectin (ABM) with fumigants dazomet (DZ) or chloropicrin (CP) significantly extended the half-life of ABM by an average of about 1.68 and 1.56 times respectively in laboratory trials, and by an average of about 2.02 and 1.69 times respectively in greenhouse trials. Laboratory experiments indicated that all the low rate ABM combination treatments controlled RKN through a synergistic effect. ABM diffused into the nematode epidermis more rapidly when ABM was combined with DZ and CP, giving effective nematode control and an increase cucumber total yield, compared to the use of these products alone. ABM combined with CP or DZ produced significantly higher total cucumber yield than when these products were used alone. Conclusions A low concentration of ABM combined with DZ in preference to CP would be an economic and practical way to control nematode and soilborne fungi in a greenhouse producing cucumbers.	[Huang, Bin; Li, Jun; Wang, Qian; Guo, Meixia; Yan, Dongdong; Fang, Wensheng; Ren, Zongjie; Wang, Qiuxia; Ouyang, Canbin; Li, Yuan; Cao, Aocheng] Chinese Acad Agr Sci, Inst Plant Protect, Beijing, Peoples R China; [Guo, Meixia; Yan, Dongdong; Fang, Wensheng; Wang, Qiuxia; Ouyang, Canbin; Li, Yuan; Cao, Aocheng] State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Cao, AC (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Beijing, Peoples R China.; Cao, AC (corresponding author), State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	caoac@vip.sina.com		Yan, Dongdong/0000-0002-8196-4615	National Natural Science Foundation project of China [31571975]; Beijing Team-Innovation, Modern Agricultural and Industrial Technology Innovation System of China [20106064]	National Natural Science Foundation project of China(National Natural Science Foundation of China (NSFC)); Beijing Team-Innovation, Modern Agricultural and Industrial Technology Innovation System of China	This work was funded by the National Natural Science Foundation project of China (31571975) and Beijing Team-Innovation, Modern Agricultural and Industrial Technology Innovation System of China (20106064).	Abd-Alrahman S, 2013, J ANIM VET ADV, V12, P1228; Ali SW, 2012, WORLD J MICROB BIOT, V28, P39, DOI 10.1007/s11274-011-0790-7; Anastassiades M, 2003, J AOAC INT, V86, P412; Awasthi A, 2013, ACTA PHARMACEUT, V63, P59, DOI 10.2478/acph-2013-0007; BULL DL, 1984, J AGR FOOD CHEM, V32, P94, DOI 10.1021/jf00121a025; Cao A, 2010, CHINA VEGETABLE, V21, P17; Cao AC, 2014, PEST MANAG SCI, V70, P219, DOI 10.1002/ps.3535; [曹坳程 Cao Aocheng], 2007, [植物保护, Plant Protection], V33, P15; Celestina TV, 2010, ECOTOX ENVIRON SAFE, V73, P18, DOI 10.1016/j.ecoenv.2009.08.008; Cheng XK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141235; COHEN Y, 1990, PHYTOPARASITICA, V18, P159, DOI 10.1007/BF02981233; Collange B, 2011, CROP PROT, V30, P1251, DOI 10.1016/j.cropro.2011.04.016; Desaeger JA, 2008, PEST MANAG SCI, V64, P230, DOI 10.1002/ps.1503; Dionisio AC, 2016, CHEMOSPHERE, V151, P17, DOI 10.1016/j.chemosphere.2016.02.058; Duniway JM, 2002, PHYTOPATHOLOGY, V92, P1337, DOI 10.1094/PHYTO.2002.92.12.1337; Elbetieha A, 2003, ECOTOX ENVIRON SAFE, V55, P307, DOI 10.1016/S0147-6513(02)00165-3; Fang WS, 2016, SCI TOTAL ENVIRON, V565, P339, DOI 10.1016/j.scitotenv.2016.04.166; Gan J., 2011, APPL ENVIRON MICROB, V67, P3245; Giannakou IO, 2005, CROP PROT, V24, P499, DOI 10.1016/j.cropro.2004.09.007; Gilreath JP, 2004, CROP PROT, V23, P347, DOI 10.1016/j.cropro.2003.09.006; GOWING DONALD P., 1960, WEEDS, V8, P379, DOI 10.2307/4040436; Gullino ML, 2002, CROP PROT, V21, P741, DOI 10.1016/S0261-2194(02)00031-5; Haar MJ, 2003, CROP PROT, V22, P109, DOI 10.1016/S0261-2194(02)00119-9; Huang B, 2016, J AGR FOOD CHEM, V64, P8710, DOI 10.1021/acs.jafc.6b01437; Huang WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089717; Ibekwe AM, 2010, J ENVIRON SCI HEAL B, V45, P416, DOI 10.1080/03601231003800073; Kamel A, 2007, FOOD CHEM, V100, P1590, DOI 10.1016/j.foodchem.2006.01.002; Klose S, 2006, SOIL BIOL BIOCHEM, V38, P1243, DOI 10.1016/j.soilbio.2005.09.025; Kolar L, 2008, ENVIRON POLLUT, V151, P182, DOI 10.1016/j.envpol.2007.02.011; Kolar L, 2006, ENVIRON POLLUT, V144, P197, DOI 10.1016/j.envpol.2005.12.019; KOMADA H, 1975, Review of Plant Protection Research, V8, P114; Laecke K, 1989, PESTIC BIOCH PHYS, V40, P181; Liu W, 2000, PLANT PATHOGENIC NEM, P373; Lopez-Aranda JM, 2009, HORTTECHNOLOGY, V19, P187, DOI 10.21273/HORTSCI.19.1.187; Mantzos N, 2014, SCI TOTAL ENVIRON, V472, P767, DOI 10.1016/j.scitotenv.2013.11.016; Mao LG, 2012, PEST MANAG SCI, V68, P602, DOI 10.1002/ps.2303; Mao LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091767; Margesin R., 2005, MANUAL SOIL ANAL MON, P47; MASAGO H, 1977, PHYTOPATHOLOGY, V67, P425, DOI 10.1094/Phyto-67-425; Nelson DW, METHODS SOIL ANAL; NOPPUN V, 1989, PESTIC BIOCHEM PHYS, V33, P83, DOI 10.1016/0048-3575(89)90079-5; Qiao K, 2014, SCI HORTIC-AMSTERDAM, V178, P248, DOI 10.1016/j.scienta.2014.08.018; Saeed IAM, 1997, PLANT DIS, V81, P773, DOI 10.1094/PDIS.1997.81.7.773; SHOOP WL, 1995, VET PARASITOL, V59, P139, DOI 10.1016/0304-4017(94)00743-V; Stapleton JJ, 2000, CROP PROT, V19, P837, DOI 10.1016/S0261-2194(00)00111-3; UNEP, 2000, HDB INT TREAT PROT O, V6th, P44; Wang QX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129448; Xie HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117980; Xie XianChuan, 2008, Scientia Agricultura Sinica, V41, P3399; Yan DD, 2013, CHEMOSPHERE, V90, P1210, DOI 10.1016/j.chemosphere.2012.09.041; Zhang Wei, 2004, Yingyong Shengtai Xuebao, V15, P2175; Zhao HH, 2015, J SEP SCI, V38, P1164, DOI 10.1002/jssc.201401234; Zhu GuoNian, 2002, Journal of Zhejiang University (Agriculture and Life Sciences), V28, P319	53	10	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0188245	10.1371/journal.pone.0188245	http://dx.doi.org/10.1371/journal.pone.0188245			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889848	Green Published, gold, Green Submitted			2022-12-26	WOS:000434786600001
J	Kikuchi, K; Yasuoka, J; Nanishi, K; Ahmed, A; Nohara, Y; Nishikitani, M; Yokota, F; Mizutani, T; Nakashima, N				Kikuchi, Kimiyo; Yasuoka, Junko; Nanishi, Keiko; Ahmed, Ashir; Nohara, Yasunobu; Nishikitani, Mariko; Yokota, Fumihiko; Mizutani, Tetsuya; Nakashima, Naoki			Postnatal care could be the key to improving the continuum of care in maternal and child health in Ratanakiri, Cambodia	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; VILLAGE MALARIA WORKERS; NEWBORN BABIES; SERVICE; INTERVENTIONS; STILLBIRTHS; DELIVERY; QUALITY	In South-East Asia, the maternal and child mortality rate has declined over the past decades; however, it varies among and within the countries in the region, including Cambodia. The continuum of care is an integrated series of care that women and children are required to avail continuously from pregnancy to the child/motherhood period. This study aimed to assess the completion rate of the continuum of care and examine the factors associated with the continuum of care in Ratanakiri, Cambodia. A cross-sectional study was conducted in Ratanakiri. Overall, 377 women were included, and data were collected via faceto-face interviews using a semi-structured questionnaire. Among them, 5.0% completed the continuum of care (antenatal care at least four times, delivery by skilled birth attendant, and postnatal care at least once). Meanwhile, 18.8% did not receive any care during pregnancy, delivery, and after birth. The highest discontinuation rate was at the postnatal care stage (73.6%). Not receiving any perinatal care was associated with neonatal complications at 6 weeks after birth (adjusted odds ratio [AOR]: 3.075; 95% confidence interval [CI]: 1.3107.215). Furthermore, a long distance to the health center was negatively associated with completion of the continuum of care (AOR: 0.877; 95% CI: 0.791-0.972). This study indicates the need for efforts to reduce the number of women who discontinue from the continuum of care, as well as who do not receive any care to avoid neonatal complications. Since the discontinuation rate was highest at the postnatal care, postnatal care needs to be promoted more through the antenatal care and delivery services. Furthermore, given that long distance to health facilities was a barrier for receiving the care continuously, our findings suggest the need for a village-based health care system that can provide the basic continuum of care in remote areas.	[Kikuchi, Kimiyo; Nishikitani, Mariko; Yokota, Fumihiko] Kyushu Univ, Inst Decis Sci Sustainable Soc, Fukuoka, Japan; [Yasuoka, Junko; Mizutani, Tetsuya] Tokyo Univ Agr & Technol, Res & Educ Ctr Prevent Global Infect Dis Anim, Tokyo, Japan; [Nanishi, Keiko] Univ Tokyo, Off Int Acad Affairs, Grad Sch Med, Tokyo, Japan; [Ahmed, Ashir; Nakashima, Naoki] Kyushu Univ, Dept Adv Informat Technol, Fukuoka, Japan; [Nohara, Yasunobu] Kyushu Univ Hosp, Med Informat Ctr, Fukuoka, Japan	Kyushu University; Tokyo University of Agriculture & Technology; University of Tokyo; Kyushu University; Kyushu University	Kikuchi, K (corresponding author), Kyushu Univ, Inst Decis Sci Sustainable Soc, Fukuoka, Japan.	Kikuchi.kimiyo.715@m.kyushu-u.ac.jp	Yasuoka, Junko/GVT-8950-2022; MIZUTANI, Tetsuya/G-1086-2013	MIZUTANI, Tetsuya/0000-0003-2570-0452; Nohara, Yasunobu/0000-0002-2805-6597; Nanishi, Keiko/0000-0001-7067-8413	JSPS KAKENHI [JP15H05284]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by JSPS KAKENHI Grant Number JP15H05284. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuin CS, 2011, LANCET, V377, P516, DOI 10.1016/S0140-6736(10)62049-1; Amooti-Kaguna B, 2000, SOC SCI MED, V50, P203, DOI 10.1016/S0277-9536(99)00275-0; [Anonymous], GLOB HLTH OBS DAT 20; Anson O, 2004, HEALTH POLICY, V70, P197, DOI 10.1016/j.healthpol.2004.03.001; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Canavati SE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1322-6; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Dingle A, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-51; Enuameh YAK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152235; Froen JF, 2016, LANCET, V387, P574, DOI 10.1016/S0140-6736(15)00818-1; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Glenton C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010414.pub2; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Hasegawa A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-292; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kikuchi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164965; Kikuchi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139288; Langlois EV, 2015, B WORLD HEALTH ORGAN, V93, P259, DOI 10.2471/BLT.14.140996; Ministry of Planning RGoC, 2013, ANN PROGR REP ACH MI; Munjanja SP, 1996, LANCET, V348, P364, DOI 10.1016/S0140-6736(96)01250-0; National Institute of Statistics Directorate General for Health The DHS Program ICF International, 2014, DIR GEN HLTH DHS PRO; Okawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130712; Rosato M, 2008, LANCET, V372, P962, DOI 10.1016/S0140-6736(08)61406-3; Sakeah E, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1291879; Stekelenburg J, 2004, TROP MED INT HEALTH, V9, P390, DOI 10.1111/j.1365-3156.2004.01202.x; ten Hoope-Bender P, 2013, LANCET, V382, P1685, DOI 10.1016/S0140-6736(13)61793-6; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; The Partnership for Maternal N and Child Health, 2010, PMNCH KNOWL SUMM 02; United Nations, SUST DEV GOALS; Wang WJ, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0497-0; WHO, 2022, WHO RECOMMENDATIONS; WHO, CAMB WHO STAT PROF 2; WHO UNICEF UNFPA, 2003, PREGN CHILDB POSTP N; World Health Organization Department of Maternal N, 2013, WHO REC POSTN CAR MO; Yasuoka J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-4; Yasuoka J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-109	37	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e019882	10.1371/journal.pone.0198829	http://dx.doi.org/10.1371/journal.pone.0198829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889894	Green Published, Green Submitted, gold			2022-12-26	WOS:000434786600057
J	Njunjic, I; Perrard, A; Hendriks, K; Schilthuizen, M; Perreau, M; Merckx, V; Baylac, M; Deharveng, L				Njunjic, Iva; Perrard, Adrien; Hendriks, Kasper; Schilthuizen, Menno; Perreau, Michel; Merckx, Vincent; Baylac, Michel; Deharveng, Louis			Comprehensive evolutionary analysis of the Anthroherpon radiation (Coleoptera, Leiodidae, Leptodirini)	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PHYLOGENETIC SIGNAL; R PACKAGE; DISPERSAL; PATTERNS; DNA; BIOGEOGRAPHY; VICARIANCE; INFERENCE; INSECTA	The genus Anthroherpon Reitter, 1889 exhibits the most pronounced troglomorphic characters among Coleoptera, and represents one of the most spectacular radiations of subterranean beetles. However, radiation, diversification, and biogeography of this genus have never been studied in a phylogenetic context. This study provides a comprehensive evolutionary analysis of the Anthroherpon radiation, using a dated molecular phylogeny as a framework for understanding Anthroherpon diversification, reconstructing the ancestral range, and exploring troglomorphic diversity. Based on 16 species and 22 subspecies, i.e. the majority of Anthroherpon diversity, we reconstructed the phylogeny using Bayesian analysis of six loci, both mitochondrial and nuclear, comprising a total of 4143 nucleotides. In parallel, a morphometric analysis was carried out with 79 landmarks on the body that were subjected to geometric morphometrics. We optimized morphometric features to phylogeny, in order to recognize the way troglomorphy was expressed in different clades of the tree, and did character evolution analyses. Finally, we reconstructed the ancestral range of the genus using BioGeoBEARS. Besides further elucidating the suprageneric classification of the East-Mediterranean Leptodirini, our main findings also show that Anthroherpon dates back to the Early Miocene (ca. 22 MYA) and that the genus diversified entirely underground. Biogeographic reconstruction of the ancestral range shows the origin of the genus in the area comprising three high mountains in western Montenegro, which is in the accordance with the available data on the paleogeography of the Balkan Peninsula. Character evolution analysis indicates that troglomorphic morphometric traits in Anthroherpon mostly evolve neutrally but may diverge adaptively under syntopic competition.	[Njunjic, Iva; Perrard, Adrien; Baylac, Michel; Deharveng, Louis] Sorbonne Univ, MNHN, Inst Syst Evolut & Biodivers, CNRS,UMR 7205,ISYEB,UPMC,EPHE, Paris, France; [Njunjic, Iva; Schilthuizen, Menno; Merckx, Vincent] Nat Biodivers Ctr, Leiden, Netherlands; [Njunjic, Iva] Univ Novi Sad, Fac Sci, Dept Biol & Ecol, Novi Sad, Serbia; [Hendriks, Kasper] Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands; [Schilthuizen, Menno] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; [Perreau, Michel] Univ Paris Diderot, Sorbonne Paris Cite, IUT Paris Diderot, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Naturalis Biodiversity Center; University of Novi Sad; University of Groningen; Leiden University; Leiden University - Excl LUMC; UDICE-French Research Universities; Universite Paris Cite	Njunjic, I (corresponding author), Sorbonne Univ, MNHN, Inst Syst Evolut & Biodivers, CNRS,UMR 7205,ISYEB,UPMC,EPHE, Paris, France.; Njunjic, I (corresponding author), Nat Biodivers Ctr, Leiden, Netherlands.; Njunjic, I (corresponding author), Univ Novi Sad, Fac Sci, Dept Biol & Ecol, Novi Sad, Serbia.	iva.enco@gmail.com	Hendriks, Kasper/HGD-0087-2022; Perreau, Michel/ADD-4708-2022	Perreau, Michel/0000-0001-6124-9334; Njunjic, Iva/0000-0001-5723-4068; Hendriks, Kasper/0000-0003-0245-8368	ATM "Formes possibles, Formes realisees" of MNHN; Martin Fellowship of Naturalis Biodiversity Center	ATM "Formes possibles, Formes realisees" of MNHN; Martin Fellowship of Naturalis Biodiversity Center	This work received support from ATM "Formes possibles, Formes realisees" of MNHN and Martin Fellowship of Naturalis Biodiversity Center: https://science.naturalis.nl/en/about-us/jobs-and-fellowships/.	Adams DC, 2014, SYST BIOL, V63, P685, DOI 10.1093/sysbio/syu030; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; [Anonymous], 2014, TRACER V1 6; [Anonymous], 1995, ADAPTATION NATURAL S, DOI DOI 10.4159/HARVARD.9780674419070; BARR TC, 1967, AM NAT, V101, P475, DOI 10.1086/282512; BARR TC, 1985, ANNU REV ECOL SYST, V16, P313, DOI 10.1146/annurev.es.16.110185.001525; Bilandzija H, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-5; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Buzaljko R, 1982, OSNOVNA GEOLOSKA KAR; Caccone A, 2001, EVOLUTION, V55, P122; Christiansen K., 1962, SPELUNCA, V2, P75, DOI DOI 10.1017/CB09781107415324.004; CROUAUROY B, 1989, GENETICS, V121, P571; CULVER D C, 1990, Memoires de Biospeologie, V17, P13; Culver D.C., 1982, P1; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Culver DC, 2009, FRESHWATER BIOL, V54, P918, DOI 10.1111/j.1365-2427.2007.01856.x; Culver DC, 2006, ECOGRAPHY, V29, P120; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Denton JSS, 2015, EVOLUTION, V69, P2425, DOI 10.1111/evo.12743; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faille A, 2010, MOL PHYLOGENET EVOL, V54, P97, DOI 10.1016/j.ympev.2009.10.008; Faille A, 2011, ZOOL SCR, V40, P282, DOI 10.1111/j.1463-6409.2010.00467.x; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fresneda J, 2011, ARTHROPOD SYST PHYLO, V69, P99; Gibert J, 2012, ENCY CAVES, P219; Grubic A, 1980, GUIDE BOOK; Gueorguiev V. B., 1990, ACTA ENT MUS NAT PRA, V42, P37; Jeannel R., 1930, Abeille Paris, V34, P123; Jeannel R., 1943, FOSSILES VIVANTS CAV; Juan C, 2010, MOL ECOL, V19, P3865, DOI 10.1111/j.1365-294X.2010.04759.x; KANE TC, 1990, PSA P SER, P151; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Klingenberg CP, 2010, SYST BIOL, V59, P245, DOI 10.1093/sysbio/syp106; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Kress WJ, 2015, TRENDS ECOL EVOL, V30, P25, DOI 10.1016/j.tree.2014.10.008; Krstic N., 2003, ACTA GEOLOGICA HUNGA, V46, P291, DOI [10.1556/AGeol.46.2003.3.4, DOI 10.1556/AGE0L.46.2003.3.4]; Krstic Nadezda, 2012, Geoloshki Anali Balkanskoga Poluostrva, V73, P37; Landis MJ, 2013, SYST BIOL, V62, P789, DOI 10.1093/sysbio/syt040; Marovic M., 2007, NEOALPINE TECTONICS; Matzke N.J., 2013, BIOGEOBEARS BIOGEOGR; Matzke N.J., 2013, FRONT BIOGEOGR, V5, P242, DOI [DOI 10.21425/F5FBG19694, 10.21425/F5FBG19694]; Miller M.A., 2010, P GAT COMP ENV WORKS; Mirkovic M, 1980, OSNOVNA GEOLOSKA KAR; Moldovan Oana Teodora, 2004, Natura Croatica, V13, P1; Njunjic I, 2016, CONTRIB ZOOL, V85, P337, DOI 10.1163/18759866-08503005; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perreau M, 2008, I NATURE CONSERVATIO, P199; Perreau M, 2008, I NATURE CONSERVATIO, P215; Perreau M., 2015, CATALOGUE PALAEARCTI, V2/1, P180; Perreau Michel, 2000, Memoires de la SEF, V4, P1; POULSON TL, 1969, SCIENCE, V165, P971; Racovitza E.G., 1907, ARCH ZOOLOGIE EXPT G, V6, P371; Rambaut A., 2012, FIGTREE VERSION 1 4; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Ribera I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-29; Rizzo V, 2013, J BIOGEOGR, V40, P1861, DOI 10.1111/jbi.12139; Robinson O, 2016, MOL BIOL EVOL, V33, P2163, DOI 10.1093/molbev/msw080; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sbordoni V, 1980, P ACCAD NAZ LINCEI, V51, P60; Schiner J.R., 1854, GROTTEN HOHLEN ADELS, P231; Sket B., 1985, Bulletin of the National Speleological Society, V47, P78; Sket B, 2004, ENCY CAVES KARST SCI, P595; Sket Boris, 2005, P158; Sket B, 2008, J NAT HIST, V42, P1549, DOI 10.1080/00222930801995762; Soares D, 2013, BIOSCIENCE, V63, P274, DOI 10.1525/bio.2013.63.4.7; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Trontelj P, 2007, ACTA CARSOLOGICA, V36, P183; Van Dam M, 2016, J BIOGEOGR; Vandel A, 1964, BIOSPEOLOGIE BIOL AN; Zagmajster M, 2008, DIVERS DISTRIB, V14, P95, DOI 10.1111/j.1472-4642.2007.00423.x; Zupan Hajna N., 2012, ENCY CAVES, P195	78	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198367	10.1371/journal.pone.0198367	http://dx.doi.org/10.1371/journal.pone.0198367			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883486	gold, Green Submitted, Green Published			2022-12-26	WOS:000434728100019
J	Peng, M; Chen, XK; Zhao, QB; Zhou, ZK				Peng, Ming; Chen, Xianke; Zhao, Qingbai; Zhou, Zongkui			Attentional scope is reduced by Internet use: A behavior and ERP study	PLOS ONE			English	Article							POSITIVE AFFECT; PSYCHOLOGICAL DISTANCE; MOTIVATIONAL INTENSITY; COGNITIVE CONTROL; BROADEN; PRECEDENCE; PERCEPTION; SELECTION; EMOTIONS; ONSET	As a crucial living environment, the Internet shapes cognition. The Internet provides massive information that can be accessed quickly via hyperlinks, but the information is typically fragmentary and concrete rather than integrative. According to construal level theory, the processing of this concrete and fragmentary information, should reduce attentional scope. Two experiments were conducted to test this hypothesis. In Experiment 1, three groups of participants were asked to shop online, read magazines or have a rest respectively, and a divided attention Navon-letter task was employed to measure the attentional scope before and after the assigned activity. It was found that the difference between reaction times in response to local vs. global targets was decreased only after Internet use, while there was no decrease in either the reading or resting group. In Experiment 2, the same procedure was used, and EEG/ERP methods were used to record both behavioral response and neural activity. Results showed that before the assigned activity, there was no significant difference in N2 amplitude in response to local vs. global targets in any of the three groups; during the activity, the lower-alpha activity induced by Internet use was significantly lower than that induced by reading or resting; after the activity, correspondingly, a more negative N2 wave was induced by the global than local targets only in the Internet group, while there were no significant differences in the other groups. Consistent with construal level theory, the results suggest that when surfing the Internet, attentional scope is reduced, and this effect might continue after Internet activity.	[Zhao, Qingbai; Zhou, Zongkui] Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Hubei, Peoples R China; Cent China Normal Univ, Sch Psychol, Wuhan, Hubei, Peoples R China	Central China Normal University	Zhao, QB; Zhou, ZK (corresponding author), Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Hubei, Peoples R China.	zqbznr@mail.ccnu.edu.cn; zhouzk@mail.ccnu.edu.cn		Peng, Ming/0000-0003-1435-7935	Chinese Postdoctoral Science Foundation [2016M592354]; National Natural Science Foundation of China [31400875]; State Key Laboratory of Cognitive Neuroscience and Learning (China) [CNLZD1604]; Fundamental Research Funds for the Central Universities [CCNU18QN038]	Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Cognitive Neuroscience and Learning (China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by grants from the Chinese Postdoctoral Science Foundation (Grant No. 2016M592354) to MP, the National Natural Science Foundation of China (Grant No. 31400875) to QZ, Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning (China) (Grant No. CNLZD1604) to QZ, and the Fundamental Research Funds for the Central Universities (Grant No. CCNU18QN038) to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M. L., 2007, BRAIN DEV LEARNING E, P65; ANDERSON ML, 2008, BRAIN EMBODIED SITUA, P15; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Bonnefond A, 2010, BEHAV BRAIN RES, V211, P185, DOI 10.1016/j.bbr.2010.03.030; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Carr N., 2011, SHALLOWS WHAT INTERN; Chajut E, 2003, J PERS SOC PSYCHOL, V85, P231, DOI 10.1037/0022-3514.85.2.231; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Fink A, 2014, NEUROSCI BIOBEHAV R, V44, P111, DOI 10.1016/j.neubiorev.2012.12.002; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Han SH, 2000, NEUROREPORT, V11, P2753, DOI 10.1097/00001756-200008210-00029; Han SH, 1997, J COGNITIVE NEUROSCI, V9, P687, DOI 10.1162/jocn.1997.9.5.687; Harmon-Jones E, 2013, CURR DIR PSYCHOL SCI, V22, P301, DOI 10.1177/0963721413481353; Harmon-Jones E, 2009, PSYCHOL SCI, V20, P406, DOI 10.1111/j.1467-9280.2009.02302.x; Heinze HJ, 1998, J COGNITIVE NEUROSCI, V10, P485, DOI 10.1162/089892998562898; HEINZE HJ, 1993, NEUROPSYCHOLOGIA, V31, P841, DOI 10.1016/0028-3932(93)90132-J; Kaynar O, 2008, COMPUT HUM BEHAV, V24, P361, DOI 10.1016/j.chb.2007.01.033; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lao J., 2013, CULTURE BRAIN, V1, P158, DOI [10.1007/s40167-013-0012-2, DOI 10.1007/S40167-013-0012-2]; Liberman N, 2009, J PERS SOC PSYCHOL, V97, P203, DOI 10.1037/a0015671; Liu L, 2014, EXP BRAIN RES, V232, P3291, DOI 10.1007/s00221-014-4014-x; Liu ZM, 2005, J DOC, V61, P700, DOI 10.1108/00220410510632040; Loh KK, 2016, NEUROSCIENTIST, V22, P506, DOI 10.1177/1073858415595005; Moisala M, 2016, NEUROIMAGE, V134, P113, DOI 10.1016/j.neuroimage.2016.04.011; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Nicholas D, 2009, J DOC, V65, P106, DOI 10.1108/00220410910926149; Ophir E, 2009, P NATL ACAD SCI USA, V106, P15583, DOI 10.1073/pnas.0903620106; Plaisted K, 1999, J CHILD PSYCHOL PSYC, V40, P733, DOI 10.1111/1469-7610.00489; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; STOFFER TH, 1994, PSYCHOL RES-PSYCH FO, V56, P83, DOI 10.1007/BF00419715; Taylor A.J, 2016, J EXPT PSYCHOL HUMAN, V8, P521; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; [尹霞云 Yin Xiayun], 2010, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V18, P763; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]	36	6	6	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198543	10.1371/journal.pone.0198543	http://dx.doi.org/10.1371/journal.pone.0198543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI7ZT	29883465	gold, Green Published, Green Submitted			2022-12-26	WOS:000434728100029
J	Veaudor, T; Ortega-Ramos, M; Jittawuttipoka, T; Bottin, H; Cassier-Chauvat, C; Chauvat, F				Veaudor, Theo; Ortega-Ramos, Marcia; Jittawuttipoka, Thichakorn; Bottin, Herve; Cassier-Chauvat, Corinne; Chauvat, Franck			Overproduction of the cyanobacterial hydrogenase and selection of a mutant thriving on urea, as a possible step towards the future production of hydrogen coupled with water treatment	PLOS ONE			English	Article							SP PCC 6803; SYNECHOCYSTIS; PCC6803; PROTEIN; GENES; MUTAGENESIS; EXPRESSION; PROMOTER; PCC-6803; VECTOR	Using a combination of various types of genetic manipulations (promoter replacement and gene cloning in replicating plasmid expression vector), we have overproduced the complex hydrogenase enzyme in the model cyanobacterium Synechocystis PCC6803. This new strain overproduces all twelve following proteins: HoxEFUYH (hydrogen production), HoxW (maturation of the HoxH subunit of hydrogenase) and HypABCDEF (assembly of the [NiFe] redox center of HoxHY hydrogenase). This strain when grown in the presence of a suitable quantities of nickel and iron used here exhibits a strong (25-fold) increase in hydrogenase activity, as compared to the WT strain growing in the standard medium. Hence, this strain can be very useful for future analyses of the cyanobacterial [NiFe] hydrogenase to determine its structure and, in turn, improve its tolerance to oxygen with the future goal of increasing hydrogen production. We also report the counterintuitive notion that lowering the activity of the Synechocystis urease can increase the photoproduction of biomass from urea-polluted waters, without decreasing hydrogenase activity. Such cyanobacterial factories with high hydrogenase activity and a healthy growth on urea constitute an important step towards the future development of an economical industrial processes coupling H-2 production from solar energy and CO2, with wastewater treatment (urea depollution).	[Veaudor, Theo; Ortega-Ramos, Marcia; Jittawuttipoka, Thichakorn; Bottin, Herve; Cassier-Chauvat, Corinne; Chauvat, Franck] Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,I2BC, Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Chauvat, F (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,I2BC, Gif Sur Yvette, France.	franck.chauvat@cea.fr	Chauvat, Franck/E-7394-2010; CASSIER-CHAUVAT, Corinne/E-7505-2010	Chauvat, Franck/0000-0002-9151-7667; CASSIER-CHAUVAT, Corinne/0000-0001-6901-5559	CEA; ANR [ANR-09-BIDE-002-01]; ANR	CEA(French Atomic Energy Commission); ANR(French National Research Agency (ANR)); ANR(French National Research Agency (ANR))	This study was supported by the CEA and ANR (ANR-09-BIDE-002-01; project EngineeringH2cyano). Theo Veaudor and Marcia Ortega-Ramos received a phD fellowship from CEA and ANR, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Aurelia Czarnecka-Kwasiborski for technical assistance and Genevieve Guedeney (BIAM CEA-Cadarache France) for the gift of the anti-HoxF and anti-HoxH antibodies. We also thank Pr Michael Scott Dubow for his help with the English of our manuscript.	Bernat G, 2009, PHOTOSYNTH RES, V99, P205, DOI 10.1007/s11120-008-9398-7; Carrieri D, 2011, BIORESOURCE TECHNOL, V102, P8368, DOI 10.1016/j.biortech.2011.03.103; Carter EL, 2009, METALLOMICS, V1, P207, DOI 10.1039/b903311d; Cassier-Chauvat C, 2014, INT J MOL SCI, V15, P19938, DOI 10.3390/ijms151119938; Cassier-Chauvat Corinne, 2014, Life-Basel, V4, P666, DOI 10.3390/life4040666; Chardonnet S, 2015, J PROTEOME RES, V14, P59, DOI 10.1021/pr500625a; Collier JL, 1999, MICROBIOL-SGM, V145, P447, DOI 10.1099/13500872-145-2-447; Cournac L, 2004, J BACTERIOL, V186, P1737, DOI 10.1128/JB.186.6.1737-1746.2003; Domain F, 2004, MOL MICROBIOL, V53, P65, DOI 10.1111/j.1365-2958.2004.04100.x; Dutheil J, 2012, J BACTERIOL, V194, P5423, DOI 10.1128/JB.00543-12; Eckert C, 2012, J BIOL CHEM, V287, P43502, DOI 10.1074/jbc.M112.392407; FERINO F, 1989, GENE, V84, P257, DOI 10.1016/0378-1119(89)90499-X; Freyermuth SK, 2000, PLANT J, V21, P53, DOI 10.1046/j.1365-313x.2000.00655.x; Germer F, 2009, J BIOL CHEM, V284, P36462, DOI 10.1074/jbc.M109.028795; Guo J, 2014, MOL CELL PROTEOMICS, V13, P3270, DOI 10.1074/mcp.M114.041160; Gutekunst K, 2014, J BIOL CHEM, V289, P1930, DOI 10.1074/jbc.M113.526376; Hoffmann D, 2006, FEBS J, V273, P4516, DOI 10.1111/j.1742-4658.2006.05460.x; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khanna N, 2015, INT J MOL SCI, V16, P10537, DOI 10.3390/ijms160510537; LABARRE J, 1989, J BACTERIOL, V171, P3449, DOI 10.1128/jb.171.6.3449-3457.1989; MACKERRAS AH, 1986, J GEN MICROBIOL, V132, P2749; McGuffin LJ, 2008, BIOINFORMATICS, V24, P586, DOI 10.1093/bioinformatics/btn014; McIntosh CL, 2011, J AM CHEM SOC, V133, P11308, DOI 10.1021/ja203376y; MERMETBOUVIER P, 1994, CURR MICROBIOL, V28, P145, DOI 10.1007/BF01571055; MERMETBOUVIER P, 1993, CURR MICROBIOL, V27, P323, DOI 10.1007/BF01568955; Oliveira P, 2009, DALTON T, P9990, DOI 10.1039/b908593a; Ortega-Ramos M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089372; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Puggioni V, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00223; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Sakamoto T, 1998, APPL ENVIRON MICROB, V64, P2361; Sakr S, 2013, INT J HYDROGEN ENERG, V38, P13547, DOI 10.1016/j.ijhydene.2013.07.124; van Vliet AHM, 2001, INFECT IMMUN, V69, P4891, DOI 10.1128/IAI.69.8.4891-4897.2001; Witte CP, 2011, PLANT SCI, V180, P431, DOI 10.1016/j.plantsci.2010.11.010	34	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198836	10.1371/journal.pone.0198836	http://dx.doi.org/10.1371/journal.pone.0198836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879209	Green Published, gold, Green Submitted			2022-12-26	WOS:000434384900089
J	Arnulfo, G; Pozzi, NG; Palmisano, C; Leporini, A; Canessa, A; Brumberg, J; Pezzoli, G; Matthies, C; Volkmann, J; Isaias, IU				Arnulfo, Gabriele; Pozzi, Nicolo Gabriele; Palmisano, Chiara; Leporini, Alice; Canessa, Andrea; Brumberg, Joachim; Pezzoli, Gianni; Matthies, Cordula; Volkmann, Jens; Isaias, Ioannis Ugo			Phase matters: A role for the subthalamic network during gait	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; BASAL GANGLIA; FUNCTIONAL-SIGNIFICANCE; PARKINSONS-DISEASE; BETA OSCILLATIONS; NEURONAL-ACTIVITY; NUCLEUS; COMMUNICATION; MOVEMENT; WALKING	The role of the subthalamic nucleus in human locomotion is unclear although relevant, given the troublesome management of gait disturbances with subthalamic deep brain stimulation in patients with Parkinson's disease. We investigated the subthalamic activity and interhemispheric connectivity during walking in eight freely-moving subjects with Parkinson's disease and bilateral deep brain stimulation. In particular, we compared the subthalamic power spectral densities and coherence, amplitude cross-correlation and phase locking value between resting state, upright standing, and steady forward walking. We observed a phase locking value drop in the beta-frequency band (approximate to 13-35Hz) during walking with respect to resting and standing. This modulation was not accompanied by specific changes in subthalamic power spectral densities, which was not related to gait phases or to striatal dopamine loss measured with [(123)l]N-omega-fluoropropyl-2 beta-carbomethoxy-3 beta-(4-iodophenyl)nortropane and single-photon computed tomography. We speculate that the subthalamic inter-hemispheric desynchronization in the beta-frequency band reflects the information processing of each body side separately, which may support linear walking. This study also suggests that in some cases (i.e. gait) the brain signal, which could allow feedback-controlled stimulation, might derive from network activity.	[Arnulfo, Gabriele; Pozzi, Nicolo Gabriele; Palmisano, Chiara; Leporini, Alice; Volkmann, Jens; Isaias, Ioannis Ugo] Univ Hosp, Dept Neurol, Wurzburg, Germany; [Arnulfo, Gabriele; Pozzi, Nicolo Gabriele; Palmisano, Chiara; Leporini, Alice; Brumberg, Joachim; Matthies, Cordula; Volkmann, Jens; Isaias, Ioannis Ugo] Julius Maximillian Univ, Wurzburg, Germany; [Arnulfo, Gabriele; Canessa, Andrea] Univ Genoa, Dept Informat Bioengn Robot & Syst Engn, Genoa, Italy; [Palmisano, Chiara] Politecn Milan, Dept Elect Informat & Bioengn, MBMC Lab, Milan, Italy; [Canessa, Andrea] Fdn Europea Ric Biomed FERB Onlus, Cernusco S-N, Milan, Italy; [Brumberg, Joachim] Univ Hosp, Dept Nucl Med, Wurzburg, Germany; [Pezzoli, Gianni] Ctr Parkinson ASST G Pini CTO, Milan, Italy; [Matthies, Cordula] Univ Hosp, Dept Neurosurg, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Genoa; Polytechnic University of Milan; University of Wurzburg; University of Wurzburg	Isaias, IU (corresponding author), Univ Hosp, Dept Neurol, Wurzburg, Germany.; Isaias, IU (corresponding author), Julius Maximillian Univ, Wurzburg, Germany.	Isaias_I@ukw.de	Isaias, Ioannis Ugo/F-4492-2014; Palmisano, Chiara/ABH-2066-2020; Matthies, Cordula/AAE-5708-2019; ARNULFO, GABRIELE/J-6812-2018; Volkmann, Jens/AAK-7570-2020; CANESSA, ANDREA/J-5587-2018; Pozzi, Nicolo/K-9989-2016	Isaias, Ioannis Ugo/0000-0002-3552-5144; ARNULFO, GABRIELE/0000-0002-1140-0320; CANESSA, ANDREA/0000-0001-8946-5290; Pozzi, Nicolo/0000-0003-1394-0168; Pezzoli, Gianni/0000-0003-4665-6710	"Interdisziplinares Zentrum fur Klinische Forschung (IZKF)" of the University Hospital Wuerzburg; Fondazione Grigioni peril Morbo di Parkinson; German Excellence Initiative to the Graduate School of Life Sciences, University of Wuerzburg	"Interdisziplinares Zentrum fur Klinische Forschung (IZKF)" of the University Hospital Wuerzburg; Fondazione Grigioni peril Morbo di Parkinson; German Excellence Initiative to the Graduate School of Life Sciences, University of Wuerzburg	The study was sponsored in part by the "Interdisziplinares Zentrum fur Klinische Forschung (IZKF)" of the University Hospital Wuerzburg and by the "Fondazione Grigioni peril Morbo di Parkinson". NGP and CP were supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wuerzburg.	Allert N, 2001, MOVEMENT DISORD, V16, P1076, DOI 10.1002/mds.1222; Bastos AM, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00175; Bastos AM, 2015, CURR OPIN NEUROBIOL, V31, P173, DOI 10.1016/j.conb.2014.11.001; Bloem BR, 2001, J NEUROL, V248, P950, DOI 10.1007/s004150170047; Brittain JS, 2014, NEUROIMAGE, V85, P637, DOI 10.1016/j.neuroimage.2013.05.084; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Brown P, 2005, CLIN NEUROPHYSIOL, V116, P2510, DOI 10.1016/j.clinph.2005.05.009; Cagnan H, 2017, BRAIN, V140, P132, DOI 10.1093/brain/aww286; Cagnan H, 2015, BRAIN, V138, P1667, DOI 10.1093/brain/awv093; Canessa A, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00611; Castle M, 2005, J COMP NEUROL, V483, P143, DOI 10.1002/cne.20421; Clark DJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00246; Darvas F, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00701; de Hemptinne C, 2015, NAT NEUROSCI, V18, P779, DOI 10.1038/nn.3997; de Hemptinne C, 2013, P NATL ACAD SCI USA, V110, P4780, DOI 10.1073/pnas.1214546110; de Solages C, 2010, EXP NEUROL, V221, P260, DOI 10.1016/j.expneurol.2009.11.012; Devos D, 2006, CLIN NEUROPHYSIOL, V117, P2315, DOI 10.1016/j.clinph.2006.06.719; Dipaola M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156420; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fogelson N, 2005, EUR J NEUROSCI, V22, P257, DOI 10.1111/j.1460-9568.2005.04179.x; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Gaynor LMFD, 2008, EUR J NEUROSCI, V28, P1686, DOI 10.1111/j.1460-9568.2008.06363.x; Giannicola G, 2010, EXP NEUROL, V226, P120, DOI 10.1016/j.expneurol.2010.08.011; Gooijers J, 2014, NEUROSCI BIOBEHAV R, V43, P1, DOI 10.1016/j.neubiorev.2014.03.008; Hohlefeld FU, 2014, EUR J NEUROSCI, V40, P3273, DOI 10.1111/ejn.12686; Hooper SL, NEUROBIOLOGY MOTOR C; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Isaias IU, 2008, BRAIN, V131, P1895, DOI 10.1093/brain/awn120; Isaias LU, 2008, NUCL MED COMMUN, V29, P349, DOI 10.1097/MNM.0b013e3282f4d307; Isaias IU, 2006, MOVEMENT DISORD, V21, P1144, DOI 10.1002/mds.20909; Isaias IU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051464; Isaias IU, 2011, J NEUROSCI, V31, P14458, DOI 10.1523/JNEUROSCI.3583-11.2011; Isaias IU, 2010, MOVEMENT DISORD, V25, P679, DOI 10.1002/mds.22870; Kajikawa Y, 2011, NEURON, V72, P847, DOI 10.1016/j.neuron.2011.09.029; Kato K, 2016, FRONT HUM NEUROSCI, V10, DOI [10.3389/fnhum.2016.00218, 10.3389/fnhum.2016.00131]; Kato K, 2015, CLIN NEUROPHYSIOL, V126, P1941, DOI 10.1016/j.clinph.2014.12.007; Kiehn O, 2016, NAT REV NEUROSCI, V17, P224, DOI 10.1038/nrn.2016.9; Kuhn AA, 2008, J NEUROSCI, V28, P6165, DOI 10.1523/JNEUROSCI.0282-08.2008; Kuhn AA, 2017, MOVEMENT DISORD, V32, P11, DOI 10.1002/mds.26703; la Fougere C, 2010, NEUROIMAGE, V50, P1589, DOI 10.1016/j.neuroimage.2009.12.060; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lalo E, 2008, J NEUROSCI, V28, P3008, DOI 10.1523/JNEUROSCI.5295-07.2008; Little S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082762; Little S, 2013, ANN NEUROL, V74, P449, DOI 10.1002/ana.23951; Litvak V, 2011, BRAIN, V134, P359, DOI 10.1093/brain/awq332; Marani E, 2008, ADV ANAT EMBRYOL CEL, V198, P1, DOI 10.1007/978-3-540-79460-8; Moran A, 2008, BRAIN, V131, P3395, DOI 10.1093/brain/awn270; Morris ME, 2001, CLIN BIOMECH, V16, P459, DOI 10.1016/S0268-0033(01)00035-3; Moshel S, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00079; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; NUTT JG, 1993, NEUROLOGY, V43, P268, DOI 10.1212/WNL.43.2.268; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Oswal A, 2013, CURR OPIN NEUROL, V26, P662, DOI 10.1097/WCO.0000000000000034; Oswal A, 2012, J NEUROSCI, V32, P9909, DOI 10.1523/JNEUROSCI.0275-12.2012; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Peterson DS, 2016, PHYSIOLOGY, V31, P95, DOI 10.1152/physiol.00034.2015; Potter-Nerger M, 2013, MOVEMENT DISORD, V28, P1609, DOI 10.1002/mds.25677; Pollak Pierre, 2013, Handb Clin Neurol, V116, P97, DOI 10.1016/B978-0-444-53497-2.00009-7; Priori A, 2004, EXP NEUROL, V189, P369, DOI 10.1016/j.expneurol.2004.06.001; Quinn EJ, 2015, MOVEMENT DISORD, V30, P1750, DOI 10.1002/mds.26376; Reich MM, 2016, BRAIN, V139, P2948, DOI 10.1093/brain/aww223; Rosa M, 2017, MOVEMENT DISORD, V32, P628, DOI 10.1002/mds.26953; Rossignol S, 2005, PHYSIOL REV, P86; Rouse AG, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036018; Sadeghi H, 2000, GAIT POSTURE, V12, P257, DOI 10.1016/S0966-6362(00)00085-0; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Seifried C, 2012, BRAIN STIMUL, V5, P378, DOI 10.1016/j.brs.2011.06.002; Silberstein P, 2005, BRAIN, V128, P1277, DOI 10.1093/brain/awh480; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Singh A, 2016, P NATL ACAD SCI USA, V113, P9629, DOI 10.1073/pnas.1606792113; Stanslaski S, 2012, IEEE T NEUR SYS REH, V20, P410, DOI 10.1109/TNSRE.2012.2183617; Steigerwald F, 2008, J NEUROPHYSIOL, V100, P2515, DOI 10.1152/jn.90574.2008; Syrkin-Nikolau J, 2017, NEUROBIOL DIS, V108, P288, DOI 10.1016/j.nbd.2017.09.002; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Takakusaki K, 2008, BRAIN RES REV, V57, P192, DOI 10.1016/j.brainresrev.2007.06.024; Takakusaki K, 2017, J MOV DISORD, V10, P1, DOI 10.14802/jmd.16062; Tard C, 2015, NEUROSCIENCE, V307, P281, DOI 10.1016/j.neuroscience.2015.08.063; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Zaidel A, 2009, MOVEMENT DISORD, V24, P1785, DOI 10.1002/mds.22674	84	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198691	10.1371/journal.pone.0198691	http://dx.doi.org/10.1371/journal.pone.0198691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874298	gold, Green Submitted, Green Published			2022-12-26	WOS:000434369400061
J	Simon-Martinez, C; dos Santos, GL; Jaspers, E; Vanderschueren, R; Mailleux, L; Klingels, K; Ortibus, E; Desloovere, K; Feys, H				Simon-Martinez, Cristina; dos Santos, Gabriela Lopes; Jaspers, Ellen; Vanderschueren, Ruth; Mailleux, Lisa; Klingels, Katrijn; Ortibus, Els; Desloovere, Kaat; Feys, Hilde			Age-related changes in upper limb motion during typical development	PLOS ONE			English	Article							UPPER EXTREMITY KINEMATICS; CHILDREN; MOVEMENTS; REACH; COORDINATION; FEATURES; JOINTS; GRASP; LIFE	Background and aim Understanding the maturation of upper limb (UL) movement characteristics in typically developing (TD) children is key to explore UL deficits in those with neurodevelopmental disorders. Three-dimensional motion analysis (3DMA) offers a reliable tool to comprehensively evaluate UL motion. However, studies thus far mainly focused on specific pre-defined parameters extracted from kinematic waveforms. Here, we investigated age-related differences in UL movement characteristics over the entire movement cycle in TD children. Participants and methods We assessed the non-dominant UL of 60 TD children (mean age 10y3m +/- 3y1m) using 3DMA during eight tasks: reaching (forwards (RF), upwards (RU), sideways (RS)), reachto-grasp (sphere (RGS), vertical cylinder (RGV)) and activities-of-daily-living mimicking tasks (hand-to-head (HTH), hand-to-mouth (HTM), hand-to-shoulder (HTS)). We investigated differences between four age-groups (5-7y, 8-10y, 11-12y, 13-15y) in: (1) spatiotemporal parameters (movement duration, peak velocity, time-to-peak velocity and trajectory straightness), and (2) 12 UL joint angles, using Statistical Parametric Mapping (SPM). Results We found that the 5-7y children moved with lower peak velocity and less straight trajectories compared to the 11-12y group (peak velocity: RS, HTS, p<0.01; trajectory: RU, RS, RGV, HTS, p<0.01) and the 13-15y group (peak velocity: RF, RS, RGS, RGV, HTH, HTS, p<0.01; trajectory, all tasks, p<0.01). The 5-7y children showed increased scapular protraction compared to older children (8-10y and 11-12y, HTS), as well as increased scapular medial rotation compared to the 13-15y group (RGS). During RU, the 5-7y children moved more towards the frontal plane (shoulder), unlike the 13-15y group. Lastly, the 5-7y group used less elbow flexion than older children (11-12y and 13-15y) during HTH and HTS. Discussion and conclusion In conclusion, our results point toward a maturation in UL movement characteristics up to age 11-12y, when UL motion seemed to reach a plateau. The reference values provided in this study will help to further optimize the interpretation of UL deficits in children with neurodevelopmental disorders.	[Simon-Martinez, Cristina; Jaspers, Ellen; Vanderschueren, Ruth; Mailleux, Lisa; Klingels, Katrijn; Desloovere, Kaat; Feys, Hilde] KU Leuven Univ Leuven, Dept Rehabil Sci, Leuven, Belgium; [dos Santos, Gabriela Lopes] Fed Univ Sao Carlos UFSCar, Dept Physiotherapy, Lab Neurol Physiotherapy Res, Sao Carlos, SP, Brazil; [Jaspers, Ellen] Swiss Fed Inst Technol, Neural Control Movement Lab, Dept Hlth Sci & Technol, Zurich, Switzerland; [Klingels, Katrijn] Hasselt Univ, BIOMED, Rehabil Res Ctr, Diepenbeek, Belgium; [Ortibus, Els] KU Leuven Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Desloovere, Kaat] Univ Hosp Leuven, Clin Mot Anal Lab, Pellenberg, Belgium	KU Leuven; Universidade Federal de Sao Carlos; Swiss Federal Institutes of Technology Domain; ETH Zurich; Hasselt University; KU Leuven; KU Leuven; University Hospital Leuven	Simon-Martinez, C (corresponding author), KU Leuven Univ Leuven, Dept Rehabil Sci, Leuven, Belgium.	cristina.simon@kuleuven.be	Mailleux, Lisa/J-6248-2019; Santos, Gabriela L Lopes dos/K-6023-2013; Vanderschueren, Ruth/AAC-9895-2019; Simon-Martinez, Cristina/P-2346-2018; Ortibus, Els/GYJ-3215-2022	Mailleux, Lisa/0000-0002-9955-098X; Vanderschueren, Ruth/0000-0002-5781-5599; Simon-Martinez, Cristina/0000-0001-6694-6358; Klingels, Katrijn/0000-0001-5853-9680	Fund Scientific Research Flanders (FWO-project) [G087213N]; Special Research Fund, KU Leuven [OT/14/127, 3M140230]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/25845-6, 2015/21695-2]	Fund Scientific Research Flanders (FWO-project); Special Research Fund, KU Leuven; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work is funded by the Fund Scientific Research Flanders (FWO-project, grant G087213N) and by the Special Research Fund, KU Leuven (OT/14/127, project grant 3M140230). GLS was funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; grant numbers: 2014/25845-6 and 2015/21695-2).	Beaudette B, 2014, J MED BIOL ENG, V34, P448, DOI 10.5405/jmbe.1697; Berthier NE, 2006, EXP BRAIN RES, V169, P507, DOI 10.1007/s00221-005-0169-9; Brochard S, 2012, CLIN BIOMECH, V27, P652, DOI 10.1016/j.clinbiomech.2012.04.001; Butler EE, 2010, GAIT POSTURE, V32, P72, DOI 10.1016/j.gaitpost.2010.03.011; Cahill-Rowley K, 2017, J BIOMECH, V52, P11, DOI 10.1016/j.jbiomech.2016.10.031; Chen CM, 2011, AM J PHYS MED REHAB, V90, P940, DOI 10.1097/PHM.0b013e3182240d54; Chiappedi M, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-173; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coluccini M, 2007, GAIT POSTURE, V25, P493, DOI 10.1016/j.gaitpost.2006.12.015; De Baets L, 2016, HUM MOVEMENT SCI, V48, P82, DOI 10.1016/j.humov.2016.04.009; DeLuca PA, 1997, J PEDIATR ORTHOPED, V17, P608, DOI 10.1097/00004694-199709000-00007; Gilliaux M, 2015, ANN BIOMED ENG, V43, P1123, DOI 10.1007/s10439-014-1189-z; HAY L, 1978, PERCEPT MOTOR SKILL, V47, P1079, DOI 10.2466/pms.1978.47.3f.1079; Janssen MMHP, 2014, J NEUROL, V261, P1269, DOI 10.1007/s00415-014-7316-9; Jaspers E, 2011, RES DEV DISABIL, V32, P2283, DOI 10.1016/j.ridd.2011.07.038; Jaspers E, 2011, GAIT POSTURE, V34, P227, DOI 10.1016/j.gaitpost.2011.05.003; Jaspers E, 2011, GAIT POSTURE, V33, P279, DOI 10.1016/j.gaitpost.2010.11.021; Jaspers E, 2009, GAIT POSTURE, V30, P395, DOI 10.1016/j.gaitpost.2009.07.110; Jongbloed-Pereboom M, 2013, J EXP CHILD PSYCHOL, V114, P295, DOI 10.1016/j.jecp.2012.08.008; Kim Hae-Young, 2015, Restor Dent Endod, V40, P172, DOI 10.5395/rde.2015.40.2.172; Konczak J, 1997, EXP BRAIN RES, V117, P346, DOI 10.1007/s002210050228; Kuhtz-Buschbeck JP, 1998, EXP BRAIN RES, V122, P424, DOI 10.1007/s002210050530; Li XT, 2016, J BIOMECH, V49, P2806, DOI 10.1016/j.jbiomech.2016.06.018; Mackey A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00117; Mahon J, 2017, PHYSIOL MEAS, V38, P524, DOI 10.1088/1361-6579/aa5c13; Mailleux L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180196; Meskers CGM, 1998, J BIOMECH, V31, P93, DOI 10.1016/S0021-9290(97)00101-2; Olivier I, 2007, EXP BRAIN RES, V179, P17, DOI 10.1007/s00221-006-0762-6; Pataky TC, 2016, J BIOMECH, V49, P1468, DOI 10.1016/j.jbiomech.2016.03.032; Pataky TC, 2010, J BIOMECH, V43, P1976, DOI 10.1016/j.jbiomech.2010.03.008; Petuskey K, 2007, GAIT POSTURE, V25, P573, DOI 10.1016/j.gaitpost.2006.06.006; Santos GL, 2018, ARCH PHYS MED REHAB, V99, P501, DOI 10.1016/j.apmr.2017.08.479; Schneiberg S, 2002, EXP BRAIN RES, V146, P142, DOI 10.1007/s00221-002-1156-z; Simon-Martinez C, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00482; VANDONKELAAR P, 1991, ACTA PSYCHOL, V77, P1; Woltring HJ, 1996, 3 DIMENSIONAL ANAL H; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Yan JH, 2000, J MOTOR BEHAV, V32, P121, DOI 10.1080/00222890009601365	38	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198524	10.1371/journal.pone.0198524	http://dx.doi.org/10.1371/journal.pone.0198524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874278	Green Submitted, Green Published, gold			2022-12-26	WOS:000434369400051
J	Lin, SY; Tu, HP; Chen, TC; Shen, MC; Chiu, YW; Chen, YH; Lu, PL				Lin, Shang-Yi; Tu, Hung-Pin; Chen, Tun-Chieh; Shen, Mei-Chiou; Chiu, Yi-Wen; Chen, Yen-Hsu; Lu, Po-Liang			Association of bacterial genotypes and epidemiological features with treatment failure in hemodialysis patients with methicillin-resistant Staphylococcus aureus bacteremia	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; UNITED-STATES; COMMUNITY; INFECTIONS; VANCOMYCIN; STRAINS; MRSA; EMERGENCE; VIRULENCE; OUTCOMES	Objectives Methicillin-resistant Staphylococcus aureus (MRSA) infections in the hemodialysis (HD) population are epidemiologically classified as healthcare-associated infections. The data about the clinical impact and bacterial characteristics of hospital-onset (HO)- and community-onset (CO)-MRSA in HD patients are scarce. The current study analyzed the difference in the clinical and molecular characteristics of HO-MRSA and CO-MRSA. Methods We performed a retrospective review and molecular analysis of clinical isolates from 106 HD patients with MRSA bacteremia from 2009 to 2014. CA genotypes were defined as isolates carrying the SCCmec type IV or V, and HA genotypes were defined as isolates harboring SCCmec type I, II, or III. Results CO-MRSA infections occurred in 76 patients, and 30 patients had HO-MRSA infections. There was no significant difference in the treatment failure rates between patients with CO-MRSA infections and those with HO-MRSA infections. CA genotypes were associated with less treatment failure (odds ratio [OR]: 0.18; 95% confidence interval [95% CI], 0.07-0.49; p = 0.001). For isolates with a vancomycin minimum inhibitory concentration (MIC) < 1.5 mg/L, the multivariate analysis revealed that HA genotypes and cuffed tunneled catheter use were associated with treatment failure. For isolates with a vancomycin MIC >1.5 mg/L, the only risk factor for treatment failure was a higher Pitt score (OR: 1.76; 95% CI, 1.02- 3.05; p = 0.043). Conclusion CA genotypes, but not the epidemiological classification of CO-MRSA, impacted the clinical outcome of MRSA bacteremia in the HD population.	[Lin, Shang-Yi; Chen, Tun-Chieh; Chen, Yen-Hsu; Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Lin, Shang-Yi; Chen, Yen-Hsu; Lu, Po-Liang] Kaohsiung Med Univ, Coll Med, Sepsis Res Ctr, Grad Inst Med,Sch Med, Kaohsiung, Taiwan; [Tu, Hung-Pin] Kaohsiung Med Univ, Coll Med, Dept Publ Hlth & Environm Med, Kaohsiung, Taiwan; [Chen, Tun-Chieh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Kaohsiung, Taiwan; [Shen, Mei-Chiou] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pharm, Kaohsiung, Taiwan; [Chiu, Yi-Wen] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Lu, PL (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan.; Lu, PL (corresponding author), Kaohsiung Med Univ, Coll Med, Sepsis Res Ctr, Grad Inst Med,Sch Med, Kaohsiung, Taiwan.; Lu, PL (corresponding author), Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan.	d830166@gmail.com	Chen, Tun-Chieh/J-2877-2013; Lu, Po-Liang/D-4499-2009	Chen, Tun-Chieh/0000-0002-9258-0692; Lu, Po-Liang/0000-0002-7423-6783; Tu, Hung-Pin/0000-0003-1044-2673; Chen, Yen-hsu/0000-0002-8667-4844	Kaohsiung Medical University Hospital, Taiwan; Center for Infectious Disease and Cancer Research, Kaohsiung Medical University [KMUTP105]; Kaohsiung Medical University Research Foundation [KMUOR105, KMUH106-6M16]	Kaohsiung Medical University Hospital, Taiwan; Center for Infectious Disease and Cancer Research, Kaohsiung Medical University; Kaohsiung Medical University Research Foundation	This work was supported by Kaohsiung Medical University Hospital, Taiwan and by a grant from the Center for Infectious Disease and Cancer Research, Kaohsiung Medical University (KMUTP105) and a grant from Kaohsiung Medical University Research Foundation (KMUOR105 and KMUH106-6M16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown M, 2011, CLIN INFECT DIS, V53, P164, DOI 10.1093/cid/cir322; Centres for Disease Control and Prevention, 2014, ACT BACT COR SURV RE; Chen SY, 2012, CLIN INFECT DIS, V55, P1329, DOI 10.1093/cid/cis717; Chua K, 2011, CLIN INFECT DIS, V52, P99, DOI 10.1093/cid/ciq067; Chuang YY, 2013, LANCET INFECT DIS, V13, P698, DOI 10.1016/S1473-3099(13)70136-1; Clinical and Laboratory Standards Institute (CLSI), 2010, M100S20 CLSI; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; Dilworth TJ, 2014, ANTIMICROB AGENTS CH, V58, P102, DOI 10.1128/AAC.01204-13; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Gilot P, 2002, J CLIN MICROBIOL, V40, P4060, DOI 10.1128/JCM.40.11.4060-4067.2002; Holzknecht BJ, 2010, J CLIN MICROBIOL, V48, P4221, DOI 10.1128/JCM.01382-10; Hota B, 2011, CLIN INFECT DIS, V53, P757, DOI 10.1093/cid/cir472; Klevens RM, 2006, EMERG INFECT DIS, V12, P1991; Langley G, 2015, EMERG INFECT DIS, V21, P1520, DOI 10.3201/eid2109.141333; Lee SC, 2013, DIAGN MICR INFEC DIS, V76, P86, DOI 10.1016/j.diagmicrobio.2013.01.017; Lin CC, 2009, INFECT CONT HOSP EP, V30, P89, DOI 10.1086/593122; Lin SY, 2014, INT J ANTIMICROB AG, V43, P384, DOI 10.1016/j.ijantimicag.2014.01.002; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Lu PL, 2008, J CHEMOTHERAPY, V20, P690, DOI 10.1179/joc.2008.20.6.690; McNicholas S, 2011, J CLIN MICROBIOL, V49, P4349, DOI 10.1128/JCM.05017-11; Millar BC, 2007, J HOSP INFECT, V67, P109, DOI 10.1016/j.jhin.2007.06.003; Nguyen DB, 2013, CLIN INFECT DIS, V57, P1393, DOI 10.1093/cid/cit546; Nissenson AR, 2005, AM J KIDNEY DIS, V46, P301, DOI 10.1053/j.ajkd.2005.04.019; Park SH, 2009, INFECT CONT HOSP EP, V30, P146, DOI 10.1086/593953; Popovich KJ, 2008, CLIN INFECT DIS, V46, P787, DOI 10.1086/528716; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Song JH, 2011, J ANTIMICROB CHEMOTH, V66, P1061, DOI 10.1093/jac/dkr024; Talan DA, 2011, CLIN INFECT DIS, V53, P144, DOI 10.1093/cid/cir308; Tsao FY, 2015, CLIN MICROBIOL INFEC, V21, P451, DOI 10.1016/j.cmi.2014.12.019; Walsh TR, 2001, J CLIN MICROBIOL, V39, P2439, DOI 10.1128/JCM.39.7.2439-2444.2001; Wu HS, 2013, J MICROBIOL IMMUNOL, V46, P96, DOI 10.1016/j.jmii.2012.02.004	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198486	10.1371/journal.pone.0198486	http://dx.doi.org/10.1371/journal.pone.0198486			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864149	gold, Green Published, Green Submitted			2022-12-26	WOS:000434097100036
J	English, EJ; Mahn, SA; Marchese, A				English, Elizabeth J.; Mahn, Sarah A.; Marchese, Adriano			Endocytosis is required for CXC chemokine receptor type 4 (CXCR4)-mediated Akt activation and antiapoptotic signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C-X-C chemokine receptor type 4 (CXCR-4); chemokine; G protein-coupled receptor (GPCR); Akt PKB; FOXO; apoptosis; anoikis; endosome; endocytosis	ARRESTIN-2 INTERACTS; BONE METASTASIS; CELL-SURVIVAL; LIGASE AIP4; ENDOSOMES; CANCER; APPL1; TRANSDUCTION; COMPLEX; UBIQUITINATION	Signaling activated by binding of the CXC motif chemokine ligand 12 (CXCL12) to its cognate G protein-coupled receptor (GPCR), chemokine CXC motif receptor 4 (CXCR4), is linked to metastatic disease. However, the mechanisms governing CXCR4 signaling remain poorly understood. Here, we show that endocytosis and early endosome antigen 1 (EEA1), which is part of the endosome fusion machinery, are required for CXCL12-mediated AKT Ser/Thr kinase (Akt) signaling selective for certain Akt substrates. Pharmacological inhibition of endocytosis partially attenuated CXCL12-induced phosphorylation of Akt, but not phosphorylation of ERK-1/2. Similarly, phosphorylation of Akt, but not ERK-1/2, stimulated by CXCL13, the cognate ligand for the chemokine receptor CXCR5, was also attenuated by inhibited endocytosis. Furthermore, siRNA-mediated depletion of the Rab5-effector EEA1, but not of adaptor protein, phosphotyrosine-interacting with PH domain and leucine zipper 1 (APPL1), partially attenuated Akt, but not ERK-1/2, phosphorylation promoted by CXCR4. Attenuation of Akt phosphorylation through inhibition of endocytosis or EEA1 depletion was associated with reduced signaling to Akt substrate forkhead box O1/3a but not the Akt substrates TSC complex subunit 2 or glycogen synthase kinase 3. This suggested that endocytosis and endosomes govern discrete aspects of CXCR4- or CXCR5-mediated Akt signaling. Consistent with this hypothesis, depletion of EEA1 reduced the ability of CXCL12 to attenuate apoptosis in suspended, but not adherent, HeLa cells. Our results suggest a mechanism whereby compartmentalized chemokine-mediated Akt signaling from endosomes suppresses the cancer-related process known as anoikis. Targeting this signaling pathway may help inhibit metastatic cancer involving receptors such as CXCR4.	[English, Elizabeth J.; Mahn, Sarah A.; Marchese, Adriano] Med Coll Wisconsin, Dept Biochem, TBRC C3850,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Marchese, A (corresponding author), Med Coll Wisconsin, Dept Biochem, TBRC C3850,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	amarchese@mcw.edu		Wedemeyer, Sarah/0000-0003-4787-4672	National Institutes of Health [GM106727, GM122889]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106727, R01GM122889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM106727 and GM122889 (to A. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alanko J, 2015, NAT CELL BIOL, V17, P1412, DOI 10.1038/ncb3250; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Drury LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012895; Ebner M, 2017, J CELL BIOL, V216, P343, DOI 10.1083/jcb.201610060; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Garcia-Regalado A, 2008, MOL BIOL CELL, V19, P4188, DOI 10.1091/mbc.E07-10-1089; Godbole A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00357-2; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jean-Alphonse FG, 2017, NAT CHEM BIOL, V13, P259, DOI [10.1038/nchembio.2267, 10.1038/NCHEMBIO.2267]; Keppler SJ, 2015, IMMUNITY, V43, P660, DOI 10.1016/j.immuni.2015.09.004; Kochetkova M, 2009, CELL DEATH DIFFER, V16, P664, DOI 10.1038/cdd.2008.190; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Lacalle RA, 2017, INT REV CEL MOL BIO, V331, P181, DOI 10.1016/bs.ircmb.2016.09.011; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Malik R, 2012, J BIOL CHEM, V287, P9013, DOI 10.1074/jbc.M111.336792; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nazarewicz Rafal Robert, 2011, J Biol Chem, V286, P2886, DOI 10.1074/jbc.M110.141499; Nechamen CA, 2007, MOL CELL ENDOCRINOL, V260, P93, DOI 10.1016/j.mce.2006.08.014; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Schmid SL, 2017, J CELL BIOL, V216, P2623, DOI 10.1083/jcb.201705017; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Slagsvold T, 2006, EMBO J, V25, P3738, DOI 10.1038/sj.emboj.7601267; Smith TH, 2017, J BIOL CHEM, V292, P13867, DOI 10.1074/jbc.M117.782359; Thomas RM, 2011, ENDOCRINOLOGY, V152, P1691, DOI 10.1210/en.2010-1353; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Varsano T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049227; Verma R, 2015, J BIOL CHEM, V290, P6810, DOI 10.1074/jbc.M114.606699; Villasenor R, 2015, ELIFE, V4, DOI 10.7554/eLife.06156; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	48	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11470	11480		10.1074/jbc.RA118.001872	http://dx.doi.org/10.1074/jbc.RA118.001872			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29899118	hybrid, Green Published			2022-12-26	WOS:000439449700017
J	Noguchi, K; Dincman, TA; Dalton, AC; Howley, BV; McCall, BJ; Mohanty, BK; Howe, PH				Noguchi, Ken; Dincman, Toros A.; Dalton, Annamarie C.; Howley, Breege V.; McCall, Buckley J.; Mohanty, Bidyut K.; Howe, Philip H.			Interleukin-like EMT inducer (ILEI) promotes melanoma invasiveness and is transcriptionally up-regulated by upstream stimulatory factor-1 (USF-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial-mesenchymal transition (EMT); melanoma; transcription factor; mRNA; cytokine; FAM3C; ILEI; interleukin-like EMT inducer; phenotype switching; USF-1	EPITHELIAL-MESENCHYMAL TRANSITION; MAPK PATHWAY INHIBITORS; CONFERS RESISTANCE; EXPRESSION; KINASE; MITF; BRAF; MYC; PROGRESSION; BINDING	Interleukin-like EMT inducer (ILEI, FAM3C) is a secreted factor that contributes to the epithelial-to-mesenchymal transition (EMT), a cell-biological process that confers metastatic properties to a tumor cell. However, very little is known about how ILEI is regulated. Here we demonstrate that ILEI is an in vivo regulator of melanoma invasiveness and is transcriptionally up-regulated by the upstream stimulatory factor-1 (USF-1), an E-box-binding, basic-helix-loop-helix family transcription factor. shRNA-mediated knockdown of ILEI in melanoma cell lines attenuated lung colonization but not primary tumor formation. We also identified the mechanism underlying ILEI transcriptional regulation, which was through a direct interaction of USF-1 with the ILEI promoter. Of note, stimulation of endogenous USF-1 by UV-mediated activation increased ILEI expression, whereas shRNA-mediated USF-1 knockdown decreased ILEI gene transcription. Finally, we report that knocking down USF-1 decreases tumor cell migration. In summary, our work reveals that ILEI contributes to melanoma cell invasiveness in vivo without affecting primary tumor growth and is transcriptionally up-regulated by USF-1.	[Noguchi, Ken; Dincman, Toros A.; Dalton, Annamarie C.; Howley, Breege V.; McCall, Buckley J.; Mohanty, Bidyut K.; Howe, Philip H.] Med Univ South Carolina, Coll Med, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Dincman, Toros A.] Med Univ South Carolina, Div Hematol & Oncol, Charleston, SC 29425 USA; [Howe, Philip H.] Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Howe, PH (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave,MSC 509,Rm 501, Charleston, SC 29425 USA.	howep@musc.edu	McCall, Buckley/AAB-3828-2021	McCall, Buckley/0000-0002-0460-1124; Howe, Philip/0000-0002-1358-1313; Dincman, Toros/0000-0002-4449-0510	National Institutes of Health NCI [F30CA203269, T32CA193201, R01CA154663]; U.S. Department of Defense (DOD) [BC170301]; NATIONAL CANCER INSTITUTE [F30CA203269, T32CA193201, R01CA154663] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Defense (DOD)(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health NCI Grants F30CA203269, T32CA193201, and R01CA154663 and U.S. Department of Defense (DOD) Grant BC170301. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; BENDALL AJ, 1994, NUCLEIC ACIDS RES, V22, P2801, DOI 10.1093/nar/22.14.2801; Caramel J, 2013, CANCER CELL, V24, P466, DOI 10.1016/j.ccr.2013.08.018; Carey Michael F, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5279; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Cormier Catherine Y., 2011, Journal of Structural and Functional Genomics, V12, P55, DOI 10.1007/s10969-011-9100-8; Cormier CY, 2010, NUCLEIC ACIDS RES, V38, pD743, DOI 10.1093/nar/gkp999; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; Corre S, 2009, J BIOL CHEM, V284, P18851, DOI 10.1074/jbc.M808605200; Csiszar A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0433-7; Denecker G, 2014, CELL DEATH DIFFER, V21, P1250, DOI 10.1038/cdd.2014.44; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Gao ZH, 2014, HISTOPATHOLOGY, V65, P527, DOI 10.1111/his.12435; Goodall J, 2004, MOL CELL BIOL, V24, P2923, DOI 10.1128/MCB.24.7.2923-2931.2004; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hock TD, 2004, BIOCHEM J, V383, P209, DOI 10.1042/BJ20040794; Hussey GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052624; Hussey GS, 2011, MOL CELL, V41, P419, DOI 10.1016/j.molcel.2011.02.003; Imagawa S, 2006, ARTERIOSCL THROM VAS, V26, P2407, DOI 10.1161/01.ATV.0000240318.61359.e3; Jansson AM, 2017, J BIOL CHEM, V292, P15501, DOI 10.1074/jbc.M117.782904; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Kim M, 2015, BRIT J HAEMATOL, V168, P583, DOI 10.1111/bjh.13164; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Kral M, 2017, FEBS J, V284, P3484, DOI 10.1111/febs.14207; Lahsnig C, 2009, ONCOGENE, V28, P638, DOI 10.1038/onc.2008.418; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Laurila PP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0015; LEFRANCOISMARTINEZ AM, 1995, J BIOL CHEM, V270, P2640, DOI 10.1074/jbc.270.6.2640; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Noguchi K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177830; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Ramsdale R, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1111; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Richard G, 2016, EMBO MOL MED, V8, P1143, DOI 10.15252/emmm.201505971; Riesenberg S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9755; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Sheridan C, 2008, J BIOL CHEM, V283, P22128, DOI 10.1074/jbc.M800271200; Smith MP, 2014, CANCER DISCOV, V4, P1214, DOI 10.1158/2159-8290.CD-13-1007; Song Q, 2014, TUMOR BIOL, V35, P1377, DOI 10.1007/s13277-013-1188-y; Steinberg SM, 2014, CANCER IMMUNOL RES, V2, P1044, DOI 10.1158/2326-6066.CIR-14-0074; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Vo BT, 2016, CANCER CELL, V29, P5, DOI 10.1016/j.ccell.2015.12.003; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wellbrock C, 2005, J CELL BIOL, V170, P703, DOI 10.1083/jcb.200505059; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Wellbrock C, 2015, PIGM CELL MELANOMA R, V28, P390, DOI 10.1111/pcmr.12370; Wu SL, 2010, HUM MOL GENET, V19, P597, DOI 10.1093/hmg/ddp526; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zhao X, 2018, CELL BIOCHEM FUNCT, V36, P46, DOI 10.1002/cbf.3316; Zhu YH, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0424-8	61	9	11	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11401	11414		10.1074/jbc.RA118.003616	http://dx.doi.org/10.1074/jbc.RA118.003616			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29871931	hybrid, Green Published			2022-12-26	WOS:000439449700011
J	Li, X; Naser, SA; Khaled, A; Hu, HY; Li, XM				Li, Xin; Naser, Saleh A.; Khaled, Annette; Hu, Haiyan; Li, Xiaoman			When old metagenomic data meet newly sequenced genomes, a case study	PLOS ONE			English	Article							PHYLOGENETIC CLASSIFICATION; ULCERATIVE-COLITIS; BACTERIA; BACTEROIDES; MICROBIOTA; MUCOSA; READS	Dozens of computational methods are developed to identify species present in a metagenomic dataset. Many of these computational methods depend on available sequenced microbial species, which are still far from being representative. To see how newly sequenced genomes affect the analysis results, we re-analyzed a shotgun metagenomic dataset composed of twelve colitis free metagenomic samples and ten colitis-related metagenomic samples. Unexpectedly, we identified at least two new phyla that may relate to colitis development in patients, together with the phylum identified previously. Compared with the previously identified phylum that differed between the two types of samples, the differences associated with the two new phyla are statistically more significant. Moreover, the abundance of the two new phyla correlates more with the severity of colitis. Surprisingly, even by repeating the analyses implemented in the previous study, we found that at least one main conclusion in the previous study is not supported. Our study indicates the importance of re-analysis of the generated metagenomic datasets and the necessity of considering multiple updated tools in metagenomic studies. It also sheds light on the limitations of the popular tools used currently and the importance to infer the presence of taxa without relying upon available sequenced genomes.	[Li, Xin; Hu, Haiyan] Univ Cent Florida, Dept Comp Sci, Orlando, FL 32816 USA; [Naser, Saleh A.; Khaled, Annette; Li, Xiaoman] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Hu, HY (corresponding author), Univ Cent Florida, Dept Comp Sci, Orlando, FL 32816 USA.; Li, XM (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	haihu@cs.ucf.edu; xiaoman@mail.ucf.edu		Khaled, Annette/0000-0001-6331-9623	National Science Foundation [1356524, 1149955, 1661414]; National Institutes of Health [R15GM123407]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM123407] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation [1356524, 1149955, 1661414] to Haiyan Hu (https://www.nsf.gov/div/index.jsp?div=DBI); and the National Institutes of Health [R15GM123407] to Xiaoman Li (https://www.nigms.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alneberg J, 2014, NAT METHODS, V11, P1144, DOI [10.1038/NMETH.3103, 10.1038/nmeth.3103]; Azuma Y, 2006, DNA RES, V13, P15, DOI 10.1093/dnares/dsi027; BARTLETT JG, 1977, J INFECT DIS, V136, P701, DOI 10.1093/infdis/136.5.701; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Campieri M, 2001, GUT, V48, P132, DOI 10.1136/gut.48.1.132; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; Du ZY, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0080-2; Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Franzosa EA, 2015, P NATL ACAD SCI USA, V112, pE2930, DOI 10.1073/pnas.1423854112; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jovel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00459; Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116; Krause L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/nar/gkn038; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Leung HCM, 2011, BIOINFORMATICS, V27, P1489, DOI 10.1093/bioinformatics/btr186; Manichanh C, 2008, NUCLEIC ACIDS RES, V36, P5180, DOI 10.1093/nar/gkn496; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nagy-Szakal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056685; Nakagawa T, 2004, APPL ENVIRON MICROB, V70, P393, DOI 10.1128/AEM.70.1.393-403.2004; Nakanishi Y, 2015, MUCOSAL IMMUNOL, V8, P152, DOI 10.1038/mi.2014.53; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Rooks MG, 2014, ISME J, V8, P1403, DOI 10.1038/ismej.2014.3; Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vigsnaes LK, 2012, BENEF MICROBES, V3, P287, DOI 10.3920/BM2012.0018; Wang Y, 2016, OMICS, V20, P470, DOI 10.1089/omi.2016.0081; Wang Y, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0473-8; Wang YW, 2016, SCRIPTA MATER, V113, P10, DOI 10.1016/j.scriptamat.2015.09.038; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Xu KH, 2017, MED SCI MONITOR, V23, DOI 10.12659/MSM.904220; Ye JX, 2008, INFLAMM BOWEL DIS, V14, P1041, DOI 10.1002/ibd.20442; Zinner SH, 1999, CLIN INFECT DIS, V29, P490, DOI 10.1086/598620	56	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198773	10.1371/journal.pone.0198773	http://dx.doi.org/10.1371/journal.pone.0198773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902201	gold, Green Published, Green Submitted			2022-12-26	WOS:000435424900040
J	Yu, JY; Li, Y; Wang, T; Zhong, X				Yu, Jiayao; Li, Yi; Wang, Tian; Zhong, Xiang			Modification of N-6-methyladenosine RNA methylation on heat shock protein expression	PLOS ONE			English	Article							M(6)A RNA; GENE-EXPRESSION; NUCLEAR-RNA; HEAT-SHOCK-PROTEIN-70; BINDING; STEM	This study was conducted to investigate effect of N-6-methyladenosine (m(6)A) RNA methylation on Heat shock proteins (HSPs) and dissect the profile of HSP RNA methylation. The results showed that m(6)A methyltransferases METTL3 mRNA was decreased in responses to heat shock stress in HepG2 cells, but m(6)A-specific binding protein YTHDF2 mRNA was upregulated in a manner similar to HSP70 induction. Immunofluorescence staining showed that the majority of YTHDF2 was present in the cytosol, however, nearly all YTHDF2 translocated from the cytosol into the nucleus after heat shock. METTL3 knockdown significantly changed HSP70, HSP60, and HSP27mRNA expression in HepG2 cells using siRNA, however, mRNA lifetime was not impacted. Silence of YTHDF2 using siRNA did not change expression of HSP70, but significantly increased HSP90, HSP60, and HSPB1 mRNA expression. In addition, m(6)A-seq revealed that HSP m(6)A methylation peaks are mainly enriched on exons and around stop codons, and shows a unique distribution profile in the 5'UTR and 3'UTR. Knockdown of METTL3 changed the methylation patterns of HSPs transcript. In conclusion, m(6)A RNA methylation regulates HSP gene expression. Differential expression of HSPs modulated by m(6)A may depend on the m(6)A site and abundance of the target gene. This finding provides insights into new regulatory mechanisms of HSPs in normal and stress situations.	[Yu, Jiayao; Li, Yi; Wang, Tian; Zhong, Xiang] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhong, X (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	zhongxiang@njau.edu.cn			National Natural Science Foundation of China [31472129]; Natural Science Foundation of Jiangsu province [BK20161446]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (31472129) and Natural Science Foundation of Jiangsu province (BK20161446).; This study was supported by a grant from National Natural Science Foundation of China (no. 31472129) and Natural Science Foundation of Jiangsu province (no. BK20161446). We thank Vanessa Leone, Ph.D. for editing the manuscript.	Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Fritah S, 2009, MOL BIOL CELL, V20, P4976, DOI 10.1091/mbc.E09-04-0295; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Marinova Z, 2011, NEUROPHARMACOLOGY, V60, P1109, DOI 10.1016/j.neuropharm.2010.09.022; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Miozzo F, 2015, J MOL BIOL, V427, P3793, DOI 10.1016/j.jmb.2015.10.007; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Smith ST, 2004, NAT CELL BIOL, V6, P162, DOI 10.1038/ncb1088; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, RNA BIOL, V11, P669, DOI 10.4161/rna.28829; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Xiang Y, 2017, NATURE, V543, P573, DOI 10.1038/nature21671; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Zhang CX, 2017, NATURE, V549, P273, DOI 10.1038/nature23883; Zhao BXS, 2017, NATURE, V542, P475, DOI 10.1038/nature21355; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhong X, 2012, CELL STRESS CHAPERON, V17, P495, DOI 10.1007/s12192-012-0326-6; Zhong XA, 2010, CELL STRESS CHAPERON, V15, P335, DOI 10.1007/s12192-009-0148-3; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377	29	31	35	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198604	10.1371/journal.pone.0198604	http://dx.doi.org/10.1371/journal.pone.0198604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902206	gold, Green Submitted, Green Published			2022-12-26	WOS:000435424900032
J	Paprocki, H; Moreira-Silva, L				Paprocki, Henrique; Moreira-Silva, Larissa			New species of Plectromacronema Ulmer 1906 (Trichoptera: Hydropsychidae) from Brazil, with association of immature stages and aspects of its biology	PLOS ONE			English	Article								Plectromacronema Ulmer 1906 is a Neotropical genus recorded sparsely from South of Mexico to the North of Argentina. The genus is placed within the Macronematinae sub-family, members of which are relatively large among the Trichoptera and bears conspicuous wing ornamentations. There are only two species recorded for Brazil, Plectromacronema comptum Ulmer 1906 and Plectromacronema subfuscum (Banks 1920). Plectromacronema lisae Flint 1983 recorded for Mexico and Costa Rica is the only species in the genus with immature stages described. Immature stages species level identification is required for water quality biomonitoring and most of the Trichoptera taxonomy is based only on adult male genitalia. In this paper, we propose a new species, Plectromacronema solaris sp.nov., larva, pupa, and adult. Aspects of the life history of the new species are also discussed. This record also represents a new genus record for the state of Minas Gerais, extending the knowledge on the diversity, distribution, biogeography, and biology of this remarkable genus.	[Paprocki, Henrique; Moreira-Silva, Larissa] Pontificia Univ Catolica Minas Gerais, Belo Horizonte, MG, Brazil	Pontificia Universidade Catolica de Minas Gerais	Paprocki, H (corresponding author), Pontificia Univ Catolica Minas Gerais, Belo Horizonte, MG, Brazil.	paprocki@pucminas.br	Paprocki, Henrique/G-5781-2015	Paprocki, Henrique/0000-0002-7535-1062; Moreira-Silva, Larissa/0000-0002-4649-3416	Fundo de Incentivo a Pesquisa PUC Minas [FIP 2017/970-S2]	Fundo de Incentivo a Pesquisa PUC Minas	This work was supported by Fundo de Incentivo a Pesquisa PUC Minas (FIP 2017/970-S2) to Henrique Paprocki. (https://www.pucminas.br/pesquisa/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks N., 1920, Bulletin of the Museum of Comparative Zoology, V64; Blahnik R.J., 2007, P 12 INT S TRICH, P9; Bueno-Soria Joaquin, 2011, P345; Buss DF, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-014-4132-8; Callisto M, 2016, ECOLOGY CONSERVATION, P87, DOI DOI 10.1007/978-3-319-29808-5_5; Fischer F.C.J., 1963, TRICHOPTERORUM CATAL, V4; Flint Jr OS, 1999, CATALOG NEOTROPICAL; Flint O.S., 1987, SMITHSONIAN CONTRIBU, V450, P1; Flint O.S. Jr, 1978, Amazoniana, V6, P373; FLINT O S JR, 1983, Proceedings of the Biological Society of Washington, V96, P225; FLINT OLIVER S., 1967, PROC U S NAT MUS, V123, P1; Flint Oliver S. Jr., 1991, Acta Amazonica, V21, P63; Flint OS., 1974, SMITH CONT ZOOL, V14, P1; Geraci Christy J., 2005, P131; Holzenthal RW, 2017, ZOOKEYS, P1, DOI 10.3897/zookeys.654.9516; Holzenthal RW, 1988, BRENESIA, V29, P51; Morse JC., 2021, TRICHOPTERA WORLD CH; MOSELY MARTIN E., 1931, ENTOMOLOGIST [LONDON], V64, P169; Nava s L., 1924, Annales de la Societe Scientifique de Bruxelles C R, V43, P249; Otah J., 2012, Annales Historico-Naturales Musei Nationalis Hungarici, V104, P215; Paprocki Henrique, 2004, Biota Neotrop., V4, P1, DOI 10.1590/S1676-06032004000100008; Paprocki Henrique, 2014, Biodivers Data J, pe1557, DOI 10.3897/BDJ.2.e1557; Ulmer G, 1913, DTSCH ENTOMOLOGISCHE, V1913, P383; Ulmer G., 1907, MONOGRAPHIE MACRONEM, P1; Ulmer G., 1906, NOTES LEYDEN MUSEUM, V28, P1; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; ZHANG ZQ, 2007, ZOOTAXA, V1668, P639	27	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197573	10.1371/journal.pone.0197573	http://dx.doi.org/10.1371/journal.pone.0197573			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897936	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700020
J	Yue, WZ; Sun, CC; Shi, P; Engel, A; Wang, YS; He, WH				Yue, Wei-zhong; Sun, Cui-ci; Shi, Ping; Engel, Anja; Wang, You-shao; He, Wei-hong			Effect of temperature on the accumulation of marine biogenic gels in the surface microlayer near the outlet of nuclear power plants and adjacent areas in the Daya Bay, China	PLOS ONE			English	Article							TRANSPARENT EXOPOLYMER PARTICLES; DISSOLVED ORGANIC-MATTER; SEA-SURFACE; WATER-QUALITY; POTENTIAL IMPLICATIONS; SIZE DISTRIBUTION; AMINO-ACIDS; UV-B; PHYTOPLANKTON; OCEAN	The surface microlayer (SML) in marine systems is often characterized by an enrichment of biogenic, gel-like particles, such as the polysaccharide-containing transparent exopolymer particles (TEP) and the protein-containing Coomassie stainable particles (CSP). This study investigated the distribution of TEP and CSP, in the SML and underlying water, as well as their bio-physical controlling factors in Daya Bay, an area impacted by warm discharge from two Nuclear power plants (Npp's) and aquaculture during a research cruise in July 2014. The SML had higher proportions of cyanobacteria and of pico-size Chl a contrast to the underlayer water, particularly at the nearest outlet station characterized by higher temperature. Diatoms, dinoflagellates and chlorophyll a were depleted in the SML. Both CSP and TEP abundance and total area were enriched in the SML relative to the underlying water, with enrichment factors (EFs) of 1.5-3.4 for CSP numbers and 1.32-3.2 for TEP numbers. Although TEP and CSP showed highest concentration in the region where high productivity and high nutrient concertation were observed, EFs of gels and of dissolved organic carbon (DOC) and dissolved acidic polysaccharide (> 1 kDa), exhibited higher values near the outlet of the Npp's than in the adjacent waters. The positive relation between EF's of gels and temperature and the enrichment of cyanobacteria in the SML may be indicative of future conditions in a warmer ocean, suggesting potential effects on adjusting phytoplankton community, biogenic element cycling and air-sea exchange processes.	[Yue, Wei-zhong; Sun, Cui-ci; Shi, Ping; Wang, You-shao] Chinese Acad Sci, South China Sea Inst Oceanol, State Key Lab Trop Oceanog, Guangzhou, Guangdong, Peoples R China; [Sun, Cui-ci; Wang, You-shao] Chinese Acad Sci, Daya Bay Marine Biol Res Stn, Shenzhen, Peoples R China; [Engel, Anja] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [He, Wei-hong] Chinese Acad Sci, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Sun, CC (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, State Key Lab Trop Oceanog, Guangzhou, Guangdong, Peoples R China.; Sun, CC (corresponding author), Chinese Acad Sci, Daya Bay Marine Biol Res Stn, Shenzhen, Peoples R China.	scuici@scsio.ac.cn		Engel, Anja/0000-0002-1042-1955	Special Fund for Public Welfare Research and Capacity Building in Guangdong Province [2016A020222018]; National Natural Science Foundation of China [CN41106106, 41430966]; National Key Research and Development Plan [2017FY100700]; China Scholarship Council [201408440016]	Special Fund for Public Welfare Research and Capacity Building in Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Plan; China Scholarship Council(China Scholarship Council)	This study was supported by Special Fund for Public Welfare Research and Capacity Building in Guangdong Province (2016A020222018), National Natural Science Foundation of China (CN41106106 and No. 41430966), the National Key Research and Development Plan (No. 2017FY100700) and China Scholarship Council 201408440016.	Aller JY, 2017, ATMOS ENVIRON, V154, P331, DOI 10.1016/j.atmosenv.2017.01.053; Bar-Zeev E, 2011, MAR ECOL PROG SER, V431, P107, DOI 10.3354/meps09110; BEAVEN GH, 1952, ADV PROTEIN CHEM, V7, P319, DOI 10.1016/S0065-3233(08)60022-4; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Berman-Frank I, 2016, BIOGEOSCIENCES, V13, P3793, DOI 10.5194/bg-13-3793-2016; Biermann A, 2014, J PLANKTON RES, V36, P658, DOI 10.1093/plankt/fbu005; Bopp L, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023653; Borchard C, 2012, BIOGEOSCIENCES, V9, P3405, DOI 10.5194/bg-9-3405-2012; Burd AB, 2009, ANNU REV MAR SCI, V1, P65, DOI 10.1146/annurev.marine.010908.163904; Campbell D, 1998, P NATL ACAD SCI USA, V95, P364, DOI 10.1073/pnas.95.1.364; Capone DG, 1998, MAR ECOL PROG SER, V172, P281, DOI 10.3354/meps172281; CARLUCCI AF, 1992, J GEOPHYS RES-OCEANS, V97, P5271, DOI 10.1029/91JC02614; CARPENTER EJ, 1977, LIMNOL OCEANOGR, V22, P60, DOI 10.4319/lo.1977.22.1.0060; Chen CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118300; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; Cisternas-Novoa C, 2015, MAR CHEM, V175, P56, DOI 10.1016/j.marchem.2015.03.009; Claquin P, 2008, AQUAT MICROB ECOL, V51, P1, DOI 10.3354/ame01187; Cunliffe M, 2013, PROG OCEANOGR, V109, P104, DOI 10.1016/j.pocean.2012.08.004; Cunliffe M, 2011, FEMS MICROBIOL REV, V35, P233, DOI 10.1111/j.1574-6976.2010.00246.x; Cunliffe M, 2009, ISME J, V3, P1001, DOI 10.1038/ismej.2009.69; Ding YX, 2008, MAR CHEM, V112, P11, DOI 10.1016/j.marchem.2008.05.003; Engel A, 2015, BIOGEOSCIENCES, V12, P5647, DOI 10.5194/bg-12-5647-2015; Engel A, 2004, NATURE, V428, P929, DOI 10.1038/nature02453; Engel A, 2002, ESTUAR COAST SHELF S, V55, P729, DOI 10.1006/ecss.2001.0927; Engel A., 2009, PRACTICAL GUIDELINES, V1st, DOI [10.1201/9781420073072, DOI 10.1201/9781420073072]; Engel A, 2016, BIOGEOSCIENCES, V13, P989, DOI 10.5194/bg-13-989-2016; Engel A, 2011, J PLANKTON RES, V33, P357, DOI 10.1093/plankt/fbq122; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Fukao T, 2012, J APPL PHYCOL, V24, P181, DOI 10.1007/s10811-011-9666-3; Galgani L, 2014, J GEOPHYS RES-OCEANS, V119, P7911, DOI 10.1002/2014JC010188; Gao Q, 2012, OCEAN SCI, V8, P401, DOI 10.5194/os-8-401-2012; GESAMP, 1995, REP STUD; Grossart HP, 1997, LIMNOL OCEANOGR, V42, P1651, DOI 10.4319/lo.1997.42.8.1651; Haidacher D, 1996, P NATL ACAD SCI USA, V93, P2290, DOI 10.1073/pnas.93.6.2290; HARVEY GW, 1972, LIMNOL OCEANOGR, V17, P156, DOI 10.4319/lo.1972.17.1.0156; HERBLAND A, 1985, DEEP-SEA RES, V32, P819, DOI 10.1016/0198-0149(85)90118-9; HSJD,RPT, 1972, PRACTICAL HDB SEAWAT; Jackson GA, 1998, ENVIRON SCI TECHNOL, V32, P2805, DOI 10.1021/es980251w; JIANG Q, 1991, ENVIRON SCI TECHNOL, V25, P2031, DOI 10.1021/es00024a007; Kamykowski D, 2005, DEEP-SEA RES PT I, V52, P1719, DOI 10.1016/j.dsr.2005.04.007; Kuznetsova M, 2004, LIMNOL OCEANOGR, V49, P1605, DOI 10.4319/lo.2004.49.5.1605; Kuznetsova M, 2001, MAR CHEM, V73, P319, DOI 10.1016/S0304-4203(00)00116-X; Lass K, 2013, BIOGEOSCIENCES, V10, P5325, DOI 10.5194/bg-10-5325-2013; Leck C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023651; Li XY, 2004, WATER RES, V38, P1305, DOI 10.1016/j.watres.2003.11.010; Liu KW, 1998, J GEOPHYS RES-ATMOS, V103, P10571, DOI 10.1029/97JD03736; Long RA, 1996, AQUAT MICROB ECOL, V10, P213, DOI 10.3354/ame010213; Ma YE, 2014, CONT SHELF RES, V72, P10, DOI 10.1016/j.csr.2013.10.012; Mari X, 1996, J PLANKTON RES, V18, P969, DOI 10.1093/plankt/18.6.969; Mari X, 2017, PROG OCEANOGR, V151, P13, DOI 10.1016/j.pocean.2016.11.002; Mohlin M, 2012, MICROB ECOL, V63, P736, DOI 10.1007/s00248-011-9964-y; Moran XAG, 2010, GLOBAL CHANGE BIOL, V16, P1137, DOI 10.1111/j.1365-2486.2009.01960.x; Orellana MV, 2011, P NATL ACAD SCI USA, V108, P13612, DOI 10.1073/pnas.1102457108; Orellana MV, 2003, LIMNOL OCEANOGR, V48, P1618, DOI 10.4319/lo.2003.48.4.1618; Passow U, 2002, PROG OCEANOGR, V55, P287, DOI 10.1016/S0079-6611(02)00138-6; Passow U, 1995, LIMNOL OCEANOGR, V40, P1326, DOI 10.4319/lo.1995.40.7.1326; PASSOW U, 1995, DEEP-SEA RES PT II, V42, P99, DOI 10.1016/0967-0645(95)00006-C; Passow U, 2012, MAR ECOL PROG SER, V470, P249, DOI 10.3354/meps09985; Piontek J, 2009, AQUAT MICROB ECOL, V54, P305, DOI 10.3354/ame01273; Prairie JC, 2013, MAR ECOL PROG SER, V487, P185, DOI 10.3354/meps10387; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Romano JC, 1996, DEEP-SEA RES PT I, V43, P411, DOI 10.1016/0967-0637(96)00024-6; Santos AL, 2012, APPL ENVIRON MICROB, V78, P2066, DOI 10.1128/AEM.06344-11; Seebah S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112379; Shatwell T, 2008, GLOBAL CHANGE BIOL, V14, P2194, DOI 10.1111/j.1365-2486.2008.01630.x; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; Sommer U, 2017, BIOL REV, V92, P1011, DOI 10.1111/brv.12266; Sun C-C, 2017, BIOGEOSCIENCES DISCU, DOI [10.5194/bg-2017-419, DOI 10.5194/BG-2017-419.]; Sun CC, 2011, INT J ENV RES PUB HE, V8, P2951, DOI 10.3390/ijerph8072951; Tang DL, 2003, REMOTE SENS ENVIRON, V84, P506, DOI 10.1016/S0034-4257(02)00149-9; Thornton DCO, 2007, LIMNOL OCEANOGR-METH, V5, P73, DOI 10.4319/lom.2007.5.73; Thornton DCO, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00135; Tilstone GH, 2010, LIMNOL OCEANOGR, V55, P1835, DOI 10.4319/lo.2010.55.5.1835; Verdugo P, 2012, ANNU REV MAR SCI, V4, P375, DOI 10.1146/annurev-marine-120709-142759; Wang HH, 2014, J SEA RES, V85, P474, DOI 10.1016/j.seares.2013.08.002; Wang YS, 2012, ENVIRON EARTH SCI, V66, P655, DOI 10.1007/s12665-011-1274-7; Wang YS, 2008, MAR POLLUT BULL, V56, P1871, DOI 10.1016/j.marpolbul.2008.07.017; Wannicke N, 2009, AQUAT MICROB ECOL, V57, P175, DOI 10.3354/ame01343; Wei X, 2013, MAR POLLUT BULL, V75, P105, DOI 10.1016/j.marpolbul.2013.07.056; Wu ML, 2016, MAR POLLUT BULL, V112, P341, DOI 10.1016/j.marpolbul.2016.07.042; Wurl O, 2011, BIOGEOSCIENCES, V8, P121, DOI 10.5194/bg-8-121-2011; Wurl O, 2008, MAR CHEM, V110, P89, DOI 10.1016/j.marchem.2008.02.009; Wurl O, 2016, PROG OCEANOGR, V144, P15, DOI 10.1016/j.pocean.2016.03.002; Wurl O, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007342; [殷建平 YIN Jianping], 2006, [海洋通报, Marine Science Bulletin], V25, P1; Zhang ZB, 2003, J COLLOID INTERF SCI, V264, P148, DOI 10.1016/S0021-9797(03)00390-4	86	7	7	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198735	10.1371/journal.pone.0198735	http://dx.doi.org/10.1371/journal.pone.0198735			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889860	Green Accepted, Green Published, gold			2022-12-26	WOS:000434786600040
J	Astvatsaturyan, K; Yue, Y; Walts, AE; Bose, S				Astvatsaturyan, Kristine; Yue, Yong; Walts, Ann E.; Bose, Shikha			Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features	PLOS ONE			English	Article							PATHOLOGISTS GUIDELINE RECOMMENDATIONS; MOLECULAR SUBTYPES; AMERICAN-SOCIETY; BASAL-LIKE; EXPRESSION; ESTROGEN; TUMORS; SURVIVAL; OUTCOMES; RESPOND	Introduction Overexpression of the androgen receptor (AR) characterizes a distinct molecular subset of triple negative breast carcinomas (TNBC). The role of AR as a prognostic/predictive bio-marker in TNBC is controversial, but increasing evidence suggests that this subset may respond to therapeutic agents targeting AR. Evaluation of AR has not been standardized, and criteria for selection of patients for antiandrogen therapy remain controversial. In this study we determine the appropriate threshold of AR immunoreactivity to define AR positive (AR+) TNBC, describe the clinicopathologic features of AR+ TNBC, and discuss the utility of AR positivity as a prognostic and predictive marker in TNBC. Materials and methods 135 invasive TNBC processed in accordance with ASCO/CAP guidelines, were immunostained for AR. Clinicopathologic features of AR+ TNBC were analyzed and compared to AR negative (AR-) TNBC. Patients' age, tumor size, tumor grade, lymph node status, proliferation rate, immunopositivity for EGFR, CK5/6, Ki-67, and disease free survival (DFS) were evaluated statistically. Results A 1% cutpoint was confirmed as the appropriate threshold for AR positivity. Using this cutpoint 41% of 135 TNBC were AR+. AR+ TNBC occurred in older women, were larger, had lower mean proliferation rate and increased incidence of axillary metastasis than AR-TNBC. 76% of TNBC with apocrine morphology were AR+. A subset of AR+ TNBC expressed basal markers (EGFR and CK5/6). A prognostic model was created. Summary AR identifies a heterogeneous group of TNBC. Additional evaluation of EGFR expression allowed us to stratify TNBCs into 3 risk groups with significant differences in DFS and therapeutic implications: low-risk (AR+ EGFR-) which represents the LAR molecular subtype with the best prognosis and may benefit the most from anti-androgen therapies; highrisk (AR-EGFR+) which represents the basal molecular subtype with the worst prognosis and may benefit the most from chemotherapy regimens; intermediate-risk (AR+ EGFR+ and AR-EGFR-) TNBC with an intermediate prognosis. Prospective trials are required to further validate this prognostic and predictive grouping.	[Astvatsaturyan, Kristine; Walts, Ann E.; Bose, Shikha] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Yue, Yong] Cedars Sinai Med Ctr, Dept Radiat Oncol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center	Astvatsaturyan, K (corresponding author), Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA.	kastvatsaturyan@mednet.ucla.edu						Barton VN, 2015, MOL CANCER THER, V14, P769, DOI 10.1158/1535-7163.MCT-14-0926; Birrell SN, 1998, J MAMMARY GLAND BIOL, V3, P95, DOI 10.1023/A:1018730519839; Choi JE, 2015, ANN SURG ONCOL, V22, P82, DOI 10.1245/s10434-014-3984-z; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Garay J. P., 2012, BREAST CANCER RES, V9, P14; Gasparini P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088525; Giannos A, 2015, ONCOTARGETS THER, V8, P1843, DOI 10.2147/OTT.S78254; Gucalp A, 2013, CLIN CANCER RES, V19, P5505, DOI 10.1158/1078-0432.CCR-12-3327; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; He JH, 2012, MED ONCOL, V29, P406, DOI 10.1007/s12032-011-9832-0; Hickey TE, 2012, MOL ENDOCRINOL, V26, P1252, DOI 10.1210/me.2012-1107; Hu R, 2011, CLIN CANCER RES, V17, P1867, DOI 10.1158/1078-0432.CCR-10-2021; Jezequel P, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0550-y; Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005; Lehmann BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157368; Luo Xiang, 2010, Chin J Cancer, V29, P585; McGhan LJ, 2014, ANN SURG ONCOL, V21, P361, DOI 10.1245/s10434-013-3260-7; Mirzania Mehrzad, 2016, Int J Hematol Oncol Stem Cell Res, V10, P115; Mrklic I, 2013, ACTA HISTOCHEM, V115, P344, DOI 10.1016/j.acthis.2012.09.006; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Niemeier LA, 2010, MODERN PATHOL, V23, P205, DOI 10.1038/modpathol.2009.159; Ogawa Y, 2008, INT J CLIN ONCOL, V13, P431, DOI 10.1007/s10147-008-0770-6; Park S, 2011, ANN ONCOL, V22, P1755, DOI 10.1093/annonc/mdq678; Park S, 2010, ANN ONCOL, V21, P488, DOI 10.1093/annonc/mdp510; Pistelli M, 2014, CANCERS, V6, P1351, DOI 10.3390/cancers6031351; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rampurwala M, 2016, CLIN ADV HEMATOL ONC, V14, P186; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Safarpour D, 2015, ARCH PATHOL LAB MED, V139, P612, DOI 10.5858/arpa.2014-0122-RA; Sutton LM, 2012, AM J CLIN PATHOL, V138, P511, DOI 10.1309/AJCP8AVF8FDPTZLH; Tang DB, 2012, MED ONCOL, V29, P526, DOI 10.1007/s12032-011-9948-2; Tsang JYS, 2014, ANN SURG ONCOL, V21, P2218, DOI 10.1245/s10434-014-3629-2; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yu KD, 2013, CLIN CANCER RES, V19, P2723, DOI 10.1158/1078-0432.CCR-12-2986; Yue Y, 2016, PLOS ONE, V11	40	53	58	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0197827	10.1371/journal.pone.0197827	http://dx.doi.org/10.1371/journal.pone.0197827			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883487	Green Published, Green Submitted, gold			2022-12-26	WOS:000434728100006
J	Ma, Z; Lasek-Nesselquist, E; Lu, J; Schneider, R; Shah, R; Oliva, G; Pata, J; McDonough, K; Pai, MP; Rose, WE; Sakoulas, G; Malik, M				Ma, Zhuo; Lasek-Nesselquist, Erica; Lu, Jackson; Schneider, Ryan; Shah, Riddhi; Oliva, George; Pata, Janice; McDonough, Kathleen; Pai, Manjunath P.; Rose, Warren E.; Sakoulas, George; Malik, Meenakshi			Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus	PLOS ONE			English	Article							METHICILLIN-RESISTANT; CELL-WALL; REDUCED SUSCEPTIBILITY; VANCOMYCIN SUSCEPTIBILITY; 2-COMPONENT SYSTEM; LIPOTEICHOIC ACID; CROSS-RESISTANCE; IN-VIVO; MEMBRANE; MPRF	The extensive use of daptomycin (DAP) for treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the last decade has led to the emergence of DAP non-susceptible (DNS) Staphylococcus aureus strains. A better understanding of the molecular changes underlying DAP-non-susceptibility is required for early diagnosis and intervention with alternate combination therapies. The phenotypic changes associated with DNS strains have been well established. However, the genotypic changes especially the kinetics of expression of the genes responsible for DAP-non-susceptibility are not well understood. In this study, we used three clinically derived isogenic pairs of DAP-susceptible (DAP-S) and DNS S. aureus strains to study gene expression profiles with the objective of identifying the potential genotypic changes associated with DAP-nonsusceptibility. We determined the expression profiles of genes involved in cell membrane (CM) charge, autolysis, cell wall (CW) synthesis, and penicillin binding proteins in DAP-S and DNS isogenic pairs. Our results demonstrate characteristic expression profiles for mprF, dItABCD, vraS, femB, and pbp2a genes, which are common to all the DNS S. aureus strains tested. Whole genome sequencing of DAP-S and DNS clinical isolates of S. aureus showed non-synonymous mutations in all DNS strains in genes involved in CM charge, CM composition, CW thickness and CW composition. To conclude, this study unravels some of the complex molecular changes involved in the development of DAP-nonsusceptibility by demonstrating distinct differences in gene expression profiles and mutations in the DNS S. aureus strains. This knowledge will aid in rapid identification of DNS S. aureus in clinical settings.	[Ma, Zhuo; Lu, Jackson; Shah, Riddhi; Oliva, George; Pai, Manjunath P.; Malik, Meenakshi] Albany Coll Pharm & Hlth Sci, Albany, NY 12208 USA; [Lasek-Nesselquist, Erica; Schneider, Ryan; Pata, Janice; McDonough, Kathleen] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Rose, Warren E.] Univ Wisconsin Madison, Sch Pharm, Madison, WI USA; [Sakoulas, George] UCSD Sch Med, Ctr Immun Infect & Inflammat, La Jolla, CA USA	Albany College of Pharmacy & Health Sciences; State University of New York (SUNY) System; Wadsworth Center; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Diego	Malik, M (corresponding author), Albany Coll Pharm & Hlth Sci, Albany, NY 12208 USA.	Meenakshi.Malik@acphs.edu	Malik, Meenakshi/F-1501-2015	Malik, Meenakshi/0000-0003-0051-4485; Ma, Zhuo/0000-0002-9766-8239	Investment in Collaborative Research at the Wadsworth Center and Albany College of Pharmacy and Health Sciences Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI132627] Funding Source: NIH RePORTER	Investment in Collaborative Research at the Wadsworth Center and Albany College of Pharmacy and Health Sciences Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by "Investment in Collaborative Research at the Wadsworth Center and Albany College of Pharmacy and Health Sciences Grant". The funders had no role in the design or execution of the experiments.; This study was supported by "Investment in Collaborative Research at the Wadsworth Center and Albany College of Pharmacy and Health Sciences Grant". The funders had no role in the design or execution of the experiments. The authors acknowledge Wadsworth Center Applied Genomics Technologies and Bioinformatics & Statistics Cores for providing technical support.	Alder J, 2008, CRIT CARE CLIN, V24, P349, DOI 10.1016/j.ccc.2007.12.010; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bayer AS, 2016, J ANTIMICROB CHEMOTH, V71, P2100, DOI 10.1093/jac/dkw142; Bayer AS, 2015, ANTIMICROB AGENTS CH, V59, P4930, DOI 10.1128/AAC.00970-15; Bayer AS, 2014, ANTIMICROB AGENTS CH, V58, P7462, DOI 10.1128/AAC.03422-14; Bayer AS, 2013, ANN NY ACAD SCI, V1277, P139, DOI 10.1111/j.1749-6632.2012.06819.x; Bayer AS, 2000, INFECT IMMUN, V68, P3548, DOI 10.1128/IAI.68.6.3548-3553.2000; Berti AD, 2012, ANTIMICROB AGENTS CH, V56, P5046, DOI 10.1128/AAC.00502-12; Bertsche U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067398; Borbulevych O, 2011, J BIOL CHEM, V286, P31466, DOI 10.1074/jbc.M111.252189; Boyle-Vavra S, 2011, ANTIMICROB AGENTS CH, V55, P2018, DOI 10.1128/AAC.01593-10; Bulchandani D, 2008, SOUTH MED J, V101, P663, DOI 10.1097/SMJ.0b013e318172f61f; Cameron DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep30823; Cameron DR, 2015, VIRULENCE, V6, P127, DOI 10.1080/21505594.2015.1011532; Cameron DR, 2012, J INFECT DIS, V205, P1677, DOI 10.1093/infdis/jis252; CANEPARI P, 1990, ANTIMICROB AGENTS CH, V34, P1220, DOI 10.1128/AAC.34.6.1220; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P1079, DOI 10.1128/AAC.50.3.1079-1082.2006; Cui LZ, 2000, ANTIMICROB AGENTS CH, V44, P2276, DOI 10.1128/AAC.44.9.2276-2285.2000; Dhand A, 2011, CLIN INFECT DIS, V53, P158, DOI 10.1093/cid/cir340; Dubrac S, 2008, ADV EXP MED BIOL, V631, P214, DOI 10.1007/978-0-387-78885-2_15; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Eisenstein BI, 2010, CLIN INFECT DIS, V50, pS10, DOI 10.1086/647938; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Fridkin SK, 1999, CLIN CHEST MED, V20, P303, DOI 10.1016/S0272-5231(05)70143-X; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Hiramatsu K, 2014, J INFECT CHEMOTHER, V20, P593, DOI 10.1016/j.jiac.2014.08.001; Hiramatsu K, 2014, J GLOB ANTIMICROB RE, V2, P213, DOI 10.1016/j.jgar.2014.04.006; Howden BP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002359; Jerga A, 2007, J BIOL CHEM, V282, P21738, DOI 10.1074/jbc.M703536200; Jones T, 2008, ANTIMICROB AGENTS CH, V52, P269, DOI 10.1128/AAC.00719-07; Kaatz GW, 2006, INT J ANTIMICROB AG, V28, P280, DOI 10.1016/j.ijantimicag.2006.05.030; Koprivnjak T, 2011, J BACTERIOL, V193, P4134, DOI 10.1128/JB.00288-11; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Manat G, 2014, MICROB DRUG RESIST, V20, P199, DOI 10.1089/mdr.2014.0035; Marco F, 2008, ANTIMICROB AGENTS CH, V52, P2538, DOI 10.1128/AAC.00510-07; Mehta S, 2012, ANTIMICROB AGENTS CH, V56, P92, DOI 10.1128/AAC.00432-10; Mishra NN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107426; Mishra Nagendra N, 2012, Int J Microbiol, V2012, P683450, DOI 10.1155/2012/683450; Mishra NN, 2013, ANTIMICROB AGENTS CH, V57, P1082, DOI 10.1128/AAC.02182-12; Mishra NN, 2012, J INFECT DIS, V206, P1160, DOI 10.1093/infdis/jis482; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Murthy MH, 2008, J MED MICROBIOL, V57, P1036, DOI 10.1099/jmm.0.2008/000588-0; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Mwangi MM, 2013, MICROB DRUG RESIST, V19, P153, DOI 10.1089/mdr.2013.0053; Parra-Ruiz J, 2010, ANTIMICROB AGENTS CH, V54, P4329, DOI 10.1128/AAC.00455-10; Peleg AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028316; Pereira SFF, 2009, MOL MICROBIOL, V72, P895, DOI 10.1111/j.1365-2958.2009.06687.x; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Sakoulas G, 2006, ANTIMICROB AGENTS CH, V50, P1581, DOI 10.1128/AAC.50.4.1581-1585.2006; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shoji M, 2011, ANTIMICROB AGENTS CH, V55, P3870, DOI 10.1128/AAC.01563-10; Sieradzki K, 2003, J CLIN MICROBIOL, V41, P1687, DOI 10.1128/JCM.41.4.1687-1693.2003; Skiest DJ, 2006, J CLIN MICROBIOL, V44, P655, DOI 10.1128/JCM.44.2.655-656.2006; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058469; Szurmant H, 2005, J BACTERIOL, V187, P5419, DOI 10.1128/JB.187.15.5419-5426.2005; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Traunmuller F, 2010, J ANTIMICROB CHEMOTH, V65, P1252, DOI 10.1093/jac/dkq109; Vadyvaloo V, 2004, MICROBIOL-SGM, V150, P3025, DOI 10.1099/mic.0.27059-0; Werth BJ, 2013, ANTIMICROB AGENTS CH, V57, P66, DOI 10.1128/AAC.01586-12; Yang SJ, 2010, ANTIMICROB AGENTS CH, V54, P3079, DOI 10.1128/AAC.00122-10; Yang SJ, 2009, J INFECT DIS, V200, P1916, DOI 10.1086/648473; Yang SJ, 2009, ANTIMICROB AGENTS CH, V53, P2636, DOI 10.1128/AAC.01415-08	65	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198366	10.1371/journal.pone.0198366	http://dx.doi.org/10.1371/journal.pone.0198366			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879195	Green Submitted, Green Published, gold			2022-12-26	WOS:000434384900035
J	Kim, M; Pyo, S; Kang, CH; Lee, CO; Lee, HK; Choi, SU; Park, CH				Kim, Minsung; Pyo, Suhkneung; Kang, Chung Hyo; Lee, Chong Ock; Lee, Heung Kyoung; Choi, Sang Un; Park, Chi Hoon			Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer	PLOS ONE			English	Article							ADOPTIVE IMMUNOTHERAPY; COLON-CARCINOMA; ANTIBODY; PROLIFERATION; FARLETUZUMAB; LYMPHOCYTES; ACTIVATION; DOMAIN; ALPHA; MODEL	Gastric cancer is a malignancy that has a high mortality rate. Although progress has been made in the treatment of gastric cancer, many patients experience cancer recurrence and metastasis. Folate receptor 1 (FOLR1) is overexpressed on the cell surface in over onethird of gastric cancer patients, but rarely is expressed in normal tissue. This makes FOLR1 a potential target for chimeric antigen receptor (CAR) T cell immunotherapy, although the function of FOLR1 has not been elucidated. CAR are engineered fusion receptor composed of an antigen recognition region and signaling domains. T cells expressing CAR have specific activation and cytotoxic effects against cancer cells containing the target antigen. In this study, we generated a CAR that targets FOLR1 composed of a single-chain variable fragment (scFv) of FOLR1 antibody and signaling domains consisting of CD28 and CD3 zeta. Both FOLR1-CAR KHYG-1, a natural killer cell line, and FOLR1-CAR T cells recognized FOLR1positive gastric cancer cells in a MHC-independent manner and induced secretion of various cytokines and caused cell death. Conclusively, this is the first study to demonstrate that CAR KHYG-1/T cells targeting FOLR1 are effective against FOLR1-positive gastric cancer cells.	[Kim, Minsung; Kang, Chung Hyo; Lee, Chong Ock; Lee, Heung Kyoung; Choi, Sang Un; Park, Chi Hoon] Korea Res Inst Chem Technol, Bio & Drug Discovery Div, Daejeon, South Korea; [Kim, Minsung; Pyo, Suhkneung] Sungkyunkwan Univ, Sch Pharm, Suwon, Kyunggi Do, South Korea; [Kang, Chung Hyo] Chungnam Natl Univ, Coll Pharm, Daejeon, South Korea; [Park, Chi Hoon] Korea Univ Sci & Technol, Dept Med Chem & Pharmacol, Daejeon, South Korea	Korea Research Institute of Chemical Technology (KRICT); Sungkyunkwan University (SKKU); Chungnam National University; University of Science & Technology (UST)	Choi, SU; Park, CH (corresponding author), Korea Res Inst Chem Technol, Bio & Drug Discovery Div, Daejeon, South Korea.; Park, CH (corresponding author), Korea Univ Sci & Technol, Dept Med Chem & Pharmacol, Daejeon, South Korea.	suchoi@krict.re.kr; chpark@krict.re.kr			KOREA RESEARCH INSTITUTE of CHEMICAL TECHNOLOGY [SI1706]; National Research Foundation of Korea [NRF-2017M2A2A6A01071250]	KOREA RESEARCH INSTITUTE of CHEMICAL TECHNOLOGY; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the KOREA RESEARCH INSTITUTE of CHEMICAL TECHNOLOGY (SI1706) and the National Research Foundation of Korea (https://www.nrf.re.kr/index) grant number: NRF-2017M2A2A6A01071250 to Chi Hoon Park. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This Research was supported by KOREA RESEARCH INSTITUTE of CHEMICAL TECHNOLOGY (SI1706) and by the National Research Foundation of Korea (NRF-2017M2A2A6A01071250).	Abrahao-Machado LF, 2016, WORLD J GASTROENTERO, V22, P4619, DOI 10.3748/wjg.v22.i19.4619; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Beecham EJ, 2000, J IMMUNOTHER, V23, P631, DOI 10.1097/00002371-200011000-00004; Boissel L, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26527; Boshnjaku V, 2012, SCI REP-UK, V2, DOI 10.1038/srep00980; Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674; Cartellieri M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956304; Cheung A, 2016, ONCOTARGET, V7, P52553, DOI 10.18632/oncotarget.9651; Dosio F, 2010, CURR OPIN INVEST DR, V11, P1424; Elnakat H, 2006, FRONT BIOSCI-LANDMRK, V11, P506, DOI 10.2741/1815; Eshhar Z, 1996, SPRINGER SEMIN IMMUN, V18, P199, DOI 10.1007/BF00820666; Finney HM, 1998, J IMMUNOL, V161, P2791; Gao JJ, 2013, TRENDS IMMUNOL, V34, P90, DOI 10.1016/j.it.2012.08.004; Gross C, 2003, CELL STRESS CHAPERON, V8, P348, DOI 10.1379/1466-1268(2003)008<0348:HSPRIA>2.0.CO;2; Haynes NM, 2002, J IMMUNOL, V169, P5780, DOI 10.4049/jimmunol.169.10.5780; Haynes NM, 2001, J IMMUNOL, V166, P182, DOI 10.4049/jimmunol.166.1.182; Hermanson DL, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00195; Heuser C, 2003, GENE THER, V10, P1408, DOI 10.1038/sj.gt.3302023; Holzinger A, 2016, CANCER IMMUNOL IMMUN, V65, P1433, DOI 10.1007/s00262-016-1895-5; Hombach A, 2001, CANCER RES, V61, P1976; Kakarla S, 2014, CANCER J, V20, P151, DOI 10.1097/PPO.0000000000000032; Kamen BA, 2012, CANCER CHEMOTH PHARM, V70, P113, DOI 10.1007/s00280-012-1890-2; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Klingemann H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00091; Kobold S, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju364; Lin JM, 2013, CANCER BIOL THER, V14, P1032, DOI 10.4161/cbt.26106; Low PS, 2009, CURR OPIN CHEM BIOL, V13, P256, DOI 10.1016/j.cbpa.2009.03.022; Maher J., 2012, ISRN ONCOL, V2012, P1; Maher J, 2009, CANCER RES, V69, P4559, DOI 10.1158/0008-5472.CAN-09-0564; Maus MV, 2014, ANNU REV IMMUNOL, V32, P189, DOI 10.1146/annurev-immunol-032713-120136; Rahman R, 2014, WORLD J GASTROENTERO, V20, P4483, DOI 10.3748/wjg.v20.i16.4483; Rousalova I, 2010, INT J ONCOL, V37, P1361, DOI 10.3892/ijo_00000788; Schonfeld K, 2015, MOL THER, V23, P330, DOI [10.1038/mt.2014.21, 10.1038/mt.2014.219]; Siu MKY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047201; Suck G, 2005, EXP HEMATOL, V33, P1160, DOI 10.1016/j.exphem.2005.06.024; Taguchi Y, 2004, BLOOD, V104, P3285, DOI 10.1182/blood-2004-03-0900; Tonn T, 2013, CYTOTHERAPY, V15, P1563, DOI 10.1016/j.jcyt.2013.06.017; Vergote IB, 2015, CANCER METAST REV, V34, P41, DOI 10.1007/s10555-014-9539-8; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Warneke VS, 2013, BRIT J CANCER, V109, P2217, DOI 10.1038/bjc.2013.536; Weijtens MEM, 1996, J IMMUNOL, V157, P836; Wen YF, 2015, CLIN CANCER RES, V21, P448, DOI 10.1158/1078-0432.CCR-14-1578; Yu SN, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0444-9; Zhang Q, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1251539	44	44	50	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198347	10.1371/journal.pone.0198347	http://dx.doi.org/10.1371/journal.pone.0198347			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874279	gold, Green Published, Green Submitted			2022-12-26	WOS:000434369400047
J	Luna, E; Agrawal, P; Mehta, R; Boone, ME; Vernhes, C; Denys, C; Small, R; Mukherjee, B; Tennagels, N; Maerten, S; Drake, DR				Luna, Ernesto; Agrawal, Pankaj; Mehta, Riyaz; Boone, Maria E.; Vernhes, Charlotte; Denys, Colombe; Small, Robert; Mukherjee, Bhaswati; Tennagels, Norbert; Maerten, Stefan; Drake, Donald R., III			Evaluation of the innate immunostimulatory potential of originator and non-originator copies of insulin glargine in an in vitro human immune model	PLOS ONE			English	Article							DENDRITIC CELLS; IMMUNOGENICITY; ANTAGONIST; EXPRESSION; RESISTANCE; SECRETION; GLUCOSE; IMPACT	Background The manufacture of insulin analogs requires sophisticated production procedures which can lead to differences in the structure, purity, and/or other physiochemical properties of resultant products that can affect their biologic activity. Here, we sought to compare originator and non-originator copies of insulin glargine for innate immune activity and mechanisms leading to differences in these response profiles in an in vitro model of human immunity. Methods An endothelial/dendritic cell-based innate immune model was used to study antigen-presenting cell activation, cytokine secretion, and insulin receptor signalling pathways induced by originator and non-originator insulin glargine products. Mechanistic studies included signalling pathway blockade with specific inhibitors, analysis of the products in a Toll-like receptor reporter cell line assay, and natural insulin removal from the products by immunopurification. Findings All insulin glargine products elicited at least a minor innate immune response comparable to natural human insulin, but some lots of a non-originator copy product induced the elevated secretion of the cytokines, IL-8 and IL-6. In studies aimed at addressing the mechanisms leading to differential cytokine production by these products, we found (1) the inflammatory response was not mediated by bacterial contaminants, (2) the innate response was driven by the native insulin receptor through the MAPK pathway, and (3) the removal of insulin glargine significantly reduced their capacity to induce innate activity. No evidence of product aggregates was detected, though the presence of some high molecular weight proteins argues for the presence of insulin glargine dimers or others contaminants in these products. Conclusion The data presented here suggests some non-originator insulin glargine product lots drive heightened in vitro human innate activity and provides preliminary evidence that changes in the biochemical composition of non-originator insulin glargine products (dimers, impurities) might be responsible for their greater immunostimulatory potential.	[Luna, Ernesto; Agrawal, Pankaj; Mehta, Riyaz; Boone, Maria E.; Vernhes, Charlotte; Small, Robert; Drake, Donald R., III] Sanofi Pasteur, Orlando, FL 32826 USA; [Denys, Colombe; Mukherjee, Bhaswati] Sanofi, Paris, France; [Tennagels, Norbert; Maerten, Stefan] Sanofi Aventis Deutschland GmbH, Frankfurt, Germany	Sanofi-Aventis; Sanofi-Aventis; Sanofi France; Sanofi-Aventis	Luna, E (corresponding author), Sanofi Pasteur, Orlando, FL 32826 USA.	Ernesto.Luna@sanofi.com			Sanofi	Sanofi(Sanofi-Aventis)	The work was funded by Sanofi. Sanofi provided support in the form of salaries for all authors [EL, PA, RM, MEB, CV, CD, RS, BM, NT, SM and DRD]. The funder had a role in the decision to publish but no role in the study design, data collection and analysis or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contribution' section.	[Anonymous], 2014, BIOSIMILARS; Box GE., 1978, STAT EXPT; Bunn RC, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-73; Chamberlain Paul D., 2009, V483, P325, DOI 10.1007/978-1-59745-407-0_19; Deng HP, 2009, INT IMMUNOPHARMACOL, V9, P1251, DOI 10.1016/j.intimp.2009.07.009; Dhir V, 2012, J IMMUNOTOXICOL, V9, P34, DOI 10.3109/1547691X.2011.613419; Drake DR, 2012, DISRUPTIVE SCI TECHN, V1, P28; Garcia-Nares H, 2015, J DIABETES, V7, P155, DOI 10.1111/1753-0407.12241; Haile LA, 2017, J PHARM SCI-US, V106, P751, DOI 10.1016/j.xphs.2016.11.001; Haile LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125078; Hedges JC, 2000, AM J RESP CELL MOL, V23, P86, DOI 10.1165/ajrcmb.23.1.4014; Heinemann L, 2015, DIABETES TECHNOL THE, V17, P510, DOI 10.1089/dia.2014.0362; Higbee RG, 2009, ATLA-ALTERN LAB ANIM, V37, P19, DOI 10.1177/026119290903701S05; Jones B., 2014, DESIGN ANAL CROSS OV; Kammerer D, 2014, TOXICOL REP, V2, P194, DOI [10.1016/j.toxrep.2014.11.019, DOI 10.1016/J.TOXREP.2014.11.019]; Kobashi C, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-25; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Luna E, 2015, CLIN APPL THROMB-HEM, V21, P211, DOI 10.1177/1076029614562037; Ma YF, 2010, IMMUNOLOGY, V130, P374, DOI 10.1111/j.1365-2567.2009.03237.x; Manowsky J, 2016, AM J PHYSIOL-ENDOC M, V310, pE938, DOI 10.1152/ajpendo.00427.2015; Owens DR, 2012, DIABETES TECHNOL THE, V14, P989, DOI 10.1089/dia.2012.0105; Radermecker RP, 2009, DIABETES-METAB RES, V25, P491, DOI 10.1002/dmrr.961; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Ratanji KD, 2014, J IMMUNOTOXICOL, V11, P99, DOI 10.3109/1547691X.2013.821564; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sano H, 1998, J BIOL CHEM, V273, P8630, DOI 10.1074/jbc.273.15.8630; Sathish JG, 2013, NAT REV DRUG DISCOV, V12, P306, DOI 10.1038/nrd3974; Sauerborn M, 2010, TRENDS PHARMACOL SCI, V31, P53, DOI 10.1016/j.tips.2009.11.001; Schaffer L, 2008, BIOCHEM BIOPH RES CO, V376, P380, DOI 10.1016/j.bbrc.2008.08.151; Sciacca L, 2010, DIABETOLOGIA, V53, P1743, DOI 10.1007/s00125-010-1760-6; Sethu S, 2012, ARCH IMMUNOL THER EX, V60, P331, DOI 10.1007/s00005-012-0189-7; Singh SK, 2012, BIOLOGICALS, V40, P364, DOI 10.1016/j.biologicals.2012.06.001; Spielman LJ, 2015, CURR ALZHEIMER RES, V12, P684, DOI 10.2174/1567205012666150710104428; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; U. S. Pharmacopeial Convention, 2014, INS GLARG INJ; Vikram A, 2010, BIOCHEM BIOPH RES CO, V398, P260, DOI 10.1016/j.bbrc.2010.06.070; Wurm S, 2008, CYTOKINE, V44, P185, DOI 10.1016/j.cyto.2008.08.003	39	1	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197478	10.1371/journal.pone.0197478	http://dx.doi.org/10.1371/journal.pone.0197478			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874257	Green Published, gold, Green Submitted			2022-12-26	WOS:000434369400025
J	McCarraher, DR; Packer, C; Mercer, S; Dennis, A; Banda, H; Nyambe, N; Stalter, RM; Mwansa, JK; Katayamoyo, P; Denison, JA				McCarraher, Donna R.; Packer, Catherine; Mercer, Sarah; Dennis, Alexis; Banda, Harry; Nyambe, Namakau; Stalter, Randy M.; Mwansa, Jonathan K.; Katayamoyo, Patrick; Denison, Julie A.			Adolescents living with HIV in the Copperbelt Province of Zambia: Their reproductive health needs and experiences	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; YOUNG-PEOPLE; TANZANIA; UGANDA; OUTCOMES; SERVICE; YOUTH	Background Understanding and meeting the reproductive health needs of adolescents living with HIV (ALHIV) is a growing concern since advances in antiretroviral therapy mean that many ALHIV are now living into adulthood and starting to have sex. Methods We conducted a mixed-methods study in the Copperbelt Province of Zambia to advance our understanding of the reproductive health needs of ALHIV and to assess the extent to which these needs are being met. We conducted in-depth interviews (IDIs) with 32 ALHIV from two HIV clinics, 23 with their caregivers, and 10 with clinic staff. ALHIV were interviewed twice. We used the data from the qualitative interviews to create a cross-sectional survey that we conducted with 312 ALHIV in three HIV clinics. Findings The vast majority of ALHIV reported they wanted to have children in the future but lacked knowledge about preventing mother-to-child transmission. Some sexually active adolescents used condoms, although they wanted more information about and access to non-condom methods. Many ALH IV reported that their first sexual encounters were forced. Religious beliefs prevented some caregivers from discussing premarital sex and contraception with ALHIV. Clinic staff and caregivers had mixed views about integrating contraceptive counseling and method provision into HIV care and treatment services. Few sexually active ALHIV reported that they disclosed their HIV status to their sexual partners and few reported that they knew their sexual partner's status. Conclusions ALHIV are in dire need of comprehensive sexual and reproductive health services and information including a range of contraceptive methods to prevent pregnancy, knowledge about preventing mother-to-child transmission and having a healthy pregnancy, skills related to HIV disclosure and condom negotiation to prevent horizontal transmission, and screening for sexual violence for both males and females if services are available.	[McCarraher, Donna R.; Packer, Catherine; Mercer, Sarah] FHI, Durham, NC 27701 USA; [Dennis, Alexis] Univ N Carolina, Dept Sociol, Chapel Hill, NC USA; [Banda, Harry] FHI, Ndola, Zambia; [Nyambe, Namakau; Katayamoyo, Patrick] FHI, Lusaka, Zambia; [Stalter, Randy M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Mwansa, Jonathan K.] Arthur Davison Childrens Hosp, Ndola, Zambia; [Denison, Julie A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	McCarraher, DR (corresponding author), FHI, Durham, NC 27701 USA.	dmccarraher@fhi360.org	Dennis, Alexis/AFJ-8084-2022; Dennis, Alexis/AAF-4948-2022	Denison, Julie/0000-0002-4670-093X; Dennis, Alexis C./0000-0001-6366-9850	U.S. Agency for International Development (USAID); USAID [GHO A 00 09 00016-00]	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID))	This work is made possible by the generous support of the American people through the U.S. Agency for International Development (USAID). Financial assistance was provided by USAID to FHI 360 under the terms of the Preventive Technologies Agreement No. GHO A 00 09 00016-00. The contents do not necessarily reflect the views of USAID or the United States Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakeera-Kitaka S, 2008, AIDS CARE, V20, P426, DOI 10.1080/09540120701867099; Beyeza-Kashesya J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-144; Birungi H, 2009, J ADOLESCENT HEALTH, V44, P184, DOI 10.1016/j.jadohealth.2008.06.004; Birungi H, 2009, AIDS CARE, V21, P725, DOI 10.1080/09540120802511901; Busza J, 2013, REPROD HEALTH MATTER, V21, P87, DOI 10.1016/S0968-8080(13)41689-0; Central Statiscal Office (CSO) Ministry of Health (MOH) Tropical Diseases Research Center (TDRC) University of Zambia Inc. MI, 2009, ZAMB DEM HLTH SURV 2; Day K, 2013, 1 AIDSTAR ON USAIDS; Denison JA, 2018, AIDS BEHAV, V22, P996, DOI 10.1007/s10461-017-1944-x; Denison JA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19358; Dow DE, 2016, AIDS CARE, V28, P825, DOI 10.1080/09540121.2016.1139043; Hargreaves JR, 2008, J EPIDEMIOL COMMUN H, V62, P113, DOI 10.1136/jech.2006.053827; Hodgson I, 2012, AIDS CARE, V24, P1204, DOI 10.1080/09540121.2012.658755; Jewkes RK, 2010, CHILD ABUSE NEGLECT, V34, P833, DOI 10.1016/j.chiabu.2010.05.002; Kennedy CE, 2010, B WORLD HEALTH ORGAN, V88, P615, DOI 10.2471/BLT.09.068213; L'Engle Kelly, 2017, Mhealth, V3, P11, DOI 10.21037/mhealth.2017.02.06; L'Engle KL, 2013, CONTRACEPTION, V87, P251, DOI 10.1016/j.contraception.2012.07.009; Mburu G, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18866; Nakimuli-Mpungu E, 2013, J AFFECT DISORDERS, V145, P221, DOI 10.1016/j.jad.2012.08.002; Nakimuli-Mpungu E, 2012, AIDS BEHAV, V16, P2101, DOI 10.1007/s10461-011-0087-8; Ndongmo Therese Ntigwa, 2017, Pan Afr Med J, V26, P71, DOI 10.11604/pamj.2017.26.71.11312; Obare F, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-34; Parker L, 2013, J HIV-AIDS SOC SERV, V12, P294, DOI 10.1080/15381501.2012.748585; Stalter RM, 2017, PEDIATR INFECT DIS J, V36, P768, DOI [10.1097/INF.0000000000001547, 10.1097/inf.0000000000001547]; Toska E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178106; UNAIDS, 2016, GLOBAL AIDS UPD 2016; UNICEF, CURR STAT PROGR HIGH; Vahdat Heather L, 2013, Int J Gynaecol Obstet, V123 Suppl 1, pe2, DOI 10.1016/j.ijgo.2013.07.009	27	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0197853	10.1371/journal.pone.0197853	http://dx.doi.org/10.1371/journal.pone.0197853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI1KD	29870562	Green Published, Green Submitted, gold			2022-12-26	WOS:000434128400008
J	Sali, M; De Maio, F; Tarantino, M; Garofolo, G; Tittarelli, M; Sacchini, L; Zilli, K; Pasquali, P; Petrucci, P; Marianelli, C; Francia, M; Sanguinetti, M; Adone, R				Sali, Michela; De Maio, Flavio; Tarantino, Michela; Garofolo, Giuliano; Tittarelli, Manuela; Sacchini, Lorena; Zilli, Katiuscia; Pasquali, Paolo; Petrucci, Paola; Marianelli, Cinzia; Francia, Massimiliano; Sanguinetti, Maurizio; Adone, Rosanna			Rapid and safe one-step extraction method for the identification of Brucella strains at genus and species level by MALDI-TOF mass spectrometry	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; TANDEM-REPEAT ANALYSIS; PCR; DIFFERENTIATION; INFECTION; SPP.; CETI; MELITENSIS; DOLPHINS; ABORTUS	Brucellosis is essentially a disease of domesticated livestock; however, humans can also be infected via the consumption of contaminated meat or dairy products, underlying the need for rapid and accurate identification methods. Procedures for microbiological identification and typing of Brucella spp. are expensive, time-consuming, and must be conducted in biohazard containment facilities to minimize operator risk. The development of a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS)-based assay has reduced the processing time while maintaining performance standards. In this study, to improve the identification accuracy and suitability of the MALDI-TOF-based assay for routine diagnosis, we developed a new protein extraction protocol and generated a custom reference database containing Brucella strains representative of the most widespread species. The reference library was then challenged with blind-coded field samples isolated from infected animals. The results indicated that the database could be used to correctly identify 99.5% and 97% of Brucella strains at the genus and species level, respectively, indicating that the performance of the assay was not affected by the different culture conditions used for microbial isolation. Moreover, the inactivated samples were stored and shipped to reference laboratories with no ill effect on protein stability, thus confirming the reliability of our method for routine diagnosis. Finally, we evaluated the epidemiological value of the protocol by comparing the clustering analysis results of Brucella melitensis strains obtained via multiple locus variable-number tandem repeat analysis or MALDI-TOF MS. The results showed that the MALDI-TOF assay could not decipher the true phylogenetic tree, suggesting that the protein profile did not correspond with the genetic evolution of Brucella.	[Sali, Michela; De Maio, Flavio; Sanguinetti, Maurizio] Univ Cattolica Sacro Cuore, Inst Microbiol, Fdn Policlin A Gemelli IRCCS, Rome, Italy; [Tarantino, Michela; Pasquali, Paolo; Petrucci, Paola; Marianelli, Cinzia; Francia, Massimiliano; Adone, Rosanna] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, Rome, Italy; [Garofolo, Giuliano; Tittarelli, Manuela; Sacchini, Lorena; Zilli, Katiuscia] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Natl & OIE Reference Lab Brucellosis, Teramo, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Istituto Superiore di Sanita (ISS); IZS Dell'abruzzo E Del Molise Giuseppe Caporale	Sali, M (corresponding author), Univ Cattolica Sacro Cuore, Inst Microbiol, Fdn Policlin A Gemelli IRCCS, Rome, Italy.	michela.sali@unicatt.it	Sanguinetti, Maurizio/A-1453-2019; De Maio, Flavio/AAD-1076-2022; De Maio, Flavio/AAL-7355-2021; Garofolo, Giuliano/B-8551-2016; De Maio, Flavio/J-9452-2018; Sacchini, Lorena/B-6847-2016; Tarantino, Michela/C-7039-2015; Marianelli, Cinzia/C-7036-2015; Tittarelli, Manuela/C-4680-2016	Sanguinetti, Maurizio/0000-0002-9780-7059; De Maio, Flavio/0000-0002-4744-9820; Garofolo, Giuliano/0000-0001-7017-3888; De Maio, Flavio/0000-0002-4744-9820; Sacchini, Lorena/0000-0001-6939-1378; Tarantino, Michela/0000-0001-5241-8044; Marianelli, Cinzia/0000-0002-5190-4574; SALI, Michela/0000-0003-3609-2990; Tittarelli, Manuela/0000-0002-6614-9989	ANHIWA (Animal Health and Welfare) project Bruepidia Brucellosis in wildlife and domestic animals: development of a direct diagnostic method and assessment of genetic diversity of Brucella melitensis and Brucella suis biovar 2 strains in the EU	ANHIWA (Animal Health and Welfare) project Bruepidia Brucellosis in wildlife and domestic animals: development of a direct diagnostic method and assessment of genetic diversity of Brucella melitensis and Brucella suis biovar 2 strains in the EU	Funding for this research was provided by the ANHIWA (Animal Health and Welfare) project Bruepidia Brucellosis in wildlife and domestic animals: development of a direct diagnostic method and assessment of genetic diversity of Brucella melitensis and Brucella suis biovar 2 strains in the EU.	Adone R, 2013, REV SCI TECH OIE, V32, P199; BRICKER BJ, 1994, J CLIN MICROBIOL, V32, P2660, DOI 10.1128/JCM.32.11.2660-2666.1994; Carannante A, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0480-y; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; Cunningham SA, 2013, J CLIN MICROBIOL, V51, P1639, DOI 10.1128/JCM.00267-13; De Carolis E, 2014, J CLIN MICROBIOL, V52, P1453, DOI 10.1128/JCM.03355-13; Dorneles EMS, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-186; Ferreira L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014235; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Garcia-Yoldi D, 2007, J CLIN MICROBIOL, V45, P4070, DOI 10.1128/JCM.01096-07; Garofolo Giuliano, 2016, BMC Res Notes, V9, P277, DOI 10.1186/s13104-016-2074-7; Garofolo G, 2014, J MED MICROBIOL, V63, P325, DOI 10.1099/jmm.0.065672-0; Garofolo G, 2013, INFECT GENET EVOL, V19, P59, DOI 10.1016/j.meegid.2013.06.021; Garofolo G, 2013, J MICROBIOL METH, V92, P103, DOI 10.1016/j.mimet.2012.11.007; Gomez G, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00017; Isidoro-Ayza M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0206-7; de Bagues MPJ, 2011, INFECT IMMUN, V79, P3934, DOI 10.1128/IAI.05542-11; Kang YX, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01375; Karger A, 2013, J CLIN MICROBIOL, V51, P3123, DOI 10.1128/JCM.01720-13; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Lista F, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-267; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pierce CY, 2007, ANAL CHIM ACTA, V583, P23, DOI 10.1016/j.aca.2006.09.065; Sankarasubramanian J, 2016, INFECT GENET EVOL, V41, P213, DOI 10.1016/j.meegid.2016.04.012; Sauer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002843; Scholz HC, 2008, INT J SYST EVOL MICR, V58, P375, DOI 10.1099/ijs.0.65356-0; Scholz HC, 2010, INT J SYST EVOL MICR, V60, P801, DOI 10.1099/ijs.0.011148-0; Scholz HC, 2008, J MED MICROBIOL, V57, P64, DOI 10.1099/jmm.0.47507-0; Singhal N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00791; Suarez S, 2015, PATHOL BIOL, V63, P43, DOI 10.1016/j.patbio.2014.10.002; Suarez-Esquivel M, 2017, GENOME BIOL EVOL, V9, P1901, DOI 10.1093/gbe/evx137; Suarez-Esquivel M, 2017, EMERG INFECT DIS, V23, P997, DOI 10.3201/eid2306.162018; Valentine N, 2005, APPL ENVIRON MICROB, V71, P58, DOI 10.1128/AEM.71.1.58-64.2005; Whatmore AM, 2014, INT J SYST EVOL MICR, V64, P4120, DOI 10.1099/ijs.0.065482-0; Whatmore AM, 2009, INFECT GENET EVOL, V9, P1168, DOI 10.1016/j.meegid.2009.07.001	36	13	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0197864	10.1371/journal.pone.0197864	http://dx.doi.org/10.1371/journal.pone.0197864			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870530	Green Submitted, gold, Green Published			2022-12-26	WOS:000434128400009
J	Wang, XL; Li, L; Wei, X; Wang, YY; Zhang, H; Shi, A; Liu, T; Yang, XD; Fang, Q				Wang, Xiaoli; Li, Liang; Wei, Xing; Wang, Yuanyuan; Zhang, Hui; Shi, Ao; Liu, Tao; Yang, Xiaodi; Fang, Qiang			Proteomic analysis of the response of Trichinella spiralis muscle larvae to exogenous nitric oxide	PLOS ONE			English	Article							EXCRETORY-SECRETORY PROTEINS; CAENORHABDITIS-ELEGANS; SODIUM-NITROPRUSSIDE; GEL-ELECTROPHORESIS; DIAGNOSTIC ANTIGENS; MASS-SPECTROMETRY; HUMAN TRICHINOSIS; MICE; IDENTIFICATION; EXPRESSION	Trichinella spiralis mainly dwells in the muscle tissue of its host and is the main causative agent of trichinellosis in humans. Nitric oxide (NO), an important intracellular signaling molecule that may restrict pathogen growth in infected hosts, has been known for its anti-pathogenic activity, including resistance to T. spiralis. Herein, we applied label-free analysis to investigate the effect of sodium nitroprusside (SNP, a NO donor compound) on the proteome of T. spiralis muscle larvae (ML), followed by Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway cluster analyses. Of the 1,476 proteins detected in the ML, 121 proteins showed differential expression, including 50 significantly upregulated and 71 downregulated proteins. The functions of the 108 annotated proteins were primarily related to signal transduction, transcription/translation, material metabolism, protein synthesis/assembly/degradation, and stress/defense/antioxidation. Quantitative real-time polymerase chain reaction (qRT-PCR) assay verified that FRMD5 and CUT-1 gene expression levels were significantly increased, while COX2 gene expression level was significantly decreased. GO annotation and KEGG pathway analyses showed that the majority of differentially expressed proteins were mainly involved in the molecular function of the catalytic activity, biological process of the immune system process, metabolic process, cellular component organization, biological adhesion, and cellular component of the macromolecular complex. Our results demonstrate the first comprehensive protein expression profile of the ML in response to NO stress and provide novel references for understanding the potential mechanism underlying the effects of NO on trichinellosis.	[Wang, Xiaoli; Wei, Xing; Wang, Yuanyuan; Zhang, Hui; Shi, Ao; Liu, Tao; Yang, Xiaodi; Fang, Qiang] Bengbu Med Coll, Dept Microbiol & Parasitol, Anhui Key Lab Infect & Immun, Bengbu, Peoples R China; [Wang, Xiaoli] Soochow Univ, Med Coll, Dept Parasitol, Suzhou, Peoples R China; [Li, Liang] Bengbu Coll, Dept Biol & Food Engn, Bengbu, Peoples R China	Bengbu Medical College; Soochow University - China; Bengbu University	Yang, XD; Fang, Q (corresponding author), Bengbu Med Coll, Dept Microbiol & Parasitol, Anhui Key Lab Infect & Immun, Bengbu, Peoples R China.	yxd_qf@163.com; fq333@sohu.com	Wang, Yuan/HHC-1520-2022; Lv, Yuanjie/AER-0767-2022; wangwangwang, yuanyaun/HHN-6432-2022	Liu, Tao/0000-0002-0506-3356; Yang, Xiaodi/0000-0002-6321-6891	Key Supporting Project of Prominent Youth in Universities of Anhui [gxyqZD2016159]; Science Research Innovation Team Project of Anhui Colleges and Universities [2016-40]; Key Projects of Science Research in Education Institutes of Anhui Colleges and Universities [KJ2016A708, KJ2015B034by]; Key Projects of Science Research of Bengbu College [2017ZR01]	Key Supporting Project of Prominent Youth in Universities of Anhui; Science Research Innovation Team Project of Anhui Colleges and Universities; Key Projects of Science Research in Education Institutes of Anhui Colleges and Universities; Key Projects of Science Research of Bengbu College	The work corresponding to Xiaodi Yang and Qiang Fang was supported by the Key Supporting Project of Prominent Youth in Universities of Anhui (gxyqZD2016159) and by the Science Research Innovation Team Project of Anhui Colleges and Universities (2016-40). The work corresponding to Xiaoli Wang and Liang Li was supported by the Key Projects of Science Research in Education Institutes of Anhui Colleges and Universities (KJ2016A708, KJ2015B034by) and by the Key Projects of Science Research of Bengbu College (2017ZR01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MA, 2007, VET PARASITOL, V143, P86, DOI 10.1016/j.vetpar.2006.07.026; Ashour DS, 2011, EXP PARASITOL, V128, P414, DOI 10.1016/j.exppara.2011.05.020; Attia RAH, 2015, MEM I OSWALDO CRUZ, V110, P1035, DOI 10.1590/0074-02760150295; Bien J, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-10; Bourens M, 2013, ANTIOXID REDOX SIGN, V19, P1940, DOI 10.1089/ars.2012.4847; Brazdova M, 2009, NUCLEIC ACIDS RES, V37, P1486, DOI 10.1093/nar/gkn1085; Cui J, 2011, ACTA TROP, V118, P1, DOI 10.1016/j.actatropica.2011.02.005; Cui J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-355; de-la-Rosa J L, 2000, Bol Chil Parasitol, V55, P108; Dea-Ayuela MA, 2005, VET PARASITOL, V132, P43, DOI 10.1016/j.vetpar.2005.05.018; Dzik JM, 2006, ACTA BIOCHIM POL, V53, P33; Favre R, 1998, J STRUCT BIOL, V123, P1, DOI 10.1006/jsbi.1998.4012; Gamble HR, 2000, VET PARASITOL, V93, P393, DOI 10.1016/S0304-4017(00)00354-X; Gebreselassie NG, 2012, J IMMUNOL, V188, P417, DOI 10.4049/jimmunol.1101980; Ghadakchiasl A, 2017, PHYSIOL MOL BIOL PLA, V23, P73, DOI 10.1007/s12298-016-0396-5; Guo T, 2017, SCI REP-UK, V7, DOI 10.1038/srep45119; Hadas E, 2002, PARASITOL RES, V88, P86, DOI 10.1007/s004360100500; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hong JK, 2008, J EXP BOT, V59, P147, DOI 10.1093/jxb/erm244; Huang L, 2014, J IMMUNOL, V193, P4178, DOI 10.4049/jimmunol.1400852; Intapan PM, 2006, PARASITOL RES, V98, P227, DOI 10.1007/s00436-005-0070-2; Jung D, 2007, PARASITOL RES, V100, P429, DOI 10.1007/s00436-006-0296-7; Kalyanasundaram A, 2017, INT J PARASITOL-PAR, V6, P195, DOI 10.1016/j.ijppaw.2017.07.002; Kawakami NY, 2016, REV SOC BRAS MED TRO, V49, P68, DOI 10.1590/0037-8682-0266-2015; Lawrence CE, 2000, J IMMUNOL, V164, P4229, DOI 10.4049/jimmunol.164.8.4229; Maffioli E, 2017, J PROTEOMICS, V166, P115, DOI 10.1016/j.jprot.2017.07.012; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Muntane J, 2013, MITOCHONDRION, V13, P257, DOI 10.1016/j.mito.2012.09.004; Murray J, 2005, MOL BIOCHEM PARASIT, V139, P197, DOI 10.1016/j.molbiopara.2004.11.008; Nagano I, 2009, PARASITOL RES, V104, P197, DOI 10.1007/s00436-008-1248-1; Nisbett LM, 2016, BIOCHEMISTRY-US, V55, P4873, DOI 10.1021/acs.biochem.6b00754; Page AP, 2003, ADV PARASIT, V53, P85, DOI 10.1016/S0065-308X(03)53003-2; Pavanelli WR, 2010, BRAZ J INFECT DIS, V14, P606, DOI 10.1590/S1413-86702010000600010; Pinelli E, 2004, EUR J CLIN MICROBIOL, V23, P57, DOI 10.1007/s10096-003-1039-7; Pozio E, 2005, INT J PARASITOL, V35, P1191, DOI 10.1016/j.ijpara.2005.07.012; Prosser SWJ, 2013, MOL ECOL RESOUR, V13, P1108, DOI 10.1111/1755-0998.12082; Robinson MW, 2005, PROTEOMICS, V5, P4525, DOI 10.1002/pmic.200402057; Sapio MR, 2005, DEV BIOL, V282, P231, DOI 10.1016/j.ydbio.2005.03.011; Sauder LA, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw052; SHIOKAWA D, 1994, EUR J BIOCHEM, V226, P23, DOI 10.1111/j.1432-1033.1994.tb20022.x; Sohn Woon-Mok, 2000, Korean Journal of Parasitology, V38, P111, DOI 10.3347/kjp.2000.38.2.111; Stewart GL, 1999, PARASITOL RES, V85, P672, DOI 10.1007/s004360050613; Sun GG, 2015, PARASITOL RES, V114, P4637, DOI 10.1007/s00436-015-4709-3; Tepass U, 2009, CURR OPIN GENET DEV, V19, P357, DOI 10.1016/j.gde.2009.05.006; Tiso M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119712; Wang B, 2013, EXP PARASITOL, V134, P148, DOI 10.1016/j.exppara.2013.03.004; Wang T, 2012, FEBS LETT, V586, P3044, DOI 10.1016/j.febslet.2012.07.019; Wang Xiao-li, 2015, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V27, P166; Wang Xiao-Li, 2012, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V30, P374; Wang ZQ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00986; Wang ZQ, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0252-z; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Zeromski J, 2005, FOLIA HISTOCHEM CYTO, V43, P157; Zhang YL, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-246; Zhao LM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00636	55	5	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0198205	10.1371/journal.pone.0198205	http://dx.doi.org/10.1371/journal.pone.0198205			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870543	Green Published, Green Submitted, gold			2022-12-26	WOS:000434128400015
J	Kim, Y; Shiba-Ishii, A; Nakagawa, T; Iemura, S; Natsume, T; Nakano, N; Matsuoka, R; Sakashita, S; Lee, S; Kawaguchi, A; Sato, Y; Noguchi, M				Kim, Yunjung; Shiba-Ishii, Aya; Nakagawa, Tomoki; Iemura, Shun-Ichiro; Natsume, Tohru; Nakano, Noriyuki; Matsuoka, Ryota; Sakashita, Shingo; Lee, SangJoon; Kawaguchi, Atsushi; Sato, Yukio; Noguchi, Masayuki			Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma	ONCOGENE			English	Article							STRUCTURAL BASIS; UBPY; USP8; 14-3-3-SIGMA; STABILITY; CANCER; ENZYME; DEUBIQUITINATION; CLASSIFICATION; TRAFFICKING	Previously we have reported that stratifin (SFN, 14-3-3 sigma) acts as a novel oncogene, accelerating the tumor initiation and progression of lung adenocarcinoma. Here, pull-down assay and LC-MS/MS analysis revealed that ubiquitin-specific protease 8 (USP8) specifically bound to SFN in lung adenocarcinoma cells. Both USP8 and SFN showed higher expression in human lung adenocarcinoma than in normal lung tissue, and USP8 expression was significantly correlated with SFN expression. Expression of SFN, but not of USP8, was associated with histological subtype, pathological stage, and poor prognosis. USP8 stabilizes receptor tyrosine kinases (RTKs) such as EGFR and MET by deubiquitination, contributing to the proliferative activity of many human cancers including non-small cell lung cancer. In vitro, USP8 binds to SFN and they co-localize at the early endosomes in lung adenocarcinoma cells. Moreover, USP8 or SFN knockdown leads to downregulation of tumor cellular proliferation and upregulation of apoptosis, p-EGFR or p-MET, which are related to the degradation pathway, and accumulation of ubiquitinated RTKs, leading to lysosomal degradation. Additionally, mutant USP8, which is unable to bind to SFN, reduces the expression of RTKs and p-STAT3. We also found that interaction with SFN is critical for USP8 to exert its auto-deubiquitination function and avoid dephosphorylation by PP1. Our findings demonstrate that SFN enhances RTK stabilization through abnormal USP8 regulation in lung adenocarcinoma, suggesting that SFN could be a more suitable therapeutic target for lung adenocarcinoma than USP8.	[Kim, Yunjung; Shiba-Ishii, Aya; Nakano, Noriyuki; Matsuoka, Ryota; Sakashita, Shingo; Noguchi, Masayuki] Univ Tsukuba, Dept Pathol, Fac Med, Ibaraki, Japan; [Nakagawa, Tomoki] Univ Tsukuba, Doctoral Program Biomed Sci, Grad Sch Comprehens Human Sci, Ibaraki, Japan; [Iemura, Shun-Ichiro] Fukushima Med Univ, Translat Res Ctr, Fukushima, Japan; [Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Tokyo, Japan; [Lee, SangJoon] Univ Tsukuba, PhD Program Human Biol, Sch Integrat & Global Majors, Ibaraki, Japan; [Kawaguchi, Atsushi] Univ Tsukuba, Dept Infect Biol, Fac Med, Ibaraki, Japan; [Sato, Yukio] Univ Tsukuba, Dept Thorac Surg, Fac Med, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; Fukushima Medical University; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; University of Tsukuba; University of Tsukuba	Shiba-Ishii, A; Noguchi, M (corresponding author), Univ Tsukuba, Dept Pathol, Fac Med, Ibaraki, Japan.	aya_shiba@md.tsukuba.ac.jp; nmasayuk@md.tsukuba.ac.jp	Lee, SangJoon/AAL-3341-2021; Kim, Yunjung/AAF-9373-2020	Lee, SangJoon/0000-0001-7500-782X; KIM, Yunjung/0000-0003-3922-3642				Aghazadeh Y, 2016, DRUG DISCOV TODAY, V21, P278, DOI 10.1016/j.drudis.2015.09.012; Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Ballif BA, 2006, J PROTEOME RES, V5, P2372, DOI 10.1021/pr060206k; Bansal P, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00112; Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Byun S, 2013, CLIN CANCER RES, V19, P3894, DOI 10.1158/1078-0432.CCR-12-3696; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Devarakonda S, 2015, LANCET ONCOL, V16, pE342, DOI 10.1016/S1470-2045(15)00077-7; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Dufner A, 2015, NAT IMMUNOL, V16, P950, DOI 10.1038/ni.3230; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Guo L, 2003, J AM SOC MASS SPECTR, V14, P1022, DOI 10.1016/S1044-0305(03)00206-X; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Huang WG, 2010, INT J BIOCHEM CELL B, V42, P137, DOI 10.1016/j.biocel.2009.10.001; Kakinuma R, 2016, J THORAC ONCOL, V11, P1012, DOI 10.1016/j.jtho.2016.04.006; Kim JO, 2015, ONCOTARGET, V6, P36551, DOI 10.18632/oncotarget.5336; Kim Y, 2017, PATHOL INT, V67, P292, DOI 10.1111/pin.12546; Komada Masayuki, 2008, Curr Drug Discov Technol, V5, P78, DOI 10.2174/157016308783769469; Ledda F, 2007, BIOMARK INSIGHTS, V2, P45; Li ZM, 2009, AM J TRANSL RES, V1, P326; Ma ZY, 2015, CELL RES, V25, P306, DOI 10.1038/cr.2015.20; Mei Yide, 2011, J Biol Chem, V286, P35380, DOI 10.1074/jbc.M111.282020; Meijer IMJ, 2013, CELL SIGNAL, V25, P919, DOI 10.1016/j.cellsig.2013.01.003; Meijer IMJ, 2011, CELL SIGNAL, V23, P458, DOI 10.1016/j.cellsig.2010.10.023; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Mizuno E, 2007, EXP CELL RES, V313, P3624, DOI 10.1016/j.yexcr.2007.07.028; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Naviglio S, 1998, EMBO J, V17, P3241, DOI 10.1093/emboj/17.12.3241; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; NOGUCHI M, 1995, CANCER-AM CANCER SOC, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#; Panner A, 2010, CANCER RES, V70, P5046, DOI 10.1158/0008-5472.CAN-09-3979; Pareja F, 2012, ONCOGENE, V31, P4599, DOI 10.1038/onc.2011.587; Perez-Rivas LG, 2015, J CLIN ENDOCR METAB, V100, pE997, DOI 10.1210/jc.2015-1453; Reincke M, 2015, NAT GENET, V47, P31, DOI 10.1038/ng.3166; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Sato T, 2017, CANCER SCI, V108, P536, DOI 10.1111/cas.13148; Savio MG, 2016, CURR BIOL, V26, P173, DOI 10.1016/j.cub.2015.11.050; Sbiera S, 2015, TRENDS ENDOCRIN MET, V26, P573, DOI 10.1016/j.tem.2015.08.003; Shiba-Ishii A, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0414-1; Shiba-Ishii A, 2012, AM J PATHOL, V180, P1653, DOI 10.1016/j.ajpath.2011.12.014; Shiba-Ishii A, 2011, INT J CANCER, V129, P2445, DOI 10.1002/ijc.25907; Shimada A, 2005, CANCER SCI, V96, P668, DOI 10.1111/j.1349-7006.2005.00100.x; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smith AJ, 2011, PHYSIOLOGY, V26, P181, DOI 10.1152/physiol.00042.2010; Smith GA, 2016, TRAFFIC, V17, P53, DOI 10.1111/tra.12341; Takeuchi K, 2011, BIOL PHARM BULL, V34, P1774, DOI 10.1248/bpb.34.1774; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Xia RH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001238; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	52	23	23	1	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 4	2018	37	40					5387	5402		10.1038/s41388-018-0342-9	http://dx.doi.org/10.1038/s41388-018-0342-9			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GV7MY	29880877				2022-12-26	WOS:000446312900002
J	Hussain, J; Khaliq, T; Ahmad, A; Akhtar, J				Hussain, Jamshad; Khaliq, Tasneem; Ahmad, Ashfaq; Akhtar, Javed			Performance of four crop model for simulations of wheat phenology, leaf growth, biomass and yield across planting dates	PLOS ONE			English	Article							HEAT-STRESS; INFRARED HEATER; CLIMATE-CHANGE; EXTREME HEAT; TEMPERATURE; IMPACT; MAIZE; GUIDELINES; MECHANISMS; RESPONSES	Robustness of four wheat simulation model were tested with 2-year field experiments of three cultivars across a wide range of sowing dates in two different climatic regions: Faisalabad (semi-arid) and Layyah (arid), in Punjab-Pakistan. Wheat growing season temperature ranged from -0.1 degrees C to 43 degrees C. The wide series of sowing dates was a unique opportunity to grow the wheat in an environment which temperatures varies from -0.1 degrees C to 43 degrees C. The CERES-Wheat, Nwheat, CROPSIM-Wheat and APSIM-Wheat model were calibrated against the least-stressed treatment for each wheat cultivar. Overall, the four models described performance of early, optimum and late sown wheat well, but poorly described yields of very late planting dates with associated high temperatures during grain filling. The poor accuracy of simulations of yield for extreme planting dates point to the need to improve the accuracy of model simulations at the high end of the growing temperature range, especially given the expected future increases in growing season temperature. Improvement in simulation of maximum leaf area index of wheat for all models is needed. APSIM-Wheat only poorly simulated days to maturity of very and extremely late sown wheat compared to other models. Overall, there is a need of improvement in function of models to response high temperature.	[Hussain, Jamshad; Khaliq, Tasneem; Ahmad, Ashfaq] Univ Agr Faisalabad, Dept Agron, Agroclimatol Lab, Faisalabad, Pakistan; [Akhtar, Javed] Univ Agr Faisalabad, Inst Soil & Environm Sci, Faisalabad, Pakistan	University of Agriculture Faisalabad; University of Agriculture Faisalabad	Hussain, J (corresponding author), Univ Agr Faisalabad, Dept Agron, Agroclimatol Lab, Faisalabad, Pakistan.	mjamshad18@gmail.com	Khaliq, Tasneem/AAS-2143-2021; Khaliq, Tasneem/B-3603-2013; Ahmad, Ashfaq/AAF-2852-2019; Hussain, Jamshad/AAZ-2662-2021; Khaliq, Tasneem/ABB-2690-2020	Khaliq, Tasneem/0000-0002-4616-8429; Khaliq, Tasneem/0000-0002-4616-8429; Ahmad, Ashfaq/0000-0002-9249-185X; Hussain, Jamshad/0000-0003-2138-3584; Akhtar, Javaid/0000-0002-9734-7056				Ahmad A., 2015, HDB CLIMATE CHANGE A; Ananda N, 2011, IND CROP PROD, V33, P779, DOI 10.1016/j.indcrop.2011.01.007; Asseng S, 2015, NAT CLIM CHANGE, V5, P143, DOI [10.1038/nclimate2470, 10.1038/NCLIMATE2470]; Asseng S, 2013, NAT CLIM CHANGE, V3, P827, DOI [10.1038/nclimate1916, 10.1038/NCLIMATE1916]; Asseng S, 2003, AGRON J, V95, P10, DOI 10.2134/agronj2003.0010; Asseng S, 1998, FIELD CROP RES, V57, P163, DOI 10.1016/S0378-4290(97)00117-2; Asseng S, 2011, GLOBAL CHANGE BIOL, V17, P997, DOI 10.1111/j.1365-2486.2010.02262.x; Bannayan M, 2004, ECOL MODEL, V180, P277, DOI 10.1016/j.ecolmodel.2004.04.022; Barlow KM, 2015, FIELD CROP RES, V171, P109, DOI 10.1016/j.fcr.2014.11.010; Bassu S, 2009, FIELD CROP RES, V111, P109, DOI 10.1016/j.fcr.2008.11.002; Boote K.J., 2005, J AGRIC METEOROL, V60, P469, DOI [10.2480/agrmet.469, DOI 10.2480/AGRMET.469]; Boote KJ, 2013, PLANT CELL ENVIRON, V36, P1658, DOI 10.1111/pce.12119; Chen C, 2010, AGR WATER MANAGE, V97, P1175, DOI 10.1016/j.agwat.2008.11.012; Craufurd PQ, 2013, AGR FOREST METEOROL, V170, P8, DOI 10.1016/j.agrformet.2011.09.003; Heiniger RW, 1997, AGRON J, V89, P84, DOI 10.2134/agronj1997.00021962008900010013x; Hoogenboom G., 2017, DECIS SUPPORT SYST; HUNT LA, 1993, AGRON J, V85, P1090, DOI 10.2134/agronj1993.00021962008500050025x; HUNT LA, 1995, CAN J PLANT SCI, V75, P619, DOI 10.4141/cjps95-107; Hussain J, 2018, INT J ENVIRON RES, V12, P117, DOI 10.1007/s41742-018-0074-2; Jamieson PD, 1998, EUR J AGRON, V8, P161, DOI 10.1016/S1161-0301(98)00020-3; Kassie BT, 2016, EUR J AGRON, V81, P27, DOI 10.1016/j.eja.2016.08.012; Keating BA, 2013, EUROPEAN J AGRONOMY, V18, P267; Kimball BA, 2005, GLOBAL CHANGE BIOL, V11, P2041, DOI 10.1111/j.1365-2486.2005.01028.x; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Krause P., 2005, ADV GEOSCI, V5, P89, DOI [10.5194/adgeo-5-89-2005, DOI 10.5194/ADGEO-5-89-2005, DOI 10.5194/ADGE0-5-89-2005]; Legates DR, 1993, WATER RESOUR RES, V35, P233; Liu B, 2016, GLOBAL CHANGE BIOL, V22, P1890, DOI 10.1111/gcb.13212; Lobell DB, 2012, NAT CLIM CHANGE, V2, P186, DOI [10.1038/nclimate1356, 10.1038/NCLIMATE1356]; McMaster GS, 2008, ANN BOT-LONDON, V102, P561, DOI 10.1093/aob/mcn115; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; O'Leary GJ, 2015, GLOBAL CHANGE BIOL, V21, P2670, DOI 10.1111/gcb.12830; Ottman MJ, 2012, AGRON J, V104, P7, DOI 10.2134/agronj2011.0212; Palosuo T, 2011, EUR J AGRON, V35, P103, DOI 10.1016/j.eja.2011.05.001; Porter JR, 1999, EUR J AGRON, V10, P23, DOI 10.1016/S1161-0301(98)00047-1; Rezaei EE, 2015, EUR J AGRON, V64, P98, DOI 10.1016/j.eja.2014.10.003; Ritchie J.R., 1985, US DEPART AGR, V38, P159, DOI DOI 10.1007/978-1-4899-3665-3_27; Ritchie JT, 1998, SYST APPR S, V7, P79; Rosenzweig C, 1996, AGR FOREST METEOROL, V80, P215, DOI 10.1016/0168-1923(95)02299-6; Sanchez B, 2014, GLOBAL CHANGE BIOL, V20, P408, DOI 10.1111/gcb.12389; Siebert S, ENV RES LETT, V204, P9; Sinsawat V, 2004, ENVIRON EXP BOT, V52, P123, DOI 10.1016/j.envexpbot.2004.01.010; Squire G. R., 1990, PHYSL TROPICAL CROP; Timsina J, 2006, AGR SYST, V90, P5, DOI 10.1016/j.agsy.2005.11.007; Wessolek G, 2006, EUR J AGRON, V24, P333, DOI 10.1016/j.eja.2005.11.001; Wheeler TR, 1996, J EXP BOT, V47, P623, DOI 10.1093/jxb/47.5.623; WILLMOTT CJ, 1982, B AM METEOROL SOC, V63, P1309, DOI 10.1175/1520-0477(1982)063<1309:SCOTEO>2.0.CO;2; Zhang Y, 2012, CAN J PLANT SCI, V92, P937, DOI [10.4141/CJPS2011-266, 10.4141/cjps2011-266]; Zhao G, 2014, ECOL MODEL, V279, P1, DOI 10.1016/j.ecolmodel.2014.02.003	48	32	32	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0197546	10.1371/journal.pone.0197546	http://dx.doi.org/10.1371/journal.pone.0197546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902178	gold, Green Submitted, Green Published			2022-12-26	WOS:000435424900005
J	Nozaki, Y; Nakamoto, T				Nozaki, Yuji; Nakamoto, Takamichi			Predictive modeling for odor character of a chemical using machine learning combined with natural language processing	PLOS ONE			English	Article							NEURAL-NETWORKS; DIMENSIONALITY; RECEPTORS	Recent studies on machine learning technology have reported successful performances in some visual and auditory recognition tasks, while little has been reported in the field of olfaction. In this paper we report computational methods to predict the odor impression of a chemical from its physicochemical properties. Our predictive model utilizes nonlinear dimensionality reduction on mass spectra data and performs the clustering of descriptors by natural language processing. Sensory evaluation is widely used to measure human impressions to smell or taste by using verbal descriptors, such as "spicy" and "sweet". However, as it requires significant amounts of time and human resources, a large-scale sensory evaluation test is difficult to perform. Our model successfully predicts a group of descriptors for a target chemical through a series of computer simulations. Although the training text data used in the language modeling is not specialized for olfaction, the experimental results show that our method is useful for analyzing sensory datasets. This is the first report to combine machine olfaction with natural language processing for odor character prediction.	[Nozaki, Yuji; Nakamoto, Takamichi] Tokyo Inst Technol, Inst Innovat Res, Yokohama, Kanagawa, Japan	Tokyo Institute of Technology	Nakamoto, T (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Yokohama, Kanagawa, Japan.	nakamoto.t.ab@m.titech.ac.jp		Nakamoto, Takamichi/0000-0002-0599-226X	Japan Science and Technology Agency (JST), Japan [JPMJMI17DD]	Japan Science and Technology Agency (JST), Japan(Japan Science & Technology Agency (JST))	This work was supported by Japan Science and Technology Agency (JST) to Takamichi Nakamoto, JST (Japan Science and Technology Agency)-Mirai Program, Grant Number JPMJMI17DD, Japan.	[Anonymous], 1990, HANDWRITTEN DIGIT RE; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHUI CK, 1992, J APPROX THEORY, V70, P131, DOI 10.1016/0021-9045(92)90081-X; Dravnieks A., 1992, ATLAS ODOR CHARACTER; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Mikolov T., 2013, ARXIV13104546 CS STA; Mikolov T, 2013, ARXIV13013781 CS; Nozaki Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157030; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; SIgma-Aldrich, FLAV FRAGR; Sireci SG, 2003, J EDUC MEAS, V40, P277, DOI 10.1111/j.1745-3984.2003.tb01108.x; SUFFET IH, 1988, WATER SCI TECHNOL, V20, P1; Szekely GJ, 2005, J CLASSIF, V22, P151, DOI 10.1007/s00357-005-0012-9; Takamichi N., 2016, ESSENTIALS MACHINE O, V1; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; TRUNK GV, 1979, IEEE T PATTERN ANAL, V1, P306, DOI 10.1109/TPAMI.1979.4766926; WIEGERINCK W, 1994, J PHYS A-MATH GEN, V27, P4425, DOI 10.1088/0305-4470/27/13/017	19	18	18	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198475	10.1371/journal.pone.0198475	http://dx.doi.org/10.1371/journal.pone.0198475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902194	Green Published, gold, Green Submitted			2022-12-26	WOS:000435424900026
J	Patael, SZ; Farris, EA; Black, JM; Hancock, R; Gabrieli, JDE; Cutting, LE; Hoeft, F				Patael, Smadar Z.; Farris, Emily A.; Black, Jessica M.; Hancock, Roeland; Gabrieli, John D. E.; Cutting, Laurie E.; Hoeft, Fumiko			Brain basis of cognitive resilience: Prefrontal cortex predicts better reading comprehension in relation to decoding	PLOS ONE			English	Article							WORKING-MEMORY; EXECUTIVE FUNCTION; SPOKEN LANGUAGE; GRAY-MATTER; SIMPLE VIEW; CHILDREN; DYSLEXIA; TEXT; SKILLS; AGE	Objective The ultimate goal of reading is to understand written text. To accomplish this, children must first master decoding, the ability to translate printed words into sounds. Although decoding and reading comprehension are highly interdependent, some children struggle to decode but comprehend well, whereas others with good decoding skills fail to comprehend. The neural basis underlying individual differences in this discrepancy between decoding and comprehension abilities is virtually unknown. Methods We investigated the neural basis underlying reading discrepancy, defined as the difference between reading comprehension and decoding skills, in a three-part study: 1) The neuroanatomical basis of reading discrepancy in a cross-sectional sample of school-age children with a wide range of reading abilities (Experiment-1; n = 55); 2) Whether a discrepancy-related neural signature is present in beginning readers and predictive of future discrepancy (Experiment-2; n = 43); and 3) Whether discrepancy-related regions are part of a domaingeneral or a language specialized network, utilizing the 1000 Functional Connectome data and large-scale reverse inference from Neurosynth.org (Experiment-3). Results Results converged onto the left dorsolateral prefrontal cortex (DLPFC), as related to having discrepantly higher reading comprehension relative to decoding ability. Increased gray matter volume (GMV) was associated with greater discrepancy (Experiment-1). Region-ofinterest (ROI) analyses based on the left DLPFC cluster identified in Experiment-1 revealed that regional GMV within this ROI in beginning readers predicted discrepancy three years later (Experiment-2). This region was associated with the fronto-parietal network that is considered fundamental for working memory and cognitive control (Experiment-3). Interpretation Processes related to the prefrontal cortex might be linked to reading discrepancy. The findings may be important for understanding cognitive resilience, which we operationalize as those individuals with greater higher-order reading skills such as reading comprehension compared to lower-order reading skills such as decoding skills. Our study provides insights into reading development, existing theories of reading, and cognitive processes that are potentially significant to a wide range of reading disorders.	[Patael, Smadar Z.; Farris, Emily A.; Hoeft, Fumiko] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Patael, Smadar Z.; Farris, Emily A.; Hoeft, Fumiko] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Patael, Smadar Z.] Tel Aviv Univ, Dept Commun Disorders, Tel Aviv, Israel; [Farris, Emily A.] Middle Tennessee State Univ, Tennessee Ctr Study & Treatment Dyslexia, Murfreesboro, TN 37130 USA; [Black, Jessica M.] Boston Coll, Sch Social Work, McGuinn Hall, Chestnut Hill, MA 02167 USA; [Hancock, Roeland] Univ Connecticut, Dept Psychol Sci, Storrs, CT USA; [Hancock, Roeland] Univ Connecticut, Brain Imaging Res Ctr, Storrs, CT USA; [Gabrieli, John D. E.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Gabrieli, John D. E.] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gabrieli, John D. E.] Inst Med Engn & Sci, Cambridge, MA USA; [Cutting, Laurie E.] Vanderbilt Univ, Peabody Coll, Nashville, TN 37203 USA; [Cutting, Laurie E.] Vanderbilt Univ, Vanderbilt Brain Inst, 221 Kirkland Hall, Nashville, TN 37235 USA; [Cutting, Laurie E.; Hoeft, Fumiko] Haskins Labs Inc, New Haven, CT 06511 USA; [Hoeft, Fumiko] UC Stanford Multiuniv Precis Learning Ctr, San Francisco, CA 94143 USA; [Hoeft, Fumiko] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Tel Aviv University; Middle Tennessee State University; Boston College; University of Connecticut; University of Connecticut; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Vanderbilt University; Vanderbilt University Peabody College; Vanderbilt University; Yale University; Haskins Laboratories; Keio University	Hoeft, F (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.; Hoeft, F (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA.; Hoeft, F (corresponding author), Haskins Labs Inc, New Haven, CT 06511 USA.; Hoeft, F (corresponding author), UC Stanford Multiuniv Precis Learning Ctr, San Francisco, CA 94143 USA.; Hoeft, F (corresponding author), Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan.	fumiko.hoeft@ucsf.edu	Hancock, Roeland/AAV-3040-2020; Gabrieli, John/AAJ-2869-2020	Hancock, Roeland/0000-0001-8932-6872; 	National Institute of Child Health and Human Development (NICHD) [K23HD054720]; NICHD [R01HD086168, R01HD078351, R01HD065794, P01HD001994, P50HD052120, R01HD067254, R01HD044073, U54HD083211, R21HD087088, R01HD089474]; National Science Foundation [NSF-1540854]; University of California Office of the President Multicampus Research Programs and Initiatives Award [MRP-17-454925]; Oak Foundation [RIO-16-012]; UCSF Dyslexia Center; Dyslexia Training Institute; Potter Family; Currey Ingram Academy; CCC-UCSF Neuroscience of Creativity Fellowship Award; Tel Aviv University post-doctoral fellowship; Boston College Ignite Grant; Boston College Research Incentive Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD078351, R37HD095519, P01HD001994, R01HD067254, R01HD044073, K23HD054720, P50HD052120, R01HD065794, R01HD086168, R21HD087088, U54HD083211, R01HD089474] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Science Foundation(National Science Foundation (NSF)); University of California Office of the President Multicampus Research Programs and Initiatives Award(University of California System); Oak Foundation; UCSF Dyslexia Center; Dyslexia Training Institute; Potter Family; Currey Ingram Academy; CCC-UCSF Neuroscience of Creativity Fellowship Award; Tel Aviv University post-doctoral fellowship; Boston College Ignite Grant; Boston College Research Incentive Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Research was funded by the National Institute of Child Health and Human Development (NICHD) K23HD054720. FH was funded by NICHD R01HD086168, R01HD078351, R01HD065794 (PI: K. Pugh), P01HD001994 (PI: J. Rueckl), P50HD052120 (PI: R. Wagner), National Science Foundation NSF-1540854, University of California Office of the President Multicampus Research Programs and Initiatives Award MRP-17-454925, Oak Foundation RIO-16-012, UCSF Dyslexia Center, Ray & Lori dePole, Dyslexia Training Institute, The Potter Family, and Currey Ingram Academy. LC was funded by NICHD R01HD067254, R01HD044073, U54HD083211, R21HD087088 and R01HD089474. SP was supported by the CCC-UCSF Neuroscience of Creativity Fellowship Award and the Tel Aviv University post-doctoral fellowship. JB was funded by the Boston College Ignite Grant and Boston College Research Incentive Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud KS, 2016, DEVELOPMENTAL SCI, V19, P632, DOI 10.1111/desc.12422; Arrington CN, 2014, SCI STUD READ, V18, P325, DOI 10.1080/10888438.2014.902461; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bailey S, 2016, ANN DYSLEXIA, V66, P256, DOI 10.1007/s11881-015-0114-y; Barnes J, 2010, NEUROIMAGE, V53, P1244, DOI 10.1016/j.neuroimage.2010.06.025; Bartres-Faz D, 2009, BIOL PSYCHOL, V80, P256, DOI 10.1016/j.biopsycho.2008.10.005; Binder Katherine S, 2012, J Res Pract Adult Lit Second Basic Educ, V1, P78; Black JM, 2012, NEUROIMAGE, V59, P3021, DOI 10.1016/j.neuroimage.2011.10.024; Bornstein Marc H., 2014, SOCIOECONOMIC STATUS, DOI DOI 10.4324/9781410607027; Cain K, 2006, BRIT J EDUC PSYCHOL, V76, P683, DOI 10.1348/000709905X67610; Carretti B, 2009, LEARN INDIVID DIFFER, V19, P246, DOI 10.1016/j.lindif.2008.10.002; Catts HW, 2006, J SPEECH LANG HEAR R, V49, P278, DOI 10.1044/1092-4388(2006/023); Catts HW, 2005, J SPEECH LANG HEAR R, V48, P1378, DOI 10.1044/1092-4388(2005/096); Christopher ME, 2012, J EXP PSYCHOL GEN, V141, P470, DOI 10.1037/a0027375; Clark KA, 2014, BRAIN, V137, P3136, DOI 10.1093/brain/awu229; Clarke PJ, 2010, PSYCHOL SCI, V21, P1106, DOI 10.1177/0956797610375449; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cutting L., 2015, READING INTERVENTION; Cutting LE, 2006, SCI STUD READ, V10, P277, DOI 10.1207/s1532799xssr1003_5; Cutting LE, 2013, BRAIN CONNECT, V3, P199, DOI 10.1089/brain.2012.0116; Cutting LE, 2009, ANN DYSLEXIA, V59, P34, DOI 10.1007/s11881-009-0022-0; Dahlin KIE, 2011, READ WRIT, V24, P479, DOI 10.1007/s11145-010-9238-y; DeGutis J, 2013, COGNITION, V126, P87, DOI 10.1016/j.cognition.2012.09.004; Dunn LM, 1997, PPVT 3 PEABODY PICTU; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Eklund KM, 2013, DYSLEXIA, V19, P1, DOI 10.1002/dys.1447; Elwer A, 2013, J EXP CHILD PSYCHOL, V115, P497, DOI 10.1016/j.jecp.2012.12.001; Fedorenko E, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00335; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; Fletcher JM, 1998, LEARNING DISABILITIE; Follmer DJ, 2018, EDUC PSYCHOL-US, V53, P42, DOI 10.1080/00461520.2017.1309295; Gimenez P, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00155; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Gough P. B., 1986, REM SPEC EDUC, V7, P6, DOI [10.1177/074193258600700104, DOI 10.1177/074193258600700104]; Haft SL, 2016, CURR OPIN BEHAV SCI, V10, P133, DOI 10.1016/j.cobeha.2016.06.005; Hoeft F, 2007, P NATL ACAD SCI USA, V104, P4234, DOI 10.1073/pnas.0609399104; Hoeft F, 2011, P NATL ACAD SCI USA, V108, P361, DOI 10.1073/pnas.1008950108; HOOVER WA, 1990, READ WRIT, V2, P127, DOI 10.1007/BF00401799; Hosseini SMH, 2013, NEUROIMAGE, V71, P260, DOI 10.1016/j.neuroimage.2013.01.013; Hudson N., 2016, PERSPECT LANG LIT, V42, P23; Hutzler F, 2014, NEUROIMAGE, V84, P1061, DOI 10.1016/j.neuroimage.2012.12.075; Jackson NE, 2002, J EDUC PSYCHOL, V94, P64, DOI 10.1037//0022-0663.94.1.64; Keenan JM, 2014, ANN PSYCHOL, V114, P753; Kintsch W, 2011, TOP COGN SCI, V3, P346, DOI 10.1111/j.1756-8765.2010.01107.x; Kovelman I, 2012, CEREB CORTEX, V22, P754, DOI 10.1093/cercor/bhr094; LABERGE D, 1974, COGNITIVE PSYCHOL, V6, P293, DOI 10.1016/0010-0285(74)90015-2; Landi N, 2017, LANG LINGUIST COMPAS, V11, DOI 10.1111/lnc3.12234; Landi N, 2013, READ WRIT Q, V29, P145, DOI 10.1080/10573569.2013.758566; Lefly DL, 2000, J LEARN DISABIL-US, V33, P286, DOI 10.1177/002221940003300306; Lieberman MD, 2015, P NATL ACAD SCI USA, V112, P15250, DOI 10.1073/pnas.1515083112; Locascio G, 2010, J LEARN DISABIL-US, V43, P441, DOI 10.1177/0022219409355476; Margolis A, 2013, J NEUROSCI, V33, P14135, DOI 10.1523/JNEUROSCI.0775-13.2013; May A, 2011, TRENDS COGN SCI, V15, P475, DOI 10.1016/j.tics.2011.08.002; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Moss J, 2011, NEUROIMAGE, V58, P675, DOI 10.1016/j.neuroimage.2011.06.034; Myers CA, 2014, PSYCHOL SCI, V25, P1870, DOI 10.1177/0956797614544511; Nation K, 2010, J CHILD PSYCHOL PSYC, V51, P1031, DOI 10.1111/j.1469-7610.2010.02254.x; Perfetti C.A., 1999, NEUROCOGNITION LANGU, P167, DOI DOI 10.1093/ACPROF:OSO/9780198507932.0006; Perfetti C, 2014, SCI STUD READ, V18, P22, DOI 10.1080/10888438.2013.827687; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Rashotte, 1999, TOWRE 2 TEST WORD RE; Reynolds R.E., 2000, SCI STUD READ, V4, P169, DOI [10.1207/s1532799xssr0403_1, DOI 10.1207/S1532799XSSR0403_1, https://doi.org/10.1207/S1532799XSSR0403_1]; Garcia JR, 2014, REV EDUC RES, V84, P74, DOI 10.3102/0034654313499616; Sesma HW, 2009, CHILD NEUROPSYCHOL, V15, P232, DOI 10.1080/09297040802220029; Spencer M, 2014, LEARN DISABIL RES PR, V29, P3, DOI 10.1111/ldrp.12024; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stuebing KK, 2002, AM EDUC RES J, V39, P469, DOI 10.3102/00028312039002469; Stuss D, 2013, PRINCIPLES FRONTAL L; Swanson HL, 2006, J LEARN DISABIL-US, V39, P252; Tanaka H, 2011, PSYCHOL SCI, V22, P1442, DOI 10.1177/0956797611419521; Thompson PA, 2015, J CHILD PSYCHOL PSYC, V56, P976, DOI 10.1111/jcpp.12412; Torgesen J.K., 1999, COMPREHENSIVE TEST P; van Viersen S, 2016, J LEARN DISABIL-US, V49, P189, DOI 10.1177/0022219414538517; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Weiderholt J, 1992, GORT 3 GRAY ORAL REA; Welcome SE, 2011, HUM BRAIN MAPP, V32, P1194, DOI 10.1002/hbm.21101; Welcome SE, 2010, BRAIN LANG, V113, P73, DOI 10.1016/j.bandl.2010.01.003; Welcome SE, 2009, READ WRIT, V22, P353, DOI 10.1007/s11145-008-9120-3; Wolf M., 2005, RAN RAS RAPID AUTOMA; Woodcock R.W., 2001, WOODCOCK JOHNSON 3 T; Woodcock R. W., 1997, WOODCOCK DIAGNOSTIC; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	86	16	17	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198791	10.1371/journal.pone.0198791	http://dx.doi.org/10.1371/journal.pone.0198791			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ5MF	29902208	Green Published, gold			2022-12-26	WOS:000435424900043
J	Zhao, CJ; Wong, LP; Zhu, Q; Yang, H				Zhao, Chanjuan; Wong, Liping; Zhu, Qing; Yang, Hao			Prevalence and correlates of chronic diseases in an elderly population: A community-based survey in Haikou	PLOS ONE			English	Article							NONCOMMUNICABLE DISEASES; RISK-FACTORS; HYPERTENSION; DETERMINANTS; BEHAVIORS; HEALTH; WOMEN; MEN	Background The escalating problem of multiple chronic conditions among older adults in China draws public health attention due to increasing proportion of the elderly population. This study sought to assess the prevalence of and factors associated with four chronic diseases in older adults in Haikou, the capital city of Hainan Province, China. Method In this cross-sectional study, 9432 community-dwelling elderly people aged 60 years and older living in rural or urban areas in Haikou were investigated. The interviews collected selfreported information on the presence of four major chronic diseases, as well as socio-demographic characteristics, lifestyle factors and self-reported height and weight. Findings Overall, 31.7% (2961/9344) reported at least one of the four chronic diseases. The prevalence of hypertension, diabetes mellitus, COPD, and stroke was 26.0% (2449/9407), 8.0% (749/9371), 1.0% (95/9360), and 1.9% (175/9382), respectively. Common correlates of the four major chronic diseases were older age, being engaged in intellectual work, currently being a smoker and obesity. Gender, locality of residence, and alcohol consumptions were also found to be associated to some of the chronic conditions. Conclusion This finding indicates that multiple chronic conditions among elderly people in Haikou are prevalent and warrant special attention to reduce diseases burden and align health care services to cater the holistic elderly patients' need.	[Zhao, Chanjuan] Hainan Med Univ, Coll Publ Hlth, Haikou, Hainan, Peoples R China; [Wong, Liping] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Zhu, Qing; Yang, Hao] Haikou Ctr Dis Control & Prevent, Dept Noncommunicable Dis Control & Prevent, Haikou, Hainan, Peoples R China	Hainan Medical University; Universiti Malaya	Zhao, CJ (corresponding author), Hainan Med Univ, Coll Publ Hlth, Haikou, Hainan, Peoples R China.	changjuan850@163.com	WONG, LI PING/B-2782-2010	WONG, LI PING/0000-0002-0107-0532	Hainan Provincial Department of Science and Technology [814384]; Industrial Informatization, Science and Technology Office of Haikou City [20150128]; Hainan Provincial Department of Education [2015041]	Hainan Provincial Department of Science and Technology; Industrial Informatization, Science and Technology Office of Haikou City; Hainan Provincial Department of Education	This work was supported by the Hainan Provincial Department of Science and Technology (http://dost.hainan.gov.cn/) (Grant 814384), the Industrial Informatization, Science and Technology Office of Haikou City (http://www.hksti.gov.cn/) (Grant 20150128), and the Hainan Provincial Department of Education (http://edu.hainan.gov.cn/) (Grant 2015041).	Abdullah ASM, 2006, J AGING HEALTH, V18, P552, DOI 10.1177/0898264305281104; Aboyade OM, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1378-4; Audrey O., 2016, J NUTR EDUC BEHAV, V48, pS111, DOI [10.1016/j.jneb.2016.04.293, DOI 10.1016/J.JNEB.2016.04.293]; Avci IA, 2016, PROG NUTR, V18, P26; Cai JL, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-016-0496-4; Cao QQ, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2835-1; [陈晨 Chen Chen], 2016, [中国全科医学, Chinese General Practice], V19, P220; China Center of Disease Control and Prevention, 2010, REP CHRON DIS RISK F; China Center of Disease Control and Prevention, 2010, REP CHRON DIS RISK F; Doulougou B, 2016, J HUM HYPERTENS, V30, P112, DOI 10.1038/jhh.2015.30; Feng XL, 2014, B WORLD HEALTH ORGAN, V92, P29, DOI 10.2471/BLT.13.124495; Frost M, 2012, AGE AGEING, V41, P177, DOI 10.1093/ageing/afr153; Gupta R, 2008, HEART, V94, P16, DOI 10.1136/hrt.2007.132951; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; He YH, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.015; Hewitt J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009161; Kraja Fatjona, 2016, Med Arch, V70, P208, DOI 10.5455/medarh.2016.70.208-212; Li YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033881; Mohan I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149437; National Health Commission of the People's Republic of China, 2015, REP CHIN RES CHRON D; Ogah OS, 2013, ETHNIC DIS, V23, P161; Ogah OS, 2016, ETHNIC DIS, V23, P161; Pan XQ, 2010, JIANGSU YU FANG YI X, V21, P17; Rani F, 2016, ANN ABBASI SHAHEED H, V21, P9; Sachs EN, 2009, NICOTINE TOB RES, V11, P433; Shaw KM, 2016, PREVENTING CHRONIC D, V13, P1; Shi J, 2007, PREVENTIVE MED TRIBU, V7, P003; Shi SongHe, 2016, Modern Preventive Medicine, V43, P115; Sun L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072537; Suzman R, 2011, GLOBAL HLTH AGING PR; Tang SN, 2013, CHINESE J HLTH POLIC, V5, P51; Terzikhan N, 2016, EUROPEAN J EPIDEMIOL, P1; [涂明利 Tu Mingli], 2016, [中华疾病控制杂志, Chinese Journal of Disease Control & Prevention], V20, P129; Wang J H, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P1220, DOI 10.3760/cma.j.issn.0254-6450.2016.09.007; World Health Organization, 2009, WHO REP GLOB TOB EP; Wu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074176; Wu XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078629; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205	38	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199006	10.1371/journal.pone.0199006	http://dx.doi.org/10.1371/journal.pone.0199006			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902222	gold, Green Published, Green Submitted			2022-12-26	WOS:000435424900072
J	Blackwell, SB; Tervo, OM; Conrad, AS; Sinding, MHS; Hansen, RG; Ditlevsen, S; Heide-Jorgensen, MP				Blackwell, Susanna B.; Tervo, Outi M.; Conrad, Alexander S.; Sinding, Mikkel H. S.; Hansen, Rikke G.; Ditlevsen, Susanne; Heide-Jorgensen, Mads Peter			Spatial and temporal patterns of sound production in East Greenland narwhals	PLOS ONE			English	Article							WHALES MESOPLODON-DENSIROSTRIS; FREE-RANGING NARWHALS; MONODON-MONOCEROS; TURSIOPS-TRUNCATUS; SIGNATURE WHISTLES; PREY CAPTURE; ECHOLOCATION; BEHAVIOR; CETACEANS; MOVEMENTS	Changes in climate are rapidly modifying the Arctic environment. As a result, human activities and the sounds they produce are predicted to increase in remote areas of Greenland, such as those inhabited by the narwhals (Monodon monoceros) of East Greenland. Meanwhile, nothing is known about these whales' acoustic behavior or their reactions to anthropogenic sounds. This lack of knowledge was addressed by instrumenting six narwhals in Scoresby Sound (Aug 2013-2016) with Acousonde (TM) acoustic tags and satellite tags. Continuous recordings over up to seven days were used to describe the acoustic behavior of the whales, in particular their use of three types of sounds serving two different purposes: echolocation clicks and buzzes, which serve feeding, and calls, presumably used for social communication. Logistic regression models were used to assess the effects of location in time and space on buzzing and calling rates. Buzzes were mostly produced at depths of 350-650 m and buzzing rates were higher in one particular fjord, likely a preferred feeding area. Calls generally occurred at shallower depths (<100 m), with more than half of these calls occurring near the surface (<7 m), where the whales also spent more than half of their time. A period of silence following release, present in all subjects, was attributed to the capture and tagging operations, emphasizing the importance of longer (multi-day) records. This study provides basic life-history information on a poorly known species and therefore control data in ongoing or future sound-effect studies.	[Blackwell, Susanna B.; Conrad, Alexander S.] Greeneridge Sci Inc, Santa Barbara, CA 93117 USA; [Tervo, Outi M.; Sinding, Mikkel H. S.; Hansen, Rikke G.; Heide-Jorgensen, Mads Peter] Greenland Inst Nat Resources, Copenhagen, Denmark; [Ditlevsen, Susanne] Univ Copenhagen, Dept Math Sci, Data Sci Lab, Copenhagen, Denmark	Greenland Institute of Natural Resources; University of Copenhagen	Blackwell, SB (corresponding author), Greeneridge Sci Inc, Santa Barbara, CA 93117 USA.	susanna@greeneridge.com	Ditlevsen, Susanne/F-6708-2012; Strander Sinding, Mikkel Holger/B-9450-2015	Ditlevsen, Susanne/0000-0002-1998-2783; Blackwell, Susanna B./0000-0001-7158-6852; Strander Sinding, Mikkel Holger/0000-0003-1371-219X	Greenland Institute of Natural Resources; Greenland Ministry of Education, Church, Culture & Gender Equality; Danish Cooperation for the Environment in the Arctic (DANCEA) under the Danish Ministry of Environment; Carlsberg Foundation [2013_01_0289, CF14-0169]; Bureau of Minerals and Petroleum in Greenland; Greeneridge Sciences, Inc.	Greenland Institute of Natural Resources; Greenland Ministry of Education, Church, Culture & Gender Equality; Danish Cooperation for the Environment in the Arctic (DANCEA) under the Danish Ministry of Environment; Carlsberg Foundation(Carlsberg Foundation); Bureau of Minerals and Petroleum in Greenland; Greeneridge Sciences, Inc.	Funding support was provided to MPHJ by the Greenland Institute of Natural Resources (www.natur.gl), the Greenland Ministry of Education, Church, Culture & Gender Equality (http://naalakkersuisut.gl/da/Naalakkersuisut/Departementer/Uddannelse-Kultur-Forskning-ogKirke/Uddannelse-og-Forskning/Forskning), the Danish Cooperation for the Environment in the Arctic (DANCEA, http://mst.dk/kemi/kemikalier/arktis/dancea-miljoestoette-til-arktis/) under the Danish Ministry of Environment, the Carlsberg Foundation (grant number 2013_01_0289 and CF14-0169, http://www.carlsbergfondet.dk/da), and the Bureau of Minerals and Petroleum in Greenland (hops://www.govmin.gl/petroleum). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SBB and ASC are employed by Greeneridge Sciences, Inc., an independent, commercial contracting company that performs studies of the interactions between underwater sounds and marine vertebrates. Greeneridge Sciences, Inc., provided support in the form of salaries for SBB and ASC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arranz P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028353; Blair HB, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0005; DeRuiter SL, 2009, J EXP BIOL, V212, P3100, DOI 10.1242/jeb.030825; Dietz Rune, 2007, BMC Ecology, V7, P14, DOI 10.1186/1472-6785-7-14; Fenton B, 2014, SPRINGER HANDB AUDIT, V51, P11, DOI 10.1007/978-1-4614-9146-0_2; Finley K.J., 1990, Canadian Bulletin of Fisheries and Aquatic Sciences, V224, P97; FORD JKB, 1978, CAN J ZOOL, V56, P552, DOI 10.1139/z78-079; Garde E, 2017, NAMMCOSC24JCNBSWG201; Heide-Jorgensen MP, 2015, J ZOOL, V297, P54, DOI 10.1111/jzo.12257; Heide-Jorgensen MP, 2017, MAR MAMMAL SCI, V33, P713, DOI 10.1111/mms.12394; Heide-Jorgensen MP, 2013, BIOL CONSERV, V158, P50, DOI 10.1016/j.biocon.2012.08.005; Heide-Jorgensen MP, 2002, POLAR BIOL, V25, P331, DOI 10.1007/s00300-001-0347-6; Heide-Jorgensen MP, 2014, ANIM BIOTELEM, V2, P9, DOI DOI 10.1186/2050-3385-2-9; Herzing DL., 2015, ANIM BEHAV COGNIT, V2, P14, DOI [10.12966/abc.02.02.2015, DOI 10.12966/ABC.02.02.2015]; Janik VM, 1998, ANIM BEHAV, V56, P829, DOI 10.1006/anbe.1998.0881; Jepsen HF, 2005, DANMARKS GRONLANDS G; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Johnson M, 2006, J EXP BIOL, V209, P5038, DOI 10.1242/jeb.02596; Johnson M, 2014, SPRINGER HANDB AUDIT, V51, P195, DOI 10.1007/978-1-4614-9146-0_7; Johnson M, 2009, MAR ECOL PROG SER, V395, P55, DOI 10.3354/meps08255; Kaplan MB, 2014, J ACOUST SOC AM, V136, P1394, DOI 10.1121/1.4892759; Koblitz JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162069; Laidre KL, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0457; Madsen PT, 2013, J COMP PHYSIOL A, V199, P451, DOI 10.1007/s00359-013-0824-8; Marcoux M, 2012, MAR MAMMAL SCI, V28, P649, DOI 10.1111/j.1748-7692.2011.00514.x; MILLER LA, 1995, MAR MAMMAL SCI, V11, P491, DOI 10.1111/j.1748-7692.1995.tb00672.x; Miller PJO, 2004, P ROY SOC B-BIOL SCI, V271, P2239, DOI 10.1098/rspb.2004.2863; MOHL B, 1990, NATO ADV SCI I A-LIF, V196, P295; Moore SE, 2012, POLAR BIOL, V35, P475, DOI 10.1007/s00300-011-1086-y; Palsboll PJ, 1997, HEREDITY, V78, P284; Rasmussen MH, 2015, AQUAT MAMM, V41, P256, DOI 10.1578/AM.41.3.2015.256; Reeves RR, 2014, MAR POLICY, V44, P375, DOI 10.1016/j.marpol.2013.10.005; SAYIGH LS, 1990, BEHAV ECOL SOCIOBIOL, V26, P247; Sayigh LS, 1999, ANIM BEHAV, V57, P41, DOI 10.1006/anbe.1998.0961; Shapiro AD, 2006, J ACOUST SOC AM, V120, P1695, DOI 10.1121/1.2226586; Soto NA, 2006, MAR MAMMAL SCI, V22, P690, DOI 10.1111/j.1748-7692.2006.00044.x; Stafford KM, 2012, MAR MAMMAL SCI, V28, pE197, DOI 10.1111/j.1748-7692.2011.00500.x; Surlykke A., 2014, SPRINGER HDB AUDITOR, V51; WATKINS WA, 1971, J ACOUST SOC AM, V49, P595, DOI 10.1121/1.1912391; Watt CA, 2015, MAR ECOL PROG SER, V525, P273, DOI 10.3354/meps11202; Watt CA, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00137.1; Williams TM, 2017, SCIENCE, V358, P1329, DOI 10.1126/science.aao2740; Wisniewska DM, 2014, J EXP BIOL, V217, P4279, DOI 10.1242/jeb.113415; Wisniewska DM, 2016, CURR BIOL, V26, P1441, DOI 10.1016/j.cub.2016.03.069; Zimmer WMX, 2005, J ACOUST SOC AM, V117, P3919, DOI 10.1121/1.1910225	46	15	17	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198295	10.1371/journal.pone.0198295	http://dx.doi.org/10.1371/journal.pone.0198295			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897955	Green Published, gold			2022-12-26	WOS:000435090700051
J	Gubensek, J; Strobl, K; Harm, S; Weiss, R; Eichhorn, T; Buturovic-Ponikvar, J; Weber, V; Hartmann, J				Gubensek, Jakob; Strobl, Karin; Harm, Stephan; Weiss, Rene; Eichhorn, Tanja; Buturovic-Ponikvar, Jadranka; Weber, Viktoria; Hartmann, Jens			Influence of citrate concentration on the activation of blood cells in an in vitro dialysis setup	PLOS ONE			English	Article							POLYMORPHONUCLEAR CELLS; EXTRACELLULAR VESICLES; ADSORBENT POLYMERS; IONIZED CALCIUM; WHOLE-BLOOD; ANTICOAGULATION; MICROVESICLES; DEGRANULATION; HEMODIALYSIS; RELEASE	Background Regional citrate anticoagulation has been associated with enhanced biocompatibility in hemodialysis, but the optimal dose of citrate remains to be established. Here, we compared parameters related to cellular activation during in vitro dialysis, using two doses of citrate. Methods Human whole blood, anticoagulated with either 3 mM or 4 mM of citrate, was recirculated in an in vitro miniaturized dialysis setup. Complement (C3a-desArg), soluble platelet factor 4 (PF4), thromboxane B2 (TXB2), myeloperoxidase (MPO), as well as platelet-and red blood cell -derived extracellular vesicles (EV) were quantified during recirculation. Dialyzer fibers were examined by scanning electron microscopy after recirculation to assess the activation of clotting and the deposition of blood cells. Results Increases in markers of platelet and leukocyte activation, PF4, TXB2, and MPO were comparable between both citrate groups. Complement activation tended to be lower at higher citrate concentration, but the difference between the two citrate groups did not reach significance. A strong increase in EVs, particularly platelet -derived EVs, was observed during in vitro dialysis for both citrate groups, which was significantly less pronounced in the high citrate group at the end of the experiment. Assessment of dialyzer clotting scores after analysis of individual fibers by scanning electron microscopy revealed significantly lower scores in the high citrate group. Conclusions Our data indicate that an increase in the citrate concentration from 3 mM to 4 mM further dampens cellular activation, thereby improving biocompatibility. A concentration of 4 mM citrate might therefore be optimal for use in clinical practice.	[Gubensek, Jakob; Buturovic-Ponikvar, Jadranka] Univ Med Ctr Ljubljana, Dept Nephrol, Ljubljana, Slovenia; [Gubensek, Jakob; Buturovic-Ponikvar, Jadranka] Univ Ljubljana, Fac Med, Ljubljana, Slovenia; [Strobl, Karin; Harm, Stephan; Weiss, Rene; Eichhorn, Tanja; Weber, Viktoria; Hartmann, Jens] Danube Univ Krems, Dept Hlth Sci & Biomed, Ctr Biomed Technol, Krems, Austria; [Weiss, Rene; Eichhorn, Tanja; Weber, Viktoria] Danube Univ Krems, Christian Doppler Lab Innovat Therapy Approaches, Krems, Austria	University Medical Centre Ljubljana; University of Ljubljana; Danube University Krems; Danube University Krems	Gubensek, J (corresponding author), Univ Med Ctr Ljubljana, Dept Nephrol, Ljubljana, Slovenia.; Gubensek, J (corresponding author), Univ Ljubljana, Fac Med, Ljubljana, Slovenia.	jakob.gubensek@kclj.si	Gubensek, Jakob/A-5077-2010	Gubensek, Jakob/0000-0002-5394-3729; Buturovic-Ponikvar, Jadranka/0000-0001-7473-3731; weber, viktoria/0000-0002-3963-9077; Weiss, Rene/0000-0003-0715-0493; Hartmann, Jens/0000-0002-7343-1851; Harm, Stephan/0000-0003-1944-9898; Eichhorn, Tanja/0000-0003-4158-026X	government of Lower Austria; European Regional Development Fund [WST3-T-91/040-2016]; Christian Doppler Society (Christian Doppler Laboratory for Innovative Therapy Approaches in Sepsis)	government of Lower Austria; European Regional Development Fund(European Commission); Christian Doppler Society (Christian Doppler Laboratory for Innovative Therapy Approaches in Sepsis)	This work was funded by the government of Lower Austria and the European Regional Development Fund (Project ID WST3-T-91/040-2016) and by the Christian Doppler Society (Christian Doppler Laboratory for Innovative Therapy Approaches in Sepsis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, NEPHROL DIAL TRANSPL, V17, P63; Apsner R, 2001, AM J KIDNEY DIS, V38, P979, DOI 10.1053/ajkd.2001.28584; Bai M, 2015, INTENS CARE MED, V41, P2098, DOI 10.1007/s00134-015-4099-0; Bos JC, 1997, NEPHROL DIAL TRANSPL, V12, P1387, DOI 10.1093/ndt/12.7.1387; Buturovic J, 2008, ARTIF ORGANS, V32, P77, DOI 10.1111/j.1525-1594.2007.00459.x; Buturovic-Ponikvar J, 2016, THER APHER DIAL, V20, P234, DOI 10.1111/1744-9987.12429; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Evenepoel P, 2002, AM J KIDNEY DIS, V39, P315, DOI 10.1053/ajkd.2002.30551; Fendl B, 2016, BIOCHEM BIOPH RES CO, V478, P168, DOI 10.1016/j.bbrc.2016.07.073; Gabutti L, 2004, J NEPHROL, V17, P819; Goubran HA, 2015, TRANSFUS APHER SCI, V52, P12, DOI 10.1016/j.transci.2014.12.015; Gritters M, 2006, NEPHROL DIAL TRANSPL, V21, P153, DOI 10.1093/ndt/gfi069; Grooteman MPC, 2000, NEPHRON, V85, P267, DOI 10.1159/000045671; HAKIM RM, 1984, KIDNEY INT, V26, P194, DOI 10.1038/ki.1984.155; HOCKEN AG, 1987, NEPHRON, V46, P7, DOI 10.1159/000184287; Hofbauer R, 1999, KIDNEY INT, V56, P1578, DOI 10.1046/j.1523-1755.1999.00671.x; Jacobs R, 2015, BLOOD PURIFICAT, V40, P194, DOI 10.1159/000438820; Melki I, 2017, PLATELETS, V28, P214, DOI 10.1080/09537104.2016.1265924; OMOKAWA S, 1990, INT J ARTIF ORGANS, V13, P768, DOI 10.1177/039139889001301110; Opatrny K, 2007, ARTIF ORGANS, V31, P200, DOI 10.1111/j.1525-1594.2007.00365.x; Richtrova P, 2011, ARTIF ORGANS, V35, P83, DOI 10.1111/j.1525-1594.2010.01038.x; Sadilkova L, 2012, CLIN LAB, V58, P177; Strobl K, 2017, INT J ARTIF ORGANS, V40, P15, DOI 10.5301/ijao.5000558; Vajen T, 2015, THROMB HAEMOSTASIS, V114, P228, DOI 10.1160/TH14-11-0962; VANDERMEULEN J, 1992, CLIN NEPHROL, V37, P36; Weiss R, 2017, J CLIN APHERESIS, V32, P375, DOI 10.1002/jca.21519; Weiss R, 2017, J BIOMED MATER RES B, V105, P636, DOI 10.1002/jbm.b.33588; Weiss R, 2014, BIOMACROMOLECULES, V15, P2648, DOI 10.1021/bm500492r; WHITFIELD LR, 1981, THROMB RES, V21, P681, DOI 10.1016/0049-3848(81)90270-X	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0199204	10.1371/journal.pone.0199204	http://dx.doi.org/10.1371/journal.pone.0199204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29898003	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700095
J	Ramos-Infante, SJ; Ten-Esteve, A; Alberich-Bayarri, A; Perez, MA				Jesus Ramos-Infante, Samuel; Ten-Esteve, Amadeo; Alberich-Bayarri, Angel; Angeles Perez, Maria			Discrete particle model for cement infiltration within open-cell structures: Prevention of osteoporotic fracture	PLOS ONE			English	Article							PROXIMAL FEMUR; TRABECULAR BONE; COMPRESSION FRACTURES; IN-VITRO; EVOLUTIONARY OPTIMIZATION; RHEOLOGICAL PROPERTIES; HIP PROTECTORS; AUGMENTATION; FEMOROPLASTY; VERTEBROPLASTY	This paper proposes a discrete particle model based on the random-walk theory for simulating cement infiltration within open-cell structures to prevent osteoporotic proximal femur fractures. Model parameters consider the cement viscosity (high and low) and the desired direction of injection (vertical and diagonal). In vitro and in silico characterizations of augmented open-cell structures validated the computational model and quantified the improved mechanical properties (Young's modulus) of the augmented specimens. The cement injection pattern was successfully predicted in all the simulated cases. All the augmented specimens exhibited enhanced mechanical properties computationally and experimentally (maximum improvements of 237.95 +/- 12.91% and 246.85 +/- 35.57%, respectively). The open-cell structures with high porosity fraction showed a considerable increase in mechanical properties. Cement augmentation in low porosity fraction specimens resulted in a lesser increase in mechanical properties. The results suggest that the proposed discrete particle model is adequate for use as a femoroplasty planning framework.	[Jesus Ramos-Infante, Samuel; Angeles Perez, Maria] Univ Zaragoza, I3A, IIS Aragon, M2BE,Dept Ingn Mecan, Zaragoza, Spain; [Ten-Esteve, Amadeo; Alberich-Bayarri, Angel] La Fe Hlth Res Inst, Biomed Imaging Res Grp, GIBI230, Valencia, Spain; [Alberich-Bayarri, Angel] QUIBIM SL, Quantitat Imaging Biomarkers Med, Valencia, Spain	University of Zaragoza	Perez, MA (corresponding author), Univ Zaragoza, I3A, IIS Aragon, M2BE,Dept Ingn Mecan, Zaragoza, Spain.	angeles@unizar.es	Ten-Esteve, Amadeo/ABG-7614-2020; Ten-Esteve, Amadeo ATE/GQQ-0265-2022; Perez, Maria Angeles/F-7584-2010; Alberich-Bayarri, Angel/E-3822-2010	Ten-Esteve, Amadeo/0000-0002-3339-7767; Ten-Esteve, Amadeo ATE/0000-0002-3339-7767; Perez, Maria Angeles/0000-0002-2901-4188; Alberich-Bayarri, Angel/0000-0002-5932-2392	Spanish Ministry of Economy and Competitiveness [DPI 2014-53401-C2-1-R]; European Research Council (ERC) [ERC-2012-stg306751]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Research Council (ERC)(European Research Council (ERC)European Commission)	The authors gratefully acknowledge support from the Spanish Ministry of Economy and Competitiveness through research project DPI 2014-53401-C2-1-R and the European Research Council (ERC) through project ERC-2012-stg306751. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquarius R, 2014, MED ENG PHYS, V36, P944, DOI 10.1016/j.medengphy.2014.03.009; Artiles MES, 2017, COMPUT METHOD BIOMEC, V20, P691, DOI 10.1080/10255842.2017.1291805; Baroud G, 2003, MED ENG PHYS, V25, P283, DOI 10.1016/S1350-4533(02)00223-0; Basafa E, 2013, P ASME DES ENG TECHN, V4; Basafa E, 2015, J BIOMECH, V48, P59, DOI 10.1016/j.jbiomech.2014.11.002; Basafa E, 2014, J BIOMECH, V47, P2237, DOI 10.1016/j.jbiomech.2014.05.002; Bayraktar HH, 2004, J BIOMECH, V37, P1671, DOI 10.1016/j.jbiomech.2004.02.045; Beckmann J, 2007, MED ENG PHYS, V29, P755, DOI 10.1016/j.medengphy.2006.08.006; Beckmann J, 2011, J ORTHOP RES, V29, P1753, DOI 10.1002/jor.21410; Bhan S, 2014, J BIOMECH, V47, P2391, DOI 10.1016/j.jbiomech.2014.04.026; Borau Carlos, 2014, In Silico Cell Tissue Sci, V1, P2; Cianferotti L, 2015, CALCIFIED TISSUE INT, V97, P1, DOI 10.1007/s00223-015-0002-9; Corey A.T., 1963, INFLUENCE SHAPE FALL; Farrar DF, 2001, BIOMATERIALS, V22, P3005, DOI 10.1016/S0142-9612(01)00047-3; Feng H, 2014, EJSO-EUR J SURG ONC, V40, P402, DOI 10.1016/j.ejso.2013.12.015; Ferrari S, 2016, ARCH OSTEOPOROS, V11, DOI 10.1007/s11657-016-0292-1; Fliri L, 2013, J BIOMATER APPL, V28, P136, DOI 10.1177/0885328212443274; Heini PF, 2004, CLIN BIOMECH, V19, P506, DOI 10.1016/j.clinbiomech.2004.01.014; Heini PF, 2001, EUR SPINE J, V10, pS205, DOI 10.1007/s005860100308; Hopley C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2332; Jaasma MJ, 2002, J BIOMECH, V35, P237, DOI 10.1016/S0021-9290(01)00193-2; Jensen ME, 1997, AM J NEURORADIOL, V18, P1897; Kanis JA, 2013, OSTEOPOROSIS INT, V24, P23, DOI 10.1007/s00198-012-2074-y; Kannus P, 1999, BONE, V25, P229, DOI 10.1016/S8756-3282(99)00154-4; KEAVENY TM, 1993, J BIOMECH, V26, P991, DOI 10.1016/0021-9290(93)90059-N; Landgraf R, 2015, ZAMM-Z ANGEW MATH ME, V95, P1530, DOI 10.1002/zamm.201400064; Loeffel M, 2008, SPINE, V33, P1352, DOI 10.1097/BRS.0b013e3181732aa9; Lu L, 2015, ACTA MECH SINICA-PRC, V31, P259, DOI 10.1007/s10409-015-0414-9; Niebur GL, 2000, J BIOMECH, V33, P1575, DOI 10.1016/S0021-9290(00)00149-4; Palumbo BT, 2014, CLIN BIOMECH, V29, P289, DOI 10.1016/j.clinbiomech.2013.12.001; Parkkari J, 1997, CALCIFIED TISSUE INT, V60, P354, DOI 10.1007/s002239900242; Perez MA, 2007, J BIOMECH, V40, P2244, DOI 10.1016/j.jbiomech.2006.10.020; Pike C, 2010, PHARMACOECONOMICS, V28, P395, DOI 10.2165/11531040-000000000-00000; Querin OM, 2000, FINITE ELEM ANAL DES, V34, P291, DOI 10.1016/S0168-874X(99)00044-X; Ramos-Infante SJ, 2017, COMPUT METHOD BIOMEC, V20, P1562, DOI 10.1080/10255842.2017.1390086; Santesso N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001255.pub5; Springorum HR, 2014, J ORTHOP TRAUMA, V28, P403, DOI 10.1097/BOT.0000000000000035; Strom O, 2011, Arch Osteoporos, V6, P59, DOI 10.1007/s11657-011-0060-1; Sutter EG, 2010, GERIATR ORTHOP SURG, V1, P22, DOI 10.1177/2151458510378406; Sutter EG, 2010, J ORTHOP TRAUMA, V24, P95, DOI 10.1097/BOT.0b013e3181b5c0c6; Tohmeh AG, 1999, SPINE, V24, P1772, DOI 10.1097/00007632-199909010-00004; van der Steenhoven TJ, 2012, CLIN BIOMECH, V27, P819, DOI 10.1016/j.clinbiomech.2012.05.007; Varga P, 2017, CLIN BIOMECH, V44, P7, DOI 10.1016/j.clinbiomech.2017.03.001; Who, 2003, WHO TECHNICAL REPORT, P9211; Widmer RP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003735; Zeiser T, 2008, P I MECH ENG H, V222, P185, DOI 10.1243/09544119JEIM261; Zhong ZW, 2011, BIORHEOLOGY, V48, P89, DOI 10.3233/BIR-2011-0587; Zimmerman S, 2010, J AM MED DIR ASSOC, V11, P106, DOI 10.1016/j.jamda.2009.09.013; Zoarski GH, 2002, J VASC INTERV RADIOL, V13, P139, DOI 10.1016/S1051-0443(07)61930-7; Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6	50	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6								10.1371/journal.pone.0199035	http://dx.doi.org/10.1371/journal.pone.0199035			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29898001	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700088
J	Jones, MM; Winthrop, KL; Nelson, SD; Duvall, SL; Patterson, OV; Nechodom, KE; Findley, KE; Radonovich, LJ; Samore, MH; Fennelly, KP				Jones, Makoto M.; Winthrop, Kevin L.; Nelson, Scott D.; Duvall, Scott L.; Patterson, Olga, V; Nechodom, Kevin E.; Findley, Kimberly E.; Radonovich, Lewis J., Jr.; Samore, Matthew H.; Fennelly, Kevin P.			Epidemiology of nontuberculous mycobacterial infections in the US Veterans Health Administration	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; UNITED-STATES; CYSTIC-FIBROSIS; AVIUM COMPLEX; LUNG-DISEASE; PREVALENCE; AZITHROMYCIN; PREVENTION; ENGLAND; TRENDS	Objective We identified patients with non-tuberculous mycobacterial (NTM) disease in the US Veterans Health Administration (VHA), examined the distribution of diseases by NTM species, and explored the association between NTM disease and the frequency of clinic visits and mortality. Methods We combined mycobacterial isolate (from natural language processing) with ICD-9-CM diagnoses from VHA data between 2008 and 2012 and then applied modified ATS/IDSA guidelines for NTM diagnosis. We performed validation against a reference standard of chart review. Incidence rates were calculated. Two nested case-control studies (matched by age and location) were used to measure the association between NTM disease and each of 1) the frequency of outpatient clinic visits and 2) mortality, both adjusted by chronic obstructive pulmonary disease (COPD), other structural lung diseases, and immunomodulatory factors. Results NTM cases were identified with a sensitivity of 94%, a specificity of >99%. The incidence of NTM was 12.6/100k patient-years. COPD was present in 68% of pulmonary NTM. NTM incidence was highest in the southeastern US. Extra-pulmonary NTM rates increased during the study period. The incidence rate ratio of clinic visits in the first year after diagnosis was 1.3 [95%Cl 1.34-1.35]. NTM patients had a hazard ratio of mortality of 1.4 [95%Cl 1.1-1.9] in the 6 months after NTM identification compared to controls and 1.99 [95%Cl 1.8-2.3] thereafter. Conclusions In VHA, pulmonary NTM disease is commonly associated with COPD, with the highest rates in the southeastern US. After adjustment, NTM patients had more clinic visits and greater mortality compared to matched patients.	[Jones, Makoto M.; Nelson, Scott D.; Duvall, Scott L.; Patterson, Olga, V; Nechodom, Kevin E.; Samore, Matthew H.] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT 84148 USA; [Jones, Makoto M.; Duvall, Scott L.; Patterson, Olga, V; Nechodom, Kevin E.; Samore, Matthew H.] Univ Utah, Dept Internal Med, Div Epidemiol, Salt Lake City, UT 84112 USA; [Winthrop, Kevin L.] Oregon Hlth & Sci Univ, Div Infect Dis, Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Nelson, Scott D.] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN USA; [Findley, Kimberly E.; Radonovich, Lewis J., Jr.; Fennelly, Kevin P.] Vet Hlth Adm, Patient Care Serv Publ Hlth, Natl Ctr Occupat Hlth & Infect Control, Gainesville, FL USA; [Fennelly, Kevin P.] NHLBI, Pulm Clin Med Sect, NIH, Bldg 10, Bethesda, MD 20892 USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Oregon Health & Science University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Jones, MM (corresponding author), VA Salt Lake City Hlth Care Syst, Salt Lake City, UT 84148 USA.; Jones, MM (corresponding author), Univ Utah, Dept Internal Med, Div Epidemiol, Salt Lake City, UT 84112 USA.	Makoto.jones@va.gov	Nelson, Scott/I-7607-2019	Nelson, Scott/0000-0002-1941-1817; DuVall, Scott/0000-0002-4898-3865	National Center for Occupational Health and Infection Control, VHA Office of Public Health, U.S. Department of Veterans Affairs [CONIC 0001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006200] Funding Source: NIH RePORTER; Veterans Affairs [IK2HX001165] Funding Source: NIH RePORTER	National Center for Occupational Health and Infection Control, VHA Office of Public Health, U.S. Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Center for Occupational Health and Infection Control, VHA Office of Public Health, U.S. Department of Veterans Affairs; CONIC 0001 to MMJ. The funders (as represented by listed authors) consulted on the design, analysis, and preparation of the manuscript, as well as supported the decision to publish.	Adjemian J, 2014, AM J RESP CRIT CARE, V190, P581, DOI 10.1164/rccm.201405-0884OC; Adjemian J, 2012, AM J RESP CRIT CARE, V186, P553, DOI 10.1164/rccm.201205-0913OC; Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; Al-Houqani M, 2012, CHEST, V141, P190, DOI 10.1378/chest.11-0089; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Billinger ME, 2009, EMERG INFECT DIS, V15, P1562, DOI 10.3201/eid1510.090196; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Donohue MJ, 2015, ENVIRON SCI TECHNOL, V49, P6127, DOI 10.1021/acs.est.5b00496; DUMOULIN GC, 1985, J CLIN MICROBIOL, V22, P9, DOI 10.1128/JCM.22.1.9-12.1985; Fennelly KP, 2013, LANCET, V381, P27, DOI 10.1016/S0140-6736(13)60013-6; Finkelstein J, 2013, AM J RESP CRITICAL C; Ford ES, 2013, CHEST, V144, P284, DOI 10.1378/chest.13-0809; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Harpaz R, 2016, JAMA-J AM MED ASSOC, V316, P2547, DOI 10.1001/jama.2016.16477; Hoefsloot W, 2013, EUR RESPIR J, V42, P1604, DOI 10.1183/09031936.00149212; Huang HC, 2011, J HEART LUNG TRANSPL, V30, P790, DOI 10.1016/j.healun.2011.02.007; Jing H, 2012, EMERG INFECT DIS, V18, P527, DOI 10.3201/eid1803.110175; Khan K, 2007, AM J RESP CRIT CARE, V176, P306, DOI 10.1164/rccm.200702-201OC; Marras TK, 2010, LUNG, V188, P289, DOI 10.1007/s00408-010-9241-8; Martin-Casabona N, 2004, INT J TUBERC LUNG D, V8, P1186; Mirsaeidi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091879; Moore JE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-612; Murphy DE, 2011, MIL MED, V176, P552, DOI 10.7205/MILMED-D-10-00377; Patterson Olga, 2010, AMIA Annu Symp Proc, V2010, P612; Pepe M. S., 2003, STAT EVALUATION MED; Pisati M., GERM STAT US GROUP M; Prevots D Rebecca, 2014, Ann Am Thorac Soc, V11, P1032, DOI 10.1513/AnnalsATS.201404-184OC; Schweitzer M, 2017, NONTUBERCULOUS MYCOB; Simpson CR, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X514729; Winthrop KL, 2010, AM J RESP CRIT CARE, V182, P977, DOI 10.1164/rccm.201003-0503OC; Yeh JJ, 2014, LUNG, V192, P403, DOI 10.1007/s00408-014-9574-9	31	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197976	10.1371/journal.pone.0197976	http://dx.doi.org/10.1371/journal.pone.0197976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897938	Green Published, gold, Green Submitted			2022-12-26	WOS:000435090700037
J	Schmid, D; Matthews, CE; Leitzmann, MF				Schmid, Daniela; Matthews, Charles E.; Leitzmann, Michael F.			Physical activity and sedentary behavior in relation to mortality among renal cell cancer survivors	PLOS ONE			English	Article							BODY-MASS INDEX; NIH-AARP DIET; COLORECTAL-CANCER; BREAST-CANCER; NATIONAL INSTITUTES; PROSTATE-CANCER; TIME; METAANALYSIS; ASSOCIATION; HEALTH	Background The relations of physical activity and sedentary behavior to mortality risk among patients with renal cell cancer have not yet been evaluated. Methods We conducted a prospective cohort study among 667 renal cell cancer survivors aged 5071 years of the National Institutes of Health (NIH)-AARP Diet and Health Study with a median follow-up time of 7.1 years. Post-diagnosis physical activity, TV viewing, and total sitting time were assessed using self-administered questionnaires. Hazard ratios (HRs) and 95% confidence intervals (CIs) for mortality were estimated using Cox proportional hazards models. Results Increasing levels of moderate to vigorous physical activity were related to decreased risk of overall mortality [multivariable-adjusted HRs for <1 hr/wk (reference), 1 to 3 hrs/wk, >= 3 to <7 hrs/wk, and >= 7 hrs/wk = 1.0, 1.16, 0.94, and 0.60 (95% CI = 0.38-0.96; p-trend = 0.03)]. In contrast, television viewing was associated with increased risk of overall mortality in the age- and sex-adjusted model (HR for >4 hrs/d vs. 0 to 2 hrs/d = 1.52, 95% CI = 1.02-2.26; p-trend = 0.04), but the relation was attenuated following further control for other covariates (multivariable-adjusted HR = 1.44, 95% CI = 0.92-2.24; p-trend = 0.11). Total sitting time was unrelated to all-cause mortality. Conclusion Among renal cancer patients, moderate to vigorous physical activity is associated with decreased risk of overall mortality. Clinicians should consider discussing the potential benefits of physical activity for longevity among survivors of renal cell cancer.	[Schmid, Daniela; Leitzmann, Michael F.] Univ Regensburg, Dept Epidemiol & Prevent Med, Regensburg, Germany; [Matthews, Charles E.] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA	University of Regensburg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schmid, D (corresponding author), Univ Regensburg, Dept Epidemiol & Prevent Med, Regensburg, Germany.	daniela.schmid@ukr.de	Schmid, Daniela/GPG-1151-2022; matthews, Charles e/E-8073-2015	matthews, Charles e/0000-0001-8037-3103	NATIONAL CANCER INSTITUTE [ZIACP010196] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arem H, 2016, CANCER CAUSE CONTROL, V27, P1403, DOI 10.1007/s10552-016-0813-7; Arem H, 2015, J CLIN ONCOL, V33, P180, DOI 10.1200/JCO.2014.58.1355; Arem H, 2014, INT J CANCER, V135, P423, DOI 10.1002/ijc.28659; Ballard-Barbash R, 2012, JNCI-J NATL CANCER I, V104, P815, DOI 10.1093/jnci/djs207; Behrens G, 2013, BRIT J CANCER, V108, P798, DOI 10.1038/bjc.2013.37; BLAIR SN, 1984, JAMA-J AM MED ASSOC, V252, P487, DOI 10.1001/jama.252.4.487; Bonn SE, 2015, CANCER EPIDEM BIOMAR, V24, P57, DOI 10.1158/1055-9965.EPI-14-0707; Campbell PT, 2013, J CLIN ONCOL, V31, P876, DOI 10.1200/JCO.2012.45.9735; Cao Y, 2015, CANCER CAUSE CONTROL, V26, P1467, DOI 10.1007/s10552-015-0645-x; Choi Y, 2013, INT J CANCER, V132, P625, DOI 10.1002/ijc.27639; Courneya KS, 2015, RES Q EXERCISE SPORT, V86, P107, DOI 10.1080/02701367.2015.991265; Danner FW, 2008, J PEDIATR PSYCHOL, V33, P1100, DOI 10.1093/jpepsy/jsn034; Dores GM, 2002, J CLIN ONCOL, V20, P3484, DOI 10.1200/JCO.2002.09.038; Fong DYT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e70; Friedenreich CM, 2016, EUR UROL, V70, P576, DOI 10.1016/j.eururo.2015.12.032; Fritz A, INT CLASSIFICATION D, V3; George SM, 2013, J CANCER SURVIV, V7, P247, DOI 10.1007/s11764-013-0265-y; George SM, 2011, ANN EPIDEMIOL, V21, P787, DOI 10.1016/j.annepidem.2011.04.012; Gidwani PP, 2002, PEDIATRICS, V110, P505, DOI 10.1542/peds.110.3.505; Gutschoven K, 2004, PREV MED, V39, P1093, DOI 10.1016/j.ypmed.2004.04.019; Hill ME, 2001, SOC SECUR BULL, V64, P45; Hobbs M, 2015, BRIT J SPORT MED, V49, P1179, DOI 10.1136/bjsports-2014-093754; Joh HK, 2011, DIABETES CARE, V34, P1552, DOI 10.2337/dc11-0132; Kang DW, 2017, CANCER EPIDEM BIOMAR, V26, P355, DOI 10.1158/1055-9965.EPI-16-0602; Kenfield SA, 2011, J CLIN ONCOL, V29, P726, DOI 10.1200/JCO.2010.31.5226; Lynch BM., 2017, CURR EPIDEMIOL REP, V4, P221, DOI [DOI 10.1007/S40471-017-0119-7, 10.1007/s40471-017-0119-7, DOI 10.1007/s40471-017-0119-7]; Matthews CE, 2018, MED SCI SPORT EXER, V50, P266, DOI 10.1249/MSS.0000000000001428; Matthews CE, 2016, AM J CLIN NUTR, V104, P1424, DOI 10.3945/ajcn.116.135129; McCabe MS, 2013, SEMIN ONCOL, V40, P804, DOI 10.1053/j.seminoncol.2013.09.004; McTiernan A, 2008, NAT REV CANCER, V8, P205, DOI 10.1038/nrc2325; Michaud D, 2005, J REGISTRY MANAGE, V2, P70; Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Rock CL, 2012, CA-CANCER J CLIN, V62, P243, DOI 10.3322/caac.21142; Scelo G, 2007, NAT CLIN PRACT UROL, V4, P205, DOI 10.1038/ncpuro0760; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Schmid D, 2014, ANN ONCOL, V25, P1293, DOI 10.1093/annonc/mdu012; Schmid D, 2016, MED SCI SPORT EXER, V48, P1312, DOI 10.1249/MSS.0000000000000913; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Speck RM, 2010, J CANCER SURVIV, V4, P87, DOI 10.1007/s11764-009-0110-5; Stojanovic M, 2009, CLIN EXP NEPHROL, V13, P295, DOI 10.1007/s10157-008-0122-x; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Vincent KR, 2002, EUR J APPL PHYSIOL, V87, P416, DOI 10.1007/s00421-002-0640-2	46	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198995	10.1371/journal.pone.0198995	http://dx.doi.org/10.1371/journal.pone.0198995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ1PQ	29894512	Green Published, Green Submitted, gold			2022-12-26	WOS:000435030900041
J	Hossein, MU; Omar, TM; Alam, I; Das, KC; Mohiuddin, AKM; Keya, CA; Salimullah, M				Hossein, Mohammad Uzzal; Omar, Taimur Md; Alam, Iftekhar; Das, Keshob Chandra; Mohiuddin, A. K. M.; Keya, Chaman Ara; Salimullah, Md			Pathway based therapeutic targets identification and development of an interactive database CampyNIBase of Campylobacter jejuni RM1221 through non-redundant protein dataset	PLOS ONE			English	Article							DRUG; FOOD; FOODBORNE; VACCINE; RESISTANCE; PREDICTION; SEQUENCE; UPDATE; GENES; SITE	The bacterial species Campylobacter jejuni RM1221 (CjR) is the primary cause of campylobacteriosis which poses a global threat for human health. Over the years the efficacy of antibiotic treatment is becoming more fruitless due to the development of multiple drug resistant strains. Therefore, identification of new drug targets is a valuable tool for the development of new treatments for affected patients and can be obtained by targeting essential protein(s) of CjR. We conducted this in silico study in order to identify therapeutic targets by subtractive CjR proteome analysis. The most important proteins of the CjR proteome, which includes chokepoint enzymes, plasmid, virulence and antibiotic resistant proteins were annotated and subjected to subtractive analyses to filter out the CjR essential proteins from duplicate or human homologous proteins. Through the subtractive and characterization analysis we have identified 38 eligible therapeutic targets including 1 potential vaccine target. Also, 12 potential targets were found in interactive network, 5 targets to be dealt with FDA approved drugs and one pathway as potential pathway based drug target. In addition, a comprehensive database 'CampyNIBase' has also been developed. Besides the results of this study, the database is enriched with other information such as 3D models of the identified targets, experimental structures and Expressed Sequence Tag (EST) sequences. This study, including the database might be exploited for future research and the identification of effective therapeutics against campylobacteriosis.	[Hossein, Mohammad Uzzal] Natl Inst Biotechnol, Bioinformat Div, Dhaka, Bangladesh; [Omar, Taimur Md; Mohiuddin, A. K. M.] Mawlana Bhashani Sci & Technol Univ, Life Sci Fac, Dept Biotechnol & Genet Engn, Santosh, Tangail, Bangladesh; [Alam, Iftekhar] Natl Inst Biotechnol, Plant Biotechnol Div, Dhaka, Bangladesh; [Das, Keshob Chandra; Salimullah, Md] Natl Inst Biotechnol, Mol Biotechnol Div, Dhaka, Bangladesh; [Keya, Chaman Ara] North South Univ, Dept Biochem & Microbiol, Dhaka, Bangladesh	National Institute of Biotechnology (NIB); Mawlana Bhashani Science & Technology University; National Institute of Biotechnology (NIB); National Institute of Biotechnology (NIB); North South University (NSU)	Salimullah, M (corresponding author), Natl Inst Biotechnol, Mol Biotechnol Div, Dhaka, Bangladesh.	salim2969@gmail.com		Salimullah, Md/0000-0001-9895-9233; Alam, Iftekhar/0000-0002-4608-6490				Al-Mazrou YY, 2004, SAUDI MED J, V25, P11; Allsop AE, 1998, CURR OPIN BIOTECH, V9, P637, DOI 10.1016/S0958-1669(98)80143-2; Altekruse SF, 1999, EMERG INFECT DIS, V5, P28, DOI 10.3201/eid0501.990104; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amineni U, 2010, J Chem Biol, V3, P165, DOI 10.1007/s12154-010-0039-1; [Anonymous], 2007, EFSA J, V5, DOI 10.2903/j.efsa.2007.130r; [Anonymous], 1997, NUTR REV, V55, P57; Barh Debmalya, 2009, In Silico Biology, V9, P225, DOI 10.3233/ISB-2009-0399; BLASER MJ, 1979, ANN INTERN MED, V91, P179, DOI 10.7326/0003-4819-91-2-179; CABASSI E, 1976, Folia Veterinaria Latina, V6, P335; Caspi R, 2004, NUCLEIC ACIDS RES, V42, pD459; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Coker AO, 2002, EMERG INFECT DIS, V8, P237, DOI 10.3201/eid0803.010233; Damte D, 2013, GENOMICS, V102, P47, DOI 10.1016/j.ygeno.2013.04.011; DONOVAN TJ, 1995, INT J FOOD MICROBIOL, V26, P77, DOI 10.1016/0168-1605(95)00015-C; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; EFSA (European Food Safety Authority), 2009, EFSA J, V7, P358, DOI [10.2903/j.efsa.2009.1438, DOI 10.2903/J.EFSA.2009.1438, 10.2903/j.efsa.2010.1496]; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Ge BL, 2005, ANTIMICROB AGENTS CH, V49, P3347, DOI 10.1128/AAC.49.8.3347-3354.2005; GRANUM PE, 1990, INT J FOOD MICROBIOL, V10, P101, DOI 10.1016/0168-1605(90)90059-E; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Hasan MA, 2015, MOL IMMUNOL, V65, P189, DOI [10.1016/j.molimm.2014.12.013, 10.1016/j.mol]; Heredia N, 2009, FOODBORNE PATHOG DIS, P20; Hossain MU, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1106-5; Hossain MU, 2016, COMPUT BIOL CHEM, V65, P29, DOI 10.1016/j.compbiolchem.2016.10.002; Hossain MU, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00153; Hossain MU, 2016, BIOINFORMATION, V12, P22, DOI 10.6026/97320630012022; Hossain MU, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3187647; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Islam Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043976; Islam Z, 2009, EMERG INFECT DIS, V15, P1316, DOI 10.3201/eid1508.090120; JONES LV, 1988, DRUGS, V36, P6, DOI 10.2165/00003495-198800364-00004; KALINA GP, 1982, ZH MIKROB EPID IMMUN, P23; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Katzenell U, 2001, EPIDEMIOL INFECT, V127, P179, DOI 10.1017/S0950268801006021; Khan MA, 2015, SCAND J IMMUNOL, V82, P25, DOI 10.1111/sji.12302; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LASTOVICA AJ, 2000, CAMPYLOBACTER, P89; Le Loir Yves, 2003, Genet Mol Res, V2, P63; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; Miller WG, 2004, CAMPYLOBACTER JEJUNI, P109; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; Oany Arafat Rahman, 2015, Adv Appl Bioinform Chem, V8, P1, DOI 10.2147/AABC.S75250; Okuyama Yusuke, 2012, Nihon Rinsho, V70, P1362; OllingerSnyder P, 1996, J AM DIET ASSOC, V96, P163, DOI 10.1016/S0002-8223(96)00046-6; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; PENNER J L, 1988, Clinical Microbiology Reviews, V1, P157; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Pumbwe L, 2004, J ANTIMICROB CHEMOTH, V54, P341, DOI 10.1093/jac/dkh331; Rahman MA, 2014, COMPUT BIOL CHEM, V52, P66, DOI 10.1016/j.compbiolchem.2014.09.005; Rampal P, 1989, Rev Prat, V39, P2583; RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293; Roy A., 2012, NUCLEIC ACIDS RES; Scharff RL, 2012, J FOOD PROTECT, V75, P123, DOI 10.4315/0362-028X.JFP-11-058; Schoeni JL, 2005, J FOOD PROTECT, V68, P636, DOI 10.4315/0362-028X-68.3.636; Sharma OP, 2016, SCI REP-UK, V6, DOI 10.1038/srep19842; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; Smith JL, 1999, J FOOD PROTECT, V62, P818, DOI 10.4315/0362-028X-62.7.818; Stumm Gabriele, 2002, Am J Pharmacogenomics, V2, P263, DOI 10.2165/00129785-200202040-00006; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tauxe RV, 1997, EMERG INFECT DIS, V3, P425, DOI 10.3201/eid0304.970403; TENOVER FC, 1989, PLASMID, V22, P52, DOI 10.1016/0147-619X(89)90035-8; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; Todd Ewen C. D., 1997, World Health Statistics Quarterly, V50, P30; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; WADSTROM T, 1991, INT J FOOD MICROBIOL, V12, P303, DOI 10.1016/0168-1605(91)90144-E; Warren BR, 2006, CRIT REV FOOD SCI, V46, P551, DOI 10.1080/10408390500295458; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6; Willison HJ, 1999, J NEUROIMMUNOL, V100, P3, DOI 10.1016/S0165-5728(99)00213-1; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Yasmin Tahirah, 2016, In Silico Pharmacology, V4, P5, DOI 10.1186/s40203-016-0020-y; Yeh W, 2004, GENOME RES, V14, P917, DOI 10.1101/gr.2050304; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	84	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198170	10.1371/journal.pone.0198170	http://dx.doi.org/10.1371/journal.pone.0198170			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883471	gold, Green Published, Green Submitted			2022-12-26	WOS:000434728100011
J	Novati, A; Yu-Taeger, L; Menendez, IG; Martinez, LQ; Nguyen, HP				Novati, Arianna; Yu-Taeger, Libo; Menendez, Irene Gonzalez; Martinez, Leticia Quintanilla; Huu Phuc Nguyen			Sexual behavior and testis morphology in the BACHD rat model	PLOS ONE			English	Article							R6/2 MOUSE MODEL; HUNTINGTONS-DISEASE; TESTOSTERONE; CHOREA; INFERTILITY; PATHOLOGY; FEATURES; BRAIN; MICE	Background Huntington disease (HD) is an autosomal dominant neurodegenerative disorder caused by a mutation in the huntingtin (HTT) gene, which results in brain neurodegeneration and peripheral pathology affecting different organs including testis. Patients with HD suffer from motor and cognitive impairment, and multiple psychiatric symptoms. Among behavioral abnormalities in HD, sexual disturbances have often been reported, but scarcely investigated in animal models. The BACHD rat model of HD carries the human full-length mutated HTT (mHTT) genomic sequence with 97 CAG-CAA repeats and displays HD-like alterations at neuropathological and behavioral level. Objective This study aims to phenotype the BACHD rats' sexual behavior and performance as well as testis morphology because alterations in these aspects have been associated to HD. Methods Two rat cohorts at the age of 3 and 7 months were subjected to mating tests to assess different parameters of sexual behavior. Histological analyses for testis morphology were performed in different rat cohorts at 1.5, 7 and 12 months of age whereas immunohistochemical analyses were carried out at 7 and 12 months of age to visualize the presence of mHTT in testicular tissue. Furthermore, western blot analyses were used to assess HTT and mHTT expression levels in striatum and testis at three months of age. Results At 3 months, BACHD rats showed a decreased time exploring the female anogenital area (AGA), decreased latency to mount, increased number of intromissions and ejaculations and enhanced hit rate. At 7 months, all sexual parameters were comparable between genotypes with the exception that BACHD rats explored the AGA less than wild type rats. Testis analyses did not reveal any morphological alteration at any of the examined ages, but showed presence of mHTT limited to Sertoli cells in transgenic rats at both 7 and 12 months. BACHD rat HTT and mHTT expression levels in testis were lower than striatum at 3 months of age. Conclusions The testis phenotype in the BACHD rat model does not mimic the changes observed in human HD testis. The altered sexual behavior in BACHD rats at three months of age could be to a certain extent representative of and share common underlying pathways with some of the sexual disturbances in HD patients. Further investigating the biological causes of the sexual phenotype in BACHD rats may therefore contribute to clarifying the mechanisms at the base of sexual behavior changes in HD.	[Novati, Arianna; Yu-Taeger, Libo; Huu Phuc Nguyen] Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany; [Novati, Arianna; Yu-Taeger, Libo; Huu Phuc Nguyen] Univ Tubingen, Ctr Rare Dis, Tubingen, Germany; [Menendez, Irene Gonzalez; Martinez, Leticia Quintanilla] Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany; [Menendez, Irene Gonzalez; Martinez, Leticia Quintanilla] Univ Tubingen, Comprehens Canc Ctr, Tubingen, Germany; [Huu Phuc Nguyen] Univ Bochum, Dept Human Genet, Bochum, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Ruhr University Bochum	Nguyen, HP (corresponding author), Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany.; Nguyen, HP (corresponding author), Univ Tubingen, Ctr Rare Dis, Tubingen, Germany.; Nguyen, HP (corresponding author), Univ Bochum, Dept Human Genet, Bochum, Germany.	hoa.nguyen@med.uni-tuebingen.de	Nguyen, Huu Phuc/HDO-3462-2022	Nguyen, Huu Phuc/0000-0001-6139-788X; Yu-Taeger, Libo/0000-0003-4091-5531	Marie Curie Industry-Academia Partnerships and Pathways (MC - IAPP) of the European Commission's 7th Framework Program "Switch HD" (FP7-PEOPLE-2012) [324495]; European Union's Horizon 2020 research and innovation programme [643417]	Marie Curie Industry-Academia Partnerships and Pathways (MC - IAPP) of the European Commission's 7th Framework Program "Switch HD" (FP7-PEOPLE-2012); European Union's Horizon 2020 research and innovation programme	This project was funded by the Marie Curie Industry-Academia Partnerships and Pathways (MC - IAPP) of the European Commission's 7th Framework Program "Switch HD" (FP7-PEOPLE-2012; grant agreement No. 324495) and the European Union's Horizon 2020 research and innovation programme under Grant agreement No 643417 (ModelPolyQ) to HPN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada YSK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071633; Abulseoud OA, 2014, INT J BIPOLAR DISORD, V2, DOI 10.1186/s40345-014-0007-8; Barrot M, 2005, P NATL ACAD SCI USA, V102, P8357, DOI 10.1073/pnas.0500587102; BOLT JMW, 1970, BRIT J PSYCHIAT, V116, P259, DOI 10.1192/bjp.116.532.259; Caneguim BH, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-19; Clemens LE, 2015, BRAIN, V138, P3632, DOI 10.1093/brain/awv290; Clemensson EKH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169051; Craufurd D, 2001, NEUROPSY NEUROPSY BE, V14, P219; Cummings JA, 2013, BEHAV NEUROSCI, V127, P47, DOI 10.1037/a0031528; DEWHURST K, 1970, BRIT J PSYCHIAT, V116, P255, DOI 10.1192/bjp.116.532.255; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Escott Gustavo M, 2014, Curr Mol Pharmacol, V7, P96; FEDOROFF JP, 1994, J NEUROPSYCH CLIN N, V6, P147; Frohmader KS, 2011, J NEUROSCI, V31, P16473, DOI 10.1523/JNEUROSCI.4013-11.2011; Hales DB, 2002, J REPROD IMMUNOL, V57, P3, DOI 10.1016/S0165-0378(02)00020-7; Hull EM, 2007, HORM BEHAV, V52, P45, DOI 10.1016/j.yhbeh.2007.03.030; Huntington G, 2003, J NEUROPSYCH CLIN N, V15, P109, DOI 10.1176/appi.neuropsych.15.1.109; Jansson EKH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105662; Jhanjee A, 2011, SINGAP MED J, V52, pE131; Kolenc M, 2015, J NEUROL SCI, V359, P312, DOI 10.1016/j.jns.2015.11.015; Kuhn S, 2016, INT REV NEUROBIOL, V129, P67, DOI 10.1016/bs.irn.2016.04.002; Macakova M, 2016, NEURODEGENER DIS, V16, P245, DOI 10.1159/000443665; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Manfre G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192289; Manfre G, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00218; Manfre G, 2016, BEHAV BRAIN RES, V299, P6, DOI 10.1016/j.bbr.2015.11.007; Markianos M, 2005, ANN NEUROL, V57, P520, DOI 10.1002/ana.20428; McCormick CM, 2013, HORM BEHAV, V63, P5, DOI 10.1016/j.yhbeh.2012.11.009; OLIVER JE, 1970, BRIT J PSYCHIAT, V116, P241, DOI 10.1192/bjp.116.532.241; Papalexi E, 2005, EUR J NEUROSCI, V22, P1541, DOI 10.1111/j.1460-9568.2005.04324.x; Papoutsi M, 2014, MOVEMENT DISORD, V29, P673, DOI 10.1002/mds.25864; Petersen A, 2006, EUR J NEUROSCI, V24, P961, DOI 10.1111/j.1460-9568.2006.04985.x; Pietsch SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024601; Pla P, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00135; Podlasek CA, 2016, J SEX MED, V13, P1183, DOI 10.1016/j.jsxm.2016.06.004; Shulman LM, 2014, PHYSIOL BEHAV, V133, P8, DOI 10.1016/j.physbeh.2014.05.001; TAGLIAMONTE A, 1969, SCIENCE, V166, P1433, DOI 10.1126/science.166.3911.1433; THOMPSON PD, 1988, BRAIN, V111, P223, DOI 10.1093/brain/111.2.223; TSUTSUI Y, 1994, PHYSIOL BEHAV, V56, P603, DOI 10.1016/0031-9384(94)90308-5; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P512, DOI 10.1016/j.nbd.2007.01.006; Van Raamsdonk JM, 2006, HUM MOL GENET, V15, P1513, DOI 10.1093/hmg/ddl072; Veening JG, 2015, EUR J PHARMACOL, V753, P209, DOI 10.1016/j.ejphar.2014.07.045; Waldvogel HJ, 2015, CURR TOP BEHAV NEURO, V22, P33, DOI 10.1007/7854_2014_354; Wood NI, 2015, J HUNTINGTONS DIS, V4, P61, DOI 10.3233/JHD-140132; Yan JT, 2016, J CELL SCI, V129, P492, DOI 10.1242/jcs.173666; Yu-Taeger L, 2012, J NEUROSCI, V32, P15426, DOI 10.1523/JNEUROSCI.1148-12.2012	47	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198338	10.1371/journal.pone.0198338	http://dx.doi.org/10.1371/journal.pone.0198338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883458	Green Published, gold, Green Submitted			2022-12-26	WOS:000434728100016
J	Ismaili, AA; Vestergaard, MB; Hansen, AE; Larsson, HBW; Johannesen, HH; Law, I; Henriksen, OM				Ismaili, Abd R. A.; Vestergaard, Mark B.; Hansen, Adam E.; Larsson, Henrik B. W.; Johannesen, Helle H.; Law, Ian; Henriksen, Otto M.			Components of day-to-day variability of cerebral perfusion measurements - Analysis of phase contrast mapping magnetic resonance imaging measurements in healthy volunteers	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; BLOOD-FLOW; GENERAL-POPULATION; ROTTERDAM SCAN; METABOLIC-RATE; BRAIN ATROPHY; CAFFEINE; OXYGEN; HUMANS; MRI	Purpose The aim of the study was to investigate the components of day-to-day variability of repeated phase contrast mapping (PCM) magnetic resonance imaging measurements of global cerebral blood flow (gCBF). Materials and methods Two dataset were analyzed. In Dataset 1 duplicated PCM measurements of total brain flow were performed in 11 healthy young volunteers on two separate days applying a strictly standardized setup. For comparison PCM measurements obtained from a previously published study (Dataset 2) were analyzed in order to assess long-term variability in an aged population in a less strictly controlled setup. Global CBF was calculated by normalizing total brain flow to brain volume. On each day measurements of hemoglobin, caffeine and glucose were obtained. Linear mixed models were applied to estimate coefficients of variation (CV) of total (CVt), between-subject (CVb), within-subject day-to-day (CVw), and intra-session residual variability (CVr). Results In Dataset 1 CVt, CVb, CVw, and CVr were estimated to be 11%, 9.4%, 4% and 4.2%, respectively, and to 8.8%, 7.2%, 2.7% and 4.3%, respectively, when adjusting for hemoglobin and plasma caffeine. In Dataset 2 CVt, CVb and CVw, were estimated to be 25.4%, 19.2%, and 15.0%, respectively, and decreased to 16.6%, 8.2% and 12.5%, respectively, when adjusting for the same covariates. Discussion Our results suggest that short-term day-to-day variability of gCBF is relatively low compared to between-subject variability when studied in standardized conditions, whereas long-term variability in an aged population appears to be much larger when studied in less a standardized setup. The results further showed that from 20% to 35% of the total variability in gCBF can be attributed to the effects of hemoglobin and caffeine.	[Ismaili, Abd R. A.; Vestergaard, Mark B.; Hansen, Adam E.; Larsson, Henrik B. W.; Johannesen, Helle H.; Henriksen, Otto M.] Univ Copenhagen, Dept Clin Physiol Nucl Med & PET, Rigshosp Blegdamsvej, Copenhagen, Denmark; [Larsson, Henrik B. W.; Law, Ian] Univ Copenhagen, Fac Hlth & Med Sci, Inst Clin Med, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Henriksen, OM (corresponding author), Univ Copenhagen, Dept Clin Physiol Nucl Med & PET, Rigshosp Blegdamsvej, Copenhagen, Denmark.	ohen0009@regionh.dk	Hansen, Adam Espe/G-7735-2011	Hansen, Adam Espe/0000-0002-6457-1537	Rigshospitalets Forskningsfond	Rigshospitalets Forskningsfond	Author A.I. was supported by Rigshospitalets Forskningsfond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project was supported by Rigshospitalets Forskningsfond. The authors wish to thank radiographer Jakup Martin Poulsen and technologists Marianne Federspiel and Karin Stahr for scanner assistance and training. The Siemens mMR hybrid PET/MR system at Copenhagen University Hospital Rigshospitalet was generously donated by the John and Birthe Meyer Foundation. We thank Julie Lyng Forman, Sect. of Biostatistics, University of Copenhagen, for statistical advice.	Aanerud J, 2012, J CEREBR BLOOD F MET, V32, P1177, DOI 10.1038/jcbfm.2012.18; Addicott MA, 2009, HUM BRAIN MAPP, V30, P3102, DOI 10.1002/hbm.20732; Appelman APA, 2008, J CEREBR BLOOD F MET, V28, P633, DOI 10.1038/sj.jcbfm.9600563; CAMERON OG, 1990, LIFE SCI, V47, P1141, DOI 10.1016/0024-3205(90)90174-P; Conroy Deirdre A, 2005, J Circadian Rhythms, V3, P3, DOI 10.1186/1740-3391-3-3; Field AS, 2003, RADIOLOGY, V227, P129, DOI 10.1148/radiol.2271012173; Goyal MS, 2014, CELL METAB, V19, P49, DOI 10.1016/j.cmet.2013.11.020; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P1314, DOI 10.1097/01.WCB.0000090506.76664.00; Henriksen OM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097363; Henriksen OM, 2013, J CEREBR BLOOD F MET, V33, P787, DOI 10.1038/jcbfm.2013.17; Henriksen OM, 2012, J MAGN RESON IMAGING, V35, P1290, DOI 10.1002/jmri.23579; Ibaraki M, 2010, J CEREBR BLOOD F MET, V30, P1296, DOI 10.1038/jcbfm.2010.13; Jain V, 2010, J CEREBR BLOOD F MET, V30, P1598, DOI 10.1038/jcbfm.2010.49; Krejza J, 2001, STROKE, V32, P30, DOI 10.1161/01.STR.32.1.30; LASSEN NA, 1985, J CEREBR BLOOD F MET, V5, P347, DOI 10.1038/jcbfm.1985.48; Liu PY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095721; Liu PY, 2013, MAGN RESON MED, V69, P675, DOI 10.1002/mrm.24295; Lu HZ, 2011, CEREB CORTEX, V21, P1426, DOI 10.1093/cercor/bhq224; MADSEN PL, 1991, J APPL PHYSIOL, V70, P2597, DOI 10.1152/jappl.1991.70.6.2597; MADSEN PL, 1993, J CEREBR BLOOD F MET, V13, P646, DOI 10.1038/jcbfm.1993.83; Majd-Ardekani J, 2000, NUCL MED COMMUN, V21, P361, DOI 10.1097/00006231-200004000-00011; Mazza M, 2011, J ALZHEIMERS DIS, V23, P375, DOI 10.3233/JAD-2010-090700; NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B; Panerai RB, 2000, IEEE T BIO-MED ENG, V47, P419, DOI 10.1109/10.827312; Pelligrino DA, 2010, J ALZHEIMERS DIS, V20, pS51, DOI 10.3233/JAD-2010-091261; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; Poels MMF, 2008, J CEREBR BLOOD F MET, V28, P1652, DOI 10.1038/jcbfm.2008.62; Sabayan B, 2013, NEUROLOGY, V81, P1922, DOI 10.1212/01.wnl.0000436618.48402.da; Spilt A, 2002, J MAGN RESON IMAGING, V16, P1, DOI 10.1002/jmri.10133; TANG C, 1993, JMRI-J MAGN RESON IM, V3, P377, DOI 10.1002/jmri.1880030213; TORACK RM, 1976, J NEUROPATH EXP NEUR, V35, P385, DOI 10.1097/00005072-197607000-00001; Vernooij MW, 2008, J CEREBR BLOOD F MET, V28, P412, DOI 10.1038/sj.jcbfm.9600526; Vestergaard MB, 2017, J MAGN RESON IMAGING, V45, P692, DOI 10.1002/jmri.25442; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Zonneveld HI, 2015, J CEREBR BLOOD F MET, V35, P1882, DOI 10.1038/jcbfm.2015.157	35	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0197807	10.1371/journal.pone.0197807	http://dx.doi.org/10.1371/journal.pone.0197807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879126	Green Published, Green Submitted, gold			2022-12-26	WOS:000434384900011
J	Spaans, JP; Burke, SM; Altikulac, S; Braams, BR; Op de Macks, ZA; Crone, EA				Spaans, Jochem P.; Burke, Sarah M.; Altikulac, Sibel; Braams, Barbara R.; Op de Macks, Zdena A.; Crone, Eveline A.			Win for your kin: Neural responses to personal and vicarious rewards when mothers win for their adolescent children	PLOS ONE			English	Article							METAANALYSIS; BEHAVIOR; PARENTS; PEERS; FMRI; SELF; ATTACHMENT; STRIATUM; FRIENDS; CORTEX	Mother-child relationships change considerably in adolescence, but it is not yet understood how mothers experience vicarious rewards for their adolescent children. In the current study, we investigated neural responses of twenty mothers winning and losing money for their best friend and for their adolescent child in a gambling task. During the task, functional neuroimaging data were acquired. We examined the activation patterns when playing for or winning for self, adolescent children and friends in four a-priori selected ROls (nucleus accumbens, dorsomedial prefrontal cortex, precuneus and temporo-parietal junction). Behaviorally, mothers indicated that they experienced most enjoyment when they gained money for their children and that their children deserved to win more, relative to friends and self. At the neural level, nucleus accumbens activity was stronger when winning versus losing. This pattern was not only found when playing for self, but also for friends and children, possibly reflecting the rewarding value of vicarious prosocial gains. In addition, dorsomedial prefrontal cortex, precuneus, and temporo-parietal junction were more active when receiving outcomes for children and friends compared to self, possibly reflecting increased recruitment of mentalizing processes. Interestingly, activity in this network was stronger for mothers who indicated that their children and friends deserved to win more. These findings provide initial evidence that vicarious rewards for one's children are processed similarly as rewards for self, and that activation in social brain regions are related to social closeness.	[Spaans, Jochem P.; Burke, Sarah M.; Op de Macks, Zdena A.; Crone, Eveline A.] Leiden Univ, Inst Psychol, Dept Dev & Educ Psychol, Leiden, Netherlands; [Spaans, Jochem P.; Burke, Sarah M.; Op de Macks, Zdena A.; Crone, Eveline A.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Altikulac, Sibel] Vrije Univ Amsterdam, Inst Psychol, Dept Clin Dev Psychol, Fac Behav & Movement Sci, Amsterdam, Netherlands; [Braams, Barbara R.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Braams, Barbara R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Harvard University; Harvard University	Spaans, JP (corresponding author), Leiden Univ, Inst Psychol, Dept Dev & Educ Psychol, Leiden, Netherlands.; Spaans, JP (corresponding author), Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands.	j.p.spaans@fsw.leidenuniv.nl	Burke, Sarah/J-6635-2019; Braams, Barbara/ABB-6422-2020	Burke, Sarah/0000-0001-7172-491X; Braams, Barbara/0000-0002-8688-5959	European Research Council [SH4, ERC-2010-StG_20091209]	European Research Council(European Research Council (ERC)European Commission)	This study was supported by a European Research Council Starting Grant (grant number: SH4, ERC-2010-StG_20091209) awarded to E.A. Crone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluja A, 2006, SCAND J PSYCHOL, V47, P23, DOI 10.1111/j.1467-9450.2006.00489.x; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Berridge KC, 2015, NEURON, V86, P646, DOI 10.1016/j.neuron.2015.02.018; Braams B. R., 2014, NEUROSCIENCE RISKY D, P73, DOI [10.1037/14322-004, DOI 10.1037/14322-004]; Braams BR, 2017, SOC COGN AFFECT NEUR, V12, P417, DOI 10.1093/scan/nsw136; Braams BR, 2015, J NEUROSCI, V35, P7226, DOI 10.1523/JNEUROSCI.4764-14.2015; Braams Barbara R, 2014, Neuroimage, V100, P281, DOI 10.1016/j.neuroimage.2014.06.020; Braams BR, 2014, SOC COGN AFFECT NEUR, V9, P1030, DOI 10.1093/scan/nst077; Brett M., Region of Interest Analysis Using an SPM Toolbox; BUKOWSKI WM, 1994, J SOC PERS RELAT, V11, P471, DOI 10.1177/0265407594113011; Bukowski WM, 2005, NEW DIR CHILD ADOLES, V21, P1736; Burnett S, 2009, J COGNITIVE NEUROSCI, V21, P1736, DOI 10.1162/jocn.2009.21121; Carter RM, 2013, TRENDS COGN SCI, V17, P328, DOI 10.1016/j.tics.2013.05.007; Cocosco CA, 1997, NEUROIMAGE, V5; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; De Goede IHA, 2009, J YOUTH ADOLESCENCE, V38, P1304, DOI 10.1007/s10964-009-9403-2; Delgado MR, 2007, ANN NY ACAD SCI, V1104, P70, DOI 10.1196/annals.1390.002; Fareri DS, 2012, J NEUROSCI, V32, P9045, DOI 10.1523/JNEUROSCI.0610-12.2012; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gorrese A, 2012, J YOUTH ADOLESCENCE, V41, P650, DOI 10.1007/s10964-012-9759-6; Guroglu B, 2008, NEUROIMAGE, V39, P903, DOI 10.1016/j.neuroimage.2007.09.007; Guroglu B, 2011, NEUROIMAGE, V57, P634, DOI 10.1016/j.neuroimage.2011.04.032; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hollenstein T, 2017, CURR OPIN PSYCHOL, V17, P140, DOI 10.1016/j.copsyc.2017.07.010; Inagaki TK, 2012, PSYCHOSOM MED, V74, P3, DOI 10.1097/PSY.0b013e3182359335; Isoda M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00232; Krall SC, 2015, BRAIN STRUCT FUNCT, V220, P587, DOI 10.1007/s00429-014-0803-z; Lemieux L, 2007, MAGN RESON IMAGING, V25, P894, DOI 10.1016/j.mri.2007.03.009; Lieberman MD, 2009, SCIENCE, V323, P890, DOI 10.1126/science.1170008; Liu XN, 2010, NEURO-ONCOLOGY, V12, P12; Lockwood PL, 2015, J NEUROSCI, V35, P13720, DOI 10.1523/JNEUROSCI.1703-15.2015; Mallers MH, 2010, DEV PSYCHOL, V46, P1651, DOI 10.1037/a0021020; MASON CA, 1994, AM J COMMUN PSYCHOL, V22, P723, DOI 10.1007/BF02521556; Mobbs D, 2009, SCIENCE 80 EUROPE PM, V324, DOI [10.1126/science.1170539, DOI 10.1126/SCIENCE.1170539]; Mobbs D, 2015, SOC COGN AFFECT NEUR, V10, P1323, DOI 10.1093/scan/nsv020; Morelli SA, 2015, NEUROIMAGE, V112, P244, DOI 10.1016/j.neuroimage.2014.12.056; OKoon J, 1997, ADOLESCENCE, V32, P471; PERRIS C, 1980, ACTA PSYCHIAT SCAND, V61, P265, DOI 10.1111/j.1600-0447.1980.tb00581.x; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Schneider BH, 2001, DEV PSYCHOL, V37, P86, DOI 10.1037//0012-1649.37.1.86; Sescousse G, 2013, NEUROSCI BIOBEHAV R, V37, P681, DOI 10.1016/j.neubiorev.2013.02.002; Steinberg L, 2001, J RES ADOLESCENCE, V11, P1, DOI 10.1111/1532-7795.00001; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547	44	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198663	10.1371/journal.pone.0198663	http://dx.doi.org/10.1371/journal.pone.0198663			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI5BF	29879189	Green Published, gold			2022-12-26	WOS:000434384900066
J	Tomassetti, M; Garavaglia, BS; Vranych, CV; Gottig, N; Ottado, J; Gramajo, H; Diacovich, L				Tomassetti, Mauro; Garavaglia, Betiana S.; Vranych, Cecilia V.; Gottig, Natalia; Ottado, Jorgelina; Gramajo, Hugo; Diacovich, Lautaro			3-methylcrotonyl Coenzyme A (CoA) carboxylase complex is involved in the Xanthomonas citri subsp citri lifestyle during citrus infection	PLOS ONE			English	Article							ESCHERICHIA-COLI; BIOTIN CARBOXYLASE; BIOLOGICAL-CONTROL; CARRIER PROTEIN; MOLECULAR-BASIS; DOMAIN PEPTIDE; BETA-SUBUNIT; EXPRESSION; VIRULENCE; PATHOGEN	Citrus canker is a disease caused by the phytopathogen Xanthomonas citri subsp. citri (Xcc), bacterium which is unable to survive out of the host for extended periods of time. Once established inside the plant, the pathogen must compete for resources and evade the defenses of the host cell. However, a number of aspects of Xcc metabolic and nutritional state, during the epiphytic stage and at different phases of infection, are poorly characterized. The 3-methyl-crotonyl-CoA carboxylase complex (MCC) is an essential enzyme for the catabolism of the branched-chain amino acid leucine, which prevents the accumulation of toxic intermediaries, facilitates the generation of branched chain fatty acids and/or provides energy to the cell. The MCC complexes belong to a group of acyl-CoA carboxylases (ACCase) enzymes dependent of biotin. In this work, we have identified two ORFs (XACO263 and XACO264) encoding for the alpha and beta subunits of an acyl-CoA carboxylase complex from Xanthomonas and demonstrated that this enzyme has MCC activity both in vitro and in vivo. We also found that this MCC complex is conserved in a group of pathogenic gram negative bacteria. The generation and analysis of an Xcc mutant strain deficient in MCC showed less canker lesions in the interaction with the host plant, suggesting that the expression of these proteins is necessary for Xcc fitness during infection.	[Tomassetti, Mauro; Garavaglia, Betiana S.; Vranych, Cecilia V.; Gottig, Natalia; Ottado, Jorgelina; Gramajo, Hugo; Diacovich, Lautaro] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario IBR CONICET, Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Diacovich, L (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario IBR CONICET, Rosario, Santa Fe, Argentina.	diacovich@ibr-conicet.gov.ar	Garavaglia, Barbara/J-5257-2018	Garavaglia, Barbara/0000-0003-4323-9145; Diacovich, Lautaro/0000-0002-3339-0100	Agencia Nacional de Promocion Cientifica y Tecnologica [P. BID PICT 2014-1454, PICT 2013-0625]; CONICET [PIP-2014-0764]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	BSG, NG, JO, HG, and LD are staff members and CW postdoctoral fellow of the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (P. BID PICT 2014-1454 to LD, PICT 2013-0625 to JO), CONICET (PIP-2014-0764 to LD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JA, 2008, J BACTERIOL, V190, P4888, DOI 10.1128/JB.00454-08; Aguilar JA, 2006, APPL ENVIRON MICROB, V72, P2070, DOI 10.1128/AEM.72.3.2070-2079.2006; Arabolaza A, 2010, BIOCHEMISTRY-US, V49, P7367, DOI 10.1021/bi1005305; Astua-Monge G, 2005, J BACTERIOL, V187, P1201, DOI 10.1128/JB.187.3.1201-1205.2005; Attwood PV, 2002, ACCOUNTS CHEM RES, V35, P113, DOI 10.1021/ar000049+; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Balhana RJC, 2013, FEMS MICROBIOL LETT, V345, P132, DOI 10.1111/1574-6968.12196; Baumgartner MR, 2001, J CLIN INVEST, V107, P495, DOI 10.1172/JCI11948; Lyonnet BB, 2017, FEBS J, V284, P1110, DOI 10.1111/febs.14046; Blanchard CZ, 1998, J BIOL CHEM, V273, P19140, DOI 10.1074/jbc.273.30.19140; Blanchard CZ, 1999, J BIOL CHEM, V274, P31767, DOI 10.1074/jbc.274.45.31767; Blanchard CZ, 1999, BIOCHEM BIOPH RES CO, V266, P466, DOI 10.1006/bbrc.1999.1844; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; CHAPMANSMITH A, 1994, BIOCHEM J, V302, P881, DOI 10.1042/bj3020881; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Dalio RJD, 2017, ANN BOT-LONDON, V119, P749, DOI [10.1093/aob/mcw238, 10.1093/aob/mcx076]; Diacovich L, 2004, BIOCHEMISTRY-US, V43, P14027, DOI 10.1021/bi049065v; Diacovich L, 2002, J BIOL CHEM, V277, P31228, DOI 10.1074/jbc.M203263200; Dianese AC, 2003, APPL ENVIRON MICROB, V69, P3484, DOI 10.1128/AEM.69.6.3484-3491.2003; Diaz-Perez AL, 2004, APPL ENVIRON MICROB, V70, P5102, DOI 10.1128/AEM.70.9.5102-5110.2004; Ehebauer MT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004623; ERFLE JD, 1973, BIOCHIM BIOPHYS ACTA, V316, P143, DOI 10.1016/0005-2760(73)90004-0; Espinoza C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014101; Ficarra FA, 2017, MOL PLANT PATHOL, V18, P720, DOI 10.1111/mpp.12433; Ficarra FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125516; Forster-Fromme K, 2006, APPL ENVIRON MICROB, V72, P4819, DOI 10.1128/AEM.00853-06; Forster-Fromme K, 2010, APPL MICROBIOL BIOT, V87, P859, DOI 10.1007/s00253-010-2644-x; Gallardo ME, 2001, AM J HUM GENET, V68, P334, DOI 10.1086/318202; Ganesan B, 2006, APPL ENVIRON MICROB, V72, P4264, DOI 10.1128/AEM.00448-06; Garavaglia BS, 2016, MOL PLANT PATHOL, V17, P1344, DOI 10.1111/mpp.12364; Gibon Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r76; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HENRIKSON KP, 1979, J BIOL CHEM, V254, P5888; Hoschle B, 2005, MICROBIOL-SGM, V151, P3649, DOI 10.1099/mic.0.28260-0; Huang CS, 2012, NATURE, V481, P219, DOI 10.1038/nature10691; HUNAITI AR, 1982, ARCH BIOCHEM BIOPHYS, V216, P362, DOI 10.1016/0003-9861(82)90222-3; Janiyani K, 2001, J BIOL CHEM, V276, P29864, DOI 10.1074/jbc.M104102200; Ji PS, 2002, APPL ENVIRON MICROB, V68, P4383, DOI 10.1128/AEM.68.9.4383-4389.2002; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Jung CW, 2012, J HUM GENET, V57, P62, DOI 10.1038/jhg.2011.116; Jurado AR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9986; Kaschani F, 2016, BIOORGAN MED CHEM, V24, P3330, DOI 10.1016/j.bmc.2016.04.051; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; Kim S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2657-7; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kruse C, 2007, PLANT BIOLOGY, V9, P608, DOI 10.1055/s-2007-965432; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE MD, 1963, P NATL ACAD SCI USA, V49, P379, DOI 10.1073/pnas.49.3.379; Levert KL, 2002, BIOCHEM BIOPH RES CO, V291, P1213, DOI 10.1006/bbrc.2002.6576; Levert KL, 2002, BIOCHEMISTRY-US, V39, P4122; Li Q, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-42; LYNEN F, 1979, CRC CR REV BIOCH MOL, V7, P103, DOI 10.3109/10409237909105428; Morscher RJ, 2012, MOL GENET METAB, V105, P602, DOI 10.1016/j.ymgme.2011.12.018; NIKOLAU BJ, 1985, ANAL BIOCHEM, V149, P448, DOI 10.1016/0003-2697(85)90596-2; Nikolau BJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P211, DOI 10.1016/S0003-9861(03)00156-5; Peng C, 2015, PLANT PHYSIOL, V169, P1807, DOI 10.1104/pp.15.00461; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Peyraud R, 2017, PLANT J, V90, P720, DOI 10.1111/tpj.13429; Rodriguez E, 1999, MICROBIOL-SGM, V145, P3109, DOI 10.1099/00221287-145-11-3109; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schatschneider S, 2014, MOL BIOSYST, V10, P2663, DOI 10.1039/c4mb00198b; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sperringer JE, 2017, NEUROCHEM RES, P1; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Subramaniam R, 2015, MOL MICROBIOL, V98, P760, DOI 10.1111/mmi.13155; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Tong L, 2013, CELL MOL LIFE SCI, V70, P863, DOI 10.1007/s00018-012-1096-0; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WALDROP GL, 1994, BIOCHEMISTRY-US, V33, P10249, DOI 10.1021/bi00200a004; Wengelnik K, 1996, J BACTERIOL, V178, P3462, DOI 10.1128/jb.178.12.3462-3469.1996; Zanatta A, 2013, CELL MOL NEUROBIOL, V33, P137, DOI 10.1007/s10571-012-9879-2; Zandberg L, 2016, INT J BIOCHEM CELL B, V78, P116, DOI 10.1016/j.biocel.2016.07.010; Zimaro T, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-96; Zimaro T, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-186	80	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198414	10.1371/journal.pone.0198414	http://dx.doi.org/10.1371/journal.pone.0198414			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879157	Green Submitted, Green Published, gold			2022-12-26	WOS:000434384900042
J	Adam, N; Kallenbach, M; Meldau, S; Veit, D; van Dam, NM; Baldwin, IT; Schuman, MC				Adam, Nora; Kallenbach, Mario; Meldau, Stefan; Veit, Daniel; van Dam, Nicole M.; Baldwin, Ian T.; Schuman, Meredith C.			Functional variation in a key defense gene structures herbivore communities and alters plant performance	PLOS ONE			English	Article							TOBACCO NICOTIANA-ATTENUATA; JASMONATE-INDUCED RESPONSES; ECOSYSTEM STABILITY; GENOTYPIC DIVERSITY; INSECT HERBIVORES; FIELD EXPERIMENTS; DATURA-WRIGHTII; MANDUCA-SEXTA; ROOT-GROWTH; POPULATIONS	Plant genetic diversity structures animal communities and affects plant population productivity. However, few studies have investigated which traits are involved and the mechanisms mediating these effects. We studied the consequences of varying the expression of a single biosynthetic gene in jasmonate (JA) defense hormones, which are essential for defense against herbivores but constrain plant growth, in experimental mesocosm populations of wild tobacco (Nicotiana attenuata) plants under attack from three native herbivores. Empoasca leafhoppers preferentially attack JA-deficient N. attenuata plants in nature, and the specialist Tupiocoris notatus mirids avoid Empoasca-damaged plants. However, in experimental mesocosm populations having equal numbers of wild-type (WT) and JA-deficient plants that are silenced in the expression of the biosynthetic gene lipoxygenase 3 (LOX3), Empoasca sp. attacked both genotypes. Empoasca sp. damage, rather than JA, determined T. notatus damage, which was reduced in mixed populations. The growth of specialist Manduca sexta larvae was reduced on WT vs. asLOX3 monocultures, but differed in mixtures depending on caterpillar density. However, seed capsule number remained similar for WT and asLOX3 plants in mixtures, not in monocultures, in two experimental scenarios reflecting high and low caterpillar attack. At high caterpillar density, WT plants growing in mixtures produced more seed capsules than those growing in monocultures while seed production of asLOX3 plants did not differ by population type. However, at low caterpillar density, asLOX3 plants growing in mixed populations produced more seed capsules than those growing in monoculture, while seed capsule production did not differ for WT by population type. Thus, mixed populations had a more stable output of seed capsules under the two scenarios. This may result from a balance between JA-mediated herbivore defense and plant competitive ability in mixed populations.	[Adam, Nora; Kallenbach, Mario; Meldau, Stefan; Baldwin, Ian T.; Schuman, Meredith C.] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany; [Adam, Nora; van Dam, Nicole M.; Schuman, Meredith C.] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Veit, Daniel] Max Planck Inst Chem Ecol, Tech Serv, Jena, Germany; [Adam, Nora] Max Planck Inst Chem Ecol, Res Grp Sequestrat & Detoxificat Insects, Jena, Germany; [Kallenbach, Mario] Shimadzu Deutschland GmbH, Tech Buro, Jena, Germany; [Meldau, Stefan] KWS SAAT AG, Einbeck, Germany	Max Planck Society; Max Planck Society; Max Planck Society; KWS Saat AG	Baldwin, IT; Schuman, MC (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany.; Schuman, MC (corresponding author), German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany.	baldwin@ice.mpg.de; mschuman@ice.mpg.de	Schuman, Meredith C./A-5529-2013; van Dam, Nicole M./B-3281-2008; Baldwin, Ian T/K-1809-2013	Schuman, Meredith C./0000-0003-3159-3534; van Dam, Nicole M./0000-0003-2622-5446; 	Max Planck Society; German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig; German Research Foundation [FZT 118]; European Research Council [293926]; Collaborative Research Centre Chemical Mediators in Complex Biosystems - ChemBioSys - German Research Foundation [CRC 1127]	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig; German Research Foundation(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Collaborative Research Centre Chemical Mediators in Complex Biosystems - ChemBioSys - German Research Foundation	This work was supported by the Max Planck Society (N.A., M.K., D.V., S.M., I.T.B.); the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, funded by the German Research Foundation (FZT 118; N.A., S.M., N.M.v.D., I.T.B., M.C.S.); European Research Council advanced grant Clockwork Green to I.T.B. (number 293926; I.T.B., M.C.S.), and in part by the Collaborative Research Centre Chemical Mediators in Complex Biosystems - ChemBioSys (CRC 1127) funded by the German Research Foundation (I.T.B., M.C.S.).	Abdala-Roberts L, 2015, AGR FOREST ENTOMOL, V17, P433, DOI 10.1111/afe.12125; Abdala-Roberts L, 2014, ECOLOGY, V95, P2879, DOI 10.1890/13-2029.1; Adam N, 2017, J INTEGR PLANT BIOL, V59, P44, DOI 10.1111/jipb.12507; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; Campos ML, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12570; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Crutsinger GM, 2016, NEW PHYTOL, V210, P65, DOI 10.1111/nph.13537; Dovciak M, 2010, ECOL LETT, V13, P1300, DOI 10.1111/j.1461-0248.2010.01524.x; Elton C. S., 1958, ECOLOGY INVASIONS AN; Fisher RA, 1930, GENETICAL THEORY NAT; Fragoso V, 2014, NEW PHYTOL, V202, P1335, DOI 10.1111/nph.12747; Gassmann AJ, 2005, OECOLOGIA, V144, P62, DOI 10.1007/s00442-005-0038-z; Glawe GA, 2003, ECOLOGY, V84, P79, DOI 10.1890/0012-9658(2003)084[0079:ECABCW]2.0.CO;2; Hajjar R, 2008, AGR ECOSYST ENVIRON, V123, P261, DOI 10.1016/j.agee.2007.08.003; Halitschke R, 2004, J PLANT GROWTH REGUL, V23, P238, DOI 10.1007/s00344-004-0037-z; Halitschke R, 2003, PLANT J, V36, P794, DOI 10.1046/j.1365-313X.2003.01921.x; Hamback PA, 2014, ECOLOGY, V95, P1370, DOI 10.1890/13-0793.1; Heiling S, 2010, PLANT CELL, V22, P273, DOI 10.1105/tpc.109.071449; Herden J, 2016, J INTEGR PLANT BIOL, V58, P656, DOI 10.1111/jipb.12458; Hersch-Green EI, 2011, PHILOS T R SOC B, V366, P1453, DOI 10.1098/rstb.2010.0331; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Hummel GM, 2007, PLANT CELL ENVIRON, V30, P1326, DOI 10.1111/j.1365-3040.2007.01718.x; Hummel GM, 2009, PLANT CELL ENVIRON, V32, P134, DOI 10.1111/j.1365-3040.2008.01905.x; Jarvis DI, 2008, P NATL ACAD SCI USA, V105, P5326, DOI 10.1073/pnas.0800607105; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; Joo Y, 2018, FUNCT ECOL, V32, P136, DOI 10.1111/1365-2435.12947; Kallenbach M, 2012, P NATL ACAD SCI USA, V109, pE1548, DOI 10.1073/pnas.1200363109; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Kessler A, 2004, PLANT J, V38, P639, DOI 10.1111/j.1365-313X.2004.02076.x; Kessler D, 2008, SCIENCE, V321, P1200, DOI 10.1126/science.1160072; Kim TN, 2015, ECOLOGY, V96, P1431, DOI 10.1890/14-1097.1; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Kumar P, 2016, P NATL ACAD SCI USA, V113, pE1328, DOI 10.1073/pnas.1600609113; Kumar P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095982; Larrieu A, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0308-8; Loreau M, 2013, ECOL LETT, V16, P106, DOI 10.1111/ele.12073; Lynds GY, 1998, OECOLOGIA, V115, P531, DOI 10.1007/PL00008820; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; Machado RAR, 2015, NEW PHYTOL, V207, P91, DOI 10.1111/nph.13337; Madritch MD, 2003, OECOLOGIA, V136, P124, DOI 10.1007/s00442-003-1253-0; McArt SH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0639; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Meldau S, 2009, NEW PHYTOL, V181, P161, DOI 10.1111/j.1469-8137.2008.02645.x; Meldau S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-213; Mitton JB, 2003, BIOSCIENCE, V53, P208, DOI 10.1641/0006-3568(2003)053[0208:TUOEAE]2.0.CO;2; Moreira X, 2016, CURR OPIN INSECT SCI, V14, P1, DOI 10.1016/j.cois.2015.10.003; Pachepsky E, 2007, ECOL MODEL, V207, P277, DOI 10.1016/j.ecolmodel.2007.05.005; Petchey OL, 2015, ECOL LETT, V18, P597, DOI 10.1111/ele.12443; Pfisterer AB, 2002, NATURE, V416, P84, DOI 10.1038/416084a; Pinheiro J, 2013, R DEV CORE TEAM NLME; Rayapuram C, 2006, PLANT CELL ENVIRON, V29, P1585, DOI 10.1111/j.1365-3040.2006.01534.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Roda AL, 2003, PHYTOCHEMISTRY, V62, P527, DOI 10.1016/S0031-9422(02)00608-8; Rudman SM, 2015, P ROY SOC B-BIOL SCI, V282, P125, DOI 10.1098/rspb.2015.1234; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Schuman MC, 2016, ANNU REV ENTOMOL, V61, P373, DOI 10.1146/annurev-ento-010715-023851; Schuman MC, 2015, ELIFE, V4, DOI 10.7554/eLife.04490; Schuman MC, 2009, NEW PHYTOL, V183, P1134, DOI 10.1111/j.1469-8137.2009.02894.x; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Steppuhn A, 2008, MOL ECOL, V17, P3717, DOI 10.1111/j.1365-294X.2008.03862.x; Steppuhn Anke, 2008, P61, DOI 10.1007/978-1-4020-8182-8_3; Stork WFJ, 2011, PLANT SIGNAL BEHAV, V6, P1893, DOI 10.4161/psb.6.12.18028; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Ullmann-Zeunert L, 2013, PLANT J, V75, P417, DOI 10.1111/tpj.12210; Underwood N, 2014, Q REV BIOL, V89, P1, DOI 10.1086/674991; van Dam NM, 1998, ECOL ENTOMOL, V23, P22, DOI 10.1046/j.1365-2311.1998.00110.x; van Dam NM, 1998, ECOL LETT, V1, P30, DOI 10.1046/j.1461-0248.1998.00010.x; Wang L, 2008, PLANT PHYSIOL, V146, P904, DOI 10.1104/pp.107.109264; Wetzel WC, 2016, NATURE, V539, P425, DOI 10.1038/nature20140; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Wright JP, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0272	76	1	1	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197221	10.1371/journal.pone.0197221	http://dx.doi.org/10.1371/journal.pone.0197221			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874269	Green Published, Green Submitted, gold			2022-12-26	WOS:000434369400016
J	Balermpas, P; Stera, S; von der Grun, JM; Loutfi-Krauss, B; Forster, MT; Wagner, M; Keller, C; Rodel, C; Seifert, V; Blanck, O; Wolff, R				Balermpas, Panagiotis; Stera, Susanne; von der Gruen, Jens Mueller; Loutfi-Krauss, Britta; Forster, Marie-Therese; Wagner, Marlies; Keller, Christian; Roedel, Claus; Seifert, Volker; Blanck, Oliver; Wolff, Robert			Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort	PLOS ONE			English	Article							POSTOPERATIVE STEREOTACTIC RADIOSURGERY; GAMMA-KNIFE RADIOSURGERY; SURGICAL RESECTION; RADIATION-THERAPY; CEREBRAL METASTASES; SALVAGE THERAPY; BREAST-CANCER; SINGLE-CENTER; SOLID TUMORS; RADIOTHERAPY	Purpose Stereotactic radiosurgery (SRS) is an established primary treatment for newly diagnosed brain metastases with high local control rates. However, data about local re-irradiation in case of local failure after SRS (re-SRS) are rare. We evaluated the feasibility, efficacy and patient selection characteristics in treating locally recurrent metastases with a second course of SRS. Methods We retrospectively evaluated patients with brain metastases treated with re-SRS for local tumor progression between 2011 and 2017. Patient and treatment characteristics as well as rates of tumor control, survival and toxicity were analyzed. Results Overall, 32 locally recurrent brain metastases in 31 patients were irradiated with re-SRS. Median age at re-SRS was 64.9 years. The primary histology was breast cancer and nonsmall-cellular lung cancer (NSCLC) in respectively 10 cases (31.3%), in 5 cases malignant melanoma (15.6%). In the first SRS-course 19 metastases (59.4%) and in the re-SRScourse 29 metastases (90.6%) were treated with CyberKnife (R) and the others with Gamma Knife. Median planning target volume (PTV) for re-SRS was 2.5 cm(3) (range, 0.1-37.5 cm(3)) and median dose prescribed to the PTV was 19 Gy (range, 12-28 Gy) in 1-5 fractions to the median 69% isodose (range, 53-80%). The 1-year overall survival rate was 61.7% and the 1-year local control rate was 79.5%. The overall rate of radiological radio-necrosis was 16.1% and four patients (12.9%) experienced grade >= 3 toxicities. Conclusions A second course of SRS for locally recurrent brain metastases after prior local SRS appears to be feasible with acceptable toxicity and can be considered as salvage treatment option for selected patients with high performance status. Furthermore, this is the first study utilizing robotic radiosurgery for this indication, as an additional option for frameless fractionated treatment.	[Balermpas, Panagiotis; Stera, Susanne; von der Gruen, Jens Mueller; Loutfi-Krauss, Britta; Keller, Christian; Roedel, Claus] Goethe Univ Frankfurt, Dept Radiat Oncol, Univ Hosp, Frankfurt, Germany; [Balermpas, Panagiotis; Keller, Christian; Blanck, Oliver; Wolff, Robert] Saphir Radiosurg Ctr, Frankfurt, Germany; [Balermpas, Panagiotis; Roedel, Claus] German Canc Res Ctr, Heidelberg, Germany; [Balermpas, Panagiotis; Roedel, Claus] German Canc Consortium DKTK Partner Site, Frankfurt, Germany; [Forster, Marie-Therese; Seifert, Volker; Wolff, Robert] Goethe Univ Frankfurt, Univ Hosp, Dept Neurosurg, Frankfurt, Germany; [Wagner, Marlies] Goethe Univ Frankfurt, Univ Hosp, Inst Neuroradiol, Frankfurt, Germany; [Blanck, Oliver] Univ Med Ctr Schleswig Holstein, Dept Radiat Oncol, Kiel, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Kiel; Schleswig Holstein University Hospital	Balermpas, P (corresponding author), Goethe Univ Frankfurt, Dept Radiat Oncol, Univ Hosp, Frankfurt, Germany.; Balermpas, P (corresponding author), Saphir Radiosurg Ctr, Frankfurt, Germany.; Balermpas, P (corresponding author), German Canc Res Ctr, Heidelberg, Germany.; Balermpas, P (corresponding author), German Canc Consortium DKTK Partner Site, Frankfurt, Germany.	panagiotis.balermpas@kgu.de	Forster, Marie-Therese/AAY-5616-2020; Wagner, Marlies/AAZ-5487-2021; Wagner, Marlies/GQA-9181-2022; Wagner, Marlies/AAL-3357-2020	Blanck, Oliver/0000-0003-1391-1308; Balermpas, Panagiotis/0000-0001-5261-6446				Ammirati M, 2010, J NEURO-ONCOL, V96, P85, DOI 10.1007/s11060-009-0055-6; Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Barajas RF, 2009, AM J NEURORADIOL, V30, P367, DOI 10.3174/ajnr.A1362; Baschnagel AM, 2013, J NEUROSURG, V118, P571, DOI 10.3171/2012.10.JNS12880; BINDAL RK, 1995, J NEUROSURG, V83, P600, DOI 10.3171/jns.1995.83.4.0600; Blanck O, 2016, J APPL CLIN MED PHYS, V17, P313, DOI 10.1120/jacmp.v17i3.6151; Brown PD, 2017, LANCET ONCOL, V18, P1049, DOI 10.1016/S1470-2045(17)30441-2; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Christodoulou C, 2005, J NEURO-ONCOL, V71, P61, DOI 10.1007/s11060-004-9176-0; Combs SE, 2004, STRAHLENTHER ONKOL, V180, P590, DOI 10.1007/s00066-004-1299-x; Filss CP, 2017, CLIN TRANSL IMAGING, V5, P209, DOI 10.1007/s40336-017-0225-z; Finn RS, 2016, NEW ENGL J MED, V375, P1925, DOI 10.1056/NEJMoa1607303; FLICKINGER JC, 1990, INT J RADIAT ONCOL, V19, P783, DOI 10.1016/0360-3016(90)90510-Q; Fogarty GB, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2433-8; Fokas E, 2010, STRAHLENTHER ONKOL, V186, P210, DOI 10.1007/s00066-010-2055-z; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gorovets D, 2017, INT J RADIAT ONCOL, V97, P246, DOI 10.1016/j.ijrobp.2016.09.043; Greto D, 2014, RADIOL MED, V119, P721, DOI 10.1007/s11547-014-0383-2; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hwu WJ, 2005, CANCER, V103, P2590, DOI 10.1002/cncr.21081; Jimenez RB, 2017, ADV RADIAT ONCOL, V2, P391, DOI 10.1016/j.adro.2017.05.008; Kaba SE, 1997, J CLIN ONCOL, V15, P1063, DOI 10.1200/JCO.1997.15.3.1063; Kang TW, 2009, EUR J RADIOL, V72, P370, DOI 10.1016/j.ejrad.2008.08.009; Kocher M, 2014, STRAHLENTHER ONKOL, V190, P521, DOI 10.1007/s00066-014-0648-7; Kocher M, 2011, J CLIN ONCOL, V29, P134, DOI 10.1200/JCO.2010.30.1655; Koffer P, 2017, WORLD NEUROSURG, V104, P589, DOI 10.1016/j.wneu.2017.04.103; Linskey ME, 2010, J NEURO-ONCOL, V96, P45, DOI 10.1007/s11060-009-0073-4; Lutterbach J, 2003, NEUROSURGERY, V52, P1066, DOI 10.1227/01.NEU.0000057695.64198.FE; Mahajan A, 2017, LANCET ONCOL, V18, P1040, DOI 10.1016/S1470-2045(17)30414-X; Mckay WH, 2017, J NEUROSURG, V127, P148, DOI 10.3171/2016.5.JNS153051; Minniti G, 2016, J NEURO-ONCOL, V126, P91, DOI 10.1007/s11060-015-1937-4; Mitsuya K, 2010, J NEURO-ONCOL, V99, P81, DOI 10.1007/s11060-009-0106-z; Mu F, 2015, J CLIN NEUROSCI, V22, P561, DOI 10.1016/j.jocn.2014.08.020; Nayak L, 2012, CURR ONCOL REP, V14, P48, DOI 10.1007/s11912-011-0203-y; Okada Hideho, 2015, Lancet Oncol, V16, pe534, DOI 10.1016/S1470-2045(15)00088-1; Patchell RA, 1998, JAMA-J AM MED ASSOC, V280, P1485, DOI 10.1001/jama.280.17.1485; Press RH, 2017, INT J RADIAT ONCOL, V98, P632, DOI 10.1016/j.ijrobp.2017.03.012; Rades D, 2008, STRAHLENTHER ONKOL, V184, P198, DOI 10.1007/s00066-008-1825-3; Rades D, 2015, ANTICANCER RES, V35, P333; Rades D, 2014, STRAHLENTHER ONKOL, V190, P786, DOI 10.1007/s00066-014-0625-1; Rana N, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00279; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Sahgal A, 2015, INT J RADIAT ONCOL, V91, P710, DOI 10.1016/j.ijrobp.2014.10.024; Shultz DB, 2015, INT J RADIAT ONCOL, V92, P993, DOI 10.1016/j.ijrobp.2015.04.036; Soffietti R, 2013, J CLIN ONCOL, V31, P65, DOI 10.1200/JCO.2011.41.0639; Truong MT, 2006, NEUROSURGERY, V59, P86, DOI 10.1227/01.NEU.0000219858.80351.38; Vecil GG, 2005, J NEUROSURG, V102, P209, DOI 10.3171/jns.2005.102.2.0209; Weybright P, 2005, AM J ROENTGENOL, V185, P1471, DOI 10.2214/AJR.04.0933; Yamanaka K, 1999, STEREOT FUNCT NEUROS, V72, P73, DOI 10.1159/000056442	50	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198692	10.1371/journal.pone.0198692	http://dx.doi.org/10.1371/journal.pone.0198692			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874299	Green Published, Green Submitted, gold			2022-12-26	WOS:000434369400062
J	Barnes, AN; Anderson, JD; Mumma, J; Mahmud, ZH; Cumming, O				Barnes, Amber N.; Anderson, John D.; Mumma, Jane; Mahmud, Zahid Hayat; Cumming, Oliver			The association between domestic animal presence and ownership and household drinking water contamination among peri-urban communities of Kisumu, Kenya	PLOS ONE			English	Article							FECAL CONTAMINATION; LIVESTOCK; MUNICIPALITY; HYGIENE; DISEASE; HEALTH; HANDS; FECES; URBAN; SOIL	Introduction Household drinking water can be contaminated by diarrheagenic enteropathogens at numerous points between the source and actual consumption. Interventions to prevent this contamination have focused on preventing exposure to human waste through interventions to improve drinking water, sanitation and hygiene (WASH). In many cases though, the infectious agent may be of zoonotic rather than human origin suggesting that unsafely managed animal waste may contribute to the contamination of household drinking water and the associated diarrheal disease burden. Methods A cross-sectional household survey of 800 households was conducted across three informal peri-urban neighborhoods of Kisumu, Kenya, collecting stored drinking water samples, administering a household survey including water, sanitation and hygiene infrastructure and behaviors, and recording domestic animal presence and ownership. We used multivariate logistic regression to assess the association of traditional WASH factors and domestic animal presence and ownership on microbial contamination of household drinking water. Results The majority of households sampled had fecally contaminated drinking water (67%), defined by the presence of any colony forming units of the fecal indicator bacteria enterococci. After adjustment for potential confounders, including socio-economic status and water and sanitation access, both household animal ownership (aOR 1.31; CI 1.00-1.73, p = 0.05) and the presence of animal waste in the household compound (aOR 1.38; CI 1.01, 1.89, p = 0.04) were found to be significantly associated with household drinking water contamination. None of the conventional WASH variables were found to be significantly associated with household drinking water contamination in the study population. Conclusions Water, sanitation, and hygiene strategies to reduce diarrheal disease should consider the promotion of safe animal contact alongside more traditional interventions focusing on the management of human waste. Future research on fecal contamination of unsafe household drinking water should utilize host-specific markers to determine whether the source is human or animal to prepare targeted public health messages.	[Barnes, Amber N.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA; [Barnes, Amber N.] Univ Florida, Dept Environm & Global Hlth, Gainesville, FL 32603 USA; [Anderson, John D.] Univ Florida, Sch Nat Resources & Environm, Emerging Pathogens Inst, Gainesville, FL USA; [Mumma, Jane] Great Lakes Univ Kisumu, Kisumu, Kenya; [Mahmud, Zahid Hayat] Int Ctr Diarrhoeal Dis Res, Environm Microbiol Lab, Dhaka, Bangladesh; [Cumming, Oliver] London Sch Hyg & Trop Med, Dept Dis Control, London, England	Duke University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; International Centre for Diarrhoeal Disease Research (ICDDR); University of London; London School of Hygiene & Tropical Medicine	Barnes, AN (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA.; Barnes, AN (corresponding author), Univ Florida, Dept Environm & Global Hlth, Gainesville, FL 32603 USA.	amber.barnes@duke.edu	Barnes, Amber/AAC-5251-2022	Barnes, Amber/0000-0001-6284-3634; Anderson, John/0000-0003-0840-9890; Cumming, Oliver/0000-0002-5074-8709	SHARE Research Consortium through UK Department for International Development	SHARE Research Consortium through UK Department for International Development	Funding for this research was provided by the SHARE Research Consortium through the UK Department for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, DEM HLTH SURV; Bain R, 2014, TROP MED INT HEALTH, V19, P917, DOI 10.1111/tmi.12334; Bain R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001644; Barnes AN, 2017, ROLE OWNERSHIP PRESE, DOI [10.1111/zph.12429/full, DOI 10.1111/ZPH.12429/FULL]; Barnes AN, 2016, DOMESTIC ANIMALS DRI; Boehm A., 2014, ENTEROCOCCI INDICATO; Boehm AB, 2016, ENVIRON SCI TECH LET, V3, P393, DOI 10.1021/acs.estlett.6b00382; Bokkers EAM, 2006, WAG UR FRON, V13, P31, DOI 10.1007/1-4020-4541-7_3; Brown J, 2013, ARCH DIS CHILD, V98, P629, DOI 10.1136/archdischild-2011-301528; Clasen T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004794.pub2; Clasen Thomas F., 2003, Journal of Water and Health, V1, P109; Conan A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005795; Council KC, 2004, KIS CIT DEV STRAT; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Ding N, 2014, SCI TOTAL ENVIRON, V470, P717, DOI 10.1016/j.scitotenv.2013.09.099; Dufour A., 2012, ANIMAL WASTE WATER Q; Eisenberg JNS, 2007, AM J PUBLIC HEALTH, V97, P846, DOI 10.2105/AJPH.2006.086207; Ercumen A, 2017, ENVIRON SCI TECHNOL, V51, P8725, DOI 10.1021/acs.est.7b01710; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Freeman MC, 2014, TROP MED INT HEALTH, V19, P906, DOI 10.1111/tmi.12339; Gorchev H.G., 1984, WHO GUIDELINES DRINK; Grace D, 2015, INT J ENV RES PUB HE, V12, P10490, DOI 10.3390/ijerph120910490; Hale CR, 2012, CLIN INFECT DIS, V54, pS472, DOI 10.1093/cid/cis051; Heitzinger K, 2015, AM J TROP MED HYG, V93, P501, DOI 10.4269/ajtmh.14-0802; Herrero M, 2013, ANIMAL, V7, P3, DOI 10.1017/S1751731112001954; Jenkins M, 2009, WATER RES; Kagira J M, 2010, East Afr J Public Health, V7, P1; Kagira JM, 2010, J S AFR VET ASSOC, V81, P82; Kang'ethe EK, 2012, TROP ANIM HEALTH PRO, V44, pS3, DOI 10.1007/s11250-012-0199-9; Luby S, 2006, TROP MED, DOI [10.1111/j.1365-3156.2006.01592.x/full, DOI 10.1111/J.1365-3156.2006.01592.X/FULL]; Lukuyu B, 2014, CHARACTERIZATION LIV; Maoulidi M., WATER SANITATION NEE, DOI [10.7916/D8SJ1TJ5, DOI 10.7916/D8SJ1TJ5]; Mattioli MC, 2013, ENVIRON SCI TECHNOL, V47, P355, DOI 10.1021/es303878d; Mintz E, 2001, AM J PUBLIC HEALTH, V91, P1565, DOI 10.2105/AJPH.91.10.1565; MINTZ ED, 1995, JAMA-J AM MED ASSOC, V273, P948, DOI 10.1001/jama.273.12.948; Mireri C, 2007, HABITAT INT, V31, P375, DOI 10.1016/j.habitatint.2007.06.006; MOE CL, 1991, B WORLD HEALTH ORGAN, V69, P305; Opisa S, 2012, WATER SCI, DOI [10.1155/2012/369417, DOI 10.1155/2012/369417]; Oswald WE, 2007, AM J TROP MED HYG, V77, P699, DOI 10.4269/ajtmh.2007.77.699; Penakalapati G, 2017, ENVIRON SCI TECHNOL, V51, P11537, DOI 10.1021/acs.est.7b02811; Perry B, 2009, PHILOS T R SOC B, V364, P2643, DOI 10.1098/rstb.2009.0097; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Psutka R, 2011, ENVIRON SCI TECHNOL, V45, P6095, DOI 10.1021/es2004045; Salas H, 2006, EXPERT CONSULT DEV A; Schlundt J, 2004, REV SCI TECH OIE, V23, P513, DOI 10.20506/rst.23.2.1506; Schriewer A, 2015, AM J TROP MED HYG, V93, P509, DOI 10.4269/ajtmh.14-0824; Shaheed A, 2014, TROP MED INT HEALTH, V19, P186, DOI 10.1111/tmi.12229; UN-Habitat, 2005, SIT AN INF SETTL KIS; Waddington H., WATER SANITATION HYG, V12009; Wagner E. G., 1958, MONOGRAPH SERIES; Waters EK, 2016, B MATH BIOL, V78, P169, DOI 10.1007/s11538-015-0136-y; WHO, 2003, FAEC POLL WAT QUAL G, P51; Who, 2011, GUID DRINK WAT QUAL, Vfourth, DOI DOI 10.1016/S1462-0758(00)00006-6; Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331; World Health Organisation, 2015, DRINK WAT; World Health Organization, 2017, STAT HLTH IN IND; World Health Organization, 2015, PROGR SAN DRINK WAT; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x; Zambrano LD, 2014, T ROY SOC TROP MED H, V108, P313, DOI 10.1093/trstmh/tru056	59	14	14	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197587	10.1371/journal.pone.0197587	http://dx.doi.org/10.1371/journal.pone.0197587			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874284	gold, Green Submitted, Green Published			2022-12-26	WOS:000434369400027
J	Esteban, I; Marean, CW; Fisher, EC; Karkanas, P; Cabanes, D; Albert, RM				Esteban, Irene; Marean, Curtis W.; Fisher, Erich C.; Karkanas, Panagiotis; Cabanes, Dan; Albert, Rosa M.			Phytoliths as an indicator of early modern humans plant gathering strategies, fire fuel and site occupation intensity during the Middle Stone Age at Pinnacle Point 5-6 (south coast, South Africa)	PLOS ONE			English	Article							WESTERN CAPE PROVINCE; DIEPKLOOF ROCK SHELTER; MODERN HUMAN ORIGINS; 13B MOSSEL BAY; BLOMBOS CAVE; ARCHAEOLOGICAL RECORD; FLORISTIC REGION; HIGH-RESOLUTION; HUMAN-BEHAVIOR; WOODY-PLANTS	The study of plant remains in archaeological sites, along with a better understanding of the use of plants by prehistoric populations, can help us shed light on changes in survival strategies of hunter-gatherers and consequent impacts on modern human cognition, social organization, and technology. The archaeological locality of Pinnacle Point (Mossel Bay, South Africa) includes a series of coastal caves, rock-shelters, and open-air sites with human occupations spanning the Acheulian through Middle Stone Age (MSA) and Later Stone Age (LSA). These sites have provided some of the earliest evidence for complex human behaviour and technology during the MSA. We used phytoliths-amorphous silica particles that are deposited in cells of plants-as a proxy for the reconstruction of past human plant foraging strategies on the south coast of South Africa during the Middle and Late Pleistocene, emphasizing the use and control of fire as well as other possible plant uses. We analysed sediment samples from the different occupation periods at the rock shelter Pinnacle Point 5-6 North (PP5-6N). We also present an overview of the taphonomic processes affecting phytolith preservation in this site that will be critical to conduct a more reliable interpretation of the original plant use in the rock shelter. Our study reports the first evidence of the intentional gathering and introduction into living areas of plants from the Restionaceae family by MSA hunter-gatherers inhabiting the south coast of South Africa. We suggest that humans inhabiting Pinnacle Point during short-term occupation events during Marine Isotope Stage (MIS) 5 built fast fires using mainly grasses with some wood from trees and/or shrubs for specific purposes, perhaps for shellfish cooking. With the onset of MIS 4 we observed a change in the plant gathering strategies towards the intentional and intensive exploitation of dry wood to improve, we hypothesise, combustion for heating silcrete. This human behaviour is associated with changes in stone tool technology, site occupation intensity and climate change.	[Esteban, Irene; Fisher, Erich C.; Albert, Rosa M.] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Esteban, Irene] Univ Witwatersrand, Sch Geosci, Johannesburg, South Africa; [Esteban, Irene; Marean, Curtis W.; Fisher, Erich C.; Albert, Rosa M.] Nelson Mandela Univ, African Ctr Coastal Palaeosci, Port Elizabeth, South Africa; [Esteban, Irene; Albert, Rosa M.] Univ Barcelona, ERAAUB Dept Hist & Arqueol, Barcelona, Spain; [Marean, Curtis W.; Fisher, Erich C.] Arizona State Univ, Sch Human Evolut & Social Change, Inst Human Origins, Tempe, AZ USA; [Karkanas, Panagiotis] Amer Sch Class Studies, Malcolm H Wiener Lab Archaeol Sci, Athens, Greece; [Cabanes, Dan] Rutgers State Univ, Dept Anthropol, Biol Sci Bldg, New Brunswick, NJ USA; [Cabanes, Dan] Rutgers State Univ, Ctr Human Evolutionary Studies, Biol Sci Bldg, New Brunswick, NJ USA; [Albert, Rosa M.] ICREA, Barcelona, Spain	University of Witwatersrand; University of Witwatersrand; Nelson Mandela University; University of Barcelona; Arizona State University; Arizona State University-Tempe; Rutgers State University New Brunswick; Rutgers State University New Brunswick; ICREA	Esteban, I (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa.; Esteban, I (corresponding author), Univ Witwatersrand, Sch Geosci, Johannesburg, South Africa.; Esteban, I (corresponding author), Nelson Mandela Univ, African Ctr Coastal Palaeosci, Port Elizabeth, South Africa.	irene.estebanalama@wits.ac.za	Karkanas, Panagiotis/N-3168-2019; Fisher, Erich/ABA-9374-2020; Albert, Rosa Maria/F-2937-2016; Esteban, Irene/K-8854-2017; Karkanas, Panagiotis/AAD-1227-2020	Karkanas, Panagiotis/0000-0002-7156-671X; Fisher, Erich/0000-0002-9499-6093; Albert, Rosa Maria/0000-0003-1722-9445; Esteban, Irene/0000-0002-4850-1715; Cabanes, Dan/0000-0001-6347-2513	Spanish Ministry of Science and Innovation and, Economy and Competitivity [HAR2010-15967, HAR2013-42054-P]; Catalan Government [2014-SGR0845]; DST-NRF Centre of Excellence in Palaeosciences; National Science Foundation [BCS- 0524087, BCS-1138073]; Hyde Family Foundations; Institute of Human Origins at Arizona State University; John Templeton Foundation	Spanish Ministry of Science and Innovation and, Economy and Competitivity; Catalan Government; DST-NRF Centre of Excellence in Palaeosciences; National Science Foundation(National Science Foundation (NSF)); Hyde Family Foundations; Institute of Human Origins at Arizona State University; John Templeton Foundation	Financial support for fieldwork and laboratory work was gratefully received from the Spanish Ministry of Science and Innovation and, Economy and Competitivity (HAR2010-15967 and HAR2013-42054-P respectively) and from the Catalan Government (2014-SGR0845) to RMA. IE acknowledges the DST-NRF Centre of Excellence in Palaeosciences. CWM acknowledges the support of the National Science Foundation (BCS- 0524087, and BCS-1138073), the Hyde Family Foundations, the Institute of Human Origins at Arizona State University, and the John Templeton Foundation to the Institute of Human Origins at Arizona State University.	Albert R. M., 2007, Israel Journal of Earth Sciences, V56, P175, DOI 10.1560/IJES.56.2-4.175; Albert RM, 1999, J ARCHAEOL SCI, V26, P1249, DOI 10.1006/jasc.1999.0355; Albert RM, 2000, J ARCHAEOL SCI, V27, P931, DOI 10.1006/jasc.2000.0507; Albert RM, 2001, PHYTOLITHS: APPLICATIONS IN EARTH SCIENCES AND HUMAN HISTORY, P251; Albert RM, 2016, J ARCHAEOL SCI, V68, P98, DOI 10.1016/j.jas.2015.10.014; Albert RM, 2012, GEOARCHAEOLOGY, V27, P363, DOI 10.1002/gea.21413; Allott L.F., 2006, S AFR HUMANIT, V18, P173; Anderson G.C., 1991, ANDRIESGROND REVISIT; Archer F., 1982, S AFRICAN J BOT, V48, P433; Avery G, 1997, J FIELD ARCHAEOL, V24, P263, DOI 10.1179/009346997792208131; Backwell L, 2008, J ARCHAEOL SCI, V35, P1566, DOI 10.1016/j.jas.2007.11.006; Backwell LR, 2014, QUATERNARY SCI REV, V99, P42, DOI 10.1016/j.quascirev.2014.06.017; Bamford MK, 2006, QUATERN INT, V148, P95, DOI 10.1016/j.quaint.2005.11.027; Bar-Matthews M, 2010, QUATERNARY SCI REV, V29, P2131, DOI 10.1016/j.quascirev.2010.05.009; Barboni D, 1999, PALAEOGEOGR PALAEOCL, V152, P87, DOI 10.1016/S0031-0182(99)00045-0; Barboni D, 2009, REV PALAEOBOT PALYNO, V158, P29, DOI 10.1016/j.revpalbo.2009.07.002; Barham LS, 2002, CURR ANTHROPOL, V43, P181, DOI 10.1086/338292; Berlin AM, 2003, J ARCHAEOL SCI, V30, P115, DOI 10.1006/jasc.2002.0812; Berna F, 2007, J ARCHAEOL SCI, V34, P358, DOI 10.1016/j.jas.2006.05.011; Bernatchez J., 2011, SAA ARCHAEOL REC, V11, P16; Botha SM, S AFRICAN J BOT; BOZARTH S, 1993, PLAINS ANTHROPOL, V38, P279, DOI 10.1080/2052546.1993.11931687; Bozarth SR., 1992, PHYTOLITH SYSTEMATIC, P193, DOI DOI 10.1007/978-1-4899-1155-1_10; Braun K., 2014, INFLUENCE AGULHAS CU; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Cabanes D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125532; Cabanes D, 2011, J ARCHAEOL SCI, V38, P2480, DOI 10.1016/j.jas.2011.05.020; Cabanes D, 2010, J ARCHAEOL SCI, V37, P2947, DOI 10.1016/j.jas.2010.07.010; Carmody RN, 2009, J HUM EVOL, V57, P379, DOI 10.1016/j.jhevol.2009.02.011; Carter P. L., 1988, BRIT ARCHAEOL REP, V406, P1; Collura LV, 2017, QUATERN INT, V434, P142, DOI 10.1016/j.quaint.2015.12.070; Colville JF, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P73; Copeland SR, 2016, QUATERNARY SCI REV, V141, P65, DOI 10.1016/j.quascirev.2016.04.002; Cordova CE, 2011, PALAEOECO A, V30, P107; Cordova CE, 2013, QUATERN INT, V287, P121, DOI 10.1016/j.quaint.2012.04.022; Crampton H., 2013, HITHERTO UNKNOWN ENS; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; D'Errico F, 2001, ANTIQUITY, V75, P309, DOI 10.1017/S0003598X00060968; d'Errico F, 2007, J HUM EVOL, V52, P142, DOI 10.1016/j.jhevol.2006.08.003; d'Errico F, 2012, P NATL ACAD SCI USA, V109, P13214, DOI 10.1073/pnas.1204213109; De Vynck JC, 2016, S AFR J BOT, V102, P60, DOI 10.1016/j.sajb.2015.09.002; De Vynck JC, 2016, J HUM EVOL, V92, P101, DOI 10.1016/j.jhevol.2016.01.008; De Vynck JC, 2016, PEERJ, V4, DOI 10.7717/peerj.1679; Deacon H.J., 1995, S AFR ARCHAEOL B, V50, P121, DOI [10.2307/3889061, DOI 10.2307/3889061]; Deacon H. J., 1978, S AFRICAN ARCHAEOLOG, V33, P39, DOI DOI 10.2307/3888251; Deacon H.J., 1993, S AFR ARCHAEOL B, V48, P86, DOI [10.2307/3888947, DOI 10.2307/3888947]; DEACON HJ, 1983, S AFR J SCI, V79, P325; DEACON HJ, 1979, WORLD ARCHAEOL, V10, P241, DOI 10.1080/00438243.1979.9979735; Deacon HJ, 1976, MONOGRAPH SERIES, V1; Deacon J, 1982, LATER STONE AGE SO C; Deacon J., 1984, SO AFRICAN PREHISTOR; Dibble HaroldL., 2007, SAA ARCHAEOLOGICAL R, V7, P33; Esteban I, 2017, ARCHAEOL ANTHROP SCI, V9, P265, DOI 10.1007/s12520-015-0279-7; Esteban I., 2016, RECONSTRUCTING VEGET; Esteban I, 2017, REV PALAEOBOT PALYNO, V245, P69, DOI 10.1016/j.revpalbo.2017.05.001; Esteban I, 2017, QUATERN INT, V434, P160, DOI 10.1016/j.quaint.2016.01.037; Fisher EC, 2015, J ARCHAEOL SCI, V57, P380, DOI 10.1016/j.jas.2015.02.022; Fisher EC, 2010, QUATERNARY SCI REV, V29, P1382, DOI 10.1016/j.quascirev.2010.01.015; Goldberg P, 2009, ARCHAEOL ANTHROP SCI, V1, P95, DOI 10.1007/s12520-009-0008-1; Heizer RF., 1963, J ROYAL ANTHR I GREA, V93, P186, DOI DOI 10.2307/2844241; Henry DO, 2004, AM ANTHROPOL, V106, P17, DOI 10.1525/aa.2004.106.1.17; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Jacobs Z, 2011, QUAT GEOCHRONOL, V6, P491, DOI 10.1016/j.quageo.2011.04.003; Jacobs Z, 2010, J HUM EVOL, V59, P289, DOI 10.1016/j.jhevol.2010.07.010; Karkanas P, 2015, J HUM EVOL, V85, P1, DOI 10.1016/j.jhevol.2015.04.006; Karkanas P, 2010, J HUM EVOL, V59, P256, DOI 10.1016/j.jhevol.2010.07.001; Katz O, 2010, J ARCHAEOL SCI, V37, P1557, DOI 10.1016/j.jas.2010.01.016; KLEIN RL, 1978, SOIL SCI, V126, P145, DOI 10.1097/00010694-197809000-00003; Lancelotti C., 2010, FUELLING HARAPPAN HE; Liengme C., 1987, PAPER PREHISTORY W C, P237; LIENGME C A, 1983, Bothalia, V14, P621; Lippmann F, 1973, SEDIMENTARY CARBONAT; Lombard M, 2005, J HUM EVOL, V48, P279, DOI 10.1016/j.jhevol.2004.11.006; Lombard M, 2010, ANTIQUITY, V84, P635, DOI 10.1017/S0003598X00100134; Madella M, 2005, ANN BOT-LONDON, V96, P253, DOI 10.1093/aob/mci172; Madella M, 2002, J ARCHAEOL SCI, V29, P703, DOI 10.1006/jasc.2001.0743; Madella M, 2012, QUATERN INT, V275, P76, DOI 10.1016/j.quaint.2011.09.008; Mallol C, 2013, J ARCHAEOL SCI, V40, P2515, DOI 10.1016/j.jas.2012.09.017; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Marean CW, 2015, ANNU REV ANTHROPOL, V44, P533, DOI 10.1146/annurev-anthro-102313-025954; Marean CW, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P164; Marean CW, 2014, J HUM EVOL, V77, P17, DOI 10.1016/j.jhevol.2014.02.025; Marean CW, 2011, INTERD CONTRIB ARCH, P421, DOI 10.1007/978-1-4419-8219-3_18; Marean CW, 2010, J HUM EVOL, V59, P425, DOI 10.1016/j.jhevol.2010.07.011; Marean CW, 2010, J HUM EVOL, V59, P234, DOI 10.1016/j.jhevol.2010.07.007; Marean CW, 2008, ANN M PAL SOC VANC B; Meehan B., 1982, SHELL BED SHELL MIDD; Menge BA, 2001, MARINE COMMUNITY ECOLOGY, P221; Mercader J, 2009, ANN BOT-LONDON, V104, P91, DOI 10.1093/aob/mcp097; Moffett R. O., 1977, S AFR ARCHAEOL B, V32, P127, DOI DOI 10.2307/3888659; Mourre V, 2010, SCIENCE, V330, P659, DOI 10.1126/science.1195550; Mulholland S. C., 1992, PHYTOLITH SYSTEMATIC, P65; Murungi M.L., 2017, PHYTOLITHS SIBUDU S; Nadel D, 2004, SCI YORK, V101; Neumann K, 2017, QUATERN INT, V434, P15, DOI 10.1016/j.quaint.2015.11.039; Novello A, 2018, QUATERN INT, V464, P440, DOI 10.1016/j.quaint.2017.10.009; Novello A, 2012, REV PALAEOBOT PALYNO, V178, P43, DOI 10.1016/j.revpalbo.2012.03.010; Oakley KP., 1961, SOCIAL LIFE EARLY MA, P176; Oestmo S., 2014, ENCY GLOBAL ARCHAEOL, P5955, DOI DOI 10.1007/978-1-4419-0465-2_1509; Ollendorf A. L, 1992, PHYTOLITH SYSTEMATIC, P91; Opperman H, 1996, QUATERN INT, V33, P45, DOI 10.1016/1040-6182(95)00096-8; Opperman H., 1990, S AFR ARCHAEOL BULL, P93, DOI DOI 10.2307/3887967; PARKINGTON J, 1991, J ARCHAEOL SCI, V18, P331, DOI 10.1016/0305-4403(91)90069-2; PARKINGTON JE, 1972, AFR STUD-UK, V31, P223, DOI 10.1080/00020187208707386; Parkington JE., 1980, S AFRICAN ARCHAEOL B, V35, P73, DOI 10.2307/3888350; Perles C, 1977, REV ARCHEOLOGIQUE S, P395; Pickering R, 2013, QUATERNARY SCI REV, V65, P39, DOI 10.1016/j.quascirev.2012.12.016; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Piperno D.R., 1988, PHYTOLITH ANAL ARCHA; Proches S, 2006, BIOL J LINN SOC, V87, P27, DOI 10.1111/j.1095-8312.2006.00557.x; Rector AL, 2010, J HUM EVOL, V59, P340, DOI 10.1016/j.jhevol.2010.07.002; Regev L, 2010, J ARCHAEOL SCI, V37, P3022, DOI 10.1016/j.jas.2010.06.027; Roberts DL, 2012, EARTH PLANET SC LETT, V357, P226, DOI 10.1016/j.epsl.2012.09.006; Rosen A.M., 1992, PHYTOLITH SYSTEMATIC, P129; Rossouw L, 2009, APPL FOSSIL GRASS PH; Rourke J., 1974, VELD FLORA, V4, P57; Schiegl S, 2004, S AFR J SCI, V100, P185; Schiegl S., 2006, SOUTH AFR HUMANIT, V18, P149; Schmidt P, 2013, J ARCHAEOL SCI, V40, P3519, DOI 10.1016/j.jas.2012.10.016; Sievers C., 2006, SOUTH AFR HUMANIT, V18, P203; Singels E, 2016, J HUM EVOL, V101, P79, DOI 10.1016/j.jhevol.2016.09.008; Skead C. J., 2009, STRELITZIA, V24; Smith EI, 2018, NATURE, V555, P511, DOI 10.1038/nature25967; Story R., 1958, SOME PLANTS USED BUS; Story R., 1964, ECOLOGICAL STUDIES S, P87; Texier PJ, 2013, J ARCHAEOL SCI, V40, P3412, DOI 10.1016/j.jas.2013.02.021; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; Tsartsidou G, 2007, J ARCHAEOL SCI, V34, P1262, DOI 10.1016/j.jas.2006.10.017; Twiss PC, 1969, SOIL SCI SOC AM P, V33; van Wyk B.E., 2000, PEOPLES PLANTS GUIDE; Wadley L., 1987, BR ARCHAEOL REPORTS, V25; Wadley L, 2011, SCIENCE, V334, P1388, DOI 10.1126/science.1213317; Wadley L, 2012, QUATERN INT, V247, P341, DOI 10.1016/j.quaint.2010.10.026; Watts I., 2009, CRADLE LANGUAGE, V12, P93; Watts I, 2010, J HUM EVOL, V59, P392, DOI 10.1016/j.jhevol.2010.07.006; Weiner S., 2010, MICROARCHAEOLOGY VIS; Wells M.J, 1965, S AFR ARCHAEOL BULL, V20, P79, DOI DOI 10.2307/3888405; Wrangham RW, 2009, CATCHING FIRE COOKIN; YOSHIOKA S, 1985, GEOCHEM J, V19, P245, DOI 10.2343/geochemj.19.245	143	23	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198558	10.1371/journal.pone.0198558	http://dx.doi.org/10.1371/journal.pone.0198558			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI0YU	29864147	Green Published, Green Submitted, gold			2022-12-26	WOS:000434097100038
J	Chiurchiu, V; Leuti, A; Smoum, R; Mechoulam, R; Maccarrone, M				Chiurchiu, Valerio; Leuti, Alessandro; Smoum, Reem; Mechoulam, Raphael; Maccarrone, Mauro			Bioactive lipids ALIAmides differentially modulate inflammatory responses of distinct subsets of primary human T lymphocytes	FASEB JOURNAL			English	Article						adaptive immunity; cytokines; N-acyl ethanolamines; T cells	ACID AMIDASE INHIBITOR; N-ACYLETHANOLAMINE; PPAR-ALPHA; IN-VITRO; PALMITOYLETHANOLAMIDE; ANANDAMIDE; OLEOYLETHANOLAMIDE; RECEPTOR; DISCOVERY; REVEALS	Autacoid local injury antagonist amides (ALIAmides) are a family of endogenous bioactive acyl ethanolamides that include the renowned palmitoyl ethanolamide (PEA), oleoyl ethanolamide (OEA), and stearoyl ethanolamide (SEA), and that are involved in several biologic processes such as nociception, lipid metabolism, and inflammation. The role of ALIAmides in the control of inflammatory processes has recently gained much attention and prompted the use of these molecules or their analogs, and the pharmacologic manipulation of their endogenous levels, as plausible therapeutic strategies in the treatment of several chronic inflammatory conditions. Since chronic inflammation is mainly driven by cells of adaptive immunity, particularly T lymphocytes, we aimed at investigating whether such bioactive lipids could directly modulate T-cell responses. We found that OEA, PEA, and eicosatrienoyl ethanolamide (ETEA) could directly inhibit both T-cell responses by reducing their production of TNF- and IFN- from CD8 T cells and TNF-, IFN- and IL-17 from CD4 T cells. Furthermore, neither SEA nor docosatrienoyl ethanolamide (DTEA) could affect cytokine production from both T cell subsets. Interestingly, unlike OEA and ETEA, PEA was also able to enhance de novo generation of forkhead box P3 (FoxP3)-expressing regulatory T cells from CD4-naive T cells. Our findings show for the first time that specific ALIAmides can directly affect different T-cell subsets, and provide proof of their anti-inflammatory role in chronic inflammation, ultimately suggesting that these bioactive lipids could offer novel tools for the management of T-cell dependent chronic inflammatory diseases.ChiurchiU, V., Leuti, A., Smoum, R., Mechoulam, R., Maccarrone, M. Bioactive lipids ALIAmides differentially modulate inflammatory responses of distinct subsets of primary human T lymphocytes.	[Chiurchiu, Valerio; Leuti, Alessandro; Maccarrone, Mauro] Campus Biomed Univ Rome, Dept Med, Via Alvaro Portillo 21, I-00128 Rome, Italy; [Chiurchiu, Valerio; Leuti, Alessandro; Maccarrone, Mauro] Santa Lucia Fdn, IRCCS, Neurochem Lipids, European Ctr Brain Res CERC, Rome, Italy; [Smoum, Reem; Mechoulam, Raphael] Hebrew Univ Jerusalem, Med Fac, Inst Cannabinoid Res, Jerusalem, Israel	University Campus Bio-Medico - Rome Italy; IRCCS Santa Lucia; Hebrew University of Jerusalem	Maccarrone, M (corresponding author), Campus Biomed Univ Rome, Dept Med, Via Alvaro Portillo 21, I-00128 Rome, Italy.; Chiurchiu, V (corresponding author), Santa Lucia Fdn, IRCCS, Neurochem Lipids, Via Fosso Fiorano 64, I-00143 Rome, Italy.	v.chiurchiu@hsantalucia.it; m.maccarrone@unicampus.it	Chiurchiu, Valerio/G-6227-2011	Chiurchiu, Valerio/0000-0002-0316-7311; Leuti, Alessandro/0000-0002-5982-0682	Italian Ministry of Education, Universities, and Research (MIUR); Research Projects of National Interest competitive grant [PRIN2015-KMMKBN]	Italian Ministry of Education, Universities, and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Research Projects of National Interest competitive grant	This work was supported by the Italian Ministry of Education, Universities, and Research (MIUR). The authors gratefully acknowledge a Research Projects of National Interest (PRIN2015-KMMKBN) competitive grant (to M.M.). The authors declare no conflicts of interest.	Alhouayek M, 2015, FASEB J, V29, P650, DOI 10.1096/fj.14-255208; Alhouayek M, 2014, DRUG DISCOV TODAY, V19, P1632, DOI 10.1016/j.drudis.2014.06.007; ALOE L, 1993, AGENTS ACTIONS, V39, pC145, DOI 10.1007/BF01972748; Bandiera T, 2014, PHARMACOL RES, V86, P11, DOI 10.1016/j.phrs.2014.04.011; Brown JD, 2017, PHYSIOL BEHAV, V176, P50, DOI 10.1016/j.physbeh.2017.02.034; Carbonare MD, 2008, J NEUROENDOCRINOL, V20, P26, DOI 10.1111/j.1365-2826.2008.01689.x; Chen L, 2015, ONCOTARGET, V6, P42530, DOI 10.18632/oncotarget.6466; Chiurchiu V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00038; Chiurchiu V, 2016, J IMMUNOL, V197, P3545, DOI 10.4049/jimmunol.1500546; Chiurchiu V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7483; Chiurchiu V, 2016, CURR OPIN PHARMACOL, V29, P54, DOI 10.1016/j.coph.2016.06.005; Chiurchiu V, 2015, IMMUNOLOGY, V144, P352, DOI 10.1111/imm.12441; Chiurchiu V, 2015, INT IMMUNOL, V27, P153, DOI 10.1093/intimm/dxu097; Cope AP, 2002, ARTHRITIS RES THER, V4, pS197, DOI 10.1186/ar557; Costa B, 2008, PAIN, V139, P541, DOI 10.1016/j.pain.2008.06.003; Hansen HS, 2009, BIOCHEM PHARMACOL, V78, P553, DOI 10.1016/j.bcp.2009.04.024; Impellizzeri D, 2016, BIOCHEM PHARMACOL, V119, P27, DOI 10.1016/j.bcp.2016.09.001; Impellizzeri D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0136-0; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Lanuti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126839; Lissoni P, 2008, ANTICANCER RES, V28, P3743; Luo GH, 2016, SCI REP-UK, V6, P1, DOI [10.1038/srep35231, 10.1038/s41598-016-0027-y]; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Onopchenko OV, 2015, LIPIDS, V50, P13, DOI 10.1007/s11745-014-3960-1; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Pontis S, 2016, CRIT REV BIOCHEM MOL, V51, P7, DOI 10.3109/10409238.2015.1092944; PRILLER J, 1995, MOL PHARMACOL, V48, P288; Rahman IAS, 2014, PHARMACOL RES, V86, P1, DOI 10.1016/j.phrs.2014.04.001; Ribeiro A, 2015, ACS CHEM BIOL, V10, P1838, DOI 10.1021/acschembio.5b00114; Sarnelli G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156198; Sasso O, 2013, PAIN, V154, P350, DOI 10.1016/j.pain.2012.10.018; Sheskin T, 1997, J MED CHEM, V40, P659, DOI 10.1021/jm960752x; Skaper SD, 2015, MOL NEUROBIOL, V52, P1034, DOI 10.1007/s12035-015-9253-8; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Wellner N, 2013, BBA-MOL CELL BIOL L, V1831, P652, DOI 10.1016/j.bbalip.2012.08.019	35	20	20	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5716	5723		10.1096/fj.201800107R	http://dx.doi.org/10.1096/fj.201800107R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29879374	Bronze			2022-12-26	WOS:000447972500042
J	Chu, H; Chan, CM; Zhang, X; Wang, YX; Yuan, SF; Zhou, J; Au-Yeung, RKH; Sze, KH; Yang, D; Shuai, HP; Hou, YX; Li, C; Zhao, XY; Poon, VKM; Leung, SP; Yeung, ML; Yan, JH; Lu, GW; Jin, DY; Gao, GF; Chan, JFW; Yuen, KY				Chu, Hin; Chan, Che-Man; Zhang, Xi; Wang, Yixin; Yuan, Shuofeng; Zhou, Jie; Au-Yeung, Rex Kwok-Him; Sze, Kong-Hung; Yang, Dong; Shuai, Huiping; Hou, Yuxin; Li, Cun; Zhao, Xiaoyu; Poon, Vincent Kwok-Man; Leung, Sze Pui; Yeung, Man-Lung; Yan, Jinghua; Lu, Guangwen; Jin, Dong-Yan; Gao, George Fu; Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung			Middle East respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						virology; virus; infectious disease; infection; GRP78; attachment factors; bat CoV-HKU9; coronavirus; GRP78; MERS-CoV; viral infection; coronavirus spike; viral attachment; viral evolution	ENDOPLASMIC-RETICULUM STRESS; INFECTIOUS-BRONCHITIS VIRUS; CROSS-SPECIES TRANSMISSION; SPIKE PROTEIN; SIALIC-ACID; DROMEDARY CAMELS; SARS-LIKE; RECEPTOR DETERMINANT; FUNCTIONAL RECEPTOR; UNFOLDED PROTEIN	Coronavirus tropism is predominantly determined by the interaction between coronavirus spikes and the host receptors. In this regard, coronaviruses have evolved a complicated receptor-recognition system through their spike proteins. Spikes from highly related coronaviruses can recognize distinct receptors, whereas spikes of distant coronaviruses can employ the same cell-surface molecule for entry. Moreover, coronavirus spikes can recognize a broad range of cell-surface molecules in addition to the receptors and thereby can augment coronavirus attachment or entry. The receptor of Middle East respiratory syndrome coronavirus (MERS-CoV) is dipeptidyl peptidase 4 (DPP4). In this study, we identified membrane-associated 78-kDa glucose-regulated protein (GRP78) as an additional binding target of the MERS-CoV spike. Further analyses indicated that GRP78 could not independently render nonpermissive cells susceptible to MERS-CoV infection but could facilitate MERS-CoV entry into permissive cells by augmenting virus attachment. More importantly, by exploring potential interactions between GRP78 and spikes of other coronaviruses, we discovered that the highly conserved human GRP78 could interact with the spike protein of bat coronavirus HKU9 (bCoV-HKU9) and facilitate its attachment to the host cell surface. Taken together, our study has identified GRP78 as a host factor that can interact with the spike proteins of two Betacoronaviruses, the lineage C MERS-CoV and the lineage D bCoV-HKU9. The capacity of GRP78 to facilitate surface attachment of both a human coronavirus and a phylogenetically related bat coronavirus exemplifies the need for continuous surveillance of the evolution of animal coronaviruses to monitor their potential for human adaptations.	[Chu, Hin; Chan, Che-Man; Zhou, Jie; Sze, Kong-Hung; Yeung, Man-Lung; Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Emerging Infect Dis, Hong Kong, Peoples R China; [Chu, Hin; Chan, Che-Man; Zhang, Xi; Wang, Yixin; Yuan, Shuofeng; Zhou, Jie; Sze, Kong-Hung; Yang, Dong; Shuai, Huiping; Hou, Yuxin; Li, Cun; Zhao, Xiaoyu; Poon, Vincent Kwok-Man; Leung, Sze Pui; Yeung, Man-Lung; Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Peoples R China; [Au-Yeung, Rex Kwok-Him] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Peoples R China; [Yeung, Man-Lung; Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immunol, Hong Kong, Peoples R China; [Yeung, Man-Lung; Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Carlo Yu Ctr Infect, Hong Kong, Peoples R China; [Jin, Dong-Yan] Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Hong Kong, Peoples R China; [Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hong Kong, Peoples R China; [Yan, Jinghua; Gao, George Fu] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Lu, Guangwen] Sichuan Univ, West China Hosp, West China Hosp Emergency Dept, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Lu, Guangwen] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Gao, George Fu] Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent China CDC, Beijing 1002206, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; University of Hong Kong; Chinese Academy of Sciences; Institute of Microbiology, CAS; Sichuan University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Chan, JFW; Yuen, KY (corresponding author), Univ Hong Kong, Queen Mary Hosp, Carol Yu Ctr Infect, Dept Microbiol,State Key Lab Emerging Infect Dis, 102 Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	jfwchan@hku.hk; kyyuen@hku.hk	Shuai, Huiping/AAE-5585-2022; CHU, HIN/ABU-1193-2022; Yeung, Kwok Him Rex Au/A-2476-2019; Lu, Guangwen/HCH-9193-2022; Li, Cun/ABD-9346-2020; Chan, Jasper F. W./D-8007-2013; Gao, George Fu/ABD-5229-2021; Yang, Dong/ABG-1653-2020; Yeung, Man Lung/E-9903-2010	Shuai, Huiping/0000-0001-8078-4113; CHU, HIN/0000-0003-2855-9837; Yeung, Kwok Him Rex Au/0000-0002-3137-0886; Chan, Jasper F. W./0000-0001-6336-6657; zhao, xiaoyu/0000-0002-0347-9104; ZHANG, Xi/0000-0003-1340-7128; ZHOU, Jie/0000-0002-2948-3873; Yeung, Man Lung/0000-0002-6117-7884; Yuan, Shuofeng/0000-0001-7996-1119; Poon, Vincent kwok-man/0000-0002-7737-8912; Yuen, Kwok-yung/0000-0002-2083-1552	Hong Kong Health and Medical Research Fund [14131392, 15140762, 16150572]; National Natural Science Foundation of China/Research Grants Council (NSFC/RGC) Joint Research Scheme [N_HKU728/14, 81461168030]; Research Grants Council, Hong Kong Special Administrative Region [T11/707/15]; Ministry of Education of China	Hong Kong Health and Medical Research Fund; National Natural Science Foundation of China/Research Grants Council (NSFC/RGC) Joint Research Scheme; Research Grants Council, Hong Kong Special Administrative Region(Hong Kong Research Grants Council); Ministry of Education of China(Ministry of Education, China)	This work was supported in part by the donations of Michael Seak-Kan Tong, Hui Ming, Hui Hoy and Chow Sin Lan Charity Fund Limited, Chan Yin Chuen Memorial Charitable Foundation, and the Providence Foundation Limited in memory of the late Dr. Lui Hac Minh; Hong Kong Health and Medical Research Fund Grants 14131392, 15140762, and 16150572; National Natural Science Foundation of China/Research Grants Council (NSFC/RGC) Joint Research Scheme Grants N_HKU728/14 and 81461168030; Theme-Based Research Scheme Grant T11/707/15 of the Research Grants Council, Hong Kong Special Administrative Region, and by funding from the Ministry of Education of China for the Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases. The authors declare that they have no conflicts of interest with the contents of this article.	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Chan CM, 2009, J VIROL, V83, P1026, DOI 10.1128/JVI.01387-08; Chan CM, 2016, J VIROL, V90, P9114, DOI 10.1128/JVI.01133-16; Chan CM, 2016, VIROLOGY, V494, P78, DOI 10.1016/j.virol.2016.04.008; Chan CP, 2006, J VIROL, V80, P9279, DOI 10.1128/JVI.00659-06; Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14; Chan JFW, 2012, J INFECTION, V65, P477, DOI 10.1016/j.jinf.2012.10.002; Chan JFW, 2015, CURR OPIN VIROL, V10, P63, DOI 10.1016/j.coviro.2015.01.006; Chan JFW, 2013, TRENDS MICROBIOL, V21, P544, DOI 10.1016/j.tim.2013.05.005; Chan JFW, 2013, J INFECT DIS, V207, P1743, DOI 10.1093/infdis/jit123; Chen ZW, 2005, J VIROL, V79, P2678, DOI 10.1128/JVI.79.5.2678-2688.2005; Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07; Chu H, 2016, J INFECT DIS, V213, P904, DOI 10.1093/infdis/jiv380; Chu H, 2014, VIROLOGY, V454, P197, DOI 10.1016/j.virol.2014.02.018; Chu H, 2012, CELL HOST MICROBE, V12, P360, DOI 10.1016/j.chom.2012.07.011; Chu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035297; Corman VM, 2016, P NATL ACAD SCI USA, V113, P9864, DOI 10.1073/pnas.1604472113; DeDiego ML, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002315; Earnest JT, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006546; Fung TS, 2014, J VIROL, V88, P12752, DOI 10.1128/JVI.02138-14; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Honda T, 2009, J VIROL, V83, P12622, DOI 10.1128/JVI.01201-09; Huang CP, 2016, BIOCHEMISTRY-US, V55, P5977, DOI 10.1021/acs.biochem.6b00790; Huang XC, 2015, J VIROL, V89, P7202, DOI 10.1128/JVI.00854-15; Hui DS, 2018, LANCET INFECT DIS, V18, pE217, DOI 10.1016/S1473-3099(18)30127-0; Jeffers SA, 2004, P NATL ACAD SCI USA, V101, P15748, DOI 10.1073/pnas.0403812101; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Krempl C, 1995, Adv Exp Med Biol, V380, P371; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lau SKP, 2013, J GEN VIROL, V94, P2679, DOI 10.1099/vir.0.055533-0; Lau SKP, 2010, J VIROL, V84, P11385, DOI 10.1128/JVI.01121-10; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Li F, 2015, J VIROL, V89, P1954, DOI 10.1128/JVI.02615-14; Li WT, 2017, P NATL ACAD SCI USA, V114, pE8508, DOI 10.1073/pnas.1712592114; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liao Y, 2013, J VIROL, V87, P8124, DOI 10.1128/JVI.00626-13; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004; Milewska A, 2014, J VIROL, V88, P13221, DOI 10.1128/JVI.02078-14; Nain M, 2017, J VIROL, V91, DOI [10.1128/jvi.02274-16, 10.1128/JVI.02274-16]; Nal B, 2005, J GEN VIROL, V86, P1423, DOI 10.1099/vir.0.80671-0; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Peck KM, 2015, ANNU REV VIROL, V2, P95, DOI 10.1146/annurev-virology-100114-055029; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Schultze B, 1996, J VIROL, V70, P5634, DOI 10.1128/JVI.70.8.5634-5637.1996; SCHULTZE B, 1991, J VIROL, V65, P6232, DOI 10.1128/JVI.65.11.6232-6237.1991; Tang JW, 2017, LANCET INFECT DIS, V17, pE320, DOI 10.1016/S1473-3099(17)30238-4; Tao Y, 2017, J VIROL, V91, DOI 10.1128/JVI.01953-16; Tao Y, 2012, VIRUS RES, V167, P67, DOI 10.1016/j.virusres.2012.04.007; Tong SX, 2009, EMERG INFECT DIS, V15, P482, DOI 10.3201/eid1503.081013; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; Tsai YL, 2015, J BIOL CHEM, V290, P8049, DOI 10.1074/jbc.M114.618736; Versteeg GA, 2007, J VIROL, V81, P10981, DOI 10.1128/JVI.01033-07; Watanabe R, 2007, VIROLOGY, V366, P16, DOI 10.1016/j.virol.2007.06.034; Woo PCY, 2007, J VIROL, V81, P1574, DOI 10.1128/JVI.02182-06; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhou J, 2014, J INFECT DIS, V209, P1331, DOI 10.1093/infdis/jit504	65	112	113	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11709	11726		10.1074/jbc.RA118.001897	http://dx.doi.org/10.1074/jbc.RA118.001897			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29887526	hybrid, Green Published			2022-12-26	WOS:000440134500005
J	Miller, PW; Pokutta, S; Mitchell, JM; Chodaparambil, JV; Clarke, DN; Nelson, WJ; Weis, WI; Nichols, SA				Miller, Phillip W.; Pokutta, Sabine; Mitchell, Jennyfer M.; Chodaparambil, Jayanth V.; Clarke, D. Nathaniel; Nelson, W. James; Weis, William I.; Nichols, Scott A.			Analysis of a vinculin homolog in a sponge (phylum Porifera) reveals that vertebrate-like cell adhesions emerged early in animal evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adherens junction; focal adhesion; epithelium; protein evolution; evolution; Oscarella; Porifera; Sponge; Vinculin	ALPHA-E-CATENIN; BETA-CATENIN; ACTIN-BINDING; AGGREGATION FACTOR; CRYSTAL-STRUCTURE; DENSE-BODY; F-ACTIN; IQ-TREE; CADHERIN; COMPLEX	The evolution of cell-adhesion mechanisms in animals facilitated the assembly of organized multicellular tissues. Studies in traditional animal models have revealed two predominant adhesion structures, the adherens junction (AJ) and focal adhesions (FAs), which are involved in the attachment of neighboring cells to each other and to the secreted extracellular matrix (ECM), respectively. The AJ (containing cadherins and catenins) and FAs (comprising integrins, talin, and paxillin) differ in protein composition, but both junctions contain the actin-binding protein vinculin. The near ubiquity of these structures in animals suggests that AJ and FAs evolved early, possibly coincident with multicellularity. However, a challenge to this perspective is that previous studies of spongesa divergent animal lineageindicate that their tissues are organized primarily by an alternative, sponge-specific cell-adhesion mechanism called "aggregation factor." In this study, we examined the structure, biochemical properties, and tissue localization of a vinculin ortholog in the sponge Oscarella pearsei (Op). Our results indicate that Op vinculin localizes to both cell-cell and cell-ECM contacts and has biochemical and structural properties similar to those of vertebrate vinculin. We propose that Op vinculin played a role in cell adhesion and tissue organization in the last common ancestor of sponges and other animals. These findings provide compelling evidence that sponge tissues are indeed organized like epithelia in other animals and support the notion that AJ- and FA-like structures extend to the earliest periods of animal evolution.	[Miller, Phillip W.; Pokutta, Sabine; Chodaparambil, Jayanth V.; Nelson, W. James; Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Pokutta, Sabine; Chodaparambil, Jayanth V.; Weis, William I.] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Clarke, D. Nathaniel; Nelson, W. James] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Mitchell, Jennyfer M.; Nichols, Scott A.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA	Stanford University; Stanford University; Stanford University; University of Denver	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA.; Nichols, SA (corresponding author), Univ Denver, Dept Biol Sci, Denver, CO 80208 USA.	bill.weis@stanford.edu; scott.nichols@du.edu	Clarke, Donald/A-8212-2019; Clarke, D. Nathaniel/K-7605-2019; Clarke, Nat/L-2946-2019; Weis, William/G-1437-2011	Clarke, Donald/0000-0002-9774-2582; Clarke, Nat/0000-0002-9774-2582; Chodaparambil, Jayanth/0000-0002-4217-8355; Nichols, Scott/0000-0002-4765-754X; Weis, William/0000-0002-5583-6150	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R35GM118064, R01GM114462] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Hadar Feinberg for assistance in the crystallographic analysis of Op vinculin, Betsy Steele for access to the Joseph Long Marine Laboratory (University of California Santa Cruz), and Christopher Lowe for use of confocal microscopy facilities at Hopkins Marine Station (Stanford University). Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research, and by NIGMS, National Institutes of Health Grant P41GM103393).	Abedin M, 2010, TRENDS CELL BIOL, V20, P734, DOI 10.1016/j.tcb.2010.08.002; Adams EDM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015040; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alatortsev VE, 1997, FEBS LETT, V413, P197, DOI 10.1016/S0014-5793(97)00901-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; BARSTEAD RJ, 1991, J CELL BIOL, V114, P715, DOI 10.1083/jcb.114.4.715; Bass MD, 2002, BIOCHEM J, V362, P761, DOI 10.1042/0264-6021:3620761; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bays JL, 2017, CELL MOL LIFE SCI, V74, P2999, DOI 10.1007/s00018-017-2511-3; Benham-Pyle BW, 2015, SCIENCE, V348, P1024, DOI 10.1126/science.aaa4559; Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Blumbach B, 1998, J CELL SCI, V111, P2635; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Boury-Esnault N, 2003, INVERTEBR BIOL, V122, P187, DOI 10.1111/j.1744-7410.2003.tb00084.x; Boute N, 1996, BIOL CELL, V88, P37, DOI 10.1016/S0248-4900(97)86829-3; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; BUCK CA, 1987, J CELL SCI, P231; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007; CAULDWELL CB, 1973, BIOCHEMISTRY-US, V12, P3051, DOI 10.1021/bi00740a017; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Clarke DN, 2016, MOL BIOL EVOL, V33, P2016, DOI 10.1093/molbev/msw084; Collins C, 2015, CURR OPIN CELL BIOL, V36, P62, DOI 10.1016/j.ceb.2015.07.004; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; den Elzen N, 2009, MOL BIOL CELL, V20, P3740, DOI 10.1091/mbc.E09-01-0023; Dickinson DJ, 2012, BIOESSAYS, V34, P833, DOI 10.1002/bies.201100187; Dickinson DJ, 2011, SCIENCE, V331, P1336, DOI 10.1126/science.1199633; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dumbauld DW, 2013, P NATL ACAD SCI USA, V110, P9788, DOI 10.1073/pnas.1216209110; Elliott GRD, 2007, J EXP BIOL, V210, P3736, DOI 10.1242/jeb.003392; Ereskovsky AV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183002; Ereskovsky AV, 2009, BIOESSAYS, V31, P89, DOI 10.1002/bies.080058; Fahey B, 2010, EVOL DEV, V12, P601, DOI 10.1111/j.1525-142X.2010.00445.x; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grice LF, 2017, MOL BIOL EVOL, V34, P1083, DOI 10.1093/molbev/msx058; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Han MKL, 2016, TRENDS CELL BIOL, V26, P612, DOI 10.1016/j.tcb.2016.03.005; Harris TJC, 2005, TRENDS CELL BIOL, V15, P234, DOI 10.1016/j.tcb.2005.03.002; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Harwood A, 2004, CURR OPIN CELL BIOL, V16, P470, DOI 10.1016/j.ceb.2004.07.011; Haseley SR, 2001, P NATL ACAD SCI USA, V98, P9419, DOI 10.1073/pnas.151111298; HENKART P, 1973, BIOCHEMISTRY-US, V12, P3045, DOI 10.1021/bi00740a016; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; HUMBERTDAVID N, 1993, EUR J BIOCHEM, V216, P255, DOI 10.1111/j.1432-1033.1993.tb18140.x; HUMPHREYS T, 1963, DEV BIOL, V8, P27, DOI 10.1016/0012-1606(63)90024-1; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kang H, 2017, J BIOL CHEM, V292, P7077, DOI 10.1074/jbc.M116.769778; Keegan RM, 2008, ACTA CRYSTALLOGR D, V64, P119, DOI 10.1107/S0907444907037195; Knoll AH, 2011, ANNU REV EARTH PL SC, V39, P217, DOI 10.1146/annurev.earth.031208.100209; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lecroisey C, 2007, J MUSCLE RES CELL M, V28, P79, DOI 10.1007/s10974-007-9104-y; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Leys SP, 2012, ADV MAR BIOL, V62, P1, DOI 10.1016/B978-0-12-394283-8.00001-1; Leys SP, 2009, INTEGR COMP BIOL, V49, P167, DOI 10.1093/icb/icp038; Maartens AP, 2016, J CELL SCI, V129, P4354, DOI 10.1242/jcs.189878; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller PW, 2013, CURR TOP MEMBR, V72, P267, DOI 10.1016/B978-0-12-417027-8.00008-8; Miller PW, 2013, J BIOL CHEM, V288, P22324, DOI 10.1074/jbc.M113.458406; MOSCONA AA, 1968, DEV BIOL, V18, P250, DOI 10.1016/0012-1606(68)90035-3; Mui KL, 2016, J CELL SCI, V129, P1093, DOI 10.1242/jcs.183699; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Nichols SA, 2012, P NATL ACAD SCI USA, V109, P13046, DOI 10.1073/pnas.1120685109; Nickel M, 2011, J EXP BIOL, V214, P1692, DOI 10.1242/jeb.049148; Nielsen C, 2008, EVOL DEV, V10, P241, DOI 10.1111/j.1525-142X.2008.00231.x; Niklas KJ, 2013, EVOL DEV, V15, P41, DOI 10.1111/ede.12013; Patel B, 2006, J BIOL CHEM, V281, P7458, DOI 10.1074/jbc.M508058200; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pokutta S, 2014, J BIOL CHEM, V289, P13589, DOI 10.1074/jbc.M114.554709; Rangarajan ES, 2013, NAT STRUCT MOL BIOL, V20, P188, DOI 10.1038/nsmb.2479; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Sanchez R, 2011, NUCLEIC ACIDS RES, V39, pW470, DOI 10.1093/nar/gkr408; Sarpal R, 2012, J CELL SCI, V125, P233, DOI 10.1242/jcs.096644; Schippers KJ, 2018, MOL BIOL EVOL, V35, P1407, DOI 10.1093/molbev/msy033; Schuster A, 2017, DIVERGENCE TIMES DEM, DOI [10.1101/159806, DOI 10.1101/159806]; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Shao XQ, 2017, J BIOL CHEM, V292, P16477, DOI 10.1074/jbc.M117.795567; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Tyler S, 2003, INTEGR COMP BIOL, V43, P55, DOI 10.1093/icb/43.1.55; Vilanova E, 2016, J BIOL CHEM, V291, P9425, DOI 10.1074/jbc.M115.708958; Wilson HV, 1907, J EXP ZOOL, V5, P245, DOI 10.1002/jez.1400050204; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	107	12	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11674	11686		10.1074/jbc.RA117.001325	http://dx.doi.org/10.1074/jbc.RA117.001325			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29880641	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000440134500003
J	Loxton, J; Jones, MS; Najorka, J; Smith, AM; Porter, JS				Loxton, Jennifer; Jones, Mary Spencer; Najorka, Jens; Smith, Abigail M.; Porter, Joanne S.			Skeletal carbonate mineralogy of Scottish bryozoans	PLOS ONE			English	Article							CALCIUM-CARBONATE; MOLECULAR PHYLOGENY; CRYSTAL-GROWTH; MAGNESIUM; SHELL; CHEILOSTOMATA; TEMPERATURE; VARIABILITY; DIFFRACTION; ECTOPROCTA	This paper describes the skeletal carbonate mineralogy of 156 bryozoan species collected from Scotland (sourced both from museum collections and from waters around Scotland) and collated from literature. This collection represents 79% of the species which inhabit Scottish waters and is a greater number and proportion of extant species than any previous regional study. The study is also of significance globally where the data augment the growing database of mineralogical analyses and offers first analyses for 26 genera and four families. Specimens were collated through a combination of field sampling and existing collections and were analysed by X-ray diffraction (XRD) and micro-XRD to determine wt% MgCO3 in calcite and wt% aragonite. Species distribution data and phylogenetic organisation were applied to understand distributional, taxonomic and phylo-mineralogical patterns. Analysis of the skeletal composition of Scottish bryozoans shows that the group is statistically different from neighbouring Arctic fauna but features a range of mineralogy comparable to other temperate regions. As has been previously reported, cyclostomes feature low Mg in calcite and very little aragonite, whereas cheilostomes show much more variability, including bimineralic species. Scotland is a highly variable region, open to biological and environmental influx from all directions, and bryozoans exhibit this in the wide range of within-species mineralogical variability they present. This plasticity in skeletal composition may be driven by a combination of environmentally-induced phenotypic variation, or physiological factors. A flexible response to environment, as manifested in a wide range of skeletal mineralogy within a species, may be one characteristic of successful invasive bryozoans.	[Loxton, Jennifer; Porter, Joanne S.] Heriot Watt Univ, Ctr Marine Biodivers & Biotechnol, Sch Life Sci, Edinburgh, Midlothian, Scotland; [Loxton, Jennifer; Jones, Mary Spencer; Porter, Joanne S.] Nat Hist Museum, Dept Life Sci, London, England; [Loxton, Jennifer] Univ Marine Biol Stn, Millport, Isle Of Cumbrae, Scotland; [Najorka, Jens] Nat Hist Museum, Core Res Labs, London, England; [Smith, Abigail M.] Univ Otago, Dept Marine Sci, Dunedin, New Zealand; [Loxton, Jennifer] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Porter, Joanne S.] Heriot Watt Univ, Int Ctr Isl Technol, Stromness, Orkney, Scotland	Heriot Watt University; Natural History Museum London; Natural History Museum London; University of Otago; University of Edinburgh; Heriot Watt University	Loxton, J (corresponding author), Heriot Watt Univ, Ctr Marine Biodivers & Biotechnol, Sch Life Sci, Edinburgh, Midlothian, Scotland.; Loxton, J (corresponding author), Nat Hist Museum, Dept Life Sci, London, England.; Loxton, J (corresponding author), Univ Marine Biol Stn, Millport, Isle Of Cumbrae, Scotland.; Loxton, J (corresponding author), Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland.	Jennifer.loxton@ed.ac.uk	Smith, Abigail M/F-7714-2011; Porter, Joanne/B-8060-2011	Smith, Abigail M/0000-0001-6468-9124; Porter, Joanne/0000-0002-5878-3912	Marine Alliance for Science and Technology in Scotland (MASTS); Marine Environmental Research Group (MERG) at Heriot-Watt University; Natural Environment Research Council [NE/M006566/2]	Marine Alliance for Science and Technology in Scotland (MASTS); Marine Environmental Research Group (MERG) at Heriot-Watt University; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors thank the Marine Alliance for Science and Technology in Scotland (MASTS) and the Marine Environmental Research Group (MERG) at Heriot-Watt University for supporting and funding J.L.'s PhD. Natural Environment Research Council [NE/M006566/2] to Dr Jennifer Loxton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGEGIAN C R, 1989, Pacific Science, V43, P56; [Anonymous], 1999, CHEILOSTOMATOUS BR 2; Appeltans W, 2012, WORLD REGISTER MARIN; Astilleros JM, 2010, CHEM GEOL, V271, P52, DOI 10.1016/j.chemgeo.2009.12.011; Bader B, 2005, PALAEOGEOGR PALAEOCL, V226, P58, DOI 10.1016/j.palaeo.2005.05.007; BADER B., 2008, P 14 INT BRYOZ ASS C, V15, P269; Barnes DKA, 2007, POLAR BIOL, V30, P1069, DOI 10.1007/s00300-007-0266-2; Barnes DKA, 2006, MAR ECOL PROG SER, V314, P187, DOI 10.3354/meps314187; Barnes DKA, 2000, MAR BIOL, V136, P813, DOI 10.1007/s002270000253; Barnes DKA, 2001, MAR ECOL PROG SER, V210, P85, DOI 10.3354/meps210085; BERGER WH, 1978, DEEP-SEA RES, V25, P447, DOI 10.1016/0146-6291(78)90552-0; Blanton TN, 2000, J APPL CRYSTALLOGR, V33, P172, DOI 10.1107/S0021889899012388; Blanton TN, 1995, POWDER DIFFR, V10, P91, DOI DOI 10.1017/S0885715600014421; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Boardman R.S., 1987, P497; BONE Y, 1993, SEDIMENT GEOL, V86, P247, DOI 10.1016/0037-0738(93)90025-Z; BORISENKO YA, 1991, BIOL MORYA-VLAD+, P80; Borszcz T, 2013, POLAR BIOL, V36, P193, DOI 10.1007/s00300-012-1250-z; Borzecka-Prokop B, 2007, J MOL STRUCT, V828, P80, DOI 10.1016/j.molstruc.2006.05.040; Brockington S, 2001, J EXP MAR BIOL ECOL, V258, P87, DOI 10.1016/S0022-0981(00)00347-6; Burton EA, 1985, GEOL SOC AM ABSTR, V17, P536; CAIRNS S D, 1992, Palaios, V7, P96, DOI 10.2307/3514799; Chang VTC, 2004, BIOCHEM BIOPH RES CO, V323, P79, DOI 10.1016/j.bbrc.2004.08.053; Chierici M, 2009, BIOGEOSCIENCES, V6, P2421, DOI 10.5194/bg-6-2421-2009; CHILINGAR GEORGE V., 1962, BULL SOUTHERN CALIFORNIA ACAD SCI, V61, P45; Clark F. W., 1917, Professional Papers US Geological Survey, V102, P1; Clarke FW, 1922, US GEOL SURV PROF PA, V124, P34; COHEN AL, 1992, PALAEOGEOGR PALAEOCL, V91, P49, DOI 10.1016/0031-0182(92)90031-Y; Cuif JP, 2005, BIOGEOSCIENCES, V2, P61, DOI 10.5194/bg-2-61-2005; Dauphin Y, 2000, COMP BIOCHEM PHYS A, V126, P367, DOI 10.1016/S1095-6433(00)00213-0; Davis KJ, 2000, SCIENCE, V290, P1134, DOI 10.1126/science.290.5494.1134; Dowsett HJ, 2011, PALAEOGEOGR PALAEOCL, V309, P83, DOI 10.1016/j.palaeo.2011.03.016; DUNTON K, 1992, TRENDS ECOL EVOL, V7, P183, DOI 10.1016/0169-5347(92)90070-R; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fu G, 2005, BIOMACROMOLECULES, V6, P1289, DOI 10.1021/bm049314v; Fuchs J, 2009, MOL PHYLOGENET EVOL, V52, P225, DOI 10.1016/j.ympev.2009.01.021; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Hall SR, 2002, J INORG BIOCHEM, V88, P410, DOI 10.1016/S0162-0134(01)00359-2; Hayward P. J., 1998, CHEILOSTOMATOUS BR 1; HAYWARD PJ, 1995, J ZOOL, V237, P37, DOI 10.1111/j.1469-7998.1995.tb02744.x; Hoff PD, 2009, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-92407-6_1; KATZ A, 1973, GEOCHIM COSMOCHIM AC, V37, P1563, DOI 10.1016/0016-7037(73)90091-4; Keene EC, 2010, CRYST GROWTH DES, V10, P1383, DOI 10.1021/cg901389v; Kembel ASW, 2013, PACKAGE PICANTE; Kembel S., 2010, INTRO PICANTE PACKAG, P1, DOI [10.1093/bioinformatics/btq166, DOI 10.1093/BIOINFORMATICS/BTQ166]; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Krzeminska M, 2016, J GEOL, V124, P411, DOI 10.1086/685507; Kuklinski P, 2009, FACIES, V55, P489, DOI 10.1007/s10347-009-0179-3; Lombardi C, 2008, FACIES, V54, P333, DOI 10.1007/s10347-008-0143-7; Loste E, 2003, J CRYST GROWTH, V254, P206, DOI 10.1016/S0022-0248(03)01153-9; LOWENSTAM HA, 1954, P NATL ACAD SCI USA, V40, P39, DOI 10.1073/pnas.40.1.39; Lowenstam HA, 1964, RECENT RES FIELDS HY, P373; Loxton J, 2017, BIOL INVASIONS, V19, P2225, DOI 10.1007/s10530-017-1440-2; Loxton J, 2017, CHEM GEOL, V474, P45, DOI 10.1016/j.chemgeo.2017.10.022; Loxton J, 2014, MAR ECOL PROG SER, V510, P45, DOI 10.3354/meps10889; Loxton J, 2014, MAR ECOL PROG SER, V507, P169, DOI 10.3354/meps10826; Mackie JA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00871; Morse JW, 1997, GEOLOGY, V25, P85, DOI 10.1130/0091-7613(1997)025<0085:IOTAMC>2.3.CO;2; Murray CC, 2011, DIVERS DISTRIB, V17, P1161, DOI 10.1111/j.1472-4642.2011.00798.x; Nudelman F, 2006, J STRUCT BIOL, V153, P176, DOI 10.1016/j.jsb.2005.09.009; Peck LS, 2004, P ROY SOC B-BIOL SCI, V271, pS18, DOI 10.1098/rsbl.2003.0053; Peebles BA, 2017, J STRUCT BIOL, V197, P250, DOI 10.1016/j.jsb.2016.12.002; Piwoni-Piorewicz A, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-5901-y; Poluzzi A., 1974, Documents Lab Geol Fac Sci Lyon Hors Ser, V3, P193; Poluzzi A., 1973, GIORNALE GEOLOGIA, V39, P11; R Core Team, 2021, R LANGUAGE ENV STAT; Ries JB, 2005, PALEOBIOLOGY, V31, P445, DOI 10.1666/0094-8373(2005)031[0445:APICSE]2.0.CO;2; Rouse S., 2010, THESIS; RUCKER J B, 1969, Journal of Paleontology, V43, P791; Ryland JS, 2011, AQUAT INVASIONS, V6, P17, DOI 10.3391/ai.2011.6.1.03; Ryland John S., 2009, Zootaxa, V2093, P43; Ryland JS, 2014, ZOOTAXA; SCHOPF THOMAS J. M., 1967, J PALEONTOL, V41, P1197; SCHOPF TJM, 1970, SCIENCE, V169, P280, DOI 10.1126/science.169.3942.280; Scottish Government, 2011, PHYS CHAR SCOTL MAR; SIESSER W G, 1972, South African Journal of Science, V68, P71; Smith AM, 2012, PHYTOCHEMISTRY, V81, P97, DOI 10.1016/j.phytochem.2012.06.003; Smith AM, 2007, PALAEOGEOGR PALAEOCL, V256, P86, DOI 10.1016/j.palaeo.2007.09.007; Smith AM, 2006, EARTH-SCI REV, V78, P287, DOI 10.1016/j.earscirev.2006.06.001; Smith AM, 2013, MAR BIOL, V160, P2281, DOI 10.1007/s00227-013-2210-z; Smith AM, 2010, PALAEOGEOGR PALAEOCL, V289, P113, DOI 10.1016/j.palaeo.2010.02.022; Smith AM, 2010, PALAIOS, V25, P229, DOI 10.2110/palo.2009.p09-106r; Smith AM, 2004, QUATERNARY RES, V61, P123, DOI 10.1016/j.yqres.2003.11.001; Smith AM, 1998, MAR GEOL, V151, P27, DOI 10.1016/S0025-3227(98)00055-3; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Steger KK, 2005, PALAEOGEOGR PALAEOCL, V218, P195, DOI 10.1016/j.palaeo.2004.12.013; Swezey DS, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2349; Tanur AE, 2010, J STRUCT BIOL, V169, P145, DOI 10.1016/j.jsb.2009.09.008; Taylor, 1990, PALEONTOLOGY BIOIMMU; Taylor P.D., 1993, P465; TAYLOR P. D., 2008, VIRGINIA MUSEUM NATU, V15, P101; Taylor PD, 2016, MAR BIOL RES, V12, P776, DOI 10.1080/17451000.2016.1203951; Taylor PD, 2009, PALAIOS, V24, P440, DOI 10.2110/palo.2008.p08-124r; TAYLOR PD, 2007, ORIGIN EVOLUTION NAT, P21; Thompson JB, 2000, BIOPHYS J, V79, P3307, DOI 10.1016/S0006-3495(00)76562-3; Tompsett S, 2009, J NAT HIST, V43, P2227, DOI 10.1080/00222930903090140; Trotter J, 2011, EARTH PLANET SC LETT, V303, P163, DOI 10.1016/j.epsl.2011.01.030; Tsyganov-Bodounov A, 2009, MOL PHYLOGENET EVOL, V52, P904, DOI 10.1016/j.ympev.2009.05.010; Waeschenbach A, 2012, MOL PHYLOGENET EVOL, V62, P718, DOI 10.1016/j.ympev.2011.11.011; Waeschenbach A, 2009, MOL PHYLOGENET EVOL, V52, P241, DOI 10.1016/j.ympev.2009.02.002; Walther J., 1885, DTSCH GEOLOGISCHE GE, V37, P329; WATABE N, 1974, J CRYST GROWTH, V24, P116, DOI 10.1016/0022-0248(74)90288-7	103	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197533	10.1371/journal.pone.0197533	http://dx.doi.org/10.1371/journal.pone.0197533			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897916	Green Published, gold, Green Submitted			2022-12-26	WOS:000435090700016
J	Van Hemelrijck, M; Ulmer, H; Nagel, G; Peter, RS; Fritz, J; Myte, R; Van Guelpen, B; Foger, B; Concin, H; Haggstrom, C; Stettin, P; Stocks, T				Van Hemelrijck, Mieke; Ulmer, Hanno; Nagel, Gabriele; Peter, Raphael Simon; Fritz, Josef; Myte, Robin; Van Guelpen, Bethany; Foeger, Bernhard; Concin, Hans; Haggstrom, Christel; Stettin, Par; Stocks, Tanja			Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60,000 men and women in Sweden and Austria	PLOS ONE			English	Article							METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; RISK-FACTORS; OBESITY; TRIGLYCERIDE; HEALTH; ASSOCIATIONS; POPULATION; OVERWEIGHT	Background Obesity is suggested to underlie development of other metabolic aberrations, but longitudinal relationships between metabolic factors at various ages has not been studied in detail. Methods Data from 27,379 men and 32,275 women with in total 122,940 health examinations in the Vasterbotten Intervention Project, Sweden and the Vorarlberg Health Monitoring and Prevention Programme, Austria were used to investigate body mass index (BMI), mid-blood pressure, and fasting levels of glucose, triglycerides, and total cholesterol at baseline in relation to 10-year changes of these factors and weight. We included paired examinations performed 10 +/- 2 years apart and used them for longitudinal analysis with linear regression of changes between the ages 30 and 40, 40 and 50, or 50 and 60 years. Results Higher levels of BMI were associated with increases in glucose and mid-blood pressure as well as triglycerides levels, and, to a lesser extent, decreases in cholesterol levels. For instance, per 5 kg/m(2) higher BMI at age 40, glucose at age 50 increased by 0.24 mmol/l (95%Cl:0.22-0.26) and mid-blood pressure increased by 1.54 mm Hg (95%Cl: 1.35-1.74). The strongest association observed was between BMI at age 30 and mid-blood pressure, which was 2.12 mm Hg (95% CI: 1.79-2.45) increase over ten years per 5 kg/m(2) higher BMI level. This association was observed at an age when blood pressure levels on average remained stable. Other associations than those with BMI at baseline were much weaker. However, triglyceride levels were associated with future glucose changes among individuals with elevated BMI, particularly in the two older age groups. Conclusion BMI was most indicative of long-term changes in metabolic factors, and the strongest impact was observed for increases in blood pressure between 30 and 40 years of age. Our study supports that lifestyle interventions preventing metabolic aberrations should focus on avoiding weight increases.	[Van Hemelrijck, Mieke] Kings Coll London, Div Canc Studies Translat Oncol & Urol Res, London, England; [Ulmer, Hanno; Fritz, Josef] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, Innsbruck, Austria; [Nagel, Gabriele; Peter, Raphael Simon] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany; [Nagel, Gabriele; Foeger, Bernhard; Concin, Hans] Agcy Prevent & Social Med, Bregenz, Austria; [Myte, Robin; Van Guelpen, Bethany] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Haggstrom, Christel] Umea Univ, Dept Biobank Res, Umea, Sweden; [Haggstrom, Christel; Stettin, Par] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Haggstrom, Christel] Umea Univ, Dept Publ Hlth & Clin Med, Nutr Res, Umea, Sweden; [Stocks, Tanja] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden	University of London; King's College London; Medical University of Innsbruck; Ulm University; Umea University; Umea University; Uppsala University; Umea University; Lund University	Stocks, T (corresponding author), Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden.	tanja.stocks@med.lu.se	Peter, Raphael/J-3101-2019; vhmpp, aks/F-9756-2012; Ulmer, Hanno/S-6615-2019; Nagel, Gabriele/C-3635-2012; Van Guelpen, Bethany/J-8159-2015	Peter, Raphael/0000-0003-4310-9500; Ulmer, Hanno/0000-0001-5911-1002; Nagel, Gabriele/0000-0001-6185-8535; Van Guelpen, Bethany/0000-0002-9692-101X; Fritz, Josef/0000-0003-1342-3435; Van Hemelrijck, Mieke/0000-0002-7317-0858	Swedish Research Council [2015-02332]; Wereld Kanker Onderzoek Fonds NL [R2010/247]; Lions Cancer Research Foundation at Umea University [LP 15-2060]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Wereld Kanker Onderzoek Fonds NL; Lions Cancer Research Foundation at Umea University	The study was funded by the Swedish Research Council (Grant 2015-02332 to TS, URL: https://www.vr.se), the Wereld Kanker Onderzoek Fonds NL (Grant R2010/247 to PS, URL: https://www.wkof.nl), and Lions Cancer Research Foundation at Umea University (Grant LP 15-2060 to CH, URL: http://www.cancerforskningsfonden.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Al-Goblan AS, 2014, DIABETES METAB SYNDR, V7, P587, DOI 10.2147/DMSO.S67400; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Blomstedt Y, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009651; Bot M, 2010, EUR J EPIDEMIOL, V25, P125, DOI 10.1007/s10654-009-9419-7; Cameron AJ, 2008, OBESITY, V16, P2707, DOI 10.1038/oby.2008.412; Chen XX, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1033; Chung KJ, 2017, NAT IMMUNOL, V18, P654, DOI 10.1038/ni.3728; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Ebbert JO, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0445-x; Franks PW, 2007, HYPERTENSION, V49, P10, DOI 10.1161/01.HYP.0000251934.55488.ae; Giannini C, 2011, DIABETES CARE, V34, P1869, DOI 10.2337/dc10-2234; Hall JE, 2010, J BIOL CHEM, V285, P17271, DOI 10.1074/jbc.R110.113175; Hallmans G, 2003, SCAND J PUBLIC HEALT, V31, P18, DOI 10.1080/14034950310001432; Haring R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039461; Hernandez M., 2018, DIABETES CARE; Howe LD, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004827; Hwang LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067436; Iwani NAKZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40055; Jellinger PS, 2017, ENDOCR PRACT, V23, P1, DOI 10.4158/EP171764.APPGL; Kerrison G, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/8493145; Klenk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084817; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mahdiani A, 2018, CURR DIABETES REV; Maison P, 2001, DIABETES CARE, V24, P1758, DOI 10.2337/diacare.24.10.1758; Rashid S, 2007, OBESITY, V15, P2875, DOI 10.1038/oby.2007.342; Scuteri A, 2009, J GERONTOL A-BIOL, V64, P590, DOI 10.1093/gerona/glp004; Tao LX, 2016, INT J MED SCI, V13, P445, DOI 10.7150/ijms.14256; Tirosh A, 2008, DIABETES CARE, V31, P2032, DOI 10.2337/dc08-0825; Ulmer H, 2003, EUR HEART J, V24, P1004, DOI 10.1016/S0195-668X(03)00170-2; Weinehall L, 1998, SCAND J PRIM HEALTH, V16, P171; Winkvist A, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0241-x; World Health Organization, 1999, REP WHO CONS 1; World Health Organization, 2008, WHO TECHNICAL REPORT	34	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197830	10.1371/journal.pone.0197830	http://dx.doi.org/10.1371/journal.pone.0197830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897925	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700031
J	Viet, AF; Krebs, S; Rat-Aspert, O; Jeanpierre, L; Belloc, C; Ezanno, P				Viet, Anne-France; Krebs, Stephane; Rat-Aspert, Olivier; Jeanpierre, Laurent; Belloc, Catherine; Ezanno, Pauline			A modelling framework based on MDP to coordinate farmers' disease control decisions at a regional scale	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; DAIRY-CATTLE HERDS; TRANSMISSION; VACCINATION; SPREAD; INCENTIVES; ALGORITHMS; IMPACT; RULES; RISK	The effectiveness of infectious disease control depends on the ability of health managers to act in a coordinated way. However, with regards to non-notifiable animal diseases, farmers individually decide whether or not to implement control measures, leading to positive and negative externalities for connected farms and possibly impairing disease control at a regional scale. Our objective was to facilitate the identification of optimal incentive schemes at a collective level, adaptive to the epidemiological situation, and minimizing the economic costs due to a disease and its control. We proposed a modelling framework based on Markov Decision Processes (MDP) to identify effective strategies to control Porcine Reproductive and Respiratory Syndrome (PRRS), a worldwide endemic infectious disease that significantly impacts pig farm productivity. Using a stochastic discrete-time compartmental model representing PRRS virus spread and control within a group of pig herds, we defined the associated MDP. Using a decision-tree framework, we translated the optimal policy into a limited number of rules providing actions to be performed per 6-month time-step according to the observed system state. We evaluated the effect of varying costs and transition probabilities on optimal policy and epidemiological results. We finally identifiedan adaptive policy that gave the best net financial benefit. The proposed framework is a tool for decision support as it allows decision-makers to identify the optimal policy and to assess its robustness to variations in the values of parameters representing an impact of incentives on farmers' decisions.	[Viet, Anne-France; Krebs, Stephane; Rat-Aspert, Olivier; Belloc, Catherine; Ezanno, Pauline] Univ Bretagne Loire, Oniris, INRA, BIOEPAR, Nantes, France; [Rat-Aspert, Olivier] Univ Bourgogne Franche Comte, INRA, AgroSup Dijon, CESAER, Dijon, France; [Jeanpierre, Laurent] Normandie Univ, GREYC, CNRS, ENSICAEN,UNICAEN, Caen, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie	Viet, AF (corresponding author), Univ Bretagne Loire, Oniris, INRA, BIOEPAR, Nantes, France.	annefrance.viet@free.fr	Ezanno, Pauline/A-4699-2009	Ezanno, Pauline/0000-0002-0034-8950; KREBS, Stephane/0000-0003-0014-4816; Jeanpierre, Laurent/0000-0002-2082-5451	French Research Agency program Investments [ANR-10-BINF-07]; European fund for the regional development (FEDER) of Pays de la Loire	French Research Agency program Investments(French National Research Agency (ANR)); European fund for the regional development (FEDER) of Pays de la Loire	This work was supported by the French Research Agency program Investments for the future, project ANR-10-BINF-07 (MIHMES) and by the European fund for the regional development (FEDER) of Pays de la Loire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDEN JM, 1992, OPER RES, V40, pS183, DOI 10.1287/opre.40.3.S183; [Anonymous], 2010, R LANG ENV STAT COMP; Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Boussard M, 2007, PROC INT C TOOLS ART, P87, DOI 10.1109/ICTAI.2007.85; Carrizosa E, 2013, COMPUT OPER RES, V40, P150, DOI 10.1016/j.cor.2012.05.015; Chades I, 2011, P NATL ACAD SCI USA, V108, P8323, DOI 10.1073/pnas.1016846108; Chan K., 2000, SENSITIVITY ANAL; Chapman GB, 2012, PSYCHOL SCI, V23, P1008, DOI 10.1177/0956797612437606; Charron MVP, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-44; Chatterjee K, 2006, ANN S THEOR ASP COMP; Chen QS, 2017, MED DECIS MAKING, V37, P243, DOI 10.1177/0272989X16670605; Corzo CA, 2010, VIRUS RES, V154, P185, DOI 10.1016/j.virusres.2010.08.016; Ekboir JM, 1999, PREV VET MED, V40, P101, DOI 10.1016/S0167-5877(99)00015-X; Flanagan D., 2005, JAVA IN A NUTSHELL; Ge L, 2010, PREV VET MED, V95, P167, DOI 10.1016/j.prevetmed.2010.04.003; Gersovitz M, 2004, ECON J, V114, P1, DOI 10.1046/j.0013-0133.2003.0174.x; Gil AJ, 2008, SIAM J COMPUT, V38, P922, DOI 10.1137/050635900; HERNANDEZLERMA O, 1993, J MATH ANAL APPL, V177, P38, DOI 10.1006/jmaa.1993.1242; Hoch T, 2008, EPIDEMIOL INFECT, V136, P1374, DOI 10.1017/S095026880700979X; Holtkamp DJ, 2013, J SWINE HEALTH PROD, V21, P72; Holtkamp DJ, 2011, J SWINE HEALTH PROD, V19, P44; Ibuka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087164; Johnson FA, 2011, J FISH WILDL MANAG, V2, P234, DOI 10.3996/012011-JFWM-003; Klein E, 2007, ENVIRON DEV ECON, V12, P707, DOI 10.1017/S1355770X0700383X; Kristensen AR, 2015, PREV VET MED, V118, P226, DOI 10.1016/j.prevetmed.2014.11.019; Kristensen AR, 2003, COMPUT ELECTRON AGR, V38, P199, DOI 10.1016/S0168-1699(02)00183-7; LePotier MF, 1997, VET MICROBIOL, V55, P355, DOI 10.1016/S0378-1135(96)01318-1; Manfredi P, 2009, VACCINE, V28, P98, DOI 10.1016/j.vaccine.2009.09.109; Marescot L, 2013, METHODS ECOL EVOL, V4, P872, DOI 10.1111/2041-210X.12082; Mason JE, 2012, IBM J RES DEV, V56, DOI 10.1147/JRD.2012.2201849; Merl D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005807; Nicol S, 2017, J APPL ECOL; Nieuwenhuis N, 2012, VET REC, V170, P225, DOI 10.1136/vr.100101; Noremark M, 2009, PREV VET MED, V90, P1, DOI 10.1016/j.prevetmed.2009.03.008; Nusinovici S, 2015, EPIDEMIOL INFECT, V143, P3316, DOI 10.1017/S0950268814003926; Pandit P, 2016, VET RES, V47, DOI 10.1186/s13567-016-0330-4; Perez AM, 2015, JAVMA-J AM VET MED A, V246, P1304, DOI 10.2460/javma.246.12.1304; Pichancourt JB, 2012, J APPL ECOL, V49, P52, DOI 10.1111/j.1365-2664.2011.02093.x; Pileri E, 2016, VET RES, V47, DOI 10.1186/s13567-016-0391-4; Puterman ML, 2005, MARKOV DECISION PROC; Qi L, EPIDEMICS; Rat- Aspert O, 2012, 2012 C AUG 18 24 FOZ; Rat-Aspert O, 2010, PREV VET MED, V93, P265, DOI 10.1016/j.prevetmed.2009.11.004; Rossi G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02567-6; Silva GS, 2017, PREV VET MED, V148, P89, DOI 10.1016/j.prevetmed.2017.10.012; Steimle LN, 2017, INT SER OPER RES MAN, V248, P189, DOI 10.1007/978-3-319-47766-4_6; Valdes-Donoso P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149498; Viet AF, 2012, COMPUT ELECTRON AGR, V80, P71, DOI 10.1016/j.compag.2011.10.015; Woodroffe R, 2006, P NATL ACAD SCI USA, V103, P14713, DOI 10.1073/pnas.0606251103; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; Yaesoubi R, 2011, EUR J OPER RES, V215, P679, DOI 10.1016/j.ejor.2011.07.016; [No title captured]	53	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197612	10.1371/journal.pone.0197612	http://dx.doi.org/10.1371/journal.pone.0197612			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897988	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700023
J	Wang, Y; Zekveld, AA; Wendt, D; Lunner, T; Naylor, G; Kramer, SE				Wang, Yang; Zekveld, Adriana A.; Wendt, Dorothea; Lunner, Thomas; Naylor, Graham; Kramer, Sophia E.			Pupil light reflex evoked by light-emitting diode and computer screen: Methodology and association with need for recovery in daily life	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; PSYCHOMETRIC PROPERTIES; DYNAMIC PUPILLOMETRY; FATIGUE; WORK; MODULATION; ATTENTION; RELIABILITY; ADAPTATION; DILATION	Objectives Pupil light reflex (PLR) has been widely used as a method for evaluating parasympathetic activity. The first aim of the present study is to develop a PLR measurement using a computer screen set-up and compare its results with the PLR generated by a more conventional setup using light-emitting diode (LED). The parasympathetic nervous system, which is known to control the 'rest and digest' response of the human body, is considered to be associated with daily life fatigue. However, only few studies have attempted to test the relationship between self-reported daily fatigue and physiological measurement of the parasympathetic nervous system. Therefore, the second aim of this study was to investigate the relationship between daily-life fatigue, assessed using the Need for Recovery scale, and parasympathetic activity, as indicated by the PLR parameters. Design A pilot study was conducted first to develop a PLR measurement set-up using a computer screen. PLRs evoked by light stimuli with different characteristics were recorded to confirm the influence of light intensity, flash duration, and color on the PLRs evoked by the system. In the subsequent experimental study, we recorded the PLR of 25 adult participants to light flashes generated by the screen set-up as well as by a conventional LED set-up. PLR parameters relating to parasympathetic and sympathetic activity were calculated from the pupil responses. We tested the split-half reliability across two consecutive blocks of trials, and the relationships between the parameters of PLRs evoked by the two set-ups. Participants rated their need for recovery prior to the PLR recordings. Results PLR parameters acquired in the screen and LED set-ups showed good reliability for amplitude related parameters. The PLRs evoked by both set-ups were consistent, but showed systematic differences in absolute values of all parameters. Additionally, higher need for recovery was associated with faster and larger constriction of the PLR. Conclusions This study assessed the PLR generated by a computer screen and the PLR generated by a LED. The good reliability within set-ups and the consistency between the PLRs evoked by the set-ups indicate that both systems provides a valid way to evoke the PLR. A higher need for recovery was associated with faster and larger constricting PLRs, suggesting increased levels of parasympathetic nervous system activity in people experiencing higher levels of need for recovery on a daily basis.	[Wang, Yang; Zekveld, Adriana A.; Kramer, Sophia E.] Vrije Univ Amsterdam Med Ctr, Dept Otolaryngol Head & Neck Surg, Sect Ear & Hearing, Amsterdam, Netherlands; [Wang, Yang; Zekveld, Adriana A.; Kramer, Sophia E.] Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands; [Wang, Yang; Wendt, Dorothea; Lunner, Thomas] Oticon AS, Eriksholm Res Ctr, Snekkersten, Denmark; [Zekveld, Adriana A.; Lunner, Thomas] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Zekveld, Adriana A.; Lunner, Thomas] Linkoping Univ, Swedish Inst Disabil Res, Linnaeus Ctr HEAD, Linkoping, Sweden; [Zekveld, Adriana A.; Lunner, Thomas] Orebro Univ, Linkoping, Sweden; [Wendt, Dorothea; Lunner, Thomas] Tech Univ Denmark, Dept Elect Engn, Lyngby, Denmark; [Naylor, Graham] MRC, Chief Scientist Off Inst Hearing Res, Scottish Sect, Glasgow, Lanark, Scotland	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Oticon; Linkoping University; Linkoping University; Technical University of Denmark	Wang, Y (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Otolaryngol Head & Neck Surg, Sect Ear & Hearing, Amsterdam, Netherlands.; Wang, Y (corresponding author), Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands.; Wang, Y (corresponding author), Oticon AS, Eriksholm Res Ctr, Snekkersten, Denmark.	y.wang@vumc.nl	Naylor, Graham/S-2902-2018; Naylor, Graham/AAN-7408-2021	Naylor, Graham/0000-0003-1544-1944; Naylor, Graham/0000-0003-1544-1944; Zekveld, Adriana/0000-0003-1320-6908; Wendt, Dorothea/0000-0002-3340-1180; Kramer, Sophia E./0000-0002-0451-8179	FP7 People: Marie-Curie Actions [607373]; Medical Research Council [MC_UU_00010/4]; Oticon Foundation; MRC [MR/S003576/1] Funding Source: UKRI	FP7 People: Marie-Curie Actions(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oticon Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by FP7 People: Marie-Curie Actions 607373 to YW, Medical Research Council MC_UU_00010/4 to GN. Oticon Foundation provided support in the form of salaries for authors TL and DW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abokyi S, 2017, EYE, V31, P615, DOI 10.1038/eye.2016.288; [Anonymous], 2016, HEART RATE VARIABILI; Arab C, 2016, PSYCHONEUROENDOCRINO, V68, P57, DOI 10.1016/j.psyneuen.2016.02.018; Atchison DA, 2011, CLIN EXP OPTOM, V94, P545, DOI 10.1111/j.1444-0938.2011.00636.x; Bar KJ, 2009, J NEUROL SCI, V279, P9, DOI 10.1016/j.jns.2009.01.010; BAKES A, 1990, BRIT J CLIN PHARMACO, V30, P377, DOI 10.1111/j.1365-2125.1990.tb03787.x; Bar KJ, 2005, CLIN NEUROPHYSIOL, V116, P790, DOI 10.1016/j.clinph.2004.11.007; Bardak H, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9578308; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Beatty J., 2000, HDB PSYCHOPHYSIOL, V2, P142; Beurskens AJHM, 2000, OCCUP ENVIRON MED, V57, P353, DOI 10.1136/oem.57.5.353; Binda P, 2017, TRENDS NEUROSCI, V40, P455, DOI 10.1016/j.tins.2017.06.007; Binda P, 2015, J VISION, V15, DOI 10.1167/15.2.1; Binda P, 2013, J VISION, V13, DOI 10.1167/13.6.8; Binda P, 2013, J NEUROSCI, V33, P2199, DOI 10.1523/JNEUROSCI.3440-12.2013; Bitsios P, 1999, J PSYCHOPHARMACOL, V13, P226, DOI 10.1177/026988119901300303; Bittner DM, 2014, J ALZHEIMERS DIS, V42, P1469, DOI 10.3233/JAD-140969; Bremner FD, 2012, INVEST OPHTH VIS SCI, V53, P7343, DOI 10.1167/iovs.12-10881; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Daluwatte C, 2012, PHYSIOL MEAS, V33, P1043, DOI 10.1088/0967-3334/33/6/1043; de Croon EM, 2006, OCCUP ENVIRON MED, V63, P202, DOI 10.1136/oem.2004.018275; Benavent SAD, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.717; Ebitz RB, 2017, J NEUROSCI, V37, P5008, DOI 10.1523/JNEUROSCI.2433-16.2017; Ebitz RB, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00100; Fagundes CP, 2011, PSYCHONEUROENDOCRINO, V36, P1137, DOI 10.1016/j.psyneuen.2011.02.005; Fan XF, 2009, J AUTISM DEV DISORD, V39, P1499, DOI 10.1007/s10803-009-0767-7; Fan XF, 2009, AUTON NEUROSCI-BASIC, V147, P9, DOI 10.1016/j.autneu.2008.12.010; Ferrari GL, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-26; Fotiou DF, 2009, INT J PSYCHOPHYSIOL, V73, P143, DOI 10.1016/j.ijpsycho.2009.01.011; Giza E, 2011, INT J NEUROSCI, V121, P37, DOI 10.3109/00207454.2010.526730; Hasson D, 2009, INT J PSYCHOPHYSIOL, V74, P93, DOI 10.1016/j.ijpsycho.2009.07.009; Hollingsworth KG, 2010, EUR J CLIN INVEST, V40, P608, DOI 10.1111/j.1365-2362.2010.02310.x; Hornsby BWY, 2016, EAR HEARING, V37, p136S, DOI 10.1097/AUD.0000000000000289; Hornsby BWY, 2016, EAR HEARING, V37, pe1, DOI 10.1097/AUD.0000000000000203; Ishikawa H, 2012, JPN J OPHTHALMOL, V56, P181, DOI 10.1007/s10384-011-0116-1; Janig W, 2000, PROG BRAIN RES, V122, P351; Jing MJ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010147; Kahneman D., 1973, ATTENTION EFFORT; Kaltsatou A, 2011, EUR J APPL PHYSIOL, V111, P2079, DOI 10.1007/s00421-011-1836-0; Kanjwal K, 2010, INT J MED SCI, V7, P62; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kramer SE, 2006, INT J AUDIOL, V45, P503, DOI 10.1080/14992020600754583; Laeng B, 2012, P NATL ACAD SCI USA, V109, P2162, DOI 10.1073/pnas.1118298109; Loewenfeld I. E., 1999, PUPIL ANATOMY PHYSL; LOEWENFELD IE, 1971, AM J OPHTHALMOL, V71, P347, DOI 10.1016/0002-9394(71)90410-7; Lorr M., 1971, MANUAL PROFILE MOOD; Mathot S, 2018, J COGNITION, V1; Mathot S, 2015, CURR DIR PSYCHOL SCI, V24, P374, DOI 10.1177/0963721415593725; Mathot S, 2014, J VISION, V14, DOI 10.1167/14.14.7; Mathot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078168; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Meijman T., 1996, PSYCHOLOOG, P236; Moriguchi CS, 2011, BRAZ J PHYS THER, V15, P154, DOI 10.1590/S1413-35552011000200011; Moriguchi CS, 2012, WORK, V41, P4838, DOI 10.3233/WOR-2012-0773-4838; Moriguchi CS, 2010, REV SAUDE PUBL, V44, P131, DOI 10.1590/S0034-89102010000100014; Muppidi S, 2013, CLIN AUTON RES, V23, P297, DOI 10.1007/s10286-013-0209-7; Naber M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00919; Naber M, 2013, J VISION, V13, DOI 10.1167/13.6.7; Nachtegaal J, 2012, EAR HEARING, V33, P94, DOI 10.1097/AUD.0b013e318228033e; Nachtegaal J, 2009, INT J AUDIOL, V48, P684, DOI 10.1080/14992020902962421; Pong M, 2000, J NEUROPHYSIOL, V84, P964, DOI 10.1152/jn.2000.84.2.964; Schmid R, 2004, J NEURO-OPHTHALMOL, V24, P228, DOI 10.1097/00041327-200409000-00010; Sluiter JK, 2003, OCCUP ENVIRON MED, V60, P62; Sousa VD, 2011, J EVAL CLIN PRACT, V17, P268, DOI 10.1111/j.1365-2753.2010.01434.x; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; Steinhauer SR, 2000, INT J PSYCHOPHYSIOL, V39, P21, DOI 10.1016/S0167-8760(00)00119-7; Tanaka M, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-46; Tanaka M, 2009, BEHAV MED, V35, P87, DOI 10.1080/08964280903231979; van Veldhoven M, 2003, OCCUP ENVIRON MED, V60, P3; van't Leven M, 2010, EUR J PUBLIC HEALTH, V20, P251, DOI 10.1093/eurpub/ckp113; Wang Y, 2017, EAR HEARING; Wang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153566; Whitehead L, 2009, J PAIN SYMPTOM MANAG, V37, P107, DOI 10.1016/j.jpainsymman.2007.08.019; Zekveld AA, 2010, EAR HEARING, V31, P480, DOI 10.1097/AUD.0b013e3181d4f251	74	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197739	10.1371/journal.pone.0197739	http://dx.doi.org/10.1371/journal.pone.0197739			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ2HI	29897946	Green Submitted, Green Published, gold			2022-12-26	WOS:000435090700026
J	Gamage, S; Howard, M; Makita, H; Cross, B; Hastings, G; Luo, M; Abate, Y				Gamage, Sampath; Howard, Marquez; Makita, Hiroki; Cross, Brendan; Hastings, Gary; Luo, Ming; Abate, Yohannes			Probing structural changes in single enveloped virus particles using nano-infrared spectroscopic imaging	PLOS ONE			English	Article							INFLUENZA-VIRUS; ABSORPTION-SPECTROSCOPY; PENETRATION; SPECTRA	Enveloped viruses, such as HIV, Ebola and Influenza, are among the most deadly known viruses. Cellular membrane penetration of enveloped viruses is a critical step in the cascade of events that lead to entry into the host cell. Conventional ensemble fusion assays rely on collective responses to membrane fusion events, and do not allow direct and quantitative studies of the subtle and intricate fusion details. Such details are accessible via single particle investigation techniques, however. Here, we implement nano-infrared spectroscopic imaging to investigate the chemical and structural modifications that occur prior to membrane fusion in the single archetypal enveloped virus, influenza X31. We traced in real space structural and spectroscopic alterations that occur during environmental pH variations in single virus particles. In addition, using nanospectroscopic imaging we quantified the effectiveness of an antiviral compound in stopping viral membrane disruption (a novel mechanism for inhibiting viral entry into cells) during environmental pH variations.	[Gamage, Sampath; Howard, Marquez; Abate, Yohannes] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA; [Makita, Hiroki; Cross, Brendan; Hastings, Gary] Georgia State Univ, Dept Phys & Astron, Atlanta, GA 30303 USA; [Luo, Ming] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	University System of Georgia; University of Georgia; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Abate, Y (corresponding author), Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA.	yabate@physast.uga.edu	Gamage, Sampath/O-2883-2017; Gamage, Sampath/AAH-2246-2019	Gamage, Sampath/0000-0002-5937-6980; Makita, Hiroki/0000-0002-4968-914X; Cross, Garnett/0000-0003-2044-0698; Hastings, Gary/0000-0001-9372-438X; abate, yohannes/0000-0002-9299-8693	National Science Foundation [1553251]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation, Award Number: 1553251, (https://www.nsf.gov/) to YA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenabar I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14402; Atkin JM, 2012, ADV PHYS, V61, P745, DOI 10.1080/00018732.2012.737982; Batishchev OV, 2016, J VIROL, V90, P575, DOI 10.1128/JVI.01539-15; Chlanda P, 2017, J VIROL, V91, DOI 10.1128/JVI.00947-17; Chlanda P, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.50, 10.1038/nmicrobiol.2016.50]; Cvitkovic A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.060801; Fontana J, 2012, J VIROL, V86, P2919, DOI 10.1128/JVI.06698-11; Greber UF, 2016, J VIROL, V90, P3802, DOI 10.1128/JVI.02568-15; Grefe SE, 2013, PHYS CHEM CHEM PHYS, V15, P18944, DOI 10.1039/c3cp53104j; Gui L, 2016, J VIROL, V90, P6948, DOI 10.1128/JVI.00240-16; Hastings G, 2008, BIOPOLYMERS, V89, P921, DOI 10.1002/bip.21036; Hull MC, 2005, ANAL CHEM, V77, P6096, DOI 10.1021/ac050990c; Huth F, 2012, NANO LETT, V12, P3973, DOI 10.1021/nl301159v; Lai AL, 2015, BIOPHYS J, V109, P2523, DOI 10.1016/j.bpj.2015.10.044; Lee KK, 2010, EMBO J, V29, P12, DOI [10.1002/bip.21036, DOI 10.1002/BIP.21036]; LEWIS RNAH, 1994, BIOPHYS J, V67, P2367, DOI 10.1016/S0006-3495(94)80723-4; Lewis RNAH, 2013, BBA-BIOMEMBRANES, V1828, P2347, DOI 10.1016/j.bbamem.2012.10.018; Luisoni S, 2015, CELL HOST MICROBE, V18, P75, DOI 10.1016/j.chom.2015.06.006; MATHLOUTHI M, 1986, ADV CARBOHYD CHEM BI, V44, P7; Nuno Z, 2011, OPT EXPRESS, V19, P20865, DOI 10.1364/OE.19.020865; Podbilewicz B, 2014, ANNU REV CELL DEV BI, V30, P111, DOI 10.1146/annurev-cellbio-101512-122422; Prathiba J, 2008, MOL BIOL REP, V35, P51, DOI 10.1007/s11033-006-9051-5; Rowse M, 2016, ACS INFECT DIS, V2, P47, DOI 10.1021/acsinfecdis.5b00109; Rowse M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122536; Stiegler JM, 2011, ACS NANO, V5, P6494, DOI 10.1021/nn2017638; Surewicz W, 1996, SPECTROSCOPIC METHOD, pxii, DOI [10.1128/JVI.06698-11, DOI 10.1128/JVI.06698-11]; Vargas CA, 2009, APPL ENVIRON MICROB, V75, P6431, DOI 10.1128/AEM.02036-08; Wood BR, 2016, CHEM SOC REV, V45, P1980, DOI 10.1039/c5cs00511f	28	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0199112	10.1371/journal.pone.0199112	http://dx.doi.org/10.1371/journal.pone.0199112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894493	Green Submitted, Green Published, gold			2022-12-26	WOS:000435030900049
J	Chen, CT; Lee, HL; Chiou, HL; Chou, CH; Wang, PH; Yang, SF; Chou, YE				Chen, Chih-Tien; Lee, Hsiang-Lin; Chiou, Hui-Ling; Chou, Chia-Hsuan; Wang, Po-Hui; Yang, Shun-Fa; Chou, Ying-Erh			Impacts of WNT1-inducible signaling pathway protein 1 polymorphism on hepatocellular carcinoma development	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; TOTAL ENTERAL NUTRITION; VITAMIN-A DEPLETION; CCN FAMILY; LUNG-CANCER; HEPATOCYTE PROLIFERATION; RETINOIC ACID; CLINICAL-FEATURES; COLORECTAL-CANCER; VIRAL-HEPATITIS	Background WNT1-inducible signaling pathway protein 1 (WISP1) is a member of CCN protein family and a downstream target of 8-catenin. Aberrant WISP1 expression is associated with carcinogenesis. In the current study, we focused on examining WISP1 single nucleotide polymorphisms (SNPs) to elucidate hepatocellular carcinoma (HCC) clinicopathologic characteristics. Methodology/Principal findings The WISP1 SNPs rs2977530, rs2977537, rs2929973, rs2929970, rs62514004, and rs16893344 were analyzed by real-time polymerase chain reaction in 332 patients with HCC and 664 cancer-free controls. Results The patients with higher frequencies of WISP1 rs62514004 (AG + GG) and rs16893344 (CT + TT) variants revealed a lower risk to reach a later clinical stage compared with their wild-type carriers. Furthermore, individuals who carried WISP1 rs62514004 and rs16893344 haplotype G-T showed a greater synergistic effect combined with alcohol drinking on HCC development (AOR = 26.590, 95% CI = 9.780-72). Conclusions Our results demonstrated that the HCC patients with WISP1 SNPs are associated with HCC development, and WISP1 SNPs may serve as markers or therapeutic targets for HCC.	[Chen, Chih-Tien; Lee, Hsiang-Lin; Chou, Chia-Hsuan; Wang, Po-Hui; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chen, Chih-Tien] Taichung Vet Gen Hosp, Dept Surg, Taichung, Taiwan; [Lee, Hsiang-Lin; Wang, Po-Hui; Chou, Ying-Erh] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lee, Hsiang-Lin] Chung Shan Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Chiou, Hui-Ling] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan; [Chiou, Hui-Ling] Chung Shan Med Univ Hosp, Dept Clin Lab, Taichung, Taiwan; [Wang, Po-Hui] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Yang, Shun-Fa; Chou, Ying-Erh] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Taichung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Chou, YE (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Chou, YE (corresponding author), Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	intointo814@gmail.com	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927	Chung Shan Medical University Hospital [CSH-2017-C-019]; Chung Shan Medical University, Taiwan [G103N0005]	Chung Shan Medical University Hospital; Chung Shan Medical University, Taiwan	This study was supported by a grant (CSH-2017-C-019) from Chung Shan Medical University Hospital and a research Grant from Chung Shan Medical University, Taiwan (G103N0005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baumgardner JN, 2007, AM J PHYSIOL-GASTR L, V293, pG355, DOI 10.1152/ajpgi.00038.2007; Brandon-Warner E, 2012, ALCOHOL CLIN EXP RES, V36, P641, DOI 10.1111/j.1530-0277.2011.01660.x; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Byam Jerome, 2013, Hepatobiliary Surg Nutr, V2, P22, DOI 10.3978/j.issn.2304-3881.2012.11.03; Chen J, 2015, CLIN LUNG CANCER, V16, P298, DOI 10.1016/j.cllc.2014.12.008; Chen J, 2014, INT J MOL SCI, V15, P21011, DOI 10.3390/ijms151121011; Chen MC, 2014, BIOMEDICINE-TAIWAN, V4, DOI 10.7603/s40681-014-0022-1; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Chiang CJ, 2015, HEPATOLOGY, V61, P1154, DOI 10.1002/hep.27630; Chung JG, 2001, CARCINOGENESIS, V22, P1213, DOI 10.1093/carcin/22.8.1213; Davies SR, 2010, INT J ONCOL, V36, P1129, DOI 10.3892/ijo_00000595; Eso Y, 2018, HEPATOL RES, V48, P597, DOI 10.1111/hepr.13181; Frank B, 2010, CARCINOGENESIS, V31, P1381, DOI 10.1093/carcin/bgq082; Gurbuz I, 2015, INT J BIOCHEM CELL B, V62, P142, DOI 10.1016/j.biocel.2015.03.007; Hashimoto Y, 1998, J EXP MED, V187, P289, DOI 10.1084/jem.187.3.289; Hassan MM, 2002, HEPATOLOGY, V36, P1206, DOI 10.1053/jhep.2002.36780; Isayama F, 2004, HEPATOLOGY, V39, P721, DOI 10.1002/hep.20137; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Katoh M, 2007, CANCER BIOL THER, V6, P832, DOI 10.4161/cbt.6.6.4196; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Lau HK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176246; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Lee LT, 2009, ANN EPIDEMIOL, V19, P323, DOI 10.1016/j.annepidem.2008.12.013; LEO MA, 1982, NEW ENGL J MED, V307, P597, DOI 10.1056/NEJM198209023071006; Li HH, 2012, AM J RESP CELL MOL, V47, P528, DOI 10.1165/rcmb.2012-0127OC; Mercer KE, 2015, ADV EXP MED BIOL, V815, P185, DOI 10.1007/978-3-319-09614-8_11; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Moulas AN, 2006, RESPIROLOGY, V11, P169, DOI 10.1111/j.1440-1843.2006.00833.x; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P103, DOI 10.1136/mp.54.2.103; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Ronis MJJ, 2011, AM J PHYSIOL-GASTR L, V300, pG109, DOI 10.1152/ajpgi.00145.2010; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Sharma S, 2010, AM J RESP CRIT CARE, V181, P328, DOI 10.1164/rccm.200907-1009OC; Shimizu Masahito, 2012, J Carcinog, V11, P11, DOI 10.4103/1477-3163.100398; Su SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159585; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Urano T, 2007, J BONE MINER METAB, V25, P253, DOI 10.1007/s00774-007-0757-9; Van Eijl S, 2011, J PHYSIOL PHARMACOL, V62, P175; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; Waller LP, 2015, WORLD J HEPATOL, V7, P2648, DOI 10.4254/wjh.v7.i26.2648; Wang CK, 2018, J FORMOS MED ASSOC, V117, P381, DOI 10.1016/j.jfma.2017.09.007; Wang SH, 2013, GENET MOL RES, V12, P1829, DOI 10.4238/2013.January.4.1; Xie D, 2001, CANCER RES, V61, P8917; Xu LF, 2000, GENE DEV, V14, P585; Xue Y, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0189-0; Yeh HW, 2017, ONCOTARGET, V8, P77734, DOI 10.18632/oncotarget.20774; Yip-Schneider MT, 2011, ALCOHOL CLIN EXP RES, V35, P2216, DOI 10.1111/j.1530-0277.2011.01568.x; Zhang HY, 2015, ONCOL REP, V33, P1481, DOI 10.3892/or.2015.3709; Zhou Xin-Da, 2002, Hepatobiliary Pancreat Dis Int, V1, P35	52	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198967	10.1371/journal.pone.0198967	http://dx.doi.org/10.1371/journal.pone.0198967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889892	gold, Green Published, Green Submitted			2022-12-26	WOS:000434786600067
J	Hasselrot, K; Lindeberg, M; Konings, P; Kallner, HK				Hasselrot, Klara; Lindeberg, Mia; Konings, Peter; Kallner, Helena Kopp			Investigating the loss of work productivity due to symptomatic leiomyoma	PLOS ONE			English	Article							UTERINE FIBROIDS; VALIDITY; BURDEN; CHART; WOMEN; LIFE	Introduction Leiomyoma affects up to 50% of fertile women, leading to morbidity such as bleeding or pain. The effect of symptomatic leiomyoma on the productivity of employed women is understudied. The present study investigates productivity loss in a Swedish setting in women with symptomatic leiomyoma compared to healthy women. Material and methods Women seeking care for leiomyoma and heavy menstrual bleeding (HMB) were recruited at nine Swedish sites. Healthy controls with self-perceived mild to normal menstruation were recruited at routine visits. Cases and controls were employed without option to work from home. After recruitment, all women reported the work productivity and activity impairment (WPAI) questionnaire, the pictorial blood assessment chart (PBAC) and pain on the visual analog scale (VAS). Results Women with symptomatic leiomyoma (n = 88) missed more working time during menses compared to asymptomatic controls (n = 34): 7.6 vs 0.2% p = 0.003. The proportion of impairment while working was also significantly higher in women with symptomatic leiomyoma (43.8 vs 12.1% p<0.001). Moreover, cases reported greater activity impairment outside office hours (43.9 vs 12.1%, p<0.001). Among healthy controls, 69.5% reported symptoms of HMB (PBAC>100). Conclusions Symptomatic leiomyoma leads to loss of working hours as well as loss of productivity during working hours, and affects women in other daily activities. Increased awareness of the impact of leiomyomas on women's lives is needed, and timely and appropriate management of the symptomatic leiomyomas could improve work productivity and quality of life.	[Hasselrot, Klara; Kallner, Helena Kopp] Danderyd Hosp, Dept Obstet & Gynecol, Stockholm, Sweden; [Hasselrot, Klara; Kallner, Helena Kopp] Danderyd Hosp, Dept Clin Sci, Div Obstet & Gynecol, Karolinska Inst, Stockholm, Sweden; [Lindeberg, Mia] Gedeon Richter Nordics AB, Stockholm, Sweden; [Konings, Peter] Parexel Int, Stockholm, Sweden	Danderyds Hospital; Danderyds Hospital; Karolinska Institutet; Parexel International	Hasselrot, K (corresponding author), Danderyd Hosp, Dept Obstet & Gynecol, Stockholm, Sweden.; Hasselrot, K (corresponding author), Danderyd Hosp, Dept Clin Sci, Div Obstet & Gynecol, Karolinska Inst, Stockholm, Sweden.	klara.hasselrot@ki.se	Kallner, Helena Kopp/AAD-4423-2020	Kallner, Helena Kopp/0000-0001-7184-9165; Konings, Peter/0000-0002-8637-5916	Gedeon Richter	Gedeon Richter	The study was fully funded by Gedeon Richter. The study was designed in collaboration with the principal investigator Helena Kopp Kallner. The decision to publish was a joint decision by the investigators (KH, HKK, PK and ML) and the company. Investigators received no compensation for manuscript writing. ML is a current employee of Gedeon Richter Nordics AB. PK was employed by Parexel at the time of data analysis but not at the time of manuscript writing and received no compensation for manuscript writing. KH has received no compensation for manuscript writing, nor does she receive any other honorariums from Gedeon Richter.	Divakar H, 2008, BEST PRACT RES CL OB, V22, P643, DOI 10.1016/j.bpobgyn.2008.01.007; Flake GP, 2003, ENVIRON HEALTH PERSP, V111, P1037, DOI 10.1289/ehp.5787; Gould D, 2001, J CLIN NURS, V10, P697, DOI 10.1046/j.1365-2702.2001.00525.x; HALLBERG L, 1966, ACTA OBSTET GYN SCAN, V45, P320, DOI 10.3109/00016346609158455; HIGHAM JM, 1990, BRIT J OBSTET GYNAEC, V97, P734, DOI 10.1111/j.1471-0528.1990.tb16249.x; Laberge PY, 2016, CURR MED RES OPIN, V32, P165, DOI 10.1185/03007995.2015.1107534; Lerner D, 2008, J OCCUP ENVIRON MED, V50, P1149, DOI 10.1097/JOM.0b013e3181895e10; Pron G, 2003, FERTIL STERIL, V79, P112, DOI 10.1016/S0015-0282(02)04539-9; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Soliman AM, 2015, AM J OBSTET GYNECOL, V213, P141, DOI 10.1016/j.ajog.2015.03.019; van den Brink MJ, 2017, FAM PRACT, V34, P673, DOI 10.1093/fampra/cmx050; Viswanathan Meera, 2007, Evid Rep Technol Assess (Full Rep), P1; Walker CL, 2005, SCIENCE, V308, P1589, DOI 10.1126/science.1112063; Williams VSL, 2006, J WOMENS HEALTH, V15, P818, DOI 10.1089/jwh.2006.15.818; Zakherah MS, 2011, GYNECOL OBSTET INVES, V71, P281, DOI 10.1159/000320336	15	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0197958	10.1371/journal.pone.0197958	http://dx.doi.org/10.1371/journal.pone.0197958			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889874	gold, Green Published, Green Submitted			2022-12-26	WOS:000434786600010
J	Hong, JW; Noh, JH; Kim, DJ				Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun			The prevalence of and factors associated with urinary cotinine-verified smoking in Korean adults: The 2008-2011 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							CIGARETTE-SMOKING; EUROPEAN COUNTRIES; WORK-ENVIRONMENT; UNITED-STATES; SELF-REPORTS; ALCOHOL-USE; LIFE-STYLE; CESSATION; OCCUPATION; SMOKERS	Background Smoking rate based on self-reporting questionnaire might be underestimated. Cotinine is the principal metabolite of nicotine and is considered an accurate biomarker of exposure to cigarette smoke. Objectives This study evaluated the prevalence of and factors associated with urinary cotinine-verified smoking in Korean adults. Methods We analyzed data from 12,110 adults in the 2008-2011 Korea National Health and Nutrition Examination Survey (KNHANES), using three threshold levels of urinary cotinine >= 100ng/ml, >= 50ng/ml, and >= 30ng/ml. Results The weighted prevalence of urinary cotinine levels of >= 100, >= 50, and >= 30 ng/mL in the whole study population was 34.7%, 37.1%, and 41.1%, respectively. Male sex, younger age, elementary school graduation, household income in the <= 24th percentile, service and sales workers and assembly workers, and high-risk alcohol drinking were associated with a higher prevalence of urinary cotinine level of >= 50 or 30 ng/mL, after we adjusted for age, sex, education level, number of family members, household income, occupation, and alcohol drinking. Logistic regression analyses were performed using the aforementioned variables as covariates to identify factors independently associated with cotinine-verified smoking. Men had a higher risk than women of having a urinary cotinine level of >= 50 ng/mL (OR 4.67, 95% CI 4.09-5.32, p < 0.001). When subjects ages 19-29 years were used as controls, adults ages 30-39 years had a 1.19-fold (CI 1.02-1.39, p = 0.026) higher risk of having a urinary cotinine level of >= 50 ng/mL. College graduates had a 32% lower risk of having a urinary cotinine level of >= 50 ng/mL than elementary school graduates (p < 0.001). A household income in the 25-49th percentile (OR 0.82, 95% CI 0.69-0.98, p =0.026), 50-74th percentile (OR 0.64, 95% CI 0.53-0.76, p < 0.001), or >= 75th percentile (OR 0.64, 95% CI 0.53-0.77, p < 0.001) was associated with a lower risk of having a urinary cotinine level of >= 50 ng/mL compared to a household income in the <= 24th percentile. High-risk (OR 2.75, 95% CI 2.37-3.18, p < 0.001) and intermediate-risk (OR 2.04, 95% CI 1.82-2.30, p < 0.001) alcohol drinking were associated with having a urinary cotinine level of >= 50 ng/mL compared to low-risk alcohol drinking. Similar to the results of the logistic regression analyses of urinary cotinine >= 50 ng/mL, male sex, younger age, elementary school education, household income in the <= 24th percentile, and high-risk alcohol drinking were significantly associated with having a urinary cotinine level of >= 30 ng/mL. Service and sales workers (OR 1.22, 95% CI 1.01-1.48, p = 0.041) had a significantly higher risk of having a urinary cotinine level of >= 30 ng/mL. Conclusions Based on a threshold urinary cotinine level of 50 ng/mL, the prevalence of cotinine-verified smoking in a representative sample of Korean adults was 37.1% (men 52.7%, women 15.4%). Younger age, male sex, low education level, service and sales workers, low household income, and high-risk alcohol drinking were associated with the risk of smoking.	[Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun] Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Internal Med, Koyang, Gyeonggi Do, South Korea	Inje University	Kim, DJ (corresponding author), Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Internal Med, Koyang, Gyeonggi Do, South Korea.	djkim@paik.ac.kr	Noh, Junghyun/AAU-8113-2020					Abd Al-Badri HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184989; Albertsen K, 2003, PUBLIC HEALTH, V117, P383, DOI 10.1016/S0033-3506(03)00103-3; Asfar T, 2016, NICOTINE TOB RES, V18, P1414, DOI 10.1093/ntr/ntv240; BENOWITZ NL, 1983, CLIN PHARMACOL THER, V34, P604, DOI 10.1038/clpt.1983.222; Bramer SL, 2003, BIOMARKERS, V8, P187, DOI 10.1080/13547500310012545; Caraballo RS, 2001, AM J EPIDEMIOL, V153, P807, DOI 10.1093/aje/153.8.807; Cook JW, 2012, J CONSULT CLIN PSYCH, V80, P1075, DOI 10.1037/a0029931; Dietz NA, 2013, DRUG ALCOHOL DEPEN, V130, P115, DOI 10.1016/j.drugalcdep.2012.10.019; Gilman SE, 2008, INT J EPIDEMIOL, V37, P615, DOI 10.1093/ije/dym250; Han SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150029; Haufroid V, 1998, INT ARCH OCC ENV HEA, V71, P162, DOI 10.1007/s004200050266; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Hong JW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000611; Hong JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175299; Hong JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167210; Jain RB, 2017, BIOMARKERS, V22, P476, DOI [10.1080/1354750X.2016.1278264, 10.1080/1354750x.2016.1278264]; JARVIS MJ, 1987, AM J PUBLIC HEALTH, V77, P1435, DOI 10.2105/AJPH.77.11.1435; Jung-Choi KH, 2012, TOB CONTROL, V21, P536, DOI 10.1136/tobaccocontrol-2011-050012; Kahler CW, 2010, NICOTINE TOB RES, V12, P781, DOI 10.1093/ntr/ntq083; Kaleta D, 2012, INT J OCCUP MED ENV, V25, P126, DOI 10.2478/S13382-012-0016-8; Kang HG, 2013, ASIAN PAC J CANCER P, V14, P6807, DOI 10.7314/APJCP.2013.14.11.6807; Kang Y.H., 2003, ANN LAB MED, V23, P92; Kim S, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1752, DOI 10.1177/1010539512461669; Korea Centers for Disease Control and Prevention (KCDC), 2010, KOR NAT HLTH NUTR EX; Korea Centers for Disease Control and Prevention (KCDC), 2017, KOR NAT HLTH NUTR EX; NELSON DE, 1994, J OCCUP ENVIRON MED, V36, P516; Palipudi KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033466; Park MB, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/s12905-014-0156-z; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; Sanderson DM, 2005, PREV MED, V41, P757, DOI 10.1016/j.ypmed.2005.06.002; Schaap MM, 2008, TOB CONTROL, V17, P248, DOI 10.1136/tc.2007.024265; Schaap MM, 2008, NICOTINE TOB RES, V10, P359, DOI 10.1080/14622200701825098; Sells JR, 2017, DRUG ALCOHOL DEPEN, V179, P267, DOI 10.1016/j.drugalcdep.2017.06.003; Shoptaw S, 2002, ADDICTION, V97, P1317, DOI 10.1046/j.1360-0443.2002.00221.x; Smith DR, 2008, IND HEALTH, V46, P77, DOI 10.2486/indhealth.46.77; Sorensen G, 2004, AM J PUBLIC HEALTH, V94, P230, DOI 10.2105/AJPH.94.2.230; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Wells AJ, 1998, AM J PUBLIC HEALTH, V88, P1503, DOI 10.2105/AJPH.88.10.1503; Wills TA, 2002, HEALTH PSYCHOL, V21, P122, DOI 10.1037//0278-6133.21.2.122; World Health Organization, 2017, WHO REP GLOB TOB EP	40	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198814	10.1371/journal.pone.0198814	http://dx.doi.org/10.1371/journal.pone.0198814			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI8PJ	29889856	gold, Green Published, Green Submitted			2022-12-26	WOS:000434786600052
J	Li, S; Yang, Y; Zhang, Q; Liu, NF; Xu, QG; Hu, LX				Li, Shuangming; Yang, Yong; Zhang, Qiang; Liu, Ningfang; Xu, Qingguo; Hu, Longxing			Differential physiological and metabolic response to low temperature in two zoysiagrass genotypes native to high and low latitude	PLOS ONE			English	Article							ABIOTIC STRESS TOLERANCE; FREEZING TOLERANCE; COLD-ACCLIMATION; ABSCISIC-ACID; CARBOHYDRATE-COMPOSITION; SEEDED BERMUDAGRASS; CHILLING TOLERANCE; GENE-EXPRESSION; SPRING WHEAT; ARABIDOPSIS	Low temperature is one of the important limiting factors for growing season and geographical distribution of plants. Zoysiagrass (Zoysia Willd) is one of the widely used warm-season turf-grass that is distribute in many parts of the world. Zoysaigrass native to high latitude may have evolved higher cold tolerance than the ones native to low latitude. The objective of this study was to investigate the cold stress response in zoysiagrass native to diverse latitude at phenotypic, physiological and metabolic levels. Two zoysiagrass (Z. japonica) genotypes, Latitude-40 (higher latitude) and Latitude-22 (lower latitude) were subjected to four temperature treatments (optimum, 30/25 degrees C, day/night; suboptimum, 18/12 degrees C; chilling, 8/2 degrees C; freezing, 2/-4 degrees C) progressively in growth chambers. Low temperature (chilling and freezing) increased leaf electrolyte leakage (EL) and reduced plant growth, turf quality, chlorophyll (Chl) content, photochemical efficiency (Fv/Fm) and photosynthesis (P-n, net photosynthetic rate; g(s), stomatal conductance; intercellular CO2; T-r, transpiration rate) in two genotypes, with more rapid changes in Latitude-22. Leaf carbohydrates content (glucose, fructose, sucrose, trehalose, fructan, starch) increased with the decreasing of temperature, to a great extend in Latitude-40. Leaf abscisic acid (ABA), salicylic acid (SA) and jasmonic acid (JA) content increased, while indole-3-acetic acid (IAA), gibberellic acid (GA(3)) and trans-zeatin ribside (t-ZR) content decreased with the reduction of temperature, with higher content in Latitude-40 than in Latitude-22. Chilling and freezing induced the up-regulation of C-repeat binding factor (ZjCBF), late embryogenesis abundant (ZjLEA3) and dehydration-responsive element binding (ZjDREB1) transcription factors in two genotypes, whereas those genes exhibited higher expression levels in Latitude-40, particularly under freezing temperature. These results suggested that zoysiagrass native to higher latitude exhibited higher freezing tolerance may attribute to the higher carbohydrates serving as energy reserves and stress protectants that stabilize cellular membranes. The phytohormones may serve signals in regulating plant growth, development and adaptation to low temperature as well as inducing the up-regulated ZjCBF, ZjLEA3 and ZjDREB1 expressions thus result in a higher cold tolerance.	[Li, Shuangming; Zhang, Qiang; Liu, Ningfang; Xu, Qingguo; Hu, Longxing] Hunan Agr Univ, Coll Agron, Dept Pratacultural Sci, Changsha, Hunan, Peoples R China; [Yang, Yong] Hunan Int Econ Univ, Golf Coll, Changsha, Hunan, Peoples R China	Hunan Agricultural University	Hu, LX (corresponding author), Hunan Agr Univ, Coll Agron, Dept Pratacultural Sci, Changsha, Hunan, Peoples R China.	grass@hunau.edu.cn	Hu, Longxing/AAS-8287-2020	Hu, Longxing/0000-0001-9068-9937	Natural Science Foundation of Hunan Province [2018JJ3223]; Science Foundation for The Excellent Youth of Hunan Provincial Education Department [17B120, 16B149]	Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Science Foundation for The Excellent Youth of Hunan Provincial Education Department	This work was financially supported by Natural Science Foundation of Hunan Province (2018JJ3223) to Longxing Hu and Science Foundation for The Excellent Youth of Hunan Provincial Education Department (17B120 and 16B149) to Longxing Hu and Yong Yang.; This work was financially supported by Natural Science Foundation of Hunan Province (2018JJ3223) to Longxing Hu and Science Foundation for The Excellent Youth of Hunan Provincial Education Department to Longxing Hu and Yong Yang (17B120 and 16B149)	Achard P, 2008, PLANT CELL, V20, P2117, DOI 10.1105/tpc.108.058941; Anderson JA, 2002, CROP SCI, V42, P190, DOI 10.2135/cropsci2002.0190; Anderson S. L., 2000, THESIS; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Assmann SM, 2010, PLANT HORMONES BIOSY, P339; Ball S, 2002, J AM SOC HORTIC SCI, V127, P45, DOI 10.21273/JASHS.127.1.45; Bush E, 2000, HORTSCIENCE, V35, P187, DOI 10.21273/HORTSCI.35.2.187; Cai QS, 2004, PLANT PROD SCI, V7, P421, DOI 10.1626/pps.7.421; Champ KI, 2007, PHYSIOL PLANTARUM, V129, P529, DOI 10.1111/j.1399-3054.2006.00826.x; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; Ding CK, 2002, PLANTA, V214, P895, DOI 10.1007/s00425-001-0698-9; Dionne J, 2001, CROP SCI, V41, P443, DOI 10.2135/cropsci2001.412443x; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; Du H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00397; Esmaili S, 2012, J PLANT PHYSIOL, V169, P851, DOI 10.1016/j.jplph.2012.01.022; Finkelstein RR, 2002, CURR OPIN PLANT BIOL, V5, P26, DOI 10.1016/S1369-5266(01)00225-4; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Ghanem ME, 2008, J EXP BOT, V59, P3039, DOI 10.1093/jxb/ern153; HILLER LK, 1979, PLANT PHYSIOL, V63, P1055, DOI 10.1104/pp.63.6.1055; Hisano H, 2004, PLANT SCI, V167, P861, DOI 10.1016/j.plantsci.2004.05.037; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Hoffman L, 2010, CROP SCI, V50, P1037, DOI 10.2135/cropsci2009.06.0293; Horvath E, 2007, J PLANT GROWTH REGUL, V26, P290, DOI 10.1007/s00344-007-9017-4; Hu LX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00179; Hu YR, 2013, PLANT CELL, V25, P2907, DOI 10.1105/tpc.113.112631; Huang BR, 2014, CRIT REV PLANT SCI, V33, P141, DOI 10.1080/07352689.2014.870411; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Janska A, 2010, PLANT BIOLOGY, V12, P395, DOI 10.1111/j.1438-8677.2009.00299.x; Kang GZ, 2003, ENVIRON EXP BOT, V50, P9, DOI 10.1016/S0098-8472(02)00109-0; Kang HM, 2002, PHYSIOL PLANTARUM, V115, P571, DOI 10.1034/j.1399-3054.2002.1150411.x; Khan MIR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00462; Knight H, 2004, PLANT PHYSIOL, V135, P1710, DOI 10.1104/pp.104.043562; Kosova K, 2012, J PLANT PHYSIOL, V169, P567, DOI 10.1016/j.jplph.2011.12.013; Kurepin LV, 2011, PLANT GROWTH REGUL, V64, P147, DOI 10.1007/s10725-010-9549-7; Levitt J, 1980, RESPONSES PLANTS ENV, VI; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livingston DP, 2009, CELL MOL LIFE SCI, V66, P2007, DOI 10.1007/s00018-009-0002-x; Llanes A., 2016, J PLANT SCI, V7, P1357, DOI [10.4236/ajps.2016.79129, DOI 10.4236/AJPS.2016.79129]; Macolino S, 2010, HORTTECHNOLOGY, V20, P758, DOI 10.21273/HORTTECH.20.4.758; Majlath I, 2012, PHYSIOL PLANTARUM, V145, P296, DOI 10.1111/j.1399-3054.2012.01579.x; Munshaw GC, 2006, CROP SCI, V46, P273, DOI 10.2135/cropsci2005.0078; Patton AJ, 2007, CROP SCI, V47, P2170, DOI 10.2135/cropsci2006.12.0784; Patton AJ, 2007, CROP SCI, V47, P1619, DOI 10.2135/cropsci2006.11.0737; Pocock TH, 2001, PHYSIOL PLANTARUM, V113, P499, DOI 10.1034/j.1399-3054.2001.1130408.x; Pompeiano A, 2015, PLANT PROD SCI, V18, P43, DOI 10.1626/pps.18.43; ROGERS RA, 1975, AGRON J, V67, P836, DOI 10.2134/agronj1975.00021962006700060029x; Ruelland E, 2010, ENVIRON EXP BOT, V69, P225, DOI 10.1016/j.envexpbot.2010.05.011; Ryu H, 2015, J PLANT BIOL, V58, P147, DOI 10.1007/s12374-015-0103-z; Sarkar D, 2009, J AM SOC HORTIC SCI, V134, P210, DOI 10.21273/JASHS.134.2.210; Shibasaki K, 2009, PLANT CELL, V21, P3823, DOI 10.1105/tpc.109.069906; Sicher R, 2011, PLANT SCI, V181, P167, DOI 10.1016/j.plantsci.2011.05.005; Souza RP, 2004, ENVIRON EXP BOT, V51, P45, DOI 10.1016/S0098-8472(03)00059-5; Strivastava LM, 2002, PLANT GROWTH DEV HOR; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Theocharis A, 2012, PLANTA, V235, P1091, DOI 10.1007/s00425-012-1641-y; Theocharis A, 2012, MOL PLANT MICROBE IN, V25, P241, DOI 10.1094/MPMI-05-11-0124; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Trischuk RG, 2014, ENVIRON EXP BOT, V106, P156, DOI 10.1016/j.envexpbot.2014.02.013; Xin Z, 2000, PLANT CELL ENVIRON, V23, P893, DOI 10.1046/j.1365-3040.2000.00611.x; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xuan JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075705; Xuan JP, 2009, TROP GRASSLANDS, V43, P118; Zhang PP, 2012, ECOTOXICOLOGY, V21, P1911, DOI 10.1007/s10646-012-0924-1; Zhang XZ, 2008, J AM SOC HORTIC SCI, V133, P542, DOI 10.21273/JASHS.133.4.542; Zhang XZ, 2008, CROP SCI, V48, P364, DOI 10.2135/cropsci2007.05.0262; Zhang XZ, 2006, CROP SCI, V46, P2598, DOI 10.2135/cropsci2006.02.0108; Zhang XZ, 2011, CROP SCI, V51, P838, DOI 10.2135/cropsci2010.06.0345	68	38	41	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198885	10.1371/journal.pone.0198885	http://dx.doi.org/10.1371/journal.pone.0198885			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889884	gold, Green Submitted, Green Published			2022-12-26	WOS:000434786600062
J	Lien, MY; Chou, CH; Lin, CC; Bai, LY; Chiu, CF; Yeh, SP; Ho, MW				Lien, Ming-Yu; Chou, Chia-Hui; Lin, Ching-Chan; Bai, Li-Yuan; Chiu, Chang-Fang; Yeh, Su-Peng; Ho, Mao-Wang			Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study	PLOS ONE			English	Article							PARENTERAL-NUTRITION; CANDIDEMIA; DISEASES; MULTICENTER; CANDIDIASIS; STRATEGIES; MANAGEMENT; RECIPIENTS; UPDATE	This study investigated the epidemiology and risk factors associated with invasive fungal infections (IFIs) during induction chemotherapy in a cohort of Taiwanese patients with newly-diagnosed acute myeloid leukemia (AML). IFIs are a significant complication in the management of immunocompromised cancer patients; such infections are associated with a high incidence of morbidity and mortality, particularly in many South-Asian countries, where IFI rates are increasing. We retrospectively analyzed IFI incidence data from 105 patients with newly diagnosed AML at a single center undergoing their first course of induction chemotherapy without primary antifungal prophylaxis between November 2008 and December 2014. Of 21 cases documented as proven/provable IFIs 16 (76%) were invasive aspergillosis, 2 (10%) were mucormycosis infections, and 3 (14%) were proven yeast infections. The lung was the most commonly affected site (n = 16; 76%); 2 patients (10%) developed fungal sinusitis. IFI cases were more often males (P = 0.020). In multivariate analysis, patients with neutropenia lasting>30 days were more than twice as likely to develop IFI (OR, 2.24 [95% CI, 2.81 +/- 31.11], P<0.001). We also confirmed patients with smoker and receiving parenteral nutrition during chemotherapy were significant associated with IFIs. Our findings suggest that antifungal prophylaxis should be considered for patients with AML during induction chemotherapy, particularly in patients from Southeastern Asia, an area of potentially high IFI rates. We recommend that clinicians determine which patients receiving induction chemotherapy for AML are at high risk of developing IFI, to allow for targeted therapeutic prophylaxis.	[Lien, Ming-Yu; Lin, Ching-Chan; Bai, Li-Yuan; Chiu, Chang-Fang; Yeh, Su-Peng] China Med Univ Hosp, Div Hematol & Oncol, Dept Internal Med, Taichung, Taiwan; [Lien, Ming-Yu] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chou, Chia-Hui; Ho, Mao-Wang] China Med Univ Hosp, Div Infect Dis, Dept Internal Med, Taichung, Taiwan; [Bai, Li-Yuan; Chiu, Chang-Fang; Yeh, Su-Peng] China Med Univ, Grad Inst Clin Med, Dept Internal Med, Clin Hematol & Oncol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Yeh, SP (corresponding author), China Med Univ Hosp, Div Hematol & Oncol, Dept Internal Med, Taichung, Taiwan.; Ho, MW (corresponding author), China Med Univ Hosp, Div Infect Dis, Dept Internal Med, Taichung, Taiwan.; Yeh, SP (corresponding author), China Med Univ, Grad Inst Clin Med, Dept Internal Med, Clin Hematol & Oncol, Taichung, Taiwan.	supengyeh@gmail.com; d7905@mail.cmuh.org.tw						Ananda-Rajah MR, 2012, HAEMATOL-HEMATOL J, V97, P459, DOI 10.3324/haematol.2011.051995; Buyukcelik A, 2004, CANCER, V101, P1100, DOI 10.1002/cncr.20461; Chen CY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-250; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Garnica M, 2015, CLIN INFECT DIS, V60, P875, DOI 10.1093/cid/ciu947; Gaspar GG, 2015, REV SOC BRAS MED TRO, V48, P77, DOI 10.1590/0037-8682-0292-2014; Hammond SP, 2010, AM J HEMATOL, V85, P695, DOI 10.1002/ajh.21776; Hsu L Y, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.02.019; Khan AAH, 2012, SAUDI J BIOL SCI, V19, P405, DOI 10.1016/j.sjbs.2012.06.002; Kontoyiannis DP, 2012, AM J MED, V125, pS25, DOI 10.1016/j.amjmed.2011.10.009; Leon C, 2009, CRIT CARE MED, V37, P1624, DOI 10.1097/CCM.0b013e31819daa14; Lewis RE, 2013, MYCOSES, V56, P638, DOI 10.1111/myc.12081; Luzzati R, 2013, MYCOSES, V56, P664, DOI 10.1111/myc.12090; Malagola M, 2008, EUR J HAEMATOL, V81, P354, DOI 10.1111/j.1600-0609.2008.01122.x; Michallet M, 2012, EUR J CLIN MICROBIOL, V31, P991, DOI 10.1007/s10096-011-1397-5; Neofytos D, 2013, DIAGN MICR INFEC DIS, V75, P144, DOI 10.1016/j.diagmicrobio.2012.10.001; Nielsen Xiaohui Chen, 2012, Open Microbiol J, V6, P98, DOI 10.2174/1874285801206010098; Ostrosky-Zeichner L, 2007, EUR J CLIN MICROBIOL, V26, P271, DOI 10.1007/s10096-007-0270-z; Pagano L, 2011, J ANTIMICROB CHEMOTH, V66, pi5, DOI 10.1093/jac/dkq437; Pagano L, 2010, HAEMATOL-HEMATOL J, V95, P644, DOI 10.3324/haematol.2009.012054; Perfect JR, 2014, CLIN INFECT DIS, V59, pS352, DOI 10.1093/cid/ciu639; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Ruping MJGT, 2008, DRUGS, V68, P1941, DOI 10.2165/00003495-200868140-00002; Stratman RC, 2010, NUTR CLIN PRACT, V25, P282, DOI 10.1177/0884533610368704; Tang JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128410	26	31	34	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0197851	10.1371/journal.pone.0197851	http://dx.doi.org/10.1371/journal.pone.0197851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883443	Green Submitted, Green Published, gold			2022-12-26	WOS:000434728100008
J	Truschel, ST; Clayton, DR; Beckel, JM; Yabes, JG; Yao, Y; Wolf-Johnston, A; Birder, LA; Apodaca, G				Truschel, Steven T.; Clayton, Dennis R.; Beckel, Jonathan M.; Yabes, Jonathan G.; Yao, Yi; Wolf-Johnston, Amanda; Birder, Lori A.; Apodaca, Gerard			Age-related endolysosome dysfunction in the rat urothelium	PLOS ONE			English	Article							BLADDER UMBRELLA CELLS; MULTIVESICULAR BODIES; URINARY-BLADDER; TRANSITIONAL EPITHELIUM; LYSOSOMAL DYSFUNCTION; ALZHEIMERS-DISEASE; PLASMA-MEMBRANE; CATHEPSIN-B; MECHANISMS; AUTOPHAGY	Lysosomal dysfunction is associated with a number of age-related pathologies that affect all organ systems. While much research has focused on neurodegenerative diseases and aging-induced changes in neurons, much less is known about the impact that aging has on lower urinary tract function. Our studies explored age-dependent changes in the content of endo-lysosomal organelles (i.e., multivesicular bodies, lysosomes, and the product of their fusion, endolysosomes) and age-induced effects on lysosomal degradation in the urothelium, the epithelial tissue that lines the inner surface of the bladder, ureters, and renal pelvis. When examined by transmission electron microscopy, the urothelium from young adult rats (similar to 3 months), mature adult rats (similar to 12 months), and aged rats (similar to 26 months old) demonstrated a progressive age-related accumulation of aberrantly large endolysosomes (up to 7 mu m in diameter) that contained undigested content, likely indicating impaired degradation. Stereo-logical analysis confirmed that aged endolysosomes occupied approximately 300% more volume than their younger counterparts while no age-related change was observed in multivesicular bodies or lysosomes. Consistent with diminished endolysosomal degradation, we observed that cathepsin B activity was significantly decreased in aged versus young urothelial cell lysates as well as in live cells. Further, the endolysosomal pH of aged urothelium was higher than that of young adult (pH 6.0 vs pH 4.6). Our results indicate that there is a progressive decline in urothelial endolysosomal function during aging. How this contributes to bladder dysfunction in the elderly is discussed.	[Truschel, Steven T.; Clayton, Dennis R.; Yabes, Jonathan G.; Yao, Yi; Wolf-Johnston, Amanda; Birder, Lori A.; Apodaca, Gerard] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Beckel, Jonathan M.; Birder, Lori A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Yabes, Jonathan G.; Yao, Yi] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Apodaca, Gerard] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Apodaca, G (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA.; Apodaca, G (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA.	gla6@pitt.edu	Apodaca, Gerard/HCJ-0048-2022; Beckel, Jonathan/A-6758-2008	Beckel, Jonathan/0000-0003-1390-2292; Truschel, Steven/0000-0003-3394-6006	National Institutes of Aging [R56AG050408, R01AG056944]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK104287, DK106115, DK114492, P30DK079307]; NIH [S10RR019003]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK106115, R01DK104287, R03DK114492, P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG050408, R01AG056944] Funding Source: NIH RePORTER	National Institutes of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Aging grants R56AG050408 and R01AG056944 (to GA and LB); the National Institute of Diabetes and Digestive and Kidney Diseases R01DK104287 (to GA); the National Institute of Diabetes and Digestive and Kidney Diseases grants DK106115 and DK114492 (to JB); Also, SW received an NIH equipment grant used to purchase the electron microscope (S10RR019003) and the morphological studies described in these studies were supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (P30DK079307), which funds in part the Kidney Imaging Core of the Pittsburgh Center for Kidney Research.	AMANO O, 1988, TOHOKU J EXP MED, V156, P417, DOI 10.1620/tjem.156.417; AMANO O, 1991, ANAT RECORD, V229, P9, DOI 10.1002/ar.1092290103; Arrighi S, 2015, ANN ANAT, V198, P73, DOI 10.1016/j.aanat.2014.11.001; Birder L, 2013, PHYSIOL REV, V93, P653, DOI 10.1152/physrev.00030.2012; Birder LA, 2007, NAT CLIN PRACT UROL, V4, P46, DOI 10.1038/ncpuro0672; Born M, 2003, EUR J CELL BIOL, V82, P343, DOI 10.1078/0171-9335-00326; Boustany RMN, 2013, NAT REV NEUROL, V9, P583, DOI 10.1038/nrneurol.2013.163; Bright NA, 2016, CURR BIOL, V26, P2233, DOI 10.1016/j.cub.2016.06.046; BROCKLEHURST JC, 1966, GERONTOL CLIN, V8, P306; Burbulla LF, 2017, SCIENCE, V357, P1255, DOI 10.1126/science.aam9080; Carmona-Gutierrez D, 2016, AGEING RES REV, V32, P2, DOI 10.1016/j.arr.2016.04.009; Christensen KA, 2002, J CELL SCI, V115, P599; Coen K, 2012, J CELL BIOL, V198, P23, DOI 10.1083/jcb.201201076; Diao JJ, 2015, NATURE, V520, P563, DOI 10.1038/nature14147; DIOKNO AC, 1994, J UROLOGY, V151, P1550, DOI 10.1016/S0022-5347(17)35299-0; Folick A, 2015, SCIENCE, V347, P83, DOI 10.1126/science.1258857; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gamp AC, 2003, HUM MOL GENET, V12, P631, DOI 10.1093/hmg/ddg062; GERSHON H, 1970, NATURE, V227, P1214, DOI 10.1038/2271214a0; GOLDSTEIN S, 1976, MECH AGEING DEV, V5, P221, DOI 10.1016/0047-6374(76)90020-8; Gowrishankar S, 2015, P NATL ACAD SCI USA, V112, pE3699, DOI 10.1073/pnas.1510329112; Guo XM, 2009, TRAFFIC, V10, P1350, DOI 10.1111/j.1600-0854.2009.00950.x; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; HIRSCH HR, 1991, EXP GERONTOL, V26, P549, DOI 10.1016/0531-5565(91)90073-U; JEZERNIK K, 1992, CELL BIOL INT REP, V16, P1219, DOI 10.1016/S0309-1651(06)80038-X; Jung M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116972; Khandelwal P, 2010, EMBO J, V29, P1961, DOI 10.1038/emboj.2010.91; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Liang QL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-37; Lim CY, 2016, J CELL BIOL, V214, P653, DOI 10.1083/jcb.201607005; LIMAS C, 1993, J CLIN PATHOL, V46, P159, DOI 10.1136/jcp.46.2.159; Madersbacher S, 1996, J UROLOGY, V156, P1662, DOI 10.1016/S0022-5347(01)65478-8; Madersbacher S, 1998, UROLOGY, V51, P206, DOI 10.1016/S0090-4295(97)00616-X; Man SM, 2016, AUTOPHAGY, V12, P2504, DOI 10.1080/15548627.2016.1239679; Martini-Stoica H, 2016, TRENDS NEUROSCI, V39, P221, DOI 10.1016/j.tins.2016.02.002; Miao YX, 2015, CELL, V161, P1306, DOI 10.1016/j.cell.2015.05.009; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Mouton P.R., 2001, PRINCIPLES PRACTICES; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Nakamura N, 1997, J BIOCHEM, V121, P338; Perera RM, 2016, ANNU REV CELL DEV BI, V32, P223, DOI 10.1146/annurev-cellbio-111315-125125; Perse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059638; Piper RC, 2001, TRAFFIC, V2, P612, DOI 10.1034/j.1600-0854.2001.20904.x; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; SORENSEN FB, 1991, J MICROSC-OXFORD, V162, P203, DOI 10.1111/j.1365-2818.1991.tb03132.x; Templeman L, 2002, J UROLOGY, V167, P742, DOI 10.1016/S0022-5347(01)69137-7; Truschel ST, 2002, MOL BIOL CELL, V13, P830, DOI 10.1091/mbc.01-09-0435; Tsujimura A, 2015, NEUROBIOL DIS, V73, P244, DOI 10.1016/j.nbd.2014.10.011; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; WAKABAYASHI Y, 1993, HISTOCHEMISTRY, V100, P401, DOI 10.1007/BF00267819; Wang CH, 2012, P NATL ACAD SCI USA, V109, P11008, DOI 10.1073/pnas.1203952109; Wang C, 2018, CURR OPIN NEUROBIOL, V48, P52, DOI 10.1016/j.conb.2017.09.005; WEBSTER GC, 1978, EXP GERONTOL, V13, P343, DOI 10.1016/0531-5565(78)90043-8; Westbroek W, 2011, TRENDS MOL MED, V17, P485, DOI 10.1016/j.molmed.2011.05.003; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	56	20	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e198817	10.1371/journal.pona.0198817	http://dx.doi.org/10.1371/journal.pona.0198817			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883476				2022-12-26	WOS:000434728100041
J	Adeyemo, TA; Ojewunmi, OO; Oyetunji, IA; Rooks, H; Rees, DC; Akinsulie, AO; Akanmu, AS; Thein, SL; Menzel, S				Adeyemo, Titilope A.; Ojewunmi, Oyesola O.; Oyetunji, Idat A.; Rooks, Helen; Rees, David C.; Akinsulie, Adebola O.; Akanmu, Alani S.; Thein, Swee Lay; Menzel, Stephan			A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemia	PLOS ONE			English	Article							INTERGENIC VARIANTS; RISK-FACTORS; DISEASE; BCL11A; HAPLOTYPES; HBS1L-MYB; MAPS; MYB; INDIVIDUALS; ASSOCIATION	Genetic variants at three quantitative trait loci (QTL) for fetal haemoglobin (HbF), BCL11A, HBS1L-MYB and the (beta-globin gene cluster, have attracted interest as potential targets of therapeutic strategies for HbF reactivation in sickle cell anaemia (SCA). We carried out the first systematic evaluation of critical single nucleotide polymorphisms at these disease modifier loci in Nigerian patients with SCA. Common variants for BCL11A and HBS1L-MYB were strongly associated with HbF levels. At both loci, secondary association signals were detected, illustrating the mapping resolution attainable in this population. For BCL11A, the two independent sites of association were represented by rs1427407 (primary site, p = 7.0 x 10(-10)) and rs6545816 (secondary site, conditioned on rs1427407: p = 0.02) and for HBS1L-MYB by rs9402686 (HMIP-2B, p = 1.23 x 10(-4)) and rs66650371 (HMIP-2A, p = 0.002). Haplotype analysis revealed similarities in the genetic architecture of BCL11 A and HBS1L-MYB in Nigerian patients. Variants at both loci also alleviated anaemia. The variant allele for the gamma globin gene promoter polymorphism Xmnl-HBG2 was too infrequent in our patients to be evaluated in this relatively small study. Studying the large and diverse SCA patient populations in African countries such as Nigeria will be key for a clearer understanding of how these loci work and for the discovery of new disease modifier genes.	[Adeyemo, Titilope A.; Akanmu, Alani S.] Univ Lagos, Coll Med, Dept Haematol & Blood Transfus, Lagos, Nigeria; [Ojewunmi, Oyesola O.; Oyetunji, Idat A.] Sickle Cell Fdn Nigeria, Lagos, Nigeria; [Rooks, Helen; Rees, David C.; Menzel, Stephan] Kings Coll London, Sch Canc & Pharmaceut Sci, London, England; [Rees, David C.] Kings Coll Hosp London, Paediat Haematol, London, England; [Akinsulie, Adebola O.] Univ Lagos, Coll Med, Dept Paediat, Lagos, Nigeria; [Thein, Swee Lay] NHLBI, Sickle Cell Branch, NIH, Bldg 10, Bethesda, MD 20892 USA	University of Lagos; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Lagos; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Adeyemo, TA (corresponding author), Univ Lagos, Coll Med, Dept Haematol & Blood Transfus, Lagos, Nigeria.; Menzel, S (corresponding author), Kings Coll London, Sch Canc & Pharmaceut Sci, London, England.	taadeyemo@cmul.edu.ng; stephan.menzel@kcl.ac.uk	Ojewunmi, Oyesola/AAU-7201-2020; Menzel, Stephan/U-6906-2019; Rees, David/B-6789-2011	Ojewunmi, Oyesola/0000-0003-2774-650X; Menzel, Stephan/0000-0002-1590-9108; Rees, David/0000-0003-3647-1050; Akinsulie, Adebola/0000-0003-2543-5871; Akanmu, Alani Sulaimon/0000-0001-7424-6060	Central Research Committee of the University of Lagos [CRC 2014/07]; European Commission; Shire UK plc	Central Research Committee of the University of Lagos; European Commission(European CommissionEuropean Commission Joint Research Centre); Shire UK plc	Funded by TAA: Central Research Committee of the University of Lagos (Grant No: CRC 2014/07). SM and SLT: FP7, European Commission (Thalamoss). SM and SLT: Shire UK plc (Collaborative Grant).; Central Research Committee of the University of Lagos (Grant No: CRC 2014/07). During this study, SM and SLT were supported by FP7, European Commission (Thalamoss) and by a research grant from Shire plc.	ADEKILE AD, 1992, ANN HEMATOL, V65, P41, DOI 10.1007/BF01715125; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bhagat S, 2013, J CLIN DIAGN RES, V7, P269, DOI 10.7860/JCDR/2013/4381.2744; Chang KH, 2017, MOL THER-METH CLIN D, V4, P137, DOI 10.1016/j.omtm.2016.12.009; Craig JE, 1996, NAT GENET, V12, P58, DOI 10.1038/ng0196-58; CRAIG JE, 1993, BRIT J HAEMATOL, V84, P106, DOI 10.1111/j.1365-2141.1993.tb03032.x; Creary LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004218; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Farrell JJ, 2011, BLOOD, V117, P4935, DOI 10.1182/blood-2010-11-317081; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Garner C, 2000, BLOOD, V95, P342; Hanchard N, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-52; HIGGS DR, 1982, NEW ENGL J MED, V306, P1441, DOI 10.1056/NEJM198206173062402; Jiang J, 2006, BLOOD, V108, P1077, DOI 10.1182/blood-2006-01-008912; KOSHY M, 1989, BLOOD, V74, P1403; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Makani J, 2011, BLOOD, V117, P1390, DOI 10.1182/blood-2010-08-302703; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Menzel S, 2014, ANN HUM GENET, V78, P434, DOI 10.1111/ahg.12077; Mtatiro SN, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0148-3; Mtatiro SN, 2015, AM J HEMATOL, V90, pE1, DOI 10.1002/ajh.23859; Mtatiro SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111464; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Sedgewick AE, 2008, BLOOD CELL MOL DIS, V41, P255, DOI 10.1016/j.bcmd.2008.06.007; Stadhouders R, 2014, J CLIN INVEST, V124, P1699, DOI 10.1172/JCI71520; Thein SL, 2008, BRIT J HAEMATOL, V141, P357, DOI 10.1111/j.1365-2141.2008.07084.x; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Wonkam A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092506; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053	34	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0197927	10.1371/journal.pone.0197927	http://dx.doi.org/10.1371/journal.pone.0197927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879141	Green Submitted, gold, Green Published			2022-12-26	WOS:000434384900014
J	Araujo-Silva, H; Pinheiro-da-Silva, J; Silva, PF; Luchiari, AC				Araujo-Silva, Heloysa; Pinheiro-da-Silva, Jaquelinne; Silva, Priscila F.; Luchiari, Ana C.			Individual differences in response to alcohol exposure in zebrafish (Danio rerio)	PLOS ONE			English	Article							BEHAVIORAL-RESPONSES; ANIMAL PERSONALITY; SHOALING BEHAVIOR; ETHANOL EXPOSURE; COPING STYLES; FISH; MECHANISMS; PREFERENCE; STRESS; MODEL	Personality traits are related to many aspects of one's life, including risk taking, sociability, and behavioral changes caused by psychoactive substances. This study aimed to investigate individual differences and behavioral changes due to alcohol exposure in zebrafish (Danio rerio). To that end, adult animals were separated into two behavioral profiles: bold and shy, according to their risk taking behavior in an emergence test. Bold and shy fish were allowed to explore a 5-chamber tank and were tested for exploration and sociability (shoaling behavior) following alcohol exposure. The acute drug exposure treatments were 0.0%, 0.1% and 0.5% (v/v%) alcohol. The behavioral parameters evaluated were average and maximum swimming speed, total distance traveled, total time spent immobile, and time spent near a shoal or exploring the tank. For the groups that received no alcohol (0.0% alcohol), shy individuals spent more time near the shoal than bold fish. However, 0.5% alcohol increased bold fish responsiveness to the shoal, while both 0.1% and 0.5% alcohol diminished shoaling in shy fish. Our results show that the behavioral profiles of zebrafish are affected differently by alcohol, with shy animals seemingly more sensitive to behavioral change due to drug exposure. Moreover, we confirm zebrafish as a model for alcohol induced functional (exploration and social behavior) changes that could be useful in high throughput drug screens.	[Araujo-Silva, Heloysa; Pinheiro-da-Silva, Jaquelinne; Silva, Priscila F.; Luchiari, Ana C.] Univ Fed Rio Grande do Norte, Dept Physiol, Biosci Ctr, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte	Luchiari, AC (corresponding author), Univ Fed Rio Grande do Norte, Dept Physiol, Biosci Ctr, Natal, RN, Brazil.	analuchiari@yahoo.com.br	Pinheiro-da-Silva, Jaquelinne/AAF-3640-2021; Araujo-Silva, Heloysa/AAC-3405-2021; Luchiari, Ana C/O-3206-2013	Pinheiro-da-Silva, Jaquelinne/0000-0002-8908-6730; Araujo-Silva, Heloysa/0000-0002-3868-866X; Luchiari, Ana/0000-0003-3294-7859	Serrapilheira Institute Serra [1709-20842]	Serrapilheira Institute Serra	This work was supported by the Serrapilheira Institute Serra-1709-20842 to ACL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim RR, 2017, ZEBRAFISH; Anderson P., 2012, ALC EUR UN CONS HARM; Backstrom T, 2017, FRONT NEUROSCI, P11, DOI [10.3389/fnins.2017.00011, DOI 10.3389/FNINS.2017.00011]; Bahi A, 2013, PHARMACOL BIOCHEM BE, V105, P83, DOI 10.1016/j.pbb.2013.01.023; Banerjee Niladri, 2014, Indian J Hum Genet, V20, P20, DOI 10.4103/0971-6866.132750; Best J D, 2008, Neuropsychiatr Dis Treat, V4, P567; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; Carpenter KJ, 2000, BERIBERI WHITE RICE; Castanheira MF, 2017, REV AQUACULT, V9, P23, DOI 10.1111/raq.12100; Cavigelli SA, 2005, BEHAVIOUR, V142, P1223, DOI 10.1163/156853905774539355; CENTERWALL BS, 1978, NEW ENGL J MED, V299, P285, DOI 10.1056/NEJM197808102990605; Chacon DM, 2014, PROG NEURO-PSYCHOPH, V53, P109, DOI 10.1016/j.pnpbp.2014.03.009; COTTON NS, 1979, J STUD ALCOHOL, V40, P89, DOI 10.15288/jsa.1979.40.89; Dzieweczynski TL, 2016, ECOTOXICOLOGY, V25, P69, DOI 10.1007/s10646-015-1568-8; Engeszer RE, 2007, ANIM BEHAV, V74, P1269, DOI 10.1016/j.anbehav.2007.01.032; Engeszer RE, 2004, CURR BIOL, V14, P881, DOI 10.1016/j.cub.2004.04.042; Gebauer DL, 2011, PHARMACOL BIOCHEM BE, V99, P480, DOI 10.1016/j.pbb.2011.04.021; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2008, ALCOHOL CLIN EXP RES, V32, P1763, DOI 10.1111/j.1530-0277.2008.00761.x; Gilpin NW, 2008, ALCOHOL RES HEALTH, V31, P185; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Guo N, 2015, ALCOHOL, V49, P727, DOI 10.1016/j.alcohol.2015.08.003; Henniger MSH, 2002, NEUROPSYCHOPHARMACOL, V26, P729, DOI 10.1016/S0893-133X(01)00408-0; Hoare DJ, 2000, J FISH BIOL, V57, P1351, DOI 10.1006/jfbi.2000.1446; Homberg JR, 2004, NEUROSCIENCE, V128, P121, DOI 10.1016/j.neuroscience.2004.05.048; Jesse S, 2017, ACTA NEUROL SCAND, V135, P4, DOI 10.1111/ane.12671; Kalueff AV, 2007, BRAIN RES REV, V53, P328, DOI 10.1016/j.brainresrev.2006.09.003; Kalueff AV, 2014, TRENDS PHARMACOL SCI, V35, P63, DOI 10.1016/j.tips.2013.12.002; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Kern EMA, 2016, ANIM BEHAV, V117, P79, DOI 10.1016/j.anbehav.2016.04.007; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 2007, BRAIN BEHAV EVOLUT, V70, P218, DOI 10.1159/000105485; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Krause J, 2000, BIOL REV, V75, P477; Lachlan RF, 1998, ANIM BEHAV, V56, P181, DOI 10.1006/anbe.1998.0760; Le Moal M, 2007, EUR NEUROPSYCHOPHARM, V17, P377, DOI 10.1016/j.euroneuro.2006.10.006; Luchiari AC, 2015, BEHAV BRAIN RES, V282, P76, DOI 10.1016/j.bbr.2014.12.013; Mathur P, 2011, BEHAV BRAIN RES, V219, P234, DOI 10.1016/j.bbr.2011.01.019; Matsui JI, 2006, INVEST OPHTH VIS SCI, V47, P4589, DOI 10.1167/iovs.05-0971; Molgaard HSFA, 2012, NEUROEPIDEMIOLOGY TH, P149; Momeni S, 2014, BEHAV BRAIN RES, V275, P288, DOI 10.1016/j.bbr.2014.08.058; Montiglio PO, 2010, ANIM BEHAV, V80, P905, DOI 10.1016/j.anbehav.2010.08.014; Moscicki MK, 2015, ANIM BEHAV, V107, P105, DOI 10.1016/j.anbehav.2015.05.027; Nadal R, 2002, PSYCHOPHARMACOLOGY, V162, P333, DOI 10.1007/s00213-002-1091-5; Nasrallah NA, 2011, P NATL ACAD SCI USA, V108, P5466, DOI 10.1073/pnas.1017732108; Norton W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-90; Nunes EA, 2014, REV LATINOAMERICANA, P528; Oliveira A., 2007, CASA DO PSICOLOGO; Oliveira TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075780; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Parker MO, 2014, PROG NEURO-PSYCHOPH, V55, P94, DOI 10.1016/j.pnpbp.2014.03.011; Pinheiro-da-Silva J, 2016, ANIM COGN, P1, DOI [10.1007/s10071-015-0908-7, DOI 10.1007/S10071-015-0908-7]; PITCHER TJ, 1983, ANIM BEHAV, V31, P611, DOI 10.1016/S0003-3472(83)80087-6; Quoilin C, 2013, ALCOHOL, V47, P317, DOI 10.1016/j.alcohol.2013.01.006; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Rey S, 2015, ZEBRAFISH, V12, P243, DOI 10.1089/zeb.2014.1076; Roman E, 2009, BEHAV BRAIN RES, V205, P249, DOI 10.1016/j.bbr.2009.08.020; Rosenbloom MJ, 2004, NEUROPSYCHOLOGY, V18, P589, DOI 10.1037/0894-4105.18.3.589; Roy T, 2017, ZEBRAFISH, V14, P393, DOI 10.1089/zeb.2017.1442; SAMSON HH, 1992, TRENDS PHARMACOL SCI, V13, P206, DOI 10.1016/0165-6147(92)90065-E; Santos LC, 2016, PHARMACOL BIOCHEM BE, V143, P34, DOI 10.1016/j.pbb.2016.01.013; Saverino C, 2008, BEHAV BRAIN RES, V191, P77, DOI 10.1016/j.bbr.2008.03.013; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Tran S, 2013, BEHAV BRAIN RES, V252, P204, DOI 10.1016/j.bbr.2013.05.065; Stewart AM, 2014, TRENDS NEUROSCI, V37, P264, DOI 10.1016/j.tins.2014.02.011; Tran S, 2016, PSYCHOPHARMACOLOGY, V233, P2119, DOI 10.1007/s00213-016-4264-3; Tudorache C, 2013, J ENDOCRINOL, V219, P251, DOI 10.1530/JOE-13-0225; Volpicelli JR, 1995, ALCOHOL ALCOHOLISM, V30, P789; von Krogh K, 2010, PHYSIOL BEHAV, V101, P32, DOI 10.1016/j.physbeh.2010.04.003; Vuadens P, ENCY MED CHIRURG; White SL, 2017, BEHAV PROCESS, V141, P220, DOI 10.1016/j.beproc.2016.08.009; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023; Zaleski Marcos, 2004, Braz. J. Psychiatry, V26, P40; Zarkin GA, 2012, HEALTH ECON, V21, P633, DOI 10.1002/hec.1735	77	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198856	10.1371/journal.pone.0198856	http://dx.doi.org/10.1371/journal.pone.0198856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI5BF	29879208	Green Submitted, gold, Green Published			2022-12-26	WOS:000434384900093
J	Neugebauer, KA; Bruce, M; Todd, T; Trick, HN; Fellers, JP				Neugebauer, Kerri A.; Bruce, Myron; Todd, Tim; Trick, Harold N.; Fellers, John P.			Wheat differential gene expression induced by different races of Puccinia triticina	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEINS; LEAF RUST; VIRULENCE; INHERITANCE; TOBACCO; ALANINE	Puccinia triticina, the causal agent of wheat leaf rust, causes significant losses in wheat yield and quality each year worldwide. During leaf rust infection, the host plant recognizes numerous molecules, some of which trigger host defenses. Although P. triticina reproduces clonally, there is still variation within the population due to a high mutation frequency, host specificity, and environmental adaptation. This study explores how wheat responds on a gene expression level to different P. triticina races. Six P. triticina races were inoculated onto a susceptible wheat variety and samples were taken at six days post inoculation, just prior to pustule eruption. RNA sequence data identified 63 wheat genes differentially expressed between the six races. A time course, conducted over the first seven days post inoculation, was used to examine the expression pattern of 63 genes during infection. Forty-seven wheat genes were verified to have differential expression. Three common expression patterns were identified. In addition, two genes were associated with race specific gene expression. Differential expression of an ER molecular chaperone gene was associated with races from two different P. triticina lineages. Also, differential expression in an alanine glyoxylate aminotransferase gene was associated with races with virulence shifts for leaf rust resistance genes.	[Neugebauer, Kerri A.; Bruce, Myron; Todd, Tim; Trick, Harold N.] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA; [Fellers, John P.] USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS 66502 USA; [Neugebauer, Kerri A.] USDA ARS, Small Grains & Potato Germplasm Res Unit, Aberdeen, ID USA	Kansas State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Fellers, JP (corresponding author), USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS 66502 USA.	john.fellers@ars.usda.gov		Bruce, Myron/0000-0001-9235-7258; Trick, Harold/0000-0001-5255-5575; Fellers, John/0000-0003-3872-2909	US Congress; US Department of Agriculture	US Congress; US Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by the US Congress and the US Department of Agriculture. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone A, 2012, PLANT SCI, V182, P12, DOI 10.1016/j.plantsci.2011.02.004; [Anonymous], 1989, GENETIC ENG PRINCIPL; Bolton MD, 2008, MOL PLANT PATHOL, V9, P563, DOI [10.1111/j.1364-3703.2008.00487.x, 10.1111/J.1364-3703.2008.00487.X]; Bozkurt TO, 2010, MOL PLANT PATHOL, V11, P625, DOI [10.1111/J.1364-3703.2010.00633.X, 10.1111/j.1364-3703.2010.00633.x]; Breen S, 2016, PLANT J, V88, P13, DOI 10.1111/tpj.13228; Bruce M, 2014, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00520; Chandra S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148453; Chen XA, 2010, AGR SCI CHINA, V9, P1577, DOI 10.1016/S1671-2927(09)60254-6; Coram TE, 2010, FUNCT INTEGR GENOMIC, V10, P383, DOI 10.1007/s10142-009-0148-5; Dugyala S, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0096-0; FLOR HH, 1955, PHYTOPATHOLOGY, V45, P680; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; HEJGAARD J, 1991, FEBS LETT, V291, P127, DOI 10.1016/0014-5793(91)81119-S; Huerta-Espino J, 2011, EUPHYTICA, V179, P143, DOI 10.1007/s10681-011-0361-x; Hulbert S, 2014, MOL PLANT MICROBE IN, V27, P207, DOI 10.1094/MPMI-09-13-0295-FI; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KAUFFMANN S, 1987, EMBO J, V6, P3209, DOI 10.1002/j.1460-2075.1987.tb02637.x; Khan M. H., 2013, Agricultural Sciences, V4, P292; KOLMER JA, 1989, PHYTOPATHOLOGY, V79, P1313, DOI 10.1094/Phyto-79-1313; Kolmer J, 2013, FORESTS, V4, P70, DOI 10.3390/f4010070; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONG DL, 1989, PHYTOPATHOLOGY, V79, P525, DOI 10.1094/Phyto-79-525; Lorkovic ZJ, 2009, TRENDS PLANT SCI, V14, P229, DOI 10.1016/j.tplants.2009.01.007; McIntosh R., 1995, WHEAT RUSTS ATLAS RU, DOI [10.1071/9780643101463, DOI 10.1071/9780643101463]; Miyashita Y, 2007, PLANT J, V49, P1108, DOI 10.1111/j.1365-313X.2006.03023.x; Molina A, 1997, PLANT MOL BIOL, V33, P803, DOI 10.1023/A:1005712803130; Muthukrishnan S, 2001, PLANT CELL TISS ORG, V64, P93, DOI 10.1023/A:1010763506802; Na R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005631; Naqvi SMS, 1998, PLANT MOL BIOL, V37, P571, DOI 10.1023/A:1006031316476; Naz R, 2014, PHYTOPATHOLOGY, V104, P933, DOI 10.1094/PHYTO-11-13-0317-R; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Ordonez ME, 2009, PHYTOPATHOLOGY, V99, P750, DOI 10.1094/PHYTO-99-6-0750; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Ricoult C, 2006, J EXP BOT, V57, P3079, DOI 10.1093/jxb/erl069; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Silverman IM, 2013, PLANT SCI, V205, P55, DOI 10.1016/j.plantsci.2013.01.009; Stakman EC, 1962, USDA RES SERV PUBL; STATLER GD, 1979, PHYTOPATHOLOGY, V69, P661, DOI 10.1094/Phyto-69-661; STATLER GD, 1977, PHYTOPATHOLOGY, V67, P906, DOI 10.1094/Phyto-67-906; Statler GD, 2000, CAN J PLANT PATHOL, V22, P276, DOI 10.1080/07060660009500475; Wang HB, 2005, J PLANT PHYSIOL, V162, P81, DOI 10.1016/j.jplph.2004.07.006; Wang XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-289; Zhu JT, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0260-0; Zipfel C, 2010, PLANT PHYSIOL, V154, P551, DOI 10.1104/pp.110.161547	45	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198350	10.1371/journal.pone.0198350	http://dx.doi.org/10.1371/journal.pone.0198350			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879135	Green Submitted, gold, Green Published			2022-12-26	WOS:000434384900033
J	Ottensmann, M; Stoffel, MA; Nichols, HJ; Hoffman, JI				Ottensmann, Meinolf; Stoffel, Martin A.; Nichols, Hazel J.; Hoffman, Joseph I.			GCalignR: An R package for aligning gas-chromatography data for ecological and evolutionary studies	PLOS ONE			English	Article							KIN RECOGNITION; ALIGNMENT; ALGORITHM	Chemical cues are arguably the most fundamental means of animal communication and play an important role in mate choice and kin recognition. Consequently, there is growing interest in the use of gas chromatography (GC) to investigate the chemical basis of eco-evolutionary interactions. Both GC-MS (mass spectrometry) and FID (flame ionization detection) are commonly used to characterise the chemical composition of biological samples such as skin swabs. The resulting chromatograms comprise peaks that are separated according to their retention times and which represent different substances. Across chromatograms of different samples, homologous substances are expected to elute at similar retention times. However, random and often unavoidable experimental variation introduces noise, making the alignment of homologous peaks challenging, particularly with GC-FID data where mass spectral data are lacking. Here we present GCalignR, a user-friendly R package for aligning GC-FID data based on retention times. The package was developed specifically for ecological and evolutionary studies that seek to investigate similarity patterns across multiple and often highly variable biological samples, for example representing different sexes, age classes or reproductive stages. The package also implements dynamic visualisations to facilitate inspection and fine-tuning of the resulting alignments and can be integrated within a broader workflow in R to facilitate downstream multivariate analyses. We demonstrate an example workflow using empirical data from Antarctic fur seals and explore the impact of user-defined parameter values by calculating alignment error rates for multiple datasets. The resulting alignments had low error rates for most of the explored parameter space and we could also show that GCalignR performed equally well or better than other available software. We hope that GCalignR will help to simplify the processing of chemical datasets and improve the standardization and reproducibility of chemical analyses in studies of animal chemical communication and related fields.	[Ottensmann, Meinolf; Stoffel, Martin A.; Hoffman, Joseph I.] Bielefeld Univ, Dept Anim Behav, Bielefeld, Germany; [Stoffel, Martin A.; Nichols, Hazel J.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Fac Sci, Liverpool, Merseyside, England	University of Bielefeld; Liverpool John Moores University	Ottensmann, M (corresponding author), Bielefeld Univ, Dept Anim Behav, Bielefeld, Germany.	meinolf.ottensmann@web.de	Hoffman, Joseph i/K-7725-2012; Ottensmann, Meinolf/AAF-2032-2020	Hoffman, Joseph i/0000-0001-5895-8949; Ottensmann, Meinolf/0000-0003-3112-6928; Stoffel, Martin/0000-0003-4030-3543	Deutsche Forschungsgemeinschaft (DFG) [HO 5122/3-1]; Liverpool John Moores University	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Liverpool John Moores University	This research was supported by a Deutsche Forschungsgemeinschaft (DFG) standard Grant (HO 5122/3-1) together with a dual PhD studentship from Liverpool John Moores University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Barbara Caspers and Sarah Goliike for helpful discussions and providing data for testing purposes during the development of the package. This research was supported by a Deutsche Forschungsgemeinschaft (DFG) standard Grant (HO 5122/3-1) to J.I.H. together with a dual PhD studentship from Liverpool John Moores University to M.A.S.	Allaire J. J., 2016, RMARKDOWN DYNAMIC DO; Bloemberg TG, 2013, ANAL CHIM ACTA, V781, P14, DOI 10.1016/j.aca.2013.03.048; Bloemberg TG, 2010, CHEMOMETR INTELL LAB, V104, P65, DOI 10.1016/j.chemolab.2010.04.008; Bonadonna F, 2012, ANIM BEHAV, V84, P509, DOI 10.1016/j.anbehav.2012.06.014; Boulay R, 2007, ANIM BEHAV, V74, P985, DOI 10.1016/j.anbehav.2007.02.013; BREED MD, 1995, ANIM BEHAV, V50, P489, DOI 10.1006/anbe.1995.0263; Burgener N, 2009, ANIM BEHAV, V77, P707, DOI 10.1016/j.anbehav.2008.11.022; Caspers BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021162; Charpentier MJE, 2010, ANIM BEHAV, V80, P101, DOI 10.1016/j.anbehav.2010.04.005; Clarke KR, 2006, MAR ECOL PROG SER, V320, P11, DOI 10.3354/meps320011; Daszykowski M, 2010, J CHROMATOGR A, V1217, P6127, DOI 10.1016/j.chroma.2010.08.008; De Meulemeester T, 2011, INSECT SOC, V58, P227, DOI 10.1007/s00040-011-0146-1; Dellicour S, 2013, J SEP SCI, V36, P3206, DOI 10.1002/jssc.201300388; Eddy SR, 2004, NAT BIOTECHNOL, V22, P909, DOI 10.1038/nbt0704-909; Foitzik S, 2007, ANIM BEHAV, V73, P999, DOI 10.1016/j.anbehav.2006.07.017; Greene LK, 2014, ANIM BEHAV, V88, P147, DOI 10.1016/j.anbehav.2013.11.019; Hoffman JI, 2016, NATURE, V534, P326, DOI 10.1038/534326d; Johnson CA, 2008, ANIM BEHAV, V76, P1965, DOI 10.1016/j.anbehav.2008.09.003; Johnson KJ, 2003, J CHROMATOGR A, V996, P141, DOI 10.1016/S0021-9673(03)00616-2; Jordan NR, 2011, ANIM BEHAV, V81, P31, DOI 10.1016/j.anbehav.2010.07.010; Kirchner M, 2007, J STAT SOFTW, V18, P12, DOI 10.18637/jss.v018.i04; Krause ET, 2012, BIOL LETTERS, V8, P327, DOI 10.1098/rsbl.2011.1093; Lange E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-375; Leclaire S, 2012, P ROY SOC B-BIOL SCI, V279, P1185, DOI 10.1098/rspb.2011.1611; Linstrom P.J, 2009, NIST STANDARD REFERE; Lorenzi MC, 2011, ANIM BEHAV, V82, P1143, DOI 10.1016/j.anbehav.2011.08.011; McNair H. M., 2011, BASIC GAS CHROMATOGR; Oksanen J, 2022, R PACKAGE VERSION; Pierce KM, 2005, J CHROMATOGR A, V1096, P101, DOI 10.1016/j.chroma.2005.04.078; Reichle C, 2013, ANIM BEHAV, V85, P225, DOI 10.1016/j.anbehav.2012.10.029; Scott R., 2003, CHROM ED BOOK SERIES, V1; Setchell JM, 2010, P ROY SOC LOND B BIO; Smith R, 2015, BRIEF BIOINFORM, V16, P104, DOI 10.1093/bib/bbt080; Stoffel MA, 2015, P NATL ACAD SCI USA, V112, pE5005, DOI 10.1073/pnas.1506076112; van Wilgenburg E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053548; Wehrens R, 2015, BIOINFORMATICS, V31, P3063, DOI 10.1093/bioinformatics/btv299; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wong JWY, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1236; Wong JWY, 2014, P ROYAL SOC B; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1	40	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198311	10.1371/journal.pone.0198311	http://dx.doi.org/10.1371/journal.pone.0198311			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879149	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000434384900030
J	Ralston, ME; Myatt, MA				Ralston, Mark E.; Myatt, Mark A.			Weight estimation for children aged 6 to 59 months in limited-resource settings: A proposal for a tape using height and mid upper arm circumference	PLOS ONE			English	Article							AGREEMENT; KAPPA	Importance A simple, reliable tool for rapid estimation of weight in children would be useful in limited resource settings where current weight estimation tools are not reliable, nearly all global under-five mortality occurs, severe acute malnutrition is a significant contributor in approximately one-third of under-five mortality, and a weight scale may not be immediately available to healthcare professionals including first-response providers. Objective To test the accuracy and precision of an existing weight estimation tool based on patient height and mid-upper arm circumference (MUAC) in children between six months and five years of age in low-to-middle income countries. Design Data were collected in 2,434 nutritional surveys during 1992-2017 using a modified Expanded Program of Immunization two-stage cluster design. Setting Locations in 51 low-to-middle income countries with high prevalence of acute and chronic malnutrition. Participants Of 1,848,979 children enrolled in the surveys, a total of 1,800,322 children met inclusion criteria (age 6-59 months; weight <= 25 kg; MUAC 80-200 mm) and exclusion criterion (bilateral pitting edema and biologically implausible measurements based on WHO flagging criteria). Exposures Weight was estimated by a regression procedure using database height and MUAC. Main outcomes and measures Mean percentage difference between true and estimated weight (MPD), proportion of estimates accurate to within 10% and 20% of true weight (PW10 and PW20), weighted Kappa statistic, and Bland-Altman bias (bias) were reported as measures of tool accuracy. Standard deviation (SD) of the MPD and Bland-Altman 95% limits of agreement (LOA) were reported as measures of tool precision. Results The height model fitted for MUAC classes was accurate and precise. MPD was +0.67% (SD = 9.95%); PW10/PW20 were 68.31% (95% CI 68.24%, 68.38%)/94.73% (95% CI 94.69%, 94.76%); and bias (LOA) were +0.06 kg (-1.97 kg; +2.10 kg). For MUAC < 115 mm, PW10/PW20 were 63.91% (95% CI 63.42%, 64.40%)/90.72% (95% CI 90.42%, 91.01%); and bias (LOA) were +0.14 kg (-1.29 kg; +1.56 kg). For 115 mm < MUAC < 125 mm, PW10/ PW20 were 76.27% (95% CI 76.03%, 76.51%)/96.36% (95% CI 96.25%, 96.46%); and bias (LOA) were +0.06 kg (-1.20 kg; +1.33 kg). For MUAC > 125 mm, PW10/PW20 were 69.93% (95% CI 69.86%, 70.00%)/95.27% (95% CI 95.24%, 95.30%); and bias (LOA) were +0.05 kg (-2.04 kg; +2.13 kg). Conclusions and relevance An updated model estimating weight from height and MUAC in a large database of children aged 6 to 59 months across a wide range of low-to-middle income countries with high prevalence of acute and chronic malnutrition was confirmed to be accurate and precise. A height based weight estimation tape stratified according to MUAC classes is proposed for children aged 6-59 months in limited-resource settings.	[Ralston, Mark E.] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA; [Myatt, Mark A.] Brixton Hlth, Llawryglyn, Powys, Wales	Uniformed Services University of the Health Sciences - USA	Ralston, ME (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA.	mark.e.ralston.civ@mail.mil		Ralston, Mark/0000-0001-7740-540X				BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; EVERITT BS, 1968, BRIT J MATH STAT PSY, V21, P97, DOI 10.1111/j.2044-8317.1968.tb00400.x; FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106; Golden M., 2006, MEASURING MORTALITY; HABICHT JP, 1974, B OFIC SANIT PANAM, V75, P375; Huber PJ, 2009, WILEY SERIES PROBABI; Myatt M, 2006, FOOD NUTR BULL, V27, pS7, DOI 10.1177/15648265060273S302; R Core Team, 2021, R LANGUAGE ENV STAT; Ralston ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159260; The World Bank, 2020, GNI PER CAP ATL METH; Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0; Wells M, 2017, INT J EMERG MED, V10, DOI 10.1186/s12245-017-0156-5; WHO, 2006, WHO CHILD GROWTH STA; World Health Organization, 2013, GUID UPD MAN SEV AC; Young KD, 2016, ANN EMERG MED, V68, P441, DOI 10.1016/j.annemergmed.2016.02.043	17	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0197769	10.1371/journal.pone.0197769	http://dx.doi.org/10.1371/journal.pone.0197769			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879127	Green Submitted, Green Published, gold			2022-12-26	WOS:000434384900010
J	Breisjoberget, JI; Odden, M; Wegge, P; Zimmermann, B; Andreassen, H				Breisjoberget, Jo Inge; Odden, Morten; Wegge, Per; Zimmermann, Barbara; Andreassen, Harry			The alternative prey hypothesis revisited: Still valid for willow ptarmigan population dynamics	PLOS ONE			English	Article							FOX VULPES-VULPES; EGG-SIZE VARIATION; RED FOX; CLIMATE-CHANGE; CYCLIC VOLES; NESTING HABITATS; PREDATOR CONTROL; LAGOPUS-LAGOPUS; RODENT DYNAMICS; GROUSE LAGOPUS	The alternative prey hypothesis predicts that the interaction between generalist predators and their main prey is a major driver of population dynamics of alternative prey species. In Fennoscandia, changes in climate and human land use are assumed to alter the dynamics of cyclic small rodents (main prey) and lead to increased densities and range expansion of an important generalist predator, the red fox Vulpes vulpes. In order to better understand the role of these potential changes in community structure on an alternative prey species, willow ptarmigan Lagopus lagopus, we analyzed nine years of population census data from SE Norway to investigate how community interactions affected their population dynamics. The ptarmigan populations showed no declining trend during the study period, and annual variations corresponded with marked periodic small rodent peaks and declines. Population growth and breeding success were highly correlated, and both demographic variables were influenced by an interaction between red fox and small rodents. Red foxes affected ptarmigan negatively only when small rodent abundance was low, which is in accordance with the alternative prey hypothesis. Our results confirm the important role of red fox predation in ptarmigan dynamics, and indicate that if small rodent cycles are disrupted, this may lead to decline in ptarmigan and other alternative prey species due to elevated predation pressure.	[Breisjoberget, Jo Inge; Odden, Morten; Zimmermann, Barbara; Andreassen, Harry] Inland Norway Univ Appl Sci, Fac Appl Ecol & Agr Sci, Campus Evenstad, Koppang, Norway; [Breisjoberget, Jo Inge] Statskog SOE, Norwegian State Owned Land & Forest Enterprise, Namsos, Norway; [Wegge, Per] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway	Inland Norway University of Applied Sciences; Norwegian University of Life Sciences	Breisjoberget, JI (corresponding author), Inland Norway Univ Appl Sci, Fac Appl Ecol & Agr Sci, Campus Evenstad, Koppang, Norway.; Breisjoberget, JI (corresponding author), Statskog SOE, Norwegian State Owned Land & Forest Enterprise, Namsos, Norway.	jo.breisjoberget@inn.no	Zimmermann, Barbara/AAA-2631-2019	Zimmermann, Barbara/0000-0001-5133-9379	Research Council of Norway [210140]; Norwegian State-owned Land and Forest Enterprise	Research Council of Norway(Research Council of Norway); Norwegian State-owned Land and Forest Enterprise	The Research Council of Norway funded JIB and this study with grant number 210140, www.forskningsradet.no. JIB is also employed by the Norwegian State-owned Land and Forest Enterprise and funded through an Industrial Ph.D. scheme, www.statskog.no. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aars J, 2002, ECOLOGY, V83, P3449, DOI 10.1890/0012-9658(2002)083[3449:IACDOP]2.0.CO;2; Anderson DR, 1998, J APPL STAT, V25, P263, DOI 10.1080/02664769823250; ANGELSTAM P, 1984, OECOLOGIA, V62, P199, DOI 10.1007/BF00379014; ANGELSTAM P, 1985, HOLARCTIC ECOL, V8, P285; [Anonymous], 1999, NATL ATLAS NORWAY VE; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bates D., 2008, LME4 LINEAR MIXED EF; BERGERUD A. T., 1988, ADAPTIVE STRATEGIES, VII; BLUMENRATH S, 2010, DATAGRUNNLAG NATURIN, P8; BRITTAS R, 1991, ORNIS SCAND, V22, P261, DOI 10.2307/3676600; Brommer JE, 2010, GLOBAL CHANGE BIOL, V16, P577, DOI 10.1111/j.1365-2486.2009.02012.x; Cavallini P, 1996, REV ECOL-TERRE VIE, V51, P173; Chailleux A, 2014, PEST MANAG SCI, V70, P1769, DOI 10.1002/ps.3916; Chaneton EJ, 2000, OIKOS, V88, P380, DOI 10.1034/j.1600-0706.2000.880217.x; Dahl F., 2005, THESIS; Elmhagen B, 2011, ANN ZOOLOGICI FENNIC; Elmhagen B, 2007, ECOL LETT, V10, P197, DOI 10.1111/j.1461-0248.2006.01010.x; Elmhagen B, 2015, AMBIO, V44, P39, DOI 10.1007/s13280-014-0606-8; ERIKSTAD KE, 1985, ORNIS SCAND, V16, P88, DOI 10.2307/3676472; ESRI, 2018, ARCGIS DESKTOP RELEA; Hagen Y., 1952, ROVFUGLENE VILTPLEIE; Hagen Y., 1969, FAUNA, V22, P126; Hannon SJ, 2006, J ZOOL, V269, P422, DOI 10.1111/j.1469-7998.2006.00159.x; Hannon SJ, 2003, WILDLIFE BIOL, V9, P317, DOI 10.2981/wlb.2003.020; HANSSON L, 1985, OECOLOGIA, V67, P394, DOI 10.1007/BF00384946; Henden JA, 2011, POLAR BIOL, V34, P533, DOI 10.1007/s00300-010-0908-7; Henden JA, 2009, J ANIM ECOL, V78, P636, DOI 10.1111/j.1365-2656.2008.01510.x; Henttonen H, 2001, MAN BIOSPH, V27, P261; HERSTEINSSON P, 1992, OIKOS, V64, P505, DOI 10.2307/3545168; Hornfeldt B, 2004, OIKOS, V107, P376, DOI 10.1111/j.0030-1299.2004.13348.x; Hornfeldt B, 2005, P ROY SOC B-BIOL SCI, V272, P2045, DOI 10.1098/rspb.2005.3141; HORNFELDT B, 1978, OECOLOGIA, V32, P141, DOI 10.1007/BF00366068; Ims RA, 2007, ECOSYSTEMS, V10, P607, DOI 10.1007/s10021-007-9060-9; JEDRZEJEWSKI W, 1992, ECOGRAPHY, V15, P212, DOI 10.1111/j.1600-0587.1992.tb00027.x; Johnsen K, 2017, ECOL EVOL, V7, P115, DOI 10.1002/ece3.2635; Johnsgard P.A, 1983, GROUSE OF THE WORLD; Kauhala K, 2000, ECOGRAPHY, V23, P161, DOI 10.1111/j.1600-0587.2000.tb00271.x; Kauhala K, 1996, ACTA THERIOL, V41, P51, DOI 10.4098/AT.arch.96-4; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Killengreen ST, 2011, J ANIM ECOL, V80, P1049, DOI 10.1111/j.1365-2656.2011.01840.x; Kjellander P, 2003, OIKOS, V101, P338, DOI 10.1034/j.1600-0706.2003.11986.x; Korpimaki E, 2002, P ROY SOC B-BIOL SCI, V269, P991, DOI 10.1098/rspb.2002.1972; Korslund L, 2006, J ANIM ECOL, V75, P156, DOI 10.1111/j.1365-2656.2005.01031.x; Krebs C.J., 2001, ECOSYSTEM DYNAMICS B; Kvasnes MAJ, 2014, J ORNITHOL, V155, P891, DOI 10.1007/s10336-014-1072-6; LINDSTROM E, 1987, OIKOS, V48, P121, DOI 10.2307/3565847; LINDSTROM E, 1988, OIKOS, V52, P115, DOI 10.2307/3565990; LINDSTROM ER, 1994, ECOLOGY, V75, P1042, DOI 10.2307/1939428; Linnell JDC, 1999, WILDLIFE BIOL, V5, P167; MARCSTROM V, 1988, J ANIM ECOL, V57, P859, DOI 10.2307/5097; MARTIN K, 1989, ECOLOGY, V70, P1788, DOI 10.2307/1938112; McKinnon L, 2013, OIKOS, V122, P1042, DOI 10.1111/j.1600-0706.2012.20708.x; MULDER JL, 1985, REV ECOL-TERRE VIE, V40, P133; Munkebye Eli, 2003, Fauna Norvegica, V23, P1; Needham R, 2014, ACTA THERIOL, V59, P391, DOI 10.1007/s13364-014-0188-7; Norwegian Meteorological Institute, MEAN TEMP JUL JAN NO; PARKER H, 1984, J WILDLIFE MANAGE, V48, P1197, DOI 10.2307/3801781; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PEDERSEN HC, 1984, ORNIS SCAND, V15, P197, DOI 10.2307/3675927; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; RANTA E, 1995, J ANIM ECOL, V64, P767, DOI 10.2307/5855; Saether BE, 1996, OIKOS, V77, P217, DOI 10.2307/3546060; Sandercock BK, 2005, ECOLOGY, V86, P2176, DOI 10.1890/04-0563; SANDERCOCK BK, 1994, CAN J ZOOL, V72, P2252, DOI 10.1139/z94-301; Sandercock BK, 2011, J ANIM ECOL, V80, P244, DOI 10.1111/j.1365-2656.2010.01769.x; Selas V, 2006, J ZOOL, V269, P299, DOI 10.1111/j.1469-7998.2006.00048.x; Selas V, 2011, POPUL ECOL, V53, P361, DOI 10.1007/s10144-010-0255-0; SMALL RJ, 1993, ECOGRAPHY, V16, P360, DOI 10.1111/j.1600-0587.1993.tb00225.x; Smedshaug CA, 1999, WILDLIFE BIOL, V5, P157, DOI 10.2981/wlb.1999.020; Smith A, 1999, J WILDLIFE MANAGE, V63, P722, DOI 10.2307/3802662; Steen H, 1996, WILDLIFE BIOL, V2, P27, DOI 10.2981/wlb.1996.005; Steen JB, 2009, WILDLIFE BIOL, V15, P53, DOI 10.2981/07-073; Storaas T, 1999, WILDLIFE BIOL, V5, P187, DOI 10.2981/wlb.1999.016; STORAAS T, 1987, J WILDLIFE MANAGE, V51, P167, DOI 10.2307/3801649; Tannerfeldt M, 2002, OECOLOGIA, V132, P213, DOI 10.1007/s00442-002-0967-8; Tovmo M, 2011, H GAUPEREGISTRERING; TREWHELLA WJ, 1988, J APPL ECOL, V25, P423, DOI 10.2307/2403834; Walton Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175291; WEGGE P, 1990, OECOLOGIA, V82, P527, DOI 10.1007/BF00319796; Wegge P, 2007, ANN ZOOLOGICI FENNIC; Wegge P, 2018, FOREST ECOLOGY MANAG; Wegge P, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1528; Wiebe KL, 1998, ANIM BEHAV, V56, P1137, DOI 10.1006/anbe.1998.0862; WITTENBERGER JF, 1978, CONDOR, V80, P126, DOI 10.2307/1367912	84	17	17	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197289	10.1371/journal.pone.0197289	http://dx.doi.org/10.1371/journal.pone.0197289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874270	Green Published, gold, Green Submitted			2022-12-26	WOS:000434369400017
J	Santos, CC; Coelho, R				Santos, Catarina C.; Coelho, Rui			Migrations and habitat use of the smooth hammerhead shark (Sphyrna zygaena) in the Atlantic Ocean	PLOS ONE			English	Article							PELAGIC LONGLINE FISHERIES; ECOLOGICAL RISK-ASSESSMENT; SATELLITE ARCHIVAL TAGS; EASTERN NORTH-ATLANTIC; TUNA THUNNUS-THYNNUS; XIPHIAS-GLADIUS; SOUTHERN AFRICA; MOVEMENTS; SWORDFISH; TRACKING	The smooth hammerhead shark, Sphyrna zygaena, is a cosmopolitan semipelagic shark captured as bycatch in pelagic oceanic fisheries, especially pelagic longlines targeting swordfish and/or tunas. From 2012 to 2016, eight smooth hammerheads were tagged with Pop-up Satellite Archival Tags in the inter-tropical region of the Northeast Atlantic Ocean, with successful transmissions received from seven tags (total of 319 tracking days). Results confirmed the smooth hammerhead is a highly mobile species, as the longest migration ever documented for this species (> 6600 km) was recorded. An absence of a diel vertical movement behavior was noted, with the sharks spending most of their time at surface waters (0-50 m) above 23 degrees C. The operating depth of the pelagic long-line gear was measured with Minilog Temperature and Depth Recorders, and the overlap with the species vertical distribution was calculated. The overlap is taking place mainly during the night and is higher for juveniles (similar to 40% of overlap time). The novel information presented can now be used to contribute to the provision of sustainable management tools and serve as input for Ecological Risk Assessments for smooth hammerheads caught in Atlantic pelagic longline fisheries.	[Santos, Catarina C.; Coelho, Rui] IP, Portuguese Inst Ocean & Atmosphere, Olhao, Portugal; [Coelho, Rui] Univ Algarve, Ctr Marine Sci CCMAR, Faro, Portugal	Instituto Portugues do Mar e da Atmosfera; Universidade do Algarve	Santos, CC (corresponding author), IP, Portuguese Inst Ocean & Atmosphere, Olhao, Portugal.	catarina.santos@ipma.pt	Fennell, Hannah/AAI-1408-2019; Coelho, Rui/C-1163-2008	Coelho, Rui/0000-0003-3813-5157; Casaca Santos, Catarina/0000-0002-2253-0737	Oceanario de Lisboa through Project "SHARK-TAG: Migrations and habitat use of the smooth hammerhead shark in the Atlantic Ocean"; Investigador-FCT from the Portuguese Foundation for Science and Technology (FCT, Fundacao para a Ciencia e Tecnologia) [Ref: IF/00253/2014]; EU European Social Fund; Programa Operacional Potencial Humano	Oceanario de Lisboa through Project "SHARK-TAG: Migrations and habitat use of the smooth hammerhead shark in the Atlantic Ocean"; Investigador-FCT from the Portuguese Foundation for Science and Technology (FCT, Fundacao para a Ciencia e Tecnologia); EU European Social Fund(European Social Fund (ESF)); Programa Operacional Potencial Humano	Financial support for this study was provided by Oceanario de Lisboa through Project "SHARK-TAG: Migrations and habitat use of the smooth hammerhead shark in the Atlantic Ocean". Rui Coelho is supported by an Investigador-FCT contract (Ref: IF/00253/2014) from the Portuguese Foundation for Science and Technology (FCT, Fundacao para a Ciencia e Tecnologia) supported by the EU European Social Fund and the Programa Operacional Potencial Humano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support for this study was provided by Oceanario de Lisboa through Project "SHARK-TAG: Migrations and habitat use of the smooth hammerhead shark in the Atlantic Ocean". We thank technicians Sergio Goes and Carlos Barbosa, and the crew of the fishing vessel Principe das Mares, for their collaboration in the shark tagging operations. R. Coelho is supported by an Investigador-FCT contract (Ref: IF/00253/2014) from the Portuguese Foundation for Science and Technology (FCT, Fundacao para a Ciencia e Tecnologia) supported by the EU European Social Fund and the Programa Operacional Potencial Humano.	Abascal FJ, 2015, FISH RES, V162, P20, DOI 10.1016/j.fishres.2014.09.011; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2015, NEWS SWFSC; [Anonymous], 2008, SPHYRN ZYG FLOR MUS; [Anonymous], 2015, DATA PORTALS LOCATIO; Bass A.J., 1975, Investigational Rep oceanogr Res Inst Durban, VNo. 38, P1; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bessudo S, 2011, ENVIRON BIOL FISH, V91, P165, DOI 10.1007/s10641-011-9769-3; Biavati G., 2014, RATMOSPHERE STANDARD; Buencuerpo V, 1998, FISH B-NOAA, V96, P667; Camhi MD, 2009, CONSERVATION STATUS; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; Casper B.M., 2005, SPHYRNA ZYGAENA, DOI DOI 10.2305/IUCN.UK.2005.RLTS.T39388A10193797.EN; Clarke S., 2015, REP PAC SHARK LIF HI; Coelho R, 2015, MAR ENVIRON RES, V112, P91, DOI 10.1016/j.marenvres.2015.10.009; Coelho R, 2011, AQUAT LIVING RESOUR, V24, P351, DOI 10.1051/alr/2011145; Compagno L. J. V., 1984, FAO FISHERIES SYNO 2, V4, P553; Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES), 2013, 16 M C PART; Cortes E., 2015, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V71, P2637; Cortes E, 2010, AQUAT LIVING RESOUR, V23, P25, DOI 10.1051/alr/2009044; Dewar H, 2011, FISH OCEANOGR, V20, P219, DOI 10.1111/j.1365-2419.2011.00581.x; Diemer KM, 2011, AFR J MAR SCI, V33, P229, DOI 10.2989/1814232X.2011.600291; Domeier ML, 2005, FISH B-NOAA, V103, P292; Fay MP, 2010, J STAT SOFTW, V36, P1; Fox J, 2011, NA R COMPANION APPL; Francis MP, 2016, NEW ZEAL J MAR FRESH, V50, P506, DOI 10.1080/00288330.2016.1171244; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hays GC, 2007, J EXP MAR BIOL ECOL, V349, P52, DOI 10.1016/j.jembe.2007.04.016; Heithaus MR, 2007, MAR BIOL, V151, P1455, DOI 10.1007/s00227-006-0583-y; Hilborn R, 2003, ANNU REV ENV RESOUR, V28, P359, DOI 10.1146/annurev.energy.28.050302.105509; Hoffmayer ER, 2013, B MAR SCI, P89; Howey-Jordan LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056588; ICCAT, 2016, REP 2 IND PERF REV I; Jorgensen SJ, 2009, J FISH BIOL, V74, P1682, DOI 10.1111/j.1095-8649.2009.02230.x; Ketchum JT, 2009, P GAL SCI S C DARW F, P127; Klimley AP, 2002, ENVIRON BIOL FISH, V63, P117; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; Lemon J., 2006, R R NEWS; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; Mas F., 2014, INT COMM CONS ATL CO, V70, P2441; Musick JA, 2000, FISHERIES, V25, P9, DOI 10.1577/1548-8446(2000)025<0009:MOSATR>2.0.CO;2; Musyl MK, 2011, MAR ECOL PROG SER, V433, P1, DOI 10.3354/meps09202; Musyl MK, 2003, FISH OCEANOGR, V12, P152, DOI 10.1046/j.1365-2419.2003.00229.x; Musyl MK, 2001, ABILITY ELECT ARCH T, P343; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nielsen A., 2012, UKFSST KALMAN FILTER; Olson D., 1994, OCEANOGRAPHY, V7, P52, DOI DOI 10.5670/OCEANOG.1994.03; Omardien A., 2007, WWF REPORT SERIES; Petersen SL, 2009, AFR J MAR SCI, V31, P215, DOI 10.2989/AJMS.2009.31.2.9.881; Poisson F, 2016, AQUAT LIVING RESOUR, V29, DOI 10.1051/alr/2016030; Queiroz N, 2016, P NATL ACAD SCI USA, V113, P1582, DOI 10.1073/pnas.1510090113; Queiroz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032374; Rosa D, 2017, MAR BIOL RES, V13, P300, DOI 10.1080/17451000.2016.1267366; Stevens JD, 2000, ICES J MAR SCI, P57; Stevens JD, 2010, MAR BIOL, V157, P575, DOI 10.1007/s00227-009-1343-6; Teets DA, 2003, COLL MATH J, P34; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0	61	11	11	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198664	10.1371/journal.pone.0198664	http://dx.doi.org/10.1371/journal.pone.0198664			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874297	gold, Green Submitted, Green Published			2022-12-26	WOS:000434369400059
J	Kus, NJ; Dolinska, MB; Young, KL; Dimitriadis, EK; Wingfield, PT; Sergeev, YV				Kus, Nicole J.; Dolinska, Monika B.; Young, Kenneth L., II; Dimitriadis, Emilios K.; Wingfield, Paul T.; Sergeev, Yuri V.			Membrane-associated human tyrosinase is an enzymatically active monomeric glycoprotein	PLOS ONE			English	Article							OCULOCUTANEOUS ALBINISM TYPE-1; HYDROXYLASE; BINDING; BRENDA	Human tyrosinase (hTyr) is a Type 1 membrane bound glycoenzyme that catalyzes the initial and rate-limiting steps of melanin production in the melanosome. Mutations in the Tyr gene are linked to oculocutaneous albinism type 1 (OCA1), an autosomal recessive disorder. Currently, the application of enzyme replacement therapy for a treatment of OCA1 is hampered by the absence of pure hTyr. Here, full-length hTyr (residues 1-529) was overexpressed in Trichoplusia ni larvae infected with a baculovirus, solubilized with detergent and purified using chromatography. Michaelis-Menten kinetics, enzymatic specific activity, and analytical ultracentrifugation were used to compare the hTyr in detergent with the soluble recombinant intra-melanosomal domain, hTyrC(tr) (residues 19-469). Active hTyr is monomeric in detergent micelles suggesting no stable interactions between protein molecules. Both, hTyr and hTyrC(tr), exhibited similar enzymatic activity and ligand affinity in L-DOPA and L-Tyrosine reactions. In addition, expression in larvae is a scalable process that will allow high yield protein production. Thus, larval production of enzymatically active human tyrosinase potentially could be a useful tool in developing a cure for OCA1.	[Kus, Nicole J.; Dolinska, Monika B.; Young, Kenneth L., II; Sergeev, Yuri V.] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Dimitriadis, Emilios K.] Natl Inst Biomed Imaging & Bioengn, Trans NIH Shared Resource Biomed Engn & Phys Sci, NIH, Bethesda, MD USA; [Wingfield, Paul T.] NIAMSD, Prot Express Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Sergeev, YV (corresponding author), NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA.	sergeevy@nih.gov		Wingfield, Paul/0000-0002-9515-4752; Young II, Kenneth/0000-0003-3950-1921	NIH [ZIA EY000476-09]; NATIONAL EYE INSTITUTE [ZIAEY000476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZICEB000085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported by the Intramural Research Program of the NIH, ZIA EY000476-09 to YVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cioaca D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019979; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Dolinska MB, 2018, BIOL CHEM, V399, P73, DOI 10.1515/hsz-2017-0178; Dolinska Monika B, 2017, Curr Protoc Protein Sci, V89, DOI 10.1002/cpps.37; Dolinska MB, 2017, PIGM CELL MELANOMA R, V30, P41, DOI 10.1111/pcmr.12546; Dolinska MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084494; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fogal S, 2015, MOL BIOTECHNOL, V57, P45, DOI 10.1007/s12033-014-9800-y; Ghanem G, 2011, MOL ONCOL, V5, P150, DOI 10.1016/j.molonc.2011.01.006; Gupta G, 2009, GLYCOCONJUGATE J, V26, P691, DOI 10.1007/s10719-008-9213-x; Han HY, 2007, J BIOMOL STRUCT DYN, V25, P165, DOI 10.1080/07391102.2007.10507165; Jeon SH, 2005, B KOREAN CHEM SOC, V26, P1135; Jeong CH, 2004, BIOSCI BIOTECH BIOCH, V68, P1984, DOI 10.1271/bbb.68.1984; Kang S., 1993, J KOREAN BIOCH, V26, P632; Kondo Taisuke, 2011, Expert Rev Dermatol, V6, P97, DOI 10.1586/edm.10.70; Kong KH, 2000, COMP BIOCHEM PHYS B, V125, P563, DOI 10.1016/S0305-0491(00)00163-2; Lai XL, 2017, ANGEW CHEM INT EDIT, V56, P9812, DOI 10.1002/anie.201704616; Lewis RA, 2013, GENEREVIEWS; Lopez-Serrano D, 2007, MICROBIOL-SGM, V153, P2241, DOI 10.1099/mic.0.2007/006833-0; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; Oetting WS, 2003, PIGM CELL RES, V16, P307, DOI 10.1034/j.1600-0749.2003.00045.x; Olivares C, 2002, BIOCHEMISTRY-US, V41, P679, DOI 10.1021/bi011535n; Salom D, 2000, BIOCHEMISTRY-US, V39, P14160, DOI 10.1021/bi001799u; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Sendovski M, 2011, J MOL BIOL, V405, P227, DOI 10.1016/j.jmb.2010.10.048; Shlyakhtenko LS, 2003, ULTRAMICROSCOPY, V97, P279, DOI 10.1016/S0304-3991(03)00053-6; Toyofuku K, 2001, FASEB J, V15, P2149, DOI 10.1096/fj.01-0216com; Vermeer LM, 2013, ANAL BIOCHEM, V432, P11, DOI 10.1016/j.ab.2012.09.005; WINDER AJ, 1991, EUR J BIOCHEM, V198, P317, DOI 10.1111/j.1432-1033.1991.tb16018.x; Young KL, 2018, PLOS ONE; YURKOW EJ, 1989, ARCH BIOCHEM BIOPHYS, V275, P122, DOI 10.1016/0003-9861(89)90356-1	32	10	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0198247	10.1371/journal.pone.0198247	http://dx.doi.org/10.1371/journal.pone.0198247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870551	gold, Green Submitted, Green Published			2022-12-26	WOS:000434128400016
J	Ramalho, JC; Rodrigues, AP; Lidon, FC; Marques, LMC; Leitao, AE; Fortunato, AS; Pais, IP; Silva, MJ; Scotti-Campos, P; Lopes, A; Reboredo, FH; Ribeiro-Barros, AI				Ramalho, Jose C.; Rodrigues, Ana P.; Lidon, Fernando C.; Marques, Luis M. C.; Eduardo Leitao, A.; Fortunato, Ana S.; Pais, Isabel P.; Silva, Maria J.; Scotti-Campos, Paula; Lopes, Antonio; Reboredo, F. H.; Ribeiro-Barros, Ana, I			Stress cross-response of the antioxidative system promoted by superimposed drought and cold conditions in Coffea spp.	PLOS ONE			English	Article							GENE-EXPRESSION; CHLOROPLAST MEMBRANES; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; PLANT-RESPONSES; LOW-TEMPERATURE; WATER-DEFICIT; ELEVATED CO2; L. PLANTS; ACCLIMATION	The understanding of acclimation strategies to low temperature and water availability is decisive to ensure coffee crop sustainability, since these environmental conditions determine the suitability of cultivation areas. In this context, the impacts of single and combined exposure to drought and cold were evaluated in three genotypes of the two major cropped species, Coffea arabica cv. Icatu, Coffea canephora cv. Apoata, and the hybrid Obata. Crucial traits of plant resilience to environmental stresses have been examined: photosynthesis, lipoperoxidation and the antioxidant response. Drought and/or cold promoted leaf dehydration, which was accompanied by stomatal and mesophyll limitations that impaired leaf C-assimilation in all genotypes. However, Icatu showed a lower impact upon stress exposure and a faster and complete photosynthetic recovery. Although lipoperoxidation was increased by drought (Icatu) and cold (all genotypes), it was greatly reduced by stress interaction, especially in Icatu. In fact, although the antioxidative system was reinforced under single drought and cold exposure (e.g., activity of enzymes as Cu,Zn-superoxide dismutase, ascorbate peroxidase, APX, glutathione reductase and catalase, CAT), the stronger increases were observed upon the simultaneous exposure to both stresses, which was accompanied with a transcriptional response of some genes, namely related to APX. Complementary, non-enzyme antioxidant molecules were promoted mostly by cold and the stress interaction, including alpha-tocopherol (in C. arabica plants), ascorbate (ASC), zeaxanthin, and phenolic compounds (all genotypes). In general, drought promoted antioxidant enzymes activity, whereas cold enhanced the synthesis of both enzyme and non-enzyme antioxidants, the latter likely related to a higher need of antioxidative capability when enzyme reactions were probably quite repressed by low temperature. Icatu showed the wider antioxidative capability, with the triggering of all studied antioxidative molecules by drought (except CAT), cold, and, particularly, stress interaction (except ASC), revealing a clear stress cross-tolerance. This justified the lower impacts on membrane lipoperoxidation and photosynthetic capacity under stress interaction conditions, related to a better ROS control. These findings are also relevant to coffee water management, showing that watering in the cold season should be largely avoided.	[Ramalho, Jose C.; Rodrigues, Ana P.; Eduardo Leitao, A.; Fortunato, Ana S.; Silva, Maria J.; Ribeiro-Barros, Ana, I] Univ Lisboa ULisboa, Linking Landscape Environm Agr & Food Unit LEAF, Dept Recursos Nat Ambiente & Terr DRAT, ISA,Plant Environm Interact & Biodivers Lab Plant, Oeiras, Portugal; [Ramalho, Jose C.; Lidon, Fernando C.; Eduardo Leitao, A.; Silva, Maria J.; Reboredo, F. H.; Ribeiro-Barros, Ana, I] Univ NOVA Lisboa UNL, FCT, Unidade Geobiociencias Geoengn & Geotecnol GeoBio, Caparica, Portugal; [Marques, Luis M. C.; Lopes, Antonio] Univ NOVA Lisboa UNL, ITQB, Coloides Polimeros & Superficies, Oeiras, Portugal; [Pais, Isabel P.; Scotti-Campos, Paula] IP INIAV, Inst Nacl Invest Agr & Vet, Unid Invest Biotecnol & Recursos Genet, Oeiras, Portugal	Universidade de Lisboa; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Instituto Nacional de Investigacao Agraria e Veterinaria, IP (INIAV)	Ramalho, JC (corresponding author), Univ Lisboa ULisboa, Linking Landscape Environm Agr & Food Unit LEAF, Dept Recursos Nat Ambiente & Terr DRAT, ISA,Plant Environm Interact & Biodivers Lab Plant, Oeiras, Portugal.; Ramalho, JC (corresponding author), Univ NOVA Lisboa UNL, FCT, Unidade Geobiociencias Geoengn & Geotecnol GeoBio, Caparica, Portugal.	cochichor@mail.telepac.pt	Ribeiro-Barros, Ana/J-4322-2017; Leitao, Antonio/P-5076-2015; Reboredo, Fernando H/C-4092-2012; Ramalho, José C/G-2427-2014; Rodrigues, Ana/AAR-7086-2020; Silva, Maria José/AAJ-8949-2021; Scotti-Campos, Paula/B-7587-2016	Ribeiro-Barros, Ana/0000-0002-6071-6460; Leitao, Antonio/0000-0002-8182-7784; Ramalho, José C/0000-0002-7639-7214; Rodrigues, Ana/0000-0002-9704-6579; Silva, Maria José/0000-0003-0597-3496; REBOREDO, FERNANDO/0000-0002-3906-4349; Scotti-Campos, Paula/0000-0003-0650-4499; Fortunato, Ana/0000-0002-9884-9947; /0000-0002-9694-9602; Marques, Luis/0000-0002-8473-7389	European Regional Development Fund (FEDER); Fundacao para a Ciencia e a Tecnologia - POPH program [PTDC/AGR-AAM/64078/2006, UID/AGR/04129/2013, UID/GEO/04035/2013, SFRH/BPD/47563/2008]; European Social Fund, under the 3rd framework program; Fundação para a Ciência e a Tecnologia [PTDC/AGR-AAM/64078/2006] Funding Source: FCT	European Regional Development Fund (FEDER)(European Commission); Fundacao para a Ciencia e a Tecnologia - POPH program; European Social Fund, under the 3rd framework program; Fundação para a Ciência e a Tecnologia	This work was supported by the European Regional Development Fund (FEDER), and by national funds from Fundacao para a Ciencia e a Tecnologia through the project PTDC/AGR-AAM/64078/2006, the research units UID/AGR/04129/2013 (LEAF) and UID/GEO/04035/2013 (GeoBioTec), as well through the grant SFRH/BPD/47563/2008 (A.S. Fortunato) co-financed through the POPH program subsidized by the European Social Fund, under the 3rd framework program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WW, 2002, PLANT BIOLOGY, V4, P545, DOI 10.1055/s-2002-35434; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Batista-Santos P, 2011, J PLANT PHYSIOL, V168, P792, DOI 10.1016/j.jplph.2010.11.013; BAUER H, 1985, PHYSIOL PLANTARUM, V64, P449, DOI 10.1111/j.1399-3054.1985.tb08521.x; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bunn C, 2015, CLIMATIC CHANGE, V129, P89, DOI 10.1007/s10584-014-1306-x; Campos PS, 2003, J PLANT PHYSIOL, V160, P283, DOI 10.1078/0176-1617-00833; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Dall'Osto L, 2012, J BIOL CHEM, V287, P41820, DOI 10.1074/jbc.M112.405498; DaMatta Fábio M., 2006, Braz. J. Plant Physiol., V18, P55, DOI 10.1590/S1677-04202006000100006; del Rio LA, 2015, J EXP BOT, V66, P2827, DOI 10.1093/jxb/erv099; Dias AS, 2010, J AGRON CROP SCI, V196, P100, DOI 10.1111/j.1439-037X.2009.00398.x; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Ensminger I, 2006, PHYSIOL PLANTARUM, V126, P28, DOI 10.1111/j.1399-3054.2006.00627.x; ESTERBAUER H, 1978, PLANT PHYSIOL, V61, P119, DOI 10.1104/pp.61.1.119; Feierabend J, 2005, BIOL SCI SER, P101, DOI 10.1002/9780470988565.ch5; Fortunato AS, 2010, J PLANT PHYSIOL, V167, P333, DOI 10.1016/j.jplph.2009.10.013; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Goulao LF, 2012, PLANT MOL BIOL REP, V30, P741, DOI 10.1007/s11105-011-0382-6; Grace SC, 2005, BIOL SCI SER, P141, DOI 10.1002/9780470988565.ch6; Guo Z, 2006, PLANT PHYSIOL BIOCH, V44, P828, DOI 10.1016/j.plaphy.2006.10.024; Halliwell B, 2006, PLANT PHYSIOL, V141, P312, DOI 10.1104/pp.106.077073; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Havaux M, 2001, PLANTA, V213, P953, DOI 10.1007/s004250100572; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; ICO, 2014, WORLD COFF TRAD 1963, P111; Joet T, 2010, FOOD CHEM, V118, P693, DOI 10.1016/j.foodchem.2009.05.048; Karpinski SWG, 2002, OXIDATIVE STRESS PLA, P63; KATO M, 1987, CAN J BOT, V65, P729, DOI 10.1139/b87-097; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Krause G.H., 1994, PHOTOINHIBITION PHOT, P331, DOI 10.1017/ S0021859600071434; Li SX, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01259; Lichtenthaler HK, 2004, ADV PHOTO RESPIRAT, V19, P713; Lima ALS, 2002, ENVIRON EXP BOT, V47, P239, DOI 10.1016/S0098-8472(01)00130-7; Logan BA, 2005, BIOL SCI SER, P250, DOI 10.1002/9780470988565.ch10; Magrach A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133071; Marais DLD, 2017, NEW PHYTOL, V214, P132, DOI 10.1111/nph.14316; Marraccini P, 2012, J EXP BOT, V63, P4191, DOI 10.1093/jxb/ers103; Martins LD, 2014, CLIMATIC CHANGE, V126, P365, DOI 10.1007/s10584-014-1236-7; Martins MQ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00947; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Mondego JMC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-30; Mondolot L, 2006, ANN BOT-LONDON, V98, P33, DOI 10.1093/aob/mcl080; Munne-Bosch S, 2006, J PHOTOCH PHOTOBIO B, V85, P191, DOI 10.1016/j.jphotobiol.2006.07.007; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Ovalle-Rivera O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124155; Partelli FL, 2011, ENVIRON EXP BOT, V74, P194, DOI 10.1016/j.envexpbot.2011.06.001; Pendergrast Mark., 2010, UNCOMMON GROUNDS HIS; Pompelli MF, 2010, J PLANT PHYSIOL, V167, P1052, DOI 10.1016/j.jplph.2010.03.001; Preston JC, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00167; Queiroz CGS, 1998, BIOL PLANTARUM, V41, P403, DOI 10.1023/A:1001802528068; Ramalho JC, 2014, THEOR EXP PLANT PHYS, V26, P5, DOI 10.1007/s40626-014-0001-7; Ramalho JC, 2014, PLANT BIOLOGY, V16, P133, DOI 10.1111/plb.12018; Ramalho JC, 2013, BIOL PLANTARUM, V57, P495, DOI 10.1007/s10535-013-0329-x; Ramalho JC, 2003, PLANT BIOLOGY, V5, P631, DOI 10.1055/s-2003-44688; Ramalho JC, 1998, PLANT SCI, V135, P115, DOI 10.1016/S0168-9452(98)00073-9; Ramalho JC, 2000, AUST J PLANT PHYSIOL, V27, P43, DOI 10.1071/PP99013; Ramalho JC, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00287; Ramalho JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082712; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Rodrigues WP, 2016, GLOBAL CHANGE BIOL, V22, P415, DOI 10.1111/gcb.13088; ROMERO-RODRIGUEZ A, 1992, SCI ALIMENT, V12, P593; Rozen S, 2000, Methods Mol Biol, V132, P365; SARUYAMA H, 1995, PLANT SCI, V109, P105, DOI 10.1016/0168-9452(95)04156-O; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; Scotti-Campos P, 2016, J PLANT PHYSIOL, V196-197, P60, DOI 10.1016/j.jplph.2016.03.012; Scotti-Campos P, 2014, J PLANT PHYSIOL, V171, P243, DOI 10.1016/j.jplph.2013.07.007; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Silva EA, 2004, FIELD CROP RES, V89, P349, DOI 10.1016/j.fcr.2004.02.010; Silva PEM, 2013, ENVIRON EXP BOT, V87, P49, DOI 10.1016/j.envexpbot.2012.09.005; Singh DV, 2001, BIOL PLANTARUM, V44, P141, DOI 10.1023/A:1017955328875; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Smirnoff N, 2005, BIOL SCI SER, P53, DOI 10.1002/9780470988565.ch3; Dinh SN, 2016, J PLANT PHYSIOL, V201, P85, DOI 10.1016/j.jplph.2016.07.004; Takahama U, 1997, PHYSIOL PLANTARUM, V101, P845; Van Buskirk HA, 2006, PHYSIOL PLANTARUM, V126, P72, DOI 10.1111/j.1399-3054.2006.00625.x; van der Vossen H, 2015, EUPHYTICA, V204, P243, DOI 10.1007/s10681-015-1398-z; van Heerden PDR, 2002, J PLANT PHYSIOL, V159, P1077, DOI 10.1078/0176-1617-00745; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidal RO, 2010, PLANT PHYSIOL, V154, P1053, DOI 10.1104/pp.110.162438; Waller J. M., 2007, Coffee pests, diseases and their management, DOI [10.1079/9781845931292.0017, 10.1079/9781845931292.0000]; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Way DA, 2015, PLANT CELL ENVIRON, V38, P991, DOI 10.1111/pce.12527; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zheng C, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01858; Zlatev ZS, 2006, BIOL PLANTARUM, V50, P389, DOI 10.1007/s10535-006-0054-9	91	33	34	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0198694	10.1371/journal.pone.0198694	http://dx.doi.org/10.1371/journal.pone.0198694			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870563	Green Published, Green Submitted, gold			2022-12-26	WOS:000434128400034
J	Imae, R; Manya, H; Tsumoto, H; Osumi, K; Tanaka, T; Mizuno, M; Kanagawa, M; Kobayashi, K; Toda, T; Endo, T				Imae, Rieko; Manya, Hiroshi; Tsumoto, Hiroki; Osumi, Kenji; Tanaka, Tomohiro; Mizuno, Mamoru; Kanagawa, Motoi; Kobayashi, Kazuhiro; Toda, Tatsushi; Endo, Tamao			CDP-glycerol inhibits the synthesis of the functional O-mannosyl glycan of -dystroglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylation; glycosyltransferase; dystroglycan; enzyme catalysis; glycobiology; fukutin; protein glycosylation; -dystroglycanopathy; CDP-glycerol; muscular dystrophy	ALPHA-DYSTROGLYCAN; RIBITOL-PHOSPHATE; MUSCULAR-DYSTROPHY; GLYCOSYLATION; REQUIRES; MAMMALS; FKRP; ISPD	alpha-Dystroglycan (-DG) is a highly glycosylated cell-surface laminin receptor. Defects in the O-mannosyl glycan of an -DG with laminin-binding activity can cause -dystroglycanopathy, a group of congenital muscular dystrophies. In the biosynthetic pathway of functional O-mannosyl glycan, fukutin (FKTN) and fukutin-related protein (FKRP), whose mutated genes underlie -dystroglycanopathy, sequentially transfer ribitol phosphate (RboP) from CDP-Rbo to form a tandem RboP unit (RboP-RboP) required for the synthesis of the laminin-binding epitope on O-mannosyl glycan. Both RboP- and glycerol phosphate (GroP)-substituted glycoforms have recently been detected in recombinant -DG. However, it is unclear how GroP is transferred to the O-mannosyl glycan or whether GroP substitution affects the synthesis of the O-mannosyl glycan. Here, we report that, in addition to having RboP transfer activity, FKTN and FKRP can transfer GroP to O-mannosyl glycans by using CDP-glycerol (CDP-Gro) as a donor substrate. Kinetic experiments indicated that CDP-Gro is a less efficient donor substrate for FKTN than is CDP-Rbo. We also show that the GroP-substituted glycoform synthesized by FKTN does not serve as an acceptor substrate for FKRP and that therefore further elongation of the outer glycan chain cannot occur with this glycoform. Finally, CDP-Gro inhibited the RboP transfer activities of both FKTN and FKRP. These results suggest that CDP-Gro inhibits the synthesis of the functional O-mannosyl glycan of -DG by preventing further elongation of the glycan chain. This is the first report of GroP transferases in mammals.	[Imae, Rieko; Manya, Hiroshi; Endo, Tamao] Tokyo Metropolitan Geriatr Hosp & Inst Gerontol, Mol Glycobiol, Res Team Mech Aging, Tokyo 1730015, Japan; [Tsumoto, Hiroki] Tokyo Metropolitan Geriatr Hosp & Inst Gerontol, Proteome Res, Res Team Mech Aging, Tokyo 1730015, Japan; [Osumi, Kenji; Tanaka, Tomohiro; Mizuno, Mamoru] Noguchi Inst, Lab Glycoorgan Chem, Tokyo 1730003, Japan; [Kanagawa, Motoi; Kobayashi, Kazuhiro; Toda, Tatsushi] Kobe Univ, Div Neurol Mol Brain Sci, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Toda, Tatsushi] Univ Tokyo, Grad Sch Med, Dept Neurol, Div Neurosci, Tokyo 1138655, Japan	Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology; Kobe University; University of Tokyo	Manya, H (corresponding author), Tokyo Metropolitan Geriatr Hosp & Inst Gerontol, Mol Glycobiol, Res Team Mech Aging, Tokyo 1730015, Japan.	manya@tmig.or.jp	Kobayashi, Kazuhiro/AAH-8638-2021	Kobayashi, Kazuhiro/0000-0001-7801-147X; Kanagawa, Motoi/0000-0003-0984-6398; Manya, Hiroshi/0000-0003-1573-9177	National Center of Neurology and Psychiatry Intramural Research Grant [29-4]; Japan Agency for Medical Research and Development Grants [JP18gm0810010, JP18ek0109197]; Japan Society for the Promotion of Science [JP17H03987, JP16K08262]; Ministry of Education, Culture, Sports, Science and Technology of Japan [JP17919697]	National Center of Neurology and Psychiatry Intramural Research Grant; Japan Agency for Medical Research and Development Grants(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by National Center of Neurology and Psychiatry Intramural Research Grant 29-4 (to T. Toda and T. E.), Japan Agency for Medical Research and Development Grants JP18gm0810010 and JP18ek0109197 (to H. M. and M. K.), Japan Society for the Promotion of Science Grants JP17H03987 (to H. M.) and JP16K08262 (to T. E.), and Ministry of Education, Culture, Sports, Science and Technology of Japan Grant JP17919697 (to M. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Akhavan A, 2012, CANCER RES, V72, P2578, DOI 10.1158/0008-5472.CAN-11-3732; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; de Bernabe DBV, 2009, J BIOL CHEM, V284, P11279, DOI 10.1074/jbc.C900007200; Esser AK, 2013, J BIOL CHEM, V288, P2132, DOI 10.1074/jbc.M112.432807; Gerin I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11534; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kanagawa M, 2018, J BIOCHEM, V163, P359, DOI 10.1093/jb/mvy020; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2017, BBA-GEN SUBJECTS, V1861, P2462, DOI 10.1016/j.bbagen.2017.06.024; Manya H, 2016, J BIOL CHEM, V291, P24618, DOI 10.1074/jbc.M116.751917; PARK YS, 1993, J BIOL CHEM, V268, P16648; Praissman JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14473; Praissman JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03943; Riemersma M, 2015, CHEM BIOL, V22, P1643, DOI 10.1016/j.chembiol.2015.10.014; Rodrigues MV, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02462-16; Sheikh MO, 2017, GLYCOBIOLOGY, V27, P806, DOI 10.1093/glycob/cwx062; Willer T, 2014, ELIFE, V3, DOI 10.7554/eLife.03941; Yagi H, 2016, MOL CELL PROTEOMICS, V15, P3424, DOI 10.1074/mcp.M116.062729; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951	22	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12186	12198		10.1074/jbc.RA118.003197	http://dx.doi.org/10.1074/jbc.RA118.003197			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29884773	hybrid, Green Published			2022-12-26	WOS:000440803200017
J	Cai, N; Lou, LP; Al-Saadi, N; Tetteh, S; Runnels, LW				Cai, Na; Lou, Liping; Al-Saadi, Namariq; Tetteh, Sandra; Runnels, Loren W.			The kinase activity of the channel-kinase protein TRPM7 regulates stability and localization of the TRPM7 channel in polarized epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transient receptor potential channels (TRP channels); ion channel; protein kinase; phosphorylation; 14-3-3 protein; proteosome-mediated turnover; transient receptor potential cation channel subfamily M member 7; TRPM7	CELLULAR MG2+ HOMEOSTASIS; SECONDARY HYPOCALCEMIA; ION-CHANNEL; PHOSPHORYLATION SITES; DUAL PHOSPHORYLATION; SURFACE EXPRESSION; IDENTIFICATION; HYPOMAGNESEMIA; NEURONS; BINDING	The channel-kinase transient receptor potential melastatin 7 (TRPM7) is a bifunctional protein with ion channel and kinase domains. The kinase activity of TRPM7 has been linked to the regulation of a broad range of cellular activities, but little is understood as to how the channel itself is regulated by its own kinase activity. Here, using several mammalian cell lines expressing WT TRPM7 or kinase-inactive variants, we discovered that compared with the cells expressing WT TRPM7, cells in which TRPM7's kinase activity was inactivated had faster degradation, elevated ubiquitination, and increased intracellular retention of the channel. Mutational analysis of TRPM7 autophosphorylation sites further revealed a role for Ser-1360 of TRPM7 as a key residue mediating both TRPM7 stability and intracellular trafficking. Additional trafficking roles were uncovered for Ser-1403 and Ser-1567, whose phosphorylation by TRPM7's kinase activity mediated the interaction of the channel with the signaling protein 14-3-3. In summary, our results point to a critical role for TRPM7's kinase activity in regulating proteasome-mediated turnover of the TRPM7 channel and controlling its cellular localization in polarized epithelial cells. Overall, these findings improve our understanding of the significance of TRPM7's kinase activity for functional regulation of its channel activity.	[Cai, Na; Lou, Liping; Al-Saadi, Namariq; Tetteh, Sandra; Runnels, Loren W.] Rutgers Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Al-Saadi, Namariq] Univ Misan, Amarah 62001, Iraq	Rutgers State University New Brunswick; Rutgers State University Medical Center; Misan University	Runnels, LW (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	runnellw@rwjms.rutgers.edu	Cai, Na/L-4951-2019	Cai, Na/0000-0002-7548-4359; Runnels, Loren/0000-0002-2537-7360	NIGMS, National Institutes of Health [GM080753]; New Jersey Commission on Brain Injury Research Grant [CBIR13IRG025]; American Heart Association [15PRE24890008, 17PRE33410172]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080753] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); New Jersey Commission on Brain Injury Research Grant; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant GM080753, New Jersey Commission on Brain Injury Research Grant CBIR13IRG025 (to L. W. R.), and American Heart Association Predoctoral Fellowships 15PRE24890008 (to N. C.) and 17PRE33410172 (to L. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Abiria SA, 2017, P NATL ACAD SCI USA, V114, pE6079, DOI 10.1073/pnas.1707380114; Brandao K, 2014, CELL MOL LIFE SCI, V71, P4853, DOI 10.1007/s00018-014-1647-7; Cai N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42739; Cho CH, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0052-3; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Clark K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001876; Clark K, 2008, J MOL BIOL, V378, P790, DOI 10.1016/j.jmb.2008.02.057; COURJAULT F, 1991, CELL BIOL INT REP, V15, P1225, DOI 10.1016/0309-1651(91)90094-Y; Crawley SW, 2009, BIOCHEM J, V420, P115, DOI 10.1042/BJ20081405; Deason-Towne F, 2012, CELL SIGNAL, V24, P2070, DOI 10.1016/j.cellsig.2012.06.015; Decker AR, 2014, DEV BIOL, V386, P428, DOI 10.1016/j.ydbio.2013.11.015; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Dorovkov MV, 2004, J BIOL CHEM, V279, P50643, DOI 10.1074/jbc.C400441200; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Elizondo MR, 2010, ENDOCRINOLOGY, V151, P5700, DOI 10.1210/en.2010-0853; Elizondo MR, 2005, CURR BIOL, V15, P667, DOI 10.1016/j.cub.2005.02.050; Fernandez-Orth J, 2017, TRAFFIC, V18, P29, DOI 10.1111/tra.12455; Gabriel L, 2012, J BIOL CHEM, V287, P32354, DOI 10.1074/jbc.M112.391458; Gotru SK, 2018, ARTERIOSCL THROM VAS, V38, P344, DOI 10.1161/ATVBAHA.117.310391; ICHIMURA T, 1988, P NATL ACAD SCI USA, V85, P7084, DOI 10.1073/pnas.85.19.7084; Ichimura T, 1997, FEBS LETT, V413, P273, DOI 10.1016/S0014-5793(97)00910-1; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Jin J, 2012, P NATL ACAD SCI USA, V109, pE225, DOI 10.1073/pnas.1120033109; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kaitsuka T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05718; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kilisch M, 2016, J CELL SCI, V129, P831, DOI 10.1242/jcs.180182; Kim TY, 2012, BIOCHEM BIOPH RES CO, V417, P1030, DOI 10.1016/j.bbrc.2011.12.085; Komiya Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15855-y; Krapivinsky G, 2014, CELL, V157, P1061, DOI 10.1016/j.cell.2014.03.046; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; LEIGHTON J, 1970, CANCER-AM CANCER SOC, V26, P1022, DOI 10.1002/1097-0142(197011)26:5<1022::AID-CNCR2820260509>3.0.CO;2-M; Liu W, 2011, DEV BIOL, V350, P348, DOI 10.1016/j.ydbio.2010.11.034; Low SE, 2011, J NEUROSCI, V31, P11633, DOI 10.1523/JNEUROSCI.4950-10.2011; LUO ZJ, 1995, J BIOL CHEM, V270, P23681, DOI 10.1074/jbc.270.40.23681; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; McNeill MS, 2007, J INVEST DERMATOL, V127, P2020, DOI 10.1038/sj.jid.5700710; Middelbeek J, 2012, CANCER RES, V72, P4250, DOI 10.1158/0008-5472.CAN-11-3863; Moeller HB, 2016, J BIOL CHEM, V291, P2469, DOI 10.1074/jbc.M115.691121; Mohammad DK, 2013, MOL CELL BIOL, V33, P3214, DOI 10.1128/MCB.00247-13; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Ogata K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18291-0; Ogunrinde A, 2017, DIFFERENTIATION, V96, P15, DOI 10.1016/j.diff.2017.06.001; Overton JD, 2015, SCI REP-UK, V5, DOI 10.1038/srep18395; Perraud AL, 2011, CELL SIGNAL, V23, P586, DOI 10.1016/j.cellsig.2010.11.011; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Romagnani A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01960-z; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanova LV, 2014, SCI REP-UK, V4, DOI 10.1038/srep07599; Ryazanova LV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1108; Ryazanova LV, 2004, J BIOL CHEM, V279, P3708, DOI 10.1074/jbc.M308820200; Ryazanova LV, 2001, MOL BIOL+, V35, P271, DOI 10.1023/A:1010499720185; Sahni J, 2008, CELL METAB, V8, P84, DOI 10.1016/j.cmet.2008.06.002; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Stritt S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11097; Su LT, 2011, BIOCHEM J, V434, P513, DOI 10.1042/BJ20101678; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; TRAXLER B, 1992, P NATL ACAD SCI USA, V89, P10852, DOI 10.1073/pnas.89.22.10852; Van der Hoeven PCJ, 2000, BIOCHEM J, V345, P297, DOI 10.1042/0264-6021:3450297; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yee NS, 2011, DIS MODEL MECH, V4, P240, DOI 10.1242/dmm.004564; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717; Zierler S, 2016, J PHYSIOL-LONDON, V594, P2957, DOI 10.1113/JP271564	72	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11491	11504		10.1074/jbc.RA118.001925	http://dx.doi.org/10.1074/jbc.RA118.001925			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29866880	Green Published, hybrid			2022-12-26	WOS:000439449700019
J	Agosta, SJ; Joshi, KA; Kester, KM				Agosta, Salvatore J.; Joshi, Kanchan A.; Kester, Karen M.			Upper thermal limits differ among and within component species in a tritrophic hostparasitoid-hyperparasitoid system	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; MANDUCA-SEXTA CATERPILLARS; CLIMATE-CHANGE; SUPRAOPTIMAL TEMPERATURES; FLUCTUATING TEMPERATURES; PHENOLOGICAL ASYNCHRONY; TERRESTRIAL ECTOTHERMS; METHODOLOGICAL CONTEXT; LEPIDOPTERA-SPHINGIDAE; PARASITE INTERACTIONS	Understanding how climate change affects host-parasite systems and predicting the consequences for ecosystems, economies, and human health has emerged as an important task for science and society. Some basic insight into this complex problem can be gained by comparing the thermal physiology of interacting host and parasite species. In this study, we compared upper thermal tolerance among three component species in a natural host-parasitoid-hyperparasitoid system from Virginia, USA. To assess the ecological relevance of our results, we also examined a record of maximum daily air temperatures collected near the study site in the last 124 years. We found that the caterpillar host Manduca sexta had a critical thermal maximum (CTmax) about 4 C higher than the parasitic wasp, Cotesia congregata, and the hyperparasitic wasp, Conura sp., had a CTmax about 6 degrees C higher than its host, C. congregata. We also found significant differences in CTmax among instars and between parasitized and non-parasitized M. sexta. The highest maximum daily air temperature recorded near the study in the last 124 years was 42 C, which equals the average CTmax of one species (C. congregata) but is several degrees lower than the average CTmax of the other two species (M. sexta, Conura sp.) in this study. Our results combined with other studies suggest that significant differences in thermal performance within and among interacting host and parasite species are common in nature and that climate change may be largely disruptive to these systems with responses that are highly variable and complex.	[Agosta, Salvatore J.] Virginia Commonwealth Univ, Ctr Environm Studies, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Agosta, Salvatore J.; Joshi, Kanchan A.; Kester, Karen M.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA	Virginia Commonwealth University; Virginia Commonwealth University	Agosta, SJ (corresponding author), Virginia Commonwealth Univ, Ctr Environm Studies, Med Coll Virginia Campus, Richmond, VA 23284 USA.; Agosta, SJ (corresponding author), Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA.	sagosta@vnu.edu		Kester, Karen M/0000-0001-6052-7806	Presidential Research Quest Fund (PRQF) from Virginia Commonwealth University	Presidential Research Quest Fund (PRQF) from Virginia Commonwealth University	This work was supported by a Presidential Research Quest Fund (PRQF) from Virginia Commonwealth University awarded to SJA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2017, J ANIM ECOL, V86, P590, DOI 10.1111/1365-2656.12647; Agosta SJ, 2010, ZOOLOGIA-CURITIBA, V27, P151, DOI 10.1590/S1984-46702010000200001; Bahar MH, 2012, ENVIRON ENTOMOL, V41, P1653, DOI 10.1603/EN12156; Bahar MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073901; Bakken GS, 2014, FUNCT ECOL, V28, P96, DOI 10.1111/1365-2435.12149; Bannerman JA, 2014, OIKOS, V123, P89, DOI 10.1111/j.1600-0706.2013.00686.x; Bates AE, 2011, OECOLOGIA, V167, P613, DOI 10.1007/s00442-011-2014-0; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Beckage NE, 2008, INSECT IMMUNOLOGY, P243, DOI 10.1016/B978-012373976-6.50012-4; BECKAGE NE, 1994, ARCH INSECT BIOCHEM, V26, P165, DOI 10.1002/arch.940260209; Bonebrake TC, 2012, ECOLOGY, V93, P449, DOI 10.1890/11-1187.1; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; Brooks DR, 2007, TRENDS PARASITOL, V23, P571, DOI 10.1016/j.pt.2007.08.016; Brooks DR, 2005, J BIOGEOGR, V32, P1291, DOI 10.1111/j.1365-2699.2005.01315.x; Brooks DR, 1993, PARASCRIPT PARASITES; Bruneaux M, 2017, FUNCT ECOL, V31, P216, DOI 10.1111/1365-2435.12701; Buckley LB, 2016, GLOBAL CHANGE BIOL, V22, P3829, DOI 10.1111/gcb.13313; Buckley LB, 2016, INTEGR COMP BIOL, V56, P98, DOI 10.1093/icb/icw004; CAMPBELL A, 1974, J APPL ECOL, V11, P431, DOI 10.2307/2402197; CASEY TM, 1976, ECOLOGY, V57, P485, DOI 10.2307/1936433; Chown SL, 2015, CURR OPIN INSECT SCI, V11, P78, DOI 10.1016/j.cois.2015.09.012; Chown SL, 2009, FUNCT ECOL, V23, P133, DOI 10.1111/j.1365-2435.2008.01481.x; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Diamond SE, 2012, GLOBAL CHANGE BIOL, V18, P448, DOI 10.1111/j.1365-2486.2011.02542.x; Dyer LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062528; Epstein PR, 2001, MICROBES INFECT, V3, P747, DOI 10.1016/S1286-4579(01)01429-0; FULTON B. B., 1940, ANN ENT SOC AMERICA, V33, P231, DOI 10.1093/aesa/33.2.231; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; GODFRAY HCJ, 1994, J ANIM ECOL, V63, P1, DOI 10.2307/5577; Gsell AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071737; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; HANSEN J D, 1980, Journal of the Kansas Entomological Society, V53, P553; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Hassell M.P., 2000, SPATIAL TEMPORAL DYN; Hoberg EP, 2017, J HELMINTHOL, V91, P409, DOI 10.1017/S0022149X17000347; Hoberg EP, 2008, J BIOGEOGR, V35, P1533, DOI 10.1111/j.1365-2699.2008.01951.x; HODGES R. W., 1971, MOTHS AM N MEXICO, V21; Hoffmann AA, 2013, FUNCT ECOL, V27, P934, DOI 10.1111/j.1365-2435.2012.02036.x; Hoover JK, 2004, GLOBAL CHANGE BIOL, V10, P1197, DOI 10.1111/j.1529-8817.2003.00796.x; Hughes GE, 2010, PHYSIOL ENTOMOL, V35, P373, DOI 10.1111/j.1365-3032.2010.00754.x; Kawahara AY, 2013, MOL PHYLOGENET EVOL, V68, P381, DOI 10.1016/j.ympev.2013.04.017; Kellermann V, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0447; Kellermann V, 2012, P NATL ACAD SCI USA, V109, P16228, DOI 10.1073/pnas.1207553109; Kester KM, 2015, ANN ENTOMOL SOC AM, V108, P1014, DOI 10.1093/aesa/sav088; KESTER KM, 1994, OECOLOGIA, V99, P151, DOI 10.1007/BF00317096; Kingsolver JG, 1997, PHYSIOL ZOOL, V70, P631, DOI 10.1086/515872; Kingsolver JG, 2000, PHYSIOL BIOCHEM ZOOL, V73, P621, DOI 10.1086/317758; Kingsolver JG, 2007, PHYSIOL BIOCHEM ZOOL, V80, P473, DOI 10.1086/519962; Kingsolver JG, 2013, FUNCT ECOL, V27, P1415, DOI 10.1111/1365-2435.12145; Kingsolver JG, 2011, INTEGR COMP BIOL, V51, P719, DOI 10.1093/icb/icr015; Klapwijk MJ, 2010, GLOBAL CHANGE BIOL, V16, P102, DOI 10.1111/j.1365-2486.2009.01918.x; Kutz Susan J., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P198, DOI 10.1016/j.ijppaw.2014.01.002; KV Krombein, 1979, CATALOG HYMENOPTERA, VI; Lighton JRB, 2004, J EXP BIOL, V207, P1903, DOI 10.1242/jeb.00970; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1553, DOI 10.1139/z97-782; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; Madden A. H., 1945, BIOL TOBACCO HORNWOR; Martinez E, 2017, PHYSIOL BIOCHEM ZOOL, V90, P294, DOI 10.1086/689871; MCNEIL JN, 1973, CAN ENTOMOL, V105, P1041, DOI 10.4039/Ent1051041-8; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Meissner K, 2000, MAR ECOL PROG SER, V202, P143, DOI 10.3354/meps202143; Menne MJ, 2012, J ATMOS OCEAN TECH, V29, P897, DOI 10.1175/JTECH-D-11-00103.1; Menne MJ, 2012, GLOBAL HIST CLIMATOL, Patent No. 510015; Moore J, 2002, OECOLOGIA, V133, P261, DOI 10.1007/s00442-002-1030-5; MULLENS BA, 1995, J NEMATOL, V27, P29; MULLER CB, 1993, NATURE, V363, P65, DOI 10.1038/363065a0; NEALIS VG, 1984, OECOLOGIA, V61, P224, DOI 10.1007/BF00396765; Paranjpe DA, 2014, INTEGR COMP BIOL, V54, P108, DOI 10.1093/icb/icu069; Petersen C, 2000, PHYSIOL ENTOMOL, V25, P35, DOI 10.1046/j.1365-3032.2000.00163.x; Pincebourde S, 2012, FUNCT ECOL, V26, P844, DOI 10.1111/j.1365-2435.2012.02013.x; Price P. W., 1980, EVOLUTIONARY BIOL PA; Rice AD, 2009, AUST J ENTOMOL, V48, P282, DOI 10.1111/j.1440-6055.2009.00717.x; Roitberg BD, 2016, ECOL ENTOMOL, V41, P653, DOI 10.1111/een.12324; Sherman E, 2008, J THERM BIOL, V33, P27, DOI 10.1016/j.jtherbio.2007.09.005; Sinclair BJ, 2016, ECOL LETT, V19, P1372, DOI 10.1111/ele.12686; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; Thomas MB, 2003, TRENDS ECOL EVOL, V18, P344, DOI 10.1016/S0169-5347(03)00069-7; Thompson LM, 2017, PHYSIOL ENTOMOL, V42, P181, DOI 10.1111/phen.12190; Thomson LJ, 2010, BIOL CONTROL, V52, P296, DOI 10.1016/j.biocontrol.2009.01.022; Tilson WM, 2002, INFORM SERIES, V02-2; van Baaren J, 2010, APHID BIODIVERSITY UNDER ENVIRONMENTAL CHANGE: PATTERNS AND PROCESSES, P55; Van Nouhuys S, 2004, J ANIM ECOL, V73, P526, DOI 10.1111/j.0021-8790.2004.00827.x; Vasseur DA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2612; VERNBERG WB, 1963, EXP PARASITOL, V14, P330, DOI 10.1016/0014-4894(63)90039-0; Wang XG, 2012, BIOL CONTROL, V60, P247, DOI 10.1016/j.biocontrol.2011.11.012; Welsh D, 2006, J PARASITOL, V92, P764, DOI 10.1645/GE-741R.1; Williams CM, 2016, INTEGR COMP BIOL, V56, P73, DOI 10.1093/icb/icw013; WILLMER PG, 1982, ADV INSECT PHYSIOL, V16, P1, DOI 10.1016/S0065-2806(08)60151-4; Woodhams DC, 2000, CAN J ZOOL, V78, P1085, DOI 10.1139/cjz-78-6-1085; Woods HA, 2013, FUNCT ECOL, V27, P1322, DOI 10.1111/1365-2435.12124	92	16	16	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198803	10.1371/journal.pone.0198803	http://dx.doi.org/10.1371/journal.pone.0198803			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894508	Green Submitted, Green Published, gold			2022-12-26	WOS:000435030900029
J	Arnold, RJG; Yang, S; Gold, EJ; Farahbakhshian, S; Sheehan, JJ				Arnold, Renee J. G.; Yang, Shuo; Gold, Edward J.; Farahbakhshian, Sepehr; Sheehan, John J.			Assessment of the relationship between diabetes treatment intensification and quality measure performance using electronic medical records	PLOS ONE			English	Article							CLINICAL INERTIA; GLYCEMIC CONTROL; CARE; PREDICTORS; PATIENT; MANAGEMENT; MELLITUS; THERAPY; COHORT; A1C	Aims Assess the relationship between timely treatment intensification and hemoglobin A1C (HbA1C) control quality-of-care performance measures, i.e., HbA1C levels, among patients with uncontrolled type 2 diabetes. Materials and methods Electronic medical records and diabetes registry data from a large, accountable care organization (ACO) were used to isolate a sample of adult patients with type 2 diabetes who received at least one oral antidiabetes agent and had at least one HbA1C level measurement >= 8.0% (64 mmol/mol; i.e., uncontrolled diabetes) between 7/1/2011 and 6/30/2015. Treatment intensification status was evaluated for each patient during a 120-day treatment intensification window following the index HbA1c measure. Two-level hierarchical generalized linear models, with patients aggregated at the physician level, were used to assess the association between treatment intensification and achieving HbA1C quality performance measures. Results 547 patients met study selection criteria and 480 patients had at least one HbA1C test after the treatment intensification window and were used for the statistical analyses. About 40% of patients who had uncontrolled diabetes received treatment intensification during the 120 day window. Greater index HbA1C, greater patient body mass index, and fewer unique pre-index oral antidiabetes agents were significantly associated with greater likelihood of receiving timely treatment intensification. The odds of receiving treatment intensification were about 1.8 times higher (P = 0.0027) among patients with poor index HbA1C control (HbA1c level >9.0% [75 mmol/mol]) compared to other patients (index HbA1c 8.0% - 9.0%). Hispanic patients (compared to White patients) were significantly more likely to exhibit poor control after treatment intensification (odds ratio [OR] 2.91, P = 0.0304), underscoring the difficulty of controlling diabetes in this vulnerable group. In contrast, being male and being treated primarily by an internist (compared to primary treatment by a family medicine specialist) were both significantly associated with achieving superior control (HbA1c level <8.0%) after treatment intensification (OR 0.53 [P = 0.0165]; OR 0.41 [P = 0.0275], respectively). Conclusions Timely treatment intensification was significantly associated with greater likelihood of patients achieving superior HbA1C control (<8.0%) and better HbA1C control quality performance for the practice. Even in an ACO with resources dedicated to diabetes control, it is incumbent upon clinicians to readily identify and open dialogues with patients who may benefit from closely supervised, individualized attention.	[Arnold, Renee J. G.; Yang, Shuo] Quorum Consulting Inc, New York, NY 10006 USA; [Arnold, Renee J. G.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Gold, Edward J.] Old Hook Med Associates, Emerson, NJ USA; [Farahbakhshian, Sepehr; Sheehan, John J.] AstraZeneca, Wilmington, DE USA; [Arnold, Renee J. G.] Navigant Consulting, New York, NY 10017 USA; [Yang, Shuo] Bristol Myers Squibb Co, Princeton, NJ USA; [Farahbakhshian, Sepehr] Shire, Chesterbrook, PA USA; [Sheehan, John J.] Janssen Sci Affairs LLC, Titusville, NJ USA	Icahn School of Medicine at Mount Sinai; AstraZeneca; Bristol-Myers Squibb; Shire Pharmaceuticals Limited; Johnson & Johnson; Janssen Pharmaceuticals	Arnold, RJG (corresponding author), Quorum Consulting Inc, New York, NY 10006 USA.; Arnold, RJG (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.; Arnold, RJG (corresponding author), Navigant Consulting, New York, NY 10017 USA.	renee.arnold@navigant.com		Arnold, Renee/0000-0001-5935-3220	AstraZeneca LP	AstraZeneca LP(AstraZeneca)	AstraZeneca LP was the funding source. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlHabdan MA, 2016, DIABET METAB SYND OB, V9, P119, DOI 10.2147/DMSO.S101877; Alonso-Fernandez M, 2015, PRIM CARE DIABETES, V9, P385, DOI 10.1016/j.pcd.2015.01.006; American Association of Clincal Endocrinologists American College of Endocrinology, 2015, CLIN PRACT GUID DEV; American Diabetes Association, 2017, DIABETES CARE, V40; Balkau B, 2012, DIABETES METAB, V38, pS29, DOI 10.1016/S1262-3636(12)71532-X; Berlowitz DR, 2005, HEALTH SERV RES, V40, P1836, DOI 10.1111/j.1475-6773.2005.00436.x; Bolen SD, 2009, DIABETES CARE, V32, P25, DOI 10.2337/dc08-1297; Centers for Medicare and Medicaid Services, 2016, PQRS 2016 MEAS LIST; Davis J, 2014, ANN PHARMACOTHER, V48, P41, DOI 10.1177/1060028013517870; Folse HJ, 2017, DIABETES OBES METAB, V19, P1006, DOI 10.1111/dom.12913; Fu AZ, 2016, DIABETES OBES METAB, V18, P892, DOI 10.1111/dom.12683; Fu AZ, 2017, CURR MED RES OPIN, V2017, p1 , DOI 10.1080/03007995.2017.1292231; Grant R, 2007, DIABETES CARE, V30, P807, DOI 10.2337/dc06-2170; Huang LY, 2015, J CLIN PHARMACOL, V55, P17, DOI 10.1002/jcph.367; Khunti K, 2013, DIABETES CARE, V36, P3411, DOI 10.2337/dc13-0331; Kogut SJ, 2004, PHARMACOEPIDEM DR S, V13, P591, DOI 10.1002/pds.1005; Lang VB, 2015, MED SCI MONITOR, V21, P403, DOI 10.12659/MSM.892248; LeBlanc ES, 2015, AM J MANAG CARE, V21, P597; Lin J, 2016, ENDOCR PRACT, V22, P151, DOI 10.4158/EP15868.OR; Martono DP, 2016, CURR MED RES OPIN, V32, P2021, DOI 10.1080/03007995.2016.1227774; McEwen LN, 2009, DIABETES CARE, V32, P971, DOI 10.2337/dc08-1911; National Pharmaceutical Council, 2014, ACC CAR MEAS HIGH CO; Sidorenkov G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024278; Zafar A, 2015, DIABETIC MED, V32, P407, DOI 10.1111/dme.12592	24	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0199011	10.1371/journal.pone.0199011	http://dx.doi.org/10.1371/journal.pone.0199011			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894495	Green Submitted, gold, Green Published			2022-12-26	WOS:000435030900043
J	Mavroudis, PD; DuBois, DC; Almon, RR; Jusko, WJ				Mavroudis, Panteleimon D.; DuBois, Debra C.; Almon, Richard R.; Jusko, William J.			Modeling circadian variability of core-clock and clock-controlled genes in four tissues of the rat	PLOS ONE			English	Article							OPEN-ACCESS DATABASE; TRANSCRIPTION; EXPRESSION; BINDING; CANCER; LIGHT; COORDINATION; ENTRAINMENT; HOMEOSTASIS; DISRUPTION	Circadian clocks, present in almost all cells of the body, are entrained to rhythmic changes in the environment (e.g. light/dark cycles). Genes responsible for this timekeeping are named core-clock genes, which through transcriptional feedback interactions mediated by transcription factor binding to Ebox/RRE/Dbox elements can generate oscillatory activity of their expression. By regulating the transcription of other clock-controlled genes (CCGs) circadian information is transmitted to tissue and organ levels. Recent studies have indicated that there is a considerable variability of clock-controlled gene expression between tissues both with respect to the circadian genes that are regulated and to their phase lags. In this work, a mathematical model was adapted to explore the dynamics of core-clock and clock controlled genes measured in four tissues of the rat namely liver, muscle, adipose, and lung. The model efficiently described the synchronous rhythmicity of core-clock genes and further predicted that their phases are mainly regulated by Per2 and Cryl transcriptional delays and Rev-Erba and Cryl degradation rates. Similarly, after mining databases for potential Ebox/RRE/Dbox elements in the promoter region of clock-controlled genes, the phase variabilities of the same genes between different tissues were described. The analysis suggests that inter-tissue circadian variability of the same clock-controlled genes is an inherent component of homeostatic function and may arise due to different transcription factor activities on Ebox/RRE/Dbox elements.	[Mavroudis, Panteleimon D.; DuBois, Debra C.; Almon, Richard R.; Jusko, William J.] SUNY Buffalo, Dept Pharmaceut Sci, Sch Pharm & Pharmaceut Sci, Buffalo, NY 14260 USA; [DuBois, Debra C.; Almon, Richard R.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Jusko, WJ (corresponding author), SUNY Buffalo, Dept Pharmaceut Sci, Sch Pharm & Pharmaceut Sci, Buffalo, NY 14260 USA.	wjjusko@buffalo.edu	Mavroudis, Panteleimon/P-8546-2018	Mavroudis, Panteleimon/0000-0002-0512-4147	National Institute of General Medical Sciences [GM 24211]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences Grant GM 24211 (WJJ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar S, 2016, P NATL ACAD SCI USA, V113, pE2124, DOI 10.1073/pnas.1603388113; Almon RR, 2008, AM J PHYSIOL-REG I, V295, pR1031, DOI 10.1152/ajpregu.90399.2008; Almon RR, 2008, J PHARMACOL EXP THER, V326, P700, DOI 10.1124/jpet.108.140186; Becker-Weimann S, 2004, BIOPHYS J, V87, P3023, DOI 10.1529/biophysj.104.040824; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Blask DE, 2005, CANCER RES, V65, P11174, DOI 10.1158/0008-5472.CAN-05-1945; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004882; Buchman TG, 2002, NATURE, V420, P246, DOI 10.1038/nature01260; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Hamilton EE, 2008, CELL, V135, P368, DOI 10.1016/j.cell.2008.09.042; Hansen J, 2001, JNCI-J NATL CANCER I, V93, P1513, DOI 10.1093/jnci/93.20.1513; Hatanaka F, 2017, CELL, V170, P599, DOI 10.1016/j.cell.2017.07.039; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Jayaram Narayan, 2016, BMC Bioinformatics, V17, P547, DOI 10.1186/s12859-016-1298-9; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Korencic A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05782; Korencic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046835; Kubo T, 2006, AM J EPIDEMIOL, V164, P549, DOI 10.1093/aje/kwj232; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mavroudis PD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197258; Mavroudis PD, 2015, MATH BIOSCI, V260, P54, DOI 10.1016/j.mbs.2014.10.006; Mavroudis PD, 2014, PHYSIOL GENOMICS, V46, P766, DOI 10.1152/physiolgenomics.00026.2014; Mavroudis PD, 2012, PHYSIOL GENOMICS, V44, P607, DOI 10.1152/physiolgenomics.00001.2012; Mirsky HP, 2009, P NATL ACAD SCI USA, V106, P11107, DOI 10.1073/pnas.0904837106; Narlikar Leelavati, 2009, Briefings in Functional Genomics & Proteomics, V8, P215, DOI 10.1093/bfgp/elp014; Nguyen TT, 2009, ALGORITHMS, V2, P582, DOI 10.3390/a2010582; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pett JP, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005266; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Relogio A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002309; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Scheff JD, 2011, PHYSIOL GENOMICS, V43, P951, DOI 10.1152/physiolgenomics.00040.2011; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Sotak M, 2016, CHRONOBIOL INT, V33, P520, DOI 10.3109/07420528.2016.1161643; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Srinivasan V, 2006, WORLD J BIOL PSYCHIA, V7, P138, DOI 10.1080/15622970600571822; Stevens RG, 2006, CANCER CAUSE CONTROL, V17, P501, DOI 10.1007/s10552-005-9001-x; Stevens RG, 2007, ENVIRON HEALTH PERSP, V115, P1357, DOI 10.1289/ehp.10200; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Sukumaran S, 2011, J APPL PHYSIOL, V110, P1732, DOI 10.1152/japplphysiol.00079.2011; Sukumaran S, 2010, PHYSIOL GENOMICS, V42A, P141, DOI 10.1152/physiolgenomics.00106.2010; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	56	10	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0197534	10.1371/journal.pone.0197534	http://dx.doi.org/10.1371/journal.pone.0197534			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894471	Green Published, gold, Green Submitted			2022-12-26	WOS:000435030900005
J	Fejes, Z; Czimmerer, Z; Szuk, T; Poliska, S; Horvath, A; Balogh, E; Jeney, V; Varadi, J; Fenyvesi, F; Balla, G; Edes, I; Balla, J; Kappelmayer, J; Nagy, B				Fejes, Zsolt; Czimmerer, Zsolt; Szuk, Tibor; Poliska, Szilard; Horvath, Attila; Balogh, Eniko; Jeney, Viktoria; Varadi, Judit; Fenyvesi, Ferenc; Balla, Gyorgy; Edes, Istvan; Balla, Jozsef; Kappelmayer, Janos; Nagy, Bela, Jr.			Endothelial cell activation is attenuated by everolimus via transcriptional and post-transcriptional regulatory mechanisms after drug-eluting coronary stenting	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; EXPRESSION; RESTENOSIS; INTERVENTION; MICRORNAS; DYSFUNCTION; ENHANCERS; SIROLIMUS; DELIVERY; ICAM-1	We previously found higher level of endothelial cell (EC) activation in patients who suffered from in-stent restenosis after bare-metal stenting compared to subjects who underwent drug-eluting stenting (DES) showing no complications. Here we investigated the potential transcriptional and post-transcriptional regulatory mechanisms by which everolimus attenuated EC activation after DES. We studied the effect of everolimus on E-selectin (SELE) and VCAM1 mRNA levels when human coronary artery (HCAECs) and human umbilical vein ECs were challenged with recombinant TNF-alpha (100 ng/mL) for 1-24 hours in the presence or absence of everolimus using 0.5 pM concentration locally maintained by DES. EC activation was evaluated via the levels of IL-1 beta and IL-6 mRNAs with miR-155 expression by RT-qPCR as well as the nuclear translocation of nuclear factor kappa beta (NF-kappa B) detected by fluorescence microscopy. To investigate the transcriptional regulation of E-selectin and VCAM-1, TNF-alpha-induced enhancer RNA (eRNA) expression at p65-bound enhancers in the neighboring genomic regions of SELE and VCAM1 genes, including SELE-11 kappa b and VCAM1-10 kappa b, were measured in HCAECs. Mature and precursor levels of E-selectin and VCAM-1 repressor miR-181b were quantified to analyze the post-transcriptional regulation of these genes in HCAECs. Circulating miR-181b was analyzed in plasma samples of stented subjects by stem-loop RT-qPCR. TNF-alpha highly elevated E-selectin and VCAM-1 expression at transcriptional level in ECs. Levels of mature, pre- and pri-miR-181b were repressed in ECs by TNF-alpha, while everolimus acted as a negative regulator of EC activation via inhibited translocation of NF-kappa B p65 subunit into cell nuclei, lowered eRNA expression at SELE and VCAM1 genes-associated enhancers and modulated expression of their posttranscriptional repressor miR-181b. Significant negative correlation was observed between plasma miR-181b and soluble E-selectin and VCAM-1 in patients. In conclusion, everolimus attenuates EC activation via reduced NF-kappa B p65 translocation causing decreased E-selectin and VCAM-1 expression at transcriptional and post-transcriptional level after DES.	[Fejes, Zsolt; Kappelmayer, Janos; Nagy, Bela, Jr.] Univ Debrecen, Fac Med, Dept Lab Med, Debrecen, Hungary; [Czimmerer, Zsolt; Poliska, Szilard; Horvath, Attila] Univ Debrecen, Fac Med, Genom Med & Bioinformat Core Facil, Dept Biochem & Mol Biol, Debrecen, Hungary; [Szuk, Tibor; Edes, Istvan] Univ Debrecen, Fac Med, Dept Cardiol, Debrecen, Hungary; [Balogh, Eniko; Jeney, Viktoria; Balla, Jozsef] Univ Debrecen, Fac Med, Dept Internal Med, Debrecen, Hungary; [Varadi, Judit; Fenyvesi, Ferenc] Univ Debrecen, Fac Pharm, Dept Pharmaceut Technol, Debrecen, Hungary; [Balla, Gyorgy] Hungarian Acad Sci, Thrombosis & Haemostasis Res Grp, MTA DE Vasc Biol, Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen; Hungarian Academy of Sciences	Nagy, B (corresponding author), Univ Debrecen, Fac Med, Dept Lab Med, Debrecen, Hungary.	nagyb80@gmail.com	Horvath, Attila/AAA-9075-2020; Jeney, Viktória/AAF-5355-2019	Varadi, Judit/0000-0003-1885-164X; Fenyvesi, Ferenc/0000-0003-2890-0783; Horvath, Attila/0000-0002-6127-8925	European Union; European Reginal Development Fund;  [GINOP-2.3.2-15-2016-00043]	European Union(European Commission); European Reginal Development Fund; 	This publication is supported by the GINOP-2.3.2-15-2016-00043 project to GB. The project is cofinanced by the European Union and the European Reginal Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao MH, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5308170; Bavry AA, 2008, LANCET, V371, P2134, DOI 10.1016/S0140-6736(08)60922-8; Boos CJ, 2007, CHEST, V132, P1920, DOI 10.1378/chest.07-1693; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Buerke M, 2007, BBA-PROTEINS PROTEOM, V1774, P5, DOI 10.1016/j.bbapap.2006.04.018; CARLOS TM, 1994, BLOOD, V84, P2068; Chen QS, 2015, J MOL CELL CARDIOL, V89, P75, DOI 10.1016/j.yjmcc.2015.10.017; Costa MA, 2005, CIRCULATION, V111, P2257, DOI 10.1161/01.CIR.0000163587.36485.A7; Czimmerer Z, 2018, IMMUNITY, V48, P75, DOI 10.1016/j.immuni.2017.12.010; Czimmerer Z, 2018, BBA-GENE REGUL MECH, V1861, P14, DOI 10.1016/j.bbagrm.2017.11.003; Czimmerer Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055168; De Rosa S, 2011, CIRCULATION, V124, P1936, DOI 10.1161/CIRCULATIONAHA.111.037572; Duan Q, 2016, BBA-GENE REGUL MECH, V1859, P564, DOI 10.1016/j.bbagrm.2016.02.004; Fejes Z, 2017, THROMB HAEMOSTASIS, V117, P529, DOI 10.1160/TH16-04-0322; Gareri C, 2016, CIRC RES, V118, P1170, DOI 10.1161/CIRCRESAHA.115.308237; He MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112043; Hortelano S, 2010, CARDIOVASC RES, V86, P283, DOI 10.1093/cvr/cvq050; Hou JY, 2016, CELL BIOL INT, V40, P318, DOI 10.1002/cbin.10572; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Izuhara M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172798; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; La Sala L, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0390-9; Li JB, 2017, J CELL MOL MED, V21, P1482, DOI 10.1111/jcmm.13074; Li SF, 2017, ONCOTARGET, V8, P48145, DOI 10.18632/oncotarget.18308; Liu RR, 2015, AM J PHYSIOL-HEART C, V309, pH303, DOI 10.1152/ajpheart.00290.2015; McNair ED, 2010, CLIN CARDIOL, V33, P678, DOI 10.1002/clc.20815; Munk PS, 2011, J THROMB THROMBOLYS, V31, P92, DOI 10.1007/s11239-010-0471-7; Nagy B, 2010, PLATELETS, V21, P147, DOI 10.3109/09537100903477582; Nazari-Jahantigh M, 2012, THROMB HAEMOSTASIS, V107, P611, DOI 10.1160/TH11-12-0826; Ota H, 2009, J AM COLL CARDIOL, V53, P2298, DOI 10.1016/j.jacc.2009.01.072; Palmieri D, 2014, BIOCHEM BIOPH RES CO, V443, P246, DOI 10.1016/j.bbrc.2013.11.092; Panoulas VF, 2015, MED DEVICES-EVID RES, V8, P317, DOI 10.2147/MDER.S66360; Piatti PM, 2005, CURR OPIN PHARMACOL, V5, P160, DOI 10.1016/j.coph.2004.10.004; Santulli G, 2014, J CLIN INVEST, V124, P4102, DOI 10.1172/JCI76069; Sun XH, 2014, CIRC RES, V114, P32, DOI 10.1161/CIRCRESAHA.113.302089; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Szuk T, 2016, PLATELETS, V27, P410, DOI 10.3109/09537104.2015.1112368; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Varadi J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170537; Vitiello D, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.24; Wang C, 2014, J EXP MED, V211, P395, DOI 10.1084/jem.20131125; Wang D, 2015, ARTERIOSCL THROM VAS, V35, P1945, DOI 10.1161/ATVBAHA.115.305597; Zampetaki A, 2012, CIRC RES, V110, P508, DOI 10.1161/CIRCRESAHA.111.247445	45	15	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0197890	10.1371/journal.pone.0197890	http://dx.doi.org/10.1371/journal.pone.0197890			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889836	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000434786600008
J	Aued, AW; Smith, F; Quimbayo, JP; Candido, DV; Longo, GO; Ferreira, CEL; Witman, JD; Floeter, SR; Segal, B				Aued, Anaide W.; Smith, Franz; Quimbayo, Juan P.; Candido, Davi V.; Longo, Guilherme O.; Ferreira, Carlos E. L.; Witman, Jon D.; Floeter, Sergio R.; Segal, Barbara			Large-scale patterns of benthic marine communities in the Brazilian Province	PLOS ONE			English	Article							PHASE-SHIFTS; CORAL-REEFS; GLOBAL PATTERNS; ALGAL TURFS; BIOGEOGRAPHY; BIODIVERSITY; DEGRADATION; VARIABILITY; DISTURBANCE; RESILIENCE	As marine ecosystems are influenced by global and regional processes, standardized information on community structure has become crucial for assessing broad-scale responses to natural and anthropogenic disturbances. Extensive biogeographic provinces, such as the Brazilian Province in the southwest Atlantic, present numerous theoretical and methodological challenges for understanding community patterns on a macroecological scale. In particular, the Brazilian Province is composed of a complex system of heterogeneous reefs and a few offshore islands, with contrasting histories and geophysical-chemical environments. Despite the large extent of the Brazilian Province (almost 8,000 kilometers), most studies of shallow benthic communities are qualitative surveys and/or have been geographically restricted. We quantified community structure of shallow reef habitats from 0 degrees to 27 degrees S latitude using a standard photographic quadrat technique. Percent cover data indicated that benthic communities of Brazilian reefs were dominated by algal turfs and frondose macroalgae, with low percent cover of reef-building corals. Community composition differed significantly among localities, mostly because of their macroalgal abundance, despite reef type or geographic region, with no evident latitudinal pattern. Benthic diversity was lower in the tropics, contrary to the general latitudinal diversity gradient pattern. Richness peaked at mid-latitudes, between 20 degrees S to 23 degrees S, where it was similar to 3.5-fold higher than localities with the lowest richness. This study provides the first large-scale description of benthic communities along the southwestern Atlantic, providing a baseline for macroecological comparisons and evaluation of future impacts. Moreover, the new understanding of richness distribution along Brazilian reefs will contribute to conservation planning efforts, such as management strategies and the spatial prioritization for the creation of new marine protected areas.	[Aued, Anaide W.; Quimbayo, Juan P.; Floeter, Sergio R.; Segal, Barbara] Univ Fed Santa Catarina, Programa Posgrad Ecol, Florianopolis, SC, Brazil; [Aued, Anaide W.; Quimbayo, Juan P.; Floeter, Sergio R.] Univ Fed Santa Catarina, Dept Ecol & Zool, Marine Macroecol & Biogeog Lab, Florianopolis, SC, Brazil; [Aued, Anaide W.; Candido, Davi V.; Segal, Barbara] Univ Fed Santa Catarina, Dept Ecol & Zool, Lab Ecol Ambientes Recifais, Florianopolis, SC, Brazil; [Aued, Anaide W.; Smith, Franz; Witman, Jon D.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Longo, Guilherme O.] Univ Fed Rio Grande do Norte, Dept Oceanog & Limnol, Marine Ecol Lab, Natal, RN, Brazil; [Ferreira, Carlos E. L.] Univ Fed Fluminense, Reef Syst Ecol & Conservat Lab, Niteroi, RJ, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Brown University; Universidade Federal do Rio Grande do Norte; Universidade Federal Fluminense	Aued, AW (corresponding author), Univ Fed Santa Catarina, Programa Posgrad Ecol, Florianopolis, SC, Brazil.; Aued, AW (corresponding author), Univ Fed Santa Catarina, Dept Ecol & Zool, Marine Macroecol & Biogeog Lab, Florianopolis, SC, Brazil.; Aued, AW (corresponding author), Univ Fed Santa Catarina, Dept Ecol & Zool, Lab Ecol Ambientes Recifais, Florianopolis, SC, Brazil.; Aued, AW (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	anaidewru@gmail.com	Quimbayo, Juan Pablo/O-9566-2015; Longo, Guilherme O/E-3372-2014	Quimbayo, Juan Pablo/0000-0001-5346-3488; Longo, Guilherme O/0000-0003-2033-7439; Floeter, Sergio/0000-0002-3201-6504; Ferreira, Carlos Eduardo/0000-0002-4311-0491; Wrublevski Aued, Anaide/0000-0002-6101-0822	SISBIOTA-Mar Rede Nacional de Pesquisa [CNPq 563276/2010-0, FAPESC 6308/2011-8]; CAPES; CAPES ("Science Without Borders") from the Brazilian Government	SISBIOTA-Mar Rede Nacional de Pesquisa; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES ("Science Without Borders") from the Brazilian Government	SISBIOTA-Mar Rede Nacional de Pesquisa (P.I: S.R. Floeter-CNPq 563276/2010-0 and FAPESC 6308/2011-8) funded the study design and data collection and CAPES to AWA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank the Marine Biodiversity Network (SISBIOTA-Mar) team for logistical and fieldwork support and Julia Correia and Debora Ferrari for help with photoquadrats analysis. This work was funded by SISBIOTA-Mar Rede Nacional de Pesquisa (P.I: S.R. Floeter-CNPq 563276/2010-0 and FAPESC 6308/2011-8). We also want to thank CAPES ("Science Without Borders") for a scholarship from the Brazilian Government to A.W.A. Thanks to the logistical support from the following institutions (and people): ICMBio, Reserva Biologica do Atol das Rocas (Maurizelia Brito and Jarian Dantas), Parque Nacional Marinho de Fernando de Noronha, SEMA-MA, IDEMA-RN, Estacao Ecologica Tupinambas, Marinha do Brasil and SECIRM (Programa PROTRINDADE). Thanks to the two anonymous reviewers for constructive criticisms that greatly improved this manuscript.	Ackleson SG, 2003, LIMNOL OCEANOGR, V48, P323, DOI 10.4319/lo.2003.48.1_part_2.0323; Airoldi L, 1998, ECOLOGY, V79, P2759, DOI 10.1890/0012-9658(1998)079[2759:RODSSA]2.0.CO;2; Althaus F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141039; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2021, LANG ENV STAT COMP; Barros K. V. S., 2014, Brazilian Journal of Aquatic Science & Technology, V18, P31, DOI 10.14210/bjast.v18n2.p31-41; Barroso CX, 2016, J BIOGEOGR, V43, P2477, DOI 10.1111/jbi.12821; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bender MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110332; Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V214, P137, DOI 10.3354/meps214137; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Briggs JC., 1995, GLOBAL BIOGEOGRAPHY; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Brown JH, 2014, J BIOGEOGR, V41, P8, DOI 10.1111/jbi.12228; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; CASTRO B. M. F., 1998, SEA, P209; Castro CB, 2001, B MAR SCI, V69, P357; Chao A, 2016, WILEY STATSREF STAT, DOI [10.1002/9780470015902.a0026329, DOI 10.1002/9780470015902.A0026329]; Chown SL, 2004, PLOS BIOL, V2, P1701, DOI 10.1371/journal.pbio.0020406; Connell SD, 2014, MAR ECOL PROG SER, V495, P299, DOI 10.3354/meps10513; Connell SD, 2010, P ROY SOC B-BIOL SCI, V277, P1409, DOI 10.1098/rspb.2009.2069; Cummings V, 2006, ANTARCT SCI, V18, P633, DOI 10.1017/S0954102006000666; de Bakker DM, 2017, CORAL REEFS, V36, P355, DOI 10.1007/s00338-016-1534-9; de Figueiredo M.A.O., 2009, OECOLOGIA AUST, V12, P258, DOI [DOI 10.4257/OECO.2008.1202.07, 10.4257/oeco.2008.1202.07]; Escobar H, 2015, SCIENCE, V350, P1138, DOI 10.1126/science.350.6265.1138; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Floeter SR, 2006, BIOL CONSERV, V128, P391, DOI 10.1016/j.biocon.2005.10.005; Floeter SR, 2001, GLOBAL ECOL BIOGEOGR, V10, P423, DOI 10.1046/j.1466-822X.2001.00245.x; Floeter SR, 2009, BIOL MARINHA, P421; Francini RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054260; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gatti G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118581; Gorgula SK, 2004, MAR BIOL, V145, P613, DOI 10.1007/s00227-004-1335-5; Gotelli NJ, 2013, ECOSIMR 1 00; Hetzel B., 1994, CORAIS BAHIA; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; Horta Paulo A., 2001, Hoehnea, V28, P243; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Human P, 2002, REEF CREATURE IDENTI; Jackson J, 2014, STATUS TRENDS CARIBB, DOI DOI 10.1111/1365-2664.12388; Laborel J., 1970, Annls Univ. Abidjan, V2, P1; Leao Z, 1997, P 8 INT COR REEF S, V2, P1767; Leao ZMAN, 2016, BRAZ J OCEANOGR, V64, DOI 10.1590/S1679-875920160916064sp2; Leao ZMAN, 2003, LATIN AMERICAN CORAL REEFS, P9, DOI 10.1016/B978-044451388-5/50003-5; Littler D. S., 2000, CARIBBEAN REEF PLANT; Littler MM, 2011, ENCY EARTH SCI SERIE; Longo GO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127176; Longo LL, 2014, HIST CIENC SAUDE-MAN, V21, DOI 10.1590/S0104-59702014000300011; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; Maida Mauro, 1997, P263; Mazzei EF, 2017, MAR POLLUT BULL, V114, P123, DOI 10.1016/j.marpolbul.2016.08.059; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; McCook LJ, 2001, CORAL REEFS, V19, P419, DOI 10.1007/s003380000119; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0018318, 10.1371/journal.pone.0021326]; Miranda LS, 2016, BIOTA NEOTROP, V16, DOI 10.1590/1676-0611-BN-2016-0169; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Oigman-Pszczol SS, 2004, MAR ECOL-P S Z N I, V25, P173, DOI 10.1111/j.1439-0485.2004.00018.x; Oksanen J., 2019, R PACKAGE VERSION; Palmeira Ana Cristina Pinto de Almeida, 2015, Rev. bras. meteorol., V30, P89, DOI 10.1590/0102-778620130679; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Picciani N, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-3010-z; Pinheiro HT, 2017, NATURE, V549, P82, DOI 10.1038/nature23680; Pirani Ghilardi Natalia, 2008, Oecologia Brasiliensis, V12, P197; PRATES AP, 2007, PRIORITIES COASTAL M, P15; Preskitt Linda B., 2004, Pacific Science, V58, P201, DOI 10.1353/psc.2004.0021; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; Rogers R, 2014, MAR BIOL RES, V10, P612, DOI 10.1080/17451000.2013.841944; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Soares MO, 2016, BRAZILIAN MARINE ANI, DOI [10.1007/978-3-319-17001-5_51-1, DOI 10.1007/978-3-319-17001-5_51-1]; Suzuki R., 2015, PVCLUST HIERARCHICAL; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Trygonis V, 2012, J EXP MAR BIOL ECOL, V424, P99, DOI 10.1016/j.jembe.2012.04.018; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P97, DOI 10.1016/S0022-0981(00)00181-7; Valentin JL, 2001, COASTAL MARINE ECOSY; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014312; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vila-Nova DA, 2014, OCEAN COAST MANAGE, V102, P88, DOI 10.1016/j.ocecoaman.2014.09.005; Villaca Roberto, 1997, Revista Brasileira de Oceanografia, V45, P35; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Witman JD, 2003, BIODIVERS CONSERV, V12, P25, DOI 10.1023/A:1021200831770; Witman JD, 2008, ECOLOGY, V89, pS66, DOI 10.1890/07-1201.1	86	61	61	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198452	10.1371/journal.pone.0198452	http://dx.doi.org/10.1371/journal.pone.0198452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883496	Green Submitted, gold, Green Published			2022-12-26	WOS:000434728100024
J	Dao, DT; Vuong, JT; Anez-Bustillos, L; Pan, A; Mitchell, PD; Fell, GL; Baker, MA; Bielenberg, DR; Puder, M				Dao, Duy T.; Vuong, Jacqueline T.; Anez-Bustillos, Lorenzo; Pan, Amy; Mitchell, Paul D.; Fell, Gillian L.; Baker, Meredith A.; Bielenberg, Diane R.; Puder, Mark			Intranasal delivery of VEGF enhances compensatory lung growth in mice	PLOS ONE			English	Article							ENDOTHELIAL-CELLS DEPENDS; LIVER-REGENERATION; EXPRESSION; ANGIOGENESIS; MIGRATION; PROLIFERATION; INCREASES; TRANSACTIVATION; ALVEOLARIZATION; HYPOTENSION	Vascular endothelial growth factor (VEGF) has previously been demonstrated to accelerate compensatory lung growth (CLG) in mice and may be a useful therapy for pulmonary hypoplasia. Systemic administration of VEGF can result in side effects such as hypotension and edema. The aim of this study was to explore nasal delivery as a route for intrapulmonary VEGF administration. Eight-week-old C57BU6 male mice underwent left pneumonectomy, followed by daily nasal instillation of VEGF at 0.5 mg/kg or isovolumetric saline. Lung volume measurement, morphometric analysis, and protein expression studies were performed on lung tissues harvested on postoperative day (POD) 4. To understand the mechanism by which VEGF accelerates lung growth, proliferation of human bronchial epithelial cells (HBEC) was assessed in a co-culture model with lung microvascular endothelial cells (HMVEC-L) treated with and without VEGF (10 ng/mL). The assay was then repeated with a heparin-binding EGF-like growth factor (HB-EGF) neutralizing antibody ranging from 0.550 mu g/mL. Compared to control mice, the VEGF-treated group displayed significantly higher lung volume (P = 0.001) and alveolar count (P = 0.005) on POD 4. VEGF treatment resulted in increased pulmonary expression of HB-EGF (P = 0.02). VEGF-treated HMVEC-L increased HBEC proliferation (P = 0.002) while the addition of an HB-EGF neutralizing antibody at 5 and 50 pg/mL abolished this effect (P = 0.01 and 0.002, respectively). These findings demonstrate that nasal delivery of VEGF enhanced CLG. These effects could be mediated by a paracrine mechanism through upregulation of HB-EGF, an epithelial cell mitogen.	[Dao, Duy T.; Vuong, Jacqueline T.; Anez-Bustillos, Lorenzo; Pan, Amy; Fell, Gillian L.; Baker, Meredith A.; Bielenberg, Diane R.; Puder, Mark] Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Dao, Duy T.; Vuong, Jacqueline T.; Anez-Bustillos, Lorenzo; Pan, Amy; Fell, Gillian L.; Baker, Meredith A.; Bielenberg, Diane R.; Puder, Mark] Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Mitchell, Paul D.] Boston Childrens Hosp, Inst Ctr Clin & Translat Res, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Puder, M (corresponding author), Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA.; Puder, M (corresponding author), Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA.	Mark.Puder@childrens.harvard.edu		Dao, Duy/0000-0001-9915-7080	Boston Children's Hospital Surgical Foundation; Corkin and Maher Family Fund; National Institutes of Health [5T32HL007734, 4T35HL110843, 1F32DK104525-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007734, T35HL110843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK104525] Funding Source: NIH RePORTER	Boston Children's Hospital Surgical Foundation; Corkin and Maher Family Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research funding for this study was provided by the Boston Children's Hospital Surgical Foundation (AP, MP), the Corkin and Maher Family Fund (PDM), and the National Institutes of Health Grants 5T32HL007734 (DTD, MAB), 4T35HL110843 (JTV), 1F32DK104525-01 (GLF).	Bates DO, 1996, AM J PHYSIOL-HEART C, V271, pH2520, DOI 10.1152/ajpheart.1996.271.6.H2520; Bernatchez PN, 1999, J BIOL CHEM, DOI [10.1152/ajplung.2001.281.4.L1001, DOI 10.1152/AJPLUNG.2001.281.4.L1001]; BRAIN JD, 1976, ENVIRON RES, V11, P13, DOI 10.1016/0013-9351(76)90107-9; Brissova M, 2014, CELL METAB, V19, P498, DOI 10.1016/j.cmet.2014.02.001; Brown KRS, 2001, AM J PHYSIOL-LUNG C, V281, pL1001, DOI 10.1152/ajplung.2001.281.4.L1001; Chang R, 2004, J PEDIATR SURG, V39, P825, DOI 10.1016/j.jpedsurg.2004.02.015; Cheng KR, 2007, BIOCHEM PHARMACOL, V73, P1001, DOI 10.1016/j.bcp.2006.11.028; Clegg LW, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004158; Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Dao DT, 2018, PEDIAT RES; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Fernandez LG, 2007, J THORAC CARDIOV SUR, V133, P309, DOI 10.1016/j.jtcvs.2006.09.003; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Graff CL, 2003, PHARM RES-DORDR, V20, P1225, DOI 10.1023/A:1025053115583; Hariawala MD, 1996, J SURG RES, V63, P77, DOI 10.1006/jsre.1996.0226; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Horowitz JR, 1997, ARTERIOSCL THROM VAS, V17, P2793, DOI 10.1161/01.ATV.17.11.2793; Jakkula M, 2000, AM J PHYSIOL-LUNG C, V279, pL600, DOI 10.1152/ajplung.2000.279.3.L600; Kaza AK, 2002, J THORAC CARDIOV SUR, V123, P288, DOI 10.1067/mtc.2002.119339; Kho AT, 2013, AM J PHYSIOL-LUNG C, V305, pL542, DOI 10.1152/ajplung.00403.2012; Kiso S, 2003, GASTROENTEROLOGY, V124, P701, DOI 10.1053/gast.2003.50097; Kivisaari AK, 2010, BRIT J DERMATOL, V163, P726, DOI 10.1111/j.1365-2133.2010.09924.x; Kunig AM, 2005, AM J PHYSIOL-LUNG C, V289, pL529, DOI 10.1152/ajplung.00336.2004; Lassus P, 1999, AM J RESP CRIT CARE, V159, P1429, DOI 10.1164/ajrccm.159.5.9806073; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maretzky T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1232; Matsumoto K, 2014, J BIOCHEM, V156, P1, DOI 10.1093/jb/mvu031; Mohamed AA, 2010, J CANCER, V1, P197; Muhlfeld C, 2013, AM J PHYSIOL-LUNG C, V305, P1205, DOI 10.1152/ajplung.00427.2012; Nieves BJ, 2009, BIOFACTORS, V35, P332, DOI 10.1002/biof.46; Noma H, 2005, AM J OPHTHALMOL, V140, P256, DOI 10.1016/j.ajo.2005.03.003; Norton K, 2016, SCI REP, V6, P36; Ochs M, 2013, AM J PHYSIOL-LUNG C, V305, pL15, DOI 10.1152/ajplung.00429.2012; Potus F, 2014, AM J RESP CRIT CARE, V190, P318, DOI 10.1164/rccm.201402-0383OC; Procianoy RS, 2016, AM J PERINAT, V33, P480, DOI 10.1055/s-0035-1566294; Radulescu A, 2011, J SURG RES, V171, P540, DOI 10.1016/j.jss.2010.06.036; Rafii S, 2016, NATURE, V529, P316, DOI 10.1038/nature17040; Sakurai MK, 2007, AM J PHYSIOL-LUNG C, V292, pL742, DOI 10.1152/ajplung.00064.2006; Sakurai MK, 2005, J INVEST SURG, V18, P201, DOI 10.1080/08941930591004485; Sakurai MK, 2007, AM J PHYSIOL-LUNG C, V2115, p742 ; Sbragia L, 2014, BRAZ J MED BIOL RES, V47, P171, DOI 10.1590/1414-431X20133221; SCHERLE W, 1970, Mikroskopie, V26, P57; Schraufstatter IU, 2003, J IMMUNOL, V171, P6714, DOI 10.4049/jimmunol.171.12.6714; Shizukuda Y, 1999, CIRC RES, V85, P247, DOI 10.1161/01.RES.85.3.247; Taniguchi E, 2001, J HISTOCHEM CYTOCHEM, V49, P121, DOI 10.1177/002215540104900112; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Tokumaru S, 2000, J CELL BIOL, V151, P209, DOI 10.1083/jcb.151.2.209; Tsuyuki S, 1997, J EXP MED, V185, P1671, DOI 10.1084/jem.185.9.1671; Valiatti FB, 2011, ARQ BRAS ENDOCRINOL, V55, P106, DOI 10.1590/S0004-27302011000200002; WEIBEL ER, 1962, J APPL PHYSIOL, V17, P343, DOI 10.1152/jappl.1962.17.2.343; Yang L, 2012, CELL BIOL INT, V36, P21, DOI 10.1042/CBI20100670; Yang RH, 1996, J CARDIOVASC PHARM, V27, P838, DOI 10.1097/00005344-199606000-00011; Yoshioka R, 2010, INVEST OPHTH VIS SCI, V51, P5630, DOI 10.1167/iovs.10-5158	55	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198700	10.1371//journal.pone.0198700	http://dx.doi.org/10.1371//journal.pone.0198700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879188				2022-12-26	WOS:000434384900074
J	Ziakas, PD; Kourbeti, IS; Poulou, LS; Vlachogeorgos, GS; Mylonakis, E				Ziakas, Panayiotis D.; Kourbeti, Irene S.; Poulou, Loukia S.; Vlachogeorgos, Georgios S.; Mylonakis, Eleftherios			Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the "rubber effect"	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; NATIONAL TRENDS; WARFARIN; PREVENTION; DABIGATRAN; DISEASE; STROKE	Introduction Direct oral anticoagulants (DOAC) have gained an increased share over warfarin for prevention and treatment of thromboembolic disease. We studied DOAC adoption across providers and medical specialties. Methods Retrospective, cross-sectional analysis of Medicare Part D public use files (PUF), 2013 to 2015. We summarized prescription data for claims and drug payment, stratified by drug class, specialty and calendar year. We treated DOAC claims as a count outcome and explored patterns of expansion across prescribers via a truncated negative binomial regression. We described dispersion and spread in DOAC prescribing, across hospital referral regions (HRRs), including the p90/p10 ratios, and the median absolute deviation from the median. Results In 2015 part D PUF, oral anticoagulant claims have climbed to approximately 24.4 million with a payment cost of approximately $3.3 billion. DOAC claims comprised 31.0% of oral anticoagulant claims, showing a relative increase of approximately 127% compared to 2013. The upper decile of prescribers accounted for half of the oral anticoagulant prescriptions and the resulting cost. The median cost per DOAC claim in 2015 was $367.4 (inter quartile range 323.9 to 445.9), as opposed to $12.3 (interquartile range 9.2 to 16.5) for warfarin. The median cost per standardized (30-day supply) prescription was $317.0 (interquartile range 303.8 to 324.3) and $8.0 (6.7 to 9.8) for DOACs and warfarin, respectively. DOAC adoption differs by specialty. Cardiologists, cardiac electrophysiologists and orthopedics had the highest predicted DOAC share per 100 claims (53.8, 72.9 and 71.5, respectively in 2015); nephrologists, family practitioners and geriatricians the lowest (22.3, 21.5 and 20.7, respectively in 2015). The p90/p10 ratio and the median absolute deviation from the median varied across HRRs and correlated positively with the prevalence of stroke and atrial fibrillation in the Medicare population. Conclusions DOACs have been increasing their share year-over-year, but adoption varies across specialties. In prevalent areas for stroke and atrial fibrillation, prescription dispersion magnifies, and this may signify a rapid adoption by top providers.	[Ziakas, Panayiotis D.] Brown Univ, Dept Med, Warren Alpert Med Sch, Providence, RI 02912 USA; [Kourbeti, Irene S.] Univ Athens, Dept Internal Med 1, Sch Med, Athens, Greece; [Poulou, Loukia S.] IASO Matern Clin, Div Med Imaging & Intervent Radiol, Athens, Greece; [Vlachogeorgos, Georgios S.] Iatriki Frontida Med Ctr, Chalkida, Greece; [Mylonakis, Eleftherios] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University; Athens Medical School; National & Kapodistrian University of Athens; Brown University	Mylonakis, E (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.	emylonakis@lifespan.org		Mylonakis, Eleftherios/0000-0002-4624-0777; Ziakas, Panayiotis/0000-0002-5943-8635				Abohelaika S, 2014, AGE AGEING, V43, P708, DOI 10.1093/ageing/afu074; Alpert JS, 2014, AM J MED, V127, P1027, DOI 10.1016/j.amjmed.2014.07.028; Baik Seo Hyon, 2016, J Manag Care Spec Pharm, V22, P281, DOI 10.18553/jmcp.2016.22.3.281; Barnes GD, 2015, AM J MED, V128, P1300, DOI 10.1016/j.amjmed.2015.05.044; Bauer KA, 2013, HEMATOL-AM SOC HEMAT, P464, DOI 10.1182/asheducation-2013.1.464; Canestaro WJ, 2013, CIRC-CARDIOVASC QUAL, V6, P724, DOI 10.1161/CIRCOUTCOMES.113.000661; Chen JH, 2016, JAMA INTERN MED, V176, P259, DOI 10.1001/jamainternmed.2015.6662; Cohen AT, 2016, NEW ENGL J MED, V375, P534, DOI 10.1056/NEJMoa1601747; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Desai NR, 2014, AM J MED, V127, P1075, DOI 10.1016/j.amjmed.2014.05.013; Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615; Freeman JV, 2017, CIRCULATION, V135, P1227, DOI 10.1161/CIRCULATIONAHA.116.022388; Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; Gilligan AM, 2018, CURR MED RES OPIN, V34, P285, DOI 10.1080/03007995.2017.1409425; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Hoadley J., 2016, MEDICARE D; Lauffenburger JC, 2013, PHARMACOEPIDEM DR S, V22, P899, DOI 10.1002/pds.3458; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Lo-Ciganic WH, 2016, MED CARE, V54, P725, DOI 10.1097/MLR.0000000000000549; Lopez-Lopez JA, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5058; Lubloy A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-469; Lutz J, 2017, INT J NEPHROL RENOV, V10, P135, DOI 10.2147/IJNRD.S105771; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Reeves R.V., 2015, STRETCHY ENDS SHAPE; Sterne JAC, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21090; Wennberg J. E., 1996, DARTMOUTH ATLAS HLTH; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414; Yazdan-Ashoori P, 2017, PRIM HEALTH CARE RES, V18, P472, DOI 10.1017/S1463423617000196	31	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198674	10.1371/journal.pone.0198674	http://dx.doi.org/10.1371/journal.pone.0198674			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879194	Green Published, gold, Green Submitted			2022-12-26	WOS:000434384900068
J	Kronenbuerger, M; Belenghi, P; Ilgner, J; Freiherr, J; Hummel, T; Neuner, I				Kronenbuerger, Martin; Belenghi, Patrizia; Ilgner, Justus; Freiherr, Jessica; Hummel, Thomas; Neuner, Irene			Olfactory functioning in adults with Tourette syndrome	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; ODOR IDENTIFICATION; PARKINSONS-DISEASE; RATING-SCALE; HUMAN BRAIN; DYSFUNCTION; CORTEX; SYSTEM; NEUROTRANSMISSION; ABNORMALITY	Tourette syndrome is a chronic tic disorder characterized by motor and vocal tics. Comorbidities such as attention deficit hyperactivity disorder and obsessive compulsive disorder can be found. The overlap between neuroanatomical regions and neurotransmitter systems in the olfactory system and the pathophysiology of Tourette syndrome let us hypothesize altered olfactory performance in Tourette syndrome. The main objective of this study was to systematically assess olfactory functioning in subjects with Tourette syndrome and to compare it to healthy controls. We assessed 28 adults with Tourette syndrome (age 33.1 +/- 9.4 years, disease duration 23.7 +/- 9.7 years) and 28 healthy controls (age 32.9 +/- 9.0 years) matched in regard to age, sex, education and smoking habits. The "Sniffin Sticks" test battery was applied to assess odor threshold, discrimination, and identification. Additionally, the combined score of the odor threshold test, the odor discrimination test and the odor identification test of the "Sniffin Sticks" test battery was calculated. Although it was not the primary aim of this study, we assessed whether tics and comorbidity could contribute to olfactory alterations in adults with Tourette syndrome. Therefore, clinical scores were used to assess severity of tics and co-morbidity such as attention deficit hyperactivity disorder, obsessive compulsive disorder, anxiety and depression in subjects with Tourette syndrome. Pathology of the nasal cavities was excluded with rhinoendoscopy. Independent sample ttests were applied to compare performance in olfactory tests. In the case of statistically significant differences (critical p-value: 0.05), multiple linear regression analysis was carried out to explore whether tic severity, social impairment, co-morbidity or medical treatment had an impact on the differences found. Descriptive values are reported as mean +/- standard deviation. Tourette syndrome subjects showed lower combined scores (Tourette syndrome subjects 31.9 +/- 5.1 versus healthy controls 35.0 +/- 3.1; p = 0.007), odor identification scores (Tourette syndrome subjects 12.4 +/- 2.0 versus healthy controls 13.7 +/- 1.4; p = 0.008) and odor discrimination scores (Tourette syndrome subjects 12.1 +/- 2.1 versus healthy controls 13.2 +/- 1.6; p = 0.041) in comparison to healthy subjects, while there was no difference in odor threshold (Tourette syndrome subjects 7.3 +/- 2.7 versus healthy controls 8.1 +/- 2.2; p = 0.22). Seven out of 28 Tourette syndrome subjects (25%) scored in the range of the age- and sex-dependent combined score for hyposmia, while two of 28 healthy controls (7%) had a similar low combined score. None of the participants were found to have functional anosmia. Multiple linear regression analyses suggest that social impairment may a predictor for low combined score and odor identification score in Tourette syndrome subjects (p = 0.003). Compared to healthy controls, altered olfaction in adults with Tourette syndrome was found in this study. Normal odor threshold level but lower scores at tasks involving supra-threshold odor concentrations point towards a central-nervous alteration in the processing of olfactory information in Tourette syndrome.	[Kronenbuerger, Martin] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Kronenbuerger, Martin] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Kronenbuerger, Martin] Ernst Moritz Arndt Univ Greifswald, Dept Neurol, Greifswald, Germany; [Belenghi, Patrizia; Neuner, Irene] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Ilgner, Justus] Rhein Westfal TH Aachen, Dept Otorhinolaryngol & Plast Head & Neck Surg, Aachen, Germany; [Freiherr, Jessica] Rhein Westfal TH Aachen, Dept Diagnost & Intervent Neuroradiol, Aachen, Germany; [Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Dresden, Germany; [Neuner, Irene] JARA Translat Brain Med, Aachen, Germany; [Neuner, Irene] Forschungszentrum, Inst Neurosci & Med 4, Julich, Germany; [Kronenbuerger, Martin] Ernst Moritz Arndt Univ Greifswald, Univ Med, Dept Neurol, Greifswald, Germany	Johns Hopkins University; RWTH Aachen University; Ernst Moritz Arndt Universitat Greifswald; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; Technische Universitat Dresden; Helmholtz Association; Ernst Moritz Arndt Universitat Greifswald	Kronenbuerger, M (corresponding author), Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA.; Kronenbuerger, M (corresponding author), Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany.; Kronenbuerger, M (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Neurol, Greifswald, Germany.; Kronenbuerger, M (corresponding author), Ernst Moritz Arndt Univ Greifswald, Univ Med, Dept Neurol, Greifswald, Germany.	martin_kronenbuerger@hotmail.com	Freiherr, Jessica/N-9695-2015; Freiherr, Jessica/U-6826-2019	Freiherr, Jessica/0000-0001-9052-4497; Neuner, Irene/0000-0002-5164-8873	research grant from RWTH Aachen University	research grant from RWTH Aachen University	This study project was supported by a research grant from the RWTH Aachen University (Start-Program) to Martin Kronenbuerger, who is the principal investiagator of this study project. There is no grant number to indicate.	Abele M, 2003, J NEUROL, V250, P1453, DOI 10.1007/s00415-003-0248-4; Adams DR, 2017, CHEM SENSES, V42, P223, DOI 10.1093/chemse/bjw108; Albrecht J, 2006, NERVENARZT, V77, P931, DOI 10.1007/s00115-006-2121-z; Belluscio BA, 2011, MOVEMENT DISORD, V26, P2538, DOI 10.1002/mds.23977; Brown C, 2001, AM J OCCUP THER, V55, P75, DOI 10.5014/ajot.55.1.75; BROWN EC, 1958, J CONSULT PSYCHOL, V22, P469, DOI 10.1037/h0039980; Cavanna Andrea Eugenio, 2009, Discov Med, V8, P191; Connelly T, 2003, J NEUROL NEUROSUR PS, V74, P1435, DOI 10.1136/jnnp.74.10.1435; Croy I, 2017, J NEUROL, V264, P631, DOI 10.1007/s00415-016-8227-8; DANIEL SE, 1992, LANCET, V340, P186, DOI 10.1016/0140-6736(92)93275-R; Demuth W, 1983, Schweiz Arch Neurol Neurochir Psychiatr, V132, P89; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Doty RL, 2009, SEMIN NEUROL, V29, P74, DOI 10.1055/s-0028-1124025; DOTY RL, 1988, NEUROLOGY, V38, P1237, DOI 10.1212/WNL.38.8.1237; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Felling RJ, 2011, J NEUROSCI, V31, P12387, DOI 10.1523/JNEUROSCI.0150-11.2011; Gilbert DL, 2006, NEUROLOGY, V67, P1695, DOI 10.1212/01.wnl.0000242733.18534.2c; Gottfried JA, 2006, NEURON, V49, P467, DOI 10.1016/j.neuron.2006.01.007; Haehner A, 2009, PARKINSONISM RELAT D, V15, P490, DOI 10.1016/j.parkreldis.2008.12.005; Hakyemez HA, 2013, J CLIN NEUROSCI, V20, P1469, DOI 10.1016/j.jocn.2012.11.017; Hallett M, 2015, BRAIN DEV-JPN, V37, P651, DOI 10.1016/j.braindev.2014.11.005; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 2017, RHINOLOGY, V54, P7, DOI 10.4193/Rhino16.248; Insausti R, 2002, BRAIN RES BULL, V57, P557, DOI 10.1016/S0361-9230(01)00684-0; Killgore WDS, 2006, J SLEEP RES, V15, P111, DOI 10.1111/j.1365-2869.2006.00502.x; Kjelvik G, 2012, J NEUROPHYSIOL, V108, P645, DOI 10.1152/jn.01036.2010; Landis BN, 2011, KIDNEY INT, V80, P886, DOI 10.1038/ki.2011.189; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Leckman JF, 1998, TOURETTES SYNDROME D; Lerner A, 2012, BRAIN, V135, P1926, DOI 10.1093/brain/aws104; Ludolph AG, 2012, DTSCH ARZTEBL INT, V109, P821, DOI 10.3238/arztebl.2012.0821; Neuner I, 2013, INT REV NEUROBIOL, V112, P35, DOI 10.1016/B978-0-12-411546-0.00002-0; NORDIN S, 1995, J GERONTOL B-PSYCHOL, V50, pP187, DOI 10.1093/geronb/50B.4.P187; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patel N, 2014, LANCET NEUROL, V13, P100, DOI 10.1016/S1474-4422(13)70213-8; Patel RM, 2014, CLIN ANAT, V27, P54, DOI 10.1002/ca.22338; Peterson BS, 2007, ARCH GEN PSYCHIAT, V64, P1281, DOI 10.1001/archpsyc.64.11.1281; Puts NAJ, 2015, J NEUROPHYSIOL, V114, P808, DOI 10.1152/jn.00060.2015; Retz-Junginger P, 2003, NERVENARZT, V74, P987, DOI 10.1007/s00115-002-1447-4; Robertson MM, 2012, ARCH DIS CHILDHOOD-E, V97, P166, DOI 10.1136/archdischild-2011-300585; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; Schecklmann M, 2013, J NEURAL TRANSM, V120, P121, DOI 10.1007/s00702-012-0855-2; Schecklmann M, 2011, NEUROPSYCHOBIOLOGY, V63, P66, DOI 10.1159/000323448; Schunke O, 2016, PARKINSONISM RELAT D, V24, P132, DOI 10.1016/j.parkreldis.2016.01.006; Segura B, 2013, INT REV NEUROBIOL, V112, P73, DOI 10.1016/B978-0-12-411546-0.00003-2; Seubert J, 2013, CEREB CORTEX, V23, P2448, DOI 10.1093/cercor/bhs230; Seubert J, 2013, NEUROIMAGE, V66, P333, DOI 10.1016/j.neuroimage.2012.10.030; Singer HS, 2010, MED HYPOTHESES, V74, P862, DOI 10.1016/j.mehy.2009.11.028; SINGER HS, 1991, ANN NEUROL, V30, P558, DOI 10.1002/ana.410300408; Steeves TDL, 2010, ANN NEUROL, V67, P170, DOI 10.1002/ana.21809; Stockhorst U, 2004, PHYSIOL BEHAV, V83, P3, DOI 10.1016/j.physbeh.2004.07.018; Udvardi PT, 2013, INT REV NEUROBIOL, V112, P95, DOI 10.1016/B978-0-12-411546-0.00004-4; Westervelt HJ, 2005, ARCH CLIN NEUROPSYCH, V20, P761, DOI 10.1016/j.acn.2005.04.010; Whitcroft KL, 2017, LARYNGOSCOPE, V127, P291, DOI 10.1002/lary.26229; White TL, 2016, BRAIN COGNITION, V104, P1, DOI 10.1016/j.bandc.2016.01.004; White TL, 2003, AM J PSYCHOL, V116, P99, DOI 10.2307/1423337; Winston JS, 2005, J NEUROSCI, V25, P8903, DOI 10.1523/JNEUROSCI.1569-05.2005; Yoon DY, 2007, J NEUROL SCI, V255, P50, DOI 10.1016/j.jns.2007.01.069; Zobel S, 2010, J NEUROL, V257, P2037, DOI 10.1007/s00415-010-5656-7	59	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197598	10.1371/journal.pone.0197598	http://dx.doi.org/10.1371/journal.pone.0197598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI4VN	29874283	Green Published, gold, Green Submitted			2022-12-26	WOS:000434369400028
J	Zhao, FQ; Holahan, MA; Wang, XH; Uslaner, JM; Houghton, AK; Evelhoch, JL; Winkelmann, CT; Hines, CDG				Zhao, Fuqiang; Holahan, Marie A.; Wang, Xiaohai; Uslaner, Jason M.; Houghton, Andrea K.; Evelhoch, Jeffrey L.; Winkelmann, Christopher T.; Hines, Catherine D. G.			fMRI study of the role of glutamate NMDA receptor in the olfactory processing in monkeys	PLOS ONE			English	Article							RECIPROCAL SYNAPSES; PIRIFORM CORTEX; ODOR STIMULI; BLOOD-FLOW; BULB; INHIBITION; LAYER; HABITUATION; RESPONSES; MICROCIRCUITS	Studies in rodents show that olfactory processing in the principal neurons of olfactory bulb (OB) and piriform cortex (PC) is controlled by local inhibitory interneurons, and glutamate NMDA receptor plays a role in this inhibitory control. It is not clear if findings from studies in rodents translate to olfactory processing in nonhuman primates (NHPs). In this study, the effect of the glutamate NMDA receptor antagonist MK801 on odorant-induced olfactory responses in the OB and PC of anesthetized NHPs (rhesus monkeys) was investigated by cerebral blood volume (CBV) fMRI. Isoamyl-acetate was used as the odor stimulant. For each NHP, sixty fMRI measurements were made during a 4-h period, with each 4-min measurement consisting of a 1-min baseline period, a 1-min odor stimulation period, and a 2-min recovery period. MK801 (0.3 mg/kg) was intravenously delivered 1 hour after starting fMRI. Before MK801 injection, olfactory fMRI activations were observed only in the OB, not in the PC. After MK801 injection, olfactory fMRI activations in the OB increased, and robust olfactory fMRI activations were observed in the PC. The data indicate that MK801 enhances the olfactory responses in both the OB and PC. The enhancement effects of MK801 are most likely from its blockage of NMDA receptors on local inhibitory interneurons and the attenuation of the inhibition onto principal neurons. This study suggests that the mechanism of local inhibitory control of principal neurons in the OB and PC derived from studies in rodents translates to NHPs.	[Zhao, Fuqiang; Holahan, Marie A.; Wang, Xiaohai; Uslaner, Jason M.; Houghton, Andrea K.; Evelhoch, Jeffrey L.; Winkelmann, Christopher T.; Hines, Catherine D. G.] Merck & Co Inc, West Point, PA 19486 USA	Merck & Company	Zhao, FQ (corresponding author), Merck & Co Inc, West Point, PA 19486 USA.	fuqiang_zhao@merck.com	Evelhoch, Jeffrey/R-2619-2019	Zhao, Fuqiang/0000-0002-5768-5413	Merck Co., Inc.	Merck Co., Inc.(Merck & Company)	All authors are current or former employees of Merck & Co., Inc., which is the funder of this work. Merck & Co., Inc. provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baumgartner R, 2017, J MAGN RESON IMAGING, V46, P124, DOI 10.1002/jmri.25499; Bennett AJ, 2005, J CARDIOVASC PHARM, V45, P383, DOI 10.1097/01.fjc.0000156820.12339.db; Chaudhury D, 2010, BEHAV NEUROSCI, V124, P490, DOI 10.1037/a0020293; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Doty, 2015, HDB OLFACTION GUSTAT, P605; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Franks KM, 2011, NEURON, V72, P49, DOI 10.1016/j.neuron.2011.08.020; Gottfried JA, 2005, BRAIN RES REV, V50, P287, DOI 10.1016/j.brainresrev.2005.08.004; Gurden H, 2006, NEURON, V52, P335, DOI 10.1016/j.neuron.2006.07.022; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Jin T, 2008, NEUROIMAGE, V43, P1, DOI 10.1016/j.neuroimage.2008.06.029; Johnson BA, 2005, J COMP NEUROL, V483, P205, DOI 10.1002/cne.20409; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Lee B, 2005, J PHARMACOL EXP THER, V312, P1232, DOI 10.1124/jpet.104.078733; Luna VM, 2010, NAT NEUROSCI, V13, P533, DOI 10.1038/nn.2524; Petzold GC, 2008, NEURON, V58, P897, DOI 10.1016/j.neuron.2008.04.029; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Poplawsky AJ, 2015, J NEUROSCI, V35, P15263, DOI 10.1523/JNEUROSCI.1015-15.2015; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; Saleem KS, 2012, COMBINED MRI HISTOLO; Sarrafchi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080621; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Stokes CCA, 2010, NEURON, V67, P452, DOI 10.1016/j.neuron.2010.06.029; Suzuki N, 2012, J NEUROSCI, V32, P919, DOI 10.1523/JNEUROSCI.4112-11.2012; Switzer R., 1985, RAT NERVOUS SYSTEM, P1; TAKAGI SF, 1986, PROG NEUROBIOL, V27, P195, DOI 10.1016/0301-0082(86)90022-5; Wackermannova M, 2016, PHYSIOL RES, V65, P369, DOI 10.33549/physiolres.932955; Xu FQ, 2000, P NATL ACAD SCI USA, V97, P10601, DOI 10.1073/pnas.180321397; Zhao FQ, 2017, NEUROIMAGE, V149, P348, DOI 10.1016/j.neuroimage.2017.01.068; Zhao FQ, 2016, NEUROIMAGE, V127, P445, DOI 10.1016/j.neuroimage.2015.10.080; Zhao FQ, 2015, NEUROIMAGE, V106, P364, DOI 10.1016/j.neuroimage.2014.12.001; Zhao FQ, 2006, NEUROIMAGE, V30, P1149, DOI 10.1016/j.neuroimage.2005.11.013	34	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0198395	10.1371/journal.pone.0198395	http://dx.doi.org/10.1371/journal.pone.0198395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870538	gold, Green Published, Green Submitted			2022-12-26	WOS:000434128400022
J	Hussain, MA; Bhuiyan, A; Luu, CD; Smith, RT; Guymer, RH; Ishikawa, H; Schuman, JS; Ramamohanarao, K				Hussain, Md Akter; Bhuiyan, Alauddin; Luu, Chi D.; Smith, R. Theodore; Guymer, Robyn H.; Ishikawa, Hiroshi; Schuman, Joel S.; Ramamohanarao, Kotagiri			Classification of healthy and diseased retina using SD-OCT imaging and Random Forest algorithm	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MACULAR DEGENERATION; CHOROIDAL THICKNESS; IMAGES; IDENTIFICATION; DIAGNOSIS	In this paper, we propose a novel classification model for automatically identifying individuals with age-related macular degeneration (AMD) or Diabetic Macular Edema (DME) using retinal features from Spectral Domain Optical Coherence Tomography (SD-OCT) images. Our classification method uses retinal features such as the thickness of the retina and the thickness of the individual retinal layers, and the volume of the pathologies such as drusen and hyper-reflective intra-retinal spots. We extract automatically, ten clinically important retinal features by segmenting individual SD-OCT images for classification purposes. The effectiveness of the extracted features is evaluated using several classification methods such as Random Forrest on 251 (59 normal, 177 AMD and 15 DME) subjects. We have performed 15-fold cross-validation tests for three phenotypes; DME, AMD and normal cases using these data sets and achieved accuracy of more than 95% on each data set with the classification method using Random Forrest. When we trained the system as a two-class problem of normal and eye with pathology, using the Random Forrest classifier, we obtained an accuracy of more than 96%. The area under the receiver operating characteristic curve (AUC) finds a value of 0.99 for each dataset. We have also shown the performance of four state-of-the-methods for classification the eye participants and found that our proposed method showed the best accuracy.	[Hussain, Md Akter; Ramamohanarao, Kotagiri] Univ Melbourne, Comp & Informat Syst, Melbourne, Vic, Australia; [Hussain, Md Akter; Bhuiyan, Alauddin] iHealthScreen Inc, Queens, NY 11367 USA; [Luu, Chi D.; Guymer, Robyn H.] Univ Melbourne, Dept Surg Ophthalmol, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Smith, R. Theodore] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Ishikawa, Hiroshi; Schuman, Joel S.] NYU, Sch Med, New York, NY USA	University of Melbourne; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Icahn School of Medicine at Mount Sinai; New York University	Hussain, MA (corresponding author), Univ Melbourne, Comp & Informat Syst, Melbourne, Vic, Australia.; Hussain, MA (corresponding author), iHealthScreen Inc, Queens, NY 11367 USA.	hussain@student.unimelb.edu.au	Ishikawa, Hiroshi/ABC-6293-2020; Schuman, Joel S/K-7304-2012; Schuman, Joel S/M-2389-2019	Ishikawa, Hiroshi/0000-0001-6310-5748; Schuman, Joel S/0000-0002-8885-3766; Schuman, Joel S/0000-0002-8885-3766; Hussain, Md Akter/0000-0002-7780-298X; Guymer, Robyn/0000-0002-9441-4356	University of Melbourne International PhD Research Scholarship; Principal Research Fellowship [1103013]; Australian Research Council (ARC) [DP110102621]	University of Melbourne International PhD Research Scholarship; Principal Research Fellowship; Australian Research Council (ARC)(Australian Research Council)	This research is funded by three funds. M.A. Hussain is supported by the University of Melbourne International PhD Research Scholarship. R.H. Guymer is supported by Principal Research Fellowship (1103013). K. Ramamohanarao is supported by Australian Research Council (ARC DP110102621).	Abramoff Michael D, 2010, IEEE Rev Biomed Eng, V3, P169, DOI 10.1109/RBME.2010.2084567; Acton JH, 2012, INVEST OPHTH VIS SCI, V53, P7618, DOI 10.1167/iovs.12-10361; Albarrak A., 2013, PROC INT C MEDICAL I, P59; [Anonymous], 2016, MATLAB VERS 9 0 0 R2; Chen TC, 2005, ARCH OPHTHALMOL-CHIC, V123, P1715, DOI 10.1001/archopht.123.12.1715; Fraccaro P, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/1471-2415-15-10; Group ETDRS, 1985, ARCH OPHTHALMOL-CHIC, V106, P1796; Guymer RH, 2011, INVEST OPHTH VIS SCI, V52, P4639, DOI 10.1167/iovs.10-7120; Hussain A., 2013, P INT C DIG IM COMP, P1; Hussain MA, 2016, IEEE T BIOMEDICAL EN; Hussain MA, 2018, COMPUT MED IMAG GRAP, V63, P41, DOI 10.1016/j.compmedimag.2018.01.001; Kanagasingam Y, 2014, PROG RETIN EYE RES, V38, P20, DOI 10.1016/j.preteyeres.2013.10.002; Lee CJ, 2006, BIOMATERIALS, V27, P1670, DOI 10.1016/j.biomaterials.2005.09.008; Lemaitre G, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/3298606; Liu YY, 2011, INVEST OPHTH VIS SCI, V52, P8316, DOI 10.1167/iovs.10-7012; Mrejen S, 2013, SURV OPHTHALMOL, V58, P387, DOI 10.1016/j.survophthal.2012.12.001; Reis ASC, 2012, INVEST OPHTH VIS SCI, V53, P1852, DOI 10.1167/iovs.11-9309; Sidibe D, 2017, COMPUT METH PROG BIO, V139, P109, DOI 10.1016/j.cmpb.2016.11.001; Srinivasan PP, 2014, BIOMED OPT EXPRESS, V5, P3568, DOI 10.1364/BOE.5.003568; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Tian J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133908; Venhuizen F. G., 2015, SPIE MED IMAGING; Vujosevic S, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/491835; Wood A, 2011, AM J OPHTHALMOL, V152, P1030, DOI 10.1016/j.ajo.2011.05.021; Wu ZC, 2013, INVEST OPHTH VIS SCI, V54, P2800, DOI 10.1167/iovs.13-11613	25	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198281	10.1371/journal.pone.0198281	http://dx.doi.org/10.1371/journal.pone.0198281			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864167	Green Published, Green Submitted, gold			2022-12-26	WOS:000434097100026
J	Sarwar, A; Brader, G; Corretto, E; Aleti, G; Abaidullah, M; Sessitsch, A; Hafeez, FY				Sarwar, Ambrin; Brader, Guenter; Corretto, Erika; Aleti, Gajendar; Abaidullah, Muhammad; Sessitsch, Angela; Hafeez, Fauzia Yusuf			Qualitative analysis of biosurfactants from Bacillus species exhibiting antifungal activity	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT-MASS-SPECTROMETRY; BIOFILM FORMATION; ITURIN-A; LIPOPEPTIDES; SUBTILIS; ANTIBIOTICS; BIOCONTROL; SURFACTIN; CELL	Bacillus spp. produce a broad spectrum of lipopeptide biosurfactants, among which surfactin, iturin and fengycin are widely studied families. The goals of this study were to characterize the biosurfactant activity of Bacillus spp. and to investigate their motility and biofilm formation capabilities. In addition, we extracted lipopeptides from these bacteria to assess their antifungal activities and analyzed these products by mass spectrometry (MS). B. amyloliquefaciens FZB42, Bacillus sp. NH 217 and B. subtilis NH-100 exhibited excellent biosurfactant and surface spreading activities, whereas B. atrophaeus 176s and Paenibacillus polymyxa C1225 showed moderate activity, and B. subtilis 168 showed no activity. Strains FZB42, NH-100, NH-217, 176s and CC125 exhibited excellent biofilm formation capabilities. Lipopeptide extracts displayed good antifungal activity against various phytopathogens and their associated diseases, such as Fusarium moniliforme (rice bakanae disease), Fusarium oxysporum (root rot), Fusarium solani (root rot) and Trichoderma atroviride (ear rot and root rot). Lipopeptide extracts of these strains also showed hemolytic activity, demonstrating their strong potential to produce surfactants. LCMS-ESI analyses identified the presence of surfactin, iturin and fengycin in the extracts of Bacillus strains. Thus, the strains assayed in this study show potential as biocontrol agents against various Fusarium and Trichoderma species.	[Sarwar, Ambrin; Abaidullah, Muhammad; Hafeez, Fauzia Yusuf] COMSATS Inst Informat Technol, Fac Sci, Dept Biosci, Islamabad, Pakistan; [Brader, Guenter; Corretto, Erika; Aleti, Gajendar; Sessitsch, Angela] AIT Austrian Inst Technol GmbH, AIT, Hlth & Environm Dept, Bioresources Unit, Konrad Lorenz Str, Tulln, Austria	COMSATS University Islamabad (CUI); Austrian Institute of Technology (AIT)	Hafeez, FY (corresponding author), COMSATS Inst Informat Technol, Fac Sci, Dept Biosci, Islamabad, Pakistan.	fauzia_y@yahoo.com	Corretto, Erika/V-5796-2019; Aleti, Gajender/AAZ-1506-2021; Hafeez, Fauzia Yusuf/Q-9421-2019; Sessitsch, Angela/AAW-3191-2020; Ullah, Muhammad Abaid/AAP-2014-2021	Corretto, Erika/0000-0002-7767-5191; Sessitsch, Angela/0000-0003-0137-930X; Ullah, Muhammad Abaid/0000-0002-9366-1523; sarwar, ambrin/0000-0002-6493-2443; Aleti, Gajender/0000-0002-1867-9758	Higher Education Commission (HEC) of Pakistan [112-22996-2BM1-183 (50022627)]; HEC project [2511]; International research support initiative program (IRSIP) by HEC	Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan); HEC project; International research support initiative program (IRSIP) by HEC	The authors are thankful to the Higher Education Commission (HEC) of Pakistan for the financial support provided by Indigenous fellowship #112-22996-2BM1-183 (50022627) and HEC project #2511; the International research support initiative program (IRSIP) by HEC; Dr. Angela Sessitsch for providing AIT Lab facility; and Dr. Mazhar lqbal (National Institute for Biotechnology and Genetic Engineering, NIBGE) for LCMS-ESI analysis. The authors are also thankful to AJE (American Journal Experts) services for improving the English and readability of the manuscript.	Aleti G., 2016, ENVIRON MICROBIOL, V18, P264; Aleti G, 2015, COMPUT STRUCT BIOTEC, V13, P192, DOI 10.1016/j.csbj.2015.03.003; Ali S, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0144-x; Arrebola E, 2010, J APPL MICROBIOL, V108, P386, DOI 10.1111/j.1365-2672.2009.04438.x; Athukorala SNP, 2009, CAN J MICROBIOL, V55, P1021, DOI [10.1139/W09-067, 10.1139/w09-067]; BANAT IM, 1993, BIOTECHNOL LETT, V15, P591, DOI 10.1007/BF00138546; Banat IM, 2000, APPL MICROBIOL BIOT, V53, P495, DOI 10.1007/s002530051648; BERNHEIMER AW, 1970, J GEN MICROBIOL, V61, P361, DOI 10.1099/00221287-61-3-361; BESSON F, 1978, J ANTIBIOT, V31, P284, DOI 10.7164/antibiotics.31.284; Bhattacharjee RB, 2012, BIOL FERT SOILS, V48, P173, DOI 10.1007/s00374-011-0614-9; Bodour AA, 1998, J MICROBIOL METH, V32, P273, DOI 10.1016/S0167-7012(98)00031-1; Bonmatin JM, 2003, COMB CHEM HIGH T SCR, V6, P541; Calvio C, 2005, J BACTERIOL, V187, P5356, DOI 10.1128/JB.187.15.5356-5366.2005; Carrillo PG, 1996, WORLD J MICROB BIOT, V12, P82, DOI 10.1007/BF00327807; Chowdhury SP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00780; Connelly MB, 2004, J BACTERIOL, V186, P4159, DOI 10.1128/JB.186.13.4159-4167.2004; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Elhanany E, 2001, RAPID COMMUN MASS SP, V15, P2110, DOI 10.1002/rcm.491; Erhard M, 1997, NAT BIOTECHNOL, V15, P906, DOI 10.1038/nbt0997-906; Hassan MN, 2014, PHYTOPATHOL MEDITERR, V53, P229; Hassan MN, 2010, BIOCONTROL, V55, P531, DOI 10.1007/s10526-010-9268-z; Hiradate S, 2002, PHYTOCHEMISTRY, V61, P693, DOI 10.1016/S0031-9422(02)00365-5; Jacobsen BJ, 2004, PHYTOPATHOLOGY, V94, P1272, DOI 10.1094/PHYTO.2004.94.11.1272; Lima TMS, 2011, BIORESOURCE TECHNOL, V102, P2957, DOI 10.1016/j.biortech.2010.09.109; Luo CP, 2015, APPL MICROBIOL BIOT, V99, P1897, DOI 10.1007/s00253-014-6195-4; MADI L, 1989, PLANT SOIL, V115, P89, DOI 10.1007/BF02220698; Mannanov RN, 2001, CHEM NAT COMPD, V37, P117, DOI 10.1023/A:1012314516354; McSpadden GBB, 2004, PHYTOPATHOLOGY, V94, P1252, DOI DOI 10.1094/PHYT0.2004.94.11.1252; Monteiro L.V.S., 2002, THESIS; Morikawa M, 2000, BBA-MOL CELL BIOL L, V1488, P211, DOI 10.1016/S1388-1981(00)00124-4; Mulligan CN, 2005, ENVIRON POLLUT, V133, P183, DOI 10.1016/j.envpol.2004.06.009; Ongena M, 2005, APPL MICROBIOL BIOT, V69, P29, DOI 10.1007/s00253-005-1940-3; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Ron EZ, 2001, ENVIRON MICROBIOL, V3, P229, DOI 10.1046/j.1462-2920.2001.00190.x; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; Sachdev DP, 2013, APPL MICROBIOL BIOT, V97, P1005, DOI 10.1007/s00253-012-4641-8; Sarwar A, 2018, MICROBIOL RES, V209, P1, DOI 10.1016/j.micres.2018.01.006; Satpute SK, 2008, INDIAN J MAR SCI, V37, P243; Singh P, 2004, BIOCHEM BIOPH RES CO, V319, P291, DOI 10.1016/j.bbrc.2004.04.155; SIVAN A, 1984, PHYTOPATHOLOGY, V74, P498, DOI 10.1094/Phyto-74-498; Somasegaran P., 1994, HDB RHIZOBIA METHODS, P450, DOI [10.1007/978-1-4613-8375-8, DOI 10.1007/978-1-4613-8375-8, https://doi.org/10.1007/978-1-4613-8375-8]; THIMON L, 1992, BIOTECHNOL APPL BIOC, V16, P144; VANITTANAKOM N, 1986, J ANTIBIOT, V39, P888, DOI 10.7164/antibiotics.39.888; Vater J, 2003, COMB CHEM HIGH T SCR, V6, P557; Vater J, 2002, APPL ENVIRON MICROB, V68, P6210, DOI 10.1128/AEM.68.12.6210-6219.2002; Walter V, 2010, ADV EXP MED BIOL, V672, P1; Wang J, 2007, APPL MICROBIOL BIOT, V76, P889, DOI 10.1007/s00253-007-1054-1; Yonebayashi H, 2000, SEKIYU GAKKAISHI, V43, P59; Youssef NH, 2004, J MICROBIOL METH, V56, P339, DOI 10.1016/j.mimet.2003.11.001; Yu GY, 2002, SOIL BIOL BIOCHEM, V34, P955, DOI 10.1016/S0038-0717(02)00027-5; Zeriouh H, 2014, ENVIRON MICROBIOL, V16, P2196, DOI 10.1111/1462-2920.12271	53	48	48	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198107	10.1371/journal.pone.0198107	http://dx.doi.org/10.1371/journal.pone.0198107			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864153	Green Published, gold, Green Submitted			2022-12-26	WOS:000434097100020
J	Stern, AL; Van der Verren, SE; Kanchugal, PS; Nasvall, J; Gutierrez-de-Teran, H; Selmer, M				Stern, Ana Laura; Van der Verren, Sander Egbert; Kanchugal, Sandesh P.; Nasvall, Joakim; Gutierrez-de-Teran, Hugo; Selmer, Maria			Structural mechanism of AadA, a dual-specificity aminoglycoside adenylyltransferase from Salmonella enterica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; enzyme structure; enzyme mechanism; X-ray crystallography; antibiotics; ATP; spectinomycin; streptomycin	RESISTANCE; SEQUENCE	Streptomycin and spectinomycin are antibiotics that bind to the bacterial ribosome and perturb protein synthesis. The clinically most prevalent bacterial resistance mechanism is their chemical modification by aminoglycoside-modifying enzymes such as aminoglycoside nucleotidyltransferases (ANTs). AadA from Salmonella enterica is an aminoglycoside (3)(9) adenylyltransferase that O-adenylates position 3 of streptomycin and position 9 of spectinomycin. We previously reported the apo-AadA structure with a closed active site. To clarify how AadA binds ATP and its two chemically distinct drug substrates, we here report crystal structures of WT AadA complexed with ATP, magnesium, and streptomycin and of an active-site mutant, E87Q, complexed with ATP and streptomycin or the closely related dihydrostreptomycin. These structures revealed that ATP binding induces a conformational change that positions the two domains for drug binding at the interdomain cleft and disclosed the interactions between both domains and the three rings of streptomycin. Spectinomycin docking followed by molecular dynamics simulations suggested that, despite the limited structural similarities with streptomycin, spectinomycin makes similar interactions around the modification site and, in agreement with mutational data, forms critical interactions with fewer residues. Using structure-guided sequence analyses of ANT(3)(9) enzymes acting on both substrates and ANT(9) enzymes active only on spectinomycin, we identified sequence determinants for activity on each substrate. We experimentally confirmed that Trp-173 and Asp-178 are essential only for streptomycin resistance. Activity assays indicated that Glu-87 is the catalytic base in AadA and that the nonadenylating E87Q mutant can hydrolyze ATP in the presence of streptomycin.	[Stern, Ana Laura; Van der Verren, Sander Egbert; Kanchugal, Sandesh P.; Gutierrez-de-Teran, Hugo; Selmer, Maria] Uppsala Univ, Dept Cell & Mol Biol, BMC, Box 596, SE-75124 Uppsala, Sweden; [Nasvall, Joakim] Uppsala Univ, Dept Med Biochem & Microbiol, BMC, SE-75123 Uppsala, Sweden; [Van der Verren, Sander Egbert] Vrije Univ Brussel, Struct & Mol Microbiol, VIB VUB Ctr Struct Biol, Pl Laan 2, B-1050 Brussels, Belgium; [Van der Verren, Sander Egbert] Vrije Univ Brussel, Struct Biol Brussels, Pl Laan 2, B-1050 Brussels, Belgium	Uppsala University; Uppsala University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel	Selmer, M (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, BMC, Box 596, SE-75124 Uppsala, Sweden.	maria.selmer@icm.uu.se	Näsvall, Joakim/F-8750-2018	Näsvall, Joakim/0000-0002-6831-3105; Selmer, Maria/0000-0001-9079-2774; Van der Verren, Sander/0000-0002-8783-1194; Kanchugal P, Sandesh/0000-0001-5127-9695	Swedish Research Council [2013-05930, 2017-03827]; Knut and Alice Wallenberg Foundation (RiboCORE); European Community's Seventh Framework Programme (FP7) under BioStruct-X Grant [283570]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation (RiboCORE); European Community's Seventh Framework Programme (FP7) under BioStruct-X Grant	This work was supported by Swedish Research Council Grants 2013-05930 and 2017-03827 and the Knut and Alice Wallenberg Foundation (RiboCORE) (to M. S.) and by funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X Grant Agreement 283570. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Azucena E, 2001, DRUG RESIST UPDATE, V4, P106, DOI 10.1054/drup.2001.0197; Bassenden AV, 2016, ACS CHEM BIOL, V11, P1339, DOI 10.1021/acschembio.5b01070; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Becker B, 2013, ACS CHEM BIOL, V8, P105, DOI 10.1021/cb3005116; Borovinskaya MA, 2007, ACS CHEM BIOL, V2, P545, DOI 10.1021/cb700100n; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Chen Y, 2015, ACTA CRYSTALLOGR D, V71, P2267, DOI 10.1107/S1399004715016429; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Clark NC, 1999, ANTIMICROB AGENTS CH, V43, P157, DOI 10.1093/jac/43.1.157; Davies J, 1997, TRENDS MICROBIOL, V5, P234, DOI 10.1016/S0966-842X(97)01033-0; Durante-Mangoni E, 2009, INT J ANTIMICROB AG, V33, P201, DOI 10.1016/j.ijantimicag.2008.09.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; HOLLINGSHEAD S, 1985, PLASMID, V13, P17, DOI 10.1016/0147-619X(85)90052-6; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim C, 2006, BIOCHEMISTRY-US, V45, P8368, DOI 10.1021/bi060723g; Koskiniemi S, 2011, MOL MICROBIOL, V80, P1464, DOI 10.1111/j.1365-2958.2011.07657.x; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minkenhof J. E., 1950, NED TIJDSCHR GENEES, V94, P2129; Morar M, 2009, STRUCTURE, V17, P1649, DOI 10.1016/j.str.2009.10.013; Nasvall J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184126; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nirdnoy W, 2005, ANTIMICROB AGENTS CH, V49, P2454, DOI 10.1128/AAC.49.6.2454-2459.2005; Papadovasilaki Maria, 2015, Biochem Biophys Rep, V4, P152, DOI 10.1016/j.bbrep.2015.09.011; PEDERSEN LC, 1995, BIOCHEMISTRY-US, V34, P13305, DOI 10.1021/bi00041a005; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Wilson DN, 2014, NAT REV MICROBIOL, V12, P35, DOI 10.1038/nrmicro3155; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013	41	17	18	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11481	11490		10.1074/jbc.RA118.003989	http://dx.doi.org/10.1074/jbc.RA118.003989			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29871922	Green Published, hybrid			2022-12-26	WOS:000439449700018
J	Yanda, MK; Liu, QN; Cebotaru, L				Yanda, Murali K.; Liu, Qiangni; Cebotaru, Liudmila			A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; cell signaling; chaperone; drug action; fucosyltransferase; glucose metabolism; I-cell disease (mucolipidosis II); ion channel; autosomal dominant polycystic kidney disease; renal cyst growth; VX-809; cystic fibrosis transmembrane conductance regulator (CFTR); kidney disfunction; heat shock protein; Hsp90	ENDOPLASMIC-RETICULUM STRESS; EPITHELIAL-CELLS; IN-VITRO; FIBROSIS; PROTEIN; PROTEOSTASIS; CANCER; GROWTH; DELTA-F508-CFTR; INHIBITION	Autosomal dominant polycystic kidney disease (ADPKD) is associated with progressive enlargement of cysts, leading to a decline in function and renal failure that cannot be prevented by current treatments. Mutations in pkd1 and pkd2, encoding the polycystin 1 and 2 proteins, induce growth-related pathways, including heat shock proteins, as occurs in some cancers, raising the prospect that pharmacological interventions that target these pathways might alleviate or prevent ADPKD. Here, we demonstrate a role for VX-809, a corrector of cystic fibrosis transmembrane conductance regulator (CFTR), conventionally used to manage cystic fibrosis in reducing renal cyst growth. VX-809 reduced cyst growth in Pkd1-knockout mice and in proximal, tubule-derived, cultured Pkd1 knockout cells. VX-809 reduced both basal and forskolin-activated cAMP levels and also decreased the expression of the adenylyl cyclase AC3 but not of AC6. VX-809 also decreased resting levels of intracellular Ca2+ but did not affect ATP-stimulated Ca2+ release. Notably, VX-809 dramatically decreased thapsigargin-induced release of Ca2+ from the endoplasmic reticulum (ER). VX-809 also reduced the levels of heat shock proteins Hsp27, Hsp70, and Hsp90 in mice cystic kidneys, consistent with the restoration of cellular proteostasis. Moreover, VX-809 strongly decreased an ER stress marker, the GADD153 protein, and cell proliferation but had only a small effect on apoptosis. Given that administration of VX-809 is safe, this drug potentially offers a new way to treat patients with ADPKD.	[Yanda, Murali K.; Liu, Qiangni; Cebotaru, Liudmila] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University	Cebotaru, L (corresponding author), Johns Hopkins Univ, Sch Med, Hunterian 415,725 N Wolfe St, Baltimore, MD 21205 USA.	lcebotaru@jhmi.edu	Yanda, Murali K/N-2324-2019	Yanda, Murali K/0000-0002-4913-470X; Cebotaru, Liudmila/0000-0002-4362-8995	NIDDK NIH HHS [P30 DK089502, P30 DK090868] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090868, P30DK089502] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Al-Bhalal L, 2005, ADV ANAT PATHOL, V12, P126, DOI 10.1097/01.pap.0000163959.29032.1f; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bastos AP, 2011, BRAZ J MED BIOL RES, V44, P606, DOI [10.1590/S0100-879X2011007500068, 10.1590/S0100-879X2011000700001]; Bobo LD, 2013, INFECT IMMUN, V81, P713, DOI 10.1128/IAI.00186-12; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Calvet JP, 2001, SEMIN NEPHROL, V21, P107, DOI 10.1053/snep.2001.20929; Cebotaru L, 2016, KIDNEY INT, V90, P90, DOI 10.1016/j.kint.2016.01.026; Dai C, 2016, TRENDS CELL BIOL, V26, P17, DOI 10.1016/j.tcb.2015.10.011; El-Hariry I., 2014, U. S. Patent, Patent No. [US8906885B2, 8906885]; FULLER CM, 1992, AM J PHYSIOL, V263, pC267, DOI 10.1152/ajpcell.1992.263.2.C267; Gurlo T, 2016, MOL ENDOCRINOL, V30, P446, DOI 10.1210/me.2015-1255; Gyrd-Hansen M, 2004, CELL CYCLE, V3, P1484, DOI 10.4161/cc.3.12.1287; Hanaoka K, 1996, AM J PHYSIOL-CELL PH, V270, pC389, DOI 10.1152/ajpcell.1996.270.1.C389; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Ikeda M, 2006, CELL PHYSIOL BIOCHEM, V18, P9, DOI 10.1159/000095133; Joly D, 2006, J BIOL CHEM, V281, P26329, DOI 10.1074/jbc.M601373200; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Krebs J, 2015, BIOCHEM BIOPH RES CO, V460, P114, DOI 10.1016/j.bbrc.2015.02.004; Li Y, 2009, J BIOL CHEM, V284, P36431, DOI 10.1074/jbc.M109.068916; Lopes-Pacheco M, 2015, J BIOL CHEM, V290, P25636, DOI 10.1074/jbc.M115.671925; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; Mangolini Alessandra, 2016, World J Nephrol, V5, P76, DOI 10.5527/wjn.v5.i1.76; Menzies RI, 2017, KIDNEY INT, V91, P315, DOI 10.1016/j.kint.2016.08.029; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Ong ACM, 2015, KIDNEY INT, V88, P699, DOI 10.1038/ki.2015.207; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Persson AEG, 2015, ACTA PHYSIOL, V213, P805, DOI 10.1111/apha.12459; Peters KW, 2011, METHODS MOL BIOL, V742, P335, DOI 10.1007/978-1-61779-120-8_20; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Proia D., 2015, U. S. Patent, Patent No. [US20150283147A1, 20150283147]; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; Rieg T, 2014, AM J PHYSIOL-RENAL, V306, pF701, DOI 10.1152/ajprenal.00656.2013; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenstein BJ, 1998, LANCET, V351, P277, DOI 10.1016/S0140-6736(97)09174-5; Roth DM, 2011, CURR OPIN CELL BIOL, V23, P126, DOI 10.1016/j.ceb.2010.11.001; Roth DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001998; Santoso NG, 2011, CELL PHYSIOL BIOCHEM, V27, P715, DOI 10.1159/000330080; Seeger-Nukpezah T, 2013, P NATL ACAD SCI USA, V110, P12786, DOI 10.1073/pnas.1301904110; Shen TS, 1997, AM J PHYSIOL-CELL PH, V273, pC323, DOI 10.1152/ajpcell.1997.273.1.C323; Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165; Southwood XC, 2016, J NEUROSCI, V36, P6803, DOI 10.1523/JNEUROSCI.1118-15.2016; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; Torres VE, 2007, J INTERN MED, V261, P17, DOI 10.1111/j.1365-2796.2006.01743.x; Torres V E, 2007, Minerva Med, V98, P669; Torres VE, 2015, ANNU REV MED, V66, P195, DOI 10.1146/annurev-med-050913-022838; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; Umemura M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089292; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wang XX, 2014, INT J ONCOL, V45, P18, DOI 10.3892/ijo.2014.2399; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Wei F, 2008, KIDNEY INT, V74, P1310, DOI 10.1038/ki.2008.395; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x; Yanda MK, 2017, J BIOL CHEM, V292, P17897, DOI 10.1074/jbc.M117.803775; Zeeshan HMA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030327	65	16	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11513	11526		10.1074/jbc.RA118.001846	http://dx.doi.org/10.1074/jbc.RA118.001846			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29875161	Green Published, hybrid			2022-12-26	WOS:000439449700021
J	Kim, Y; Austin, SB; Subramanian, SV; Kawachi, I				Kim, Yongjoo; Austin, S. Bryn; Subramanian, S., V; Kawachi, Ichiro			Body weight perception, disordered weight control behaviors, and depressive symptoms among Korean adults: The Korea National Health and Nutrition Examination Survey 2014	PLOS ONE			English	Article							YOUNG-ADULTS; SELF-PERCEPTION; SOUTH-KOREA; DIETARY-SUPPLEMENTS; ALCOHOL-CONSUMPTION; PHYSICAL-ACTIVITY; EATING-DISORDERS; MENTAL-HEALTH; RISK-FACTORS; ADOLESCENTS	Background/Purpose Despite emerging evidence suggesting harmful influences of accurate weight perception on psychological health among individuals with obesity, little is known about the association in Asian populations. The aim of this study was investigate the association between body weight perception and depressive symptoms among Korean adults, and potential differential associations across gender. Methods We used data from the sixth Korea National Health and Nutrition Examination Survey in 2014, comprising 3,318 female (n = 1,876) and male (n = 1,442) participants, aged 19-65 years, with no history of depression and a body-mass index (BMI)> = 18.5kg/m(2). Depressive symptoms were measured by the Patient Health Questionnaire-9 Korean version. Weight perception patterns were categorized by comparing self-perceived and objectively measured weight status. Gender-stratified four-level multilevel linear models adjusted for age, BMI, menopause, education, income, marital status, urbanicity, chronic conditions, exercise, smoking, and alcohol use. Subgroup analyses were performed across BMI category. Results Among women with obesity, those who underperceived their weight status reported fewer depressive symptoms compared to those who accurately perceived their weight status (beta = -1.25, p<0.05). Among women with normal weight, those who overperceived their weight status reported more depressive symptoms compared to those who accurately perceived their weight status (beta = 1.00, p<0.05). The same associations were not found in men. Conclusion Awareness-oriented strategies for obesity prevention and weight management focused on providing information on weight status may need to consider unintended consequences of accurate weight perception on mental health among individuals with obesity, particularly among women.	[Kim, Yongjoo; Austin, S. Bryn; Subramanian, S., V; Kawachi, Ichiro] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Austin, S. Bryn] Boston Childrens Hosp, Div Adolescent & Young Adult Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital	Kim, Y (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA.	yongjoo.kim@mail.harvard.edu	Kim, Yongjoo/N-9751-2019	Kim, Yongjoo/0000-0002-0768-9256	Ellen Feldberg Gordon Challenge Fund for Eating Disorders Research; Strategic Training Initiative for the Prevention of Eating Disorders	Ellen Feldberg Gordon Challenge Fund for Eating Disorders Research; Strategic Training Initiative for the Prevention of Eating Disorders	This work was supported by the Ellen Feldberg Gordon Challenge Fund for Eating Disorders Research and the Strategic Training Initiative for the Prevention of Eating Disorders (https://www.hsph.harvard.edu/striped/for-students/development-award/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mamun A, 2007, OBESITY, V15, P3097, DOI 10.1038/oby.2007.369; Ali MM, 2010, J MENT HEALTH POLICY, V13, P53; Almond D, 2016, P NATL ACAD SCI USA, V113, P3488, DOI 10.1073/pnas.1518443113; An Je Yong, 2013, [Journal of the Korean Society of Biological Therapies in Psychiatry, 생물치료정신의학], V19, P47; Antin TMJ, 2011, BODY IMAGE, V8, P149, DOI 10.1016/j.bodyim.2011.01.002; Apovian CM, 2015, J CLIN ENDOCR METAB, V100, P342, DOI 10.1210/jc.2014-3415; Austin SB, 2013, EAT DISORD, V21, P91, DOI 10.1080/10640266.2013.761080; Brown RA, 1996, J AM ACAD CHILD PSY, V35, P1602, DOI 10.1097/00004583-199612000-00011; Calzo JP, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4073; Chamay-Weber C, 2005, J ADOLESCENT HEALTH, V37, P417, DOI 10.1016/j.jadohealth.2004.09.014; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; Clapham JC, 2001, PHARMACOL THERAPEUT, V89, P81, DOI 10.1016/S0163-7258(00)00105-4; Daly M, 2017, PSYCHOL SCI, V28, P872, DOI 10.1177/0956797617696311; Dollar E, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.170006; Duncan DT, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-20; Dunn A.L., 2001, PHYS ACTIVITY DOSE R; Dunn EC, 2015, AM J PUBLIC HEALTH, V105, P732, DOI 10.2105/AJPH.2014.302374; Edwards NM, 2010, PEDIATRICS, V125, pE452, DOI 10.1542/peds.2009-0185; Gaskin JL, 2013, J AFFECT DISORDERS, V150, P350, DOI 10.1016/j.jad.2013.04.017; Grant BF, 2003, DRUG ALCOHOL DEPEN, V71, P7, DOI 10.1016/S0376-8716(03)00070-X; Han CS, 2008, COMPR PSYCHIAT, V49, P218, DOI 10.1016/j.comppsych.2007.08.006; Haynes A, 2018, OBES REV, V19, P347, DOI 10.1111/obr.12634; Heeringa SG, 2017, APPL SURVEY DATA ANA, VSecond, DOI DOI 10.1201/9781315153278; Holliday R, 2012, BODY SOC, V18, P58, DOI 10.1177/1357034X12440828; Hunger JM, 2014, JAMA PEDIATR, V168, P579, DOI 10.1001/jamapediatrics.2014.122; Joh HK, 2013, OBESITY FACTS, V6, P17, DOI 10.1159/000346805; Johnson F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a494; Jung J, 2007, PSYCHOL WOMEN QUART, V31, P381, DOI 10.1111/j.1471-6402.2007.00387.x; Kang JG, 2012, DIABETES METAB J, V36, P13, DOI 10.4093/dmj.2012.36.1.13; Kim CS, 2014, DIABETES METAB J, V38, P35, DOI 10.4093/dmj.2014.38.1.35; Kim HJ, 2014, FOOD ADDIT CONTAM A, V31, P777, DOI 10.1080/19440049.2014.888497; Kim MK, 2014, ENDOCRINOL METAB, V29, P405, DOI 10.3803/EnM.2014.29.4.405; Kim M, 2010, NUTR RES PRACT, V4, P499, DOI 10.4162/nrp.2010.4.6.499; Kim Y, 2018, INT J EAT DISORDER, V51, P124, DOI 10.1002/eat.22820; Kim Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154826; Korea Centers for Disease Control and Prevention, 2015, STAT 11 KOR YOUTH RI; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lange K, 2015, J HEALTH PSYCHOL, V20, P1558, DOI 10.1177/1359105313517275; Lee K, 2018, J ADOLESCENCE, V63, P118, DOI 10.1016/j.adolescence.2017.12.008; Liechty JM, 2013, INT J EAT DISORDER, V46, P790, DOI 10.1002/eat.22174; Lim HJ, 2013, OBESITY, V21, P2596, DOI 10.1002/oby.20361; Lin YC, 2018, OBESITY, V26, P397, DOI 10.1002/oby.22041; Marini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083543; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Park S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016098; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Pike KM, 2015, J EAT DISORD, V3, DOI 10.1186/s40337-015-0070-2; Powell AG, 2011, CLIN PHARMACOL THER, V90, P40, DOI 10.1038/clpt.2011.82; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; 박승진, 2010, [Anxiety and Mood, 대한불안의학회지], V6, P119; Robinson E, 2017, INT J OBESITY, V41, P1160, DOI 10.1038/ijo.2017.85; Robinson E, 2015, INT J OBESITY, V39, P1721, DOI 10.1038/ijo.2015.143; Rocha T, 2016, COMPR REV FOOD SCI F, V15, P43, DOI 10.1111/1541-4337.12173; Samat Ashish, 2008, Recent Pat Cardiovasc Drug Discov, V3, P187, DOI 10.2174/157489008786264014; Sonneville KR, 2016, INT J OBESITY, V40, P328, DOI 10.1038/ijo.2015.166; Sonneville KR, 2016, INT J EAT DISORDER, V49, P937, DOI 10.1002/eat.22565; Stice E, 2001, DEV PSYCHOL, V37, P597, DOI 10.1037/0012-1649.37.5.597; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; ter Bogt TFM, 2006, J ADOLESCENT HEALTH, V39, P27, DOI 10.1016/j.jadohealth.2005.09.007; Thurston I.B., 2016, PREV SCI, P1; Unger ES, 2017, J ADOLESCENT HEALTH, V60, P680, DOI 10.1016/j.jadohealth.2016.12.017; Voelker R, 2017, JAMA-J AM MED ASSOC, V317, P2477, DOI 10.1001/jama.2017.7240; Weitzman ER, 2004, J NERV MENT DIS, V192, P269, DOI 10.1097/01.nmd.0000120885.17362.94; Winter AL, 2002, CAN J PUBLIC HEALTH, V93, P362, DOI 10.1007/BF03404570; Yoon J, 2016, NICOTINE TOB RES, V18, P2138, DOI 10.1093/ntr/ntw116; Yuan ASV, 2010, J YOUTH ADOLESCENCE, V39, P927, DOI 10.1007/s10964-009-9428-6	67	28	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198841	10.1371/journal.pone.0198841	http://dx.doi.org/10.1371/journal.pone.0198841			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ5MF	29902214	Green Submitted, Green Published, gold			2022-12-26	WOS:000435424900046
J	Stromberg, LR; Mendez, HM; Kubicek-Sutherland, JZ; Graves, SW; Hengartner, NW; Mukundan, H				Stromberg, Loreen R.; Mendez, Heather M.; Kubicek-Sutherland, Jessica Z.; Graves, Steven W.; Hengartner, Nicolas W.; Mukundan, Harshini			Presentation matters: Impact of association of amphiphilic LPS with serum carrier proteins on innate immune signaling	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; LIPOPOLYSACCHARIDE (LPS)-BINDING PROTEIN; CRITICAL MICELLE CONCENTRATION; PATTERN-RECOGNITION RECEPTORS; BACTERIAL LIPOPOLYSACCHARIDES; LIPOTEICHOIC ACID; BINDING PROTEIN; PATHOGEN RECOGNITION; ENDOGENOUS LIGANDS; GENE-EXPRESSION	Recognition of Pathogen-associated Molecular Patterns (PAMPs) by Toll-like receptors is central to innate immunity. Many bacterial PAMPs such as lipopolysaccharide (LPS) and lipoteichoic acid have amphiphilic properties. The hydrophobicity of amphiphilic PAMPs contributes to increasing entropy and causes these molecules to self-aggregate or bind host carrier proteins in aqueous physiological environments. The goal of this work was to determine how innate immune signaling is impacted by physical presentation and association of amphiphilic PAMPs with serum carrier proteins, using LPS as an example molecule. Specifically, we measured LPS-induced cytokine profiles in murine macrophages when the antigen was presented associated with the various serum carrier proteins in serum versus a serum-depleted system. Our study demonstrates that the observed cytokine profiles are dramatically different when LPS is presented in buffer, versus in serum when it is associated with proteins, specifically with respect to inhibition of pro-inflammatory cytokines in the latter. These studies suggest that LPS-mediated cytokine expression is dependent on its presentation in physiological systems. The amphiphilicity of bacterial PAMPs and consequent association with lipoproteins is a feature, which should be taken into account in the design of in vitro experiments. Further studies of the interdependencies of different serum carriers can identify pathways for drug delivery and diagnostics.	[Stromberg, Loreen R.; Mendez, Heather M.; Graves, Steven W.; Mukundan, Harshini] Univ New Mexico, Ctr Biomed Engn, Albuquerque, NM 87131 USA; [Stromberg, Loreen R.; Mendez, Heather M.; Kubicek-Sutherland, Jessica Z.; Mukundan, Harshini] Los Alamos Natl Lab, Phys Chem & Appl Spect, Los Alamos, NM 87545 USA; [Stromberg, Loreen R.; Mendez, Heather M.; Mukundan, Harshini] New Mexico Consortium, Los Alamos, NM 87544 USA; [Hengartner, Nicolas W.] Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM USA; [Stromberg, Loreen R.] Iowa State Univ, Mech Engn, Ames, IA USA	University of New Mexico; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Iowa State University	Mukundan, H (corresponding author), Univ New Mexico, Ctr Biomed Engn, Albuquerque, NM 87131 USA.; Mukundan, H (corresponding author), Los Alamos Natl Lab, Phys Chem & Appl Spect, Los Alamos, NM 87545 USA.; Mukundan, H (corresponding author), New Mexico Consortium, Los Alamos, NM 87544 USA.	harshini@lanl.gov	Kubicek-Sutherland, Jessica/ABB-5887-2020	Kubicek-Sutherland, Jessica/0000-0001-6215-4871	National Nuclear Security Administration of the United States Department of Energy [DE-AC52-06NA25396]; Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture's National Institute of Food and Agriculture [2012-68003-30155]; Los Alamos National Laboratory Directed Research Award, Integrative Biosurveillance	National Nuclear Security Administration of the United States Department of Energy(National Nuclear Security Administration); Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture's National Institute of Food and Agriculture; Los Alamos National Laboratory Directed Research Award, Integrative Biosurveillance	Los Alamos National Laboratory, an affirmative action equal opportunity employer, is operated by Los Alamos National Security, LLC, for the National Nuclear Security Administration of the United States Department of Energy under contract No. DE-AC52-06NA25396. H.M., H.M.M, S.W.G and L.R.S. were supported in part by Agriculture and Food Research Initiative Competitive Grant No. 2012-68003-30155 from the United States Department of Agriculture's National Institute of Food and Agriculture. N.W.H. was supported by Los Alamos National Laboratory Directed Research Award, Integrative Biosurveillance (Mukundan and McMahon).	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Aurell CA, 1998, BIOCHEM BIOPH RES CO, V253, P119, DOI 10.1006/bbrc.1998.9773; BECKER S, 1987, J IMMUNOL, V139, P3703; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Brandenburg K, 2009, ADV EXP MED BIOL, V667, P25, DOI 10.1007/978-1-4419-1603-7_3; CAVAILLON JM, 1990, INFECT IMMUN, V58, P2375, DOI 10.1128/IAI.58.7.2375-2382.1990; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; EGAN RW, 1976, J BIOL CHEM, V251, P4442; EISENBERG S, 1984, J LIPID RES, V25, P1017; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; Feingold KR, 2011, J LIPID RES, V52, P1, DOI 10.1194/jlr.E012138; Fenton MJ, 1998, J LEUKOCYTE BIOL, V64, P25, DOI 10.1002/jlb.64.1.25; Fukuno N, 2011, BIOCHEM BIOPH RES CO, V408, P202, DOI 10.1016/j.bbrc.2011.02.127; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Grunfeld C, 1999, J LIPID RES, V40, P245; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Haeffner E, 1988, CHEM CARCINOGENESIS, P475; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Han SH, 2003, INFECT IMMUN, V71, P5541, DOI 10.1128/IAI.71.10.5541-5548.2003; HARRIS HW, 1990, J CLIN INVEST, V86, P696, DOI 10.1172/JCI114765; Hoshino K, 1999, J IMMUNOL, V162, P3749; Katsuta H, 1973, Methods Cell Biol, V6, P1, DOI 10.1016/S0091-679X(08)60046-1; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Koh JS, 1998, J CLIN INVEST, V102, P716, DOI 10.1172/JCI1002; Lamping N, 1998, J CLIN INVEST, V101, P2065, DOI 10.1172/JCI2338; Lorenz E, 2002, INFECT IMMUN, V70, P4892, DOI 10.1128/IAI.70.9.4892-4896.2002; Lu B, J EXPT MED; Maeda H, 1997, J PHYS CHEM B, V101, P7378, DOI 10.1021/jp9633815; MAUEL J, 1971, J EXP MED, V134, P335, DOI 10.1084/jem.134.2.335; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Mita Y, 2001, BRIT J HAEMATOL, V112, P1041, DOI 10.1046/j.1365-2141.2001.02658.x; MOCARELLI P, 1973, IMMUNOL COMMUN, V2, P441, DOI 10.3109/08820137309022816; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; MORRISON DC, 1976, IMMUNOCHEMISTRY, V13, P813, DOI 10.1016/0019-2791(76)90181-6; Muller M, 2003, J ENDOTOXIN RES, V9, P181, DOI 10.1179/096805103125001595; Netea MG, 1998, CYTOKINE, V10, P766, DOI 10.1006/cyto.1998.0364; Oliveira MDL, 2011, J COLLOID INTERF SCI, V362, P194, DOI 10.1016/j.jcis.2011.06.042; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; Ortiz-Montero P, 2017, J CELL COMMUN SIGNAL, V15; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Quan N, 2001, J NEUROIMMUNOL, V115, P36, DOI 10.1016/S0165-5728(01)00273-9; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rangin M, 2004, J AM CHEM SOC, V126, P5038, DOI 10.1021/ja039822x; READ TE, 1995, SURGERY, V117, P62, DOI 10.1016/S0039-6060(05)80231-4; Ryan J., 2008, ENDOTOXINS CELL CULT; Ryu JK, 2017, IMMUNITY, V46, P38, DOI 10.1016/j.immuni.2016.11.007; SCHAEDLER R, 1961, J EXP MED, V113, P559, DOI 10.1084/jem.113.3.559; Schromm AB, 1998, J IMMUNOL, V161, P5464; Shimazu R, 1999, J EXPER MED, V189; Stromberg LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156295; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tapping RI, 2003, J ENDOTOXIN RES, V9, P264, DOI 10.1179/096805103225001477; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Triantafilou M, 2004, J BIOL CHEM, V279, P40882, DOI 10.1074/jbc.M400466200; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; van Bergenhenegouwen J, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0180-x; VANLENTEN BJ, 1986, P NATL ACAD SCI USA, V83, P2704; VICTOROV AV, 1989, BIOCHIM BIOPHYS ACTA, V984, P119, DOI 10.1016/0005-2736(89)90351-9; Vreugdenhil ACE, 2001, J CLIN INVEST, V107, P225, DOI 10.1172/JCI10832; WALKER WS, 1980, EXP CELL RES, V129, P15, DOI 10.1016/0014-4827(80)90326-2; WURFEL MM, 1994, J EXP MED, V180, P1025, DOI 10.1084/jem.180.3.1025; Yu B, 1997, J CLIN INVEST, V99, P315, DOI 10.1172/JCI119160; Zhou X, 2010, CURR OPIN CLIN NUTR, V13, P541, DOI 10.1097/MCO.0b013e32833cf3bc	73	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198531	10.1371/journal.pone.0198531	http://dx.doi.org/10.1371/journal.pone.0198531			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902192	Green Submitted, gold, Green Published			2022-12-26	WOS:000435424900027
J	Choi, J; Kim, Y; Kim, HS; Choi, IY; Yu, H				Choi, Jingyun; Kim, Yejin; Kim, Hun-Sung; Choi, In Young; Yu, Hwanjo			Phenotyping of Korean patients with better-than-expected efficacy of moderate-intensity statins using tensor factorization	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN; MANAGEMENT	Several studies have been conducted to evaluate the efficacy of statins in Korean and Asian patients. However, most previous studies only observed the percent reduction in low-density lipoprotein cholesterol (LDL-C) and did not consider the effects of various patient conditions simultaneously, such as abnormal test results, patient demographics, and prescribed drugs before taking a statin. Moreover, the characteristics of the patients whose percent reduction in LDL-C was higher than expected were not provided. Therefore, in this study, we aimed to derive meaningful phenotypes by using tensor factorization to observe the characteristics of the patients whose percent reduction in LDL-C was higher than expected among patients taking moderate-intensity statins. In addition, we used the derived phenotypes to predict how much the LDL-C levels of new patients decreased. We consequently identified eight phenotypes that represented the characteristics of the patients whose percent reduction in LDL-C was higher than expected. Moreover, the latent representations of the derived phenotypes achieved prediction performance similar to that obtained using the raw data. These results demonstrate that the derived phenotypes and latent representations are useful tools for observing the characteristics of patients and predicting LDL-C levels. Additionally, our findings provide direction on how to conduct clinical studies in the future.	[Choi, Jingyun; Kim, Yejin; Yu, Hwanjo] Pohang Univ Sci & Technol, Dept Comp Sci & Engn, Pohang, South Korea; [Kim, Hun-Sung; Choi, In Young] Catholic Univ Korea, Coll Med, Dept Med Informat, Seoul, South Korea	Pohang University of Science & Technology (POSTECH); Catholic University of Korea	Yu, H (corresponding author), Pohang Univ Sci & Technol, Dept Comp Sci & Engn, Pohang, South Korea.; Choi, IY (corresponding author), Catholic Univ Korea, Coll Med, Dept Med Informat, Seoul, South Korea.	iychoi@catholic.ac.kr; hwanjoyu@postech.ac.kr			National Research Foundation of Korea (NRF) - Korean Government (MSIP) [2016R1A2B4015922]; Kyung-hee University [2014-0-00147]	National Research Foundation of Korea (NRF) - Korean Government (MSIP); Kyung-hee University	This research was partly supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP, 2016R1A2B4015922) to IYC and Kyung-hee University (2014-0-00147) to HY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn P, 2013, ENDOCRINOL METAB, V28, P331, DOI 10.3803/EnM.2013.28.4.331; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Bader B. W., 2012, MATLAB TENSOR TOOLBO; Barter PJ, 2013, ENDOCRINOL METAB, V28, P169, DOI 10.3803/EnM.2013.28.3.169; Che ZP, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P507, DOI 10.1145/2783258.2783365; Choi J, 2017, ACM-BCB' 2017: PROCEEDINGS OF THE 8TH ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY,AND HEALTH INFORMATICS, P516, DOI 10.1145/3107411.3107423; Choi J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177629; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dormuth CR, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f880; Ference BA, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0312-1; Gotto AM, 2012, AM J CARDIOL, V110, p3A, DOI 10.1016/j.amjcard.2012.04.002; Henderson J, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI), P214, DOI 10.1109/ICHI.2017.61; Ho JC, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P115, DOI 10.1145/2623330.2623658; Ho JC, 2014, J BIOMED INFORM, V52, P199, DOI 10.1016/j.jbi.2014.07.001; Kim HS, 2016, J CLIN PHARM THER, V41, P70, DOI 10.1111/jcpt.12350; Kim HS, 2017, BASIC CLIN PHARMACOL, V121, P272, DOI 10.1111/bcpt.12765; Kim HS, 2016, INT J CLIN PHARM TH, V54, P864, DOI 10.5414/CP202332; Kim Y, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P887, DOI 10.1145/3097983.3098118; Kim YJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01139-y; Koo BK, 2014, DIABETES METAB J, V38, P32, DOI 10.4093/dmj.2014.38.1.32; Lasko TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066341; Lee SH, 2014, DIABETES METAB J, V38, P64, DOI 10.4093/dmj.2014.38.1.64; Mancini GBJ, 2011, CAN J CARDIOL, V27, P635, DOI 10.1016/j.cjca.2011.05.007; Mills EJ, 2011, QJM-INT J MED, V104, P109, DOI 10.1093/qjmed/hcq165; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Wang YC, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1265, DOI 10.1145/2783258.2783395; Yang K, 2017, AAAI CONF ARTIF INTE, P2824; Yoon JS, 2013, DIABETES METAB J, V37, P415, DOI 10.4093/dmj.2013.37.6.415	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197518	10.1371/journal.pone.0197518	http://dx.doi.org/10.1371/journal.pone.0197518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897980	gold, Green Published, Green Submitted			2022-12-26	WOS:000435090700015
J	Deodati, A; Argemi, J; Germani, D; Puglianiello, A; Alisi, A; De Stefanis, C; Ferrero, R; Nobili, V; Aragon, T; Cianfarani, S				Deodati, Annalisa; Argemi, Josepmaria; Germani, Daniela; Puglianiello, Antonella; Alisi, Anna; De Stefanis, Cristiano; Ferrero, Roberto; Nobili, Valerio; Aragon, Tomas; Cianfarani, Stefano			The exposure to uteroplacental insufficiency is associated with activation of unfolded protein response in postnatal life	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INTRAUTERINE GROWTH-RETARDATION; THRIFTY PHENOTYPE HYPOTHESIS; ISCHEMIC-HEART-DISEASE; FATTY LIVER-DISEASE; ER STRESS; MODEL; CONSEQUENCES; INHIBITION; METABOLISM	Early life events are associated with the susceptibility to chronic diseases in adult life. Perturbations of endoplasmic reticulum (ER) homeostasis activate the unfolded protein response (UPR), which contributes to the development of metabolic alterations. Our aim was to evaluate liver UPR in an animal model of intrauterine growth restriction (IUGR). A significantly increased expression of X-box binding protein-1 spliced (XBP1s) mRNA (p<0.01), Endoplasmic Reticulum-localized DnaJ homologue (Erdj4) mRNA (p<0.05) and Bip/GRP78-glucose-regulated protein 78 (Bip) mRNA (p<0.05) was observed in the liver of IUGR rats at birth. Furthermore, the expression of gluconeogenesis genes and lipogenesis genes were significantly upregulated (p<0.05) in IUGR pups. At 105 d, IUGR male rats showed significantly reduced glucose tolerance (p<0.01). A significant decreased expression of XBP1s mRNA (p<0.01) and increased expression of double-stranded RNA-dependent protein kinase-like ER kinase (PERK) and Asparagine synthetase (ASNS) (p<0.05) was observed in the liver of IUGR male adult rats. Liver focal steatosis and periportal fibrosis were observed in IUGR rats. These findings show for the first time that fetal exposure to uteroplacental insufficiency is associated with the activation of hepatic UPR and suggest that UPR signaling may play a role in the metabolic risk.	[Deodati, Annalisa; Puglianiello, Antonella; Cianfarani, Stefano] Univ Roma Tor Vergata, Bambino Gesu Childrens Hosp, Dipartimento Pediat, Univ Osped, Rome, Italy; [Argemi, Josepmaria; Ferrero, Roberto; Aragon, Tomas] Univ Navarra, Ctr Appl Med Res CIMA, Div Hepatol & Gene Therapy, Pamplona, Spain; [Germani, Daniela] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Alisi, Anna; De Stefanis, Cristiano; Nobili, Valerio] Bambino Gesu Pediat Hosp, Hepatometab Unit, Rome, Italy; [Cianfarani, Stefano] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden	IRCCS Bambino Gesu; University of Rome Tor Vergata; University of Navarra; University of Rome Tor Vergata; IRCCS Bambino Gesu; Karolinska Institutet	Cianfarani, S (corresponding author), Univ Roma Tor Vergata, Bambino Gesu Childrens Hosp, Dipartimento Pediat, Univ Osped, Rome, Italy.; Cianfarani, S (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	stefano.cianfarani@uniroma2.it	Argemi, Josepmaria/AAD-1964-2020; Geremia, Caterina/AAA-9380-2020; Aragon, Tomas/ABH-4616-2020; De Stefanis, Cristiano/AAA-1524-2020; Alisi, Anna/A-6469-2010; cianfarani, stefano/K-2079-2016	Argemi, Josepmaria/0000-0003-1696-7753; Aragon, Tomas/0000-0002-1700-2729; De Stefanis, Cristiano/0000-0001-5898-9518; Alisi, Anna/0000-0001-7241-6329; cianfarani, stefano/0000-0002-2580-8781				BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1986, LANCET, V1, P1077; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Deng YF, 2013, J CLIN INVEST, V123, P455, DOI 10.1172/JCI62819; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Flanagan DE, 2000, AM J PHYSIOL-ENDOC M, V278, pE700, DOI 10.1152/ajpendo.2000.278.4.E700; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Gluckman PD, 2005, EARLY HUM DEV, V81, P51, DOI 10.1016/j.earlhumdev.2004.10.003; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gluckman PD, 2009, LANCET, V373, P1654, DOI 10.1016/S0140-6736(09)60234-8; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee SI, 2012, J PERIODONTAL RES, V47, P299, DOI 10.1111/j.1600-0765.2011.01432.x; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Mao T, 2011, P NATL ACAD SCI USA, V108, P15852, DOI 10.1073/pnas.1107394108; Mounir Z, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001630; Ning J, 2011, ENDOCRINOLOGY, V152, P2247, DOI 10.1210/en.2010-1036; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Puglianiello A, 2007, PEDIATR RES, V61, P433, DOI 10.1203/pdr.0b013e3180332d4e; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Vuguin P, 2004, DIABETES, V53, P2617, DOI 10.2337/diabetes.53.10.2617; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Yung HW, 2012, J PATHOL, V228, P554, DOI 10.1002/path.4068; Yung HW, 2012, FASEB J, V26, P1970, DOI 10.1096/fj.11-190082; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52; Zhou YJ, 2011, NAT MED, V17, P356, DOI 10.1038/nm.2293	32	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198490	10.1371/journal.pone.0198490	http://dx.doi.org/10.1371/journal.pone.0198490			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897997	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700055
J	Peeters, T; Monteagudo, S; Tylzanowski, P; Luyten, FP; Lories, R; Cailotto, F				Peeters, Tine; Monteagudo, Silvia; Tylzanowski, Przemko; Luyten, Frank P.; Lories, Rik; Cailotto, Frederic			SMOC2 inhibits calcification of osteoprogenitor and endothelial cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; DIFFERENTIATION; BINDING; EXPRESSION; IDENTIFY; DISEASES; RECEPTOR	Tissue calcification is an important physiological process required for the normal structure and function of bone. However, ectopic or excessive calcification contributes to diseases such as chondrocalcinosis, to calcium deposits in the skin or to vascular calcification. SMOC2 is a member of the BM-40/osteonectin family of calcium-binding secreted matricellular proteins. Using osteoprogenitor MC3T3-E1 cells stably overexpressing SMOC2, we show that SMOC2 inhibits osteogenic differentiation and extracellular matrix mineralization. Stable Smoc2 knockdown in these cells had no effect on mineralization suggesting that endogenous SMOC2 is not essential for the mineralization process. Mineralization in MC3T3-E1 cells overexpressing mutant SMOC2 lacking the extracellular calcium-binding domain was significantly increased compared to cells overexpressing full length SMOC2. When SMOC2 overexpressing cells were cultured in the presence of extracellular calcium supplementation, SMOC2's inhibitory effect on calcification was rescued. Our observations were translationally validated in primary human periosteal-derived cells. Furthermore, SMOC2 was able to impair mineralization in transdifferentiated human umbilical vein endothelial cells. Taken together, our data indicate that SMOC2 can act as an inhibitor of mineralization. We propose a possible role for SMOC2 to prevent calcification disorders.	[Peeters, Tine; Monteagudo, Silvia; Lories, Rik; Cailotto, Frederic] Katholieke Univ Leuven, Dept Dev & Regenerat, Skeletal Biol & Engn Res Ctr, Lab Tissue Homeostasis & Dis, Leuven, Belgium; [Tylzanowski, Przemko; Luyten, Frank P.] Katholieke Univ Leuven, Dept Dev & Regenerat, Skeletal Biol & Engn Res Ctr, Lab Dev & Stem Cell Biol, Leuven, Belgium; [Tylzanowski, Przemko] Med Univ Lublin, Dept Biochem & Mol Biol, Lublin, Poland; [Luyten, Frank P.; Lories, Rik] Univ Hosp Leuven, Div Rheumatol, Leuven, Belgium; [Cailotto, Frederic] Univ Lorraine, UMR CNRS 7365, Ingn Mol & Physiopathol Articulaire IMoPA, Biopole Univ Lorraine, Campus Biol Sante, Vandoeuvre Les Nancy, France	KU Leuven; KU Leuven; Medical University of Lublin; KU Leuven; University Hospital Leuven; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine	Lories, R (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Skeletal Biol & Engn Res Ctr, Lab Tissue Homeostasis & Dis, Leuven, Belgium.; Lories, R (corresponding author), Univ Hosp Leuven, Div Rheumatol, Leuven, Belgium.	Rik.Lories@kuleuven.be	Lories, Rik/T-2196-2017; Lories, Rik/Q-8328-2019; Luyten, Frank/GPS-7793-2022	Lories, Rik/0000-0002-5986-3092; Lories, Rik/0000-0002-5986-3092; Tylzanowski, Przemko/0000-0003-0769-559X; Cailotto, Frederic/0000-0002-4941-9238; MONTEAGUDO, SILVIA/0000-0002-3849-6270	FWO Vaanderen grant [G.0717.09]; FP7 Health grant TREATOA; Marie Curie Fellowship "SMOOS"	FWO Vaanderen grant; FP7 Health grant TREATOA; Marie Curie Fellowship "SMOOS"	The study was supported by FWO Vaanderen grant G.0717.09 to RL and by FP7 Health grant TREATOA to RL, FPL and PT. FC was the recipient of a Marie Curie Fellowship "SMOOS". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloch-Zupan A, 2011, AM J HUM GENET, V89, P773, DOI 10.1016/j.ajhg.2011.11.002; Bostrom KI, 2016, VASC PHARMACOL, V84, P8, DOI 10.1016/j.vph.2016.05.014; Chang SC, 1994, J BIOL CHEM, V269; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Gutierrez A, 2012, DERMATOL THER, V25, P195, DOI 10.1111/j.1529-8019.2012.01492.x; Habel B, 1998, EUR BIOPHYS J BIOPHY, V27, P411, DOI 10.1007/s002490050149; Hoang B, 1996, J BIOL CHEM, V271, P26131, DOI 10.1074/jbc.271.42.26131; Ivory Dedri, 2012, Mo Med, V109, P64; Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197; Maier S, 2008, EXP CELL RES, V314, P2477, DOI 10.1016/j.yexcr.2008.05.020; Melvin VS, 2013, DEV DYNAM, V242, P817, DOI 10.1002/dvdy.23969; Molloy ES, 2006, RHEUM DIS CLIN N AM, V32, P383, DOI 10.1016/j.rdc.2006.02.001; Mommaerts H, 2014, DEV DYNAM, V243, P1375, DOI 10.1002/dvdy.24164; Novinec M, 2008, PROTEIN EXPRES PURIF, V62, P75, DOI 10.1016/j.pep.2008.07.009; Pazin DE, 2009, DEV DYNAM, V238, P2877, DOI 10.1002/dvdy.22124; Pugliese G, 2015, ATHEROSCLEROSIS, V238, P220, DOI 10.1016/j.atherosclerosis.2014.12.011; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Rennenberg RJMW, 2010, J CELL MOL MED, V14, P2203, DOI 10.1111/j.1582-4934.2010.01139.x; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Thomas JT, 2017, ELIFE, V6, DOI 10.7554/eLife.17935; Thomas JT, 2009, J BIOL CHEM, V284, P18994, DOI 10.1074/jbc.M807759200; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532; Yamauchi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE608, DOI 10.1152/ajpendo.00229.2004	24	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198104	10.1371/journal.pone.0198104	http://dx.doi.org/10.1371/journal.pone.0198104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897942	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700043
J	Postlethwaite, VR; McGowan, AE; Kohfeld, KE; Robinson, CLK; Pellatt, MG				Postlethwaite, Victoria R.; McGowan, Aimee E.; Kohfeld, Karen E.; Robinson, Cliff L. K.; Pellatt, Marlow G.			Low blue carbon storage in eelgrass (Zostera marina) meadows on the Pacific Coast of Canada	PLOS ONE			English	Article							ORGANIC-CARBON; SEAGRASS; BIOMASS; GROWTH; SEQUESTRATION; VARIABILITY; DYNAMICS; BAY; L.; TEMPERATURE	Seagrass habitats provide important ecosystem services, including their ability to take up and store substantial amounts of organic carbon, known as 'blue carbon.' However, the paucity of geospatial and carbon storage information along the Pacific Coast of Canada hinders the inclusion of blue carbon storage data in conservation planning and policy development in coastal habitats. We assessed the carbon storage and accumulation rates in three eel grass (Zostera marina) meadows in southern Clayoquot Sound on the Pacific Coast of British Columbia. The intertidal and subtidal portions of each meadow were mapped and sampled to estimate eelgrass density, biomass, and carbon, and sediment cores were analyzed to estimate sediment carbon storage and accumulation rates. Aboveground biomass measurements were consistent with estimates for Z marina in other regions, with average aboveground carbon biomass estimates of 16.78 g C m(-2) and 16.25 g C m(-2) in the intertidal and subtidal areas, respectively. However, the estimated aboveground to belowground biomass ratio was an order of magnitude higher than for seagrass species in temperate/tropical areas, largely because belowground biomass was up to 10 times lower than for other Z marina meadows, averaging 6.17 g C m(-2) and 5.03 g C m(-2) in the intertidal and subtidal zones, respectively. Sediment carbon concentrations did not exceed 1.30%C-org, and carbon accumulation rates ranged from 2.90-39.61 g C-org M-2 yr(-1), decreasing with depth and averaging 10.8 5.2 g C-org m(-2) yr(-1). While sediment carbon stocks were generally higher in the eelgrass meadows relative to non-vegetated reference sites, carbons stocks averaged 1343 +/- 482 g C-org m(-2), substantially less than global averages. These carbon results confirm that eelgrass does contribute to carbon storage in Clayoquot Sound but at lower rates than identified for more tropical seagrasses. By improving the quantification of site-specific carbon dynamics, eelgrass' role in climate change mitigation and conservation planning can be assessed.	[Postlethwaite, Victoria R.; McGowan, Aimee E.; Kohfeld, Karen E.] Simon Fraser Univ, Resource & Environm Management, Burnaby, BC, Canada; [Robinson, Cliff L. K.] Univ Victoria, Marine Protected Areas Res Grp, Victoria, BC, Canada; [Pellatt, Marlow G.] Protected Areas Estab & Conservat Directorate, Pk Canada, Vancouver, BC, Canada	Simon Fraser University; University of Victoria	Postlethwaite, VR (corresponding author), Simon Fraser Univ, Resource & Environm Management, Burnaby, BC, Canada.	vpostlet@sfu.ca	Pellatt, Marlow/L-5915-2019; BITOUN, RACHEL Elisabeth/AAC-9538-2021; Pellatt, Marlow/AAU-6156-2021	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Kohfeld, Karen/0000-0001-7241-1624; Pellatt, Marlow/0000-0002-3925-461X	Commission for Environment Cooperation [2016-1528]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2013-342251]; Canada Research Chairs [950-228166]; Social Sciences and Humanities Research Council Canada Graduate Scholarships	Commission for Environment Cooperation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs(Canada Research ChairsCGIAR); Social Sciences and Humanities Research Council Canada Graduate Scholarships	This work was funded as part of the Commission for Environment Cooperation's (http://www.cec.org) 2015-2016 project "North American Blue Carbon: Next Steps in Science for Policy" (Contract #2016-1528), awarded to CLKR and KEK. KEK was also supported by the Natural Sciences and Engineering Research Council of Canada Discovery Grants (#RGPIN-2013-342251) and Canada Research Chairs (#950-228166) programs (http://www.nserc-crsng.gc.ca/Professors-Professeurs/grants-subs/DGIGP-PSIGP_eng.asp and http://www.chairs-chaires.gc.ca/program-programme/admin_guide-eng.aspx). VRP was supported by the Social Sciences and Humanities Research Council Canada Graduate Scholarships (http://www.sshrc-crsh.gc.ca/funding-financement/programs-programmes/fellowships/cgs_masters-besc_maitrise-eng.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage AR, 2016, BIOGEOSCIENCES, V13, P313, DOI 10.5194/bg-13-313-2016; Beal BF, 2004, NORTHEAST NAT, V11, P197, DOI 10.1656/1092-6194(2004)11[197:AABAPE]2.0.CO;2; Bekkby T, 2008, ICES J MAR SCI, V65, P1093, DOI 10.1093/icesjms/fsn095; Bouraoui F, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013451; Brisson CP, 2014, BIOL CONSERV, V179, P1, DOI 10.1016/j.biocon.2014.08.013; Bureau of Meteorology, 2017, ANN CLIM STAT 2016; Cabello-Pasini A, 2003, AQUAT BOT, V76, P31, DOI 10.1016/S0304-3770(03)00012-3; Chmura GF, 2016, PROJECT REPORT; ClimaTemps, 2014, SUNSH DAYL HOURS LOS; Dahl M, 2016, J ECOL, V104, P654, DOI 10.1111/1365-2745.12564; Duarte CM, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P141, DOI 10.1016/B978-044450891-1/50008-6; DUARTE CM, 1990, MAR ECOL PROG SER, V67, P201, DOI 10.3354/meps067201; Duarte CM, 2010, GLOBAL BIOGEOCHEMICA, P24; Environmental Systems Research Institute (ESRI), 2018, ARCGIS 10 3; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Gacia E, 2002, LIMNOL OCEANOGR, V47, P23, DOI 10.4319/lo.2002.47.1.0023; Greiner JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072469; Hamrick K, 2015, AHEAD CURVE STATE VO; Hodgson C, 2016, 20141362 N AM PARTN; Howard J., 2014, COASTAL BLUE CARBON, P99; JACOBS RPWM, 1979, AQUAT BOT, V7, P151, DOI 10.1016/0304-3770(79)90019-6; Jankowska E, 2016, J GEOPHYS RES-BIOGEO, V121, P2918, DOI 10.1002/2016JG003424; Johannessen SC, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/11/113001; Kaldy JE, 2014, J EXP MAR BIOL ECOL, V453, P108, DOI 10.1016/j.jembe.2013.12.020; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; Kim JH, 2016, OCEAN SCI J, V51, P635, DOI 10.1007/s12601-016-0058-0; Lavery PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073748; Lee KS, 2007, J EXP MAR BIOL ECOL, V350, P144, DOI 10.1016/j.jembe.2007.06.016; Mazzotti S, 2008, J GEOPHYS RES, P113; MCKENZIE LJ, 1994, AUST J MAR FRESH RES, V45, P1337, DOI 10.1071/MF9941337; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Miyajima T, 2015, GLOBAL BIOGEOCHEM CY, V29, P397, DOI 10.1002/2014GB004979; MURRAY L, 1992, AQUAT BOT, V44, P83, DOI 10.1016/0304-3770(92)90083-U; Nelson DS, 2016, COMPONENTS COMPLETE; Tue NT, 2011, ENVIRON EARTH SCI, V64, P1475, DOI 10.1007/s12665-011-0970-7; ORTH RJ, 1986, AQUAT BOT, V24, P335, DOI 10.1016/0304-3770(86)90100-2; Osborne J, 2013, EELGRASS MONITORING; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Precision Identification Biological Consultants, 2002, METH MAPP MON EELGR; Prentice C., 2018, REDUCED WATER MOTION; QGIS Development Team, 2018, GEOGRAPHIC INFORM SY; R Studio Team, 2018, RSTUDIO INT DEV R; Raposa K, 2009, 20095 NARR BAY RES R; Ricart AM, 2015, MAR POLLUT BULL, V100, P476, DOI 10.1016/j.marpolbul.2015.09.032; Richardson K., 2016, MAPS DATASETS BLUE C; Rohr ME, 2016, BIOGEOSCIENCES, V13, P6139, DOI 10.5194/bg-13-6139-2016; ROWAN DJ, 1995, J PALEOLIMNOL, V13, P107, DOI 10.1007/BF00678101; Salo T, 2014, J EXP MAR BIOL ECOL, V461, P425, DOI 10.1016/j.jembe.2014.09.010; Serrano O, 2014, GLOBAL BIOGEOCHEM CY, V28, P950, DOI 10.1002/2014GB004872; Sfriso A, 1998, AQUAT BOT, V61, P207, DOI 10.1016/S0304-3770(98)00064-3; Short FT, 2015, SEAGRASSNET MANUAL S; Subramaniam A, 2008, P NATL ACAD SCI USA, V105, P10460, DOI 10.1073/pnas.0710279105; Sutton-Grier A, 2016, COAST MANAGE, V44; The Weather Network, 2017, TOF STAT; Thom RM, 2003, ESTUARIES, V26, P1117, DOI 10.1007/BF02803368; THOM RM, 1990, MAR BIOL, V104, P129, DOI 10.1007/BF01313166; Udy JW, 1997, J EXP MAR BIOL ECOL, V217, P253, DOI 10.1016/S0022-0981(97)00060-9; US Climate Data, 2010, CLIM FLOR TALL; van Tussenbroek BI, 1998, AQUAT BOT, V61, P69, DOI 10.1016/S0304-3770(98)00058-8; Yu ZX, 2012, BASIC APPL ECOL, V13, P673, DOI 10.1016/j.baae.2012.09.009	60	18	18	13	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198348	10.1371/journal.pone.0198348	http://dx.doi.org/10.1371/journal.pone.0198348			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897953	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700052
J	Sato, H; Wang, C; Yamazaki, M; Saito, K; Uchiyama, M				Sato, Hajime; Wang, Chao; Yamazaki, Mami; Saito, Kazuki; Uchiyama, Masanobu			Computational study on a puzzle in the biosynthetic pathway of anthocyanin: Why is an enzymatic oxidation/ reduction process required for a simple tautomerization?	PLOS ONE			English	Article							POTENTIAL-ENERGY SURFACES; HYPERSPHERE SEARCH METHOD; MECHANISM; GENES; EXPRESSION; FLAVONOIDS; SYNTHASE; CLONING; FORMA; KEGG	In the late stage of anthocyanin biosynthesis, dihydroflavonol reductase (DFR) and anthocyanidin synthase (ANS) mediate a formal tautomerization. However, such oxidation/reduction process requires high energy and appears to be unnecessary, as the oxidation state does not change during the transformation. Thus, a non-enzymatic pathway of tautomerization has also been proposed. To resolve the long-standing issue of whether this non-enzymatic pathway is the main contributor for the biosynthesis, we carried out density functional theory (DFT) calculations to examine this non-enzymatic pathway from dihydroflavonol to anthocyanidin. We show here that the activation barriers for the proposed non-enzymatic tautomerization are too high to enable the reaction to proceed under normal aqueous conditions in plants. The calculations also explain the experimentally observed requirement for acidic conditions during the final step of conversion of 2-flaven-3,4-diol to anthocyanidin; a thermodynamically and kinetically favorable concerted pathway can operate under these conditions.	[Sato, Hajime; Yamazaki, Mami; Saito, Kazuki] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan; [Sato, Hajime; Wang, Chao; Uchiyama, Masanobu] RIKEN, Elements Chem Lab, Wako Campus,2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Sato, Hajime; Wang, Chao; Uchiyama, Masanobu] RIKEN, Ctr Sustainable Resource Sci, Wako Campus,2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Wang, Chao; Uchiyama, Masanobu] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Saito, Kazuki] RIKEN, Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama Campus,1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan	Chiba University; RIKEN; RIKEN; University of Tokyo; RIKEN	Saito, K (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.; Uchiyama, M (corresponding author), RIKEN, Elements Chem Lab, Wako Campus,2-1 Hirosawa, Wako, Saitama 3510198, Japan.; Uchiyama, M (corresponding author), RIKEN, Ctr Sustainable Resource Sci, Wako Campus,2-1 Hirosawa, Wako, Saitama 3510198, Japan.; Uchiyama, M (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.; Saito, K (corresponding author), RIKEN, Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama Campus,1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	ksaito@faculty.chiba-u.jp; uchiyama@mol.f.u-tokyo.ac.jp	Uchiyama, Masanobu/B-7181-2015; Yamazaki, Mami/A-9050-2010; Saito, Kazuki/D-2670-2009; WANG, Chao/B-1350-2015	Yamazaki, Mami/0000-0001-6157-5287; Saito, Kazuki/0000-0001-6310-5342; WANG, Chao/0000-0002-9165-7758; Uchiyama, Masanobu/0000-0001-6385-5944; Sato, Hajime/0000-0001-5185-096X	JSPS KAKENHI [17H06173]; JSPS [17H05430, JP16H06454]; HOKUASAI [G14001, G15011, G16028, G17022]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); HOKUASAI	This work was supported by JSPS KAKENHI (S) (No. 17H06173, Dr. Uchiyama's grant, https://www.jsps.go.jp/), JSPS Grant-in-Aid for Scientific Research on Innovative Areas (No. 17H05430, Dr. Uchiyama's grant, https://www.jsps.go.jp/ and No. JP16H06454 Dr. Yamazaki's grant, https://www.jsps.go.jp/). Allotment of computational resource (Project G14001, G15011, G16028 and G17022) from HOKUASAI and RICC (RIKEN Integrated Cluster of Clusters, http://accc.riken.jp/tag/hokusai/) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchanan B.B., 2015, BIOCHEM MOL BIOL PLA; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Cossi M, 2000, J CHEM PHYS, V112, P2427, DOI 10.1063/1.480808; Fauconneau B, 1997, LIFE SCI, V61, P2103, DOI 10.1016/S0024-3205(97)00883-7; Feild TS, 2001, PLANT PHYSIOL, V127, P566, DOI 10.1104/pp.010063; Frisch M. J, GAUSSIAN 09 REVISION; Gong ZZ, 1997, PLANT MOL BIOL, V35, P915, DOI 10.1023/A:1005959203396; Hong YJ, 2015, ORG BIOMOL CHEM, V13, P10273, DOI 10.1039/c5ob01785h; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kurepa J, 2014, PLANT J, V77, P443, DOI 10.1111/tpj.12361; Maeda S, 2005, J PHYS CHEM A, V109, P5742, DOI 10.1021/jp0513162; Maeda S., 2012, GRRM 11 VERSION 11 0; Maeda S, 2013, PHYS CHEM CHEM PHYS, V15, P3683, DOI 10.1039/c3cp44063j; Moriya Y, 2016, J CHEM INF MODEL, V56, P510, DOI 10.1021/acs.jcim.5b00216; Nakajima J, 2001, J BIOL CHEM, V276, P25797, DOI 10.1074/jbc.M100744200; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ohno K, 2004, CHEM PHYS LETT, V384, P277, DOI 10.1016/j.cplett.2003.12.030; Plata RE, 2015, J AM CHEM SOC, V137, P3811, DOI 10.1021/ja5111392; Saito K, 1999, PLANT J, V17, P181, DOI 10.1046/j.1365-313X.1999.00365.x; Saito K, 2002, NEW PHYTOL, V155, P9, DOI 10.1046/j.1469-8137.2002.00440.x; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Sato H, 2015, SCI REP, V5, P10; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; Tohge T, 2005, BIOTECHNOL LETT, V27, P297, DOI 10.1007/s10529-005-0683-7; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Turnbull JJ, 2004, J BIOL CHEM, V279, P1206, DOI 10.1074/jbc.M309228200; Wang H, 2013, PHYTOCHEMISTRY, V94, P123, DOI 10.1016/j.phytochem.2013.05.007; Watanabe Y, 2007, CHEM PHYS LETT, V447, P21, DOI 10.1016/j.cplett.2007.09.002; Yu PY, 2015, J AM CHEM SOC, V137, P13518, DOI 10.1021/jacs.5b06656	30	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198944	10.1371/journal.pone.0198944	http://dx.doi.org/10.1371/journal.pone.0198944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897974	Green Published, gold, Green Submitted			2022-12-26	WOS:000435090700080
J	Weng, PH; Chen, JH; Chiou, JM; Tu, YK; Chen, TF; Chiu, MJ; Tang, SC; Yeh, SJ; Chen, YC				Weng, Pei-Hsuan; Chen, Jen-Hau; Chiou, Jeng-Min; Tu, Yu-Kang; Chen, Ta-Fu; Chiu, Ming-Jang; Tang, Sung-Chun; Yeh, Shin-Joe; Chen, Yen-Ching			The effect of lifestyle on late-life cognitive change under different socioeconomic status	PLOS ONE			English	Article							DOSE-RESPONSE METAANALYSIS; ALZHEIMERS-DISEASE; LEISURE ACTIVITIES; PHYSICAL-ACTIVITY; DIETARY PATTERNS; RISK-FACTORS; HEALTH; DEMENTIA; DECLINE; EDUCATION	This study aimed to identify lifestyle factors associated with cognitive change and to explore whether the effect of lifestyle varies by socioeconomic status (SES). Participants aged 65 years and older were recruited from elderly health checkup programs from 2011 to 2013 in Taiwan. Neuropsychological tests, including tests of global cognition, logical memory, executive function, verbal fluency and attention, were administered at baseline (N = 603) and 2 years later (N = 509). After literature review, 9 lifestyle factors and 3 SES indicators were chosen and their effects on cognitive change were evaluated using linear regression adjusting for age, sex, education, APOE epsilon 4 status, and baseline cognitive score. Five lifestyle factors (high vegetable and fish intake, regular exercise, not smoking, and light to moderate alcohol consumption) and 3 SES indicators [annual household income (> 33,333 USD vs. less), occupational complexity (high vs. low mental demanding job), and years of education (> 12 years vs. less)] were found to be protective against cognitive decline (P < 0.1 in any cognitive domains, beta ranging from 0.06 to 0.38). After further adjusting for all the lifestyle and SES factors, fish intake, higher income and occupational complexity remained protective. Significant interactions were found between a healthful lifestyle (defined as having >= 3 healthful lifestyle factors) and income on changes of global cognition and verbal fluency (P-interaction = 0.02 and 0.04). The protective effect of a healthful lifestyle was observed only among participants with lower income in global cognition and logical memory [beta = 0.17, 95% confidence interval (CI) = 0.07-0.26; beta = 0.30, 95% CI = 0.14-0.46]. To the best of our knowledge, this study for the first time explored how the interactions of lifestyle and SES affect cognitive change. Our findings will aid in developing dementia prevention programs and reduce health inequalities.	[Weng, Pei-Hsuan] Taiwan Adventist Hosp, Dept Family Med, Taipei, Taiwan; [Weng, Pei-Hsuan; Tu, Yu-Kang; Chen, Yen-Ching] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Chen, Jen-Hau] Natl Taiwan Univ Hosp, Dept Geriatr & Gerontol, Taipei, Taiwan; [Chiou, Jeng-Min] Acad Sinica, Inst Stat Sci, Taipei, Taiwan; [Chen, Ta-Fu; Chiu, Ming-Jang; Tang, Sung-Chun; Yeh, Shin-Joe] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Chen, Yen-Ching] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei, Taiwan; [Chen, Yen-Ching] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Chen, YC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan.; Chen, YC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei, Taiwan.; Chen, YC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei, Taiwan.	karenchen@ntu.edu.tw	Chen, Jen-Hau/AFP-2878-2022; Chiu, Ming-Jang/AAR-3940-2020; yeh, shin-joe/HGV-0244-2022; Chiou, Jeng-Min/AAQ-3736-2021; Chen, Yen-Ching/D-1098-2010	Chiu, Ming-Jang/0000-0002-4158-4423; Chen, Yen-Ching/0000-0002-8159-7202; Tang, Sung-Chun/0000-0003-3731-5973; Yeh, Shin-Joe/0000-0003-1511-6295; Chen, Ta-Fu/0000-0003-1988-6924; Chiou, Jeng-Min/0000-0003-4554-9454; Tu, Yu-Kang/0000-0002-2461-474X	Ministry of Science and Technology in Taiwan [100-2314-B-002-103, 101-2314-B-002-126-MY3, 104-2314-B-002-038-MY3]; Academia Sinica	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by grants from the Ministry of Science and Technology in Taiwan (100-2314-B-002-103, 101-2314-B-002-126-MY3, and 104-2314-B-002-038-MY3), and a grant from Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alzheimer's Association, 2015, CHANG TRAJ ALZH DIS; American Heart Association, 2016, FISH OM 3 FATT AC; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Birch S, 2000, SOC SCI MED, V51, P307, DOI 10.1016/S0277-9536(99)00455-4; Blaxter M., 1990, HLTH LIFESTYLES; Bobko P, 2007, ORGAN RES METHODS, V10, P689, DOI 10.1177/1094428106294734; Cassarino M, 2015, AGEING RES REV, V23, P167, DOI 10.1016/j.arr.2015.06.003; Chapko D, 2018, AGING MENT HEALTH, V22, P915, DOI 10.1080/13607863.2017.1348471; Chapman J, 1996, NEUROLOGY, V46, P1484, DOI 10.1212/WNL.46.5.1484-a; Chen YC, 2017, J AM GERIATR SOC, V65, P1159, DOI 10.1111/jgs.14741; Cheng ST, 2005, INT J GERIATR PSYCH, V20, P465, DOI 10.1002/gps.1314; Chiao C, 2014, INT HEALTH, V6, P322, DOI 10.1093/inthealth/ihu046; de Araujo NB, 2011, CLINICS, V66, P623, DOI 10.1590/S1807-59322011000400017; de Oliveira RS, 2014, EINSTEIN-SAO PAULO, V12, P149, DOI 10.1590/S1679-45082014AO2954; Deckers K, 2015, INT J GERIATR PSYCH, V30, P234, DOI 10.1002/gps.4245; Deng HB, 2008, MED SCI SPORT EXER, V40, P303, DOI 10.1249/mss.0b013e31815b0db5; Eibner C, 2005, J HUM RESOUR, V40, P591; Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223; Everson SA, 2002, J PSYCHOSOM RES, V53, P891, DOI 10.1016/S0022-3999(02)00303-3; Galobardes B, 2003, AM J PUBLIC HEALTH, V93, P1302, DOI 10.2105/AJPH.93.8.1302; Guure CB, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9016924; Hwang AC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003809; Ilomaki J, 2015, CURR CLIN PHARMACOL, V10, P204, DOI 10.2174/157488471003150820145539; Kondo N, 2012, J EPIDEMIOL, V22, P2, DOI 10.2188/jea.JE20110116; Kuiper JS, 2015, AGEING RES REV, V22, P39, DOI 10.1016/j.arr.2015.04.006; Lee MS, 2006, ASIA PAC J CLIN NUTR, V15, P161; Lee Y, 2010, DEMENT GERIATR COGN, V29, P523, DOI 10.1159/000315507; Loef M, 2012, J NUTR HEALTH AGING, V16, P626, DOI 10.1007/s12603-012-0097-x; Mayen AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Ouvrard C, 2016, DEMENT GERIATR COGN, V41, P137, DOI 10.1159/000443790; Pampel FC, 2004, J HEALTH SOC BEHAV, V45, P306, DOI 10.1177/002214650404500305; Parker AJR, 2008, BMJ-BRIT MED J, V336, P496, DOI 10.1136/bmj.39483.457708.80; Parrott MD, 2013, J NUTR, V143, P1767, DOI 10.3945/jn.113.181115; Schneider ALC, 2012, J AM GERIATR SOC, V60, P1847, DOI 10.1111/j.1532-5415.2012.04164.x; Seeman T, 2010, ANN NY ACAD SCI, V1186, P223, DOI 10.1111/j.1749-6632.2009.05341.x; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Sink KM, 2015, JAMA-J AM MED ASSOC, V314, P781, DOI 10.1001/jama.2015.9617; Smart EL, 2014, NEUROLOGY, V83, P2285, DOI 10.1212/WNL.0000000000001075; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Thrane C, 2006, SOC SCI MED, V62, P467, DOI 10.1016/j.socscimed.2005.06.010; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wilson BA, 2000, J INT NEUROPSYCH SOC, V6, P469, DOI 10.1017/S1355617700644053; Wu L, 2017, CLIN NUTR, V36, P730, DOI 10.1016/j.clnu.2016.05.015; Wu SQ, 2015, NEUROSCI BIOBEHAV R, V48, P1, DOI 10.1016/j.neubiorev.2014.11.008; Xu W, 2016, MOL NEUROBIOL, V53, P3113, DOI 10.1007/s12035-015-9211-5; Xu X, 2015, J GERONTOL B-PSYCHOL, V70, P661, DOI 10.1093/geronb/gbu095; Yang SY, 2015, J FORMOS MED ASSOC, V114, P1216, DOI 10.1016/j.jfma.2014.09.006; Yates LA, 2016, INT PSYCHOGERIATR, V28, P1791, DOI 10.1017/S1041610216001137; Zhong GC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118333	53	27	27	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197676	10.1371/journal.pone.0197676	http://dx.doi.org/10.1371/journal.pone.0197676			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ2HI	29897986	Green Published, gold, Green Submitted			2022-12-26	WOS:000435090700024
J	Ross, K; Stoler, J; Carcioppolo, N				Ross, Katherine; Stoler, Justin; Carcioppolo, Nick			The relationship between low perceived numeracy and cancer knowledge, beliefs, and affect	PLOS ONE			English	Article							MEDICAL DECISION-MAKING; TRENDS SURVEY HINTS; HEALTH LITERACY; SUBJECTIVE NUMERACY; INFORMATION-SEEKING; RISK COMMUNICATION; WORRY; COMPREHENSION; PERCEPTIONS; SCALE	Low numeracy may skew patient perceptions of information about cancer. This paper examines the relationship between self-reported measures of perceived numeracy and cancer knowledge, beliefs, and affect, using results from 3,052 respondents to the 2007 Health Information National Trends Survey (HINTS-3). Chi-squared tests were used to identify differences in responses between high- and low-numeracy groups using three measures of perceived numeracy. Multivariable logistic regression models were used to evaluate the association between the three perceived numeracy measures and cancer information overload, cancer fatalism, cancer prevention knowledge, and cancer worry. Respondents with low perceived numeracy as expressed by discomfort with medical statistics were more likely to report information overload, to display fatalistic attitudes towards cancer, to lack knowledge about cancer prevention, and to indicate that they worried about cancer more frequently. After controlling for sociodemographic characteristics, this measure of perceived numeracy remained significantly associated with information overload, fatalism, lower prevention knowledge, and worry. The other measures of perceived numeracy, which measured understanding and use of health statistics, were not associated with cancer perceptions. Our findings suggest that individuals with low perceived numeracy broadly differ from individuals with high perceived numeracy in their perceptions of cancer and cancer prevention. By improving our understanding of how perceived numeracy affects patient perceptions of cancer, health providers can improve educational strategies and targeted health messaging.	[Ross, Katherine] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Ross, Katherine] Univ Miami, Sch Nursing & Hlth Studies, Coral Gables, FL 33124 USA; [Stoler, Justin] Univ Miami, Dept Geog & Reg Studies, Coral Gables, FL 33124 USA; [Stoler, Justin] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Carcioppolo, Nick] Univ Miami, Dept Commun Studies, Coral Gables, FL 33124 USA	Emory University; Rollins School Public Health; University of Miami; University of Miami; University of Miami; University of Miami	Stoler, J (corresponding author), Univ Miami, Dept Geog & Reg Studies, Coral Gables, FL 33124 USA.; Stoler, J (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.	stoler@miami.edu	Stoler, Justin/AAY-8224-2021	Stoler, Justin/0000-0001-8435-7012				Aggarwal A, 2007, AM J HEALTH BEHAV, V31, pS57; Ancker JS, 2007, J AM MED INFORM ASSN, V14, P713, DOI 10.1197/jamia.M2464; Apter AJ, 2006, J ASTHMA, V43, P705, DOI 10.1080/02770900600925585; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Centers for Disease Control and Prevention, UND LIT NUM 2014; Chen YX, 2014, HEALTH COMMUN, V29, P843, DOI 10.1080/10410236.2013.807904; Ciampa PJ, 2010, J HEALTH COMMUN, V15, P157, DOI 10.1080/10810730.2010.522699; Davids SL, 2004, J GEN INTERN MED, V19, P310, DOI 10.1111/j.1525-1497.2004.20801.x; Dolan JG, 2016, MED DECIS MAKING, V36, P868, DOI 10.1177/0272989X15584332; Donelle L, 2008, CHRONIC DIS CAN, V29, P1; Fagerlin A, 2007, MED DECIS MAKING, V27, P672, DOI 10.1177/0272989x07304449; Ginde AA, 2008, PATIENT EDUC COUNS, V72, P350, DOI 10.1016/j.pec.2008.03.012; Hay JL, 2005, PSYCHO-ONCOLOGY, V14, P517, DOI 10.1002/pon.864; Institute of Medicine, 2004, HLTH LITERACY PRESCR; Jensen JD, 2014, PATIENT EDUC COUNS, V94, P90, DOI 10.1016/j.pec.2013.09.016; Jensen JD, 2010, J PSYCHOSOC ONCOL, V28, P470, DOI 10.1080/07347332.2010.498459; Kiechle ES, 2015, J GEN INTERN MED, V30, P1538, DOI 10.1007/s11606-015-3288-4; Kobayashi LC, 2016, HEALTH EDUC BEHAV, V43, P461, DOI 10.1177/1090198115604616; Kon AA, 2010, JAMA-J AM MED ASSOC, V304, P903, DOI 10.1001/jama.2010.1208; Kutner M, 2006, HLTH LITERACY AM ADU; Lee SY, 2016, HEALTH COMMUN, V31, P926, DOI 10.1080/10410236.2015.1018701; MATHEWS A, 1990, BEHAV RES THER, V28, P455, DOI 10.1016/0005-7967(90)90132-3; Miron-Shatz T, 2015, JUDGM DECIS MAK, V10, P386; Nelson DE, 2004, J HEALTH COMMUN, V9, P443, DOI 10.1080/10810730490504233; Niederdeppe J, 2007, CANCER EPIDEM BIOMAR, V16, P998, DOI 10.1158/1055-9965.EPI-06-0608; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; Powe BD, 2003, CANCER NURS, V26, P454; Reyna VF, 2008, MED DECIS MAKING, V28, P829, DOI 10.1177/0272989X08327069; Reyna VF, 2007, LEARN INDIVID DIFFER, V17, P147, DOI 10.1016/j.lindif.2007.03.010; Schapira MM, 2011, J CANCER EDUC, V26, P103, DOI 10.1007/s13187-010-0133-7; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; Waldrop-Valverde D, 2010, AIDS BEHAV, V14, P799, DOI 10.1007/s10461-009-9604-4; Weinstein ND, 2004, J HEALTH COMMUN, V9, P53, DOI 10.1080/10810730490271647; Woloshin S, 2005, J GEN INTERN MED, V20, P996, DOI 10.1007/s11606-005-0245-7; Zikmund-Fisher BJ, 2007, MED DECIS MAKING, V27, P663, DOI 10.1177/0272989x07303824	36	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198992	10.1371/journal.pone.0198992	http://dx.doi.org/10.1371/journal.pone.0198992			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI8PJ	29889890	Green Published, gold, Green Submitted			2022-12-26	WOS:000434786600070
J	Shigeta, M; Kanazawa, H; Yokoyama, T				Shigeta, Masaki; Kanazawa, Hirotaka; Yokoyama, Takahiko			Tubular cell loss in early inv/nphp2 mutant kidneys represents a possible homeostatic mechanism in cortical tubular formation	PLOS ONE			English	Article							RIGHT DETERMINANT INVERSIN; CYST FORMATION; CHROMOSOME FRAGMENTATION; MITOTIC CATASTROPHE; EPITHELIAL-CELLS; PRIMARY CILIA; HISTONE H2AX; DISEASE; MICE; PROLIFERATION	Inversion of embryonic turning (inv) cystic mice develop multiple renal cysts and are a model for type II nephronophthisis (NPHP2). The defect of planar cell polarity (PCP) by oriented cell division was proposed as the underlying cellular phenotype, while abnormal cell proliferation and apoptosis occur in some polycystic kidney disease models. However, how these cystogenic phenotypes are linked and what is most critical for cystogenesis remain largely unknown. In particular, in early cortical cytogenesis in the inv mutant cystic model, it remains uncertain whether the increased proliferation index results from changes in cell cycle length or cell fate determination. To address tubular cell kinetics, doubling time and total number of tubular cells, as well as amount of genomic DNA (gDNA), were measured in mutant and normal control kidneys. Despite a significantly higher bromodeoxyuridine (BrdU)-proliferation index in the mutant, total tubular cell number and doubling time were unaffected. Unexpectedly, the mutant had tubular cell loss, characterized by a temporal decrease in tubular cells incorporating 5-ethynyl-2'-deoxyuridine (EdU) and significantly increased nuclear debris. Based on current data we established a new multi-population shift model in postnatal renal development, indicating that a few restricted tubular cell populations contribute to cortical tubular formation. As in the inv mutant phenotype, the model simulation revealed a large population of tubular cells with rapid cell cycling and tubular cell loss. The proposed cellular kinetics suggest not only the underlying mechanism of the inv mutant phenotype but also a possible renal homeostatic mechanism for tubule formation.	[Shigeta, Masaki; Kanazawa, Hirotaka; Yokoyama, Takahiko] Kyoto Prefectural Med, Dept Anat & Dev Biol, Grad Sch Med, Kyoto, Japan	Kyoto Prefectural University of Medicine	Shigeta, M (corresponding author), Kyoto Prefectural Med, Dept Anat & Dev Biol, Grad Sch Med, Kyoto, Japan.	mshigeta@koto.kpu-m.ac.jp			JSPS KAKENHI Grant [26461235, 25870691]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for this study was provided by JSPS KAKENHI Grant Numbers 26461235 and 25870691. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkader RCRM, 2008, RENAL FAILURE, V30, P667, DOI 10.1080/08860220802212460; Airik R, 2014, J AM SOC NEPHROL, V25, P2573, DOI 10.1681/ASN.2013050565; Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Arai S, 2016, NAT MED, V22, P183, DOI 10.1038/nm.4012; Artus C, 2010, EMBO J, V29, P1585, DOI 10.1038/emboj.2010.43; Carroll TJ, 2011, ORGANOGENESIS, V7, P180, DOI 10.4161/org.7.3.18320; Chang M, 2008, PEDIATR RES, V64, P240, DOI 10.1203/PDR.0b013e318180e47a; Choi HJC, 2013, MOL CELL, V51, P423, DOI 10.1016/j.molcel.2013.08.006; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Fukui H, 2012, FEBS LETT, V586, P2273, DOI 10.1016/j.febslet.2012.05.064; Gattone VH, 2002, KIDNEY INT, V62, P1560, DOI 10.1046/j.1523-1755.2002.00632.x; Gotoh N, 2010, CYTOSKELETON, V67, P178, DOI 10.1002/cm.20435; Husson H, 2004, GENOMICS, V84, P497, DOI 10.1016/j.ygeno.2004.03.009; Jiang ST, 2006, AM J PATHOL, V168, P205, DOI 10.2353/ajpath.2006.050342; Kunimoto K, 2017, CURR BIOL, V27, P3120, DOI 10.1016/j.cub.2017.09.011; Lee JE, 2004, J BIOCHEM MOL BIOL, V37, P612; Li ZW, 2016, CELL STEM CELL, V19, P516, DOI 10.1016/j.stem.2016.07.016; Loftus H, 2013, PEDIATR NEPHROL, V28, P33, DOI 10.1007/s00467-012-2221-x; Luyten A, 2010, J AM SOC NEPHROL, V21, P1521, DOI 10.1681/ASN.2010010127; Martini E, 2016, CELL REP, V14, P1062, DOI 10.1016/j.celrep.2016.01.010; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Mochizuki T, 1998, NATURE, V395, P177, DOI 10.1038/26006; Morgan D, 2002, HUM GENET, V110, P377, DOI 10.1007/s00439-002-0696-4; Nishio S, 2010, J AM SOC NEPHROL, V21, P295, DOI 10.1681/ASN.2009060603; Ohtaki M, 1993, JPN J BIOMETRICS, V14, P47; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Phillips CL, 2004, J AM SOC NEPHROL, V15, P1744, DOI 10.1097/01.ASN.0000131520.07008.B3; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Rein ID, 2015, CELL CYCLE, V14, P3261, DOI 10.1080/15384101.2015.1087617; Rosen S, 2008, J AM SOC NEPHROL, V19, P871, DOI 10.1681/ASN.2007080913; Rumballe BA, 2011, DEV BIOL, V360, P110, DOI 10.1016/j.ydbio.2011.09.011; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Sharma N, 2013, J AM SOC NEPHROL, V24, P456, DOI 10.1681/ASN.2012020154; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Solier S, 2014, CELL MOL LIFE SCI, V71, P2289, DOI 10.1007/s00018-013-1555-2; Stevens JB, 2007, CANCER RES, V67, P7686, DOI 10.1158/0008-5472.CAN-07-0472; Stevens JB, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-20; Sugiyama N, 2006, GENES CELLS, V11, P1213, DOI 10.1111/j.1365-2443.2006.01011.x; Suizu F, 2016, EMBO J, V35, P1346, DOI 10.15252/embj.201593003; Sun Y, 2011, ACTA PHARMACOL SIN, V32, P805, DOI 10.1038/aps.2011.29; TYSON JJ, 1986, J MATH BIOL, V23, P231, DOI 10.1007/BF00276959; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; Werner ME, 2013, AM J PHYSIOL-CELL PH, V305, pC36, DOI 10.1152/ajpcell.00279.2012; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178	51	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198580	10.1371/journal.pone.0198580	http://dx.doi.org/10.1371/journal.pone.0198580			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889867	gold, Green Published, Green Submitted			2022-12-26	WOS:000434786600029
J	Wang, JZ; Wang, J; Wang, X; Li, RB; Chen, BS				Wang, Jinzi; Wang, Jun; Wang, Xin; Li, Rongbai; Chen, Baoshan			Proteomic response of hybrid wild rice to cold stress at the seedling stage	PLOS ONE			English	Article							LIPID TRANSFER PROTEINS; HEAT-SHOCK PROTEINS; CELL-DEATH; LOW-TEMPERATURE; PLANT DEFENSE; CHILLING TOLERANCE; ABIOTIC STRESS; GENE; PHOTOSYNTHESIS; IDENTIFICATION	Low temperature at the seedling stage is a major damaging factor for rice production in southern China. To better understand the cold response of cultivated and wild rice, cold sensitive cultivar 93-11 (Oryza sativa L. ssp. Indica) and cold-resistant hybrid wild rice DC907 with a 93-11 genetic background were used for a quantitative proteomic analysis with tandem mass tags (TMT) in parallel. Rice seedlings grown for four weeks at a normal temperature (25 degrees C) were treated at 8-10 degrees C for 24, 72 and 120 h. The number of differentially expressed proteins increased gradually over time in the cold-exposed rice in comparison with the untreated rice. A total of 366 unique proteins involved in ATP synthesis, photosystem, reactive oxygen species, stress response, cell growth and integrity were identified as responding to cold stress in DC907. While both DC907 and 93-11 underwent similar alterations in proteomic profiles in response to cold stress, DC907 responded in a prompter manner in terms of expressing cold-responding proteins, maintained a higher level of photosynthesis to power the cells, and possessed a stable and higher level of DIR proteins to prevent the plant from obtaining irreversible cell structure damage. The observations made in this study may lay a new foundation for further investigation of cold sensitivity or tolerance mechanisms in rice.	[Wang, Jinzi; Wang, Jun; Li, Rongbai; Chen, Baoshan] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Peoples R China; [Wang, Jinzi; Wang, Xin; Li, Rongbai] Guangxi Univ, Coll Agr, Nanning, Peoples R China; [Wang, Jun; Chen, Baoshan] Guangxi Univ, Coll Life Sci & Technol, Nanning, Peoples R China	Guangxi University; Guangxi University; Guangxi University	Li, RB; Chen, BS (corresponding author), Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Peoples R China.; Li, RB (corresponding author), Guangxi Univ, Coll Agr, Nanning, Peoples R China.; Chen, BS (corresponding author), Guangxi Univ, Coll Life Sci & Technol, Nanning, Peoples R China.	lirongbai@126.com; chenyaoj@gxu.edu.cn	WANG, JUN/AAZ-9489-2020	WANG, JUN/0000-0002-5051-4873	Guangxi Department of Science and Technology [GKG 1123001-3B, GKZ 14121001-1-5]; Guangxi University Key Program of Funds [XDZ 110082]	Guangxi Department of Science and Technology; Guangxi University Key Program of Funds	This work was supported in part by the grants from Guangxi Department of Science and Technology (GKG 1123001-3B, GKZ 14121001-1-5), and Guangxi University Key Program of Funds (XDZ 110082) to RL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2011, PROTEOMICS, V11, P1630, DOI 10.1002/pmic.201000696; Allen DJ, 2001, TRENDS PLANT SCI, V6, P36, DOI 10.1016/S1360-1385(00)01808-2; Bhuiyan NH, 2009, PLANT SIGNAL BEHAV, V4, P158, DOI 10.4161/psb.4.2.7688; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Boucher V, 2010, PLANT CELL ENVIRON, V33, P418, DOI 10.1111/j.1365-3040.2009.02093.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cui SX, 2005, PROTEOMICS, V5, P3162, DOI 10.1002/pmic.200401148; Dong CN, 2002, PLANT PHYSIOL, V129, P1368, DOI 10.1104/pp.001925; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; GRAHAM D, 1982, ANNU REV PLANT PHYS, V33, P347, DOI 10.1146/annurev.pp.33.060182.002023; Guo JL, 2012, PLANT CELL REP, V31, P1801, DOI 10.1007/s00299-012-1293-1; Huang M, 2013, FIELD CROP RES, V146, P10, DOI 10.1016/j.fcr.2013.03.007; HUNER NPA, 1993, PHOTOSYNTH RES, V37, P19, DOI 10.1007/BF02185436; Ji L, 2017, PROTEIN J, V36, P299, DOI 10.1007/s10930-017-9721-2; Jones PG, 1996, P NATL ACAD SCI USA, V93, P76, DOI 10.1073/pnas.93.1.76; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kim KY, 2004, J EXP BOT, V55, P1153, DOI 10.1093/jxb/erh125; Lawlor DW, 2002, ANN BOT, V89, DOI [10.1093/aob/, DOI 10.1093/AOB/]; Le Gall Hyacinthe, 2015, Plants-Basel, V4, P112, DOI 10.3390/plants4010112; Lee SC, 2005, MOL CELLS, V19, P212; Lei YB, 2014, TREES-STRUCT FUNCT, V28, P923, DOI 10.1007/s00468-014-1007-0; Li XM, 2011, J EXP BOT, V62, P4763, DOI 10.1093/jxb/err084; Liu F, 2015, J EXP BOT, V66, P5663, DOI 10.1093/jxb/erv313; Ma Y, 2015, CELL, V160, P1209, DOI 10.1016/j.cell.2015.01.046; Manishankar P, 2015, CELL, V160, P1045, DOI 10.1016/j.cell.2015.02.037; Neilson KA, 2011, PROTEOMICS, V11, P1696, DOI 10.1002/pmic.201000727; Polle A, 2001, PLANT PHYSIOL, V126, P445, DOI 10.1104/pp.126.1.445; Ralph S, 2006, PLANT MOL BIOL, V60, P21, DOI 10.1007/s11103-005-2226-y; Ryu HS, 2006, PLANT CELL REP, V25, P836, DOI 10.1007/s00299-006-0138-1; Saito K, 2001, THEOR APPL GENET, V103, P862, DOI 10.1007/s001220100661; Salcedo G, 2007, BBA-MOL CELL BIOL L, V1771, P781, DOI 10.1016/j.bbalip.2007.01.001; Shakiba E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172133; SOBCZYK EA, 1985, PHYSIOL PLANTARUM, V63, P399, DOI 10.1111/j.1399-3054.1985.tb02317.x; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Tezara W, 1999, NATURE, V401, P914, DOI 10.1038/44842; Tian T, 2017, NUCLEIC ACIDS RES, V45, pW122, DOI 10.1093/nar/gkx382; Timperio AM, 2008, J PROTEOMICS, V71, P391, DOI 10.1016/j.jprot.2008.07.005; Ukaji N, 2001, PLANT PHYSIOL, V126, P1588, DOI 10.1104/pp.126.4.1588; Van Breusegem F, 2006, PLANT PHYSIOL, V141, P384, DOI 10.1104/pp.106.078295; Wang D, 2016, RICE, V9, DOI 10.1186/s12284-016-0133-2; Wei KF, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0281-8; Wu J, 2015, CELL RES, V25, P621, DOI 10.1038/cr.2015.46; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yadav SK, 2010, AGRON SUSTAIN DEV, V30, P515, DOI 10.1051/agro/2009050; Yu GH, 2014, PLANT CELL REP, V33, P1757, DOI 10.1007/s00299-014-1655-y; Zhang LR, 2008, PLANT CELL PHYSIOL, V49, P1092, DOI 10.1093/pcp/pcn086; Zhang ZY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14788; Zhao JL, 2017, PLANT BIOTECHNOL J, V15, P1141, DOI 10.1111/pbi.12704; Zulak KG, 2009, MOL CELL PROTEOMICS, V8, P86, DOI 10.1074/mcp.M800211-MCP200	49	14	14	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198675	10.1371/journal.pone.0198675	http://dx.doi.org/10.1371/journal.pone.0198675			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879216	Green Published, Green Submitted, gold			2022-12-26	WOS:000434384900069
J	Wang, XM; Kwak, KJ; Yang, ZG; Zhang, AL; Zhang, XL; Sullivan, R; Lin, D; Lee, RL; Castro, C; Ghoshal, K; Schmidt, C; Lee, LJ				Wang, Xinmei; Kwak, Kwang Joo; Yang, Zhaogang; Zhang, Aili; Zhang, Xiaoli; Sullivan, Rachael; Lin, Dan; Lee, Robert L.; Castro, Carlos; Ghoshal, Kalpana; Schmidt, Carl; Lee, L. James			Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma	PLOS ONE			English	Article							CIRCULATING MICRORNAS; LIVER-CANCER; BIOMARKERS; GLYPICAN-3; INFECTION; HEPATITIS	Hepatocellular carcinoma (HCC) remains one of the major causes of cancer related deaths. Although ultrasonography (US), computed tomography (CT) and/or high-cost magnetic resonance imaging (MRI) have been shown to improve early detection of liver cancer and mortality rates in high-risk individuals, such imaging based methods are limited by high rates of false positivity leading to unnecessary patient anxiety and invasive procedures. Complementary blood biomarkers could increase the accuracy of early detection. Although Alphafetoprotein (AFP) in blood is widely used in HCC screening and diagnosis, the false-negative rate as high as 30% and 40% is found in advanced HCC and early stage HCC respectively. We detected AFP messenger RNA (mRNA) in extracellular vesicles (EVs) in patient plasma using designed molecular beacons and a novel tethered lipoplex nanoparticle (TLN) biochip. Together with glypican-3 (GPC-3) mRNA, another well-known HCC marker, we observed much improved performance of AFP protein-based HCC detection. Comparing normal donors (N = 38) and HCC patients (N = 40), our TLN biochip using EV AFP and GPC-3 mRNAs provided an AUC (area under the ROC curve) of 0.995, better than that of a single marker. This 2-mRNA combination also provided a perfect positive predictive value (PPV = 1) at a negative predictive value (NPV) of 0.95 and 20% prevalence, while the blood AFP protein or plasma EV GPC3 mRNA alone could only provide a PPV of 0.61 and 0.79 respectively at the same conditions. Thus, this facile new method may complement current models for risk stratification in liver cancer screening, therapeutic monitoring, and after-treatment surveillance. However, large scale validation will need to be conducted to confirm its clinical potential.	[Wang, Xinmei; Kwak, Kwang Joo; Yang, Zhaogang; Zhang, Aili; Lin, Dan; Lee, L. James] Ohio State Univ, Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Wang, Xinmei; Lin, Dan; Lee, Robert L.; Lee, L. James] Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA; [Zhang, Xiaoli] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Sullivan, Rachael; Schmidt, Carl] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Sullivan, Rachael; Schmidt, Carl] Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA; [Castro, Carlos] Ohio State Univ, Dept Mech Engn, Columbus, OH 43210 USA; [Ghoshal, Kalpana] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Ghoshal, Kalpana] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Lee, LJ (corresponding author), Ohio State Univ, Dept Chem & Biomol Engn, Columbus, OH 43210 USA.; Lee, LJ (corresponding author), Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA.	Lee.31@osu.edu	Yang, Zhaogang/AAB-4148-2019; KWAK, KWANG JOO/AAR-2592-2021	Yang, Zhaogang/0000-0002-6350-4455; 	NCI, NIH [R21 CA-185707]; National Science Foundation [EEC-0914790]; NATIONAL CANCER INSTITUTE [R21CA185707, P30CA016058] Funding Source: NIH RePORTER	NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from NCI, NIH (R21 CA-185707) and National Science Foundation (EEC-0914790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gao W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7536; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Lee LJ, 2016, AM J RESP CRIT CARE, V193, P1431, DOI 10.1164/rccm.201511-2129LE; Li JP, 2011, BIOCHEM BIOPH RES CO, V406, P70, DOI 10.1016/j.bbrc.2011.01.111; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li R, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2156-x; Liu AM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000825; Llovet JM, 2012, CLIN CANCER RES, V18, P2290, DOI 10.1158/1078-0432.CCR-11-2175; Shirakawa H, 2009, INT J ONCOL, V34, P649, DOI 10.3892/ijo_00000190; Song PP, 2013, LIVER CANCER, V2, P31, DOI 10.1159/000346220; Tomimaru Y, 2012, J HEPATOL, V56, P167, DOI 10.1016/j.jhep.2011.04.026; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wu Y, 2013, ANAL CHEM, V85, P11265, DOI 10.1021/ac401983w; Xiao DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046874; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Yao M, 2013, HEPATOB PANCREAT DIS, V12, P171, DOI 10.1016/S1499-3872(13)60028-4; Zhang Y, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005642; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697	20	35	35	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198552	10.1371/journal.pone.0198552	http://dx.doi.org/10.1371/journal.pone.0198552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879168	Green Published, gold, Green Submitted			2022-12-26	WOS:000434384900053
J	Weppelmann, TA; Stephenson, CJ; Musih, E; Dame, JB; Remy, MY; Nicolas, R; von Fricken, ME				Weppelmann, Thomas A.; Stephenson, Caroline J.; Musih, Elisha; Dame, John B.; Remy, Marie Y.; Nicolas, Robert; von Fricken, Michael E.			Elimination or more accurate estimation? Investigation of trends in malaria diagnoses in the Ouest Department of Haiti from 2008 to 2017	PLOS ONE			English	Article							PROGRESS	Background According to the 2016 World Malaria Report, the malaria incidence in Haiti declined by > 40% between 2010 and 2015. Though elimination efforts have likely contributed, this time period also corresponded to a national change in diagnostic methods. Methods Monthly reports of aggregated patient data were acquired from five clinics in the Ouest Department of Haiti. Generalized linear models were used to compare the number of febrile patients tested, the number of positive tests, and the proportion of tests that were positive (TRP) before and after the national adoption of rapid diagnostic tests (RDTs). Results Prior to the earthquake when microcopy was used for diagnosis, a total of 1,727 patients with 557 (32.3%) positive; post-earthquake testing was reduced and the TPR was variable; during the post recovery period when RDTs were used exclusivly, a total of 5,132 patients were tested using RDTs, only 83 (1.62%) were positive. Compared to the pre-earthquake period, there was a 69% increase in the number of patients tested (IRR: 1.69; 95% CI IRR 1.59, 2.79), and a 97.0% decrease in the proportion of patients with a positive test result (IRR: 0.03; 95% CI IRR 0.02, 0.04) in the post-recovery period. Conclusions While the decline in malaria indicators between 2010 and 2015 has been cited as evidence of progress towards elimination, these reports derived estimates of the malaria burden in Haiti using two different diagnostic tests. Thus, comparison of these periods in the context of malaria elimination should be made with caution.	[Weppelmann, Thomas A.] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Stephenson, Caroline J.; Musih, Elisha; von Fricken, Michael E.] George Mason Univ, Dept Global & Community Hlth, Fairfax, VA 22030 USA; [Dame, John B.] Univ Florida, Coll Vet Med, Gainesville, FL USA; [Remy, Marie Y.; Nicolas, Robert] African Methodist Episcopal Church Serv & Dev Agc, Washington, DC USA	State University System of Florida; Florida International University; George Mason University; State University System of Florida; University of Florida	von Fricken, ME (corresponding author), George Mason Univ, Dept Global & Community Hlth, Fairfax, VA 22030 USA.	mvonfric@gmu.edu	Michael vonFricken, MPH/H-3214-2019	Michael vonFricken, MPH/0000-0003-2938-4549; Stephenson, Caroline/0000-0001-5615-4920; Dame, John B./0000-0002-5772-5454	College of Health and Human Services, George Mason University	College of Health and Human Services, George Mason University	This study was conducted with internal funds provided by the College of Health and Human Services, George Mason University given to MEV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, B WORLD HEALTH ORGAN, V66, P575; [Anonymous], 2016, WORLD MAL REP 2015; Boncy PJ, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0753-9; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1372; Clinton Health Access Initiative, 2013, LEGEND WANYEH BELIEF; Eisele TP, 2007, EMERG INFECT DIS, V13, P1494, DOI 10.3201/eid1310.070567; Elbadry MA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1051-2; Frederick J, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1436-x; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Kachur SP, 1995, REV PANAM SALUD PUBL; Landman KZ, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0901-2; Landman KZ, 2012, MALARIA J, V14, P394; Lemoine JF, 2017, AM J TROP MED HYG, V97, P43, DOI 10.4269/ajtmh.16-0902; Lowrance DW, 2017, AM J TROP MED HYG, V97, P1, DOI 10.4269/ajtmh.17-0347; MSPP. de la Sante A Publique et de la Population, 2009, PLAN STRAT GIQ NAT L; Roth JM, 2016, CRIT REV CL LAB SCI, V53, P87, DOI 10.3109/10408363.2015.1084991; Steinhardt LC, 2017, LANCET GLOB HEALTH, V5, pE96, DOI 10.1016/S2214-109X(16)30238-8; Townes D, 2012, AM J TROP MED HYG, V86, P29, DOI 10.4269/ajtmh.2012.11-0431; von Fricken ME, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-361; Zanotti L, 2010, THIRD WORLD Q, V31, P755, DOI 10.1080/01436597.2010.503567	20	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198070	10.1371/journal.pone.0198070	http://dx.doi.org/10.1371/journal.pone.0198070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879170	Green Published, Green Submitted, gold			2022-12-26	WOS:000434384900017
J	Kumar, AP; Lukman, S				Kumar, Ammu Prasanna; Lukman, Suryani			Allosteric binding sites in Rab11 for potential drug candidates	PLOS ONE			English	Article							PROTEIN-KINASE-II; STRUCTURAL BASIS; NETWORK ANALYSIS; CRYSTAL-STRUCTURE; CELL-DEATH; MYOSIN-V; GTPASE; DISCOVERY; FAMILY; TRAFFICKING	Rab11 is an important protein subfamily in the RabGTPase family. These proteins physiologically function as key regulators of intracellular membrane trafficking processes. Pathologically, Rab11 proteins are implicated in many diseases including cancers, neurodegenerative diseases and type 2 diabetes. Although they are medically important, no previous study has found Rab11 allosteric binding sites where potential drug candidates can bind to. In this study, by employing multiple clustering approaches integrating principal component analysis, independent component analysis and locally linear embedding, we performed structural analyses of Rab11 and identified eight representative structures. Using these representatives to perform binding site mapping and virtual screening, we identified two novel binding sites in Rab11 and small molecules that can preferentially bind to different conformations of these sites with high affinities. After identifying the binding sites and the residue interaction networks in the representatives, we computationally showed that these binding sites may allosterically regulate Rab11, as these sites communicate with switch 2 region that binds to GTP/GDP. These two allosteric binding sites in Rab11 are also similar to two allosteric pockets in Ras that we discovered previously.	[Kumar, Ammu Prasanna; Lukman, Suryani] Khalifa Univ Sci & Technol, Dept Chem, Coll Arts & Sci, Abu Dhabi, U Arab Emirates	Khalifa University of Science & Technology	Kumar, AP; Lukman, S (corresponding author), Khalifa Univ Sci & Technol, Dept Chem, Coll Arts & Sci, Abu Dhabi, U Arab Emirates.	ammuajith34@gmail.com; suryani.lukman@ku.ac.ae		Lukman, Suryani/0000-0002-8913-1343				Agola JO, 2012, ACS CHEM BIOL, V7, P1095, DOI 10.1021/cb3001099; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Anant JS, 1998, BIOCHEMISTRY-US, V37, P12559, DOI 10.1021/bi980881a; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Barakat K., 2014, J PHARM CARE HLTH SY, V1, pe119, DOI [10.4172/2376-0419.1000e119, DOI 10.4172/2376-0419.1000E119]; BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x; Bouquier N, 2009, CHEM BIOL, V16, P657, DOI 10.1016/j.chembiol.2009.04.012; Breda C, 2015, HUM MOL GENET, V24, P1077, DOI 10.1093/hmg/ddu521; Bruce EA, 2010, J VIROL, V84, P5848, DOI 10.1128/JVI.00307-10; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Burke JE, 2014, SCIENCE, V344, P1035, DOI 10.1126/science.1253397; Cardama GA, 2014, ANTI-CANCER AGENT ME, V14, P840, DOI 10.2174/18715206113136660334; Chakrabarty B, 2016, NUCLEIC ACIDS RES, V44, pW375, DOI 10.1093/nar/gkw383; Cheng W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002528; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Chung YC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-587; Cortes C, 2007, INFECT IMMUN, V75, P5586, DOI 10.1128/IAI.01020-07; Costantini S, 2008, BIOINFORMATION, V2, P271, DOI 10.6026/97320630002271; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; del Sol A, 2005, PROTEINS, V58, P672, DOI 10.1002/prot.20348; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P8637, DOI 10.1073/pnas.122076099; Dong N, 2012, CELL, V150, P1029, DOI 10.1016/j.cell.2012.06.050; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Eyrisch S, 2007, J MED CHEM, V50, P3457, DOI 10.1021/jm070095g; Forli S, 2016, NAT PROTOC, V11, P905, DOI 10.1038/nprot.2016.051; Fowler ML, 2016, PROTEIN SCI, V25, P826, DOI 10.1002/pro.2879; Gavriljuk K, 2012, P NATL ACAD SCI USA, V109, P21348, DOI 10.1073/pnas.1214431110; Gazdag EM, 2013, EMBO REP, V14, P199, DOI 10.1038/embor.2012.211; Gebhardt C, 2005, AM J PATHOL, V167, P243, DOI 10.1016/S0002-9440(10)62969-0; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P15711, DOI 10.1073/pnas.0704459104; GIARDIELLO FM, 1993, NEW ENGL J MED, V328, P1313, DOI 10.1056/NEJM199305063281805; Glazer DS, 2009, STRUCTURE, V17, P919, DOI 10.1016/j.str.2009.05.010; Gorfe AA, 2010, CURR MED CHEM, V17, P1, DOI 10.2174/092986710789957832; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Grant BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025711; Grant BJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000325; Greenfield JP, 2002, J BIOL CHEM, V277, P12128, DOI 10.1074/jbc.M110009200; Grover AK, 2013, MED PRIN PRACT, V22, P418, DOI 10.1159/000350417; Gurung AB, 2017, SAUDI J BIOL SCI, V24, P379, DOI 10.1016/j.sjbs.2016.01.008; Hall DR, 2012, METHODS MOL BIOL, V819, P13, DOI 10.1007/978-1-61779-465-0_2; Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Haugsten EM, 2014, TRAFFIC, V15, P665, DOI 10.1111/tra.12168; Herrmann C, 1998, ONCOGENE, V17, P1769, DOI 10.1038/sj.onc.1202085; Hocker HJ, 2014, J CHEM INF MODEL, V54, P530, DOI 10.1021/ci400474u; Horgan CP, 2013, BIOCHEM BIOPH RES CO, V441, P214, DOI 10.1016/j.bbrc.2013.10.043; Horgan Conor P, 2012, Front Biosci (Schol Ed), V4, P547; Horgan CP, 2009, BIOCHEM SOC T, V37, P1032, DOI 10.1042/BST0371032; Hu G, 2014, J THEOR BIOL, V348, P55, DOI 10.1016/j.jtbi.2014.01.023; Huang SH, 2013, J NEUROSCI, V33, P9214, DOI 10.1523/JNEUROSCI.3256-12.2013; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jagoe WN, 2006, STRUCTURE, V14, P1273, DOI 10.1016/j.str.2006.06.010; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Junutula JR, 2004, J BIOL CHEM, V279, P33430, DOI 10.1074/jbc.M404633200; Kawabata T, 2011, J CHEM INF MODEL, V51, P1775, DOI 10.1021/ci2001023; Kayo O, 2006, LOCALLY LINEAR EMBED; Kelly EE, 2012, BIOCHEM SOC T, V40, P1360, DOI 10.1042/BST20120157; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Koes DR, 2013, J CHEM INF MODEL, V53, P1893, DOI 10.1021/ci300604z; Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043; Krishnan M, 2013, MOL BIOL CELL, V24, P818, DOI 10.1091/mbc.E12-10-0745; Kumar AP, 2018, PROTEINS, V86, P301, DOI 10.1002/prot.25440; LAI F, 1994, GENOMICS, V22, P610, DOI 10.1006/geno.1994.1434; Lall P, 2013, BBA-PROTEINS PROTEOM, V1834, P2679, DOI 10.1016/j.bbapap.2013.09.005; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Laskowski RA, 2009, FEBS LETT, V583, P1692, DOI 10.1016/j.febslet.2009.03.019; Li XY, 2010, J NEUROSCI, V30, P4552, DOI 10.1523/JNEUROSCI.5865-09.2010; Lionta E, 2014, CURR TOP MED CHEM, V14, P1923, DOI 10.2174/1568026614666140929124445; Lipinski AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000615; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Lukman S, 2007, INTERACTING AMINO AC, P69, DOI [10.1142/9781848161092_0010, DOI 10.1142/9781848161092_0010]; Lukman S, 2017, PROTEINS, V85, P859, DOI 10.1002/prot.25254; Lukman S, 2016, PROCEDIA COMPUT SCI, V80, P2292, DOI 10.1016/j.procs.2016.05.419; Lukman S, 2015, PROCEDIA COMPUT SCI, V51, P735, DOI 10.1016/j.procs.2015.05.192; Lukman S, 2015, J ENDOCRINOL METAB, V5, P273, DOI 10.14740/jem302w; Lukman S, 2014, ADV EXP MED BIOL, V805, P245, DOI 10.1007/978-3-319-02970-2_11; Lukman S, 2012, PROTEINS, V80, P1066, DOI 10.1002/prot.24008; Lukman S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000922; Lukman S, 2010, FEBS LETT, V584, P1235, DOI 10.1016/j.febslet.2010.02.035; McCarthy M, 2016, ACTA BIOCH BIOPH SIN, V48, P3, DOI 10.1093/abbs/gmv100; McRobb FM, 2014, ENVIRON SCI TECHNOL, V48, P1964, DOI 10.1021/es404568a; Meanwell NA, 2007, CURR OPIN INVEST DR, V8, P669; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Mishra AK, 2013, J BIOL CHEM, V288, P24000, DOI 10.1074/jbc.M113.470625; Mitra S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00888-8; Naritomi Y, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3554380; Naz S, 2017, PEERJ, V5, DOI 10.7717/peerj.3765; Nemeth EF, 2004, J PHARMACOL EXP THER, V308, P627, DOI 10.1124/jpet.103.057273; Nguyen MN, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw819; Nguyen MN, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr348; Panjkovich A, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-9; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Pasqualato S, 2005, STRUCTURE, V13, P533, DOI 10.1016/j.str.2005.01.014; Pasqualato S, 2004, J BIOL CHEM, V279, P11480, DOI 10.1074/jbc.M310558200; Patschull AOM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036612; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugrath JW, 2015, ACTA CRYSTALLOGR F, V71, P622, DOI 10.1107/S2053230X15008304; Pietro OD, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Piovesan D, 2016, NUCLEIC ACIDS RES, V44, pW367, DOI 10.1093/nar/gkw315; Prakash P, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004469; Pylypenko O, 2016, ELIFE, V5, DOI [10.7554/eLife.17523, 10.7554/elife.17523]; Pylypenko O, 2013, P NATL ACAD SCI USA, V110, P20443, DOI 10.1073/pnas.1314329110; Quiroga R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155183; Reger AS, 2014, J BIOL CHEM, V289, P25393, DOI 10.1074/jbc.M114.575894; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Salentin S, 2015, NUCLEIC ACIDS RES, V43, pW443, DOI 10.1093/nar/gkv315; Scapin G, 2003, BIOCHEMISTRY-US, V42, P11451, DOI 10.1021/bi035098j; Schames JR, 2004, J MED CHEM, V47, P1879, DOI 10.1021/jm0341913; Sebti SM, 2000, ONCOGENE, V19, P6584, DOI 10.1038/sj.onc.1204146; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Shiba T, 2006, P NATL ACAD SCI USA, V103, P15416, DOI 10.1073/pnas.0605357103; Sousa SF, 2008, CURR MED CHEM, V15, P1478, DOI 10.2174/092986708784638825; Souza VP, 2016, FEBS J, V283, P1124, DOI 10.1111/febs.13659; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stein M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034870; Sugawara K, 2009, GENES CELLS, V14, P445, DOI 10.1111/j.1365-2443.2009.01285.x; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Surviladze Z, 2010, J BIOMOL SCREEN, V15, P10, DOI 10.1177/1087057109352240; Teichmann SA, 2002, J MOL BIOL, V324, P399, DOI 10.1016/S0022-2836(02)01144-0; Thornton JM, 2001, PROTEIN SCI, V10, P3, DOI 10.1110/ps.10.1.3; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Vale-Costa S, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030064; van de Graaf SFJ, 2006, AM J PHYSIOL-RENAL, V290, pF1295, DOI 10.1152/ajprenal.00443.2005; van de Graaf SFJ, 2006, MOL CELL BIOL, V26, P303, DOI 10.1128/MCB.26.1.303-312.2006; Vasilyeva A, 2009, DNA REPAIR, V8, P103, DOI 10.1016/j.dnarep.2008.09.008; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Vetter M, 2015, NAT STRUCT MOL BIOL, V22, P695, DOI 10.1038/nsmb.3065; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wenthur CJ, 2014, ANNU REV PHARMACOL, V54, P165, DOI 10.1146/annurev-pharmtox-010611-134525; Westlake CJ, 2007, P NATL ACAD SCI USA, V104, P1236, DOI 10.1073/pnas.0610500104; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Yip K.W., 2011, ENCYCL CANC, P3451, DOI [10.1007/978-3-642-16483-5_5376, DOI 10.1007/978-3-642-16483-5_5376]; Yoon SO, 2005, CANCER RES, V65, P2761, DOI 10.1158/0008-5472.CAN-04-4122; Yu Q, 2013, CELL RES, V23, P775, DOI 10.1038/cr.2013.54; Yuasa K, 2008, BIOCHEM BIOPH RES CO, V374, P522, DOI 10.1016/j.bbrc.2008.07.071; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200; Zhu YQ, 2010, P NATL ACAD SCI USA, V107, P4699, DOI 10.1073/pnas.0914231107	147	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198632	10.1371/journal.pone.0198632	http://dx.doi.org/10.1371/journal.pone.0198632			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874286	gold, Green Published, Green Submitted			2022-12-26	WOS:000434369400054
J	Nyamukondiwa, C; Chidawanyika, F; Machekano, H; Mutamiswa, R; Sands, B; Mgidiswa, N; Wall, R				Nyamukondiwa, Casper; Chidawanyika, Frank; Machekano, Honest; Mutamiswa, Reyard; Sands, Bryony; Mgidiswa, Neludo; Wall, Richard			Climate variability differentially impacts thermal fitness traits in three coprophagic beetle species	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; DROSOPHILA-MELANOGASTER; PHENOTYPIC PLASTICITY; DUNG BEETLES; TEMPERATURE VARIABILITY; CERATITIS-CAPITATA; COLD TOLERANCE; THAUMATOTIBIA-LEUCOTRETA; DESICCATION RESISTANCE; TERRESTRIAL ECTOTHERMS	While the impacts of extreme and rising mean temperatures are well documented, increased thermal variability associated with climate change may also threaten ectotherm fitness and survival, but remains poorly explored. Using three wild collected coprophagic species Copris elphenor, Metacatharsius opacus and Scarabaeus zambezianus, we explored the effects of thermal amplitude around the mean on thermal tolerance. Using standardized protocols, we measured traits of high- (critical thermal maxima [CTmax] and heat knockdown time [HKDT]) and -low temperature tolerance (critical thermal minima [CTmin], chill coma recovery time [CCRT] and supercooling points [SCPs]) following variable temperature pulses (delta 0, delta 3, delta 6 and delta 9 degrees C) around the mean (27 degrees C). Our results show that increased temperature variability may offset basal and plastic responses to temperature and differs across species and metrics tested. Furthermore, we also show differential effects of body mass, body water content (BWC) and body lipid content (BLC) on traits of thermal tolerance. For example, body mass significantly influenced C. elphenor and S. zambezianus CTmax and S. zambezianus HKDT but not CTmin and CCRT. BWC significantly affected M. opacus and C. elphenor CTmax and in only M. opacus HKDT, CTmin and CCRT. Similarly, BLC only had a significant effect for M opacus CTmin. These results suggest differential and species dependent effects of climate variability of thermal fitness traits. It is therefore likely that the ecological services provided by these species may be constrained in the face of climate change. This implies that, to develop more realistic predictions for the effects of climate change on insect biodiversity and ecosystem function, thermal variability is a significant determinant.	[Nyamukondiwa, Casper; Machekano, Honest; Mutamiswa, Reyard; Mgidiswa, Neludo] BIUST, Dept Biol Sci & Biotechnol, Palapye, Botswana; [Chidawanyika, Frank] Agr Res Council, Plant Protect Res Inst, Weeds Div, Hilton, South Africa; [Chidawanyika, Frank] Univ KwaZulu Natal, Sch Lifesci, Pietermaritzburg, South Africa; [Sands, Bryony; Wall, Richard] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Mutamiswa, Reyard] Univ Free State, Dept Zool & Entomol, Bloemfontein, South Africa	Agricultural Research Council of South Africa; University of Kwazulu Natal; University of Bristol; University of the Free State	Nyamukondiwa, C (corresponding author), BIUST, Dept Biol Sci & Biotechnol, Palapye, Botswana.	nyamukondiwac@biust.ac.bw	Machekano, Honest/AAL-7848-2020; Chidawanyika, Frank/AAJ-7551-2020	Chidawanyika, Frank/0000-0002-4601-768X; Sands, Bryony/0000-0003-0036-6400; Machekano, Honest/0000-0001-9660-8587	BIUST internal research grant [BIUST/ds/ri/17/2016]	BIUST internal research grant	Research was funded through BIUST internal research grant REF: BIUST/ds/r&i/17/2016 to CN.	Almeida S, 2011, BIOTROPICA, V43, P704, DOI 10.1111/j.1744-7429.2011.00751.x; Angilletta MJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P282, DOI 10.1086/499990; Basson CH, 2012, EVOLUTION, V66, P296, DOI 10.1111/j.1558-5646.2011.01419.x; BERGSTROM RC, 1976, P HELM SOC WASH, V43, P171; Beynon SA, 2015, ECOL ENTOMOL, V40, P124, DOI 10.1111/een.12240; Beynon SA, 2012, J APPL ECOL, V49, P1365, DOI 10.1111/j.1365-2664.2012.02210.x; Boardman L, 2015, J INSECT PHYSIOL, V82, P75, DOI 10.1016/j.jinsphys.2015.09.001; Boardman L, 2013, J INSECT PHYSIOL, V59, P781, DOI 10.1016/j.jinsphys.2013.05.005; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; Bozinovic F, 2016, J COMP PHYSIOL B, V186, P581, DOI 10.1007/s00360-016-0980-6; Braga RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057786; Brans KI, 2017, GLOBAL CHANGE BIOL, V23, P5218, DOI 10.1111/gcb.13784; Bubliy OA, 2012, FUNCT ECOL, V26, P245, DOI 10.1111/j.1365-2435.2011.01928.x; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Chidawanyika F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169371; Chidawanyika F, 2011, J INSECT PHYSIOL, V57, P108, DOI 10.1016/j.jinsphys.2010.09.013; Chidawanyika F, 2011, EVOL APPL, V4, P534, DOI 10.1111/j.1752-4571.2010.00168.x; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Chown SL, 1999, FUNCT ECOL, V13, P838, DOI 10.1046/j.1365-2435.1999.00373.x; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Clavijo-Baquet S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05349; Clusella-Trullas S, 2010, PHYSIOL BIOCHEM ZOOL, V83, P519, DOI 10.1086/651387; COULSON SC, 1992, J INSECT PHYSIOL, V38, P421, DOI 10.1016/0022-1910(92)90118-W; Davis A. L. V., 2008, AFRICAN DUNG BEETLE; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Diamond SE, 2010, AM NAT, V175, P1, DOI 10.1086/648602; Dick CA, 2013, PHYSIOL BIOCHEM ZOOL, V86, P432, DOI 10.1086/671462; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Diffenbaugh NS, 2005, P NATL ACAD SCI USA, V102, P15774, DOI 10.1073/pnas.0506042102; Donat MG, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052459; Dowd WW, 2015, J EXP BIOL, V218, P1956, DOI 10.1242/jeb.114926; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Estay SA, 2014, OIKOS, V123, P131, DOI 10.1111/j.1600-0706.2013.00607.x; Estay SA, 2011, POPUL ECOL, V53, P53, DOI 10.1007/s10144-010-0216-7; Fischer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015284; Folguera G, 2011, COMP BIOCHEM PHYS A, V159, P242, DOI 10.1016/j.cbpa.2011.03.002; Geister TL, 2007, BEHAV ECOL, V18, P658, DOI 10.1093/beheco/arm024; Gerken AR, 2015, P NATL ACAD SCI USA, V112, P4399, DOI 10.1073/pnas.1503456112; Gunderson AR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0401; Gunderson AR, 2017, FUNCTIONAL ECOLOGY, V31, P529; Helmuth B, 2009, J EXP BIOL, V212, P753, DOI 10.1242/jeb.023861; Hoffmann AA, 2000, FUNCT ECOL, V14, P55, DOI 10.1046/j.1365-2435.2000.00388.x; Huey R.B., 1996, Society for Experimental Biology Seminar Series, V59, P205; Jacobs CT, 2010, J INSECT CONSERV, V14, P389, DOI 10.1007/s10841-010-9270-x; Kellett M, 2005, FUNCT ECOL, V19, P853, DOI 10.1111/j.1365-2435.2005.01025.x; Kingsolver JG, 2013, FUNCT ECOL, V27, P1415, DOI 10.1111/1365-2435.12145; Klockmann M, 2017, GLOBAL CHANGE BIOL, V23, P686, DOI 10.1111/gcb.13407; Kristensen TN, 2008, P NATL ACAD SCI USA, V105, P216, DOI 10.1073/pnas.0708074105; Kruger K, 1999, B ENTOMOL RES, V89, P543, DOI 10.1017/S0007485399000693; Lachenicht MW, 2010, J INSECT PHYSIOL, V56, P822, DOI 10.1016/j.jinsphys.2010.02.010; Le Lagadec MD, 1998, J COMP PHYSIOL B, V168, P112, DOI 10.1007/s003600050127; Lease HM, 2011, PHYSIOL ENTOMOL, V36, P29, DOI 10.1111/j.1365-3032.2010.00767.x; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Ma FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103279; Mann CM, 2015, MED VET ENTOMOL, V29, P189, DOI 10.1111/mve.12104; Marais E, 2009, J INSECT PHYSIOL, V55, P336, DOI 10.1016/j.jinsphys.2008.11.016; Marshall KE, 2010, P ROY SOC B-BIOL SCI, V277, P963, DOI 10.1098/rspb.2009.1807; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Milton CC, 2008, J INSECT PHYSIOL, V54, P32, DOI 10.1016/j.jinsphys.2007.08.001; Mitchell KA, 2017, FUNCTIONAL ECOLOGY, V24, P694; Mitchell KA, 2017, COMP BIOCHEM PHYS A, V212, P15, DOI 10.1016/j.cbpa.2017.06.019; Mudavanhu P, 2014, ENTOMOL EXP APPL, V153, P55, DOI 10.1111/eea.12228; Mutamiswa R, 2017, INSECT SCI, P1; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Nyamukondiwa C, 2011, J EVOLUTION BIOL, V24, P1927, DOI 10.1111/j.1420-9101.2011.02324.x; Nyamukondiwa C, 2013, J INSECT PHYSIOL, V59, P1199, DOI 10.1016/j.jinsphys.2013.09.004; Nyamukondiwa C, 2010, PHYSIOL ENTOMOL, V35, P255, DOI 10.1111/j.1365-3032.2010.00736.x; Nyamukondiwa C, 2009, J THERM BIOL, V34, P406, DOI 10.1016/j.jtherbio.2009.09.002; Oberg EW, 2012, INSECT SOC, V59, P167, DOI 10.1007/s00040-011-0201-y; Paaijmans KP, 2013, GLOBAL CHANGE BIOL, V19, P2373, DOI 10.1111/gcb.12240; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Piyaphongkul J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047413; R Development Core Team, 2016, R LANG ENV STAT COMP; Ragland GJ, 2008, EVOL ECOL RES, V10, P29; Sands B, 2017, J APPL ECOL, V54, P1180, DOI 10.1111/1365-2664.12821; Saunders LM, 2002, J PARASITOL, V88, P1271, DOI 10.1645/0022-3395(2002)088[1271:SANED]2.0.CO;2; Scharf I, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1344-5; Scheiner SM, 2002, J EVOLUTION BIOL, V15, P889, DOI 10.1046/j.1420-9101.2002.00468.x; Schulte PM, 2011, INTEGR COMP BIOL, V51, P691, DOI 10.1093/icb/icr097; Sejerkilde M, 2003, J INSECT PHYSIOL, V49, P719, DOI 10.1016/S0022-1910(03)00095-7; Sgro CM, 2016, ANNU REV ENTOMOL, V61, P433, DOI 10.1146/annurev-ento-010715-023859; Shah AA, 2017, FUNCT ECOL, V31, P2118, DOI 10.1111/1365-2435.12906; Shreve SM, 2007, CRYOLETTERS, V28, P33; Sinclair BJ, 2003, BIOL REV, V78, P181, DOI 10.1017/S1464793102006024; Sinclair BJ, 2015, J THERM BIOL, V53, P180, DOI 10.1016/j.jtherbio.2015.11.003; Sinclair BJ, 2015, J THERM BIOL, V54, P5, DOI 10.1016/j.jtherbio.2014.07.007; Smolka J, 2012, CURR BIOL, V22, pR863, DOI 10.1016/j.cub.2012.08.057; Speight M.R., 2008, ECOLOGY INSECTS CONC, V2nd ed.; Spicer J. I., 1999, PHYSL DIVERSITY ITS; Stotter RL, 2009, J THERM BIOL, V34, P320, DOI 10.1016/j.jtherbio.2009.05.002; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; Terblanche JS, 2010, ENTOMOL EXP APPL, V137, P304, DOI 10.1111/j.1570-7458.2010.01067.x; Thompson RM, 2013, ECOL LETT, V16, P799, DOI 10.1111/ele.12095; Valladares F, 2014, ECOL LETT, V17, P1351, DOI 10.1111/ele.12348; Vasseur DA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2612; Weldon CW, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0147-z; Weldon CW, 2011, J THERM BIOL, V36, P479, DOI 10.1016/j.jtherbio.2011.08.005; Yamada Daigo, 2007, Grassland Science, V53, P121, DOI 10.1111/j.1744-697X.2007.00082.x; Zhou ZS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074760	103	17	17	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198610	10.1371/journal.pone.0198610	http://dx.doi.org/10.1371/journal.pone.0198610			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874290	gold, Green Published, Green Submitted			2022-12-26	WOS:000434369400053
J	Reckmann, AN; Tomczyk, CUM; Davidoff, MS; Michurina, TV; Arnhold, S; Muller, D; Mietens, A; Middendorff, R				Reckmann, Ansgar N.; Tomczyk, Claudia U. M.; Davidoff, Michail S.; Michurina, Tatyana V.; Arnhold, Stefan; Mueller, Dieter; Mietens, Andrea; Middendorff, Ralf			Nestin in the epididymis is expressed in vascular wall cells and is regulated during postnatal development and in case of testosterone deficiency	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT PROTEIN; ANDROGEN RECEPTOR PROTEIN; STEM-CELLS; PROGENITOR CELLS; ENDOTHELIAL-CELLS; DOWN-REGULATION; LEYDIG-CELLS; ADULT; PERICYTES; PROSTATE	Vascular smooth muscle cells (SMCs), distinguished by the expression of the neuronal stem cell marker nestin, may represent stem cell-like progenitor cells in various organs including the testis. We investigated epididymal tissues of adult nestin-GFP mice, rats after Leydig cell depletion via ethane dimethane sulfonate (EDS), rats and mice during postnatal development and human tissues. By use of Clarity, a histochemical method to illustrate a three-dimensional picture, we could demonstrate nestin-GFP positive cells within the vascular network. We localized nestin in the epididymis in proliferating vascular SMCs by colocalization with both smooth muscle actin and PCNA, and it was distinct from CD31-positive endothelial cells. The same nestin localization was found in the human epididymis. However, nestin was not found in SMCs of the epididymal duct. Nestin expression is high during postnatal development of mouse and rat and down-regulated towards adulthood when testosterone levels increase. Nestin increases dramatically in rats after Leydig cell ablation with EDS and subsequently low testosterone levels. Interestingly, during this period, the expression of androgen receptor in the epididymis is low and increases until nestin reaches normal levels of adulthood. Here we show that nestin, a common marker for neuronal stem cells, is also expressed in the vasculature of the epididymis. Our results give new insights into the yet underestimated role of proliferating nestin-expressing vascular SMCs during postnatal development and repair of the epididymis.	[Reckmann, Ansgar N.; Tomczyk, Claudia U. M.; Mueller, Dieter; Mietens, Andrea; Middendorff, Ralf] Justus Liebig Univ Giessen, Inst Anat & Cell Biol, Giessen, Germany; [Davidoff, Michail S.] Univ Med Ctr Hamburg Eppendorf, Inst Anat & Expt Morphol, Hamburg, Germany; [Michurina, Tatyana V.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Michurina, Tatyana V.] SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; [Michurina, Tatyana V.] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA; [Michurina, Tatyana V.] Moscow Inst Phys & Technol, Moscow, Russia; [Arnhold, Stefan] Justus Liebig Univ Giessen, Inst Vet Anat Histol & Embryol, Giessen, Germany	Justus Liebig University Giessen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Moscow Institute of Physics & Technology; Justus Liebig University Giessen	Mietens, A; Middendorff, R (corresponding author), Justus Liebig Univ Giessen, Inst Anat & Cell Biol, Giessen, Germany.	Andrea.Mietens@anatomie.med.uni-giessen.de; Ralf.Middendorff@anatomie.med.uni-giessen.de			Deutsche Forschungsgemeinschaft [KFO 181-2, GRK 1871]; research grant of the University Medical Center Giessen and Marburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); research grant of the University Medical Center Giessen and Marburg	This work was supported by Deutsche Forschungsgemeinschaft (KFO 181-2, GRK 1871) and by research grant of the University Medical Center Giessen and Marburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	About I, 2000, AM J PATHOL, V157, P287, DOI 10.1016/S0002-9440(10)64539-7; Aihara M, 2004, LAB INVEST, V84, P1581, DOI 10.1038/labinvest.3700186; Alliot F, 1999, J NEUROSCI RES, V58, P367; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Atanassova N, 2006, FOLIA HISTOCHEM CYTO, V44, P81; Bernardo AS, 2006, MOL CELL ENDOCRINOL, V253, P14, DOI 10.1016/j.mce.2006.03.003; Bertelli E, 2007, J HISTOCHEM CYTOCHEM, V55, P411, DOI 10.1369/jhc.6A7058.2007; Birbrair A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00245; BLOK LJ, 1992, INT J ANDROL, V15, P182, DOI 10.1111/j.1365-2605.1992.tb01125.x; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Daniel C, 2008, LAB INVEST, V88, P387, DOI 10.1038/labinvest.2008.5; Davidoff MS, 2004, J CELL BIOL, V167, P935, DOI 10.1083/jcb.200409107; de Celis MFR, 2015, STEM CELLS, V33, P2037, DOI 10.1002/stem.2002; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; El-Helou V, 2013, J CELL PHYSIOL, V228, P1844, DOI 10.1002/jcp.24345; Ergun S, 2011, ANTIOXID REDOX SIGN, V15, P981, DOI 10.1089/ars.2010.3507; Esni F, 2004, MECH DEVELOP, V121, P15, DOI 10.1016/j.mod.2003.08.010; Ferland-McCollough D, 2017, PHARMACOL THERAPEUT, V171, P30, DOI 10.1016/j.pharmthera.2016.11.008; Gleiberman AS, 2005, DEV DYNAM, V234, P413, DOI 10.1002/dvdy.20536; Gravdal K, 2009, CANCER RES, V69, P4708, DOI 10.1158/0008-5472.CAN-08-4417; Han Seung Hee, 2013, Dev Reprod, V17, P469, DOI 10.12717/DR.2013.17.4.469; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; KACHINSKY AM, 1994, DEV BIOL, V165, P216, DOI 10.1006/dbio.1994.1248; KACHINSKY AM, 1995, J HISTOCHEM CYTOCHEM, V43, P843, DOI 10.1177/43.8.7542682; Kim HS, 2002, APPL IMMUNOHISTO M M, V10, P121, DOI 10.1097/00022744-200206000-00005; Klein D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00169; Klein T, 2003, J HISTOCHEM CYTOCHEM, V51, P697, DOI 10.1177/002215540305100601; Koning JJ, 2016, J IMMUNOL, V197, P2686, DOI 10.4049/jimmunol.1501162; KRONGRAD A, 1991, MOL CELL ENDOCRINOL, V76, P79, DOI 10.1016/0303-7207(91)90262-Q; Kulkarni S, 2017, P NATL ACAD SCI USA, V114, pE3709, DOI 10.1073/pnas.1619406114; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Mahler J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-89; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mokry J, 2004, STEM CELLS DEV, V13, P658, DOI 10.1089/scd.2004.13.658; Muller D, 2011, REPRODUCTION, V142, P333, DOI 10.1530/REP-10-0517; Oikawa H, 2010, EXP CELL RES, V316, P940, DOI 10.1016/j.yexcr.2009.10.025; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Psaltis PJ, 2011, J CARDIOVASC TRANSL, V4, P161, DOI 10.1007/s12265-010-9248-9; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P22, DOI 10.1210/mend-4-1-22; Ribatti D, 2015, METHODS MOL BIOL, V1214, P1, DOI 10.1007/978-1-4939-1462-3_1; Robaire B, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1071; Saboor F, 2016, EUR RESPIR J, V47, P876, DOI 10.1183/13993003.00574-2015; Scobioala S, 2008, FASEB J, V22, P1021, DOI 10.1096/fj.07-8252com; Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592; Shi HL, 2008, J COMP NEUROL, V508, P867, DOI 10.1002/cne.21719; SUN EL, 1979, AM J ANAT, V154, P27, DOI 10.1002/aja.1001540104; Suzuki S, 2010, J HISTOCHEM CYTOCHEM, V58, P721, DOI 10.1369/jhc.2010.955609; Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867; Tardif K, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0119-6; Teerds KJ, 2007, LEYDIG CELL HLTH DIS, P91, DOI DOI 10.1007/978-1-59745-453-7_6; Vaittinen S, 2001, J NEUROPATH EXP NEUR, V60, P588, DOI 10.1093/jnen/60.6.588; VREEBURG JTM, 1988, J REPROD FERTIL, V84, P63; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Worsdorfer P, 2017, PHARMACOL THERAPEUT, V171, P13, DOI 10.1016/j.pharmthera.2016.07.017; Yamahatsu K, 2012, INT J ONCOL, V40, P1345, DOI 10.3892/ijo.2012.1333; Zengin E, 2006, DEVELOPMENT, V133, P1543, DOI 10.1242/dev.02315	56	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0194585	10.1371/journal.pone.0194585	http://dx.doi.org/10.1371/journal.pone.0194585			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874225	Green Published, gold, Green Submitted			2022-12-26	WOS:000434369400002
J	Souza, VP; Ikegami, CM; Arantes, GM; Marana, SR				Souza, Valquiria P.; Ikegami, Cecilia M.; Arantes, Guilherme M.; Marana, Sandro R.			Mutations close to a hub residue affect the distant active site of a GH1 beta-glucosidase	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; PROTEIN STRUCTURES; ALLOSTERIC SIGNAL; NETWORK; GLYCOSIDASE; CATALYSIS; MECHANISM; BINDING	The tertiary structure of proteins has been represented as a network, in which residues are nodes and their contacts are edges. Protein structure networks contain residues, called hubs or central, which are essential to form short connection pathways between any pair of nodes. Hence hub residues may effectively spread structural perturbations through the protein. To test whether modifications nearby to hub residues could affect the enzyme active site, mutations were introduced in the beta-glycosidase Sf beta gly (PDB-ID: 5CGO) directed to residues that form an a-helix (260-265) and a beta-strand (335-337) close to one of its main hub residues, F251, which is approximately 14 angstrom from the Sf beta gly active site. Replacement of residues A263 and A264, which side-chains project from the alpha-helix towards F251, decreased the rate of substrate hydrolysis. Mutation A263F was shown to weaken noncovalent interactions involved in transition state stabilization within the Sf beta gly active site. Mutations placed on the opposite side of the same alpha-helix did not show these effects. Consistently, replacement of V336, which side-chain protrudes from a beta-strand face towards F251, inactivated Sf beta gly. Next to V336, mutation S337F also caused a decrease in noncovalent interactions involved in transition state stabilization. Therefore, we suggest that mutations A263F, A264F, V336F and S337F may directly perturb the position of the hub F251, which could propagate these perturbations into the Sf beta gly active site through short connection pathways along the protein network.	[Souza, Valquiria P.; Ikegami, Cecilia M.; Arantes, Guilherme M.; Marana, Sandro R.] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Marana, SR (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, SP, Brazil.	srmarana@iq.usp.br	Arantes, Guilherme Menegon/A-1940-2008; Marana, Sandro/D-3867-2012	Arantes, Guilherme Menegon/0000-0001-5356-7703; Marana, Sandro/0000-0002-5117-1921; Souza, Valquiria/0000-0002-3052-2112	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [08/57619-4, 14/19439-5, 16/22365-9]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); Fapesp; Capes	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This project was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Grants 08/57619-4, 14/19439-5 and 16/22365-9) to Sandro R. Marana and Valquiria P Souza, CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) to Guilherme Menegon Arantes and Sandro R. Marana, and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) to Cecilia Midori Ikegami and Sandro R. Marana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; S.R.M. and G.M.A. are staff members of the "Departamento de Bioquimica-IQUSP" and CNPq Research Fellows. V.P.S. and C.M.I. are graduate students supported by Fapesp and Capes, respectively. We thank Juliana Raveli Domingos for providing technical assistance.	Aftabuddin M, 2007, BIOPHYS J, V93, P225, DOI 10.1529/biophysj.106.098004; Amaro RE, 2007, BIOCHEMISTRY-US, V46, P2156, DOI 10.1021/bi061708e; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Badieyan S, 2012, BIOCHEMISTRY-US, V51, P8907, DOI 10.1021/bi300675x; Bagler G, 2005, PHYSICA A, V346, P27, DOI 10.1016/j.physa.2004.08.046; Burmeister WP, 2000, J BIOL CHEM, V275, P39385, DOI 10.1074/jbc.M006796200; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; del Sol A, 2005, PROTEINS, V58, P672, DOI 10.1002/prot.20348; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Doshi U, 2016, P NATL ACAD SCI USA, V113, P4735, DOI 10.1073/pnas.1523573113; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; KEMPTON JB, 1992, BIOCHEMISTRY-US, V31, P9961, DOI 10.1021/bi00156a015; Kundu S, 2005, PHYSICA A, V346, P104, DOI 10.1016/j.physa.2004.08.055; Marana SR, 2006, IUBMB LIFE, V58, P63, DOI 10.1080/15216540600617156; Marana SR, 2004, EUR J BIOCHEM, V271, P4169, DOI 10.1111/j.1432-1033.2004.04354.x; Marana SR, 2003, EUR J BIOCHEM, V270, P4866, DOI 10.1046/j.1432-1033.2003.03887.x; Marana SR, 2002, EUR J BIOCHEM, V269, P3705, DOI 10.1046/j.1432-1033.2002.03061.x; Marana SR, 2001, BBA-PROTEIN STRUCT M, V1545, P41, DOI 10.1016/S0167-4838(00)00260-0; Mendonca LMF, 2008, FEBS J, V275, P2536, DOI 10.1111/j.1742-4658.2008.06402.x; Namchuk MN, 1995, BIOCHEMISTRY-US, V34, P16194, DOI 10.1021/bi00049a035; Park K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S23; Richard J, 2016, J BIOL CHEM, V291, P20932, DOI 10.1074/jbc.M116.733675; Souza VP, 2016, FEBS J, V283, P1124, DOI 10.1111/febs.13659; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Szalay KZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078059; Tamaki FK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167978; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	33	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198696	10.1371/journal.pone.0198696	http://dx.doi.org/10.1371/journal.pone.0198696			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874288	gold, Green Published, Green Submitted			2022-12-26	WOS:000434369400063
J	Cuperus, T; Kraaij, MD; Zomer, AL; van Dijk, A; Haagsman, HP				Cuperus, Tryntsje; Kraaij, Marina D.; Zomer, Aldert L.; van Dijk, Albert; Haagsman, Henk P.			Immunomodulation and effects on microbiota after in ovo administration of chicken cathelicidin-2	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; ANTIMICROBIAL PEPTIDE; SMALL-INTESTINE; GOBLET CELLS; PERFORMANCE; MORPHOLOGY; LL-37; INFLAMMATION; PARAMETERS; PROTECTION	Host Defense Peptides (HDPs) such as cathelicidins are multifunctional effectors of the innate immune system with both antimicrobial and pleiotropic immunomodulatory functions. Chicken cathelicidin-2 (CATH-2) has multiple immunomodulatory effects in vitro and the D-amino acid analog of this peptide has been shown to partially protect young chicks from a bacterial infection. However, the mechanisms responsible for CATH-2 mediated in vivo protection have not been investigated so far. In this study, D-CATH-2 was administered in ovo and the immune status and microbiota of the chicks were investigated at 7 days posthatch to elucidate the in vivo mechanisms of the peptide. In three consecutive studies, no effects on numbers and functions of immune cells were found and only small changes were seen in gene expression of Peripheral Blood Mononuclear Cells (PBMCs). In two studies, intestinal microbiota composition was determined which was highly variable, suggesting that it was strongly influenced by environmental factors. In both studies, in ovo D-CATH-2 treatment caused significant reduction of Ruminococcaceae and Butyricicoccus in the cecum and Escherichia/Shigella in both ileum and cecum. In conclusion, this study shows that, in the absence of an infectious stimulus, in ovo administration of a CATH-2 analog alters the microbiota composition but does not affect the chicks' immune system posthatch.	[Cuperus, Tryntsje; Kraaij, Marina D.; van Dijk, Albert; Haagsman, Henk P.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Mol Host Def, Utrecht, Netherlands; [Zomer, Aldert L.] Univ Utrecht, Div Clin Infectiol, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands	Utrecht University; Utrecht University	Haagsman, HP (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Mol Host Def, Utrecht, Netherlands.	h.p.haagsman@uu.nl	Haagsman, Henk P/F-8919-2010	Haagsman, Henk/0000-0002-4931-5201; Zomer, Aldert/0000-0002-0758-5190	Immuno Valley ALTernatives to ANTibiotics (ALTANT) Animal Specific Immunomodulatory Antimicrobials (ASIA) program of the Dutch Ministry of Economic Affairs	Immuno Valley ALTernatives to ANTibiotics (ALTANT) Animal Specific Immunomodulatory Antimicrobials (ASIA) program of the Dutch Ministry of Economic Affairs	The work was supported by the Immuno Valley ALTernatives to ANTibiotics (ALTANT) Animal Specific Immunomodulatory Antimicrobials (ASIA) program of the Dutch Ministry of Economic Affairs. This program is a public-private partnership. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranska-Rybak W, 2006, J ANTIMICROB CHEMOTH, V57, P260, DOI 10.1093/jac/dki460; Bassett SA, 2015, NUTRIENTS, V7, P1798, DOI 10.3390/nu7031798; Baurhoo B, 2009, POULTRY SCI, V88, P2262, DOI 10.3382/ps.2008-00562; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Brown KL, 2011, J IMMUNOL, V186, P5497, DOI 10.4049/jimmunol.1002508; Cheled-Shoval SL, 2011, POULTRY SCI, V90, P2301, DOI 10.3382/ps.2011-01488; Chen LP, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000051; CHENG GY, 2014, FRONT MICROBIOL, V0005; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Coorens M, 2015, J IMMUNOL, V195, P3970, DOI 10.4049/jimmunol.1501242; Cuperus T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26622; Czerwinski J, 2012, ARCH ANIM NUTR, V66, P102, DOI 10.1080/1745039X.2012.663668; Fasina YO, 2010, AVIAN DIS, V54, P841, DOI 10.1637/9055-090809-Reg.1; Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631; Guard BC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127259; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Hou M, 2013, CELL PHYSIOL BIOCHEM, V32, P614, DOI 10.1159/000354465; Kabat AM, 2014, TRENDS IMMUNOL, V35, P507, DOI 10.1016/j.it.2014.07.010; Kandasamy SK, 2006, BBA-BIOMEMBRANES, V1758, P1274, DOI 10.1016/j.bbamem.2006.02.030; Kizerwetter-Swida M, 2008, J ANIM FEED SCI, V17, P224, DOI 10.22358/jafs/66602/2008; Kogut MH, 2007, INT IMMUNOPHARMACOL, V7, P912, DOI 10.1016/j.intimp.2007.02.011; Kogut MH, 2010, FOODBORNE PATHOG DIS, V7, P23, DOI 10.1089/fpd.2009.0346; Kovach MA, 2012, J IMMUNOL, V189, P304, DOI 10.4049/jimmunol.1103196; Lu J, 2008, ANIMAL, V2, P669, DOI 10.1017/S1751731108001894; Luna L, 1968, AFIP MANUAL OF HISTO; Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; McCafferty J, 2013, ISME J, V7, P2116, DOI 10.1038/ismej.2013.106; Murakami T, 2009, INT IMMUNOL, V21, P905, DOI 10.1093/intimm/dxp057; Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Pound LD, 2015, DIABETES, V64, P4135, DOI 10.2337/db15-0788; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Rubio LA, 2015, J ANIM PHYSIOL AN N, V99, P418, DOI 10.1111/jpn.12256; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schubert AM, 2014, MBIO, V5, DOI 10.1128/mBio.01021-14; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Stanley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084290; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Steinstraesser L, 2011, IMMUNOBIOLOGY, V216, P322, DOI 10.1016/j.imbio.2010.07.003; Tai EKK, 2008, J CELL BIOCHEM, V104, P251, DOI 10.1002/jcb.21615; Tamburini S, 2016, NAT MED, V22, P713, DOI 10.1038/nm.4142; Thorkildsen LT, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/636785; Tomkovich S, 2016, IMMUNOLOGY, V147, P1, DOI 10.1111/imm.12538; Uni Z, 2003, POULTRY SCI, V82, P1747, DOI 10.1093/ps/82.11.1747; Uni Z, 2003, POULTRY SCI, V82, P320, DOI 10.1093/ps/82.2.320; UNI Z, 1995, POULTRY SCI, V74, P1622, DOI 10.3382/ps.0741622; van Dijk A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147919; van Wageningen S, 2010, CELL, V143, P991, DOI 10.1016/j.cell.2010.11.021; Wang L, 2014, J MOL MICROB BIOTECH, V24, P234, DOI 10.1159/000365572; Wang YQ, 1998, J BIOL CHEM, V273, P33115, DOI 10.1074/jbc.273.50.33115; Wu ZG, 2010, IMMUNOLOGY, V129, P133, DOI 10.1111/j.1365-2567.2009.03129.x; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yi HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep25679	57	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0198188	10.1371/journal.pone.0198188	http://dx.doi.org/10.1371/journal.pone.0198188			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870564	Green Published, gold			2022-12-26	WOS:000434128400014
J	Gisch, N; Auger, JP; Thomsen, S; Roy, D; Xu, JG; Schwudke, D; Gottschalk, M				Gisch, Nicolas; Auger, Jean-Philippe; Thomsen, Simone; Roy, David; Xu, Jianguo; Schwudke, Dominik; Gottschalk, Marcelo			Structural analysis and immunostimulatory potency of lipoteichoic acids isolated from three Streptococcus suis serotype 2 strains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); mass spectrometry (MS); glycolipid structure; bacteria; cell wall; bacterial virulence; host evasion; lipoprotein; lipoteichoic acid; Streptococcus suis	CELL-WALL; IDENTIFICATION; LIPOPROTEINS; REEVALUATION; RECOGNITION; VIRULENCE	Streptococcus suis serotype 2 is an important porcine and human pathogen. Lipoteichoic acid (LTA) from S. suis has been suggested to contribute to its virulence, and absence of d-alanylation from the S. suis LTA is associated with increased susceptibility to cationic antimicrobial peptides. Here, using high-resolution NMR spectroscopy and MS analyses, we characterized the LTA structures from three S. suis serotype 2 strains differing in virulence, sequence type (ST), and geographical origin. Our analyses revealed that these strains possess-in addition to the typical type I LTA present in other streptococci-a second, mixed-type series of LTA molecules of high complexity. We observed a ST-specific difference in the incorporation of glycosyl residues into these mixed-type LTAs. We found that strains P1/7 (ST1, high virulence) and SC84 (ST7, very high virulence) can attach a 1,2-linked -d-Glcp residue as branching substituent to an -d-Glcp that is 1,3-linked to glycerol phosphate moieties and that is not present in strain 89-1591 (ST25, intermediate virulence). In contrast, the latter strain could glycosylate its LTA at the glycerol O-2 position, which was not observed in the other two strains. Using LTA preparations from WT strains and from mutants with an inactivated prolipoprotein diacylglyceryl transferase, resulting in deficient lipoprotein acylation, we show that S. suis LTAs alone do not induce Toll-like receptor 2-dependent pro-inflammatory mediator production from dendritic cells. In summary, our study reveals an unexpected complexity of LTAs present in three S. suis serotype 2 strains differing in genetic background and virulence.	[Gisch, Nicolas; Thomsen, Simone; Schwudke, Dominik] Leibniz Lung Ctr, Res Ctr Borstel, Prior Area Infect, Div Bioanalyt Chem, D-23845 Borstel, Germany; [Auger, Jean-Philippe; Roy, David; Gottschalk, Marcelo] Univ Montreal, Dept Pathol & Microbiol, Fac Vet Med, St Hyacinthe, PQ J2S 2M2, Canada; [Xu, Jianguo] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China	Forschungszentrum Borstel; Universite de Montreal; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Gisch, N (corresponding author), Leibniz Lung Ctr, Res Ctr Borstel, Div Bioanalyt Chem, Parkallee 4a-4c, D-23845 Borstel, Germany.	ngisch@fz-borstel.de	Schwudke, Dominik/B-3478-2013	Schwudke, Dominik/0000-0002-1379-9451; Gisch, Nicolas/0000-0003-3260-5269	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We gratefully acknowledge B. Buske, H. Kassner, and B. Kunz (all at Research Center Borstel, Borstel, Germany) as well as S. Lacouture and C. Duquette (University of Montreal, Quebec, Canada) for excellent technical assistance. This publication made use of the Multilocus Sequence Typing Website (http://www.mlst.net) (Please note that the JBC is not responsible for the long-term archiving and maintenance of this site or any other third party hosted site.) at Imperial College London developed by D. Aanensen and funded by the Wellcome Trust.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Auger JP, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5030048; Calzas C, 2013, INFECT IMMUN, V81, P3106, DOI 10.1128/IAI.00113-13; Czabanska A, 2012, CARBOHYD RES, V361, P200, DOI 10.1016/j.carres.2012.09.007; Fischer K, 2011, GLYCOBIOLOGY, V21, P1588, DOI 10.1093/glycob/cwr071; Fittipaldi N, 2008, INFECT IMMUN, V76, P3587, DOI 10.1128/IAI.01568-07; Fittipaldi N, 2011, EMERG INFECT DIS, V17, P2239, DOI 10.3201/eid1712.110609; Gisch N, 2015, SCI REP-UK, V5, DOI 10.1038/srep16718; Gisch N, 2013, J BIOL CHEM, V288, P15654, DOI 10.1074/jbc.M112.446963; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; GOTTSCHALK M, 1992, VET MICROBIOL, V30, P59, DOI 10.1016/0378-1135(92)90094-A; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Hess N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01720-z; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Lachance C, 2013, INFECT IMMUN, V81, P1928, DOI 10.1128/IAI.01317-12; Lecours MP, 2011, J INFECT DIS, V204, P919, DOI 10.1093/infdis/jir415; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Morr M, 2002, EUR J IMMUNOL, V32, P3337, DOI 10.1002/1521-4141(2002012)32:12<3337::AID-IMMU3337>3.0.CO;2-I; Percy MG, 2016, J BACTERIOL, V198, P2029, DOI 10.1128/JB.00116-16; Percy MG, 2014, ANNU REV MICROBIOL, V68, P81, DOI 10.1146/annurev-micro-091213-112949; Rismondo J, 2018, J BIOL CHEM, V293, P3293, DOI 10.1074/jbc.RA117.001614; Roy D, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5030047; Schreur PJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022299; Slater JD, 2003, VET MICROBIOL, V93, P197, DOI 10.1016/S0378-1135(03)00030-0; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Ye CY, 2008, EMERG INFECT DIS, V14, P787, DOI 10.3201/eid1405.070437; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	32	14	14	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12011	12025		10.1074/jbc.RA118.002174	http://dx.doi.org/10.1074/jbc.RA118.002174			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29884769	Green Published, hybrid			2022-12-26	WOS:000440803200004
J	Shibata, T; Kobayashi, Y; Ikeda, Y; Kawabata, S				Shibata, Toshio; Kobayashi, Yuki; Ikeda, Yuto; Kawabata, Shun-ichiro			Intermolecular autocatalytic activation of serine protease zymogen factor C through an active transition state responding to lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endotoxin; lipopolysaccharide (LPS); protein-protein interaction; serine protease; enzyme processing; autocatalytic activation; hemolymph coagulation; proteolytic cascade; transition state	HORSESHOE-CRAB HEMOCYTES; TACHYPLEUS-TRIDENTATUS HEMOCYTES; LIMULUS FACTOR-C; INVERTEBRATE IMMUNITY; COAGULATION CASCADE; PROCLOTTING ENZYME; ALPHA-CHYMOTRYPSIN; CRYSTAL-STRUCTURE; FACTOR-B; STAPHYLOCOAGULASE	Horseshoe crab hemolymph coagulation is believed to be triggered by the autocatalytic activation of serine protease zymogen factor C to the active form, -factor C, belonging to the trypsin family, through an active transition state of factor C responding to bacterial lipopolysaccharide (LPS), designated factor C*. However, the existence of factor C* is only speculative, and its proteolytic activity has not been validated. In addition, it remains unclear whether the proteolytic cleavage of the Phe(737)-Ile(738) bond (Phe(737) site) of factor C required for the conversion to -factor C occurs intramolecularly or intermolecularly between the factor C molecules. Here we show that the Phe(737) site of a catalytic Ser-deficient mutant of factor C is LPS-dependently hydrolyzed by a Phe(737) site-uncleavable mutant, clearly indicating the existence of the active transition state of factor C without cleavage of the Phe(737) site. Moreover, we found the following facts using several mutants of factor C: the autocatalytic cleavage of factor C occurs intermolecularly between factor C* molecules on the LPS surface; factor C* does not exhibit intrinsic chymotryptic activity against the Phe(737) site, but it may recognize a three-dimensional structure around the cleavage site; and LPS is required not only to complete the substrate-binding site and oxyanion hole of factor C* by interacting with the N-terminal region but also to allow the Phe(737) site to be cleaved by inducing a conformational change around the Phe(737) site or by acting as a scaffold to induce specific protein-protein interactions between factor C* molecules.	[Shibata, Toshio; Kobayashi, Yuki; Kawabata, Shun-ichiro] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8190395, Japan; [Shibata, Toshio; Ikeda, Yuto; Kawabata, Shun-ichiro] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8190395, Japan; [Kobayashi, Yuki] Seikagaku Corp, LAL Res & Dev Dept, Tokyo 2070021, Japan	Kyushu University; Kyushu University; Seikagaku Corporation	Kawabata, S (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	skawascb@kyudai.jp			Joint Research Fund of Seikagaku Corp.	Joint Research Fund of Seikagaku Corp.	This study was supported by the Joint Research Fund of Seikagaku Corp. The authors declare that they have no conflicts of interest with the contents of this article.	Ariki S, 2004, P NATL ACAD SCI USA, V101, P953, DOI 10.1073/pnas.0306904101; Ariki S, 2008, J IMMUNOL, V181, P7994, DOI 10.4049/jimmunol.181.11.7994; Armstrong Peter B., 2003, P288; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Doolittle RF, 2011, J INNATE IMMUN, V3, P9, DOI 10.1159/000321005; FREER ST, 1970, BIOCHEMISTRY-US, V9, P1997, DOI 10.1021/bi00811a022; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Fujii Y, 2016, J CELL SCI, V129, P1512, DOI 10.1242/jcs.176685; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; Higashi S, 1996, J BIOL CHEM, V271, P26569, DOI 10.1074/jbc.271.43.26569; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Kato Y, 2006, BIOCHEM BIOPH RES CO, V349, P1301, DOI 10.1016/j.bbrc.2006.08.171; KAWABATA S, 1985, J BIOCHEM, V98, P1603, DOI 10.1093/oxfordjournals.jbchem.a135430; KAWABATA S, 1986, J BIOL CHEM, V261, P1427; Kawabata S., 2011, INVERTEBRATE IMMUNIT, P122; Kawabata S, 2010, J BIOCHEM, V147, P611, DOI 10.1093/jb/mvq026; Kawasaki H, 2000, J BIOL CHEM, V275, P35297, DOI 10.1074/jbc.M006856200; Kobayashi Y, 2015, J BIOL CHEM, V290, P19379, DOI 10.1074/jbc.M115.653196; Kobayashi Y, 2014, J BIOL CHEM, V289, P25987, DOI 10.1074/jbc.M114.586933; Koshiba T, 2007, J BIOL CHEM, V282, P3962, DOI 10.1074/jbc.M609198200; Le Saux A, 2008, J MOL BIOL, V377, P902, DOI 10.1016/j.jmb.2008.01.045; Levin Jack, 2003, P310; Loof TG, 2011, J INNATE IMMUN, V3, P34, DOI 10.1159/000321641; Mizumura H, 2017, INNATE IMMUN-LONDON, V23, P136, DOI 10.1177/1753425916681074; MUTA T, 1991, J BIOL CHEM, V266, P6554; MUTA T, 1993, J BIOL CHEM, V268, P21384; MUTA T, 1990, J BIOL CHEM, V265, P22426; Myamoto DT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146992; NAKAMURA T, 1988, J BIOCHEM, V103, P370, DOI 10.1093/oxfordjournals.jbchem.a122276; NAKAMURA T, 1986, EUR J BIOCHEM, V154, P511, DOI 10.1111/j.1432-1033.1986.tb09427.x; NAKAMURA T, 1988, EUR J BIOCHEM, V176, P89, DOI 10.1111/j.1432-1033.1988.tb14254.x; NAKAMURA T, 1985, J BIOCHEM, V97, P1561, DOI 10.1093/oxfordjournals.jbchem.a135213; Panizzi P, 2004, CELL MOL LIFE SCI, V61, P2793, DOI 10.1007/s00018-004-4285-7; Renatus M, 1997, EMBO J, V16, P4797, DOI 10.1093/emboj/16.16.4797; Tagawa K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036783; TOKUNAGA F, 1991, J BIOCHEM, V109, P150, DOI 10.1093/oxfordjournals.jbchem.a123337; TOKUNAGA F, 1987, EUR J BIOCHEM, V167, P405, DOI 10.1111/j.1432-1033.1987.tb13352.x; Urbanova V, 2014, DEV COMP IMMUNOL, V46, P439, DOI 10.1016/j.dci.2014.05.016; Versteeg HH, 2013, PHYSIOL REV, V93, P327, DOI 10.1152/physrev.00016.2011; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533	42	10	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11589	11599		10.1074/jbc.RA118.002311	http://dx.doi.org/10.1074/jbc.RA118.002311			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29866883	Green Published, hybrid			2022-12-26	WOS:000439449700027
J	Zhang, L; Wang, J; Fu, GZ; Zhao, YG				Zhang, Li; Wang, Jing; Fu, Guozhan; Zhao, Yonggan			Rotary tillage in rotation with plowing tillage improves soil properties and crop yield in a wheat-maize cropping system	PLOS ONE			English	Article							ENZYME-ACTIVITIES; ROOT-GROWTH; BIOCHEMICAL-PROPERTIES; CONSERVATION TILLAGE; RESIDUE MANAGEMENT; C SEQUESTRATION; SEMIARID AREAS; SUMMER MAIZE; QUALITY; PRODUCTIVITY	Soil rotational tillage is an effective measure to overcome the problems caused by long-term of a single tillage, but the effect of the interval time of rotational tillage practices is not very well understood. Therefore, we conducted a 3-year field study in a wheat-maize cropping system to evaluate the effects of rotary tillage (RT) in rotation with plowing tillage (PT) on soil properties in northern China. Four practices were designed as follows: 3 years of RT to a depth of 10-15 cm (3RT), 3 years of PT to a depth of 30-35 cm (3PT), 1 year of PT followed by 2 years of RT (PT+2RT), and 2 years of PT followed by 1 year of RT (2PT+RT). Within 20 cm of the surface soil, the 3RT treatment significantly increased the soil quality index (SQI) by 6.0%, 8.8% and 13.1%, respectively, relative to the PT+2RT, 2PT+RT and 3PT treatments. The improvement was closely related to the significant increase in the soil organic carbon (SOC) and available nutrients concentrations in the 0-20 cm depths and the improvement of soil invertase, urease, alkaline phosphatase and catalase activities in the topsoil (0-10 cm). However, the opposite effects were observed in the subsoil (20-40 cm). Compared with the 3RT treatment, the 3PT, 2PT+RT and PT+2RT treatments decreased soil bulk density, and significantly enhanced enzyme activities, resulting in an increase in SQI of 32.6%, 24.4% and 0.7%, respectively, especially in the 3PT and 2PT+RT treatments, the difference was significant. When averaged across to all soil depths, the SQI under the 3RT and 2PT+RT treatments was much higher than that under the other treatments. The yields of wheat and maize under the 2PT+RT treatment were 15.0% and 14.3% higher than those under the 3RT treatment, respectively. The 2PT+RT treatment was the most effective tillage practice. These results suggest that RT in rotation with PT could improve soil quality in the soil profile whilst enhancing crop yield after continuous RT, and the benefits were enhanced with an interval time of one year. Therefore, the 2PT+RT treatment could act as an effective method for both soil quality and crop yield improvement in a wheat-maize cropping system under straw incorporation conditions.	[Zhang, Li; Fu, Guozhan] Henan Univ Sci & Technol, Coll Agr, Luoyang, Peoples R China; [Zhang, Li; Wang, Jing] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing, Peoples R China; [Zhao, Yonggan] Tsinghua Univ, Dept Energy & Power Engn, Beijing, Peoples R China	Henan University of Science & Technology; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Tsinghua University	Fu, GZ (corresponding author), Henan Univ Sci & Technol, Coll Agr, Luoyang, Peoples R China.; Zhao, YG (corresponding author), Tsinghua Univ, Dept Energy & Power Engn, Beijing, Peoples R China.	fuguozhan@163.com; zhaoyonggan@tsinghua.edu.cn	Yonggan, Zhao/AGT-7226-2022	Yonggan, Zhao/0000-0002-4471-4406	Henan Provincial Key Science Plan Foundation, China [132102110028]; National Natural Science Foundation of China [41501314]	Henan Provincial Key Science Plan Foundation, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the Henan Provincial Key Science Plan Foundation, China (132102110028) and the National Natural Science Foundation of China (41501314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandick AK, 1999, SOIL BIOL BIOCHEM, V31, P1471, DOI 10.1016/S0038-0717(99)00051-6; Bengough AG, 2011, J EXP BOT, V62, P59, DOI 10.1093/jxb/erq350; BURNS RG, 1982, SOIL BIOL BIOCHEM, V14, P423, DOI 10.1016/0038-0717(82)90099-2; Caldwell BA, 2005, PEDOBIOLOGIA, V49, P637, DOI 10.1016/j.pedobi.2005.06.003; Carter MR, 2002, SOIL TILL RES, V67, P85, DOI 10.1016/S0167-1987(02)00043-0; Deng SP, 1996, BIOL FERT SOILS, V22, P202; Devine S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084988; Ge GF, 2009, ECOL COMPLEX, V6, P421, DOI 10.1016/j.ecocom.2009.02.001; Geng YQ, 2012, APPL SOIL ECOL, V62, P1, DOI 10.1016/j.apsoil.2012.07.001; Gonzalez-Prieto S, 2013, SOIL TILL RES, V134, P49, DOI 10.1016/j.still.2013.07.007; Gu Y, 2009, EUR J SOIL BIOL, V45, P436, DOI 10.1016/j.ejsobi.2009.06.003; Guan S.Y., 1986, SOIL ENZYMES RES MET; Hamido SA, 2009, SOIL TILL RES, V105, P269, DOI 10.1016/j.still.2009.09.007; He J, 2007, SOIL TILL RES, V94, P493, DOI 10.1016/j.still.2006.10.005; Hou XQ, 2012, FIELD CROP RES, V129, P7, DOI 10.1016/j.fcr.2011.12.021; Hou XQ, 2011, SOIL RES, V49, P625, DOI 10.1071/SR11143; Jin K, 2009, SOIL TILL RES, V104, P115, DOI 10.1016/j.still.2009.02.004; KANDELER E, 1988, BIOL FERT SOILS, V6, P68, DOI 10.1007/BF00257924; Karlen DL, 2001, ADV AGRON, V74, P1, DOI 10.1016/S0065-2113(01)74029-1; Li CF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034642, 10.1371/journal.pone.0030026, 10.1371/journal.pone.0047442]; Li HW, 2007, AUST J SOIL RES, V45, P344, DOI 10.1071/SR07003; Liu ZJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172767; Lopez-Fando C, 2009, SOIL TILL RES, V104, P278, DOI 10.1016/j.still.2009.03.005; Lu R.K, 2000, ANAL METHOD SOIL AGR; Mu XY, 2016, EUR J AGRON, V78, P32, DOI 10.1016/j.eja.2016.04.010; Paz-Ferreiro J, 2009, BIOL FERT SOILS, V45, P711, DOI 10.1007/s00374-009-0382-y; PIERCE FJ, 1994, SOIL SCI SOC AM J, V58, P1782, DOI 10.2136/sssaj1994.03615995005800060029x; Poll C, 2008, SOIL BIOL BIOCHEM, V40, P1306, DOI 10.1016/j.soilbio.2007.04.002; Qi YB, 2009, GEODERMA, V149, P325, DOI 10.1016/j.geoderma.2008.12.015; Rashidi M., 2007, International Journal of Agriculture and Biology, V9, P274; Roldan A, 2005, APPL SOIL ECOL, V30, P11, DOI 10.1016/j.apsoil.2005.01.004; Seddaiu G, 2016, EUR J AGRON, V77, P166, DOI 10.1016/j.eja.2016.02.008; Shukla MK, 2006, SOIL TILL RES, V87, P194, DOI 10.1016/j.still.2005.03.011; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Smith KA, 2003, EUR J SOIL SCI, V54, P779, DOI 10.1046/j.1351-0754.2003.0567.x; Sun XF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174952; Tabatabai M. A., 1972, Soil Biology and Biochemistry, V4, P479, DOI 10.1016/0038-0717(72)90064-8; Linh TB, 2015, SOIL TILL RES, V154, P44, DOI 10.1016/j.still.2015.06.011; Varsa EC, 1997, SOIL TILL RES, V43, P219, DOI 10.1016/S0167-1987(97)00041-X; Wang YuLing, 2015, Transactions of the Chinese Society of Agricultural Engineering, V31, P107; Yang XM, 2008, SOIL TILL RES, V100, P120, DOI 10.1016/j.still.2008.05.003; Yang XM, 1999, SOIL TILL RES, V52, P1, DOI 10.1016/S0167-1987(99)00051-3; Zhai LC, 2017, SOIL TILL RES, V170, P167, DOI 10.1016/j.still.2017.03.013; Zhang XL, 2012, FIELD CROP RES, V130, P28, DOI 10.1016/j.fcr.2012.02.008	44	17	18	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198193	10.1371/journal.pone.0198193	http://dx.doi.org/10.1371/journal.pone.0198193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902193	gold, Green Submitted, Green Published			2022-12-26	WOS:000435424900014
J	Inchiosa, MA				Inchiosa, Mario A., Jr.			Anti-tumor activity of phenoxybenzamine and its inhibition of histone deacetylases	PLOS ONE			English	Article							REGIONAL PAIN SYNDROME; REFLEX SYMPATHETIC DYSTROPHY; GENE-EXPRESSION; CONNECTIVITY MAP; COLON-CANCER; XERODERMA-PIGMENTOSUM; VIRAL REPLICATION; CELL MATURATION; HDAC INHIBITORS; DORSAL-HORN	The principal finding from this study was the recognition that the a-adrenergic antagonist, phenoxybenzamine, possesses histone deacetylase inhibitory activity. Phenoxybenzamine is approved by the United States Food and Drug Administration for the treatment of hypertensive crises associated with tumors of the adrenal medulla, pheochromocytomas. It has several "off label" indications relative to its capacity to relax vascular smooth muscle and smooth muscle of the urogenital tract. The drug also has a long history of apparent efficacy in ameliorating, and perhaps reversing, the severe symptoms of neuropathic pain syndromes. Our interest in this feature of the drug relates to the fact that certain types of neuropathic pain, in particular complex regional pain syndrome, demonstrate a proliferative nature, with the capacity to spread from an injured limb, for example, to a non-injured limb and perhaps to essentially the entire body. Sensory neuronal sprouting in the spinal cord has been observed under conditions where there is a high sensory input from painful stimuli. Searches of gene expression signatures in the BroadBuild02 Molecular Signature Database using their connectivity map software suggested that phenoxybenzamine may have histone deacetylase inhibitory activity. Studies by others have reported inhibitory effects of phenoxybenzamine on growth, invasion and migration of human tumor cell cultures and, in one study, inhibition of tumor expansion in animal experiments. Inhibitory effects on human tumor cell cultures are also reported in the present study. Phenoxybenzamine was also found to have histone deacetylase inhibitory activity; histone deacetylase isoforms 5, 6, and 9 were the most sensitive to inhibition by phenoxybenzamine. The importance of elevated levels of these isoforms as biomarkers of poor prognosis in human malignant disease, and the recognized suppression of tumor growth that may accrue from their inhibition, opens consideration of possible translation of phenoxybenzamine to new clinical applications. This might be facilitated by the fact that phenoxybenzamine is already an approved drug entity. There appears to be no previous report of the activity of phenoxybenzamine as a histone deacetylase inhibitor.	[Inchiosa, Mario A., Jr.] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; [Inchiosa, Mario A., Jr.] New York Med Coll, Dept Anesthesiol, Valhalla, NY 10595 USA	New York Medical College; New York Medical College	Inchiosa, MA (corresponding author), New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA.; Inchiosa, MA (corresponding author), New York Med Coll, Dept Anesthesiol, Valhalla, NY 10595 USA.	mario_inchiosa@nymc.edu		Inchiosa, Mario/0000-0002-5933-5222				American Hospital Formulary (AHFS), 2017, DRUG INF; Bennett DS, 2006, PAIN MED, V7, pS64, DOI 10.1111/j.1526-4637.2006.00124.x; Chang ET, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-2116; Chang M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-56; Chigancas V, 2008, CANCER RES, V68, P6074, DOI 10.1158/0008-5472.CAN-07-6695; Cobret L, 2015, BRIT J PHARMACOL, V172, P841, DOI 10.1111/bph.12945; Cody JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092919; da Costa RMA, 2005, ONCOGENE, V24, P1359, DOI 10.1038/sj.onc.1208288; Dazard JE, 2003, ONCOGENE, V22, P2993, DOI 10.1038/sj.onc.1206537; Gheeya J, 2010, CANCER LETT, V293, P124, DOI 10.1016/j.canlet.2010.01.004; Glaser KB, 2003, MOL CANCER THER, V2, P151; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Inchiosa MA, 2013, ANESTHESIOL RES PRAC, V2013, DOI 10.1155/2013/978615; Inchiosa Mario A Jr, 2008, Pain Pract, V8, P125, DOI 10.1111/j.1533-2500.2007.00170.x; IVERSEN LL, 1972, BRIT J PHARMACOL, V46, P647, DOI 10.1111/j.1476-5381.1972.tb06890.x; Janig W, 2003, LANCET NEUROL, V2, P687, DOI 10.1016/S1474-4422(03)00557-X; Johnson JL, 2014, J INVEST DERMATOL, V134, P2154, DOI 10.1038/jid.2014.124; Kakumu E, 2017, GENES CELLS, V22, P310, DOI 10.1111/gtc.12479; Karagiannis TC, 2006, CELL CYCLE, V5, P288, DOI 10.4161/cc.5.3.2421; Karube K, 2013, CANCER LETT, V333, P47, DOI 10.1016/j.canlet.2012.12.022; Kim J, 2015, CIRCULATION, V131, P190, DOI 10.1161/CIRCULATIONAHA.114.013339; Krukowski K, 2017, PAIN, V158, P1126, DOI 10.1097/j.pain.0000000000000893; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee SK, 1986, KOREAN J THORAC CARD, V19, P1; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Li AQ, 2016, ONCOTARGET, V7, P37966, DOI 10.18632/oncotarget.9274; Li SS, 2012, INT J MOL SCI, V13, P12461, DOI 10.3390/ijms131012461; Lin XB, 2016, TUMOR BIOL, V37, P2901, DOI 10.1007/s13277-015-4102-y; Liu TC, 2008, MOL THER, V16, P1041, DOI 10.1038/mt.2008.58; Maleki J, 2000, PAIN, V88, P259, DOI 10.1016/S0304-3959(00)00332-8; Malik VK, 1998, ANESTHESIOLOGY, V88, P823, DOI 10.1097/00000542-199803000-00036; Mannion RJ, 1996, J NEUROSCI, V16, P5189; Mariadason JM, 2000, CANCER RES, V60, P4561; Mariadason JM, 2008, EPIGENETICS-US, V3, P28, DOI 10.4161/epi.3.1.5736; Mearow KM, 1998, EXP NEUROL, V151, P14, DOI 10.1006/exnr.1998.6791; Milde T, 2010, CLIN CANCER RES, V16, P3240, DOI 10.1158/1078-0432.CCR-10-0395; Murphy JC, 2002, EMBO J, V21, P1112, DOI 10.1093/emboj/21.5.1112; Nakamura S, 1999, BRAIN RES, V818, P285, DOI 10.1016/S0006-8993(98)01291-8; Nakashima H, 2015, J CLIN INVEST, V125, P4269, DOI 10.1172/JCI80713; Nevels M, 2004, P NATL ACAD SCI USA, V101, P17234, DOI 10.1073/pnas.0407933101; Pullamsetti SS, 2014, AM J RESP CRIT CARE, V189, P394, DOI 10.1164/rccm.201308-1543PP; Qu XYA, 2012, DRUG DISCOV TODAY, V17, P1289, DOI 10.1016/j.drudis.2012.07.017; Schwartzman RJ, 2006, EXPERT REV NEUROTHER, V6, P669, DOI 10.1586/14737175.6.5.669; Simpson CL, 2010, AM J PATHOL, V177, P2921, DOI 10.2353/ajpath.2010.100397; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Te AE, 2002, CLIN THER, V24, P851, DOI 10.1016/S0149-2918(02)80003-0; Wang LL, 2012, BIOSCI TRENDS, V6, P192, DOI 10.5582/bst.2012.v6.4.192; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Xu JJ, 2016, ANESTH ANALG, V122, P843, DOI 10.1213/ANE.0000000000000999; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620	51	5	5	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198514	10.1371/journal.pone.0198514	http://dx.doi.org/10.1371/journal.pone.0198514			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897996	Green Submitted, Green Published, gold			2022-12-26	WOS:000435090700056
J	Chao, YH; Chen, DY; Lan, JL; Tang, KT; Lin, CC				Chao, Ya-Hsuan; Chen, Der-Yuan; Lan, Joung-Liang; Tang, Kuo-Tung; Lin, Chi-Chien			Tolerogenic beta 2-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; T-CELLS; CYCLOSPORINE-A; BETA(2)-GLYCOPROTEIN I; TACROLIMUS; IMMUNIZATION; AUTOIMMUNITY; PATHOGENESIS; INDUCTION; TOLERANCE	DNA vaccines have recently emerged as a therapeutic agent for treating autoimmune diseases, such as multiple sclerosis. Antiphospholipid antibody syndrome (APS) is an auto immune disease characterized by132-glycoprotein I (beta 2-GPO-targeting antiphospholipid antibodies (APAs) and vascular thrombosis or obstetrical complications. To examine the therapeutic potential of a p2-GPI DNA vaccine, we administered a vaccine mixed with FK506 as an adjuvant to a mouse model of obstetric APS. First, the pCMV3-132-GPI DNA vaccine, which encodes the full-length human 132-GPI gene, was constructed. Then, we administered the (beta 2-GPI DNA vaccine in 0.1 ml of saline, mixed with or without 100 mu g of FK506, intramuscularly to the mice on days 28, 35 and 42. Blood titers of the anti-I beta 2-GPI antibody, platelet counts, activated partial thromboplastin times (aPTTs), and the percentage of fetal loss were measured. We also stimulated murine splenic T cells ex vivo with 132-GPI and determined the T helper cell proportion and cytokine secretion. The administration of the 132-GPI DNA vaccine mixed with FK506 reduced the blood IgG anti-I beta 2-GPI antibody titers and suppressed APS manifestations in mice. The combination also suppressed interferon-y and interleukin (IL)-17A secretion but increased the Treg cell proportion and IL-10 secretion in murine splenic T cells following ex vivo stimulation with 132-GPI. Our results demonstrated the therapeutic efficacy of a beta 2-GPI DNA vaccine and FK506 as an adjuvant in a murine model of obstetric APS. Possible mechanisms include the inhibition of Th1 and Th17 responses and the up-regulation of Treg cells.	[Chao, Ya-Hsuan; Lin, Chi-Chien] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, Der-Yuan; Lan, Joung-Liang] China Med Univ Hosp, Div Immunol & Rheumatol, Dept Internal Med, Taichung, Taiwan; [Tang, Kuo-Tung] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Lin, Chi-Chien] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Lin, Chi-Chien] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	National Chung Hsing University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taichung Veterans General Hospital; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lin, CC (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan.; Tang, KT (corresponding author), Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Lin, CC (corresponding author), Asia Univ, Dept Biotechnol, Taichung, Taiwan.; Lin, CC (corresponding author), China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	crashbug1982@gmail.com; lincc@dragon.nchu.edu.tw	Chao, Ya-Hsuan/AAW-3470-2020	Chao, Ya-Hsuan/0000-0001-8283-6589; Lin, Chi-Chien/0000-0002-1464-0231; Tang, Kuo-Tung/0000-0002-5468-1329	ministry of science and technology, R.O.C. [105-2320-B-005 -006]; Taichung Veterans General Hospital Research Program [TCVGH-1063802B]	ministry of science and technology, R.O.C.; Taichung Veterans General Hospital Research Program	The works were supported by a grant (105-2320-B-005 -006) form the ministry of science and technology, R.O.C. (https://www.most.gov.tw/?I=en). This study was also supported by a grant from the Taichung Veterans General Hospital Research Program, TCVGH-1063802B (https://www.vghtc.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P63, DOI 10.1016/S0162-3109(00)00186-7; ARON AL, 1995, CLIN EXP IMMUNOL, V101, P78; Bar-Or A, 2007, ARCH NEUROL-CHICAGO, V64, P1407, DOI 10.1001/archneur.64.10.nct70002; Benagiano M, 2017, J IMMUNOL, V198, P2640, DOI 10.4049/jimmunol.1600305; Blank M, 1998, J IMMUNOL, V161, P5303; Chighizola CB, 2018, J AUTOIMMUN, V90, P76, DOI 10.1016/j.jaut.2018.02.002; Chighizola CB, 2015, CURR OPIN RHEUMATOL, V27, P476, DOI 10.1097/BOR.0000000000000200; Davidson AH, 2005, JAVMA-J AM VET MED A, V226, P240, DOI 10.2460/javma.2005.226.240; Fischetti F, 2005, BLOOD, V106, P2340, DOI 10.1182/blood-2005-03-1319; Fissolo N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-139; Garren H, 2001, IMMUNITY, V15, P15, DOI 10.1016/S1074-7613(01)00171-6; Garren H, 2008, ANN NEUROL, V63, P611, DOI 10.1002/ana.21370; Garver KA, 2005, DIS AQUAT ORGAN, V64, P13, DOI 10.3354/dao064013; Giannakopoulos B, 2013, NEW ENGL J MED, V368, P1033, DOI 10.1056/NEJMra1112830; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; Gropp K, 2011, BLOOD, V118, P2774, DOI 10.1182/blood-2011-02-339564; Hattori N, 2000, ARTHRITIS RHEUM-US, V43, P65, DOI 10.1002/1529-0131(200001)43:1<65::AID-ANR9>3.0.CO;2-I; Ho PP, 2006, AUTOIMMUNITY, V39, P675, DOI 10.1080/08916930601061603; Holers VM, 2002, J EXP MED, V195, P211, DOI 10.1084/jem.200116116; Iverson GM, 1998, P NATL ACAD SCI USA, V95, P15542, DOI 10.1073/pnas.95.26.15542; Jurewicz WA, 2003, NEPHROL DIAL TRANSPL, V18, P7, DOI 10.1093/ndt/gfg1028; Kang YM, 2009, J GENE MED, V11, P1064, DOI 10.1002/jgm.1387; Karakantza M, 2004, ANN HEMATOL, V83, P704, DOI 10.1007/s00277-004-0910-7; Kogina K, 2009, MOL CELLS, V28, P125, DOI 10.1007/s10059-009-0114-z; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Kuwana M, 2003, AUTOIMMUN REV, V2, P192, DOI 10.1016/S1568-9972(03)00007-7; Lee YR, 2005, BLOOD, V105, P3951, DOI 10.1182/blood-2004-10-3927; Lin CC, 2004, MOL THER, V10, P290, DOI 10.1016/j.ymthe.2004.05.015; Macian F, 2004, CURR OPIN IMMUNOL, V16, P209, DOI 10.1016/j.coi.2004.01.013; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Matsue H, 2002, J IMMUNOL, V169, P3555, DOI 10.4049/jimmunol.169.7.3555; Mok CC, 2016, NAT REV RHEUMATOL, V12, P221, DOI 10.1038/nrrheum.2015.174; Morelli AE, 2000, J IMMUNOL, V165, P226, DOI 10.4049/jimmunol.165.1.226; Popovic-Kuzmanovic D, 2013, IMMUNOBIOLOGY, V218, P186, DOI 10.1016/j.imbio.2012.03.002; Prud'homme GJ, 2007, GENE THER, V14, P553, DOI 10.1038/sj.gt.3302907; Roep BO, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006103; Saeki Y, 2012, EXPERT REV CLIN IMMU, V8, P455, DOI [10.1586/eci.12.35, 10.1586/ECI.12.35]; Schif-Zuck S, 2006, J IMMUNOL, V177, P8241, DOI 10.4049/jimmunol.177.11.8241; Szabo G, 2001, J INVEST MED, V49, P442, DOI 10.2310/6650.2001.33789; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; TOMER Y, 1994, ARTHRITIS RHEUM-US, V37, P1236, DOI 10.1002/art.1780370819; Wefer J, 2004, J NEUROIMMUNOL, V149, P66, DOI 10.1016/j.jneuroim.2003.12.012; Weissert R, 2000, P NATL ACAD SCI USA, V97, P1689, DOI 10.1073/pnas.030390097; Willis R, 2013, ANN NY ACAD SCI, V1285, P44, DOI 10.1111/nyas.12080; Woltman AM, 2000, EUR J IMMUNOL, V30, P1807, DOI 10.1002/1521-4141(200007)30:7<1807::AID-IMMU1807>3.0.CO;2-N; Xiao J, 2012, MOL MED REP, V6, P1035, DOI 10.3892/mmr.2012.1055	46	3	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198821	10.1371/journal.pone.0198821	http://dx.doi.org/10.1371/journal.pone.0198821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894515	Green Published, gold, Green Submitted			2022-12-26	WOS:000435030900030
J	Sense, F; van Rijn, H				Sense, Florian; van Rijn, Hedderik			Probabilistic motor sequence learning in a virtual reality serial reaction time task	PLOS ONE			English	Article							ATTENTION	The serial reaction time task is widely used to study learning and memory. The task is traditionally administered by showing target positions on a computer screen and collecting responses using a button box or keyboard. By comparing response times to random or sequenced items or by using different transition probabilities, various forms of learning can be studied. However, this traditional laboratory setting limits the number of possible experimental manipulations. Here, we present a virtual reality version of the serial reaction time task and show that learning effects emerge as expected despite the novel way in which responses are collected. We also show that response times are distributed as expected. The current experiment was conducted in a blank virtual reality room to verify these basic principles. For future applications, the technology can be used to modify the virtual reality environment in any conceivable way, permitting a wide range of previously impossible experimental manipulations.	[Sense, Florian; van Rijn, Hedderik] Univ Groningen, Dept Expt Psychol, Groningen, Netherlands; [Sense, Florian; van Rijn, Hedderik] Univ Groningen, Behav & Cognit Neurosci, Groningen, Netherlands	University of Groningen; University of Groningen	Sense, F (corresponding author), Univ Groningen, Dept Expt Psychol, Groningen, Netherlands.; Sense, F (corresponding author), Univ Groningen, Behav & Cognit Neurosci, Groningen, Netherlands.	f.sense@rug.nl	; van Rijn, Hedderik/L-3685-2014	Sense, Florian/0000-0001-9982-4701; van Rijn, Hedderik/0000-0002-0461-9850	SNN VIA grant - European Regional Development Fund [VIRTu CPR VI16SN006]; research program "Interval Timing in the Real World: A functional, computational and neuroscience approach" - Netherlands Organisation for Scientific Research (NWO) [453-16-005]	SNN VIA grant - European Regional Development Fund; research program "Interval Timing in the Real World: A functional, computational and neuroscience approach" - Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Sense was supported by SNN VIA grant "VIRTu CPR VI16SN006" financed by the European Regional Development Fund; Van Rijn was partially supported by the research program "Interval Timing in the Real World: A functional, computational and neuroscience approach", project number 453-16-005, financed by the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Charlotte Schluter for collecting the data and Stark Learning in Groningen, The Netherlands for developing the virtual reality environment for this task. Sense was supported by SNN VIA grant "VIRTu CPR VI16SN006" financed by the European Regional Development Fund, Van Rijn was partially supported by the research program "Interval Timing in the Real World: A functional, computational and neuroscience approach", project number 453-16-005, financed by the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have declared that no competing interests exist. The online supplement including the raw data, the analyses reported here, and additional analyses and visualizations can be found at https://osf.io/exnvd. We would like to thank George Kachergis and two anonymous reviewers for their helpful feedback.	[Anonymous], 2015, BAYESFACTOR 0 9 12 2; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; Du YX, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00013; Franklin MS, 2016, PSYCHON B REV, V23, P223, DOI 10.3758/s13423-015-0885-5; Kachergis G, 2014, IEEE C DEV LEARN EPI; Kraeutner SN, 2017, ACTA PSYCHOL, V178, P48, DOI 10.1016/j.actpsy.2017.05.009; Loomis JM, 1999, BEHAV RES METH INS C, V31, P557, DOI 10.3758/BF03200735; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Munoz FJG, 2018, Q J EXP PSYCHOL, V71, P2603, DOI 10.1177/1747021817749582; Negut A, 2016, CLIN NEUROPSYCHOL, V30, P165, DOI 10.1080/13854046.2016.1144793; Negut A, 2016, COMPUT HUM BEHAV, V54, P414, DOI 10.1016/j.chb.2015.08.029; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Parsons TD, 2016, IEEE T AFFECT COMPUT; Parsons TD, 2017, APPL NEUROPSYCH-ADUL, DOI [10.1080/23279095.2017, DOI 10.1080/23279095.2017]; Parsons TD, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7040042; Parsons TD, 2016, J AUTISM DEV DISORD, V46, P1255, DOI 10.1007/s10803-015-2663-7; Parsons TD, 2013, J CLIN EXP NEUROPSYC, V35, P812, DOI 10.1080/13803395.2013.824556; Rizzo A, 2017, NEUROPSYCHOLOGY, V31, P877, DOI 10.1037/neu0000405; Robertson EM, 2007, J NEUROSCI, V27, P10073, DOI 10.1523/JNEUROSCI.2747-07.2007; Schvaneveldt RW, 1998, PSYCHOL RES-PSYCH FO, V61, P175, DOI 10.1007/s004260050023; Willingham DB, 2002, J NEUROPHYSIOL, V88, P1451, DOI 10.1152/jn.2002.88.3.1451	22	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198759	10.1371/journal.pone.0198759	http://dx.doi.org/10.1371/journal.pone.0198759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ1PQ	29894504	gold, Green Published, Green Submitted			2022-12-26	WOS:000435030900025
J	Samuel, S; Mukherjee, S; Ammannagari, N; Pokuri, VK; Kuvshinoff, B; Groman, A; LeVea, CM; Iyer, R				Samuel, Sandeep; Mukherjee, Sarbajit; Ammannagari, Nischala; Pokuri, Venkata K.; Kuvshinoff, Boris; Groman, Adrienne; LeVea, Charles M.; Iyer, Renuka			Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study	PLOS ONE			English	Article							ADENOSQUAMOUS CARCINOMA; CELL-CARCINOMA; SQUAMOUS-CELL; SURVIVAL; FEATURES; EXPRESSION; ADENOMAS; DISEASE; SURGERY; GRADE	Background There is limited literature about the clinicopathological characteristics and outcomes of rare histologic variants of gallbladder cancer (GBC). Methods Using SEER database, surgically managed GBC patients with microscopically confirmed adenocarcinoma, adenosquamous/squamous cell carcinoma and papillary carcinoma were identified from 1988 to 2009. Patients with second primary cancer and distant metastasis at presentation were excluded. The effect of clinicopathological variables on overall survival (OS) and disease specific survival (DSS) were analyzed using univariate and multivariate proportional hazards modeling. All associations were considered statistically significant at an alpha error of 0.01. Results Out of 4738 cases, 217 adenosquamous/squamous (4.6%), 367 papillary (7.7%), and 4154 adenocarcinomas (87.7%) were identified. Median age was 72 years. Higher tumor grade (grade 2, 3, 4 versus grade 1), higher T stage (T2, T3, T4 versus T1), lymph node positivity (N1 versus NO) and adenosquamous/squamous histology (versus adenocarcinoma) had worse OS and DSS (p < .001). Papillary GBC had better OS and DSS than adenocarcinoma (HR = 0.7; p < .001). Radical surgery (versus simple cholecystectomy) had better OS (HR = 0.83, p = 0.002) in multivariate analysis. OS rates at 3 and 5 years were 0.56 and 0.44 for papillary, 0.3 and 0.22 for adenocarcinoma, and 0.14 and 0.12 for adenosquamous/squamous histology, while DSS rates at 3 and 5 years were 0.67 and 0.61 for papillary, 0.38 and 0.31 for adenocarcinoma, and 0.17 and 0.16 for adenosquamous/squamous subtypes respectively. Conclusion Papillary GBC had better survival outcomes while adenosquamous/squamous GBC had worse survival outcomes compared to gallbladder adenocarcinoma.	[Samuel, Sandeep] SUNY Buffalo, Dept Med, Buffalo, NY USA; [Mukherjee, Sarbajit] Univ Oklahoma, Hlth Sci Ctr, Div Hematol Oncol, Oklahoma City, OK USA; [Ammannagari, Nischala; Pokuri, Venkata K.; Iyer, Renuka] Roswell Pk Canc Inst, Dept Med Oncol, Buffalo, NY 14263 USA; [Kuvshinoff, Boris] Roswell Pk Canc Inst, Dept Surg Oncol, Buffalo, NY 14263 USA; [Groman, Adrienne] Roswell Pk Canc Inst, Dept Biostat Bioinformat, Buffalo, NY 14263 USA; [LeVea, Charles M.] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Oklahoma System; University of Oklahoma Health Sciences Center; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Iyer, R (corresponding author), Roswell Pk Canc Inst, Dept Med Oncol, Buffalo, NY 14263 USA.	renuka.iyer@roswellpark.org	Ammannagari, Nischala/AAO-9351-2020; Mukherjee, Sarbajit/I-3927-2019		National Cancer Institute (NCI) [P30CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute (NCI) grant P30CA016056 involving the use of Roswell Park Cancer Institute's Biostatistics Shared Resource. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Cancer Institute (NCI) grant P30CA016056 involving the use of Roswell Park Cancer Institute's Biostatistics Shared Resource.	Adsay V, 2012, AM J SURG PATHOL, V36, P1279, DOI 10.1097/PAS.0b013e318262787c; Albores-Saavedra J, 2005, ARCH PATHOL LAB MED, V129, P905; Albores-Saavedra J, 2012, HUM PATHOL, V43, P1506, DOI 10.1016/j.humpath.2011.11.011; Aloia TA, 2015, HPB, V17, P681, DOI 10.1111/hpb.12444; Ausania F, 2013, HPB, V15, P633, DOI 10.1111/hpb.12032; Belli G, 2011, J LAPAROENDOSC ADV S, V21, P531, DOI 10.1089/lap.2011.0078; Benson AB, 2017, J NATL COMPR CANC NE, V15, P563, DOI 10.6004/jnccn.2017.0059; Butte JM, 2010, J SURG ONCOL, V102, P620, DOI 10.1002/jso.21681; Cariati A, 2014, EUR J GASTROEN HEPAT, V26, P562, DOI 10.1097/MEG.0000000000000074; Chan KM, 2007, J SURG ONCOL, V95, P129, DOI 10.1002/jso.20576; Coburn NG, 2008, J AM COLL SURGEONS, V207, P371, DOI 10.1016/j.jamcollsurg.2008.02.031; D'Hondt M, 2013, EJSO-EUR J SURG ONC, V39, P548, DOI 10.1016/j.ejso.2013.02.010; Dixon E, 2005, ANN SURG, V241, P385, DOI 10.1097/01.sla.0000154118.07704.ef; Edge S B, 2010, AJCC CANC STAGING MA; Emura F, 2003, INT J ONCOL, V23, P1293; HENSON DE, 1992, CANCER, V70, P1493, DOI 10.1002/1097-0142(19920915)70:6<1493::AID-CNCR2820700608>3.0.CO;2-U; Jensen EH, 2009, J GASTROINTEST SURG, V13, P722, DOI 10.1007/s11605-008-0772-8; Kalayarasan R, 2013, AM J SURG, V206, P380, DOI 10.1016/j.amjsurg.2012.12.012; Kim WS, 2011, J SURG ONCOL, V103, P239, DOI 10.1002/jso.21813; Kondo M, 2002, HEPATO-GASTROENTEROL, V49, P1230; Mayo SC, 2010, J GASTROINTEST SURG, V14, P1578, DOI 10.1007/s11605-010-1335-3; Onuma Masaru, 2013, Nihon Shokakibyo Gakkai Zasshi, V110, P95; Oohashi Y, 2002, CANCER, V94, P3000, DOI 10.1002/cncr.10578; Pawlik TM, 2007, J GASTROINTEST SURG, V11, P1478, DOI 10.1007/s11605-007-0309-6; Roa I, 2006, J SURG ONCOL, V93, P615, DOI 10.1002/jso.20527; Roa JC, 2011, MODERN PATHOL, V24, P1069, DOI 10.1038/modpathol.2011.68; Roppongi T, 2000, JPN J CLIN ONCOL, V30, P43, DOI 10.1093/jjco/hyd010; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song HW, 2015, J SURG ONCOL, V112, P677, DOI 10.1002/jso.24065; Wan XS, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000131; Yang ZL, 2014, INT J CLIN ONCOL, V19, P325, DOI 10.1007/s10147-013-0550-9	31	24	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198809	10.1371/journal.pone.0198809	http://dx.doi.org/10.1371/journal.pone.0198809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889907	Green Published, gold, Green Submitted			2022-12-26	WOS:000434786600050
J	Wongchana, W; Kongkavitoon, P; Tangtanatakul, P; Sittplangkoon, C; Butta, P; Chawalitpong, S; Pattarakankul, T; Osborne, BA; Palaga, T				Wongchana, Wipawee; Kongkavitoon, Pornrat; Tangtanatakul, Pattarin; Sittplangkoon, Chutamath; Butta, Patcharavadee; Chawalitpong, Supatta; Pattarakankul, Thitiporn; Osborne, Barbara A.; Palaga, Tanapat			Notch signaling regulates the responses of lipopolysaccharide-stimulated macrophages in the presence of immune complexes	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FC-GAMMA RECEPTORS; TRANSCRIPTIONAL REGULATION; ACTIVATED MACROPHAGES; CYTOKINE PRODUCTION; IL-10 PRODUCTION; PATHWAY; CELLS; POLARIZATION; EXPRESSION	Macrophages exhibit diverse effector phenotypes depending on the stimuli and their microenvironment. Classically activated macrophages are primed with interferon (IFN)gamma and stimulated with pathogen-associated molecular patterns. They produce inflammatory mediators and inflammatory cytokines, such as IL-12. In the presence of immune complexes (ICs), activated macrophages have decreased IL-12 production and increased IL-10 production and presumably act as regulatory macrophages. Notch signaling has been shown to regulate the effector functions of classically activated macrophages. In this study, we investigated whether Notch signaling is active in lipopolysaccharide (LPS)-stimulated macrophages in the presence of ICs. LPS/IC stimulation increased the level of cleaved Notch1 in murine macrophages, while IC stimulation alone did not. Delta-like 4, but not Jagged1, was responsible for generating cleaved Notch1. The activation of Notch signaling by LPS/ICs depended upon NF-kappa B and MEK/Erk pathway activation. Macrophages with the targeted deletion of Rbpj, which encodes a DNA-binding protein central to canonical Notch signaling, produced significantly less IL-10 upon LPS/IC stimulation. A similar impact on IL-10 production was observed when Notch signaling was inhibited with a gamma-secretase inhibitor (GSI). Defects in NF-kappa B p50 nuclear localization were observed in GSI-treated macrophages and in Rbpj(-/-) macrophages, suggesting cross-regulation between the Notch and NF-kappa B pathways. Transcriptomic analysis revealed that Notch signaling regulates the transcription of genes involved in the cell cycle, macrophage activation, leukocyte migration and cytokine production in LPS/IC-stimulated macrophages. Taken together, these results suggest that the Notch signaling pathway plays an important role in regulating the functions of macrophages activated by LPS and ICs.	[Wongchana, Wipawee; Sittplangkoon, Chutamath; Chawalitpong, Supatta] Chulalongkorn Univ, Fac Sci, Grad Program Biotechnol, Bangkok, Thailand; [Wongchana, Wipawee; Kongkavitoon, Pornrat; Tangtanatakul, Pattarin; Sittplangkoon, Chutamath; Butta, Patcharavadee; Chawalitpong, Supatta; Pattarakankul, Thitiporn; Palaga, Tanapat] Chulalongkorn Univ, Ctr Excellence Immunol & Immune Mediated Dis, Bangkok, Thailand; [Kongkavitoon, Pornrat; Butta, Patcharavadee; Pattarakankul, Thitiporn; Palaga, Tanapat] Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand; [Osborne, Barbara A.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Palaga, Tanapat] Chulalongkorn Univ, Omics Sci & Bioinformat Ctr, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; University of Massachusetts System; University of Massachusetts Amherst; Chulalongkorn University	Palaga, T (corresponding author), Chulalongkorn Univ, Ctr Excellence Immunol & Immune Mediated Dis, Bangkok, Thailand.; Palaga, T (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand.; Palaga, T (corresponding author), Chulalongkorn Univ, Omics Sci & Bioinformat Ctr, Bangkok, Thailand.	tanapat.p@chula.ac.th			Thailand Research Fund (TRF) [BRG5880007]; Ratchadaphiseksomphot Endowment Fund; Chulalongkorn University [2014-023]; Ratchadaphiseksomphot Fund from Chulalongkorn University; Chulalongkorn Academic Advancement into Its 2nd Century Project; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0337/2551]; Ratchadaphiseksomphot Fund (The Graduate School of Chulalongkorn University)	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Ratchadaphiseksomphot Endowment Fund; Chulalongkorn University(Chulalongkorn University); Ratchadaphiseksomphot Fund from Chulalongkorn University; Chulalongkorn Academic Advancement into Its 2nd Century Project; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Ratchadaphiseksomphot Fund (The Graduate School of Chulalongkorn University)	This work was supported in part by the Thailand Research Fund (TRF grant no. BRG5880007), the Ratchadaphiseksomphot Endowment Fund (2013), Chulalongkorn University (Sci-Super 2014-023), and the grant for Chulalongkorn Research Scholars from the Ratchadaphiseksomphot Fund from Chulalongkorn University and Chulalongkorn Academic Advancement into Its 2nd Century Project to TP. WW is supported by the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (PHD/0337/2551). PK is supported by a postdoctoral fellowship from the Ratchadaphiseksomphot Fund (The Graduate School of Chulalongkorn University).	Anderson CF, 2002, J LEUKOCYTE BIOL, V72, P101; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Boonyatecha N, 2012, MOL IMMUNOL, V51, P255, DOI 10.1016/j.molimm.2012.03.017; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Espinosa L, 2010, CANCER CELL, V18, P268, DOI 10.1016/j.ccr.2010.08.006; Fleming BD, 2015, J LEUKOCYTE BIOL, V98, P395, DOI 10.1189/jlb.2A1114-560R; Foldi J, 2010, J IMMUNOL, V185, P5023, DOI 10.4049/jimmunol.1001544; Gerber JS, 2001, MICROBES INFECT, V3, P131, DOI 10.1016/S1286-4579(00)01360-5; Golde TE, 2013, BBA-BIOMEMBRANES, V1828, P2898, DOI 10.1016/j.bbamem.2013.06.005; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Iyer SS, 2010, J IMMUNOL, V185, P6599, DOI 10.4049/jimmunol.1002041; Kovall RA, 2007, CURR OPIN STRUC BIOL, V17, P117, DOI 10.1016/j.sbi.2006.11.004; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Luo Y, 2010, J BIOL CHEM, V285, P4232, DOI 10.1074/jbc.M109.037168; Ma Xiaojing, 2015, F1000Res, V4, DOI 10.12688/f1000research.7010.1; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Minter LM, 2012, CURR TOP MICROBIOL, V360, P99, DOI 10.1007/82_2012_233; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nandagopal N, 2018, CELL, V172, P869, DOI 10.1016/j.cell.2018.01.002; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Pereira SG, 2008, INT J BIOCHEM CELL B, V40, P1425, DOI 10.1016/j.biocel.2007.05.004; Polumuri SK, 2007, J IMMUNOL, V179, P236, DOI 10.4049/jimmunol.179.1.236; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Rutz S, 2008, P NATL ACAD SCI USA, V105, P3497, DOI 10.1073/pnas.0712102105; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Saraiva M, 2005, J IMMUNOL, V175, P1041, DOI 10.4049/jimmunol.175.2.1041; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; Tierney JB, 2009, IMMUNOL CELL BIOL, V87, P235, DOI 10.1038/icb.2008.99; Vogelpoel LTC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6444; Wang YC, 2010, CANCER RES, V70, P4840, DOI 10.1158/0008-5472.CAN-10-0269; Wongchana W, 2015, J IMMUNOL, V195, P5337, DOI 10.4049/jimmunol.1401770; Wongchana W, 2012, CELL MOL IMMUNOL, V9, P155, DOI 10.1038/cmi.2011.36; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Zhang Y, 2009, J IMMUNOL, V182, P554, DOI 10.4049/jimmunol.182.1.554	40	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198609	10.1371/journal.pone.0198609	http://dx.doi.org/10.1371/journal.pone.0198609			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889863	gold, Green Published, Green Submitted			2022-12-26	WOS:000434786600031
J	Zemet, R; Schiff, E; Manovitch, Z; Cahan, T; Yoeli-Ullman, R; Brandt, B; Hendler, I; Dorfman-Margolis, L; Yinon, Y; Sivan, E; Mazaki-Tovi, S				Zemet, Roni; Schiff, Eyal; Manovitch, Zipora; Cahan, Tal; Yoeli-Ullman, Rakefet; Brandt, Benny; Hendler, Israel; Dorfman-Margolis, Lilia; Yinon, Yoav; Sivan, Eyal; Mazaki-Tovi, Shali			Quantitative assessment of physical activity in pregnant women with sonographic short cervix and the risk for preterm delivery: A prospective pilot study	PLOS ONE			English	Article							BED REST; PREMATURE RUPTURE; BIRTH; OBESE	Objective Bed rest or activity restriction is a common obstetrical practice, despite a paucity of data to support its efficacy. The aim of this study was to determine whether physical activity, as assessed by a smart band activity tracker, is associated with preterm birth in pregnant women at high risk for preterm delivery. Methods This was a pilot prospective cohort study including pregnant women at high risk for preterm delivery between 24 and 32 weeks-of-gestation. Physical activity level was assessed by smart band activity. Patients with sonographic short cervical length (< 20 mm) were asked to wear the smart band activity tracker continuously for at least one week, including one weekend. Both physicians and patients were blinded to the data stored in the smart band activity tracker. No specific recommendations were given to participants as to the level or intensity of physical activity. The primary outcome was the rate of preterm birth (< 37 weeksof-gestation). Secondary outcomes included the rate of delivery before 34 weeks of gestation and neonatal outcome. Parametric and nonparametric statistics were used for analysis. Results Study population included 49 pregnant women: 37 women (75.7%) delivered preterm and 12 (24.5%) delivered at or after 37 weeks-of-gestation. The median steps per day was significantly lower in patients who delivered preterm (3576, IQR: 2478-4775 vs. 4554, IQR: 3632-6337, p = 0.02). Regression analysis revealed that the median number of steps per day was independently inversely associated with preterm birth, after adjustment for maternal age, body mass index, gestational age at recruitment, cervical length, cervical dilatation and plurality. Conclusion This pilot study represents the first quantitative assessment of the association between physical activity and preterm birth. The results of this pilot study do not support the efficacy of decreased physical activity in the prevention of preterm birth in patients with sonographic short cervical length.	[Zemet, Roni; Schiff, Eyal; Manovitch, Zipora; Cahan, Tal; Yoeli-Ullman, Rakefet; Brandt, Benny; Hendler, Israel; Dorfman-Margolis, Lilia; Yinon, Yoav; Sivan, Eyal; Mazaki-Tovi, Shali] Sheba Med Ctr, Dept Obstet & Gynecol, Tel Hashomer, Israel; [Zemet, Roni; Schiff, Eyal; Manovitch, Zipora; Cahan, Tal; Yoeli-Ullman, Rakefet; Brandt, Benny; Hendler, Israel; Yinon, Yoav; Sivan, Eyal; Mazaki-Tovi, Shali] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Mazaki-Tovi, S (corresponding author), Sheba Med Ctr, Dept Obstet & Gynecol, Tel Hashomer, Israel.; Mazaki-Tovi, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.	shalimazaki@gamil.com			Talpiot Medical Leadership Program, Sheba Medical Center, Tel Hashomer, Israel.	Talpiot Medical Leadership Program, Sheba Medical Center, Tel Hashomer, Israel.	This study was supported by a grant from the Talpiot Medical Leadership Program, Sheba Medical Center, Tel Hashomer (S.M.T.), Israel. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our colleagues Dr. Ronen Itai, Prof. Simchen Michal and Dulitzky Mordechai who provided insight and expertise that greatly assisted the research. We thank Ms. Maya Mazaki-Tovi for reviewing the manuscript for grammar, style and language, and to Mr. Isaac Tovi for his technical support. This study was supported by grants from the Talpiot Medical Leadership Program, Sheba Medical Center, Tel Hashmer (S.M.T.), Israel.	Adamopoulos S, 2002, J AM COLL CARDIOL, V39, P653, DOI 10.1016/S0735-1097(01)01795-8; Aleman A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003576.pub2; [Anonymous], 2015, Obstet Gynecol, V126, pe82, DOI 10.1097/AOG.0000000000001105; [Anonymous], BIOMATERIALS, V110, P115, DOI [10.1002/jbm.b.34895, DOI 10.1002/JBM.B.34895, DOI 10.1002/14651858.CD000110]; Bigelow C, 2011, MT SINAI J MED, V78, P291, DOI 10.1002/msj.20243; Biggio JR, 2013, OBSTET GYNECOL, V121, P1158, DOI 10.1097/AOG.0b013e318294480d; Cohen TR, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/787032; Comm Obstet Practice, 2015, OBSTET GYNECOL, V126, pe135, DOI 10.1097/AOG.0000000000001214; De Craemer M, 2015, J SCI MED SPORT, V18, P289, DOI 10.1016/j.jsams.2014.06.001; Fox NS, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.007; GOELDENBERG RL, 1994, OBSTET GYNECOL, V84, P131; Grobman WA, 2013, OBSTET GYNECOL, V121, P1181, DOI 10.1097/AOG.0b013e3182917529; Harrison CL, 2012, BJOG-INT J OBSTET GY, V119, P731, DOI 10.1111/j.1471-0528.2012.03296.x; Harrison CL, 2013, OBESITY, V21, P904, DOI 10.1002/oby.20163; Harrison CL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-19; Kovacevich GJ, 2000, AM J OBSTET GYNECOL, V182, P1089, DOI 10.1067/mob.2000.105405; Lee JY, 2015, OBSTET GYNECOL, V126, P947, DOI 10.1097/AOG.0000000000001099; Lee JA, 2015, J SPORT SCI, V33, P991, DOI 10.1080/02640414.2014.981848; Lindseth G, 2005, WESTERN J NURS RES, V27, P722, DOI 10.1177/0193945905276523; Liu C, 2016, BJOG-INT J OBSTET GY, V123, P1973, DOI 10.1111/1471-0528.13891; Lorenz RP, 2014, OBSTET GYNECOL, V124, P377, DOI 10.1097/AOG.0000000000000399; Maloni J A, 2001, J Obstet Gynecol Neonatal Nurs, V30, P165, DOI 10.1111/j.1552-6909.2001.tb01532.x; Maloni JA, 2010, BIOL RES NURS, V12, P106, DOI 10.1177/1099800410375978; McCall CA, 2013, OBSTET GYNECOL, V121, P1305, DOI 10.1097/AOG.0b013e318293f12f; McCarty-Singleton S, 2014, CLIN OBSTET GYNECOL, V57, P616, DOI 10.1097/GRF.0000000000000048; Micheli K, 2011, EPIDEMIOLOGY, V22, P738, DOI 10.1097/EDE.0b013e31822546fd; Mottola MF, 2013, NUTR REV, V71, pS31, DOI 10.1111/nure.12064; Promislow JHE, 2004, AM J OBSTET GYNECOL, V191, P1077, DOI 10.1016/j.ajog.2004.05.058; Renault K, 2010, ACTA OBSTET GYN SCAN, V89, P956, DOI 10.3109/00016341003792459; Sciscione AC, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.005; Sosa CG, 2015, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003581.PUB3; TEITELMAN AM, 1990, AM J EPIDEMIOL, V131, P104, DOI 10.1093/oxfordjournals.aje.a115463; Vinter CA, 2011, DIABETES CARE, V34, P2502, DOI 10.2337/dc11-1150	33	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198949	10.1371/journal.pone.0198949	http://dx.doi.org/10.1371/journal.pone.0198949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889906	Green Published, gold, Green Submitted			2022-12-26	WOS:000434786600066
J	Bruni, R; Villano, U; Equestre, M; Chionne, P; Madonna, E; Trandeva-Bankova, D; Peleva-Pishmisheva, M; Tenev, T; Cella, E; Ciccozzi, M; Pisani, G; Golkocheva-Markova, E; Ciccaglione, AR				Bruni, Roberto; Villano, Umbertina; Equestre, Michele; Chionne, Paola; Madonna, Elisabetta; Trandeva-Bankova, Dilyana; Peleva-Pishmisheva, Maria; Tenev, Tencho; Cella, Eleonora; Ciccozzi, Massimo; Pisani, Giulio; Golkocheva-Markova, Elitsa; Ciccaglione, Anna Rita			Hepatitis E virus genotypes and subgenotypes causing acute hepatitis, Bulgaria, 2013-2015	PLOS ONE			English	Article							INFECTION	Background In industrialized areas of the world, including Europe, Hepatitis E Virus (HEV) is considered an emerging pathogen. In fact, autochthonous cases caused by HEV genotype 3 (HEV-3) are increasingly reported. Several studies described the human HEV-3 subtypes and strains circulating in West Europe countries; in contrast, very little is known about the HEV strains responsible for acute hepatitis E in countries of East Europe/Balkans, such as Bulgaria. Methods and findings Anti-HEV IgM positive serum samples (n = 103) from acute hepatitis cases (2013-2015) from all over Bulgaria were analysed for HEV RNA by Real-Time PCR. Viremia was detected in 90/103 samples. A fragment of the viral genome (ORF-2 region) was amplified by nested PCR from 76/90 viremic samples, leading to a sequence in 64 of them. Genotyping by phylogenetic analysis with standard reference sequences showed HEV-1 in 1/64 cases, HEV-3 in 63/64. Subtyping of HEV-3 sequences showed 3e (39/63, 62%), 3f (n = 15/63, 24%) and 3c (n = 8/63, 13%) subtypes; in one case the sequence subtype was uncertain and classified as 3hi. In the phylogenetic tree, most 3e sequences grouped in two well distinct clusters (A and B), each one with very low intragroup genetic distances. In contrast, 3f and 3c were interspersed with reference sequences and showed lower tendency to cluster and/or higher intragroup distances. Geographically, while 3f and 3c were scattered throughout the country, 3e was restricted to the South-West area, with most cases in two towns about 40 kilometres apart from each other. Conclusions Most acute hepatitis E cases in Bulgaria are caused by HEV-3, subtypes 3e, 3f and 3c. Circulation of 3e appears quite different from 3f and 3c, with 3e restricted to the South-West area while 3f and 3c diffused over the country. The factors underlying the observed molecular and geographical differences remain to be investigated.	[Bruni, Roberto; Villano, Umbertina; Chionne, Paola; Madonna, Elisabetta; Ciccaglione, Anna Rita] Ist Super Sanita, Dept Infect Dis, Viral Hepatitis & Oncovirus & Retrovirus Dis Unit, Rome, Italy; [Equestre, Michele] Ist Super Sanita, Dept Neurosci, Rome, Italy; [Trandeva-Bankova, Dilyana; Tenev, Tencho; Golkocheva-Markova, Elitsa] Natl Ctr Infect & Parasit Dis, Dept Virol, Sofia, Bulgaria; [Peleva-Pishmisheva, Maria] Reg Hosp Pazardzhik, Dept Infect Dis, Pazardzhik, Bulgaria; [Cella, Eleonora] Sapienza Univ, Publ Hlth & Infect Dis, Rome, Italy; [Ciccozzi, Massimo] Campus Biomed Univ, Unit Clin Lab Sci, Rome, Italy; [Pisani, Giulio] Ist Super Sanita, Natl Ctr Control & Evaluat Med, Biol & Biotechnol Unit, Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Bulgarian Academy of Sciences; Medical University Sofia; Ministry of Health Bulgaria; National Centre of Infectious & Parasitic Diseases; Sapienza University Rome; University Campus Bio-Medico - Rome Italy; Istituto Superiore di Sanita (ISS)	Bruni, R (corresponding author), Ist Super Sanita, Dept Infect Dis, Viral Hepatitis & Oncovirus & Retrovirus Dis Unit, Rome, Italy.	roberto.bruni@iss.it	Equestre, Michele/AAC-2129-2019; Bruni, Roberto/ABA-8555-2021; Cella, Eleonora/J-9961-2016; BRUNI, ROBERTO/M-2957-2015; Equestre, Michele/AAV-4993-2020; Pisani, Giulio/M-9482-2017; MADONNA, ELISABETTA/M-2962-2015; villano, umbertina/M-2967-2015; Ciccozzi, Massimo/AAC-3271-2022; CICCAGLIONE, ANNA RITA/M-2956-2015	Bruni, Roberto/0000-0002-3035-5510; Cella, Eleonora/0000-0002-7870-9744; BRUNI, ROBERTO/0000-0002-3035-5510; Equestre, Michele/0000-0001-7883-1371; Pisani, Giulio/0000-0002-5569-8915; MADONNA, ELISABETTA/0000-0003-3288-2346; villano, umbertina/0000-0001-5236-041X; Ciccozzi, Massimo/0000-0003-3866-9239; CICCAGLIONE, ANNA RITA/0000-0002-3791-3781; , Maria Pishmisheva-Peleva/0000-0001-6792-9146				Adlhoch C, 2016, J CLIN VIROL, V82, P9, DOI 10.1016/j.jcv.2016.06.010; Baymakova M, 2016, SRP ARK CELOK LEK, V144, P63, DOI 10.2298/SARH1602063B; Domanovic D, 2017, EUROSURVEILLANCE, V22, P6, DOI 10.2807/1560-7917.ES.2017.22.16.30514; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Jothikumar N, 2006, J VIROL METHODS, V131, P65, DOI 10.1016/j.jviromet.2005.07.004; Kamar N, 2012, LANCET, V380, P730; Kamar N, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.86; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Lee GH, 2016, GASTROENTEROLOGY, V150, P355, DOI 10.1053/j.gastro.2015.10.048; Said B, 2009, EMERG INFECT DIS, V15, P1738, DOI 10.3201/eid1511.091094; Smith DB, 2016, J GEN VIROL, V97, P537, DOI 10.1099/jgv.0.000393; Smith DB, 2015, J GEN VIROL, V96, P3255, DOI 10.1099/jgv.0.000264; Smith DB, 2014, J GEN VIROL, V95, P2223, DOI 10.1099/vir.0.068429-0; Sridhar S, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.107; Stoykova Zh., 2017, Meditsinski Pregled / Medical Review, V53, P30; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teoharov P, 2013, 11 NAT C CLIN MICR I; Teoharov P, 2014, CR ACAD BULG SCI, V67, P1427; Vina-Rodriguez A, 2015, VIRUSES-BASEL, V7, P2704, DOI 10.3390/v7052704; WHO, 2003, REC STAND SURV SEL V; Woo PCY, 2016, EMERG INFECT DIS, V22, P2219, DOI 10.3201/eid2212.160979; Zehender G, 2014, INFECT GENET EVOL, V25, P138, DOI 10.1016/j.meegid.2014.04.016	23	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198045	10.1371/journal.pone.0198045	http://dx.doi.org/10.1371/journal.pone.0198045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879148	Green Submitted, Green Published, gold			2022-12-26	WOS:000434384900016
J	Ranaweera, S; Amarasinghe, H; Chandraratne, N; Thavorncharoensap, M; Ranasinghe, T; Karunaratna, S; Kumara, D; Santatiwongchai, B; Chaikledkaew, U; Abeykoon, P; De Silva, A				Ranaweera, Sajeeva; Amarasinghe, Hemantha; Chandraratne, Nadeeka; Thavorncharoensap, Montarat; Ranasinghe, Thushara; Karunaratna, Sumudu; Kumara, Dinesh; Santatiwongchai, Benjarin; Chaikledkaew, Usa; Abeykoon, Palitha; De Silva, Amala			Economic costs of alcohol use in Sri Lanka	PLOS ONE			English	Article							CONSUMPTION; TOBACCO; DISEASE; CANCER	Aim Alcohol related disease conditions are responsible for a significant proportion of morbidity and mortality in Sri Lanka. This study quantified the economic cost of selected alcohol related disease conditions in Sri Lanka in 2015. Methods This study uses the prevalence-based cost of illness methodology specified by the World Health Organization, and uses the gross costing approach. The direct costs includes the costs of curative care (inpatient and outpatient care borne by the state and out of pocket expenditure borne by patients) for alcohol related diseases, weighted by the respective population attributable fractions. Indirect costs consist of lost earnings due to absenteeism of the patient and carers due to seeking care and recuperation, and the loss of income due to mortality. Data form the Ministry of Health, Registrar General's Department, Department of Census and Statistics and the National Cancer Registry was used. Systemic and house costs and population attributable fractions were obtained from research studies. Economists, Public Health Experts, Medical Administrators and Clinical Specialists were iteratively consulted during the estimation and validation of the costs and the results. Results The estimated present value of current and future economic cost of the alcohol-related conditions for Sri Lanka in 2015 was USD 885.86 million, 1.07% of the GDP of that year. The direct cost of alcohol related disease conditions was USD 388.35 million, which was 44% of the total cost, while the indirect cost was USD 497.50 million, which was 66% of the total cost. Road Injury cost was the highest cost category among the conditions studied. Conclusion Addressing alcohol use and its harms through effective implementation of evidence-based polices and interventions is urgently required to address the economic costs of alcohol use in Sri Lanka as it imposes a significant burden to the country.	[Ranaweera, Sajeeva; Amarasinghe, Hemantha; Chandraratne, Nadeeka] Sri Lanka Med Assoc, Colombo, Sri Lanka; [Amarasinghe, Hemantha] Minist Hlth Nutr & Indigenous Med, Inst Oral Hlth, Maharagama, Sri Lanka; [Thavorncharoensap, Montarat; Chaikledkaew, Usa] Mahidol Univ, Dept Pharm, Fac Pharm, Bangkok, Thailand; [Ranasinghe, Thushara] World Hlth Org Country Off, Colombo, Sri Lanka; [Karunaratna, Sumudu] Minist Hlth Nutr & Indigenous Med, Colombo, Sri Lanka; [Kumara, Dinesh; Abeykoon, Palitha] Minist Hlth Nutr & Indigenous Med, Natl Author Tobacco & Alcohol, Battaramulla, Sri Lanka; [Santatiwongchai, Benjarin] Minist Publ Hlth, Hlth Intervent & Technol Assessment Program, Nonthaburi, Thailand; [De Silva, Amala] Univ Colombo, Colombo, Sri Lanka	Mahidol University; World Health Organization; Ministry of Public Health - Thailand; University of Colombo	Chandraratne, N (corresponding author), Sri Lanka Med Assoc, Colombo, Sri Lanka.	nadkamil@yahoo.com		Chandraratne, Nadeeka/0000-0002-3093-9102; Karunaratna, Sumudu/0000-0001-6482-4007; Ranaweera, Sajeeva/0000-0001-5034-5021; Kumara, Dinesh/0000-0002-6411-3528; Abeykoon, Palitha/0000-0003-0545-3829; ranasinghe, Thushara/0000-0002-8789-7337	World Health Organization Regional Office for South East Asia; Thailand Research Fund (TRF); International Decision Support Initiative (iDSI); TRF [RTA5980011]; Bill & Melinda Gates Foundation; UK's Department for International Development; Rockefeller Foundation	World Health Organization Regional Office for South East Asia; Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); International Decision Support Initiative (iDSI); TRF(Thailand Research Fund (TRF)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK's Department for International Development; Rockefeller Foundation	This project is supported by the World Health Organization Regional Office for South East Asia and partly supported by the Thailand Research Fund (TRF) and the International Decision Support Initiative (iDSI). The Health Intervention and Technology Assessment Program (HITAP) is funded by the TRF under a grant for Senior Research Scholar (RTA5980011). HITAP's International Unit is supported by iDSI to provide technical assistance on health intervention and technology assessment to governments in low and middle-income countries. iDSI is funded by the Bill & Melinda Gates Foundation, the UK's Department for International Development, and the Rockefeller Foundation. The findings, interpretations, and conclusions expressed in this article do not necessarily reflect the views of the funding agencies.	Anderson P, 2009, ALCOHOL WORK PRODUCT; Anderson P.Anderson, 2008, ALCOHOL EUROPE PUBLI; [Anonymous], 2016, UNDERSTANDING RELATI; Australian Institute of Health and Welfare, 2008, EFF COST EFF POL PRO; Bagnardi V, 2015, BRIT J CANCER, V112, P580, DOI 10.1038/bjc.2014.579; Baklien Bergljot, 2003, ALCOHOL POVERTY SRI; Barrio P, 2017, DRUG ALCOHOL REV, V36, P578, DOI 10.1111/dar.12504; Centers for Disease Control and Prevention (CDC), 2016, ALC PUBL HLTH ALC RE; Central Bank of Sri Lanka, 2017, CENTR BANK SRI LANK; Chikritzhs T, 2003, AUSTR ALCOHOL INDICA, P200; de Silva V., 2009, Ceylon Medical Journal, V54, P119; de Silva V, 2011, DRUG ALCOHOL REV, V30, P69, DOI 10.1111/j.1465-3362.2010.00202.x; Family Health Bureau Ministry of Health, 2015, NAT HLTH YOUTH SURV; Fergusson DM, 2009, ARCH GEN PSYCHIAT, V66, P260, DOI 10.1001/archgenpsychiatry.2008.543; International Agency for Research on Cancer, 2012, GLOB 2012 EST CANC I; Johnston MC, 2012, ALCOHOL ALCOHOLISM, V47, P725, DOI 10.1093/alcalc/ags092; Katulanda P, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-612; Leong DP, 2014, CIRCULATION, V130, P390, DOI 10.1161/CIRCULATIONAHA.113.007627; Lucas DL, 2005, J AM COLL CARDIOL, V45, P1916, DOI 10.1016/j.jacc.2005.02.075; Medical Statistics Unit Ministry of Health, 2016, MIN HLTH NUTR IND ME; Ministry of Health Nutrition and Indigenous Medicine World Health Organization, 2015, NONC DIS RISK FACT S; National Cancer Control Programme, 2015, CANC INC DAT SRI LAN; Ogden GR, 1998, BRIT J ORAL MAX SURG, V36, P247, DOI 10.1016/S0266-4356(98)90707-0; Organisation for Economic Co-operation and Development and World Health Organization, 2003, DEV ASS COMM DAC GUI; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Single E, 2000, CAN MED ASSOC J, V162, P1669; Single E., 2003, INT GUIDELINES ESTIM, V2nd ed.; Sornpaisarn B, 2017, RESOURCE TOOL ALCOHO; Thavorncharoensap M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-323; Thavorncharoensap M, 2009, SUBST ABUSE TREAT PR, V4, DOI 10.1186/1747-597X-4-20; Tramacere I, 2010, ORAL ONCOL, V46, P497, DOI 10.1016/j.oraloncology.2010.03.024; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organisation, 2016, INT CLASS DIS REL HL; Zeisser C, 2013, ALCOHOLISM CLIN EX S, pE1, DOI [10.1111/J.1530-0277.2012, DOI 10.1111/J.1530-0277.2012]	35	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198640	10.1371/journal.pone.0198640	http://dx.doi.org/10.1371/journal.pone.0198640			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879178	gold, Green Submitted, Green Published			2022-12-26	WOS:000434384900064
J	Cambras, T; Castro-Marrero, J; Zaragoza, MC; Diez-Noguera, A; Alegre, J				Cambras, Trinitat; Castro-Marrero, Jesus; Cleofe Zaragoza, Maria; Diez-Noguera, Antoni; Alegre, Jose			Circadian rhythm abnormalities and autonomic dysfunction in patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis	PLOS ONE			English	Article							CORE BODY-TEMPERATURE; ACTIVITY LEVEL; SLEEP; SYMPTOMS; SENSITIVITY; POLYSOMNOGRAPHY; FIBROMYALGIA; VALIDATION; ACTIGRAPHY; DISORDERS	Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) patients frequently show autonomic symptoms which may be associated with a hypothalamic dysfunction. This study aimed to explore circadian rhythm patterns in rest and activity and distal skin temperature (DST) and their association with self-reported outcome measures, in CFS/ME patients and healthy controls at two different times of year. Ten women who met both the 1994 CDC/Fukuda definition and 2003 Canadian criteria for CFS/ME were included in the study, along with ten healthy controls matched for age, sex and body mass index. Self-reported measures were used to assess fatigue, sleep quality, anxiety and depression, autonomic function and health-related quality of life. The ActTrust actigraph was used to record activity, DST and light intensity, with data intervals of one minute over seven consecutive days. Sleep variables were obtained through actigraphic analysis and from subjective sleep diary. The circadian variables and the spectral analysis of the rhythms were calculated. Linear regression analysis was used to evaluate the relationship between the rhythmic variables and clinical features. Recordings were taken in the same subjects in winter and summer. Results showed no differences in rhythm stability, sleep latency or number of awakenings between groups as measured with the actigraph. However, daily activity, the relative amplitude and the stability of the activity rhythm were lower in CFS/ME patients than in controls. DST was sensitive to environmental temperature and showed lower nocturnal values in CFS/ME patients than controls only in winter. A spectral analysis showed no differences in phase or amplitude of the 24h rhythm, but the power of the second harmonic (12h), revealed differences between groups (controls showed a post-lunch dip in activity and peak in DST, while CFS/ME patients did not) and correlated with clinical features. These findings suggest that circadian regulation and skin vasodilator responses may play a role in CFS/ME.	[Cambras, Trinitat; Diez-Noguera, Antoni] Univ Barcelona, Fac Pharm & Food Sci, Dept Physiol & Biochem, Chronobiol Grp, Barcelona, Spain; [Castro-Marrero, Jesus; Cleofe Zaragoza, Maria; Alegre, Jose] Univ Autonoma Barcelona, CFS ME Unit, Vall dHebron Univ Hosp, Res Inst, Barcelona, Spain; [Cleofe Zaragoza, Maria] Labs Vinas, Clin Res Dept, Barcelona, Spain	University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Cambras, T (corresponding author), Univ Barcelona, Fac Pharm & Food Sci, Dept Physiol & Biochem, Chronobiol Grp, Barcelona, Spain.; Castro-Marrero, J (corresponding author), Univ Autonoma Barcelona, CFS ME Unit, Vall dHebron Univ Hosp, Res Inst, Barcelona, Spain.	cambras@ub.edu; jesus.castro@vhir.org	Zaragozá Jiménez, Maria Cleofé/ABF-8509-2021; Cambras, Trinitat/S-3881-2019; Alegre, Jose/M-7218-2014	Zaragozá Jiménez, Maria Cleofé/0000-0002-9797-0219; Cambras, Trinitat/0000-0002-9009-4690; Castro-Marrero, Jesus/0000-0002-2481-3052; Alegre, Jose/0000-0002-7582-7585				Akerstedt T, 2014, J SLEEP RES, V23, P240, DOI 10.1111/jsr.12158; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, V3rd; Blackwell T, 2008, SLEEP, V31, P283, DOI 10.1093/sleep/31.2.283; Buijs FN, 2016, CIRCADIAN SYSTEM REG, P170, DOI [10.1046/j.1365-2281.2001.00321.x, DOI 10.1046/J.1365-2281.2001.00321.X]; Buijs RM, 2003, J COMP NEUROL, V464, P36, DOI 10.1002/cne.10765; Burgess HJ, 2017, PAIN MED, V18, P116, DOI 10.1093/pm/pnw160; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [DOI 10.1300/J092V11N01_02, 10.1300/J092v11n01_02]; Castro-Marrero J, 2017, BRIT J PHARMACOL, V174, P345, DOI 10.1111/bph.13702; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; Duffy JF, 2015, SLEEP MED CLIN, V10, P423, DOI 10.1016/j.jsmc.2015.08.002; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Foster RG, 2013, PROG MOL BIOL TRANSL, V119, P325, DOI 10.1016/B978-0-12-396971-2.00011-7; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gaggioni G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00126; Hamilos DL, 1998, BIOL PSYCHIAT, V43, P293, DOI 10.1016/S0006-3223(97)83214-3; Hamilos DL, 2001, CLIN PHYSIOL, V21, P184, DOI 10.1046/j.1365-2281.2001.00321.x; Hasselberg MJ, 2013, SLEEP MED, V14, P5, DOI 10.1016/j.sleep.2010.12.011; Herrero MJ, 2003, GEN HOSP PSYCHIAT, V25, P277, DOI 10.1016/S0163-8343(03)00043-4; Hutchinson CV, 2014, BRIT J OPHTHALMOL, V98, P144, DOI 10.1136/bjophthalmol-2013-304439; Jammes Y, 2005, J INTERN MED, V257, P299, DOI 10.1111/j.1365-2796.2005.01452.x; Jones DEJ, 2011, J INTERN MED, V269, P182, DOI 10.1111/j.1365-2796.2010.02306.x; Jones DEJ, 2010, J INTERN MED, V267, P394, DOI 10.1111/j.1365-2796.2009.02160.x; Kalsbeek A, 2011, ESSAYS BIOCHEM, V49, P137, DOI [10.1042/bse0490137, 10.1042/BSE0480137]; Krauchi K, 2012, CHRONOBIOL INT, V29, P1273, DOI 10.3109/07420528.2012.719961; Lack LC, 2008, SLEEP MED REV, V12, P307, DOI 10.1016/j.smrv.2008.02.003; Marino M, 2013, SLEEP, V36, P1747, DOI 10.5665/sleep.3142; Martinez-Nicolas A, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx067; Monk TH, 1996, CHRONOBIOL INT, V13, P123, DOI 10.3109/07420529609037076; Morriss RK, 1997, J PSYCHOSOM RES, V42, P597, DOI 10.1016/S0022-3999(97)89895-9; Naschitz JE, 2004, MED HYPOTHESES, V62, P203, DOI 10.1016/S0306-9877(03)00331-1; Newton JL, 2007, QJM-INT J MED, V100, P519, DOI 10.1093/qjmed/hcm057; Ortiz-Tudela E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000996; Pedersen M, 2017, J SLEEP RES, V26, P595, DOI 10.1111/jsr.12547; Powell P, 2004, BRIT J PSYCHIAT, V184, P142, DOI 10.1192/bjp.184.2.142; Racciatti D, 2001, INT J IMMUNOPATH PH, V14, P11, DOI 10.1177/039463200101400103; Rahman K, 2011, SLEEP, V34, P671, DOI 10.1093/sleep/34.5.671; Reid KJ, 2011, PROG BRAIN RES, V190, P3, DOI 10.1016/B978-0-444-53817-8.00001-3; Reynolds Kenneth J, 2004, Cost Eff Resour Alloc, V2, P4, DOI 10.1186/1478-7547-2-4; Rutherford Gina, 2016, J Aging Res, V2016, P2497348, DOI 10.1155/2016/2497348; Sarabia JA, 2008, PHYSIOL BEHAV, V95, P570, DOI 10.1016/j.physbeh.2008.08.005; SCHEIRER CJ, 1976, BIOMETRICS, V32, P429, DOI 10.2307/2529511; Sletten DM, 2012, MAYO CLIN PROC, V87, P1196, DOI 10.1016/j.mayocp.2012.10.013; Smith AK, 2011, NEUROPSYCHOBIOLOGY, V64, P183, DOI 10.1159/000326692; Theadom A, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0464-y; Thorpe T, 2016, FATIGUE, V4, P175, DOI 10.1080/21641846.2016.1206176; Tomoda A., 2001, J CHRONIC FATIGUE SY, V8, P29, DOI DOI 10.1300/J092V08N02_; Tryon WW, 2004, PHYSIOL BEHAV, V82, P849, DOI 10.1016/j.physbeh.2004.07.005; Van Someren EJW, 1999, CHRONOBIOL INT, V16, P505, DOI 10.3109/07420529908998724; Wallin BG, 2007, MUSCLE NERVE, V36, P595, DOI 10.1002/mus.20831; Williams G, 2002, EUR J CLIN INVEST, V32, P831, DOI 10.1046/j.1365-2362.2002.01058.x; Williams G, 1996, CLIN PHYSIOL, V16, P327, DOI 10.1111/j.1475-097X.1996.tb00722.x; WITTING W, 1990, BIOL PSYCHIAT, V27, P563, DOI 10.1016/0006-3223(90)90523-5; Wright KP, 2013, CURR BIOL, V23, P1554, DOI 10.1016/j.cub.2013.06.039; Wyller VB, 2007, PEDIATRICS, V120, pE129, DOI 10.1542/peds.2006-2759	57	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0198106	10.1371/journal.pone.0198106	http://dx.doi.org/10.1371/journal.pone.0198106			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI4VN	29874259	Green Published, gold			2022-12-26	WOS:000434369400041
J	Liu, J; Zhang, Z; Li, XW; Chen, J; Wang, GD; Tian, ZH; Qian, MR; Chen, ZQ; Guo, H; Tang, GB; Huang, WJ; Tian, DA; Wang, DW; Nie, YZ; Fan, DM; Wu, KC; Xia, LM				Liu, Jian; Zhang, Zhe; Li, Xiaowei; Chen, Jie; Wang, Guodong; Tian, Zuhong; Qian, Meirui; Chen, Zhangqian; Guo, Hao; Tang, Guangbo; Huang, Wenjie; Tian, Dean; Wang, Daowen; Nie, Yongzhan; Fan, Daiming; Wu, Kaichun; Xia, Limin			Forkhead box Cl promotes colorectal cancer metastasis through transactivating ITGA7 and FGFR4 expression	ONCOGENE			English	Article							FIBROBLAST-GROWTH-FACTOR; TO-MESENCHYMAL TRANSITION; INDICATES POOR-PROGNOSIS; TUMOR-METASTASIS; FOXC1; CARCINOMA; GENE; OVEREXPRESSION; INHIBITION; MUTATION	Metastatic colorectal cancer (CRC) is one of the most common causes of cancer death worldwide; however, the molecular mechanism underlying CRC metastasis remains unknown. Using an integrated approach, we identified forkhead box C1 (FOXC1) as a novel regulator of CRC metastasis. Elevated expression of FOXC1 is significantly correlated with metastasis, recurrence and reduced survival. FOXC1 overexpression promotes CRC invasion and lung metastasis, whereas FOXC1 knockdown has the opposite effect. In addition, FOXC1 directly binds its target genes integrin ea (ITGA7) and fibroblast growth factor receptor 4 (FGFR4) and activates their expression. Genetic epistasis analysis confirmed that ITGA7 and FGFR4 act downstream of FOXC1. Furthermore, pharmaceutical inhibition of FGFR4 can reverse CRC metastasis mediated by FOXC1 overexpression. These results suggest that FOXC1 is a prognostic biomarker in CRC patients and targeting the FGFR4 signaling pathway may provide a promising strategy for the treatment of FOXC1-driven CRC metastasis.	[Liu, Jian; Zhang, Zhe; Li, Xiaowei; Chen, Jie; Wang, Guodong; Tian, Zuhong; Qian, Meirui; Chen, Zhangqian; Guo, Hao; Tang, Guangbo; Huang, Wenjie; Nie, Yongzhan; Fan, Daiming; Wu, Kaichun; Xia, Limin] Fourth Mil Med Univ, Natl Clin Res Ctr Digest Dis, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China; [Liu, Jian; Zhang, Zhe; Li, Xiaowei; Chen, Jie; Wang, Guodong; Tian, Zuhong; Qian, Meirui; Chen, Zhangqian; Guo, Hao; Tang, Guangbo; Huang, Wenjie; Nie, Yongzhan; Fan, Daiming; Wu, Kaichun; Xia, Limin] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian, Shaanxi, Peoples R China; [Huang, Wenjie; Tian, Dean; Wang, Daowen; Xia, Limin] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Gastroenterol, Wuhan 430030, Hubei, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Huazhong University of Science & Technology	Wu, KC; Xia, LM (corresponding author), Fourth Mil Med Univ, Natl Clin Res Ctr Digest Dis, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China.; Wu, KC; Xia, LM (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian, Shaanxi, Peoples R China.; Xia, LM (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Gastroenterol, Wuhan 430030, Hubei, Peoples R China.	kaicwu@fmmu.edu.cn; xialimin@fmmu.edu.cn			National Natural Science Foundation of China [81522031, 81772623, 81627807, 81421003]; National Center for Clinical Research of Digestive Diseases [2015BAI13B07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Center for Clinical Research of Digestive Diseases	This study was supported by the National Natural Science Foundation of China (Nos. 81522031, 81772623, 81627807, and 81421003) and the National Center for Clinical Research of Digestive Diseases (2015BAI13B07).	Babina IS, 2017, NAT REV CANCER, V17, P318, DOI 10.1038/nrc.2017.8; Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003; Brabletz T, 2018, NAT REV CANCER, V18, P128, DOI 10.1038/nrc.2017.118; Chung TKH, 2012, INT J CANCER, V130, P1036, DOI 10.1002/ijc.26060; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; El-Shami K, 2015, CA-CANCER J CLIN, V65, P427, DOI 10.3322/caac.21286; Haas TL, 2017, CELL STEM CELL, V21, P35, DOI 10.1016/j.stem.2017.04.009; Hagel M, 2015, CANCER DISCOV, V5, P424, DOI 10.1158/2159-8290.CD-14-1029; Han BC, 2018, ONCOGENE, V37, P1399, DOI 10.1038/s41388-017-0021-2; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Honkanen RA, 2003, AM J OPHTHALMOL, V135, P368, DOI 10.1016/S0002-9394(02)02061-5; Huang L, 2017, AM J TRANSL RES, V9, P1297; Huang WJ, 2015, GASTROENTEROLOGY, V149, P1053, DOI 10.1053/j.gastro.2015.05.058; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jensen TW, 2015, JNCI-J NATL CANCER I, V107, P1; Li CS, 2014, BIOMARKERS, V19, P81, DOI 10.3109/1354750X.2013.876555; Liu R, 2013, CANCER RES, V73, P5926, DOI 10.1158/0008-5472.CAN-12-4718; MCNUTT NS, 1981, LAB INVEST, V44, P309; Ming XY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13568; Mortemousque B, 2004, ARCH OPHTHALMOL-CHIC, V122, P1527, DOI 10.1001/archopht.122.10.1527; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Packer LM, 2015, CANCER DISCOV, V5, P355, DOI 10.1158/2159-8290.CD-15-0246; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; Sizemore ST, 2012, J BIOL CHEM, V287, P24631, DOI 10.1074/jbc.M112.375865; Somerville TDD, 2015, CANCER CELL, V28, P329, DOI 10.1016/j.ccell.2015.07.017; Su Y, 2014, INT J MOL MED, V34, P842, DOI 10.3892/ijmm.2014.1819; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Turkington RC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.10; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wang L, 2013, TUMOR BIOL, V34, P853, DOI 10.1007/s13277-012-0617-7; Xia LM, 2017, CANCER CELL, V31, P653, DOI 10.1016/j.ccell.2017.04.005; Xia LM, 2014, HEPATOLOGY, V59, P958, DOI 10.1002/hep.26735; Xia LM, 2013, HEPATOLOGY, V57, P610, DOI 10.1002/hep.26029; Xia LM, 2012, J HEPATOL, V57, P600, DOI 10.1016/j.jhep.2012.04.020; Xie MH, 1999, CYTOKINE, V11, P729, DOI 10.1006/cyto.1999.0485; Xu Y, 2014, HISTOPATHOLOGY, V64, P963, DOI 10.1111/his.12347; Yao CC, 1996, J BIOL CHEM, V271, P25598, DOI 10.1074/jbc.271.41.25598; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	38	37	38	0	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 11	2018	37	41					5477	5491		10.1038/s41388-018-0355-4	http://dx.doi.org/10.1038/s41388-018-0355-4			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GW5QO	29884889				2022-12-26	WOS:000446991200001
J	Miess, H; Dankworth, B; Gouw, AM; Rosenfeldt, M; Schmitz, W; Jiang, M; Saunders, B; Howell, M; Downward, J; Felsher, DW; Peck, B; Schulze, A				Miess, Heike; Dankworth, Beatrice; Gouw, Arvin M.; Rosenfeldt, Mathias; Schmitz, Werner; Jiang, Ming; Saunders, Becky; Howell, Michael; Downward, Julian; Felsher, Dean W.; Peck, Barrie; Schulze, Almut			The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma	ONCOGENE			English	Article							GLUTAMINE-METABOLISM; TUMOR SUPPRESSION; OXIDATIVE STRESS; C-MYC; CANCER; HYPOXIA; DEATH; PROLIFERATION; PROGRESSION; EXPRESSION	Metabolic reprogramming is a prominent feature of clear cell renal cell carcinoma (ccRCC). Here we investigated metabolic dependencies in a panel of ccRCC cell lines using nutrient depletion, functional RNAi screening and inhibitor treatment. We found that ccRCC cells are highly sensitive to the depletion of glutamine or cystine, two amino acids required for glutathione (GSH) synthesis. Moreover, silencing of enzymes of the GSH biosynthesis pathway or glutathione peroxidases, which depend on GSH for the removal of cellular hydroperoxides, selectively reduced viability of ccRCC cells but did not affect the growth of non-malignant renal epithelial cells. Inhibition of GSH synthesis triggered ferroptosis, an iron-dependent form of cell death associated with enhanced lipid peroxidation. VHL is a major tumour suppressor in ccRCC and loss of VHL leads to stabilisation of hypoxia inducible factors HIF-1 alpha and HIF-2 alpha. Restoration of functional VHL via exogenous expression of pVHL reverted ccRCC cells to an oxidative metabolism and rendered them insensitive to the induction of ferroptosis. VHL reconstituted cells also exhibited reduced lipid storage and higher expression of genes associated with oxidiative phosphorylation and fatty acid metabolism. Importantly, inhibition of beta-oxidation or mitochondrial ATP-synthesis restored ferroptosis sensitivity in VHL reconstituted cells. We also found that inhibition of GSH synthesis blocked tumour growth in a MYC-dependent mouse model of renal cancer. Together, our data suggest that reduced fatty acid metabolism due to inhibition of beta-oxidation renders renal cancer cells highly dependent on the GSH/GPX pathway to prevent lipid peroxidation and ferroptotic cell death.	[Miess, Heike; Peck, Barrie; Schulze, Almut] Canc Res UK London Res Inst, Gene Express Anal Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England; [Miess, Heike] Francis Crick Inst, Oncogene Biol Lab, 1 Midland Rd London, London NW1 1AT, England; [Dankworth, Beatrice; Schmitz, Werner; Schulze, Almut] Theodor Boveri Inst, Bioctr, D-97074 Wurzburg, Germany; [Gouw, Arvin M.; Felsher, Dean W.] Stanford Univ, Div Med Oncol, Sch Med, Stanford, CA 94305 USA; [Rosenfeldt, Mathias] Univ Hosp Wurzburg, Inst Pathol, D-97080 Wurzburg, Germany; [Jiang, Ming; Saunders, Becky; Howell, Michael] Francis Crick Inst, High Throughput Screening, 1 Midland Rd London, London NW1 1AT, England; [Downward, Julian; Peck, Barrie] Inst Canc Res, Div Canc Biol, 237 Fulham Rd, London SW7 3RP, England; [Schulze, Almut] Comprehens Canc Ctr Mainfranken, Josef Schneider Str 6, D-97080 Wurzburg, Germany	Cancer Research UK; Francis Crick Institute; University of Wurzburg; Stanford University; University of Wurzburg; Francis Crick Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Wurzburg	Schulze, A (corresponding author), Canc Res UK London Res Inst, Gene Express Anal Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.; Schulze, A (corresponding author), Theodor Boveri Inst, Bioctr, D-97074 Wurzburg, Germany.; Schulze, A (corresponding author), Comprehens Canc Ctr Mainfranken, Josef Schneider Str 6, D-97080 Wurzburg, Germany.	almut.schulze@uni-wuerzburg.de	Schulze, Almut/AAX-8257-2020; Rosenfeldt, Mathias/ABE-4736-2022	Schulze, Almut/0000-0002-8199-6422; Rosenfeldt, Mathias/0000-0001-7650-8458; Peck, Barrie/0000-0002-6687-8495; Howell, Michael/0000-0003-0912-0079; Downward, Julian/0000-0002-2331-4729; Gouw, Arvin/0000-0002-9552-635X	Cancer Research UK; German Research Foundation [FOR2314]; German Cancer Aid [111917]; NATIONAL CANCER INSTITUTE [T32CA196585] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); German Research Foundation(German Research Foundation (DFG)); German Cancer Aid(Deutsche Krebshilfe); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the LRI research services for technical support. We also thank Prof. William Kaelin (Dana Faber Cancer Institute, Boston) for providing isogenic renal cancer cell lines. This study was funded by Cancer Research UK, the German Research Foundation (FOR2314) and the German Cancer Aid (111917).	AVISSAR N, 1994, AM J PHYSIOL, V266, pC367, DOI 10.1152/ajpcell.1994.266.2.C367; Bensaad K, 2014, CELL REP, V9, P349, DOI 10.1016/j.celrep.2014.08.056; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bierl C, 2004, J BIOL CHEM, V279, P26839, DOI 10.1074/jbc.M401907200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brigelius-Flohe R, 2009, BBA-GEN SUBJECTS, V1790, P1555, DOI 10.1016/j.bbagen.2009.03.006; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Carroll PA, 2015, CANCER CELL, V27, P271, DOI 10.1016/j.ccell.2014.11.024; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Drabkin HA, 2012, CURR OPIN PHARMACOL, V12, P742, DOI 10.1016/j.coph.2012.08.002; Faronato M, 2007, HISTOL HISTOPATHOL, V22, P1109, DOI 10.14670/HH-22.1109; Gatto F, 2015, SCI REP-UK, V5, DOI 10.1038/srep10738; Gatto F, 2014, P NATL ACAD SCI USA, V111, pE866, DOI 10.1073/pnas.1319196111; GEBHARD RL, 1987, J LIPID RES, V28, P1177; Gerlinger M, 2012, J PATHOL, V227, P146, DOI 10.1002/path.4006; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Hakimi AA, 2016, CANCER CELL, V29, P104, DOI 10.1016/j.ccell.2015.12.004; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kwon MY, 2015, ONCOTARGET, V6, P24393, DOI 10.18632/oncotarget.5162; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Li LJ, 2007, MOL CELL BIOL, V27, P5381, DOI 10.1128/MCB.00282-07; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Perroud B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-64; Qiu B, 2015, CANCER DISCOV, V5, P652, DOI 10.1158/2159-8290.CD-14-1507; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Saito K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28932; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Shroff EH, 2015, P NATL ACAD SCI USA, V112, P6539, DOI 10.1073/pnas.1507228112; Singer EA, 2013, CURR OPIN ONCOL, V25, P273, DOI 10.1097/CCO.0b013e32835fc857; Sullivan LB, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-17; Tang SW, 2009, CANCER LETT, V273, P35, DOI 10.1016/j.canlet.2008.07.038; Tang XH, 2016, CANCER RES, V76, P1892, DOI 10.1158/0008-5472.CAN-15-2328; Warner GJ, 2000, J BIOL CHEM, V275, P28110; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Yang WS, 2016, P NATL ACAD SCI USA, V113, pE4966, DOI 10.1073/pnas.1603244113; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yusenko MV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-152	56	146	152	4	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 4	2018	37	40					5435	5450		10.1038/s41388-018-0315-z	http://dx.doi.org/10.1038/s41388-018-0315-z			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GV7MY	29872221	Green Accepted, Green Submitted			2022-12-26	WOS:000446312900005
J	Zheng, AJ; Shi, YJ; Shen, Z; Wang, G; Shi, JL; Xiong, QQ; Fang, LR; Xiao, SB; Fu, ZF; Peng, GQ				Zheng, Anjun; Shi, Yuejun; Shen, Zhou; Wang, Gang; Shi, Jiale; Xiong, Qiqi; Fang, Liurong; Xiao, Shaobo; Fu, Zhen F.; Peng, Guiqing			Insight into the evolution of nidovirus endoribonuclease based on the finding that nsp15 from porcine Deltacoronavirus functions as a dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						viral protein; endoribonuclease; protein purification; oligomerization; protein evolution; endoribonuclease; evolution; nidovirus; oligomerization; PDCoV nsp15	MOUSE HEPATITIS-VIRUS; REPLICATIVE ENDORIBONUCLEASE; CORONAVIRUS ENDORIBONUCLEASE; CRYSTAL-STRUCTURE; PROTEIN; XENDOU; INDUCTION; DISCOVERY; MURINE	Nidovirus endoribonucleases (NendoUs) include nonstructural protein 15 (nsp15) from coronaviruses and nsp11 from arteriviruses, both of which have been reported to participate in the viral replication process and in the evasion of the host immune system. Results from a previous study of coronaviruses SARS-CoV, HCoV-229E, and MHV nsp15 indicate that it mainly forms a functional hexamer, whereas nsp11 from the arterivirus PRRSV is a dimer. Here, we found that porcine Deltacoronavirus (PDCoV) nsp15 primarily exists as dimers and monomers in vitro. Biological experiments reveal that a PDCoV nsp15 mutant lacking the first 27 amino acids of the N-terminal domain (Asn-1-Asn-27) forms more monomers and displays decreased enzymatic activity, indicating that this region is important for its dimerization. Moreover, multiple sequence alignments and three-dimensional structural analysis indicated that the C-terminal region (His-251-Val-261) of PDCoV nsp15 is 10 amino acids shorter and forms a shorter loop than that formed by the equivalent sequence (Gln-259-Phe-279) of SARS-CoV nsp15. This result may explain why PDCoV nsp15 failed to form hexamers. We speculate that NendoUs may have originated from XendoU endoribonucleases (XendoUs) forming monomers in eukaryotic cells, that NendoU from arterivirus gained the ability to form dimers, and that the coronavirus variants then evolved the capacity to assemble into hexamers. We further propose that PDCoV nsp15 may be an intermediate in this evolutionary process. Our findings provide a theoretical basis for improving our understanding of NendoU evolution and offer useful clues for designing drugs and vaccines against nidoviruses.	[Zheng, Anjun; Shi, Yuejun; Shen, Zhou; Wang, Gang; Shi, Jiale; Fang, Liurong; Xiao, Shaobo; Peng, Guiqing] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, 1 Shi Zi Shan St, Wuhan 430070, Hubei, Peoples R China; [Zheng, Anjun; Shi, Yuejun; Shen, Zhou; Wang, Gang; Shi, Jiale; Fang, Liurong; Xiao, Shaobo; Peng, Guiqing] Huazhong Agr Univ, Key Lab Prevent Vet Med Hubei Prov, Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan 430070, Hubei, Peoples R China; [Shi, Yuejun; Xiong, Qiqi] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Hubei, Peoples R China; [Fu, Zhen F.] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; University System of Georgia; University of Georgia	Peng, GQ (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, 1 Shi Zi Shan St, Wuhan 430070, Hubei, Peoples R China.	penggq@mail.hzau.edu.cn		Xiao, Shaobo/0000-0003-0023-9188; Shen, Zhou/0000-0001-8772-2978	National Key RD Plan of China [2018YFD0500100]; National Natural Science Foundation of China [31702249, 31722056]; China Postdoctoral Science Foundation [2017M612484]; Natural Science Foundation of Hubei Province of China [2016CFA069]	National Key RD Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province)	This work was supported by National Key R&D Plan of China Grant 2018YFD0500100, National Natural Science Foundation of China Grants 31702249 and 31722056, China Postdoctoral Science Foundation Grant 2017M612484, and Natural Science Foundation of Hubei Province of China Grant 2016CFA069. The authors declare that they have no conflicts of interest with the contents of this article.	Balasuriya UBR, 2017, CURR OPIN VIROL, V27, P57, DOI 10.1016/j.coviro.2017.11.005; Bergendahl LT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05084-8; Bhardwaj K, 2004, J VIROL, V78, P12218, DOI 10.1128/JVI.78.22.12218-12224.2004; Bhardwaj K, 2006, J MOL BIOL, V361, P243, DOI 10.1016/j.jmb.2006.06.021; BRIERLEY I, 1987, EMBO J, V6, P3779, DOI 10.1002/j.1460-2075.1987.tb02713.x; Cao JZ, 2012, VIRUS RES, V167, P247, DOI 10.1016/j.virusres.2012.05.006; Cao JZ, 2008, INTERVIROLOGY, V51, P342, DOI 10.1159/000175837; Chen QG, 2012, VIRUS RES, V163, P650, DOI 10.1016/j.virusres.2011.11.008; Cong Y., 2017, VIRUSES, V9, pE182; Deng XF, 2018, VIROLOGY, V517, P157, DOI 10.1016/j.virol.2017.12.024; Deng XF, 2017, P NATL ACAD SCI USA, V114, pE4251, DOI 10.1073/pnas.1618310114; Di H, 2018, VIROLOGY, V517, P38, DOI 10.1016/j.virol.2018.01.026; Gioia U, 2005, J BIOL CHEM, V280, P18996, DOI 10.1074/jbc.M501160200; Gosert R, 2002, J VIROL, V76, P3697, DOI 10.1128/JVI.76.8.3697-3708.2002; Guarino LA, 2005, J MOL BIOL, V353, P1106, DOI 10.1016/j.jmb.2005.09.007; Guo ZH, 2018, VIROL J, V15, DOI 10.1186/s12985-017-0910-6; Huo T, 2015, ACTA CRYSTALLOGR F, V71, P1156, DOI 10.1107/S2053230X15007359; Ivanov KA, 2004, P NATL ACAD SCI USA, V101, P12694, DOI 10.1073/pnas.0403127101; Joseph JS, 2007, J VIROL, V81, P6700, DOI 10.1128/JVI.02817-06; Kang H, 2007, J VIROL, V81, P13587, DOI 10.1128/JVI.00547-07; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; Laneve P, 2003, J BIOL CHEM, V278, P13026, DOI 10.1074/jbc.M211937200; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lauber C, 2012, ARCH VIROL, V157, P1623, DOI 10.1007/s00705-012-1295-x; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lorsirigool A, 2016, ARCH VIROL, V161, P2909, DOI 10.1007/s00705-016-2983-8; Ma YM, 2015, MBIO, V6, DOI 10.1128/mBio.00064-15; McCluskey BJ, 2016, PREV VET MED, V123, P185, DOI 10.1016/j.prevetmed.2015.10.018; Nedialkova DD, 2009, J VIROL, V83, P5671, DOI 10.1128/JVI.00261-09; Orr HA, 2009, NAT REV GENET, V10, P531, DOI 10.1038/nrg2603; Nga PT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002215; Posthuma CC, 2006, J VIROL, V80, P1653, DOI 10.1128/JVI.80.4.1653-1661.2006; Renzi F, 2006, P NATL ACAD SCI USA, V103, P12365, DOI 10.1073/pnas.0602426103; Ricagno S, 2006, P NATL ACAD SCI USA, V103, P11892, DOI 10.1073/pnas.0601708103; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shi XB, 2011, MOL IMMUNOL, V48, P1568, DOI 10.1016/j.molimm.2011.03.004; Shi YJ, 2016, J VIROL, V90, P4579, DOI 10.1128/JVI.03065-15; Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0; Vasilakis N, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-97; Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11; Xu XL, 2006, J VIROL, V80, P7909, DOI 10.1128/JVI.00525-06; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	42	9	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12054	12067		10.1074/jbc.RA118.003756	http://dx.doi.org/10.1074/jbc.RA118.003756			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29887523	Green Published, hybrid			2022-12-26	WOS:000440803200007
J	Ball, WB; Baker, CD; Neff, JK; Apfel, GL; Lagerborg, KA; Zun, G; Petrovic, U; Jain, M; Gohil, VM				Ball, Writoban Basu; Baker, Charli D.; Neff, John K.; Apfel, Gabriel L.; Lagerborg, Kim A.; Zun, Gasper; Petrovic, Uros; Jain, Mohit; Gohil, Vishal M.			Ethanolamine ameliorates mitochondrial dysfunction in cardiolipin-deficient yeast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; cardiolipin; mitochondrial respiratory chain complex; cytochrome c oxidase (Complex IV); phospholipid; Barth syndrome; ethanolamine; respiratory supercomplexes	RESPIRATORY-CHAIN SUPERCOMPLEXES; MEMBRANE-PROTEIN COMPLEXES; SACCHAROMYCES-CEREVISIAE; BARTH-SYNDROME; OXIDATIVE-PHOSPHORYLATION; MAMMALIAN MITOCHONDRIA; PHOSPHATIDYLETHANOLAMINE; STABILITY; METABOLISM; TRANSPORT	Cardiolipin (CL) is a signature phospholipid of the mitochondria required for the formation of mitochondrial respiratory chain (MRC) supercomplexes. The destabilization of MRC supercomplexes is the proximal cause of the pathology associated with the depletion of CL in patients with Barth syndrome. Thus, promoting supercomplex formation could ameliorate mitochondrial dysfunction associated with CL depletion. However, to date, physiologically relevant small-molecule regulators of supercomplex formation have not been identified. Here, we report that ethanolamine (Etn) supplementation rescues the MRC defects by promoting supercomplex assembly in a yeast model of Barth syndrome. We discovered this novel role of Etn while testing the hypothesis that elevating mitochondrial phosphatidylethanolamine (PE), a phospholipid suggested to overlap in function with CL, could compensate for CL deficiency. We found that the Etn supplementation rescues the respiratory growth of CL-deficient Saccharomyces cerevisiae cells in a dose-dependent manner but independently of its incorporation into PE. The rescue was specifically dependent on Etn but not choline or serine, the other phospholipid precursors. Etn improved mitochondrial function by restoring the expression of MRC proteins and promoting supercomplex assembly in CL-deficient cells. Consistent with this mechanism, overexpression of Cox4, the MRC complex IV subunit, was sufficient to promote supercomplex formation in CL-deficient cells. Taken together, our work identifies a novel role of a ubiquitous metabolite, Etn, in attenuating mitochondrial dysfunction caused by CL deficiency.	[Ball, Writoban Basu; Baker, Charli D.; Neff, John K.; Apfel, Gabriel L.; Gohil, Vishal M.] Texas A&M Univ, Dept Biochem & Biophys, 301 Old Main Dr,ILSB 2146A, College Stn, TX 77843 USA; [Lagerborg, Kim A.; Jain, Mohit] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lagerborg, Kim A.; Jain, Mohit] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Zun, Gasper; Petrovic, Uros] Jozef Stefan Inst, Dept Mol & Biomed Sci, Jamova 39, Ljubljana, Slovenia; [Zun, Gasper] Univ Ljubljana, Fac Chem & Chem Technol, Vecna Pot 113, Ljubljana 1000, Slovenia; [Petrovic, Uros] Univ Ljubljana, Biotech Fac, Dept Biol, Vecna Pot 111, Ljubljana 1000, Slovenia	Texas A&M University System; Texas A&M University College Station; University of California System; University of California San Diego; University of California System; University of California San Diego; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; University of Ljubljana	Gohil, VM (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, 301 Old Main Dr,ILSB 2146A, College Stn, TX 77843 USA.	vgohil@tamu.edu		Petrovic, Uros/0000-0002-9743-9145; Neff, John/0000-0003-2473-6306; Basu Ball, Writoban/0000-0001-7678-126X; Gohil, Vishal/0000-0002-9920-2563	Welch Foundation [A-1810]; American Heart Association Award [16GRNT31020028]; National Institutes of Health [R01GM111672, 1R01ES027595, 1R03HL133720, 1S10OD020025]; University of California, San Diego, Frontiers of Innovation Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL133720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES027595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111672] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020025] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); American Heart Association Award(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego, Frontiers of Innovation Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by Welch Foundation Grant A-1810, American Heart Association Award 16GRNT31020028, National Institutes of Health Grants R01GM111672 (to V.M.G.) and 1R01ES027595, 1R03HL133720, and 1S10OD020025 (to M.J.), and the University of California, San Diego, Frontiers of Innovation Scholars Program (to K.A.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009; Amberg DC., 2005, METHODS YEAST GENETI; Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733; Baker CD, 2016, MOL BIOL CELL, V27, P2161, DOI 10.1091/mbc.E15-12-0865; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bazan S, 2013, J BIOL CHEM, V288, P401, DOI 10.1074/jbc.M112.425876; Becker T, 2013, J BIOL CHEM, V288, P16451, DOI 10.1074/jbc.M112.442392; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Bottinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Chaban Y, 2014, BBA-BIOENERGETICS, V1837, P418, DOI 10.1016/j.bbabio.2013.10.004; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; Cui TZ, 2014, J BIOL CHEM, V289, P6133, DOI 10.1074/jbc.M113.523688; Fernandez-Murray JP, 2013, J BIOL CHEM, V288, P36106, DOI 10.1074/jbc.M113.499855; FOLCH J, 1957, J BIOL CHEM, V226, P497; Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002; Gohil VM, 2013, J BIOL CHEM, V288, P35387, DOI 10.1074/jbc.M113.489237; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Gohil VM, 2009, J CELL BIOL, V184, P468, DOI 10.1083/jcb.200901127; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gu JK, 2016, NATURE, V537, P639, DOI 10.1038/nature19359; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Hsu P, 2015, AUTOPHAGY, V11, P643, DOI 10.1080/15548627.2015.1023984; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Kim KS, 1999, J BIOL CHEM, V274, P14857, DOI 10.1074/jbc.274.21.14857; Kishi S, 2015, EBIOMEDICINE, V2, P1090, DOI 10.1016/j.ebiom.2015.07.035; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Merkel O, 2005, BBA-MOL CELL BIOL L, V1734, P215, DOI 10.1016/j.bbalip.2005.03.004; Modica-Napolitano JS, 2004, BIOL PSYCHIAT, V55, P273, DOI 10.1016/S0006-3223(03)00784-4; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Ostrander DB, 2001, J BIOL CHEM, V276, P25262, DOI 10.1074/jbc.M103689200; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Raja V, 2014, CHEM PHYS LIPIDS, V179, P49, DOI 10.1016/j.chemphyslip.2013.12.009; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; RIETVELD AG, 1993, J BIOL CHEM, V268, P12427; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Schuler MH, 2016, J BIOL CHEM, V291, P18718, DOI 10.1074/jbc.M116.722694; Storey MK, 2001, J BIOL CHEM, V276, P48539, DOI 10.1074/jbc.M109043200; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Su XF, 2006, MOL CELL BIOL, V26, P743, DOI 10.1128/MCB.26.3.743-753.2006; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Ye CQ, 2014, J BIOL CHEM, V289, P3114, DOI 10.1074/jbc.M113.529487; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200	68	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10870	10883		10.1074/jbc.RA118.004014	http://dx.doi.org/10.1074/jbc.RA118.004014			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29866881	hybrid, Green Published			2022-12-26	WOS:000438882800003
J	Mohammed, H; Clarke, M; Koehler, A; Watson, M; Marshall, H				Mohammed, Hassen; Clarke, Michelle; Koehler, Ann; Watson, Maureen; Marshall, Helen			Factors associated with uptake of influenza and pertussis vaccines among pregnant women in South Australia	PLOS ONE			English	Article							CROSS-SECTIONAL SURVEY; MATERNAL IMMUNIZATION; ACELLULAR PERTUSSIS; VACCINATION; INFANTS; DIPHTHERIA; ATTITUDES; TETANUS; SAFETY; CARE	Background Maternal immunization is an effective strategy to protect pregnant women and their infants from vaccine-preventable diseases. Despite the recommendation of maternal influenza and more recently pertussis immunization in Australia, uptake of these vaccines has been sub-optimal. A midwife delivered immunization program for pregnant women at the Women's and Children's Hospital in South Australia commenced in April 2015. Monitoring the uptake of the current funded vaccine programs for pregnant women is limited. The study aimed to estimate maternal vaccine uptake and assess factors associated with influenza and pertussis vaccine uptake among pregnant women. Methods This prospective study was undertaken between November 2014 and July 2016 at the Women's and Children's Hospital. Following consent, demographic details and vaccination history for South Australian pregnant women who attended the antenatal clinic were collected. A standardised self-reported survey was completed during pregnancy with a follow up telephone interview at 8-10 weeks post-delivery. Results 205 women consented and completed the self-reported survey. Of the 180 pregnant women who completed the study, 76% and 81% received maternal influenza and pertussis vaccines respectively. The adjusted odds of women receiving maternal vaccines during pregnancy were significantly higher for women delivering after the implementation of the midwife delivered program compared with women who delivered babies prior to the program for both pertussis vaccination (AOR 21.17, 95% CI 6.14-72.95; p<0.001) and influenza vaccination (AOR 5.95, 95% CI 2.13-16.61, p<0.001). Women receiving a recommendation from a health care provider and first time mothers were significantly more likely to receive influenza vaccination during pregnancy. Conclusions High uptake of influenza and pertussis vaccines during pregnancy can be attained with health care provider recommendation and inclusion of maternal immunization as part of standard antenatal care. A midwife delivered maternal immunization program is a promising approach to improve maternal vaccine uptake by pregnant women.	[Mohammed, Hassen; Clarke, Michelle; Marshall, Helen] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Mohammed, Hassen; Clarke, Michelle; Marshall, Helen] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia; [Mohammed, Hassen; Clarke, Michelle; Marshall, Helen] Womens & Childrens Hosp, VIRTU, Adelaide, SA, Australia; [Koehler, Ann; Watson, Maureen] CDCB, Adelaide, SA, Australia; [Marshall, Helen] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide; University of Adelaide; University of Adelaide	Mohammed, H (corresponding author), Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia.; Mohammed, H (corresponding author), Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia.; Mohammed, H (corresponding author), Womens & Childrens Hosp, VIRTU, Adelaide, SA, Australia.	hassen.mohammed@adelaide.edu.au	Mohammed, Hassen/HGB-3057-2022; Mohammed, Hassen/K-1421-2019	Mohammed, Hassen/0000-0003-0189-3739; Marshall, Helen/0000-0003-2521-5166; Clarke, Michelle/0000-0001-9635-8784	Communicable Disease Control Branch (CDCB)-SA Health, Government of South Australia	Communicable Disease Control Branch (CDCB)-SA Health, Government of South Australia	This research has been funded by the Communicable Disease Control Branch (CDCB)-SA Health, Government of South Australia.	Amirthalingam G, 2016, HUM VACC IMMUNOTHER, V12, P2934, DOI 10.1080/21645515.2016.1210730; Amirthalingam G, 2014, LANCET, V384, P1521, DOI 10.1016/S0140-6736(14)60686-3; Australian Bureau of Statistics, 33010 AUSTR BUR STAT; Australian Government Department of Health, 2015, AUSTR IMM HDB; Australian Institute of Health and Welfare, 2011, 2009 AD VACC SURV; Beard FH, 2015, COMMUN DIS INTELL, V39, pE329; Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309; Blanchard-Rohner G, 2011, VACCINE, V29, P7542, DOI 10.1016/j.vaccine.2011.08.013; Bodeker B, 2014, VACCINE, V32, P4131, DOI 10.1016/j.vaccine.2014.06.007; Butler AM, 2017, OBSTET GYNECOL, V129, P629, DOI 10.1097/AOG.0000000000001927; Collins J, 2014, HUM VACC IMMUNOTHER, V10, P2922, DOI 10.4161/21645515.2014.971606; CONDON JT, 1990, BRIT J MED PSYCHOL, V63, P369, DOI 10.1111/j.2044-8341.1990.tb01632.x; Hayles EH, 2016, AUST NZ J OBSTET GYN, V56, P185, DOI 10.1111/ajo.12429; Hildingsson I, 2002, ACTA OBSTET GYN SCAN, V81, P118, DOI 10.1034/j.1600-0412.2002.810206.x; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Koepke R, 2015, MMWR-MORBID MORTAL W, V64, P746; Lu AB, 2012, VACCINE, V30, P4055, DOI 10.1016/j.vaccine.2012.04.012; MacDougall DM, 2016, HUM VACC IMMUNOTHER, V12, P879, DOI 10.1080/21645515.2015.1130193; Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480; Maertens K, 2014, VACCINE, V32, P1786, DOI 10.1016/j.vaccine.2014.01.083; McCarthy EA, 2012, AUST NZ J OBSTET GYN, V52; MCCARTHY EA, 2015, BMC PREGNANCY CHILDB, V15, P1; McMillan M, 2015, VACCINE, V33, P2108, DOI 10.1016/j.vaccine.2015.02.068; McMillan M, 2017, OBSTET GYNECOL, V129, P560, DOI 10.1097/AOG.0000000000001888; McNeil SA, 2011, AM J OBSTET GYNECOL, V204, pS54, DOI 10.1016/j.ajog.2011.04.031; Munoz Flor M, 2006, Semin Pediatr Infect Dis, V17, P14, DOI 10.1053/j.spid.2005.11.005; O'Grady KAF, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005676; Quinn HE, 2007, COMMUN DIS INTELL, V31, P205; Rasmussen SA, 2012, AM J OBSTET GYNECOL, V207, pS3, DOI 10.1016/j.ajog.2012.06.068; REUMAN PD, 1987, PEDIATR INFECT DIS J, V6, P398, DOI 10.1097/00006454-198704000-00011; Robbins SCC, 2011, VACCINE, V29, P5591, DOI 10.1016/j.vaccine.2011.05.049; SA Health, UND VACC MIDW VACC R; Scheil W, 2013, PREGNANCY OUTCOME S; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Soltani H, 2005, BR J MIDWIFERY, V13, P633, DOI [DOI 10.12968/BJOM.2005.13.10.19838, DOI 10.12968/bjom.2005.13.10.19838]; Sukumaran L, 2015, OBSTET GYNECOL, V126, P1069, DOI 10.1097/AOG.0000000000001066; Szekeres-Bartho Julia, 2002, Int Rev Immunol, V21, P471, DOI 10.1080/08830180215017; Taksdal SE, 2013, AUST FAM PHYSICIAN, V42, P582; van Bakel HJA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-138; van Lier A, 2012, VACCINE, V30, P2892, DOI 10.1016/j.vaccine.2012.02.030; Vizzotti C, 2015, VACCINE, V33, P6413, DOI 10.1016/j.vaccine.2015.07.109; Webb H, 2014, HUM VACC IMMUNOTHER, V10, P1114, DOI 10.4161/hv.27893; Wiley KE, 2015, QUAL HEALTH RES, V25, P360, DOI 10.1177/1049732314551061; Wiley KE, 2013, MED J AUSTRALIA, V198, P373, DOI 10.5694/mja12.11849; Wilson RJ, 2015, VACCINE, V33, P6420, DOI 10.1016/j.vaccine.2015.08.046; Wong CY, 2015, HUM VACC IMMUNOTHER, V11, P1165, DOI 10.1080/21645515.2015.1019188; Yudin MH, 2014, INT J WOMENS HEALTH, V6, P681, DOI 10.2147/IJWH.S47235; Yuen CYS, 2014, VACCINE, V32, P4602, DOI 10.1016/j.vaccine.2014.06.067; Zafar Ahmed A, 2003, ScientificWorldJournal, V3, P1081	50	45	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0197867	10.1371/journal.pone.0197867	http://dx.doi.org/10.1371/journal.pone.0197867			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902184	Green Published, Green Submitted, gold			2022-12-26	WOS:000435424900008
J	Tan, DW; Maybery, MT; Clarke, MW; Di Lorenzo, R; Evans, MO; Mancinone, M; Pantos, C; Whitehouse, AJO				Tan, Diana Weiting; Maybery, Murray T.; Clarke, Michael W.; Di Lorenzo, Renata; Evans, Melissa O.; Mancinone, Michael; Pantos, Christina; Whitehouse, Andrew J. O.			No relationship between autistic traits and salivary testosterone concentrations in men from the general population	PLOS ONE			English	Article							TYPICALLY DEVELOPING-CHILDREN; SPECTRUM QUOTIENT; VALIDITY; FEATURES; EXPOSURE	It is suggested that testosterone may play a part in the higher prevalence of Autism Spectrum Disorder (ASD) in males compared to females. Previous studies have reported elevated postnatal testosterone levels in children and women with ASD but not in men. We compared levels of salivary testosterone across 67 undergraduate males (M-age 19.5 yrs, SD 1.92) selected for low, mid-range and high levels of autistic traits assessed using the Autism-spectrum Quotient. Analyses revealed no significant differences in testosterone concentrations across the three groups. The current data add to the increasing evidence for the lack of relationship between autistic traits and postnatal levels of testosterone in men.	[Tan, Diana Weiting; Maybery, Murray T.; Di Lorenzo, Renata; Evans, Melissa O.; Mancinone, Michael; Pantos, Christina] Univ Western Australia, Sch Psychol Sci, Neurocognit Dev Unit, Perth, WA, Australia; [Tan, Diana Weiting; Whitehouse, Andrew J. O.] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Clarke, Michael W.] Univ Western Australia, Biol & Mol Mass Spectrometry Facil, Ctr Microscopy Characterisat & Anal, Perth, WA, Australia; [Di Lorenzo, Renata] Univ Utrecht, Helmholtz Inst, Dept Expt Psychol, Utrecht, Netherlands; [Di Lorenzo, Renata] Univ Utrecht, Dept Dev Psychol, Utrecht, Netherlands	University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia; Utrecht University; Utrecht University	Tan, DW (corresponding author), Univ Western Australia, Sch Psychol Sci, Neurocognit Dev Unit, Perth, WA, Australia.; Tan, DW (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia.	diana.tan@uwa.edu.au	Whitehouse, Andrew J.O./AGJ-2519-2022; Tan, Diana/I-3523-2019; Clarke, Michael W/H-8997-2014	Whitehouse, Andrew J.O./0000-0001-8722-1575; Tan, Diana/0000-0002-6394-8435; Clarke, Michael W/0000-0002-9639-5670; Maybery, Murray/0000-0002-3760-1382	International Postgraduate Research Scholarship in Australia; Western Australian State Government; Australian Federal Government, through the National Collaborative Research Infrastructure Strategy; National Health and Medical Research Council [APP1077966]; Australian Research Council Discovery Project [DP120104713]	International Postgraduate Research Scholarship in Australia; Western Australian State Government; Australian Federal Government, through the National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Discovery Project(Australian Research Council)	Diana Tan was supported by an International Postgraduate Research Scholarship in Australia (https//www.education.gov.au/research-training-program). Analysis for this work was performed by the Centre for Microscopy, Characterisation and Analysis (Metabolomics Australia) and was supported by infrastructure funding from the Western Australian State Government in partnership with the Australian Federal Government, through the National Collaborative Research Infrastructure Strategy (https://www.education.gov.au/national-collaborative-research-infrastructure-strategy-ncris). Andrew Whitehouse was supported by a Senior Research Fellowship from the National Health and Medical Research Council (APP1077966; https://www.nhmrc.gov.au/grants-funding/apply-funding/research-fellowships). Data collection was partly supported by an Australian Research Council Discovery Project grant (DP120104713) to Murray Maybery and Andrew Whitehouse (http://www.arc.gov.au/discovery-projects). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auyeung B, 2012, MOL AUTISM, V3, P1, DOI [10.1186/2040-2392-3-1, DOI 10.1186/2040-2392-3-1]; Auyeung B, 2013, PFLUG ARCH EUR J PHY, V465, P557, DOI 10.1007/s00424-013-1268-2; Auyeung B, 2009, BRIT J PSYCHOL, V100, P1, DOI 10.1348/000712608X311731; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2015, MOL PSYCHIATR, V20, P369, DOI 10.1038/mp.2014.48; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S, 2005, SCIENCE, P310; Bejerot S, 2012, BRIT J PSYCHIAT, V201, P116, DOI 10.1192/bjp.bp.111.097899; Constantinescu M, 2012, CHILD DEV PERSPECT, V6, P407, DOI 10.1111/j.1750-8606.2012.00257.x; Cribb SJ, 2016, J AUTISM DEV DISORD, V46, P2924, DOI 10.1007/s10803-016-2832-3; El-Baz Farida, 2014, Int J Adolesc Med Health, V26, P79, DOI 10.1515/ijamh-2012-0116; Flyckt RL, 2009, MENOPAUSE, V16, P680, DOI 10.1097/gme.0b013e318199d5c4; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Gilani SZ, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9109-6; Granger DA, 2004, PSYCHONEUROENDOCRINO, V29, P1229, DOI 10.1016/j.psyneuen.2004.02.005; Gray E, 2014, FAMILY FORMATION 21, P123, DOI [10.1007/978-94-017-9279-0_7, DOI 10.1007/978-94-017-9279-0_7]; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Kung KTF, 2016, J CHILD PSYCHOL PSYC, V57, P1455, DOI 10.1111/jcpp.12602; Majewska MD, 2014, EUR CHILD ADOLES PSY, V23, P485, DOI 10.1007/s00787-013-0472-0; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Phoenix C, 1959, ENDOCRINOLOGY, V65; Pohl A, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-27; Posserud MB, 2006, J CHILD PSYCHOL PSYC, V47, P167, DOI 10.1111/j.1469-7610.2005.01462.x; Ruta L, 2011, PSYCHONEUROENDOCRINO, V36, P1154, DOI 10.1016/j.psyneuen.2011.02.007; Ruzich E, 2015, MOL AUTISM, V6, DOI [10.1186/s13229-015-0038-8, 10.1186/2040-2392-6-2]; Schmidtova E, 2010, ENDOCRINOLOGIST, V20, P245, DOI 10.1097/TEN.0b013e3181f661d2; Schwarz E, 2011, MOL PSYCHIATR, V16, P1213, DOI 10.1038/mp.2010.102; Shirtcliff EA, 2002, HORM BEHAV, V42, P62, DOI 10.1006/hbeh.2002.1798; Takagishi H, 2010, NEUROENDOCRINOL LETT, V31, P837; Tan DW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131780; van Anders SM, 2014, ARCH SEX BEHAV, V43, P231, DOI 10.1007/s10508-013-0123-z; Whitehouse AJO, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-25; Whitehouse AJO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023029	33	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198779	10.1371/journal.pone.0198779	http://dx.doi.org/10.1371/journal.pone.0198779			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ5MF	29902186	Green Published, Green Submitted, gold			2022-12-26	WOS:000435424900041
J	Paape, D; Hemforth, B; Vasishth, S				Paape, Dario; Hemforth, Barbara; Vasishth, Shravan			Processing of ellipsis with garden-path antecedents in French and German: Evidence from eye tracking	PLOS ONE			English	Article							LINGERING MISINTERPRETATIONS; SENTENCES; COMPREHENSION; MEMORY; AMBIGUITIES; ACTIVATION; DISCOURSE	In a self-paced reading study on German sluicing, Paape (Paape, 2016) found that reading times were shorter at the ellipsis site when the antecedent was a temporarily ambiguous garden-path structure. As a post-hoc explanation of this finding, Paape assumed that the antecedent's memory representation was reactivated during syntactic reanalysis, making it easier to retrieve. In two eye tracking experiments, we subjected the reactivation hypothesis to further empirical scrutiny. Experiment 1, carried out in French, showed no evidence in favor in the reactivation hypothesis. Instead, results for one out of the three types of garden path sentences that were tested suggest that subjects sometimes failed to resolve the temporary ambiguity in the antecedent clause, and subsequently failed to resolve the ellipsis. The results of Experiment 2, a conceptual replication of Paape's (Paape, 2016) original study carried out in German, are compatible with the reactivation hypothesis, but leave open the possibility that the observed speedup for ambiguous antecedents may be due to occasional retrievals of an incorrect structure.	[Paape, Dario; Vasishth, Shravan] Univ Potsdam, Dept Linguist, Potsdam, Germany; [Hemforth, Barbara] Univ Paris Diderot, Lab Linguist Formelle, Paris, France	University of Potsdam; UDICE-French Research Universities; Universite Paris Cite	Paape, D (corresponding author), Univ Potsdam, Dept Linguist, Potsdam, Germany.	paape@uni-potsdam.de		Paape, Dario/0000-0002-7148-5258	French National Research Agency (ANR) as part of the progam 'Investissements d'Avenir' [ANR-10-LABX-0083]; University of Potsdam; Deutsche Forschungsgemeinschaft (Collaborative Research Centre) at the University of Potsdam, Germany [Sonderforschungsbereich 1287]; Volkswagen Foundation [89 953]	French National Research Agency (ANR) as part of the progam 'Investissements d'Avenir'(French National Research Agency (ANR)); University of Potsdam; Deutsche Forschungsgemeinschaft (Collaborative Research Centre) at the University of Potsdam, Germany; Volkswagen Foundation(Volkswagen)	This work is partially supported by a public grant overseen by the French National Research Agency (ANR) as part of the progam 'Investissements d'Avenir' (Reference: ANR-10-LABX-0083). Experiment 2 was funded by the University of Potsdam. We thank the Deutsche Forschungsgemeinschaft for funding from the Sonderforschungsbereich (Collaborative Research Centre) 1287 at the University of Potsdam, Germany, which partly funded the first author. For partial support, we also thank the Volkswagen Foundation through grant 89 953 to Shravan Vasishth.	Ambridge B, 2008, COGN LINGUIST, V19, P357, DOI 10.1515/COGL.2008.014; Arregui A, 2006, J MEM LANG, V55, P232, DOI 10.1016/j.jml.2006.02.005; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bever T. G., 1970, COGNITION DEV LANGUA, P279, DOI 10.1093/acprof:oso/9780199677139.003.0001; Bick E., 2005, 10 MODE UDFORSKNINGE, P46; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Caplan D, 1999, BEHAV BRAIN SCI, V22, P77; CHARVILLAT A, 1991, J CHILD LANG, V18, P591, DOI 10.1017/S0305000900011260; Christianson K, 2001, COGNITIVE PSYCHOL, V42, P368, DOI 10.1006/cogp.2001.0752; Chung Sandra, 1995, NAT LANG SEMANT, V3, P239, DOI DOI 10.1007/BF01248819; De Vincenzi M., 1991, SYNTACTIC PARSING ST; Deprez V., 1988, P 5 E STAT C LING CO, P71; Drummond A, IBEX FARM; FERREIRA F, 1986, J MEM LANG, V25, P348, DOI 10.1016/0749-596X(86)90006-9; Frazier L, 2000, J PSYCHOLINGUIST RES, V29, P125, DOI 10.1023/A:1005136826534; Frazier L, 2001, SYNTAX-UK, V4, P1, DOI [DOI 10.1111/1467-9612.00034, 10.1111/1467-9612.00034]; Frenck-Mestre C., 2002, BILINGUAL SENTENCE P, P217, DOI [10.1016/S0166-4115(02)80012-7, DOI 10.1016/S0166-4115(02)80012-7]; Gabry J., 2016, RSTANARM BAYESIAN AP; Gorrell P, 1996, J PSYCHOLINGUIST RES, V25, P135, DOI 10.1007/BF01708423; Hardt D., 1993, THESIS; Hemforth Barbara, 1993, KOGNITIVES PARSING R; Jaeger TF, 2013, COGNITION, V127, P57, DOI 10.1016/j.cognition.2012.10.013; JUST MA, 1982, J EXP PSYCHOL GEN, V111, P228, DOI 10.1037/0096-3445.111.2.228; Karimi H, 2016, Q J EXP PSYCHOL, V69, P1013, DOI 10.1080/17470218.2015.1053951; KAYNE R, 1978, LINGUIST INQ, V9, P595; Kim CS, 2011, SYNTAX-UK, V14, P318, DOI 10.1111/j.1467-9612.2011.00160.x; Koornneef AW, 2006, J MEM LANG, V54, P445, DOI 10.1016/j.jml.2005.12.003; Lahousse K., 2003, THESIS; Lassotta R, 2015, Q J EXPT PSYCHOL, P1; Lewandowski D, 2009, J MULTIVARIATE ANAL, V100, P1989, DOI 10.1016/j.jmva.2009.04.008; Lewis RL, 2005, COGNITIVE SCI, V29, P375, DOI 10.1207/s15516709cog0000_25; Logacev P, 2013, EM2 COMPUTE EYE FIXA; Martin AE, 2008, J MEM LANG, V58, P879, DOI 10.1016/j.jml.2007.06.010; Martin AE, 2009, J EXP PSYCHOL LEARN, V35, P1231, DOI 10.1037/a0016271; Meng M, 2000, LANG SPEECH, V43, P43, DOI 10.1177/00238309000430010201; Merchant J, 2013, LINGUIST INQ, V44, P77, DOI 10.1162/LING_a_00120; MURPHY GL, 1985, J MEM LANG, V24, P290, DOI 10.1016/0749-596X(85)90029-4; Nicenboim B, 2016, LANG LINGUIST COMPAS, V10, P591, DOI 10.1111/lnc3.12207; Nicenboim B, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00280; Paape DLJF, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00027; Patson ND, 2009, J EXP PSYCHOL LEARN, V35, P280, DOI 10.1037/a0014276; Phillips C, 2014, LINGUA, V151, P78, DOI 10.1016/j.lingua.2013.10.003; Ross John Robert, 1969, CHICAGO LINGUISTIC S, V5, P252, DOI DOI 10.1093/ACPROF:OSO/9780199645763.003.0002; Schlesewsky M., 2000, GERMAN SENTENCE PROC, P65, DOI DOI 10.1007/978-94-015-9618-3_3; Slattery TJ, 2013, J MEM LANG, V69, P104, DOI 10.1016/j.jml.2013.04.001; SPIVEYKNOWLTON MJ, 1993, CAN J EXP PSYCHOL, V47, P276, DOI 10.1037/h0078826; Stan Development Team, 2016, STAN VERS 2 15 0; Swets B, 2008, MEM COGNITION, V36, P201, DOI 10.3758/MC.36.1.201; Townsend D.J., 2001, SENTENCE COMPREHENSI; van Gompel RPG, 2006, J MEM LANG, V55, P335, DOI 10.1016/j.jml.2006.06.004; Vasishth S, 2018, PREPRINT; von der Malsburg T, 2017, J MEM LANG, V94, P119, DOI 10.1016/j.jml.2016.10.003; Walsh C., 2007, HIERPART PACKAGE VER; WILLIAMS ES, 1977, LINGUIST INQ, V8, P101; Witzel N, 2012, J PSYCHOLINGUIST RES, V41, P105, DOI 10.1007/s10936-011-9179-x; Zagar D, 1997, Q J EXP PSYCHOL-A, V50, P421, DOI 10.1080/027249897392161	56	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198620	10.1371/journal.pone.0198620	http://dx.doi.org/10.1371/journal.pone.0198620			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ2HI	29897956	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700061
J	Wang, SJ; Sommer, B; Cheng, WL; Schreiber, F				Wang, Stephen Jia; Sommer, Bjoern; Cheng, Wenlong; Schreiber, Falk			The Virtual-Spine Platform-Acquiring, visualizing, and analyzing individual sitting behavior	PLOS ONE			English	Article							POSTURE; PAIN; RELIABILITY; DEVICE; VALIDITY; MONITOR; MOTION; WORK	Back pain is a serious medical problem especially for those people sitting over long periods during their daily work. Here we present a system to help users monitoring and examining their sitting behavior. The Virtual-Spine Platform (VSP) is an integrated system consisting of a real-time body position monitoring module and a data visualization module to provide individualized, immediate, and accurate sitting behavior support. It provides a comprehensive spine movement analysis as well as accumulated data visualization to demonstrate behavior patterns within a certain period. The two modules are discussed in detail focusing on the design of the VSP system with adequate capacity for continuous monitoring and a web based interactive data analysis method to visualize and compare the sitting behavior of different persons. The data was collected in an experiment with a small group of subjects. Using this method, the behavior of five subjects was evaluated over a working day, enabling inferences and suggestions for sitting improvements. The results from the accumulated data module were used to elucidate the basic function of body position recognition of the VSP. Finally, an expert user study was conducted to evaluate VSP and support future developments.	[Wang, Stephen Jia] Royal Coll Art, Sch Design, Dept Innovat Design Engn, London, England; [Wang, Stephen Jia] Monash Univ, Int Tangible Interact Design Lab, Melbourne, Vic, Australia; [Sommer, Bjoern; Schreiber, Falk] Univ Konstanz, Dept Comp & Informat Sci, Constance, Baden Wurttembe, Germany; [Sommer, Bjoern; Schreiber, Falk] Monash Univ, Fac Informat Technol, Melbourne, Vic, Australia; [Cheng, Wenlong] Monash Univ, Fac Engn, Melbourne, Vic, Australia	Royal College of Art - UK; Monash University; University of Konstanz; Monash University; Monash University	Wang, SJ (corresponding author), Royal Coll Art, Sch Design, Dept Innovat Design Engn, London, England.; Wang, SJ (corresponding author), Monash Univ, Int Tangible Interact Design Lab, Melbourne, Vic, Australia.; Sommer, B (corresponding author), Univ Konstanz, Dept Comp & Informat Sci, Constance, Baden Wurttembe, Germany.; Sommer, B (corresponding author), Monash Univ, Fac Informat Technol, Melbourne, Vic, Australia.	stephen.wang@rca.ac.uk; bjoem@CELLmicrocosmos.org	Cheng, Wenlong/C-7516-2012; Wang, Stephen/A-6494-2016	Cheng, Wenlong/0000-0002-2346-4970; Sommer, Bjorn/0000-0003-1514-9898; Wang, Stephen/0000-0001-9835-9932	Monash University, Australia	Monash University, Australia(Monash University)	This work is financially supported by Pro Vice-Chancellor's Interdisciplinary Research (IDR) Seed Grant, Monash University, Australia.	[Anonymous], 2017, SAFE LIFTING TECHNIQ; Bauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003; Bergstrom N, 1992, PRESSURE ULCERS ADUL; Berlowitz D, 1993, IMPROVING CARE NURSI, V4, P102, DOI [10.4135/9781483325903.n4, DOI 10.4135/9781483325903.N4]; Billinghurst M, 1999, MIXED REALITY, P261; Bostock M, 2011, IEEE T VIS COMPUT GR, V17, P2301, DOI 10.1109/TVCG.2011.185; BRANDEIS GH, 1994, J AM GERIATR SOC, V42, P388, DOI 10.1111/j.1532-5415.1994.tb07486.x; Breed DS, 2014, ARRANGEMENT SENSING; Brink Y, 2013, MANUAL THER, V18, P281, DOI 10.1016/j.math.2012.11.003; Burnett AF, 2004, MANUAL THER, V9, P211, DOI 10.1016/j.math.2004.06.002; Caihua W., 2012, VERTEBRA CTR DETECTI; Calancie B, 1998, J NEUROSURG, V88, P457, DOI 10.3171/jns.1998.88.3.0457; Callaghan V, 2004, BT TECHNOL J, V22, P233, DOI 10.1023/B:BTTJ.0000047137.42670.4d; Chang TC, 2015, IEEE GLOB COMM CONF, DOI [10.1109/ICSENS.2015.7370446, 10.1109/GLOCOM.2015.7417476]; Chavalitsakulchai P., 1993, Journal of Human Ergology, V22, P95; Claus AP, 2009, MANUAL THER, V14, P404, DOI 10.1016/j.math.2008.06.001; Cohen D, 1998, AVIAT SPACE ENVIR MD, V69, P410; Corlett EN, 2006, ERGONOMICS, V49, P1538, DOI 10.1080/00140130600766261; DELETIS V, 2004, CURR OPIN ORTHOP, V15, P154, DOI DOI 10.1097/01.bco.0000127314.99341.ad; Donatell GJ, 2005, IEEE T NEUR SYS REH, V13, P18, DOI 10.1109/TNSRE.2005.843446; Dublin P, 2015, SITTING CAUSES BACK; Faust E, 1999, METHOD QUANTITATIVE; Gadotti IC, 2013, MANUAL THER, V18, P243, DOI 10.1016/j.math.2012.10.012; Gleckler AD, 2013, PROVIDING INFORM REL; Green-Armytage P., 2010, COLOR CREATIVITY, V5, P1; Grundy BL, 1986, ANESTHESIOLOGY, P211; Helander MG, 1997, ERGONOMICS, V40, P895, DOI 10.1080/001401397187739; Keim DA, 2002, IEEE T VIS COMPUT GR, V8, P1, DOI 10.1109/2945.981847; Koskelo R, 2007, ERGONOMICS, V50, P1643, DOI 10.1080/00140130701587236; Kovanci G, 2016, J INTEGRATIVE BIOINF, V13, P47, DOI [10.1515/jib-2016-298, DOI 10.1515/JIB-2016-298]; Magnusson ML, 2008, SPINE, V33, pE532, DOI 10.1097/BRS.0b013e31817dfd9a; Mannion AF, 2004, EUR SPINE J, V13, P122, DOI 10.1007/s00586-003-0618-8; Monette M, 1999, P RESNA ANN C, P218; Munzner T., 2014, VISUALIZATION ANAL D, DOI [10.1201/b17511/visualization-analysis-design-tamara-munzner, DOI 10.1201/B17511]; Nachemson A, 1970, Scand J Rehabil Med Suppl, V1, P1; Nachemson AL, 1976, LUMBAR SPINE ORTHOPA, V1, P59, DOI [10.1097/00007632-197603000-00009, DOI 10.1097/00007632-197603000-00009]; NASH CL, 1977, CLIN ORTHOP RELAT R, P100; NUWER MR, 1995, EVOKED POTENTIAL, V96, P6, DOI 10.1016/0013-4694(94)00235-D; Nuwer MR, 1999, MUSCLE NERVE, V22, P1620, DOI 10.1002/(SICI)1097-4598(199912)22:12<1620::AID-MUS2>3.0.CO;2-1; O'Sullivan K., 2010, PHYSIOTHER PRACT RES, V31, P16, DOI [10.3233/ppr-2010-31104, DOI 10.3233/PPR-2010-31104]; O'Sullivan K, 2012, MANUAL THER, V17, P77, DOI 10.1016/j.math.2011.09.006; O'Sullivan K, 2011, ERGONOMICS, V54, P82, DOI 10.1080/00140139.2010.535020; O'Sullivan PB, 2003, SPINE, V28, P1074, DOI 10.1097/00007632-200305150-00022; Podoloff RM, 1993, SAE TECHNICAL PAPER; Reenalda J, 2009, J REHABIL RES DEV, V46, P577, DOI 10.1682/JRRD.2008.12.0164; Roffey DM, 2010, SPINE J, V10, P252, DOI 10.1016/j.spinee.2009.12.005; Ryan CG, 2011, ERGONOMICS, V54, P531, DOI 10.1080/00140139.2011.570458; Shaw G, 1991, Assist Technol, V3, P11; Sheeran L, 2010, EUR SPINE J, V19, P995, DOI 10.1007/s00586-009-1241-0; Shneiderman B., 2003, P IEEE S VIS LANG, P336; Sommer B, 2013, J BIOINF COMPUT BIOL, V11, DOI 10.1142/S0219720013400052; Spielholz P, 2001, ERGONOMICS, V44, P588, DOI 10.1080/00140130118050; Spielman SB, 1995, APPARATUS MONITORING; Straker LM, 2009, MANUAL THER, V14, P321, DOI 10.1016/j.math.2008.04.004; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Vos-Draper TL, 2013, P RESNA C; Wang S.J., 2013, FIELDS INTERACTION D; Wang SJ, 2013, INT CONF PER COMP, P45, DOI 10.4108/icst.pervasivehealth.2013.252108; Ward M.O., 2010, INTERACTIVE DATA VIS; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005	60	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0195670	10.1371/journal.pone.0195670	http://dx.doi.org/10.1371/journal.pone.0195670			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ2HI	29897910	Green Accepted, gold, Green Published			2022-12-26	WOS:000435090700003
J	Konishi, T; Funayama, N; Yamamoto, T; Hotta, D; Tanaka, S				Konishi, Takao; Funayama, Naohiro; Yamamoto, Tadashi; Hotta, Daisuke; Tanaka, Shinya			Relationship between left main and left anterior descending arteries bifurcation angle and coronary artery calcium score in chronic kidney disease: A 3-dimensional analysis of coronary computed tomography	PLOS ONE			English	Article							GROWTH-FACTOR 23; VASCULAR CALCIFICATION; CT ANGIOGRAPHY; RISK-FACTORS; ATHEROSCLEROSIS; QUANTIFICATION; INTERVENTION; ASSOCIATION; PROGRESSION; RESTENOSIS	Background A high coronary artery calcium score (CACS) predicts a poor prognosis in patients with coronary artery disease. We examined the relationship between the bifurcation angle and the CACS of the left main (LM) and left anterior descending (LAD) arteries in patients suffering from chronic kidney disease (CKD). Methods We analyzed the data of 121 patients who underwent coronary computed tomography between October 2014 and June 2015 and whose estimated glomerular filtration rate (eGFR) was <60 ml/min/1.73 m(2). The LM-LAD bifurcation angle was measured by 3-dimensional coronary computed tomography. The CACS of the LM-LAD arteries was also calculated. We excluded stent recipients and patient who had undergone coronary artery bypass graft surgery. Results In the overall sample, the mean standard deviation (range) LM-LAD bifurcation angle was 35.9 +/- 11.4 degrees (6.8-79.4 degrees) and mean CACS was 227 +/- 351 (0 to 1,695). The mean LM-LAD arteries angle was 40.3 degrees +/- 10.0 degrees in 39 patients whose CACS was >= 200, versus 33.8 degrees +/- 11.6 degrees in 82 patients with CACS <200 (p = 0.003). A weak, but positive correlation (r = 0.269, p = 0.003) was observed between the LM-LAD arteries angle and CACS of the LM-LAD arteries. By multiple variable analysis, hemoglobin A1c, triglycerides, eGFR and the LM-LAD arteries angle were independent predictors of a high CACS of the LM-LAD arteries. Conclusion In patients with CKD, a wide LM-LAD arteries angle was associated with a high CACS of the LM-LAD arteries. The prognostic value of this observation warrants further evaluation.	[Konishi, Takao; Funayama, Naohiro; Yamamoto, Tadashi; Hotta, Daisuke] Hokkaido Cardiovasc Hosp, Dept Cardiol, Sapporo, Hokkaido, Japan; [Konishi, Takao; Tanaka, Shinya] Hokkaido Univ, Dept Canc Pathol, Grad Sch Med, Sapporo, Hokkaido, Japan	Hokkaido University	Konishi, T (corresponding author), Hokkaido Cardiovasc Hosp, Dept Cardiol, Sapporo, Hokkaido, Japan.; Konishi, T (corresponding author), Hokkaido Univ, Dept Canc Pathol, Grad Sch Med, Sapporo, Hokkaido, Japan.	takaokonishi0915@gmail.com	Tanaka, Shinya/AAO-8771-2021; Stefanadis, Christodoulos/ABH-2232-2020; Tanaka, Shinya/D-3586-2011	Tanaka, Shinya/0000-0001-6470-3301; Stefanadis, Christodoulos/0000-0001-5974-6454; Konishi, Takao/0000-0001-8429-631X				Afshar M, 2017, J AM COLL CARDIOL, V69, P84, DOI 10.1016/S0735-1097(17)33473-3; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Alluri K, 2015, J CARDIOVASC COMPUT, V9, P337, DOI 10.1016/j.jcct.2015.03.015; Bonaca MP, 2018, CIRCULATION, V137, P338, DOI 10.1161/CIRCULATIONAHA.117.032235; Calais F, 2013, INT J CARDIOL, V170, P227, DOI 10.1016/j.ijcard.2013.10.060; Carson AP, 2015, DIABETES CARE, V38, P66, DOI 10.2337/dc14-0360; Chaichana T, 2011, J BIOMECH, V44, P1869, DOI 10.1016/j.jbiomech.2011.04.033; Cui Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174352; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; di Giuseppe R, 2015, EUR J EPIDEMIOL, V30, P131, DOI 10.1007/s10654-014-9982-4; Girasis C, 2013, JACC-CARDIOVASC INTE, V6, P1250, DOI 10.1016/j.jcin.2013.08.009; Gross ML, 2007, CLIN J AM SOC NEPHRO, V2, P121, DOI 10.2215/CJN.01760506; Hoffmann MHK, 2005, JAMA-J AM MED ASSOC, V293, P2471, DOI 10.1001/jama.293.20.2471; Hosoi M, 2002, DIABETES CARE, V25, P696, DOI 10.2337/diacare.25.4.696; Jimbo R, 2014, KIDNEY INT, V85, P1103, DOI 10.1038/ki.2013.332; Juan YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01679-3; Kawasaki T, 2009, CATHETER CARDIO INTE, V73, P653, DOI 10.1002/ccd.21916; Kim MK, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0589-4; KLEIN LW, 1986, AM J CARDIOL, V58, P42, DOI 10.1016/0002-9149(86)90238-9; Konishi T, 2016, CORONARY ARTERY DIS, V27, P449, DOI 10.1097/MCA.0000000000000381; Kramer H, 2005, J AM SOC NEPHROL, V16, P507, DOI 10.1681/ASN.2004070610; MAHMARIAN JJ, 1991, J AM COLL CARDIOL, V17, P355, DOI 10.1016/S0735-1097(10)80099-3; McClelland RL, 2015, J AM COLL CARDIOL, V66, P1643, DOI 10.1016/j.jacc.2015.08.035; Mintz GS, 1997, J AM COLL CARDIOL, V29, P268, DOI 10.1016/S0735-1097(96)00479-2; Nakanishi R, 2016, EUR HEART J-CARD IMG, V17, P1305, DOI 10.1093/ehjci/jev328; Nakayama M, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-22; Navarro-Gonzalez JF, 2014, HEART, V100, P34, DOI 10.1136/heartjnl-2013-304746; Qi L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154852; Rosen BD, 2009, JACC-CARDIOVASC IMAG, V2, P1175, DOI 10.1016/j.jcmg.2009.06.014; Russo D, 2011, KIDNEY INT, V80, P112, DOI 10.1038/ki.2011.69; Schwarz U, 2000, NEPHROL DIAL TRANSPL, V15, P218, DOI 10.1093/ndt/15.2.218; Stefanadis C, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005543; Sun ZH, 2016, INT J CARDIOL, V203, P78, DOI 10.1016/j.ijcard.2015.10.079; Sun ZH, 2011, EUR J RADIOL, V79, pE90, DOI 10.1016/j.ejrad.2011.04.015; Temov K, 2016, INT J CARDIOVAS IMAG, V32, pS129, DOI 10.1007/s10554-016-0884-2; Tota-Maharaj R, 2015, ATHEROSCLEROSIS, V238, P126, DOI 10.1016/j.atherosclerosis.2014.11.008; Yahagi K, 2017, ARTERIOSCL THROM VAS, V37, P191, DOI 10.1161/ATVBAHA.116.306256	37	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2018	13	6							e0198566	10.1371/journal.pone.0198566	http://dx.doi.org/10.1371/journal.pone.0198566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ1PQ	29894482	Green Published, gold, Green Submitted			2022-12-26	WOS:000435030900019
J	Christensen, ME; Beck-Nielsen, SS; Dalgard, C; Larsen, SD; Lykkedegn, S; Kyhl, HB; Husby, S; Christesen, HT				Christensen, Mathilde Egelund; Beck-Nielsen, Signe Sparre; Dalgard, Christine; Larsen, Sos Dragsbaek; Lykkedegn, Sine; Kyhl, Henriette Boye; Husby, Steffen; Christesen, Henrik Thybo			A novel inverse association between cord 25-hydroxyvitamin D and leg length in boys up to three years. An Odense Child Cohort study	PLOS ONE			English	Article							VITAMIN-D STATUS; D DEFICIENCY; EARLY-PREGNANCY; BONE MASS; GROWTH; RICKETS; BLOOD; SOX9; DIFFERENTIATION; MULTICENTER	Background and aim Long standing vitamin D deficiency in children causes rickets with growth impairment. We investigated whether sub-ischial leg length (SLL) is shorter, and cephalo-caudal length: length (CCL:L) ratio and sitting height:height (SH:H) ratio larger, with lower cord s-25-hydroxyvitamin D (250HD) in the population-based prospective Odense Child Cohort, Denmark. Methods We included healthy singletons born to term with available measures of cord 250HD and anthropometrics up to three years' age. Linear regression was stratified by sex a priori and adjusted for maternal ethnicity, pre-pregnancy body mass index and smoking during pregnancy, season of blood sampling and child age. Results Median (IQR) cord 250HD was 48.0 (34.0-62.4) nmol/L. At mean age 19.1 months, n = 504, mean (SD) SLL was 31.7 (1.7) cm; CCL:L-ratio 0.62 (0.01). At 36.3 months, n = 956, mean SLL was 42.9 (2.0) cm; SH:H-ratio 0.56 (0.01). No participants had rickets. In adjusted analyses, 19-months-old boys had 0.1 cm shorter SLL (p = 0.009) and 0.1% higher CCL:Lratio (p = 0.04) with every 10 nmol/L increase in cord 250HD. Similar findings were seen for late pregnancy 250HD. In the highest cord 250HD quartile (>60.7 nmol/L), SLL was 0.8 cm shorter (95% C.I.: 1.36;-0.29, linear trend, p = 0.004), and CCL:L-ratio 0.8% higher (95% C.I. 8.0x10(-05) ;0.01, linear trend, p = 0.01), compared to lowest quartile (<30.7 nmol/L). Similar associations with cord 250HD were observed in 3-year-old boys. No consistent associations between 250HD and anthropometrics were seen in girls at either age. Conclusion No leg shortening was found with decreasing cord s-250HD in a healthy population of infants. A small, yet significant inverse association between cord 250HD and SLL in boys 11/2-3 years warrants further investigations.	[Christensen, Mathilde Egelund; Larsen, Sos Dragsbaek; Christesen, Henrik Thybo] Univ Southern Denmark, Fac Hlth Sci, Dept Clin Res, Odense, Denmark; [Christensen, Mathilde Egelund; Larsen, Sos Dragsbaek; Lykkedegn, Sine; Husby, Steffen; Christesen, Henrik Thybo] Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, Odense, Denmark; [Beck-Nielsen, Signe Sparre] Kolding Cty Hosp, Dept Pediat, Kolding, Denmark; [Beck-Nielsen, Signe Sparre; Dalgard, Christine] Univ Southern Denmark, Fac Hlth Sci, Dept Reg Hlth Res, Odense, Denmark; [Dalgard, Christine] Univ Southern Denmark, Dept Publ Hlth, Environm Med, Odense, Denmark; [Kyhl, Henriette Boye; Husby, Steffen; Christesen, Henrik Thybo] Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, Odense Child Cohort, Odense, Denmark; [Kyhl, Henriette Boye] Univ Southern Denmark, OPEN, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Kolding Hospital; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Christesen, HT (corresponding author), Univ Southern Denmark, Fac Hlth Sci, Dept Clin Res, Odense, Denmark.; Christesen, HT (corresponding author), Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, Odense, Denmark.; Christesen, HT (corresponding author), Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, Odense Child Cohort, Odense, Denmark.	henrik.christesen@rsyd.dk	Christesen, Henrik/AAR-9023-2021	Christesen, Henrik/0000-0001-5330-6853; Beck-Nielsen, Signe/0000-0002-7561-9217; Egelund Christensen, Mathilde/0000-0002-8528-6671; Dalgard, Christine/0000-0001-8184-3429; Husby, Steffen/0000-0002-6286-2496				Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Andersen LB, 2013, CLIN ENDOCRINOL, V79, P333, DOI 10.1111/cen.12147; Beck-Nielsen SS, 2009, EUR J ENDOCRINOL, V160, P491, DOI 10.1530/EJE-08-0818; Bell KA, 2017, AM J CLIN NUTR, V106, P491, DOI 10.3945/ajcn.116.151126; Curtis EM, 2014, CURR OSTEOPOROS REP, V12, P194, DOI 10.1007/s11914-014-0210-7; Czech-Kowalska J, 2012, BONE, V51, P781, DOI 10.1016/j.bone.2012.06.023; Eckhardt CL, 2015, ANN HUM BIOL, V42, P215, DOI 10.3109/03014460.2014.954616; Elidrissy ATH, 2016, CALCIFIED TISSUE INT, V99, P227, DOI 10.1007/s00223-016-0146-2; Evans KN, 2004, J SOC GYNECOL INVEST, V11, P263, DOI 10.1016/j.jsgi.2004.02.002; Fernandez-Cancio M, 2009, GROWTH HORM IGF RES, V19, P232, DOI 10.1016/j.ghir.2008.10.004; Foedevareinstituttet D, 2015, FOED 2015; Greer FR, 2004, AM J CLIN NUTR, V80, p1759S, DOI 10.1093/ajcn/80.6.1759S; HILLMAN LS, 1974, J PEDIATR-US, V84, P742, DOI 10.1016/S0022-3476(74)80024-7; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Kiely M, 2017, J STEROID BIOCHEM, V167, P162, DOI 10.1016/j.jsbmb.2016.12.006; Kirby BJ, 2013, J BONE MINER RES, V28, P1987, DOI 10.1002/jbmr.1925; Kovacs C.S., 2011, VITAMIN D, P625; Kovacs CS, 2014, PHYSIOL REV, V94, P1143, DOI 10.1152/physrev.00014.2014; Kramer CK, 2016, CLIN ENDOCRINOL, V84, P680, DOI 10.1111/cen.12989; Krieger JP, 2018, BRIT J NUTR, V119, P299, DOI 10.1017/S0007114517003634; Kyhl HB, 2015, PAEDIATR PERINAT EP, V29, P250, DOI 10.1111/ppe.12183; Lamberg-Allardt C, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.22671; Lefebvre V, 2017, CONNECT TISSUE RES, V58, P2, DOI 10.1080/03008207.2016.1183667; Liu CF, 2015, NUCLEIC ACIDS RES, V43, P8183, DOI 10.1093/nar/gkv688; Lykkedegn S, 2017, CLIN NUTR, V36, P1621, DOI 10.1016/j.clnu.2016.10.008; Murray PG, 2013, AM J MED GENET C, V163C, P76, DOI 10.1002/ajmg.c.31357; NICHOLSON GC, 1988, BIOCHEM J, V250, P877, DOI 10.1042/bj2500877; Ong YL, 2016, BRIT J NUTR, V116, P621, DOI 10.1017/S0007114516000623; Ostergard M, 2011, EUR J CLIN NUTR, V65, P657, DOI 10.1038/ejcn.2010.285; Pettifor JM, 2011, BEST PRACT RES CL EN, V25, P573, DOI 10.1016/j.beem.2011.06.010; Phinney KW, 2008, AM J CLIN NUTR, V88, p511S, DOI 10.1093/ajcn/88.2.511S; Rosen CJ, 2012, J CLIN ENDOCR METAB, V97, P1146, DOI 10.1210/jc.2011-2218; Ryan JW, 2016, J STEROID BIOCHEM, V164, P361, DOI 10.1016/j.jsbmb.2015.12.005; Saraf R, 2015, MATERN CHILD NUTR, DOI [10.1111/mcn, DOI 10.1111/MCN]; Stoutjesdijk E, 2017, BRIT J NUTR, V118, P804, DOI 10.1017/S000711451700277X; Tinggaard J, 2014, ACTA PAEDIATR, V103, P214, DOI 10.1111/apa.12468; van Eijsden M, 2013, EUR J CLIN NUTR, V67, P972, DOI 10.1038/ejcn.2013.106; Viljakainen HT, 2011, OSTEOPOROSIS INT, V22, P883, DOI 10.1007/s00198-010-1499-4; Wang ZH, 2014, BRAZ J MED BIOL RES, V47, P279, DOI 10.1590/1414-431X20133539; Wheeler BJ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010086; Ygil KH., 2013, DIMENSIONS WEIGHT PO; Zosky Graeme R, 2014, Ann Am Thorac Soc, V11, P571, DOI [10.1513/AnnalsATS.201312-423OC, 10.1513/AnnalsATS.201407-331LE]	44	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198724	10.1371/journal.pone.0198724	http://dx.doi.org/10.1371/journal.pone.0198724			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889866	Green Published, Green Submitted, gold			2022-12-26	WOS:000434786600038
J	Fa, R; Cozzetto, D; Wan, C; Jones, DT				Fa, Rui; Cozzetto, Domenico; Wan, Cen; Jones, David T.			Predicting human protein function with multi-task deep neural networks	PLOS ONE			English	Article							ALGORITHM	Machine learning methods for protein function prediction are urgently needed, especially now that a substantial fraction of known sequences remains unannotated despite the extensive use of functional assignments based on sequence similarity. One major bottleneck supervised learning faces in protein function prediction is the structured, multi-label nature of the problem, because biological roles are represented by lists of terms from hierarchically organised controlled vocabularies such as the Gene Ontology. In this work, we build on recent developments in the area of deep learning and investigate the usefulness of multitask deep neural networks (MTDNN), which consist of upstream shared layers upon which are stacked in parallel as many independent modules (additional hidden layers with their own output units) as the number of output GO terms (the tasks). MTDNN learns individual tasks partially using shared representations and partially from task-specific characteristics. When no close homologues with experimentally validated functions can be identified, MTDNN gives more accurate predictions than baseline methods based on annotation frequencies in public databases or homology transfers. More importantly, the results show that MTDNN binary classification accuracy is higher than alternative machine learning-based methods that do not exploit commonalities and differences among prediction tasks. Interestingly, compared with a single-task predictor, the performance improvement is not linearly correlated with the number of tasks in MTDNN, but medium size models provide more improvement in our case. One of advantages of MTDNN is that given a set of features, there is no requirement for MTDNN to have a bootstrap feature selection procedure as what traditional machine learning algorithms do. Overall, the results indicate that the proposed MTDNN algorithm improves the performance of protein function prediction. On the other hand, there is still large room for deep learning techniques to further enhance prediction ability.	[Fa, Rui; Cozzetto, Domenico; Wan, Cen; Jones, David T.] Francis Crick Inst, London, England; [Fa, Rui; Cozzetto, Domenico; Wan, Cen; Jones, David T.] UCL, Comp Sci Dept, London, England	Francis Crick Institute; University of London; University College London	Jones, DT (corresponding author), Francis Crick Inst, London, England.; Jones, DT (corresponding author), UCL, Comp Sci Dept, London, England.	d.t.jones@ucl.ac.uk	Cozzetto, Domenico/Y-6345-2019	Cozzetto, Domenico/0000-0001-6752-5432; Fa, Rui/0000-0003-4588-7971	Elsevier; UK Biotechnology and Biological Sciences Research Council [BB/L020505/1, BB/L002817/1]; Biotechnology and Biological Sciences Research Council [BB/L002817/1, BB/L020505/1] Funding Source: researchfish; BBSRC [BB/L020505/1, BB/L002817/1] Funding Source: UKRI	Elsevier; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	RF received funding from Elsevier; DC and CW are supported by the UK Biotechnology and Biological Sciences Research Council (references: BB/L020505/1 and BB/L002817/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bergstra J, P 30 INT C MACH LEAR; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Clark WT, 2011, PROTEINS, V79, P2086, DOI 10.1002/prot.23029; Cozzetto D, 2017, METHODS MOL BIOL, V1446, P55, DOI 10.1007/978-1-4939-3743-1_5; Cozzetto D, 2016, SCI REP-UK, V6, DOI 10.1038/srep31865; Cozzetto D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S3-S1; Galperin MY, 2014, LECT NOTES COMPUTER, P1; Gaudet P, 2011, BRIEF BIOINFORM, V12, P449, DOI 10.1093/bib/bbr042; Hanson J, 2017, BIOINFORMATICS, V33, P685, DOI 10.1093/bioinformatics/btw678; Hauser M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-248; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Huntley RP, 2015, NUCLEIC ACIDS RES, V43, pD1057, DOI 10.1093/nar/gku1113; Ioffe S., 2015, INT C ONMACHINE LEAR, V37, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Jiang YX, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1037-6; Ketkar N, 2017, INTRO THEANO DEEP LE, P33; Lee BJ, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-27; Lobley AE, 2008, NUCLEIC ACIDS RES, V36, pW297, DOI 10.1093/nar/gkn193; Ma XT, 2014, BRIEF BIOINFORM, V15, P685, DOI 10.1093/bib/bbt041; Mayr A, 2016, FRONT ENV SCI-SWITZ, V3, DOI 10.3389/fenvs.2015.00080; Min S, 2017, BRIEF BIOINFORM, V18, P851, DOI 10.1093/bib/bbw068; Minneci F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063754; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nair V., 2010, P 27 INT C INT C MAC, P807; Pellegrini M, 2012, METHODS MOL BIOL, V804, P167, DOI 10.1007/978-1-61779-361-5_9; Piovesan D, 2015, NUCLEIC ACIDS RES, V43, pW134, DOI 10.1093/nar/gkv523; Qi YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032235; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Ramsundar B, 2015, ARXIV150202072; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Sonderby SK, PROTEIN SECONDARY ST; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; TheGeneOntologyConsortium, 2017, Nucleic Acids Res, V45, pD331, DOI 10.1093/nar/gkw1108; Troyanskaya OG, 2005, BRIEF BIOINFORM, V6, P34, DOI 10.1093/bib/6.1.34; Wang S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005324; Wass MN, 2012, NUCLEIC ACIDS RES, V40, pW466, DOI 10.1093/nar/gks489	36	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198216	10.1371/journal.pone.0198216	http://dx.doi.org/10.1371/journal.pone.0198216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889900	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000434786600018
J	Jackson, JC; Hester, N; Gray, K				Jackson, Joshua Conrad; Hester, Neil; Gray, Kurt			The faces of God in America: Revealing religious diversity across people and politics	PLOS ONE			English	Article							MENTAL REPRESENTATIONS; TIGHTNESS-LOOSENESS; AUTHORITARIAN; ATTITUDES; CHILDREN; VIEWS; MINDS	Literature and art have long depicted God as a stern and elderly white man, but do people actually see Him this way? We use reverse correlation to understand how a representative sample of American Christians visualize the face of God, which we argue is indicative of how believers think about God's mind. In contrast to historical depictions, Americans generally see God as young, Caucasian, and loving, but perceptions vary by believers' political ideology and physical appearance. Liberals see God as relatively more feminine, more African American, and more loving than conservatives, who see God as older, more intelligent, and more powerful. All participants see God as similar to themselves on attractiveness, age, and, to a lesser extent, race. These differences are consistent with past research showing that people's views of God are shaped by their group-based motivations and cognitive biases. Our results also speak to the broad scope of religious differences: even people of the same nationality and the same faith appear to think differently about God's appearance.	[Jackson, Joshua Conrad; Hester, Neil; Gray, Kurt] Univ North Carolina Chapel Hill, Dept Psychol & Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Jackson, JC (corresponding author), Univ North Carolina Chapel Hill, Dept Psychol & Neurosci, Chapel Hill, NC 27599 USA.	joshcj@live.unc.edu		Gray, Kurt/0000-0001-5816-2676	National Science Foundation; Royster Society of Fellows; National Science Foundation [SES-1534083]	National Science Foundation(National Science Foundation (NSF)); Royster Society of Fellows; National Science Foundation(National Science Foundation (NSF))	This work was supported by a National Science Foundation Graduate Fellowship to JCJ, the Royster Society of Fellows to JCJ, and the National Science Foundation grant no. SES-1534083 to KG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas M, 2016, J CROSS CULT PSYCHOL, V47, P294, DOI 10.1177/0022022115606802; Atran S., 2004, GODS WE TRUST EVOLUT; Barrett JL, 1996, COGNITIVE PSYCHOL, V31, P219, DOI 10.1006/cogp.1996.0017; Barrett JL, 2000, TRENDS COGN SCI, V4, P29, DOI 10.1016/S1364-6613(99)01419-9; Barrett JL, 2011, J SCI STUD RELIG, V50, P229, DOI 10.1111/j.1468-5906.2011.01564.x; Barrett JustinL., 1999, METHOD THEORY STUDY, V11, P325, DOI DOI 10.1163/157006899X00078; Becker E, 1997, DENIAL DEATH; Boyer P., 2007, RELIG EXPLAINED EVOL; Brown-Iannuzzi JL, 2018, J EXP PSYCHOL GEN, V147, P292, DOI 10.1037/xge0000376; Brown-Iannuzzi JL, 2017, PSYCHOL SCI, V28, P92, DOI 10.1177/0956797616674999; Caluori NE, 2018, WARFARE CHANGES PEOP; Chou HTG, 2012, MENT HEALTH RELIG CU, V15, P677, DOI 10.1080/13674676.2011.613371; Dickie JR, 2006, J SCI STUD RELIG, V45, P57, DOI 10.1111/j.1468-5906.2006.00005.x; Dotsch R, 2012, SOC PSYCHOL PERS SCI, V3, P562, DOI 10.1177/1948550611430272; Draper S, 2017, SOCIOL COMPASS, V11, DOI 10.1111/soc4.12532; Epley N, 2004, J PERS SOC PSYCHOL, V87, P327, DOI 10.1037/0022-3514.87.3.327; Epley N, 2009, P NATL ACAD SCI USA, V106, P21533, DOI 10.1073/pnas.0908374106; Freud Sigmund, 1989, INTRO LECT PSYCHO AN; Gastwirth Paul, 1972, RELIG STUD, V8, P147; Gelfand M, 2016, TRUMP CULTURE THREAT; GORSUCH RL, 1968, J SCI STUD RELIG, V7, P56, DOI 10.2307/1385110; Gray HM, 2007, SCIENCE, V315, P619, DOI 10.1126/science.1134475; Gray K, 2010, PERS SOC PSYCHOL REV, V14, P7, DOI 10.1177/1088868309350299; Harrington JR, 2014, P NATL ACAD SCI USA, V111, P7990, DOI 10.1073/pnas.1317937111; Hegy P, 2007, OUR LIVES; Heiphetz L, 2016, COGNITIVE SCI, V40, P121, DOI 10.1111/cogs.12232; Heiphetz L, 2015, COGNITION, V144, P134, DOI 10.1016/j.cognition.2015.07.017; James L, 2007, WE IMAGINE GOD BE; Johnson KA, 2015, PSYCHOL RELIG SPIRIT, V7, P227, DOI 10.1037/rel0000011; Johnson KA, 2013, PSYCHOL RELIG SPIRIT, V5, P15, DOI 10.1037/a0030138; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Kay AC, 2010, PERS SOC PSYCHOL REV, V14, P37, DOI 10.1177/1088868309353750; KIRKPATRICK LA, 1992, PERS SOC PSYCHOL B, V18, P266, DOI 10.1177/0146167292183002; Krause N, 2000, J AGING STUD, V14, P191, DOI 10.1016/S0890-4065(00)80011-0; Lakoff G., 2010, MORAL POLITICS LIBER; Marx K., 1844, RELIGION; Muller F. M., 1892, NATURAL RELIG GIFFOR; Purzycki BG, 2016, CURR ANTHROPOL, V57, pS88, DOI 10.1086/685729; Purzycki BG, 2013, COGNITION, V129, P163, DOI 10.1016/j.cognition.2013.06.010; Ross LD, 2012, P NATL ACAD SCI USA, V109, P3616, DOI 10.1073/pnas.1117557109; Schjoedt U, 2009, SOC COGN AFFECT NEUR, V4, P199, DOI 10.1093/scan/nsn050; Shariff AF, 2011, INT J PSYCHOL RELIG, V21, P85, DOI 10.1080/10508619.2011.556990; SPILKA B, 1964, REV RELIG RES, V6, P28, DOI 10.2307/3510880; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; Tylor E.B., 1871, PRIMITIVE CULTURE RE, V6th ed.; Willard A. K., 2017, EVOLUTION HUMAN BEHA	46	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198745	10.1371/journal.pone.0198745	http://dx.doi.org/10.1371/journal.pone.0198745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI8PJ	29889879	Green Published, Green Submitted, gold			2022-12-26	WOS:000434786600041
J	Ondiba, IM; Oyieke, FA; Ong'amo, GO; Olumula, MM; Nyamongo, IK; Estambale, BBA				Ondiba, Isabella M.; Oyieke, Florence A.; Ong'amo, George O.; Olumula, Macrae M.; Nyamongo, Isaac K.; Estambale, Benson B. A.			Malaria vector abundance is associated with house structures in Baringo County, Kenya	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; ANOPHELES-ARABIENSIS; EAVE TUBES; HUMAN EXPOSURE; AFRICA; POPULATION; IMPACT; RISK; CONSTRUCTION; TRANSMISSION	Malaria, a major cause of morbidity and mortality, is the most prevalent vector borne disease in Baringo County; a region which has varied house designs in arid and semi-arid areas. This study investigated the association between house structures and indoor-malaria vector abundance in Baringo County. The density of malaria vectors in houses with open eaves was higher than that for houses with closed eaves. Grass thatched roof houses had higher density of malaria vectors than corrugated iron sheet roofs. Similarly, mud walled houses had higher vector density than other wall types. Houses in the riverine zone were significantly associated with malaria vector abundance (p<0.000) possibly due to more varied house structures. In Kamnarok village within riverine zone, a house made of grass thatched roof and mud wall but raised on stilts with domestic animals (sheep/goats) kept at the lower level had lower mosquito density (5.8 per collection) than ordinary houses made of same materials but at ground level (30.5 mosquitoes per collection), suggestive of a change in behavior of mosquito feeding and resting. House modifications such as screening of eaves, improvement of construction material and building stilted houses can be incorporated in the integrated vector management (IVM) strategy to complement insecticide treated bed nets and indoor residual spray to reduce indoor malaria vector density.	[Ondiba, Isabella M.; Oyieke, Florence A.; Ong'amo, George O.] Univ Nairobi, Sch Biol Sci, Nairobi, Kenya; [Olumula, Macrae M.; Estambale, Benson B. A.] Jaramogi Oginga Odinga Univ Sci & Technol, Div Res Innovat & Outreach, Bondo, Kenya; [Nyamongo, Isaac K.] Cooperat Univ Kenya, Cooperat Dev Res & Innovat, Nairobi, Kenya	University of Nairobi; Jaramogi Oginga Odinga University of Science & Technology; Cooperative University of Kenya	Ondiba, IM (corresponding author), Univ Nairobi, Sch Biol Sci, Nairobi, Kenya.	bellamoraa@yahoo.co.uk		Nyamongo, Isaac K./0000-0003-1796-9590	World Health Organization's special program for Tropical Disease Research (TDR) through International Development Research Centre of Canada [10690500]	World Health Organization's special program for Tropical Disease Research (TDR) through International Development Research Centre of Canada	This study received financial assistance from World Health Organization's special program for Tropical Disease Research (TDR) through a grant agreement with the International Development Research Centre of Canada (10690500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Animut A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-393; [Anonymous], ENV ASS IRS NAT KE S; [Anonymous], PUBLICATION S AFRICA; [Anonymous], KEN DEM HLTH SURV 20; [Anonymous], 1975, MANUAL PRACTICAL ENT; [Anonymous], BARINGO COUNTY GOVT; [Anonymous], ROLL BACK MAL VECT C; [Anonymous], 2016, KEN MAL IND SURV 201; [Anonymous], GEOSC REM SENS S IGA; [Anonymous], 2014, US GEOLOGICAL SURVEY; Asale A, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0366-3; Atieli H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-108; Bradley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080626; Charlwood JD, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-2; Chuma J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-144; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P77, DOI 10.4269/ajtmh.1991.45.77; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Haines A, 2013, J URBAN HEALTH, V90, P810, DOI 10.1007/s11524-012-9773-8; Hiscox A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062769; Howell PI, 2007, J VECTOR ECOL, V32, P69, DOI 10.3376/1081-1710(2007)32[69:TIOHCO]2.0.CO;2; Huho B, 2013, INT J EPIDEMIOL, V42, P235, DOI 10.1093/ije/dys214; Kirby MJ, 2010, AM J TROP MED HYG, V83, P965, DOI 10.4269/ajtmh.2010.10-0311; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Knols BGJ, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1452-x; Konradsen F, 2003, AM J TROP MED HYG, V68, P177, DOI 10.4269/ajtmh.2003.68.177; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Lindsay SW, 2002, TRENDS PARASITOL, V18, P510, DOI 10.1016/S1471-4922(02)02382-6; Mala AO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-121; Massebo F, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-319; Mayagaya VS, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0536-8; Njie M, 2009, J MED ENTOMOL, V46, P505, DOI 10.1603/033.046.0314; Okumu F, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1859-z; Omondi CJ, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1904-y; Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77; Seyoum A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-101; Snetselaar J, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1926-5; Snyman K, 2015, AM J TROP MED HYG, V92, P1207, DOI 10.4269/ajtmh.14-0828; Spitzen J, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1293-7; Sternberg ED, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1499-8; Swai JK, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1616-8; Tusting LS, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1349-8; Tusting LS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0724-1; Waite JL, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1505-1; Walker N, 2010, AM J TROP MED HYG, V83, P963, DOI 10.4269/ajtmh.2010.10-0405; Wanzirah H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117396; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2015, GLOB TECHN STRAT MAL; Ye Y, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-8; Zhou G, 2007, AM J TROP MED HYG, V77, P29, DOI 10.4269/ajtmh.2007.77.29	49	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198970	10.1371/journal.pone.0198970	http://dx.doi.org/10.1371/journal.pone.0198970			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889888	gold, Green Published			2022-12-26	WOS:000434786600068
J	Prasad, R; Gunn, SK; Rotz, CA; Karsten, H; Roth, G; Buda, A; Stoner, AMK				Prasad, Rishi; Gunn, Stephan Kpoti; Rotz, Clarence Alan; Karsten, Heather; Roth, Greg; Buda, Anthony; Stoner, Anne M. K.			Projected climate and agronomic implications for corn production in the Northeastern United States	PLOS ONE			English	Article							EXTREME HEAT; DATE TRENDS; MAIZE; TEMPERATURE; GROWTH; IMPACTS; YIELDS; FROST; TOLERANCE; VIABILITY	Corn has been a pillar of American agriculture for decades and continues to receive much attention from the scientific community for its potential to meet the food, feed and fuel needs of a growing human population in a changing climate. By midcentury, global temperature increase is expected to exceed 2 degrees C where local effects on heat, cold and precipitation extremes will vary. The Northeast United States is a major dairy producer, corn consumer, and is cited as the fastest warming region in the contiguous U.S. It is important to understand how key agronomic climate variables affect corn growth and development so that adaptation strategies can be tailored to local climate changes. We analyzed potential local effects of climate change on corn growth and development at three major dairy locations in the Northeast (Syracuse, New York; State College, Pennsylvania and Landisville, Pennsylvania) using downscaled projected climate data (2000-2100) from nine Global Climate Models under two emission pathways (Representative Concentration Pathways (RCP) 4.5 and 8.5). Our analysis indicates that corn near the end of the 21 st century will experience fewer spring and fall freezes, faster rate of growing degree day accumulation with a reduction in time required to reach maturity, greater frequencies of daily high temperature >35 degrees C during key growth stages such as silking-anthesis and greater water deficit during reproductive (R1-R6) stages. These agronomic anomalies differ between the three locations, illustrating varying impacts of climate change in the more northern regions vs. the southern regions of the Northeast. Management strategies such as shifting the planting dates based on last spring freeze and irrigation during the greatest water deficit stages (R1-R6) will partially offset the projected increase in heat and drought stress. Future research should focus on understanding the effects of global warming at local levels and determining adaptation strategies that meet local needs.	[Prasad, Rishi; Gunn, Stephan Kpoti; Rotz, Clarence Alan; Buda, Anthony] USDA ARS, Pasture Syst & Watershed Management Res Unit, University Pk, PA 16802 USA; [Prasad, Rishi] Auburn Univ, Crop Soil & Environm Sci Dept, Auburn, AL 36849 USA; [Karsten, Heather; Roth, Greg] Penn State Univ, Plant Sci Dept, University Pk, PA 16802 USA; [Stoner, Anne M. K.] Texas Tech Univ, Climate Sci Ctr, Lubbock, TX 79409 USA	United States Department of Agriculture (USDA); Auburn University System; Auburn University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Texas Tech University System; Texas Tech University	Prasad, R (corresponding author), USDA ARS, Pasture Syst & Watershed Management Res Unit, University Pk, PA 16802 USA.; Prasad, R (corresponding author), Auburn Univ, Crop Soil & Environm Sci Dept, Auburn, AL 36849 USA.	rzp0050@auburn.edu	Buda, Anthony/ABA-3525-2021		Agricultural Research Service (ARS) of the United States Department of Agriculture [8070-11130-003-00D]; ARS [58-8070-5-010]; Pennsylvania State University; Texas Tech University; Directorate For Engineering [1231326] Funding Source: National Science Foundation	Agricultural Research Service (ARS) of the United States Department of Agriculture; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Pennsylvania State University; Texas Tech University; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Support for CAR and AB came from the Agricultural Research Service (ARS) of the United States Department of Agriculture Project 8070-11130-003-00D (https://www.ars.usda.gov/research/project/?accnNo=428423). Support for RP and SG came from ARS to The Pennsylvania State University through cooperative agreement 58-8070-5-010. The Pennsylvania State University (http://www.psu.edu/) supported HK and GR, and Texas Tech University (https://www.ttu.edu/) supported AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LV, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006290; Angel JR, 2017, CLIM RISK MANAG, V15, P73, DOI 10.1016/j.crm.2016.10.002; Asseng S, 2013, NAT CLIM CHANGE, V3, P827, DOI [10.1038/nclimate1916, 10.1038/NCLIMATE1916]; Barlow KM, 2015, FIELD CROP RES, V171, P109, DOI 10.1016/j.fcr.2014.11.010; BENJAMIN JG, 2014, OPEN J SOIL SCI, V4, P151, DOI DOI 10.4236/OJSS.2014.44018; CARTER PR, 1995, J PROD AGRIC, V8, P203, DOI 10.2134/jpa1995.0203; Chang R., 2014, PHYS CHEM CHEM SCI; Choi YS, 2017, INT J CLIMATOL, V37, P1595, DOI 10.1002/joc.4799; COOTER EJ, 1995, INT J CLIMATOL, V15, P65, DOI 10.1002/joc.3370150108; Cox B, 2013, MANAGEMENT, V24, p9 ; DUPUIS I, 1990, PLANT PHYSIOL, V94, P665, DOI 10.1104/pp.94.2.665; Fonseca AE, 2005, FIELD CROP RES, V94, P114, DOI 10.1016/j.fcr.2004.12.001; Gourdji SM, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024041; Griffiths ML, 2007, J CLIMATE, V20, P5401, DOI 10.1175/2007JCLI1594.1; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; Hatfield JL, 2015, WEATHER CLIM EXTREME, V10, P4, DOI 10.1016/j.wace.2015.08.001; Helsel D R, 2002, STAT METHODS WATER R, V323; HERRERO MP, 1980, CROP SCI, V20, P796, DOI 10.2135/cropsci1980.0011183X002000060030x; HIRSCH RM, 1982, WATER RESOUR RES, V18, P107, DOI 10.1029/WR018i001p00107; Hu Q, 2003, J APPL METEOROL, V42, P1626, DOI 10.1175/1520-0450(2003)042&lt;1626:CEOCYI&gt;2.0.CO;2; Iizumi T, 2014, J AGRIC METEOROL, V70, P73, DOI 10.2480/agrmet.D-13-00023; Jassby A, 2013, ZYP PREWHITENED NONL; Jin Z, 2017, GLOBAL CHANGE BIOL, V23, P2687, DOI 10.1111/gcb.13617; Jin ZN, 2016, GLOBAL CHANGE BIOL, V22, P3112, DOI 10.1111/gcb.13376; JONES RJ, 1984, CROP SCI, V24, P133, DOI 10.2135/cropsci1984.0011183X002400010031x; Karmalkar AV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168697; Kucharik CJ, 2008, AGRON J, V100, P328, DOI 10.2134/agronj2007.0145; Kucharik CJ, 2006, AGRON J, V98, P1544, DOI 10.2134/agronj2006.0156; Lobell DB, 2014, SCIENCE, V344, P516, DOI 10.1126/science.1251423; Lobell DB, 2013, NAT CLIM CHANGE, V3, P497, DOI [10.1038/nclimate1832, 10.1038/NCLIMATE1832]; Lobell DB, 2012, PLANT PHYSIOL, V160, P1686, DOI 10.1104/pp.112.208298; Lobell DB, 2003, SCIENCE, V299, P1032, DOI 10.1126/science.1077838; Lu HM, 2015, J HYDROL-REG STUD, V4, P713, DOI 10.1016/j.ejrh.2015.10.004; Luo QY, 2011, CLIMATIC CHANGE, V109, P583, DOI 10.1007/s10584-011-0028-6; Mahanna B, 2012, TIPS COMP CORN MATUR; Marlay S., 2011, EXTERNAL PUBLICATION; McMaster GS, 1997, AGR FOREST METEOROL, V87, P291, DOI 10.1016/S0168-1923(97)00027-0; Meehl GA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040736; Mourtzinis S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29777; Natzke D, 2017, PROGR DAIRYMAN; NCEI (National Centers for Environmental Information), EXP YOUR LAST SPRING; Neild R.E., 1990, GROWING SEASON CHARA; Nielsen DC, 2010, FIELD CROP RES, V118, P259, DOI 10.1016/j.fcr.2010.06.004; Nielsen RLB, 2016, SILK DEV EMERGENCE C; Niyogi D, 2017, EARTH INTERACT, V21, DOI 10.1175/EI-D-15-0045.1; NRCC (Northeast Regional Climate Center), NORM MAX TEMP DEG F; NRCC (Northeast Regional Climate Center), AV LAST FROST DAT; Olesen J, 2004, FARM POLICY J, P1; Overton T, 2013, MANAGER PRO DAIRY; Pachauri R.K., CLIMATE CHANGE 2014; Prasad PVV, ADV AGR SYSTEMS MODE, V1, P301; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Roth GW, 2016, CONSIDERATIONS SELEC, V34; Rotz CA, 2016, T ASABE, V59, P1771, DOI 10.13031/trans.59.11594; Schauberger B., 2016, NAT COMMUN, V8, P13931; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; SCHOPER JB, 1987, PLANT PHYSIOL, V83, P121, DOI 10.1104/pp.83.1.121; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Setter TL, 2001, CROP SCI, V41, P1530, DOI 10.2135/cropsci2001.4151530x; Stoner AMK, 2013, INT J CLIMATOL, V33, P2473, DOI 10.1002/joc.3603; Teixeira EI, 2013, AGR FOREST METEOROL, V170, P206, DOI 10.1016/j.agrformet.2011.09.002; Theil H., 1950, NEDERLANDSCHE AKAD W, V53, P1397; Vanuytrecht E, 2014, AGR FOREST METEOROL, V195, P12, DOI 10.1016/j.agrformet.2014.04.017; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wake C.P., 2005, INDICATORS CLIMATE C; White JW, 2011, FIELD CROP RES, V124, P357, DOI 10.1016/j.fcr.2011.07.001; Xu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156083; Zhang XB, 2000, ATMOS OCEAN, V38, P395, DOI 10.1080/07055900.2000.9649654; Zhou QQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05773-4	70	21	21	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198623	10.1371/journal.pone.0198623	http://dx.doi.org/10.1371/journal.pone.0198623			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889853	Green Published, Green Submitted, gold			2022-12-26	WOS:000434786600032
J	Blifernez-Klassen, O; Chaudhari, S; Klassen, V; Wordenweber, R; Steffens, T; Cholewa, D; Niehaus, K; Kalinowski, J; Kruse, O				Blifernez-Klassen, Olga; Chaudhari, Swapnil; Klassen, Viktor; Woerdenweber, Robin; Steffens, Tim; Cholewa, Dominik; Niehaus, Karsten; Kalinowski, Joern; Kruse, Olaf			Metabolic survey of Botryococcus braunii: Impact of the physiological state on product formation	PLOS ONE			English	Article							GREEN-ALGA; CHLAMYDOMONAS-REINHARDTII; HYDROCARBON BIOSYNTHESIS; SECONDARY CAROTENOIDS; RACE B; ACCUMULATION; MICROALGAE; BIOFUELS; STRAINS; BIOMASS	The microalga Botryococcus braunii is widely regarded as a potential renewable and sustainable source for industrial applications because of its capability to produce large amounts of metabolically expensive (exo-) polysaccharides and lipids, notably hydrocarbons. A comprehensive and systematic metabolic characterization of the Botryococcus braunii race A strain CCAP 807/2 was conducted within the present study, including the detailed analysis of growth-associated and physiological parameters. In addition, the intracellular metabolome was profiled for the first time and showed growth- and product-specific fluctuations in response to the different availability of medium resources during the cultivation course. Among the identified metabolites, a constant expression of raffinose was observed for the first time under standard conditions, which has until now only been described for higher plants. Overall, the multilayered analysis during the cultivation of strain CCAP 807/2 allowed the differentiation of four distinct physiological growth phases and revealed differences in the production profiles and content of liquid hydrocarbons and carbohydrates with up to 84% of organic dry weight (oDW). In the process, an enhanced production of carbohydrates with up to 63% of oDW (1.36 +/- 0.03 g L-1) could be observed during the late linear growth phase, whereas the highest accumulation of extracellular hydrocarbons with up to 24% of oDW (0.66 +/- 0.12 g L-1) occurred mainly during the stationary growth phase. Altogether, the knowledge obtained is potentially useful for the general understanding of the overall physiology of Botryococcus braunii and provide important insights into the growth behavior and product formation of this microalga, and is thus relevant for large scale biofuel production and industrial applications.	[Blifernez-Klassen, Olga; Chaudhari, Swapnil; Klassen, Viktor; Woerdenweber, Robin; Kruse, Olaf] Bielefeld Univ, Algae Biotechnol & Bioenergy, Fac Biol, Ctr Biotechnol CeBiTec, Univ Str 27, Bielefeld, Germany; [Steffens, Tim; Niehaus, Karsten] Bielefeld Univ, Proteome & Metabolome Res, Ctr Biotechnol CeBiTec, Univ Str 27, Bielefeld, Germany; [Cholewa, Dominik] Bielefeld Univ, Fermentat Engn, Fac Technol, Univ Str 25, Bielefeld, Germany; [Kalinowski, Joern] Bielefeld Univ, Microbial Genom & Biotechnol, Ctr Biotechnol CeBiTec, Sequenz 1, Bielefeld, Germany	University of Bielefeld; University of Bielefeld; University of Bielefeld; University of Bielefeld	Kruse, O (corresponding author), Bielefeld Univ, Algae Biotechnol & Bioenergy, Fac Biol, Ctr Biotechnol CeBiTec, Univ Str 27, Bielefeld, Germany.	olaf.kruse@uni-bielefeld.de	Kruse, Olaf/O-1127-2015	Kruse, Olaf/0000-0001-9874-382X; Cholewa, Dominik/0000-0002-2190-8881	European Union [311956]	European Union(European Commission)	This work was supported by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no311956 (relating to project "SPLASH - Sustainable PoLymers from Algae Sugars and Hydrocarbons") to OK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARD B, 1990, PHYTOCHEMISTRY, V29, P1875, DOI 10.1016/0031-9422(90)85031-A; Astals S, 2012, BIORESOURCE TECHNOL, V110, P63, DOI 10.1016/j.biortech.2012.01.080; Banerjee A, 2002, CRIT REV BIOTECHNOL, V22, P245, DOI 10.1080/07388550290789513; Barupal DK, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-40; Becker EW, 2007, BIOTECHNOL ADV, V25, P207, DOI 10.1016/j.biotechadv.2006.11.002; Bogen C, 2013, BIORESOURCE TECHNOL, V133, P622, DOI 10.1016/j.biortech.2013.01.164; Borowitzka M.A., 2013, ALGAE BIOFUELS ENERG, P1; Brodie J, 2017, TRENDS PLANT SCI, V22, P726, DOI 10.1016/j.tplants.2017.05.005; CASADEVALL E, 1985, BIOTECHNOL BIOENG, V27, P286, DOI 10.1002/bit.260270312; Cheng JS, 2012, J CHEM TECHNOL BIOT, V87, P1409, DOI 10.1002/jctb.3759; Cook C., 2017, Biofuels and bioenergy, P157; Dayananda C, 2007, BIOMASS BIOENERG, V31, P87, DOI 10.1016/j.biombioe.2006.05.001; Doebbe A, 2010, J BIOL CHEM, V285, P30247, DOI 10.1074/jbc.M110.122812; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Eroglu E, 2011, J APPL PHYCOL, V23, P763, DOI 10.1007/s10811-010-9577-8; Eroglu E, 2010, BIORESOURCE TECHNOL, V101, P2359, DOI 10.1016/j.biortech.2009.11.043; Farrar J, 2000, PLANT SCI, V154, P1, DOI 10.1016/S0168-9452(99)00260-5; FERNANDES HL, 1989, BIOTECHNOL LETT, V11, P433, DOI 10.1007/BF01089478; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Frommolt R, 2001, PLANTA, V213, P446, DOI 10.1007/s004250100589; Georgianna DR, 2012, NATURE, V488, P329, DOI 10.1038/nature11479; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Gouveia JD, 2017, J BIOTECHNOL, V248, P77, DOI 10.1016/j.jbiotec.2017.03.008; Griffin JL, 2006, PHILOS T R SOC B, V361, P147, DOI 10.1098/rstb.2005.1734; GRUNG M, 1994, COMP BIOCHEM PHYS B, V107, P265, DOI 10.1016/0305-0491(94)90049-3; GRUNG M, 1989, BIOCHEM SYST ECOL, V17, P263, DOI 10.1016/0305-1978(89)90001-X; Hannon M, 2010, BIOFUELS-UK, V1, P763, DOI 10.4155/BFS.10.44; Hartmann MA, 1998, TRENDS PLANT SCI, V3, P170, DOI 10.1016/S1360-1385(98)01233-3; Hirose M, 2013, EUKARYOT CELL, V12, P1132, DOI 10.1128/EC.00088-13; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jin J, 2016, PROCESS BIOCHEM, V51, P1866, DOI 10.1016/j.procbio.2015.11.026; Johnson X, 2013, EUKARYOT CELL, V12, P776, DOI 10.1128/EC.00318-12; Kawachi M, 2012, ALGAL RES, V1, P114, DOI 10.1016/j.algal.2012.05.003; Keller R, 1998, PLANT J, V16, P403, DOI 10.1046/j.1365-313x.1998.00309.x; Khatri W, 2014, BIOTECHNOL BIOENG, V111, P493, DOI 10.1002/bit.25126; Klassen V, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0871-4; Klassen V, 2015, J BIOTECHNOL, V215, P44, DOI 10.1016/j.jbiotec.2015.05.008; Koch K.E., 1997, MOL APPROACH PRIMARY, P105; LARGEAU C, 1980, PHYTOCHEMISTRY, V19, P1081, DOI 10.1016/0031-9422(80)83060-3; LARGEAU C, 1980, PHYTOCHEMISTRY, V19, P1043, DOI 10.1016/0031-9422(80)83054-8; Lemaitre T, 2008, PLANT CELL PHYSIOL, V49, P1056, DOI 10.1093/pcp/pcn081; Li Y, 2013, BIOMASS BIOENERG, V52, P103, DOI 10.1016/j.biombioe.2013.03.002; Li YT, 2010, BIOTECHNOL BIOENG, V107, P258, DOI 10.1002/bit.22807; Loewus FA, 2000, PLANT SCI, V150, P1, DOI 10.1016/S0168-9452(99)00150-8; Lu YDX, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-81; LUPI FM, 1994, ENZYME MICROB TECH, V16, P546, DOI 10.1016/0141-0229(94)90116-3; Martin-Creuzburg D, 2016, J PLANKTON RES, V38, P865, DOI 10.1093/plankt/fbw034; Metzger P, 2005, APPL MICROBIOL BIOT, V66, P486, DOI 10.1007/s00253-004-1779-z; METZGER P, 1986, PHYTOCHEMISTRY, V25, P1869, DOI 10.1016/S0031-9422(00)81165-6; METZGER P, 1990, J PHYCOL, V26, P258, DOI 10.1111/j.0022-3646.1990.00258.x; METZGER P, 1985, PHYTOCHEMISTRY, V24, P2305, DOI 10.1016/S0031-9422(00)83032-0; Metzger P., 1991, FORT CHEM ORG NAT, P1, DOI DOI 10.1007/978-3-7091-9119-4; Metzger P, 1999, CHEM MICROALGAE; Moheimani NR, 2013, J APPL PHYCOL, V25, P1653, DOI 10.1007/s10811-013-0012-9; Molnar I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-576; Moutel B, 2016, PROCESS BIOCHEM, V51, P1855, DOI 10.1016/j.procbio.2016.05.002; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; PLUMLEY FG, 1989, P NATL ACAD SCI USA, V86, P2678, DOI 10.1073/pnas.86.8.2678; Prochazkova G, 2014, J APPL PHYCOL, V26, P1359, DOI 10.1007/s10811-013-0154-9; Rawsthorne S, 2002, PROG LIPID RES, V41, P182, DOI 10.1016/S0163-7827(01)00023-6; SALERNO GL, 1989, PLANT PHYSIOL, V89, P648, DOI 10.1104/pp.89.2.648; Schwarzhans JP, 2015, J APPL PHYCOL, V27, P1389, DOI 10.1007/s10811-014-0458-4; Sengupta S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00656; Steffens T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0710-y; Tefsen B, 2012, GLYCOBIOLOGY, V22, P456, DOI 10.1093/glycob/cwr144; TEMPLIER J, 1984, PHYTOCHEMISTRY, V23, P1017, DOI 10.1016/S0031-9422(00)82602-3; Tonegawa I, 1998, FISHERIES SCI, V64, P305, DOI 10.2331/fishsci.64.305; Watt TF, 2009, J BIOTECHNOL, V140, P59, DOI 10.1016/j.jbiotec.2008.12.003; Weiss TL, 2012, EUKARYOT CELL, V11, P1424, DOI 10.1128/EC.00184-12; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; YAMAGUCHI K, 1987, AGR BIOL CHEM TOKYO, V51, P493, DOI 10.1080/00021369.1987.10868040; YONG TPC, 1986, NEW J CHEM, V10, P701; Yoshimura T, 2013, BIORESOURCE TECHNOL, V133, P232, DOI 10.1016/j.biortech.2013.01.095	74	20	21	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198976	10.1371/journal.pone.0198976	http://dx.doi.org/10.1371/journal.pone.0198976			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879215	Green Published, Green Submitted, gold			2022-12-26	WOS:000434384900102
J	Alahmari, AA; Sreekumar, B; Patel, V; Ashat, M; Alexandre, M; Uduman, AK; Akinbiyi, E; Ceplenski, A; Shugrue, CA; Kolodecik, TR; Tashkandi, N; Messenger, SW; Groblewski, GE; Gorelick, FS; Thrower, EC				Alahmari, A. A.; Sreekumar, B.; Patel, V.; Ashat, M.; Alexandre, M.; Uduman, A. K.; Akinbiyi, E.; Ceplenski, A.; Shugrue, C. A.; Kolodecik, T. R.; Tashkandi, N.; Messenger, S. W.; Groblewski, G. E.; Gorelick, F. S.; Thrower, E. C.			Cigarette toxin 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces experimental pancreatitis through alpha 7 nicotinic acetylcholine receptors (nAChRs) in mice	PLOS ONE			English	Article							TOBACCO-SPECIFIC CARCINOGEN; INDUCED ZYMOGEN ACTIVATION; KINASE-C-DELTA; ACINAR-CELLS; CATHEPSIN-B; IN-VITRO; T-CELLS; SMOKING; RISK; ADENOCARCINOMA	Clinical studies have shown that cigarette smoking is a dose-dependent and independent risk factor for acute pancreatitis. Cigarette smoke contains nicotine which can be converted to the potent receptor ligand and toxin, NNK [4-(methylnitrosamino)-1-(3-pyridyI)-1-butanone]. Previously, we have shown that NNK induces premature activation of pancreatic zymogens in rats, an initiating event in pancreatitis, and this activation is prevented by pharmacologic inhibition of nicotinic acetylcholine receptors (nAChR). In this study, we determined whether NNK mediates pancreatitis through the alpha 7 isoform of nAChR using alpha 7nAChR knockout mice. PCR analysis confirmed expression of non-neuronal alpha 7nAChR in C57BL/6 (WT) mouse and human acinar cells. NNK treatment stimulated trypsinogen activation in acini from WT but not alpha 7nAChR(-/-) mice. NNK also stimulated trypsinogen activation in human acini. To further confirm these findings, WT and alpha 7nAChR(-/-) mice were treated with NNK in vivo and markers of pancreatitis were measured. As observed in acini NNK treatment induced trypsinogen activation in WT but not alpha 7nAChR(-/-) mice. NNK also induced other markers of pancreatitis including pancreatic edema, vacuolization and pyknotic nuclei in WT but not alpha 7nAChR(-/-) animals. NNK treatment led to increased neutrophil infiltration, a marker of inflammation, in WT mice and to a significantly lesser extent in alpha 7nAChR(-/-) mice. We also examined downstream targets of alpha 7nAChR activation and found that calcium and PKC activation are involved down stream of NNK stimulation of alpha 7nAChR. In this study we used genetic deletion of the alpha 7nAChR to confirm our previous inhibitor studies that demonstrated NNK stimulates pancreatitis by activating this receptor. Lastly, we demonstrate that NNK can also stimulate zymogen activation in human acinar cells and thus may play a role in human disease.	[Alahmari, A. A.; Sreekumar, B.; Patel, V.; Ashat, M.; Alexandre, M.; Uduman, A. K.; Akinbiyi, E.; Ceplenski, A.; Shugrue, C. A.; Kolodecik, T. R.; Tashkandi, N.; Gorelick, F. S.; Thrower, E. C.] Yale Univ, Sect Digest Dis, Dept Internal Med, Sch Med, New Haven, CT 06510 USA; [Alahmari, A. A.; Sreekumar, B.; Patel, V.; Ashat, M.; Alexandre, M.; Uduman, A. K.; Akinbiyi, E.; Ceplenski, A.; Shugrue, C. A.; Kolodecik, T. R.; Tashkandi, N.; Gorelick, F. S.; Thrower, E. C.] Vet Affairs Connecticut Healthcare, West Haven, CT 06516 USA; [Messenger, S. W.; Groblewski, G. E.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA; [Gorelick, F. S.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of Wisconsin System; University of Wisconsin Madison; Yale University	Thrower, EC (corresponding author), Yale Univ, Sect Digest Dis, Dept Internal Med, Sch Med, New Haven, CT 06510 USA.; Thrower, EC (corresponding author), Vet Affairs Connecticut Healthcare, West Haven, CT 06516 USA.	edwin.thrower@yale.edu	Alahmari, Abdulrahman A/ADD-4780-2022	Alahmari, Abdulrahman A/0000-0002-7211-3739; Gorelick, Fred/0000-0001-8293-6803	National Institute on Alcohol Abuse and Alcoholism [R21 AA-020847-01]; Connecticut Department of Public Health [2014-0138]; Veterans Administration Merit Award; National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK-34989]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007665] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Connecticut Department of Public Health; Veterans Administration Merit Award; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute on Alcohol Abuse and Alcoholism R21 AA-020847-01 and Connecticut Department of Public Health grant 2014-0138 (to E. C. Thrower), a Veterans Administration Merit Award (Principal Investigator: F. S. Gorelick), and National Institute of Diabetes and Digestive and Kidney Diseases Grant P30 DK-34989 (to the Yale Liver Center) and use of its Morphology Core Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Wadei HAN, 2009, J PATHOL, V218, P437, DOI 10.1002/path.2542; Alexandre M, 2012, AM J PHYSIOL-GASTR L, V303, pG696, DOI 10.1152/ajpgi.00138.2012; Arredondo J, 2006, J CANCER RES CLIN, V132, P653, DOI 10.1007/s00432-006-0113-9; Baez-Pagan CA, 2015, J NEUROIMMUNE PHARM, V10, P468, DOI 10.1007/s11481-015-9601-5; Chernyavsky AI, 2010, AM J PHYSIOL-CELL PH, V299, pC903, DOI 10.1152/ajpcell.00216.2010; Cormier A, 2004, MOL PHARMACOL, V66, P1712, DOI 10.1124/mol.104.000463; Cote GA, 2011, CLIN GASTROENTEROL H, V9, P266, DOI 10.1016/j.cgh.2010.10.015; DUAN RD, 1994, BIOCHEM BIOPH RES CO, V199, P368, DOI 10.1006/bbrc.1994.1238; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; GREENBAUM LM, 1959, J BIOL CHEM, V234, P2885; Haberberger RV, 2003, HISTOCHEM CELL BIOL, V120, P173, DOI 10.1007/s00418-003-0550-3; Husain SZ, 2005, P NATL ACAD SCI USA, V102, P14386, DOI 10.1073/pnas.0503215102; Ji B, 2002, PHARMACOL TOXICOL, V91, P327, DOI 10.1034/j.1600-0773.2002.910610.x; Law R, 2010, PANCREATOLOGY, V10, P54, DOI 10.1159/000225927; Lin Y, 2000, PANCREAS, V21, P109, DOI 10.1097/00006676-200008000-00001; Lu Z, 2002, AM J PHYSIOL-GASTR L, V282, pG501, DOI 10.1152/ajpgi.00388.2001; Majumder S, 2015, PANCREAS, V44, P540, DOI 10.1097/MPA.0000000000000301; Messenger SW, 2015, CELL MOL GASTROENTER, V1, P695, DOI 10.1016/j.jcmgh.2015.08.002; Murphy JA, 2008, GASTROENTEROLOGY, V135, P632, DOI 10.1053/j.gastro.2008.05.026; Narayanapillai SC, 2016, CHEM RES TOXICOL, V29, P1828, DOI 10.1021/acs.chemrestox.6b00203; Prokopczyk B, 2002, CHEM RES TOXICOL, V15, P677, DOI 10.1021/tx0101088; Pryor WA, 1998, CHEM RES TOXICOL, V11, P441, DOI 10.1021/tx970159y; Reed AM, 2011, J BIOL CHEM, V286, P1919, DOI 10.1074/jbc.M110.158329; Saluja AK, 1997, GASTROENTEROLOGY, V113, P304, DOI 10.1016/S0016-5085(97)70108-2; Sato KZ, 1999, NEUROSCI LETT, V266, P17, DOI 10.1016/S0304-3940(99)00259-1; Schuller HM, 2007, LIFE SCI, V80, P2274, DOI 10.1016/j.lfs.2007.03.006; Schuller HM, 1999, CANCER RES, V59, P4510; Schuller HM, 2002, NAT REV CANCER, V2, P455, DOI 10.1038/nrc824; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; Song MY, 2017, FOOD FUNCT, V8, P954, DOI 10.1039/c6fo01367h; Srinivasan P, 2016, AM J PHYSIOL-GASTR L, V310, pG874, DOI 10.1152/ajpgi.00461.2015; Srinivasan P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143575; Srinivasan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078853; Talamini G, 1999, DIGEST DIS SCI, V44, P1303, DOI 10.1023/A:1026670911955; Therriault MJ, 2003, CLIN EXP IMMUNOL, V132, P232, DOI 10.1046/j.1365-2249.2003.02142.x; Thrower EC, 2008, AM J PHYSIOL-GASTR L, V294, pG1344, DOI 10.1152/ajpgi.00020.2008; Thrower EC, 2009, PANCREAS, V38, P930, DOI 10.1097/MPA.0b013e3181b8476a; Tolstrup JS, 2009, ARCH INTERN MED, V169, P603, DOI 10.1001/archinternmed.2008.601; Tsoyi K, 2011, ANTIOXID REDOX SIGN, V14, P2057, DOI 10.1089/ars.2010.3555; Vang A, 2017, AM J PHYSIOL-LUNG C, V312, P1748, DOI 10.1152/ajplung.00393.2016; Wang DW, 2010, J PHARMACOL EXP THER, V335, P553, DOI 10.1124/jpet.110.169961; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wildi S, 2007, GUT, V56, P685, DOI 10.1136/gut.2006.105833; Yadav D, 2010, NAT REV GASTRO HEPAT, V7, P131, DOI 10.1038/nrgastro.2010.6; Yadav D, 2009, ARCH INTERN MED, V169, P1035, DOI 10.1001/archinternmed.2009.125; Zabala V, 2015, ALCOHOL ALCOHOLISM, V50, P118, DOI 10.1093/alcalc/agu083; Zheng YS, 2015, PANCREAS, V44, P500, DOI 10.1097/MPA.0000000000000294	47	3	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0197362	10.1371/journal.pone.0197362	http://dx.doi.org/10.1371/journal.pone.0197362			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870540	Green Published, gold, Green Submitted			2022-12-26	WOS:000434128400005
J	Dantas, VKC; Soares, JD; Medeiros, LBD; Sarmento, ASC; Nobre, TTX; de Andrade, FB; de Lima, JG; Campos, JTAD				Candido Dantas, Veronica Kristina; Soares, Joice da Silva; de Azevedo Medeiros, Lazaro Batista; Craveiro Sarmento, Aquiles Sales; Xavier Nobre, Thaiza Teixeira; de Andrade, Fabia Barbosa; de Lima, Josivan Gomes; Araujo de Melo Campos, Julliane Tamara			Nurses' knowledge about Berardinelli-Seip Congenital Lipodystrophy	PLOS ONE			English	Article							GENERALIZED LIPODYSTROPHY; BONE-DENSITY; NUTRITION; EXERCISE; MUSCLE	Berardinelli-Seip Congenital Lipodystrophy (BSCL) is a rare autosomal recessive disease characterized by the almost complete absence of adipose tissue. Due to a strong founder effect that resulted in a higher prevalence of BSCL in Rio Grande do Norte (RN), a state in northeastern Brazil, it has been essential that health professionals develop knowledge about this disease. Nurses are often the first point of contact with patients during health care assistance. The purpose of this study was to investigate the knowledge of these professionals about BSCL in two main hospitals in RNstate. A questionnaire was applied to 199 nurses working in the Hospital Regional Mariano Coelho-HRMC (Regional Hospital Mariano Coelho), in Currais Novos-RN, and in the Hospital Universitario Onofre Lopes-HUOL (University Hospital Onofre Lopes), in Natal-RN. This study showed that most nursing professionals do not know about the disease, although they have already received patients with BSCL in those hospitals. The nurses from HRMC and HUOL lacked knowledge of BSCL and the healthcare of these patients requires immediate improvement. Significant efforts are required to close the gap between current and needed practice patterns.	[Candido Dantas, Veronica Kristina; Soares, Joice da Silva; de Azevedo Medeiros, Lazaro Batista; Xavier Nobre, Thaiza Teixeira; de Andrade, Fabia Barbosa; Araujo de Melo Campos, Julliane Tamara] Univ Fed Rio Grande do Norte, Fac Ciencias Saude Trairi, Santa Cruz, RN, Brazil; [de Azevedo Medeiros, Lazaro Batista; Craveiro Sarmento, Aquiles Sales; Araujo de Melo Campos, Julliane Tamara] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Biol Celular & Genet, Lab Biol Mol & Genom, Natal, RN, Brazil; [de Lima, Josivan Gomes] Univ Fed Rio Grande do Norte, Dept Med Clin, HUOL, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Campos, JTAD (corresponding author), Univ Fed Rio Grande do Norte, Fac Ciencias Saude Trairi, Santa Cruz, RN, Brazil.; Campos, JTAD (corresponding author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Biol Celular & Genet, Lab Biol Mol & Genom, Natal, RN, Brazil.	julliane@facisa.ufm.br	Araújo de Melo Campos, Julliane Tamara/I-2528-2018; Sarmento, Aquiles Sales Craveiro/AAA-6641-2020; Nobre, Thaiza Teixeira Xavier/ABC-5353-2021	Araújo de Melo Campos, Julliane Tamara/0000-0002-8501-5521; Sarmento, Aquiles Sales Craveiro/0000-0003-1207-830X; Nobre, Thaiza Teixeira Xavier/0000-0002-8673-0009; Medeiros, Lazaro/0000-0003-1289-0795; Andrade, Fabia Barbosa de/0000-0002-7055-8726	LBAM; VKCD; ASCS; UFRN [PIK6980-2011, PVL11978-2015]	LBAM; VKCD; ASCS; UFRN	JTAMC obtained funding for individual undergraduate scientific training for the students LBAM, VKCD and ASCS. These students participated in the research project, titled "Epidemiologic and Genetic Profile of Berardinelli-Seip Syndrome (UFRN registration numbers: PIK6980-2011 and PVL11978-2015). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano RY, 2014, WORLD J DIABETES, V5, P659, DOI 10.4239/wjd.v5.i5.659; BERARDINELLI W, 1954, J CLIN ENDOCR METAB, V14, P193, DOI 10.1210/jcem-14-2-193; Bloomfield Jacqueline, 2012, Nurs Stand, V26, P52; Brown RJ, 2016, J CLIN ENDOCR METAB, V101, P4500, DOI 10.1210/jc.2016-2466; Cauza E, 2005, ARCH PHYS MED REHAB, V86, P1527, DOI 10.1016/j.apmr.2005.01.007; Medeiros LBD, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0280-7; do Rego AG, 2010, ARQ BRAS CARDIOL, V94, P109, DOI 10.1590/S0066-782X2010000100017; Gottems LBD, 2007, REV LAT-AM ENFERM, V15, P1033, DOI 10.1590/S0104-11692007000500023; Fu M, 2004, J CLIN ENDOCR METAB, V89, P2916, DOI 10.1210/jc.2003-030485; Garg A, 2000, AM J MED, V108, P143, DOI 10.1016/S0002-9343(99)00414-3; Garg A, 1999, J CLIN ENDOCR METAB, V84, P3390, DOI 10.1210/jc.84.9.3390; Garg A, 2009, BBA-MOL CELL BIOL L, V1791, P507, DOI 10.1016/j.bbalip.2008.12.014; Gupta N, 2017, J CLIN ENDOCR METAB, V102, P363, DOI 10.1210/jc.2016-2271; Haghighi A, 2016, CLIN GENET, V89, P434, DOI 10.1111/cge.12623; Hasani-Ranjbar S, 2017, INT J PEDIATR-MASSHA, V5, P4275, DOI 10.22038/ijp.2016.7849; Herranz P, 2008, DERMATOL CLIN, V26, P569, DOI 10.1016/j.det.2008.05.004; Instituto Brasileiro de Geografia e Estat A o stica D IBGE, PESQ NAC SAU 2013 CI; Instituto Brasileiro de Geografia e Estat o A stica D IBGE, EST DEM FIC FAT RISC; Jeru I, 2016, EUR J HUM GENET, V24, DOI 10.1038/ejhg.2016.53; Lima JG, 2015, J CLIN MOL ENDOCRINO, V1, DOI [10.21767/2572-5432.10001, DOI 10.21767/2572-5432.10001]; Lima JG, 2018, J CLIN DENSITOM, V21, P61, DOI 10.1016/j.jocd.2016.10.002; Lima JG, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0140-x; Lima JG, 2017, BONE, V101, P21, DOI 10.1016/j.bone.2017.03.053; Mackay L, 1995, Prof Nurse, V10, P427; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Ponte CMM, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-017-0738-4; MOORE SA, 1994, PRIMARY CARE, V21, P69; SEIP M, 1959, Acta Paediatr, V48, P555; Seip M, 1996, ACTA PAEDIATR, V85, P2, DOI 10.1111/j.1651-2227.1996.tb14262.x; Stanford KI, 2014, ADV PHYSIOL EDUC, V38, P308, DOI 10.1152/advan.00080.2014; Tappenden KA, 2013, J ACAD NUTR DIET, V113, P1219, DOI 10.1016/j.jand.2013.05.015; Thomas Linda V, 2016, Br J Community Nurs, V21, P130, DOI 10.12968/bjcn.2016.21.3.130; Van Maldergem L, 2002, J MED GENET, V39, P722, DOI 10.1136/jmg.39.10.722; Van Maldergem L., GENEREVIEWS	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0197784	10.1371/journal.pone.0197784	http://dx.doi.org/10.1371/journal.pone.0197784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864145	Green Published, gold, Green Submitted			2022-12-26	WOS:000434097100009
J	Boboila, S; Lopez, G; Yu, JY; Banerjee, D; Kadenhe-Chiweshe, A; Connolly, EP; Kandel, JJ; Rajbhandari, P; Silva, JM; Califano, A; Yamashiro, DJ				Boboila, Shuobo; Lopez, Gonzalo; Yu, Jiyang; Banerjee, Debarshi; Kadenhe-Chiweshe, Angela; Connolly, Eileen P.; Kandel, Jessica J.; Rajbhandari, Presha; Silva, Jose M.; Califano, Andrea; Yamashiro, Darrell J.			Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; THERAPEUTIC TARGETS; EXPRESSION; AP4; METASTASIS; NETWORK; GENES; IDENTIFICATION; PROGRESSION; ASSOCIATION	Despite the identification of MYCN amplification as an adverse prognostic marker in neuroblastoma, MYCN inhibitors have yet to be developed. Here, by integrating evidence from a whole-genome shRNA library screen and the computational inference of master regulator proteins, we identify transcription factor activating protein 4 (TFAP4) as a critical effector of MYCN amplification in neuroblastoma, providing a novel synthetic lethal target. We demonstrate that TFAP4 is a direct target of MYCN in neuroblastoma cells, and that its expression and activity strongly negatively correlate with neuroblastoma patient survival. Silencing TFAP4 selectively inhibits MYCN-amplified neuroblastoma cell growth both in vitro and in vivo, in xenograft mouse models. Mechanistically, silencing TFAP4 induces neuroblastoma differentiation, as evidenced by increased neurite outgrowth and upregulation of neuronal markers. Taken together, our results demonstrate that TFAP4 is a key regulator of MYCN-amplified neuroblastoma and may represent a valuable novel therapeutic target.	[Boboila, Shuobo; Banerjee, Debarshi; Yamashiro, Darrell J.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA; [Boboila, Shuobo; Yamashiro, Darrell J.] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10032 USA; [Boboila, Shuobo; Connolly, Eileen P.] Columbia Univ, Dept Radiat Oncol, Med Ctr, New York, NY 10032 USA; [Lopez, Gonzalo; Yu, Jiyang; Rajbhandari, Presha; Califano, Andrea] Columbia Univ, Dept Syst Biol, Med Ctr, New York, NY 10032 USA; [Lopez, Gonzalo] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Banerjee, Debarshi; Kadenhe-Chiweshe, Angela; Yamashiro, Darrell J.] Columbia Univ, Dept Surg, Med Ctr, New York, NY 10032 USA; [Kandel, Jessica J.] Univ Chicago Med & Biol Sci, Dept Surg, Sect Pediat Surg, Chicago, IL 60637 USA; [Rajbhandari, Presha] Columbia Univ, Dept Biol Sci, New York, NY 10025 USA; [Silva, Jose M.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Lopez, Gonzalo] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Lopez, Gonzalo] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Yu, Jiyang] St Jude Childrens Res Hosp, Dept Computat Biol, Kay Res & Care Ctr, IA6053,262 Danny Thomas Pl,Mail Stop 1135, Memphis, TN 38105 USA	Columbia University; Columbia University; Columbia University; Columbia University; University of Pennsylvania; Pennsylvania Medicine; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; St Jude Children's Research Hospital	Yamashiro, DJ (corresponding author), Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA.; Yamashiro, DJ (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10032 USA.; Califano, A (corresponding author), Columbia Univ, Dept Syst Biol, Med Ctr, New York, NY 10032 USA.; Yamashiro, DJ (corresponding author), Columbia Univ, Dept Surg, Med Ctr, New York, NY 10032 USA.	ac2248@cumc.columbia.edu; dy39@cumc.columbia.edu	Connolly, Eileen/AAX-9112-2021; banerjee, debarshi/AAF-5704-2020	Lopez, Gonzalo/0000-0002-5092-1284; Yamashiro, Darrell/0000-0002-1250-0235; Connolly, Eileen/0000-0001-6558-1932; Califano, Andrea/0000-0003-4742-3679	Alex's Lemonade Stand Foundation; Hyundai Hope on Wheels; Cancer Target Discovery and Development Consortium; National Cancer Institute (NCI) Outstanding Investigator Award [R35CA197745-02];  [NIH-1S10OD021764];  [NIH-1S10OD012351]; NATIONAL CANCER INSTITUTE [U01CA217858, R35CA197745] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012351, S10OD021764] Funding Source: NIH RePORTER	Alex's Lemonade Stand Foundation; Hyundai Hope on Wheels; Cancer Target Discovery and Development Consortium; National Cancer Institute (NCI) Outstanding Investigator Award; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from Alex's Lemonade Stand Foundation (DJY), Hyundai Hope on Wheels (DJY), The Cancer Target Discovery and Development Consortium (AC, GL, JS), the National Cancer Institute (NCI) Outstanding Investigator Award (R35CA197745-02) (AC). The computational analyses were supported by instrumentation grants NIH-1S10OD021764 and NIH-1S10OD012351. The results published here are, in part, based upon data generated by the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative managed by the NCI. We thank Dr. Jose Silva, Icahn School of Medicine at Mount Sinai, for the generous gift of whole-genome shRNA library. We thank Dr. Garrett Brodeur, Children's Hospital of Philadelphia, for the SHEP21N engineered neuroblastoma cell line. We thank Dr. C. Patrick Reynolds, Texas Tech University, for the CHLA-255 neuroblastoma cell line.	Alvarez MJ, 2016, NAT GENET, V48, P838, DOI 10.1038/ng.3593; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Bhadury J, 2014, P NATL ACAD SCI USA, V111, pE2721, DOI 10.1073/pnas.1406722111; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Califano A, 2017, NAT REV CANCER, V17, P116, DOI 10.1038/nrc.2016.124; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chong CM, 2016, MOL BIOSYST, V12, P2713, DOI 10.1039/c6mb00343e; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; D'Annibale S, 2014, J BIOL CHEM, V289, P7730, DOI 10.1074/jbc.M114.549535; Dart AE, 2013, EUR J CELL BIOL, V92, P129, DOI 10.1016/j.ejcb.2013.03.002; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Egawa T, 2011, P NATL ACAD SCI USA, V108, P14873, DOI 10.1073/pnas.1112293108; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hong SJ, 2008, NEUROCHEM RES, V33, P1821, DOI 10.1007/s11064-008-9639-3; Hsu CL, 2016, ONCOTARGET, V7, P36293, DOI 10.18632/oncotarget.9202; Huang JZ, 2003, P NATL ACAD SCI USA, V100, P7785, DOI 10.1073/pnas.1432908100; Jackstadt R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.282; Jackstadt R, 2013, J EXP MED, V210, P1331, DOI 10.1084/jem.20120812; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Kesanakurti D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.182; Keshelava N, 2005, METH MOLEC MED, V110, P139; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kim MY, 2006, P NATL ACAD SCI USA, V103, P13074, DOI 10.1073/pnas.0601915103; KOHL NE, 1983, CELL, V35, P359, DOI 10.1016/0092-8674(83)90169-1; LAVENIUS E, 1994, GROWTH FACTORS, V10, P29, DOI 10.3109/08977199409019601; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Loh SHY, 2008, CELL DEATH DIFFER, V15, P283, DOI 10.1038/sj.cdd.4402258; Lutz W, 1996, ONCOGENE, V13, P803; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Matthay KK, 2012, CLIN CANCER RES, V18, P2740, DOI 10.1158/1078-0432.CCR-11-1939; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; Rajbhandari P, 2018, CANCER DISCOV, V8, P582, DOI 10.1158/2159-8290.CD-16-0861; Rodriguez-Barrueco R, 2015, GENE DEV, V29, P1631, DOI 10.1101/gad.262642.115; Schofield AV, 2013, CRIT REV BIOCHEM MOL, V48, P301, DOI 10.3109/10409238.2013.786671; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Shi L, 2014, CANCER RES, V74, P532, DOI 10.1158/0008-5472.CAN-13-2203; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tian YM, 2011, DEV BIOL, V353, P206, DOI 10.1016/j.ydbio.2011.02.026; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; Wyce A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072967; Xue CY, 2016, ONCOTARGET, V7, P54937, DOI 10.18632/oncotarget.10709; Yu Jiyang, 2013, Methods Mol Biol, V980, P371, DOI 10.1007/978-1-62703-287-2_22; Zhou J, 2003, WORLD J GASTROENTERO, V9, P9, DOI 10.3748/wjg.v9.i1.9; Zhou ZX, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-944	50	14	15	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 4	2018	37	40					5451	5465		10.1038/s41388-018-0326-9	http://dx.doi.org/10.1038/s41388-018-0326-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GV7MY	29880876	hybrid, Green Published			2022-12-26	WOS:000446312900006
J	Hayashi, S; Nakahata, Y; Kohno, K; Matsui, T; Bessho, Y				Hayashi, Shinichi; Nakahata, Yasukazu; Kohno, Kenji; Matsui, Takaaki; Bessho, Yasumasa			Presomitic mesoderm-specific expression of the transcriptional repressor Hes7 is controlled by E-box, T-box, and Notch signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mouse; development; transcription factor; transcription regulation; Notch pathway; Hes7; mesogenin1; somitogenesis; Tbx6	SOMITE SEGMENTATION CLOCK; MOUSE EMBRYOS; TBX6; SOMITOGENESIS; MESP2; GASTRULATION; MECHANISMS; LEFTY-2; PROTEIN; XENOPUS	Somites are a pair of epithelial spheres beside a neural tube and are formed with an accurate periodicity during embryogenesis in vertebrates. It has been known that Hes7 is one of the core clock genes for somitogenesis, and its expression domain is restricted in the presomitic mesoderm (PSM). However, the molecular mechanism of how Hes7 transcription is regulated is not clear. Here, using transgenic mice and luciferase-based reporter assays and in vitro binding assays, we unravel the mechanism by which Hes7 is expressed exclusively in the PSM. We identified a Hes7 essential region residing -1.5 to -1.1 kb from the transcription start site of mouse Hes7, and this region was indispensable for PSM-specific Hes7 expression. We also present detailed analyses of cis-regulatory elements within the Hes7 essential region that directs Hes7 expression in the PSM. Hes7 expression in the PSM was up-regulated through the E-box, T-box, and RBPj-binding element in the Hes7 essential region, presumably through synergistic signaling involving mesogenin1, T-box6 (Tbx6), and Notch. Furthermore, we demonstrate that Tbx18, Ripply2, and Hes7 repress the activation of the Hes7 essential region by the aforementioned transcription factors. Our findings reveal that a unified transcriptional regulatory network involving a Hes7 essential region confers robust PSM-specific Hes7 gene expression.	[Hayashi, Shinichi; Nakahata, Yasukazu; Matsui, Takaaki; Bessho, Yasumasa] Nara Inst Sci & Technol NAIST, Grad Sch Biol Sci, Inst Res Initiat, Lab Gene Regulat Res, Ikoma, Nara 6300192, Japan; [Kohno, Kenji] Nara Inst Sci & Technol NAIST, Grad Sch Biol Sci, Inst Res Initiat, Lab Mol & Cell Genet, Ikoma, Nara 6300192, Japan; [Hayashi, Shinichi] Tokushima Univ, Embryol, Inst Adv Med Sci, Tokushima 7708503, Japan	Nara Institute of Science & Technology; Nara Institute of Science & Technology; Tokushima University	Nakahata, Y; Bessho, Y (corresponding author), Nara Inst Sci & Technol NAIST, Grad Sch Biol Sci, Inst Res Initiat, Lab Gene Regulat Res, Ikoma, Nara 6300192, Japan.	yasu-nakahata@bs.naist.jp; ybessho@bs.naist.jp	Kohno, Kenji/AAZ-6573-2020	Kohno, Kenji/0000-0002-3503-6551; Nakahata, Yasukazu/0000-0003-3814-5822	Japan Society for the Promotion of Science KAKENHI Grant [JP24659086]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant [JP17H05768]; Uehara Memorial Foundation; Senri Life Science Foundation	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uehara Memorial Foundation(Uehara Memorial Foundation); Senri Life Science Foundation	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant JP24659086 (to Y. N.) and by Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant JP17H05768 (to Y. B.) and in part by The Uehara Memorial Foundation and Senri Life Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Barrantes ID, 1999, CURR BIOL, V9, P470, DOI 10.1016/S0960-9822(99)80212-7; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Biris KK, 2007, DEV DYNAM, V236, P3167, DOI 10.1002/dvdy.21342; Chalamalasetty RB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1381; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Ferjentsik Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000662; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Garnett AT, 2009, DEVELOPMENT, V136, P749, DOI 10.1242/dev.024703; Gonzalez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053323; Hayashi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005603; Hitachi K, 2008, DEV BIOL, V313, P816, DOI 10.1016/j.ydbio.2007.10.015; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kawamura A, 2008, MOL CELL BIOL, V28, P3236, DOI 10.1128/MCB.01754-07; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kondow A, 2007, BIOCHEM BIOPH RES CO, V359, P959, DOI 10.1016/j.bbrc.2007.05.211; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Lieven O, 2010, DEV BIOL, V340, P256, DOI 10.1016/j.ydbio.2010.01.037; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Meno C, 2001, DEV CELL, V1, P127, DOI 10.1016/S1534-5807(01)00006-5; Nikaido M, 2002, NAT GENET, V31, P195, DOI 10.1038/ng899; Niwa Y, 2007, DEV CELL, V13, P298, DOI 10.1016/j.devcel.2007.07.013; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Saijoh Y, 1999, GENE DEV, V13, P259, DOI 10.1101/gad.13.3.259; Sasaki N, 2011, DEVELOPMENT, V138, P55, DOI 10.1242/dev.055533; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Takahashi J, 2010, DEV BIOL, V342, P134, DOI 10.1016/j.ydbio.2010.03.015; Wardle FC, 2008, CURR OPIN GENET DEV, V18, P418, DOI 10.1016/j.gde.2008.07.017; Wittler L, 2007, EMBO REP, V8, P784, DOI 10.1038/sj.embor.7401030; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103; Yasuhiko Y, 2008, DEVELOPMENT, V135, P3511, DOI 10.1242/dev.027144; Yoon JK, 2000, DEV BIOL, V222, P376, DOI 10.1006/dbio.2000.9717	39	9	9	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12167	12176		10.1074/jbc.RA118.003728	http://dx.doi.org/10.1074/jbc.RA118.003728			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29895619	Green Published, hybrid			2022-12-26	WOS:000440803200015
J	Wu, GY; Yang, X; Shen, YQ				Wu, Guangyan; Yang, Xue; Shen, Yuequan			Identification of a single aspartate residue critical for both fast and slow calcium-dependent inactivation of the human TRPML1 channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUCOLIPIDOSIS TYPE-IV; RECEPTOR POTENTIAL CHANNEL; CA2+-DEPENDENT INACTIVATION; RELEASE CHANNEL; CALMODULIN; MECHANISMS; PROTEINS; LYSOSOME; CELLS; DISEASE	Transient receptor potential mucolipin subfamily 1 (TRPML1) is a nonselective cation channel mainly located in late endosomes and lysosomes. Mutations of the gene encoding human TRPML1 can cause severe lysosomal diseases. The activity of TRPML1 is regulated by both Ca2+ and H+, which are important for its critical physiological functions in membrane trafficking, exocytosis, autophagy, and intracellular signal transduction. However, the molecular mechanism of its dual regulation by Ca2+ and H+ remains elusive. Here, using a mutant screening method in combination with a whole-cell patch clamp technique, we identified a key TRPML1 residue, Asp-472, responsible for both fast calcium-dependent inactivation (FCDI) and slow calcium-dependent inactivation (SCDI) as well as H+ regulation. We also found that, in acidic pH, H+ can significantly delay FCDI and abolish SCDI and thereby presumably facilitate the ion conductance of the human TRPML1 channel. In summary, we have identified a key residue critical for Ca2+-induced inhibition of TRPML1 channel currents and uncovered pH-dependent regulation of this channel, providing vital information regarding the detailed mechanism of action of human TRPML1.	[Wu, Guangyan; Yang, Xue; Shen, Yuequan] Nankai Univ, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China; [Wu, Guangyan; Yang, Xue; Shen, Yuequan] Nankai Univ, Coll Life Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China; [Shen, Yuequan] Synerget Innovat Ctr Chem Sci & Engn, 94 Weijin Rd, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Shen, YQ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China.; Shen, YQ (corresponding author), Nankai Univ, Coll Life Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China.; Shen, YQ (corresponding author), Synerget Innovat Ctr Chem Sci & Engn, 94 Weijin Rd, Tianjin 300071, Peoples R China.	yshen@nankai.edu.cn	Wu, Guangyan/P-4083-2019; Shen, Yuequan/C-8950-2013	Wu, Guang/0000-0002-7969-0192; Shen, Yuequan/0000-0002-3775-0900	National Key R&D Program of China [2017YFA0504801]; National Natural Science Foundation of China [31570750, 31370826]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key R&D Program of China Grant 2017YFA0504801 (to Y.S.) and National Natural Science Foundation of China Grants 31570750 and 31370826 (to Y.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao Q, 2017, J BIOL CHEM, V292, P8424, DOI 10.1074/jbc.M116.772160; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; Christensen KA, 2002, J CELL SCI, V115, P599; de Groot T, 2011, MOL CELL BIOL, V31, P2845, DOI 10.1128/MCB.01319-10; Di Paola S, 2018, CELL CALCIUM, V69, P112, DOI 10.1016/j.ceca.2017.06.006; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; Grant L, 2008, J NEUROPHYSIOL, V99, P2183, DOI 10.1152/jn.01174.2007; Grieben M, 2017, NAT STRUCT MOL BIOL, V24, P114, DOI 10.1038/nsmb.3343; Grimm C, 2017, CELL CALCIUM, V67, P148, DOI 10.1016/j.ceca.2017.04.003; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; Li MH, 2017, NAT STRUCT MOL BIOL, V24, P205, DOI 10.1038/nsmb.3362; Li XR, 2016, NAT CELL BIOL, V18, P404, DOI 10.1038/ncb3324; Li XN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01241-9; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lubensky IA, 1999, AM J SURG PATHOL, V23, P1527, DOI 10.1097/00000478-199912000-00010; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Manzoni M, 2004, FEBS LETT, V567, P219, DOI 10.1016/j.febslet.2004.04.080; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Niemeyer BA, 2001, P NATL ACAD SCI USA, V98, P3600, DOI 10.1073/pnas.051511398; Parekh AB, 1998, J BIOL CHEM, V273, P14925, DOI 10.1074/jbc.273.24.14925; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2017, CELL CALCIUM, V63, P20, DOI 10.1016/j.ceca.2016.12.003; Parkinson-Lawrence EJ, 2010, PHYSIOLOGY, V25, P102, DOI 10.1152/physiol.00041.2009; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; ROSENMUND C, 1995, J NEUROPHYSIOL, V73, P427, DOI 10.1152/jn.1995.73.1.427; Schmiege P, 2017, NATURE, V550, P366, DOI 10.1038/nature24036; Schwake M, 2013, TRAFFIC, V14, P739, DOI 10.1111/tra.12056; Shen PS, 2016, CELL, V167, P763, DOI 10.1016/j.cell.2016.09.048; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Venkatachalam K, 2015, CELL CALCIUM, V58, P48, DOI 10.1016/j.ceca.2014.10.008; Wilkes M, 2017, NAT STRUCT MOL BIOL, V24, P123, DOI 10.1038/nsmb.3357; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445	47	1	1	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11736	11745		10.1074/jbc.RA118.003250	http://dx.doi.org/10.1074/jbc.RA118.003250			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29884771	hybrid, Green Published			2022-12-26	WOS:000440134500007
J	You, X; Qin, Z; Yan, QJ; Yang, SQ; Li, YX; Jiang, ZQ				You, Xin; Qin, Zhen; Yan, Qiaojuan; Yang, Shaoqing; Li, Yanxiao; Jiang, Zhengqiang			Structural insights into the catalytic mechanism of a novel glycoside hydrolase family 113 beta-1,4-mannanase from Amphibacillus xylanus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-ACTIVE ENZYMES; BETA-MANNANASE; SUBSTRATE-RECOGNITION; ENZYMATIC CHARACTERIZATION; GENE CLONING; PROTEIN; REVEALS; BINDING; ENDO-BETA-1,4-MANNANASE; TRANSGLYCOSIDASE	beta-1,4-Mannanase degrades beta-1,4-mannan polymers into manno-oligosaccharides with a low degree of polymerization. To date, only one glycoside hydrolase (GH) family 113 beta-1,4-mannanase, from Alicyclobacillus acidocaldarius (AaManA), has been structurally characterized, and no complex structure of enzyme-manno-oligosaccharides from this family has been reported. Here, crystal structures of a GH family 113 beta-1,4-mannanase from Amphibacillus xylanus (AxMan113A) and its complexes with mannobiose, mannotriose, mannopentaose, and mannahexaose were solved. AxMan113A had higher affinity for -1 and -1 mannoses, which explains why the enzyme can hydrolyze mannobiose. At least six subsites -4 to +2) exist in the groove, but mannose units preferentially occupied subsites -4 to -1 because of steric hindrance formed by Lys-238 and Trp-239. Based on the structural information and bioinformatics, rational design was implemented to enhance hydrolysis activity. Enzyme activity of AxMan113A mutants V139C, N237W, K238A, and W239Y was improved by 93.7, 63.4, 112.9, and 36.4%, respectively, compared with the WT. In addition, previously unreported surface-binding sites were observed. Site-directed mutagenesis studies and kinetic data indicated that key residues near the surface sites play important roles in substrate binding and recognition. These first GH family 113 beta-1,4-mannanase-manno-oligosaccharide complex structures may be useful in further studying the catalytic mechanism ofGH family 113 members, and provide novel insight into protein engineering of GHs to improve their hydrolysis activity.	[You, Xin; Yan, Qiaojuan; Li, Yanxiao] China Agr Univ, Coll Engn, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing 100083, Peoples R China; [Qin, Zhen] East China Univ Sci & Technol, R&D Ctr Separat & Extract Technol Fermentat Ind, Sch Biotechnol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China; [Yang, Shaoqing; Jiang, Zhengqiang] China Agr Univ, Coll Food Sci & Nutrit Engn, Beijing 100083, Peoples R China	China Agricultural University; East China University of Science & Technology; China Agricultural University	Jiang, ZQ (corresponding author), China Agr Univ, POB 294,17 Qinghua Donglu, Beijing 100083, Peoples R China.	zhqjiang@cau.edu.cn		qin, zhen/0000-0003-2133-8572	National Natural Science Foundation of China [31630096];  [T2014055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This work was supported in part by the Key Program of the National Natural Science Foundation of China Grant 31630096 and Program for Changjiang Scholars Grant T2014055. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arab-Jaziri F, 2013, NEW BIOTECHNOL, V30, P536, DOI 10.1016/j.nbt.2013.04.002; Asano I, 2003, FOOD SCI TECHNOL RES, V9, P62, DOI 10.3136/fstr.9.62; Benech RO, 2007, ENZYME MICROB TECH, V41, P740, DOI 10.1016/j.enzmictec.2007.06.012; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cockburn D, 2014, BIOLOGIA, V69, P705, DOI 10.2478/s11756-014-0373-9; Couturier M, 2013, J BIOL CHEM, V288, P14624, DOI 10.1074/jbc.M113.459438; Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537; Daskiran M, 2004, POULTRY SCI, V83, P662, DOI 10.1093/ps/83.4.662; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng HY, 2005, J BIOL CHEM, V280, P37088, DOI 10.1074/jbc.M502873200; Fukamizo T, 2000, J BIOL CHEM, V275, P25633, DOI 10.1074/jbc.M002574200; Golovanov AP, 1998, J BIOMOL STRUCT DYN, V15, P673, DOI 10.1080/07391102.1998.10508984; Guo W, 2014, LANGMUIR, V30, P243, DOI 10.1021/la403494q; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Jin Y, 2016, ACS CENTRAL SCI, V2, P896, DOI 10.1021/acscentsci.6b00232; Katrolia P, 2013, J AGR FOOD CHEM, V61, P394, DOI 10.1021/jf303319h; Kim MK, 2014, PROTEINS, V82, P3217, DOI 10.1002/prot.24655; Kumagai Y, 2015, FEBS J, V282, P4001, DOI 10.1111/febs.13401; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsson AM, 2006, J MOL BIOL, V357, P1500, DOI 10.1016/j.jmb.2006.01.044; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Le Nours K, 2005, BIOCHEMISTRY-US, V44, P12700, DOI 10.1021/bi050779v; Li JM, 2016, FOOD HYDROCOLLOID, V53, P46, DOI 10.1016/j.foodhyd.2015.01.035; Li YX, 2015, J MOL CATAL B-ENZYM, V122, P265, DOI 10.1016/j.molcatb.2015.09.018; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo ZC, 2017, APPL BIOCHEM BIOTECH, V182, P1259, DOI 10.1007/s12010-017-2397-4; Lyu QQ, 2015, BBA-GEN SUBJECTS, V1850, P1953, DOI 10.1016/j.bbagen.2015.06.011; Ma YH, 2004, EXTREMOPHILES, V8, P447, DOI 10.1007/s00792-004-0405-4; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Murphy GS, 2012, STRUCTURE, V20, P1086, DOI 10.1016/j.str.2012.03.026; Nielsen PK, 2003, BIOCHEMISTRY-US, V42, P1478, DOI 10.1021/bi020508+; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace CN, 2001, BIOCHEMISTRY-US, V40, P310, DOI 10.1021/bi001574j; Puchart V, 2005, BBA-GEN SUBJECTS, V1726, P206, DOI 10.1016/j.bbagen.2005.07.015; Robert X, 2003, STRUCTURE, V11, P973, DOI 10.1016/S0969-2126(03)00151-5; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rosengren A, 2014, APPL MICROBIOL BIOT, V98, P10091, DOI 10.1007/s00253-014-5871-8; Sakai K, 2017, APPL MICROBIOL BIOT, V101, P3237, DOI 10.1007/s00253-017-8107-x; Srivastava PK, 2017, BIOTECHNOL ADV, V35, P1, DOI 10.1016/j.biotechadv.2016.11.001; Takano K, 2001, BIOCHEMISTRY-US, V40, P4853, DOI 10.1021/bi002792f; Teze D, 2014, PROTEIN ENG DES SEL, V27, P13, DOI 10.1093/protein/gzt057; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vuong TV, 2010, BIOTECHNOL BIOENG, V107, P195, DOI 10.1002/bit.22838; Williams RJ, 2014, ANGEW CHEM INT EDIT, V53, P1087, DOI 10.1002/anie.201308334; Wu YF, 2013, FOOD CHEM, V138, P1588, DOI 10.1016/j.foodchem.2012.11.052; Xia W, 2016, APPL ENVIRON MICROB, V82, P2718, DOI 10.1128/AEM.04071-15; Yamabhai M, 2016, CRIT REV BIOTECHNOL, V36, P32, DOI 10.3109/07388551.2014.923372; Yoon SJ, 2008, J CLIN BIOCHEM NUTR, V42, P1, DOI 10.3164/jcbn.2008001; You X, 2018, BBA-GEN SUBJECTS, V1862, P1376, DOI 10.1016/j.bbagen.2018.03.016; Zakariassen H, 2011, BIOCHEMISTRY-US, V50, P5693, DOI 10.1021/bi2002532; Zhang YL, 2008, J BIOL CHEM, V283, P31551, DOI 10.1074/jbc.M803409200	56	7	7	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11746	11757		10.1074/jbc.RA118.002363	http://dx.doi.org/10.1074/jbc.RA118.002363			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29871927	hybrid, Green Published			2022-12-26	WOS:000440134500008
J	Chen, SP; Yang, J; Zhang, Y; Duan, CY; Liu, Q; Huang, ZY; Xu, Y; Zhou, L; Xu, GQ				Chen, Suping; Yang, Jing; Zhang, Yang; Duan, Chunyan; Liu, Qing; Huang, Zhengyun; Xu, Ying; Zhou, Liang; Xu, Guoqiang			Ubiquitin-conjugating enzyme UBE2O regulates cellular clock function by promoting the degradation of the transcription factor BMAL1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin-conjugating enzyme (E2 enzyme); ubiquitylation (ubiquitination); ubiquitin; clock gene; transcription factor; BMAL1; circadian function; degradation; UBE2O; polyubiquitination; transcriptional activity	CIRCADIAN CLOCK; PROTEIN BMAL1; LIGASE UBE2O; CELLS; PHOSPHORYLATION; MECHANISM; APOPTOSIS; HEALTH; PER1; ACETYLATION	Dysregulation of the circadian rhythm is associated with many diseases, including diabetes, obesity, and cancer. Aryl hydrocarbon receptor nuclear translocator-like protein 1 (Arntl or Bmal1) is the only clock gene whose loss disrupts circadian locomotor behavior in constant darkness. BMAL1 levels are affected by proteasomal inhibition and by several enzymes in the ubiquitin-proteasome system, but the exact molecular mechanism remains unclear. Here, using immunoprecipitation and MS analyses, we discovered an interaction between BMAL1 and ubiquitin-conjugating enzyme E2 O (UBE2O), an E3-independent E2 ubiquitin-conjugating enzyme (i.e. hybrid E2/E3 enzyme). Biochemical experiments with cell lines and animal tissues validated this specific interaction and uncovered that UBE2O expression reduces BMAL1 levels by promoting its ubiquitination and degradation. Moreover, UBE2O expression/knockdown diminished/increased, respectively, BMAL1-mediated transcriptional activity but did not affect BMAL1 gene expression. Bioluminescence experiments disclosed that UBE2O knockdown elevates the amplitude of the circadian clock in human osteosarcoma U2OS cells. Furthermore, mapping of the BMAL1-interacting domain in UBE2O and analyses of BMAL1 stability and ubiquitination revealed that the conserved region 2 (CR2) in UBE2O significantly enhances BMAL1 ubiquitination and decreases BMAL1 protein levels. A Cys-to-Ser substitution experiment identified the critical Cys residue in the CR2 domain responsible for BMAL1 ubiquitination. This work identifies UBE2O as a critical regulator in the ubiquitin-proteasome system, which modulates BMAL1 transcriptional activity and circadian function by promoting BMAL1 ubiquitination and degradation under normal physiological conditions.	[Chen, Suping; Yang, Jing; Zhang, Yang; Duan, Chunyan; Liu, Qing; Zhou, Liang; Xu, Guoqiang] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Chen, Suping; Yang, Jing; Zhang, Yang; Duan, Chunyan; Liu, Qing; Zhou, Liang; Xu, Guoqiang] Soochow Univ, Coll Pharmaceut Sci, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Xu, Guoqiang] Soochow Univ, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Huang, Zhengyun; Xu, Ying] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Huang, Zhengyun; Xu, Ying] Soochow Univ, Cambridge Suda Genom Resource Ctr, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Zhou, L; Xu, GQ (corresponding author), Soochow Univ, Coll Pharmaceut Sci, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China.	liangzhou@suda.edu.cn; gux2002@suda.edu.cn	Xu, Ying/AAF-3081-2019; Xu, Ying/A-3009-2013	Xu, Ying/0000-0002-6689-7768; Xu, Ying/0000-0002-6689-7768; Xu, Guoqiang/0000-0002-4753-4769	National Basic Research Program of China (973 Program) [2012CB947602]; National Natural Science Foundation of China [31670833, 81703535]; China Postdoctoral Science Foundation [2017M611895]; Natural Science Foundation of Jiangsu Higher Education Institutions of China [17KJD180005]; Jiangsu Postdoctoral Science Foundation [1701130C]; Jiangsu Key Laboratory of Neuropsychiatric Diseases Grant [BM2013003]; National Center for International Research Grant [2017B01012]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Jiangsu Higher Education Institutions of China; Jiangsu Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Key Laboratory of Neuropsychiatric Diseases Grant; National Center for International Research Grant; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This work was supported by the National Basic Research Program of China (973 Program, 2012CB947602), National Natural Science Foundation of China (31670833 and 81703535), China Postdoctoral Science Foundation (2017M611895), Natural Science Foundation of Jiangsu Higher Education Institutions of China (17KJD180005), Jiangsu Postdoctoral Science Foundation (1701130C), Jiangsu Key Laboratory of Neuropsychiatric Diseases Grant BM2013003, National Center for International Research Grant 2017B01012, and a project funded by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Berleth ES, 1996, BIOCHEMISTRY-US, V35, P1664, DOI 10.1021/bi952105y; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Dang FB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12696; Duan WW, 2016, PROTEOMICS, V16, P60, DOI 10.1002/pmic.201500356; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Evans JA, 2013, PROG MOL BIOL TRANSL, V119, P283, DOI 10.1016/B978-0-12-396971-2.00010-5; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gossan NC, 2014, NUCLEIC ACIDS RES, V42, P5765, DOI 10.1093/nar/gku225; Hardie DG, 2017, CANCER CELL, V31, P163, DOI 10.1016/j.ccell.2017.01.010; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirano A, 2016, NAT STRUCT MOL BIOL, V23, P1053, DOI 10.1038/nsmb.3326; Hirano A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154263; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hormaechea-Agulla D, 2018, MOL CELLS, V41, P168, DOI 10.14348/molcells.2018.0008; Hou XO, 2015, ACTA PHARMACOL SIN, V36, P1300, DOI 10.1038/aps.2015.54; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Khapre RV, 2014, AGING-US, V6, P48, DOI 10.18632/aging.100633; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Lee J, 2008, MOL CELL BIOL, V28, P6056, DOI 10.1128/MCB.00583-08; Lee Y, 2015, BBA-MOL CELL RES, V1853, P2697, DOI 10.1016/j.bbamcr.2015.07.005; Liang KW, 2017, CELL, V168, P59, DOI 10.1016/j.cell.2016.12.011; Lipton JO, 2015, CELL, V161, P1138, DOI 10.1016/j.cell.2015.04.002; Liu ZW, 2014, CELL REP, V7, P1509, DOI 10.1016/j.celrep.2014.04.032; Mashtalir N, 2014, MOL CELL, V54, P392, DOI 10.1016/j.molcel.2014.03.002; Nguyen AT, 2017, SCIENCE, V357, DOI 10.1126/science.aan0218; Puram RV, 2016, CELL, V165, P303, DOI 10.1016/j.cell.2016.03.015; Ren HG, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-40; Ribas-Latre A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10954; Roenneberg T, 2016, CURR BIOL, V26, pR432, DOI 10.1016/j.cub.2016.04.011; Sahar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008561; Sanada K, 2002, J BIOL CHEM, V277, P267, DOI 10.1074/jbc.M107850200; Scoma HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025382; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shi GS, 2016, CELL REP, V14, P823, DOI 10.1016/j.celrep.2015.12.076; Stojkovic K, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00069; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; Tamaru T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002293; Tamaru T, 2009, NAT STRUCT MOL BIOL, V16, P446, DOI 10.1038/nsmb.1578; Tang QM, 2017, CANCER RES, V77, P532, DOI 10.1158/0008-5472.CAN-16-1322; Tong X, 2012, J BIOL CHEM, V287, P25280, DOI 10.1074/jbc.M112.340786; Vila IK, 2017, MOL CELL ONCOL, V4, DOI 10.1080/23723556.2017.1304846; Vila IK, 2017, CANCER CELL, V31, P208, DOI 10.1016/j.ccell.2017.01.003; Xu GQ, 2013, J BIOL CHEM, V288, P29573, DOI 10.1074/jbc.M113.472092; Xu YJ, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0499-7; Yanagitani K, 2017, SCIENCE, V357, P472, DOI 10.1126/science.aan0178; Yang YM, 2014, J BIOL RHYTHM, V29, P243, DOI 10.1177/0748730414544741; Yang YM, 2012, BIOL OPEN, V1, P789, DOI 10.1242/bio.20121990; Zhang XF, 2013, EMBO J, V32, P996, DOI 10.1038/emboj.2013.38; Zhang XF, 2013, CELL RES, V23, P366, DOI 10.1038/cr.2013.21; Zhang Y, 2018, BIOCHEM J, V475, P1507, DOI 10.1042/BCJ20180005; Zhou YQ, 2016, J PROTEOMICS, V148, P94, DOI 10.1016/j.jprot.2016.07.015	58	29	30	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11296	11309		10.1074/jbc.RA117.001432	http://dx.doi.org/10.1074/jbc.RA117.001432			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29871923	Green Published, hybrid			2022-12-26	WOS:000439449700004
J	Han, X; Zhao, JX; Ruddy, KJ; Lin, CC; Sineshaw, HM; Jemal, A				Han, Xuesong; Zhao, Jingxuan; Ruddy, Kathryn J.; Lin, Chun Chieh; Sineshaw, Helmneh M.; Jemal, Ahmedin			The impact of dependent coverage expansion under the Affordable Care Act on time to breast cancer treatment among young women	PLOS ONE			English	Article							ADULTS; SURVIVAL; DELAY; INITIATION; DIAGNOSIS; INSURANCE; OUTCOMES	Introduction Breast cancer in young women tends to be more aggressive, but timely treatment may not be always available, particularly to those without health insurance. We aim to examine whether the dependent coverage expansion under the Affordable Care Act (ACA-DCE) implemented in 2010 was associated with changes in time to treatment among women diagnosed with early stage breast cancer. Methods A total of 7,176 patients diagnosed with early stage breast cancer in 2007-2009 (pre-ACA) and 2011-2013 (post-ACA) were identified from the National Cancer Database. A quasi experimental design difference-in-differences (DD) approach was used, with patients aged 19-25 (targeted by the policy) considered as the intervention group, and patients aged 2634 years (not affected by the policy) as the control group. Changes in the following treatment outcomes were examined: time from diagnosis to surgery, time from surgery to adjuvant chemotherapy, and time from adjuvant chemotherapy to radiation. Results Compared with the control group of patients aged 26-34, young patients aged 19-25 experienced a statistically nonsignificant decrease of 2.7 percentage points (95% Cl [-1.2, 6.5]) in the uninsured rate. This did not translate into more reduction in delays to surgery (DD = 2.7 days, 95% Cl [-3.2, 8.3]), chemotherapy (DD = -1.0 days, 95% CI [-7.2, 5.2]) or radiation (DD = 5.3 days, 95% Cl [-15.6, 26.3]) in the younger cohort than the older cohort. Conclusions and Relevance No significant changes in time to treatment were found among young women diagnosed with early stage breast cancer after the implementation of the ACA-DCE. Future studies examining impacts of health care policy reform on breast cancer care are warranted to include patients from low-income families and to consider effects from Medicaid expansion.	[Han, Xuesong; Zhao, Jingxuan; Lin, Chun Chieh; Sineshaw, Helmneh M.; Jemal, Ahmedin] Amer Canc Soc, Surveillance & Hlth Serv Res, Atlanta, GA 30329 USA; [Han, Xuesong; Zhao, Jingxuan; Jemal, Ahmedin] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Ruddy, Kathryn J.] Mayo Clin, Dept Oncol, Rochester, MN USA	American Cancer Society; Emory University; Rollins School Public Health; Mayo Clinic	Han, X (corresponding author), Amer Canc Soc, Surveillance & Hlth Serv Res, Atlanta, GA 30329 USA.; Han, X (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	xuesong.han@cancer.org		Han, Xuesong/0000-0001-7159-7949	NCATS NIH HHS [KL2 TR002379] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Adolescent and Young Adult Oncology Program Review Group, 2006, CLOS GAP RES CAR IMP; American College of Surgeons, NAT CANC DAT; Barr RD, 2016, JAMA PEDIATR, V170, P495, DOI 10.1001/jamapediatrics.2015.4689; Bleicher RJ, 2016, JAMA ONCOL, V2, P330, DOI 10.1001/jamaoncol.2015.4508; Bleyer A, 2006, CANC EPIDEMIOLOGY OL; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chavez-MacGregor M, 2016, JAMA ONCOL, V2, P322, DOI 10.1001/jamaoncol.2015.3856; Gagliato DD, 2014, J CLIN ONCOL, V32, P735, DOI 10.1200/JCO.2013.49.7693; Han XS, 2016, J ADOLESCENT HEALTH, V59, P648, DOI 10.1016/j.jadohealth.2016.07.027; Han XS, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw058; Hebert-Croteau N, 2002, BREAST CANCER RES TR, V74, P77, DOI 10.1023/A:1016089215070; Huang J, 2003, J CLIN ONCOL, V21, P555, DOI 10.1200/JCO.2003.04.171; Liederbach E, 2015, ANN SURG ONCOL, V22, P899, DOI 10.1245/s10434-014-4086-7; McLaughlin JM, 2012, J CLIN ONCOL, V30, P4493, DOI 10.1200/JCO.2012.39.7695; Parsons HM, 2016, CANCER-AM CANCER SOC, V122, P1766, DOI 10.1002/cncr.29982; Smith EC, 2013, JAMA SURG, V148, P516, DOI 10.1001/jamasurg.2013.1680; Sommers BD, 2013, HEALTH AFFAIR, V32, P165, DOI 10.1377/hlthaff.2012.0552	17	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0198771	10.1371/journal.pone.0198771	http://dx.doi.org/10.1371/journal.pone.0198771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897976	Green Published, Green Submitted, gold			2022-12-26	WOS:000435090700067
J	Vicente, A; Bystrom, B; Lindstrom, M; Stenevi, U; Domellof, FP				Vicente, Andre; Bystrom, Berit; Lindstrom, Mona; Stenevi, Ulf; Domellof, Fatima Pedrosa			Aniridia-related keratopathy: Structural changes in naive and transplanted corneal buttons	PLOS ONE			English	Article							STEM-CELL DEFICIENCY; CONGENITAL ANIRIDIA; OCULAR SURFACE; EPITHELIAL-CELLS; EXPRESSION; MANAGEMENT; FIBROSIS; COLLAGEN; DISEASE; EYE	Background To study structural changes in naive and surgically treated corneas of aniridia patients with advanced aniridia-related keratopathy (ARK). Methods and findings Two naive corneal buttons from patients with advanced ARK submitted to penetrating keratoplasty for the first time, one corneal button from an ARK patient that had undergone a keratolimbal allograft (KLAL), two corneal buttons from ARK patients who had previously undergone centered or decentered transplantation and were now retransplanted and two adult healthy donor control corneas were processed for immunohistochemistry. Antibodies against extracellular matrix components in the stroma and in the epithelial basement membrane (collagen I and IV, collagen receptor alpha 11 integrin and laminin alpha 3 chain), markers of fibrosis, wound healing and vascularization (fibronectin, tenascin-C, vimentin, alpha-SMA and caveolin-1), cell division (Ki-67) and macrophages (CD68) were used. Naive ARK, KLAL ARK corneas and transplanted corneal buttons presented similar histopathological changes with irregular epithelium and disruption or absence of epithelial basal membrane. There was a loss of the orderly pattern of collagen lamellae and absence of collagen I in all ARK corneas. Vascularization was revealed by the presence of caveolin-1 and collagen IV in the pannus of all ARK aniridia corneas. The changes observed in decentered and centered transplants were analogous. Conclusions Given the similar pathological features of all cases, conditions inherent to the host seem to play an important role on the pathophysiology of the ARK in the long run.	[Vicente, Andre; Bystrom, Berit; Domellof, Fatima Pedrosa] Umea Univ, Dept Clin Sci, Ophthalmol, Umea, Sweden; [Lindstrom, Mona; Domellof, Fatima Pedrosa] Umea Univ, Dept Integrat Med Biol, Sect Anat, Umea, Sweden; [Stenevi, Ulf] Univ Gothenburg, Dept Ophthalmol, Gothenburg, Sweden	Umea University; Umea University; University of Gothenburg	Domellof, FP (corresponding author), Umea Univ, Dept Clin Sci, Ophthalmol, Umea, Sweden.; Domellof, FP (corresponding author), Umea Univ, Dept Integrat Med Biol, Sect Anat, Umea, Sweden.	fatima.pedrosa-domellof@umu.se		Vicente, Andre/0000-0002-7240-6515	Swedish Research Council (Stockholm, Sweden) [2015-02438]; County Council of Vasterbotten - Cutting Edge Medical Research (Umea, Sweden); Kronprinsessan Margaretas Arbetsnamnd for Synskadade (Valdemarsvik, Sweden); Medical Faculty, Umea University (Umea, Sweden)	Swedish Research Council (Stockholm, Sweden)(Swedish Research Council); County Council of Vasterbotten - Cutting Edge Medical Research (Umea, Sweden); Kronprinsessan Margaretas Arbetsnamnd for Synskadade (Valdemarsvik, Sweden); Medical Faculty, Umea University (Umea, Sweden)	This study was financially supported by grants from the Swedish Research Council (2015-02438; Stockholm, Sweden), County Council of Vasterbotten - Cutting Edge Medical Research (Umea, Sweden), Kronprinsessan Margaretas Arbetsnamnd for Synskadade (Valdemarsvik, Sweden) and The Medical Faculty, Umea University (Umea, Sweden). Fatima Pedrosa Domellof was the recipient of the above mentioned grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage WJ, 2003, INVEST OPHTH VIS SCI, V44, P3326, DOI 10.1167/iovs.02-1255; Auw-Haedrich C, 2011, ACTA OPHTHALMOL, V89, P47, DOI 10.1111/j.1755-3768.2009.01603.x; Bakhtiari P, 2010, MIDDLE EAST AFR J OP, V17, P9, DOI 10.4103/0974-9233.61211; Bystrom B, 2006, INVEST OPHTH VIS SCI, V47, P777, DOI 10.1167/iovs.05-0367; Bystrom B, 2007, HISTOCHEM CELL BIOL, V127, P657, DOI 10.1007/s00418-007-0288-4; Bystrom B, 2009, INVEST OPHTH VIS SCI, V50, P5044, DOI 10.1167/iovs.08-3261; Das SK, 2014, INVEST OPHTH VIS SCI, V55, P4030, DOI 10.1167/iovs.13-13494; de la Paz MF, 2008, ACTA OPHTHALMOL, V86, P735, DOI 10.1111/j.1755-3768.2008.01293.x; Eden U, 2008, ACTA OPHTHALMOL, V86, P730, DOI 10.1111/j.1755-3768.2008.01310.x; Eden U, 2012, OPHTHALMOLOGY, V119, P1803, DOI 10.1016/j.ophtha.2012.02.043; Eden U, 2010, CORNEA, V29, P1096, DOI 10.1097/ICO.0b013e3181d20493; Espana EM, 2004, INVEST OPHTH VIS SCI, V45, P2961, DOI 10.1167/iovs.03-1397; Gal RL, 2008, OPHTHALMOLOGY, V115, P620, DOI 10.1016/j.ophtha.2008.01.003; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Holland E J, 1996, Trans Am Ophthalmol Soc, V94, P677; Holland EJ, 2003, OPHTHALMOLOGY, V110, P125, DOI 10.1016/S0161-6420(02)01451-3; Holland EJ, 2000, CORNEA, V19, P688, DOI 10.1097/00003226-200009000-00014; HSU JKW, 1993, ARCH OPHTHALMOL-CHIC, V111, P1057, DOI 10.1001/archopht.1993.01090080053018; Ihanamaki T, 2004, PROG RETIN EYE RES, V23, P403, DOI 10.1016/j.preteyeres.2004.04.002; Ihnatko R, 2016, OCUL SURF, V14, P196, DOI 10.1016/j.jtos.2015.10.003; Karamichos D, 2010, INVEST OPHTH VIS SCI, V51, P1382, DOI 10.1167/iovs.09-3860; Kawashima M, 2010, MOL VIS, V16, P2727; Kim Joung Y, 2003, Ophthalmol Clin North Am, V16, P67, DOI 10.1016/S0896-1549(02)00107-4; Lagali N, 2013, INVEST OPHTH VIS SCI, V54, P5333, DOI 10.1167/iovs.13-11780; Lagali N, 2009, INVEST OPHTH VIS SCI, V50, P2673, DOI 10.1167/iovs.08-2923; Le Q, 2013, EYE, V27, P763, DOI 10.1038/eye.2013.50; Lee H, 2008, ACTA OPHTHALMOL, V86, P708, DOI 10.1111/j.1755-3768.2008.01427.x; Lim HT, 2017, CURR OPIN OPHTHALMOL, V28, P436, DOI 10.1097/ICU.0000000000000405; Ljubimov AV, 2015, PROG RETIN EYE RES, V49, P17, DOI 10.1016/j.preteyeres.2015.07.002; LJUBIMOV AV, 1995, LAB INVEST, V72, P461; Ljubimov AV, 1998, EXP EYE RES, V67, P265, DOI 10.1006/exer.1998.0511; Bausili MM, 2016, OPHTHALMIC RES, V56, P202, DOI 10.1159/000444930; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nagamoto T, 2000, INVEST OPHTH VIS SCI, V41, P1122; Ramaesh T, 2005, EXP EYE RES, V81, P224, DOI 10.1016/j.exer.2005.02.002; Ramaesh T, 2003, INVEST OPHTH VIS SCI, V44, P1871, DOI 10.1167/iovs.02-0576; Reinhard T, 2004, OPHTHALMOLOGY, V111, P775, DOI 10.1016/j.ophtha.2003.07.013; Rhim JH, 2010, MOL MED, V16, P527, DOI 10.2119/molmed.2010.00046; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Saika S, 2016, EXP EYE RES, V142, P40, DOI 10.1016/j.exer.2014.12.015; Sheppard J, 2010, INVEST OPHTH VIS SCI, V51, P2936, DOI 10.1167/iovs.09-4612; Singh V, 2012, EXP EYE RES, V98, P1, DOI 10.1016/j.exer.2012.03.006; Sumioka T, 2011, INVEST OPHTH VIS SCI, V52, P2462, DOI 10.1167/iovs.10-5750; Torp SH, 1997, J CLIN PATHOL-MOL PA, V50, P198, DOI 10.1136/mp.50.4.198; Torricelli AAM, 2013, INVEST OPHTH VIS SCI, V54, P6390, DOI 10.1167/iovs.13-12547; Tsai JH, 2005, AM J OPHTHALMOL, V140, P1075, DOI 10.1016/j.ajo.2005.07.035; TSUBOTA K, 1995, OPHTHALMOLOGY, V102, P1486; Tuori A, 1997, GRAEF ARCH CLIN EXP, V235, P222, DOI 10.1007/BF00941763; WILSON SE, 1994, EXP EYE RES, V59, P665, DOI 10.1006/exer.1994.1152; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200	50	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198822	10.1371/journal.pone.0198822	http://dx.doi.org/10.1371/journal.pone.0198822			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889891	Green Published, Green Submitted, gold			2022-12-26	WOS:000434786600055
J	Lima, JG; Nobrega, LHC; Lima, NN; dos Santos, MCF; Silva, PHD; Baracho, MDP; Lima, DN; Campos, JTAD; Ferreira, LC; Neto, FPF; Mendes-Aguiar, CD; Jeronimo, SMB				Lima, Josivan Gomes; Nobrega, Lucia Helena C.; Lima, Natalia Nobrega; Ferreira dos Santos, Marcel Catao; Dantas Silva, Pedro Henrique; Baracho, Maria de Fatima P.; Lima, Debora Nobrega; Araujo de Melo Campos, Julliane Tamara; Ferreira, Leonardo Capistrano; Freire Neto, Francisco Paulo; Mendes-Aguiar, Carolina de O.; Jeronimo, Selma Maria B.			Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy	PLOS ONE			English	Article							CARDIOMYOPATHY	Introduction Berardinelli-Seip Congenital Lipodystrophy (BSCL) is a rare autosomal recessive disease that affects the development of adipocytes and leads to an inability to store fat in adipocytes. This study aimed to evaluate the life expectancy and the causes of death of patients with BSCL. Method We analyzed death certificates, and medical records of BSCL patients who died between 1997 and 2017. If the death certificate was incomplete or unavailable, we reviewed the medical records, and if they were not available too, we collected information from the patient's relatives to understand how the death happened. We calculated the potential years of life lost as a result of premature death. Results Twenty patients (12 female and 8 male) died between 1997 and 2017. The mean age at the time of death was 27.1 +/- 12.4 years (women 25.2 +/- 12.5 vs. men 29.9 +/- 12.6 years, p = 0.41). Life expectancy for the study population was 62.9 +/- 4.8 years. The potential number of years of life lost was 35.6 +/- 16.6 years. The causes of deaths were divided into three major groups: infections (7 patients, 35%), liver disease (7 patients, 35%), and other causes (acute pancreatitis, one patient; renal failure, three patients; sudden death/myocardial infarction, two patients). Three patients had pulmonary fibrosis. Conclusion BSCL led to premature death, cutting the patients' lifespan by 30 or more years. The majority of these young patients died of liver disease or infection. Other studies are needed to understand better the mechanisms that predispose to infections, as well as to assess whether new therapies can alter the natural history of this disease.	[Lima, Josivan Gomes; Nobrega, Lucia Helena C.; Lima, Natalia Nobrega; Ferreira dos Santos, Marcel Catao; Dantas Silva, Pedro Henrique; Baracho, Maria de Fatima P.] Hosp Univ Onofre Lopes HUOL UFRN, Dept Med Clin, Natal, RN, Brazil; [Lima, Debora Nobrega] Univ Fed Pernambuco, Recife, PE, Brazil; [Araujo de Melo Campos, Julliane Tamara] Fac Ciencias Saude Trairi UFRN, Santa Cruz, RN, Brazil; [Ferreira, Leonardo Capistrano; Freire Neto, Francisco Paulo; Mendes-Aguiar, Carolina de O.; Jeronimo, Selma Maria B.] Inst Med Trop Rio Grande Norte UFRN, Natal, RN, Brazil	Universidade Federal de Pernambuco	Lima, JG (corresponding author), Hosp Univ Onofre Lopes HUOL UFRN, Dept Med Clin, Natal, RN, Brazil.	josivanlima@gmail.com	Araújo de Melo Campos, Julliane Tamara/I-2528-2018; FERREIRA, LEONARDO CAPISTRANO/GSX-2559-2022; Jeronimo, Selma/AAY-4033-2020; Ferreira, Leonardo Capistrano/D-7097-2019; Gomes Lima, Josivan/I-6362-2013	Araújo de Melo Campos, Julliane Tamara/0000-0002-8501-5521; Jeronimo, Selma/0000-0002-4784-9904; Ferreira, Leonardo Capistrano/0000-0001-9268-4881; Gomes Lima, Josivan/0000-0002-1627-7018				Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Akinci B, 2016, J CLIN ENDOCR METAB, V101, P2759, DOI 10.1210/jc.2016-1005; [Anonymous], 2017, LIF EXP BIRTH TOT YE; Berardinelli W, 1954, J CLIN ENDOCR METAB, P14; Berglund L, 2012, J CLIN ENDOCR METAB, V97, P2969, DOI 10.1210/jc.2011-3213; Chiquette Elaine, 2017, Diabetes Metab Syndr Obes, V10, P375, DOI 10.2147/DMSO.S130810; Dayakar A, 2016, EXP PARASITOL, V160, P54, DOI 10.1016/j.exppara.2015.12.002; Medeiros LBD, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0280-7; Debray FG, 2013, MOL GENET METAB, V109, P227, DOI 10.1016/j.ymgme.2013.04.011; Drummond MB, 2010, COPD, V7, P179, DOI 10.3109/15412555.2010.481695; Fu M, 2004, J CLIN ENDOCR METAB, P89; Ghosh J, 2014, INFECT IMMUN, V82, P607, DOI 10.1128/IAI.00583-13; Gupta N, 2017, J CLIN ENDOCR METAB, V102, P363, DOI 10.1210/jc.2016-2271; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hsu RH, 2018, J FORMOS MED ASS; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; Lima JG, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0140-x; Madsen CM, 2017, EUR HEART J; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Patni N, 2015, NAT REV ENDOCRINOL, V11, P522, DOI 10.1038/nrendo.2015.123; RHEUBAN KS, 1986, J PEDIATR-US, V109, P301, DOI 10.1016/S0022-3476(86)80389-4; Seip M, 1959, ACTA PAEDIATR, P48; Van Maldergem L, 2002, J MED GENET, V39, P722, DOI 10.1136/jmg.39.10.722	23	32	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0199052	10.1371/journal.pone.0199052	http://dx.doi.org/10.1371/journal.pone.0199052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883474	Green Published, gold, Green Submitted			2022-12-26	WOS:000434728100046
J	Sabir, JSM; Theriot, EC; Manning, SR; Al-Malki, AL; Khiyami, MA; Al-Ghamdi, AK; Sabir, MJ; Romanovicz, DK; Hajrah, NH; El Omri, A; Jansen, RK; Ashworth, MP				Sabir, Jamal S. M.; Theriot, Edward C.; Manning, Schonna R.; Al-Malki, Abdulrahman L.; Khiyami, Mohammad A.; Al-Ghamdi, Areej K.; Sabir, Mumdooh J.; Romanovicz, Dwight K.; Hajrah, Nahid H.; El Omri, Abdelfatteh; Jansen, Robert K.; Ashworth, Matt P.			Phylogenetic analysis and a review of the history of the accidental phytoplankter, Phaeodactylum tricornutum Bohlin (Bacillariophyta)	PLOS ONE			English	Review							DIATOMS BACILLARIOPHYTA; BENTHIC DIATOMS; WATER COLUMN; MARINE; MICROCYSTIS; MODEL; BUOYANCY; GROWTH; CELLS; COLONIZATION	The diatom Phaeodactylum tricornutum has been used as a model for cell biologists and ecologists for over a century. We have incorporated several new raphid pennates into a three gene phylogenetic dataset (SSU, rbcL, psbC), and recover Gomphonemopsis sp. as sister to P. tricornutum with 100% BS support. This is the first time a close relative has been identified for P. tricornutum with robust statistical support. We test and reject a succession of hypotheses for other relatives. Our molecular data are statistically significantly incongruent with placement of either or both species among the Cymbellales, an order of diatoms with which both have been associated. We believe that further resolution of the phylogenetic position of P. tricornutum will rely more on increased taxon sampling than increased genetic sampling. Gomphonemopsis is a benthic diatom, and its phylogenetic relationship with P. tricornutum is congruent with the hypothesis that P. tricornutum is a benthic diatom with specific adaptations that lead to active recruitment into the plankton. We hypothesize that other benthic diatoms are likely to have similar adaptations and are not merely passively recruited into the plankton.	[Sabir, Jamal S. M.; Al-Ghamdi, Areej K.; Hajrah, Nahid H.; El Omri, Abdelfatteh; Jansen, Robert K.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Genom & Biotechnol Res Grp, Jeddah, Saudi Arabia; [Theriot, Edward C.; Jansen, Robert K.; Ashworth, Matt P.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Manning, Schonna R.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Al-Malki, Abdulrahman L.] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia; [Khiyami, Mohammad A.] King Abdulaziz City Sci & Technol, Riyadh, Saudi Arabia; [Sabir, Mumdooh J.] King Abdulaziz Univ, Fac Comp & Informat Technol, Dept Informat Technol, Jeddah, Saudi Arabia; [Romanovicz, Dwight K.] Univ Texas Austin, Ctr Biomed Res Support, Austin, TX 78712 USA	King Abdulaziz University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; King Abdulaziz University; King Abdulaziz City for Science & Technology; King Abdulaziz University; University of Texas System; University of Texas Austin	Theriot, EC (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	etheriot@austin.utexas.edu	Omri, Abdelfatteh El/AAN-5602-2020; Sabir, Jamal S M/C-8102-2014; Hajrah, Nahid/AAY-3196-2020; OMRI, Abdelfatteh EL/O-3708-2019; Hajrah, Nahid/AAT-2659-2021	OMRI, Abdelfatteh EL/0000-0003-4112-7924; Hajrah, Nahid/0000-0001-6404-1627	King Abdulaziz City for Science and Technology (SA) [AT-35-53]	King Abdulaziz City for Science and Technology (SA)	This work was supported by King Abdulaziz City for Science and Technology (SA) Award Number: AT-35-53 to JSMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Allen E J, 1910, J MAR BIOL ASS, V8, P421, DOI [DOI 10.1017/50025315400073690, DOI 10.1017/S0025315400073690]; Hernandez UA, 2010, HIDROBIOLOGICA, V20, P13; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Ashworth MP, 2017, PROTIST, V168, P48, DOI 10.1016/j.protis.2016.11.001; Ashworth MP, 2012, PHYCOLOGIA, V51, P684, DOI 10.2216/12-004.1; Bahulikar RA, 2008, J PHYCOL, V44, P1465, DOI 10.1111/j.1529-8817.2008.00609.x; BARBIERO RP, 1992, FRESHWATER BIOL, V27, P249, DOI 10.1111/j.1365-2427.1992.tb00537.x; BARKER H. ALBERT, 1935, ARCH MIKROBIOL, V6, P141, DOI 10.1007/BF00407284; Beltrones DAS, 2006, REV BIOL TROP, V54, P287; Beltrones David A. Siqueiros, 2004, Pacific Science, V58, P435; Bender SJ, 2014, FRONTIERS MARINE SCI, V1; Bi R, 2012, J PHYCOL, V48, P539, DOI 10.1111/j.1529-8817.2012.01163.x; Bohlin K, 1897, OFVERS KONGL SVENSKA, V54, P507; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; CONLEY DJ, 1989, LIMNOL OCEANOGR, V34, P205, DOI 10.4319/lo.1989.34.1.0205; Conley DJ, 1994, P 11 INT DIAT S CAL, P95; De Martino A, 2007, J PHYCOL, V43, P992, DOI 10.1111/j.1529-8817.2007.00384.x; De Martino A, 2011, PROTIST, V162, P462, DOI 10.1016/j.protis.2011.02.002; Desrosiers C, 2014, J APPL PHYCOL, V26, P1759, DOI 10.1007/s10811-013-0204-3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feng TY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10373; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; GUTENBRUNNER SA, 1994, J PHYCOL, V30, P129, DOI 10.1111/j.0022-3646.1994.00129.x; HECKY RE, 1973, MAR BIOL, V19, P323, DOI 10.1007/BF00348902; HENDEY NI, 1954, J MAR BIOL ASSOC UK, V33, P335, DOI 10.1017/S0025315400008377; IBELINGS BW, 1991, J PLANKTON RES, V13, P419, DOI 10.1093/plankt/13.2.419; IWASA K, 1972, EXP CELL RES, V74, P552, DOI 10.1016/0014-4827(72)90416-8; JOHANSEN JR, 1991, GREAT BASIN NAT, V51, P310; Khodse VB, 2010, BIOFOULING, V26, P527, DOI 10.1080/08927014.2010.492468; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; Kooistra WHCF, 2009, MAR ECOL-EVOL PERSP, V30, P1, DOI 10.1111/j.1439-0485.2008.00262.x; KROMKAMP JC, 1984, FEMS MICROBIOL LETT, V25, P105, DOI 10.1016/0378-1097(84)90055-7; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lavaud J, 2002, PLANT PHYSIOL, V129, P1398, DOI 10.1104/pp.002014; Lebour M.V., 1930, ROY SOC PUBL, V116, P1; Levitan O, 2015, P NATL ACAD SCI USA, V112, P412, DOI 10.1073/pnas.1419818112; LEWIN JC, 1958, J GEN MICROBIOL, V18, P418, DOI 10.1099/00221287-18-2-418; LEWIN JC, 1958, J GEN MICROBIOL, V18, P427, DOI 10.1099/00221287-18-2-427; Li CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139300; Li FT, 2017, GLOBAL CHANGE BIOL, V23, P127, DOI 10.1111/gcb.13501; Li YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096173; Lobban Christopher S., 2012, Micronesica, V43, P237; Martin-Jezequel V, 2013, MAR FRESHW BOTANY, P43; Medlin L.K., 1986, DIATOM RES, V1, P205, DOI DOI 10.1080/0269249X.1986.9704970; Moore JK, 1996, MAR ECOL PROG SER, V132, P203, DOI 10.3354/meps132203; Muller AM, 1997, INT REV GES HYDROBIO, V82, P315, DOI 10.1002/iroh.19970820304; Nakov T, 2015, ISME J, V9, P246, DOI 10.1038/ismej.2014.108; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Percival A, 1970, CARBOHYDRATES CHEM B, P537; Raven JA, 2004, NEW PHYTOL, V162, P45, DOI 10.1111/j.1469-8137.2004.01022.x; ROSZKOWSKI W, 1989, EXPERIENTIA, V45, P584, DOI 10.1007/BF01990514; Round F. E., 1990, DIATOMS BIOL MORPHOL; SHAFFER GP, 1988, J PHYCOL, V24, P132; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Singler HR, 2005, J PLANKTON RES, V27, P545, DOI 10.1093/plankt/fbi030; Siqueiros-Beltrones David, 2005, Pacific Science, V59, P79, DOI 10.1353/psc.2005.0014; Siqueiros-Beltrones David, 2005, Pacific Science, V59, P581, DOI 10.1353/psc.2005.0047; Siqueiros-Beltrones DA, 2015, REV MEX BIODIVERS, V86, P111, DOI 10.7550/rmb.47977; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STEVENSON RJ, 1989, J PHYCOL, V25, P120, DOI 10.1111/j.0022-3646.1989.00120.x; Tesson B, 2009, BOT MAR, V52, P104, DOI 10.1515/BOT.2009.012; Theriot EC, 2011, DIATOM WORLD CELLULA, V19, P112; Theriot EC, 2015, MOL PHYLOGENET EVOL, V89, P28, DOI 10.1016/j.ympev.2015.03.012; Theriot EC, 2010, PLANT ECOL EVOL, V143, P278, DOI 10.5091/plecevo.2010.418; Thornton DCO, 2002, EUR J PHYCOL, V37, P149, DOI 10.1017/S0967026202003657; Vartanian M, 2009, NEW PHYTOL, V182, P429, DOI 10.1111/j.1469-8137.2009.02769.x; Verspagen JMH, 2004, J PHYCOL, V40, P260, DOI 10.1111/j.1529-8817.2004.03174.x; Villareal TA, 1996, J PLANKTON RES, V18, P1103, DOI 10.1093/plankt/18.7.1103; VISSER PM, 1995, J PLANKTON RES, V17, P919, DOI 10.1093/plankt/17.5.919; WALSBY AE, 1977, BRIT PHYCOL J, V12, P215, DOI 10.1080/00071617700650231; Wetherbee R, 1998, J PHYCOL, V34, P9, DOI 10.1046/j.1529-8817.1998.340009.x; Wilson DP, 1942, NATURE, V149, P331, DOI 10.1038/149331a0; WILSON DP, 1946, J MAR BIOL ASSOC UK, V26, P235, DOI 10.1017/S002531540001211X; Yu M, PLASTID GENOME EVOLU, pxxx	78	14	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0196744	10.1371/journal.pone.0196744	http://dx.doi.org/10.1371/journal.pone.0196744			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883488	Green Submitted, gold, Green Published			2022-12-26	WOS:000434728100001
J	Sauvard, D; Imbault, V; Darrouzet, E				Sauvard, Daniel; Imbault, Vanessa; Darrouzet, Eric			Flight capacities of yellow-legged hornet (Vespa velutina nigrithorax, Hymenoptera: Vespidae) workers from an invasive population in Europe	PLOS ONE			English	Article							MILL; PERFORMANCE; LEPIDOPTERA; APIDAE; HYM.; AGE	The invasive yellow-legged hornet, Vespa velutina nigrithorax Lepeletier, 1836 (Hymenoptera: Vespidae), is native to Southeast Asia. It was first detected in France (in the southwest) in 2005. It has since expanded throughout Europe and has caused significant harm to honeybee populations. We must better characterize the hornet's flight capacity to understand the species' success and develop improved control strategies. Here, we carried out a study in which we quantified the flight capacities of V. velutina workers using computerized flight mills. We observed that workers were able to spend around 40% of the daily 7-hour flight tests flying. On average, they flew 10km to 30km during each flight test, although there was a large amount of variation. Workers sampled in early summer had lower flight capacities than workers sampled later in the season. Flight capacity decreased as workers aged. However, in the field, workers probably often die before this decrease becomes significant. During each flight test, workers performed several continuous flight phases of variable length that were separated by rest phases. Based on the length of those continuous flight phases and certain key assumptions, we estimated that V. velutina colony foraging radius is at least 700 m (half that in early summer); however, some workers are able to forage much farther. While these laboratory findings remain to be confirmed by field studies, our results can nonetheless help inform V. velutina biology and control efforts.	[Sauvard, Daniel; Imbault, Vanessa] INRA, UR 633, Zool Forestiere, 2163 Ave Pomme Pin,CS 40001 Ardon, F-45075 Orleans 2, France; [Darrouzet, Eric] Univ Tours, Inst Rech Biol Insecte, Fac Sci, CNRS,UMR 7261, Parc Grandmont, F-37200 Tours, France; [Imbault, Vanessa] FREDON Ctr Val De Loire, 13 Ave Droits Homme, F-45921 Orleans 9, France	INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours	Sauvard, D (corresponding author), INRA, UR 633, Zool Forestiere, 2163 Ave Pomme Pin,CS 40001 Ardon, F-45075 Orleans 2, France.	daniel.sauvard@inra.fr			Region Centre-Val de Loire, project FRELON; French region Centre-Val de Loire	Region Centre-Val de Loire, project FRELON; French region Centre-Val de Loire(Region Centre-Val de Loire)	This work was supported by Region Centre-Val de Loire, project FRELON 2011-2014 (ED, DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by funding from the French region Centre-Val de Loire, namely the awarding of a French regional grant for our "FRELON" project ("Frelon asiatique: etude et lutte ciblee contre une espece invasive predatrice des abeilles"; 2011-2014). The authors thank Eric Velluet, at that time at Inra in Orleans, France, for developing the application which controls the flight mill systems. The authors finally thank the beekeepers and other people who helped hornet samples, especially Les Apiculteurs associes (La-Ferte-Saint-Aubin, Loiret, France) and Jeremy Gevar (IRBI, Tours, Indre-et-Loire, France).	Abrol D. P., 1994, Korean Journal of Apiculture, V9, P5; Agence franc E aise de se A curite A sanitaire des aliments, 2008, MORT EFF AFF COL AB; Agence nationale de se A curite A sanitaire de l'alimentation de l'environnement et du travail, 2015, 2014SA0103 AG NAT SE; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arca M, 2015, BIOL INVASIONS, V17, P2357, DOI 10.1007/s10530-015-0880-9; Archer M, 2012, MONOGRAPH SERIES, V4; Avalos JA, 2014, B ENTOMOL RES, V104, P462, DOI 10.1017/S0007485314000121; Beggs JR, 2011, BIOCONTROL, V56, P505, DOI 10.1007/s10526-011-9389-z; Beil M, 2008, APIDOLOGIE, V39, P456, DOI 10.1051/apido:2008021; Blackmer JL, 2004, ENVIRON ENTOMOL, V33, P1389, DOI 10.1603/0046-225X-33.5.1389; Budge GE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185172; Darrouzet E, 2014, LA SANTE DE LABEILLE, V259, P49; Darrouzet E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136680; David G, 2014, J APPL ENTOMOL, V138, P566, DOI 10.1111/jen.12110; Dubois GF, 2009, PENSOFT SER FAUNIST, P219; Goldarazena A., 2015, Bulletin OEPP, V45, P133, DOI 10.1111/epp.12185; Hagler JR, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.14401; Harrison JF, 2000, ANNU REV PHYSIOL, V62, P179, DOI 10.1146/annurev.physiol.62.1.179; Haxaire Jean, 2006, Bulletin de la Societe Entomologique de France, V111, P194; Hughes J, 2002, ENTOMOL EXP APPL, V103, P171, DOI 10.1023/A:1020351800534; Jones HBC, 2016, ECOL EVOL, V6, P181, DOI 10.1002/ece3.1861; Kammer A.E., 1978, Advances in Insect Physiology, V13, P133, DOI 10.1016/S0065-2806(08)60266-0; Ken T, 2005, NATURWISSENSCHAFTEN, V92, P492, DOI 10.1007/s00114-005-0026-5; Kenis Marc, 2010, BioRisk, V4, P51; LeConte Y, 2004, ABEILLES ET FLEURS, V648, P20; Maes S, 2014, BIOCONTROL, V59, P415, DOI 10.1007/s10526-014-9576-9; Matsuura M., 1984, B FAC AGR MEIJI U, V69, P1; Monceau K, 2014, J PEST SCI, V87, P1, DOI 10.1007/s10340-013-0537-3; Monceau K, 2013, APIDOLOGIE, V44, P209, DOI 10.1007/s13592-012-0172-7; MUZAFFAR N, 1990, Pakistan Journal of Zoology, V22, P203; Pimental D, 2002, BIOLOGICAL INVASIONS, P285; Portelli G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019486; Rome Q, 2015, J APPL ENTOMOL, V139, P771, DOI 10.1111/jen.12210; Rome Q., 2017, FRELON ASIATIQUE VES; Roques Alain, 2009, V3, P63; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sarvary MA, 2008, J ECON ENTOMOL, V101, P314, DOI 10.1603/0022-0493(2008)101[314:DFPAFP]2.0.CO;2; Schumacher P, 1997, PHYSIOL ENTOMOL, V22, P149, DOI 10.1111/j.1365-3032.1997.tb01152.x; Silva AG, 2014, SOCIOBIOLOGY, V61, P494; Spiewok S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P188, DOI 10.1086/498181; Sugahara M, 2009, NATURWISSENSCHAFTEN, V96, P1133, DOI 10.1007/s00114-009-0575-0; Taylor RAJ, 2010, J INSECT BEHAV, V23, P128, DOI 10.1007/s10905-010-9202-3; Tenczar P, 2014, ANIM BEHAV, V95, P41, DOI 10.1016/j.anbehav.2014.06.006; UNEP, 2010, UNEP EMERGING ISSUES; Villemant C., 2006, INSECTES, V143, P3; Villemant Claire, 2008, Bulletin de la Societe Entomologique de France, V113, P312; Walker TJ, 2016, BOOK INSECT RECORDS; Warfvinge K, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0372; Wolf S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103989; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003	50	16	16	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198597	10.1371/journal.pone.0198597	http://dx.doi.org/10.1371/journal.pone.0198597			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883467	Green Published, Green Submitted, gold			2022-12-26	WOS:000434728100032
J	Zhang, ZJ; Zhang, B; Cao, CM; Chen, WY				Zhang, Zhanjia; Zhang, Bing; Cao, Chunmei; Chen, Weiyun			The effects of using an active workstation on executive function in Chinese college students	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PERFORMANCE; EXERCISE; WALKING; TIME	This study aimed to examine the effects of active workstation use on the executive function by measuring the three components of executive function (Inhibition, Updating, and Shifting) during sitting, standing, and walking at an active workstation with different speeds. Twenty-four college students completed a cognitive test battery while sitting, standing, walking on an active workstation with a self-selected speed (mean = 2.3 km/h) and a faster speed (mean = 3.5 km/h). The three components of executive function (Inhibition, Updating, and Shifting) were assessed by Stroop task, N-back task, More-odd shifting task, respectively. Performance of each task was determined by the response time and accuracy. Repeated measures ANOVAs were conducted with workstation condition and trial type as within-subjects factors. There were no significant main effects for workstation condition and no interaction between workstation condition x trial type in Stroop task and More-odd shifting task. There was a significant main effect for workstation condition (F (3, 69) = 4.029, p = 0.011) and interaction effect between workstation condition x trial type (F (6, 138) = 9.371, p < 0.001) in N-back task. Decomposition of the interaction showed that accuracy of 2-back task in self-paced walking was significantly lower than that in sitting condition (p = 0.017) and in standing condition (p < .001). But there was no difference in accuracy of 2-back task between self-paced walking condition and faster walking condition (p = 0.517). Our results suggest that using an active workstation may have a selective impact on three components of executive function, in which the Updating may be impaired to a certain extent while the Inhibition and Shifting remain unaffected.	[Zhang, Zhanjia; Chen, Weiyun] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Zhang, Bing; Cao, Chunmei] Tsinghua Univ, Dept Sports Sci & Phys Educ, Beijing, Peoples R China	University of Michigan System; University of Michigan; Tsinghua University	Zhang, ZJ (corresponding author), Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA.	zzj@umich.edu		Zhang, Bing/0000-0002-0859-0530				Abernethy B, 2002, GAIT POSTURE, V15, P256, DOI 10.1016/S0966-6362(01)00195-3; Alderman BL, 2014, J PHYS ACT HEALTH, V11, P752, DOI 10.1123/jpah.2012-0097; Brisswalter J, 2002, SPORTS MED, V32, P555, DOI 10.2165/00007256-200232090-00002; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; CHMURA J, 1994, INT J SPORTS MED, V15, P172, DOI 10.1055/s-2007-1021042; Dishman RK, 1998, AM J PREV MED, V15, P344, DOI 10.1016/S0749-3797(98)00077-4; Edelson N, 1989, SIGCHI B, V21, P72, DOI DOI 10.1145/67880.67890; Ehmann PJ, 2017, MED SCI SPORT EXER, V49, P965, DOI 10.1249/MSS.0000000000001189; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Funk RE, 2012, PERCEPT MOTOR SKILL, V115, P309, DOI 10.2466/06.23.26.PMS.115.4.309-318; Funk RE, 2009, USING ACTIVE WORKSTA; GLASS GV, 1972, REV EDUC RES, V42, P237, DOI 10.2307/1169991; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; John D, 2009, J PHYS ACT HEALTH, V6, P617, DOI 10.1123/jpah.6.5.617; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Kline RB, 2005, PRINCIPLES PRACTICE; Koepp GA, 2013, OBESITY, V21, P705, DOI 10.1002/oby.20121; Kruger J, 2007, AM J HEALTH PROMOT, V21, P439, DOI 10.4278/0890-1171-21.5.439; Levine JA, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.032755; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Ohlinger CM, 2009, EFFECT ACTIVE WORKST; Regnaux JP, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-19; REILLY T, 1986, ERGONOMICS, V29, P601, DOI 10.1080/00140138608968294; Romine CB, 2004, NEUROPSYCHOL REV, V14, P43, DOI 10.1023/B:NERV.0000026648.94811.32; Sparling PB, 2010, PREV CHRONIC DIS, V7; Straker LM, 2009, HUM FACTORS, V51, P831, DOI 10.1177/0018720810362079; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Thompson WG, 2011, WORK, V40, P473, DOI 10.3233/WOR-2011-1258; Wickens C.D., 1991, MULTIPLE TASK PERFOR, V1991, P3, DOI [10.1201/9781003069447-2, DOI 10.1201/9781003069447-2]; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	30	5	6	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0197740	10.1371/journal.pone.0197740	http://dx.doi.org/10.1371/journal.pone.0197740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI5BF	29879124	Green Published, gold, Green Submitted			2022-12-26	WOS:000434384900009
J	Spasojevic, T; Wedmann, S; Klopfstein, S				Spasojevic, Tamara; Wedmann, Sonja; Klopfstein, Seraina			Seven remarkable new fossil species of parasitoid wasps (Hymenoptera, Ichneumonidae) from the Eocene Messel Pit	PLOS ONE			English	Article							RUSSIAN FAR-EAST; INSECTA HYMENOPTERA; HARTIG HYMENOPTERA; ANTS HYMENOPTERA; GRUBE MESSEL; 1ST RECORD; DISPERSAL; SUBFAMILY; RECONSTRUCTION; ESTABLISHMENT	Parasitoid wasps of the family lchneumonidae are one of the most diverse and species-rich groups of organisms with a worldwide distribution. We here describe seven new ichneumonid fossil species and two new genera from a remarkable insect fossil site, the Eocene Messel Pit in Germany (similar to 47Ma). The unique fossil preservation allows us to place five out of the seven new species unequivocally in extant subfamilies and genera. For the first time, lobed claws which are a clear synapomorphy for the subfamily Pimplinae, are observed in a fossil, making the newly described Scambus fossilobus sp. nov. the oldest unequivocal representative of the group. We also describe a fossil of Labeninae (Trigonator macrocheirus gen. et sp. nov.), an ichneumonid subfamily that was until now believed to be an exclusively Gondwanan element. Furthermore, the newly described Rhyssella vera sp. nov., Xanthopimpla messelensis sp. nov., and X praeclara sp. nov. provide evidence that these extant genera date back as far as the Early/Middle Eocene. In contrast to the clear placement of most of the newly described species, we were unable to place Polyhelictes bipolarus gen. et sp. nov. and Mesornatus markovici gen. et sp. nov. in an ichneumonid subfamily, mostly due to the high levels of homoplasy found in this group. These findings on the one hand demonstrate the need for a more rigorous approach in the taxonomic placement of fossil ichneumonids, and on the other hand provide more precise minimum ages for several ichneumonid genera and subfamilies.	[Spasojevic, Tamara; Klopfstein, Seraina] Nat Hist Museum Bern, Wirbellose Tiere, Bern, Switzerland; [Spasojevic, Tamara; Klopfstein, Seraina] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Wedmann, Sonja] Senckenberg Forschungsinst & Nat Museum, Forsch Stn Grube Messel, Messel, Germany	University of Bern; Senckenberg Gesellschaft fur Naturforschung (SGN)	Spasojevic, T (corresponding author), Nat Hist Museum Bern, Wirbellose Tiere, Bern, Switzerland.; Spasojevic, T (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.	tamara.spasojevic@students.unibe.ch		Wedmann, Sonja/0000-0002-9778-4125; Spasojevic, Tamara/0000-0001-5301-5722	Swiss National Science Foundation [PZ00P3_154791]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (http://www.snf.ch; grant PZ00P3_154791 to S.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antropov AV, 2014, EARTH ENV SCI T R SO, V104, P335, DOI 10.1017/S1755691014000103; Archibald SB, 2006, ANN ENTOMOL SOC AM, V99, P487, DOI 10.1603/0013-8746(2006)99[487:BAOTEO]2.0.CO;2; Archibald SB, 2005, ANN ENTOMOL SOC AM, V98, P503, DOI 10.1603/0013-8746(2005)098[0503:EADOCE]2.0.CO;2; Archibald SB, 2001, P R SOC B, V278, P3679; Ashmead WH. Order Hymenoptera, 1900, INS NEW JERS NOT THO, DOI [10.1111/j.1096-3642.2000.tb00015.x, DOI 10.1111/J.1096-3642.2000.TB00015.X]; Brikiatis L, 2016, EARTH-SCI REV, V159, P47, DOI 10.1016/j.earscirev.2016.05.002; Broad GR, 2014, J HYMENOPT RES, V41, P31, DOI 10.3897/JHR.41.8099; Broad GR, 2018, HDB IDENTIFICATION B; Brues CT, 1906, FOSSIL PARASITIC PHY; Buchel G, 2014, RECONSTRUCTION EOCEN, P93; Cockerell T.D.A., 1919, ENTOMOLOGIST, V52, P121, DOI [10.4039/Ent51121-6, DOI 10.4039/ENT51121-6]; Colleary C, 2015, P NATL ACAD SCI USA, V112, P12592, DOI 10.1073/pnas.1509831112; Collinson M.E., 2012, FOSSIL FRUITS SEEDS; Contreras Daniel, 2006, Journal of Orthoptera Research, V15, P91, DOI 10.1665/1082-6467(2006)15[91:MPEFMD]2.0.CO;2; de Saussure H., 1890, HIST PHYS NATURELLE, P1; Dlussky G.M., 2015, Caucasian Entomological Bulletin, V11, P131; Dlussky GM, 2012, J SYST PALAEONTOL, V10, P725, DOI 10.1080/14772019.2011.628341; Eskov K., 1992, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V185, P311; Eskov K. Yu., 2002, P427; Evanoff Emmett, 2001, Proceedings of the Denver Museum of Nature & Science, V4, P1; Felder M, 2004, COURIER FORSCHUNGS I, P151; Fitton M.G., 1988, Handbooks for the Identification of British Insects, V7, P1; Fitton M.G., 1984, INTRO ICHNEUMONIDAE, P353; Franzen JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137985; Gauld ID, 2002, ZOOL J LINN SOC-LOND, V136, P421, DOI 10.1046/j.1096-3642.2002.00031.x; GAULD ID, 1982, SYST ENTOMOL, V7, P73, DOI 10.1111/j.1365-3113.1982.tb00127.x; Gauld ID, 2000, ZOOL J LINN SOC-LOND, V129, P271, DOI 10.1111/j.1096-3642.2000.tb00015.x; Gomez IC, 2015, ZOOTAXA, V3956, P437, DOI 10.11646/zootaxa.3956.3.8; Gomez IC, 2014, ZOOTAXA, V 3774, P57, DOI 10.11646/zootaxa.3774.1.4; Goth K., 1990, COUR FORSCH I SENCKE, V131, P1; Goulet H., 1993, HYMENOPTERA WORLD ID, V1894E; Grein M, 2011, NEUES JAHRB GEOL P-A, V260, P305, DOI 10.1127/0077-7749/2011/0139; Gruber G., 2007, MESSEL TREASURES EOC; Harms F. J., 1999, HANNOVER DTSCH GEOLO; Hartig T., 1838, CHARLOTTENBURGER FOR, V1, P246; HEER O., 1867, FOSSILE HYMENOPTEREN, P1; Heinrich GH, 1978, VOST PER NAS POD ICH, P3; Hellen W, 1915, ACTA SOC PRO FAUNA F, V40, P1; Joyce WG, 2012, BIOL LETTERS, V8, P846, DOI 10.1098/rsbl.2012.0361; Khalaim A.I., 2008, ALAVESIA, V2, P101; Klopfstein S, 2014, ZOOTAXA, V3801, P1, DOI 10.11646/zootaxa.3801.1.1; Kolarov JA, 2014, FAUNA BULGARICA 1; Kopylov DS, 2012, PALEONTOL J+, V46, P383, DOI 10.1134/S0031030112040041; Kopylov DS, 2010, PALEONTOL J+, V44, P422, DOI 10.1134/S003103011004009X; Kopylov DS, 2010, PALEONTOL J+, V44, P180, DOI 10.1134/S0031030110020097; Kopylov D, 2009, PALEONTOL J+, V43, P83, DOI 10.1134/S0031030109010092; Kopylov DS, 2010, AFR INVERTEBR, V51, P423, DOI 10.5733/afin.051.0211; Lenz OK, 2007, REV PALAEOBOT PALYNO, V145, P217, DOI 10.1016/j.revpalbo.2006.11.001; Lenz OK, 2015, INT J EARTH SCI, V104, P873, DOI 10.1007/s00531-014-1126-2; Lenz OK, 2010, GEOLOGY, V38, P627, DOI 10.1130/G30889.1; Li LF, 2017, CRETACEOUS RES, V70, P152, DOI 10.1016/j.cretres.2016.11.001; Lutz H., 1990, Courier Forschungsinstitut Senckenberg, V124, P1; MATTHEWS S C, 1973, Palaeontology (Oxford), V16, P713; Mayr G, 2017, BIOL REV, V92, P1174, DOI 10.1111/brv.12274; Mayr G, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0223; McKellar RC, 2013, FOSS REC, V16, P217, DOI 10.1002/mmng.201300011; McNamara ME, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001200; Menier J.-J., 2004, Geologica Acta, V2, P83; Mertz DF, COURIER FORSCHUNGS I, V255, P67; Mezger JE, 2013, Z DTSCH GES GEOWISS, V164, P639, DOI 10.1127/1860-1804/2013/0034; Micklich Norbert, 2012, Palaeobiodiversity Palaeoenvironments, V92, P585, DOI 10.1007/s12549-012-0106-4; Morley C, 1913, TRIBES RHYSSIDES E 2, DOI [10.5962/bhl.title.8761, DOI 10.5962/BHL.TITLE.8761]; Munro VMW, 1998, BIOCONTROL SCI TECHN, V8, P559, DOI 10.1080/09583159830072; PaleoBioDB, 2017, PALEOBIOLOGY DATABAS; Parker AR, 2003, P ROY SOC B-BIOL SCI, V270, pS151, DOI 10.1098/rsbl.2003.0055; Peters RS, 2017, CURR BIOL, V27, P1013, DOI 10.1016/j.cub.2017.01.027; Pham Nhi Thi, 2011, Zootaxa, V3056, P1; Praz CJ, 2014, MOL PHYLOGENET EVOL, V81, P258, DOI 10.1016/j.ympev.2014.09.003; PRICE PW, 1970, CAN ENTOMOL, V102, P1102, DOI 10.4039/Ent1021102-9; QUEDNAU FW, 1990, CAN ENTOMOL, V122, P921, DOI 10.4039/Ent122921-9; Quicke DLJ, 1999, ZOOL SCR, V28, P175, DOI 10.1046/j.1463-6409.1999.00005.x; Rasnitsyn A.P, 2002, HIST INSECTS, P1; Rohwer S. A., 1920, Proceedings of the United States National Museum, V57; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Schaal S., 1992, MESSEL INSIGHT HIST; Schulz R., 2002, Z ANGEW GEOL, V2002, P9; Scudder S.H., 1890, REPORT US GEOLOGICAL, V13, P1, DOI [10.5962/bhl.title.44698, DOI 10.5962/BHL.TITLE.44698, 10.5962/bhl.title.2507]; Sharkey M.J., 1992, Journal of Hymenoptera Research, V1, P15; Skartveit John, 2015, Studia Dipterologica, V22, P77; Smith KT, 2016, PALAEOBIO PALAEOENV, V96, P589, DOI 10.1007/s12549-016-0244-1; Smith ME, 2008, GEOL SOC AM BULL, V120, P54, DOI 10.1130/B26073.1; Spasojevic T, 2017, PALEONTOL Z, P1, DOI [10.1007/s12542-017-0365-5, DOI 10.1007/S12542-017-0365-5]; Theobal N., 1937, INSECTES FOSSILES TE; Thorne BL, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P77; TOWNES H., 1969, GENERA ICHNEUMONID 1; Vinther J, 2010, BIOL LETTERS, V6, P128, DOI 10.1098/rsbl.2009.0524; von Koenigswald W, 1998, MESSEL POMPEJI PALA; Wahl David B., 1993, HYMENOPTERA WORLD ID, P358; Wahl DB, 1998, SYST ENTOMOL, V23, P265, DOI 10.1046/j.1365-3113.1998.00057.x; Wappler T, 2015, CURR BIOL, V25, P3092, DOI 10.1016/j.cub.2015.09.021; Wedmann S, 2011, PALAEONTOLOGY, V54, P965, DOI 10.1111/j.1475-4983.2011.01088.x; Wesmael C., 1844, TENTAMEN DISPOSITION, DOI [10.5962/bhl.title.66034, DOI 10.5962/BHL.TITLE.66034]; Whitfield JB, 2002, P NATL ACAD SCI USA, V99, P7508, DOI 10.1073/pnas.112067199; Yu DSK, 2012, ICHNEUMONOIDEA	94	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197477	10.1371/journal.pone.0197477	http://dx.doi.org/10.1371/journal.pone.0197477			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874268	gold, Green Published, Green Submitted			2022-12-26	WOS:000434369400024
J	Tomita, S; Oeda, T; Umemura, A; Kohsaka, M; Park, K; Yamamoto, K; Sugiyama, H; Sawada, H				Tomita, Satoshi; Oeda, Tomoko; Umemura, Atsushi; Kohsaka, Masayuki; Park, Kwiyoung; Yamamoto, Kenji; Sugiyama, Hiroshi; Sawada, Hideyuki			Video-fluoroscopic swallowing study scale for predicting aspiration pneumonia in Parkinson's disease	PLOS ONE			English	Article							GASTROINTESTINAL DYSFUNCTION; INTERRATER RELIABILITY; DYSPHAGIA; INTRARATER; IMPACT	Introduction A number of video-fluoroscopic swallowing study (VFSS) abnormalities have been reported in patients with Parkinson's disease (PD). However, the most crucial finding of subsequent aspiration pneumonia has not been validated fully. We conducted a retrospective and case-control study to determine the clinically significant VFSS findings in this population, and to propose a practical scale for predicting aspiration pneumonia in patients with PD. Methods We enrolled 184 PD patients who underwent VFSS because of suspected dysphagia. The patients who developed aspiration pneumonia within six months of the VFSS were assigned as cases and the patients without aspiration pneumonia at six months were designated as controls. Logistic regression analysis was performed to determine the prognostic VFSS features based on the data of swallowing 3 mL of jelly, which were used to make a PD VFSS scale (PDVFS). The validity of the new PDVFS was evaluated by ROC analysis. Additionally, we used the survival time analysis to compare time to death between groups, stratified by the PDVFS score. Results Twenty-five patients developed aspiration pneumonia. Among the previously-proposed VFSS features, mastication, lingual motility prior to transfer, aspiration, and total swallow time were identified as significant prognostic factors. We combined these factors to form the PDVFS. The PDVFS score ranges from 0 to 12, with 12 being the worst. ROC analysis revealed 92% sensitivity and 82% specificity at a cutoff point of 3. The higher PDVFS group showed shorter time-to-death than the lower PDVFS group (log rank P = 0.001). Conclusion Our newly developed VFSS severity scale (based on jelly swallowing) for patients with PD was easy to rate and could predict subsequent aspiration pneumonia and poor prognosis in patients with PD.	[Sawada, Hideyuki] Utano Natl Hosp, Clin Res Ctr, Kyoto, Japan; Utano Natl Hosp, Dept Neurol, Kyoto, Japan		Sawada, H (corresponding author), Utano Natl Hosp, Clin Res Ctr, Kyoto, Japan.	sawada@unh.hosp.go.jp	Yamamoto, Kenji/AAD-8766-2019; Umemura, Atsushi/ABC-4716-2021	Yamamoto, Kenji/0000-0003-1240-6369; Umemura, Atsushi/0000-0001-8557-6014; Sawada, Hideyuki/0000-0002-5909-3366				Argolo N, 2015, INT J LANG COMM DIS, V50, P659, DOI 10.1111/1460-6984.12158; Baijens L, 2013, EUR J RADIOL, V82, P1683, DOI 10.1016/j.ejrad.2013.05.009; BUSHMANN M, 1989, NEUROLOGY, V39, P1309, DOI 10.1212/WNL.39.10.1309; de Lau LML, 2014, PARKINSONISM RELAT D, V20, P613, DOI 10.1016/j.parkreldis.2014.02.030; Esayag Yaacov, 2010, Am J Med, V123, DOI 10.1016/j.amjmed.2009.09.012; Fasano A, 2015, LANCET NEUROL, V14, P625, DOI 10.1016/S1474-4422(15)00007-1; Fuh JL, 1997, CLIN NEUROL NEUROSUR, V99, P106, DOI 10.1016/S0303-8467(97)00606-9; Han TR, 2008, DYSPHAGIA, V23, P59, DOI 10.1007/s00455-007-9097-0; Hunter PC, 1997, J NEUROL NEUROSUR PS, V63, P579, DOI 10.1136/jnnp.63.5.579; Jo H, 2016, DYSPHAGIA, V31, P41, DOI 10.1007/s00455-015-9656-8; Komiya K, 2015, AGING DIS, V6, P27, DOI 10.14336/AD.2014.0127; Kuhlemeier KV, 1998, DYSPHAGIA, V13, P142, DOI 10.1007/PL00009564; Lee JH, 2016, ANN REHABIL MED-ARM, V40, P440, DOI 10.5535/arm.2016.40.3.440; Leopold NA, 1997, DYSPHAGIA, V12, P11, DOI 10.1007/PL00009512; Leow LP, 2010, DYSPHAGIA, V25, P216, DOI 10.1007/s00455-009-9245-9; LOGEMANN JA, 1975, JAMA-J AM MED ASSOC, V231, P69, DOI 10.1001/jama.1975.03240130051031; Macleod AD, 2014, MOVEMENT DISORD, V29, P1615, DOI 10.1002/mds.25898; Mu LC, 2013, J NEUROPATH EXP NEUR, V72, P614, DOI 10.1097/NEN.0b013e3182965886; Muller J, 2001, ARCH NEUROL-CHICAGO, V58, P259, DOI 10.1001/archneur.58.2.259; Nagaya M, 1998, DYSPHAGIA, V13, P95, DOI 10.1007/PL00009562; Nilsson H, 1996, DYSPHAGIA, V11, P144, DOI 10.1007/BF00417905; Nobrega AC, 2008, PARKINSONISM RELAT D, V14, P646, DOI 10.1016/j.parkreldis.2007.12.007; Pfeiffer RF, 2003, LANCET NEUROL, V2, P107, DOI 10.1016/S1474-4422(03)00307-7; Silbiger M L, 1967, Invest Radiol, V2, P442; Stoeckli SJ, 2003, DYSPHAGIA, V18, P53, DOI 10.1007/s00455-002-0085-0; Sung HY, 2010, MOVEMENT DISORD, V25, P2361, DOI 10.1002/mds.23290; Suttrup I, 2016, DYSPHAGIA, V31, P24, DOI 10.1007/s00455-015-9671-9; Umemura A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094944; Van Lieshout PHHM, 2011, MOVEMENT DISORD, V26, P1725, DOI 10.1002/mds.23690; Volonte MA, 2002, NEUROL SCI, V23, pS121, DOI 10.1007/s100720200099; WINTZEN AR, 1994, CAN J NEUROL SCI, V21, P53, DOI 10.1017/S0317167100048770; Yamamoto T, 2010, PARKINSONISM RELAT D, V16, P503, DOI 10.1016/j.parkreldis.2010.06.002	32	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197608	10.1371/journal.pone.0197608	http://dx.doi.org/10.1371/journal.pone.0197608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874285	Green Published, Green Submitted, gold			2022-12-26	WOS:000434369400029
J	Huang, J; Han, QS; Li, JJ				Huang, Jian; Han, Qisheng; Li, Junjian			Soil propagule bank of ectomycorrhizal fungi associated with Masson pine (Pinus massoniana) grown in a manganese mine wasteland	PLOS ONE			English	Article							RESISTANT PROPAGULES; COMMUNITIES; FOREST; SEEDLINGS; SITES	Ectomycorrhizal (ECM) fungal propagule bank could facilitate the regeneration and plantation of seedlings in disturbed area. In this study, Masson pine (Pinus massoniana) seedlings were used to bait the ECM fungal propagule bank buried in the soils collected from a manganese (Mn) mine wasteland and a non-polluted area in China. After 6-month growth, we found the seedlings grown in the Mn mine soil (Mn:3200 mg kg(-1)) did not display any toxicity symptoms. Based on morphotyping and ITS-PCR sequencing, we identified a total of 16 ECM fungal OTUs (operative taxonomic units) at 97% similarity threshold, among which 11 OTUs were recovered in the Mn mine soils and 14 in the non-polluted soil. Two soil types shared 9 OTUs and both of them were dominated by a Tylospora sp. Based on those soil propagule banks in Masson pine forests reported in previous, we speculated that some Atheliaceae species may be preferred in the soil propagule bank of some pine species, such as Masson pine. In addition, NMDS ordination displayed geographical position effects on soil propagule banks in five Masson pine forest from three sites at regional scale. In conclusion, Masson pine ECM seedlings could grow well in the Mn wasteland as a suitable tree species used for reforestation application in Mn mineland, in addition, Mn pollution did not alter the dominant ECM fungal species in the soil propagule banks.	[Huang, Jian; Han, Qisheng] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Han, Qisheng] Chinese Acad Agr Sci, Farmland Irrigat Res Inst, Xinxiang, Peoples R China; [Li, Junjian] Shanxi Univ, Inst Loess Plateau, Taiyuan, Shanxi, Peoples R China	Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Farmland Irrigation Research Institute, CAAS; Shanxi University	Huang, J (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	huangj@nwsuaf.edu.cn	LI, junjian/HHC-3968-2022; Han, Qisheng/HGF-3163-2022		National Natural Science Foundation of China [31300525, 41771548]; Cyrus Tang foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cyrus Tang foundation	This work was supported by National Natural Science Foundation of China (31300525, 41771548) and Cyrus Tang foundation to Dr. Huang(2017). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen K, 2004, NEW PHYTOL, V161, P549, DOI 10.1046/j.1469-8137.2003.00941.x; Baar J, 1999, NEW PHYTOL, V143, P409, DOI 10.1046/j.1469-8137.1999.00452.x; Canton GC, 2016, MYCORRHIZA, V26, P475, DOI 10.1007/s00572-016-0686-3; Colpaert JV, 2011, ANN FOREST SCI, V68, P17, DOI 10.1007/s13595-010-0003-9; Colpaert JV., 2008, STRESS YEASTS FILAME, P157, DOI [10.1016/S0275-0287(08)80053-7, DOI 10.1016/S0275-0287(08)80053-7]; Colwell RK, 2013, ESTIMATES STAT ESTIM; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Ducic T, 2006, NEW PHYTOL, V170, P11, DOI 10.1111/j.1469-8137.2006.01666.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Glassman SI, 2016, ISME J, V10, P1228, DOI 10.1038/ismej.2015.182; Glassman SI, 2015, NEW PHYTOL, V205, P1619, DOI 10.1111/nph.13240; Horst WJ, 1988, MANGANESE SOILS PLAN, P175, DOI DOI 10.1007/978-94-009-2817-6_13; Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143; Huang J, 2015, MICROB ECOL, V69, P768, DOI 10.1007/s00248-014-0484-4; Huang J, 2012, MYCORRHIZA, V22, P589, DOI 10.1007/s00572-012-0436-0; Izzo A, 2006, MYCOL RES, V110, P196, DOI 10.1016/j.mycres.2005.08.010; Jones MD, 2003, NEW PHYTOL, V157, P399, DOI 10.1046/j.1469-8137.2003.00698.x; Leyval C, 1997, EFFECT HEAVY METAL P; Long DF, 2016, SCI REP-UK, V6, DOI 10.1038/srep24336; Luo ZB, 2014, ENVIRON EXP BOT, V108, P47, DOI 10.1016/j.envexpbot.2013.10.018; Ma YL, 2014, PLANT CELL ENVIRON, V37, P627, DOI 10.1111/pce.12183; Miyamoto Y, 2016, MYCORRHIZA, V26, P189, DOI 10.1007/s00572-015-0658-z; Murata M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189957; Op De Beeck M, 2015, ENVIRON MICROBIOL, V17, P2035, DOI 10.1111/1462-2920.12547; Qi YL, 2016, WATER AIR SOIL POLL, V227, DOI 10.1007/s11270-016-3183-6; Reverchon F, 2012, FEMS MICROBIOL ECOL, V80, P479, DOI 10.1111/j.1574-6941.2012.01314.x; Ross S. M., 1994, TOXIC METALS SOIL PL; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Thavamani P, 2017, ENVIRON POLLUT, V230, P495, DOI 10.1016/j.envpol.2017.06.056; Wen ZG, 2018, MYCORRHIZA, V28, P49, DOI 10.1007/s00572-017-0800-1; Xue SG, 2004, ENVIRON POLLUT, V131, P393, DOI 10.1016/j.envpol.2004.03.011; Zhao Nan-xing, 2017, Yingyong Shengtai Xuebao, V28, P3855, DOI 10.13287/j.1001-9332.201712.006; Zong K, 2015, J FOREST RES-JPN, V20, P493, DOI 10.1007/s10310-015-0506-1	33	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2018	13	6							e0198628	10.1371/journal.pone.0198628	http://dx.doi.org/10.1371/journal.pone.0198628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI1KD	29870548	Green Published, gold, Green Submitted			2022-12-26	WOS:000434128400031
J	Steenson, S; Ozcebe, H; Arslan, U; Unlu, HK; Araz, OM; Yardim, M; Uner, S; Bilir, N; Huang, TTK				Steenson, Sharalyn; Ozcebe, Hilal; Arslan, Umut; Unlu, Hande Konsuk; Araz, Ogur M.; Yardim, Mahmut; Uner, Sarp; Bilir, Nazmi; Huang, Terry T-K			Assessing the validity and reliability of family factors on physical activity: A case study in Turkey	PLOS ONE			English	Article							PREVENTING CHILDHOOD OBESITY; METABOLIC SYNDROME; SOCIAL SUPPORT; CHILDREN; ADOLESCENTS; OVERWEIGHT; PARENTS; DETERMINANTS; PERCEPTIONS; HEALTH	Background Childhood obesity rates have been rising rapidly in developing countries. A better understanding of the risk factors and social context is necessary to inform public health interventions and policies. This paper describes the validation of several measurement scales for use in Turkey, which relate to child and parent perceptions of physical activity (PA) and enablers and barriers of physical activity in the home environment. Method The aim of this study was to assess the validity and reliability of several measurement scales in Turkey using a population sample across three socio-economic strata in the Turkish capital, Ankara. Surveys were conducted in Grade 4 children (mean age = 9.7 years for boys; 9.9 years for girls), and their parents, across 6 randomly selected schools, stratified by SES (n = 641 students, 483 parents). Construct validity of the scales was evaluated through exploratory and confirmatory factor analysis. Internal consistency of scales and test-retest reliability were assessed by Cronbach's alpha and intra-class correlation. Results The scales as a whole were found to have acceptable-to-good model fit statistics (PA Barriers: RMSEA = 0.076, SRMR = 0.0577, AGFI = 0.901; PA Outcome Expectancies: RMSEA = 0.054, SRMR = 0.0545, AGFI = 0.916, and PA Home Environment: RMSEA = 0.038, SRMR = 0.0233, AGFI = 0.976). The PA Barriers subscales showed good internal consistency and poor to fair test-retest reliability (personal alpha = 0.79, ICC = 0.29, environmental alpha = 0.73, ICC = 0.59). The PA Outcome Expectancies subscales showed good internal consistency and test-retest reliability (negative alpha = 0.77, ICC = 0.56; positive alpha = 0.74, ICC = 0.49). Only the PA Home Environment subscale on support for PA was validated in the final confirmatory model; it showed moderate internal consistency and test-retest reliability (alpha = 0.61, ICC = 0.48). Discussion This study is the first to validate measures of perceptions of physical activity and the physical activity home environment in Turkey. Our results support the originally hypothesized two-factor structures for Physical Activity Barriers and Physical Activity Outcome Expectancies. However, we found the one-factor rather than two-factor structure for Physical Activity Home Environment had the best model fit. This study provides general support for the use of these scales in Turkey in terms of validity, but test-retest reliability warrants further research.	[Steenson, Sharalyn; Araz, Ogur M.; Huang, Terry T-K] Univ Nebraska, Med Ctr, Coll Publ Hlth, Omaha, NE 68182 USA; [Ozcebe, Hilal; Arslan, Umut; Unlu, Hande Konsuk; Yardim, Mahmut; Uner, Sarp; Bilir, Nazmi] Hacettepe Univ, Inst Publ Hlth, Ankara, Turkey; [Araz, Ogur M.] Univ Nebraska, Lincoln Coll Business Adm, Lincoln, NE USA; [Huang, Terry T-K] CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA	University of Nebraska System; University of Nebraska Medical Center; Hacettepe University; University of Nebraska System; University of Nebraska Lincoln; City University of New York (CUNY) System	Huang, TTK (corresponding author), Univ Nebraska, Med Ctr, Coll Publ Hlth, Omaha, NE 68182 USA.; Huang, TTK (corresponding author), CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA.	terry.huang@sph.cuny.edu	Uner, Sarp/E-9613-2013; OZCEBE, LUTFIYE HILAL/I-9383-2013; Konşuk Ünlü, Hande/E-6177-2013; Araz, Ozgur/AAC-5266-2020; Yardim, Mahmut/B-5977-2013	Uner, Sarp/0000-0002-9880-8811; Konşuk Ünlü, Hande/0000-0003-3572-0254; Yardim, Mahmut/0000-0002-4130-8883; Huang, Terry/0000-0001-5544-5187	Scientific Research Projects Coordination Unit of Hacettepe University [TUA-2015-5521]; University of Nebraska Office of the President	Scientific Research Projects Coordination Unit of Hacettepe University(Hacettepe University); University of Nebraska Office of the President	This project (TUA-2015-5521) was financed by the Scientific Research Projects Coordination Unit of Hacettepe University and by the University of Nebraska Office of the President as part of their commitment to global collaboration. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins S, 2004, OBES RES, V12, p38S, DOI 10.1038/oby.2004.267; Allison KR, 1999, PREV MED, V28, P608, DOI 10.1006/pmed.1999.0489; Anderson-Bill ES, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1551; [Anonymous], 2005, PREVENTING CHILDHOOD, DOI [DOI 10.17226/11015, 10.17226/11015]; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Bandura A., 1986, SOCIAL FDN THOUGHT A; Beger G, 2011, YOUTH TURK ONL EXPL; Bereket A, 2012, J CLIN RES PEDIATR E, V4, P1, DOI 10.4274/jcrpe.506; Birch LL, 2009, INT J OBESITY, V33, pS74, DOI 10.1038/ijo.2009.22; Chen FN, 2008, SOCIOL METHOD RES, V36, P462, DOI 10.1177/0049124108314720; Cizmecioglu FM, 2009, J PEDIATR ENDOCR MET, V22, P703; Davison KK, 2003, MED SCI SPORT EXER, V35, P1589, DOI 10.1249/01.MSS.0000084524.19408.0C; Gibson LY, 2007, MED J AUSTRALIA, V186, P591, DOI 10.5694/j.1326-5377.2007.tb01061.x; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Hambleton RK, 2005, ADAPTING EDUCATIONAL AND PSYCHOLOGICAL TESTS FOR CROSS- CULTURAL ASSESSMENT, P3; Hooper D, 2002, ELECT J BUS RES METH, V6, P53; Huang TT, 2009, PREV CHRONIC DIS, V6; Hume C, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-16; Kelishadi R, 2007, EPIDEMIOL REV, V29, P62, DOI 10.1093/epirev/mxm003; Lindsay AC, 2006, FUTURE CHILD, V16, P169, DOI 10.1353/foc.2006.0006; Maffeis C, 1998, INT J OBESITY, V22, P758, DOI 10.1038/sj.ijo.0800655; Ozkan S, 2014, TURKEY CHILDHOOD AGE; Ozmert EN, 2011, WORLD J PEDIATR, V7, P37, DOI 10.1007/s12519-011-0243-2; Pirasteh A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-150; Pocock M, 2010, OBES REV, V11, P338, DOI 10.1111/j.1467-789X.2009.00648.x; Reimers AK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-705; Republic of Turkey Ministry of Health, 2011, HLTH NUTR ACT LIF PR; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; SALLIS JF, 1992, AM J DIS CHILD, V146, P1383, DOI 10.1001/archpedi.1992.02160230141035; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Saunders RP, 1997, PREV MED, V26, P241, DOI 10.1006/pmed.1996.0134; Schaefer-Graf UM, 2005, DIABETES CARE, V28, P1745, DOI 10.2337/diacare.28.7.1745; Sherwood NE, 2004, PREV MED, V38, pS60, DOI 10.1016/j.ypmed.2003.12.030; STUCKYROPP RC, 1993, PREV MED, V22, P880, DOI 10.1006/pmed.1993.1079; Timperio A, 2004, PREV MED, V38, P39, DOI 10.1016/j.ypmed.2003.09.026; Trost SG, 2003, AM J PREV MED, V25, P277, DOI 10.1016/S0749-3797(03)00217-4; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Wang ZM, 2002, ASIA PAC J CLIN NUTR, V11, P200, DOI 10.1046/j.1440-6047.2002.00291.x; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; World Health Organization, 2012, POP BAS APPR CHILDH; Yardim M, 2018, E MEDITERR J HEAL PR; Yong AG, 2013, TUTOR QUANT METHODS, V9, P79, DOI 10.20982/tqmp.09.2.p079; Yuceahin M., 2011, COGRAFI BILIMLER DER, V9, P159	43	2	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0197920	10.1371/journal.pone.0197920	http://dx.doi.org/10.1371/journal.pone.0197920			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ5MF	29902175	gold, Green Published			2022-12-26	WOS:000435424900009
J	Zhang, H; Kang, H; Su, CL; Qi, YX; Liu, XM; Pu, JJ				Zhang, He; Kang, Hao; Su, Chulian; Qi, Yanxiang; Liu, Xiaomei; Pu, Jinji			Genome-wide identification and expression profile analysis of the NAC transcription factor family during abiotic and biotic stress in woodland strawberry	PLOS ONE			English	Article							FACTOR GENE FAMILY; TOR SIGNALING PATHWAY; NO-APICAL-MERISTEM; RESPONSIVE GENES; LEAF SENESCENCE; COMPREHENSIVE ANALYSIS; FUNCTIONAL-ANALYSIS; DROUGHT TOLERANCE; SALT TOLERANCE; ARABIDOPSIS	The NAC transcription factors involved plant development and response to various stress stimuli. However, little information is available concerning the NAC family in the woodland strawberry. Herein, 37 NAC genes were identified from the woodland strawberry genome and were classified into 13 groups based on phylogenetic analysis. And further analyses of gene structure and conserved motifs showed closer relationship of them in every subgroup. Quantitative real-time PCR evaluation different tissues revealed distinct spatial expression profiles of the FvNAC genes. The comprehensive expression of FvNAC genes revealed under abiotic stress (cold, heat, drought, salt), signal molecule treatments (H2O2, ABA, melatonin, rapamycin), biotic stress (Colletotrichum gloeosporioides and Ralstonia solanacearum). Expression profiles derived from quantitative real-time PCR suggested that 5 FvNAC genes responded dramatically to the various abiotic and biotic stresses, indicating their contribution to abiotic and biotic stresses resistance in woodland strawberry. Interestingly, FvNAC genes showed greater extent responded to the cold treatment than other abiotic stress, and H2O2 exhibited a greater response than ABA, melatonin, and rapamycin. For biotic stresses, 3 FvNAC genes were up-regulated during infection with C. gloeosporbodes, while 6 FvNAC genes were down-regulated during infection with R. solanacearum. In conclusion, this study identified candidate FvNAC genes to be used for the genetic improvement of abiotic and biotic stress tolerance in woodland strawberry.	[Zhang, He; Kang, Hao; Qi, Yanxiang; Pu, Jinji] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Minist Agr, Key Lab Integrated Pest Management Trop Crops, Haikou, Hainan, Peoples R China; [Su, Chulian; Liu, Xiaomei] Hainan Univ, Inst Trop Agr & Forestry, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Hainan University	Zhang, H; Pu, JJ (corresponding author), Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Minist Agr, Key Lab Integrated Pest Management Trop Crops, Haikou, Hainan, Peoples R China.	atzzhef@163.com; simmonpjj@163.com	Zhang, He/AAF-5700-2020		National Natural Science Foundation of China [31460455]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No. 31460455). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Baranwal VK, 2016, MOL GENET GENOMICS, V291, P1305, DOI 10.1007/s00438-016-1186-z; Bu QY, 2008, CELL RES, V18, P756, DOI 10.1038/cr.2008.53; Cenci A, 2014, PLANT MOL BIOL, V85, P63, DOI 10.1007/s11103-013-0169-2; Collinge M, 2001, PLANT MOL BIOL, V46, P521, DOI 10.1023/A:1010639225091; Delessert C, 2005, PLANT J, V43, P745, DOI 10.1111/j.1365-313X.2005.02488.x; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Goto M, 2009, ANN PHYTOPATH SOC JA, V44, P270; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hegedus D, 2003, PLANT MOL BIOL, V53, P383, DOI 10.1023/B:PLAN.0000006944.61384.11; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Hu W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136993; Hu Y, 2009, IEEE T GEOSCI REMOTE, V47, P3313; Jensen MK, 2008, PLANT J, V56, P867, DOI 10.1111/j.1365-313X.2008.03646.x; Jensen MK, 2007, PLANT MOL BIOL, V65, P137, DOI 10.1007/s11103-007-9204-5; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; Jiang HL, 2009, PLANT SIGNAL BEHAV, V4, P464, DOI [10.1104/pp.109.135269, 10.4161/psb.4.5.8543]; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; Kikuchi K, 2000, MOL GEN GENET, V262, P1047, DOI 10.1007/PL00008647; Kim HS, 2012, NUCLEIC ACIDS RES, V40, P9182, DOI 10.1093/nar/gks683; Kim HJ, 2014, J EXP BOT, V65, P4023, DOI 10.1093/jxb/eru112; Kim SG, 2007, PLANTA, V226, P647, DOI 10.1007/s00425-007-0513-3; Kim SG, 2008, PLANT SIGNAL BEHAV, V3, P877, DOI 10.4161/psb.3.10.6247; Kim SY, 2007, NUCLEIC ACIDS RES, V35, P203, DOI 10.1093/nar/gkl1068; Kim YS, 2013, PLANT CELL PHYSIOL, V54, P1660, DOI 10.1093/pcp/pct113; Kim YS, 2006, PLANT CELL, V18, P3132, DOI 10.1105/tpc.106.043018; Ko JH, 2007, PLANT J, V50, P1035, DOI 10.1111/j.1365-313X.2007.03109.x; Kou XH, 2012, J EXP BOT, V63, P6139, DOI 10.1093/jxb/ers266; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee S, 2012, PLANT J, V70, P831, DOI 10.1111/j.1365-313X.2012.04932.x; Lin RM, 2007, PLANT SCI, V172, P120, DOI 10.1016/j.plantsci.2006.07.019; Liu H, 2014, J INTEGR PLANT BIOL, V56, P350, DOI 10.1111/jipb.12150; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu PL, 2007, PLANT MOL BIOL, V63, P289, DOI 10.1007/s11103-006-9089-8; Marroquin-Guzman M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004851; McGrann GRD, 2015, MOL PLANT PATHOL, V16, P201, DOI 10.1111/mpp.12173; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Ng S, 2013, PLANT CELL, V25, P3450, DOI 10.1105/tpc.113.113985; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Park J, 2011, PLANT PHYSIOL, V156, P537, DOI 10.1104/pp.111.177071; Peng XJ, 2015, J GENET, V94, P377, DOI 10.1007/s12041-015-0526-9; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Reiter RJ, 2015, MOLECULES, V20, P7396, DOI 10.3390/molecules20047396; Ren T, 2000, PLANT CELL, V12, P1917, DOI 10.1105/tpc.12.10.1917; Ruiz-Rojas JJ, 2010, THEOR APPL GENET, V121, P449, DOI 10.1007/s00122-010-1322-9; Rushton PJ, 2008, PLANT PHYSIOL, V147, P280, DOI 10.1104/pp.107.114041; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Saga H, 2012, MOL PLANT MICROBE IN, V25, P684, DOI 10.1094/MPMI-09-11-0244; Sakuraba Y, 2015, PLANT CELL, V15; Sanghera GS, 2011, CURR GENOMICS, V12, P30, DOI 10.2174/138920211794520178; SEHGAL SN, 1975, J ANTIBIOT, V28, P727, DOI 10.7164/antibiotics.28.727; Seo PJ, 2010, PLANT SIGNAL BEHAV, V5, P481, DOI 10.4161/psb.11083; Shahnejat-Bushehri S, 2012, PLANT SIGNAL BEHAV, V7, P1518, DOI 10.4161/psb.22092; Shang HH, 2013, J INTEGR PLANT BIOL, V55, P663, DOI 10.1111/jipb.12085; Shiriga K, 2014, META GENE, V2, P407, DOI 10.1016/j.mgene.2014.05.001; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Song SY, 2011, PLANTA, V234, P331, DOI 10.1007/s00425-011-1403-2; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Sperotto RA, 2009, PLANTA, V230, P985, DOI 10.1007/s00425-009-1000-9; Su HY, 2015, J PLANT BIOCHEM BIOT, V24, P176, DOI 10.1007/s13562-014-0255-9; Su HY, 2013, PLANT PHYSIOL BIOCH, V71, P11, DOI 10.1016/j.plaphy.2013.06.022; Takasaki H, 2010, MOL GENET GENOMICS, V284, P173, DOI 10.1007/s00438-010-0557-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Van Ha C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114107; Voitsik AM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-85; Wang N, 2013, PLANT CELL REP, V32, P61, DOI 10.1007/s00299-012-1340-y; Wang XE, 2009, MOL PLANT MICROBE IN, V22, P1227, DOI 10.1094/MPMI-22-10-1227; Wang YX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166727; Wei S, 2016, PLANT CELL REP, V35, P1, DOI [10.1007/s00299-015-1872-z, DOI 10.1007/S00299-015-1872-Z]; Wilkins MR, 2007, PROTEOMICS PROTOCOLS, P571; Wu YR, 2009, CELL RES, V19, P1279, DOI 10.1038/cr.2009.108; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xie Q, 1999, PLANT MOL BIOL, V39, P647, DOI 10.1023/A:1006138221874; Xiong FJ, 2017, NEW PHYTOL, V213, P233, DOI 10.1111/nph.14118; Xiong Y, 2014, PLANT PHYSIOL, V164, P499, DOI 10.1104/pp.113.229948; Xu ZY, 2013, PLANT CELL, V25, P4708, DOI 10.1105/tpc.113.119099; Yang SD, 2011, PLANT CELL, V23, P2155, DOI 10.1105/tpc.111.084913; Yao DX, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S15-S10; Yoshii M, 2009, PLANT J, V57, P615, DOI 10.1111/j.1365-313X.2008.03712.x; Yu FW, 2014, NEW PHYTOL, V203, P219, DOI 10.1111/nph.12776; Zhang Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163647; Zhang QY, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.7; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y	93	19	19	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2018	13	6							e0197892	10.1371/journal.pone.0197892	http://dx.doi.org/10.1371/journal.pone.0197892			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2HI	29897926	Green Published, gold, Green Submitted			2022-12-26	WOS:000435090700032
J	Cairns, KM; Shannon, LM; Koler-Matznick, J; Ballard, JWO; Boyko, AR				Cairns, Kylie M.; Shannon, Laura M.; Koler-Matznick, Janice; Ballard, J. William O.; Boyko, Adam R.			Elucidating biogeographical patterns in Australian native canids using genome wide SNPs	PLOS ONE			English	Article							HOLOCENE GENE FLOW; INBREEDING DEPRESSION; MITOCHONDRIAL-DNA; TROPHIC REGULATOR; FRASER ISLAND; FERAL CATS; GRAY WOLF; DINGO; POPULATION; DOG	Dingoes play a strong role in Australia's ecological framework as the apex predator but are under threat from hybridization and agricultural control programs. Government legislation lists the conservation of the dingo as an important aim, yet little is known about the biogeography of this enigmatic canine, making conservation difficult. Mitochondrial and Y chromosome DNA studies show evidence of population structure within the dingo. Here, we present the data from Illumina HD canine chip genotyping for 23 dingoes from five regional populations, and five New Guinea Singing Dogs to further explore patterns of biogeography using genome-wide data. Whole genome single nucleotide polymorphism (SNP) data supported the presence of three distinct dingo populations (or ESUs) subject to geographical subdivision: southeastern (SE), Fraser Island (FI) and northwestern (NW). These ESUs should be managed discretely. The FI dingoes are a known reservoir of pure, genetically distinct dingoes. Elevated inbreeding coefficients identified here suggest this population may be genetically compromised and in need of rescue; current lethal management strategies that do not consider genetic information should be suspended until further data can be gathered. D statistics identify evidence of historical admixture or ancestry sharing between southeastern dingoes and South East Asian village dogs. Conservation efforts on mainland Australia should focus on the SE dingo population that is under pressure from domestic dog hybridization and high levels of lethal control. Further data concerning the genetic health, demographics and prevalence of hybridization in the SE and FI dingo populations is urgently needed to develop evidence based conservation and management strategies.	[Cairns, Kylie M.; Ballard, J. William O.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Shannon, Laura M.; Boyko, Adam R.] Cornell Univ, Dept Biomed Sci, New York, NY 10021 USA; [Koler-Matznick, Janice] New Guinea Singing Dog Conservat Soc, Central Point, OR USA; [Cairns, Kylie M.] Univ New South Wales, Ctr Ecosyst Sci, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Shannon, Laura M.] Univ Minnesota, Dept Hort Sci, St Paul, MN USA	University of New South Wales Sydney; Cornell University; University of New South Wales Sydney; University of Minnesota System; University of Minnesota Twin Cities	Cairns, KM (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.; Cairns, KM (corresponding author), Univ New South Wales, Ctr Ecosyst Sci, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	kylie@kyliecairns.com	Ballard, John William O./ABB-2743-2020; Cairns, Kylie/AAG-3059-2020; Cairns, Kylie/I-4697-2013	Ballard, John William O./0000-0002-2358-6003; Cairns, Kylie/0000-0003-3700-2854; Cairns, Kylie/0000-0003-3700-2854	Hermon Slade Foundation Research grant [HSF11/6]; Embark Veterinary Inc.	Hermon Slade Foundation Research grant; Embark Veterinary Inc.	This work was supported by a Hermon Slade Foundation Research grant (HSF11/6) to JWOB, Alan N Wilton and KMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Embark Veterinary Inc. provides support in the form of salary for author ARB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The role of specific authors is articulated in the 'author contributions' section.	Adler D, 2014, RGL 3D VISUALIZATION; Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246; Allen BL, 2015, AUSTRALAS J ENV MAN, V22, P197, DOI 10.1080/14486563.2014.999134; Allen BL, 2015, BIOL INVASIONS, V17, P761, DOI 10.1007/s10530-014-0767-1; Allen LR, 2015, ECOL MANAG RESTOR, V16, P58, DOI 10.1111/emr.12138; Allen LR, 2014, ANIM PROD SCI, V54, P214, DOI 10.1071/AN12356; [Anonymous], 2010, R LANG ENV STAT COMP; Appleby R., 2011, ANAL PRELIMINARY DIN; Ardalan A, 2012, GENETICA, V140, P65, DOI 10.1007/s10709-012-9658-5; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Ballou Jonathan D., 1998, Council of Europe Environmental Encounters Series, V38, P27; Benson JF, 2011, J ANIM ECOL, V80, P958, DOI 10.1111/j.1365-2656.2011.01809.x; Bouckaert RR, 2018, NAT ECOL EVOL, V2, P741, DOI 10.1038/s41559-018-0489-3; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Brown SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028496; Brownrigg R, 2014, MAPS DRAW GEOGRAPHIC; Cairns KM, 2017, ECOL EVOL, V7, P9787, DOI 10.1002/ece3.3487; Cairns KM, 2016, GENETICA, V144, P553, DOI 10.1007/s10709-016-9924-z; CAUGHLEY G, 1980, AUST WILDLIFE RES, V7, P1, DOI 10.1071/WR9800001; Cheng L.-G., 2013, NAT COMMUN, V4, P1860, DOI [10.1038/ncomms2814, DOI 10.1038/ncomms2814]; Colman NJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3094; Corbett L. K., 2001, DINGO AUSTR ASIA; Corbett L. K., 2008, IUCN RED LIST THREAT; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Crowther MS, 2014, J ZOOL, V293, P192, DOI 10.1111/jzo.12134; Davis E, 2001, S DING SYDN ROY ZOL; Department of Environment and Heritage Protection (DEHP), 2013, FRAS ISL DING CONS R; Department of National Parks Sport and Racing (DNPSR), 2014, FRAS ISL DING MYTHS; Downward RJ, P 14 VET PEST C; Druzhkova AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057754; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Elledge AE, 2006, MAMMAL REV, V36, P142, DOI 10.1111/j.1365-2907.2006.00086.x; Elledge AE, 2008, WILDLIFE RES, V35, P812, DOI 10.1071/WR07056; Fain SR, 2010, CONSERV GENET, V11, P1747, DOI 10.1007/s10592-010-0068-x; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fleming P., 2001, MANAGING IMPACTS DIN; Fleming P. J. S., 2014, CARNIVORES AUSTR PRE, P105; Fleming PJS, 2012, AUST MAMMAL, V34, P119, DOI 10.1071/AM11012; Fleming PJS, 2006, AUST J EXP AGR, V46, P753, DOI 10.1071/EA06009; Frankham R, 1998, NATURE, V392, P441, DOI 10.1038/33022; Frantz LAF, 2016, SCIENCE, V352, P1228, DOI 10.1126/science.aaf3161; Gadagkar SR, 2005, J EXP ZOOL PART B, V304B, P64, DOI 10.1002/jez.b.21026; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Glen AS, 2007, AUSTRAL ECOL, V32, P492, DOI 10.1111/j.1442-9993.2007.01721.x; Glen AS, 2005, BIOL REV, V80, P387, DOI 10.1017/S1464793105006718; Gollan K., 1984, P921; Gordon C. E., 2015, P R SOC B, V282, P1802; Hemmings L, 1991, NOMINATION FRASER IS; Humphries EM, 2011, MOL ECOL, V20, P573, DOI 10.1111/j.1365-294X.2010.04965.x; Huson HJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-71; Jackson SM, 2017, ZOOTAXA, V4317, P201, DOI 10.11646/zootaxa.4317.2.1; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johnson CN, 2009, J APPL ECOL, V46, P641, DOI 10.1111/j.1365-2664.2009.01650.x; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Kayser M, 2001, AM J HUM GENET, V68, P173, DOI 10.1086/316949; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kennedy M, 2012, AUSTRAL ECOL, V37, P134, DOI 10.1111/j.1442-9993.2011.02256.x; KENNEDY PK, 1991, CAN J ZOOL, V69, P1183, DOI 10.1139/z91-168; Koler-Matznick J, 2003, J ZOOL, V261, P109, DOI 10.1017/S0952836903004060; LAIKRE L, 1991, CONSERV BIOL, V5, P33, DOI 10.1111/j.1523-1739.1991.tb00385.x; Lee TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-162; Leroy G, 2009, ANIM GENET, V40, P323, DOI 10.1111/j.1365-2052.2008.01842.x; Letnic M, 2009, ANIM CONSERV, V12, P302, DOI 10.1111/j.1469-1795.2009.00250.x; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; Letnic M, 2011, GLOBAL ECOL BIOGEOGR, V20, P343, DOI 10.1111/j.1466-8238.2010.00600.x; Letnic M, 2010, AUSTRAL ECOL, V35, P167, DOI 10.1111/j.1442-9993.2009.02022.x; Letnic M, 2009, P ROY SOC B-BIOL SCI, V276, P3249, DOI 10.1098/rspb.2009.0574; Macintosh N.W.G., 1975, P87; MARSACK P, 1990, AUST WILDLIFE RES, V17, P349, DOI 10.1071/WR9900349; McEvoy BP, 2010, AM J HUM GENET, V87, P297, DOI 10.1016/j.ajhg.2010.07.008; Milham P, 1976, MANKIND, V10, P175, DOI DOI 10.1111/J.1835-9310.1976.TB01149.X); Miller JM, 2012, MOL ECOL, V21, P1583, DOI 10.1111/j.1365-294X.2011.05427.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Moseby Katherine E., 2012, International Journal of Ecology, P1; Mulvaney D. J, 1975, PREHISTORY AUSTR; Nagle N, 2017, SCI REP-UK, V7, DOI 10.1038/srep43041; Nielsen R, 2017, NATURE, V541, P302, DOI 10.1038/nature21347; O'Grady JJ, 2006, BIOL CONSERV, V133, P42, DOI 10.1016/j.biocon.2006.05.016; O'Neill Adam J., 2017, Pacific Conservation Biology, V23, P4, DOI 10.1071/PC16026; Olafsdottir GA, 2008, CONSERV GENET, V9, P1639, DOI 10.1007/s10592-008-9526-0; Oskarsson MCR, 2012, P ROY SOC B-BIOL SCI, V279, P967, DOI 10.1098/rspb.2011.1395; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pimm SL, 2006, ANIM CONSERV, V9, P115, DOI 10.1111/j.1469-1795.2005.00010.x; Price MH, 2013, P NATL ACAD SCI USA, V110, pE2948, DOI 10.1073/pnas.1306505110; Pugach I, 2013, P NATL ACAD SCI USA, V110, pE2949, DOI 10.1073/pnas.1307961110; Pugach I, 2013, P NATL ACAD SCI USA, V110, P1803, DOI 10.1073/pnas.1211927110; Purcell S, 2014, PLINK 1 9; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raikkonen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067218; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; ROBERTSHAW JD, 1986, AUST WILDLIFE RES, V13, P141, DOI 10.1071/WR9860141; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Sacks BN, 2013, MOL BIOL EVOL, V30, P1103, DOI 10.1093/molbev/mst027; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Shannon LM, 2015, P NATL ACAD SCI USA, V112, P13639, DOI 10.1073/pnas.1516215112; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Skoglund P, 2015, CURR BIOL, V25, P1515, DOI 10.1016/j.cub.2015.04.019; Stenglein JL, 2011, J MAMMAL, V92, P784, DOI 10.1644/10-MAMM-A-200.1; Stephens D., 2011, THESIS; Stephens D, 2015, MOL ECOL, V24, P5643, DOI 10.1111/mec.13416; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; Tobler R, 2017, NATURE, V544, P180, DOI 10.1038/nature21416; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Trinkel M, 2011, J WILDLIFE DIS, V47, P494, DOI 10.7589/0090-3558-47.3.494; vonHoldt BM, 2011, GENOME RES, V21, P1294, DOI 10.1101/gr.116301.110; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wallach AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006861; Wang GD, 2016, CELL RES, V26, P21, DOI 10.1038/cr.2015.147; Weeks AR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01182-3; Whiteley AR, 2015, TRENDS ECOL EVOL, V30, P42, DOI 10.1016/j.tree.2014.10.009; Wilton Alan N., 2001, P49; Wilton AN, 1999, J HERED, V90, P108, DOI 10.1093/jhered/90.1.108; Woodall PF, 1996, WILDLIFE RES, V23, P581, DOI 10.1071/WR9960581; Xu YC, 2007, CONSERV GENET, V8, P1199, DOI 10.1007/s10592-006-9276-9; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	119	14	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198754	10.1371/journal.pone.0198754	http://dx.doi.org/10.1371/journal.pone.0198754			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889854	Green Published, Green Submitted, gold			2022-12-26	WOS:000434786600043
J	Saegerman, C; Bertagnoli, S; Meyer, G; Ganiere, JP; Caufour, P; De Clercq, K; Jacquiet, P; Fournie, G; Hautefeuille, C; Etore, F; Casal, J				Saegerman, Claude; Bertagnoli, Stephane; Meyer, Gilles; Ganiere, Jean-Pierre; Caufour, Philippe; De Clercq, Kris; Jacquiet, Philippe; Fournie, Guillaume; Hautefeuille, Claire; Etore, Florence; Casal, Jordi			Risk of introduction of lumpy skin disease in France by the import of vectors in animal trucks	PLOS ONE			English	Article							STABLE FLIES DIPTERA; STOMOXYS-CALCITRANS; MECHANICAL TRANSMISSION; AEDES-AEGYPTI; VIRUS; CATTLE; TICKS; MUSCIDAE; BIRDS; FLY	Background The lumpy skin disease virus (LSDV) is a dsDNA virus belonging to the Poxviridae family and the Capripoxvirus genus. Lumpy skin diseases (LSD) is a highly contagious transboundary disease in cattle producing major economic losses. In 2014, the disease was first reported in the European Union (in Cyprus); it was then reported in 2015 (in Greece) and has spread through different Balkan countries in 2016. Indirect vector transmission is predominant at small distances, but transmission between distant herds and between countries usually occurs through movements of infected cattle or through vectors found mainly in animal trucks. Methods and principal findings In order to estimate the threat for France due to the introduction of vectors found in animal trucks (cattle or horses) from at-risk countries (Balkans and neighbours), a quantitative import risk analysis (QIRA) model was developed according to the international standard. Using stochastic QIRA modelling and combining experimental/field data and expert opinion, the yearly risk of LSDV being introduced by stable flies (Stomoxys calcitrans), that travel in trucks transporting animals was between 6 x 10(-5) and 5.93 x 10(-3) with a median value of 89.9 x 10(-5); it was mainly due to the risk related to insects entering farms in France from vehicles transporting cattle from the at-risk area. The risk related to the transport of cattle going to slaughterhouses or the transport of horses was much lower (between 2 x 10(-7) and 3.73 x 10(-5) and between 5 x 10(-10) and 3.95 x 10(-8) for cattle and horses, respectively). The disinsectisation of trucks transporting live animals was important to reduce this risk. Conclusion and significance The development of a stochastic QIRA made it possible to quantify the risk of LSD being introduced in France through the import of vectors that travel in trucks transporting animals. This tool is of prime importance because the LSD situation in the Balkans is continuously changing. Indeed, this model can be updated to process new information on vectors and the changing health situation, in addition to new data from the TRAde Control and Expert System (TRACES, EU database). This model is easy to adapt to different countries and to other vectors and diseases.	[Saegerman, Claude] Univ Liege, Ctr Fundamental & Appl Res Anim & Hlth FARAH, Liege, Belgium; [Saegerman, Claude; Meyer, Gilles; Ganiere, Jean-Pierre; Fournie, Guillaume; Casal, Jordi] ANSES, Expert Comm Anim Hlth & Welf, Maisons Alfort, France; [Bertagnoli, Stephane; Meyer, Gilles; Jacquiet, Philippe] Univ Toulouse, INRA, ENVT, IHAP, Toulouse, France; [Ganiere, Jean-Pierre] ONIRIS, Nantes, France; [Caufour, Philippe] CIRAD, BIOS Dept, CIRAD INRA ASTRE Joint Res Unit UMR, Montpellier, France; [De Clercq, Kris] CODA CERVA, Brussels, Belgium; [Fournie, Guillaume] Royal Vet Coll, Dept Pathobiol & Populat Sci, Vet Epidemiol Econ & Publ Hlth Grp, Hatfield, Herts, England; [Hautefeuille, Claire; Etore, Florence] French Agcy Food Environm & Occupat Hlth & Safety, Maisons Alfort, France; [Casal, Jordi] Univ Autonoma Barcelona, IRTA, CReSA, Dept Sanitat & Anat Anim, Barcelona, Spain	University of Liege; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; CIRAD; INRAE; University of London; University of London Royal Veterinary College; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Autonomous University of Barcelona; IRTA	Saegerman, C (corresponding author), Univ Liege, Ctr Fundamental & Appl Res Anim & Hlth FARAH, Liege, Belgium.; Saegerman, C (corresponding author), ANSES, Expert Comm Anim Hlth & Welf, Maisons Alfort, France.	claude.saegerman@ulg.ac.be	Casal, Jordi/F-3020-2016	Casal, Jordi/0000-0002-6909-9366; , Etore/0000-0001-7225-4323; Fournie, Guillaume/0000-0002-6998-1201; Saegerman, Claude/0000-0001-9087-7436				Alemayehu G, 2013, TROP ANIM HEALTH PRO, V45, P1153, DOI 10.1007/s11250-012-0340-9; [Anonymous], 2005, OFF J EUR UNION L, VL3, P1; Arsevska E, 2016, B EPIDEMIOLOGIQUE, V75, P20; Berg C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.3986; Campbell JB, 2001, J ECON ENTOMOL, V94, P780, DOI 10.1603/0022-0493-94.3.780; CARN VM, 1995, EPIDEMIOL INFECT, V114, P219, DOI 10.1017/S0950268800052067; Chihota CM, 2003, MED VET ENTOMOL, V17, P294, DOI 10.1046/j.1365-2915.2003.00445.x; Chihota CM, 2001, EPIDEMIOL INFECT, V126, P317, DOI 10.1017/S0950268801005179; CIV, 2004, CIV TRANSP BIEN ETR; DOUGHERTY CT, 1995, APPL ANIM BEHAV SCI, V42, P231, DOI 10.1016/0168-1591(94)00546-Q; ECDC, AED AEG CURR KNOWN D; Eicher SD, 2001, J DAIRY SCI, V84, P1822, DOI [10.3168/jds.S0022-0302(01)74621-8, 10.3168/jds.S0022-0302(01)70192-0]; European Commission, 2016, OFFICIAL J EUROPEA L, VL310, P51; European Council, 1998, OFFICIAL J EUROPEA L, VL52, P8; Gari G, 2010, EPIDEMIOL INFECT, V138, P1657, DOI 10.1017/S0950268810000506; Gomes AD, 2005, REV SAUDE PUBL, V39, P206, DOI 10.1590/S0034-89102005000200010; House J A, 1990, J Vet Diagn Invest, V2, P111; Interbev, 2015, INT ESS FIL QUIN FRA; Kahana-Sutin E, 2017, MED VET ENTOMOL, V31, P150, DOI 10.1111/mve.12217; Kazarina A, 2015, TICKS TICK-BORNE DIS, V6, P178, DOI 10.1016/j.ttbdis.2014.11.011; Klaus C, 2016, PARASITOL RES, V115, P2729, DOI 10.1007/s00436-016-5022-5; Kwan NCL, 2017, EPIDEMIOL INFECT, V145, P1168, DOI [10.1017/S0950268816002995, 10.1017/s0950268816002995]; LaBrecque G.C., 1972, Florida Entomologist, V55, P101, DOI 10.2307/3493346; Loss SR, 2016, OECOLOGIA, V182, P947, DOI 10.1007/s00442-016-3731-1; Lubinga JC, 2015, TRANSBOUND EMERG DIS, V62, P174, DOI 10.1111/tbed.12102; Lubinga JC, 2014, EXP APPL ACAROL, V62, P67, DOI 10.1007/s10493-013-9722-6; LYSYK TJ, 1995, J MED ENTOMOL, V32, P508, DOI 10.1093/jmedent/32.4.508; Magori-Cohen R, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-1; MELLOR PS, 1987, RES VET SCI, V43, P109, DOI 10.1016/S0034-5288(18)30753-7; Mullens BA, 2006, MED VET ENTOMOL, V20, P122, DOI 10.1111/j.1365-2915.2006.00608.x; Office International des Epizooties (OIE), 2004, HDB IMP RISK AN AN A, VII; PROZESKY L, 1982, ONDERSTEPOORT J VET, V49, P167; Rodhain F, 2015, REV SCI TECH OIE, V34, P83; Santman-Berends IMGA, 2017, PREV VET MED, V146, P103, DOI 10.1016/j.prevetmed.2017.08.003; SUTHERLAND B, 1978, ONDERSTEPOORT J VET, V45, P209; Taylor DB, 2010, ENVIRON ENTOMOL, V39, P1101, DOI 10.1603/EN10057; Tuppurainen E, 2017, LUMPY SKIN DIS FIELD, V20, P60; Tuppurainen ESM, 2015, TICKS TICK-BORNE DIS, V6, P134, DOI 10.1016/j.ttbdis.2014.11.002; Tuppurainen ESM, 2012, TRANSBOUND EMERG DIS, V59, P40, DOI 10.1111/j.1865-1682.2011.01242.x; Tuppurainen ESM, 2011, TRANSBOUND EMERG DIS, V58, P93, DOI 10.1111/j.1865-1682.2010.01184.x; Tuppurainen ESM, 2013, TICKS TICK-BORNE DIS, V4, P329, DOI 10.1016/j.ttbdis.2013.01.006; WARNES ML, 1987, MED VET ENTOMOL, V1, P53, DOI 10.1111/j.1365-2915.1987.tb00322.x; YERUHAM I, 1994, VET REC, V135, P330, DOI 10.1136/vr.135.14.330; YERUHAM I, 1995, VET REC, V137, P91, DOI 10.1136/vr.137.4.91; Yousefi PS, 2017, TRANSBOUND EMERG DIS, V64, P1782, DOI 10.1111/tbed.12565	45	21	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2018	13	6							e0198506	10.1371/journal.pone.0198506	http://dx.doi.org/10.1371/journal.pone.0198506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI8PJ	29889905	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000434786600026
J	Shao, JY; Cao, W; Qu, HB; Pan, JY; Gong, XC				Shao, Jingyuan; Cao, Wen; Qu, Haibin; Pan, Jianyang; Gong, Xingchu			A novel quality by design approach for developing an HPLC method to analyze herbal extracts: A case study of sugar content analysis	PLOS ONE			English	Article							CAPILLARY-ELECTROPHORESIS METHOD; SPACE; CHROMATOGRAPHY; OPTIMIZATION; VALIDATION; COMPONENTS; SEPARATION; FRUITS; UV	The aim of this study was to present a novel analytical quality by design (AQbD) approach for developing an HPLC method to analyze herbal extracts. In this approach, critical method attributes (CMAs) and critical method parameters (CMPs) of the analytical method were determined using the same data collected from screening experiments. The HPLC-ELSD method for separation and quantification of sugars in Codonopsis Radix extract (CRE) samples and Astragali Radix extract (ARE) samples was developed as an example method with a novel AQbD approach. Potential CMAs and potential CMPs were found with Analytical Target Profile. After the screening experiments, the retention time of the D-glucose peak of CRE samples, the signal-to-noise ratio of the D-glucose peak of CRE samples, and retention time of the sucrose peak in ARE samples were considered CMAs. The initial and final composition of the mobile phase, flow rate, and column temperature were found to be CMPs using a standard partial regression coefficient method. The probability-based design space was calculated using a Monte-Carlo simulation method and verified by experiments. The optimized method was validated to be accurate and precise, and then it was applied in the analysis of CRE and ARE samples. The present AQbD approach is efficient and suitable for analysis objects with complex compositions.	[Shao, Jingyuan; Cao, Wen; Qu, Haibin; Pan, Jianyang; Gong, Xingchu] Zhejiang Univ, Pharmaceut Informat Inst, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Gong, XC (corresponding author), Zhejiang Univ, Pharmaceut Informat Inst, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China.	gongxingchu@zju.edu.cn			National Project for Standardization of Chinese Materia Medica [ZYBZH-C-GD-04]; Science and Technology Project of Guangdong Province [2015B090901035]	National Project for Standardization of Chinese Materia Medica; Science and Technology Project of Guangdong Province	This work was supported by the National Project for Standardization of Chinese Materia Medica (ZYBZH-C-GD-04). The URL is http://www.satcm.gov.cn/. This work was also supported by the Science and Technology Project of Guangdong Province (2015B090901035). The URL is http://www.gdstc.gov.cn/. Funds were used to buy materials, chemicals, and pay labor costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, TOP Q8 R2 PHARM DEV, P4; Dai SY, 2016, J LIQ CHROMATOGR R T, V39, P504, DOI 10.1080/10826076.2016.1198914; Debrus B, 2013, J PHARMACEUT BIOMED, V84, P215, DOI 10.1016/j.jpba.2013.06.013; Dispas A, 2014, J PHARMACEUT BIOMED, V88, P519, DOI 10.1016/j.jpba.2013.09.030; Dong J, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-137; Ferey L, 2017, J PHARM BIOMED ANAL, V148, P361, DOI [10.1016/j.jpba.2017.10, DOI 10.1016/J.JPBA.2017.10]; Gong XC, 2016, ANAL METHODS-UK, V8, P2282, DOI [10.1039/c5ay03119b, 10.1039/C5AY03119B]; Gong XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128236; Khurana RK, 2016, J CHROMATOGR SCI, V54, P829, DOI 10.1093/chromsci/bmw001; Kochling J, 2016, J PHARMACEUT BIOMED, V125, P130, DOI 10.1016/j.jpba.2016.03.031; Landagaray E, 2016, J PHARMACEUT BIOMED, V120, P297, DOI 10.1016/j.jpba.2015.12.041; [林慧 Lin Hui], 2013, [食品科学, Food Science], V34, P286; [刘爽悦 Liu Shuangyue], 2016, [中草药, Chinese Traditional and Herbal Drugs], V47, P3193; Ma CM, 2014, FOOD CHEM, V145, P784, DOI 10.1016/j.foodchem.2013.08.135; Molloy S, 2015, J PHARM SCI-US, V104, P508, DOI 10.1002/jps.24240; Musters J, 2013, ORG PROCESS RES DEV, V17, P87, DOI 10.1021/op300292a; Orlandini S, 2015, ELECTROPHORESIS, V36, P2642, DOI 10.1002/elps.201500155; Orlandini S, 2014, ELECTROPHORESIS, V35, P2538, DOI 10.1002/elps.201400173; Peraman R, 2015, INT J ANAL CHEM, V2015, DOI 10.1155/2015/868727; Qi FH, 2015, BIOSCI TRENDS, V9, P16, DOI 10.5582/bst.2015.01019; Rozet E, 2013, TRAC-TREND ANAL CHEM, V42, P157, DOI 10.1016/j.trac.2012.09.007; Sandhu PS, 2017, J LIQ CHROMATOGR R T, V40, P506, DOI 10.1080/10826076.2017.1329744; Sandhu PS, 2016, J CHROMATOGR SCI, V54, P1373, DOI 10.1093/chromsci/bmw090; Schmidt AH, 2014, J PHARMACEUT BIOMED, V91, P97, DOI 10.1016/j.jpba.2013.12.023; Shanmugavelan P, 2013, CARBOHYD RES, V380, P112, DOI 10.1016/j.carres.2013.06.024; Shao J, 2018, ZHONGGUO ZHONG YAO Z; Tol T, 2016, J CHROMATOGR A, V1432, P26, DOI 10.1016/j.chroma.2015.12.080; Wang L, 2016, ANAL BIOANAL CHEM, V408, P2133, DOI 10.1007/s00216-016-9316-3; [徐波 Xu Bo], 2012, [华西药学杂志, West China Journal of Pharmaceutical Sciences], V27, P708; Yan Bin-Jun, 2013, Zhongguo Zhong Yao Za Zhi, V38, P1672; Zhang X, 2017, J CHROMATOGR A, V1514, P44, DOI 10.1016/j.chroma.2017.07.062; Zhou L., 2010, AM PHARM REV, V13, P74	32	18	20	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198515	10.1371/journal.pone.0198515	http://dx.doi.org/10.1371/journal.pone.0198515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883452	Green Published, Green Submitted, gold			2022-12-26	WOS:000434728100025
J	Torner, K; Nakanishi, T; Matsuura, T; Kato, Y; Watanabe, H				Torner, Kerstin; Nakanishi, Tsuyoshi; Matsuura, Tomoaki; Kato, Yasuhiko; Watanabe, Hajime			Genomic integration and ligand- dependent activation of the human estrogen receptor a in the crustacean Daphnia magna	PLOS ONE			English	Article							IN-VIVO; OPTIMIZATION; CULTURE; IMPACT; ASSAYS; LIFE	The freshwater crustacean Daphnia have a long history in water quality assessments and now lend themselves to detection of targeted chemicals using genetically encoded reporter gene due to recent progress in the development of genome editing tools. By introducing human genes into Daphnia, we may be able to detect chemicals that affect the human system, or even apply it to screening potentially useful chemicals. Here, we aimed to develop a transgenic line of Daphnia magna that contains the human estrogen receptor alpha (hER alpha) and shows a fluorescence response to exposure of estrogens. We designed plasmids to express hERa in Daphnia (EF1 alpha 1: esr1) and to report estrogenic activity via red fluorescence (ERE: mcherry) under the control of estrogen response element (ERE). After confirmation of functionality of the plasmids by microinjection into embryos, the two plasmids were joined, a TALE site was added and integrated into the D. magna genome using TALEN. When the resulting transgenic Daphnia named the ES line was exposed to Diethylstilbestrol (DES) or 17 beta-Estradiol (E2), the ES line could reliably expressed red fluorescence derived from mCherry in a ligand-dependent manner, indicating that an estrogen-responsive line of D. magna was established. This is the first time a human gene was expressed in Daphnia, showcasing potential for further research.	[Torner, Kerstin; Matsuura, Tomoaki; Kato, Yasuhiko; Watanabe, Hajime] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan; [Nakanishi, Tsuyoshi] Gifu Pharmaceut Univ, Lab Hyg Chem & Mol Toxicol, Gifu, Gifu, Japan; [Kato, Yasuhiko] Osaka Univ, Grad Sch Engn, Frontier Res Base Global Young Researchers, Suita, Osaka, Japan	Osaka University; Gifu Pharmaceutical University; Osaka University	Watanabe, H (corresponding author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan.	watanabe@bio.eng.osaka-u.ac.jp	Matsuura, Tomoaki/W-6086-2019; Kato, Yasuhiko/AES-3929-2022; WATANABE, Hajime/AAJ-8904-2021; matsuura, tomoaki/O-7368-2018; Watanabe, Hajime/S-8957-2019	Matsuura, Tomoaki/0000-0003-1015-6781; Kato, Yasuhiko/0000-0002-1041-1044; matsuura, tomoaki/0000-0003-1015-6781; Watanabe, Hajime/0000-0001-9657-6554	Japan Society for the Promotion of Science KAKENHI [JP26281027]; JSPS KAKENHI [JP26281027]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	One of the authors (YK) acknowledges the support of the Frontier Research Base for Global Young Researchers, Osaka University. This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number JP26281027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; One of the authors (Y.K.) acknowledges the support of the Frontier Research Base for Global Young Researchers, Osaka University. This work was supported by JSPS KAKENHI Grant Number JP26281027.	Adeel M, 2017, ENVIRON INT, V99, P107, DOI 10.1016/j.envint.2016.12.010; Asada M, 2014, MAR ENVIRON RES, V93, DOI [10.1016/j.marenvres.2013.11, DOI 10.1016/J.MARENVRES.2013.11]; Ayyar BV, 2017, METHODS, V116, P51, DOI 10.1016/j.ymeth.2017.01.009; Baker ME, 2008, BIOCHEM BIOPH RES CO, V375, P623, DOI 10.1016/j.bbrc.2008.08.047; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Comba S, 2012, COMPUT STRUCT BIOTEC, V3, DOI 10.5936/csbj.201210016; ELENDT BP, 1990, WATER RES, V24, P1157, DOI 10.1016/0043-1354(90)90180-E; Eyster KM, 2016, METHODS MOL BIOL, V1366, P1, DOI 10.1007/978-1-4939-3127-9_1; Folmar LC, 2002, AQUAT TOXICOL, V60, P101, DOI 10.1016/S0166-445X(01)00276-4; Furst AL, 2017, ACS CENTRAL SCI, V3, P110, DOI 10.1021/acscentsci.6b00322; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; GERSICH FM, 1986, ARCH ENVIRON CON TOX, V15, P741, DOI 10.1007/BF01054921; Gorelick DA, 2011, ENDOCRINOLOGY, V152, P2690, DOI 10.1210/en.2010-1257; Gorr TA, 2004, J BIOL CHEM, V279, P36038, DOI 10.1074/jbc.M403981200; Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173; Ha MH, 2009, ARCH ENVIRON CON TOX, V57, P330, DOI 10.1007/s00244-007-9079-0; Hanson AM, 2017, GEN COMP ENDOCR, V246, P120, DOI 10.1016/j.ygcen.2016.07.002; Kato Y, 2011, DEV GENES EVOL, V220, P337, DOI 10.1007/s00427-011-0353-9; Kato Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152912; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; Kumagai H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186112; Kurauchi K, 2005, ENVIRON SCI TECHNOL, V39, P2762, DOI 10.1021/es0486465; Leader JE, 2006, ANN NY ACAD SCI, V1089, P73, DOI 10.1196/annals.1386.047; Legler J, 1999, TOXICOL SCI, V48, P55, DOI 10.1093/toxsci/48.1.55; Leskinen P, 2005, CHEMOSPHERE, V61, P259, DOI 10.1016/j.chemosphere.2005.01.080; Ma L, 2009, TRENDS ENDOCRIN MET, V20, P357, DOI 10.1016/j.tem.2009.03.009; Martins J, 2007, ENVIRON INT, V33, P414, DOI 10.1016/j.envint.2006.12.006; Mykles DL, 2011, J STEROID BIOCHEM, V127, P196, DOI 10.1016/j.jsbmb.2010.09.001; Naitou A, 2015, BIOL OPEN, V4, P364, DOI 10.1242/bio.20149738; Nakanishi T, 2016, SCI REP-UK, V6, DOI 10.1038/srep36252; Nakanishi T, 2015, SCI REP-UK, V5, DOI 10.1038/srep18312; Nakanishi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098363; Nardulli AM, 1996, MOL ENDOCRINOL, V10, P694, DOI 10.1210/me.10.6.694; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Orsini L, 2011, BIOL LETTERS, V7, P2, DOI 10.1098/rsbl.2010.0629; Potapova TA, 2011, MOL BIOL CELL, V22, P1191, DOI 10.1091/mbc.E10-07-0599; Rhode SC, 2001, NATURE, V412, P69, DOI 10.1038/35083567; Schumpert CA, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0209-x; Torner K, 2014, MOL GENET GENOMICS, V289, DOI [10.1007/s00438-014-0921-6, DOI 10.1007/S00438-014-0921-6]; Webster GR, 2017, BIOTECHNOL BIOENG, V114, P492, DOI 10.1002/bit.26183; Yoshioka H, 2012, TOXICOL LETT, V211, P257, DOI 10.1016/j.toxlet.2012.04.005; Zhang ZB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14585	44	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2018	13	6							e0198023	10.1371/journal.pone.0198023	http://dx.doi.org/10.1371/journal.pone.0198023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI7ZT	29883470	Green Published, gold, Green Submitted			2022-12-26	WOS:000434728100010
J	Bradley, J; West-Sadler, S; Foster, E; Sommerville, J; Allen, R; Stephen, AM; Adamson, AJ				Bradley, Jennifer; West-Sadler, Sarah; Foster, Emma; Sommerville, Jill; Allen, Rachel; Stephen, Alison M.; Adamson, Ashley J.			Feasibility of an estimated method using graduated utensils to estimate food portion size in infants aged 4 to 18 months	PLOS ONE			English	Article							CHILDREN; HEALTH	The Diet and Nutrition Survey of Infants and Young Children (DNSIYC) was carried out in 2011 to assess the nutrient intakes of 4 to 18 month old infants in the UK. Prior to the main stage of DNSIYC, pilot work was undertaken to determine the impact of using graduated utensils to estimate portion sizes. The aims were to assess whether the provision of graduated utensils altered either the foods given to infants or the amount consumed by comparing estimated intakes to weighed intakes. Parents completed two 4-day food diaries over a two week period; an estimated diary using graduated utensils and a weighed diary. Two estimated diary formats were tested; half the participants completed estimated diaries in which they recorded the amount of food/drink served and the amount left over, and the other half recorded the amount of food/drink consumed only. Median daily food intake for the estimated and the weighed method were similar; 980g and 928g respectively. There was a small (6.6%) but statistically significant difference in energy intake reported by the estimated and the weighed method; 3189kJ and 2978kJ respectively. There were no statistically significant differences between estimated intakes from the served and left over diaries and weighed intakes (p>0.05). Estimated intakes from the amount consumed diaries were significantly different to weighed intakes (food weight (g) p = 0.02; energy (kJ) p = 0.01). There were no differences in intakes of amorphous (foods which take the shape of the container, e.g. pureed foods, porridge) and discrete food items (individual pieces of food e.g. biscuits, rice cakes) between the two methods. The results suggest that the household measures approach to reporting portion size, with the combined use of the graduated utensils, and recording the amount served and the amount left over in the food diaries, may provide a feasible alternative to weighed intakes.	[Bradley, Jennifer; Foster, Emma; Adamson, Ashley J.] Newcastle Univ, Inst Hlth & Soc, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [West-Sadler, Sarah; Sommerville, Jill; Stephen, Alison M.] Elsie Widdowson Labs, MRC Human Nutr Res, Cambridge, England; [Allen, Rachel] Publ Hlth England, London, England; [Allen, Rachel] Food Stand Agcy, London, England; [Stephen, Alison M.] Univ Surrey, Dept Nutr Sci, Sch Biosci & Med, Fac Hlth & Med Sci, Guildford, Surrey, England	Newcastle University - UK; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Public Health England; University of Surrey	Bradley, J (corresponding author), Newcastle Univ, Inst Hlth & Soc, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England.	jen.bradley@ncl.ac.uk	Bradley, Jennifer/GLT-8437-2022; Arumainathan, Stephen/D-5010-2011	Arumainathan, Stephen/0000-0003-2434-672X; Bradley, Jennifer/0000-0001-7461-9074; Adamson, Ashley/0000-0003-3735-2846	Department of Health	Department of Health	This was a pilot study for the Diet and Nutrition Survey of Infants and Young Children (DNSIYC) which was commissioned by the Department of Health (DH) and the Food Standards Agency (FSA). The study was funded by the Department of Health. The funders had no role in study design, data collection and analysis. However they agreed to publication and provided comments on the manuscript prior to submission. Research assistant salary for JB came from the project fund.	Bates B, 2016, NATL DIET NUTR SURVE; Brisbois TD, 2012, OBES REV, V13, P347, DOI 10.1111/j.1467-789X.2011.00965.x; Burrows TL, 2010, J AM DIET ASSOC, V110, P1501, DOI 10.1016/j.jada.2010.07.008; Carter MC, 2015, NUTRIENTS, V7, P4016, DOI 10.3390/nu7064016; Delve J, 2012, P NUTR SOC, V71; Foster E, 2008, BRIT J NUTR, V99, P175, DOI 10.1017/S000711450779390X; Foster E, 2014, P NUTR SOC, V73, P201, DOI 10.1017/S0029665114000020; Gregory J., 2000, NATL DIET NUTR SURVE, V1, P4; Henderson L, 2002, NATL DIET NUTR SURVE, V1; Koletzko B, 2012, P NUTR SOC, V71, P371, DOI 10.1017/S0029665112000596; Lanigan JA, 2001, EUR J CLIN NUTR, P55; Lennox A, 2013, DIET NUTR SURVEY INF; LIVINGSTONE MBE, 1990, BRIT MED J, V300, P708, DOI 10.1136/bmj.300.6726.708; Mills A, 1992, FOOD NUTR INTAKES BR; NHS, 2017, START4LIFE; Simpson E, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020118; Stephen AM, 2013, P NUTR SOC, V72, P77, DOI 10.1017/S0029665112002923; Timon Claire M, 2017, J Med Internet Res, V19, pe158, DOI 10.2196/jmir.6407; Weng SF, 2012, ARCH DIS CHILD, V97, P1019, DOI 10.1136/archdischild-2012-302263; World Health Organization, 2001, OPT DUR EXCL BREASTF	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0197591	10.1371/journal.pone.0197591	http://dx.doi.org/10.1371/journal.pone.0197591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879140	Green Published, gold, Green Submitted			2022-12-26	WOS:000434384900007
J	Rodrigues, NCP; Daumas, RP; de Almeida, AS; dos Santos, RS; Koster, I; Rodrigues, PP; Gomes, MD; Macedo, AD; Gerardi, A; Lett, ID				Pinheiro Rodrigues, Nadia Cristina; Daumas, Regina Paiva; de Almeida, Andrea Sobral; dos Santos, Reinaldo Souza; Koster, Isabella; Rodrigues, Pedro Pinheiro; Gomes, Marcelly de Freitas; Macedo, Auriane de Fatima; Gerardi, Alyssa; Lett, Iuri da Costa			Risk factors for arbovirus infections in a low-income community of Rio de Janeiro, Brazil, 2015-2016	PLOS ONE			English	Article							ZIKA VIRUS; DENGUE	Background Dengue epidemics have occurred in the city of Rio de Janeiro (Brazil) since 1986. In the year 2015, Zika and chikungunya viruses were introduced in the city, causing sequential and simultaneous epidemics. Poor socioeconomic conditions have been suggested as contributing factors of arboviral infection. Objective To describe the spatial distribution of human cases of symptomatic arboviral infections and to identify risk factors for infection in a poor community of Rio de Janeiro in the years 2015 and 2016. Methods We built thematic maps of incidence rates for 78 micro-areas in the Manguinhos neighborhood. The micro-areas congregate about 600 inhabitants. Simple and multiple multilevel logistic regression models were used to evaluate the association between the incidence of arboviral diseases and socio-demographic factors at both the individual and micro-area levels. Results From 2015 to 2016, 370 human cases of arbovirus infection were reported in the Manguinhos community: 123 in 2015 and 247 in 2016. There was a significant difference in the risk of arbovirus diseases among different micro-areas, but this was not explained by water and sanitation indicators. The cumulative incidence rate was 849/100,000 in two years. The incidence was greater in those individuals with familiar vulnerability (1,156/100,000 vs. 794/100,000). The multilevel adjusted model showed that the odds of acquiring an arbovirus infection was 55% greater in those with familiar vulnerability. Conclusion Arbovirus infections cause a high burden of disease in Brazilian urban centers. Our results suggest that even in poor neighborhoods, there is a high spatial variability in the risk of acquiring an arbovirus infection. The conditions that favor vector proliferation and infection by arboviruses are complex and involve both individual and environmental characteristics that vary from place to place. To reduce the burden of arboviral diseases, continued public health policies and basic services should be provided to the communities at risk that consider specific local needs.	[Pinheiro Rodrigues, Nadia Cristina; Daumas, Regina Paiva; de Almeida, Andrea Sobral; dos Santos, Reinaldo Souza; Koster, Isabella; Rodrigues, Pedro Pinheiro; Gomes, Marcelly de Freitas; Macedo, Auriane de Fatima; Lett, Iuri da Costa] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth Sergio Arouca, Rio De Janeiro, Brazil; [Pinheiro Rodrigues, Nadia Cristina] Univ Estado Rio De Janeiro, Sch Med Sci, Rio De Janeiro, Brazil; [Rodrigues, Pedro Pinheiro; Gomes, Marcelly de Freitas] Univ Fed Fluminense, Niteroi, RJ, Brazil; [Gerardi, Alyssa] Georgetown Univ, Washington, DC USA	Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Universidade Federal Fluminense; Georgetown University	Rodrigues, NCP (corresponding author), Fundacao Oswaldo Cruz, Natl Sch Publ Hlth Sergio Arouca, Rio De Janeiro, Brazil.; Rodrigues, NCP (corresponding author), Univ Estado Rio De Janeiro, Sch Med Sci, Rio De Janeiro, Brazil.	nadiacristinapr@gmail.com	DAUMAS, REGINA P/M-9387-2013; Sobral, Andrea/K-2319-2016	DAUMAS, REGINA P/0000-0002-8923-7711; Sobral, Andrea/0000-0003-0552-771X; Koster, Isabella/0000-0001-6061-2824; Rodrigues, Nadia/0000-0002-2613-5283; Souza dos Santos, Reinaldo/0000-0003-2387-6999	Territorio Integrado de Atencao a Sakle (Teias) - Escola Manguinhos Project	Territorio Integrado de Atencao a Sakle (Teias) - Escola Manguinhos Project	We received funding from Territorio Integrado de Atencao a Sakle (Teias) - Escola Manguinhos Project, which only covered recruitment costs.	Aquino Junior J., 2014, DENGUE INT BORDER AR; Barcellos C, 2005, REV SOC BRAS MED TRO, V38, P246, DOI 10.1590/S0037-86822005000300008; Barcellos C, 2009, EPIDEMIOL SERV SAUDE, V18, P285; Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Casa Fluminense, 2017, NIETZSCHE CORPO; Coelho F, 2004, APPL FAMILY RISK SCA; Teixeira TRD, 2011, CAD SAUDE PUBLICA, V27, P591, DOI 10.1590/S0102-311X2011000300019; Almeida MCD, 2007, J URBAN HEALTH, V84, P334, DOI 10.1007/s11524-006-9154-2; Fernandes TM, 2013, TEMPO-NITEROI, V19, P117, DOI [10.5533/TEM-1980-542X-2013173410eng, 10.5533/TEM-1980-542X-2013173410]; Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332; Fonseca AF Corbo AMA, 2007, TERRITORIO PROCESSO; FUNASA BHM, 2011, HIST PUBL HLTH CHR; Garcia-Betancourt T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129054; Heringer M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2488-4; Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515; IBGE, 2010, SUBN CLUST TERR INF; IIED, 2008, ACH MILL DEV GOALS L; Jacobi P., 2004, URBAN ENV IMPACTS RI, P169; Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937; Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196; Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006791, 10.1590/s1518-8787.2016050006791]; Little E, 2017, J MED ENTOMOL, V54, P1183, DOI 10.1093/jme/tjx103; Matysiak A, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/8947067; Mendonça Francisco de Assis, 2009, Soc. nat., V21, P257, DOI 10.1590/S1982-45132009000300003; Mulligan K, 2015, PATHOG GLOB HEALTH, V109, P10, DOI 10.1179/2047773214Y.0000000168; Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112; Rodrigues NCP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165945; PMRJ, 2018, STORY MAP J RIO DE J; PMRJ, 2018, ARM RIO DE JAN; Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395; Schutz G, 2012, INTEGRATED AREA HLTH, P25; Silverman B.W., 1986, DENSITY ESTIMATION S; Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x; Torres EM, 2005, DENGUE; Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2012, GLOB STRAT DENG PREV; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192; Zoonoses GdDTpVe, 2016, B EPIDEMIOLOGICO ABR	40	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198357	10.1371/journal.pone.0198357	http://dx.doi.org/10.1371/journal.pone.0198357			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879155	Green Published, gold, Green Submitted			2022-12-26	WOS:000434384900034
J	Romairone, J; Jimenez, J; Luque-Larena, JJ; Mougeot, F				Romairone, Juan; Jimenez, Jose; Jose Luque-Larena, Juan; Mougeot, Francois			Spatial capture-recapture design and modelling for the study of small mammals	PLOS ONE			English	Article							VOLES MICROTUS-ARVALIS; MALE SNOW VOLES; DENSITY-ESTIMATION; LIVE-TRAPS; SPACE USE; REPRODUCTIVE SUCCESS; HABITAT SELECTION; POPULATION-CYCLES; MICROHABITAT USE; MORTALITY	Spatial capture-recapture modelling (SCR) is a powerful analytical tool to estimate density and derive information on space use and behaviour of elusive animals. Yet, SCR has been seldom applied to the study of ecologically keystone small mammals. Here we highlight its potential and requirements with a case study on common voles (Microtus arvalis). First, we address mortality associated with live-trapping, which can be high in small mammals, and must be kept minimal. We designed and tested a nest box coupled with a classic Sherman trap and show that it allows a 5-fold reduction of mortality in traps. Second, we address the need to adjust the trapping grid to the individual home range to maximize spatial recaptures. In May-June 2016, we captured and tagged with transponders 227 voles in a 1.2-ha area during two monthly sessions. Using a Bayesian SCR with a multinomial approach, we estimated: (1) the baseline detection rate and investigated variation according to sex, time or behaviour (aversion/attraction after a previous capture); (2) the parameter sigma that describes how detection probability declines as a function of the distance to an individual's activity centre, and investigated variation according to sex; and (3) density and population sex-ratio. We show that reducing the maximum distance between traps from 12 to 9.6m doubled spatial recaptures and improved model predictions. Baseline detection rate increased over time (after overcoming a likely aversion to entering new odourless traps) and was greater for females than males in June. The sigma parameter of males was twice that of females, indicating larger home ranges. Density estimates were of 142.92 +/- 38.50 and 168.25 +/- 15.79 voles/ha in May and June, respectively, with 2-3 times more females than males. We highlight the potential and broad applicability that SCR offers and provide specific recommendations for using it to study small mammals like voles.	[Romairone, Juan; Jose Luque-Larena, Juan] Univ Valladolid, Escuela Tecn Super Ingn, Dept Ciencias Agroforestales, Avda Madrid, Palencia, Spain; [Romairone, Juan; Jose Luque-Larena, Juan] Inst Univ Invest Gest Forestal Sostenible iuFOR, Avda Madrid, Palencia, Spain; [Jimenez, Jose; Mougeot, Francois] CSIC UCLM JCCM, IREC, Inst Invest Recursos Cineget, Ciudad Real, Spain	Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Romairone, J (corresponding author), Univ Valladolid, Escuela Tecn Super Ingn, Dept Ciencias Agroforestales, Avda Madrid, Palencia, Spain.; Romairone, J (corresponding author), Inst Univ Invest Gest Forestal Sostenible iuFOR, Avda Madrid, Palencia, Spain.	juanagustin.romairone@uva.es	Mougeot, Francois/Y-9569-2019; Luque-Larena, Juan Jose/D-6454-2014; Jimenez, Jose/I-9840-2019	Mougeot, Francois/0000-0002-5819-6275; Luque-Larena, Juan Jose/0000-0001-6425-637X; Jimenez, Jose/0000-0003-0607-6973	Ministerio de Economia y Competitividad (MINECO), Spain [CGL2012-35348, CGL2015-66962-C2-1-R]; University of Valladolid (UVA) [PEJ-2014A-05890_IEJ15/15]	Ministerio de Economia y Competitividad (MINECO), Spain; University of Valladolid (UVA)	This study was funded by research projects ECOVOLE (CGL2012-35348) and ECOTULA (CGL2015-66962-C2-1-R), financed by Ministerio de Economia y Competitividad (MINECO), Spain (JJLL). JR held a research contract (PEJ-2014A-05890_IEJ15/15; "Contrato de empleo joven e implantacion de la garantia juvenil I+D+I", 2015-2017) at the University of Valladolid (UVA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anthony NM, 2005, WILDLIFE SOC B, V33, P1018, DOI 10.2193/0091-7648(2005)33[1018:CEOLAS]2.0.CO;2; BOONSTRA R, 1976, J ZOOL, V180, P467; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Borowski Z, 2003, ACTA THERIOL, V48, P325, DOI 10.1007/BF03194172; Briner T, 2005, AGR ECOSYST ENVIRON, V105, P173, DOI 10.1016/j.agee.2004.04.007; Brouard MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145006; Brugger A, 2010, MAMMALIA, V74, P311, DOI 10.1515/MAMM.2010.035; Bryja J, 2005, CAN J ZOOL, V83, P1391, DOI 10.1139/Z05-133; Bujalska Gabriela, 2000, Polish Journal of Ecology, V48, P37; Chandler RB, 2013, ANN APPL STAT, V7, P936, DOI 10.1214/12-AOAS610; Chao A, 2005, HDB CAPTURE RECAPTUR, P23; CHITTY D, 1949, ECOLOGY, V30, P536, DOI 10.2307/1932457; Cornulier T, 2013, SCIENCE, V340, P63, DOI 10.1126/science.1228992; de Valpine P, 2017, J COMPUT GRAPH STAT, V26, P403, DOI 10.1080/10618600.2016.1172487; Dillon A, 2007, ORYX, V41, P469, DOI 10.1017/S0030605307000518; Distiller G, 2015, ECOL EVOL, V5, P5075, DOI 10.1002/ece3.1748; Dizney Laurie, 2008, Northwestern Naturalist, V89, P171; Eccard JA, 2013, ANN ZOOL FENN, V50, P371, DOI 10.5735/086.050.0602; Efford M, 2004, OIKOS, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; Efford MG, 2016, SECR SPATIALLY EXPLI; Efford MG, 2009, ENVIRON ECOL STAT SE, V3, P255, DOI 10.1007/978-0-387-78151-8_11; Ergon T, 2014, METHODS ECOL EVOL, V5, P1327, DOI 10.1111/2041-210X.12133; Gardner B, 2010, J WILDLIFE MANAGE, V74, P318, DOI 10.2193/2009-101; Gerber BD, 2015, ECOL APPL, V25, P695, DOI 10.1890/14-0960.1; GURNELL J, 1983, J ZOOL, V200, P289; Han BA, 2015, P NATL ACAD SCI USA, V112, P7039, DOI 10.1073/pnas.1501598112; Hooten MB, 2015, ECOL MONOGR, V85, P3, DOI 10.1890/14-0661.1; Jackson DM, 2001, J ANIM ECOL, V70, P633, DOI 10.1046/j.1365-2656.2001.00518.x; Jacob J, 2000, OIKOS, V91, P131, DOI 10.1034/j.1600-0706.2000.910112.x; Jacob J, 2003, J ETHOL, V21, P45, DOI 10.1007/s10164-002-0073-8; Jacob J., 2010, RODENT OUTBREAKS ECO, P207; Jacob J, 2014, PEST MANAG SCI, V70, P869, DOI 10.1002/ps.3695; Jareno D, 2015, BIOL INVASIONS, V17, P2315, DOI 10.1007/s10530-015-0877-4; Jareno D, 2014, ECOL INDIC, V36, P111, DOI 10.1016/j.ecolind.2013.07.019; Jimenez J, 2017, SCI REP-UK, V7, DOI 10.1038/srep41036; Luque-Larena JJ, 2015, VECTOR-BORNE ZOONOT, V15, P568, DOI 10.1089/vbz.2015.1770; Jung TS, 2005, CAN FIELD NAT, V119, P445, DOI 10.22621/cfn.v119i3.160; Jung TS, 2016, MAMMAL RES, V61, P57, DOI 10.1007/s13364-015-0251-z; Kery M, 2012, HIERARCHICAL PERSPEC; Klemola T, 2002, OIKOS, V96, P291, DOI 10.1034/j.1600-0706.2002.960211.x; Krebs C.J., 2013, POPULATION FLUCTUATI; Krebs CJ, 2011, J MAMMAL, V92, P974, DOI 10.1644/10-MAMM-A-313.1; KREBS CJ, 1984, CAN J ZOOL, V62, P2440, DOI 10.1139/z84-360; Kuo L., 1998, SANKHYA, V60, P65, DOI DOI 10.1186/1471-2105-12-186; Lambin X, 2006, J ANIM ECOL, V75, P340, DOI 10.1111/j.1365-2656.2006.01051.x; Lambin X, 1997, J ZOOL, V242, P400; Luque-Larena JJ, 2002, CAN J ZOOL, V80, P36, DOI 10.1139/Z01-197; Luque-Larena JJ, 2002, ETHOLOGY, V108, P273, DOI 10.1046/j.1439-0310.2002.00770.x; Luque-Larena JJ, 2001, ANIM BEHAV, V62, P1089, DOI 10.1006/anbe.2001.1865; Luque-Larena JJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006622; Mackin-Rogalska R., 1981, Polish Ecological Studies, V7, P213; MONTGOMERY WI, 1980, ACTA THERIOL, V25, P277, DOI 10.4098/AT.arch.80-25; Morin DJ, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1623; Noguerales V, 2015, REV ECOL-TERRE VIE, V70, P70; OSTFELD RS, 1988, J ANIM ECOL, V57, P385, DOI 10.2307/4912; Otis D.L., 1978, WILDLIFE MONOGR, P3, DOI DOI 10.2307/3830650; Parmenter RR, 2003, ECOL MONOGR, V73, P1, DOI 10.1890/0012-9615(2003)073[0001:SMDEAF]2.0.CO;2; Pinot A, 2016, POPUL ECOL, V58, P395, DOI 10.1007/s10144-016-0552-3; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Rodriguez-Pastor R, 2017, EMERG INFECT DIS, V23, P1377, DOI 10.3201/eid2308.161194; Rodriguez-Pastor R, 2016, AGR ECOSYST ENVIRON, V231, P206, DOI 10.1016/j.agee.2016.06.041; ROSENBERG DK, 1993, CAN J ZOOL, V71, P660, DOI 10.1139/z93-090; Rosenberg DK, 1992, CAN J ZOOL, V71, P660; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2014, METHODS ECOL EVOL, V5, P37, DOI 10.1111/2041-210X.12135; Royle JA, 2013, METHODS ECOL EVOL, V4, P520, DOI 10.1111/2041-210X.12039; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Royle JA, 2017, BIORXIV103341, V40, DOI [10.1111/ecog.03170, DOI 10.1111/ECOG.03170]; Schaub M, 2014, METHODS ECOL EVOL, V5, P1316, DOI 10.1111/2041-210X.12134; SEBER GAF, 1986, BIOMETRICS, V42, P267, DOI 10.2307/2531049; SHERIDAN M, 1988, BEHAV ECOL SOCIOBIOL, V22, P85, DOI 10.1007/BF00303542; Sollmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034575; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Spiegelhalter D, 2003, WINBUGS USER MANUAL, V2, P1; Stenseth NC, BIOL LEMMINGS; Stephens RB, 2014, WILDLIFE SOC B, V38, P619, DOI 10.1002/wsb.418; STODDART DM, 1986, OIKOS, V46, P194, DOI 10.2307/3565467; Stromgren EJ, 2008, IMPROVING LIVE TRAPP; Stromgren EJ, 2014, ACTA THERIOL, V59, P203, DOI 10.1007/s13364-013-0149-6; Sun CC, 2017, J WILDLIFE MANAGE, V81, P814, DOI 10.1002/jwmg.21248; Sun CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088025; Sutherland C, 2018, OSCR MULTISESSION SE; Sutherland CS, 2014, ECOLOGY, V95, P3149; Tanaka R., 1963, Researches on Population Ecology Japan, V5, P139, DOI 10.1007/BF02518838; Taylor AK, 2011, ANN ZOOL FENN, V48, P45, DOI 10.5735/086.048.0105; THOMSON D, 2009, MODELING DEMOGRAPHIC, DOI DOI 10.1007/978-0-387-78151-8; Tkadlec E, 2001, P ROY SOC B-BIOL SCI, V268, P1547, DOI 10.1098/rspb.2001.1694; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; Willson JD, 2011, J WILDLIFE MANAGE, V75, P36, DOI 10.1002/jwmg.15; WILSON KR, 1985, J MAMMAL, V66, P13, DOI 10.2307/1380951; WOLFF JO, 1990, ANIM BEHAV, V39, P1222, DOI 10.1016/S0003-3472(05)80799-7; Ylonen H, 2003, ANN ZOOL FENN, V40, P537; YLONEN H, 1990, OECOLOGIA, V83, P333, DOI 10.1007/BF00317556	96	18	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2018	13	6							e0198766	10.1371/journal.pone.0198766	http://dx.doi.org/10.1371/journal.pone.0198766			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI5BF	29879211	Green Published, Green Submitted, gold			2022-12-26	WOS:000434384900080
J	Awan, R; Al-Maadeed, S; Al-Saady, R				Awan, Ruqayya; Al-Maadeed, Somaya; Al-Saady, Rafif			Using spectral imaging for the analysis of abnormalities for colorectal cancer: When is it helpful?	PLOS ONE			English	Article							TEXTURAL FEATURES; CLASSIFICATION; REPRESENTATION; IMAGES; RECOGNITION; PERCEPTION	The spectral imaging technique has been shown to provide more discriminative information than the RGB images and has been proposed for a range of problems. There are many studies demonstrating its potential for the analysis of histopathology images for abnormality detection but there have been discrepancies among previous studies as well. Many multispectral based methods have been proposed for histopathology images but the significance of the use of whole multispectral cube versus a subset of bands or a single band is still arguable. We performed comprehensive analysis using individual bands and different subsets of bands to determine the effectiveness of spectral information for determining the anomaly in colorectal images. Our multispectral colorectal dataset consists of four classes, each represented by infra-red spectrum bands in addition to the visual spectrum bands. We performed our analysis of spectral imaging by stratifying the abnormalities using both spatial and spectral information. For our experiments, we used a combination of texture descriptors with an ensemble classification approach that performed best on our dataset. We applied our method to another dataset and got comparable results with those obtained using the stateof-the-art method and convolutional neural network based method. Moreover, we explored the relationship of the number of bands with the problem complexity and found that higher number of bands is required for a complex task to achieve improved performance. Our results demonstrate a synergy between infra-red and visual spectrum by improving the classification accuracy (by 6%) on incorporating the infra-red representation. We also highlight the importance of how the dataset should be divided into training and testing set for evaluating the histopathology image-based approaches, which has not been considered in previous studies on multispectral histopathology images.	[Awan, Ruqayya; Al-Maadeed, Somaya] Qatar Univ, Dept Comp Sci & Engn, Doha, Qatar; [Al-Saady, Rafif] Al Ahli Hosp, Doha, Qatar	Qatar University; Al Ahli Hospital	Awan, R (corresponding author), Qatar Univ, Dept Comp Sci & Engn, Doha, Qatar.	r.awan.1@warwick.ac.uk		Al-maadeed, Somaya/0000-0002-0241-2899; , rafif/0000-0001-7797-9614; Awan, Ruqayya/0000-0002-2223-329X	Qatar National Research Fund through National Priority Research Program (NPRP) [6-249-1-053]	Qatar National Research Fund through National Priority Research Program (NPRP)	This publication was made possible using a grant from the Qatar National Research Fund through National Priority Research Program (NPRP) No. 6-249-1-053. The content of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the Qatar National Research Fund or Qatar University.	Ahonen T, 2009, LECT NOTES COMPUT SC, V5575, P61, DOI 10.1007/978-3-642-02230-2_7; Beyerer J., 2015, MACHINE VISION AUTOM; Bianconi F, 2015, NEUROCOMPUTING, V154, P119, DOI 10.1016/j.neucom.2014.12.012; Boucheron LE, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-S1-S8; Bradley P. S., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P82; Chaddad A., 2011, 2011 IEEE International Conference on Computer Applications and Industrial Electronics (ICCAIE 2011), P87, DOI 10.1109/ICCAIE.2011.6162110; Chaddad A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149893; Dicker DT, 2006, CANCER BIOL THER, V5, P1033, DOI 10.4161/cbt.5.8.3261; Du Q, 2008, IEEE GEOSCI REMOTE S, V5, P696, DOI 10.1109/LGRS.2008.2003180; Fernandez DC, 2005, NAT BIOTECHNOL, V23, P469, DOI 10.1038/nbt1080; Gultekin T, 2015, IEEE T MED IMAGING, V34, P275, DOI 10.1109/TMI.2014.2354373; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Guyon I, 2006, STUD FUZZ SOFT COMP, V207, P1; Haj-Hassan Hawraa, 2017, J Pathol Inform, V8, P1, DOI 10.4103/jpi.jpi_47_16; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hyvrinen  A., 2009, NATURAL IMAGE STAT P; Irshad H, 2013, ARXIV13044041; Itzkowitz SH, 2004, GASTROENTEROLOGY, V126, P1634, DOI 10.1053/j.gastro.2004.03.025; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; JULESZ B, 1981, NATURE, V290, P91, DOI 10.1038/290091a0; Kannala J, 2012, INT C PATT RECOG, P1363; Kather JN, 2016, SCI REP-UK, V6, DOI 10.1038/srep27988; Khelifi R, 2012, EURASIP J ADV SIG PR, P1, DOI 10.1186/1687-6180-2012-118; Kramer K., 2011, Proceedings 2011 IEEE Symposium on Computational Intelligence and Data Mining (CIDM 2011), P318, DOI 10.1109/CIDM.2011.5949457; L.I. Smith, 2002, TUTORIAL PRINCIPAL C; Levenson RM, 2006, CYTOM PART A, V69A, P592, DOI 10.1002/cyto.a.20292; Liu WL, 2016, TRANSL ONCOL, V9, P521, DOI 10.1016/j.tranon.2016.09.007; Liu Y., 2017, ARXIV170302442; Masood K, 2006, Second International Conference on Emerging Technologies 2006, Proceedings, P735, DOI 10.1109/ICET.2006.335947; Masood K, 2008, ANN BMVA, V2008, P1; Masood K, 2009, I S BIOMED IMAGING, P1011, DOI 10.1109/ISBI.2009.5193226; Ojansivu V, 2008, PATT REC 2008 ICPR 2; Ojansivu V, 2008, LECT NOTES COMPUT SC, V5099, P236, DOI 10.1007/978-3-540-69905-7_27; Olgun G, 2014, IEEE J BIOMED HEALTH, V18, P1390, DOI 10.1109/JBHI.2013.2281335; Peyret R, 2018, NEUROCOMPUTING, V275, P83, DOI 10.1016/j.neucom.2017.05.010; Peyreti R, 2015, IEEE ENG MED BIO, P7218, DOI 10.1109/EMBC.2015.7320057; Rathore S, 2014, COMPUT BIOL MED, V47, P76, DOI 10.1016/j.compbiomed.2013.12.010; Rodriguez-Lujan I, 2013, KNOWL-BASED SYST, V52, P279, DOI 10.1016/j.knosys.2013.08.002; Roula MA, 2003, SEVENTH INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND ITS APPLICATIONS, VOL 2, PROCEEDINGS, P37, DOI 10.1109/ISSPA.2003.1224809; Shlens J., 2005, TUTORIAL PRINCIPAL C; Silva H, 2007, P INT C ART INT KNOW, V6, P1; TAMURA H, 1978, IEEE T SYST MAN CYB, V8, P460, DOI 10.1109/TSMC.1978.4309999; Wang D, 2016, ARXIV16060S5718; Wild CP, 2017, APPL SOFT COMPUT; WOERNLEY DL, 1952, CANCER RES, V12, P516; Woolfe F., 1999, IEEE T MED IMAGING, V99; Wu XQ, 2012, IEEE T BIO-MED ENG, V59, P1539, DOI 10.1109/TBME.2012.2188892; Zhou SR, 2013, NEUROCOMPUTING, V116, P260, DOI 10.1016/j.neucom.2012.05.036; Zimmerman-Moreno G, 2016, IEEE ENG MED BIO, P3973, DOI 10.1109/EMBC.2016.7591597	51	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2018	13	6							e0197431	10.1371/journal.pone.0197431	http://dx.doi.org/10.1371/journal.pone.0197431			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI4VN	29874262	Green Published, gold			2022-12-26	WOS:000434369400022
J	Forma, E; Jozwiak, P; Ciesielski, P; Zaczek, A; Starska, K; Brys, M; Krzeslak, A				Forma, Ewa; Jozwiak, Pawel; Ciesielski, Piotr; Zaczek, Agnieszka; Starska, Katarzyna; Brys, Magdalena; Krzeslak, Anna			Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells	PLOS ONE			English	Article							O-GLCNAC TRANSFERASE; PROGNOSTIC MARKER; POLYCOMB; REPRESSION; PROLIFERATION; GLCNACYLATION; METHYLATION; PROSTATE; ER	Enhancer of zest homolog 2 (EZH2) is a histone methyltransferase which plays a crucial role in cancer progression by regulation of genes involved in cellular processes such as proliferation, invasion and self-renewal. Activity and biological function of EZH2 are regulated by posttranslational modifications. It is suggested that EZH2 stability may be regulated by O-GIcNAc transferase (OGT), which is an enzyme catalyzing the addition of GIcNAc moieties to target proteins. In this study, we determined the impact of OGT on expression of EZH2 target genes FOXA1 and FOXC1, that are involved in breast cancer progression. The results of chromatin immunoprecipitation experiments showed that both EZH2 and OGT are targeted to the promoter regions of FOXA1 and FOXC1 and knockdown of EZH2 or OGT affects expression of studied genes in breast non-malignant (MCF10A) and cancer cells (MCF7, T47D and MDA-MB-231). The results showed that OGT silencing affects EZH2 binding to FOXC1 promoter but the effect is cell-context dependent. Despite the slight decrease in EZH2 protein level in cells with OGT depletion, EZH2 binding to FOXC1 was increased. Moreover, OGT binding to promoter regions of FOXA1 and FOXC1 was increased in cells with knockdown of EZH2. Increased expression of FOXA1 and FOXC1 in cells with OGT deregulation was associated with increased acetylation level of histone H3. The results suggest that OGT is involved in regulation of FOXA1 and FOXC1 expression but its role is not associated with regulation of EZH2 protein stability.	[Forma, Ewa; Jozwiak, Pawel; Ciesielski, Piotr; Zaczek, Agnieszka; Brys, Magdalena; Krzeslak, Anna] Univ Lodz, Fac Biol & Environm Protect, Dept Cytobiochem, Lodz, Poland; [Starska, Katarzyna] Med Univ Lodz, Dept Otolaryngol & Laryngol Oncol, Lodz, Poland	University of Lodz; Medical University Lodz	Krzeslak, A (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Cytobiochem, Lodz, Poland.	anna.krzeslak@biol.uni.lodz.pl	Starska-Kowarska, Katarzyna/S-9327-2016	Krzeslak, Anna/0000-0002-4982-7901; Starska, Katarzyna/0000-0002-8671-2222; Zaczek, Agnieszka/0000-0002-0194-6506; Jozwiak, Pawel/0000-0002-1340-6355; Brys, Magdalena/0000-0002-7725-5429; Forma, Ewa/0000-0003-0230-6831; Ciesielski, Piotr/0000-0001-8455-3507	National Science Centre of Poland [DEC-2012/07/B/NZ3/00234]	National Science Centre of Poland(National Science Centre, Poland)	This study was supported by grant DEC-2012/07/B/NZ3/00234 from the National Science Centre of Poland (AK).	Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Champattanachai V, 2013, PROTEOMICS, V13, P2088, DOI 10.1002/pmic.201200126; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Collett K, 2006, CLIN CANCER RES, V12, P1168, DOI 10.1158/1078-0432.CCR-05-1533; Cox EJ, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-101; Du J, 2012, BREAST CANCER RES TR, V131, P65, DOI 10.1007/s10549-011-1396-3; Fardini Y, 2013, FRONT ENDOCRINOL, V4, DOI 10.3389/fendo.2013.00099; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gong C, 2015, ONCOGENE, V34, P5012, DOI 10.1038/onc.2014.421; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hu Q, 2014, ASIAN PAC J CANCER P, V15, P11, DOI 10.7314/APJCP.2014.15.1.11; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Krzeslak A, 2012, CLIN EXP MED, V12, P61, DOI 10.1007/s10238-011-0138-5; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Mehta RJ, 2012, BREAST CANCER RES TR, V131, P881, DOI 10.1007/s10549-011-1482-6; Myers SA, 2011, P NATL ACAD SCI USA, V108, P9490, DOI 10.1073/pnas.1019289108; Ray PS, 2010, CANCER RES, V70, P3870, DOI 10.1158/0008-5472.CAN-09-4120; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Sizemore ST, 2012, J BIOL CHEM, V287, P24631, DOI 10.1074/jbc.M112.375865; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Takashina T, 2016, CANCER SCI, V107, P955, DOI 10.1111/cas.12957; Volkel P, 2015, AM J TRANSL RES, V7, P175; Wang J, 2012, ONCOGENE, V31, P4798, DOI 10.1038/onc.2011.635; Wang X, 2015, BIOMED PHARMACOTHER, V75, P218, DOI 10.1016/j.biopha.2015.07.038; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yamaguchi H, 2014, CANCER RES TREAT, V46, P209, DOI 10.4143/crt.2014.46.3.209; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3	28	16	16	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198351	10.1371/journal.pone.0198351	http://dx.doi.org/10.1371/journal.pone.0198351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864144	Green Submitted, Green Published, gold			2022-12-26	WOS:000434097100028
J	Weiland, S; Smit, IH; Reinders-Messelink, H; van der Woude, LHV; van Kammen, K; den Otter, R				Weiland, Sylvana; Smit, Ineke H.; Reinders-Messelink, Heleen; van der Woude, Lucas H., V; van Kammen, Klaske; den Otter, Rob			The effect of asymmetric movement support on muscle activity during Lokomat guided gait in able-bodied individuals	PLOS ONE			English	Article							SPEED; LEG; ACTIVATION; HEMIPLEGIA; WALKING; PATTERN; STROKE; FORCE; LIMB	Background To accommodate training for unilaterally affected patients (e.g. stroke), the Lokomat (a popular robotic exoskeleton-based gait trainer) provides the possibility to set the amount of movement guidance for each leg independently. Given the interlimb couplings, such asymmetrical settings may result in complex effects, in which ipsilateral activity co-depends on the amount of guidance offered to the contralateral leg. To test this idea, the effect of asymmetrical guidance on muscle activity was explored. Methods 15 healthy participants walked in the Lokomat at two speeds (1 and 2 km/h) and guidance levels (30% and 100%), during symmetrical (both legs receiving 30% or 100% guidance) and asymmetrical conditions (one leg receiving 30% and the other 100% guidance) resulting in eight unique conditions. Activity of the right leg was recorded from Erector Spinae, Gluteus Medius, Biceps Femoris, Semitendinosus, Vastus Medialis, Rectus Femoris, Medial Gastrocnemius and Tibialis Anterior. Statistical Parametric Mapping was used to assess whether ipsilateral muscle activity depended on guidance settings for the contralateral leg. Results Muscle output amplitude not only depended on ipsilateral guidance settings, but also on the amount of guidance provided to the contralateral leg. More specifically, when the contralateral leg received less guidance, ipsilateral activity of Gluteus Medius and Medial Gastrocnemius increased during stance. Conversely, when the contralateral leg received more guidance, ipsilateral muscle activity for these muscles decreased. These effects were specifically observed at 1 km/h, but not at 2 km/h. Conclusions This is the first study of asymmetrical guidance on muscle activity in the Lokomat, which shows that ipsilateral activity co-depends on the amount of contralateral guidance. In therapy, these properties may be exploited e.g. to promote active contributions by the more affected leg. Therefore, the present results urge further research on the use of asymmetrical guidance in patient groups targeted by Lokomat training.	[Weiland, Sylvana; Smit, Ineke H.; van der Woude, Lucas H., V; van Kammen, Klaske; den Otter, Rob] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Reinders-Messelink, Heleen; van der Woude, Lucas H., V] Rehabil Ctr Revalidatie Friesland, Beetsterzwaag, Netherlands; [Reinders-Messelink, Heleen; van der Woude, Lucas H., V] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Groningen, Netherlands	University of Groningen; University of Groningen	den Otter, R (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	a.r.den.otter@umcg.nl	; van der Woude, Lucas/E-7986-2018	den Otter, Rob/0000-0003-4633-4340; Smit, Ineke/0000-0002-9269-9634; van der Woude, Lucas/0000-0002-8472-334X				Adler RJ., 2009, RANDOM FIELDS GEOMET; Arya K. N., 2014, Annals of Physical and Rehabilitation Medicine, V57, P696, DOI 10.1016/j.rehab.2014.06.003; Banala SK, 2007, INT C REHAB ROBOT, P401, DOI 10.1109/ICORR.2007.4428456; Bohannon RW, 1989, CLIN REHABIL, V3, P47; Calabro RS, 2016, NEUROL SCI, V37, P503, DOI 10.1007/s10072-016-2474-4; Cho JE, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4085298; Dietz V, 2002, BRAIN, V125, P2626, DOI 10.1093/brain/awf273; DIETZ V, 1992, PHYSIOL REV, V72, P33, DOI 10.1152/physrev.1992.72.1.33; Dietz V, 2009, ANN NY ACAD SCI, V1164, P97, DOI 10.1111/j.1749-6632.2008.03710.x; Duschau-Wicke A, 2010, IEEE T NEUR SYS REH, V18, P38, DOI 10.1109/TNSRE.2009.2033061; Ferris DP, 2004, SPINAL CORD, V42, P14, DOI 10.1038/sj.sc.3101542; Freriks B, 1995, EUROPEAN RECOMMENDAT, P15; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gizzi L, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-76; Hidler JM, 2005, CLIN BIOMECH, V20, P184, DOI 10.1016/j.clinbiomech.2004.09.016; Honeine JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052943; Hussain S, 2011, MED ENG PHYS, V33, P527, DOI 10.1016/j.medengphy.2010.12.010; Kautz SA, 2006, J NEUROPHYSIOL, V95, P3154, DOI 10.1152/jn.00951.2005; Kautz SA, 2005, J NEUROPHYSIOL, V93, P2460, DOI 10.1152/jn.00963.2004; Kawashima N, 2005, J NEUROPHYSIOL, V93, P777, DOI 10.1152/jn.00817.2004; Kuo AD, 2001, J BIOMECH ENG-T ASME, V123, P264, DOI 10.1115/1.1372322; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; LAZARUS JAC, 1992, ARCH PHYS MED REHAB, V73, P1044; Lefmann S, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-016-0214-x; Liu J, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-20; Lotze M, 2003, BRAIN, V126, P866, DOI 10.1093/brain/awg079; Moreno JC, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-79; Nadeau S, 1999, CLIN BIOMECH, V14, P125, DOI 10.1016/S0268-0033(98)00062-X; OLNEY SJ, 1994, PHYS THER, V74, P872, DOI 10.1093/ptj/74.9.872; Pataky TC, 2010, J BIOMECH, V43, P1976, DOI 10.1016/j.jbiomech.2010.03.008; Riener R, 2010, J HEALTHC ENG, V1, P197, DOI 10.1260/2040-2295.1.2.197; Sherrington C., 1910, INTEGRATIVE ACTION N; Swinnen SP, 2012, NEURO BEHAV DETERMIN; Teasell Robert W, 2003, Top Stroke Rehabil, V10, P29; van Kammen K, 2016, CLIN BIOMECH, V36, P65, DOI 10.1016/j.clinbiomech.2016.04.013; Van Kammen K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107323; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	38	4	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198473	10.1371/journal.pone.0198473	http://dx.doi.org/10.1371/journal.pone.0198473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864143	Green Submitted, Green Published, gold			2022-12-26	WOS:000434097100033
